Psyllid ID: psy10603

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------
Protein Sequence
MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQVK
Secondary Structure (PSIPRED)
ccccccccccccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHcccccccccEEEcEEEEccEEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEEcccccEEcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccHHHHHcccccccccccccccccccccEEEcccccEEEcccccccEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEcccccEEEEEEEEcccccEEEEEEEEHHHcccHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEccccHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccccccHccccHHHHcccccccccccEEHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHccccccccccccccHHHHHHHHHHHHHccHHHHHHHHHHHHcccHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHccccccccccHHHHHHHHHHccccccccccccEEEEEEEEEccccEEEEEc
Coil and Loop (DISEMBL)
mssvtfsvspgqgrfgkVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAegnslklgdfgsavkisahttvpgelngfvgtqaymapevfmdtnkvghgraVDIWSLGCVLVemssgkrpwaeydsnYQIMFKVgmgetptipeslsdEGQAFAELCLRHDPAQRATIFELlqhpflivsceedvcnprsvpaSVLQDYLKLgivlppmsedsvKVYARANIFLTAegnslklgdfgsavkisahttvpgelngfvgtqaymapevfmdtnkvghgraVDIWSLGCVLVEmssgktnlSGVVVSAevfgsggwwfqvk
Flexible Loop (DISEMBL)
mssvtfsvspgqgrfgkVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRileginqknlVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAevfgsggwwfqvk
Low Complexity Region (SEG)
MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQVK
Disordered region (IsUnstruct)
*************RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET**********GQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQ**
Disordered Region (DISOPRED)
*SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQ**************VELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA****PGE*NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGI***************ANIFLTAEGNSLKLGDFGSA******************TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQ**
Disordered Region (DISEMBL)
**********GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQVK
Disordered Region (DISPRO)
MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDF************************************VGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQVK
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSGGWWFQVK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	407	2.2.26 [Sep-21-2011]
O08648	1597	Mitogen-activated protein	yes	N/A	0.633	0.161	0.560	4e-80
Q9Y6R4	1608	Mitogen-activated protein	yes	N/A	0.633	0.160	0.553	2e-79
O14299	1401	MAP kinase kinase kinase	yes	N/A	0.611	0.177	0.428	1e-52
P25390	1331	Serine/threonine-protein	yes	N/A	0.621	0.190	0.396	2e-49
P53599	1579	MAP kinase kinase kinase	no	N/A	0.621	0.160	0.367	2e-47
Q54R82	942	Mitogen-activated protein	no	N/A	0.643	0.278	0.344	2e-44
O22042	651	Mitogen-activated protein	no	N/A	0.614	0.384	0.362	2e-43
O74304	1436	MAP kinase kinase kinase	no	N/A	0.611	0.173	0.369	4e-43
Q9FZ36	651	Mitogen-activated protein	no	N/A	0.614	0.384	0.347	2e-42
Q9WTR2	1291	Mitogen-activated protein	no	N/A	0.611	0.192	0.386	3e-42

>sp|O08648|M3K4_MOUSE Mitogen-activated protein kinase kinase kinase 4 OS=Mus musculus GN=Map3k4 PE=1 SV=2

 Score =  298 bits (764), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 148/264 (56%), Positives = 191/264 (72%), Gaps = 6/264 (2%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct: 1339 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1397

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREEM +FME C EGTLE +   +  GL E ++R YTKQ+  AI+ LHE+ IVHRDIK
Sbjct: 1398 ELHREEMYIFMEYCDEGTLEEV---SRLGLQEHVIRLYTKQITVAINVLHEHGIVHRDIK 1454

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct: 1455 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1513

Query: 190  AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+AF   CL  
Sbjct: 1514 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKAFLSHCLES 1573

Query: 250  DPAQRATIFELLQHPFLIVSCEED 273
            DP  R T  +LL H F+ V  +E+
Sbjct: 1574 DPKIRWTASQLLDHAFVKVCTDEE 1597

Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2

 Score =  296 bits (757), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 146/264 (55%), Positives = 190/264 (71%), Gaps = 6/264 (2%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct: 1350 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1408

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREEM +FME C EGTLE +   +  GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct: 1409 ELHREEMYIFMEYCDEGTLEEV---SRLGLQEHVIRLYSKQITIAINVLHEHGIVHRDIK 1465

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct: 1466 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1524

Query: 190  AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct: 1525 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLSHCLES 1584

Query: 250  DPAQRATIFELLQHPFLIVSCEED 273
            DP  R T  +LL H F+ V  +E+
Sbjct: 1585 DPKMRWTASQLLDHSFVKVCTDEE 1608

Component of a protein kinase signal transduction cascade. Activates the CSBP2, P38 and JNK MAPK pathways, but not the ERK pathway. Specifically phosphorylates and activates MAP2K4 and MAP2K6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O14299|WIS4_SCHPO MAP kinase kinase kinase wis4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=wis4 PE=3 SV=1

 Score =  207 bits (527), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 114/266 (42%), Positives = 158/266 (59%), Gaps = 17/266 (6%)

Query: 13   GRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDML-VELRILEGINQKNLVKYYGVE 71
            G FG VYT VN ETG+L+A+KEI+L      R   D +  E+ +LE +N  N+V YYGVE
Sbjct: 1046 GMFGDVYTGVNMETGDLLAVKEIKLQDSRTFRSTVDQIHNEMTVLERLNHPNVVTYYGVE 1105

Query: 72   IHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +HRE++ +FME C  G+L  L+     ED   E +++ Y  QL++ ++ +H   I+HRDI
Sbjct: 1106 VHREKVYIFMEFCQGGSLADLLAHGRIED---ENVLKVYVVQLLEGLAYIHSQHILHRDI 1162

Query: 130  KSANIFLTAEGNSLKLGDFGSAVKISAHTT-------VPGELNGFVGTQAYMAPEVFMDT 182
            K ANI L   G  +K  DFGSA+ +S  T        +  EL    GT  YMAPE+ + T
Sbjct: 1163 KPANILLDHRG-MIKYSDFGSALYVSPPTDPEVRYEDIQPELQHLAGTPMYMAPEIILGT 1221

Query: 183  NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQ 240
             K   G A+DIWSLGCV++EM +G  PW+E D+ + IM+ V    TP+IP  E +S   +
Sbjct: 1222 KKGDFG-AMDIWSLGCVILEMMTGSTPWSEMDNEWAIMYHVAAMHTPSIPQNEKISSLAR 1280

Query: 241  AFAELCLRHDPAQRATIFELLQHPFL 266
             F E C   DP QR    +LL HP++
Sbjct: 1281 DFIEQCFERDPEQRPRAVDLLTHPWI 1306

Involved in a signal transduction pathway that is activated in under conditions of heat shock, oxidative stress or limited nutrition. Unlike win1, it is not activated by changes in the osmolarity of the extracellular environment. Activates the wis1 MAP kinase kinase by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P25390|SSK22_YEAST Serine/threonine-protein kinase SSK22 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SSK22 PE=1 SV=2

 Score =  196 bits (499), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 109/275 (39%), Positives = 167/275 (60%), Gaps = 22/275 (8%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVE-LRILEGINQKNLVKYYG 69
            G G FG+VY+A+N E GE++A+KEI++H     + +  ++ E + +LE +N  N+V+YYG
Sbjct: 1041 GGGTFGQVYSAINLENGEILAVKEIKIHDTTTMKKIFPLIKEEMTVLEMLNHPNIVQYYG 1100

Query: 70   VEIHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            VE+HR+++ +FME C  G+L SL+     ED   E++ + YT +L++ ++ LH++ +VHR
Sbjct: 1101 VEVHRDKVNIFMEYCEGGSLASLLDHGRIED---EMVTQVYTFELLEGLAYLHQSGVVHR 1157

Query: 128  DIKSANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPG-----------ELNGFVGTQAYM 174
            DIK  NI L   G  +K  DFG+A  +  S   TV              LN  +GT  YM
Sbjct: 1158 DIKPENILLDFNG-IIKYVDFGTARTVVGSRTRTVRNAAVQDFGVETKSLNEMMGTPMYM 1216

Query: 175  APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-- 232
            APE    +   G   A D+W+LGCV++EM++G+RPW+  D+ + IM+ V  G  P +P  
Sbjct: 1217 APETISGSAVKGKLGADDVWALGCVVLEMATGRRPWSNLDNEWAIMYHVAAGRIPQLPNR 1276

Query: 233  ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
            + ++  G+AF E CL  DP  RAT  ELL  P++I
Sbjct: 1277 DEMTAAGRAFLERCLVQDPTMRATAVELLIDPWMI 1311

Kinase involved in a signal transduction pathway that is activated by changes in the osmolarity of the extracellular environment. Activates the PBS2 MAP kinase kinase by phosphorylation.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53599|SSK2_YEAST MAP kinase kinase kinase SSK2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SSK2 PE=1 SV=1

 Score =  190 bits (482), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 107/291 (36%), Positives = 165/291 (56%), Gaps = 38/291 (13%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVE-LRILEGINQKNLVKYYG 69
            G G FG+VY+AV+ + GE++A+KEI +      + +  ++ E + +LE +N  N+V YYG
Sbjct: 1273 GGGTFGRVYSAVDLDNGEILAVKEINIQDSKSMQKIFPLIKEEMSVLEILNHPNIVSYYG 1332

Query: 70   VEIHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            VE+HR+++ +FME C  G+L +L++    ED   E++ + YT QL++ ++ LHE+ IVHR
Sbjct: 1333 VEVHRDKVNIFMEYCEGGSLAALLEHGRIED---EMVTQVYTLQLLEGLAYLHESGIVHR 1389

Query: 128  DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN---------------------- 165
            D+K  NI L   G  +K  DFG+A KI+ + T    +N                      
Sbjct: 1390 DVKPENILLDFNG-VIKYVDFGAAKKIANNGTRLASMNKIENADGEHEDVTHVSDSKAVK 1448

Query: 166  -------GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
                     +GT  YMAPE    +   G   A D+WSLGCV++EM +G+RPWA  D+ + 
Sbjct: 1449 NNENALLDMMGTPMYMAPESITGSTTKGKLGADDVWSLGCVVLEMITGRRPWANLDNEWA 1508

Query: 219  IMFKVGMGETPTIP--ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
            IM+ V  G TP  P  + +S  G  F E CL  +P++RA+  ELL  P+++
Sbjct: 1509 IMYHVAAGHTPQFPTKDEVSSAGMKFLERCLIQNPSKRASAVELLMDPWIV 1559

Kinase involved in a signal transduction pathway that is activated by changes in the osmolarity of the extracellular environment. Activates the PBS2 MAP kinase kinase by phosphorylation.

Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  180 bits (457), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 95/276 (34%), Positives = 158/276 (57%), Gaps = 14/276 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV----ELRILEGINQKNLVK 66
           G+G +G VY  +N +TGEL A+K++++   N    +K+M++    E+ ++  +   N+V+
Sbjct: 177 GRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSLRHDNIVR 236

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           Y G  + +  + +F+E    G++ SL+        E +++ YTKQ++  +S LH N+I+H
Sbjct: 237 YLGTSLDQSFLSVFLEYIPGGSISSLL-GKFGAFSENVIKVYTKQILQGLSFLHANSIIH 295

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RDIK ANI +  +G  +KL DFG +   S    +  +     GT  +MAPEV   T   G
Sbjct: 296 RDIKGANILIDTKG-IVKLSDFGCSKSFSG---IVSQFKSMQGTPYWMAPEVIKQT---G 348

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAEL 245
           HGR+ DIWSLGCV+VEM++ + PW+       +M+ +    + P IP  +S E   F  L
Sbjct: 349 HGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNL 408

Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVP 281
           C + DP +R    +LL+HPF I++ ++++  P   P
Sbjct: 409 CFKRDPKERPDANQLLKHPF-IMNLDDNIQLPTISP 443

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  177 bits (448), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 95/262 (36%), Positives = 154/262 (58%), Gaps = 12/262 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL-----HKQNDARFVKDMLVELRILEGINQKNLV 65
           G G FG+VY  +N ++GEL+A+K++ +      K+     ++++  E+++L+ ++  N+V
Sbjct: 75  GCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLKNLSHPNIV 134

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +Y G     + + + ME    G++ SL++      PE ++  YTKQL+  +  LH N I+
Sbjct: 135 RYLGTVRESDSLNILMEFVPGGSISSLLEKF-GSFPEPVIIMYTKQLLLGLEYLHNNGIM 193

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRDIK ANI +  +G  ++L DFG++ K+    TV G      GT  +MAPEV + T   
Sbjct: 194 HRDIKGANILVDNKG-CIRLADFGASKKVVELATVNGA-KSMKGTPYWMAPEVILQT--- 248

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAE 244
           GH  + DIWS+GC ++EM++GK PW+E    +  +  +G  +  P IPE LS E + F  
Sbjct: 249 GHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKDFLM 308

Query: 245 LCLRHDPAQRATIFELLQHPFL 266
            CL  +P+ R +  ELLQHPF+
Sbjct: 309 KCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O74304|WIN1_SCHPO MAP kinase kinase kinase win1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=win1 PE=1 SV=1

 Score =  176 bits (445), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 106/287 (36%), Positives = 160/287 (55%), Gaps = 38/287 (13%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR-FVKDMLVELRILEGINQKNLVKYYG 69
            G G FG VY AVN +TG+L+A+KE+ LHK   +R  +K +  E+ +LE  +  N+V YYG
Sbjct: 1127 GSGSFGTVYRAVNLDTGDLMAVKEVALHKPRISRPMIKRIKGEMLVLELFDHPNVVSYYG 1186

Query: 70   VEIHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            +E+HRE++ +FMELC   +L   ++    ED   E++++ Y  QL++ ++ +H   + H+
Sbjct: 1187 IEVHREKVNIFMELCQGSSLFEFLRYGRIED---ELVIQVYVLQLLEGLAYIHSCGVSHQ 1243

Query: 128  DIKSANIFLTAEGNSLKLGDFGSA-VKISAHTTVPGELN--------------------- 165
            D+K  NI     G  +K  DFGSA +  SA T +  +L                      
Sbjct: 1244 DVKPENILFDHNG-IMKFTDFGSAKMSGSASTKIFEQLTQQEEEEFEKDSEFLQHLDQNR 1302

Query: 166  --GFVGTQAYMAPEVFM--DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF 221
                 GT  YMAPE+ +   + +VG   A+DIWSLGCV+VEM++G  PW   D+++ +M+
Sbjct: 1303 GYSLTGTPTYMAPELILGNPSERVG---AMDIWSLGCVIVEMATGSPPWPRLDNHFSLMY 1359

Query: 222  KVGMGETPTIP--ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +     P IP  + LS  GQ F + C   DP QRAT  ELL  P++
Sbjct: 1360 HIAAHNPPIIPADDQLSPLGQNFLKRCFVSDPNQRATAAELLMDPWV 1406

Involved in a signal transduction pathway that is activated by changes in the osmolarity of the extracellular environment. Activates the wis1 MAP kinase kinase by phosphorylation.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  174 bits (440), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 155/262 (59%), Gaps = 12/262 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL-----HKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG VY  +N ++GEL+A+K++ +      K+     ++++  E+++L+ ++  N+V
Sbjct: 75  GRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIV 134

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +Y G     E + + +E    G++ SL++      PE +VR YT QL+  +  LH + I+
Sbjct: 135 RYLGTVREDETLNILLEFVPGGSISSLLEKF-GAFPESVVRTYTNQLLLGLEYLHNHAIM 193

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRDIK ANI +  +G  +KL DFG++ +++   T+ G      GT  +MAPEV + T   
Sbjct: 194 HRDIKGANILVDNQG-CIKLADFGASKQVAELATISG-AKSMKGTPYWMAPEVILQT--- 248

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAE 244
           GH  + DIWS+GC ++EM +GK PW++       +F +G  ++ P IP+++S +   F  
Sbjct: 249 GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLL 308

Query: 245 LCLRHDPAQRATIFELLQHPFL 266
            CL+ +P  R T  ELL+HPF+
Sbjct: 309 KCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9WTR2|M3K6_MOUSE Mitogen-activated protein kinase kinase kinase 6 OS=Mus musculus GN=Map3k6 PE=1 SV=4

 Score =  173 bits (438), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/259 (38%), Positives = 147/259 (56%), Gaps = 10/259 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY   +  T   +A+KEI    + D+RF + +  E+ + + +  KN+V+Y G 
Sbjct: 656 GRGTYGVVYAGRDRHTRVRIAIKEI---PERDSRFSQPLHEEIALHKRLRHKNIVRYLGS 712

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLP--EVLVRRYTKQLVDAISALHENTIVHRD 128
                 + +FME    G+L SL++S    L   E  +  YT+Q++  +S LHEN IVHRD
Sbjct: 713 ASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNESTISFYTRQILQGLSYLHENRIVHRD 772

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK  N+ +      LK+ DFG++ +++  T        F GT  YMAPE+ +D    G+G
Sbjct: 773 IKGDNVLINTFSGLLKISDFGTSKRLAGITPC---TETFTGTLQYMAPEI-IDQGPRGYG 828

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELCL 247
           +A DIWSLGC ++EM++G+ P+ E  S    MF+VGM +  P +P SLS E QAF     
Sbjct: 829 KAADIWSLGCTVIEMATGRPPFHELGSPQAAMFQVGMYKVHPPVPGSLSAEAQAFLLRTF 888

Query: 248 RHDPAQRATIFELLQHPFL 266
             DP  RA+  ELL  PFL
Sbjct: 889 EPDPRLRASAQELLGDPFL 907

Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
328706323	1128	PREDICTED: mitogen-activated protein kin	0.695	0.250	0.687	1e-112
332028559	1155	Mitogen-activated protein kinase kinase	0.641	0.225	0.661	1e-102
195145980	1572	GL23109 [Drosophila persimilis] gi|19410	0.621	0.160	0.698	1e-102
198451628	1574	GA20540, isoform A [Drosophila pseudoobs	0.621	0.160	0.698	1e-102
390177766	1502	GA20540, isoform B [Drosophila pseudoobs	0.621	0.168	0.698	1e-102
195343214	1621	GM18685 [Drosophila sechellia] gi|194133	0.621	0.156	0.690	1e-101
15186734	1571	mekk1a [Drosophila melanogaster]	0.621	0.161	0.690	1e-101
194742313	1573	GF17866 [Drosophila ananassae] gi|190626	0.621	0.160	0.690	1e-101
24648046	1571	Mekk1, isoform B [Drosophila melanogaste	0.621	0.161	0.690	1e-101
195569833	1621	GD20154 [Drosophila simulans] gi|1941988	0.621	0.156	0.690	1e-101

>gi|328706323|ref|XP_001943417.2| PREDICTED: mitogen-activated protein kinase kinase kinase 4-like [Acyrthosiphon pisum]

 Score =  410 bits (1053), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 196/285 (68%), Positives = 234/285 (82%), Gaps = 2/285 (0%)

Query: 8    VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
            +  GQGRFGKVYTAVNNETGEL+AMKEIQL +  D   ++++ VELRI EGI  ++LV+Y
Sbjct: 843  IKIGQGRFGKVYTAVNNETGELMAMKEIQL-QPFDHNAIRNVAVELRIFEGITHEHLVRY 901

Query: 68   YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            YGVEIHREEM++FMELC EGTLE+LV +TE GLPE L+RR+TKQLV  +  LH++ IVHR
Sbjct: 902  YGVEIHREEMLIFMELCAEGTLENLVAATESGLPEALLRRFTKQLVSGVDVLHQHAIVHR 961

Query: 128  DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
            DIKSANIFLT EGN LKLGDFGSAVK+ AHTTVPGEL GFVGTQAYMAPEVFM +N  GH
Sbjct: 962  DIKSANIFLTDEGNCLKLGDFGSAVKMKAHTTVPGELKGFVGTQAYMAPEVFMKSNTEGH 1021

Query: 188  GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            GRA DIWS+GCV++EM+SGKRPW EYDSNYQIMFKVGMG  PT+P++L DEGQ F + CL
Sbjct: 1022 GRAADIWSIGCVIIEMASGKRPWHEYDSNYQIMFKVGMGVLPTVPDTLCDEGQQFVDSCL 1081

Query: 248  RHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLG 292
            +HDP  RATI EL +H F+ V  EE V + R    ++L++Y+KLG
Sbjct: 1082 QHDPYLRATISELQEHNFIKVMPEECV-SCRISSTAMLEEYIKLG 1125

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332028559|gb|EGI68596.1| Mitogen-activated protein kinase kinase kinase 4 [Acromyrmex echinatior]

 Score =  379 bits (974), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 176/266 (66%), Positives = 217/266 (81%), Gaps = 5/266 (1%)

Query: 4    VTFS----VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
            VTF+    +  GQGRFGKVYT VNN+TGEL+AMKE+QL +  D R ++ +  EL+I EGI
Sbjct: 872  VTFTWQRGIKIGQGRFGKVYTVVNNQTGELLAMKEVQL-QPGDHRAIRRVAEELQIFEGI 930

Query: 60   NQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
              ++LV+YYG+EIHREEM++FME C EGTLESLV  + +GLPE LVR+YT QL+ A++AL
Sbjct: 931  QHQHLVRYYGLEIHREEMLIFMEFCAEGTLESLVAGSGNGLPESLVRKYTHQLLSAVAAL 990

Query: 120  HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            H + IVHRDIK+ANIFLT EGNSLKLGDFGSAV+I AHTT+PGEL GFVGTQAYMAPEVF
Sbjct: 991  HSHGIVHRDIKTANIFLTDEGNSLKLGDFGSAVQIKAHTTMPGELQGFVGTQAYMAPEVF 1050

Query: 180  MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
            M +   GHGRAVDIWS+GC ++EM+SG+RPW++YDSNYQIMFKVGMGETP +P++LS EG
Sbjct: 1051 MKSESSGHGRAVDIWSVGCCIIEMASGRRPWSDYDSNYQIMFKVGMGETPALPKNLSAEG 1110

Query: 240  QAFAELCLRHDPAQRATIFELLQHPF 265
                + CL+HDP +R+T   L  HPF
Sbjct: 1111 IDLVKKCLQHDPKKRSTASNLFAHPF 1136

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195145980|ref|XP_002013968.1| GL23109 [Drosophila persimilis] gi|194102911|gb|EDW24954.1| GL23109 [Drosophila persimilis]

 Score =  379 bits (973), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 178/255 (69%), Positives = 211/255 (82%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1292 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1350

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T  GLPEV+ RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1351 EVHREELLIFMELCSEGTLESLVEMTA-GLPEVVARRFTAQLLSGVSELHKHGIVHRDIK 1409

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1410 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1469

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct: 1470 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFVDHCLQHD 1529

Query: 251  PAQRATIFELLQHPF 265
            P QR T  ELL+H F
Sbjct: 1530 PKQRLTAMELLEHNF 1544

Source: Drosophila persimilis

Species: Drosophila persimilis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|198451628|ref|XP_001358448.2| GA20540, isoform A [Drosophila pseudoobscura pseudoobscura] gi|198131574|gb|EAL27587.2| GA20540, isoform A [Drosophila pseudoobscura pseudoobscura]

 Score =  377 bits (968), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 178/255 (69%), Positives = 210/255 (82%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1294 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1352

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T  GLPEV+ RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1353 EVHREELLIFMELCSEGTLESLVEMTA-GLPEVVARRFTAQLLSGVSELHKHGIVHRDIK 1411

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1412 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1471

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F   CL+HD
Sbjct: 1472 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFVGHCLQHD 1531

Query: 251  PAQRATIFELLQHPF 265
            P QR T  ELL+H F
Sbjct: 1532 PKQRLTAMELLEHNF 1546

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|390177766|ref|XP_003736483.1| GA20540, isoform B [Drosophila pseudoobscura pseudoobscura] gi|388859187|gb|EIM52556.1| GA20540, isoform B [Drosophila pseudoobscura pseudoobscura]

 Score =  377 bits (967), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 178/255 (69%), Positives = 210/255 (82%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1222 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1280

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T  GLPEV+ RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1281 EVHREELLIFMELCSEGTLESLVEMTA-GLPEVVARRFTAQLLSGVSELHKHGIVHRDIK 1339

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1340 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1399

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F   CL+HD
Sbjct: 1400 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFVGHCLQHD 1459

Query: 251  PAQRATIFELLQHPF 265
            P QR T  ELL+H F
Sbjct: 1460 PKQRLTAMELLEHNF 1474

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195343214|ref|XP_002038193.1| GM18685 [Drosophila sechellia] gi|194133043|gb|EDW54611.1| GM18685 [Drosophila sechellia]

 Score =  374 bits (959), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 176/255 (69%), Positives = 209/255 (81%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1339 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1397

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T   LPE L RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1398 EVHREELLIFMELCSEGTLESLVELT-GNLPEALTRRFTAQLLSGVSELHKHGIVHRDIK 1456

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1457 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1516

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct: 1517 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFIDHCLQHD 1576

Query: 251  PAQRATIFELLQHPF 265
            P +R T  ELL+H F
Sbjct: 1577 PKRRLTAVELLEHNF 1591

Source: Drosophila sechellia

Species: Drosophila sechellia

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|15186734|dbj|BAB62891.1| mekk1a [Drosophila melanogaster]

 Score =  374 bits (959), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 176/255 (69%), Positives = 209/255 (81%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1289 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1347

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T   LPE L RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1348 EVHREELLIFMELCSEGTLESLVELT-GNLPEALTRRFTAQLLSGVSELHKHGIVHRDIK 1406

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1407 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1466

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct: 1467 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFIDHCLQHD 1526

Query: 251  PAQRATIFELLQHPF 265
            P +R T  ELL+H F
Sbjct: 1527 PKRRLTAVELLEHNF 1541

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194742313|ref|XP_001953647.1| GF17866 [Drosophila ananassae] gi|190626684|gb|EDV42208.1| GF17866 [Drosophila ananassae]

 Score =  374 bits (959), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 176/255 (69%), Positives = 209/255 (81%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1293 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1351

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T  GLPE L RR+T QL+  ++ LH++ IVHRDIK
Sbjct: 1352 EVHREELLIFMELCSEGTLESLVELTA-GLPEALARRFTAQLLSGVAELHKHGIVHRDIK 1410

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1411 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1470

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct: 1471 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFIDHCLQHD 1530

Query: 251  PAQRATIFELLQHPF 265
            P QR T  ELL+  F
Sbjct: 1531 PKQRLTAMELLEQNF 1545

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|24648046|ref|NP_732373.1| Mekk1, isoform B [Drosophila melanogaster] gi|21428736|gb|AAM50028.1| SD09178p [Drosophila melanogaster] gi|23171673|gb|AAN13787.1| Mekk1, isoform B [Drosophila melanogaster]

 Score =  374 bits (959), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 176/255 (69%), Positives = 209/255 (81%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1289 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1347

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T   LPE L RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1348 EVHREELLIFMELCSEGTLESLVELT-GNLPEALTRRFTAQLLSGVSELHKHGIVHRDIK 1406

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1407 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1466

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct: 1467 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFIDHCLQHD 1526

Query: 251  PAQRATIFELLQHPF 265
            P +R T  ELL+H F
Sbjct: 1527 PKRRLTAVELLEHNF 1541

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195569833|ref|XP_002102913.1| GD20154 [Drosophila simulans] gi|194198840|gb|EDX12416.1| GD20154 [Drosophila simulans]

 Score =  374 bits (959), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 176/255 (69%), Positives = 209/255 (81%), Gaps = 2/255 (0%)

Query: 11   GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct: 1339 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1397

Query: 71   EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            E+HREE+++FMELC+EGTLESLV+ T   LPE L RR+T QL+  +S LH++ IVHRDIK
Sbjct: 1398 EVHREELLIFMELCSEGTLESLVELT-GNLPEALTRRFTAQLLSGVSELHKHGIVHRDIK 1456

Query: 131  SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct: 1457 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1516

Query: 191  VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
             DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct: 1517 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFIDHCLQHD 1576

Query: 251  PAQRATIFELLQHPF 265
            P +R T  ELL+H F
Sbjct: 1577 PKRRLTAVELLEHNF 1591

Source: Drosophila simulans

Species: Drosophila simulans

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	407
FB|FBgn0024329	1571	Mekk1 "Mekk1" [Drosophila mela	0.621	0.161	0.690	2.5e-92
ZFIN|ZDB-GENE-990603-4	1488	map3k4 "mitogen activated prot	0.633	0.173	0.556	1.3e-73
UNIPROTKB|F1SB84	297	LOC100518100 "Uncharacterized	0.633	0.868	0.549	2.2e-73
UNIPROTKB|K7GP00	337	LOC100518100 "Uncharacterized	0.633	0.765	0.549	2.2e-73
MGI|MGI:1346875	1597	Map3k4 "mitogen-activated prot	0.633	0.161	0.560	2.6e-73
UNIPROTKB|E1BXN6	1565	MAP3K4 "Uncharacterized protei	0.633	0.164	0.553	3.2e-73
UNIPROTKB|J3KNB8	1554	MAP3K4 "Mitogen-activated prot	0.633	0.166	0.553	1.4e-72
UNIPROTKB|F1N3T0	1554	MAP3K4 "Uncharacterized protei	0.633	0.166	0.549	1.4e-72
UNIPROTKB|F5H538	1604	MAP3K4 "Mitogen-activated prot	0.633	0.160	0.553	1.5e-72
UNIPROTKB|Q9Y6R4	1608	MAP3K4 "Mitogen-activated prot	0.633	0.160	0.553	1.5e-72

FB|FBgn0024329 Mekk1 "Mekk1" [Drosophila melanogaster (taxid:7227)]

 Score = 929 (332.1 bits), Expect = 2.5e-92, P = 2.5e-92
 Identities = 176/255 (69%), Positives = 210/255 (82%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             GQGRFGKVYTAVNN TGEL+AMKEI + +  + R +K++  EL+ILEGI  KNLV+YYG+
Sbjct:  1289 GQGRFGKVYTAVNNNTGELMAMKEIAI-QPGETRALKNVAEELKILEGIKHKNLVRYYGI 1347

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREE+++FMELC+EGTLESLV+ T + LPE L RR+T QL+  +S LH++ IVHRDIK
Sbjct:  1348 EVHREELLIFMELCSEGTLESLVELTGN-LPEALTRRFTAQLLSGVSELHKHGIVHRDIK 1406

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             +ANIFL    NSLKLGDFGSAVKI AHTTVPGEL G+VGTQAYMAPEVF  TN  GHGRA
Sbjct:  1407 TANIFLVDGSNSLKLGDFGSAVKIQAHTTVPGELQGYVGTQAYMAPEVFTKTNSDGHGRA 1466

Query:   191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
              DIWS+GCV+VEM+SGKRPWA++DSN+QIMFKVGMGE P  PESLS EG  F + CL+HD
Sbjct:  1467 ADIWSVGCVVVEMASGKRPWAQFDSNFQIMFKVGMGEKPQAPESLSQEGHDFIDHCLQHD 1526

Query:   251 PAQRATIFELLQHPF 265
             P +R T  ELL+H F
Sbjct:  1527 PKRRLTAVELLEHNF 1541

GO:0004709 "MAP kinase kinase kinase activity" evidence=IDA;NAS;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;NAS;TAS

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=NAS

GO:0031434 "mitogen-activated protein kinase kinase binding" evidence=IPI

GO:0034605 "cellular response to heat" evidence=IDA;IMP

GO:0071475 "cellular hyperosmotic salinity response" evidence=IMP

GO:0000165 "MAPK cascade" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0071276 "cellular response to cadmium ion" evidence=IMP

GO:0046330 "positive regulation of JNK cascade" evidence=IMP

GO:0071243 "cellular response to arsenic-containing substance" evidence=IMP

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0002385 "mucosal immune response" evidence=IMP

GO:0045793 "positive regulation of cell size" evidence=IGI;IMP

GO:0001934 "positive regulation of protein phosphorylation" evidence=IGI

GO:0031452 "negative regulation of heterochromatin assembly" evidence=IMP

GO:0070059 "intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress" evidence=IGI

ZFIN|ZDB-GENE-990603-4 map3k4 "mitogen activated protein kinase kinase kinase 4" [Danio rerio (taxid:7955)]

 Score = 754 (270.5 bits), Expect = 1.3e-73, P = 1.3e-73
 Identities = 147/264 (55%), Positives = 191/264 (72%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT +N +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1230 GEGQYGKVYTCINVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1288

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct:  1289 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITTAINVLHEHGIVHRDIK 1345

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1346 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1404

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCVL+EM +GKRPW EY+ N+QIM++VGMG  P IPE LS EG+ F   CL  
Sbjct:  1405 AADIWSLGCVLIEMVTGKRPWHEYEHNFQIMYRVGMGHKPPIPEKLSTEGKDFLAHCLES 1464

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             +P +R T   LL HPF+ V  +E+
Sbjct:  1465 EPKRRWTASALLDHPFVKVCTDEE 1488

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|F1SB84 LOC100518100 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
 Identities = 145/264 (54%), Positives = 190/264 (71%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:    39 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 97

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct:    98 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITVAINVLHEHGIVHRDIK 154

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:   155 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 213

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct:   214 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLAHCLES 273

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             +P  R T  +LL H F+ V  +E+
Sbjct:   274 EPRMRWTASQLLDHSFIKVCTDEE 297

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|K7GP00 LOC100518100 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
 Identities = 145/264 (54%), Positives = 190/264 (71%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:    79 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 137

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct:   138 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITVAINVLHEHGIVHRDIK 194

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:   195 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 253

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct:   254 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLAHCLES 313

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             +P  R T  +LL H F+ V  +E+
Sbjct:   314 EPRMRWTASQLLDHSFIKVCTDEE 337

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:1346875 Map3k4 "mitogen-activated protein kinase kinase kinase 4" [Mus musculus (taxid:10090)]

 Score = 752 (269.8 bits), Expect = 2.6e-73, P = 2.6e-73
 Identities = 148/264 (56%), Positives = 191/264 (72%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1339 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1397

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R YTKQ+  AI+ LHE+ IVHRDIK
Sbjct:  1398 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYTKQITVAINVLHEHGIVHRDIK 1454

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1455 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1513

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+AF   CL  
Sbjct:  1514 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKAFLSHCLES 1573

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             DP  R T  +LL H F+ V  +E+
Sbjct:  1574 DPKIRWTASQLLDHAFVKVCTDEE 1597

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001890 "placenta development" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IDA

GO:0010468 "regulation of gene expression" evidence=IMP

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019100 "male germ-line sex determination" evidence=IMP

GO:0043507 "positive regulation of JUN kinase activity" evidence=IDA;IMP

GO:0046872 "metal ion binding" evidence=IEA

GO:0048263 "determination of dorsal identity" evidence=ISO

GO:0060718 "chorionic trophoblast cell differentiation" evidence=IMP

UNIPROTKB|E1BXN6 MAP3K4 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 751 (269.4 bits), Expect = 3.2e-73, P = 3.2e-73
 Identities = 146/264 (55%), Positives = 193/264 (73%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1307 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1365

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE +   ++ GL E ++R YTKQ+  AI+ LHE+ IVHRDIK
Sbjct:  1366 ELHREEMYIFMEYCDEGTLEEV---SKLGLQEHVIRLYTKQITIAINVLHEHGIVHRDIK 1422

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +T T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1423 GANIFLTSSG-LIKLGDFGCSVKLKNNTQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1481

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM++VGMG  P IP+ +S EG+ F   CL  
Sbjct:  1482 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYRVGMGHKPPIPDKVSPEGKDFLCHCLES 1541

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             DP  R T  +LL HPF+ V  +E+
Sbjct:  1542 DPKMRWTASQLLDHPFVKVCTDEE 1565

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001890 "placenta development" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0010468 "regulation of gene expression" evidence=IEA

GO:0019100 "male germ-line sex determination" evidence=IEA

GO:0043507 "positive regulation of JUN kinase activity" evidence=IEA

GO:0060718 "chorionic trophoblast cell differentiation" evidence=IEA

UNIPROTKB|J3KNB8 MAP3K4 "Mitogen-activated protein kinase kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 745 (267.3 bits), Expect = 1.4e-72, P = 1.4e-72
 Identities = 146/264 (55%), Positives = 190/264 (71%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1296 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1354

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct:  1355 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITIAINVLHEHGIVHRDIK 1411

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1412 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1470

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct:  1471 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLSHCLES 1530

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             DP  R T  +LL H F+ V  +E+
Sbjct:  1531 DPKMRWTASQLLDHSFVKVCTDEE 1554

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1N3T0 MAP3K4 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 745 (267.3 bits), Expect = 1.4e-72, P = 1.4e-72
 Identities = 145/264 (54%), Positives = 190/264 (71%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT +N +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1296 GEGQYGKVYTCINVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1354

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRD+K
Sbjct:  1355 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITVAINVLHEHGIVHRDVK 1411

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1412 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1470

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct:  1471 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLSHCLES 1530

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             +P  R T  +LL H F+ V  +E+
Sbjct:  1531 EPRMRWTASQLLDHSFVKVCTDEE 1554

GO:0060718 "chorionic trophoblast cell differentiation" evidence=IEA

GO:0043507 "positive regulation of JUN kinase activity" evidence=IEA

GO:0019100 "male germ-line sex determination" evidence=IEA

GO:0010468 "regulation of gene expression" evidence=IEA

GO:0007243 "intracellular protein kinase cascade" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0001890 "placenta development" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F5H538 MAP3K4 "Mitogen-activated protein kinase kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 745 (267.3 bits), Expect = 1.5e-72, P = 1.5e-72
 Identities = 146/264 (55%), Positives = 190/264 (71%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1346 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1404

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct:  1405 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITIAINVLHEHGIVHRDIK 1461

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1462 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1520

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct:  1521 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLSHCLES 1580

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             DP  R T  +LL H F+ V  +E+
Sbjct:  1581 DPKMRWTASQLLDHSFVKVCTDEE 1604

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q9Y6R4 MAP3K4 "Mitogen-activated protein kinase kinase kinase 4" [Homo sapiens (taxid:9606)]

 Score = 745 (267.3 bits), Expect = 1.5e-72, P = 1.5e-72
 Identities = 146/264 (55%), Positives = 190/264 (71%)

Query:    11 GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G+G++GKVYT ++ +TGEL+AMKEI+  + ND + +K+   EL+I EGI   NLV+Y+GV
Sbjct:  1350 GEGQYGKVYTCISVDTGELMAMKEIRF-QPNDHKTIKETADELKIFEGIKHPNLVRYFGV 1408

Query:    71 EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             E+HREEM +FME C EGTLE + +    GL E ++R Y+KQ+  AI+ LHE+ IVHRDIK
Sbjct:  1409 ELHREEMYIFMEYCDEGTLEEVSRL---GLQEHVIRLYSKQITIAINVLHEHGIVHRDIK 1465

Query:   131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              ANIFLT+ G  +KLGDFG +VK+  +  T+PGE+N  +GT AYMAPEV       GHGR
Sbjct:  1466 GANIFLTSSG-LIKLGDFGCSVKLKNNAQTMPGEVNSTLGTAAYMAPEVITRAKGEGHGR 1524

Query:   190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             A DIWSLGCV++EM +GKRPW EY+ N+QIM+KVGMG  P IPE LS EG+ F   CL  
Sbjct:  1525 AADIWSLGCVVIEMVTGKRPWHEYEHNFQIMYKVGMGHKPPIPERLSPEGKDFLSHCLES 1584

Query:   250 DPAQRATIFELLQHPFLIVSCEED 273
             DP  R T  +LL H F+ V  +E+
Sbjct:  1585 DPKMRWTASQLLDHSFVKVCTDEE 1608

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA

GO:0001890 "placenta development" evidence=IEA

GO:0010468 "regulation of gene expression" evidence=IEA

GO:0019100 "male germ-line sex determination" evidence=IEA

GO:0060718 "chorionic trophoblast cell differentiation" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0043507 "positive regulation of JUN kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0007243 "intracellular protein kinase cascade" evidence=ISS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0006950 "response to stress" evidence=TAS

GO:0007254 "JNK cascade" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9Y6R4	M3K4_HUMAN	2, ., 7, ., 1, 1, ., 2, 5	0.5530	0.6339	0.1604	yes	N/A
O08648	M3K4_MOUSE	2, ., 7, ., 1, 1, ., 2, 5	0.5606	0.6339	0.1615	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	407
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-126
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-100
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-87
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-74
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-72
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-70
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-68
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-65
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-62
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-58
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-57
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-56
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-56
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-55
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-55
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-54
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-54
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-53
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-52
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-51
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-50
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-50
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-49
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-48
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-47
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-47
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-46
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-45
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-44
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-44
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-44
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-44
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-44
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-44
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-43
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-43
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-43
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-42
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-42
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-41
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-40
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-40
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-40
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-40
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-39
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-38
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-38
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-38
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-37
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-37
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-37
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-37
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-37
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-37
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-37
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-36
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-36
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-36
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-35
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-35
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-35
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-35
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-35
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-34
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-33
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-33
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-32
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-32
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-32
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-31
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-31
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-31
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-31
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-31
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-31
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-31
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-31
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-31
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-31
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-30
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-30
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-30
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-29
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-29
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-29
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-29
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-28
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-28
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-28
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-28
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-28
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-28
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-27
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-27
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-27
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-26
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-26
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-26
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-25
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-25
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-25
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-25
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-25
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-25
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-24
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-24
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-24
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-24
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-24
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-24
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-23
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-23
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-23
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-23
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-22
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-22
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-22
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-21
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-21
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-21
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-21
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-21
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-21
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-21
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-20
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-20
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-20
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-20
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-20
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-19
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-19
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-19
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-19
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-18
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-18
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-18
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-17
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-17
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-17
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-16
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-16
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-16
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-16
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-14
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-13
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-13
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-11
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	9e-11
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-10
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-09
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-09
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-09
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-07
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-06
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-04
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.001
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.001
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.002
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.002
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.003
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.003

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  364 bits (936), Expect = e-126
 Identities = 141/259 (54%), Positives = 184/259 (71%), Gaps = 6/259 (2%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVYTAVN +TGEL+A+KEI++   ND + +K++  E+++LE +   NLVKYYGV
Sbjct: 9   GGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
           E+HRE++ +FME C+ GTLE L++     L E ++R YT QL++ ++ LH + IVHRDIK
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 189
            ANIFL   G  +KLGDFG AVK+  +TT  GE +    GT AYMAPEV       GHGR
Sbjct: 127 PANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAELCL 247
           A DIWSLGCV++EM++GKRPW+E D+ +QIMF VG G  P IP+S  LS EG+ F + CL
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCL 245

Query: 248 RHDPAQRATIFELLQHPFL 266
             DP +R T  ELLQHPF+
Sbjct: 246 ESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  297 bits (764), Expect = e-100
 Identities = 110/259 (42%), Positives = 162/259 (62%), Gaps = 10/259 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG VY A++ +TGEL+A+K ++L   ++   ++ +  E+RIL  +   N+V+YYG 
Sbjct: 9   GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHPNIVRYYGS 67

Query: 71  EIHREEMVL--FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           E   E+  L  F+E  + G+L SL++     LPE ++R+YT+Q+++ ++ LH N IVHRD
Sbjct: 68  ERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRD 126

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK ANI + ++G  +KL DFG A ++              GT  +MAPEV        +G
Sbjct: 127 IKGANILVDSDGV-VKLADFGCAKRLGD-IETGEGTGSVRGTPYWMAPEVIRGE---EYG 181

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFAELCL 247
           RA DIWSLGC ++EM++GK PW+E  +    ++K+G  GE P IPE LS+E + F   CL
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241

Query: 248 RHDPAQRATIFELLQHPFL 266
           R DP +R T  ELLQHPFL
Sbjct: 242 RRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  264 bits (677), Expect = 6e-87
 Identities = 99/259 (38%), Positives = 141/259 (54%), Gaps = 15/259 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKVY A + +TG+LVA+K I   K+   +  + +L E++IL+ +   N+V+ Y V
Sbjct: 8   GEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               +++ L ME C  G L  L++     L E   R Y +Q++ A+  LH   IVHRD+K
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLK 124

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L  +G+ +KL DFG A ++        +L  FVGT  YMAPEV +     G+G+A
Sbjct: 125 PENILLDEDGH-VKLADFGLARQLDP----GEKLTTFVGTPEYMAPEVLLGK---GYGKA 176

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEGQAFAELCL 247
           VDIWSLG +L E+ +GK P+   D     +FK      P  P     +S E +      L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPG-DDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235

Query: 248 RHDPAQRATIFELLQHPFL 266
             DP +R T  E LQHPF 
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  231 bits (591), Expect = 4e-74
 Identities = 98/259 (37%), Positives = 146/259 (56%), Gaps = 12/259 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN-DAR-FVKDMLVELRILEGINQKNLVKYY 68
           G G FG VY  +N + G+  A+KE+ L       +  VK +  E+ +L  +   N+V+Y 
Sbjct: 9   GSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYL 68

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G E   + + +F+EL   G+L  L++      PE ++R YT+Q++  +  LH+   VHRD
Sbjct: 69  GTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK ANI +   G  +KL DFG A ++            F G+  +MAPEV       G+G
Sbjct: 128 IKGANILVDTNG-VVKLADFGMAKQVVEF----SFAKSFKGSPYWMAPEVIAQQG--GYG 180

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIPESLSDEGQAFAELCL 247
            A DIWSLGC ++EM++GK PW++ +     +FK+G   E P IP+ LSDE + F   CL
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239

Query: 248 RHDPAQRATIFELLQHPFL 266
           + DP+ R T  ELL+HPF+
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  225 bits (577), Expect = 6e-72
 Identities = 86/261 (32%), Positives = 130/261 (49%), Gaps = 13/261 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A +  TG++VA+K ++   +   +       E+RIL  ++  N+V+    
Sbjct: 8   GSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRLSHPNIVRLIDA 66

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ + L ME C  G L   + S    L E   ++   Q++  +  LH N I+HRD+K
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLK 125

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L   G  +K+ DFG A K          L  FVGT  YMAPEV +  N  G+G  
Sbjct: 126 PENILLDENGV-VKIADFGLAKK---LLKSSSSLTTFVGTPWYMAPEVLLGGN--GYGPK 179

Query: 191 VDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETP---TIPESLSDEGQAFAEL 245
           VD+WSLG +L E+ +GK P+         Q++ ++             S S+E +   + 
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 246 CLRHDPAQRATIFELLQHPFL 266
           CL  DP++R T  E+LQHP+ 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  220 bits (564), Expect = 1e-70
 Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 40/254 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG VY A + +TG+ VA+K I   K++ +  ++++L E+ IL+ +N  N+VK YGV
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L ME C  G+L+ L++  E  L E  + R   Q+++ +  LH N I+HRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L ++   +KL DFG +  +++       L   VGT AYMAPEV +   K  +   
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSD---KSLLKTIVGTPAYMAPEVLL--GKGYYSEK 174

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG +L E+                                  E +      L+ D
Sbjct: 175 SDIWSLGVILYEL---------------------------------PELKDLIRKMLQKD 201

Query: 251 PAQRATIFELLQHP 264
           P +R +  E+L+H 
Sbjct: 202 PEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  216 bits (552), Expect = 3e-68
 Identities = 95/257 (36%), Positives = 148/257 (57%), Gaps = 14/257 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+VY A +  TG+ VA+K I+L  +     +   + E++IL+     N+VKYYG 
Sbjct: 9   GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKKCKHPNIVKYYGS 65

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + ++E+ + ME C+ G+L+ L++ST   L E  +    K+L+  +  LH N I+HRDIK
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIK 125

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +ANI LT++G  +KL DFG + ++S         N  VGT  +MAPEV    N   +   
Sbjct: 126 AANILLTSDG-EVKLIDFGLSAQLSDT----KARNTMVGTPYWMAPEVI---NGKPYDYK 177

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAELCLR 248
            DIWSLG   +E++ GK P++E     + +FK+     P +      SDE + F + CL+
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPP-MKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236

Query: 249 HDPAQRATIFELLQHPF 265
            +P +R T  +LL+HPF
Sbjct: 237 KNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  209 bits (533), Expect = 2e-65
 Identities = 93/257 (36%), Positives = 144/257 (56%), Gaps = 12/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG VY  +N ETG+ VA+K+I L K      +K ++ E+ +L+ +   N+VKY G 
Sbjct: 9   GRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +E    G+L  +++      PE LV  Y  Q++  ++ LHE  ++HRDIK
Sbjct: 68  IETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +ANI  T +G  +KL DFG A K++    V  +    VGT  +MAPEV       G   A
Sbjct: 127 AANILTTKDGV-VKLADFGVATKLND---VSKDDASVVGTPYWMAPEVI---EMSGASTA 179

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            DIWSLGC ++E+ +G  P+  YD N    +F++   + P +PE +S E + F   C + 
Sbjct: 180 SDIWSLGCTVIELLTGNPPY--YDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237

Query: 250 DPAQRATIFELLQHPFL 266
           DP  R T  +LL+HP++
Sbjct: 238 DPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  201 bits (513), Expect = 3e-62
 Identities = 88/259 (33%), Positives = 138/259 (53%), Gaps = 12/259 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKVY       G+L  +KEI L   ++ +  +D L E++IL+ +N  N++KYY  
Sbjct: 9   GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYES 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
              + ++ + ME    G L   ++  +      PE  +  +  QL  A+  LH   I+HR
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  NIFLT+ G  +KLGDFG +  +S+   +       VGT  Y++PE+        +
Sbjct: 128 DIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDL---AKTVVGTPYYLSPELC---QNKPY 180

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
               DIWSLGCVL E+ + K P+ E ++  ++  K+  G+ P IP   S E +      L
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239

Query: 248 RHDPAQRATIFELLQHPFL 266
           + DP +R +I ++LQ PF+
Sbjct: 240 QKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  190 bits (483), Expect = 6e-58
 Identities = 85/258 (32%), Positives = 146/258 (56%), Gaps = 9/258 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND--ARFVKDMLVELRILEGINQKNLVKYY 68
           GQG FG+VY   + +TG  +A+K++     +    + V  +  E+++L+ +  + +V+YY
Sbjct: 11  GQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYY 70

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G     E + +FME    G+++  ++     L E + R+YT+Q+++ +  LH N IVHRD
Sbjct: 71  GCLRDDETLSIFMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK ANI   + GN +KLGDFG++ ++    +    +    GT  +M+PEV    +  G+G
Sbjct: 130 IKGANILRDSAGN-VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI---SGEGYG 185

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELCL 247
           R  D+WS+GC +VEM + K PWAE+++    +FK+    T P +P  +S + + F     
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEA-MAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244

Query: 248 RHDPAQRATIFELLQHPF 265
             +  +R +  ELL+H F
Sbjct: 245 VENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  188 bits (479), Expect = 3e-57
 Identities = 91/261 (34%), Positives = 145/261 (55%), Gaps = 11/261 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVKY 67
           G G F   Y A + +TG L+A+K++   +   +     V+ +  E+R++  +N  ++++ 
Sbjct: 9   GTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRM 68

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            G         LF+E    G++  L+ S      E ++  YT+QL+  +S LHEN I+HR
Sbjct: 69  LGATCEDSHFNLFVEWMAGGSVSHLL-SKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVG 186
           D+K AN+ + + G  L++ DFG+A +++A  T  GE  G  +GT A+MAPEV        
Sbjct: 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ--- 184

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW-AEYDSN-YQIMFKVGMG-ETPTIPESLSDEGQAFA 243
           +GR+ D+WS+GCV++EM++ K PW AE  SN   ++FK+      P+IPE LS   +   
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVT 244

Query: 244 ELCLRHDPAQRATIFELLQHP 264
             CL   P  R    ELL+HP
Sbjct: 245 LRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  185 bits (473), Expect = 2e-56
 Identities = 86/261 (32%), Positives = 135/261 (51%), Gaps = 16/261 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VY   +  TG++ A+K+I +    + R  K +L EL+ L       +VK YG 
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCYGA 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRDI 129
                E+ + +E    G+L  L++     +PE ++    +Q++  +  LH +  I+HRDI
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHG 188
           K +N+ + ++G  +K+ DFG    IS       +  N FVGT  YM+PE         + 
Sbjct: 127 KPSNLLINSKGE-VKIADFG----ISKVLENTLDQCNTFVGTVTYMSPERI-QGES--YS 178

Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPESL-SDEGQAFAEL 245
            A DIWSLG  L+E + GK P+      S +++M  +  G  P++P    S E + F   
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA 238

Query: 246 CLRHDPAQRATIFELLQHPFL 266
           CL+ DP +R +  ELLQHPF+
Sbjct: 239 CLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  185 bits (471), Expect = 6e-56
 Identities = 82/257 (31%), Positives = 142/257 (55%), Gaps = 13/257 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+VY A++  T ++VA+K I L +  D   ++D+  E++ L       + KYYG 
Sbjct: 10  GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME C  G+   L++     L E  +    ++++  +  LHE   +HRDIK
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +ANI L+ EG+ +KL DFG + ++++  +   + N FVGT  +MAPEV   +   G+   
Sbjct: 126 AANILLSEEGD-VKLADFGVSGQLTSTMS---KRNTFVGTPFWMAPEVIKQS---GYDEK 178

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL-SDEGQAFAELCLRH 249
            DIWSLG   +E++ G+ P ++     +++F +     P++  +  S   + F  LCL  
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHP-MRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237

Query: 250 DPAQRATIFELLQHPFL 266
           DP +R +  ELL+H F+
Sbjct: 238 DPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  183 bits (465), Expect = 3e-55
 Identities = 99/259 (38%), Positives = 147/259 (56%), Gaps = 10/259 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +  T   +A+KEI    + D+R+V+ +  E+ +   +  +N+V+Y G 
Sbjct: 17  GKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLP--EVLVRRYTKQLVDAISALHENTIVHRD 128
           +       +FME    G+L +L++S    L   E  +  YTKQ+++ +  LH+N IVHRD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK  N+ +      +K+ DFG++ +++           F GT  YMAPEV +D    G+G
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMAPEV-IDKGPRGYG 189

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELCL 247
              DIWSLGC +VEM++GK P+ E       MFKVGM +  P IPESLS E + F   C 
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249

Query: 248 RHDPAQRATIFELLQHPFL 266
             DP +RA+  +LLQ PFL
Sbjct: 250 EPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  182 bits (465), Expect = 4e-55
 Identities = 90/267 (33%), Positives = 127/267 (47%), Gaps = 21/267 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G+G FG V        G+++  KEI      +    K  LV E+ IL  +   N+V+YY 
Sbjct: 9   GKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELKHPNIVRYYD 66

Query: 70  VEIHREEMVLF--MELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDAISALH---- 120
             I R    L+  ME C  G L  L+Q        + E  + R   QL+ A+   H    
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 121 -ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
             NT++HRD+K ANIFL A  N +KLGDFG A KI  H +       +VGT  YM+PE  
Sbjct: 127 PGNTVLHRDLKPANIFLDANNN-VKLGDFGLA-KILGHDSSFA--KTYVGTPYYMSPEQL 182

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
              +   +    DIWSLGC++ E+ +   P+    +  Q+  K+  G+   IP   S E 
Sbjct: 183 NHMS---YDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
               +  L  DP +R +  ELLQ P +
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  182 bits (464), Expect = 1e-54
 Identities = 88/264 (33%), Positives = 142/264 (53%), Gaps = 14/264 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G+VY A +  TG+ VA+K+++L KQN    +     E+ I++     N+V YY  
Sbjct: 28  GEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYDS 83

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  ++      + E  +    ++++  +  LH   ++HRDIK
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIK 143

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L+ +G S+KL DFG A +++       + N  VGT  +MAPEV    +   +G  
Sbjct: 144 SDNILLSKDG-SVKLADFGFAAQLTKEK---SKRNSVVGTPYWMAPEVIKRKD---YGPK 196

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM+ G+ P+   +   + +F +     P +  PE  S E + F   CL 
Sbjct: 197 VDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 249 HDPAQRATIFELLQHPFLIVSCEE 272
            DP +R +  ELLQHPFL  +C +
Sbjct: 256 KDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  181 bits (461), Expect = 1e-54
 Identities = 93/264 (35%), Positives = 143/264 (54%), Gaps = 15/264 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND---ARFVKDMLVELRILEGINQKNLVKY 67
           G+G +G VY  + N  G+L+A+K+++L   N     +  + +  E+ +L+ +   N+V+Y
Sbjct: 9   GKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            G  +    + +FME    G++ S++      LPE +  +YTKQ++D ++ LH N +VHR
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI---SAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           DIK  N+ L   G  +KL DFG A ++     H T    L    GT  +MAPEV    N+
Sbjct: 127 DIKGNNVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI---NE 182

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET--PTIPESLSDEGQAF 242
            G+GR  DIWS+GC + EM++GK P A  D     MF +G      P +P+S S     F
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDR-LAAMFYIGAHRGLMPRLPDSFSAAAIDF 241

Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
              CL  D  +R +  +LL+H FL
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  177 bits (450), Expect = 4e-53
 Identities = 86/258 (33%), Positives = 141/258 (54%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A++ ETG++VA+K + + +       ++++ E+ IL+  +   +VKYYG 
Sbjct: 12  GEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPYIVKYYGS 66

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ + ME C  G++  +++ T   L E  +     Q +  +  LH N  +HRDIK
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L  EG + KL DFG + +++  T    + N  +GT  +MAPEV     ++G+   
Sbjct: 127 AGNILLNEEGQA-KLADFGVSGQLT-DTM--AKRNTVIGTPFWMAPEVIQ---EIGYNNK 179

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQAFAELCLR 248
            DIWSLG   +EM+ GK P+++     + +F +     PT   PE  S E   F + CL 
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238

Query: 249 HDPAQRATIFELLQHPFL 266
            DP +R +  +LLQHPF+
Sbjct: 239 KDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  176 bits (448), Expect = 2e-52
 Identities = 92/264 (34%), Positives = 143/264 (54%), Gaps = 20/264 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A + ETG   A K IQ+  + +   ++D +VE+ IL      N+V  Y  
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEIDILSECKHPNIVGLYEA 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             +  ++ + +E C  G L+S++   E GL E  +R   +Q+++A++ LH + ++HRD+K
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130

Query: 131 SANIFLTAEGNSLKLGDFGSAVK----ISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK- 184
           + NI LT +G+ +KL DFG + K    +    T       F+GT  +MAPEV   +T K 
Sbjct: 131 AGNILLTLDGD-VKLADFGVSAKNKSTLQKRDT-------FIGTPYWMAPEVVACETFKD 182

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAF 242
             +    DIWSLG  L+E++  + P  E  +  +++ K+   E PT+  P   S     F
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241

Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            + CL  DP  R T  ELL+HPF+
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  174 bits (443), Expect = 4e-52
 Identities = 93/262 (35%), Positives = 135/262 (51%), Gaps = 21/262 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVK-Y 67
           G+G FGKV      +TG+L AMK   L K+     + V+  L E  IL  IN   +VK +
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMK--VLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 68  YGVEIHREE-MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           Y      EE + L +E    G L S +   E    E   R Y  ++V A+  LH   I++
Sbjct: 60  YA--FQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIY 116

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  NI L A+G+ +KL DFG A ++S+  +     N F GT  Y+APEV +     G
Sbjct: 117 RDLKPENILLDADGH-IKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLL---GKG 169

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           +G+AVD WSLG +L EM +GK P+  Y  + + +++  + +    PE LS E +      
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPF--YAEDRKEIYEKILKDPLRFPEFLSPEARDLISGL 227

Query: 247 LRHDPAQR---ATIFELLQHPF 265
           L+ DP +R       E+  HPF
Sbjct: 228 LQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  176 bits (446), Expect = 3e-51
 Identities = 80/273 (29%), Positives = 126/273 (46%), Gaps = 20/273 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYG 69
           G+G FG+VY A + +    VA+K +    ++ ++ V+  L E++IL  +N   N+VK Y 
Sbjct: 9   GEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHENTIVHR 127
                  + L ME    G+LE L++       L E        Q++ A+  LH   I+HR
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISA---HTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           DIK  NI L  +G  +KL DFG A  +      +++P   +  VGT  YMAPEV +  + 
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSL 185

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN------YQIMFKVGMGETP-----TIPE 233
                + DIWSLG  L E+ +G  P+    ++       +I+ ++           + PE
Sbjct: 186 AYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPE 245

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            +S       +  L  DP  R +    L H  L
Sbjct: 246 LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  169 bits (431), Expect = 4e-50
 Identities = 95/267 (35%), Positives = 148/267 (55%), Gaps = 17/267 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK---QNDARFVKDMLVELR----ILEGINQKN 63
           G+G +G+VY A+N  TGE++A+K+++L            KDM+  LR     L+ ++  N
Sbjct: 10  GKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN 69

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +V+Y G E   E + +F+E    G++ S ++ T     E LVR +T+Q+++ ++ LH   
Sbjct: 70  IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-TYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K+ N+ + A+G   K+ DFG   K S       +     G+  +MAPEV + + 
Sbjct: 129 ILHRDLKADNLLVDADG-ICKISDFG-ISKKSDDIYDNDQNMSMQGSVFWMAPEV-IHSY 185

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIPE----SLSDE 238
             G+   VDIWSLGCV++EM +G+RPW++ +     MFK+G     P IP     +LS  
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSD-EEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244

Query: 239 GQAFAELCLRHDPAQRATIFELLQHPF 265
              F   C   +P  R T  ELLQHPF
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  169 bits (430), Expect = 5e-50
 Identities = 93/267 (34%), Positives = 151/267 (56%), Gaps = 19/267 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL---HKQNDARFVKDMLV----ELRILEGINQKN 63
           G G FG VY  +N  +GEL+A+K+++L      +  R  + ML     E+ +L+ +  +N
Sbjct: 9   GSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDR-KRSMLDALAREIALLKELQHEN 67

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +V+Y G  +  + + +F+E    G++ +L+ +      E LVR + +Q++  ++ LH   
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG----FVGTQAYMAPEVF 179
           I+HRDIK ANI +  +G  +K+ DFG + K+ A++    + NG      G+  +MAPEV 
Sbjct: 127 IIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLS-TKTNGARPSLQGSVFWMAPEVV 184

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
             T+   + R  DIWSLGC++VEM +GK P+ +     Q +FK+G   +P IP ++S E 
Sbjct: 185 KQTS---YTRKADIWSLGCLVVEMLTGKHPFPDCT-QLQAIFKIGENASPEIPSNISSEA 240

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
             F E     D  +R T  ELL+HPFL
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  167 bits (425), Expect = 3e-49
 Identities = 86/261 (32%), Positives = 140/261 (53%), Gaps = 16/261 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G VY A +  TGELVA+K I+L   +D    + +  E+ +L+     N+V Y+G 
Sbjct: 12  GSGTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQEISMLKECRHPNIVAYFGS 68

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R+++ + ME C  G+L+ + Q T   L E+ +    ++ +  ++ LHE   +HRDIK
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            ANI LT +G+ +KL DFG + +++A  T+  +   F+GT  +MAPEV     K G+   
Sbjct: 129 GANILLTEDGD-VKLADFGVSAQLTA--TI-AKRKSFIGTPYWMAPEVAAVERKGGYDGK 184

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG------QAFAE 244
            DIW+LG   +E++  + P  +      +     + ++   P  L D+         F +
Sbjct: 185 CDIWALGITAIELAELQPPMFDLHPMRALFL---ISKSNFPPPKLKDKEKWSPVFHDFIK 241

Query: 245 LCLRHDPAQRATIFELLQHPF 265
            CL  DP +R T  +LLQHPF
Sbjct: 242 KCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  163 bits (414), Expect = 9e-48
 Identities = 93/260 (35%), Positives = 152/260 (58%), Gaps = 12/260 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYY 68
           GQG FG+VY   + +TG  +A K++Q   ++   ++ V  +  E+++L+ +  + +V+YY
Sbjct: 11  GQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYY 70

Query: 69  GVEIHREE--MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           G    R E  + +FME    G+++  +++    L E + R+YT+Q+++ +S LH N IVH
Sbjct: 71  GCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVH 129

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RDIK ANI   + GN +KLGDFG++ ++         +    GT  +M+PEV    +  G
Sbjct: 130 RDIKGANILRDSAGN-VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI---SGEG 185

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAEL 245
           +GR  D+WSLGC +VEM + K PWAEY++   I FK+    T P +P  +S+  + F   
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-FKIATQPTNPQLPSHISEHARDFLG- 243

Query: 246 CLRHDPAQRATIFELLQHPF 265
           C+  +   R +  ELL+HPF
Sbjct: 244 CIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 1e-47
 Identities = 89/272 (32%), Positives = 139/272 (51%), Gaps = 27/272 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G+G +GKVY A + +TG+LVA+K + + +  +    +++  E  IL    N  N+  +YG
Sbjct: 15  GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSNHPNIATFYG 70

Query: 70  V------EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALH 120
                    + +++ L MELC  G++  LV+        L E  +    ++ +  ++ LH
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP-GELNGFVGTQAYMAPEVF 179
           EN ++HRDIK  NI LT     +KL DFG    +SA      G  N F+GT  +MAPEV 
Sbjct: 131 ENKVIHRDIKGQNILLTKNAE-VKLVDFG----VSAQLDSTLGRRNTFIGTPYWMAPEVI 185

Query: 180 M-DTNKVGH--GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PES 234
             D         R+ D+WSLG   +E++ GK P  +     + +FK+     PT+  PE+
Sbjct: 186 ACDEQPDASYDARS-DVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNPPPTLKSPEN 243

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            S +   F   CL  +  QR  + ELL+HPF+
Sbjct: 244 WSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  161 bits (409), Expect = 7e-47
 Identities = 86/257 (33%), Positives = 140/257 (54%), Gaps = 12/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+F  VY A+    G +VA+K++Q+ +  DA+  +D L E+ +L+ ++  N++KY   
Sbjct: 11  GKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLAS 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
            I   E+ + +EL   G L  +++  +     +PE  + +Y  QL  A+  +H   I+HR
Sbjct: 71  FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR 130

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK AN+F+TA G  +KLGD G     S+ TT     +  VGT  YM+PE   +    G+
Sbjct: 131 DIKPANVFITATG-VVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHEN---GY 183

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIP-ESLSDEGQAFAEL 245
               DIWSLGC+L EM++ + P+     N Y +  K+   + P +P +  S+E +     
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243

Query: 246 CLRHDPAQRATIFELLQ 262
           C+  DP +R  I  +LQ
Sbjct: 244 CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  160 bits (408), Expect = 1e-46
 Identities = 83/291 (28%), Positives = 138/291 (47%), Gaps = 51/291 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A + +TGE+VA+K+I+L  + +       L E+ +L+ +   N+VK   V
Sbjct: 8   GEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IPSTALREISLLKELKHPNIVKLLDV 66

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ L  E C +  L+  +      L   L++    QL+  ++  H + I+HRD+K
Sbjct: 67  IHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLK 125

Query: 131 SANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
             NI +  +G  LKL DFG A    + +  +T         V T  Y APE+ + +    
Sbjct: 126 PQNILINRDGV-LKLADFGLARAFGIPLRTYTHE-------VVTLWYRAPEILLGSKH-- 175

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPTIPESLSD------ 237
           +  AVDIWS+GC+  EM +GK P    DS   Q+  +F++ +G TPT  ES         
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK-PLFPGDSEIDQLFKIFQI-LG-TPT-EESWPGVTKLPD 231

Query: 238 --------EGQAFAELC--------------LRHDPAQRATIFELLQHPFL 266
                     +   ++               L+++PA+R +  E L+HP+ 
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  156 bits (396), Expect = 4e-45
 Identities = 90/261 (34%), Positives = 151/261 (57%), Gaps = 12/261 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYY 68
           GQG FG+VY   + +TG  +A+K++Q   ++   ++ V  +  E+++L+ +  + +V+YY
Sbjct: 11  GQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYY 70

Query: 69  GV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           G   +     + +FME    G+++  ++S    L E + R+YT+Q+++ +S LH N IVH
Sbjct: 71  GCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVH 129

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RDIK ANI   + GN +KLGDFG++ ++         +    GT  +M+PEV    +  G
Sbjct: 130 RDIKGANILRDSVGN-VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI---SGEG 185

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAEL 245
           +GR  DIWS+GC +VEM + K PWAE+++   I FK+    T P +P  +SD  + F + 
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQPTNPVLPPHVSDHCRDFLKR 244

Query: 246 CLRHDPAQRATIFELLQHPFL 266
               +   R +  ELL+H F+
Sbjct: 245 IFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  154 bits (391), Expect = 2e-44
 Identities = 83/267 (31%), Positives = 136/267 (50%), Gaps = 22/267 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G    VY A+     E VA+K I L K      V ++  E++ +   N  N+VKYY  
Sbjct: 10  GVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            +  +E+ L M   + G+L  +++S+    GL E ++    K+++  +  LH N  +HRD
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-----LNGFVGTQAYMAPEVFMDTN 183
           IK+ NI L  +G S+K+ DFG    +SA     G+        FVGT  +MAPEV     
Sbjct: 128 IKAGNILLGEDG-SVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWMAPEVM--EQ 180

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE--GQA 241
             G+    DIWS G   +E+++G  P+++Y     +M  +   + P++      +   ++
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL-QNDPPSLETGADYKKYSKS 239

Query: 242 FAEL---CLRHDPAQRATIFELLQHPF 265
           F ++   CL+ DP++R T  ELL+H F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  154 bits (391), Expect = 3e-44
 Identities = 84/267 (31%), Positives = 140/267 (52%), Gaps = 27/267 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V   ++  TG+++A+K I+L + N+A   K +L EL IL   N   +V +YG 
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIRL-EINEAIQ-KQILRELDILHKCNSPYIVGFYGA 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDI 129
             +  ++ + ME    G+L+ +++  +  +PE ++ +    ++  ++ LHE   I+HRD+
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNK 184
           K +NI + + G  +KL DFG          V G+L       FVGT +YMAPE       
Sbjct: 128 KPSNILVNSRGQ-IKLCDFG----------VSGQLVNSLAKTFVGTSSYMAPERIQGN-- 174

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW----AEYDSNYQIMFKVGMGETPTIPES-LSDEG 239
             +    DIWSLG  L+E+++G+ P+       D  ++++  +     P +P    S + 
Sbjct: 175 -DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
           Q F  LCL  DP +R +  ELL+HPF+
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  154 bits (390), Expect = 3e-44
 Identities = 83/257 (32%), Positives = 135/257 (52%), Gaps = 10/257 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V+  V      + AMK+I L K N  R  ++ + E R+L  ++   +++YY  
Sbjct: 9   GKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + + ++ + ME    G L  L++      LPE  V R+  Q++  ++ LH   I+HRDI
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDI 127

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           KS N+FL A  N +K+GD G A  +S +T      N  VGT  Y++PE+  D     +  
Sbjct: 128 KSLNLFLDAYDN-VKIGDLGVAKLLSDNTNFA---NTIVGTPYYLSPELCEDKP---YNE 180

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             D+W+LG VL E  +GK P+ + ++   ++ K+  G  P + +  S +     + CL  
Sbjct: 181 KSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 250 DPAQRATIFELLQHPFL 266
           D  QR   F+LL++P L
Sbjct: 240 DYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  154 bits (390), Expect = 3e-44
 Identities = 81/259 (31%), Positives = 125/259 (48%), Gaps = 14/259 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY        +  A+KE+ L   +     +D + E+RIL  +N  N++ Y   
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHPNIISYKEA 67

Query: 71  EIHREEMVLFMELCTEGTLESLV---QSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            +   ++ + ME    G L   +   +     +PE  + R   QL+  + ALHE  I+HR
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+KSANI L A  + +K+GD G + K+             +GT  YMAPEV+       +
Sbjct: 128 DLKSANILLVA-NDLVKIGDLGIS-KVLKKNM----AKTQIGTPHYMAPEVWKGR---PY 178

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
               DIWSLGC+L EM++   P+ E  S   + +KV  G+ P IP   S + Q F    L
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237

Query: 248 RHDPAQRATIFELLQHPFL 266
           +  P  R    ++L  P +
Sbjct: 238 QVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  154 bits (391), Expect = 3e-44
 Identities = 94/263 (35%), Positives = 146/263 (55%), Gaps = 12/263 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ETG L A K I    + +   ++D +VE+ IL   +  N+VK    
Sbjct: 14  GDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDA 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             +   + + +E C  G +++++   E  L E  +R   KQ ++A++ LHEN I+HRD+K
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   + 
Sbjct: 131 AGNILFTLDGD-IKLADFGVSAK---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              D+WSLG  L+EM+  + P  E +   +++ K+   E PT+  P   S E + F + C
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245

Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L  +   R T  +LLQHPF+ V+
Sbjct: 246 LEKNVDARWTTTQLLQHPFVTVN 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 4e-44
 Identities = 97/288 (33%), Positives = 141/288 (48%), Gaps = 41/288 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G +G V    N  TGE+VA+K+  +     D +  K  L E+++L  +  +N+V    
Sbjct: 10  GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVNLKE 67

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               +  + L  E   E TL  L++++  GLP   VR Y  QL+ AI+  H + I+HRDI
Sbjct: 68  AFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDI 126

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHG 188
           K  NI L +E   LKL DFG A  + A    P  L  +V T+ Y APE+ + DTN   +G
Sbjct: 127 KPENI-LVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELLVGDTN---YG 180

Query: 189 RAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVG-----MGET------------ 228
           + VD+W++GC++ E+  G+  +    + D  Y I   +G       E             
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240

Query: 229 PTI--PESL--------SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           P    PESL        S     F + CLR DP +R T  ELLQHP+ 
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 1e-43
 Identities = 91/260 (35%), Positives = 149/260 (57%), Gaps = 12/260 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLH--KQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G FG+VY   + +TG  +A+K++      Q  ++ V  +  E+++L+ +    +V+YY
Sbjct: 11  GRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYY 70

Query: 69  GVEIHREE--MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           G     EE  + +F+E    G+++  +++    L E + RRYT+Q++  +S LH N IVH
Sbjct: 71  GCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVH 129

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RDIK ANI   + GN +KLGDFG++ +I         +    GT  +M+PEV    +  G
Sbjct: 130 RDIKGANILRDSAGN-VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI---SGEG 185

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAEL 245
           +GR  D+WS+ C +VEM + K PWAEY++   I FK+    T P +P+ +SD  + F + 
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-FKIATQPTKPMLPDGVSDACRDFLKQ 244

Query: 246 CLRHDPAQRATIFELLQHPF 265
            +  +  +R T   LL+HPF
Sbjct: 245 -IFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  153 bits (387), Expect = 2e-43
 Identities = 87/279 (31%), Positives = 147/279 (52%), Gaps = 23/279 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLH-KQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG VY A +  T E+VA+K++    KQ++ ++ +D++ E+R L+ +   N ++Y G
Sbjct: 24  GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW-QDIIKEVRFLQQLRHPNTIEYKG 82

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             +      L ME C  G+   +++  +  L EV +       +  ++ LH +  +HRDI
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDI 141

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ NI LT  G ++KL DFGSA  +S     P   N FVGT  +MAPEV +  ++  +  
Sbjct: 142 KAGNILLTEPG-TVKLADFGSASLVS-----PA--NSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAFAELCLR 248
            VD+WSLG   +E++  K P    ++    ++ +   ++PT+  +  SD  + F + CL+
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252

Query: 249 HDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
             P  R +  ELL+H F++          R  P +V+ D
Sbjct: 253 KIPQDRPSSEELLKHRFVL----------RERPPTVIID 281

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  152 bits (385), Expect = 3e-43
 Identities = 88/260 (33%), Positives = 142/260 (54%), Gaps = 12/260 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ETG L A K I+   + +   ++D +VE+ IL   N   +VK  G 
Sbjct: 21  GDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYMVEIEILATCNHPYIVKLLGA 77

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ + +E C  G +++++   + GL E  ++   +Q+++A+  LH   I+HRD+K
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + N+ LT +G+ +KL DFG + K   +       + F+GT  +MAPEV M +T K   + 
Sbjct: 138 AGNVLLTLDGD-IKLADFGVSAK---NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              DIWSLG  L+EM+  + P  E +   +++ K+   E PT+  P   S E + F +  
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTA 252

Query: 247 LRHDPAQRATIFELLQHPFL 266
           L   P  R +  +LL+HPF+
Sbjct: 253 LDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 3e-42
 Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 38/285 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +  TGE+VA+K+I+L  +++    K  L E+++L+ +N  N++K   V
Sbjct: 8   GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG-IPKTALREIKLLKELNHPNIIKLLDV 66

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H+ ++ L  E   +  L  L++  + GLPE L++ Y  QL+  ++  H + I+HRD+K
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  EG  LKL DFG A       +       +V T+ Y APE+ +     G+   
Sbjct: 126 PENLLINTEG-VLKLADFGLARSFG---SPVRPYTHYVVTRWYRAPELLL--GDKGYSTP 179

Query: 191 VDIWSLGCVLVEMSSGK------------------------RPWAE-----YDSNYQIMF 221
           VDIWS+GC+  E+ S +                          W +      +  +    
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239

Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           K GM   P +  + S +        L +DP +R T  + L HP+ 
Sbjct: 240 KAGM-PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  149 bits (379), Expect = 3e-42
 Identities = 81/289 (28%), Positives = 127/289 (43%), Gaps = 45/289 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V+ A + ETGE VA+K++ L +          L E++ L+      +VK   V
Sbjct: 9   GEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQACQHPYVVKLLDV 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H    VL ME      L  +++  E  LPE  V+ Y + L+  ++ +H N I+HRD+K
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            AN+ ++A+G  LK+ DFG A   S     P   +  V T+ Y APE+     K  +   
Sbjct: 127 PANLLISADG-VLKIADFGLARLFSEEE--PRLYSHQVATRWYRAPELLYGARK--YDPG 181

Query: 191 VDIWSLGCVLVEMSSGKRP-------------------------WAEYDS--NY-QIMFK 222
           VD+W++GC+  E+ +G  P                         W    S  +Y +I F 
Sbjct: 182 VDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240

Query: 223 VGMGET-----PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                      P       D  +      L +DP++R +  E L+HP+ 
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGL----LVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 4e-41
 Identities = 78/260 (30%), Positives = 138/260 (53%), Gaps = 15/260 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ---KNLVKY 67
           G+G +G VY   +  TG +VA+K I L   +D   V D+  E+ +L  + Q    N+ KY
Sbjct: 10  GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--VSDIQREVALLSQLRQSQPPNITKY 67

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           YG  +    + + ME    G++ +L+++    + E  +    ++++ A+  +H+  ++HR
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIHKVGVIHR 125

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK+ANI +T  GN +KL DFG A  +        + + FVGT  +MAPEV  +     +
Sbjct: 126 DIKAANILVTNTGN-VKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITEG--KYY 179

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQAFAELC 246
               DIWSLG  + EM++G  P+++ D+ ++ M  +   + P + +   S   + F   C
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238

Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  +P +R +  ELL+  ++
Sbjct: 239 LDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  145 bits (367), Expect = 1e-40
 Identities = 90/270 (33%), Positives = 139/270 (51%), Gaps = 17/270 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G+G  G V  A +  TG  VA+K++ L KQ      +++L  E+ I+      N+V+ Y 
Sbjct: 28  GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR----RELLFNEVVIMRDYQHPNIVEMYS 83

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDI
Sbjct: 84  SYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDI 141

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           KS +I LT++G  +KL DFG   ++S    VP      VGT  +MAPEV    +++ +G 
Sbjct: 142 KSDSILLTSDGR-VKLSDFGFCAQVSKE--VP-RRKSLVGTPYWMAPEVI---SRLPYGT 194

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCL 247
            VDIWSLG +++EM  G+ P+   +   Q M ++     P +     +S   ++F +  L
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253

Query: 248 RHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
             DPAQRAT  ELL HPFL  +       P
Sbjct: 254 VRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  144 bits (364), Expect = 2e-40
 Identities = 86/252 (34%), Positives = 136/252 (53%), Gaps = 12/252 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+F +VY A     G  VA+K++Q+    DA+   D + E+ +L+ +N  N++KYY  
Sbjct: 11  GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
            I   E+ + +EL   G L  +++  +     +PE  V +Y  QL  A+  +H   ++HR
Sbjct: 71  FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK AN+F+TA G  +KLGD G     S+ TT    L   VGT  YM+PE   +    G+
Sbjct: 131 DIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHEN---GY 183

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIP-ESLSDEGQAFAEL 245
               DIWSLGC+L EM++ + P+     N Y +  K+   + P +P +  S+E +    +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243

Query: 246 CLRHDPAQRATI 257
           C+  DP +R  I
Sbjct: 244 CINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  142 bits (361), Expect = 8e-40
 Identities = 88/267 (32%), Positives = 126/267 (47%), Gaps = 19/267 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            +G +G+V+ A    TG++ A+K I+         V  +L E  IL       +VK Y  
Sbjct: 2   SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ + L ME    G L SL+++    L E + R Y  ++V A+  LH N I+HRD+K
Sbjct: 62  FQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 131 SANIFLTAEGNSLKLGDFG-SAVKISAHTTVPG----ELNGFVGTQAYMAPEVFMDTNKV 185
             NI + + G+ LKL DFG S V +            E    VGT  Y+APEV       
Sbjct: 121 PDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI---LGQ 176

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV---GMGETPTIPESLSDEGQAF 242
           GH + VD WSLGC+L E   G  P+  +    + +F+    G  E P   E +SDE    
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPF--HGETPEEIFQNILNGKIEWPEDVE-VSDEAIDL 233

Query: 243 AELCLRHDPAQRA---TIFELLQHPFL 266
               L  DP +R    +I E+  HPF 
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  142 bits (361), Expect = 9e-40
 Identities = 79/282 (28%), Positives = 127/282 (45%), Gaps = 39/282 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQ-KNLVK 66
           G+G F  V  A   ET +  A+K   + QL K+   ++VK   +E  +L  +N    ++K
Sbjct: 10  GEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK---IEKEVLTRLNGHPGIIK 66

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            Y      E +   +E    G L   ++     L E   R Y  +++ A+  LH   I+H
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGIIH 125

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG------------------FV 168
           RD+K  NI L  + + +K+ DFG+A K+    + P    G                  FV
Sbjct: 126 RDLKPENILLDKDMH-IKITDFGTA-KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183

Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGE 227
           GT  Y++PE  +   K   G++ D+W+LGC++ +M +GK P+    SN Y    K+ +  
Sbjct: 184 GTAEYVSPE--LLNEKPA-GKSSDLWALGCIIYQMLTGKPPF--RGSNEYLTFQKI-LKL 237

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIF----ELLQHPF 265
             + P +   + +   E  L  DP  R  +     EL  HPF
Sbjct: 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  144 bits (363), Expect = 9e-40
 Identities = 90/282 (31%), Positives = 148/282 (52%), Gaps = 23/282 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLH-KQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG VY A N+ T E+VA+K++    KQ + ++ +D++ E++ L+ +   N ++Y G
Sbjct: 30  GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW-QDIIKEVKFLQQLKHPNTIEYKG 88

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRDI
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ NI LT  G  +KL DFGSA K S         N FVGT  +MAPEV +  ++  +  
Sbjct: 148 KAGNILLTEPGQ-VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDG 199

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAFAELCLR 248
            VD+WSLG   +E++  K P    ++    ++ +   ++PT+  +  +D  + F + CL+
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258

Query: 249 HDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
             P +R    ELL+H F+           R  PA VL D ++
Sbjct: 259 KIPQERPASAELLRHDFV----------RRDRPARVLIDLIQ 290

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  140 bits (355), Expect = 3e-39
 Identities = 85/257 (33%), Positives = 139/257 (54%), Gaps = 12/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+F +VY A      + VA+K++Q+ +  DA+  +D + E+ +L+ +N  N++KY   
Sbjct: 11  GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDS 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
            I   E+ + +EL   G L  +++  +     +PE  V +Y  QL  A+  +H   ++HR
Sbjct: 71  FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK AN+F+TA G  +KLGD G     S+ TT    L   VGT  YM+PE   +    G+
Sbjct: 131 DIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHEN---GY 183

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIP-ESLSDEGQAFAEL 245
               DIWSLGC+L EM++ + P+     N + +  K+   + P +P E  S++ +    +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243

Query: 246 CLRHDPAQRATIFELLQ 262
           C+  DP QR  I  + Q
Sbjct: 244 CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  141 bits (357), Expect = 6e-39
 Identities = 89/281 (31%), Positives = 143/281 (50%), Gaps = 21/281 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A +  T E+VA+K++    +      +D++ E++ L+ I   N ++Y G 
Sbjct: 34  GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC 93

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRDIK
Sbjct: 94  YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI LT  G  +KL DFGSA   S         N FVGT  +MAPEV +  ++  +   
Sbjct: 153 AGNILLTEPGQ-VKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAFAELCLRH 249
           VD+WSLG   +E++  K P    ++    ++ +   E+PT+  +  SD  + F + CL+ 
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 263

Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
            P  R T  ELL+H F++          R  P +VL D ++
Sbjct: 264 IPQDRPTSEELLKHMFVL----------RERPETVLIDLIQ 294

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 1e-38
 Identities = 79/287 (27%), Positives = 136/287 (47%), Gaps = 40/287 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+VY A N +TGELVA+K+I++  + +  F    + E+++L+ +   N+V+   +
Sbjct: 8   GEGTYGQVYKARNKKTGELVALKKIRMENEKEG-FPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 71  EIHREEMVLFMEL-CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
              + +  ++M     +  L  L+ S E    E  ++ Y KQL++ +  LH N I+HRDI
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDI 126

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI +  +G  LKL DFG A   +       +    V T  Y  PE+ +   +  +G 
Sbjct: 127 KGSNILINNDGV-LKLADFGLARPYTKRN--SADYTNRVITLWYRPPELLLGATR--YGP 181

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTI---------------- 231
            VD+WS+GC+L E+  GK  +       Q+  +F++  G +PT                 
Sbjct: 182 EVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL-CG-SPTDENWPGVSKLPWFENLK 239

Query: 232 -----PESLSDE-----GQAFAELC---LRHDPAQRATIFELLQHPF 265
                   L +        +  +L    L  DP +R +  + LQH +
Sbjct: 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  139 bits (352), Expect = 2e-38
 Identities = 87/275 (31%), Positives = 140/275 (50%), Gaps = 22/275 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY  ++  TG  +AMKEI+L + ++++F   +++EL IL       +V +YG 
Sbjct: 10  GKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKF-NQIIMELDILHKAVSPYIVDFYGA 67

Query: 71  EIHREEMVLFMELCTEGTLESLV--QSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHR 127
                 + + ME    G+L+ L       +G+PE ++RR T  +V  +  L E   I+HR
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127

Query: 128 DIKSANIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  N+ +   G  +KL DFG +   V   A T +        G Q+YMAPE       
Sbjct: 128 DVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNI--------GCQSYMAPERIKSGGP 178

Query: 185 VGHGR---AVDIWSLGCVLVEMSSGKRPWA--EYDSNYQIMFKVGMGETPTIPESLSDEG 239
             +       D+WSLG  ++EM+ G+ P+    Y + +  +  +  G+ PT+P   SD+ 
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
           Q F   CL   P +R T  +LL+HP+L+     DV
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  137 bits (348), Expect = 4e-38
 Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 34/267 (12%)

Query: 11  GQGRFGKVY----TAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+VY         +    VA+K ++          ++ L E RI+  ++  N+VK
Sbjct: 8   GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHPNVVK 65

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             GV    E + + ME    G L S ++     L    +  +  Q+   +  L     +H
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKI-------SAHTTVPGELNGFVGTQAYMAPEVF 179
           RD+ + N  +  E   +K+ DFG +  +            +P      +    +MAPE  
Sbjct: 126 RDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLP------I---RWMAPESL 175

Query: 180 MD---TNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
            +   T+K       D+WS G +L E+ + G++P+    SN +++  +  G     P + 
Sbjct: 176 KEGKFTSK------SDVWSFGVLLWEIFTLGEQPYPG-MSNEEVLEYLKNGYRLPQPPNC 228

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQ 262
             E       C   DP  R T  EL++
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  137 bits (348), Expect = 5e-38
 Identities = 82/264 (31%), Positives = 119/264 (45%), Gaps = 22/264 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV      +T ++ AMK +   K  +   V+++L E RIL+ +N   LV  +  
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 71  EIHREEMVLFMELCTEGTL----ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
               E M L ++L   G L       V+ +E+      V+ +  ++V A+  LH   I+H
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWICEIVLALEYLHSKGIIH 123

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RDIK  NI L  +G+ + + DF  A K++  T          GT  YMAPEV     + G
Sbjct: 124 RDIKPDNILLDEQGH-VHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLC---RQG 175

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET--PTIPESLSDEGQAFAE 244
           +  AVD WSLG    E   GKRP+    S           ET     P + S E      
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPY-RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN 234

Query: 245 LCLRHDPAQR--ATIFELLQHPFL 266
             L  DP +R    + +L  HP+ 
Sbjct: 235 KLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  136 bits (344), Expect = 2e-37
 Identities = 79/262 (30%), Positives = 141/262 (53%), Gaps = 12/262 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D   ++D+  E+ +L   +   + KYYG 
Sbjct: 13  GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L+++      E  +    K+++  +  LH    +HRDIK
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 129 AANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIQQS---AYDSK 181

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P ++     +++F +     PT+    S   + F + CL  D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHP-MRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240

Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P+ R T  ELL+H F++ + ++
Sbjct: 241 PSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  136 bits (345), Expect = 2e-37
 Identities = 89/259 (34%), Positives = 142/259 (54%), Gaps = 17/259 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           GQG  G VYTA++  TG+ VA+K++ L +Q      K++++ E+ ++      N+V Y  
Sbjct: 28  GQGASGTVYTAIDVATGQEVAIKQMNLQQQPK----KELIINEILVMRENKHPNIVNYLD 83

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDI
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 141

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           KS NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G 
Sbjct: 142 KSDNILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGP 194

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCL 247
            VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253

Query: 248 RHDPAQRATIFELLQHPFL 266
             D  +R +  ELLQHPFL
Sbjct: 254 EMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  135 bits (342), Expect = 3e-37
 Identities = 81/257 (31%), Positives = 130/257 (50%), Gaps = 10/257 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+       E   LV  KE+ L  +   +  +D L E+ IL  +   N++ YY  
Sbjct: 9   GKGAFGEATLYRRTEDDSLVVWKEVNL-TRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    +++ ME    GTL + +V+       E +V  Y  Q+V A+S +H+  I+HRDI
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ NIFLT +   +KLGDFG +  + +  ++   +   VGT  YM+PE+      V +  
Sbjct: 128 KTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETV---VGTPYYMSPEL---CQGVKYNF 180

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             DIW+LGCVL E+ + KR + +  +   ++ K+  G    +    S E  +     L+ 
Sbjct: 181 KSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239

Query: 250 DPAQRATIFELLQHPFL 266
           DP +R T  E+L  P L
Sbjct: 240 DPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  136 bits (343), Expect = 3e-37
 Identities = 87/258 (33%), Positives = 141/258 (54%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G V+TA++  TG+ VA+K+I L KQ     +   + E+ +++ +   N+V +   
Sbjct: 28  GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKNPNIVNFLDS 84

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S N+ L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  
Sbjct: 143 SDNVLLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPK 195

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254

Query: 249 HDPAQRATIFELLQHPFL 266
            D  +R +  ELLQHPFL
Sbjct: 255 MDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  135 bits (342), Expect = 3e-37
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 35/268 (13%)

Query: 11  GQGRFGKVY----TAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+VY        +     VA+K ++          ++ L E RI+  ++  N+VK
Sbjct: 8   GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHPNIVK 65

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIV 125
             GV    E +++ ME    G L   ++      L    +  +  Q+   +  L     +
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI 125

Query: 126 HRDIKSANIFLTAEGNSLKLGDFG-------SAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           HRD+ + N  +  E   +K+ DFG                 +P      +    +MAPE 
Sbjct: 126 HRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVKGGKLP------I---RWMAPES 175

Query: 179 FMD---TNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
             +   T+K       D+WS G +L E+ + G+ P+    SN +++  +  G     P +
Sbjct: 176 LKEGKFTSK------SDVWSFGVLLWEIFTLGEEPYPG-MSNAEVLEYLKKGYRLPKPPN 228

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQ 262
              E       C   DP  R T  EL++
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  135 bits (341), Expect = 6e-37
 Identities = 81/257 (31%), Positives = 136/257 (52%), Gaps = 12/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+VY  ++N T E+VA+K I L +  D   ++D+  E+ +L   +   + +YYG 
Sbjct: 13  GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYGS 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 129 AANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDFK 181

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P ++     +++F +     PT+    S   + F E CL  D
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHP-MRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240

Query: 251 PAQRATIFELLQHPFLI 267
           P  R T  ELL+H F+ 
Sbjct: 241 PRFRPTAKELLKHKFIT 257

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  137 bits (346), Expect = 7e-37
 Identities = 91/267 (34%), Positives = 138/267 (51%), Gaps = 27/267 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G VY  ++  TG L A+K I  + ++  R  + +  E+ IL  +N  N+VK + +
Sbjct: 83  GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVKCHDM 140

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H  E+ + +E    G+LE    + E  L +V      +Q++  I+ LH   IVHRDIK
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV-----ARQILSGIAYLHRRHIVHRDIK 195

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNKVGH-G 188
            +N  L     ++K+ DFG + +I A T  P   N  VGT AYM+PE +  D N   + G
Sbjct: 196 PSN-LLINSAKNVKIADFGVS-RILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDG 251

Query: 189 RAVDIWSLGCVLVEMSSGKRP--------WAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
            A DIWSLG  ++E   G+ P        WA       +M  + M + P  P + S E +
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPFGVGRQGDWA------SLMCAICMSQPPEAPATASREFR 305

Query: 241 AFAELCLRHDPAQRATIFELLQHPFLI 267
            F   CL+ +PA+R +  +LLQHPF++
Sbjct: 306 HFISCCLQREPAKRWSAMQLLQHPFIL 332

Length = 353

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  135 bits (341), Expect = 8e-37
 Identities = 93/286 (32%), Positives = 144/286 (50%), Gaps = 41/286 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V    + ETG++VA+K+  L  ++D    K  + E+R+L+ +  +NLV    V
Sbjct: 10  GEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ + L  E      L+ L +   +GL E  VR+Y  Q++  I   H + I+HRDIK
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDL-EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI ++  G  +KL DFG A  ++A    PGE+   +V T+ Y APE+ +   K  +GR
Sbjct: 128 PENILVSQSG-VVKLCDFGFARTLAA----PGEVYTDYVATRWYRAPELLVGDTK--YGR 180

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN----YQIMFKVG---------MGETP-----TI 231
           AVDIW++GC++ EM +G+ P    DS+    Y I+  +G           + P      +
Sbjct: 181 AVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239

Query: 232 PE------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
           PE             LS      A+ CLR DP  R +  +LL H F
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  134 bits (339), Expect = 2e-36
 Identities = 88/258 (34%), Positives = 139/258 (53%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA+K++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 84

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  
Sbjct: 143 SDNILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPK 195

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254

Query: 249 HDPAQRATIFELLQHPFL 266
            D  +R +  ELLQHPFL
Sbjct: 255 MDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  133 bits (337), Expect = 2e-36
 Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 30/270 (11%)

Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+VY       +     VA+K ++     + R  KD L E R+++ +   N+V+ 
Sbjct: 4   GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNVVRL 61

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQST--------EDGLPEVLVRRYTKQLVDAISAL 119
            GV    E + L +E    G L   ++ +        +  L    +  +  Q+   +  L
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA-----YM 174
                VHRD+ + N  +  E   +K+ DFG +  +        +      T       +M
Sbjct: 122 ASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYD------DDYYRKKTGGKLPIRWM 174

Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           APE   D          D+WS G +L E+ + G  P+    SN +++  +  G     PE
Sbjct: 175 APESLKDGI---FTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRLPKPE 230

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQH 263
              DE       C + DP  R T  EL++ 
Sbjct: 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  132 bits (333), Expect = 7e-36
 Identities = 80/257 (31%), Positives = 137/257 (53%), Gaps = 12/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D   ++D+  E+ +L   +   + KYYG 
Sbjct: 13  GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 129 AANVLLSEHG-EVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDSK 181

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P +E     +++F +     PT+  + S   + F E CL  +
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHP-MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 240

Query: 251 PAQRATIFELLQHPFLI 267
           P+ R T  ELL+H F++
Sbjct: 241 PSFRPTAKELLKHKFIV 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  131 bits (331), Expect = 2e-35
 Identities = 85/285 (29%), Positives = 144/285 (50%), Gaps = 39/285 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V+   N ETG++VA+K+  +  ++D    K  L E+R+L+ +   NLV    V
Sbjct: 10  GEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              + ++ L  E C    L  L ++   G+PE L+++   Q + A++  H++  +HRD+K
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGR 189
             NI +T +G  +KL DFG A  +   T    +   +V T+ Y APE+ + DT    +G 
Sbjct: 128 PENILITKQG-QIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPELLVGDTQ---YGP 180

Query: 190 AVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVG----------------MGETPT 230
            VD+W++GCV  E+ +G+  W   ++ D  Y I   +G                 G +  
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240

Query: 231 IPES----------LSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
            PE+          +S    +F + CL+ DP +R +  ELL+HP+
Sbjct: 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  131 bits (331), Expect = 2e-35
 Identities = 86/261 (32%), Positives = 139/261 (53%), Gaps = 15/261 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 85

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +    +   VGT  +MAPEV     +  +G  
Sbjct: 144 SDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEV---VTRKAYGPK 196

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 249 HDPAQRATIFELLQHPFLIVS 269
            D  +R +  ELLQH FL ++
Sbjct: 256 MDVEKRGSAKELLQHQFLKIA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  130 bits (327), Expect = 5e-35
 Identities = 82/261 (31%), Positives = 134/261 (51%), Gaps = 17/261 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G VY A N  TGEL A+K I+L    D   V+    E+ +++     N+V Y+G 
Sbjct: 18  GSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFGS 74

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R+++ + ME C  G+L+ +   T   L E  +   +++ +  +  LH    +HRDIK
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            ANI LT  G+ +KL DFG + +I+A      +   F+GT  +MAPEV     K G+ + 
Sbjct: 134 GANILLTDNGH-VKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ------AFAE 244
            DIW++G   +E++  + P  +      +     M ++   P  L D+ +       F +
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFL---MTKSNFQPPKLKDKMKWSNSFHHFVK 246

Query: 245 LCLRHDPAQRATIFELLQHPF 265
           + L  +P +R T  +LLQHPF
Sbjct: 247 MALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  130 bits (327), Expect = 7e-35
 Identities = 89/258 (34%), Positives = 139/258 (53%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    TG+ VA+K++ L KQ        +  E+ I+   + +N+V  Y  
Sbjct: 31  GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDMYNS 87

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT++G  +KL DFG   ++S    VP +    VGT  +MAPEV    +++ +G  
Sbjct: 146 SDSILLTSDGR-IKLSDFGFCAQVSKE--VP-KRKSLVGTPYWMAPEVI---SRLPYGTE 198

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+   +   Q M ++     P + +S  +S   + F +L L 
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257

Query: 249 HDPAQRATIFELLQHPFL 266
            +P+QRAT  ELLQHPFL
Sbjct: 258 REPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  130 bits (327), Expect = 9e-35
 Identities = 80/258 (31%), Positives = 137/258 (53%), Gaps = 13/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLH-KQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG VY A +    E+VA+K++    KQ++ ++ +D++ E+R L+ +   N ++Y G
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-QDIIKEVRFLQKLRHPNTIQYRG 82

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRD+
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ NI L+  G  +KLGDFGSA       ++    N FVGT  +MAPEV +  ++  +  
Sbjct: 142 KAGNILLSEPG-LVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAFAELCLR 248
            VD+WSLG   +E++  K P    ++    ++ +   E+P +     S+  + F + CL+
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 249 HDPAQRATIFELLQHPFL 266
             P  R T   LL+H F+
Sbjct: 253 KIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  128 bits (325), Expect = 1e-34
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 24/266 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V            A+K ++     +    + +  E  ILE  N   +VK Y  
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ + + ME C  G L ++++       E   R Y   +V A   LH   I++RD+K
Sbjct: 62  FKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 131 SANIFLTAEGNSLKLGDFGSAVKIS----AHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
             N+ L + G  +KL DFG A K+       T        F GT  Y+APE+ +  NK G
Sbjct: 121 PENLLLDSNG-YVKLVDFGFAKKLKSGQKTWT--------FCGTPEYVAPEIIL--NK-G 168

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK--VGMGETPTIPESLSDEGQAFAE 244
           +  +VD WSLG +L E+ +G+ P+ E D +   ++   +        P  +    +   +
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK 228

Query: 245 LCLRHDPAQR-----ATIFELLQHPF 265
             LR +P +R       I ++ +H +
Sbjct: 229 QLLRRNPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  128 bits (323), Expect = 2e-34
 Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 23/263 (8%)

Query: 11  GQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+VY          T   VA+K   L +       ++ L E  I++ ++  N+V+
Sbjct: 8   GEGAFGEVYKGTLKGDGEGTETKVAVK--TLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             GV    E + +  E    G L   ++   + L    + +   Q+   +  L     VH
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY-----MAPEVFMD 181
           RD+ + N  +T E   +K+ DFG +        +  +               MAPE   D
Sbjct: 126 RDLAARNCLVT-ENLVVKISDFGLS------RDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 182 TNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
             K       D+WS G +L E+ + G++P+    SN +++  +  G     PE+  DE  
Sbjct: 179 -GKFTS--KSDVWSFGVLLWEIFTLGEQPYPGM-SNEEVLELLEDGYRLPRPENCPDELY 234

Query: 241 AFAELCLRHDPAQRATIFELLQH 263
                C  +DP  R T  EL++ 
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  127 bits (319), Expect = 1e-33
 Identities = 89/259 (34%), Positives = 133/259 (51%), Gaps = 15/259 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G  VA+K + L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 30  GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNVVEMYKS 86

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  EE+ + ME    G L  +V  T   L E  +    + ++ A+  LH   ++HRDIK
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   +IS    VP +    VGT  +MAPEV    ++  +G  
Sbjct: 145 SDSILLTLDGR-VKLSDFGFCAQIS--KDVP-KRKSLVGTPYWMAPEVI---SRTPYGTE 197

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+   DS  Q M ++     P +  +  +S   + F E  L 
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 249 HDPAQRATIFELLQHPFLI 267
            +P +RAT  ELL HPFL+
Sbjct: 257 REPQERATAQELLDHPFLL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  124 bits (313), Expect = 4e-33
 Identities = 81/261 (31%), Positives = 132/261 (50%), Gaps = 17/261 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G VY A N  TGEL A+K I+L   +D   ++    E+ +++     N+V Y+G 
Sbjct: 18  GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFGS 74

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + RE++ + ME C  G+L+ +   T   L E+ +    ++ +  ++ LH    +HRDIK
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            ANI LT  G+ +KL DFG A KI+A      +   F+GT  +MAPEV       G+ + 
Sbjct: 134 GANILLTDNGD-VKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ------AFAE 244
            DIW++G   +E++  + P  +      +     M ++   P  L D+ +       F +
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFL---MSKSNFQPPKLKDKTKWSSTFHNFVK 246

Query: 245 LCLRHDPAQRATIFELLQHPF 265
           + L  +P +R T   LL H F
Sbjct: 247 ISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  123 bits (310), Expect = 1e-32
 Identities = 75/262 (28%), Positives = 128/262 (48%), Gaps = 16/262 (6%)

Query: 11  GQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG VY   +        L  +KEI + + N    V+    E ++L  ++   +VK+
Sbjct: 9   GKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN-QEAQLLSKLDHPAIVKF 67

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +   + R+   +  E C    L+  ++    T   L E  V  +  QL+  +  +H+  I
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K+ NIFL  + N LK+GDFG +  +     +      F GT  YM+PE       
Sbjct: 128 LHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLA---TTFTGTPYYMSPEAL---KH 179

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
            G+    DIWSLGC+L EM      +   +    ++ ++  G TP++PE+ S +  +  +
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRIVEGPTPSLPETYSRQLNSIMQ 238

Query: 245 LCLRHDPAQRATIFELLQHPFL 266
             L  DP+ R +  E+L++PF+
Sbjct: 239 SMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  123 bits (311), Expect = 2e-32
 Identities = 86/306 (28%), Positives = 138/306 (45%), Gaps = 59/306 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V   ++  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 10  GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIR--NQIIRELKVLHECNSPYIVGFYGA 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E   I+HRD+
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLREKHKIMHRDV 126

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNK 184
           K +NI + + G  +KL DFG          V G+L     N FVGT++YM+PE    T+ 
Sbjct: 127 KPSNILVNSRGE-IKLCDFG----------VSGQLIDSMANSFVGTRSYMSPERLQGTHY 175

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMF--KVGMGETPTIPESL------ 235
                  DIWSLG  LVEM+ G+ P         + MF   V  GE       +      
Sbjct: 176 TVQS---DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 236 ---------------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
                                      SDE Q F + CL+ +P +RA + EL +HPF+  
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Query: 269 SCEEDV 274
           +  E+V
Sbjct: 293 AELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 3e-32
 Identities = 82/263 (31%), Positives = 120/263 (45%), Gaps = 24/263 (9%)

Query: 12  QGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK---NLVKYY 68
           +G FG VY A    TG+  A+K ++         V ++  E  I+  + Q     + K Y
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM--MIQGESPYVAKLY 63

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
                ++ + L ME    G   SL++ T  GLPE   ++Y  ++V  +  LH+  I+HRD
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGH 187
           IK  N+ +   G+ LKL DFG         +  G  N  FVGT  Y+APE  +    VG 
Sbjct: 123 IKPENLLIDQTGH-LKLTDFG--------LSRNGLENKKFVGTPDYLAPETILG---VGD 170

Query: 188 GRAVDIWSLGCVLVEMSSGKRPW-AEY-DSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +  D WSLGCV+ E   G  P+ AE  D+ +  +    +     + E  S E       
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230

Query: 246 CLRHDPAQR---ATIFELLQHPF 265
            L  DPA+R       E+  HPF
Sbjct: 231 LLCMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  122 bits (309), Expect = 5e-32
 Identities = 84/268 (31%), Positives = 140/268 (52%), Gaps = 25/268 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-LEGINQKNLVKYYG 69
           G G  G+VY     +TG ++A+K  Q+ +  +    K +L++L + L+  +   +VK YG
Sbjct: 24  GSGTCGQVYKMRFKKTGHVMAVK--QMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH----ENTIV 125
             I   ++ + ME      L+ L++  +  +PE ++ + T   V  + ALH    ++ ++
Sbjct: 82  YFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMT---VAIVKALHYLKEKHGVI 137

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMAPE-VFMD 181
           HRD+K +NI L A GN +KL DFG +   V   A T          G  AYMAPE +   
Sbjct: 138 HRDVKPSNILLDASGN-VKLCDFGISGRLVDSKAKTRS-------AGCAAYMAPERIDPP 189

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEG 239
                +    D+WSLG  LVE+++G+ P+    + ++++ K+   E P++P  E  S + 
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLI 267
            +F +LCL  D  +R    ELLQHPF+ 
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  120 bits (303), Expect = 1e-31
 Identities = 62/164 (37%), Positives = 80/164 (48%), Gaps = 44/164 (26%)

Query: 256 TIFELLQHPFLIVSC------EEDV------CNPRSVPASVLQDYLKLGIVLPPMSEDSV 303
            + ELL+HP L V         E V      C+  +     L++ L+ G +L    E  +
Sbjct: 51  KVLELLKHPNL-VKYYGVEVHREKVYIFMEYCSGGT-----LEELLEHGRILD---EHVI 101

Query: 304 KVYAR---------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-L 341
           +VY                       ANIFL   G  +KLGDFG AVK+  +TT  GE +
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEV 160

Query: 342 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
               GT AYMAPEV       GHGRA DIWSLGCV++EM++GK 
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 1e-31
 Identities = 84/297 (28%), Positives = 138/297 (46%), Gaps = 62/297 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--QLHKQNDARFVKDMLVELRILEGINQ-KNLVKY 67
           G G FG VY A N ETGELVA+K++  + +   +   ++    E++ L  +N+  N+VK 
Sbjct: 8   GDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKL 63

Query: 68  YGVEIHREEMVLF--MELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTI 124
              E+ RE   L+   E   EG L  L++  +     E ++R    Q++  ++ +H++  
Sbjct: 64  K--EVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA---HTTVPGELNGFVGTQAYMAPEVFM- 180
            HRD+K  N+ L +    +K+ DFG A +I +   +T        +V T+ Y APE+ + 
Sbjct: 121 FHRDLKPENL-LVSGPEVVKIADFGLAREIRSRPPYTD-------YVSTRWYRAPEILLR 172

Query: 181 DTNKVGHGRAVDIWSLGCVLVEM------------------------SSGKRPWAEYDSN 216
            T+   +   VDIW+LGC++ E+                        +  K+ W E    
Sbjct: 173 STS---YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE---G 226

Query: 217 YQIMFKVGMGETPTIPESL-------SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           Y++  K+G       P SL       S E     +  LR DP +R T  + LQHP+ 
Sbjct: 227 YKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  121 bits (304), Expect = 2e-31
 Identities = 86/257 (33%), Positives = 132/257 (51%), Gaps = 13/257 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 29  GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 85

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 144 SDSILLTHDGR-VKLSDFGFCAQVSKE--VP-RRKSLVGTPYWMAPELI---SRLPYGPE 196

Query: 191 VDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           VDIWSLG +++EM  G+ P+  E       M +  +         +S   + F +  L  
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256

Query: 250 DPAQRATIFELLQHPFL 266
           DPAQRAT  ELL+HPFL
Sbjct: 257 DPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  120 bits (303), Expect = 2e-31
 Identities = 84/269 (31%), Positives = 130/269 (48%), Gaps = 22/269 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G+G +GKVY   N + G L A+K +      D    +++  E  IL+ + N  N+VK+YG
Sbjct: 31  GKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPNHPNVVKFYG 86

Query: 70  VEIHREEMV-----LFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE 121
           +    +++V     L +ELC  G++  LV+        L E ++       +  +  LH 
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           N I+HRD+K  NI LT EG  +KL DFG + ++   T+     N  VGT  +MAPEV   
Sbjct: 147 NRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIAC 202

Query: 182 TNKV--GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSD 237
             +    +    D+WSLG   +E+  G  P  +     + +FK+     PT+  PE    
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-VKTLFKIPRNPPPTLLHPEKWCR 261

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
               F   CL  D   R ++  LL+HPF+
Sbjct: 262 SFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  121 bits (305), Expect = 2e-31
 Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 41/286 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM--LVELRILEGINQKNLVKYY 68
           G+G +  VY A + ETG +VA+K+I+L ++ +A+   +   L E+++L+ +   N++   
Sbjct: 9   GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLL 68

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            V  H+  + L  E   E  LE +++     L    ++ Y    +  +  LH N I+HRD
Sbjct: 69  DVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ + ++G  LKL DFG A    +  +   ++   V T+ Y APE+       G G
Sbjct: 128 LKPNNLLIASDG-VLKLADFGLA---RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVG 183

Query: 189 RAVDIWSLGCVLVEMSSGK------------------------RPWAEYDSNYQIMFKVG 224
             VD+WS+GC+  E+                              W        +   V 
Sbjct: 184 --VDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV---TSLPDYVE 238

Query: 225 MGETPTIP-----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
               P  P      + SD+     +  L  +P +R T  + L+HP+
Sbjct: 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  121 bits (305), Expect = 2e-31
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 33/219 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY--- 67
           G+G FG+VY A   +TG +VA+K+I +H + D  F    L E++IL+ +   N+V     
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDM 75

Query: 68  ---YGVEIHREEMVLFM-------ELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAI 116
                 +  R+   ++M       +L   G LE+  V+ TE       ++ Y  QL++ I
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSVKLTESQ-----IKCYMLQLLEGI 128

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG--------ELNGFV 168
           + LHEN I+HRDIK+ANI +  +G  LK+ DFG A         P         +    V
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGI-LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 207
            T+ Y  PE+ +   +  +  AVDIW +GCV  EM + +
Sbjct: 188 VTRWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 3e-31
 Identities = 86/295 (29%), Positives = 128/295 (43%), Gaps = 57/295 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFV---KDMLVELRILEGINQKNL 64
           G+G FG+V+   + +TG++ AMK +    + K+N    V   +D+L +       +   +
Sbjct: 10  GRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD------ADSPWI 63

Query: 65  VK-YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           VK YY  +   E + L ME    G L +L+   +D  PE   R Y  +LV A+ ++H+  
Sbjct: 64  VKLYYSFQ-DEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF---------------- 167
            +HRDIK  NI + A+G+ +KL DFG   K++        LN                  
Sbjct: 122 FIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 168 ----------VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN- 216
                     VGT  Y+APEV        +G   D WSLG +L EM  G  P+       
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLR---GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237

Query: 217 --YQIM-FKVGMGETPTIPES--LSDEGQAFAELCLRHDPAQRATIFE-LLQHPF 265
              +I+ +K    E+   P    +S E        L  DP  R   FE +  HPF
Sbjct: 238 TYNKIINWK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  120 bits (301), Expect = 3e-31
 Identities = 83/273 (30%), Positives = 140/273 (51%), Gaps = 30/273 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ-LHKQNDARFVKDMLVELRILEGI-NQKNLVKYY 68
           G+G +GKV+  +N + G   A+K +  +H  ++     ++  E  IL+ + +  N+VK+Y
Sbjct: 27  GKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-----EIEAEYNILKALSDHPNVVKFY 81

Query: 69  GVEIHRE-----EMVLFMELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDAISALH 120
           G+   ++     ++ L +ELC  G++  LV+      + + E ++     + +  +  LH
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF- 179
            N  +HRD+K  NI LT EG  +KL DFG + ++   T+     N  VGT  +MAPEV  
Sbjct: 142 VNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIA 197

Query: 180 ----MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PE 233
               +D+    +    D+WSLG   +E+  G  P A+     + +FK+     PT+  PE
Sbjct: 198 CEQQLDST---YDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIPRNPPPTLHQPE 253

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             S+E   F   CL  D  +R T+ +LLQH F+
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  120 bits (302), Expect = 3e-31
 Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 52/291 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFV-KDMLVELRILEGINQKNLVKYYG 69
           G+G +G V+ A N ET E+VA+K ++L   +D   V    L E+ +L+ +  KN+V+ Y 
Sbjct: 9   GEGTYGTVFKAKNRETHEIVALKRVRL--DDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 70  VEIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           V +H + ++ L  E C +  L+    S    +   +V+ +  QL+  ++  H + ++HRD
Sbjct: 67  V-LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124

Query: 129 IKSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           +K  N+ +   G  LKL DFG A      V+  +   V         T  Y  P+V    
Sbjct: 125 LKPQNLLINKNGE-LKLADFGLARAFGIPVRCYSAEVV---------TLWYRPPDVLFGA 174

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKV----------GMGETP 229
               +  ++D+WS GC+  E+++  RP     + D   + +F++          G+ + P
Sbjct: 175 K--LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 230 TIPE---------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                               L+  G+   +  L  +P QR +  E LQHP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  120 bits (302), Expect = 3e-31
 Identities = 74/272 (27%), Positives = 137/272 (50%), Gaps = 17/272 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--QLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G V    +  TG ++A+K I   ++ Q   R + D+ + +R    ++    V +Y
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS---VDCPYTVTFY 66

Query: 69  GVEIHREEMVLFMELCTEGTLESL---VQSTEDGLPEVLVRRYTKQLVDAISALHEN-TI 124
           G      ++ + ME+  + +L+     V      +PE ++ +    +V A+  LH   ++
Sbjct: 67  GALFREGDVWICMEV-MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTN 183
           +HRD+K +N+ +   G  +KL DFG    IS +           G + YMAPE +  + N
Sbjct: 126 IHRDVKPSNVLINRNGQ-VKLCDFG----ISGYLVDSVAKTIDAGCKPYMAPERINPELN 180

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAF 242
           + G+    D+WSLG  ++E+++G+ P+  + + +Q + +V    +P +P E  S E Q F
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDF 240

Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
              CL+ +  +R    ELLQHPF  +   ++ 
Sbjct: 241 VNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  119 bits (300), Expect = 3e-31
 Identities = 81/267 (30%), Positives = 145/267 (54%), Gaps = 20/267 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G G +G+VY   + +TG+L A+K + +    +    +++  E+ +L+  +  +N+  YYG
Sbjct: 15  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYG 70

Query: 70  VEIHR------EEMVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHEN 122
             I +      +++ L ME C  G++  L+++T+ + L E  +    ++++  +S LH++
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-D 181
            ++HRDIK  N+ LT E   +KL DFG + ++    TV G  N F+GT  +MAPEV   D
Sbjct: 131 KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD--RTV-GRRNTFIGTPYWMAPEVIACD 186

Query: 182 TN-KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDEG 239
            N    +    D+WSLG   +EM+ G  P  +     + +F +     P +  +  S + 
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPAPRLKSKKWSKKF 245

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
           Q+F E CL  + +QR T  +L++HPF+
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 6e-31
 Identities = 86/294 (29%), Positives = 140/294 (47%), Gaps = 56/294 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +  TGE+VA+K+I+L +  D       + E+ +L+ +N  N+V+   V
Sbjct: 8   GEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 71  EIHREE---MVL-FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            +H E    +V  F++L  +  ++S       GL   L++ Y  QL+  I+  H + ++H
Sbjct: 67  -VHSENKLYLVFEFLDLDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           RD+K  N+ +  EG  LKL DFG A      V+   H  V         T  Y APE+ +
Sbjct: 123 RDLKPQNLLIDREGA-LKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILL 172

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-------------GMGE 227
            + +  +   VDIWS+GC+  EM + +RP    DS    +F++             G+  
Sbjct: 173 GSRQ--YSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229

Query: 228 TP----TIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            P    T P+           +L ++G       L +DPA+R +    LQHP+ 
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  119 bits (299), Expect = 7e-31
 Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 20/265 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V       TG++ A K++   +    +  +  L E +ILE ++ + +V   Y 
Sbjct: 2   GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYA 61

Query: 70  VEIHREEMVLFMELCTEGTLE-SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            E  ++++ L M L   G L+  +    E G PE     Y  Q++  +  LH+  IV+RD
Sbjct: 62  FET-KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ L   GN +++ D G AV++     +     G  GT  YMAPEV     +V + 
Sbjct: 121 LKPENVLLDDHGN-VRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQ--GEV-YD 172

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +VD ++LGC L EM +G+ P+ +        ++  +  +      P+  S E +   E 
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEA 231

Query: 246 CLRHDPAQR-----ATIFELLQHPF 265
            L+ DP +R      +  E+ +HP 
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 9e-31
 Identities = 82/266 (30%), Positives = 124/266 (46%), Gaps = 27/266 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           GQG +G+V+ A   +TGE+VA+K ++   L K N+ R V   L E  IL     + LVK 
Sbjct: 10  GQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV---LTERDILTTTKSEWLVKL 66

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
                  E + L ME    G   +L+ +    L E   R Y  ++ +A+ ALHE   +HR
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGYIHR 125

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  N  + A G+ +KL DFG +  I  +       N  VG+  YMAPEV       G+
Sbjct: 126 DLKPENFLIDASGH-IKLTDFGLSKGIVTYA------NSVVGSPDYMAPEVLRGK---GY 175

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWA--------EYDSNYQIMFKVGMGETPTIPESLSDEG 239
              VD WSLGC+L E   G  P++        E    ++   +  + + P    +LSDE 
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF--NLSDEA 233

Query: 240 QAFAELCLRHDPAQRATIFELLQHPF 265
                  +     +  ++ ++  HPF
Sbjct: 234 WDLITKLINDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 9e-31
 Identities = 79/303 (26%), Positives = 128/303 (42%), Gaps = 70/303 (23%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVE---LRILEGINQKNLVKY 67
           G+G +G VY A +  TG  VA+K++++   ++       L E   L+ LE     N+V+ 
Sbjct: 8   GEGAYGTVYKARDLNTGRFVALKKVRVP-LSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 68  Y----GVEIHRE-EMVLFMELCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
                G    RE ++ L  E   +     L    +    GLP   ++   +QL+  +  L
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP---GLPPETIKDLMRQLLRGVDFL 123

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI----SAHTTVPGELNGFVGTQAYMA 175
           H + IVHRD+K  NI +T++G  +K+ DFG A +I     A T+V       V T  Y A
Sbjct: 124 HSHRIVHRDLKPQNILVTSDG-QVKIADFGLA-RIYSFEMALTSV-------VVTLWYRA 174

Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK---------------------------- 207
           PEV +   +  +   VD+WS+GC+  E+   +                            
Sbjct: 175 PEVLL---QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 208 ----RPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P + + S     FK       +    + +EG    +  L  +P +R + FE LQH
Sbjct: 232 RNVSLPRSSFPSYTPRSFK-------SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 264 PFL 266
           P+ 
Sbjct: 285 PYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  118 bits (298), Expect = 1e-30
 Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 19/215 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF--VKDMLVELRILEGINQKNLVKYY 68
           G G FG+V    +  +G+  A+K   L K    +   V+ +L E RIL+ I    LV  Y
Sbjct: 10  GTGSFGRVMLVRHKGSGKYYALK--ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G       + L ME    G L S ++      PE + R Y  Q+V A+  LH   IV+RD
Sbjct: 68  GSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRD 126

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           +K  N+ L ++G  +K+ DFG A ++   T T+        GT  Y+APE+ +  +K G+
Sbjct: 127 LKPENLLLDSDG-YIKITDFGFAKRVKGRTYTL-------CGTPEYLAPEIIL--SK-GY 175

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK 222
           G+AVD W+LG ++ EM +G  P+  +D N   +++
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPF--FDDNPIQIYE 208

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  119 bits (300), Expect = 2e-30
 Identities = 74/308 (24%), Positives = 135/308 (43%), Gaps = 41/308 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +AV+  TG  VA+K+I      D    K +L E+++L  +  +N++    +
Sbjct: 9   GSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 71  EIHR-----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
                     ++ +  EL  E  L  +++S +  L +  ++ +  Q++  +  LH   ++
Sbjct: 68  LRPPSPEDFNDVYIVTEL-METDLHKVIKSPQP-LTDDHIQYFLYQILRGLKYLHSANVI 125

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K +NI + +    LK+ DFG A  +       G L  +V T+ Y APE+ + +++ 
Sbjct: 126 HRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR- 183

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGM--------GETPTIPES 234
            + +A+DIWS+GC+  E+ + K  +   D   Q   I+  +G           +      
Sbjct: 184 -YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNY 242

Query: 235 LSD----EGQAFAEL--------------CLRHDPAQRATIFELLQHPFL-IVSCEEDVC 275
           L        +  ++L               L  DP +R T  E L HP+L  +   ED  
Sbjct: 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302

Query: 276 NPRSVPAS 283
             +     
Sbjct: 303 VAKPPFDF 310

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  117 bits (295), Expect = 4e-30
 Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 38/285 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +  +GE+VA+K++++  + D   +   L E+ +L  +   N+V+   V
Sbjct: 16  GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHPNIVELKEV 74

Query: 71  EI--HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            +  H + + L ME C E  L SL+ +      E  V+    QL+  +  LHEN I+HRD
Sbjct: 75  VVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRD 133

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +N+ LT +G  LK+ DFG A     +      +   V T  Y APE+ +      + 
Sbjct: 134 LKVSNLLLTDKG-CLKIADFGLA---RTYGLPAKPMTPKVVTLWYRAPELLLGCTT--YT 187

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-----------------TI 231
            A+D+W++GC+L E+ + K          Q+   + +  TP                 T+
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247

Query: 232 PES-----------LSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
           P+            LS+ G       L +DP +RAT  E L+  +
Sbjct: 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  116 bits (291), Expect = 5e-30
 Identities = 70/256 (27%), Positives = 127/256 (49%), Gaps = 12/256 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG V+        +LV +K+I + +   D R       E ++L+ ++  N+++YY 
Sbjct: 9   GRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEYYE 66

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRD 128
             +  + +++ ME    GTL   +Q   +  L E  +  +  Q++ A+  +H   I+HRD
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRD 126

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K+ NI L      +K+GDFG    IS   +   +    VGT  Y++PE+        + 
Sbjct: 127 LKTQNILLDKHKMVVKIGDFG----ISKILSSKSKAYTVVGTPCYISPEL---CEGKPYN 179

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           +  DIW+LGCVL E++S KR + E  +   ++ K+  G    I +  S + +      L 
Sbjct: 180 QKSDIWALGCVLYELASLKRAF-EAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238

Query: 249 HDPAQRATIFELLQHP 264
            DP++R  + +++  P
Sbjct: 239 LDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  115 bits (290), Expect = 8e-30
 Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 15/260 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV---ELRILEGINQKNLVKY 67
           G+G FGK+Y A      E   +KEI L K      VK+      E+ +L  +   N+V +
Sbjct: 9   GEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP----VKEKEASKKEVILLAKMKHPNIVTF 64

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVH 126
           +        + + ME C  G L   +      L  E  +  +  Q+   +  +H+  I+H
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILH 124

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RDIKS NIFL+  G   KLGDFG A +++    +       VGT  Y++PE+  +     
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQNRP--- 178

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           +    DIWSLGCVL E+ + K P+ E ++ +Q++ K+  G    I  + S + ++     
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQL 237

Query: 247 LRHDPAQRATIFELLQHPFL 266
            +  P  R +I  +L+ PFL
Sbjct: 238 FKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  115 bits (291), Expect = 1e-29
 Identities = 85/293 (29%), Positives = 132/293 (45%), Gaps = 54/293 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI------QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G+G  G V       TG + A+K I       L KQ        +L EL I +      +
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ--------ILRELEINKSCKSPYI 61

Query: 65  VKYYG--VEIHREEMVLFMELCTEGTLESL---VQSTEDGLPEVLVRRYTKQLVDAISAL 119
           VKYYG  ++     + + ME C  G+L+S+   V+     + E ++ +  + ++  +S L
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYM 174
           H   I+HRDIK +NI LT +G  +KL DFG          V GEL       F GT  YM
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQ-VKLCDFG----------VSGELVNSLAGTFTGTSFYM 170

Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA-------------EYDSNYQIMF 221
           APE         +    D+WSLG  L+E++  + P+               Y  N   M 
Sbjct: 171 APERIQGKP---YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MP 224

Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
              + + P      S+E + F + CL  DP +R T +++L+HP++    ++ V
Sbjct: 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  114 bits (287), Expect = 2e-29
 Identities = 79/256 (30%), Positives = 130/256 (50%), Gaps = 19/256 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY--- 67
           G+G FG+     +  + +  AMKEI+L K + A  V+D   E  +L  +   N+V +   
Sbjct: 9   GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVH 126
           +  + H   + + ME C  G L   ++     L PE  + ++  Q+   +  +HE  ++H
Sbjct: 67  FEADGH---LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKV 185
           RDIKS NIFLT  G  +KLGDFGSA ++      PG     +VGT  Y+ PE++     +
Sbjct: 124 RDIKSKNIFLTQNGK-VKLGDFGSA-RLLTS---PGAYACTYVGTPYYVPPEIW---ENM 175

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +    DIWSLGC+L E+ + K P+ + +S   ++ KV  G    +P   S E ++  + 
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF-QANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234

Query: 246 CLRHDPAQRATIFELL 261
             + +P  R +   +L
Sbjct: 235 MFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  115 bits (289), Expect = 2e-29
 Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 50/290 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  VY   N  TGE+VA+KEI L  +         + E+ +++ +  +N+V+ + V
Sbjct: 9   GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHDV 66

Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALHENTIVHR 127
            IH E +++L  E   +  L+  + +      L    V+ +T QL+  I+  HEN ++HR
Sbjct: 67  -IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF---VGTQAYMAPEVFMDTNK 184
           D+K  N+ +   G  LKL DFG A        +P  +N F   V T  Y AP+V + +  
Sbjct: 125 DLKPQNLLINKRGE-LKLADFGLARAFG----IP--VNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETP---TIPE-SLSDE 238
             +  ++DIWS+GC++ EM +G+  +   ++  Q+  +F++ MG TP   T P  S   E
Sbjct: 178 --YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI-MG-TPTESTWPGISQLPE 233

Query: 239 GQAFAELC-----------------------LRHDPAQRATIFELLQHPF 265
            +                             L+ +P  R +  + LQHP+
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  115 bits (289), Expect = 2e-29
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 28/270 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR-ILEGINQKNLVKYYG 69
           G+G FG V   ++  +G ++A+K I+     D +  K +L++L  ++   +   +VK+YG
Sbjct: 13  GRGAFGTVNKMLHKPSGTIMAVKRIRS--TVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 70  VEIHREEMVLFMELCTEGTLESLVQ----STEDGLPEVLVRRYTKQLVDAISALHEN-TI 124
                 +  + MEL  + +L+   +      +  +PE ++ +     V A++ L E   I
Sbjct: 71  ALFREGDCWICMEL-MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF-----VGTQAYMAPEVF 179
           +HRD+K +NI L   GN +KL DFG    IS        ++        G + YMAPE  
Sbjct: 130 IHRDVKPSNILLDRNGN-IKLCDFG----ISGQL-----VDSIAKTRDAGCRPYMAPERI 179

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL---- 235
             + + G+    D+WSLG  L E+++GK P+ +++S +  + +V  G+ P +  S     
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQHPF 265
           S     F  LCL  D ++R    ELL+HPF
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 3e-29
 Identities = 82/265 (30%), Positives = 126/265 (47%), Gaps = 19/265 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+VY     +T  + AMK +   +    + V   + E  IL            G+
Sbjct: 2   GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGL 61

Query: 71  EIHRE---EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +   +   ++ L  +  + G L   +Q  E    E   + Y  +LV A+  LH+  IV+R
Sbjct: 62  KFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 128 DIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           D+K  NI L A G+ + L DFG S   ++ + T     N F GT  Y+APEV +D  + G
Sbjct: 121 DLKPENILLDATGH-IALCDFGLSKANLTDNKTT----NTFCGTTEYLAPEVLLD--EKG 173

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDEGQAFAEL 245
           + + VD WSLG ++ EM  G  P+  Y  + Q M++ +  G+       LSDEG+ F + 
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231

Query: 246 CLRHDPAQR----ATIFELLQHPFL 266
            L  +P  R        EL +HPF 
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  114 bits (287), Expect = 3e-29
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 50/290 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 9   GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 67

Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 68  -IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 127 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 176

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-------------GMGETP- 229
              +  AVDIWSLGC+  EM + +R     DS    +F++             G+   P 
Sbjct: 177 Y--YSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233

Query: 230 --------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                          +   L ++G+      L +DP +R +    L HPF
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  115 bits (289), Expect = 5e-29
 Identities = 72/208 (34%), Positives = 105/208 (50%), Gaps = 12/208 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V       TG++ AMK +    L  Q    F ++   E  IL   N   + + 
Sbjct: 10  GRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDILSISNSPWIPQL 66

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
                 ++ + L ME    G L SL+   ED   E + + Y  +LV AI ++H+   VHR
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN---K 184
           DIK  N+ +   G+ +KL DFGSA +++A+  V  +L   VGT  Y+APEV    N   K
Sbjct: 127 DIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEVLTTMNGDGK 183

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAE 212
             +G   D WSLG +  EM  G+ P+ E
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  113 bits (283), Expect = 1e-28
 Identities = 81/267 (30%), Positives = 142/267 (53%), Gaps = 20/267 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G G +G+VY   + +TG+L A+K + + +  +    +++ +E+ +L+  +  +N+  YYG
Sbjct: 25  GNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHRNIATYYG 80

Query: 70  VEI------HREEMVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHEN 122
             I      H +++ L ME C  G++  LV++T+ + L E  +    ++++  ++ LH +
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-D 181
            ++HRDIK  N+ LT E   +KL DFG + ++    TV G  N F+GT  +MAPEV   D
Sbjct: 141 KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD--RTV-GRRNTFIGTPYWMAPEVIACD 196

Query: 182 TN-KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDEG 239
            N    +    DIWSLG   +EM+ G  P  +     + +F +     P +  +  S + 
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPPPKLKSKKWSKKF 255

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
             F E CL  +   R +  +LL+HPF+
Sbjct: 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  113 bits (283), Expect = 1e-28
 Identities = 75/226 (33%), Positives = 123/226 (54%), Gaps = 11/226 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM-LVELRILEGINQKNLVKYYG 69
           G+G +G V    + ET E+VA+K+ +  ++N+   VK+  L EL++L  + Q+N+V+   
Sbjct: 10  GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE--VKETTLRELKMLRTLKQENIVELKE 67

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               R ++ L  E   +  LE L++   +G+P   VR Y  QL+ AI   H+N IVHRDI
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ ++   + LKL DFG A  +S  +        +V T+ Y +PE+ +      +G+
Sbjct: 127 KPENLLISHN-DVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAP---YGK 180

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           AVD+WS+GC+L E+S G+ P    +S    +F +     P   E +
Sbjct: 181 AVDMWSVGCILGELSDGQ-PLFPGESEIDQLFTIQKVLGPLPAEQM 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  113 bits (284), Expect = 2e-28
 Identities = 89/283 (31%), Positives = 134/283 (47%), Gaps = 29/283 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK----EIQLHKQNDARFVKDMLVELRILEGINQKNL-- 64
           G+G FGKV       TG+  AMK    E+ + K      V   L E R+L+      L  
Sbjct: 4   GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE----VAHTLTESRVLQNTRHPFLTA 59

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +KY      R  +   ME    G L   + S E    E   R Y  ++V A+  LH   +
Sbjct: 60  LKYSFQTHDR--LCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALGYLHSCDV 116

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           V+RD+K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +
Sbjct: 117 VYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND 171

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
              +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++  
Sbjct: 172 ---YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLSPEAKSLL 226

Query: 244 ELCLRHDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
              L+ DP QR         E+++H F      +DV   +  P
Sbjct: 227 AGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP 269

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  113 bits (284), Expect = 3e-28
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 53/307 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-- 68
           G G  G V++AV+++  + VA+K+I L    D + VK  L E++I+  ++  N+VK Y  
Sbjct: 14  GCGSNGLVFSAVDSDCDKRVAVKKIVL---TDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 69  ------------GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAI 116
                       G       + +  E   E  L ++++  +  L E   R +  QL+  +
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE--QGPLSEEHARLFMYQLLRGL 127

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
             +H   ++HRD+K AN+F+  E   LK+GDFG A  +  H +  G L+  + T+ Y +P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA-------------------EYDSN- 216
            + +  N   + +A+D+W+ GC+  EM +GK  +A                   E D N 
Sbjct: 188 RLLLSPNN--YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245

Query: 217 ------YQIMFKVGMGETP---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL- 266
                   +    G    P    +P  ++ E   F E  L  +P  R T  E L HP++ 
Sbjct: 246 LLNVIPSFVRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304

Query: 267 IVSCEED 273
             SC  D
Sbjct: 305 CYSCPFD 311

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  111 bits (278), Expect = 3e-28
 Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 14/259 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FGK     + E G+   +KEI + K     R  ++   E+ +L  +   N+V+Y  
Sbjct: 9   GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER--EESRKEVAVLSNMKHPNIVQYQE 66

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRD 128
                  + + M+ C  G L   + +    L PE  +  +  Q+  A+  +H+  I+HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGH 187
           IKS NIFLT +G ++KLGDFG A  +  ++TV  EL    +GT  Y++PE+    N+  +
Sbjct: 127 IKSQNIFLTKDG-TIKLGDFGIARVL--NSTV--ELARTCIGTPYYLSPEIC--ENRPYN 179

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ DIW+LGCVL EM + K  + E  +   ++ K+  G  P +    S + +       
Sbjct: 180 NKS-DIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237

Query: 248 RHDPAQRATIFELLQHPFL 266
           + +P  R ++  +L+  F+
Sbjct: 238 KRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  111 bits (279), Expect = 9e-28
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 20/205 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+ A + +T ++VA+K++ +  + +  F    L E++IL+ +  +N+V     
Sbjct: 21  GQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLI-- 77

Query: 71  EIHREE----------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
           EI R +            L  E C E  L  L+ +         +++  K L++ +  +H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVF 179
            N I+HRD+K+ANI +T +G  LKL DFG A   S    + P      V T  Y  PE+ 
Sbjct: 137 RNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195

Query: 180 M-DTNKVGHGRAVDIWSLGCVLVEM 203
           + + +   +G  +D+W  GC++ EM
Sbjct: 196 LGERD---YGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  110 bits (277), Expect = 1e-27
 Identities = 88/282 (31%), Positives = 135/282 (47%), Gaps = 27/282 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK----EIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV       TG   AMK    E+ + K      V   + E R+L+      L  
Sbjct: 4   GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----VAHTVTESRVLQNTRHPFLTA 59

Query: 67  Y-YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y  + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V
Sbjct: 60  LKYAFQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +RDIK  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D + 
Sbjct: 118 YRDIKLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND- 171

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
             +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++   
Sbjct: 172 --YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLA 227

Query: 245 LCLRHDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
             L+ DP QR     +   E+++H F +    +DV   + +P
Sbjct: 228 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 269

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  108 bits (271), Expect = 6e-27
 Identities = 81/294 (27%), Positives = 137/294 (46%), Gaps = 55/294 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G+G +G VY   N +TG++VAMK+I+L  + +   V    + E+ +L+ +   N+V    
Sbjct: 9   GEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG--VPSTAIREISLLKELQHPNIVCLQD 66

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHENTIVHR 127
           V +    + L  E  +   L+  + S   G  +   LV+ Y  Q++  I   H   ++HR
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125

Query: 128 DIKSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           D+K  N+ +  +G  +KL DFG A      V++  H  V         T  Y APEV + 
Sbjct: 126 DLKPQNLLIDNKGV-IKLADFGLARAFGIPVRVYTHEVV---------TLWYRAPEVLLG 175

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV--GMGETPT--------- 230
           + +  +   VDIWS+G +  EM++ K+P    DS    +F++   +G TPT         
Sbjct: 176 SPR--YSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILG-TPTEDVWPGVTS 231

Query: 231 IPE------------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           +P+                  +L ++G    E  L +DPA+R +  + L HP+ 
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  108 bits (271), Expect = 9e-27
 Identities = 81/296 (27%), Positives = 138/296 (46%), Gaps = 53/296 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN-LVKYYG 69
           G+G +GKVY A +  TG+LVA+K+ +L + ++       L E+ +L+ +++   +V+   
Sbjct: 10  GEGTYGKVYKARDKNTGKLVALKKTRL-EMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 70  VEIHREE-------MVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
           VE H EE        ++F  L ++  L+  + S   G    LP   ++ +  QL+  ++ 
Sbjct: 69  VE-HVEEKNGKPSLYLVFEYLDSD--LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP-GELNGFVGTQAYMAPE 177
            H++ ++HRD+K  N+ +  +   LK+ D G    +    ++P       + T  Y APE
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLG----LGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV--GMGETPT----- 230
           V + +    +   VDIWS+GC+  EMS  K+P    DS  Q +  +   +G TPT     
Sbjct: 182 VLLGSTH--YSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLLHIFKLLG-TPTEQVWP 237

Query: 231 ---------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                                    LS EG    +  LR+DPA+R +    L HP+
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  108 bits (272), Expect = 9e-27
 Identities = 68/287 (23%), Positives = 121/287 (42%), Gaps = 42/287 (14%)

Query: 18  VYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM 77
           V+ A +  T  LVA+K+I L   +     K +  E+     +   N++ Y    I   E+
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDSCSKEDL-KLLQQEIITSRQLQHPNILPYVTSFIVDSEL 74

Query: 78  VLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL 136
            +   L   G+ E L+++   +GLPE+ +    K +++A+  +H    +HR +K+++I L
Sbjct: 75  YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL 134

Query: 137 TAEGNSLKLGDFGSAVKISAHTTVPGELNGF----VGTQAYMAPEVFMDTNKVGHGRAVD 192
           + +G    L     +V +  H      ++ F    V    +++PEV +  N  G+    D
Sbjct: 135 SGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV-LQQNLQGYNEKSD 192

Query: 193 IWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP------TIPESLSDEGQ------ 240
           I+S+G    E+++G  P+ +  +   ++ KV  G  P      T P       Q      
Sbjct: 193 IYSVGITACELANGHVPFKDMPATQMLLEKVR-GTVPCLLDKSTYPLYEDSMSQSRSSNE 251

Query: 241 ---------------------AFAELCLRHDPAQRATIFELLQHPFL 266
                                 F ELCL+ DP  R +  +LL H F 
Sbjct: 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  107 bits (268), Expect = 3e-26
 Identities = 88/281 (31%), Positives = 131/281 (46%), Gaps = 24/281 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   L E R+L+      L    Y 
Sbjct: 4   GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH E  +V+RD
Sbjct: 64  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 129 IKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K  N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +  
Sbjct: 122 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA------TMKTFCGTPEYLAPEVLEDND-- 172

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++    
Sbjct: 173 -YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLSPEAKSLLSG 229

Query: 246 CLRHDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            L+ DP QR         E++QH F      +DV   + VP
Sbjct: 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP 270

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  106 bits (265), Expect = 5e-26
 Identities = 81/287 (28%), Positives = 134/287 (46%), Gaps = 45/287 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V    +  TG ++A K + +  ++  R  K +L EL+I+       +V +YG 
Sbjct: 14  GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYGA 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            ++   + + ME    G+L+ +    + G +P  ++ +    +V+ ++ L+  + I+HRD
Sbjct: 72  FLNENNICMCMEFMDCGSLDRI--YKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTN 183
           IK +NI + + G  +KL DFG          V GEL     + FVGT  YM+PE      
Sbjct: 130 IKPSNILVNSRGQ-IKLCDFG----------VSGELINSIADTFVGTSTYMSPERIQ--- 175

Query: 184 KVGHGRAV--DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG-----------ETP 229
             G    V  D+WSLG  ++E++ GK P+A   SN     +   MG             P
Sbjct: 176 --GGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGILDLLQQIVQEPPP 231

Query: 230 TIPES-LSDEGQAFAELCLRHDPAQRATIFELL-QHPFLIVSCEEDV 274
            +P S   ++ + F + CL  DP +R T  +L    PF+      +V
Sbjct: 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  105 bits (265), Expect = 6e-26
 Identities = 88/294 (29%), Positives = 144/294 (48%), Gaps = 56/294 (19%)

Query: 12  QGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY---- 67
           +G +G VY A + +TGE+VA+K++++ K+ +  F    L E+ IL  +   N+V      
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-FPITSLREINILLKLQHPNIVTVKEVV 73

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            G  + +  MV  ME   E  L+SL+++ +    +  V+    QL+  ++ LH+N I+HR
Sbjct: 74  VGSNLDKIYMV--ME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K++N+ L   G  LK+ DFG A +     +        V T  Y APE+ +   +   
Sbjct: 131 DLKTSNLLLNNRG-ILKICDFGLAREYG---SPLKPYTQLVVTLWYRAPELLLGAKEYST 186

Query: 188 GRAVDIWSLGCVLVEMSSGKRPW----AEYDSNYQIMFKVGMGETPTI---PE------- 233
             A+D+WS+GC+  E+ + K+P     +E D   +I FK+ +G TPT    P        
Sbjct: 187 --AIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNKI-FKL-LG-TPTEKIWPGFSELPGA 240

Query: 234 --------------------SLSDEGQAFAELC--LRHDPAQRATIFELLQHPF 265
                               SLSD G  F  L   L +DPA+R +  + L+HP+
Sbjct: 241 KKKTFTKYPYNQLRKKFPALSLSDNG--FDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 2e-25
 Identities = 78/311 (25%), Positives = 142/311 (45%), Gaps = 60/311 (19%)

Query: 11  GQGRFGKVYTAV--NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G+VY A   N + G+  A+K+ +  K+      +    E+ +L  +  +N+V   
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 69  GVEIHREEMVLFMEL-CTEGTLESLV----QSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V +   +  +++     E  L  ++    Q+    +P  +V+    Q+++ +  LH N 
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128

Query: 124 IVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           ++HRD+K ANI +  EG     +K+GD G A   +A      +L+  V T  Y APE+ +
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL 188

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPW----AEYDSN--YQI-----MFKVGMGETP 229
                 + +A+DIW++GC+  E+ + +  +    A+   +  +Q      +F+V +G TP
Sbjct: 189 GARH--YTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV-LG-TP 244

Query: 230 T---------IPE----------------SLSD--------EGQAFAEL--CLRHDPAQR 254
           T         +PE                SL+         + Q F  L   L +DP +R
Sbjct: 245 TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304

Query: 255 ATIFELLQHPF 265
            T  E L+HP+
Sbjct: 305 ITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)

Query: 6   FSVSP--------GQGRFGKVYTAVNNETGELVAMKEIQ-LHKQNDARFVKDMLVELRIL 56
           F V P        G+G +G V +A +  TG  VA+K+I     Q    F +  L E++IL
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKIL 57

Query: 57  EGINQKNLVKYYGVEI--HREEM--VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQL 112
                +N++    +      E    V  ++   E  L  L+++    L    ++ +  Q+
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQYFLYQI 115

Query: 113 VDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA 172
           +  +  +H   ++HRD+K +N+ L    + LK+ DFG A          G L  +V T+ 
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
           Y APE+ M  +K G+ +A+DIWS+GC+L EM S +  +   D  +Q+   +G+  TP+  
Sbjct: 175 YRAPEI-MLNSK-GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232

Query: 233 E--------------SL-SDEGQAFAELCLRHD--------------PAQRATIFELLQH 263
           +              SL       + +L    D              P +R T+ E L H
Sbjct: 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292

Query: 264 PFL 266
           P+L
Sbjct: 293 PYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  105 bits (262), Expect = 2e-25
 Identities = 81/276 (29%), Positives = 127/276 (46%), Gaps = 15/276 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV       +G+  AMK ++         V   L E R+L+      L      
Sbjct: 4   GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ +   ME    G L     S E    E   R Y  ++V A+  LH   IV+RD+K
Sbjct: 64  FQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L  +G+ +K+ DFG         T    +  F GT  Y+APEV  D +   +GRA
Sbjct: 123 LENLMLDKDGH-IKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDND---YGRA 175

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS + ++     L  D
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKD 233

Query: 251 PAQRA-----TIFELLQHPFLIVSCEEDVCNPRSVP 281
           P +R         E+++H F      +DV + + VP
Sbjct: 234 PNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  103 bits (260), Expect = 3e-25
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 59/294 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQ-----NDARFVKDMLVELRILEGINQKNLV 65
           G+G F +V  A + +TG+  A+K ++ H +     N+ R ++ +    R L      N++
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQAL----RRLSP--HPNIL 61

Query: 66  KYYGVEIHREE----MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
           +   +E+  +     + L  EL  +  L  L++  +  LPE  V+ Y  QL+ ++  +H 
Sbjct: 62  RL--IEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           N I HRDIK  NI +  + + LKL DFGS   I  ++  P     ++ T+ Y APE  + 
Sbjct: 119 NGIFHRDIKPENILI--KDDILKLADFGSCRGI--YSKPP--YTEYISTRWYRAPECLLT 172

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSS------G------------------------KRPWA 211
               G    +DIW++GCV  E+ S      G                         R   
Sbjct: 173 DGYYGP--KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230

Query: 212 EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
               NY    K G G    +P + S EG    +  L +DP +R T  + L+HP+
Sbjct: 231 H--MNYNFPSKKGTGLRKLLP-NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  103 bits (257), Expect = 3e-25
 Identities = 74/258 (28%), Positives = 129/258 (50%), Gaps = 11/258 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G+G +G+V    +   G+   +K++ L +    R  K    E ++L  +   N+V Y   
Sbjct: 9   GKGSYGEVSLVRHRTDGKQYVIKKLNL-RNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 70  VEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            E     + + M  C  G L   L +     LPE  V  +  Q+  A+  LHE  I+HRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K+ N+FLT   N +K+GD G A  +     +   L   +GT  YM+PE+F  +NK  + 
Sbjct: 128 LKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELF--SNKPYNY 181

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           ++ D+W+LGC + EM++ K  +   D N  +++++  G+ P +P+  S E        L 
Sbjct: 182 KS-DVWALGCCVYEMATLKHAFNAKDMN-SLVYRIIEGKLPPMPKDYSPELGELIATMLS 239

Query: 249 HDPAQRATIFELLQHPFL 266
             P +R ++  +L+ P++
Sbjct: 240 KRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  104 bits (262), Expect = 4e-25
 Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 52/296 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +A++  +G+ VA+K+I  H  +     K  L EL+IL      N++     
Sbjct: 14  GSGAYGVVCSAIDTRSGKKVAIKKIP-HAFDVPTLAKRTLRELKILRHFKHDNIIAI--R 70

Query: 71  EIHREEMVLF------MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +I R     F      M+L  E  L  ++ S +  L E  +R +  QL+  +  +H   +
Sbjct: 71  DILRPPGADFKDVYVVMDL-MESDLHHIIHSDQP-LTEEHIRYFLYQLLRGLKYIHSANV 128

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF----VGTQAYMAPEVFM 180
           +HRD+K +N+ L  E   L++GDFG A  +S   + P E   F    V T+ Y APE+ +
Sbjct: 129 IHRDLKPSNL-LVNEDCELRIGDFGMARGLS---SSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKR---PWAEYDSNYQ-IMFKVGMGETPTIPESLS 236
                 +  A+D+WS+GC+  EM  G+R   P   Y    + I+  +G      +    S
Sbjct: 185 SLP--EYTTAIDMWSVGCIFAEM-LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241

Query: 237 DEGQAFAELC--------------------------LRHDPAQRATIFELLQHPFL 266
           D  + + +                            L+ DP +R T+ + LQHPFL
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 4e-25
 Identities = 85/293 (29%), Positives = 123/293 (41%), Gaps = 49/293 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G  G+V+      TG+L A+K +   ++ K+N    VK +L E  IL  ++   L   
Sbjct: 10  GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK---VKRVLTEQEILATLDHPFLPTL 66

Query: 68  YGVEIHREEMVLF-MELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIV 125
           Y      E  +   M+ C  G L  L+Q      L E + R Y  +++ A+  LH   IV
Sbjct: 67  YAS-FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125

Query: 126 HRDIKSANIFLTAEGN--------SLKLGDFGSAVKISAHTTVPGEL------------- 164
           +RD+K  NI L   G+        S +       V  +                      
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185

Query: 165 ----NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM 220
               N FVGT+ Y+APEV    +  GHG AVD W+LG +L EM  G  P+    SN    
Sbjct: 186 SFRSNSFVGTEEYIAPEVI---SGDGHGSAVDWWTLGILLYEMLYGTTPFK--GSNRDET 240

Query: 221 FKVGMGETPTIPES--LSDEGQAFAELCLRHDPAQR------ATIFELLQHPF 265
           F   + +  T P S  +S   +      L  DP++R      A   E+ QHPF
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA--EIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  103 bits (260), Expect = 4e-25
 Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 18/262 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN-LVKYYG 69
           G+G FGKV  A    T EL A+K ++         V+  + E R+L    +   L + + 
Sbjct: 4   GKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHS 63

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               ++ +   ME    G L   +Q +     E   R Y  ++V  +  LHE  I++RD+
Sbjct: 64  CFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L +EG+ +K+ DFG    +     + G   + F GT  Y+APE+        +G
Sbjct: 123 KLDNVLLDSEGH-IKIADFG----MCKEGILGGVTTSTFCGTPDYIAPEILSYQP---YG 174

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
            AVD W+LG +L EM +G+ P+   D +   +F+  + +    P  LS E ++  +  L 
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQSILEDEVRYPRWLSKEAKSILKSFLT 232

Query: 249 HDPAQR----ATIF-ELLQHPF 265
            +P +R     T   ++  HPF
Sbjct: 233 KNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  102 bits (257), Expect = 7e-25
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 26/213 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+VY A + +TGELVA+K+++L  + +  F    + E++IL  +N +N+V    +
Sbjct: 16  GEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-FPITAIREIKILRQLNHRNIVNLKEI 74

Query: 71  EIHREEMVLF-------------MELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAI 116
              +++ + F             M+    G LES LV  +ED      ++ + KQL++ +
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-----IKSFMKQLLEGL 129

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           +  H+   +HRDIK +NI L  +G  +KL DFG A   ++  + P      V T  Y  P
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNNKGQ-IKLADFGLARLYNSEESRP--YTNKVITLWYRPP 186

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP 209
           E+ +   +  +G A+D+WS GC+L E+ + K+P
Sbjct: 187 ELLLGEER--YGPAIDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  101 bits (253), Expect = 2e-24
 Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 21/268 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V       TG+L A K++   +    +  +  +VE RIL  ++ + +V   Y 
Sbjct: 2   GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA 61

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVH 126
            +  + ++ L M +   G L   + + ++   G PE     YT Q++  +  LH+  I++
Sbjct: 62  FQT-KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L  +GN +++ D G AV++    +   +  G+ GT  +MAPE+        
Sbjct: 121 RDLKPENVLLDNDGN-VRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEE--- 173

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           +  +VD ++LG  L EM + + P+    E   N ++  ++ + ++ T P+  S   ++F 
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFC 232

Query: 244 ELCLRHDPAQR-----ATIFELLQHPFL 266
           E  L  DP +R          L  HP  
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 81/274 (29%), Positives = 131/274 (47%), Gaps = 31/274 (11%)

Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKN 63
           G G +GKV+       ++ G+L AMK ++    + K   A   +    E ++LE + +  
Sbjct: 9   GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR---TERQVLEAVRRCP 65

Query: 64  LVKYYGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +    V +H       ++ L ++    G L + +   E    E  VR Y  ++V A+  
Sbjct: 66  FL----VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-FTESEVRVYIAEIVLALDH 120

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           LH+  I++RDIK  NI L +EG+ + L DFG + +  A          F GT  YMAPEV
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEE--ERAYSFCGTIEYMAPEV 177

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPESL 235
            +     GH +AVD WSLG +  E+ +G  P+    E +S  +I  ++ +   P  P+++
Sbjct: 178 -IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI-LKSKPPFPKTM 235

Query: 236 SDEGQAFAELCLRHDPAQR---ATIFELLQHPFL 266
           S E + F +  L  DP +R       E+  HPF 
Sbjct: 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  103 bits (259), Expect = 2e-24
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 54/295 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV----K 66
           G G FG VY A+  +T E VA+K++    Q   R       EL I++ +N  N++     
Sbjct: 75  GNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFLKDY 127

Query: 67  YYGVEIHREEMVLFMELCTEGTLESL------VQSTEDGLPEVLVRRYTKQLVDAISALH 120
           YY     + E  +F+ +  E   +++             LP  LV+ Y+ QL  A++ +H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVF 179
              I HRD+K  N+ +    ++LKL DFGSA  + A     G+ +  ++ ++ Y APE+ 
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-----GQRSVSYICSRFYRAPELM 242

Query: 180 M-DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT-------- 230
           +  TN   H   +D+WSLGC++ EM  G   ++   S  Q++  + +  TPT        
Sbjct: 243 LGATNYTTH---IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299

Query: 231 -------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                               P+   D+   F    L+++P +R    E L  PF 
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354

Length = 440

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  102 bits (255), Expect = 2e-24
 Identities = 82/253 (32%), Positives = 117/253 (46%), Gaps = 26/253 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQ----NDARFVKDMLVELRILEGINQKN--- 63
           G+G FGKV  A   +TGEL A+K   L K      D   V+ ++ E RI E  N +    
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIK--ALKKGDIIARDE--VESLMCEKRIFETANSERHPF 63

Query: 64  LVKYYGVEIHREEMVLF-MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           LV  +      E+ V F ME    G L   +    D   E     Y   +V  +  LHEN
Sbjct: 64  LVNLFAC-FQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHEN 120

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMD 181
            IV+RD+K  N+ L  EG  +K+ DFG    +       G+    F GT  ++APEV  +
Sbjct: 121 KIVYRDLKLDNLLLDTEGF-VKIADFG----LCKEGMGFGDRTSTFCGTPEFLAPEVLTE 175

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
           T+   + RAVD W LG ++ EM  G+ P+   D   + +F   + +    P  LS E  +
Sbjct: 176 TS---YTRAVDWWGLGVLIYEMLVGESPFPGDDE--EEVFDSIVNDEVRYPRFLSREAIS 230

Query: 242 FAELCLRHDPAQR 254
                LR +P +R
Sbjct: 231 IMRRLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  102 bits (256), Expect = 2e-24
 Identities = 92/343 (26%), Positives = 155/343 (45%), Gaps = 76/343 (22%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DAR--FVKDM-LVELRILEGINQKNLV 65
           G+G +G V+ A++  T E+VA+K+I    +N  DA+  F + M L EL      +  N+V
Sbjct: 16  GKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIV 70

Query: 66  KYYGVEIHREE------MVL-FMELCTEGTLESLVQSTEDGLPEVLVRRY-TKQLVDAIS 117
           K   V   + E      +V  +ME  T+  L +++++    + E + +RY   QL+ A+ 
Sbjct: 71  KLLNV--IKAENDKDIYLVFEYME--TD--LHAVIRA---NILEDVHKRYIMYQLLKALK 121

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--LNGFVGTQAYMA 175
            +H   ++HRD+K +NI L ++   +KL DFG A  +S     P    L  +V T+ Y A
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK--------------------RPWAE--- 212
           PE+ + + +  + + VD+WS+GC+L EM  GK                     P AE   
Sbjct: 181 PEILLGSTR--YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 213 -YDSNY--QIMFKVGMGETPTIPESL---SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
              S +   ++  +       + E L   SD+     +  L  +P +R T  E L+HP++
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298

Query: 267 IVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSED---SVKVY 306
                    NP   P            +  P+ ++   SV  Y
Sbjct: 299 -----AQFHNPSDEPVL-------PYPITIPLDDNVKLSVAEY 329

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 4e-24
 Identities = 93/320 (29%), Positives = 141/320 (44%), Gaps = 44/320 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFV--KDMLVELRILEGINQKNL 64
           G+G FG+V       TG++ AMK +     L +   A F   +D+LV      G  +   
Sbjct: 10  GRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-----GDRRWIT 64

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
             +Y  +     + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   
Sbjct: 65  NLHYAFQ-DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY 123

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDT 182
           VHRDIK  N+ L   G+ ++L DFGS +++ A  TV  + N  VGT  Y++PE+   M+ 
Sbjct: 124 VHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTV--QSNVAVGTPDYISPEILQAMED 180

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAE--YDSNYQIMFKVGMGETPTIPESLSDEG 239
            K  +G   D WSLG  + EM  G+ P +AE   ++  +IM      + P     +S+E 
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 240 QAFAE--LCLRHDPAQRATIFELLQHPFLI-----------------VSCEEDVCNPRSV 280
           +      +C       R  + +   HPF                   VS   D  N    
Sbjct: 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSN---- 296

Query: 281 PASVLQDYLKLGIVLPPMSE 300
              V  D L+    LPP S 
Sbjct: 297 -FDVDDDDLRNTESLPPSSH 315

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V+   +  +    A+K + + +    +  + +  E R+L+ ++   +++ +  
Sbjct: 10  GTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
           E  +  + + ME    G L S ++++           Y  ++V A+  LH   IV+RD+K
Sbjct: 70  EHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L  EG+ +KL DFG A K+   T          GT  Y+APEV       GH +A
Sbjct: 129 PENILLDKEGH-IKLTDFGFAKKLRDRTWT------LCGTPEYLAPEVIQSK---GHNKA 178

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSN 216
           VD W+LG ++ EM  G  P+  +D N
Sbjct: 179 VDWWALGILIYEMLVGYPPF--FDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 83/289 (28%), Positives = 126/289 (43%), Gaps = 42/289 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVKY 67
           G G +G VY A +  +G  VA+K +++    D      V+++ + L+ LE  +  N+V+ 
Sbjct: 9   GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVRL 67

Query: 68  YGV----EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
             V       RE  V L  E   +     L +    GLP   ++   +Q +  +  LH N
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            IVHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APEV + +
Sbjct: 128 CIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMA----LTPVVVTLWYRAPEVLLQS 182

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               +   VD+WS+GC+  EM   K  +   +E D   +I   +G+      P  ++   
Sbjct: 183 T---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239

Query: 240 QAF-------------------AELCLR---HDPAQRATIFELLQHPFL 266
            AF                   A+L L     +P +R + F  LQHPF 
Sbjct: 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 82/319 (25%), Positives = 136/319 (42%), Gaps = 55/319 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKD------MLVELRILEGI 59
           G+G +GKV  A +  TG++VA+K     EI      D + V         L EL+I+  I
Sbjct: 18  GEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77

Query: 60  NQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
             +N++    V +  + + L M++     L+ +V   +  L E  V+    Q+++ ++ L
Sbjct: 78  KHENIMGLVDVYVEGDFINLVMDI-MASDLKKVVDR-KIRLTESQVKCILLQILNGLNVL 135

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-----------ELNGFV 168
           H+   +HRD+  ANIF+ ++G   K+ DFG A +                    E+   V
Sbjct: 136 HKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194

Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWA-EYDSNYQIMFKVGM 225
            T  Y APE+ M   K     AVD+WS+GC+  E+ +GK   P   E D   +I   +G 
Sbjct: 195 VTLWYRAPELLMGAEKYHF--AVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252

Query: 226 GE----------------TPTIPESLSDEGQAFAELC-------LRHDPAQRATIFELLQ 262
                             TP  P+ L       ++         L+ +P +R +  E L+
Sbjct: 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312

Query: 263 HPFLIVSCEEDVCNPRSVP 281
           H +         C+P  +P
Sbjct: 313 HEYFKSDPLP--CDPSQLP 329

Length = 335

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  100 bits (251), Expect = 3e-23
 Identities = 76/244 (31%), Positives = 126/244 (51%), Gaps = 16/244 (6%)

Query: 28  ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG 87
           E V  K + L+ +  A + +    EL  L   +   +VK++      ++++L ME  + G
Sbjct: 94  EKVVAKFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150

Query: 88  TLESLV-QSTEDGLP----EVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS 142
            L   + Q  ++ LP    EV +  Y  Q+V A+  +H   ++HRD+KSANIFL   G  
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFY--QIVLALDEVHSRKMMHRDLKSANIFLMPTG-I 207

Query: 143 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 202
           +KLGDFG + + S   ++    + F GT  Y+APE++    +  + +  D+WSLG +L E
Sbjct: 208 IKLGDFGFSKQYSDSVSL-DVASSFCGTPYYLAPELW---ERKRYSKKADMWSLGVILYE 263

Query: 203 MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           + +  RP+ +  S  +IM +V  G+    P  +S   +A  +  L  +PA R T  +LL 
Sbjct: 264 LLTLHRPF-KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322

Query: 263 HPFL 266
             FL
Sbjct: 323 TEFL 326

Length = 478

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 81/274 (29%), Positives = 132/274 (48%), Gaps = 27/274 (9%)

Query: 13  GRFGKVYTAVNNETGELVAMKEIQLHKQNDA--RFVKDMLVELRILEGINQKNLVKYYGV 70
           G +G VY   + ET +  AMK+I  +KQN      ++ + VE  IL       +V  +  
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKI--NKQNLILRNQIQQVFVERDILTFAENPFVVSMFCS 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +  + + ME    G   +L+++    LP  + R Y  + V A+  LH   IVHRD+K
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128

Query: 131 SANIFLTAEGNSLKLGDFG-SAVKISAHTT------VPGELNGFV-----GTQAYMAPEV 178
             N+ +T+ G+ +KL DFG S + + + TT      +  +   F+     GT  Y+APEV
Sbjct: 129 PDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV--GMGETPTIPESLS 236
            +   + G+G+ VD W++G +L E   G  P+   D+  ++  +V     E P   E+L 
Sbjct: 188 IL---RQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEGDEALP 243

Query: 237 DEGQAFAELCLRHDPAQR---ATIFELLQHPFLI 267
            + Q      LR +P +R      FE+ QH F +
Sbjct: 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 43/274 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G VY A +  T  ++A+K I L    + +  K ++ EL IL   +   ++ +YG 
Sbjct: 10  GHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIGFYGA 67

Query: 71  EIHREEMVLFME----LCTE----GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
                    F+E    +CTE    G+L+   +     +PE ++ R    +V  ++ L   
Sbjct: 68  --------FFVENRISICTEFMDGGSLDVYRK-----IPEHVLGRIAVAVVKGLTYLWSL 114

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFM 180
            I+HRD+K +N+ +   G  +KL DFG + ++  S   T       +VGT AYMAPE   
Sbjct: 115 KILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSIAKT-------YVGTNAYMAPERIS 166

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY------QIMFKVGMGETPTIPES 234
                 +G   D+WSLG   +E++ G+ P+ +   N       Q++  +   + P +P  
Sbjct: 167 GEQ---YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223

Query: 235 L-SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
             S++   F   C+R  P +R     L+ HPF++
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 59/295 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +  T E +A+K+I+L +Q D       + E+ +L+ +   N+V+   V
Sbjct: 11  GEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 71  EIHREE-MVLFMELCTEGTLESLVQSTEDGLPEV-----LVRRYTKQLVDAISALHENTI 124
            +H E+ + L  E      L+  ++   D  P+      L++ Y  Q++  I+  H + +
Sbjct: 70  -VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEV 178
           +HRD+K  N+ +    N+LKL DFG A      V+   H  V         T  Y APE+
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---------TLWYRAPEI 174

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-------------GM 225
            + +    +   VDIWS+GC+  EM + ++P    DS    +FK+             G+
Sbjct: 175 LLGSRH--YSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231

Query: 226 GETP---------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              P               T+  +L   G       LR DP++R T    L+H +
Sbjct: 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 78/276 (28%), Positives = 122/276 (44%), Gaps = 17/276 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV      +T  + A+K I+         V   L E  +L  +N   +V     
Sbjct: 2   GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFS 61

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               E++ L +     G L   +Q  E        R YT +L+ A+  LH+  +++RD+K
Sbjct: 62  FQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG-- 188
             NI L  +G+ + L DFG   K++       + N F GT  Y+APE+ +     GHG  
Sbjct: 121 PENILLDYQGH-IALCDFG-LCKLNMKDD--DKTNTFCGTPEYLAPELLL-----GHGYT 171

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           +AVD W+LG +L EM +G  P+  YD N   M++  + E    P+    + +      L 
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPF--YDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLS 229

Query: 249 HDPAQRATIF---ELLQHPFLIVSCEEDVCNPRSVP 281
            DP +R       E+  HPF      + +      P
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQP 265

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 75/270 (27%), Positives = 122/270 (45%), Gaps = 35/270 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV  A +   G+  A+K +Q   + K+ +    K ++ E  +L     KN+   
Sbjct: 4   GKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ---KHIMAERNVL----LKNVKHP 56

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           + V +H      +++   ++    G L   +Q  E   PE   R Y  ++  A+  LH  
Sbjct: 57  FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL 115

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            I++RD+K  NI L ++G+ + L DFG     ++ S  T+       F GT  Y+APEV 
Sbjct: 116 NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTST------FCGTPEYLAPEVL 168

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               K  + R VD W LG VL EM  G  P+  Y  +   M+   + +   +  ++S   
Sbjct: 169 R---KQPYDRTVDWWCLGAVLYEMLYGLPPF--YSRDTAEMYDNILNKPLRLKPNISVSA 223

Query: 240 QAFAELCLRHDPAQR----ATIFELLQHPF 265
           +   E  L+ D  +R        E+  H F
Sbjct: 224 RHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 78/271 (28%), Positives = 118/271 (43%), Gaps = 32/271 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM-LVELRILEGINQKNLVKY-Y 68
           G+G FG+V       TG++ A K+++  K+   R  + M L E +ILE +N + +V   Y
Sbjct: 9   GKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 69  GVEIHREEMVLFMELCTEGTLE-SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             E  ++ + L + L   G L+  +      G  E     Y  ++   +  LH   IV+R
Sbjct: 68  AYET-KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L   G+ +++ D G AV+I    T+ G     VGT  YMAPEV        +
Sbjct: 127 DLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV---VKNERY 178

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE--------TPTIPESLSDEG 239
             + D W LGC++ EM  GK P+ +         KV   E             E  S+  
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKE------KVKREEVERRVKEDQEEYSEKFSEAA 232

Query: 240 QAFAELCLRHDPAQR-----ATIFELLQHPF 265
           ++     L  DP  R         E+  HPF
Sbjct: 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 48/163 (29%), Positives = 68/163 (41%), Gaps = 49/163 (30%)

Query: 257 IFELLQHPFLIVSC---EEDV-----------CNPRSVPASVLQDYLKLGIVLPPMSEDS 302
           I   LQHP  IV     E D             +  S+ +S+L+ + KL        E  
Sbjct: 52  ILSSLQHPN-IVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKL-------PEPV 102

Query: 303 VKVYAR---------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL 341
           ++ Y R                     ANI + ++G  +KL DFG A ++          
Sbjct: 103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGD-IETGEGT 160

Query: 342 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
               GT  +MAPEV        +GRA DIWSLGC ++EM++GK
Sbjct: 161 GSVRGTPYWMAPEVIRGE---EYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 93.6 bits (233), Expect = 7e-22
 Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 32/265 (12%)

Query: 11  GQGRFGKVYTAV-NNETGEL--VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG V     +   G++  VA+K ++  K +D   + D L E  I+  ++ +NL++ 
Sbjct: 4   GDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIRL 61

Query: 68  YGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           YGV +    +++  EL   G+L + L +          +  Y  Q+ + +  L     +H
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120

Query: 127 RDIKSANIFLTAEGNSLKLGDFG--SAVKI-------SAHTTVPGELNGFVGTQAYMAPE 177
           RD+ + NI L A  + +K+GDFG   A+           H  VP          A+ APE
Sbjct: 121 RDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP---------FAWCAPE 170

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESL 235
             + T    H  A D+W  G  L EM + G+ PWA   S  QI+ K+   GE    PE+ 
Sbjct: 171 S-LRTRTFSH--ASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEAC 226

Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
             +       C  H+PA R T   L
Sbjct: 227 PQDIYNVMLQCWAHNPADRPTFAAL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 70/265 (26%), Positives = 119/265 (44%), Gaps = 25/265 (9%)

Query: 11  GQGRFGKVYTA-VNNETGELVAMKEIQLHKQNDARF-------VKDMLVELRIL-EGINQ 61
           G G FG VY     N    L+A+KEI +H     +        + D++ E+ I+ E +  
Sbjct: 9   GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68

Query: 62  KNLVKYYGVEIHREEMVLFMEL---CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            N+V+YY   +  + + + M+L      G   + ++  +    E  +     Q+V A+  
Sbjct: 69  PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128

Query: 119 LH-ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 177
           LH E  IVHRD+   NI L  E + + + DFG A +    +    +L   VGT  Y  PE
Sbjct: 129 LHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES----KLTSVVGTILYSCPE 183

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM-FKVGMGETPTIPESL- 235
           +        +G   D+W+ GC+L +M + + P+  Y +N   +  K+       +PE + 
Sbjct: 184 I---VKNEPYGEKADVWAFGCILYQMCTLQPPF--YSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
           S++       CL  D   R  I ++
Sbjct: 239 SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 33/270 (12%)

Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQLHKQNDARFVKDML---VELRILEGINQKNL 64
           GQG FGKV+        + G+L AMK +   K+   + V+D +   +E  IL  +N   +
Sbjct: 5   GQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLK-VRDRVRTKMERDILAEVNHPFI 60

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           VK +       ++ L ++    G L + + S E    E  V+ Y  +L  A+  LH   I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           ++RD+K  NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    N+
Sbjct: 120 IYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEV---VNR 172

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF----KVGMGETPTIPESLSDEGQ 240
            GH ++ D WS G ++ EM +G  P+   D    +      K+GM      P+ LS E Q
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM------PQFLSPEAQ 226

Query: 241 AFAELCLRHDPAQR-----ATIFELLQHPF 265
           +      + +PA R       + E+ +HPF
Sbjct: 227 SLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 50/157 (31%), Positives = 68/157 (43%), Gaps = 40/157 (25%)

Query: 257 IFELLQHPFLIVSCEEDVCNPRS-------VPASVLQDYLKLGIVLPPMSEDSVKVYAR- 308
           I + L+HP  IV   +   +               L D LK       +SED  + Y R 
Sbjct: 50  ILKKLKHPN-IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEARFYLRQ 105

Query: 309 --------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ 348
                                NI L  +G+ +KL DFG A ++        +L  FVGT 
Sbjct: 106 ILSALEYLHSKGIVHRDLKPENILLDEDGH-VKLADFGLARQLDP----GEKLTTFVGTP 160

Query: 349 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
            YMAPEV +     G+G+AVDIWSLG +L E+ +GK 
Sbjct: 161 EYMAPEVLLGK---GYGKAVDIWSLGVILYELLTGKP 194

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 88/293 (30%), Positives = 135/293 (46%), Gaps = 45/293 (15%)

Query: 11  GQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDML---VELRILEGINQKNL 64
           G+G +GKV+        +TG++ AMK   L K    R  KD      E  ILE +    +
Sbjct: 5   GKGGYGKVFQVRKVTGADTGKIFAMK--VLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 65  V----------KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD 114
           V          K Y +  +     LFM L  EG         ED         Y  ++  
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF------MED-----TACFYLSEISL 111

Query: 115 AISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAY 173
           A+  LH+  I++RD+K  NI L A+G+ +KL DFG   K S H    G + + F GT  Y
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGH-VKLTDFG-LCKESIHE---GTVTHTFCGTIEY 166

Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           MAPE+ M   + GHG+AVD WSLG ++ +M +G  P+   ++  + + K+  G+   +P 
Sbjct: 167 MAPEILM---RSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL-NLPP 221

Query: 234 SLSDEGQAFAELCLRHDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            L+ E +   +  L+ +P+ R         E+  HPF      +D+   +  P
Sbjct: 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEP 274

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 84/310 (27%), Positives = 140/310 (45%), Gaps = 56/310 (18%)

Query: 11  GQGRFGKVYTAVNNET--GELVAMKEIQLHKQNDARFVKDMLV-----ELRILEGI-NQK 62
           GQG +G V +A N ET   E VA+K+I         F K +L      EL++L      K
Sbjct: 9   GQGAYGIVCSARNAETSEEETVAIKKIT------NVFSKKILAKRALRELKLLRHFRGHK 62

Query: 63  NLVKYYGVEIHR----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           N+   Y ++I       E+ L+ EL  E  L  +++S    L +   + +  Q++  +  
Sbjct: 63  NITCLYDMDIVFPGNFNELYLYEEL-MEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKY 120

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTTVPGELNGFVGTQAYMAPE 177
           +H   ++HRD+K  N+ + A+   LK+ DFG A   S       G +  +V T+ Y APE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ--------------IMFKV 223
           + +  +   + +A+D+WS+GC+L E+   K  +   D   Q               + ++
Sbjct: 180 IML--SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237

Query: 224 G-------MGETPTIP----ESL----SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
           G       +   P IP    ES+    +       E  L  DP +R ++ E L+HP+L +
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297

Query: 269 ---SCEEDVC 275
                +E VC
Sbjct: 298 WHDPDDEPVC 307

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 81/309 (26%), Positives = 143/309 (46%), Gaps = 57/309 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 14  GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 131 KPSNILVNSRG-EIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 181

Query: 190 AVDIWSLGCVLVEMSSGK------------------------------------RPWAEY 213
             DIWS+G  LVEM+ G+                                    RP + Y
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241

Query: 214 --DSN-----YQIMFKVGMGETPTIPESL-SDEGQAFAELCLRHDPAQRATIFELLQHPF 265
             DS      ++++  +     P +P  +   E Q F   CL  +PA+RA + +L+ H F
Sbjct: 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301

Query: 266 LIVSCEEDV 274
           +  S  E+V
Sbjct: 302 IKRSEAEEV 310

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 93/313 (29%), Positives = 141/313 (45%), Gaps = 36/313 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+V         ++ AMK +     L +   A F ++  V   ++ G NQ     
Sbjct: 10  GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV---LVNGDNQWITTL 66

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +     + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   VH
Sbjct: 67  HYAFQ-DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 184
           RDIK  NI +   G+ ++L DFGS +K+    TV   +   VGT  Y++PE+   M+  K
Sbjct: 126 RDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDGK 182

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRP-WAE--YDSNYQIMFKVGMGETPTIPESLSDEGQA 241
             +G   D WSLG  + EM  G+ P +AE   ++  +IM      E    P  ++D  + 
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHKERFQFPAQVTDVSED 239

Query: 242 FAEL-----CLRHDPAQRATIFELLQHPFL-------IVSCEEDVCNPRSVPA-----SV 284
             +L     C R     +  I +  QHPF        I +CE       S P       V
Sbjct: 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDV 299

Query: 285 LQDYLKLGIVLPP 297
             D LK    +PP
Sbjct: 300 DDDCLKNSETMPP 312

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 12/216 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V  A +  TGE  A+K ++  +    + V+ +  E  IL  ++   +V     
Sbjct: 27  GTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCS 86

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 +   +E    G L + ++      P  + + Y  +LV A   LH   I++RD+K
Sbjct: 87  FQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L  +G+ +K+ DFG A K+   T          GT  Y+APEV       GHG+A
Sbjct: 146 PENLLLDNKGH-VKVTDFGFAKKVPDRTFT------LCGTPEYLAPEVIQSK---GHGKA 195

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG 226
           VD W++G +L E  +G  P+ + D+ ++I  K+  G
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230

Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 20/265 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V    +  + ++ AMK +   ++ K++D+ F  +   E  I+   N + +V+ 
Sbjct: 52  GRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAHANSEWIVQL 108

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +      + + + ME    G L +L+ + +  +PE   R YT ++V A+ A+H    +HR
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG- 186
           D+K  N+ L   G+ LKL DFG+ +K+ A+  V    +  VGT  Y++PEV       G 
Sbjct: 167 DVKPDNMLLDKSGH-LKLADFGTCMKMDANGMV--RCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE--TPTIPESLSDEGQAFAE 244
           +GR  D WS+G  L EM  G  P+  Y  +    +   M    + T P+ +    QA   
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281

Query: 245 LCL----RHDPAQRATIFELLQHPF 265
           +C     R     R  + E+  HPF
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 93.2 bits (232), Expect = 4e-21
 Identities = 77/292 (26%), Positives = 139/292 (47%), Gaps = 47/292 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G V +A N+ET E VA+K+I     N  DA   K  L E+++L  ++ +N++   
Sbjct: 14  GRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVIAIK 70

Query: 69  GV--EIHRE---EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            +    HRE   ++ +  EL  +  L  +++S++  L +   + +  QL+  +  +H   
Sbjct: 71  DIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSAN 128

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           ++HRD+K +N+ L A    LK+ DFG A      +     +  +V T+ Y APE+ ++ +
Sbjct: 129 VLHRDLKPSNLLLNAN-CDLKICDFGLA---RTTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD--- 237
           +  +  A+D+WS+GC+  E+   K  +   D  +Q   I   +G      +    ++   
Sbjct: 185 E--YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242

Query: 238 ---------EGQAFAEL--------------CLRHDPAQRATIFELLQHPFL 266
                      Q+FA L               L  DP++R T+ E L HP+L
Sbjct: 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 92.0 bits (228), Expect = 5e-21
 Identities = 74/266 (27%), Positives = 123/266 (46%), Gaps = 20/266 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V       TG++ A K ++  +    +     L E +ILE +N + +V   Y 
Sbjct: 9   GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYA 68

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            E  ++ + L + +   G L+  + +  + G  E     Y  +++  +  LH    V+RD
Sbjct: 69  YET-KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  NI L   G+ +++ D G AVKI    ++ G     VGT  YMAPEV    N   + 
Sbjct: 128 LKPENILLDDYGH-IRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVL---NNQRYT 179

Query: 189 RAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            + D W LGC++ EM  G+ P+    E     ++  +V   E        S+E ++  ++
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-VYSAKFSEEAKSICKM 238

Query: 246 CLRHDPAQR-----ATIFELLQHPFL 266
            L  DP QR         E+ +HPF 
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 84/271 (30%), Positives = 134/271 (49%), Gaps = 26/271 (9%)

Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKN- 63
           G G +GKV+       ++TG+L AMK +Q   L ++  A+ V+    E  +LE + Q   
Sbjct: 9   GTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK--AKTVEHTRTERNVLEHVRQSPF 66

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           LV  +       ++ L ++  + G +   L Q   D   E  VR Y+ +++ A+  LH+ 
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            IV+RDIK  NI L +EG+ + L DFG + +    +        F GT  YMAPE+    
Sbjct: 125 GIVYRDIKLENILLDSEGHVV-LTDFGLSKEFL--SEEKERTYSFCGTIEYMAPEII--R 179

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEG 239
            K GHG+AVD WSLG ++ E+ +G  P+    E ++  ++  ++ +   P  P  +  E 
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-LKCDPPFPSFIGPEA 238

Query: 240 QAFAELCLRHDPAQR-----ATIFELLQHPF 265
           Q      LR DP +R         E+ +HPF
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 80/281 (28%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TGE+VA+K++Q    + A  ++D   E+ IL+ +   N+VK
Sbjct: 13  GKGNFGSVELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R  + L ME    G+L   +Q   + L    +  Y  Q+   +  L     
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRY 129

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKI----SAHTTV--PGELNGFVGTQAYMAPEV 178
           VHRD+ + NI + +E N +K+GDFG   K+      +  V  PGE   F     + APE 
Sbjct: 130 VHRDLATRNILVESE-NRVKIGDFGLT-KVLPQDKEYYKVREPGESPIF-----WYAPES 182

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTI---- 231
             + +K     A D+WS G VL E+ +    +++   +    F   MG       I    
Sbjct: 183 LTE-SKFSV--ASDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235

Query: 232 ------------PESLSDEGQAFAELCLRHDPAQRATIFEL 260
                       P     E  A  + C  +DP+QR +  EL
Sbjct: 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 90.9 bits (225), Expect = 1e-20
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 24/268 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V       TG++ A K+++  +    +     L E +ILE +N + +V   Y 
Sbjct: 9   GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYA 68

Query: 70  VEIHREEMVLFMELCTEGTLE-SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            E  ++ + L + L   G L+  +    E G  E     Y  ++   +  LH+  IV+RD
Sbjct: 69  YET-KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  NI L   G+ +++ D G AV +    T+ G     VGT  YMAPEV  +     + 
Sbjct: 128 LKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER---YT 179

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYD-----SNYQIMFKVGMGETPTIPESLSDEGQAFA 243
            + D W+LGC+L EM +G+ P+ +          + + K    E     E  S + ++  
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE---YSEKFSPDARSLC 236

Query: 244 ELCLRHDPAQR-----ATIFELLQHPFL 266
           ++ L  DP +R         E+ +HP  
Sbjct: 237 KMLLCKDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 89/312 (28%), Positives = 143/312 (45%), Gaps = 30/312 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+V       T  + AMK +     L +   A F ++  V   ++ G  Q     
Sbjct: 10  GRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV---LVNGDCQWITTL 66

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +     + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   VH
Sbjct: 67  HYAFQ-DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 184
           RDIK  N+ L   G+ ++L DFGS +K++   TV   +   VGT  Y++PE+   M+   
Sbjct: 126 RDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVA--VGTPDYISPEILQAMEDGM 182

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRP-WAE--YDSNYQIMFKVGMGETPTIPESLSDEGQA 241
             +G   D WSLG  + EM  G+ P +AE   ++  +IM      + P+    +S+E + 
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKD 242

Query: 242 FAE--LCLRHDPAQRATIFELLQHPFL-------IVSCEE----DVCNPRSVPA-SVLQD 287
             +  +C R     +  I +  +H F        I + E     DV +P       V  D
Sbjct: 243 LIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDD 302

Query: 288 YLKLGIVLPPMS 299
            L+   + PP S
Sbjct: 303 VLRNPEIAPPSS 314

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 78/271 (28%), Positives = 129/271 (47%), Gaps = 24/271 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G+G + KV      +T  + AMK ++    ND   +  +  E  + E   N   LV  + 
Sbjct: 4   GRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 63

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  +   +E    G L   +Q  +  LPE   R Y+ ++  A++ LHE  I++RD+
Sbjct: 64  CFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L +EG+ +KL D+G    +      PG+  + F GT  Y+APE+    +   +G
Sbjct: 123 KLDNVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YG 174

Query: 189 RAVDIWSLGCVLVEMSSGKRPW------AEYDSNYQ-IMFKVGMGETPTIPESLSDEGQA 241
            +VD W+LG ++ EM +G+ P+         D N +  +F+V + +   IP SLS +  +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234

Query: 242 FAELCLRHDPAQR-----ATIFELLQ-HPFL 266
             +  L  DP +R      T F  +Q HPF 
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 47/288 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V +A +  TG+ VA+K+I +   +     K    EL++L+ +  +N++    +
Sbjct: 19  GMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 71  EIH-REEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            I   E++    EL   GT L  L+ S    L +  ++ +  Q++  +  +H   +VHRD
Sbjct: 78  FISPLEDIYFVTEL--LGTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAGVVHRD 133

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI L  E   LK+ DFG A +I        ++ G+V T+ Y APE+ +   K  + 
Sbjct: 134 LKPSNI-LINENCDLKICDFGLA-RIQDP-----QMTGYVSTRYYRAPEIMLTWQK--YD 184

Query: 189 RAVDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKVGMGETP----------------- 229
             VDIWS GC+  EM  GK   P  ++ + + I+  + +G  P                 
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL-LGTPPDDVINTICSENTLRFVQ 243

Query: 230 TIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           ++P+           +         E  L  DP +R +  E L HP+L
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 93.6 bits (232), Expect = 2e-20
 Identities = 67/250 (26%), Positives = 124/250 (49%), Gaps = 36/250 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G GRFG+V+   +  T E    K I  ++    R    +++E+ ++  +  KN+V+Y   
Sbjct: 22  GNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 71  EIHR--EEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHE---- 121
            +++  +++ + ME C  G L   +Q        + E  +   T+QL+ A++  H     
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 122 ---NTIVHRDIKSANIFL----------TAEGNSL------KLGDFGSAVKISAHTTVPG 162
                ++HRD+K  NIFL          TA+ N+L      K+GDFG    +S +  +  
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG----LSKNIGIES 196

Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK 222
             +  VGT  Y +PE+ +   K    ++ D+W+LGC++ E+ SGK P+ + ++  Q++ +
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDDKS-DMWALGCIIYELCSGKTPFHKANNFSQLISE 255

Query: 223 VGMGETPTIP 232
           +  G  P +P
Sbjct: 256 LKRG--PDLP 263

Length = 1021

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y  + + TGE VA+K +  H   +     D   E+ IL  ++ +N+VK
Sbjct: 13  GEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQH-RSDFEREIEILRTLDHENIVK 70

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV  +     + L ME    G+L   +Q   D +    +  ++ Q+   +  L     
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRY 130

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA---HTTV--PGELNGFVGTQAYMAPEVF 179
           +HRD+ + NI + +E + +K+ DFG A  +     +  V  PGE   F     + APE  
Sbjct: 131 IHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-----WYAPECL 184

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRP 209
             T+K     A D+WS G  L E+ +   P
Sbjct: 185 R-TSKF--SSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 26/260 (10%)

Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKD-MLVELRILEGINQKNLVKYY 68
           G+G+FG VY  V  +   E +A+  ++  K   +  V++  L E  I+   +  ++VK  
Sbjct: 15  GEGQFGDVYQGVYMSPENEKIAVA-VKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV I    + + MEL   G L S +Q  +  L    +  Y+ QL  A++ L     VHRD
Sbjct: 74  GV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRD 132

Query: 129 IKSANIFLTAEGNSLKLGDFG-------SAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           I + N+ L +  + +KLGDFG        +   ++   +P +         +MAPE    
Sbjct: 133 IAARNV-LVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK---------WMAPE---S 179

Query: 182 TNKVGHGRAVDIWSLG-CVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
            N      A D+W  G C+   +  G +P+    +N  I  ++  GE   +P +      
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENGERLPMPPNCPPTLY 238

Query: 241 AFAELCLRHDPAQRATIFEL 260
           +    C  +DP++R    EL
Sbjct: 239 SLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 15/249 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V       TG++ A K+++  +    +     L E RILE +N + +V   Y 
Sbjct: 9   GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYA 68

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            E  ++ + L + +   G L+  + +  + G  E     Y  +L   +  L    IV+RD
Sbjct: 69  YET-KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  NI L   G+ +++ D G AV+I    TV G     VGT  YMAPEV    N   + 
Sbjct: 128 LKPENILLDDRGH-IRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVI---NNEKYT 179

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPTIPESLSDEGQAFAEL 245
            + D W LGC++ EM  G+ P+ +        ++  +V   +     E  S++ ++   +
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEKFSEDAKSICRM 238

Query: 246 CLRHDPAQR 254
            L  +P +R
Sbjct: 239 LLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V       TG++ A K++   +       K  L+E  ILE +N   +V   Y 
Sbjct: 2   GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA 61

Query: 70  VEIHREEMVLFMELCTEGTLE-SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
            E  +  + L M L   G L+  +    E GL    V  Y+ Q+   I  LH   IV+RD
Sbjct: 62  FE-SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ L  +GN  +L D G AV++    T+        GT  YMAPE+  +     + 
Sbjct: 121 MKPENVLLDDQGNC-RLSDLGLAVELKDGKTITQR----AGTNGYMAPEILKEEP---YS 172

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEY 213
             VD +++GC + EM +G+ P+ ++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 56/300 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVK- 66
           G+G FG+V      +TG + AMK++   ++ ++     V+    E  IL   +   +VK 
Sbjct: 10  GRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR---AERDILAEADNPWVVKL 66

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           YY  +     + L ME    G + +L+   +D   E   R Y  + + AI ++H+   +H
Sbjct: 67  YYSFQ-DENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIH 124

Query: 127 RDIKSANIFLTAEGNSLKLGDFG--SAVKISAHTT---------VPGELNGF-------- 167
           RDIK  N+ L A+G+ +KL DFG  + +K  +H T         +P     F        
Sbjct: 125 RDIKPDNLLLDAKGH-IKLSDFGLCTGLK-KSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 168 -----------------VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
                            VGT  Y+APEVF+   + G+ +  D WSLG ++ EM  G  P+
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFL---QTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 211 AEYDSNYQIMFKV-GMGETPTIPES--LSDEGQAFAE--LCLRHDPAQRATIFELLQHPF 265
              D+  +   K+    ET   P+   LS E +   +   C          + E+  HPF
Sbjct: 240 CS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 88.5 bits (219), Expect = 9e-20
 Identities = 71/245 (28%), Positives = 117/245 (47%), Gaps = 21/245 (8%)

Query: 11  GQGRFGKVYTAVN-NETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVK 66
           G+G +GKV+ A +    G  VA+K +++    +      ++++ V LR LE     N+V+
Sbjct: 10  GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVR 68

Query: 67  YYGV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            + V       RE ++ L  E   +     L +  E G+P   ++    QL+  +  LH 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           + +VHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APEV + 
Sbjct: 129 HRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQ 183

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK---RPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           ++   +   VD+WS+GC+  EM   K   R  ++ D   +I+  +G+      P  ++  
Sbjct: 184 SS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240

Query: 239 GQAFA 243
            QAF 
Sbjct: 241 RQAFH 245

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 49/155 (31%), Positives = 61/155 (39%), Gaps = 34/155 (21%)

Query: 257 IFELLQHPFLIVSCEEDVCNPRSVPASVLQ-----DYLKLGIVLPPMSEDSVKVYAR--- 308
           I   L HP  IV    D    +     V++     D         P+SED  K  A    
Sbjct: 51  ILRRLSHPN-IVRLI-DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQIL 108

Query: 309 ------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY 350
                              NI L   G  +K+ DFG A K          L  FVGT  Y
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENGV-VKIADFGLAKK---LLKSSSSLTTFVGTPWY 164

Query: 351 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           MAPEV +  N  G+G  VD+WSLG +L E+ +GK 
Sbjct: 165 MAPEVLLGGN--GYGPKVDVWSLGVILYELLTGKP 197

Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 33/271 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILE-GINQKNLVKY 67
           G+G FGKV  A   E+G L A+K ++  +  Q+D   V+  + E RIL    N   L + 
Sbjct: 4   GKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD--VECTMTEKRILSLARNHPFLTQL 61

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      + +   ME    G L   +Q +     E   R Y  ++  A+  LH+  I++R
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDT 182
           D+K  N+ L  EG+  KL DFG   +        G  NG     F GT  Y+APE+  + 
Sbjct: 121 DLKLDNVLLDHEGHC-KLADFGMCKE--------GIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
               +G +VD W++G +L EM  G  P+ AE + +   +F+  + +    P  LS +   
Sbjct: 172 L---YGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILNDEVVYPTWLSQDAVD 225

Query: 242 FAELCLRHDPAQRATIFEL------LQHPFL 266
             +  +  +P  R     L      L+HPF 
Sbjct: 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 41/287 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +A++  TGE VA+K++    Q++  F K    EL +L+ +  +N++    V
Sbjct: 24  GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
                    F +  L        L +     L E  V+    Q++  +  +H   I+HRD
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ +  E   LK+ DFG A    A      E+ G+V T+ Y APEV +  N + + 
Sbjct: 143 LKPGNLAVN-EDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVIL--NWMHYN 193

Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEY-DSNYQIMFKVGMGET----------------- 228
           + VDIWS+GC++ EM +GK  +   +Y D   QI+   G+                    
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253

Query: 229 -PTIPE--------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            P  P           S +     E  L  D  +R T  E L+HP+ 
Sbjct: 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 83/300 (27%), Positives = 140/300 (46%), Gaps = 57/300 (19%)

Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN-- 63
           ++SP G G +G+V +A + +TG  VA+K++    Q  A   K    ELR+L+ ++ +N  
Sbjct: 19  NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVI 77

Query: 64  -LVKYYGVEIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
            L+  +      E+   + L   L     L ++V+  +  L +  ++    Q++  +  +
Sbjct: 78  GLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVKCQK--LSDDHIQFLVYQILRGLKYI 134

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H   I+HRD+K +NI +  E   LK+ DFG A           E+ G+V T+ Y APE+ 
Sbjct: 135 HSAGIIHRDLKPSNIAVN-EDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIM 187

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEYDSNY-QIMFKVGMGETPTIPESL- 235
           +  N + + + VDIWS+GC++ E+ +GK   P +++     +IM  VG   TP   E L 
Sbjct: 188 L--NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG---TPD-EELLQ 241

Query: 236 ---SDEGQA------------FAELCLRH--------------DPAQRATIFELLQHPFL 266
              S+  +             F E+                  DP +R T  E L HP+L
Sbjct: 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 76/265 (28%), Positives = 126/265 (47%), Gaps = 18/265 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V    +  + ++ AMK   + ++ K++D+ F  +   E  I+   N   +V+ 
Sbjct: 52  GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQL 108

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +      + + + ME    G L +L+ + +  +PE   + YT ++V A+ A+H   ++HR
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMGLIHR 166

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG- 186
           D+K  N+ L   G+ LKL DFG+ +K+     V    +  VGT  Y++PEV       G 
Sbjct: 167 DVKPDNMLLDKHGH-LKLADFGTCMKMDETGMV--RCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDEGQAFAEL 245
           +GR  D WS+G  L EM  G  P+   DS      K+     +   PE +     A   +
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282

Query: 246 CL----RHDPAQRATIFELLQHPFL 266
           C     R     R  + E+ QHPF 
Sbjct: 283 CAFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 87.4 bits (216), Expect = 5e-19
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 12/204 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V    +  T ++ AMK   + ++ K++D+ F  +   E  I+   N   +V+ 
Sbjct: 52  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQL 108

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +        + + ME    G L +L+ + +  +PE   R YT ++V A+ A+H    +HR
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG- 186
           D+K  N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G 
Sbjct: 167 DVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW 210
           +GR  D WS+G  L EM  G  P+
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 26/265 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD----MLVELRILE-GINQKNLV 65
           G+G FGKV+ A    T +  A+K ++     D   + D     +VE R+L        L 
Sbjct: 4   GKGSFGKVFLAELKGTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTI 124
             Y     +E +   ME    G L   +QS     LP      Y  +++  +  LH   I
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGI 117

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--LNGFVGTQAYMAPEVFMDT 182
           V+RD+K  NI L  +G+ +K+ DFG   +      + G+     F GT  Y+APE+ +  
Sbjct: 118 VYRDLKLDNILLDTDGH-IKIADFGMCKE-----NMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
               +  +VD WS G +L EM  G+ P+  +D   + +F+    + P  P  L+ E +  
Sbjct: 172 K---YNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIRMDNPCYPRWLTREAKDI 226

Query: 243 AELCLRHDPAQRATIF-ELLQHPFL 266
                  +P +R  +  ++ QHPF 
Sbjct: 227 LVKLFVREPERRLGVKGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 43/293 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V      +TG + AMK ++     +   V  +  E  IL   +   +VK +  
Sbjct: 10  GRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +  + L ME    G + +L+   +D L E   + Y  + V AI A+H+   +HRDIK
Sbjct: 70  FQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKI-SAHTT---------VPGELN--------------- 165
             N+ L A+G+ +KL DFG    +  AH T          P + +               
Sbjct: 129 PDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187

Query: 166 -------GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
                    VGT  Y+APEVFM T   G+ +  D WSLG ++ EM  G  P+        
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQT---GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRH--DPAQR---ATIFELLQHPFL 266
               +   ET   P  +    +A  +L LR   D   R     + E+  HPF 
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKA-KDLILRFCTDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 22/262 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD----MLVELRILEGINQKN--L 64
           G+G FGKV  A    T E  A+K ++     D     D     +VE R+L  +  ++  L
Sbjct: 4   GKGSFGKVMLAELKGTNEFFAIKALK----KDVVLEDDDVECTMVERRVL-ALAWEHPFL 58

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
              +     +E +   ME    G L   +QS+     E   R Y  +++  +  LH+  I
Sbjct: 59  THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           ++RD+K  N+ L  +G+ +K+ DFG       +    G+ + F GT  Y+APE+      
Sbjct: 118 IYRDLKLDNVLLDKDGH-IKIADFGMC---KENMNGEGKASTFCGTPDYIAPEILKGQK- 172

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
             +  +VD WS G +L EM  G+ P+   D +   +F   + + P  P  +S E +    
Sbjct: 173 --YNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSILNDRPHFPRWISKEAKDCLS 228

Query: 245 LCLRHDPAQRATIF-ELLQHPF 265
                DP +R  +  ++ QHPF
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 35/119 (29%), Positives = 49/119 (41%), Gaps = 28/119 (23%)

Query: 285 LQDYLKLGIVLPPMSEDSVKVYAR---------------------ANIFLTAEGNSLKLG 323
           L+D LK       +SED +                           NI L ++   +KL 
Sbjct: 78  LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLA 135

Query: 324 DFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS 382
           DFG +  +++       L   VGT AYMAPEV +   K  +    DIWSLG +L E+  
Sbjct: 136 DFGLSKLLTSD---KSLLKTIVGTPAYMAPEVLL--GKGYYSEKSDIWSLGVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 80/295 (27%), Positives = 137/295 (46%), Gaps = 56/295 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +A++  TG  VA+K++    Q++  F K    ELR+L+ +  +N++    V
Sbjct: 24  GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 71  --------EIHREEMVL-FMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
                     H   +V+ FM     GT L  L++   + L E  ++    Q++  +  +H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFM-----GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIH 135

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K  N+ +  E   LK+ DFG A +  +      E+ G+V T+ Y APEV +
Sbjct: 136 AAGIIHRDLKPGNLAVN-EDCELKILDFGLARQTDS------EMTGYVVTRWYRAPEVIL 188

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT---IPESLSD 237
             N + + + VDIWS+GC++ EM +GK  +  +D   Q+M  + +  TP+   + +  S+
Sbjct: 189 --NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246

Query: 238 EGQAFA--------------------------ELCLRHDPAQRATIFELLQHPFL 266
           + + +                           E  L  D   R T  E L HP+ 
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 29/279 (10%)

Query: 1   MSSVTFSVSPGQGRFGKVY-----TAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI 55
              +T     GQG FG VY       V  E    VA+K +  +     R   + L E  +
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASV 62

Query: 56  LEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQST-----EDGLPEVLVR---- 106
           ++  N  ++V+  GV    +  ++ MEL  +G L+S ++S       +            
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 107 RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG 166
           +   ++ D ++ L     VHRD+ + N  + AE  ++K+GDFG    I           G
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNC-MVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 167 FVGTQAYMAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK 222
            +  + +MAPE   D   T K       D+WS G VL EM++  ++P+    SN +++  
Sbjct: 182 LLPVR-WMAPESLKDGVFTTKS------DVWSFGVVLWEMATLAEQPYQGL-SNEEVLKF 233

Query: 223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
           V  G    +PE+  D+      +C +++P  R T  E++
Sbjct: 234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 76/269 (28%), Positives = 129/269 (47%), Gaps = 21/269 (7%)

Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKN-LV 65
           G G +GKV+       +++G+L AMK ++       A+  +    E ++LE I Q   LV
Sbjct: 9   GTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 68

Query: 66  KYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
             +       ++ L ++    G L   L Q       E  V+ Y+ ++V A+  LH+  I
Sbjct: 69  TLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           ++RDIK  NI L + G+ + L DFG + +   H         F GT  YMAP++ +    
Sbjct: 127 IYRDIKLENILLDSNGHVV-LTDFGLSKEF--HEDEVERAYSFCGTIEYMAPDI-VRGGD 182

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
            GH +AVD WS+G ++ E+ +G  P+    E +S  +I  ++ +   P  P+ +S   + 
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQEMSALAKD 241

Query: 242 FAELCLRHDPAQR-----ATIFELLQHPF 265
             +  L  DP +R     +   E+ +HPF
Sbjct: 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 59/200 (29%), Positives = 107/200 (53%), Gaps = 13/200 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V    +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 14  GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++  +  +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 131 KPSNILVNSRG-EIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 181

Query: 190 AVDIWSLGCVLVEMSSGKRP 209
             DIWS+G  LVE++ G+ P
Sbjct: 182 QSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 24/270 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G+G + KV      +T  + AMK I+    ND   +  +  E  + E   N   LV  + 
Sbjct: 4   GRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS 63

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  +   +E  + G L   +Q  +  LPE   R Y+ ++  A++ LHE  I++RD+
Sbjct: 64  CFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L AEG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G
Sbjct: 123 KLDNVLLDAEGH-IKLTDYG----MCKEGIRPGDTTSTFCGTPNYIAPEILRGED---YG 174

Query: 189 RAVDIWSLGCVLVEMSSGKRPW------AEYDSNYQ-IMFKVGMGETPTIPESLSDEGQA 241
            +VD W+LG ++ EM +G+ P+         D N +  +F+V + +   IP SLS +  +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234

Query: 242 FAELCLRHDPAQR------ATIFELLQHPF 265
             +  L  DP +R          ++  HPF
Sbjct: 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 76/266 (28%), Positives = 121/266 (45%), Gaps = 24/266 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILE-GINQKNLVKY 67
           G+G FGKV  A    T E+ A+K ++     Q+D   V   + E RIL        L   
Sbjct: 4   GKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD--VDCTMTEKRILALAAKHPFLTAL 61

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +     ++ +   ME    G L   +Q +     E   R Y  ++  A+  LH + +++R
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVG 186
           D+K  NI L AEG+  KL DFG    +     + G     F GT  Y+APE+  +     
Sbjct: 121 DLKLDNILLDAEGH-CKLADFG----MCKEGILNGVTTTTFCGTPDYIAPEILQELE--- 172

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           +G +VD W+LG ++ EM +G+ P+ E D N   +F+  + +    P  LS E  +  +  
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF-EAD-NEDDLFESILHDDVLYPVWLSKEAVSILKAF 230

Query: 247 LRHDPAQR-------ATIFELLQHPF 265
           +  +P +R            + QHPF
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 32/77 (41%), Positives = 51/77 (66%), Gaps = 4/77 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ + + G  L++ DFG+A +++A  T  GE  G  +GT A+MAPEV        +GR+
Sbjct: 132 ANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ---YGRS 188

Query: 368 VDIWSLGCVLVEMSSGK 384
            D+WS+GCV++EM++ K
Sbjct: 189 CDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 11/198 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  VY  ++   G+LVA+K I +  +    F    + E  +L+G+   N+V  + +
Sbjct: 14  GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLKGLKHANIVLLHDI 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH +E + F+       L   +     GL    VR +  QL+  ++ +H   I+HRD+K
Sbjct: 72  -IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ ++  G  LKL DFG A   S    +P +  +  V T  Y  P+V +      +  
Sbjct: 131 PQNLLISYLG-ELKLADFGLARAKS----IPSQTYSSEVVTLWYRPPDVLLGATD--YSS 183

Query: 190 AVDIWSLGCVLVEMSSGK 207
           A+DIW  GC+ +EM  G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 70/254 (27%), Positives = 119/254 (46%), Gaps = 22/254 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKN-LVK 66
           G+G + KV      +  ++ AMK ++   +H   D  +V+    E  + E  +    LV 
Sbjct: 4   GRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQ---TEKHVFEQASSNPFLVG 60

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            +        + L +E    G L   +Q  +  LPE   R Y  ++  A++ LHE  I++
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKV 185
           RD+K  N+ L A+G+ +KL D+G    +      PG+    F GT  Y+APE+       
Sbjct: 120 RDLKLDNVLLDADGH-IKLTDYG----MCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-- 172

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI-----MFKVGMGETPTIPESLSDEGQ 240
            +G +VD W+LG ++ EM +G+ P+     N  +     +F+V + +   IP  LS +  
Sbjct: 173 -YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS 231

Query: 241 AFAELCLRHDPAQR 254
              +  L  DP +R
Sbjct: 232 HVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 84.9 bits (210), Expect = 7e-18
 Identities = 54/155 (34%), Positives = 88/155 (56%), Gaps = 8/155 (5%)

Query: 111 QLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVG 169
           Q++ A+  +H   ++HRDIKSANI L + G  +KLGDFG +   +A  TV  ++   F G
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAA--TVSDDVGRTFCG 207

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
           T  Y+APE++    +  + +  D++SLG +L E+ + KRP+ + ++  ++M K   G   
Sbjct: 208 TPYYVAPEIW---RRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRYD 263

Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP 264
            +P S+S E Q      L  DP +R +  +LL  P
Sbjct: 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 82.8 bits (204), Expect = 9e-18
 Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  VY   +   G+LVA+K I+L ++    F    + E  +L+G+   N+V  + +
Sbjct: 14  GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA--IREASLLKGLKHANIVLLHDI 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH +E +  +       L   +     GL    V+ +  QL+  +S +H+  I+HRD+K
Sbjct: 72  -IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLK 130

Query: 131 SANIFLTAEGNSLKLGDFG--SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ ++  G  LKL DFG   A  + +HT      +  V T  Y  P+V + + +  + 
Sbjct: 131 PQNLLISDTG-ELKLADFGLARAKSVPSHT-----YSNEVVTLWYRPPDVLLGSTE--YS 182

Query: 189 RAVDIWSLGCVLVEMSSG 206
             +D+W +GC+ VEM  G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 37/267 (13%)

Query: 13  GRFGKVYTAVNNETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGINQKNLVK-YYGV 70
           G+FGKV    +  T +L   K I+    N     V  ++         +  N +K YY V
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK--------DNPNFIKLYYSV 78

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +   VL M+   +G L  L++  E  L E  V++  +QLV+A++ LH++ I+H DIK
Sbjct: 79  TTLKG-HVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV-GH-- 187
             N+      + + L D+G   KI    +       + GT  Y +PE      K+ GH  
Sbjct: 137 LENVLYDRAKDRIYLCDYG-LCKIIGTPSC------YDGTLDYFSPE------KIKGHNY 183

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-----PTIPESLSDEGQAF 242
             + D W++G +  E+ +GK P   +  +      +              +++S     F
Sbjct: 184 DVSFDWWAVGVLTYELLTGKHP---FKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240

Query: 243 AELCLRHDPAQRATIF-ELLQHPFLIV 268
            +  L+++   R T + E+++HPFL +
Sbjct: 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 67/213 (31%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A     G+  A+K +Q     + +  K ++ E  +L     KN+   + V
Sbjct: 4   GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL----LKNVKHPFLV 59

Query: 71  EIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            +H      E++   ++    G L   +Q  E   PE   R Y  ++  A+  LH   IV
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 126 HRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           +RD+K  NI L ++G+ + L DFG     +  S  TT       F GT  Y+APEV    
Sbjct: 119 YRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTT------FCGTPEYLAPEVI--- 168

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS 215
            K  +   VD W LG VL EM  G  P+   D 
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 62/223 (27%), Positives = 113/223 (50%), Gaps = 15/223 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  V+   +  T  LVA+KEI+L  +  A      + E+ +L+ +   N+V  + +
Sbjct: 14  GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKNLKHANIVTLHDI 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH E  +  +    +  L+  + +  + +    V+ +  QL+  +S  H+  I+HRD+K
Sbjct: 72  -IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  +G  LKL DFG A   S  T T   E    V T  Y  P+V + + +  +  
Sbjct: 131 PQNLLINEKG-ELKLADFGLARAKSVPTKTYSNE----VVTLWYRPPDVLLGSTE--YST 183

Query: 190 AVDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKVGMGETPT 230
            +D+W +GC+L EM++G+   P +       ++F++ +G TPT
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL-LG-TPT 224

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 81.0 bits (200), Expect = 6e-17
 Identities = 75/251 (29%), Positives = 117/251 (46%), Gaps = 23/251 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK----QNDARFVKDMLVELRILEGINQKN--L 64
           G+G FGKV  A    T EL A+K   L K    Q+D   V+  +VE R+L  +  K   L
Sbjct: 9   GKGSFGKVMLAERKGTDELYAIK--ILKKDVIIQDDD--VECTMVEKRVL-ALPGKPPFL 63

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
            + +      + +   ME    G L   +Q       E     Y  ++   +  LH   I
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTN 183
           ++RD+K  N+ L AEG+ +K+ DFG    +       G+    F GT  Y+APE+     
Sbjct: 123 IYRDLKLDNVMLDAEGH-IKIADFG----MCKENIFGGKTTRTFCGTPDYIAPEIIAYQP 177

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
              +G++VD W+ G +L EM +G+ P+   D +   +F+  M    + P+SLS E  +  
Sbjct: 178 ---YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHNVSYPKSLSKEAVSIC 232

Query: 244 ELCLRHDPAQR 254
           +  L   PA+R
Sbjct: 233 KGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 40/101 (39%), Positives = 59/101 (58%), Gaps = 7/101 (6%)

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
           ++L++A++ LH   I+HRD+K+ NIFL    N++ LGDFG+A K+ AH   P +  G+ G
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYGWSG 249

Query: 170 TQAYMAPEVF-MDTNKVGHGRAVDIWSLGCVLVEMSSGKRP 209
           T    +PE+  +D     +    DIWS G VL EMS     
Sbjct: 250 TLETNSPELLALDP----YCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 14/245 (5%)

Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG+V  A   NE    VA+K  +  K    + V  +  E +IL  IN    V  YG
Sbjct: 39  GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYG 98

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  + L +E    G   + ++  +   P  +   Y  Q+V     L    IV+RD+
Sbjct: 99  SFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYLQSLNIVYRDL 157

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L  +G  +K+ DFG A  +   T          GT  Y+APE+ ++   VGHG+
Sbjct: 158 KPENLLLDKDG-FIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEILLN---VGHGK 207

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           A D W+LG  + E+  G  P+  Y +   ++++  +      P+ L +  +   +  L H
Sbjct: 208 AADWWTLGIFIYEILVGCPPF--YANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSH 265

Query: 250 DPAQR 254
           D  +R
Sbjct: 266 DLTKR 270

Length = 340

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 79/292 (27%), Positives = 136/292 (46%), Gaps = 50/292 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  VY   +  TG+LVA+KEI+L  +  A F    + E  +L+ +   N+V  + +
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA--IREASLLKDLKHANIVTLHDI 71

Query: 71  EIHREE-MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH ++ + L  E   +  L+  +     GL    VR +  QL+  ++  H+  ++HRD+
Sbjct: 72  -IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL 129

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ ++  G  LKL DFG A   S  + T   E    V T  Y  P+V + + +  + 
Sbjct: 130 KPQNLLISERG-ELKLADFGLARAKSVPSKTYSNE----VVTLWYRPPDVLLGSTE--YS 182

Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQI--MFKVGMGETPT-------------I 231
            ++D+W +GC+  EM++G RP      D   Q+  +F+V +G TPT              
Sbjct: 183 TSLDMWGVGCIFYEMATG-RPLFPGSTDVEDQLHKIFRV-LG-TPTEETWPGVSSNPEFK 239

Query: 232 PESLSD-----------------EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           P S                     G+  A   L+++P +R +  E ++HP+ 
Sbjct: 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 71/271 (26%), Positives = 118/271 (43%), Gaps = 33/271 (12%)

Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+      G G+FG+V+  + N T   VA+K ++    +     KD L E +I++ +   
Sbjct: 7   SIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD----PKDFLAEAQIMKKLRHP 61

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISAL 119
            L++ Y V    E + +  EL   G+L   +Q        LP+++      Q+   ++ L
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYL 119

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAP 176
                +HRD+ + N+ L  E N  K+ DFG A  I              G +    + AP
Sbjct: 120 EAQNYIHRDLAARNV-LVGENNICKVADFGLARVI-----KEDIYEAREGAKFPIKWTAP 173

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVG----MGETPTI 231
           E  +  N+       D+WS G +L E ++ G+ P+    +N +++ +V     M   P  
Sbjct: 174 EAAL-YNRF--SIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRMPCPPGC 229

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           P+ L D        C + DP  R T FE LQ
Sbjct: 230 PKELYDIMLD----CWKEDPDDRPT-FETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 37/232 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V      +TG + AMK ++     +   V  +  E  IL   +   +VK +  
Sbjct: 10  GRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +  + L ME    G + +L+   +D L E   + Y  + V AI ++H+   +HRDIK
Sbjct: 70  FQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKI-SAHTT---------VPGELN--------------- 165
             N+ L ++G+ +KL DFG    +  AH T         +P +                 
Sbjct: 129 PDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKR 187

Query: 166 -------GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
                    VGT  Y+APEVFM T   G+ +  D WSLG ++ EM  G  P+
Sbjct: 188 NRRQLAFSTVGTPDYIAPEVFMQT---GYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y    + TGE VA+K   L  ++    + D+  E+ IL  +  +N+VK
Sbjct: 13  GEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G+  E     + L ME    G+L+  +   ++ +      +Y  Q+   +  L     
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY 130

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA---HTTVPGELNGFVGTQAYMAPEVFMD 181
           VHRD+ + N+ + +E + +K+GDFG    I     + TV  +L+  V    + APE  + 
Sbjct: 131 VHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPV---FWYAPECLIQ 186

Query: 182 TNKVGHGRAVDIWSLGCVLVEM 203
           +       A D+WS G  L E+
Sbjct: 187 SK---FYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 79.0 bits (193), Expect = 4e-16
 Identities = 44/163 (26%), Positives = 58/163 (35%), Gaps = 33/163 (20%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRSVPASV--------LQDYLKLGIVLPPMSEDSVKVY 306
             I   L HP  IV    D          V        L+D LK      P+SE      
Sbjct: 48  IQILASLNHPPNIVK-LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFI 106

Query: 307 AR---------------------ANIFLTAEGNSLKLGDFGSAVKISA---HTTVPGELN 342
                                   NI L  +G  +KL DFG A  +      +++P   +
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 343 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
             VGT  YMAPEV +  +      + DIWSLG  L E+ +G  
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 14/232 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  VY   +  T  LVA+KEI+L  +  A      + E+ +L+ +   N+V  + +
Sbjct: 15  GEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLHDI 72

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH E+ +  +    +  L+  +    + +    V+ +  QL+  ++  H   ++HRD+K
Sbjct: 73  -IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +   G  LKL DFG A   S  T T   E    V T  Y  P++ + +    +  
Sbjct: 132 PQNLLINERG-ELKLADFGLARAKSIPTKTYSNE----VVTLWYRPPDILLGSTD--YST 184

Query: 190 AVDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKV-GMGETPTIPESLSDE 238
            +D+W +GC+  EMS+G+   P +  +     +F++ G     T P  LS+E
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 23/273 (8%)

Query: 4   VTFSVSPGQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY       V +E    VA+K +        R   + L E  +++ 
Sbjct: 8   ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 65

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTK----- 110
            N  ++V+  GV    +  ++ MEL T G L+S ++S     +  P        K     
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 111 -QLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 185 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVMEGGL 239

Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 78/281 (27%), Positives = 116/281 (41%), Gaps = 25/281 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A     G   A+K +Q       +    ++ E  +L     KNL   + V
Sbjct: 4   GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL----LKNLKHPFLV 59

Query: 71  EIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            +H      E++   ++    G L   +Q  E    E   R Y  ++  AI  LH   I+
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNII 118

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNK 184
           +RD+K  NI L ++G+ + L DFG    +      P E    F GT  Y+APEV     K
Sbjct: 119 YRDLKPENILLDSQGHVV-LTDFG----LCKEGVEPEETTSTFCGTPEYLAPEVL---RK 170

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
             + R VD W LG VL EM  G  P+  Y  +   M+   + +   +P   +        
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPF--YSRDVSQMYDNILHKPLQLPGGKTVAACDLLV 228

Query: 245 LCLRHDPAQR----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
             L  D  +R    A   E+  H F      +D+ + R  P
Sbjct: 229 GLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 75/266 (28%), Positives = 118/266 (44%), Gaps = 28/266 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD----MLVELRILE-GINQKNLV 65
           G+G FGKV  A     GE  A+K ++     D   + D     +VE R+L        L 
Sbjct: 4   GKGSFGKVLLAELKGKGEYFAVKALK----KDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR--YTKQLVDAISALHENT 123
             Y     +E +   ME    G L   +Q  + G  + L R   Y  ++V  +  LH   
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQ--DKGRFD-LYRATFYAAEIVCGLQFLHSKG 116

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--LNGFVGTQAYMAPEVFMD 181
           I++RD+K  N+ L  +G+ +K+ DFG   +      V G+   + F GT  Y+APE+   
Sbjct: 117 IIYRDLKLDNVMLDRDGH-IKIADFGMCKE-----NVFGDNRASTFCGTPDYIAPEILQG 170

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
                +  +VD WS G +L EM  G+ P+   D +   +F+    +TP  P  ++ E + 
Sbjct: 171 LK---YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESIRVDTPHYPRWITKESKD 225

Query: 242 FAELCLRHDPAQRATIF-ELLQHPFL 266
             E     DP +R  +   +  HPF 
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 38/269 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G FG+V++         VA+K  +  L     A+F    L E RIL+  +  N+V+  
Sbjct: 4   GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKF----LQEARILKQYSHPNIVRLI 59

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA---LHENTIV 125
           GV   ++ + + MEL   G   + +++  +G P + V+   + + +A +    L     +
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRT--EG-PRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYM--------APE 177
           HRD+ + N  +T E N LK+ DFG + +         E +G   +   M        APE
Sbjct: 117 HRDLAARNCLVT-EKNVLKISDFGMSRE---------EEDGVYASTGGMKQIPVKWTAPE 166

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
                N   +    D+WS G +L E  S G  P+A   SN Q    +  G     PE   
Sbjct: 167 AL---NYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVRLPCPELCP 222

Query: 237 DEGQAFAELCLRHDPAQR---ATIFELLQ 262
           D      E C  +DP QR   +T+ + LQ
Sbjct: 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 23/280 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A +    +  A+K +Q       +  K ++ E  +L     KN+   + V
Sbjct: 4   GKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFLV 59

Query: 71  EIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            +H      +++   ++    G L   +Q  E    E   R Y  ++  A+  LH   IV
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K  NI L ++G+ + L DFG   +   H    G  + F GT  Y+APEV    +K 
Sbjct: 119 YRDLKPENILLDSQGH-IVLTDFGLCKENIEHN---GTTSTFCGTPEYLAPEVL---HKQ 171

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            + R VD W LG VL EM  G  P+  Y  N   M+   + +   +  ++++  +   E 
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 229

Query: 246 CLRHDPAQRA----TIFELLQHPFLIVSCEEDVCNPRSVP 281
            L+ D  +R        E+  H F      +D+ N +  P
Sbjct: 230 LLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 49/244 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V  A   +T  L AMK ++     +   V  +  E  IL   + + +VK Y  
Sbjct: 10  GIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYS 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ +   M+    G + SL+   E   PEVL R Y  +L  AI ++H+   +HRDIK
Sbjct: 70  FQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHRDIK 128

Query: 131 SANIFLTAEGNSLKLGDFG---------------SAVKISAHTTVPGEL----------- 164
             NI +  +G+ +KL DFG                   I   +  P +L           
Sbjct: 129 PDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187

Query: 165 ------------------NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 206
                             +  VGT  Y+APEV +   + G+ +  D WS+G +L EM  G
Sbjct: 188 RLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL---RKGYTQLCDWWSVGVILFEMLVG 244

Query: 207 KRPW 210
           + P+
Sbjct: 245 QPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 8e-16
 Identities = 35/76 (46%), Positives = 48/76 (63%), Gaps = 7/76 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L A+G+ +KL DFG A ++S+  +     N F GT  Y+APEV +     G+G+AVD
Sbjct: 123 NILLDADGH-IKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLL---GKGYGKAVD 175

Query: 370 IWSLGCVLVEMSSGKT 385
            WSLG +L EM +GK 
Sbjct: 176 WWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 66/251 (26%), Positives = 102/251 (40%), Gaps = 67/251 (26%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V      +T  L AMK ++   +  +N A  VK    E  IL   + + +VK 
Sbjct: 10  GIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEADNEWVVKL 66

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y     ++ +   M+    G + SL+        E L R Y  +L  AI ++H+   +HR
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKMGFIHR 125

Query: 128 DIKSANIFLTAEGNSLKLGDFG-------------------------------SAV---- 152
           DIK  NI +  +G+ +KL DFG                               S +    
Sbjct: 126 DIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184

Query: 153 -------------KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV 199
                        +  AH+ V        GT  Y+APEV +   + G+ +  D WS+G +
Sbjct: 185 LKPLERRRKRQHQRCLAHSLV--------GTPNYIAPEVLL---RTGYTQLCDWWSVGVI 233

Query: 200 LVEMSSGKRPW 210
           L EM  G+ P+
Sbjct: 234 LYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 82/300 (27%), Positives = 127/300 (42%), Gaps = 61/300 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V++  +   G+ VA+K++    QN     K +  EL++L      N++    +
Sbjct: 9   GYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS-CKRVFRELKMLCFFKHDNVLS--AL 65

Query: 71  EIHR-------EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +I +       EE+ +  EL  +  L  ++ S +  L    V+ +  Q++  +  LH   
Sbjct: 66  DILQPPHIDPFEEIYVVTEL-MQSDLHKIIVSPQP-LSSDHVKVFLYQILRGLKYLHSAG 123

Query: 124 IVHRDIKSANIFLTAEGNS---LKLGDFGSAVK----ISAHTTVPGELNGFVGTQAYMAP 176
           I+HRDIK  N+ +    NS   LK+ DFG A       S H T        V TQ Y AP
Sbjct: 124 ILHRDIKPGNLLV----NSNCVLKICDFGLARVEEPDESKHMTQE------VVTQYYRAP 173

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK------RPWAEYD--------SNYQIMFK 222
           E+ M +    +  AVDIWS+GC+  E+   +       P  + D         + + M  
Sbjct: 174 EILMGSRH--YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231

Query: 223 VGMGET------PTIPESLS--------DEGQAFAELC--LRHDPAQRATIFELLQHPFL 266
              G        P  P SL            +A   LC  L  DP +R +  + L HP+L
Sbjct: 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 75/285 (26%), Positives = 114/285 (40%), Gaps = 52/285 (18%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+             ELVA+K ++    NDAR  KD   E  +L     +N+V
Sbjct: 14  GEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHENIV 71

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS-------------TEDGLPEVLVRRYTKQL 112
           K+YGV    +  ++  E    G L   ++S                 L    + +   Q+
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 113 VDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--------VKISAHTTVPGEL 164
              +  L     VHRD+ + N  L      +K+GDFG +         ++  HT +P   
Sbjct: 132 ASGMVYLASQHFVHRDLATRNC-LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR- 189

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIM 220
                   +M PE  M      + +     D+WS G VL E+ + GK+PW    SN +++
Sbjct: 190 --------WMPPESIM------YRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVI 234

Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRAT---IFELLQ 262
             +  G     P +   E       C + DP QR     I E LQ
Sbjct: 235 ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 23/267 (8%)

Query: 11  GQGRFGKVYTAVNNE--TGEL---VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY     +   GE    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 15  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVR---RYTKQLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 133 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WMAP 190

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D          D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 191 ESLKDGVFTTSS---DMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 246

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQ 262
            +       +C + +P  R T  E++ 
Sbjct: 247 PERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 43/273 (15%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+ A        +   LVA+K ++    ++AR  KD   E  +L  +  +++V
Sbjct: 14  GEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNAR--KDFHREAELLTNLQHEHIV 70

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS--------TEDGLPEVLVRRYTKQLVDAIS 117
           K+YGV +  + +++  E    G L   +++         E   P  L +     +   I+
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 118 A----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--------VKISAHTTVPGELN 165
           A    L     VHRD+ + N  L  E   +K+GDFG +         ++  HT +P    
Sbjct: 131 AGMVYLASQHFVHRDLATRNC-LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-- 187

Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVG 224
                  +M PE  M           D+WSLG VL E+ + GK+PW +  SN +++  + 
Sbjct: 188 -------WMPPESIMYRKFTTES---DVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 236

Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATI 257
            G     P +   E       C + +P  R  I
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 59/172 (34%), Positives = 84/172 (48%), Gaps = 28/172 (16%)

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNG 166
           + ++ AI  LHEN I+HRDIK+ NIF+   G+ + LGDFG+A   V I+A+     +  G
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAACFPVDINAN-----KYYG 242

Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY-------DSNYQI 219
           + GT A  APE+     +  +G AVDIWS G VL EM++      E        DS+ QI
Sbjct: 243 WAGTIATNAPELLA---RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299

Query: 220 MF---KVGM--GETPTIPESLSDEGQAFAELCLR--HDPAQRATIFELLQHP 264
                + G    E P   ++  DE   +  L  +    P  R     L + P
Sbjct: 300 KLIIRRSGTHPNEFPIDAQANLDE--IYIGLAKKSSRKPGSRPLWTNLYELP 349

Length = 391

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 67/245 (27%), Positives = 124/245 (50%), Gaps = 21/245 (8%)

Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 21  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 79

Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 80  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 137

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 138 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 190

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEY-DSNYQIMFKVGMGETPTIPESLSD 237
             N + + + VDIWS+GC++ E+ +G+   P  ++ D    I+  VG      + +  S+
Sbjct: 191 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248

Query: 238 EGQAF 242
             + +
Sbjct: 249 SARNY 253

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 24/233 (10%)

Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y   N+ TGE+VA+K   L ++   +       E+ IL+ +  +N+VK
Sbjct: 13  GEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G   E   + + L ME    G+L   +   +  L ++L+  + +Q+ + ++ LH    
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQICEGMAYLHSQHY 128

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA-----YMAPEVF 179
           +HRD+ + N+ L  +   +K+GDFG A  +       G     V         + A E  
Sbjct: 129 IHRDLAARNVLLDND-RLVKIGDFGLAKAVPE-----GHEYYRVREDGDSPVFWYAVECL 182

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
            + NK  +  A D+WS G  L E+ +           ++ M     G+   + 
Sbjct: 183 KE-NKFSY--ASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 75/261 (28%), Positives = 127/261 (48%), Gaps = 41/261 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQKNL 64
           G G +G V +A +    + VA+K++       +H +   R       ELR+L+ +  +N+
Sbjct: 24  GSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-------ELRLLKHMKHENV 76

Query: 65  VKYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +    V      +  F E  L T      L ++V+  +  L +  V+    QL+  +  +
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK--LSDEHVQFLIYQLLRGLKYI 134

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H   I+HRD+K +N+ +  E   L++ DFG A +         E+ G+V T+ Y APE+ 
Sbjct: 135 HSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQAD------DEMTGYVATRWYRAPEIM 187

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEY-DSNYQIMFKVGMGETPTIPESL- 235
           +  N + + + VDIWS+GC++ E+  GK   P  +Y D   +IM  VG   TP+ PE L 
Sbjct: 188 L--NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG---TPS-PEVLK 241

Query: 236 ---SDEGQAFAELCLRHDPAQ 253
              S+  + + +  L H P Q
Sbjct: 242 KISSEHARKYIQ-SLPHMPQQ 261

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 71/257 (27%), Positives = 121/257 (47%), Gaps = 25/257 (9%)

Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKN 63
           F +  G+G FGKV  A    T EL A+K ++  +  Q+D   V+  +VE R+L   ++  
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVLALQDKPP 61

Query: 64  LVKYYGVEIHR-----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +     ++H      + +   ME    G L   +Q       E     Y  ++   +  
Sbjct: 62  FL----TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFF 116

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPE 177
           LH   I++RD+K  N+ L +EG+ +K+ DFG    +     V G     F GT  Y+APE
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGH-IKIADFG----MCKEHMVDGVTTRTFCGTPDYIAPE 171

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
           +        +G++VD W+ G +L EM +G+ P+   D +   +F+  M    + P+SLS 
Sbjct: 172 IIAYQP---YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHNVSYPKSLSK 226

Query: 238 EGQAFAELCLRHDPAQR 254
           E  +  +  +   P++R
Sbjct: 227 EAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 12/88 (13%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NIFLT+ G  +KLGDFG +  +S+   +       VGT  Y++PE+        +    
Sbjct: 132 QNIFLTSNGL-VKLGDFGISKVLSSTVDL---AKTVVGTPYYLSPELC---QNKPYNYKS 184

Query: 369 DIWSLGCVLVEMSSGK-----TNLSGVV 391
           DIWSLGCVL E+ + K      NL  + 
Sbjct: 185 DIWSLGCVLYELCTLKHPFEGENLLELA 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 30/212 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG- 69
           G+G +G V +A++  TGE VA+K+I     +    V D     RIL  I    L+++   
Sbjct: 9   GKGSYGVVCSAIDTHTGEKVAIKKI----NDVFEHVSD---ATRILREIKLLRLLRHPDI 61

Query: 70  VEIH-----------REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           VEI            ++  V+F EL  E  L  ++++ +D  PE   + +  QL+ A+  
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVF-EL-MESDLHQVIKANDDLTPE-HHQFFLYQLLRALKY 118

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +H   + HRD+K  NI   A+   LK+ DFG A      T        +V T+ Y APE+
Sbjct: 119 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 179 ---FMDTNKVGHGRAVDIWSLGCVLVEMSSGK 207
              F       +  A+DIWS+GC+  E+ +GK
Sbjct: 178 CGSFFSK----YTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 77/281 (27%), Positives = 116/281 (41%), Gaps = 48/281 (17%)

Query: 11  GQGRFGKVYTAV----NNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY  +    + +  EL VA+K + +   + D     D L+E  I+   N +N+
Sbjct: 15  GHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE---SDFLMEALIMSKFNHQNI 71

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISA---- 118
           V+  GV   R    + +EL   G L+S ++        P  L  +        ++     
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKI--------SAHTTVPGELNGFV 168
           L EN  +HRDI + N  LT +G     K+ DFG A  I             +P +     
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK----- 186

Query: 169 GTQAYMAPEVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVG 224
               +M PE F+D   T+K       D+WS G +L E  S G  P+    +N ++M  V 
Sbjct: 187 ----WMPPEAFLDGIFTSK------TDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVT 235

Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQR---ATIFELLQ 262
            G     P+            C +H P  R   ATI E +Q
Sbjct: 236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 35/213 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V+  +       VA+K +   K +D    +D   E++ L+ +  K+L+  + V
Sbjct: 15  GSGYFGEVWEGLWKNRVR-VAIKIL---KSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVHR 127
               E + +  EL  +G+L + ++S E     +  ++      Q+ + ++ L E   +HR
Sbjct: 71  CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI--DMACQVAEGMAYLEEQNSIHR 128

Query: 128 DIKSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           D+ + NI L  E    K+ DFG A      V +S+   +P +         + APE    
Sbjct: 129 DLAARNI-LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---------WTAPEA--- 175

Query: 182 TNKVGHGR---AVDIWSLGCVLVEMSS-GKRPW 210
                HG      D+WS G +L EM + G+ P+
Sbjct: 176 ---ASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 74/263 (28%), Positives = 116/263 (44%), Gaps = 27/263 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG VY  V     E VA+K  +     D +  +  L E  IL+  +  N+VK  GV
Sbjct: 4   GKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA---LHENTIVHR 127
            + ++ + + MEL   G+L + ++  ++ L    V++  +  +DA +    L     +HR
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLESKNCIHR 117

Query: 128 DIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           D+ + N  L  E N LK+ DFG S  +     TV   L        + APE       + 
Sbjct: 118 DLAARNC-LVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEA------LN 168

Query: 187 HGR---AVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
           +GR     D+WS G +L E  S G  P+    SN Q   ++  G     P+   +E    
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGYRMPAPQLCPEEIYRL 227

Query: 243 AELCLRHDPAQR---ATIFELLQ 262
              C  +DP  R   + I+  LQ
Sbjct: 228 MLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 28/268 (10%)

Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T + VA+K ++        F++    E +I++ +   
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHD 61

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV  Y V +  E + +  E   +G+L   ++   DG    LP+++      Q+ D ++ 
Sbjct: 62  KLVPLYAV-VSEEPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLV--DMAAQIADGMAY 117

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     +HRD+++ANI L  +    K+ DFG A  I        E N +   Q    P  
Sbjct: 118 IERMNYIHRDLRAANI-LVGDNLVCKIADFGLARLI--------EDNEYTARQGAKFPIK 168

Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
           +       +GR     D+WS G +L E+ + G+ P+     N +++ +V  G     P+ 
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRMPCPQG 227

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQ 262
             +      +LC + DP +R T FE +Q
Sbjct: 228 CPESLHELMKLCWKKDPDERPT-FEYIQ 254

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI +   G  +KL DFG A ++            F G+  +MAPEV       G+G A 
Sbjct: 131 ANILVDTNG-VVKLADFGMAKQVVEF----SFAKSFKGSPYWMAPEVIAQQG--GYGLAA 183

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLGC ++EM++GK
Sbjct: 184 DIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI LT++G  +KL DFG + ++S         N  VGT  +MAPEV    N   +    
Sbjct: 127 ANILLTSDG-EVKLIDFGLSAQLSDT----KARNTMVGTPYWMAPEVI---NGKPYDYKA 178

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ GK
Sbjct: 179 DIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 71/250 (28%), Positives = 117/250 (46%), Gaps = 21/250 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKN--LVK 66
           G+G FGKV  A    T EL A+K ++  +  Q+D   V+  +VE R+L  ++ K   L +
Sbjct: 9   GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVL-ALSGKPPFLTQ 65

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            +      + +   ME    G L   +Q       E     Y  ++   +  LH   I++
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVK--ISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           RD+K  N+ L +EG+ +K+ DFG   +      TT       F GT  Y+APE+      
Sbjct: 125 RDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTT-----KTFCGTPDYIAPEIIAYQP- 177

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
             +G++VD W+ G +L EM +G+ P+   D +   +F+  M      P+S+S E  A  +
Sbjct: 178 --YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHNVAYPKSMSKEAVAICK 233

Query: 245 LCLRHDPAQR 254
             +   P +R
Sbjct: 234 GLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 67/256 (26%), Positives = 119/256 (46%), Gaps = 19/256 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N + + VA+K ++    +    V+  L E  +++ +    LV+ Y V
Sbjct: 15  GAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
               E + +  E   +G+L   ++S E G   LP+++   ++ Q+ + ++ +     +HR
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHR 127

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++AN+ L +E    K+ DFG A  I  +     E   F     + APE     N    
Sbjct: 128 DLRAANV-LVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI---NFGSF 181

Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L E+ + GK P+    SN  +M  +  G      E+  DE     + C
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIPYPGM-SNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240

Query: 247 LRHDPAQRATIFELLQ 262
            +    +R T F+ LQ
Sbjct: 241 WKEKAEERPT-FDYLQ 255

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 32/76 (42%), Positives = 42/76 (55%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI  T +G  +KL DFG A K++    V  +    VGT  +MAPEV       G   A 
Sbjct: 128 ANILTTKDGV-VKLADFGVATKLND---VSKDDASVVGTPYWMAPEVI---EMSGASTAS 180

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLGC ++E+ +G 
Sbjct: 181 DIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/223 (25%), Positives = 112/223 (50%), Gaps = 15/223 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  V+   +  T  LVA+KEI+L  +  A      + E+ +L+ +   N+V  + +
Sbjct: 15  GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLHDI 72

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +H ++ +  +    +  L+  +    + +    V+ +  Q++  ++  H   ++HRD+K
Sbjct: 73  -VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +   G  LKL DFG A   S  T T   E    V T  Y  P+V + +++  +  
Sbjct: 132 PQNLLINERG-ELKLADFGLARAKSVPTKTYSNE----VVTLWYRPPDVLLGSSE--YST 184

Query: 190 AVDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKVGMGETPT 230
            +D+W +GC+  EM+SG+   P +  +    ++F++ +G TPT
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL-LG-TPT 225

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 34/271 (12%)

Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDAISAL 119
            LV+ Y V +  E + +  E  ++G+L   ++        LP+++      Q+   ++ +
Sbjct: 62  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYV 118

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
                VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  +
Sbjct: 119 ERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIKW 169

Query: 180 MDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPTI 231
                  +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P  
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPEC 228

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           PESL D        C R +P +R T FE LQ
Sbjct: 229 PESLHD----LMCQCWRKEPEERPT-FEYLQ 254

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 11/198 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +   G  VA+K++    QN     K    EL +L+ +N KN++    V
Sbjct: 30  GSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNHKNIISLLNV 88

Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q     L    +     Q++  I  LH   I+HRD
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A     +      +  +V T+ Y APEV +    +G+ 
Sbjct: 149 LKPSNIVVKSDC-TLKILDFGLARTACTNFM----MTPYVVTRYYRAPEVILG---MGYK 200

Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ E+  G
Sbjct: 201 ENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 62/250 (24%), Positives = 117/250 (46%), Gaps = 17/250 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+VY     +TG++ AMK      I++ KQ +   + + ++   +  G     + 
Sbjct: 3   GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y      +++   ++L   G L   + S      E  +R Y  +++  +  +H   +V
Sbjct: 62  MTYAFHT-PDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K ANI L   G+  ++ D G A   S         +  VGT  YMAPEV       
Sbjct: 120 YRDLKPANILLDEHGHV-RISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQ--KGT 171

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE 244
            +  + D +SLGC+L ++  G  P+ ++ + +   + ++ +     +P+S S E ++  E
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231

Query: 245 LCLRHDPAQR 254
             L+ D ++R
Sbjct: 232 GLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 71.0 bits (174), Expect = 7e-14
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 25/270 (9%)

Query: 11  GQGRFGKVY--TAVN---NETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY  TA +     +G + VA+K   L K    +  K+ L E  ++   N  N+
Sbjct: 4   GSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVD---AISA 118
           VK  GV +  E   + MEL   G L S ++       G P + ++      +D       
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 119 LHENTIVHRDIKSANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYM 174
           L +   +HRD+ + N  ++ +G      +K+GDFG A  I        E  G +  + +M
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WM 180

Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           APE  +D          D+WS G ++ E ++ G++P+    +N +++  V  G     PE
Sbjct: 181 APESLLDGKFTTQS---DVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRLQKPE 236

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           +  D+       C   DP++R T F+ +Q 
Sbjct: 237 NCPDKIYQLMTNCWAQDPSERPT-FDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A   +  +    KE  L +            E+ +L  +   N++    V
Sbjct: 10  GRGTYGHVYKAKRKDGKD---EKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 71  EI-HREEMVLFMELCTEGTLESLVQSTEDG--------LPEVLVRRYTKQLVDAISALHE 121
            + H +  V  +    E  L  +++             LP  +V+    Q++D I  LH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 122 NTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           N ++HRD+K ANI +  EG     +K+ D G A   ++      +L+  V T  Y APE+
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEM 203
            +      + +A+DIW++GC+  E+
Sbjct: 187 LLGARH--YTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 51/300 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 84

Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 145 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 196

Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ E LQHP++ V
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.7 bits (173), Expect = 9e-14
 Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 22/267 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+VY     +TG++ AMK      I++ KQ +   + + ++   +  G     + 
Sbjct: 3   GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y      +++   ++L   G L   + S      E  +R Y  +++  +  +H   +V
Sbjct: 62  MSYAFHT-PDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V
Sbjct: 120 YRDLKPANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGV 171

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIPESLSDEGQAFAE 244
            +  + D +SLGC+L ++  G  P+ ++ +  +       +     +P+S S E ++  E
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 231

Query: 245 LCLRHDPAQRATIF-----ELLQHPFL 266
             L+ D  +R         E+ +HPF 
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 32/82 (39%), Positives = 50/82 (60%), Gaps = 7/82 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L+ EG+ +KL DFG + ++++  +   + N FVGT  +MAPEV   +   G+    
Sbjct: 127 ANILLSEEGD-VKLADFGVSGQLTSTMS---KRNTFVGTPFWMAPEVIKQS---GYDEKA 179

Query: 369 DIWSLGCVLVEMSSGKTNLSGV 390
           DIWSLG   +E++ G+  LS +
Sbjct: 180 DIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 38/100 (38%), Positives = 56/100 (56%), Gaps = 6/100 (6%)

Query: 106 RRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
           R   KQL+ A+  +H+  ++HRDIK  NIFL  +G  + LGDFG+A+          +  
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTAMPFE-KEREAFDY- 326

Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS 205
           G+VGT A  +PE+       G+    DIWS G +L++M S
Sbjct: 327 GWVGTVATNSPEILA---GDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 73/267 (27%), Positives = 118/267 (44%), Gaps = 39/267 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N T + VA+K +   K       +  L E +I++ +    LV+ Y V
Sbjct: 15  GAGQFGEVWMGTWNGTTK-VAVKTL---KPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVHR 127
               E + +  E  ++G+L   ++S E     LP+++      Q+ + ++ L     +HR
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAAQIAEGMAYLESRNYIHR 127

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVFMDTNK 184
           D+ + NI L  E    K+ DFG A  I        E     G +    + APE       
Sbjct: 128 DLAARNI-LVGENLVCKIADFGLARLIEDDEYTARE-----GAKFPIKWTAPEA------ 175

Query: 185 VGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVG----MGETPTIPESLS 236
             +GR     D+WS G +L E ++ G+ P+    +N +++ +V     M   P  PE L 
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRMPRPPNCPEELY 234

Query: 237 DEGQAFAELCLRHDPAQRATIFELLQH 263
           D        C   DP +R T FE LQ 
Sbjct: 235 D----LMLQCWDKDPEERPT-FEYLQS 256

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 4/76 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI   + GN +KLGDFG++ ++    +    +    GT  +M+PEV    +  G+GR  
Sbjct: 133 ANILRDSAGN-VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI---SGEGYGRKA 188

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC +VEM + K
Sbjct: 189 DVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 7/77 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANIFL A  N +KLGDFG A KI  H +       +VGT  YM+PE     +   +    
Sbjct: 139 ANIFLDANNN-VKLGDFGLA-KILGHDSSFA--KTYVGTPYYMSPEQLNHMS---YDEKS 191

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWSLGC++ E+ +   
Sbjct: 192 DIWSLGCLIYELCALSP 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 5/107 (4%)

Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISA 156
           LP  +V+    Q++D I  LH N ++HRD+K ANI +  EG     +K+ D G A   ++
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
                 +L+  V T  Y APE+ +      + +A+DIW++GC+  E+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +  TG+ VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 25  GSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH-AKRAYRELVLMKLVNHKNIIGLLNV 83

Query: 71  EIHR------EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
              +      +++ L MEL       +L Q  +  L    +     Q++  I  LH   I
Sbjct: 84  FTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI 139

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSA-VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HRD+K +NI + ++  +LK+ DFG A    ++    P     +V T+ Y APEV +   
Sbjct: 140 IHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTP-----YVVTRYYRAPEVILG-- 191

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGK 207
            +G+   VDIWS+GC++ EM  G 
Sbjct: 192 -MGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 68/272 (25%), Positives = 114/272 (41%), Gaps = 35/272 (12%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGEL-----VAMKEIQLHKQNDARFVKDMLVELRIL 56
           S +TF    G G+FG V        G+      VA+K I+    ++  F++    E +++
Sbjct: 4   SELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVM 53

Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAI 116
             ++  NLV+ YGV   +  + +  E    G L + ++  +  L    +      + +A+
Sbjct: 54  MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AY 173
             L  N  +HRD+ + N  L  E N +K+ DFG A        +  +     GT+    +
Sbjct: 114 EYLESNGFIHRDLAARNC-LVGEDNVVKVSDFGLA-----RYVLDDQYTSSQGTKFPVKW 167

Query: 174 MAPEVFMDTNKVGHGR---AVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETP 229
             PEVF       + R     D+WS G ++ E+ S GK P+ E  SN +++  V  G   
Sbjct: 168 APPEVFD------YSRFSSKSDVWSFGVLMWEVFSEGKMPY-ERFSNSEVVESVSAGYRL 220

Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
             P+    E       C    P  R    +LL
Sbjct: 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 27/259 (10%)

Query: 11  GQGRFGKVYTA-VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG+V+   + ++T   V   +  L ++   +F    L E RIL+  +  N+VK  G
Sbjct: 4   GKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKF----LSEARILKQYDHPNIVKLIG 59

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           V   R+ + + MEL   G   S ++  +D L    + ++       ++ L     +HRD+
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA-------YMAPEVFMDT 182
            + N  L  E N LK+ DFG + +         E +G   +         + APE     
Sbjct: 120 AARNC-LVGENNVLKISDFGMSRQ---------EDDGIYSSSGLKQIPIKWTAPEAL--- 166

Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
           N   +    D+WS G +L E  S G  P+    +N Q   +V  G   + P+   D+   
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRMSCPQKCPDDVYK 225

Query: 242 FAELCLRHDPAQRATIFEL 260
             + C  + P  R    EL
Sbjct: 226 VMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 34/277 (12%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           S VT     G G FG+V        G+    VA+K   L   +  +   D L E  I+  
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIK--TLKAGSSDKQRLDFLTEASIMGQ 61

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAIS 117
            +  N+++  GV      +++  E    G+L+  ++  +       LV    + +   + 
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV-GMLRGIASGMK 120

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI----SAHTTVPGELNGFVGTQAY 173
            L E   VHRD+ + NI + +     K+ DFG + ++    + +TT  G++        +
Sbjct: 121 YLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKI-----PIRW 174

Query: 174 MAPEVFMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETP 229
            APE       + + +   A D+WS G V+ E MS G+RP+ +  SN  ++  V  G   
Sbjct: 175 TAPEA------IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRL 227

Query: 230 TIPESLSDEGQAFAEL---CLRHDPAQRATIFELLQH 263
             P    D   A  +L   C + D  +R T  +++  
Sbjct: 228 PPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 71  EIHREEMVLFMEL--CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F ++    E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203

Query: 189 RAVDIWSLGCVLVEMSSGK 207
             VDIWS+GC++ EM  G 
Sbjct: 204 ENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           N+V  +   +  + + L ++    G L S + S    +PE  V+R+  ++V A+ ALH  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            IV RD+   NI L   G+ ++L  F    +      V    +G      Y APEV   +
Sbjct: 105 GIVCRDLNPNNILLDDRGH-IQLTYFSRWSE------VEDSCDGEAVENMYCAPEVGGIS 157

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
            +     A D WSLG +L E+ +GK     + S       +    T  IPE +S+E ++ 
Sbjct: 158 EET---EACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSL 208

Query: 243 AELCLRHDPAQR-----ATIFELLQHPF 265
            +  L+ +P +R     A + ++  HPF
Sbjct: 209 LQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 26/259 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E +I++ +    LV+ Y V
Sbjct: 15  GNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESF----LEEAQIMKKLRHDKLVQLYAV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVHR 127
            +  E + +  E  ++G+L   ++  E     LP ++      Q+   ++ +     +HR
Sbjct: 70  -VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERMNYIHR 126

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D++SANI L  +G   K+ DFG A  I        E N +   Q    P  +       +
Sbjct: 127 DLRSANI-LVGDGLVCKIADFGLARLI--------EDNEYTARQGAKFPIKWTAPEAALY 177

Query: 188 GRAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           GR     D+WS G +L E+ + G+ P+   + N +++ +V  G     P+          
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERGYRMPCPQDCPISLHELM 236

Query: 244 ELCLRHDPAQRATIFELLQ 262
             C + DP +R T FE LQ
Sbjct: 237 LQCWKKDPEERPT-FEYLQ 254

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 49/277 (17%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+ A     +  +   LVA+K ++   ++ AR  +D   E  +L  +  +++V
Sbjct: 14  GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-AR--QDFQREAELLTVLQHQHIV 70

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS----------TED------GLPEVLVRRYT 109
           ++YGV      +++  E    G L   ++S           ED       L ++L     
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML--AIA 128

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--------VKISAHTTVP 161
            Q+   +  L     VHRD+ + N  L  +G  +K+GDFG +         ++   T +P
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNC-LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIM 220
                      +M PE  +           DIWS G VL E+ + GK+PW +  SN + +
Sbjct: 188 IR---------WMPPESILYRKFTTES---DIWSFGVVLWEIFTYGKQPWYQL-SNTEAI 234

Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATI 257
             +  G     P +   E  A  + C + +P QR  I
Sbjct: 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVI 271

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 50/281 (17%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+ A        +   LVA+K +   K       KD   E  +L  +  +++V
Sbjct: 14  GEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS-----------------TEDGLPEVLVRRY 108
           K+YGV    + +++  E    G L   +++                  E GL ++L    
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML--HI 128

Query: 109 TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--------VKISAHTTV 160
             Q+   +  L     VHRD+ + N  L      +K+GDFG +         ++  HT +
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNC-LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQI 219
           P           +M PE  M           D+WS G +L E+ + GK+PW +  SN ++
Sbjct: 188 PIR---------WMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEV 234

Query: 220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
           +  +  G     P     E       C + +P QR  I E+
Sbjct: 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG+V+ A     +  E   +VA+K   L ++  A    D   E  ++   +  N+V
Sbjct: 14  GQGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 66  KYYGVEIHREEMVL------------FMELCTEGTLESLVQSTEDGLPEVLVR------- 106
           K  GV    + M L            F+   +     SL  ST       L         
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 107 --RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL 164
                KQ+   ++ L E   VHRD+ + N  L  E   +K+ DFG +  I +        
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNC-LVGENMVVKIADFGLSRNIYSADYYKASE 190

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKV 223
           N  +  + +M PE     N+  +    D+W+ G VL E+ S G +P+    ++ ++++ V
Sbjct: 191 NDAIPIR-WMPPESIF-YNR--YTTESDVWAYGVVLWEIFSYGMQPYYGM-AHEEVIYYV 245

Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQR---ATIFELLQH 263
             G   + P++   E      LC    P+ R   A+I  +LQ 
Sbjct: 246 RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKI---SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L   G  +KL DFG A ++     H T    L    GT  +MAPEV    N+ G+GR
Sbjct: 132 NVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI---NESGYGR 187

Query: 367 AVDIWSLGCVLVEMSSGKTNLSGVVVSAEVFGSG 400
             DIWS+GC + EM++GK  L+ +   A +F  G
Sbjct: 188 KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 59/263 (22%), Positives = 116/263 (44%), Gaps = 21/263 (7%)

Query: 4   VTFSVSPGQGRFGKVYTAVNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           +TF    G G+FG V        G+  VA+K I+    ++  F++    E +++  ++ +
Sbjct: 6   LTFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            LV+ YGV   +  + +  E  + G L + ++          +    K + + ++ L   
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVF 179
             +HRD+ + N  +  +G  +K+ DFG +  +     +  E    VG++    +  PEV 
Sbjct: 120 QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYV-----LDDEYTSSVGSKFPVRWSPPEVL 173

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           + +         D+W+ G ++ E+ S GK P+  ++ N + + KV  G     P   S++
Sbjct: 174 LYSK---FSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVEKVSQGLRLYRPHLASEK 229

Query: 239 GQAFAELCLRHDPAQRATIFELL 261
             A    C      +R T  +LL
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 14/207 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G++G+VY  V  +    VA+K ++     D   V++ L E  +++ I   NLV+  GV
Sbjct: 15  GGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  E  T G L + L +     +  V++     Q+  A+  L +   +HRD+
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
            + N  L  E + +K+ DFG +  ++  T T      G      + APE  +  NK    
Sbjct: 131 AARNC-LVGENHLVKVADFGLSRLMTGDTYTAHA---GAKFPIKWTAPES-LAYNKF--S 183

Query: 189 RAVDIWSLGCVLVEMSS-GKRPWAEYD 214
              D+W+ G +L E+++ G  P+   D
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGID 210

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 66/260 (25%), Positives = 125/260 (48%), Gaps = 28/260 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+ A  N+  + VA+K ++    +    V+  L E  +++ +    LVK + V
Sbjct: 15  GAGQFGEVWMATYNKHTK-VAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
            + +E + +  E   +G+L   ++S E     LP+++   ++ Q+ + ++ + +   +HR
Sbjct: 70  -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHR 126

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++ANI ++A     K+ DFG A  I  +     E   F     + APE     N    
Sbjct: 127 DLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI---NFGSF 180

Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQAF 242
               D+WS G +L+E+ + G+ P+    SN +++  +  G         PE L +     
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRPENCPEELYN----I 235

Query: 243 AELCLRHDPAQRATIFELLQ 262
              C ++ P +R T FE +Q
Sbjct: 236 MMRCWKNRPEERPT-FEYIQ 254

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 65.7 bits (161), Expect = 5e-12
 Identities = 31/74 (41%), Positives = 44/74 (59%), Gaps = 7/74 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L+ +G S+KL DFG A +++       + N  VGT  +MAPEV    +   +G  VD
Sbjct: 146 NILLSKDG-SVKLADFGFAAQLTKEK---SKRNSVVGTPYWMAPEVIKRKD---YGPKVD 198

Query: 370 IWSLGCVLVEMSSG 383
           IWSLG + +EM+ G
Sbjct: 199 IWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 30/84 (35%), Positives = 43/84 (51%), Gaps = 16/84 (19%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKIS----AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           N+ L + G  +KL DFG A K+       T        F GT  Y+APE+ +  NK G+ 
Sbjct: 123 NLLLDSNG-YVKLVDFGFAKKLKSGQKTWT--------FCGTPEYVAPEIIL--NK-GYD 170

Query: 366 RAVDIWSLGCVLVEMSSGKTNLSG 389
            +VD WSLG +L E+ +G+     
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 65/260 (25%), Positives = 107/260 (41%), Gaps = 25/260 (9%)

Query: 11  GQGRFGKVYTAVNNETGEL---VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG V   V          VA+K   L +++ A   K+ L E  ++  ++   +V+ 
Sbjct: 4   GHGNFGSVVKGVYLMKSGKEVEVAVK--TLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    E ++L MEL   G L   ++   + +P   ++    Q+   ++ L     VHR
Sbjct: 62  IGV-CKGEPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA------YMAPEVFMD 181
           D+ + N+ L     + K+ DFG +  + A +        +  T A      + APE    
Sbjct: 120 DLAARNVLLVNRHQA-KISDFGMSRALGAGSDY------YRATTAGRWPLKWYAPECI-- 170

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
            N        D+WS G  L E  S G +P+ E     +++  +  GE    PE    E  
Sbjct: 171 -NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGERLPRPEECPQEIY 228

Query: 241 AFAELCLRHDPAQRATIFEL 260
           +    C ++ P  R T  EL
Sbjct: 229 SIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 29/82 (35%), Positives = 48/82 (58%), Gaps = 4/82 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI LT +G+ +KL DFG + +++A  T+  +   F+GT  +MAPEV     K G+    
Sbjct: 130 ANILLTEDGD-VKLADFGVSAQLTA--TI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 369 DIWSLGCVLVEMSSGKTNLSGV 390
           DIW+LG   +E++  +  +  +
Sbjct: 186 DIWALGITAIELAELQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 63/266 (23%), Positives = 115/266 (43%), Gaps = 20/266 (7%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           S +T     G G+FG V+     E  + VA+K I+    ++  F++    E +++  ++ 
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIE----EAQVMMKLSH 58

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
             LV+ YGV   R  + L  E    G L   +++      +  +      + + ++ L  
Sbjct: 59  PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEV 178
           + ++HRD+ + N  L  E   +K+ DFG          +  +     GT+    + +PEV
Sbjct: 119 SNVIHRDLAARNC-LVGENQVVKVSDFG-----MTRFVLDDQYTSSTGTKFPVKWSSPEV 172

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
           F  +    +    D+WS G ++ E+ S GK P+ E  SN +++  +  G     P   S 
Sbjct: 173 FSFSK---YSSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSEVVETINAGFRLYKPRLASQ 228

Query: 238 EGQAFAELCLRHDPAQRATIFELLQH 263
                 + C +  P  R + F LL H
Sbjct: 229 SVYELMQHCWKERPEDRPS-FSLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.4 bits (158), Expect = 1e-11
 Identities = 42/156 (26%), Positives = 62/156 (39%), Gaps = 46/156 (29%)

Query: 261 LQHPFLIVSCEEDVCNPRSVPASV-------LQDYLKLGIVLPPMSEDSVKVYAR----- 308
           L+HP  IV   + +   R +   V       L+ YL       P+S + +K         
Sbjct: 55  LKHPN-IVKLLDVIHTERKL-YLVFEYCDMDLKKYLDK--RPGPLSPNLIKSIMYQLLRG 110

Query: 309 ----------------ANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQ 348
                            NI +  +G  LKL DFG A    + +  +T         V T 
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHE-------VVTL 162

Query: 349 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
            Y APE+ + +    +  AVDIWS+GC+  EM +GK
Sbjct: 163 WYRAPEILLGSKH--YSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 28/75 (37%), Positives = 46/75 (61%), Gaps = 12/75 (16%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L ++G  +K+ DFG A ++   T T+        GT  Y+APE+ +  +K G+G+AV
Sbjct: 131 NLLLDSDG-YIKITDFGFAKRVKGRTYTL-------CGTPEYLAPEIIL--SK-GYGKAV 179

Query: 369 DIWSLGCVLVEMSSG 383
           D W+LG ++ EM +G
Sbjct: 180 DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 62/262 (23%), Positives = 115/262 (43%), Gaps = 13/262 (4%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           S +TF    G G+FG V+        + VA+K I       A   +D + E +++  ++ 
Sbjct: 4   SELTFMKELGSGQFGVVHLGKWRAQIK-VAIKAIN----EGAMSEEDFIEEAKVMMKLSH 58

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
             LV+ YGV   ++ + +  E    G L + ++  +  L + ++    + + + +  L  
Sbjct: 59  PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           N+ +HRD+ + N  +++ G  +K+ DFG    +            F     +  PEVF  
Sbjct: 119 NSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVF-- 173

Query: 182 TNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
            N   +    D+WS G ++ E+ + GK P+ +  SNY+++  +  G     P+  S    
Sbjct: 174 -NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-SNYEVVEMISRGFRLYRPKLASMTVY 231

Query: 241 AFAELCLRHDPAQRATIFELLQ 262
                C    P  R T  ELL+
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 7/82 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI L  EG + KL DFG + +++  T    + N  +GT  +MAPEV     ++G+    
Sbjct: 128 GNILLNEEGQA-KLADFGVSGQLT-DTM--AKRNTVIGTPFWMAPEVIQ---EIGYNNKA 180

Query: 369 DIWSLGCVLVEMSSGKTNLSGV 390
           DIWSLG   +EM+ GK   S +
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 32/73 (43%), Positives = 42/73 (57%), Gaps = 7/73 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+TA G  +KLGD G     S+ TT     +  VGT  YM+PE   +    G+    
Sbjct: 135 ANVFITATG-VVKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHEN---GYNFKS 187

Query: 369 DIWSLGCVLVEMS 381
           DIWSLGC+L EM+
Sbjct: 188 DIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 25/77 (32%), Positives = 44/77 (57%), Gaps = 3/77 (3%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + +    LK+ DFG A  +       G L  +V T+ Y APE+ + +++  + +A+
Sbjct: 132 SNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR--YTKAI 188

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWS+GC+  E+ + K 
Sbjct: 189 DIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 70/287 (24%), Positives = 118/287 (41%), Gaps = 47/287 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G+VY A +      VA+K+I+     +    K  L E +I   +    +V  Y +
Sbjct: 11  GKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSI 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQST--EDGLPE---------VLVRRYTKQLVDAISAL 119
               + +   M      TL+SL++S   ++ L +           +  + K +   I  +
Sbjct: 71  CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK-ICATIEYV 129

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA------------------HTTVP 161
           H   ++HRD+K  NI L   G  + L D+G+A+                        T+P
Sbjct: 130 HSKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIP 188

Query: 162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-----N 216
           G++   VGT  YMAPE  +         + DI++LG +L +M +   P+           
Sbjct: 189 GKI---VGTPDYMAPERLLGVPA---SESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242

Query: 217 YQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR-ATIFELLQ 262
             I+  + +     IP  LS      A   L  DPA+R +++ EL Q
Sbjct: 243 DVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELKQ 285

Length = 932

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 29/75 (38%), Positives = 43/75 (57%), Gaps = 4/75 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +      +K+ DFG++ +++           F GT  YMAPEV +D    G+G   D
Sbjct: 138 NVLVNTYSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMAPEV-IDKGPRGYGAPAD 193

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLGC +VEM++GK
Sbjct: 194 IWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 66/275 (24%), Positives = 111/275 (40%), Gaps = 31/275 (11%)

Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
              +    + G+G FG V        G+ VA+K ++    +D+   +  L E  ++  + 
Sbjct: 5   SKELKLGATIGKGEFGDVMLGD--YRGQKVAVKCLK----DDSTAAQAFLAEASVMTTLR 58

Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQL----VDAI 116
             NLV+  GV +    + +  E   +G+L   ++S       V+             + +
Sbjct: 59  HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGM 115

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
             L E   VHRD+ + N+ L +E    K+ DFG A + S      G+L        + AP
Sbjct: 116 EYLEEKNFVHRDLAARNV-LVSEDLVAKVSDFGLAKEASQGQDS-GKL-----PVKWTAP 168

Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E   +   + K       D+WS G +L E+ S G+ P+        ++  V  G     P
Sbjct: 169 EALREKKFSTK------SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAP 221

Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
           E    E     + C   DPA+R T  +L +   LI
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 35/247 (14%)

Query: 1   MSSVTFSVSPGQGRFGKVY-----TAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI 55
           +S+V F    G+G FGKVY           +   VA+K   L +  + +  ++   E  +
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIK--TLKENAEPKVQQEFRQEAEL 61

Query: 56  LEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL-ESLV-QSTEDGLPEVLVRRYTKQLV 113
           +  +   N+V   GV    +   +  E    G L E LV  S    +         K  +
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 114 DAISALH-------------ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
           D    LH              +  VHRD+ + N  L  EG ++K+ DFG +  I +    
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC-LVGEGLTVKISDFGLSRDIYSADYY 180

Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEM-SSGKRPWAEYDSN 216
             +    +  + +M PE  +      +G+     DIWS G VL E+ S G +P+  + SN
Sbjct: 181 RVQSKSLLPVR-WMPPEAIL------YGKFTTESDIWSFGVVLWEIFSYGLQPYYGF-SN 232

Query: 217 YQIMFKV 223
            +++  +
Sbjct: 233 QEVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 66/283 (23%), Positives = 119/283 (42%), Gaps = 45/283 (15%)

Query: 11  GQGRFGKVYTAVNNETGEL-----VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV  A             VA+K   L +   +  ++D+L E  +L+ +N  +++
Sbjct: 9   GEGEFGKVVKATAFRLKGRAGYTTVAVK--MLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQ-----------------STEDGLPEV----- 103
           K YG       ++L +E    G+L S ++                 S+    P+      
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 104 -LVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
             +  +  Q+   +  L E  +VHRD+ + N+ L AEG  +K+ DFG +  +    +   
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNV-LVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 163 ELNGFVGTQAYMAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQ 218
              G +  + +MA E   D   T +       D+WS G +L E+ + G  P+       +
Sbjct: 186 RSKGRIPVK-WMAIESLFDHIYTTQ------SDVWSFGVLLWEIVTLGGNPYPGIAP--E 236

Query: 219 IMFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
            +F  +  G     PE+ S+E       C + +P +R T  ++
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 51/223 (22%), Positives = 100/223 (44%), Gaps = 21/223 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ-LHKQNDAR---FVKDMLVELRILEGINQKNLVK 66
           GQG F K++  +  E G+   + + + L K  D     + +       ++  ++ K+LV 
Sbjct: 4   GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +  +E ++  E    G+L++ ++  ++ +         KQL  A+  L +  + H
Sbjct: 64  NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTH 123

Query: 127 RDIKSANIFLTAEGNS-------LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            ++ + N+ L  E +        +KL D G ++     T +P E+   +    ++ PE  
Sbjct: 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-----TVLPKEI--LLERIPWVPPECI 176

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMF 221
            +   +    A D WS G  L E+ S G +P +  DS  ++ F
Sbjct: 177 ENPQNL--SLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 54/291 (18%)

Query: 26  TGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC 84
           TGE V ++ I L    N+   V  +  EL + +  N  N+V Y    I   E+ +     
Sbjct: 24  TGEYVTVRRINLEACTNE--MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81

Query: 85  TEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL 143
             G+ + L+ +   DG+ E+ +    + ++ A+  +H    VHR +K+++I ++ +G  +
Sbjct: 82  AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-V 140

Query: 144 KLGDFGSAVKISAHTTVPGELNGF----VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV 199
            L    S + +  H      ++ F    V    +++PEV +  N  G+    DI+S+G  
Sbjct: 141 YLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV-LQQNLQGYDAKSDIYSVGIT 199

Query: 200 LVEMSSGKRPWAEYDSNYQIMFKV-----------------------------GMGETPT 230
             E+++G  P+ +  +   ++ K+                             G+GE+ T
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTT 259

Query: 231 IPESLSDEGQ---------------AFAELCLRHDPAQRATIFELLQHPFL 266
           +       G+                F E CL+ +P  R +   LL H F 
Sbjct: 260 VSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 44/166 (26%), Positives = 58/166 (34%), Gaps = 56/166 (33%)

Query: 256 TIFELLQHPFLIVSCEEDVCNPRSVPASVLQD----YLKLGIVL-----------PPMSE 300
            I + L HPFL         N         QD    YL + ++L              SE
Sbjct: 52  RILQELNHPFL--------VNLWYS----FQDEENMYLVVDLLLGGDLRYHLSQKVKFSE 99

Query: 301 DSVKVYARA---------------------NIFLTAEGNSLKLGDFGSAVKISAHTTVPG 339
           + VK +                        NI L  +G+ + + DF  A K++  T    
Sbjct: 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDT---- 154

Query: 340 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
                 GT  YMAPEV     + G+  AVD WSLG    E   GK 
Sbjct: 155 LTTSTSGTPGYMAPEVLC---RQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 27/265 (10%)

Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           +  +T     G+G FG V       TG+ VA+K I+      A      L E  ++  ++
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA-----FLEETAVMTKLH 57

Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISAL 119
            KNLV+  GV +H   + + MEL ++G L + +++    L   + + +++  + + +  L
Sbjct: 58  HKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
               +VHRD+ + NI L +E    K+ DFG A            ++       + APE  
Sbjct: 117 ESKKLVHRDLAARNI-LVSEDGVAKVSDFGLA------RVGSMGVDNSKLPVKWTAPEA- 168

Query: 180 MDTNKVGHGR---AVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
                + H +     D+WS G +L E+ S G+ P+ +     ++   V  G     PE  
Sbjct: 169 -----LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECVEKGYRMEPPEGC 222

Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
             +       C   +P +R +  +L
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 57/248 (22%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK---QNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V  A   +T  L AMK ++      +N    VK    E  IL   + + +V+ 
Sbjct: 10  GIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVK---AERDILAEADNEWVVRL 66

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVH 126
           Y     ++ +   M+    G + SL+     G+ PE L R Y  +L  A+ ++H+   +H
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYIAELTCAVESVHKMGFIH 124

Query: 127 RDIKSANIFLTAEGNSLKLG----------------------------DFGSAVKISAHT 158
           RDIK  NI +  +G+ +KL                             DF +     A+ 
Sbjct: 125 RDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 159 TVPGEL----------------NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 202
                L                +  VGT  Y+APEV + T   G+ +  D WS+G +L E
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT---GYTQLCDWWSVGVILYE 240

Query: 203 MSSGKRPW 210
           M  G+ P+
Sbjct: 241 MLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 32/82 (39%), Positives = 43/82 (52%), Gaps = 6/82 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI +T  GN +KL DFG A  +        + + FVGT  +MAPEV  +     +    
Sbjct: 130 ANILVTNTGN-VKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITEG--KYYDTKA 183

Query: 369 DIWSLGCVLVEMSSGKTNLSGV 390
           DIWSLG  + EM++G    S V
Sbjct: 184 DIWSLGITIYEMATGNPPYSDV 205

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 75/306 (24%), Positives = 117/306 (38%), Gaps = 59/306 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR----ILEGINQKNLVK 66
           G+G FG+V      +TG++ AMK   L K     F KD L  ++    +L   +   +V 
Sbjct: 10  GKGAFGEVRLVQKKDTGKIYAMK--TLLKSE--MFKKDQLAHVKAERDVLAESDSPWVVS 65

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            Y      + + L ME    G L +++    D   E + R Y  + V AI A+H+   +H
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIH 124

Query: 127 RDIKSANIFLTAE--------GNSL---KLGDFGSAVKISAHTTVPGELNGF-------- 167
           RDIK  NI +           G S    K  D     K+    +    ++          
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184

Query: 168 ------------------------VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
                                   VGT  Y+APE+F+     G+G+  D WSLG ++ E 
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ---GYGQECDWWSLGAIMFEC 241

Query: 204 SSGKRPWAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAELCLRHDPAQ--RATIFE 259
             G  P+   +S+      +   ET   P+   LS E +      + +   +  R    E
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHE 301

Query: 260 LLQHPF 265
           +  HPF
Sbjct: 302 IKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 8/94 (8%)

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
           KQ+++ +  LH   I+HRD+K+ NIF+    + + +GD G+A         P  L G  G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAA---QFPVVAPAFL-GLAG 218

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
           T    APEV     +  +    DIWS G VL EM
Sbjct: 219 TVETNAPEVLA---RDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 2/81 (2%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+  E   LK+GDFG A  +  H +  G L+  + T+ Y +P + +  N   + +A+
Sbjct: 143 ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN--YTKAI 200

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+W+ GC+  EM +GK   +G
Sbjct: 201 DMWAAGCIFAEMLTGKPLFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 62/252 (24%), Positives = 107/252 (42%), Gaps = 21/252 (8%)

Query: 11  GQGRFGKVYTAV--NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V   +    ++ + VA+K I  +  ND     ++L E  +++ ++   +V+  
Sbjct: 4   GSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQS----TEDGLPEVLVRRYTKQLVDAISALHENTI 124
           G+    E  +L MEL   G L   +Q     TE  + E++      Q+   +  L E   
Sbjct: 63  GI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV-----HQVSMGMKYLEETNF 116

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTTVPGELNGFVGTQAYMAPEVFMDTN 183
           VHRD+ + N+ L  + +  K+ DFG +  + A       + +G    + Y APE     N
Sbjct: 117 VHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECM---N 171

Query: 184 KVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
                   D+WS G ++ E  S G++P+     N      +  GE    P+    E    
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-IESGERMECPQRCPPEMYDL 230

Query: 243 AELCLRHDPAQR 254
            +LC  +   +R
Sbjct: 231 MKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 33/249 (13%)

Query: 25  ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF--ME 82
            TG  VA+K ++     +         E  +   +   N+V            +LF   E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD-SGEAPPGLLFAVFE 59

Query: 83  LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS 142
                TL  ++   +  LP     R   Q++DA++  H   IVHRD+K  NI ++  G  
Sbjct: 60  YVPGRTLREVLA-ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR 118

Query: 143 --LKLGDFGSAVKIS-------AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV-- 191
              K+ DFG    +        A  T   E    +GT  Y APE          G  V  
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTE---VLGTPTYCAPEQL-------RGEPVTP 168

Query: 192 --DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL---C 246
             D+++ G + +E  +G+R   +  S  +I+++       ++P  +   G    ++    
Sbjct: 169 NSDLYAWGLIFLECLTGQRV-VQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKA 225

Query: 247 LRHDPAQRA 255
           L  DP QRA
Sbjct: 226 LNKDPRQRA 234

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 31/76 (40%), Positives = 45/76 (59%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGRA 367
            NI L +E   LKL DFG A  + A    P  L  +V T+ Y APE+ + DTN   +G+ 
Sbjct: 129 ENI-LVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELLVGDTN---YGKP 182

Query: 368 VDIWSLGCVLVEMSSG 383
           VD+W++GC++ E+  G
Sbjct: 183 VDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 23/94 (24%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG------------------FVGTQAYM 351
           NI L  + + +K+ DFG+A K+    + P    G                  FVGT  Y+
Sbjct: 132 NILLDKDMH-IKITDFGTA-KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 352 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           +PE  +   K   G++ D+W+LGC++ +M +GK 
Sbjct: 190 SPE--LLNEKPA-GKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 31/75 (41%), Positives = 39/75 (52%), Gaps = 10/75 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  EG+ +KL DFG A K+   T          GT  Y+APEV       GH +AVD
Sbjct: 131 NILLDKEGH-IKLTDFGFAKKLRDRTWT------LCGTPEYLAPEVIQSK---GHNKAVD 180

Query: 370 IWSLGCVLVEMSSGK 384
            W+LG ++ EM  G 
Sbjct: 181 WWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.1 bits (144), Expect = 8e-10
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 5/76 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI +  +G  LKL DFG A   +       +    V T  Y  PE+ +   +  +G  V
Sbjct: 129 SNILINNDGV-LKLADFGLARPYTKRN--SADYTNRVITLWYRPPELLLGATR--YGPEV 183

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC+L E+  GK
Sbjct: 184 DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 8e-10
 Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 9/96 (9%)

Query: 109 TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNG 166
            +QL+ AI  +H   I+HRDIK+ N+ +    + + LGDFG+A   + S  T       G
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED-ICLGDFGAACFARGSWSTPFH---YG 321

Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 202
             GT    APEV        +  +VDIWS G V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDP---YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 28/77 (36%), Positives = 40/77 (51%), Gaps = 9/77 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRA 367
           +N+ + ++G  +K+ DFG    IS       +  N FVGT  YM+PE         +  A
Sbjct: 129 SNLLINSKGE-VKIADFG----ISKVLENTLDQCNTFVGTVTYMSPERI-QGES--YSYA 180

Query: 368 VDIWSLGCVLVEMSSGK 384
            DIWSLG  L+E + GK
Sbjct: 181 ADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 30/106 (28%), Positives = 39/106 (36%), Gaps = 30/106 (28%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF------------------------- 344
           NI + A+G+ +KL DFG   K++        LN                           
Sbjct: 131 NILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189

Query: 345 -VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
            VGT  Y+APEV        +G   D WSLG +L EM  G      
Sbjct: 190 TVGTPDYIAPEVLR---GTPYGLECDWWSLGVILYEMLYGFPPFYS 232

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 5/78 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           +NI L ++   +KL DFG A  +S     P    L  +V T+ Y APE+ + + +  + +
Sbjct: 136 SNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTR--YTK 192

Query: 367 AVDIWSLGCVLVEMSSGK 384
            VD+WS+GC+L EM  GK
Sbjct: 193 GVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 33/79 (41%), Positives = 45/79 (56%), Gaps = 8/79 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI LT  G ++KL DFGSA  +S     P   N FVGT  +MAPEV +  ++  +   V
Sbjct: 144 GNILLTEPG-TVKLADFGSASLVS-----PA--NSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 369 DIWSLGCVLVEMSSGKTNL 387
           D+WSLG   +E++  K  L
Sbjct: 196 DVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 28/65 (43%), Positives = 39/65 (60%), Gaps = 2/65 (3%)

Query: 320 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 379
           LK+ DFG A          G L  +V T+ Y APE+ M  +K G+ +A+DIWS+GC+L E
Sbjct: 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI-MLNSK-GYTKAIDIWSVGCILAE 202

Query: 380 MSSGK 384
           M S +
Sbjct: 203 MLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 35/75 (46%), Positives = 47/75 (62%), Gaps = 9/75 (12%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L A+G+ +KL DFG   K S H    G + + F GT  YMAPE+ M   + GHG+AV
Sbjct: 130 NILLDAQGH-VKLTDFG-LCKESIHE---GTVTHTFCGTIEYMAPEILM---RSGHGKAV 181

Query: 369 DIWSLGCVLVEMSSG 383
           D WSLG ++ +M +G
Sbjct: 182 DWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 26/66 (39%), Positives = 40/66 (60%), Gaps = 8/66 (12%)

Query: 320 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 379
           LK+ DFG A           E+ G+V T+ Y APE+ +  N + + + VDIWS+GC++ E
Sbjct: 157 LKILDFGLARHTDD------EMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAE 208

Query: 380 MSSGKT 385
           + +GKT
Sbjct: 209 LLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 64/255 (25%), Positives = 116/255 (45%), Gaps = 18/255 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +    LV+ Y V
Sbjct: 15  GAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAF----LAEANLMKQLQHPRLVRLYAV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T +G  L    +     Q+ + ++ +     +HRD
Sbjct: 70  -VTQEPIYIITEYMENGSLVDFLK-TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L +E    K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 128 LRAANI-LVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAI---NYGTFT 181

Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRMPRPDNCPEELYELMRLCW 240

Query: 248 RHDPAQRATIFELLQ 262
           +  P +R T FE L+
Sbjct: 241 KEKPEERPT-FEYLR 254

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 11  GQGRFGKVYTAVNNETGEL----VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  V    GE     VA+K ++  ++   +  K++L E  ++  ++  ++V+
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +   ++ L  +L   G L   V++ +D +    +  +  Q+   +S L E  +VH
Sbjct: 74  LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV---FMDTN 183
           RD+ + N+ L      +K+ DFG A  +           G V  + +MA E     + T+
Sbjct: 133 RDLAARNV-LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK-WMALESILHRIYTH 190

Query: 184 KVGHGRAVDIWSLGCVLVE-MSSGKRPWA 211
           K       D+WS G  + E M+ G +P+ 
Sbjct: 191 K------SDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 8/101 (7%)

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG- 226
           +GT  Y+APE+ +      HG AVD W+LG  L E  +G  P+   D   Q +F+  +  
Sbjct: 541 LGTPDYLAPELLL---GKPHGPAVDWWALGVCLFEFLTGIPPFN--DETPQQVFQNILNR 595

Query: 227 --ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
               P   E LS   Q   E+ L  DP +RA + EL QHP 
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 34/81 (41%), Positives = 46/81 (56%), Gaps = 7/81 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+TA G  +KLGD G     S+ TT    L   VGT  YM+PE   +    G+    
Sbjct: 135 ANVFITATG-VVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHEN---GYNFKS 187

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWSLGC+L EM++ ++   G
Sbjct: 188 DIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 33/74 (44%), Positives = 43/74 (58%), Gaps = 7/74 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+TA G  +KLGD G     S+ TT    L   VGT  YM+PE   +    G+    
Sbjct: 135 ANVFITATG-VVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHEN---GYNFKS 187

Query: 369 DIWSLGCVLVEMSS 382
           DIWSLGC+L EM++
Sbjct: 188 DIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 4/89 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI   + GN +KLGDFG++ +I         +    GT  +M+PEV    +  G+GR  
Sbjct: 135 ANILRDSAGN-VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI---SGEGYGRKA 190

Query: 369 DIWSLGCVLVEMSSGKTNLSGVVVSAEVF 397
           D+WS+ C +VEM + K   +     A +F
Sbjct: 191 DVWSVACTVVEMLTEKPPWAEYEAMAAIF 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 32/79 (40%), Positives = 39/79 (49%), Gaps = 9/79 (11%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPG----ELNGFVGTQAYMAPEVFMDTNKVGH 364
           NI + + G+ LKL DFG S V +            E    VGT  Y+APEV       GH
Sbjct: 123 NILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI---LGQGH 178

Query: 365 GRAVDIWSLGCVLVEMSSG 383
            + VD WSLGC+L E   G
Sbjct: 179 SKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 30/78 (38%), Positives = 36/78 (46%), Gaps = 9/78 (11%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
           FL      +KL DFG +  I  +       N  VG+  YMAPEV       G+   VD W
Sbjct: 132 FLIDASGHIKLTDFGLSKGIVTYA------NSVVGSPDYMAPEVLRGK---GYDFTVDYW 182

Query: 372 SLGCVLVEMSSGKTNLSG 389
           SLGC+L E   G    SG
Sbjct: 183 SLGCMLYEFLCGFPPFSG 200

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 30/70 (42%), Positives = 42/70 (60%), Gaps = 8/70 (11%)

Query: 320 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 379
           LK+ DFG A    A      E+ G+V T+ Y APEV +  N + + + VDIWS+GC++ E
Sbjct: 156 LKILDFGLARHADA------EMTGYVVTRWYRAPEVIL--NWMHYNQTVDIWSVGCIMAE 207

Query: 380 MSSGKTNLSG 389
           M +GKT   G
Sbjct: 208 MLTGKTLFKG 217

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 61/298 (20%), Positives = 120/298 (40%), Gaps = 51/298 (17%)

Query: 18  VYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM 77
           VY A +  TG LV ++   L    +   +K +  E+ +       N++  + V      +
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEEH-LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 78  VLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL 136
            +       G+  SL+++   +G+ E L+       +  ++ LH+N  +HR+IK+++I +
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI 134

Query: 137 TAEG-NSLK-LGDFGSAVKISAHTTVPGELNGF-VGTQAYMAPEVFMDTNKVGHGRAVDI 193
           + +G  SL  L    S V+      V  +   F      +++PE+ +  +  G+    DI
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDI 193

Query: 194 WSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-----------------------------G 224
           +S+G    E+++G+ P+ +      ++ K+                             G
Sbjct: 194 YSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSG 253

Query: 225 MGETPTI----------------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           +GE+                    ++ S   Q   ELCL+ DP +R +   LL H F 
Sbjct: 254 IGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 58/274 (21%), Positives = 120/274 (43%), Gaps = 29/274 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE---GINQKNLVKY 67
           G G FGKV      E    ++   + + +   +    + L+ L+ ++    +N  N+++ 
Sbjct: 4   GNGWFGKVLLG---EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQST---EDGLPE-VLVRRYTKQLVDAISALHENT 123
            G  I     +L +E C  G L++ ++S       + +  +++R   ++   +  LH+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAV-KISAHTTVPGELNGFVGTQAYMAPEVF--- 179
            +H D+   N  LTA+ + +K+GD+G A+ +      +  + +       ++APE+    
Sbjct: 121 FIHSDLALRNCQLTADLS-VKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPELVEIR 177

Query: 180 -MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE-----TPTIP 232
             D       +  +IWSLG  + E+ +   +P+ +  S+ Q++ +V   +      P + 
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQVLKQVVREQDIKLPKPQLD 236

Query: 233 ESLSDEGQAFAELCLRHDPAQRAT---IFELLQH 263
              SD      + C   DP  R T   + ELL +
Sbjct: 237 LKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 32/80 (40%), Positives = 48/80 (60%), Gaps = 9/80 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG----FVGTQAYMAPEVFMDTNKVGH 364
           ANI +  +G  +K+ DFG + K+ A++    + NG      G+  +MAPEV   T+   +
Sbjct: 135 ANILVDNKG-GIKISDFGISKKLEANSLS-TKTNGARPSLQGSVFWMAPEVVKQTS---Y 189

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
            R  DIWSLGC++VEM +GK
Sbjct: 190 TRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI   + GN +KLGDFG++ ++         +    GT  +M+PEV    +  G+GR  
Sbjct: 135 ANILRDSAGN-VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI---SGEGYGRKA 190

Query: 369 DIWSLGCVLVEMSSGKTNLSGVVVSAEVF 397
           D+WSLGC +VEM + K   +     A +F
Sbjct: 191 DVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 29/80 (36%), Positives = 40/80 (50%), Gaps = 12/80 (15%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-----LNGFVGTQAYMAPEVFMDTNKVGH 364
           NI L  +G S+K+ DFG    +SA     G+        FVGT  +MAPEV       G+
Sbjct: 132 NILLGEDG-SVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWMAPEVM--EQVHGY 184

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
               DIWS G   +E+++G 
Sbjct: 185 DFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 6/76 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +  EG  LKL DFG A       +       +V T+ Y APE+ +     G+   V
Sbjct: 127 ENLLINTEG-VLKLADFGLARSFG---SPVRPYTHYVVTRWYRAPELLL--GDKGYSTPV 180

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+GC+  E+ S +
Sbjct: 181 DIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 8/79 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI LT  G  +KL DFGSA K S         N FVGT  +MAPEV +  ++  +   V
Sbjct: 150 GNILLTEPGQ-VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Query: 369 DIWSLGCVLVEMSSGKTNL 387
           D+WSLG   +E++  K  L
Sbjct: 202 DVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 31/75 (41%), Positives = 43/75 (57%), Gaps = 8/75 (10%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L A G+ + L DFG S   ++ + T     N F GT  Y+APEV +D  + G+ + V
Sbjct: 126 NILLDATGH-IALCDFGLSKANLTDNKTT----NTFCGTTEYLAPEVLLD--EKGYTKHV 178

Query: 369 DIWSLGCVLVEMSSG 383
           D WSLG ++ EM  G
Sbjct: 179 DFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 28/77 (36%), Positives = 39/77 (50%), Gaps = 9/77 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L A  + +K+GD G + K+             +GT  YMAPEV+       +    
Sbjct: 132 ANILLVA-NDLVKIGDLGIS-KVLKKNM----AKTQIGTPHYMAPEVWKGR---PYSYKS 182

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWSLGC+L EM++   
Sbjct: 183 DIWSLGCLLYEMATFAP 199

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 28/75 (37%), Positives = 43/75 (57%), Gaps = 8/75 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGRAV 368
           NI +T +G  +KL DFG A  +   T    +   +V T+ Y APE+ + DT    +G  V
Sbjct: 130 NILITKQG-QIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPELLVGDTQ---YGPPV 182

Query: 369 DIWSLGCVLVEMSSG 383
           D+W++GCV  E+ +G
Sbjct: 183 DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 32/76 (42%), Positives = 44/76 (57%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NIFLT  G  +KLGDFGSA ++      PG     +VGT  Y+ PE++     + +    
Sbjct: 130 NIFLTQNGK-VKLGDFGSA-RLLTS---PGAYACTYVGTPYYVPPEIW---ENMPYNNKS 181

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLGC+L E+ + K
Sbjct: 182 DIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 32/75 (42%), Positives = 48/75 (64%), Gaps = 8/75 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI ++  G  +KL DFG A  ++A    PGE+   +V T+ Y APE+ +   K  +GRAV
Sbjct: 130 NILVSQSG-VVKLCDFGFARTLAA----PGEVYTDYVATRWYRAPELLVGDTK--YGRAV 182

Query: 369 DIWSLGCVLVEMSSG 383
           DIW++GC++ EM +G
Sbjct: 183 DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 29/80 (36%), Positives = 40/80 (50%), Gaps = 19/80 (23%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNKVGH 364
           NI + + G  +KL DFG          V G+L       FVGT +YMAPE         +
Sbjct: 131 NILVNSRGQ-IKLCDFG----------VSGQLVNSLAKTFVGTSSYMAPERIQGN---DY 176

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
               DIWSLG  L+E+++G+
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 25/76 (32%), Positives = 42/76 (55%), Gaps = 4/76 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISA-HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ + A+   LK+ DFG A   S       G +  +V T+ Y APE+ +  +   + +A+
Sbjct: 135 NLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML--SFQSYTKAI 191

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC+L E+   K
Sbjct: 192 DVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 33/261 (12%)

Query: 11  GQGRFGKVYTAV--NNETGEL--------VAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           GQG F  +Y  V       ++        V +K +    ++   F +     L     ++
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFE--TASLMSQ--LS 59

Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            K+LVK YGV + R+E ++  E    G L+  +   ++ +         KQL  A+  L 
Sbjct: 60  HKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE 118

Query: 121 ENTIVHRDIKSANIFLT----AEGNSL--KLGDFGSAVKISAHTTVPGELNGFVGTQAYM 174
           +  +VH ++   NI +      EG     KL D G  + I+  +              ++
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG--IPITVLSREERVER-----IPWI 171

Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           APE  +   +     A D WS G  L+E+ S+G+ P +   S+ +  F       P +P+
Sbjct: 172 APE-CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-MPD 229

Query: 234 SLSDEGQAFAELCLRHDPAQR 254
               E       C  +DP +R
Sbjct: 230 --CAELANLINQCWTYDPTKR 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 3/75 (4%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ + A+G   K+ DFG   K S       +     G+  +MAPEV + +   G+   VD
Sbjct: 138 NLLVDADG-ICKISDFG-ISKKSDDIYDNDQNMSMQGSVFWMAPEV-IHSYSQGYSAKVD 194

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLGCV++EM +G+
Sbjct: 195 IWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI   + GN +KLGDFG++ ++         +    GT  +M+PEV    +  G+GR  
Sbjct: 135 ANILRDSVGN-VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI---SGEGYGRKA 190

Query: 369 DIWSLGCVLVEMSSGKTNLSGVVVSAEVF 397
           DIWS+GC +VEM + K   +     A +F
Sbjct: 191 DIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 26/105 (24%)

Query: 297 PMSEDSVKVYAR---------------------ANIFLTAEGNSLKLGDFGSAVKISAHT 335
           P+ E  VK Y R                     AN+ ++A+G  LK+ DFG A   S   
Sbjct: 95  PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEE 153

Query: 336 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 380
             P   +  V T+ Y APE+     K  +   VD+W++GC+  E+
Sbjct: 154 --PRLYSHQVATRWYRAPELLYGARK--YDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 8/79 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI L+  G  +KLGDFGSA       ++    N FVGT  +MAPEV +  ++  +   V
Sbjct: 144 GNILLSEPG-LVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 369 DIWSLGCVLVEMSSGKTNL 387
           D+WSLG   +E++  K  L
Sbjct: 196 DVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 32/273 (11%)

Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           M  +    + G+G FG V   + +  G  VA+K I+    NDA   +  L E  ++  + 
Sbjct: 5   MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK----NDAT-AQAFLAEASVMTQLR 57

Query: 61  QKNLVKYYGVEIHREEMVLFM--ELCTEGTL----ESLVQSTEDGLPEVLVRRYTKQLVD 114
             NLV+  GV I  E+  L++  E   +G+L     S  +S   G  + L++ ++  + +
Sbjct: 58  HSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLK-FSLDVCE 113

Query: 115 AISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYM 174
           A+  L  N  VHRD+ + N+ L +E N  K+ DFG   + S+ T   G+L        + 
Sbjct: 114 AMEYLEANNFVHRDLAARNV-LVSEDNVAKVSDFGLTKEASS-TQDTGKL-----PVKWT 166

Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           APE   +          D+WS G +L E+ S G+ P+        ++ +V  G     P+
Sbjct: 167 APEALREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPD 222

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFEL---LQH 263
                     + C   D A R +  +L   L+H
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 32/79 (40%), Positives = 42/79 (53%), Gaps = 8/79 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI LT  G  +KL DFGSA   S         N FVGT  +MAPEV +  ++  +   V
Sbjct: 154 GNILLTEPGQ-VKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 369 DIWSLGCVLVEMSSGKTNL 387
           D+WSLG   +E++  K  L
Sbjct: 206 DVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 12/90 (13%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NIFLT +   +KLGDFG +  + +  ++   +   VGT  YM+PE+      V +    
Sbjct: 130 LNIFLT-KAGLIKLGDFGISKILGSEYSMAETV---VGTPYYMSPEL---CQGVKYNFKS 182

Query: 369 DIWSLGCVLVEMSSGK-----TNLSGVVVS 393
           DIW+LGCVL E+ + K     TN   +VV 
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVK 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 8/77 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ L   GN +++ D G AV++     +     G  GT  YMAPEV     +V +  +V
Sbjct: 124 ENVLLDDHGN-VRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQ--GEV-YDFSV 175

Query: 369 DIWSLGCVLVEMSSGKT 385
           D ++LGC L EM +G++
Sbjct: 176 DWFALGCTLYEMIAGRS 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 6/79 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN---KVGHGR 366
           N+ +   G+ +KL DFGSA +++A+  V  +L   VGT  Y+APEV    N   K  +G 
Sbjct: 132 NVLIDRTGH-IKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEVLTTMNGDGKGTYGV 188

Query: 367 AVDIWSLGCVLVEMSSGKT 385
             D WSLG +  EM  G++
Sbjct: 189 ECDWWSLGVIAYEMIYGRS 207

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 28/74 (37%), Positives = 40/74 (54%), Gaps = 10/74 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +G+ +K+ DFG A K+   T          GT  Y+APEV       GHG+AVD
Sbjct: 148 NLLLDNKGH-VKVTDFGFAKKVPDRTFT------LCGTPEYLAPEVIQSK---GHGKAVD 197

Query: 370 IWSLGCVLVEMSSG 383
            W++G +L E  +G
Sbjct: 198 WWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 21/262 (8%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           S +T     G G FG+V+  +    G     VA+K ++       R  +D L E  I+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQ 62

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +  N+++  GV    +  ++  E    G L+  ++  +       +    + +   +  
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAY 173
           L +   VHRD+ + NI + +     K+ DFG +  +       +TT  G++        +
Sbjct: 123 LSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLEDDPEGTYTTSGGKI-----PIRW 176

Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
            APE            A D+WS G V+ E MS G+RP+ +  SN+++M  +  G     P
Sbjct: 177 TAPEAIAYRK---FTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRLPAP 232

Query: 233 ESLSDEGQAFAELCLRHDPAQR 254
                        C + D A+R
Sbjct: 233 MDCPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 34/84 (40%), Positives = 44/84 (52%), Gaps = 7/84 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF-MDTNKVGHGRAV 368
           NIFL    N++ LGDFG+A K+ AH   P +  G+ GT    +PE+  +D     +    
Sbjct: 215 NIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYGWSGTLETNSPELLALDP----YCAKT 268

Query: 369 DIWSLGCVLVEMSSGKTNLSGVVV 392
           DIWS G VL EMS     L G  V
Sbjct: 269 DIWSAGLVLFEMSVKNVTLFGKQV 292

Length = 392

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 29/76 (38%), Positives = 41/76 (53%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+FL A  N +K+GD G A  +S +T      N  VGT  Y++PE+  D     +    
Sbjct: 130 LNLFLDAYDN-VKIGDLGVAKLLSDNTNFA---NTIVGTPYYLSPELCEDKP---YNEKS 182

Query: 369 DIWSLGCVLVEMSSGK 384
           D+W+LG VL E  +GK
Sbjct: 183 DVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 65/267 (24%), Positives = 117/267 (43%), Gaps = 29/267 (10%)

Query: 11  GQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G G FGKV  A      +      VA+K ++    +  R  + ++ EL+I+  +   +N+
Sbjct: 44  GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHENI 101

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVL-VRRYTKQLVDAISALHENT 123
           V   G       +++  E C  G L + ++   +    +  +  ++ Q+   ++ L    
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD-- 181
            +HRD+ + N+ LT  G  +K+ DFG A  I   +    + N  +  + +MAPE   +  
Sbjct: 162 CIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-WMAPESIFNCV 219

Query: 182 -TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAE--YDSNYQIMFKVG--MGETPTIPESL 235
            T +       D+WS G +L E+ S G  P+     DS +  + K G  M +    PE  
Sbjct: 220 YTFE------SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ----PEHA 269

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQ 262
             E     + C   DP +R T  +++Q
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 29/275 (10%)

Query: 1   MSSVTFSVSPGQGRFGKVYTA----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +S+V F    G+  FGK+Y         +  +LVA+K   L   N+ +   +   E  ++
Sbjct: 4   LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINNPQQWGEFQQEASLM 61

Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLV-----------QSTEDG-----L 100
             ++  N+V   GV    + + +  E   +G L   +            S EDG     L
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                     Q+   +  L  +  VH+D+ + NI L  E   +K+ D G + +I +    
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI-LIGEQLHVKISDLGLSREIYSADYY 180

Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQI 219
             +    +  + +M PE  M           DIWS G VL E+ S G +P+  + SN ++
Sbjct: 181 RVQPKSLLPIR-WMPPEAIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGF-SNQEV 235

Query: 220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +  V   +     E       +    C +  P++R
Sbjct: 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 29/73 (39%), Positives = 42/73 (57%), Gaps = 4/73 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI LT  G+ +KL DFG A KI+A      +   F+GT  +MAPEV       G+ +  
Sbjct: 135 ANILLTDNGD-VKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190

Query: 369 DIWSLGCVLVEMS 381
           DIW++G   +E++
Sbjct: 191 DIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 30/74 (40%), Positives = 40/74 (54%), Gaps = 4/74 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L +EG+ + L DFG + +  A          F GT  YMAPEV +     GH +AVD
Sbjct: 135 NILLDSEGH-VVLTDFGLSKEFLAEEE--ERAYSFCGTIEYMAPEV-IRGGSGGHDKAVD 190

Query: 370 IWSLGCVLVEMSSG 383
            WSLG +  E+ +G
Sbjct: 191 WWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)

Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 155 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 206

Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 207 IMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 5/145 (3%)

Query: 12  QGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK-YYGV 70
           +G FGKVY        +L A+K ++     +   V  +  E   L       +V  YY +
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
           +     + L ME    G ++SL+        E +  +Y  ++  A+  LH + I+HRD+K
Sbjct: 74  Q-SANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 131 SANIFLTAEGNSLKLGDFG-SAVKI 154
             N+ ++ EG+ +KL DFG S V +
Sbjct: 132 PDNMLISNEGH-IKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 5/75 (6%)

Query: 309 ANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           ANI +  EG     +K+GD G A   +A      +L+  V T  Y APE+ +      + 
Sbjct: 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARH--YT 194

Query: 366 RAVDIWSLGCVLVEM 380
           +A+DIW++GC+  E+
Sbjct: 195 KAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 30/76 (39%), Positives = 41/76 (53%), Gaps = 9/76 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI L  E   LK+ DFG A +I        ++ G+V T+ Y APE+ +   K  +   V
Sbjct: 137 SNI-LINENCDLKICDFGLA-RIQDP-----QMTGYVSTRYYRAPEIMLTWQK--YDVEV 187

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS GC+  EM  GK
Sbjct: 188 DIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 7e-08
 Identities = 24/44 (54%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 342 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           N FVGT+ Y+APEV    +  GHG AVD W+LG +L EM  G T
Sbjct: 190 NSFVGTEEYIAPEVI---SGDGHGSAVDWWTLGILLYEMLYGTT 230

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 29/74 (39%), Positives = 43/74 (58%), Gaps = 8/74 (10%)

Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG A +  +      E+ G+V T+ Y APEV +  N + + + VDIWS+GC
Sbjct: 153 EDCELKILDFGLARQTDS------EMTGYVVTRWYRAPEVIL--NWMHYTQTVDIWSVGC 204

Query: 376 VLVEMSSGKTNLSG 389
           ++ EM +GK    G
Sbjct: 205 IMAEMLTGKPLFKG 218

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 29/199 (14%)

Query: 198 CVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP---ESLSDEGQAF--AELCLRHDPA 252
           CV+ E+   K P  E +++ + +  +   + P I     S  + G+ F   E C   D  
Sbjct: 28  CVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLM 87

Query: 253 QRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSV--KVYARAN 310
           +R       Q   L     ED          +L  ++++ + L  + +  +  +     N
Sbjct: 88  KRIN----RQRGVLF---SED---------QILSWFVQISLGLKHIHDRKILHRDIKSQN 131

Query: 311 IFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDI 370
           IFL+  G   KLGDFG A +++    +       VGT  Y++PE+  +     +    DI
Sbjct: 132 IFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQNRP---YNNKTDI 185

Query: 371 WSLGCVLVEMSSGKTNLSG 389
           WSLGCVL E+ + K    G
Sbjct: 186 WSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 32/275 (11%)

Query: 11  GQGRFGKVYTA----VNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A    ++N      VA+K   L      + + D++ E+ +++ I + KN+
Sbjct: 21  GEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQS---------------TEDGLPEVLVRRYT 109
           +   GV      + + +E    G L   +++                E+ L +  +  + 
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            Q+   +  L     +HRD+ + N+ +T E + +K+ DFG A  I          NG + 
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFK-VGMGE 227
            + +MAPE   D     H    D+WS G +L E  + G  P+       + +FK +  G 
Sbjct: 198 VK-WMAPEALFD-RVYTH--QSDVWSFGVLLWEIFTLGGSPYPGIPV--EELFKLLKEGY 251

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
               P++ + E       C    P+QR T  +L++
Sbjct: 252 RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 20/210 (9%)

Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V        G+    VA+K ++       R  +D L E  I+   +  N++  
Sbjct: 13  GAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIHL 70

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV      +++  E    G L+S ++  +     + +    + +   +  L E   VHR
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR 130

Query: 128 DIKSANIFLTAEGNS---LKLGDFGSAVKISAHTTVP---GELNGFVGTQAYMAPEVFMD 181
           D+ + NI +    NS    K+ DFG +  +   T+ P     L G +  + + APE    
Sbjct: 131 DLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR-WTAPEAIAY 185

Query: 182 TNKVGHGRAVDIWSLGCVLVE-MSSGKRPW 210
                   A D+WS G V+ E MS G+RP+
Sbjct: 186 RKFTS---ASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 14/94 (14%)

Query: 307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-----------ELNGFVGTQAYMAPEV 355
           + ANIF+ ++G   K+ DFG A +                    E+   V T  Y APE+
Sbjct: 146 SPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL 204

Query: 356 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
            M   K     AVD+WS+GC+  E+ +GK    G
Sbjct: 205 LMGAEKYHF--AVDMWSVGCIFAELLTGKPLFPG 236

Length = 335

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 28/73 (38%), Positives = 43/73 (58%), Gaps = 4/73 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI LT  G+ +KL DFG + +I+A      +   F+GT  +MAPEV     K G+ +  
Sbjct: 135 ANILLTDNGH-VKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190

Query: 369 DIWSLGCVLVEMS 381
           DIW++G   +E++
Sbjct: 191 DIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 31/75 (41%), Positives = 47/75 (62%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT++G  +KL DFG   ++S    VP +    VGT  +MAPEV    +++ +G  VD
Sbjct: 148 SILLTSDGR-IKLSDFGFCAQVSKE--VP-KRKSLVGTPYWMAPEVI---SRLPYGTEVD 200

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 201 IWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 32/75 (42%), Positives = 45/75 (60%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   +IS    VP +    VGT  +MAPEV    ++  +G  VD
Sbjct: 147 SILLTLDGR-VKLSDFGFCAQIS--KDVP-KRKSLVGTPYWMAPEVI---SRTPYGTEVD 199

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 200 IWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 32/81 (39%), Positives = 43/81 (53%), Gaps = 19/81 (23%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNKVG 363
           +NI + + G  +KL DFG          V G+L     N FVGT++YM+PE    T+   
Sbjct: 129 SNILVNSRGE-IKLCDFG----------VSGQLIDSMANSFVGTRSYMSPERLQGTHYTV 177

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
                DIWSLG  LVEM+ G+
Sbjct: 178 QS---DIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 29/76 (38%), Positives = 37/76 (48%), Gaps = 13/76 (17%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRA 367
            N+ +   G+ LKL DFG         +  G  N  FVGT  Y+APE  +    VG  + 
Sbjct: 126 ENLLIDQTGH-LKLTDFG--------LSRNGLENKKFVGTPDYLAPETILG---VGDDKM 173

Query: 368 VDIWSLGCVLVEMSSG 383
            D WSLGCV+ E   G
Sbjct: 174 SDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 6/71 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ + ++G  LKL DFG A    +  +   ++   V T+ Y APE+       G G  V
Sbjct: 131 NNLLIASDG-VLKLADFGLA---RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVG--V 184

Query: 369 DIWSLGCVLVE 379
           D+WS+GC+  E
Sbjct: 185 DMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 34/76 (44%), Positives = 50/76 (65%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NIFLT +G ++KLGDFG A  +  ++TV  EL    +GT  Y++PE+    N+  + ++ 
Sbjct: 131 NIFLTKDG-TIKLGDFGIARVL--NSTV--ELARTCIGTPYYLSPEIC--ENRPYNNKS- 182

Query: 369 DIWSLGCVLVEMSSGK 384
           DIW+LGCVL EM + K
Sbjct: 183 DIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 31/80 (38%), Positives = 42/80 (52%), Gaps = 7/80 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    N+ GH ++ D
Sbjct: 128 NILLDEEGH-IKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEV---VNRRGHTQSAD 180

Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WS G ++ EM +G     G
Sbjct: 181 WWSFGVLMFEMLTGSLPFQG 200

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 8/205 (3%)

Query: 8   VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD-MLVELRILEGINQKNLVK 66
           V  G G FG V   V     + + +  I++ K  + + V+D M+ E  I+  ++   +V+
Sbjct: 1   VELGSGNFGCVKKGVYKMRKKQIDVA-IKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             GV    E ++L ME+ + G L   +   +D +    V     Q+   +  L     VH
Sbjct: 60  MIGV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L  + +  K+ DFG +  + A  +     +       + APE     N   
Sbjct: 119 RDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI---NFRK 174

Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
                D+WS G  + E  S G++P+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 61/275 (22%), Positives = 118/275 (42%), Gaps = 30/275 (10%)

Query: 11  GQGRFGKVYTA----VNNETGELVAMKEIQLHKQNDA-RFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A    ++ E    V    +++ K +   + + D++ E+ +++ I + KN+
Sbjct: 27  GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 86

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQS----------TEDGLPEVLVR-----RYT 109
           +   G       + + +E  ++G L   +++              +PE  +         
Sbjct: 87  INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            Q+   +  L     +HRD+ + N+ +T E N +K+ DFG A  I          NG + 
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK-VGMGE 227
            + +MAPE   D     +    D+WS G +L E+ + G  P+       + +FK +  G 
Sbjct: 206 VK-WMAPEALFDRI---YTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFKLLKEGH 259

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
               P + ++E       C    P+QR T  +L++
Sbjct: 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 14/82 (17%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVK----ISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-V 362
            NI LT +G+ +KL DFG + K    +    T       F+GT  +MAPEV   +T K  
Sbjct: 132 GNILLTLDGD-VKLADFGVSAKNKSTLQKRDT-------FIGTPYWMAPEVVACETFKDN 183

Query: 363 GHGRAVDIWSLGCVLVEMSSGK 384
            +    DIWSLG  L+E++  +
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 31/74 (41%), Positives = 45/74 (60%), Gaps = 7/74 (9%)

Query: 311 IFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDI 370
           I LT++G  +KL DFG   ++S    VP      VGT  +MAPEV    +++ +G  VDI
Sbjct: 146 ILLTSDGR-VKLSDFGFCAQVSKE--VP-RRKSLVGTPYWMAPEVI---SRLPYGTEVDI 198

Query: 371 WSLGCVLVEMSSGK 384
           WSLG +++EM  G+
Sbjct: 199 WSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 29/76 (38%), Positives = 40/76 (52%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AV+I    T+ G     VGT  YMAPEV        +  + D
Sbjct: 132 NILLDDYGH-IRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV---VKNERYTFSPD 183

Query: 370 IWSLGCVLVEMSSGKT 385
            W LGC++ EM  GK+
Sbjct: 184 WWGLGCLIYEMIEGKS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 57/192 (29%), Positives = 84/192 (43%), Gaps = 45/192 (23%)

Query: 222 KVGMGETPTIPESLSDEGQAFAE---LC-LRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
           +V + + P + ++L    + F E   LC  +HD    A   ++LQ P +     E++   
Sbjct: 27  RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA--LDILQPPHI--DPFEEI--- 79

Query: 278 RSVPASVLQDYLKLGIVLP-PMSEDSVKVYA----RANIFLTAEG-------------NS 319
             V   ++Q  L   IV P P+S D VKV+     R   +L + G             NS
Sbjct: 80  -YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS 138

Query: 320 ---LKLGDFGSAVK----ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWS 372
              LK+ DFG A       S H T        V TQ Y APE+ M +    +  AVDIWS
Sbjct: 139 NCVLKICDFGLARVEEPDESKHMTQE------VVTQYYRAPEILMGSRH--YTSAVDIWS 190

Query: 373 LGCVLVEMSSGK 384
           +GC+  E+   +
Sbjct: 191 VGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 29/212 (13%)

Query: 55  ILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD 114
           ++  ++ K++V  YGV +   E ++  E    G L+  +    D L      +  KQL  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116

Query: 115 AISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ--- 171
           A+S L +  +VH ++ + NI L  EG     G+ G  +K+S     PG     +  Q   
Sbjct: 117 ALSYLEDKDLVHGNVCTKNILLAREGID---GECGPFIKLSD----PGIPITVLSRQECV 169

Query: 172 ---AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS-SGKRP-----WAEYDSNYQIMFK 222
               ++APE   D+  +    A D WS G  L E+  +G+ P      AE +  Y+    
Sbjct: 170 ERIPWIAPECVEDSKNL--SIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC- 226

Query: 223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
             M  TP+  E L+D        C+ +DP QR
Sbjct: 227 --MLVTPSCKE-LAD----LMTHCMNYDPNQR 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 33/262 (12%)

Query: 14  RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVK------DMLVEL-RILEGINQKNLVK 66
           +FG +   + ++ GE V       +K  DARF +      D+  +L R L+ I       
Sbjct: 95  KFGNLSNYLRSKRGEFVP------YKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSA 148

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR----YTKQLVDAISALHEN 122
             G          F+E  +   +E      ED   +VL       Y+ Q+   +  L   
Sbjct: 149 SSG----------FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR 198

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
             +HRD+ + NI L+ E N +K+ DFG A  I        + +  +  + +MAPE   D 
Sbjct: 199 KCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WMAPETIFD- 255

Query: 183 NKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
            +V +    D+WS G +L E+ S G  P+     + +   ++  G     P+  + E   
Sbjct: 256 -RV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 313

Query: 242 FAELCLRHDPAQRATIFELLQH 263
               C   +P+QR T  EL++H
Sbjct: 314 TMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 13/205 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQ-LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG VY  +    GE V +   I+ L++    +   + + E  I+  ++  +LV+  
Sbjct: 16  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 75

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV +    + L  +L   G L   V   +D +   L+  +  Q+   +  L E  +VHRD
Sbjct: 76  GVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 134

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ--AYMAPEVFMDTNKVG 186
           + + N+ L    N +K+ DFG A  +        E N   G     +MA E  +   K  
Sbjct: 135 LAARNV-LVKSPNHVKITDFGLARLLEGDEK---EYNADGGKMPIKWMALEC-IHYRKFT 189

Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           H    D+WS G  + E M+ G +P+
Sbjct: 190 H--QSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 53/274 (19%), Positives = 107/274 (39%), Gaps = 38/274 (13%)

Query: 11  GQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+V+ A      E     LV +K +Q  K  +     +   EL +   ++ KN+V
Sbjct: 14  GRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKNVV 71

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTK--------QLVDAIS 117
           +  G+    E   + +E    G L+  +++T+    ++     +         Q+   + 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA----HTTVPGELNGFVGTQA- 172
            L     VHRD+ + N  ++++            VK+S           E          
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQ----------REVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 173 --YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETP 229
             ++APE   + +        D+WS G ++ E+ + G+ P+    S+ +++ ++  G+  
Sbjct: 182 LRWLAPEAVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLE 237

Query: 230 -TIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
             +PE            C   +P  R +  EL+ 
Sbjct: 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 32/83 (38%), Positives = 41/83 (49%), Gaps = 10/83 (12%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVP-GELNGFVGTQAYMAPEVFM-DTNKVGH--G 365
           NI LT     +KL DFG    +SA      G  N F+GT  +MAPEV   D         
Sbjct: 143 NILLTKNAE-VKLVDFG----VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDA 197

Query: 366 RAVDIWSLGCVLVEMSSGKTNLS 388
           R+ D+WSLG   +E++ GK  L 
Sbjct: 198 RS-DVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 30/74 (40%), Positives = 43/74 (58%), Gaps = 6/74 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGRA 367
           N+ LT +G+ +KL DFG + K   +       + F+GT  +MAPEV M +T K   +   
Sbjct: 140 NVLLTLDGD-IKLADFGVSAK---NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYK 195

Query: 368 VDIWSLGCVLVEMS 381
            DIWSLG  L+EM+
Sbjct: 196 ADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 42/174 (24%), Positives = 61/174 (35%), Gaps = 33/174 (18%)

Query: 112 LVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
            +  + AL E   +HR  KS NI LT +G  LKL   GS                     
Sbjct: 23  CLQCLGALRE---LHRQAKSGNILLTWDG-LLKL--DGSVAFK-------TPEQSRP-DP 68

Query: 172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETP 229
            +MAPEV        +    DI+SLG  L E    + P   Y+   ++  + ++ +   P
Sbjct: 69  YFMAPEVIQ---GQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEILLNGMP 122

Query: 230 T-------IPESLSDEGQA--FAELCLRHDPAQRATIFELLQHPFLIV--SCEE 272
                     E +S       F  LC    P +R      L H   +   + E 
Sbjct: 123 ADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 30/75 (40%), Positives = 44/75 (58%), Gaps = 6/75 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGR 366
            NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   +  
Sbjct: 132 GNILFTLDGD-IKLADFGVSAK---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 367 AVDIWSLGCVLVEMS 381
             D+WSLG  L+EM+
Sbjct: 188 KADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 31/77 (40%), Positives = 42/77 (54%), Gaps = 4/77 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG-HGRAV 368
           N+ L   G+ LKL DFG+ +K+ A+  V    +  VGT  Y++PEV       G +GR  
Sbjct: 172 NMLLDKSGH-LKLADFGTCMKMDANGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 229 DWWSVGVFLYEMLVGDT 245

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 11/89 (12%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPG--------ELNGFVGTQAYMAPEVFMDTN 360
           ANI +  +G  LK+ DFG A         P         +    V T+ Y  PE+ +   
Sbjct: 144 ANILIDNQGI-LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER 202

Query: 361 KVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  +  AVDIW +GCV  EM + +  L G
Sbjct: 203 R--YTTAVDIWGIGCVFAEMFTRRPILQG 229

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 9/81 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  EG  +K+ DFG    +       G+    F GT  ++APEV  +T+   + RAV
Sbjct: 131 NLLLDTEGF-VKIADFG----LCKEGMGFGDRTSTFCGTPEFLAPEVLTETS---YTRAV 182

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D W LG ++ EM  G++   G
Sbjct: 183 DWWGLGVLIYEMLVGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 50.1 bits (119), Expect = 7e-07
 Identities = 30/75 (40%), Positives = 42/75 (56%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +    +   VGT  +MAPEV     +  +G  VD
Sbjct: 146 NILLGMDG-SVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEV---VTRKAYGPKVD 198

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 199 IWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 18/39 (46%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 345 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 383
           VGT  Y+APEVF+   + G+ +  D WSLG ++ EM  G
Sbjct: 200 VGTPDYIAPEVFL---QTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 30/80 (37%), Positives = 42/80 (52%), Gaps = 8/80 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AVKI    ++ G     VGT  YMAPEV    N   +  + D
Sbjct: 132 NILLDDYGH-IRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVL---NNQRYTLSPD 183

Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            W LGC++ EM  G++   G
Sbjct: 184 YWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 49.9 bits (119), Expect = 9e-07
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 145 NILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPKVD 197

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 198 IWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 58/275 (21%), Positives = 118/275 (42%), Gaps = 30/275 (10%)

Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A       ++  E V +    L      + + D++ E+ +++ I + KN+
Sbjct: 24  GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 83

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQS---------------TEDGLPEVLVRRYT 109
           +   G       + + +E  ++G L   +++                ++ +    +   T
Sbjct: 84  INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143

Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            Q+   +  L     +HRD+ + N+ +T E N +K+ DFG A  ++         NG + 
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK-VGMGE 227
            + +MAPE   D  +V +    D+WS G ++ E+ + G  P+       + +FK +  G 
Sbjct: 203 VK-WMAPEALFD--RV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEELFKLLKEGH 256

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
               P + ++E       C    P+ R T  +L++
Sbjct: 257 RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 130 ANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIQQS---AYDSKA 182

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 183 DIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 29/75 (38%), Positives = 43/75 (57%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 145 NVLLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPKVD 197

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 198 IWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 130 ANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDFKA 182

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 183 DIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 29/71 (40%), Positives = 37/71 (52%), Gaps = 8/71 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NIFL  + N LK+GDFG +  +     +      F GT  YM+PE        G+    D
Sbjct: 136 NIFL--KNNLLKIGDFGVSRLLMGSCDLA---TTFTGTPYYMSPEAL---KHQGYDSKSD 187

Query: 370 IWSLGCVLVEM 380
           IWSLGC+L EM
Sbjct: 188 IWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 29/80 (36%), Positives = 37/80 (46%), Gaps = 19/80 (23%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNKVGH 364
           NI LT +G  +KL DFG          V GEL       F GT  YMAPE         +
Sbjct: 135 NILLTRKGQ-VKLCDFG----------VSGELVNSLAGTFTGTSFYMAPERIQGKP---Y 180

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
               D+WSLG  L+E++  +
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 5/78 (6%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L +  + LKL DFG A  +S  +        +V T+ Y +PE+ +      +G+AVD+W
Sbjct: 131 LLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAP---YGKAVDMW 185

Query: 372 SLGCVLVEMSSGKTNLSG 389
           S+GC+L E+S G+    G
Sbjct: 186 SVGCILGELSDGQPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 125 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YGRAV 176

Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 177 DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+FLT   N +K+GD G A  +     +   L   +GT  YM+PE+F  +NK  + ++ D
Sbjct: 132 NVFLT-RTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELF--SNKPYNYKS-D 184

Query: 370 IWSLGCVLVEMSSGK 384
           +W+LGC + EM++ K
Sbjct: 185 VWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 24/66 (36%), Positives = 36/66 (54%), Gaps = 9/66 (13%)

Query: 319 SLKLGDFGSAVKISAHTTVPGELNGF----VGTQAYMAPEVFMDTNKVGHGRAVDIWSLG 374
            L++GDFG A  +S   + P E   F    V T+ Y APE+ +      +  A+D+WS+G
Sbjct: 145 ELRIGDFGMARGLS---SSPTEHKYFMTEYVATRWYRAPELLLSLP--EYTTAIDMWSVG 199

Query: 375 CVLVEM 380
           C+  EM
Sbjct: 200 CIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 30/78 (38%), Positives = 45/78 (57%), Gaps = 5/78 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           N+ L   G+ ++L DFGS +++ A  TV  + N  VGT  Y++PE+   M+  K  +G  
Sbjct: 132 NVLLDKNGH-IRLADFGSCLRLLADGTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPE 188

Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 189 CDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 30/76 (39%), Positives = 43/76 (56%), Gaps = 5/76 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L +EG+ + L DFG + +    +        F GT  YMAPE+     K GHG+AVD
Sbjct: 135 NILLDSEGHVV-LTDFGLSKEFL--SEEKERTYSFCGTIEYMAPEII--RGKGGHGKAVD 189

Query: 370 IWSLGCVLVEMSSGKT 385
            WSLG ++ E+ +G +
Sbjct: 190 WWSLGILIFELLTGAS 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 12/81 (14%)

Query: 310 NIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NIF+   G+ + LGDFG+A   V I+A+     +  G+ GT A  APE+     +  +G 
Sbjct: 212 NIFINHPGD-VCLGDFGAACFPVDINAN-----KYYGWAGTIATNAPELLA---RDPYGP 262

Query: 367 AVDIWSLGCVLVEMSSGKTNL 387
           AVDIWS G VL EM++   +L
Sbjct: 263 AVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 8/74 (10%)

Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   L++ DFG A +         E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 153 EDCELRILDFGLARQAD------DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 204

Query: 376 VLVEMSSGKTNLSG 389
           ++ E+  GK    G
Sbjct: 205 IMAELLKGKALFPG 218

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 6/156 (3%)

Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSAR 237

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   D  KV +    D+WS G +L E+ S G  P+     N +   ++  G
Sbjct: 238 LPLK-WMAPESIFD--KV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293

Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
                PE+ + E       C + DP +R T   L++
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 9/203 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQLHKQNDA-RFVKDMLVELRILEGINQKNLVKYY 68
           G G FG VY  +    GE V +   I++ ++N + +  K++L E  ++ G+    + +  
Sbjct: 16  GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLL 75

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G+ +    + L  +L   G L   V+  +D +    +  +  Q+   +S L E  +VHRD
Sbjct: 76  GICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRD 134

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           + + N+ L    N +K+ DFG A  +    T      G V  + +MA E  +   +  H 
Sbjct: 135 LAARNV-LVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILH-RRFTH- 190

Query: 189 RAVDIWSLGCVLVE-MSSGKRPW 210
              D+WS G  + E M+ G +P+
Sbjct: 191 -QSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 48.6 bits (115), Expect = 2e-06
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 145 NILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPKVD 197

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 198 IWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 125 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YGRAV 176

Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 177 DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 23/83 (27%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNKVG 363
           +NI + + G  +KL DFG          V GEL     + FVGT  YM+PE        G
Sbjct: 133 SNILVNSRGQ-IKLCDFG----------VSGELINSIADTFVGTSTYMSPERIQ-----G 176

Query: 364 HGRAV--DIWSLGCVLVEMSSGK 384
               V  D+WSLG  ++E++ GK
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 29/75 (38%), Positives = 40/75 (53%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +G+ +K+ DFG         T    +  F GT  Y+APEV  D +   +GRAVD
Sbjct: 125 NLMLDKDGH-IKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDND---YGRAVD 177

Query: 370 IWSLGCVLVEMSSGK 384
            W LG V+ EM  G+
Sbjct: 178 WWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 9/82 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +K+ DFG    +     + G   + F GT  Y+APE+        +G AV
Sbjct: 126 NVLLDSEGH-IKIADFG----MCKEGILGGVTTSTFCGTPDYIAPEILSYQP---YGPAV 177

Query: 369 DIWSLGCVLVEMSSGKTNLSGV 390
           D W+LG +L EM +G++   G 
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 46/277 (16%)

Query: 12  QGRFGKVYTAV-NNETG---ELVAMK-------EIQLHKQNDARFVKDMLVELRILEGIN 60
           +G FG+++  +  +E     E V +K       EIQ+           +L E  +L G++
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL---------LLQESCLLYGLS 66

Query: 61  QKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD---- 114
            +N++    V  E      VL+      G L+  +Q    G         T+QLV     
Sbjct: 67  HQNILPILHVCIEDGEPPFVLY-PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 115 ---AISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
               +S LH+  ++H+DI + N  +  E   +K+ D  +A+   +    P + +     +
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITD--NAL---SRDLFPMDYHCLGDNE 179

Query: 172 ----AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                +MA E  +  NK  +  A D+WS G +L E M+ G+ P+ E D  +++   +  G
Sbjct: 180 NRPVKWMALESLV--NKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYLKDG 235

Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P +  DE  A    C   DP +R + F  L  
Sbjct: 236 YRLAQPINCPDELFAVMACCWALDPEERPS-FSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 26/85 (30%), Positives = 39/85 (45%), Gaps = 19/85 (22%)

Query: 86  EGTLESLVQSTE-------------DGLPE------VLVRRYTKQLVDAISALHENTIVH 126
           E TL  L+QS E               LP+       +++   +Q++ A+  LH   IVH
Sbjct: 219 ESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSA 151
           RD+K  NI  +    S K+ D G+A
Sbjct: 279 RDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 48.2 bits (114), Expect = 3e-06
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 130 ANVLLSEHG-EVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDSKA 182

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 183 DIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +   +GR
Sbjct: 126 NLMLDKDGH-IKITDFGLCKEGIKDGA------TMKTFCGTPEYLAPEVLEDND---YGR 175

Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 133 SNILVNSRG-EIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 183

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 184 DIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AV +    T+ G     VGT  YMAPEV  +     +  + D
Sbjct: 132 NILLDDHGH-IRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER---YTFSPD 183

Query: 370 IWSLGCVLVEMSSGKT 385
            W+LGC+L EM +G++
Sbjct: 184 WWALGCLLYEMIAGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 30/76 (39%), Positives = 41/76 (53%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AV+I    TV G     VGT  YMAPEV    N   +  + D
Sbjct: 132 NILLDDRGH-IRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVI---NNEKYTFSPD 183

Query: 370 IWSLGCVLVEMSSGKT 385
            W LGC++ EM  G++
Sbjct: 184 WWGLGCLIYEMIQGQS 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 20/170 (11%)

Query: 96  TEDGLPEVL--VRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK 153
           TED  P  L  + R++ Q+   +  L     +HRD+ + N+ LT +G   K+ DFG A  
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLARD 261

Query: 154 I--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPW 210
           I   ++  V G     V    +MAPE   D     +    D+WS G +L E+ S GK P+
Sbjct: 262 IMNDSNYVVKGNARLPV---KWMAPESIFDCV---YTVQSDVWSYGILLWEIFSLGKSPY 315

Query: 211 AE--YDSNYQIMFKVG--MGETPTIPESLSDEGQAFAELCLRHDPAQRAT 256
                +S +  M K G  M      P+    E  +  ++C   +P +R T
Sbjct: 316 PGILVNSKFYKMVKRGYQMSR----PDFAPPEIYSIMKMCWNLEPTERPT 361

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 146 SILLTHDGR-VKLSDFGFCAQVSKE--VP-RRKSLVGTPYWMAPELI---SRLPYGPEVD 198

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 199 IWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 16/76 (21%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKI----SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 364
            NI +T++G  +K+ DFG A +I     A T+V       V T  Y APEV +   +  +
Sbjct: 136 QNILVTSDG-QVKIADFGLA-RIYSFEMALTSV-------VVTLWYRAPEVLL---QSSY 183

Query: 365 GRAVDIWSLGCVLVEM 380
              VD+WS+GC+  E+
Sbjct: 184 ATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 6/74 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFM-DTNKVGHGR 366
           ANI +T +G  LKL DFG A   S    + P      V T  Y  PE+ + + +   +G 
Sbjct: 148 ANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERD---YGP 203

Query: 367 AVDIWSLGCVLVEM 380
            +D+W  GC++ EM
Sbjct: 204 PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 6/164 (3%)

Query: 98  DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH 157
           +GL  + +  +T Q+   +  L     VHRD+ + N+ L A+G  +K+ DFG A  I   
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL-AQGKIVKICDFGLARDIMHD 290

Query: 158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN 216
           +    + + F+  + +MAPE   D     +    D+WS G +L E+ S G  P+     +
Sbjct: 291 SNYVSKGSTFLPVK-WMAPESIFDNL---YTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346

Query: 217 YQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
                K+  G     P+  + E       C   +P +R +   L
Sbjct: 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)

Query: 11  GQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE     VA+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 16  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L  +L   G L   V+  +D +    +  +  Q+   ++ L E  +VH
Sbjct: 74  LLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVH 132

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ +      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 133 RDLAARNVLVKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIK-WMALESILHRI--- 187

Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 30/75 (40%), Positives = 41/75 (54%), Gaps = 5/75 (6%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNKVGH-GRAVD 369
            L     ++K+ DFG + +I A T  P   N  VGT AYM+PE +  D N   + G A D
Sbjct: 199 LLINSAKNVKIADFGVS-RILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGD 255

Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG  ++E   G+
Sbjct: 256 IWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 12/78 (15%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF---VGTQAYMAPEVFMDTNKVGHGR 366
           N+ +   G  LKL DFG A        +P  +N F   V T  Y AP+V + +    +  
Sbjct: 130 NLLINKRGE-LKLADFGLARAFG----IP--VNTFSNEVVTLWYRAPDVLLGSRT--YST 180

Query: 367 AVDIWSLGCVLVEMSSGK 384
           ++DIWS+GC++ EM +G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 30/77 (38%), Positives = 39/77 (50%), Gaps = 13/77 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L ++G+ + L DFG     ++ S  T+       F GT  Y+APEV     K  + R
Sbjct: 126 NILLDSQGH-VVLTDFGLCKEGIEHSKTTST------FCGTPEYLAPEVLR---KQPYDR 175

Query: 367 AVDIWSLGCVLVEMSSG 383
            VD W LG VL EM  G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 5/78 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           NI +   G+ ++L DFGS +K+    TV   +   VGT  Y++PE+   M+  K  +G  
Sbjct: 132 NILMDMNGH-IRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDGKGKYGPE 188

Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 189 CDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +GN  +L D G AV++    T+        GT  YMAPE+  +     +   VD
Sbjct: 125 NVLLDDQGNC-RLSDLGLAVELKDGKTITQR----AGTNGYMAPEILKEEP---YSYPVD 176

Query: 370 IWSLGCVLVEMSSGKT 385
            +++GC + EM +G+T
Sbjct: 177 WFAMGCSIYEMVAGRT 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +      G+    VA+K ++       R  +D L E  I+   +  N++  
Sbjct: 13  GAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNIIHL 70

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L++ ++  +     + +    + +   +  L +   VHR
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR 130

Query: 128 DIKSANIFLTAEGNS---LKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVF 179
           D+ + NI +    NS    K+ DFG +  +     +A+TT  G++        + APE  
Sbjct: 131 DLAARNILV----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTAPEAI 181

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAE 212
                     A D+WS G V+ E MS G+RP+ E
Sbjct: 182 AYRK---FTSASDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 34/281 (12%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELV--AMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + + F    G+G FG+V  A   + G  +  A+K ++ +   D    +D   EL +L  +
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKL 64

Query: 60  N-QKNLVKYYGVEIHREEMVLFMELCTEGTLE---------------SLVQSTEDGLPEV 103
               N++   G   HR  + L +E    G L                ++  ST   L   
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 104 LVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG--SAVKISAHTTVP 161
            +  +   +   +  L +   +HRD+ + NI L  E    K+ DFG     ++    T+ 
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNI-LVGENYVAKIADFGLSRGQEVYVKKTM- 182

Query: 162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM 220
           G L        +MA E     N   +    D+WS G +L E+ S G  P+    +  ++ 
Sbjct: 183 GRL-----PVRWMAIESL---NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELY 233

Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
            K+  G     P +  DE       C R  P +R +  ++L
Sbjct: 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 30/270 (11%)

Query: 11  GQGRFGKVYTA-VNNE-TGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVK 66
           G G FGKV    VN+  T   V +KE+++    Q   +F    L E +    +   NL++
Sbjct: 4   GNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKF----LEEAQPYRSLQHSNLLQ 59

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGLPEVLV-RRYTKQLVDAISALHEN 122
             G        +L ME C  G L+  ++S    E   P+    +R   ++   +  LH+N
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMAPEVF 179
             +H D+   N  LTA+  ++K+GD+G +    K   + T P +L  +V  + ++APE+ 
Sbjct: 120 NFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYVT-PDQL--WVPLR-WIAPELV 174

Query: 180 MDTNK----VGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
            + +     V   +  ++WSLG  + E+   G +P+        + + V   +     P 
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234

Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFEL 260
           +   LSD      + C    P QR +  E+
Sbjct: 235 LKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 27/81 (33%), Positives = 39/81 (48%), Gaps = 18/81 (22%)

Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG  LKL DFG A      V+   H  V         T  Y APE+ + + +  
Sbjct: 129 NLLIDREGA-LKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGSRQ-- 176

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
           +   VDIWS+GC+  EM + +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 12/88 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L      +K+GDFG    IS   +   +    VGT  Y++PE+        + +  D
Sbjct: 131 NILLDKHKMVVKIGDFG----ISKILSSKSKAYTVVGTPCYISPEL---CEGKPYNQKSD 183

Query: 370 IWSLGCVLVEMSSGK-----TNLSGVVV 392
           IW+LGCVL E++S K      NL  +V+
Sbjct: 184 IWALGCVLYELASLKRAFEAANLPALVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.2 bits (114), Expect = 7e-06
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 11/79 (13%)

Query: 313 LTAEGNSL------KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           +TA+ N+L      K+GDFG    +S +  +    +  VGT  Y +PE+ +   K    +
Sbjct: 168 ITAQANNLNGRPIAKIGDFG----LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223

Query: 367 AVDIWSLGCVLVEMSSGKT 385
           + D+W+LGC++ E+ SGKT
Sbjct: 224 S-DMWALGCIIYELCSGKT 241

Length = 1021

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 9/76 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 133 SNILVNSRG-EIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 183

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVE++ G+
Sbjct: 184 DIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 10/74 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +G  +K+ DFG A  +   T          GT  Y+APE+ ++   VGHG+A D
Sbjct: 161 NLLLDKDG-FIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEILLN---VGHGKAAD 210

Query: 370 IWSLGCVLVEMSSG 383
            W+LG  + E+  G
Sbjct: 211 WWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 22/165 (13%)

Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI--------SAHTT 159
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I             
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQ 218
           +P +         +MAPE   D  KV   ++ D+WS G +L E+ S G  P+     + +
Sbjct: 237 LPLK---------WMAPESIFD--KVYTTQS-DVWSFGVLLWEIFSLGASPYPGVQIDEE 284

Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
              ++  G     PE  + E  +    C  ++P  R T  EL++ 
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 16/98 (16%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFM-DTNKVGHGRA 367
           N+ +    ++LKL DFGSA  + A     G+ +  ++ ++ Y APE+ +  TN   H   
Sbjct: 200 NLLIDPNTHTLKLCDFGSAKNLLA-----GQRSVSYICSRFYRAPELMLGATNYTTH--- 251

Query: 368 VDIWSLGCVLVEMS------SGKTNLSGVVVSAEVFGS 399
           +D+WSLGC++ EM       SG++++  +V   +V G+
Sbjct: 252 IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289

Length = 440

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 15/79 (18%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISA---HTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHG 365
           N+ L +    +K+ DFG A +I +   +T        +V T+ Y APE+ +  T+   + 
Sbjct: 129 NL-LVSGPEVVKIADFGLAREIRSRPPYTD-------YVSTRWYRAPEILLRSTS---YS 177

Query: 366 RAVDIWSLGCVLVEMSSGK 384
             VDIW+LGC++ E+ + +
Sbjct: 178 SPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ LT +G  LK+ DFG A     +      +   V T  Y APE+ +      +  A+
Sbjct: 137 SNLLLTDKG-CLKIADFGLA---RTYGLPAKPMTPKVVTLWYRAPELLLGCTT--YTTAI 190

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+W++GC+L E+ + K  L G
Sbjct: 191 DMWAVGCILAELLAHKPLLPG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 28/77 (36%), Positives = 37/77 (48%), Gaps = 18/77 (23%)

Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 130 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 177

Query: 364 HGRAVDIWSLGCVLVEM 380
           +  AVDIWSLGC+  EM
Sbjct: 178 YSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 32/76 (42%), Positives = 42/76 (55%), Gaps = 6/76 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTN-KVGHGRA 367
           N+ LT E   +KL DFG + ++    TV G  N F+GT  +MAPEV   D N    +   
Sbjct: 151 NVLLT-ENAEVKLVDFGVSAQLD--RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYR 206

Query: 368 VDIWSLGCVLVEMSSG 383
            DIWSLG   +EM+ G
Sbjct: 207 SDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 27/71 (38%), Positives = 36/71 (50%), Gaps = 8/71 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G  +KL DFG A   S        L   V T  Y APEV + +    +   VD
Sbjct: 138 NILVTSGG-QVKLADFGLARIYSCQMA----LTPVVVTLWYRAPEVLLQST---YATPVD 189

Query: 370 IWSLGCVLVEM 380
           +WS+GC+  EM
Sbjct: 190 MWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 23/76 (30%), Positives = 40/76 (52%), Gaps = 6/76 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A    LK+ DFG A      +     +  +V T+ Y APE+ ++ ++  +  A+D
Sbjct: 138 NLLLNAN-CDLKICDFGLA---RTTSEKGDFMTEYVVTRWYRAPELLLNCSE--YTTAID 191

Query: 370 IWSLGCVLVEMSSGKT 385
           +WS+GC+  E+   K 
Sbjct: 192 VWSVGCIFAELLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 5/78 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           N+ L   G+ ++L DFGS +K++   TV   +   VGT  Y++PE+   M+     +G  
Sbjct: 132 NVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVA--VGTPDYISPEILQAMEDGMGKYGPE 188

Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 189 CDWWSLGVCMYEMLYGET 206

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 4/77 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH-GRAV 368
           N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G+ GR  
Sbjct: 172 NMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 229 DWWSVGVFLYEMLVGDT 245

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 28/76 (36%), Positives = 41/76 (53%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L AEG+  KL DFG    +     + G     F GT  Y+APE+  +     +G +V
Sbjct: 126 NILLDAEGH-CKLADFG----MCKEGILNGVTTTTFCGTPDYIAPEILQELE---YGPSV 177

Query: 369 DIWSLGCVLVEMSSGK 384
           D W+LG ++ EM +G+
Sbjct: 178 DWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 6/81 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L   G  LK+ DFG A +     +        V T  Y APE+ +   +     A+
Sbjct: 135 SNLLLNNRG-ILKICDFGLAREYG---SPLKPYTQLVVTLWYRAPELLLGAKEYST--AI 188

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS+GC+  E+ + K    G
Sbjct: 189 DMWSVGCIFAELLTKKPLFPG 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 25/73 (34%), Positives = 38/73 (52%), Gaps = 8/73 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +  + + LKL DFGS   I  ++  P     ++ T+ Y APE  +     G    +D
Sbjct: 130 NILI--KDDILKLADFGSCRGI--YSKPP--YTEYISTRWYRAPECLLTDGYYGPK--MD 181

Query: 370 IWSLGCVLVEMSS 382
           IW++GCV  E+ S
Sbjct: 182 IWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 27/81 (33%), Positives = 38/81 (46%), Gaps = 17/81 (20%)

Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +    N+LKL DFG A      V+   H  V         T  Y APE+ + +    
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---------TLWYRAPEILLGSRH-- 180

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
           +   VDIWS+GC+  EM + K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 30/77 (38%), Positives = 40/77 (51%), Gaps = 4/77 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH-GRAV 368
           N+ L   G+ LKL DFG+ +K+     V    +  VGT  Y++PEV       G+ GR  
Sbjct: 172 NMLLDKHGH-LKLADFGTCMKMDETGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 229 DWWSVGVFLFEMLVGDT 245

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 7/80 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +G+ +K+ DFG       +    G+ + F GT  Y+APE+        +  +VD
Sbjct: 126 NVLLDKDGH-IKIADFGMC---KENMNGEGKASTFCGTPDYIAPEILKGQK---YNESVD 178

Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WS G +L EM  G++   G
Sbjct: 179 WWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 16/176 (9%)

Query: 90  ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG 149
           + L   TED L       ++ Q+   +S L     +HRD+ + NI LT  G   K+ DFG
Sbjct: 207 DELALDTEDLL------SFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFG 259

Query: 150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKR 208
            A  I   +    + N  +  + +MAPE   +     +    D+WS G +L E+ S G  
Sbjct: 260 LARDIRNDSNYVVKGNARLPVK-WMAPESIFNCV---YTFESDVWSYGILLWEIFSLGSS 315

Query: 209 PWA--EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           P+     DS +  M K G       PE    E     + C   DP +R T  +++Q
Sbjct: 316 PYPGMPVDSKFYKMIKEGYRMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 6/77 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNKVGHGRA 367
           +N+ +   G  +KL DFG    IS +           G + YMAPE +  + N+ G+   
Sbjct: 133 SNVLINRNGQ-VKLCDFG----ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVK 187

Query: 368 VDIWSLGCVLVEMSSGK 384
            D+WSLG  ++E+++G+
Sbjct: 188 SDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 32/80 (40%), Positives = 43/80 (53%), Gaps = 6/80 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTN-KVGHGRA 367
           N+ LT E   +KL DFG + ++    TV G  N F+GT  +MAPEV   D N    +   
Sbjct: 141 NVLLT-ENAEVKLVDFGVSAQLD--RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFK 196

Query: 368 VDIWSLGCVLVEMSSGKTNL 387
            D+WSLG   +EM+ G   L
Sbjct: 197 SDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 15/81 (18%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF-----VGTQAYMAPEVFMDTNKVG 363
           +NI L   GN +KL DFG    IS        ++        G + YMAPE    + + G
Sbjct: 137 SNILLDRNGN-IKLCDFG----ISGQL-----VDSIAKTRDAGCRPYMAPERIDPSARDG 186

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
           +    D+WSLG  L E+++GK
Sbjct: 187 YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 22/75 (29%), Positives = 35/75 (46%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVP-GELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  +   LK+ D G    +    ++P       + T  Y APEV + +    +   V
Sbjct: 140 NLLVDKQKGLLKIADLG----LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTH--YSTPV 193

Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC+  EMS  
Sbjct: 194 DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 27/72 (37%), Positives = 42/72 (58%), Gaps = 5/72 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANIFL   G  +KLGDFG + + S   ++    + F GT  Y+APE++    +  + +  
Sbjct: 198 ANIFLMPTG-IIKLGDFGFSKQYSDSVSL-DVASSFCGTPYYLAPELW---ERKRYSKKA 252

Query: 369 DIWSLGCVLVEM 380
           D+WSLG +L E+
Sbjct: 253 DMWSLGVILYEL 264

Length = 478

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 30/76 (39%), Positives = 43/76 (56%), Gaps = 11/76 (14%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG--RA 367
           NI L  +G+ + L DFG   K++       + N F GT  Y+APE+ +     GHG  +A
Sbjct: 123 NILLDYQGH-IALCDFG-LCKLNMKDD--DKTNTFCGTPEYLAPELLL-----GHGYTKA 173

Query: 368 VDIWSLGCVLVEMSSG 383
           VD W+LG +L EM +G
Sbjct: 174 VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 9/67 (13%)

Query: 319 SLKLGDFGSA-VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL 377
           +LK+ DFG A    ++    P     +V T+ Y APEV +    +G+   VDIWS+GC++
Sbjct: 156 TLKILDFGLARTAGTSFMMTP-----YVVTRYYRAPEVILG---MGYKENVDIWSVGCIM 207

Query: 378 VEMSSGK 384
            EM  G 
Sbjct: 208 GEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 39/246 (15%)

Query: 1   MSSVTFSVSPGQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDAR--FVKDMLVEL 53
           +S+V F    G+ RFGKVY          E  + VA+K ++   +   R  F  + ++  
Sbjct: 4   LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRS 63

Query: 54  RILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL---------ESLVQSTED------ 98
           R    +   N+V   GV    + + +    C+   L          S V ST+D      
Sbjct: 64  R----LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 99  GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT 158
            L          Q+   +  L  + +VH+D+ + N+ L  +  ++K+ D G   ++ A  
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV-LVFDKLNVKISDLGLFREVYAAD 178

Query: 159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA---VDIWSLGCVLVEM-SSGKRPWAEYD 214
                 N  +  + +M+PE  M      +G+     DIWS G VL E+ S G +P+  Y 
Sbjct: 179 YYKLMGNSLLPIR-WMSPEAIM------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY- 230

Query: 215 SNYQIM 220
           SN  ++
Sbjct: 231 SNQDVI 236

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 65/300 (21%), Positives = 116/300 (38%), Gaps = 62/300 (20%)

Query: 11  GQGRFGKVY------------TAVNNETGE--LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           G+G+FG+V+                   G+  LVA+K ++      AR   D L E++I+
Sbjct: 14  GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR--NDFLKEIKIM 71

Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE--------DGLPEVLVRR- 107
             +   N+++  GV +  + + +  E    G L   +   E        + +P V +   
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL--KLGDFGSAVKISAHTTVPGE 163
                Q+   +  L     VHRD+ + N  +   GN    K+ DFG +  + +     G+
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYS-----GD 183

Query: 164 LNGFVGTQAYMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEMSS--GKRPWAEYDSNYQ 218
                G    + P  +M    +  G+   A D+W+ G  L EM +   ++P++   S+ Q
Sbjct: 184 YYRIQGRA--VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-SDEQ 240

Query: 219 IMFKVG-----------MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
           ++   G           + +TP  P  +          C   D   R T F  + H FL 
Sbjct: 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFK----LMMRCWSRDIKDRPT-FNKIHH-FLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 26/77 (33%), Positives = 45/77 (58%), Gaps = 9/77 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +KL D+G    +      PG+  + F GT  Y+APE+    +   +G +V
Sbjct: 126 NVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSV 177

Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 178 DWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 6/76 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV--GHGRA 367
           NI LT EG  +KL DFG + ++   T+     N  VGT  +MAPEV     +    +   
Sbjct: 158 NILLTTEG-GVKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDAR 213

Query: 368 VDIWSLGCVLVEMSSG 383
            D+WSLG   +E+  G
Sbjct: 214 CDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 56/255 (21%), Positives = 106/255 (41%), Gaps = 28/255 (10%)

Query: 18  VYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG--VEIHRE 75
           +Y  + N   + V ++  +   +     +     E++ L  I+  N++K YG  ++I  +
Sbjct: 36  IYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 76  --EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDA---ISALHENT-IVHRDI 129
              + L +E CT G L  ++   +D    +  +      +D    +  L++ T   ++++
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL 149

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-NKVGHG 188
            S + FL  E   LK+       KI +    P   N  V    Y + ++  D  ++  + 
Sbjct: 150 TSVS-FLVTENYKLKII-CHGLEKILS---SPPFKN--VNFMVYFSYKMLNDIFSE--YT 200

Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
              DI+SLG VL E+ +GK P+        Y ++          +P     E +   E C
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--KLPLDCPLEIKCIVEAC 258

Query: 247 LRHDPAQRATIFELL 261
             HD  +R  I E+L
Sbjct: 259 TSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 64/273 (23%), Positives = 109/273 (39%), Gaps = 36/273 (13%)

Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELV--AMKEI-QLHKQNDARFVKDMLVELRILEGIN 60
           + F    G+G FG+V  A+  + G  +  A+K + +   +ND R   D   EL +L  + 
Sbjct: 4   IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKLG 60

Query: 61  QK-NLVKYYGVEIHREEMVLFMELCTEGTLESLVQST-----------EDGLPEVLVRRY 108
              N++   G   +R  + + +E    G L   ++ +           E G    L  + 
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 109 TKQL-VDAISALH---ENTIVHRDIKSANIFLTAEGNSLKLGDFG--SAVKISAHTTVPG 162
             Q   D  + +    E   +HRD+ + N+ L  E  + K+ DFG     ++    T+ G
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNV-LVGENLASKIADFGLSRGEEVYVKKTM-G 178

Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF 221
            L        +MA E     N   +    D+WS G +L E+ S G  P+    +  ++  
Sbjct: 179 RL-----PVRWMAIESL---NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYE 229

Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           K+  G     P +  DE       C R  P +R
Sbjct: 230 KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 22/229 (9%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEG 58
            S+      G GRFG++         +    VA+  ++    +  R  +  L E   L  
Sbjct: 5   KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQ 62

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +  N+V+  GV      M++  E  + G L+S ++  E  L    +      L   +  
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV--KISA-HTTVPGELNGFVGTQAYMA 175
           L E   VH+ + +A+  L       K+  F      K  A +TT+ G+         + A
Sbjct: 123 LSEMGYVHKGL-AAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGK-----SPVLWAA 176

Query: 176 PEVFMDTNKVGH-GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFK 222
           PE      +  H   A D+WS G V+ E MS G+RP+  +D + Q + K
Sbjct: 177 PE----AIQYHHFSSASDVWSFGIVMWEVMSYGERPY--WDMSGQDVIK 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 9/77 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L AEG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G +V
Sbjct: 126 NVLLDAEGH-IKLTDYG----MCKEGIRPGDTTSTFCGTPNYIAPEILRGED---YGFSV 177

Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 178 DWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 6/132 (4%)

Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           ++ Q+ + +  L     VHRD+ + N+ L  EG  +K+ DFG A  I   +    + + F
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNV-LICEGKLVKICDFGLARDIMRDSNYISKGSTF 302

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   +     +    D+WS G +L E+ + G  P+ E   N Q    +  G
Sbjct: 303 LPLK-WMAPESIFNNL---YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358

Query: 227 ETPTIPESLSDE 238
                P   SDE
Sbjct: 359 YRMAKPAHASDE 370

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 4/76 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L + G+ + L DFG + +   H         F GT  YMAP++ +     GH +AVD
Sbjct: 135 NILLDSNGHVV-LTDFGLSKEF--HEDEVERAYSFCGTIEYMAPDI-VRGGDGGHDKAVD 190

Query: 370 IWSLGCVLVEMSSGKT 385
            WS+G ++ E+ +G +
Sbjct: 191 WWSMGVLMYELLTGAS 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 7/86 (8%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDI 370
            L  E   LKL DFG A   S  T T   E    V T  Y  P+V + + +  +   +D+
Sbjct: 134 LLINEKGELKLADFGLARAKSVPTKTYSNE----VVTLWYRPPDVLLGSTE--YSTPIDM 187

Query: 371 WSLGCVLVEMSSGKTNLSGVVVSAEV 396
           W +GC+L EM++G+    G  V  E+
Sbjct: 188 WGVGCILYEMATGRPMFPGSTVKEEL 213

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 30/74 (40%), Positives = 39/74 (52%), Gaps = 7/74 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L ++G+ + L DFG   +   H    G  + F GT  Y+APEV    +K  + R VD
Sbjct: 126 NILLDSQGH-IVLTDFGLCKENIEHN---GTTSTFCGTPEYLAPEVL---HKQPYDRTVD 178

Query: 370 IWSLGCVLVEMSSG 383
            W LG VL EM  G
Sbjct: 179 WWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 11/83 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           NI L  +G+ +K+ DFG   +      + G+     F GT  Y+APE+ +      +  +
Sbjct: 126 NILLDTDGH-IKIADFGMCKE-----NMLGDAKTCTFCGTPDYIAPEILLGQK---YNTS 176

Query: 368 VDIWSLGCVLVEMSSGKTNLSGV 390
           VD WS G +L EM  G++   G 
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGH 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 30/271 (11%)

Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG V  A     + + + VA+K ++      +  +++ L E   ++  +  N++K 
Sbjct: 8   GKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 68  YGVEIHREE-------MVL--FMELCTEGTLESLVQSTEDG-----LPEVLVRRYTKQLV 113
            GV +           MV+  FM+    G L + +  +  G     LP   + R+   + 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMK---HGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 114 DAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQA 172
             +  L     +HRD+ + N  L  E  ++ + DFG + KI S      G  +       
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCML-NENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVK 180

Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTI 231
           ++A E   D     H    D+W+ G  + E M+ G+ P+A  + N +I   +  G     
Sbjct: 181 WLALESLADNVYTTHS---DVWAFGVTMWEIMTRGQTPYAGVE-NSEIYNYLIKGNRLKQ 236

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           P    ++       C   +P  R +   L  
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 30/80 (37%), Positives = 40/80 (50%), Gaps = 12/80 (15%)

Query: 309 ANIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNKVGH 364
           +NI L A GN +KL DFG +   V   A T          G  AYMAPE +        +
Sbjct: 144 SNILLDASGN-VKLCDFGISGRLVDSKAKTRS-------AGCAAYMAPERIDPPDPNPKY 195

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
               D+WSLG  LVE+++G+
Sbjct: 196 DIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/84 (35%), Positives = 43/84 (51%), Gaps = 12/84 (14%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF-----MDTNKVGH 364
           NI LT EG  +KL DFG + ++   T+     N  VGT  +MAPEV      +D+    +
Sbjct: 154 NILLTTEG-GVKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIACEQQLDST---Y 206

Query: 365 GRAVDIWSLGCVLVEMSSGKTNLS 388
               D+WSLG   +E+  G   L+
Sbjct: 207 DARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 18/81 (22%)

Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  +G  +KL DFG A      V++  H  V         T  Y APEV + + +  
Sbjct: 131 NLLIDNKGV-IKLADFGLARAFGIPVRVYTHEVV---------TLWYRAPEVLLGSPR-- 178

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
           +   VDIWS+G +  EM++ K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 17/89 (19%)

Query: 302 SVKVYAR----ANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEV 355
           S+K+  R    +N+ +   G  +KL DFG + ++  S   T       +VGT AYMAPE 
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSIAKT-------YVGTNAYMAPER 164

Query: 356 FMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
                   +G   D+WSLG   +E++ G+
Sbjct: 165 ISGEQ---YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 9/77 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L A+G+ +KL D+G    +      PG+    F GT  Y+APE+        +G +V
Sbjct: 126 NVLLDADGH-IKLTDYG----MCKEGLGPGDTTSTFCGTPNYIAPEILRGEE---YGFSV 177

Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 178 DWWALGVLMFEMMAGRS 194

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/77 (38%), Positives = 37/77 (48%), Gaps = 13/77 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L ++G+ + L DFG     +  S  TT       F GT  Y+APEV     K  +  
Sbjct: 126 NILLDSQGH-VVLTDFGLCKEGIAQSDTTTT------FCGTPEYLAPEVI---RKQPYDN 175

Query: 367 AVDIWSLGCVLVEMSSG 383
            VD W LG VL EM  G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 9/81 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L AEG+ +K+ DFG    +       G+    F GT  Y+APE+        +G++V
Sbjct: 131 NVMLDAEGH-IKIADFG----MCKENIFGGKTTRTFCGTPDYIAPEIIAYQP---YGKSV 182

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D W+ G +L EM +G+    G
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 7/86 (8%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDI 370
            L  E   LKL DFG A   S  T T   E    V T  Y  P+V + +++  +   +D+
Sbjct: 135 LLINERGELKLADFGLARAKSVPTKTYSNE----VVTLWYRPPDVLLGSSE--YSTQIDM 188

Query: 371 WSLGCVLVEMSSGKTNLSGVVVSAEV 396
           W +GC+  EM+SG+    G  V  E+
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDEL 214

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 6/73 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NIFL  +G  + LGDFG+A+          +  G+VGT A  +PE+       G+    D
Sbjct: 297 NIFLNCDGKIV-LGDFGTAMPFE-KEREAFDY-GWVGTVATNSPEILA---GDGYCEITD 350

Query: 370 IWSLGCVLVEMSS 382
           IWS G +L++M S
Sbjct: 351 IWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 71/283 (25%), Positives = 113/283 (39%), Gaps = 52/283 (18%)

Query: 11  GQGRFGKVYTA-VNNETGEL--VAMKEIQL--HKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG V    ++ + G    VA+K ++L  H  ++   +++ L E   ++  +  N++
Sbjct: 8   GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPNVM 64

Query: 66  KYYGVEIHREE-------MVL--FMELCTEGTLES-LVQSTEDGLPEVL-VRRYTKQLVD 114
           K  GV             MV+  FM+    G L S L+ S   GLPE L ++   K +VD
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMK---HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 115 AISA---LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
                  L     +HRD+ + N  L  E  ++ + DFG + KI          +G    Q
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCML-REDMTVCVADFGLSKKI---------YSGDYYRQ 171

Query: 172 A--------YMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWA--EYDSNYQIM 220
                    ++A E   D          D+W+ G  + E  + G+ P+   E    Y  +
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKS---DVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228

Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                G     PE   DE       C R DP  R T  +L + 
Sbjct: 229 RH---GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 61/266 (22%), Positives = 106/266 (39%), Gaps = 36/266 (13%)

Query: 11  GQGRFGKVYTAVNNETGELV--AMKEIQLH-KQNDARFVKDMLVELRILEGI-NQKNLVK 66
           G+G FG+V  A   + G  +  A+K ++ +  ++D R   D   EL +L  + +  N++ 
Sbjct: 4   GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNIIN 60

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQST-----------EDGLPEVL----VRRYTKQ 111
             G   HR  + L +E    G L   ++ +            +     L    +  +   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 112 LVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG--SAVKISAHTTVPGELNGFVG 169
           +   +  L +   +HRD+ + NI L  E    K+ DFG     ++    T+ G L     
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNI-LVGENYVAKIADFGLSRGQEVYVKKTM-GRL----- 173

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
              +MA E     N   +    D+WS G +L E+ S G  P+    +  ++  K+  G  
Sbjct: 174 PVRWMAIESL---NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYR 229

Query: 229 PTIPESLSDEGQAFAELCLRHDPAQR 254
              P +  DE       C R  P +R
Sbjct: 230 LEKPLNCDDEVYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +GN +++ D G AV++    +   +  G+ GT  +MAPE+        +  +VD
Sbjct: 127 NVLLDNDGN-VRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEE---YDFSVD 179

Query: 370 IWSLGCVLVEMSSGK 384
            ++LG  L EM + +
Sbjct: 180 YFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 24/112 (21%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTT------VPGELNGFV-----GTQAYMAPEVFM 357
           N+ +T+ G+ +KL DFG S + + + TT      +  +   F+     GT  Y+APEV +
Sbjct: 131 NLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189

Query: 358 DTNKVGHGRAVDIWSLGCVLVEMSSG--------KTNLSGVVVSAEVFGSGG 401
              + G+G+ VD W++G +L E   G           L G V+S ++    G
Sbjct: 190 ---RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 27/71 (38%), Positives = 37/71 (52%), Gaps = 8/71 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G  +KL DFG A   S        L   V T  Y APEV + ++   +   VD
Sbjct: 140 NILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSS---YATPVD 191

Query: 370 IWSLGCVLVEM 380
           +WS+GC+  EM
Sbjct: 192 LWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 20/39 (51%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 345 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 383
           VGT  Y+APEVFM T   G+ +  D WSLG ++ EM  G
Sbjct: 197 VGTPDYIAPEVFMQT---GYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 7/71 (9%)

Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
           +LK+ DFG A     +      +  +V T+ Y APEV +    +G+   VDIWS+GC++ 
Sbjct: 161 TLKILDFGLARTACTNFM----MTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMG 213

Query: 379 EMSSGKTNLSG 389
           E+  G     G
Sbjct: 214 ELVKGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 32/144 (22%), Positives = 57/144 (39%), Gaps = 21/144 (14%)

Query: 13  GRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV--KYYGV 70
           G   +VY  +  +  + V      L          D   E+ IL+ + +K L   K    
Sbjct: 9   GLTNRVYL-LGTKDEDYV------LKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE---NTIVHR 127
                   L ME   EG  E+L + +E+   ++      +QL + ++ LH+     + H 
Sbjct: 62  GESDGWSYLLMEWI-EG--ETLDEVSEEEKEDIA-----EQLAELLAKLHQLPLLVLCHG 113

Query: 128 DIKSANIFLTAEGNSLKLGDFGSA 151
           D+   NI +  +G  L + D+  A
Sbjct: 114 DLHPGNILVD-DGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 55  ILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD 114
           ++  ++  +L   +GV +   E ++  E    G L+  ++  +  +P        +QL  
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128

Query: 115 AISALHENTIVHRDIKSANIFLT----AEGNS--LKLGDFGSAVKISAHTTVPGELNGFV 168
           A+S L +  +VH ++ + NI L     AEG S  +KL D G +      T +  E    V
Sbjct: 129 ALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF-----TALSREER--V 181

Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS-SGKRPWAEYDSNYQIMF---KVG 224
               ++APE     N +    A D WS G  L+E+   G+ P  E   + +  F   K  
Sbjct: 182 ERIPWIAPECVPGGNSL--STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR 239

Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           + E P+  E  +   Q     CL ++P QR +   +L+
Sbjct: 240 LPE-PSCKELATLISQ-----CLTYEPTQRPSFRTILR 271

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 28/79 (35%), Positives = 39/79 (49%), Gaps = 17/79 (21%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDTNKVGH 364
           N+ L  EG+  KL DFG   +        G  NG     F GT  Y+APE+  +     +
Sbjct: 126 NVLLDHEGHC-KLADFGMCKE--------GIFNGKTTSTFCGTPDYIAPEILQEML---Y 173

Query: 365 GRAVDIWSLGCVLVEMSSG 383
           G +VD W++G +L EM  G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 30/75 (40%), Positives = 37/75 (49%), Gaps = 9/75 (12%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L ++G+ + L DFG    +      P E    F GT  Y+APEV     K  + R V
Sbjct: 126 NILLDSQGHVV-LTDFG----LCKEGVEPEETTSTFCGTPEYLAPEVL---RKEPYDRTV 177

Query: 369 DIWSLGCVLVEMSSG 383
           D W LG VL EM  G
Sbjct: 178 DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 22/87 (25%), Positives = 37/87 (42%), Gaps = 11/87 (12%)

Query: 298 MSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 357
             +DS++     +         L+        +  AH+         VGT  Y+APEV +
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS--------LVGTPNYIAPEVLL 217

Query: 358 DTNKVGHGRAVDIWSLGCVLVEMSSGK 384
              + G+ +  D WS+G +L EM  G+
Sbjct: 218 ---RTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 27/71 (38%), Positives = 40/71 (56%), Gaps = 7/71 (9%)

Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
           +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   VDIWS+GC++ 
Sbjct: 164 TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMG 216

Query: 379 EMSSGKTNLSG 389
           EM  G     G
Sbjct: 217 EMIKGGVLFPG 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 51/235 (21%), Positives = 100/235 (42%), Gaps = 52/235 (22%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A + +  E  A+K ++    N  ++ +D  +E++ +E + Q +    + +
Sbjct: 138 GEGTFGKVVEAWDRKRKEYCAVKIVR----NVPKYTRDAKIEIQFMEKVRQADPADRFPL 193

Query: 71  -EIHRE------EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLV----DAISAL 119
            +I R        M + M       L+ +++            R+  Q++     A+   
Sbjct: 194 MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGP------FSHRHLAQIIFQTGVALDYF 247

Query: 120 H-ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--------LNG---- 166
           H E  ++H D+K  NI +          D  + V    +  +P +        L G    
Sbjct: 248 HTELHLMHTDLKPENILMET-------SD--TVVDPVTNRALPPDPCRVRICDLGGCCDE 298

Query: 167 ------FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS 215
                  V T+ Y +PEV +    +G   + D+WS+GC++ E+ +GK  +  +D+
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLG---LGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350

Length = 467

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 17/90 (18%)

Query: 307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA-----YMAPEVFMDTNK 361
           AR N  +  E   +K+ DFG +  +        +      T       +MAPE   D   
Sbjct: 133 AR-NCLVG-EDLVVKISDFGLSRDVYD------DDYYRKKTGGKLPIRWMAPESLKDGI- 183

Query: 362 VGHGRAVDIWSLGCVLVEMSS-GKTNLSGV 390
                  D+WS G +L E+ + G T   G+
Sbjct: 184 --FTSKSDVWSFGVLLWEIFTLGATPYPGL 211

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRA 367
           ANI L + G  +KLGDFG +   +A  TV  ++   F GT  Y+APE++    +  + + 
Sbjct: 172 ANILLCSNG-LVKLGDFGFSKMYAA--TVSDDVGRTFCGTPYYVAPEIW---RRKPYSKK 225

Query: 368 VDIWSLGCVLVEMSSGKTNLSGV 390
            D++SLG +L E+ + K    G 
Sbjct: 226 ADMFSLGVLLYELLTLKRPFDGE 248

Length = 496

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 51/232 (21%)

Query: 11  GQGRFGKVYTA--------------VNNETGE--LVAMKEIQLHKQNDARFVKDMLVELR 54
           G+G+FG+V+                 N   G   LVA+K ++     +AR   D L E++
Sbjct: 14  GEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR--NDFLKEVK 71

Query: 55  ILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLES------LVQSTEDGLPEV----- 103
           IL  +   N+++  GV +  + + +  E    G L        L    E+G   V     
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 104 -LVRRYTK------QLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA 156
                Y+       Q+   +  L     VHRD+ + N  L  E  ++K+ DFG +  + A
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNC-LVGENLTIKIADFGMSRNLYA 190

Query: 157 --HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEM 203
             +  + G     V    +MA E  +       G+   A D+W+ G  L E+
Sbjct: 191 GDYYRIQGRA---VLPIRWMAWECIL------MGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 5/75 (6%)

Query: 309 ANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           ANI +  EG     +K+ D G A   ++      +L+  V T  Y APE+ +      + 
Sbjct: 137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YT 194

Query: 366 RAVDIWSLGCVLVEM 380
           +A+DIW++GC+  E+
Sbjct: 195 KAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 5/75 (6%)

Query: 309 ANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           ANI +  EG     +K+ D G A   ++      +L+  V T  Y APE+ +      + 
Sbjct: 137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YT 194

Query: 366 RAVDIWSLGCVLVEM 380
           +A+DIW++GC+  E+
Sbjct: 195 KAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 39/232 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-----------GI 59
           G G FG VY         +      ++    +   V + LV   I +            I
Sbjct: 21  GCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI 80

Query: 60  NQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL------PEVLVRRYTKQLV 113
           +   + KYYG    +   + +  +     LE LV++T++         + L++   K ++
Sbjct: 81  DHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNIMKDML 136

Query: 114 DAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG--------ELN 165
             +  +HE+ I H DIK  NI +        + D+G    I++H  + G        + +
Sbjct: 137 TTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYG----IASHFIIHGKHIEYSKEQKD 191

Query: 166 GFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN 216
              GT  Y      +D  N     R  D+ SLG  +++ +  K PW  +  N
Sbjct: 192 LHRGTLYYAG----LDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239

Length = 294

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 53/234 (22%), Positives = 107/234 (45%), Gaps = 37/234 (15%)

Query: 11  GQGRFGKV-----YTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQ 61
           G G FGKV     YT   +     V +KE++      +QN+  F++      RIL+    
Sbjct: 4   GNGWFGKVLLSEIYT---DTGVARVVVKELKANASSKEQNE--FLQQG-DPYRILQ---H 54

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPE---VLVRRYTKQLVDAISA 118
            N+++  G  +     +L  E C  G L+S +   +        +L++R   ++   ++ 
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +H++  +H D+   N FLT++   +K+GD+G          +  E +  V  + ++APE+
Sbjct: 115 MHKHNFLHSDLALRNCFLTSDLT-VKVGDYGIGPSRYKEDYIETEDDKCVPLR-WLAPEL 172

Query: 179 FMDTNKVGHGRAV--------DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKV 223
             +     HG  +        ++W+LG  L E+  +  +P++   S+ +++  V
Sbjct: 173 VGEF----HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-SDREVLNHV 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 6e-04
 Identities = 20/39 (51%), Positives = 25/39 (64%), Gaps = 3/39 (7%)

Query: 345 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 383
           VGT  Y+APEVFM T   G+ +  D WSLG ++ EM  G
Sbjct: 197 VGTPDYIAPEVFMQT---GYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 9/81 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +K+ DFG    +     V G     F GT  Y+APE+        +G++V
Sbjct: 131 NVMLDSEGH-IKIADFG----MCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP---YGKSV 182

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D W+ G +L EM +G+    G
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 27/71 (38%), Positives = 40/71 (56%), Gaps = 7/71 (9%)

Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
           +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   VDIWS+GC++ 
Sbjct: 157 TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMG 209

Query: 379 EMSSGKTNLSG 389
           EM   K    G
Sbjct: 210 EMVRHKILFPG 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 19/51 (37%), Positives = 33/51 (64%), Gaps = 1/51 (1%)

Query: 104 LVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI 154
           +++   +Q++  +  LH   IVHRDIK  N+ +T +G  +K+ DFG+AV +
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKIIDFGAAVDM 359

Length = 507

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.8 bits (95), Expect = 9e-04
 Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 7/86 (8%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDI 370
            L  E   LKL DFG A   S  T T   E    V T  Y  P++ + +    +   +D+
Sbjct: 135 LLINERGELKLADFGLARAKSIPTKTYSNE----VVTLWYRPPDILLGSTD--YSTQIDM 188

Query: 371 WSLGCVLVEMSSGKTNLSGVVVSAEV 396
           W +GC+  EMS+G+    G  V  ++
Sbjct: 189 WGVGCIFYEMSTGRPLFPGSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 40.7 bits (95), Expect = 9e-04
 Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 29/172 (16%)

Query: 4   VTFSVSPGQGRFGKVY----------------TAVNNETGELVAMKEIQLHKQNDARFVK 47
           +TF    G+G+FG+V+                  V+     LVA+K ++     +AR   
Sbjct: 7   LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR--N 64

Query: 48  DMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL----------ESLVQSTE 97
           D L E++I+  +   N+++   V I  + + +  E    G L          E+  ++  
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 98  DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG 149
             +    +     Q+   +  L     VHRD+ + N  L  +  ++K+ DFG
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC-LVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 25/81 (30%), Positives = 37/81 (45%), Gaps = 15/81 (18%)

Query: 310 NIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ +   G  +KL DFG +   V   A T +        G Q+YMAPE         +  
Sbjct: 133 NVLVNGNG-QVKLCDFGVSGNLVASLAKTNI--------GCQSYMAPERIKSGGPNQNPT 183

Query: 367 ---AVDIWSLGCVLVEMSSGK 384
                D+WSLG  ++EM+ G+
Sbjct: 184 YTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 25/72 (34%), Positives = 39/72 (54%), Gaps = 5/72 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI L  +G  +KL DFG A   ++  + P      V T  Y  PE+ +   +  +G A+
Sbjct: 145 SNILLNNKGQ-IKLADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGEER--YGPAI 199

Query: 369 DIWSLGCVLVEM 380
           D+WS GC+L E+
Sbjct: 200 DVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 7/72 (9%)

Query: 320 LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
           LKL DFG A   S    +P +  +  V T  Y  P+V +      +  A+DIW  GC+ +
Sbjct: 142 LKLADFGLARAKS----IPSQTYSSEVVTLWYRPPDVLLGATD--YSSALDIWGAGCIFI 195

Query: 379 EMSSGKTNLSGV 390
           EM  G+    GV
Sbjct: 196 EMLQGQPAFPGV 207

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 11/82 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVK--ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L +EG+ +K+ DFG   +      TT       F GT  Y+APE+        +G++
Sbjct: 131 NVMLDSEGH-IKIADFGMCKENMWDGVTT-----KTFCGTPDYIAPEIIAYQP---YGKS 181

Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           VD W+ G +L EM +G+    G
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 21/80 (26%), Positives = 34/80 (42%), Gaps = 18/80 (22%)

Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +   G  LKL DFG A      V+  +   V         T  Y  P+V        
Sbjct: 129 NLLINKNGE-LKLADFGLARAFGIPVRCYSAEVV---------TLWYRPPDVLFGAK--L 176

Query: 364 HGRAVDIWSLGCVLVEMSSG 383
           +  ++D+WS GC+  E+++ 
Sbjct: 177 YSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 24/68 (35%), Positives = 34/68 (50%), Gaps = 7/68 (10%)

Query: 320 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV---FMDTNKVGHGRAVDIWSLGCV 376
           LK+ DFG A      T        +V T+ Y APE+   F       +  A+DIWS+GC+
Sbjct: 142 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCI 197

Query: 377 LVEMSSGK 384
             E+ +GK
Sbjct: 198 FAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 24/81 (29%), Positives = 39/81 (48%), Gaps = 9/81 (11%)

Query: 312 FLTAEGNSLKLGDFG--SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
            L ++   LKL DFG   A  + +HT      +  V T  Y  P+V + + +  +   +D
Sbjct: 134 LLISDTGELKLADFGLARAKSVPSHT-----YSNEVVTLWYRPPDVLLGSTE--YSTCLD 186

Query: 370 IWSLGCVLVEMSSGKTNLSGV 390
           +W +GC+ VEM  G     G+
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGM 207

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 26/75 (34%), Positives = 37/75 (49%), Gaps = 8/75 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V +  + 
Sbjct: 126 ANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGVAYDSSA 177

Query: 369 DIWSLGCVLVEMSSG 383
           D +SLGC+L ++  G
Sbjct: 178 DWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	407
KOG0581|consensus	364		100.0
KOG0615|consensus	475		100.0
KOG0598|consensus	357		100.0
KOG0575|consensus	592		100.0
KOG0592|consensus	604		100.0
KOG0595|consensus	429		100.0
KOG0198|consensus	313		100.0
KOG0591|consensus	375		100.0
KOG0616|consensus	355		100.0
KOG0593|consensus	396		100.0
KOG0583|consensus	370		100.0
KOG0600|consensus	560		100.0
KOG0582|consensus	516		100.0
KOG0661|consensus	538		100.0
KOG0605|consensus	550		100.0
KOG0588|consensus	786		100.0
KOG0578|consensus	550		100.0
KOG0192|consensus	362		100.0
KOG0694|consensus	694		100.0
KOG0033|consensus	355		100.0
KOG0659|consensus	318		100.0
KOG0597|consensus	808		100.0
KOG0580|consensus	281		100.0
KOG0585|consensus	576		100.0
KOG0201|consensus	467		100.0
KOG0611|consensus	668		100.0
KOG0663|consensus	419		100.0
KOG0660|consensus	359		100.0
KOG4645|consensus	1509		100.0
KOG4279|consensus	1226		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0032|consensus	382		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610|consensus	459		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0599|consensus	411		100.0
KOG4717|consensus	864		100.0
KOG0589|consensus	426		100.0
KOG0658|consensus	364		100.0
KOG0986|consensus	591		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0690|consensus	516		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0574|consensus	502		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594|consensus	323		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0579|consensus	1187		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0577|consensus	948		100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0197|consensus	468		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0983|consensus	391		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0667|consensus	586		100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0193|consensus	678		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0586|consensus	596		100.0
KOG0584|consensus	632		100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0596|consensus	677		100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG4236|consensus	888		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0604|consensus	400		100.0
KOG4721|consensus	904		100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0607|consensus	463		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0612|consensus	1317		100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0696|consensus	683		100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0194|consensus	474		100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG1989|consensus	738		100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0662|consensus	292		100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG1006|consensus	361		100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG2345|consensus	302		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1187|consensus	361		100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG1026|consensus	774		100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0695|consensus	593		100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1035|consensus	1351		100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0666|consensus	438		100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0669|consensus	376		100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0668|consensus	338		100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0603|consensus	612		100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG1095|consensus	1025		100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4250|consensus	732		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0614|consensus	732		100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1151|consensus	775		100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0587|consensus	953		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0608|consensus	1034		100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0576|consensus	829		100.0
KOG0196|consensus	996		100.0
KOG0671|consensus	415		100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0603|consensus	612		100.0
KOG4257|consensus	974		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984|consensus	282		100.0
KOG0199|consensus	1039		100.0
KOG1094|consensus	807		100.0
KOG4278|consensus	1157		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027|consensus	903		100.0
KOG0664|consensus	449		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0670|consensus	752		100.0
KOG0665|consensus	369		100.0
KOG2052|consensus	513		100.0
KOG0200|consensus	609		100.0
KOG1290|consensus	590		100.0
KOG3653|consensus	534		100.0
KOG1025|consensus	1177		100.0
KOG1167|consensus	418		100.0
KOG1152|consensus	772		100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345|consensus	378		100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG1024|consensus	563		99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG0590|consensus	601		99.95
KOG0590|consensus	601		99.95
KOG1164|consensus	322		99.95
KOG1163|consensus	341		99.93
KOG0195|consensus	448		99.93
KOG1165|consensus	449		99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK10345	210	hypothetical protein; Provisional	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG0606|consensus	1205		99.9
KOG1240|consensus	1431		99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG4158|consensus	598		99.88
KOG1023|consensus	484		99.85
smart00090	237	RIO RIO-like kinase.	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
KOG1166|consensus	974		99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
KOG1033|consensus	516		99.83
KOG0601|consensus	524		99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
KOG0591|consensus	375		99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0616|consensus	355		99.68
KOG0593|consensus	396		99.67
KOG0598|consensus	357		99.66
KOG0658|consensus	364		99.63
KOG0660|consensus	359		99.62
KOG1035|consensus	1351		99.62
KOG4721|consensus	904		99.6
KOG0661|consensus	538		99.6
KOG0667|consensus	586		99.59
KOG0606|consensus	1205		99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
KOG0694|consensus	694		99.56
KOG0983|consensus	391		99.55
KOG0601|consensus	524		99.55
KOG1266|consensus	458		99.55
KOG0986|consensus	591		99.53
KOG0659|consensus	318		99.53
KOG0663|consensus	419		99.53
KOG0600|consensus	560		99.52
KOG0201|consensus	467		99.52
KOG0575|consensus	592		99.52
KOG0595|consensus	429		99.51
KOG0594|consensus	323		99.51
KOG0614|consensus	732		99.5
KOG0615|consensus	475		99.49
KOG0581|consensus	364		99.48
KOG0696|consensus	683		99.48
KOG0597|consensus	808		99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
KOG0578|consensus	550		99.46
KOG4645|consensus	1509		99.46
KOG0198|consensus	313		99.46
KOG0666|consensus	438		99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG0670|consensus	752		99.45
KOG0592|consensus	604		99.45
KOG0582|consensus	516		99.44
KOG1006|consensus	361		99.44
KOG0605|consensus	550		99.43
KOG0596|consensus	677		99.42
KOG0984|consensus	282		99.41
KOG4279|consensus	1226		99.41
KOG0574|consensus	502		99.39
KOG1243|consensus	690		99.39
KOG0192|consensus	362		99.38
KOG0610|consensus	459		99.37
KOG0577|consensus	948		99.37
KOG0583|consensus	370		99.37
KOG0690|consensus	516		99.37
KOG3087|consensus	229		99.36
KOG2345|consensus	302		99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG0612|consensus	1317		99.33
KOG0588|consensus	786		99.32
KOG0695|consensus	593		99.32
KOG0589|consensus	426		99.32
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.31
PTZ00036	440	glycogen synthase kinase; Provisional	99.3
KOG0599|consensus	411		99.29
KOG0664|consensus	449		99.29
KOG0033|consensus	355		99.29
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.28
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.27

>KOG0581|consensus

Probab=100.00  E-value=9.6e-62  Score=436.92  Aligned_cols=255  Identities=32%  Similarity=0.560  Sum_probs=229.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-eEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-EMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~   81 (407)
                      ++.....||+|..|+||+|+|+.|++.+|+|+|..  ..++...+++.+|+++++.++||+||++||+|..++ .++|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            44455599999999999999999999999999954  356778899999999999999999999999999999 599999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||.+|+|+.+++.. +.++|.....++.+++.||.|||+ ++||||||||+|||++.+| .|||||||.++.+...   
T Consensus       158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS---  232 (364)
T ss_pred             hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh---
Confidence            999999999999764 559999999999999999999995 8999999999999999976 6999999999887543   


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC----CchHHHHHHHhCCCCCCCCCc-c
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY----DSNYQIMFKVGMGETPTIPES-L  235 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~----~~~~~~~~~~~~~~~~~~~~~-~  235 (407)
                        ..++++||..|||||.+.+   ..|+.++||||||++++||++|+.||...    .+..+++..+..+..|.+|.. +
T Consensus       233 --~a~tfvGT~~YMsPERi~g---~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISG---ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             --hcccccccccccChhhhcC---CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence              2377999999999999965   45789999999999999999999999863    345677888888899999997 9


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      |+++++|+..||++||.+||++.|+++|||+...
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            9999999999999999999999999999998643

>KOG0615|consensus

Probab=100.00  E-value=5.9e-62  Score=441.47  Aligned_cols=254  Identities=31%  Similarity=0.436  Sum_probs=219.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHH----HHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR----FVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .||+|+||.|.+|..+.||+.||||++.+.+.....    -.....+|+++|++|+|||||++++++..++..||||||+
T Consensus       179 ~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v  258 (475)
T KOG0615|consen  179 TLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYV  258 (475)
T ss_pred             eecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEe
Confidence            899999999999999999999999999876543311    1233569999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +||+|.+.+-. .+.+.|..-+.+++|++.|+.|||++||+||||||+|||+..+  ...+||+|||+|+.....    .
T Consensus       259 ~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~----s  333 (475)
T KOG0615|consen  259 EGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG----S  333 (475)
T ss_pred             cCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc----e
Confidence            99999998864 4558899999999999999999999999999999999999764  346999999999876432    2


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~  239 (407)
                      ..+++||||.|.|||++...+...+..++|||||||+||.+++|.+||.+.........++..|..   |..+..+|+++
T Consensus       334 fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea  413 (475)
T KOG0615|consen  334 FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEA  413 (475)
T ss_pred             ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHH
Confidence            457899999999999998766555667999999999999999999999876555445566666654   44567799999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++||++||..||++|||+.|+|+||||.
T Consensus       414 ~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  414 LDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             HHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            9999999999999999999999999995

>KOG0598|consensus

Probab=100.00  E-value=1.4e-59  Score=422.78  Aligned_cols=256  Identities=32%  Similarity=0.487  Sum_probs=227.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++....+||+|+||+||.++.+.|++.||+|++++....+....+....|..||.+++||+||+++..|++.+.+|+|+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            45566699999999999999999999999999998877776677889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+.||+|..++++ .+.|+|..++.|+.+|+.||.|||++|||||||||+|||+|.+| +++|+|||||+.......   
T Consensus       106 ~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~~~---  180 (357)
T KOG0598|consen  106 YLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKDGD---  180 (357)
T ss_pred             ccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccCCC---
Confidence            9999999999975 55699999999999999999999999999999999999999986 699999999986543322   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ...++|||+.|||||++..   .+|+.++|.|||||++|||++|.+||.. .+......++..+..+..|..+|.+++++
T Consensus       181 ~t~tfcGT~eYmAPEil~~---~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~~~p~~ls~~ardl  256 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLG---KGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLPLPPGYLSEEARDL  256 (357)
T ss_pred             ccccccCCccccChHHHhc---CCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence            2356899999999999976   3689999999999999999999999985 34455566666666677777899999999


Q ss_pred             HHHhcccCCCCcC----CHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRA----TIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~----t~~e~l~hp~~~  267 (407)
                      ++++|++||++|.    .+.++.+||||.
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~  285 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFK  285 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence            9999999999995    688999999984

>KOG0575|consensus

Probab=100.00  E-value=4.7e-59  Score=442.48  Aligned_cols=249  Identities=31%  Similarity=0.572  Sum_probs=222.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|||+.||.+++..+|+.||+|+|.+....+...++.+.+||+|.++|+|||||+++++|++.+.+|||+|+|..++
T Consensus        25 ~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~s  104 (592)
T KOG0575|consen   25 FLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGS  104 (592)
T ss_pred             eeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCcc
Confidence            89999999999999999999999999988766677778889999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.++++ .++.++|.+++.+++||+.||.|||+++|||||||..|+|++.+ ..|||+|||||..+.....   ...+.|
T Consensus       105 L~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~E---rk~TlC  179 (592)
T KOG0575|consen  105 LMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGE---RKKTLC  179 (592)
T ss_pred             HHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCccc---ccceec
Confidence            999997 46679999999999999999999999999999999999999875 5699999999988865432   246789


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR  248 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~  248 (407)
                      |||.|+|||++..   .+++..+||||+||++|.|+.|++||+.. +-.+...++ ......+|..+|.+++++|..+|+
T Consensus       180 GTPNYIAPEVl~k---~gHsfEvDiWSlGcvmYtLL~G~PPFetk-~vkety~~I-k~~~Y~~P~~ls~~A~dLI~~lL~  254 (592)
T KOG0575|consen  180 GTPNYIAPEVLNK---SGHSFEVDIWSLGCVMYTLLVGRPPFETK-TVKETYNKI-KLNEYSMPSHLSAEAKDLIRKLLR  254 (592)
T ss_pred             CCCcccChhHhcc---CCCCCchhhhhhhhHHHhhhhCCCCcccc-hHHHHHHHH-HhcCcccccccCHHHHHHHHHHhc
Confidence            9999999999963   56799999999999999999999999842 223333333 334556788999999999999999


Q ss_pred             cCCCCcCCHHHHhcCCeee
Q psy10603        249 HDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       249 ~dp~~R~t~~e~l~hp~~~  267 (407)
                      .||.+|||+.++|.|+||.
T Consensus       255 ~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  255 PNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             CCcccCCCHHHHhcCHhhh
Confidence            9999999999999999994

>KOG0592|consensus

Probab=100.00  E-value=3.5e-57  Score=423.19  Aligned_cols=259  Identities=29%  Similarity=0.521  Sum_probs=227.0

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv   80 (407)
                      .|+.|...||+|+|++|++|++..++++||||++.+....+++.++...+|-.+|.+| .||.|++||-.|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4788999999999999999999999999999999877666666667788999999999 899999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      +||+++|+|.++|++. +.|++..++.|+.||+.||+|||++|||||||||+|||++.++ ++||+|||.|+.+.+....
T Consensus       153 Le~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhhcc
Confidence            9999999999999764 5699999999999999999999999999999999999999875 7999999999887543211


Q ss_pred             ------C--C--cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        161 ------P--G--ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       161 ------~--~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                            +  .  ...+++||..|.+||+|.+.   ..++.+|+|+||||+|.|+.|.+||.+. +.+. +++.+......
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~---~~~~~sDiWAlGCilyQmlaG~PPFra~-Neyl-iFqkI~~l~y~  305 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDS---PAGPSSDLWALGCILYQMLAGQPPFRAA-NEYL-IFQKIQALDYE  305 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCC---CCCcccchHHHHHHHHHHhcCCCCCccc-cHHH-HHHHHHHhccc
Confidence                  1  1  12569999999999999663   4578999999999999999999999853 3443 44444456667


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +|+.+++.+++|++++|..||.+|+|+.|+.+||||.
T Consensus       306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence            8999999999999999999999999999999999995

>KOG0595|consensus

Probab=100.00  E-value=4.7e-56  Score=403.46  Aligned_cols=256  Identities=30%  Similarity=0.537  Sum_probs=220.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||.|+||+||+|+++.++..||||.|.+.+. ..+.++.+..|+.+|+.++|||||.++++...++.+|||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            34455589999999999999999999999999986543 45667788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-C----CeEEEEcccCceecCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-G----NSLKLGDFGSAVKISAH  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-~----~~vkl~DFGla~~~~~~  157 (407)
                      ||.||+|.++++. ++.++|..++.++.||+.||++||+++||||||||.||||+.. +    -.+||+|||+|+.+...
T Consensus        90 yC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            9999999999976 4469999999999999999999999999999999999999864 2    25899999999988644


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--CCCCCCCCCcc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--MGETPTIPESL  235 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (407)
                      .    ...+.||+|.|||||+++.   ..|+.|+|+||+|+++|+|++|+.||... +..++...+.  ....|.++..+
T Consensus       169 ~----~a~tlcGSplYMAPEV~~~---~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~-t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  169 S----MAETLCGSPLYMAPEVIMS---QQYDAKADLWSIGTILYQCLTGKPPFDAE-TPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             h----HHHHhhCCccccCHHHHHh---ccccchhhHHHHHHHHHHHHhCCCCcccc-CHHHHHHHHhccccccCchhhhc
Confidence            3    3456899999999999964   34789999999999999999999999853 3444443333  33456777888


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++...+++...|+.+|.+|.+..+-+.|+++..
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             cCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence            888899999999999999999999999998753

>KOG0198|consensus

Probab=100.00  E-value=2.3e-56  Score=408.55  Aligned_cols=257  Identities=43%  Similarity=0.730  Sum_probs=216.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--eEEEEEecC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--EMVLFMELC   84 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~E~~   84 (407)
                      ...||+|+||.||++.+..+|+.+|||.+....  ... .+.+.+|+++|.+++|||||+++|......  .++++|||+
T Consensus        22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            348999999999999999999999999998652  222 567889999999999999999999755444  699999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++|+|.++++...+.++|..++.+++||+.||.|||++|||||||||+|||++..++.+||+|||+++............
T Consensus        99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~  178 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSE  178 (313)
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccccc
Confidence            99999999987554699999999999999999999999999999999999999843579999999998776422222233


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCCCCCCCccCHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~~i  243 (407)
                      ..+.||+.|||||++..  ....++++|||||||++.||+||+.||.+.......+..+. ....|.+|..+|+++++|+
T Consensus       179 ~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl  256 (313)
T KOG0198|consen  179 LSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFL  256 (313)
T ss_pred             ccccCCccccCchhhcC--CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence            46789999999999964  12224599999999999999999999986323334444444 3347889999999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+|+++||++|||+.|+|+|||...
T Consensus       257 ~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  257 RKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             HHHhhcCcccCcCHHHHhhChhhhc
Confidence            9999999999999999999999854

>KOG0591|consensus

Probab=100.00  E-value=1.5e-57  Score=394.07  Aligned_cols=244  Identities=38%  Similarity=0.637  Sum_probs=216.0

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEE-EEEeCce-EEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG-VEIHREE-MVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~~lv~E   82 (407)
                      ....+||+|+||+||++++..+|+.+|.|.++-. ..+.+..+....|+.+|++|+|||||++|+ .+..++. ++||||
T Consensus        22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            3445899999999999999999999999999843 456777888999999999999999999998 5555555 899999


Q ss_pred             cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         83 LCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE--NT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        83 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~--~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      ||.+|+|..+++.   .+..+||..++.++.|++.||.+||+  ..  |+||||||.||+++..| .+||+|||+++.++
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhHhHhc
Confidence            9999999998864   35569999999999999999999999  44  99999999999999865 69999999999887


Q ss_pred             CCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC-Cc
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ES  234 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~  234 (407)
                      .....   ..+++|||.||+||.+.+   .+|+.++||||+||++|||+.-+.||.+ ++-.++..++..+..|++| +.
T Consensus       180 s~~tf---A~S~VGTPyYMSPE~i~~---~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  180 SKTTF---AHSLVGTPYYMSPERIHE---SGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             chhHH---HHhhcCCCcccCHHHHhc---CCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHH
Confidence            65432   356899999999999965   5678999999999999999999999986 4677888899999999999 78


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCH
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATI  257 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~  257 (407)
                      +|.++.++|..|+..||++||+.
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc
Confidence            99999999999999999999985

>KOG0616|consensus

Probab=100.00  E-value=1e-55  Score=385.34  Aligned_cols=252  Identities=28%  Similarity=0.454  Sum_probs=224.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||.|+||+|.+++++.+|..||+|++.+...-+.+.++...+|..+|+.+.||+++++++.+.+.+.+|||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            55666799999999999999999999999999998877777888899999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++||.|..++++.+ .|++..++.|+.||+.||+|||+++|++|||||+|||+|.+| .+||+|||+|+.....     
T Consensus       125 yv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r-----  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR-----  197 (355)
T ss_pred             ccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc-----
Confidence            999999999997644 499999999999999999999999999999999999999876 6999999999987654     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       .-+.||||.|+|||+++.   .+|+.++|.|||||++|||+.|.+||.... ..++..++. ...-.+|..+|.++++|
T Consensus       198 -T~TlCGTPeYLAPEii~s---k~ynkavDWWalGVLIYEMlaG~pPF~~~~-~~~iY~KI~-~~~v~fP~~fs~~~kdL  271 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQS---KGYNKAVDWWALGVLIYEMLAGYPPFYDDN-PIQIYEKIL-EGKVKFPSYFSSDAKDL  271 (355)
T ss_pred             -EEEecCCccccChHHhhc---CCCCcchhHHHHHHHHHHHHcCCCCCcCCC-hHHHHHHHH-hCcccCCcccCHHHHHH
Confidence             246799999999999954   567899999999999999999999998543 334444444 44556799999999999


Q ss_pred             HHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++++|+.|-.+|.     ...++..||||.
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence            9999999999993     467899999995

>KOG0593|consensus

Probab=100.00  E-value=2.2e-56  Score=390.37  Aligned_cols=255  Identities=33%  Similarity=0.584  Sum_probs=212.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +....++|+|+||+||+|+++.||+.||||.+. +...++...+-.+||++.|++|+|||+|.+.++|..+..++||+||
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~-Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV-ESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeec-cCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            334458999999999999999999999999885 3445666667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      |+..-| +-+.....++++..+..|++|++.|+.|||++++|||||||+|||++.++ .+||||||+|+.+....   ..
T Consensus        83 ~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pg---d~  157 (396)
T KOG0593|consen   83 CDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPG---DN  157 (396)
T ss_pred             cchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCc---ch
Confidence            987444 44556677899999999999999999999999999999999999999875 69999999999887432   24


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH-HHHhCCCC--------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM-FKVGMGET--------------  228 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~-~~~~~~~~--------------  228 (407)
                      .+.++.|.+|+|||++.+.  ..|+.++||||+||++.||++|.+-|++..+-.++. .+...|..              
T Consensus       158 YTDYVATRWYRaPELLvGD--tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGD--TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             hhhhhhhhhccChhhhccc--CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            5788999999999999763  568999999999999999999999998754433321 11111111              


Q ss_pred             -----CCC--C-------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        229 -----PTI--P-------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       229 -----~~~--~-------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                           |..  +       ..++.-+.+|++.||..||++|++.+|++.|++|
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence                 110  0       2356778999999999999999999999999998

>KOG0583|consensus

Probab=100.00  E-value=1.7e-54  Score=411.73  Aligned_cols=256  Identities=33%  Similarity=0.531  Sum_probs=218.9

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccC-cH-HHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-DA-RFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ....||+|+||+|++|++..+++.||+|++...... .. ...+.+.+|+.+++.++ ||||+++++++.....+|+|||
T Consensus        21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE  100 (370)
T KOG0583|consen   21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME  100 (370)
T ss_pred             eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence            344899999999999999999999999987654222 11 23455668999999999 9999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||.||+|.+++.. .+.++|..++.+++|+++|++|||++||+||||||+|||++.+...+||+|||++....   ....
T Consensus       101 y~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~---~~~~  176 (370)
T KOG0583|consen  101 YCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP---GEDG  176 (370)
T ss_pred             ecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC---CCCC
Confidence            9999999999987 67799999999999999999999999999999999999999873469999999998763   1123


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCcc-CHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL-SDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~  241 (407)
                      ...++|||+.|+|||++.+.. ...+.++||||+||+||.|++|+.||.+.  +...+...+......+|..+ |+++++
T Consensus       177 ~l~t~cGsp~Y~aPEvl~~~~-~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  177 LLKTFCGSPAYAAPEVLSGKG-TYSGKAADVWSLGVILYVLLCGRLPFDDS--NVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             cccCCCCCcccCCHHHhCCCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCc--cHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            457789999999999997643 13478999999999999999999999862  33333333455566778888 999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++.+||..||.+|+|+.+++.||||..
T Consensus       254 Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999975

>KOG0600|consensus

Probab=100.00  E-value=2.4e-54  Score=401.03  Aligned_cols=267  Identities=29%  Similarity=0.504  Sum_probs=223.0

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEEEecC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLFMELC   84 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~E~~   84 (407)
                      ..+||+|+||.||+|++..||+.||+|.++... .++.+..-..|||.||++|+||||+++.+...++  ..+|||+|||
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM  200 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM  200 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence            349999999999999999999999999998764 3455667788999999999999999999998876  6899999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +. +|.-++....-.|++.+++.|++|++.||+|||++||+|||||.+|||||.+| .+||+|||||+.+.....  ..+
T Consensus       201 dh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~~~--~~~  276 (560)
T KOG0600|consen  201 DH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPSGS--APY  276 (560)
T ss_pred             cc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCCCC--ccc
Confidence            86 89888876666799999999999999999999999999999999999999876 599999999998765443  236


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCC------CCC----
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETP------TIP----  232 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~------~~~----  232 (407)
                      +..+-|++|.|||+|.+.  ..|+.++|+||.||||.||++|++.|.+..+..|+  +++..-....      .+|    
T Consensus       277 T~rVvTLWYRpPELLLG~--t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~  354 (560)
T KOG0600|consen  277 TSRVVTLWYRPPELLLGA--TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATI  354 (560)
T ss_pred             ccceEEeeccChHHhcCC--cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccc
Confidence            778889999999999864  56899999999999999999999999976554443  2222211110      111    


Q ss_pred             ---------------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeeecCCcCCCCCCCch
Q psy10603        233 ---------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPA  282 (407)
Q Consensus       233 ---------------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~p~  282 (407)
                                     ..++..+.+|+..+|..||++|.|+.++|+|+||.  .....|+|..+|.
T Consensus       355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~--t~p~~~~p~~Lp~  417 (560)
T KOG0600|consen  355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT--TEPLPCDPSSLPK  417 (560)
T ss_pred             cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc--cCCCCCCcccCCC
Confidence                           23678899999999999999999999999999993  3445566666654

>KOG0582|consensus

Probab=100.00  E-value=6.7e-54  Score=392.59  Aligned_cols=263  Identities=30%  Similarity=0.506  Sum_probs=225.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.....+||.|.-++||+|+...+++.||||++..+++.+.  ...+.+|++.|+.++||||++++..|..+..+|+||.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            34455599999999999999999999999999999887665  6788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||.+|++.++++.. ..+++|..+..+++++++||.|||++|.||||||+.||||+.+| .|||+|||.+-.+.....+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeecccCcee
Confidence            99999999998763 56799999999999999999999999999999999999999986 69999999986665433332


Q ss_pred             Ccc-cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC-----CC---
Q psy10603        162 GEL-NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT-----IP---  232 (407)
Q Consensus       162 ~~~-~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----~~---  232 (407)
                      ... ++++||++|||||+++. +..+|+.|+||||||++..||++|..||........++.++. +..|.     ++   
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q-~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-n~pp~~~t~~~~~d~  261 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQ-QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-NDPPTLLTSGLDKDE  261 (516)
T ss_pred             eEeeccccCcccccChHHhhh-cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCCCCcccccCChHH
Confidence            222 77899999999999765 456789999999999999999999999997765554444443 33331     11   


Q ss_pred             -CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeeec
Q psy10603        233 -ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSC  270 (407)
Q Consensus       233 -~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~  270 (407)
                       ..++..++.++..||.+||.+|||+.++|+|+||....
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence             34677899999999999999999999999999996443

>KOG0661|consensus

Probab=100.00  E-value=1.6e-54  Score=399.44  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=211.7

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCc-eEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHRE-EMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~~lv~E~~~~   86 (407)
                      +||.|+||.||+|+..++|+.||||.++.....-++..  -+||++.|++++ |||||++.+++.+.+ .+|+|||||+.
T Consensus        17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~   94 (538)
T KOG0661|consen   17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC   94 (538)
T ss_pred             HhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh
Confidence            89999999999999999999999999976544333222  369999999999 999999999999888 99999999986


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                       +|.++++.++..|+|..++.|++||++||+|+|.+|+.|||+||||||+... ..+||+|||+|+......    ..+.
T Consensus        95 -NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~Skp----PYTe  168 (538)
T KOG0661|consen   95 -NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRSKP----PYTE  168 (538)
T ss_pred             -hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccccCC----Ccch
Confidence             9999998888889999999999999999999999999999999999999864 469999999999876543    3477


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH---HHhCCC----------------
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF---KVGMGE----------------  227 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~---~~~~~~----------------  227 (407)
                      ++-|.+|+|||+|...  ..|+.+.||||+||+++|+.+-++-|++..+..++..   .++...                
T Consensus       169 YVSTRWYRAPEvLLrs--~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf  246 (538)
T KOG0661|consen  169 YVSTRWYRAPEVLLRS--GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF  246 (538)
T ss_pred             hhhcccccchHHhhhc--cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence            8999999999999764  4578999999999999999999999997654433321   111100                


Q ss_pred             -CCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        228 -TPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       228 -~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                       .|.        +-.+++.++.++|.+||++||++|||+.|+|+||||...
T Consensus       247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence             011        113478999999999999999999999999999999744

>KOG0605|consensus

Probab=100.00  E-value=1.3e-53  Score=399.34  Aligned_cols=258  Identities=33%  Similarity=0.502  Sum_probs=214.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++....+||+|+||+||+|+.+.||+.||+|++++..-.....++....|..+|...++|+||++|..|++.+.+|||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            55566799999999999999999999999999987665566677888999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC-----
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH-----  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~-----  157 (407)
                      |++||++.-+|.. .+.|+|.++++|+.+++.|++-+|+.|+|||||||+|+|||..| ++||+|||||.-+...     
T Consensus       222 ylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  222 YLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             ecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhhhhhhh
Confidence            9999999999975 45699999999999999999999999999999999999999876 6999999998432110     


Q ss_pred             ----------------CCCCC-----------------------cccccccCCcccccccccccccCCCCcchhHHHHHH
Q psy10603        158 ----------------TTVPG-----------------------ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC  198 (407)
Q Consensus       158 ----------------~~~~~-----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv  198 (407)
                                      ...+.                       -..+.+|||-|||||++.+   .+|+..+|.|||||
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~---kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG---KGYGKECDWWSLGC  376 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc---CCCCccccHHHHHH
Confidence                            00010                       0113579999999999976   45789999999999


Q ss_pred             HHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCC--CccCHHHHHHHHHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        199 VLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIP--ESLSDEGQAFAELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       199 ~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~--~~~s~~~~~~i~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      |+|||+.|.+||...... +...++.. ...-.+|  ..+|++++|||.+||. ||++|..   ++||.+||||.
T Consensus       377 ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~  449 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFK  449 (550)
T ss_pred             HHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccc
Confidence            999999999999865433 33222221 1122222  4578999999999999 9999975   89999999996

>KOG0588|consensus

Probab=100.00  E-value=7.1e-54  Score=408.90  Aligned_cols=251  Identities=31%  Similarity=0.478  Sum_probs=223.3

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .+.||+|+-|.|-+|+|..||+..|||+|.+...........+.+||-+|+-++||||+++|++++++.++|+|+||+++
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g   96 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG   96 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence            45899999999999999999999999999876444444456688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |.|.+++-. ++.++|.+++++++||+.|+.|||..+|+||||||+|+|++.+++ +||+|||+|..-.++    ..+.+
T Consensus        97 GELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~g----klLeT  170 (786)
T KOG0588|consen   97 GELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPG----KLLET  170 (786)
T ss_pred             chhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCC----ccccc
Confidence            999999965 566999999999999999999999999999999999999999876 999999999654332    34577


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHh
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC  246 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~  246 (407)
                      .||+|.|.|||++++..  +.+.++||||.|||||.|+||+.||. .++-..++.++..|.. ..|..+|.++++|+.+|
T Consensus       171 SCGSPHYA~PEIV~G~p--YdG~~sDVWSCGVILfALLtG~LPFd-DdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~m  246 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRP--YDGRPSDVWSCGVILFALLTGKLPFD-DDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRM  246 (786)
T ss_pred             cCCCcccCCchhhcCCC--CCCCccccchhHHHHHHHHhCCCCCC-CccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHH
Confidence            89999999999998753  45899999999999999999999998 3556667777777655 45799999999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |..||++|.|+.|+++|||+.
T Consensus       247 l~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  247 LDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             hccCccccccHHHHhhCchhh
Confidence            999999999999999999985

>KOG0578|consensus

Probab=100.00  E-value=5.6e-54  Score=404.76  Aligned_cols=247  Identities=36%  Similarity=0.588  Sum_probs=220.8

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      +||+|+-|.||.|+...+++.||||++.+..+...   +-+++|+.+|+..+|+|||++++.|...+.+|+||||++||+
T Consensus       280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs  356 (550)
T KOG0578|consen  280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS  356 (550)
T ss_pred             hhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence            89999999999999999999999999998776654   457899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.+.+..  ..++|.+++.++++++.||+|||.+||+|||||.+|||++.+| .+||+|||+|.++.....   ...+.+
T Consensus       357 LTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~---KR~TmV  430 (550)
T KOG0578|consen  357 LTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQS---KRSTMV  430 (550)
T ss_pred             hhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccC---cccccc
Confidence            9999854  3489999999999999999999999999999999999999876 599999999988876543   345679


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHHHh
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC  246 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~~~  246 (407)
                      |||+|||||+...   ..|++++||||||++++||+.|.+||-. ++..+.+..+....+|.+  ++.+|+++++|+.+|
T Consensus       431 GTPYWMAPEVvtr---k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c  506 (550)
T KOG0578|consen  431 GTPYWMAPEVVTR---KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC  506 (550)
T ss_pred             CCCCccchhhhhh---cccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence            9999999999854   4589999999999999999999999986 445566666666666654  678999999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |+.|+++|+++.|+|+|||+..
T Consensus       507 L~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  507 LVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             hhcchhcCCCHHHHhcChhhhh
Confidence            9999999999999999999954

>KOG0192|consensus

Probab=100.00  E-value=4e-52  Score=391.94  Aligned_cols=249  Identities=28%  Similarity=0.451  Sum_probs=215.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcE-EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-eEEEEEec
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-EMVLFMEL   83 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~E~   83 (407)
                      ....+|+|+||+||+|.++.  +. ||+|++......+.. .+.|.+|+.+|.+++|||||+++|++.+.. .+++||||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            34479999999999998874  45 999999865544444 788999999999999999999999998887 79999999


Q ss_pred             CCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         84 CTEGTLESLVQS-TEDGLPEVLVRRYTKQLVDAISALHENT-IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        84 ~~~g~L~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~-iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      +++|+|.+++.. ....++...+..++.||+.|++|||+++ ||||||||+|||++.+..++||+|||+++......   
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---
Confidence            999999999977 3667999999999999999999999999 99999999999999865479999999998765421   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-hCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~  240 (407)
                      ...+...||+.|||||++.+. ...++.|+||||||+++|||+||+.||.+... .+....+ ..+.+|.+|..+++...
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~  276 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLS  276 (362)
T ss_pred             ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHH
Confidence            122346899999999999753 45689999999999999999999999998766 5555544 47788999999999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||..||++||++.|++.
T Consensus       277 ~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999864

>KOG0694|consensus

Probab=100.00  E-value=1.9e-52  Score=401.80  Aligned_cols=255  Identities=30%  Similarity=0.457  Sum_probs=222.9

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv   80 (407)
                      .++++..+||+|+||+|++|..+.+++.||||++++........++..+.|.+|+.-.+ ||.+++++..|++++++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            36788889999999999999999999999999999877666666788889999987665 99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+.||++..+.  ....|++..++.|+++|+.||+|||++|||+||||.+|||+|.+| .+||+|||+++....... 
T Consensus       448 mey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g~-  523 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQGD-  523 (694)
T ss_pred             EEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCCC-
Confidence            9999999954443  235599999999999999999999999999999999999999987 599999999987543322 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                        ...++||||.|||||++.+   ..|+.++|.|||||+||||+.|..||++.  +.+.++..+....+..|..+|.|+.
T Consensus       524 --~TsTfCGTpey~aPEil~e---~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--dEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  524 --RTSTFCGTPEFLAPEVLTE---QSYTRAVDWWGLGVLLYEMLVGESPFPGD--DEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             --ccccccCChhhcChhhhcc---CcccchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCCCCcccHHHH
Confidence              3467999999999999965   45789999999999999999999999853  3445555566677788999999999


Q ss_pred             HHHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      ++++++|.+||++|..     +.++.+||||.
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr  628 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR  628 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence            9999999999999985     47899999995

>KOG0033|consensus

Probab=100.00  E-value=4.7e-54  Score=365.46  Aligned_cols=249  Identities=27%  Similarity=0.434  Sum_probs=214.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      +||+|.|+.|+++.+..||+.+|+|++...+.... ..+.+.+|++|-+.|+||||+++.+...+....|||+|++.|++
T Consensus        18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d   96 (355)
T KOG0033|consen   18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   96 (355)
T ss_pred             HHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence            89999999999999999999999999986654333 45778999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |..-+-.+ ..++|..+..+++||++||.|||.+||||||+||+|+|+..+  +.-+||+|||+|..+....    ...+
T Consensus        97 l~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~----~~~G  171 (355)
T KOG0033|consen   97 LFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE----AWHG  171 (355)
T ss_pred             HHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc----cccc
Confidence            87655332 448999999999999999999999999999999999999754  3469999999999887322    3456


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC---CCCCCCccCHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFA  243 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~~~i  243 (407)
                      ++|||.|||||++..   .+|+..+||||-||+||-|+.|.+||.+.+ ...+..++..+.   .++.++.+++++++++
T Consensus       172 ~~GtP~fmaPEvvrk---dpy~kpvDiW~cGViLfiLL~G~~PF~~~~-~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv  247 (355)
T KOG0033|consen  172 FAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI  247 (355)
T ss_pred             ccCCCcccCHHHhhc---CCCCCcchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence            899999999999953   568999999999999999999999998533 334444554443   3345678999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++||..||.+|.|+.|.|+|||+.
T Consensus       248 rrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  248 RRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             HHHhccChhhhccHHHHhCCchhc
Confidence            999999999999999999999985

>KOG0659|consensus

Probab=100.00  E-value=5.3e-52  Score=356.98  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=212.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...+|+|.||.||+|++..||+.||||.|+..+..+ ......+|||+.|+.++|+||+.+.++|...+.+.||+||++.
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t   85 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT   85 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence            348999999999999999999999999998765433 2334578999999999999999999999999999999999985


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                       +|...++.....++..+++.|+.+++.||+|||++.|+||||||.|+|++++| .+||+|||+|+.+......   .+.
T Consensus        86 -dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~~---~~~  160 (318)
T KOG0659|consen   86 -DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNRI---QTH  160 (318)
T ss_pred             -cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCcc---ccc
Confidence             99999988777899999999999999999999999999999999999999876 5999999999988654322   233


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC-CC---------------
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE-TP---------------  229 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~-~~---------------  229 (407)
                      .+-|.+|.|||++.+.+  .|+..+||||.|||+.||+-|.+-|++..+-.|+..... .|. .+               
T Consensus       161 ~V~TRWYRAPELLfGsr--~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSR--QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ceeeeeccChHHhccch--hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            47799999999998764  478999999999999999999888876544444322111 111 11               


Q ss_pred             ----C-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        230 ----T-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       230 ----~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                          .     +-...++++.+|+..+|.+||.+|+|+.|+++|+||..
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                0     11235678899999999999999999999999999964

>KOG0597|consensus

Probab=100.00  E-value=7.9e-53  Score=394.68  Aligned_cols=254  Identities=33%  Similarity=0.480  Sum_probs=220.8

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +.+..-..||+|+||.||+|+.+.+.+.||||.+.+... .++..+.+.+|++|++.++|||||.++++|++..++|+|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            334444589999999999999999999999999987644 4455788999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||.| +|..++.. .+.+||+.++.++.|++.||.|||+++|+|||+||.|||+... +.+|+||||+|+.+..+..  
T Consensus        81 e~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~--  155 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTS--  155 (808)
T ss_pred             hhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCce--
Confidence            99987 99999965 5669999999999999999999999999999999999999874 5799999999998876543  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       -.+...|||.|||||+..+   .+|+..+|+|||||++|||++|++||.. .+-.++... +....+..|...|.++..
T Consensus       156 -vltsikGtPlYmAPElv~e---~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~-I~~d~v~~p~~~S~~f~n  229 (808)
T KOG0597|consen  156 -VLTSIKGTPLYMAPELVEE---QPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKS-ILKDPVKPPSTASSSFVN  229 (808)
T ss_pred             -eeeeccCcccccCHHHHcC---CCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHH-HhcCCCCCcccccHHHHH
Confidence             3456789999999999853   5678999999999999999999999974 233344444 444555567799999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+..+|.+||.+|.|-.+++.|||..
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k  255 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWK  255 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHh
Confidence            99999999999999999999999974

>KOG0580|consensus

Probab=100.00  E-value=8.9e-53  Score=356.77  Aligned_cols=255  Identities=26%  Similarity=0.452  Sum_probs=222.5

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .|++....||+|.||.||+|+.+.++-.||+|++.+.........+++.+|++|.+.|+||||+++|++|.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            47788889999999999999999999999999998765555555677899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ||.+.|++...++.. ...+++..+..|++|++.||.|||.++||||||||+|+|++.++ .+||+|||.+..-..    
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p~----  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS----  176 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecCC----
Confidence            999999999999743 34499999999999999999999999999999999999999876 699999999876431    


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       +...+.|||.-|.+||...+   ..++..+|+|++|++.||++.|.+||....  .....+.+....-.+|..+|.+++
T Consensus       177 -~kR~tlcgt~dyl~pEmv~~---~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~~~p~~is~~a~  250 (281)
T KOG0580|consen  177 -NKRKTLCGTLDYLPPEMVEG---RGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDLKFPSTISGGAA  250 (281)
T ss_pred             -CCceeeecccccCCHhhcCC---CCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccccCCcccChhHH
Confidence             23467899999999999854   457889999999999999999999998543  333333344445567899999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+|.+||.++|.+|.+..|++.|||+.
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHH
Confidence            999999999999999999999999984

>KOG0585|consensus

Probab=100.00  E-value=7.6e-52  Score=381.43  Aligned_cols=261  Identities=27%  Similarity=0.464  Sum_probs=210.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHH-----------HHHHHHHHHHHHhcCCCCCcceEEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR-----------FVKDMLVELRILEGINQKNLVKYYGVEI   72 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~   72 (407)
                      ++....||+|.||+|-+|++..+++.||||++.+.......           -.+...+||.||+++.|||||+|+++.-
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            34445899999999999999999999999999764321111           1246789999999999999999999976


Q ss_pred             e--CceEEEEEecCCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         73 H--REEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        73 ~--~~~~~lv~E~~~~g~L~~~~~~~~~~-~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      +  .+.+|||+|||..|.+...-.  ... +.+.+++.|+++++.||+|||.+|||||||||+|+|++.+| ++||+|||
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsDFG  255 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISDFG  255 (576)
T ss_pred             CcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeeccc
Confidence            5  457999999999999865432  233 89999999999999999999999999999999999999875 79999999


Q ss_pred             CceecCCCCCC--CCcccccccCCcccccccccccc-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC
Q psy10603        150 SAVKISAHTTV--PGELNGFVGTQAYMAPEVFMDTN-KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG  226 (407)
Q Consensus       150 la~~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~  226 (407)
                      .+.........  ...+...+|||.|||||++.+.. ....+.+.||||+||+||.|+.|+.||.+  +....++..+..
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~--~~~~~l~~KIvn  333 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD--DFELELFDKIVN  333 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--chHHHHHHHHhc
Confidence            99776332111  12234478999999999987633 44457899999999999999999999974  343444444444


Q ss_pred             CCCCCCCc--cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        227 ETPTIPES--LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       227 ~~~~~~~~--~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      ..-.+|..  +.++++++|.++|++||++|.+..++..|||+...
T Consensus       334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            44455554  78999999999999999999999999999998644

>KOG0201|consensus

Probab=100.00  E-value=2.5e-53  Score=388.52  Aligned_cols=252  Identities=32%  Similarity=0.590  Sum_probs=222.0

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|.+..+++.||+|+++.....+  .++.+.+|+.+|.+++++||.++|+.+.....++++||||.|
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g   95 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG   95 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence            348999999999999999999999999999875444  356788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |++.++++. ...+.|..+..++++++.||.|||+++.+|||||+.|||+..++ .+||+|||++.++......   ..+
T Consensus        96 Gsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~r---r~t  170 (467)
T KOG0201|consen   96 GSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKR---RKT  170 (467)
T ss_pred             cchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhc---ccc
Confidence            999999965 33358889999999999999999999999999999999999874 6999999999887654432   278


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHh
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC  246 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~  246 (407)
                      ++|||.|||||++..   .+|+.|+||||||++.+||++|.+|+..... ..+++.+-....|.+...+|+.+++|+..|
T Consensus       171 fvGTPfwMAPEVI~~---~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQ---SGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccccchhhhcc---ccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence            999999999999963   4688999999999999999999999987654 344455556667777788999999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      |.+||+.||++.++|+|+|+..+
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999998643

>KOG0611|consensus

Probab=100.00  E-value=5.6e-52  Score=375.25  Aligned_cols=252  Identities=28%  Similarity=0.494  Sum_probs=222.7

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      +...||+|.||+|.+|+....|+.||||.|++.+..+++..-.+.+||+||+.||||||+.+|++|++.+.+.|||||..
T Consensus        57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS  136 (668)
T KOG0611|consen   57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYAS  136 (668)
T ss_pred             HHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecC
Confidence            44589999999999999999999999999999988888888899999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|.|.+|+.. .+.++|.+++.+++||++|+.|||.++++|||||.+|||+|.++ .+||+|||++..+...    ..+.
T Consensus       137 ~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~----kfLq  210 (668)
T KOG0611|consen  137 GGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADK----KFLQ  210 (668)
T ss_pred             CccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhccc----cHHH
Confidence            9999999976 45599999999999999999999999999999999999999865 5999999999766433    3467


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      +|||+|.|.+||.+.+..  +-++.+|-|||||+||.|+.|..||.+.+ ...++.++..|.... |+ -+.++.-+|+.
T Consensus       211 TFCGSPLYASPEIvNG~P--Y~GPEVDsWsLGvLLYtLVyGtMPFDG~D-hk~lvrQIs~GaYrE-P~-~PSdA~gLIRw  285 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTP--YKGPEVDSWSLGVLLYTLVYGTMPFDGRD-HKRLVRQISRGAYRE-PE-TPSDASGLIRW  285 (668)
T ss_pred             HhcCCcccCCccccCCCC--CCCCccchhhHHHHHHHHhhcccccCCch-HHHHHHHhhcccccC-CC-CCchHHHHHHH
Confidence            899999999999997643  34789999999999999999999998654 555667777766543 22 34567889999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||..||++|.|+.++..|-|+..
T Consensus       286 mLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  286 MLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHhcCcccchhHHHHhhhheeec
Confidence            99999999999999999999863

>KOG0663|consensus

Probab=100.00  E-value=2.9e-51  Score=362.69  Aligned_cols=251  Identities=29%  Similarity=0.462  Sum_probs=210.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~E~~~~   86 (407)
                      .|++|+||.||+|++..|++.||+|.++..+. +..+--.-+|||.+|.+++|||||.+.++.+.  -+.+|||||||+.
T Consensus        83 rI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   83 RIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            89999999999999999999999999986653 22333345799999999999999999998764  4579999999986


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                       +|..++.+....|...+++.++.|++.|++|||.+.|+||||||+|+|+++.| .+||+|||+|+.+....   ...+.
T Consensus       162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~---k~~T~  236 (419)
T KOG0663|consen  162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPL---KPYTP  236 (419)
T ss_pred             -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhcCCc---ccCcc
Confidence             99999988877899999999999999999999999999999999999999876 59999999999887542   23566


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC-----------CC-----
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE-----------TP-----  229 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~-----------~~-----  229 (407)
                      .+-|.+|.|||+|.+.  ..|+.++||||+|||+.||+++++-|++.....|+-.... .|.           .|     
T Consensus       237 lVVTLWYRaPELLLG~--~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  237 LVVTLWYRAPELLLGA--KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             eEEEeeecCHHHhcCC--cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            7889999999999875  4579999999999999999999999987554433321111 110           00     


Q ss_pred             ------------CCCC-ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 ------------TIPE-SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ------------~~~~-~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                  .++. .+|+.+.+|++.+|.+||.+|.|+.|.|+|.||.
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence                        0111 2678999999999999999999999999999995

>KOG0660|consensus

Probab=100.00  E-value=2.2e-51  Score=368.46  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=211.0

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-----REEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~lv~E~   83 (407)
                      .||+|+||.|+.|.+..+|+.||||.+... ..+....++..||+++|+.++|+||+.+++++..     -+.+|+|+|+
T Consensus        29 ~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   29 PIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             cccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            699999999999999999999999998632 3345567889999999999999999999998765     2369999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      |+ -+|...++.. ..++++.+..+++|++.||+|+|+.+|+||||||+|+|++.+ ..+||+|||+|+..... .....
T Consensus       108 Me-tDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~-~~~~~  183 (359)
T KOG0660|consen  108 ME-TDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLARYLDKF-FEDGF  183 (359)
T ss_pred             Hh-hHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccceeecccc-Ccccc
Confidence            94 5899999753 349999999999999999999999999999999999999986 46999999999988765 34456


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--------------HHHh-----
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--------------FKVG-----  224 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--------------~~~~-----  224 (407)
                      .+.++.|.+|.|||++..  ...|+.+.||||.|||+.||++|++-|.+.+...|+-              .++.     
T Consensus       184 mTeYVaTRWYRAPElll~--~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  184 MTEYVATRWYRAPELLLN--SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             hhcceeeeeecCHHHHhc--cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            688999999999999854  3568999999999999999999999998754332221              1111     


Q ss_pred             -----CCCCCCCC-----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 -----MGETPTIP-----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 -----~~~~~~~~-----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                           ....|..|     ++.++.+.+++.+||..||.+|+|++|+|+|||+.
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~  314 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA  314 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence                 11122221     46789999999999999999999999999999986

>KOG4645|consensus

Probab=100.00  E-value=2e-53  Score=430.91  Aligned_cols=256  Identities=53%  Similarity=0.906  Sum_probs=237.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||.|.||.||.|.+..+|+..|+|.+..+... .+..+...+|..+|+.++|||+|++||+-.+++.++|.||||.+|+
T Consensus      1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             ccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            899999999999999999999999999766433 5556778899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC-CCCCccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGF  167 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~-~~~~~~~~~  167 (407)
                      |.++++. .+..+|...+.|..|++.|+.|||++|||||||||+|||++..| .+|++|||.|+.+..+. +.+++++..
T Consensus      1321 La~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1321 LASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred             HHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhcCCHHHHhh
Confidence            9999965 34467778889999999999999999999999999999999866 79999999999988765 567788899


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+-|||||++.+....+.+.++|||||||++.||+||+.||.+.+++.+++++++.|..|.+|+.+|.+.++|+.+||
T Consensus      1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl 1478 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCL 1478 (1509)
T ss_pred             cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHH
Confidence            99999999999998877788999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCcCCHHHHhcCCeee
Q psy10603        248 RHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.||++|.++.|+++|.|-.
T Consensus      1479 ~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1479 EQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             hcCchhhhHHHHHHHhhccc
Confidence            99999999999999999853

>KOG4279|consensus

Probab=100.00  E-value=1.6e-51  Score=393.20  Aligned_cols=254  Identities=39%  Similarity=0.659  Sum_probs=230.8

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      +||+|.||+||.|++..|...+|||.|..   .+.++.+-+..||.+.++|+|.|||++.|.+..++.+-|.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE---KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc---ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            99999999999999999999999999863   455677888999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         89 LESLVQSTEDGL--PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        89 L~~~~~~~~~~~--~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |..++++.-+.+  .|.++..|.+||++||.|||++.|||||||-+|+|++.-.+.+||+|||.++++..-..   ...+
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP---~TET  735 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP---CTET  735 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc---cccc
Confidence            999998876767  78999999999999999999999999999999999998778899999999988754321   2457


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC-CCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~~i~~  245 (407)
                      +.||+.|||||++.. +.-+|+.++|||||||++.||+||++||.+..+....++++++-. .|++|+.+|.+++.||.+
T Consensus       736 FTGTLQYMAPEvIDq-G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQ-GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             cccchhhhChHhhcc-CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            899999999999954 456799999999999999999999999999888888899887644 688999999999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      |+.+||.+||++.++|+.||+...
T Consensus       815 cFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HcCCCcccCccHHHhccCcccccC
Confidence            999999999999999999998644

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-50  Score=382.92  Aligned_cols=249  Identities=31%  Similarity=0.458  Sum_probs=211.5

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|++..+|+.||+|++.............+.+|+.+|.+++||||+++++.+...+.+|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            58999999999999999999999999986543344455678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   ......+
T Consensus        82 L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~---~~~~~~~  156 (323)
T cd05571          82 LFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG---ATMKTFC  156 (323)
T ss_pred             HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC---Cccccee
Confidence            9998865 44589999999999999999999999999999999999998765 69999999987532211   1224568


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR  248 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~  248 (407)
                      ||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+ ..... .........+|..+++++++++.+||+
T Consensus       157 gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~-~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         157 GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLF-ELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCccccChhhhcC---CCCCccccCcccchhhhhhhcCCCCCCCCC-HHHHH-HHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence            9999999999854   346889999999999999999999997533 22222 233334556788899999999999999


Q ss_pred             cCCCCcC-----CHHHHhcCCeee
Q psy10603        249 HDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       249 ~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +||++||     ++.++++||||.
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~  255 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFA  255 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcC
Confidence            9999999     899999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0032|consensus

Probab=100.00  E-value=4.8e-50  Score=380.96  Aligned_cols=251  Identities=31%  Similarity=0.470  Sum_probs=218.6

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..||+|.||.||+|+++.||+.+|+|.+.+......+....+.+|+.+|++++ |||||.+++++++.+.+++|||+|.|
T Consensus        41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G  120 (382)
T KOG0032|consen   41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG  120 (382)
T ss_pred             hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence            48999999999999999999999999998776655555677889999999999 99999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC---CeEEEEcccCceecCCCCCCCCc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~---~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      |+|.+.+...  .++|.++..+++|++.|+.|||+.||+||||||+|+|+....   ..+|++|||++......    ..
T Consensus       121 GeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~  194 (382)
T KOG0032|consen  121 GELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG----ER  194 (382)
T ss_pred             chHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC----ce
Confidence            9999998765  499999999999999999999999999999999999997653   26999999999887652    23


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEGQ  240 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~  240 (407)
                      ....+||+.|+|||++..   .+|+..+||||+||++|.|++|..||..... ......+..+..   ...++.+|+.++
T Consensus       195 ~~~~~Gtp~y~APEvl~~---~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-~~~~~~i~~~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  195 LHTIVGTPEYVAPEVLGG---RPYGDEVDVWSIGVILYILLSGVPPFWGETE-FEIFLAILRGDFDFTSEPWDDISESAK  270 (382)
T ss_pred             EeeecCCccccCchhhcC---CCCCcccchhHHHHHHHHHhhCCCCCcCCCh-hHHHHHHHcCCCCCCCCCccccCHHHH
Confidence            567899999999999954   4678999999999999999999999986543 333444544432   233567899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +|+.++|..||.+|+|+.++|+|||+..
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccC
Confidence            9999999999999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-50  Score=381.23  Aligned_cols=252  Identities=26%  Similarity=0.453  Sum_probs=215.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++......+.+..+.+.+|+.+|++++||||+++++.+...+..|+|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            45566699999999999999999999999999976543344455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....     
T Consensus        99 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~-----  171 (329)
T PTZ00263         99 FVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR-----  171 (329)
T ss_pred             CCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC-----
Confidence            9999999999875 44589999999999999999999999999999999999998765 6999999999765432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       ....+||+.|+|||++..   ..++.++|||||||++|||++|+.||.+. +..+....+.. ..+.+|..++.+++++
T Consensus       172 -~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~-~~~~~p~~~~~~~~~l  245 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQS---KGHGKAVDWWTMGVLLYEFIAGYPPFFDD-TPFRIYEKILA-GRLKFPNWFDGRARDL  245 (329)
T ss_pred             -cceecCChhhcCHHHHcC---CCCCCcceeechHHHHHHHHcCCCCCCCC-CHHHHHHHHhc-CCcCCCCCCCHHHHHH
Confidence             134579999999999864   34578999999999999999999999753 33333344433 3455678899999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +.+||++||.+|++     +.+++.||||.
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence            99999999999997     79999999985

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-49  Score=370.25  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=210.9

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+|.+++|+||+++++.+...+.+++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence            44589999999999999999999999999875543333334567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +|+|..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++.......    ..
T Consensus        84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~----~~  158 (285)
T cd05631          84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE----TV  158 (285)
T ss_pred             CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC----ee
Confidence            99998887543 34589999999999999999999999999999999999998764 69999999997754322    12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ....||+.|+|||++..   ..++.++|||||||++|||++|+.||......  ...............+..+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         159 RGRVGTVGYMAPEVINN---EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             cCCCCCCCccCHhhhcC---CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            34579999999999864   34678999999999999999999999854332  12222222233345567799999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +.+||++||.+||+     +.++++||||.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~  265 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFK  265 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence            99999999999997     89999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610|consensus

Probab=100.00  E-value=6.4e-50  Score=363.66  Aligned_cols=257  Identities=30%  Similarity=0.452  Sum_probs=218.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||.|.-|+||+|+...++..+|+|++.+......+...+...|.+||+.++||.++++|..++.+...|+|||||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            33448999999999999999999999999999877666677788889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC-------
Q psy10603         85 TEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-------  156 (407)
Q Consensus        85 ~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~-------  156 (407)
                      +||+|..+.+++. +.|++..+++|+.+++.||+|||-.|||.|||||+|||+..+| +|.|+||-|+....-       
T Consensus       160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~~~~Pt~~~s  238 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRCPVSPTLVKS  238 (459)
T ss_pred             CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccCCCCCeeecc
Confidence            9999999988754 4599999999999999999999999999999999999998876 699999998744210       


Q ss_pred             ----------------------C---C-C------------------C--CCcccccccCCcccccccccccccCCCCcc
Q psy10603        157 ----------------------H---T-T------------------V--PGELNGFVGTQAYMAPEVFMDTNKVGHGRA  190 (407)
Q Consensus       157 ----------------------~---~-~------------------~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~  190 (407)
                                            .   . .                  .  ....++++||-.|.|||++.+   .+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G---~GHgsA  315 (459)
T KOG0610|consen  239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG---EGHGSA  315 (459)
T ss_pred             CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec---CCCCch
Confidence                                  0   0 0                  0  012346889999999999965   567899


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC--ccCHHHHHHHHHhcccCCCCcCC----HHHHhcCC
Q psy10603        191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAELCLRHDPAQRAT----IFELLQHP  264 (407)
Q Consensus       191 ~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~~i~~~l~~dp~~R~t----~~e~l~hp  264 (407)
                      +|.|+|||.+|||+.|..||.+..+. +.+. ...+..+.+|+  .+|..++|||+++|.+||.+|..    +.||.+||
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~-NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNK-ETLR-NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCch-hhHH-HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence            99999999999999999999975444 3333 33344555553  57899999999999999999998    99999999


Q ss_pred             eee
Q psy10603        265 FLI  267 (407)
Q Consensus       265 ~~~  267 (407)
                      ||.
T Consensus       394 FF~  396 (459)
T KOG0610|consen  394 FFE  396 (459)
T ss_pred             ccc
Confidence            995

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-50  Score=373.75  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=214.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++......+.+..+.+.+|+.+|++++||||+++++.+.+.+.+|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            45566799999999999999999999999999975443344455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....     
T Consensus        82 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~-----  154 (291)
T cd05612          82 YVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR-----  154 (291)
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC-----
Confidence            9999999999875 34589999999999999999999999999999999999998765 6999999998765432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       ....+||+.|+|||++..   ..++.++|||||||++|+|++|+.||.... .......+.. ..+.+|..++++++++
T Consensus       155 -~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~~~~~~l  228 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQS---KGHNKAVDWWALGILIYEMLVGYPPFFDDN-PFGIYEKILA-GKLEFPRHLDLYAKDL  228 (291)
T ss_pred             -cccccCChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-CCcCCCccCCHHHHHH
Confidence             134579999999999854   346789999999999999999999998543 3333333332 3455677889999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +.+||+.||.+|++     +.|+++|||+.
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence            99999999999995     99999999985

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-50  Score=376.32  Aligned_cols=248  Identities=29%  Similarity=0.428  Sum_probs=210.5

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|+||+||+|++..+++.||+|++.............+.+|+.+|.+++||||+++++.+...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999754433444566788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccccc
Q psy10603         90 ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG  169 (407)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~g  169 (407)
                      .+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......+|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~~g  155 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDD---DKTNTFCG  155 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCC---CccccccC
Confidence            999865 44589999999999999999999999999999999999998765 69999999987543221   12245679


Q ss_pred             CCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhccc
Q psy10603        170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH  249 (407)
Q Consensus       170 t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~  249 (407)
                      |+.|+|||++.+   ..++.++|||||||++|||++|+.||.... ..+.... .......+|..+++++++++.+||++
T Consensus       156 t~~y~aPE~~~~---~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         156 TPEYLAPELLLG---HGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRK-ILQEPLRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CcccCCHHHHcC---CCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHH-HHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence            999999999854   346889999999999999999999997543 2233333 33345567888999999999999999


Q ss_pred             CCCCcC---CHHHHhcCCeee
Q psy10603        250 DPAQRA---TIFELLQHPFLI  267 (407)
Q Consensus       250 dp~~R~---t~~e~l~hp~~~  267 (407)
                      ||++||   ++.|++.|||+.
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcC
Confidence            999997   579999999985

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-49  Score=375.74  Aligned_cols=249  Identities=30%  Similarity=0.446  Sum_probs=211.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|++..+++.||+|++.............+.+|+++|+.++||||+++++.+...+.+|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            68999999999999999999999999976544344455678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   ......+
T Consensus        82 L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~---~~~~~~~  156 (328)
T cd05593          82 LFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA---ATMKTFC  156 (328)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc---ccccccc
Confidence            9988865 34589999999999999999999999999999999999998765 69999999987533221   1223467


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR  248 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~  248 (407)
                      ||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...+ ....... .......+|..+++++.+++.+||+
T Consensus       157 gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~Pf~~~~-~~~~~~~-~~~~~~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         157 GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFEL-ILMEDIKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             CCcCccChhhhcC---CCCCccCCccccchHHHHHhhCCCCCCCCC-HHHHHHH-hccCCccCCCCCCHHHHHHHHHHcC
Confidence            9999999999854   346789999999999999999999997533 2233332 3334456788899999999999999


Q ss_pred             cCCCCcC-----CHHHHhcCCeee
Q psy10603        249 HDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       249 ~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +||++|+     ++.|+++|||+.
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~  255 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFT  255 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcC
Confidence            9999997     899999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0599|consensus

Probab=100.00  E-value=1.1e-50  Score=349.91  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=214.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEecccc-----CcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ-----NDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+|.|..++|-++.++.+|+++|+|++.....     ...+.+++..+|+.||+++ .||+|+++.+.++.+..+++|+|
T Consensus        24 ilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFd  103 (411)
T KOG0599|consen   24 ILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFD  103 (411)
T ss_pred             HhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhh
Confidence            79999999999999999999999999975422     2334566778999999997 59999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      .|+.|.|.+++.+ .-.++|...+++++|+.+|++|||.++|+||||||+|||++++ ..+||+|||+|+.+....    
T Consensus       104 l~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~l~~Ge----  177 (411)
T KOG0599|consen  104 LMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQLEPGE----  177 (411)
T ss_pred             hcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeeccCCch----
Confidence            9999999999965 4459999999999999999999999999999999999999875 569999999999886543    


Q ss_pred             cccccccCCcccccccccc---cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-hCCC---CCCCCCcc
Q psy10603        163 ELNGFVGTQAYMAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGE---TPTIPESL  235 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~---~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~-~~~~---~~~~~~~~  235 (407)
                      .+...||||+|.|||.+..   .+..+|+..+|+||+|||+|.|+.|.+||.+.  .+..+.+. ..|.   ..+-+..+
T Consensus       178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--kQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--KQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--HHHHHHHHHHhcccccCCcchhhc
Confidence            3567899999999998853   34567899999999999999999999999853  22233333 3333   22335678


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |.+.+++|.+||+.||.+|.|++|+|+||||+
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            99999999999999999999999999999996

>KOG4717|consensus

Probab=100.00  E-value=3.4e-50  Score=373.16  Aligned_cols=254  Identities=31%  Similarity=0.476  Sum_probs=224.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .++.||+|.|+.|.+|+|.-||++||||+|++.+.. .-....+++|++.|+-++|||||++|++......+|||+|+=.
T Consensus        22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD  100 (864)
T KOG4717|consen   22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD  100 (864)
T ss_pred             hhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence            345899999999999999999999999999987543 3445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|.++|-+...++.|+.++.|++||+.|+.|||+..+|||||||+|+.+-.+-+.|||+|||++..+.+.    ..++
T Consensus       101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG----~kL~  176 (864)
T KOG4717|consen  101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG----KKLT  176 (864)
T ss_pred             CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----chhh
Confidence            999999998888889999999999999999999999999999999999887655557999999999777654    3468


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ++||++.|.|||.|.+.++  ..+++||||||||||.|++|++||....+... + ..++.....+|..+|.+++++|..
T Consensus       177 TsCGSLAYSAPEILLGDsY--DAPAVDiWSLGVILyMLVCGq~PFqeANDSET-L-TmImDCKYtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSY--DAPAVDIWSLGVILYMLVCGQPPFQEANDSET-L-TMIMDCKYTVPSHVSKECRDLIQS  252 (864)
T ss_pred             cccchhhccCchhhhcCcc--CCcchhhhHHHHHHHHHHhCCCccccccchhh-h-hhhhcccccCchhhhHHHHHHHHH
Confidence            8999999999999987543  46899999999999999999999997554433 2 334566778899999999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||..||.+|.+.+|+..|+|+..
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             HHhcCchhhccHHHHhccccccC
Confidence            99999999999999999999863

>KOG0589|consensus

Probab=100.00  E-value=2.6e-50  Score=377.71  Aligned_cols=252  Identities=31%  Similarity=0.548  Sum_probs=225.9

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce-EEEEEecCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE-MVLFMELCT   85 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~E~~~   85 (407)
                      ..++|+|+||.+++++++..++.|++|.|......+.. .+...+|+.++++++|||||.+++.++.++. ++|||+||+
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE   87 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence            34899999999999999999999999999987765543 4578899999999999999999999999998 999999999


Q ss_pred             CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ||++.+.+...+ ..|+|+.+..|+.|++.|+.|||++.|+|||||+.|||++.++ .|||+|||+|+.+.....   ..
T Consensus        88 Gg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~---~a  163 (426)
T KOG0589|consen   88 GGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPEDS---LA  163 (426)
T ss_pred             CCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCchh---hh
Confidence            999999997765 5699999999999999999999999999999999999999876 589999999999876542   23


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      .+.+|||.||+||++.+   .+|+.|+|||||||++|||++-+++|... +...+..++..+...++|...|.+++.+++
T Consensus       164 ~tvvGTp~YmcPEil~d---~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSD---IPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             heecCCCcccCHHHhCC---CCCCccCcchhhcchHHHHHhcccccCcc-chHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence            56799999999999955   56899999999999999999999999854 455677777777778889999999999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .||.++|+.||++.++|.+|.+.
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhh
Confidence            99999999999999999998764

>KOG0658|consensus

Probab=100.00  E-value=3.5e-50  Score=361.35  Aligned_cols=250  Identities=28%  Similarity=0.434  Sum_probs=205.5

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-----eEEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-----EMVLFM   81 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv~   81 (407)
                      ...+|.|+||.||.|...++++.||||.+-..+.-.       -+|+++|+.++|||||++.-+|....     ...+||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            348999999999999999999999999886443221       26999999999999999988776432     356899


Q ss_pred             ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||+|. +|...++.   ....++...++-|++||+.||.|||+.||+||||||.|+|+|.+.+.+||||||.|+.+..++
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            99986 88888864   245589999999999999999999999999999999999999998899999999999887554


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC----------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET----------  228 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~----------  228 (407)
                      .    ..++..|..|+|||++.+.  ..|+.+.||||.||++.||+-|++-|.+.+...|+...+..-..          
T Consensus       181 p----niSYicSRyYRaPELifga--~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  181 P----NISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             C----ceeEEEeccccCHHHHcCc--cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            2    2567889999999999875  45899999999999999999999999975544443322111001          


Q ss_pred             --------CC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeeec
Q psy10603        229 --------PT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSC  270 (407)
Q Consensus       229 --------~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~  270 (407)
                              |.         +....++++.+|+.++|+++|.+|.++.|++.||||-...
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                    11         2345789999999999999999999999999999996433

>KOG0986|consensus

Probab=100.00  E-value=1.1e-50  Score=371.54  Aligned_cols=277  Identities=28%  Similarity=0.458  Sum_probs=236.7

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      +||+|+||+||-|+.+.||+.||+|.+.+....+.+.....++|.++|++++.+.||.+-.+|++++.+|+||..|+||+
T Consensus       192 vlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGD  271 (591)
T KOG0986|consen  192 VLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGD  271 (591)
T ss_pred             EEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCc
Confidence            99999999999999999999999999987766665556678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         89 LESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        89 L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      |..+|.+. ..+|+|..++.|+.+|+.||++||+.+||.||+||+|||+|+.| +++|+|+|||..+.....    ..+.
T Consensus       272 LkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAvei~~g~~----~~~r  346 (591)
T KOG0986|consen  272 LKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAVEIPEGKP----IRGR  346 (591)
T ss_pred             eeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEEecCCCCc----cccc
Confidence            99888653 34799999999999999999999999999999999999999876 599999999999876543    3556


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      +||.+|||||++...   .|+..+|.|||||++|||+.|+.||.....  ..+.+.+.........++.+|++++++++.
T Consensus       347 vGT~GYMAPEvl~ne---~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~  423 (591)
T KOG0986|consen  347 VGTVGYMAPEVLQNE---VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEG  423 (591)
T ss_pred             cCcccccCHHHHcCC---cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHH
Confidence            999999999999653   378899999999999999999999975432  222344444455566789999999999999


Q ss_pred             hcccCCCCcC-----CHHHHhcCCeeeeecCCcCCCCCCCchhhHHhhhhcCccCCCCCcccccccCC
Q psy10603        246 CLRHDPAQRA-----TIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYAR  308 (407)
Q Consensus       246 ~l~~dp~~R~-----t~~e~l~hp~~~~~~~~~~~~~~~~p~~~~~~~l~~~~~~~~~s~~~i~~~~~  308 (407)
                      +|++||++|.     ++.++.+||||.               .+....+..+.+.||+.++.-.+|++
T Consensus       424 LL~Kdp~~RLGcrg~ga~evk~HpfFk---------------~lnw~rleagml~PPfiPdp~aVyak  476 (591)
T KOG0986|consen  424 LLTKDPEKRLGCRGEGAQEVKEHPFFK---------------DLNWRRLEAGMLEPPFIPDPGAVYAK  476 (591)
T ss_pred             HHccCHHHhccCCCcCcchhhhCcccc---------------cCCHhHHhccCCCCCCCCCccccchh
Confidence            9999999997     467899999994               23344566777888888887777776

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-49  Score=373.79  Aligned_cols=249  Identities=31%  Similarity=0.460  Sum_probs=210.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|++..+|+.||+|++.............+.+|++++++++||||+++++.+...+.+|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            68999999999999999999999999976543344455677889999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   .......
T Consensus        82 L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~---~~~~~~~  156 (323)
T cd05595          82 LFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG---ATMKTFC  156 (323)
T ss_pred             HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC---Ccccccc
Confidence            9988865 34589999999999999999999999999999999999998765 69999999987532221   1223467


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR  248 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~  248 (407)
                      ||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+. ......+ ......+|..+++++++++.+||+
T Consensus       157 gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~~-~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         157 GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI-LMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             CCcCcCCcccccC---CCCCchhchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHH-hcCCCCCCCCCCHHHHHHHHHHcc
Confidence            9999999999854   3467899999999999999999999975432 2222222 233445678899999999999999


Q ss_pred             cCCCCcC-----CHHHHhcCCeee
Q psy10603        249 HDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       249 ~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +||++|+     ++.++++||||.
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcC
Confidence            9999998     899999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-49  Score=376.22  Aligned_cols=252  Identities=27%  Similarity=0.439  Sum_probs=212.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCC-cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||.||+|.+..++ ..||+|.+...........+.+.+|+.++..++||||+++++++...+.+|+||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            3455669999999999999876655 689999987654434445667889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....    
T Consensus       111 Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~~----  184 (340)
T PTZ00426        111 EFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDTR----  184 (340)
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCCC----
Confidence            99999999999975 34599999999999999999999999999999999999998765 6999999999765422    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                        ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... .......+. .....+|..+++++++
T Consensus       185 --~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~i~-~~~~~~p~~~~~~~~~  257 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLN---VGHGKAADWWTLGIFIYEILVGCPPFYANE-PLLIYQKIL-EGIIYFPKFLDNNCKH  257 (340)
T ss_pred             --cceecCChhhcCHHHHhC---CCCCccccccchhhHHHHHhcCCCCCCCCC-HHHHHHHHh-cCCCCCCCCCCHHHHH
Confidence              234679999999999854   346789999999999999999999998543 222233333 3344567889999999


Q ss_pred             HHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++++||+.||++|+     ++.|+++||||.
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence            99999999999995     899999999985

>KOG0690|consensus

Probab=100.00  E-value=9.6e-51  Score=358.03  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=225.9

Q ss_pred             CCccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          1 MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         1 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      |+++.|.+.||+|.||+|-+|+.+.+++.||||++++........+...+.|-++|++.+||.+..+...|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            45677788999999999999999999999999999887766666677888999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||..||.|..++.+ ...++|+.++.|..+|+.||.|||+++||.||||.+|+|+|.+| ++||+|||+++.-..   .
T Consensus       247 MeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~---~  321 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIK---Y  321 (516)
T ss_pred             EEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhccc---c
Confidence            999999999999865 55699999999999999999999999999999999999999986 699999999976332   2


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      .....++||||.|+|||++.+   ..|++++|.|.+||++|||++|+.||.+.+.  ..++..+.-..-.+|..+|++++
T Consensus       322 g~t~kTFCGTPEYLAPEVleD---nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl~ed~kFPr~ls~eAk  396 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED---NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELILMEDLKFPRTLSPEAK  396 (516)
T ss_pred             cceeccccCChhhcCchhhcc---ccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHHhhhccCCccCCHHHH
Confidence            334578999999999999965   4689999999999999999999999985432  33444444455567999999999


Q ss_pred             HHHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      .++..+|.+||.+|.     .+.|+.+|+||.
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~  428 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA  428 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence            999999999999996     489999999985

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.5e-49  Score=380.52  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=209.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|++......+....+.+.+|+.+|++++||||+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            34566789999999999999999999999999986544445556778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC--
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--  160 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~--  160 (407)
                      |+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+......  
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccccc
Confidence            9999999999865 34589999999999999999999999999999999999998765 6999999997543210000  


Q ss_pred             ------------------------------------------CCcccccccCCcccccccccccccCCCCcchhHHHHHH
Q psy10603        161 ------------------------------------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC  198 (407)
Q Consensus       161 ------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv  198 (407)
                                                                .......+||+.|+|||++..   ..++.++|||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DiwSlG~  236 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR---KGYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC---CCCCCccceeehhh
Confidence                                                      000124579999999999854   34678999999999


Q ss_pred             HHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC--CccCHHHHHHHHHhc--ccCCCCcCCHHHHhcCCeee
Q psy10603        199 VLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQAFAELCL--RHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       199 ~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~~i~~~l--~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++|||++|+.||....................+|  ..+++++.+++.+++  ..+|.+|+++.|+++||||.
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~  309 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS  309 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence            9999999999998644332222222222223333  358999999999854  56666799999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0574|consensus

Probab=100.00  E-value=5.4e-52  Score=362.53  Aligned_cols=247  Identities=30%  Similarity=0.599  Sum_probs=217.0

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      +||+|+||.||+|.|+++|..+|||.+...     ..+++++.|+.||++++.|++|++||.+.....+|+|||||..|+
T Consensus        40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            899999999999999999999999988654     235789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      +.+.++.+++.++|.++..+++..+.||+|||...-||||||..|||++.+| ..||+|||.|.++....   ...++..
T Consensus       115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM---AKRNTVI  190 (502)
T KOG0574|consen  115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM---AKRNTVI  190 (502)
T ss_pred             HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhH---HhhCccc
Confidence            9999988888899999999999999999999999999999999999999986 69999999998765332   2346789


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHHHh
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC  246 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~~~  246 (407)
                      |||.|||||++..   .+|..++||||||++..||+.|++||.+...... ++.+-....|.+  |+.+|+++.+|++.|
T Consensus       191 GTPFWMAPEVI~E---IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-IFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  191 GTPFWMAPEVIEE---IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-IFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             cCcccccHHHHHH---hccchhhhHhhhcchhhhhhcCCCCcccccccce-eEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            9999999999954   5678999999999999999999999986554433 333333334433  677999999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |.++|++|.|+.++++|||+..
T Consensus       267 LiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             hcCCHHHHHHHHHHhhhhhhcC
Confidence            9999999999999999999853

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.9e-49  Score=371.86  Aligned_cols=251  Identities=29%  Similarity=0.441  Sum_probs=211.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++......+......+.+|..++..+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            589999999999999999999999999865444445556788899999888 7999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~---~~~~~~  156 (329)
T cd05588          82 DLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPG---DTTSTF  156 (329)
T ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCC---Cccccc
Confidence            99988865 35599999999999999999999999999999999999998765 69999999986532211   122456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------chHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-------SNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      +||+.|+|||++.+   ..++.++|+|||||++|+|++|+.||....       .......+........+|..++.++.
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  233 (329)
T cd05588         157 CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAS  233 (329)
T ss_pred             cCCccccCHHHHcC---CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence            89999999999854   346789999999999999999999996311       11223334444455667888999999


Q ss_pred             HHHHHhcccCCCCcCC------HHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRAT------IFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t------~~e~l~hp~~~  267 (407)
                      +++.+||++||.+|++      +.++++||||.
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            9999999999999987      78999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0594|consensus

Probab=100.00  E-value=8.7e-49  Score=352.80  Aligned_cols=252  Identities=30%  Similarity=0.515  Sum_probs=206.7

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC-cceEEEEEEeCc------eEEEE
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN-LVKYYGVEIHRE------EMVLF   80 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------~~~lv   80 (407)
                      ..||+|+||+||+|++..+|+.||+|+++..... +..-...++|+.+|+.++|+| |+.+++++.+.+      .+++|
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            3699999999999999999999999999876432 223345689999999999999 999999998877      89999


Q ss_pred             EecCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         81 MELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      +||+.. +|..++....   .+++...++.+++||+.||+|||+++|+||||||.|||++++| .+||+|||+|+...-.
T Consensus        96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAra~~ip  173 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLARAFSIP  173 (323)
T ss_pred             EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchHHHhcCC
Confidence            999975 9999997755   4688899999999999999999999999999999999999865 6999999999866532


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--------
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------  229 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--------  229 (407)
                      .   ...+.-++|.+|.|||++.+..  .|+..+||||+|||++||++++.-|.+..+..++......-.+|        
T Consensus       174 ~---~~yt~evvTlWYRaPEvLlGs~--~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  174 M---RTYTPEVVTLWYRAPEVLLGST--SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             c---ccccccEEEeeccCHHHhcCCC--cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            2   1245668999999999998753  47899999999999999999999998755433332111100011        


Q ss_pred             --------CC-----C-------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 --------TI-----P-------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 --------~~-----~-------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                              .+     +       ...++++.+++.+||+.||.+|.|+..+|+||||.
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~  306 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS  306 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence                    01     1       12335889999999999999999999999999985

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-48  Score=362.92  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=205.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .++.....||+|+||+||+|++..+++.||+|+++.....  .....+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            3455666999999999999999999999999998754322  22345678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~---  157 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPT---  157 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCC---
Confidence            99985 89888876555689999999999999999999999999999999999998765 69999999997643221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--HHHhCCC------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--FKVGMGE------------  227 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--~~~~~~~------------  227 (407)
                      .......||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||..........  .......            
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             ccccCceecccccChHHhcCC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            112345789999999998542  346789999999999999999999997644322211  1110000            


Q ss_pred             ------CCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 ------TPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 ------~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                            .|.        ....+++++++++.+||++||.+|||+.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                  000        113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-48  Score=370.01  Aligned_cols=249  Identities=28%  Similarity=0.445  Sum_probs=208.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++...........+.+.+|..++..+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            589999999999999999999999999754333333456677888888776 6999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~---~~~~~~  156 (320)
T cd05590          82 DLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNG---KTTSTF  156 (320)
T ss_pred             hHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCC---Cccccc
Confidence            999988654 4599999999999999999999999999999999999998865 69999999987543221   122446


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... .......+ ....+..|..+++++++++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~L  231 (320)
T cd05590         157 CGTPDYIAPEILQE---MLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAI-LNDEVVYPTWLSQDAVDILKAFM  231 (320)
T ss_pred             ccCccccCHHHHcC---CCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHHHH-hcCCCCCCCCCCHHHHHHHHHHc
Confidence            79999999999854   346789999999999999999999998543 33333333 33445567789999999999999


Q ss_pred             ccCCCCcCCH------HHHhcCCeee
Q psy10603        248 RHDPAQRATI------FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~------~e~l~hp~~~  267 (407)
                      ++||++|+++      .++++||||.
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~  257 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFK  257 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence            9999999998      8999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.5e-48  Score=374.12  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=208.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.............+.+|+.++.+++||||+++++.+.+.+.+|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            45666799999999999999999999999999976443344455678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC--
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--  160 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~--  160 (407)
                      ||++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+......  
T Consensus        82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          82 FLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCcccccccccccc
Confidence            9999999999965 45599999999999999999999999999999999999998765 6999999998754321100  


Q ss_pred             ------------------------------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy10603        161 ------------------------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW  210 (407)
Q Consensus       161 ------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf  210 (407)
                                                    .......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ---TGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC---CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                          001134589999999999854   34678999999999999999999999


Q ss_pred             CCCCchHHHHHHHhCC-CCCCCCC--ccCHHHHHHHHHhcc--cCCCCcCCHHHHhcCCeee
Q psy10603        211 AEYDSNYQIMFKVGMG-ETPTIPE--SLSDEGQAFAELCLR--HDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       211 ~~~~~~~~~~~~~~~~-~~~~~~~--~~s~~~~~~i~~~l~--~dp~~R~t~~e~l~hp~~~  267 (407)
                      .... .......+... ....+|.  .+++++++++.+++.  .++..||++.|+++||||.
T Consensus       237 ~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~  297 (363)
T cd05628         237 CSET-PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE  297 (363)
T ss_pred             CCCC-HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence            8543 33333333321 2223333  478999999998664  2334568999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.2e-49  Score=372.25  Aligned_cols=249  Identities=31%  Similarity=0.453  Sum_probs=210.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||+||+|++..+|+.||+|++.............+.+|++++..++||||+++++.+...+.+|+||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            58999999999999999999999999986544344455677889999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      |..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~---~~~~~~  156 (325)
T cd05594          82 LFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG---ATMKTF  156 (325)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC---cccccc
Confidence            9988865 3458999999999999999999997 7999999999999998765 69999999987543221   122346


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... ...... ........+|..+++++.+++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tG~~Pf~~~~-~~~~~~-~i~~~~~~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         157 CGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFE-LILMEEIRFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             cCCcccCCHHHHcc---CCCCCccccccccceeeeeccCCCCCCCCC-HHHHHH-HHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            79999999999854   346789999999999999999999997543 223333 3333445567889999999999999


Q ss_pred             ccCCCCcC-----CHHHHhcCCeee
Q psy10603        248 RHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++||++|+     ++.++++|||+.
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            99999997     899999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-48  Score=370.77  Aligned_cols=253  Identities=31%  Similarity=0.465  Sum_probs=211.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|++..+++.||+|++...........+.+.+|+.+|..++||||+++++.+...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            35566799999999999999999999999999976543333445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....      
T Consensus        82 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~------  153 (333)
T cd05600          82 YVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT------  153 (333)
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc------
Confidence            9999999999965 34589999999999999999999999999999999999998765 699999999976533      


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----CCCCCCC---Ccc
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GETPTIP---ESL  235 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~---~~~  235 (407)
                      .....+||+.|+|||++.+.   .++.++|||||||++|||++|..||...... +....+..    -..|...   ..+
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  229 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGK---GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKETLQRPVYDDPRFNL  229 (333)
T ss_pred             ccCCcccCccccChhHhcCC---CCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHHHHhccccccCCCCCcccccc
Confidence            22456799999999998643   4688999999999999999999999854322 22222211    1122221   256


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++.+++.+||..+|.+||++.|+++|||+.
T Consensus       230 s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         230 SDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             CHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence            89999999999999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-48  Score=377.50  Aligned_cols=258  Identities=28%  Similarity=0.399  Sum_probs=208.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+++.||+|++...........+.+.+|+.+|++++||||+++++.+.+.+.+|+||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            45566999999999999999999999999999764433445566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC-----
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-----  158 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~-----  158 (407)
                      |++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....     
T Consensus        83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          83 IPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCcccccccccccc
Confidence            9999999998653 4589999999999999999999999999999999999998765 69999999975331000     


Q ss_pred             ---------------------------------------CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHH
Q psy10603        159 ---------------------------------------TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV  199 (407)
Q Consensus       159 ---------------------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~  199 (407)
                                                             .........+||+.|+|||++..   ..++.++|||||||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DiwSlGvi  237 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR---TGYTQLCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC---CCCCCeeeEEechHH
Confidence                                                   00001124579999999999854   346889999999999


Q ss_pred             HHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC--CccCHHHHHHHHHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        200 LVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQAFAELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       200 l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~~i~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      +|||++|+.||.....................|  ..+++++.+++.+++ .||.+|++   +.|+++||||.
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  309 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK  309 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence            999999999998644332222222222222233  468999999998876 59999997   99999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.7e-48  Score=359.68  Aligned_cols=251  Identities=26%  Similarity=0.465  Sum_probs=208.1

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|+||+||+|.+..+++.||+|.+...........+.+..|+++|+.++||||+++.+.+..++.+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999998755433334456678899999999999999999999999999999999999999


Q ss_pred             HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         90 ESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ..++..   ....+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++..+.....   ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~---~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQS---KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCc---cccc
Confidence            887743   234589999999999999999999999999999999999998764 699999999976543221   1234


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ..||+.|+|||++.+   ..++.++|||||||++|||++|+.||......  ...............+..+++++.+++.
T Consensus       157 ~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (280)
T cd05608         157 YAGTPGFMAPELLQG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE  233 (280)
T ss_pred             cCCCcCccCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHH
Confidence            578999999999864   34678999999999999999999999754322  1122222223334556789999999999


Q ss_pred             HhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        245 LCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +||+.||++||     ++.++++||||.
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~  261 (280)
T cd05608         234 ALLAKDPEKRLGFRDGNCDGLRTHPLFR  261 (280)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence            99999999999     889999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.5e-48  Score=369.02  Aligned_cols=251  Identities=28%  Similarity=0.437  Sum_probs=210.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++.+....+....+.+.+|+.++.++ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            589999999999999999999999999866444555566788899988776 8999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~---~~~~~~  156 (329)
T cd05618          82 DLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG---DTTSTF  156 (329)
T ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC---Cccccc
Confidence            99988865 34599999999999999999999999999999999999998865 69999999987532211   122346


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------chHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-------SNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||....       ................+|..++.++.
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~  233 (329)
T cd05618         157 CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA  233 (329)
T ss_pred             cCCccccCHHHHcC---CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            89999999999854   346789999999999999999999995211       11223333444455667889999999


Q ss_pred             HHHHHhcccCCCCcCC------HHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRAT------IFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t------~~e~l~hp~~~  267 (407)
                      +++++||++||++|++      +.++++||||.
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~  266 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  266 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            9999999999999998      57999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=375.14  Aligned_cols=258  Identities=29%  Similarity=0.435  Sum_probs=210.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||||++......+......+.+|+.+|..++||||+++++.+.+.+.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            45566799999999999999999999999999976433344455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC-
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP-  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~-  161 (407)
                      |+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..+....... 
T Consensus        82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceeccccccccc
Confidence            9999999999865 34599999999999999999999999999999999999998865 69999999987653211000 


Q ss_pred             ----------------------------------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCC
Q psy10603        162 ----------------------------------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  207 (407)
Q Consensus       162 ----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~  207 (407)
                                                        ......+||+.|+|||++..   ..++.++|||||||++|||++|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ---TGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC---CCCCCeeeeecchhHHHHhhcCC
Confidence                                              00113479999999999854   34688999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHhCC-CCCCCCC--ccCHHHHHHHHHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        208 RPWAEYDSNYQIMFKVGMG-ETPTIPE--SLSDEGQAFAELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       208 ~Pf~~~~~~~~~~~~~~~~-~~~~~~~--~~s~~~~~~i~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      .||.... ..+....+... ....+|.  .+++++++++.+||. ||.+|++   +.|+++|||+.
T Consensus       237 ~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         237 PPFCSDN-PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCC-HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            9998543 33333333221 2222232  578999999999997 9999998   99999999985

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.8e-48  Score=363.05  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=204.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.......  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4555669999999999999999999999999987543221  22456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++ ++|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......   .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~---~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPS---H  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCC---c
Confidence            996 577777766556699999999999999999999999999999999999998765 69999999987543221   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--CCCC-----------C
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--MGET-----------P  229 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--~~~~-----------~  229 (407)
                      ......||+.|+|||++.+.  ..++.++|||||||++|+|++|..||.+..+....+..+.  .+..           +
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             cCCCCcccCCCCChHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            22345789999999998542  3467899999999999999999999986544333222111  0000           0


Q ss_pred             C---------CC---------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 T---------IP---------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ~---------~~---------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .         .+         ...++++++++.+||++||++|||+.|+++||||.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence            0         00         12457889999999999999999999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-48  Score=374.58  Aligned_cols=258  Identities=27%  Similarity=0.395  Sum_probs=211.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+++.||+|++......+....+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05596          45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY  124 (370)
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence            44556899999999999999999999999999754333333345577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|+|..++..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.........  .
T Consensus       125 ~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~~--~  199 (370)
T cd05596         125 MPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGMV--R  199 (370)
T ss_pred             CCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCcc--c
Confidence            999999999864  3489999999999999999999999999999999999998765 6999999999776432211  1


Q ss_pred             ccccccCCcccccccccccc-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC-CCCCCCC--ccCHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTN-KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIPE--SLSDEG  239 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~-~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~--~~s~~~  239 (407)
                      ....+||+.|+|||++.... ...++.++|||||||++|||++|+.||..... ......+... ....+|.  .+|.++
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            23467999999999986432 22367899999999999999999999985432 2333333222 2233444  579999


Q ss_pred             HHHHHHhcccCCCC--cCCHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQ--RATIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~--R~t~~e~l~hp~~~  267 (407)
                      ++++.+||+.+|.+  |+|+.|+++|||+.
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            99999999999988  99999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.8e-48  Score=366.71  Aligned_cols=249  Identities=28%  Similarity=0.465  Sum_probs=207.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|+++..........+.+..|..++.. .+||||+++++.+...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            68999999999999999999999999976533333344556677777764 58999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..+++. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~---~~~~~~  156 (316)
T cd05592          82 DLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGE---GKASTF  156 (316)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCC---Cccccc
Confidence            99998865 34599999999999999999999999999999999999998765 69999999997643222   123456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+ ..+....+ ....+.+|..+++++.+++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~G~~Pf~~~~-~~~~~~~i-~~~~~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         157 CGTPDYIAPEILKG---QKYNESVDWWSFGVLLYEMLIGQSPFHGED-EDELFDSI-LNDRPHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             cCCccccCHHHHcC---CCCCCcccchhHHHHHHHHHhCCCCCCCCC-HHHHHHHH-HcCCCCCCCCCCHHHHHHHHHHc
Confidence            89999999999854   346789999999999999999999998543 33333333 34566778889999999999999


Q ss_pred             ccCCCCcCCH-HHHhcCCeee
Q psy10603        248 RHDPAQRATI-FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~-~e~l~hp~~~  267 (407)
                      +.||++||++ .++++|||+.
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~  252 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFR  252 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccC
Confidence            9999999986 4788999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.3e-48  Score=367.14  Aligned_cols=249  Identities=28%  Similarity=0.391  Sum_probs=208.7

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++...........+.+..|.+++..+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            589999999999999999999999999764333334456677899998865 7999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......   ......
T Consensus        82 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~---~~~~~~  156 (321)
T cd05591          82 DLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNG---VTTTTF  156 (321)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCC---cccccc
Confidence            99988865 34589999999999999999999999999999999999998765 69999999987543221   122446


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+.. .....|..++.++.+++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         157 CGTPDYIAPEILQE---LEYGPSVDWWALGVLMYEMMAGQPPFEADN-EDDLFESILH-DDVLYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             ccCccccCHHHHcC---CCCCCccceechhHHHHHHhcCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHh
Confidence            79999999999854   346889999999999999999999998543 3333333333 344557778999999999999


Q ss_pred             ccCCCCcC-------CHHHHhcCCeee
Q psy10603        248 RHDPAQRA-------TIFELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~-------t~~e~l~hp~~~  267 (407)
                      ++||++|+       ++.++++|||+.
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~  258 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFK  258 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence            99999999       899999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0579|consensus

Probab=100.00  E-value=1.1e-49  Score=377.35  Aligned_cols=251  Identities=34%  Similarity=0.577  Sum_probs=221.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||.|+||+||+|.++.++-.-|-|+|...   ..+.++.++.||.||..+.||+||++++.|...+.+||+.|||+||-
T Consensus        39 ELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA  115 (1187)
T KOG0579|consen   39 ELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA  115 (1187)
T ss_pred             hhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence            689999999999999999988899998643   34567889999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      +..++-.....+++.++.-+++|++.||.|||+++|||||||..|||++.+| .++|+|||.+.+....   .....+|+
T Consensus       116 VDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t---~qkRDsFI  191 (1187)
T KOG0579|consen  116 VDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST---RQKRDSFI  191 (1187)
T ss_pred             HhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhH---Hhhhcccc
Confidence            9998877788899999999999999999999999999999999999999987 5999999998553221   12335789


Q ss_pred             cCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHH
Q psy10603        169 GTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAE  244 (407)
Q Consensus       169 gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~  244 (407)
                      |||+|||||+.+..  ...+|++++||||||++|.||+.+.+|-... +...++.++....+|.+  |..+|.++.||+.
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVllKiaKSePPTLlqPS~Ws~~F~DfLk  270 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK  270 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence            99999999998642  3456889999999999999999999998754 45567777777777765  7789999999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +||.+||..||++.++++|||+.
T Consensus       271 ~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  271 RCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             HHHhcCCccCCCHHHHhhCcccc
Confidence            99999999999999999999985

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-48  Score=375.67  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=208.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||||++......+....+.+.+|+++|.+++||||+++++++.+.+.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            34556789999999999999999999999999875433334455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC---
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT---  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~---  159 (407)
                      |+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....   
T Consensus        82 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          82 FLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeeccccccccccccccc
Confidence            9999999999865 45589999999999999999999999999999999999998765 699999999964321000   


Q ss_pred             ---------CC--------------------------------CcccccccCCcccccccccccccCCCCcchhHHHHHH
Q psy10603        160 ---------VP--------------------------------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC  198 (407)
Q Consensus       160 ---------~~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv  198 (407)
                               ..                                ......+||+.|+|||++..   ..++.++|||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGv  236 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ---QGYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc---CCCCCceeeEecch
Confidence                     00                                00013579999999999854   34688999999999


Q ss_pred             HHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCC--ccCHHHHHHHHHhcccCCCCc---CCHHHHhcCCeee
Q psy10603        199 VLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPE--SLSDEGQAFAELCLRHDPAQR---ATIFELLQHPFLI  267 (407)
Q Consensus       199 ~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~--~~s~~~~~~i~~~l~~dp~~R---~t~~e~l~hp~~~  267 (407)
                      ++|||++|..||..... ......+.. .....+|.  .++.++++++.+||+ +|.+|   +++.|+++|||+.
T Consensus       237 il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~  309 (377)
T cd05629         237 IMFECLIGWPPFCSENS-HETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR  309 (377)
T ss_pred             hhhhhhcCCCCCCCCCH-HHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence            99999999999975433 233333322 22233343  578999999999998 77765   5999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4e-48  Score=365.66  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||.||+|++..+|+.||+|+++..........+.+..|..++.. ++||||+++++.+...+.+|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            68999999999999999999999999975432222234556778888875 58999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~  156 (316)
T cd05620          82 DLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGD---NRASTF  156 (316)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCC---Cceecc
Confidence            99998865 34589999999999999999999999999999999999998765 69999999986532211   123456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+ ..+... ......+.+|..++.++++++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~el~~g~~Pf~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         157 CGTPDYIAPEILQG---LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-EDELFE-SIRVDTPHYPRWITKESKDILEKLF  231 (316)
T ss_pred             CCCcCccCHHHHcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHH-HHHhCCCCCCCCCCHHHHHHHHHHc
Confidence            79999999999864   346789999999999999999999997543 333333 3333456678889999999999999


Q ss_pred             ccCCCCcCCH-HHHhcCCeee
Q psy10603        248 RHDPAQRATI-FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~-~e~l~hp~~~  267 (407)
                      +.||++|+++ .++++||||.
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~  252 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFK  252 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcC
Confidence            9999999998 5788999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-47  Score=368.55  Aligned_cols=255  Identities=31%  Similarity=0.506  Sum_probs=209.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+++.||||++...  .+....+.+.+|+++|+.++|+||+++++++...+.+++||||
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34445899999999999999999999999998643  2344557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|+|...     ...++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+.....   .
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~---~  224 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMD---P  224 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccc---c
Confidence            999998643     2256788889999999999999999999999999999998765 699999999977643221   1


Q ss_pred             ccccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--chHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      .....||+.|+|||++...  .....+.++|||||||++|||++|+.||....  +.......+.....+..+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            2345799999999987432  11234568999999999999999999997322  2223334444555666778899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      ++|+.+||+.||++|||+.|+++|||+...
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            999999999999999999999999999643

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.7e-48  Score=364.37  Aligned_cols=254  Identities=28%  Similarity=0.406  Sum_probs=211.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK-NLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~E   82 (407)
                      +.+...||+|+||.||+|++..+++.||+|++.+.........+.+..|.+++..++|+ +|+.+++++...+.+|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            55677999999999999999999999999999765333334456788899999999875 58889999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......   .
T Consensus        82 ~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~---~  156 (324)
T cd05587          82 YVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGG---K  156 (324)
T ss_pred             CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCC---C
Confidence            9999999998865 34589999999999999999999999999999999999998765 69999999986532211   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+ ....+.+|..++.++.++
T Consensus       157 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~~i-~~~~~~~~~~~~~~~~~l  231 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGED-EDELFQSI-MEHNVSYPKSLSKEAVSI  231 (324)
T ss_pred             ceeeecCCccccChhhhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHH-HcCCCCCCCCCCHHHHHH
Confidence            2245679999999999854   346789999999999999999999997543 33333333 334556788899999999


Q ss_pred             HHHhcccCCCCcCCH-----HHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATI-----FELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~-----~e~l~hp~~~  267 (407)
                      +.+||.+||.+|++.     .++++|||+.
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~  261 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFR  261 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence            999999999999986     8999999985

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.8e-48  Score=369.02  Aligned_cols=260  Identities=30%  Similarity=0.387  Sum_probs=214.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            45667799999999999999999999999999986544344455678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++.....+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++..+......  
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~--  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANKMV--  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCCce--
Confidence            9999999999977656799999999999999999999999999999999999998765 6999999999876433221  


Q ss_pred             cccccccCCcccccccccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCC--CccC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTN---KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIP--ESLS  236 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~--~~~s  236 (407)
                      ......||+.|+|||++....   ...++.++|||||||++|||++|+.||...... .....+.. .....+|  ..++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcCCCccCCCCCCCCC
Confidence            123357899999999985321   234678999999999999999999999754332 22222222 1222223  3578


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++.+++..||. ||.+|||+.++++|||+.
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence            999999999998 999999999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-48  Score=359.36  Aligned_cols=256  Identities=31%  Similarity=0.474  Sum_probs=205.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            345667899999999999999999999999999754332 2345667899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++++++..+.+ ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .+||+|||++........  .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~--~  156 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSN--A  156 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCccccccccc--c
Confidence            999887766553 345699999999999999999999999999999999999998765 699999999977643221  1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-hCCC--------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGE--------------  227 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~-~~~~--------------  227 (407)
                      ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||............. ..+.              
T Consensus       157 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG---APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             cccccccccccCCcHHHcC---CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            2234578999999999854   336789999999999999999999998643322111100 0000              


Q ss_pred             -----CCC----------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 -----TPT----------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 -----~~~----------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                           .+.          ....+|+++.+|+++||++||++|||+.|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                 000          112368889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.6e-48  Score=371.86  Aligned_cols=259  Identities=26%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+..++.+|+||||
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY  124 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence            34455899999999999999999999999999754333333445677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|+|.+++...  .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........  ..
T Consensus       125 ~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~--~~  199 (370)
T cd05621         125 MPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGM--VR  199 (370)
T ss_pred             CCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCc--ee
Confidence            9999999998643  489999999999999999999999999999999999998765 699999999987643221  11


Q ss_pred             ccccccCCccccccccccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC-CCCCCCC--ccCHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIPE--SLSDEG  239 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~-~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~--~~s~~~  239 (407)
                      ....+||+.|+|||++..... ..++.++|||||||++|||++|+.||.... .......+... ....+|.  .++..+
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCcccCCCCcccCCHHH
Confidence            235679999999999865321 236789999999999999999999998543 22333333222 2233444  579999


Q ss_pred             HHHHHHhcccCCCC--cCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQ--RATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~--R~t~~e~l~hp~~~~  268 (407)
                      ++++..||..++.+  |+|+.|+++|||+..
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            99999999855543  889999999999853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-48  Score=375.46  Aligned_cols=259  Identities=28%  Similarity=0.370  Sum_probs=208.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.....||+|+||+||+|++..+++.||+|++...........+.+.+|+.+|..++||||+++++.+...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            34566779999999999999999999999999987543323334566789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC--
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT--  159 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~--  159 (407)
                      |||++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+.....  
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccccc
Confidence            99999999999965 44589999999999999999999999999999999999998765 699999999753310000  


Q ss_pred             --------------------------------------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHH
Q psy10603        160 --------------------------------------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  201 (407)
Q Consensus       160 --------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~  201 (407)
                                                            ........+||+.|||||++.+   ..++.++|||||||++|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvily  235 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR---TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC---CCCCcceeeeeccceee
Confidence                                                  0000123579999999999854   34678999999999999


Q ss_pred             HHHcCCCCCCCCCchHHHHHHHhC-CCCCCC--CCccCHHHHHHHHHhcccCCCCcC---CHHHHhcCCeee
Q psy10603        202 EMSSGKRPWAEYDSNYQIMFKVGM-GETPTI--PESLSDEGQAFAELCLRHDPAQRA---TIFELLQHPFLI  267 (407)
Q Consensus       202 em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~--~~~~s~~~~~~i~~~l~~dp~~R~---t~~e~l~hp~~~  267 (407)
                      ||++|+.||...... .....+.. .....+  ...+++++.+++.+|+ .+|.+|+   |+.|+++|||+.
T Consensus       236 ell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~  305 (376)
T cd05598         236 EMLVGQPPFLADTPA-ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK  305 (376)
T ss_pred             ehhhCCCCCCCCCHH-HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence            999999999864432 22222222 112222  2368999999999976 5999999   999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.4e-48  Score=363.36  Aligned_cols=249  Identities=27%  Similarity=0.428  Sum_probs=207.0

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||||+++..........+....|..++.. ++||||+++++++.+.+.+|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            68999999999999999999999999976432222234556778888875 59999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~  156 (316)
T cd05619          82 DLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGD---AKTCTF  156 (316)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCC---Cceeee
Confidence            999998653 4589999999999999999999999999999999999998765 69999999987542211   122446


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... ..+....+. ...+..|..++.++++++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         157 CGTPDYIAPEILLG---QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-EEELFQSIR-MDNPCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             cCCccccCHHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHH-hCCCCCCccCCHHHHHHHHHHh
Confidence            79999999999854   346889999999999999999999997543 333333333 3345667789999999999999


Q ss_pred             ccCCCCcCCHH-HHhcCCeee
Q psy10603        248 RHDPAQRATIF-ELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~~-e~l~hp~~~  267 (407)
                      ++||++|+++. ++++|||+.
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~  252 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFR  252 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccC
Confidence            99999999996 899999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0577|consensus

Probab=100.00  E-value=4.7e-49  Score=370.68  Aligned_cols=249  Identities=33%  Similarity=0.574  Sum_probs=219.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||.|+||.||-|++..+.+.||||.+...-....+.-+.++.|++.|.+++|||+|.+.|+|......|||||||- |+
T Consensus        33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GS  111 (948)
T KOG0577|consen   33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GS  111 (948)
T ss_pred             HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-cc
Confidence            79999999999999999999999999874322222334679999999999999999999999999999999999996 58


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      ..+++.-..+++-|..+..++.+.+.||.|||+.+.||||||..|||+++.| .|||+|||.|..+.+       .++|+
T Consensus       112 AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~P-------AnsFv  183 (948)
T KOG0577|consen  112 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMAP-------ANSFV  183 (948)
T ss_pred             HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcCc-------hhccc
Confidence            8888877677799999999999999999999999999999999999998765 799999999865542       36799


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC-ccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~~i~~~l  247 (407)
                      |||+|||||++.......|+-++||||||++..||+..++|+.+.. ....+..+.....|.++. .+|+.+..|+..||
T Consensus       184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            9999999999976666668889999999999999999999998653 445667777778888765 58999999999999


Q ss_pred             ccCCCCcCCHHHHhcCCeee
Q psy10603        248 RHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++-|.+|||..+++.|+|+.
T Consensus       263 qKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             hhCcccCCcHHHHhhcchhc
Confidence            99999999999999999985

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.5e-48  Score=365.40  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=205.8

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR-ILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+|+.||+|++...........+.+.+|.. +++.++||||+++++.+...+..|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            6899999999999999999999999997643333333455666655 467899999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..+++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~  156 (323)
T cd05575          82 ELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHS---KTTSTF  156 (323)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCC---Cccccc
Confidence            99998865 44589999999999999999999999999999999999998865 69999999986542221   123446


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|..||...+ ..+....+. .....++..+++++.+++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l  231 (323)
T cd05575         157 CGTPEYLAPEVLRK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNIL-NKPLRLKPNISVSARHLLEGLL  231 (323)
T ss_pred             cCChhhcChhhhcC---CCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHh
Confidence            79999999999854   346789999999999999999999998543 333333333 3344556678999999999999


Q ss_pred             ccCCCCcCCH----HHHhcCCeee
Q psy10603        248 RHDPAQRATI----FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~----~e~l~hp~~~  267 (407)
                      ++||.+||++    .|+++|||+.
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~  255 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFS  255 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcC
Confidence            9999999987    6999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0197|consensus

Probab=100.00  E-value=3.5e-48  Score=364.61  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=209.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|.||+||+|.++.+ ..||+|.+.......    +.|.+|+++|++|+|+|||++++++..++.+|||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            345556999999999999998754 369999987543322    567799999999999999999999998889999999


Q ss_pred             cCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQS-TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+.|+|.++++. .+..+...+...++.||++|++||+++++|||||-..|||++.+ ..+||+|||||+....+....
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccCCCceee
Confidence            9999999999986 45568899999999999999999999999999999999999886 479999999999554333221


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      ..  +.-=...|.|||.+..   ..++.|+|||||||+||||+| |+.||... ++.+++..+..|.+.+.|+.+|++.-
T Consensus       361 ~~--~~kfPIkWtAPEa~~~---~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~le~GyRlp~P~~CP~~vY  434 (468)
T KOG0197|consen  361 SE--GGKFPIKWTAPEALNY---GKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLELLERGYRLPRPEGCPDEVY  434 (468)
T ss_pred             cC--CCCCCceecCHHHHhh---CCcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHHHhccCcCCCCCCCCHHHH
Confidence            11  1111347999999965   347899999999999999998 89999865 56788899999999999999999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHh
Q psy10603        241 AFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      +++..||..+|++|||+..+.
T Consensus       435 ~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  435 ELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHhhCCcccCCCHHHHH
Confidence            999999999999999998654

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-47  Score=364.25  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++......+....+.+.+|+.++.++ +||||+.+++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            589999999999999999999999999865444455567788999999888 5999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~  156 (327)
T cd05617          82 DLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPG---DTTSTF  156 (327)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCC---Cceecc
Confidence            99988865 34599999999999999999999999999999999999998865 69999999987532211   122456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----chHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-----SNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|+.||....     +...............+|..++.++.++
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  233 (327)
T cd05617         157 CGTPNYIAPEILRG---EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV  233 (327)
T ss_pred             cCCcccCCHHHHCC---CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            89999999999854   346789999999999999999999996321     2223344444445556788899999999


Q ss_pred             HHHhcccCCCCcCC------HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT------IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t------~~e~l~hp~~~  267 (407)
                      +.+||++||++|++      +.++++||||.
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~  264 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFR  264 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence            99999999999998      56999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-47  Score=363.35  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=207.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHH---hcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL---EGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ....||+|+||+||+|.+..+++.||||++...........+.+.+|++++   ++++||||+++++++...+..|+|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            456899999999999999999999999999754322333445566666554   57789999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|..+++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   .
T Consensus        83 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~---~  156 (324)
T cd05589          83 YAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFG---D  156 (324)
T ss_pred             CCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCC---C
Confidence            9999999988753  4599999999999999999999999999999999999998865 69999999986532211   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... ..+....+.. ..+..|..+++++.++
T Consensus       157 ~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~G~~pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~~~~l  231 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTE---TSYTRAVDWWGLGVLIYEMLVGESPFPGDD-EEEVFDSIVN-DEVRYPRFLSREAISI  231 (324)
T ss_pred             cccccccCccccCHhHhcC---CCCCcccchhhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-CCCCCCCCCCHHHHHH
Confidence            2245689999999999854   346789999999999999999999998543 3333333332 3445678899999999


Q ss_pred             HHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +.+||++||++||     ++.++++||||.
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~  261 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFR  261 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence            9999999999999     689999999984

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-47  Score=362.71  Aligned_cols=249  Identities=29%  Similarity=0.417  Sum_probs=209.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||||++......+......+.+|.+++..+ +||||+++++++...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            589999999999999999999999999865333334456677899999877 6999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~  156 (318)
T cd05570          82 DLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGG---VTTSTF  156 (318)
T ss_pred             CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCC---Ccccce
Confidence            999988653 4599999999999999999999999999999999999998865 69999999986532211   112345


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.... ....... .....+.+|..+++++.+++.+||
T Consensus       157 ~g~~~y~aPE~~~~---~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~~-i~~~~~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         157 CGTPDYIAPEILSY---QPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQS-ILEDEVRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             ecCccccCHHHhcC---CCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHHH-HHcCCCCCCCcCCHHHHHHHHHHc
Confidence            79999999999854   346789999999999999999999997543 3233332 333455667889999999999999


Q ss_pred             ccCCCCcCCH-----HHHhcCCeee
Q psy10603        248 RHDPAQRATI-----FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~-----~e~l~hp~~~  267 (407)
                      .+||.+||++     .++++|||+.
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~  256 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFR  256 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            9999999999     9999999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-47  Score=364.08  Aligned_cols=258  Identities=30%  Similarity=0.456  Sum_probs=211.2

Q ss_pred             cceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||+||+|++.   .+++.||+|++...... .....+.+.+|+.+|..++ ||||+++++.+...+.++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            445668999999999999864   57899999998753222 2234456788999999995 899999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        82 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          82 LILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccccC
Confidence            99999999999999865 44599999999999999999999999999999999999998865 69999999997654322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--chHHHHHHHhCCCCCCCCCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      ..  .....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||....  .....+........+.++..++
T Consensus       160 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd05614         160 KE--RTYSFCGTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG  235 (332)
T ss_pred             CC--ccccccCCccccCHHHhcCC--CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence            11  12346799999999998542  335789999999999999999999996432  2222233333345566788899


Q ss_pred             HHHHHHHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +++++++.+||+.||++||     ++.++++|||+.
T Consensus       236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            9999999999999999999     788999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-47  Score=362.32  Aligned_cols=250  Identities=29%  Similarity=0.461  Sum_probs=207.6

Q ss_pred             eecccccCeEEEEEEEC---CCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          8 VSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQ-NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      ..||+|+||.||+|++.   .+++.||+|++..... .+......+.+|+.+|+.++||||+++++.+..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            36999999999999864   5788999999975322 1223345677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......   .
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~---~  156 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGT---V  156 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCC---c
Confidence            999999999865 44588999999999999999999999999999999999998765 699999999875432211   1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      ....+||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+.. ....+|..+++++.+++
T Consensus       157 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~li  231 (323)
T cd05584         157 THTFCGTIEYMAPEILMR---SGHGKAVDWWSLGALMYDMLTGAPPFTAEN-RKKTIDKILK-GKLNLPPYLTPEARDLL  231 (323)
T ss_pred             ccccCCCccccChhhccC---CCCCCcceecccHHHHHHHhcCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCHHHHHHH
Confidence            234579999999999854   345789999999999999999999998543 3333333333 34456788999999999


Q ss_pred             HHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      .+||++||++||     ++.++++|||+.
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence            999999999999     899999999985

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-47  Score=361.65  Aligned_cols=255  Identities=26%  Similarity=0.391  Sum_probs=211.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.+.........+.+..|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            355677999999999999999999999999999865433334455677888888777 4789999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~---  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDG---  155 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCC---
Confidence            999999999988653 4589999999999999999999999999999999999998865 69999999987543221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+. .....+|..++.++.+
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~-~~~~~~p~~~s~~~~~  230 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM-EHNVAYPKSMSKEAVA  230 (323)
T ss_pred             CccccCCCChhhcCHHHhcC---CCCCCccchhchhHHHHHHHhCCCCCCCCC-HHHHHHHHH-hCCCCCCCcCCHHHHH
Confidence            12245679999999999864   346889999999999999999999998543 333333333 3445667889999999


Q ss_pred             HHHHhcccCCCCcCCH-----HHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATI-----FELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~-----~e~l~hp~~~  267 (407)
                      ++.+||++||++|++.     .++++|||+.
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~  261 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  261 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence            9999999999999984     8899999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-48  Score=369.42  Aligned_cols=258  Identities=31%  Similarity=0.446  Sum_probs=211.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|++...........+.+.+|+.+|..++||||+++++.+.+.+.+|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            34556799999999999999999999999999976543333445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC----
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT----  158 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~----  158 (407)
                      |+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......    
T Consensus        82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCcccc
Confidence            99999999999764 5699999999999999999999999999999999999998865 69999999997654322    


Q ss_pred             ----------------------CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch
Q psy10603        159 ----------------------TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN  216 (407)
Q Consensus       159 ----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~  216 (407)
                                            ..........||+.|+|||++...   .++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT---PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCC---CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                  001122346799999999998653   4688999999999999999999999865432


Q ss_pred             HHHHHHHhC-CCCCCCC--CccCHHHHHHHHHhcccCCCCcCC-HHHHhcCCeee
Q psy10603        217 YQIMFKVGM-GETPTIP--ESLSDEGQAFAELCLRHDPAQRAT-IFELLQHPFLI  267 (407)
Q Consensus       217 ~~~~~~~~~-~~~~~~~--~~~s~~~~~~i~~~l~~dp~~R~t-~~e~l~hp~~~  267 (407)
                       .....+.. .....+|  ..+++++.+++.+||. ||.+|++ +.|+++|||+.
T Consensus       237 -~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         237 -ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             -HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence             22222222 1122222  2369999999999997 9999999 99999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.6e-47  Score=374.94  Aligned_cols=250  Identities=28%  Similarity=0.467  Sum_probs=197.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--------c
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--------E   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~   75 (407)
                      +.....||+|+||+||+|.+..+++.||||++....       ....+|+.+|+.++||||+++++++...        .
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            344458999999999999999999999999885321       1234699999999999999998876432        2


Q ss_pred             eEEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         76 EMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      .+++||||+++ +|..++..   ....+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||+|+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            47799999985 66665532   345689999999999999999999999999999999999998766679999999998


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC----
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE----  227 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~----  227 (407)
                      .+....    .....+||+.|+|||++.+.  ..++.++|||||||++|||++|.+||.+.....+....+. .+.    
T Consensus       220 ~~~~~~----~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        220 NLLAGQ----RSVSYICSRFYRAPELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             hccCCC----CcccCCCCcCccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            764322    12346789999999998542  3468899999999999999999999986443322211111 000    


Q ss_pred             ----------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 ----------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 ----------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                            ...+|...++++.+|+.+||++||.+|||+.|+++||||.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence                                  0113456788999999999999999999999999999985

>KOG0983|consensus

Probab=100.00  E-value=2.2e-48  Score=335.72  Aligned_cols=257  Identities=29%  Similarity=0.514  Sum_probs=222.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.+...||.|+.|.|++++.+.+|..+|||.+...  .+.+..++++..+.++...+ .|.||+.+|+|..+..+++.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            344455899999999999999999999999999754  44556788899998876654 799999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |.|.. -++.+++...+.+||..+-.+...+++||.||.. ++|||||+||+|||+|..|+ +||||||++.++....  
T Consensus       171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn-iKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN-IKLCDFGISGRLVDSK--  246 (391)
T ss_pred             HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC-EEeecccccceeeccc--
Confidence            99853 4666666666779999999999999999999976 58999999999999998764 9999999997765432  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC--ccCHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE--SLSDE  238 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~~  238 (407)
                        ..+...|.+.|||||.+.-.....|+.++||||||++++||+||..||.+.+...+.+.++...+.|.+|.  .+|+.
T Consensus       247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~  324 (391)
T KOG0983|consen  247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPD  324 (391)
T ss_pred             --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHH
Confidence              23445789999999999765566788999999999999999999999999888889999888888887764  48999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++|+..||.+|+.+||...++|+|||+.
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            99999999999999999999999999975

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.1e-47  Score=358.73  Aligned_cols=251  Identities=28%  Similarity=0.497  Sum_probs=207.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..++..+|+|.+...  ......+++.+|+++|++++||||+++++++..++..++||||
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            44455899999999999999999999999998754  2344567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++|+|.++++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++......     
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-----  157 (331)
T cd06649          85 MDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-----  157 (331)
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-----
Confidence            9999999999653 4589999999999999999999986 699999999999998865 6999999998765332     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH----------------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM----------------------  220 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~----------------------  220 (407)
                      ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+.. ...                      
T Consensus       158 ~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 MANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ccccCCCCcCcCCHhHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCccc
Confidence            1234579999999999854   34678999999999999999999999643221 111                      


Q ss_pred             ------------------------HHHhCCCCCCCC-CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        221 ------------------------FKVGMGETPTIP-ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       221 ------------------------~~~~~~~~~~~~-~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                              ..+.....+..+ ..+++++++|+.+||++||++|||+.|+++|||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                    001111122222 24688999999999999999999999999999985

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-47  Score=368.63  Aligned_cols=258  Identities=29%  Similarity=0.427  Sum_probs=209.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.............+.+|+.++.+++||||+++++.+...+.+|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            45566799999999999999999999999999975433334455678889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC---
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT---  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~---  159 (407)
                      |+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..+.....   
T Consensus        82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          82 FLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             CCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCccccccccccc
Confidence            9999999999865 44599999999999999999999999999999999999998765 699999999875432100   


Q ss_pred             -----------------------------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCC
Q psy10603        160 -----------------------------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW  210 (407)
Q Consensus       160 -----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf  210 (407)
                                                   ........+||+.|+|||++.+   ..++.++|||||||++|||++|+.||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ---TGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC---CCCCCcceeccccceeeecccCCCCC
Confidence                                         0001124579999999999854   34678999999999999999999999


Q ss_pred             CCCCchHHHHHHHhC-CCCCCCCC--ccCHHHHHHHHHhcccCCCCcC---CHHHHhcCCeee
Q psy10603        211 AEYDSNYQIMFKVGM-GETPTIPE--SLSDEGQAFAELCLRHDPAQRA---TIFELLQHPFLI  267 (407)
Q Consensus       211 ~~~~~~~~~~~~~~~-~~~~~~~~--~~s~~~~~~i~~~l~~dp~~R~---t~~e~l~hp~~~  267 (407)
                      ..... ......+.. .....+|.  .+++++++++.+++ .||.+|+   ++.|+++||||.
T Consensus       237 ~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         237 CSETP-QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CCCCH-HHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence            85433 233333322 12222333  47899999999977 4999998   479999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-48  Score=365.98  Aligned_cols=250  Identities=31%  Similarity=0.462  Sum_probs=204.8

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI---NQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ||+|+||+||+|++..+++.||||++................|..++..+   +||||+++++.+...+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999754333333445566777777665   699999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~---~~~~~  155 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDN---KTTNT  155 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCC---CCccC
Confidence            999998865 45599999999999999999999999999999999999998765 69999999986532221   12345


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHh
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC  246 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~  246 (407)
                      .+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||... +..+....+..+........+++++++++.+|
T Consensus       156 ~~gt~~y~aPE~~~~~--~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~  232 (330)
T cd05586         156 FCGTTEYLAPEVLLDE--KGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGL  232 (330)
T ss_pred             ccCCccccCHHHHcCC--CCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence            6899999999998542  33678999999999999999999999753 33333444443333222345799999999999


Q ss_pred             cccCCCCcC----CHHHHhcCCeee
Q psy10603        247 LRHDPAQRA----TIFELLQHPFLI  267 (407)
Q Consensus       247 l~~dp~~R~----t~~e~l~hp~~~  267 (407)
                      |++||.+||    ++.|+++|||+.
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCcccc
Confidence            999999998    789999999985

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.6e-47  Score=366.53  Aligned_cols=259  Identities=27%  Similarity=0.377  Sum_probs=208.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++..+++.+|+|++......+....+.+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  123 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            34555689999999999999999999999999875433333344567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........  
T Consensus       124 y~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~~--  198 (371)
T cd05622         124 YMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMV--  198 (371)
T ss_pred             CCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCcc--
Confidence            9999999999865  3489999999999999999999999999999999999998765 6999999999876432211  


Q ss_pred             cccccccCCccccccccccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC-CCCCCC--CccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIP--ESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~--~~~s~~  238 (407)
                      .....+||+.|+|||++..... ..++.++|||||||++|||++|+.||.... .......+... ....+|  ..++.+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCcccCCCcCCCCHH
Confidence            1235679999999999864321 236789999999999999999999998533 32333333222 122233  368999


Q ss_pred             HHHHHHHhcccCCCC--cCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQ--RATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~--R~t~~e~l~hp~~~  267 (407)
                      +++++..||..++.+  |+++.|+++|||+.
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence            999999999844433  78999999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-47  Score=353.41  Aligned_cols=253  Identities=27%  Similarity=0.425  Sum_probs=210.3

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||+||++.+..+++.||+|++.............+.+|+.++++++||||+++++.+..++.+++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence            34899999999999999999999999999754433333445678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         87 GTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        87 g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      |+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .++|+|||++.......    ...
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~----~~~  159 (285)
T cd05605          85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE----TIR  159 (285)
T ss_pred             CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC----ccc
Confidence            9999887543 34589999999999999999999999999999999999998764 69999999997754322    123


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH--HHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--QIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      ..+||+.|+|||++..   ..++.++||||+||++|||++|+.||.......  ..+........+..+..+++.+.+++
T Consensus       160 ~~~~~~~y~aPE~~~~---~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         160 GRVGTVGYMAPEVVKN---ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccCCCCccCcHHhcC---CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            4578999999999854   346789999999999999999999998543321  11222222334456677999999999


Q ss_pred             HHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      .+||..||++||     ++.++++|||+.
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            999999999999     899999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.9e-47  Score=362.26  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=201.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-----eEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-----EMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l   79 (407)
                      .....||+|+||.||+|++..+++.||||.+..... ......++.+|+.+|++++||||+++++++...+     .+|+
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            445689999999999999999999999999874322 2223456889999999999999999999876432     5899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||+ ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        82 v~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          82 VFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCccccccccccC
Confidence            999996 689888865 34589999999999999999999999999999999999998765 699999999976533222


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--H------------HH--
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--F------------KV--  223 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--~------------~~--  223 (407)
                      ........+||+.|+|||++.... ..++.++|||||||++|||++|+.||.......+..  .            .+  
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccc-cccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            112224568999999999985421 346789999999999999999999997543221110  0            00  


Q ss_pred             ---------hCCCCC-CC---CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        224 ---------GMGETP-TI---PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       224 ---------~~~~~~-~~---~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                               .....+ .+   ...+++++.+++.+||+.||++|||+.|+++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~  294 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK  294 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence                     000011 00   124678889999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-47  Score=359.40  Aligned_cols=261  Identities=28%  Similarity=0.394  Sum_probs=210.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.+....+....+.+.+|+.++..++||||+++++++.+.+.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            45667799999999999999999999999999975433334445668889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++..+......  
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~--  158 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADGTV--  158 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCCCc--
Confidence            9999999999976556699999999999999999999999999999999999998765 6999999999765432211  


Q ss_pred             cccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CC---CCCCCCccC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GE---TPTIPESLS  236 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~---~~~~~~~~s  236 (407)
                      .....+||+.|+|||++....  ...++.++|||||||++|||++|+.||.... ..+....+.. ..   .+.....++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~  237 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKEHFQFPPDVTDVS  237 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCcccCCCccCCCC
Confidence            112357999999999985321  2345789999999999999999999997543 2222222221 11   222234589


Q ss_pred             HHHHHHHHHhcccCCC--CcCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPA--QRATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~--~R~t~~e~l~hp~~~  267 (407)
                      +++++++.+||..++.  .|+++.++++|||+.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~  270 (331)
T cd05597         238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE  270 (331)
T ss_pred             HHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence            9999999998865444  378999999999984

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.1e-47  Score=350.55  Aligned_cols=250  Identities=27%  Similarity=0.418  Sum_probs=203.1

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|+||+||++++..+|+.||+|.+...........+.+..|+++|++++||||+++++.+..+..+|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999998653322222334556799999999999999999999999999999999999999


Q ss_pred             HHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         90 ESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        90 ~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      ..++... ...+++..+..++.|++.||+|||+.||+||||||+|||++.++ .+||+|||++.......    ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~----~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGK----TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCc----eeeccC
Confidence            8887543 33588999999999999999999999999999999999998765 69999999987664322    123457


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch---HHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN---YQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ||+.|+|||++...   .++.++|+|||||++|||++|+.||......   ............+.....+++++++++.+
T Consensus       156 ~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (277)
T cd05607         156 GTNGYMAPEILKEE---PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL  232 (277)
T ss_pred             CCCCccCHHHHccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence            89999999998543   3688999999999999999999999754322   12222222222222335689999999999


Q ss_pred             hcccCCCCcCCH----HHHhcCCeee
Q psy10603        246 CLRHDPAQRATI----FELLQHPFLI  267 (407)
Q Consensus       246 ~l~~dp~~R~t~----~e~l~hp~~~  267 (407)
                      ||++||++||++    .+++.||||.
T Consensus       233 ~L~~~P~~R~~~~~~~~~~~~h~~f~  258 (277)
T cd05607         233 FLAKKPEDRLGSREKNDDPRKHEFFK  258 (277)
T ss_pred             HhccCHhhCCCCccchhhhhcChhhc
Confidence            999999999999    6678999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.2e-47  Score=359.57  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=205.5

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR-ILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++......+....+.+.+|.. +++.++||||+++++.+...+..|+||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6899999999999999999999999997643333334455666664 578899999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~  156 (321)
T cd05603          82 ELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPE---ETTSTF  156 (321)
T ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCC---Cccccc
Confidence            99988865 44589999999999999999999999999999999999998865 69999999987532211   122456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++..   ..++.++|||||||++|||++|..||...+ ..+....+ ......+|...+.++.+++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l  231 (321)
T cd05603         157 CGTPEYLAPEVLRK---EPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNI-LHKPLQLPGGKTVAACDLLVGLL  231 (321)
T ss_pred             cCCcccCCHHHhcC---CCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHH-hcCCCCCCCCCCHHHHHHHHHHc
Confidence            79999999999854   346789999999999999999999997543 22333333 33345567788999999999999


Q ss_pred             ccCCCCcCCH----HHHhcCCeee
Q psy10603        248 RHDPAQRATI----FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~----~e~l~hp~~~  267 (407)
                      ++||.+|+++    .|+++|+|+.
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~  255 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFS  255 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcC
Confidence            9999999875    5999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.3e-47  Score=357.73  Aligned_cols=254  Identities=26%  Similarity=0.393  Sum_probs=210.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~E   82 (407)
                      +++...||+|+||+||+|++..+|+.||+|++...........+.+..|..++..+.| ++|+++++.+...+.+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            4667799999999999999999999999999975433333345667889999988865 678889999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   .
T Consensus        82 y~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~---~  156 (323)
T cd05615          82 YVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDG---V  156 (323)
T ss_pred             CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCC---c
Confidence            9999999999865 34599999999999999999999999999999999999999765 69999999987543221   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+. ......|..++.++.++
T Consensus       157 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~pf~~~~-~~~~~~~i~-~~~~~~p~~~~~~~~~l  231 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAY---QPYGKSVDWWAYGVLLYEMLAGQPPFDGED-EDELFQSIM-EHNVSYPKSLSKEAVSI  231 (323)
T ss_pred             cccCccCCccccCHHHHcC---CCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHH-hCCCCCCccCCHHHHHH
Confidence            2234679999999999854   346789999999999999999999998543 333333332 34455678899999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +.+||++||.+|++     ..++++||||.
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~  261 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFR  261 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence            99999999999997     47899999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.8e-47  Score=360.45  Aligned_cols=249  Identities=29%  Similarity=0.393  Sum_probs=205.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR-ILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+|+.||+|++......+....+.+.+|.. +++.++||||+++++.+...+.+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5899999999999999999999999997653333344455666665 467899999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~---~~~~~~  156 (325)
T cd05604          82 ELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQS---DTTTTF  156 (325)
T ss_pred             CHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCC---CCcccc
Confidence            99988865 44589999999999999999999999999999999999998865 69999999986532211   123456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|||++|..||...+ ..+....+.. ....++...+.++.+++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         157 CGTPEYLAPEVIRK---QPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMYDNILH-KPLVLRPGASLTAWSILEELL  231 (325)
T ss_pred             cCChhhCCHHHHcC---CCCCCcCccccccceehhhhcCCCCCCCCC-HHHHHHHHHc-CCccCCCCCCHHHHHHHHHHh
Confidence            79999999999854   346789999999999999999999998543 3333333333 233445578999999999999


Q ss_pred             ccCCCCcCCH----HHHhcCCeee
Q psy10603        248 RHDPAQRATI----FELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~----~e~l~hp~~~  267 (407)
                      ++||.+||++    .++++||||.
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~  255 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFE  255 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcC
Confidence            9999999976    5899999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.2e-47  Score=359.52  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=203.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR-ILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||+|++.............+.+|.. +++.++||||+++++.+...+.+|+||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            6899999999999999999999999997543322233344555554 568899999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......
T Consensus        82 ~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~---~~~~~~  156 (325)
T cd05602          82 ELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN---GTTSTF  156 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCC---CCcccc
Confidence            99999865 44588999999999999999999999999999999999998765 69999999987543211   123456


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.... .......+. .....++..+++++++++.+||
T Consensus       157 ~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l  231 (325)
T cd05602         157 CGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL-NKPLQLKPNITNSARHLLEGLL  231 (325)
T ss_pred             cCCccccCHHHHcC---CCCCCccccccccHHHHHHhcCCCCCCCCC-HHHHHHHHH-hCCcCCCCCCCHHHHHHHHHHc
Confidence            89999999999854   346789999999999999999999998543 333333332 2333456678999999999999


Q ss_pred             ccCCCCcCCHH----HHhcCCeee
Q psy10603        248 RHDPAQRATIF----ELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~~----e~l~hp~~~  267 (407)
                      ++||.+|+++.    ++++|+|+.
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~  255 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFS  255 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccC
Confidence            99999999875    899999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-46  Score=358.11  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=210.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||++++..+++.+|+|++.+.........+.+.+|+.++..++|+||+++++.+.+.+.+|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            45667799999999999999999999999999875433333344557789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++......+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++.........  
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~~~--  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTV--  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCCcc--
Confidence            9999999999976556699999999999999999999999999999999999998765 6999999999765432211  


Q ss_pred             cccccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC-C---CCCCCCccC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-E---TPTIPESLS  236 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~-~---~~~~~~~~s  236 (407)
                      .....+||+.|+|||++...  ....++.++|||||||++|||++|+.||.... ..+....+... .   .|..+..++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCccccCCCccccCC
Confidence            12345799999999998532  12346789999999999999999999998543 33333333222 1   233334679


Q ss_pred             HHHHHHHHHhcccCCCC--cCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQ--RATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~--R~t~~e~l~hp~~~  267 (407)
                      +++++++.+||..++.+  |+++.|+++||||.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~  270 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT  270 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence            99999999998655444  68999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-46  Score=341.38  Aligned_cols=257  Identities=32%  Similarity=0.620  Sum_probs=213.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||.||+|.+..+++.+|+|.+......  .....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            3445899999999999999999999999998754322  12234578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||+++..........
T Consensus        85 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~~~~~  162 (263)
T cd06625          85 YMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICSSGT  162 (263)
T ss_pred             ECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceeccccccccc
Confidence            99999999998653 4589999999999999999999999999999999999998754 699999999976543222111


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ......|+..|+|||++.+.   .++.++||||||+++|||++|+.||..................+.+|..++.++.++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         163 GMKSVTGTPYWMSPEVISGE---GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             cccCCCcCccccCcceeccC---CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence            12345688899999998653   367899999999999999999999976544333333333344566788899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+||.+||.+|||+.|+++||||
T Consensus       240 i~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         240 LRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-46  Score=358.06  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=201.7

Q ss_pred             cceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc-e
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE-E   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~-~   76 (407)
                      +.....||+|+||.||+|.+.     .+++.||+|++...  ......+.+.+|+.+|.++ +||||+++++++...+ .
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            345568999999999999752     44578999998643  2233456788999999999 8999999999877644 5


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-----------------------------------------------------------
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-----------------------------------------------------------   97 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-----------------------------------------------------------   97 (407)
                      +++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            899999999999999986421                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccc
Q psy10603         98 --DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMA  175 (407)
Q Consensus        98 --~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~a  175 (407)
                        ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........ .......+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDY-VRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcch-hcccCCCCCccccC
Confidence              2367788899999999999999999999999999999998764 6999999999765432211 11122345678999


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCc
Q psy10603        176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR  254 (407)
Q Consensus       176 PE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R  254 (407)
                      ||++.+   ..++.++|||||||++|||++ |..||...............+..+..|..+++++.+++.+||+.||++|
T Consensus       245 PE~~~~---~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         245 PESIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             cHHhhc---CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999854   346889999999999999997 9999986554444444455555666678899999999999999999999


Q ss_pred             CCHHHHhc
Q psy10603        255 ATIFELLQ  262 (407)
Q Consensus       255 ~t~~e~l~  262 (407)
                      ||+.|+++
T Consensus       322 Ps~~el~~  329 (338)
T cd05102         322 PTFSALVE  329 (338)
T ss_pred             cCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-46  Score=370.27  Aligned_cols=253  Identities=30%  Similarity=0.424  Sum_probs=212.9

Q ss_pred             eeeecccccCeEEEEEEECCC-CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNET-GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ....||+|+||.||+|.+..+ ++.||+|.+...   +......+.+|+.+|+.++||||+++++.+...+.+||||||+
T Consensus        71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            344899999999999998877 788999976532   3344456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++|+|.++++.   ....+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++.+..... .
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~~-~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDSVS-L  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCccc-c
Confidence            99999988753   233588999999999999999999999999999999999999765 699999999987643321 1


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||... +....+..+..+..+..|..+++++++
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWER---KRYSKKADMWSLGVILYELLTLHRPFKGP-SQREIMQQVLYGKYDPFPCPVSSGMKA  301 (478)
T ss_pred             ccccccCCCccccCHhHhCC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence            12345679999999999854   34688999999999999999999999753 344555555556666677889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+||.+||++||++.+++.|+|+.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHH
Confidence            99999999999999999999999874

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-46  Score=347.77  Aligned_cols=254  Identities=27%  Similarity=0.435  Sum_probs=210.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|.+..+++.||+|.+........+....+.+|+.++++++|+||+.+++.+...+.+++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            34589999999999999999999999999876544444445567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .++|+|||++........    .
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~----~  158 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQT----I  158 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCcc----c
Confidence            99999888543 33589999999999999999999999999999999999998765 699999999876543221    2


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ....||+.|+|||++..   ..++.++|||||||++|+|++|+.||......  ...............+..++++++++
T Consensus       159 ~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            34578999999999854   34678999999999999999999999854321  11222222222334567789999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +.+||+.||++|||     +.|+++||||.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence            99999999999999     89999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0667|consensus

Probab=100.00  E-value=8.3e-47  Score=362.70  Aligned_cols=248  Identities=33%  Similarity=0.544  Sum_probs=203.6

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-C-----CCcceEEEEEEeCceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-Q-----KNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~~~~lv   80 (407)
                      ...||+|+||.|-+|.+..|++.||||+++.    +..+..+...|+++|+.|+ |     -|+|+++++|..++++|||
T Consensus       191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEecccccceeEEEEecCCCcEEEEEeecc----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            3489999999999999999999999999973    4466777889999999998 4     3899999999999999999


Q ss_pred             EecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC-CeEEEEcccCceecCCCC
Q psy10603         81 MELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG-NSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~-~~vkl~DFGla~~~~~~~  158 (407)
                      +|.+.. +|.++++.. ..+++...++.++.||+.||..||+.+|||+|||||||||.+.+ ..|||+|||.|+..... 
T Consensus       267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-  344 (586)
T KOG0667|consen  267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-  344 (586)
T ss_pred             ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc-
Confidence            999964 999999764 45799999999999999999999999999999999999997543 46999999999875432 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCCC--------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETP--------  229 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~~--------  229 (407)
                           ..+++.+..|+|||++.+   .+|+.+.||||||||++||.+|.+.|++.....++...+. .|..|        
T Consensus       345 -----vytYiQSRfYRAPEVILG---lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  345 -----VYTYIQSRFYRAPEVILG---LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             -----ceeeeeccccccchhhcc---CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence                 236788999999999986   4578999999999999999999988886544333221110 00000        


Q ss_pred             -----------------------------------------CCC-C----------ccCHHHHHHHHHhcccCCCCcCCH
Q psy10603        230 -----------------------------------------TIP-E----------SLSDEGQAFAELCLRHDPAQRATI  257 (407)
Q Consensus       230 -----------------------------------------~~~-~----------~~s~~~~~~i~~~l~~dp~~R~t~  257 (407)
                                                               ..| .          .-...+.+|+++||.+||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                                                     011 0          112356899999999999999999


Q ss_pred             HHHhcCCeeee
Q psy10603        258 FELLQHPFLIV  268 (407)
Q Consensus       258 ~e~l~hp~~~~  268 (407)
                      .|+|+|||+..
T Consensus       497 ~qal~Hpfl~~  507 (586)
T KOG0667|consen  497 AQALNHPFLTG  507 (586)
T ss_pred             HHHhcCccccc
Confidence            99999999963

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.9e-47  Score=358.08  Aligned_cols=249  Identities=31%  Similarity=0.459  Sum_probs=207.1

Q ss_pred             eecccccCeEEEEEEE---CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          8 VSPGQGRFGKVYTAVN---NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ..||+|+||.||++++   ..+|+.||+|++..... .......+.+|+++|.+++||||+++++.+...+.+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            3699999999999986   46789999999975432 2223456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   ...
T Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~---~~~  155 (318)
T cd05582          81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHE---KKA  155 (318)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCC---Cce
Confidence            99999999865 34589999999999999999999999999999999999998765 69999999987653321   122


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ...+||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+.. ....+|..+++++++++.
T Consensus       156 ~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~i~~-~~~~~p~~~~~~~~~li~  230 (318)
T cd05582         156 YSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGSLPFQGKD-RKETMTMILK-AKLGMPQFLSPEAQSLLR  230 (318)
T ss_pred             ecccCChhhcCHHHHcC---CCCCCccceeccceEeeeeccCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCHHHHHHHH
Confidence            34679999999999854   345789999999999999999999997543 3333333332 334567789999999999


Q ss_pred             HhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        245 LCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +||++||++||+     +.+++.|||+.
T Consensus       231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~  258 (318)
T cd05582         231 ALFKRNPANRLGAGPDGVEEIKRHPFFS  258 (318)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence            999999999999     77799999984

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.5e-46  Score=370.59  Aligned_cols=257  Identities=28%  Similarity=0.361  Sum_probs=214.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--------   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------   75 (407)
                      +.....||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|+||+++++.+...+        
T Consensus        34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            3445599999999999999999999999999976533 3445567889999999999999999988765432        


Q ss_pred             eEEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         76 EMVLFMELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      .+++||||+++|+|.++++..   ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFGls~  191 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFGFSK  191 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecccCe
Confidence            378999999999999988642   23589999999999999999999999999999999999998865 69999999998


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP  232 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  232 (407)
                      .+...... ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||... +..........+..+.+|
T Consensus       192 ~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~---~~~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~~~~~~~~~~~~  266 (496)
T PTZ00283        192 MYAATVSD-DVGRTFCGTPYYVAPEIWRR---KPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTLAGRYDPLP  266 (496)
T ss_pred             eccccccc-cccccccCCcceeCHHHhCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCCCCCCC
Confidence            76432211 12245689999999999854   34688999999999999999999999853 344455555566666778


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+++++.+++.+||+.||.+||++.++++|||+.
T Consensus       267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~  301 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK  301 (496)
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHH
Confidence            89999999999999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.7e-46  Score=352.96  Aligned_cols=254  Identities=29%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|.+..+++.+|+|.+....  .....+.+.+|+++|++++||||+++++++..++.+++|||
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            3445568999999999999999999999999887542  33445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++|+|.++++. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++......    
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~----  157 (333)
T cd06650          84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----  157 (333)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh----
Confidence            9999999999965 34589999999999999999999985 799999999999998765 6999999998655322    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH----------------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI----------------------  219 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~----------------------  219 (407)
                       ......||+.|+|||++.+   ..++.++|+|||||++|+|++|+.||.........                      
T Consensus       158 -~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             -ccccCCCCccccCHHHhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence             1234578999999999854   34678999999999999999999999743221110                      


Q ss_pred             ---------------------HHHHhCCCCCCCCC-ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        220 ---------------------MFKVGMGETPTIPE-SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       220 ---------------------~~~~~~~~~~~~~~-~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                           ...+.....+.++. .+++++++|+.+||++||++|||+.|+++|||+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~  304 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  304 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence                                 01111112222222 36789999999999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0193|consensus

Probab=100.00  E-value=1.1e-47  Score=363.46  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=216.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+...+.||+|+||+||+|++..+   ||||++......++ ..+.|.+|+..+++.+|.||+-+.|++..++. .||..
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             Hhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            345566999999999999998754   99999987655444 77899999999999999999999999987776 99999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +|+|.+|..+++-.+..|...+.+.|++||++|+.|||.++|||||||..|||+..+ .+|||+||||+..-.-- ....
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w-~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRW-SGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeee-cccc
Confidence            999999999998777779999999999999999999999999999999999999876 57999999998542211 1223


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC----CCCccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT----IPESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~s~~  238 (407)
                      ......|...|||||+++.+...+|++.+|||||||++|||++|..||. ..+..++++.++.|+...    +-...+.+
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHH
Confidence            3455678899999999988888889999999999999999999999999 677788899998885332    22346679


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .++|+..||.+++++||++.++|.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999875

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.3e-46  Score=349.67  Aligned_cols=257  Identities=23%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .......||+|+||+||+|++..+++.||+|.+.......  ....+.+|+.++++++||||+++++++..++..++|||
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            3445568999999999999999999999999987543222  22456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++ +|..++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......   
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~---  159 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTK---  159 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCcc---
Confidence            9985 88888766555689999999999999999999999999999999999998765 699999999876433221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCC--------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMG--------------  226 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~--------------  226 (407)
                      ......+|+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.........  .......              
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccCCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            12334678999999988542  34678999999999999999999999754322111  1110000              


Q ss_pred             ----CCCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        227 ----ETPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       227 ----~~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                          ..+.        ....+++++++++.+||+.||.+|||+.|+++||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence                0000        11347889999999999999999999999999999963

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.1e-46  Score=345.80  Aligned_cols=243  Identities=21%  Similarity=0.282  Sum_probs=203.1

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEEEEec
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVLFMEL   83 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~E~   83 (407)
                      ..||+|++|.||+|..  +|+.||||.+...........+.+.+|+.+|.+++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            4899999999999987  588999999976555555556788899999999999999999999876    3478999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++.+....    
T Consensus       104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcccc----
Confidence            999999999975 34589999999999999999999984 899999999999998864 69999999987654321    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-hCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~  241 (407)
                        ....||+.|+|||++.+. ...++.++|||||||++|||++|+.||.... ..+....+ ..+..+..|..+++++++
T Consensus       178 --~~~~~~~~y~aPE~~~~~-~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDI-FSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             --ccccCcccccCHHHhhhc-cccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence              234688999999998542 1346889999999999999999999998653 33333333 334456667678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||+.||++|||+.|+++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999985

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-46  Score=355.63  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=209.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||++++..+++.||+|++.............+..|+.++..++|+||+++++.+...+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            45566799999999999999999999999999875333333344557789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|..++......+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++........  
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~--  158 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTV--  158 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCCce--
Confidence            9999999999976556699999999999999999999999999999999999998765 6999999999776433211  


Q ss_pred             cccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCC---CccC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIP---ESLS  236 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~---~~~s  236 (407)
                      .....+||+.|+|||++....  ...++.++|||||||++|||++|+.||.... ..+....+.. .....+|   ..++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~~  237 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHEERFQFPSHITDVS  237 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-HHHHHHHHHcCCCcccCCCccccCC
Confidence            112357999999999985421  1235789999999999999999999997543 2233333322 2222233   3478


Q ss_pred             HHHHHHHHHhcccCCCC--cCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQ--RATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~--R~t~~e~l~hp~~~  267 (407)
                      +++++++.+||..++.+  |+++.++++||||.
T Consensus       238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~  270 (331)
T cd05624         238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE  270 (331)
T ss_pred             HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence            99999999999876654  56899999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0586|consensus

Probab=100.00  E-value=3e-47  Score=362.23  Aligned_cols=374  Identities=24%  Similarity=0.327  Sum_probs=267.9

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|.|++|.+|++..++..||||++++.. .+...++.+.+|+++|..++|||||+++.+.+.+..+|+||||+.+
T Consensus        61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~-ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ-LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeccceeEEEEeeEecCCCceEEEEEehhcc-cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            348999999999999999999999999998764 4555556689999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |.+.+++.+ ++...+..++.++.|++.|++|||+++|+|||||.+||||+.+ ..+||+|||++..+....    ...+
T Consensus       140 ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~----~lqt  213 (596)
T KOG0586|consen  140 GELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGL----MLQT  213 (596)
T ss_pred             chhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeecccc----cccc
Confidence            999999976 4447789999999999999999999999999999999999876 459999999998876432    3567


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHh
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC  246 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~  246 (407)
                      +||++.|.|||++.+..  ..++.+|+||+|+++|.|+.|.+||.+.. -.....++. .....+|-.+|-+++++|+++
T Consensus       214 ~cgsppyAaPEl~~g~~--y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr~rvl-~gk~rIp~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKK--YDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELRPRVL-RGKYRIPFYMSCDCEDLLRKF  289 (596)
T ss_pred             cCCCCCccChHhhcCcc--cCCcceehhhhhhhheeeeecccccCCcc-cccccchhe-eeeecccceeechhHHHHHHh
Confidence            89999999999997654  45899999999999999999999998532 111111222 223356788999999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeeeecCCcCCCCCCCchhhH---Hhh---hhcCccCCCCCccccccc-----CCccEEEec
Q psy10603        247 LRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVL---QDY---LKLGIVLPPMSEDSVKVY-----ARANIFLTA  315 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~p~~~~---~~~---l~~~~~~~~~s~~~i~~~-----~~~nill~~  315 (407)
                      |.++|.+|+++++++.|.|+........+.|...+...+   .++   ...+.. ....++++..+     ....+++..
T Consensus       290 lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~~~m~~~G~~-~~~i~~sL~~~k~d~i~a~y~ll~~  368 (596)
T KOG0586|consen  290 LVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRILHMNSIGHR-RLKIEESLAKQKFDDINATYLLLGY  368 (596)
T ss_pred             hccCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHHHHHHhhccc-hhhHHHHHhhhhHHHHHHHHhhcch
Confidence            999999999999999999987544443444333221111   111   011110 01111111111     111222322


Q ss_pred             -CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC-CCCCCCCcee
Q psy10603        316 -EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-KTNLSGVVVS  393 (407)
Q Consensus       316 -~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g-~~~~~~~~~~  393 (407)
                       .......+|++. ..+...    ......++++.|..++.+.....  .+...+-|+.+.+.++.+.. +.++...--+
T Consensus       369 ~~~~s~~~~~~~~-~~~~~~----~~~~~~~~s~~~~~~d~~~p~~~--~~~~~~~~~~~~~~~s~~~e~~~~a~~~~~~  441 (596)
T KOG0586|consen  369 RKQRSIESADFGL-KTIELN----YMCSARCGSPDYVSVDRLMPVPY--DGHLTDTWDGSVILYSLLDEDRLPARDLPNA  441 (596)
T ss_pred             hhhccchhhhcCC-Cccccc----cccccccCCCCcccccccCCCCc--ccccccccccCccchhhhhcccCCCCCcccc
Confidence             122344556654 221111    11112245555666666543322  24557899999999999987 7777766555


Q ss_pred             eEEEec
Q psy10603        394 AEVFGS  399 (407)
Q Consensus       394 ~~~~~~  399 (407)
                      ..+.++
T Consensus       442 s~~~~~  447 (596)
T KOG0586|consen  442 SARSRS  447 (596)
T ss_pred             cccccc
Confidence            554443

>KOG0584|consensus

Probab=100.00  E-value=1.7e-47  Score=364.34  Aligned_cols=254  Identities=26%  Similarity=0.506  Sum_probs=220.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce--EEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE--MVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lv~   81 (407)
                      .|..+||+|+|-+||+|.+..+|.+||--.++... ...++..++|..|+.+|+.|+|||||++|+++.+...  +-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34559999999999999999999999965554332 2345667899999999999999999999999987654  88999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN--TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |++..|+|..|+++ .+.+....++.|++||+.||.|||++  .|||||||++||||+...+.|||+|+|||..+.... 
T Consensus       123 EL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            99999999999976 44488999999999999999999997  599999999999999887899999999998765432 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC-CCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~  238 (407)
                          ....+|||.|||||++.    ..|...+||||||++++||+|+..||.+..+..++..++..|..|.- ..--.++
T Consensus       201 ----aksvIGTPEFMAPEmYE----E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe  272 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE----ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE  272 (632)
T ss_pred             ----cceeccCccccChHHHh----hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence                23468999999999983    35789999999999999999999999999999999999999988753 3333689


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      .++||.+||.. .++|+|+.|+|.||||...
T Consensus       273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  273 VREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99999999999 9999999999999999743

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.1e-46  Score=358.72  Aligned_cols=256  Identities=26%  Similarity=0.386  Sum_probs=204.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-----eEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-----EMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~   78 (407)
                      +.....||+|+||+||+|.+..+++.||+|.+.... .+....+++.+|+++|+.++||||+++++++...+     ..|
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            445668999999999999999999999999986432 23334567889999999999999999999988776     799


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+. ++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCc
Confidence            9999997 578777754 44589999999999999999999999999999999999998765 69999999997654322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH---------------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV---------------  223 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~---------------  223 (407)
                      .  .......+|+.|+|||++.+.  ..++.++|||||||++|||++|+.||.......+.....               
T Consensus       158 ~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         158 S--KHMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             c--ccCCCCCcCCCcCCHHHHcCC--CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            1  122345789999999998643  235789999999999999999999997644322111000               


Q ss_pred             --------hCCCC-C------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        224 --------GMGET-P------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       224 --------~~~~~-~------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                              ..... +      .+....++++.+|+.+||+.||++|||+.|+++|||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  292 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD  292 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence                    00111 1      12344688999999999999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.8e-46  Score=345.71  Aligned_cols=252  Identities=27%  Similarity=0.484  Sum_probs=195.0

Q ss_pred             cceeeecccccCeEEEEEEECC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc---CCCCCcceEEEEEEe-----C
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-TGELVAMKEIQLHKQNDARFVKDMLVELRILEG---INQKNLVKYYGVEIH-----R   74 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~---l~hpniv~~~~~~~~-----~   74 (407)
                      +.....||+|+||+||+|++.. +++.||+|.+......+ .....+.+|+.+++.   ++||||+++++++..     .
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            3455689999999999999864 46889999987543322 122345566666655   479999999998752     4


Q ss_pred             ceEEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         75 EEMVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        75 ~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      ..+++||||++ ++|..++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  159 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARI  159 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceEe
Confidence            46899999997 5888888653 34589999999999999999999999999999999999998765 699999999976


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC----C-
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE----T-  228 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~----~-  228 (407)
                      .....    ......||+.|+|||++..   ..++.++|||||||++|||++|++||........ +..+....    . 
T Consensus       160 ~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~  231 (290)
T cd07862         160 YSFQM----ALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE  231 (290)
T ss_pred             ccCCc----ccccccccccccChHHHhC---CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChh
Confidence            54321    2244578999999999854   3467899999999999999999999986443222 21111000    0 


Q ss_pred             ----------------C-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        229 ----------------P-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       229 ----------------~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                      +     .+...+++.+++++.+||+.||++|||+.|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                            0     0113467888999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-45  Score=355.23  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=196.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~l   79 (407)
                      ....||+|+||.||+|++..+|+.||+|++.... .+....+.+.+|+.+++.++||||+++++++...+      .+|+
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  103 (359)
T cd07876          25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL  103 (359)
T ss_pred             EEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence            3448999999999999999999999999986543 23344567789999999999999999999886543      5799


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++ +|...+.   ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus       104 v~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~-  177 (359)
T cd07876         104 VMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNF-  177 (359)
T ss_pred             EEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCc-
Confidence            9999976 5655553   2388999999999999999999999999999999999998865 69999999997543221 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH----------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV----------------  223 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~----------------  223 (407)
                         ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...+.........                
T Consensus       178 ---~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         178 ---MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ---cCCCCcccCCCCCchhccC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence               1234578999999999854   346789999999999999999999998543221110000                


Q ss_pred             ----hCCCCCC--------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        224 ----GMGETPT--------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       224 ----~~~~~~~--------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                          .....+.                    .+...++++++|+.+||+.||++|||+.|+++|||+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                0000000                    1122467899999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-45  Score=342.87  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=210.7

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|.+..+++.+|+|.+......+......+.+|+++|++++|+||+.+++.+..++..+++|||++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            34589999999999999999999999999876544444444567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......    ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~----~~  158 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGE----SI  158 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCC----cc
Confidence            99999887543 34599999999999999999999999999999999999998764 69999999987653221    12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH--HHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--QIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ....|++.|+|||++..   ..++.++|+|||||++|+|++|..||.......  ...........+..+..++.++.++
T Consensus       159 ~~~~g~~~~~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNN---QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            34578999999999854   346789999999999999999999998543321  1122222222345567789999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~~  268 (407)
                      +.+||++||++||+     +.+++.|+|+..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence            99999999999999     889999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.9e-45  Score=334.39  Aligned_cols=254  Identities=32%  Similarity=0.545  Sum_probs=217.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.+...||+|+||.||+|.+..+++.|++|.+..... .......+.+|++++++++||||+++++.+...+..|+||||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5667899999999999999999999999999875432 334557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++.......   
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~---  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN---  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc---
Confidence            9999999998764 35689999999999999999999999999999999999999865 699999999877654321   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ......|++.|+|||++..   ..++.++|+|||||++++|++|+.||.... .......+..+..+.++..++.++.++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd08529         157 FANTIVGTPYYLSPELCED---KPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKIIRGVFPPVSQMYSQQLAQL  232 (256)
T ss_pred             hhhccccCccccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCccccCHHHHHH
Confidence            1234578899999999854   235789999999999999999999997543 444455555666777777889999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.5e-46  Score=349.97  Aligned_cols=251  Identities=24%  Similarity=0.394  Sum_probs=191.6

Q ss_pred             eecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEEEec
Q psy10603          8 VSPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLFMEL   83 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~E~   83 (407)
                      .+||+|+||+||+|++.  .+++.||+|.+.....     ...+.+|+++|++++||||+++++.+..  ...+|++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            38999999999999965  4678999999864321     2346789999999999999999998864  4568999999


Q ss_pred             CCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec---CCCeEEEEcccCce
Q psy10603         84 CTEGTLESLVQST--------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA---EGNSLKLGDFGSAV  152 (407)
Q Consensus        84 ~~~g~L~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~---~~~~vkl~DFGla~  152 (407)
                      +++ +|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||++.   ..+.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            965 787776431        124899999999999999999999999999999999999942   23469999999998


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--------HHHHHHH-
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--------YQIMFKV-  223 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--------~~~~~~~-  223 (407)
                      ................||+.|+|||++.+.  ..++.++||||+||++|||++|++||......        ...+..+ 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC--CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            765432222233456889999999998643  34678999999999999999999999643211        0000000 


Q ss_pred             -hCCCC-----------CC------------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        224 -GMGET-----------PT------------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       224 -~~~~~-----------~~------------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                       ..+..           +.                        .....+.++.+++.+||++||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             00000           00                        001235678899999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-45  Score=357.72  Aligned_cols=247  Identities=28%  Similarity=0.373  Sum_probs=195.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.||+|....         ..+.+|+++|++++||||+++++++......++|||+
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3445589999999999999999999999996431         3467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +. ++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......  ...
T Consensus       165 ~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~--~~~  239 (391)
T PHA03212        165 YK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDIN--ANK  239 (391)
T ss_pred             CC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccccccc--ccc
Confidence            96 688888765 34589999999999999999999999999999999999998765 69999999996532211  112


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-------hHHHHHHH-hCCC--------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-------NYQIMFKV-GMGE--------  227 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-------~~~~~~~~-~~~~--------  227 (407)
                      ....+||+.|+|||++..   ..++.++|||||||++|||++|..||.....       ..+....+ ..+.        
T Consensus       240 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        240 YYGWAGTIATNAPELLAR---DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccCccCCCChhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            234689999999999854   3468999999999999999999988753211       01100000 0000        


Q ss_pred             ------------------CCC-CC-----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 ------------------TPT-IP-----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 ------------------~~~-~~-----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                        .+. .+     ..++.++.+++.+||++||.+|||+.|+|+||||.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                              000 00     12466889999999999999999999999999985

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.2e-45  Score=336.24  Aligned_cols=254  Identities=38%  Similarity=0.640  Sum_probs=210.9

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|++..++..||+|.+...   .....+.+.+|+.++++++|+||+++++++...+..++|+||++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            445899999999999999999999999988643   23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         86 EGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~--~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|.+++......+  ++..+..++.|++.||.|||++||+||||||+||+++.+...+||+|||++........   .
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~---~  165 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---C  165 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC---c
Confidence            999999987643445  88889999999999999999999999999999999986556799999999876532211   1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-hCCCCCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....|++.|+|||++... ...++.++|+||||+++|+|++|+.||............. .....+.+|..++++++++
T Consensus       166 ~~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKG-PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             cccCCCCccccChhhhccc-cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence            2234678999999998542 2336789999999999999999999997654433333222 2344566788899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+||+.+|++|||+.|++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.5e-45  Score=336.32  Aligned_cols=258  Identities=34%  Similarity=0.637  Sum_probs=211.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l   79 (407)
                      ......||+|+||.||+|.+..+++.||+|.+......  ..+..+.+.+|+.++++++||||+++++.+..  .+.+++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            34456899999999999999999999999998754322  23445678899999999999999999998775  357899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ++||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+++.+.....
T Consensus        84 ~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          84 FMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccccc
Confidence            99999999999998653 3489999999999999999999999999999999999998764 699999999976543221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      .........++..|+|||++..   ..++.++|+|||||++|||++|+.||..................+.+|..+++.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISG---EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA  238 (266)
T ss_pred             cCCccccCCccccccCHHHhCC---CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence            1122234568899999999854   3457899999999999999999999986554444444444444667778889999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++ +||..||++||++.|+++||||.
T Consensus       239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         239 RDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            9999 67778999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.2e-45  Score=337.35  Aligned_cols=254  Identities=30%  Similarity=0.526  Sum_probs=206.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.||+|.++....   .....+.+|+.+++.++||||+++++.+...+.+|+||||
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            3444589999999999999999999999999875422   2234577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++.. .+.+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.......   ..
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~---~~  162 (267)
T cd06645          88 CGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATI---AK  162 (267)
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcc---cc
Confidence            999999999865 34589999999999999999999999999999999999998765 69999999987654322   12


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CC--CCccCHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TI--PESLSDEGQ  240 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~--~~~~s~~~~  240 (407)
                      .....|++.|+|||++.......++.++|+|||||++|+|++|..||..................+ ..  ...++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            244678999999999753333446789999999999999999999997544333222211111122 11  124678999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      +++.+||+.||++|||+.++++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-45  Score=343.13  Aligned_cols=259  Identities=23%  Similarity=0.409  Sum_probs=206.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++..+++.||+|.+......  .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            345566899999999999999999999999998754322  223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++ ++|..++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~---  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTK---  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCCC---
Confidence            997 588888876566689999999999999999999999999999999999998765 699999999865432211   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--HHhCC--------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--KVGMG--------------  226 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--~~~~~--------------  226 (407)
                      ......+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||...+...+...  .....              
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             cccccceeecccCcHHHhCC--CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            12334678999999998542  3467899999999999999999999985443222111  00000              


Q ss_pred             ----CCCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeeec
Q psy10603        227 ----ETPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSC  270 (407)
Q Consensus       227 ----~~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~  270 (407)
                          ..+.        ....+++++++++.+||+.||.+|||+.|+++||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                0010        1135788999999999999999999999999999996433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0596|consensus

Probab=100.00  E-value=2.6e-46  Score=350.46  Aligned_cols=256  Identities=30%  Similarity=0.507  Sum_probs=208.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ..++||.||-++||++.... ...||+|.+... ..|.+.+..+.+|+.+|.+|+ |.+||++|++...++.+||||||=
T Consensus       365 ilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G  442 (677)
T KOG0596|consen  365 ILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG  442 (677)
T ss_pred             HHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence            34499999999999997654 456777776543 457777889999999999996 689999999999999999999964


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                       ..+|..+++......+.-.++.|..||+.|+.++|.+||||-||||.|+|+-+ | .+||+|||+|..+..+++. --.
T Consensus       443 -d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G-~LKLIDFGIA~aI~~DTTs-I~k  518 (677)
T KOG0596|consen  443 -DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G-RLKLIDFGIANAIQPDTTS-IVK  518 (677)
T ss_pred             -cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e-eEEeeeechhcccCccccc-eee
Confidence             56999999876666776799999999999999999999999999999999976 3 6999999999888765432 122


Q ss_pred             cccccCCccccccccccccc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC-CCCCCcc
Q psy10603        165 NGFVGTQAYMAPEVFMDTNK--------VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESL  235 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~--------~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (407)
                      .+.+||+.|||||.+.+.+.        ...++++||||||||||+|+.|+.||....+....+..+..... -++|..-
T Consensus       519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~  598 (677)
T KOG0596|consen  519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP  598 (677)
T ss_pred             ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC
Confidence            45699999999999965322        22578999999999999999999999876655555555543311 1233322


Q ss_pred             C-HHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 S-DEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s-~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      + .++.++++.||+.||.+|||+.|+|+|||+.
T Consensus       599 ~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~  631 (677)
T KOG0596|consen  599 ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ  631 (677)
T ss_pred             CchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence            2 3499999999999999999999999999985

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.9e-45  Score=333.81  Aligned_cols=258  Identities=33%  Similarity=0.615  Sum_probs=211.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ--NDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~   78 (407)
                      ++.....||+|+||.||+|++..+++.||+|.+.....  ...+..+.+.+|++++++++||||+++++.+.+.  ..++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            45566799999999999999999999999999864322  2234456788999999999999999999987663  4688


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ++|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||++.......
T Consensus        83 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCcccccccccc
Confidence            999999999999998653 4488999999999999999999999999999999999998764 69999999987654322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      ..........|+..|+|||++.+   ...+.++|+|||||++|||++|+.||..................+..|..++..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISG---EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             ccccccccCCCCccccChhhhcC---CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence            21222344568999999999854   335789999999999999999999998654343333333333456677788999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+++.+||. +|++||++.|+++|||+
T Consensus       238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         238 CRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             HHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            9999999995 99999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.3e-45  Score=346.10  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=202.3

Q ss_pred             eeecccc--cCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          7 SVSPGQG--RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         7 ~~~iG~G--~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ...||+|  +|++||++.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            3478999  7889999999999999999998755332 334556778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC--
Q psy10603         85 TEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP--  161 (407)
Q Consensus        85 ~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~--  161 (407)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .++++|||.+..........  
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhccccccccccc
Confidence            999999998653 34589999999999999999999999999999999999998865 69999998764432111100  


Q ss_pred             --CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC----------
Q psy10603        162 --GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP----------  229 (407)
Q Consensus       162 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~----------  229 (407)
                        .......++..|+|||++... ...++.++|||||||++|||++|+.||........... ...+..+          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccceecccChHHhhcc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH-HhcCCccccccccchhh
Confidence              001223567889999998542 23468899999999999999999999975432221111 1111111          


Q ss_pred             -----------------------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 -----------------------------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 -----------------------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                                         .....+++++++|+.+||+.||++|||+.|+++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                                               01123577899999999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-44  Score=335.31  Aligned_cols=253  Identities=35%  Similarity=0.579  Sum_probs=209.7

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      ..||+|+||.||+|.+..+++.+|+|.+...   .....+.+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643          11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             hhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            4799999999999999999999999988543   3344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..++......+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++.......   ......
T Consensus        88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~---~~~~~~  163 (282)
T cd06643          88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI---QRRDSF  163 (282)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccc---cccccc
Confidence            99988765455689999999999999999999999999999999999998764 69999999987653321   122345


Q ss_pred             ccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC--CCCCCccCHHHHHHH
Q psy10603        168 VGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET--PTIPESLSDEGQAFA  243 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~i  243 (407)
                      .||+.|+|||++...  ....++.++|+|||||++|||++|+.||..... ............  ...|..++.++++++
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSEFKDFL  242 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence            789999999998421  223456799999999999999999999986443 333333332222  234567899999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+||++||.+||++.++++|||+..
T Consensus       243 ~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         243 KKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             HHHccCChhhCcCHHHHhcCCCEec
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-45  Score=351.34  Aligned_cols=249  Identities=29%  Similarity=0.409  Sum_probs=196.4

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l   79 (407)
                      ....||+|+||.||+|++..+++.||+|.+..... +....+.+.+|+.+++.++||||+++++++...      ...|+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   99 (355)
T cd07874          21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL   99 (355)
T ss_pred             EEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence            34589999999999999999999999999875432 334456788999999999999999999987643      35799


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++ ++.+.+..   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus       100 v~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~-  173 (355)
T cd07874         100 VMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF-  173 (355)
T ss_pred             Ehhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCcc-
Confidence            9999976 56666543   388999999999999999999999999999999999998765 69999999997653321 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH---HHHh------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM---FKVG------------  224 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~---~~~~------------  224 (407)
                         ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.+.+......   ....            
T Consensus       174 ---~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         174 ---MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             ---ccCCccccCCccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence               1234678999999999854   346789999999999999999999997543211110   0000            


Q ss_pred             -----CCCCC--------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 -----MGETP--------------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 -----~~~~~--------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                           ....+                    ..+...+.++++++.+||+.||++|||+.|+++|||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~  315 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN  315 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence                 00000                    01122456789999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.9e-45  Score=335.61  Aligned_cols=255  Identities=30%  Similarity=0.494  Sum_probs=205.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|++..+++.||+|++......   ....+.+|+.++.+++||||+++++.+...+..++|||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            344556999999999999999999999999998754222   23457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..+.....   
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~---  161 (267)
T cd06646          87 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIA---  161 (267)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeeccccc---
Confidence            9999999998865 34589999999999999999999999999999999999998765 599999999987643221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC-CC--CCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PT--IPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~-~~--~~~~~s~~~  239 (407)
                      ......|++.|+|||.+.......++.++|+|||||++|||++|..||.................. +.  .+..++.++
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            123457889999999885433344678999999999999999999999654322221111111111 11  123578999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      .+++.+||..||++|||+.++++|+|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-44  Score=334.88  Aligned_cols=252  Identities=29%  Similarity=0.557  Sum_probs=204.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC------ceEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR------EEMVL   79 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~------~~~~l   79 (407)
                      ...||+|+||.||+|++..+++.+|+|.+......    ...+.+|+.++.++ +||||+++++.+...      +.+|+
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            34799999999999999999999999998754221    24567899999998 699999999998753      46899


Q ss_pred             EEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         80 FMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +|||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++.......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceeccccc
Confidence            99999999999998763 34589999999999999999999999999999999999998765 69999999997654322


Q ss_pred             CCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                         .......|++.|+|||++....  ...++.++|||||||++|||++|+.||.....................+..++
T Consensus       166 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         166 ---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             ---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence               1224467899999999985322  23467899999999999999999999975443333222222222333345688


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .++.+++.+||..||.+|||+.|++.||||
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-44  Score=332.92  Aligned_cols=255  Identities=35%  Similarity=0.668  Sum_probs=213.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCc------HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND------ARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      ....||+|+||.||+|.+..+++.+|+|.+.......      .+..+.+.+|+.++++++||||+++++.+...+..++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            4458999999999999999999999999887543322      2334668899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++++|..++... ..+++..+..++.|++.||+|||++|++||||||+||++++++ .+||+|||+++.......
T Consensus        84 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~  161 (267)
T cd06628          84 FLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSL  161 (267)
T ss_pred             EEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCcccccccc
Confidence            99999999999999653 4589999999999999999999999999999999999998764 699999999977653211


Q ss_pred             C---CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        160 V---PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       160 ~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      .   ........|++.|+|||.+..   ..++.++|+|||||++|+|++|+.||..... ............+.++..++
T Consensus       162 ~~~~~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06628         162 STKTNGARPSLQGSVFWMAPEVVKQ---TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIGENASPEIPSNIS  237 (267)
T ss_pred             cCCccccccccCCCcCccChhHhcc---CCCCchhhhHHHHHHHHHHhhCCCCCCCccH-HHHHHHHhccCCCcCCcccC
Confidence            1   111223568899999999854   3357899999999999999999999986533 33444445556677788899


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .++.+++.+||++||.+||++.|+++||||
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-44  Score=337.51  Aligned_cols=252  Identities=31%  Similarity=0.501  Sum_probs=215.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .++....||+|+||.||+|.+..+++.+|+|++......+.+....+.+|+++|++++||||+++++.+...+.+|+|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            45677799999999999999999999999999876544444556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++......     
T Consensus        82 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-----  154 (290)
T cd05580          82 YVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-----  154 (290)
T ss_pred             cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC-----
Confidence            99999999998764 5599999999999999999999999999999999999998865 6999999998775432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       .....|++.|+|||.+...   ..+.++|+||||+++|+|++|+.||.... .......+. ...+.+|..++..++++
T Consensus       155 -~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSK---GYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKIL-EGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             -CCCCCCCccccChhhhcCC---CCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh-cCCccCCccCCHHHHHH
Confidence             2335789999999988542   35789999999999999999999997543 222233333 34556778889999999


Q ss_pred             HHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +.+||+.||.+|+     ++.|+++|||+.
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence            9999999999999     899999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.3e-44  Score=328.57  Aligned_cols=254  Identities=27%  Similarity=0.478  Sum_probs=211.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~E   82 (407)
                      +.+...||+|++|.||++.+..+++.+|+|.+..... .....+.+.+|+.++++++|||++++++.+.. +..+|++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            3456799999999999999999999999999875432 33345668899999999999999999988764 446899999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++... ...+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........  
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~--  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD--  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC--
Confidence            99999999988653 34589999999999999999999999999999999999998764 699999999977643221  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       ......|++.|+|||++..   ..++.++|+|||||++++|++|+.||...+ ..........+..+..+...++++.+
T Consensus       158 -~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSN---KPYNYKSDVWALGCCVYEMATLKHAFNAKD-MNSLVYRIIEGKLPPMPKDYSPELGE  232 (257)
T ss_pred             -ccccccCCcCccChhHhcC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCCCCccccCHHHHH
Confidence             2234578999999999854   235789999999999999999999997543 33334444555566677789999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ++.+||+.||++|||+.++++|||+
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-44  Score=334.55  Aligned_cols=250  Identities=28%  Similarity=0.515  Sum_probs=205.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||.||+|++..+++.||+|.+....  .....+.+.+|+.+|.+++||||+++++.+...+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4556678999999999999999999999999986542  23345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|..+.     .+++..+..++.|++.||.|||++||+|+||||+|||++.++ .+||+|||++......     
T Consensus        80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-----  148 (279)
T cd06619          80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-----  148 (279)
T ss_pred             cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-----
Confidence            99999996542     378999999999999999999999999999999999998865 6999999999765432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch------HHHHHHHhCCCCCCC-CCcc
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN------YQIMFKVGMGETPTI-PESL  235 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~------~~~~~~~~~~~~~~~-~~~~  235 (407)
                      .....+||..|+|||++.+   ..++.++|+|||||++|+|++|+.||......      ............+.. ....
T Consensus       149 ~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (279)
T cd06619         149 IAKTYVGTNAYMAPERISG---EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF  225 (279)
T ss_pred             cccCCCCChhhcCceeecC---CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcC
Confidence            1234678999999999864   34678999999999999999999999643211      111222222222332 2357


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++++++++.+||+.||++||++.|+++|||+..
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            889999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.3e-45  Score=373.64  Aligned_cols=258  Identities=25%  Similarity=0.460  Sum_probs=209.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLF   80 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv   80 (407)
                      .+.....||+|+||+||+|++..+++.+|+|++..... .......+.+|+.+|.+++|||||++++.+..  ...+|||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            34555689999999999999999999999999875432 34455778999999999999999999998865  3569999


Q ss_pred             EecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCEEEecC-----------
Q psy10603         81 MELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHEN-------TIVHRDIKSANIFLTAE-----------  139 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~-------~iiHrdlKp~Nill~~~-----------  139 (407)
                      |||+++|+|..++...   ...+++..++.++.||+.||.|||+.       +||||||||+|||++..           
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            9999999999988642   24599999999999999999999984       49999999999999642           


Q ss_pred             -----CCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy10603        140 -----GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD  214 (407)
Q Consensus       140 -----~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~  214 (407)
                           ...+||+|||++..+....    .....+||+.|+|||++.... ..++.++|||||||++|||++|+.||....
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~-~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHET-KSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccC-CCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                 1248999999997654322    123457999999999985432 346789999999999999999999998655


Q ss_pred             chHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        215 SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ...+.+..+..+.... ....+.++.+||..||..||.+||++.|+|.|||+.
T Consensus       248 ~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        248 NFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             cHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            5444444433322211 245789999999999999999999999999999985

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.3e-45  Score=339.67  Aligned_cols=252  Identities=29%  Similarity=0.507  Sum_probs=194.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHh---cCCCCCcceEEEEEEe-----Cce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE---GINQKNLVKYYGVEIH-----REE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~---~l~hpniv~~~~~~~~-----~~~   76 (407)
                      .....||+|+||+||+|++..+++.||+|.+......+ .....+.+|+.+++   +++||||+++++++..     ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            34568999999999999999999999999987543222 11223445666555   4579999999998764     245


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      ++++|||+++ +|..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~~  159 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYS  159 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCcccccc
Confidence            8999999985 8888876533 4589999999999999999999999999999999999998765 69999999997654


Q ss_pred             CCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh---CCC-----
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG---MGE-----  227 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~---~~~-----  227 (407)
                      ...    ......||+.|+|||++.+   ..++.++|||||||++|+|++|++||..............   ...     
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         160 CQM----ALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             Ccc----cCCCccccccccCchHhhC---CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            322    1234578999999999854   3468899999999999999999999975433222111100   000     


Q ss_pred             ----------CC-------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 ----------TP-------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 ----------~~-------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                .+       .+...++.++++++.+||++||++|||+.|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                      00       0123467889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-45  Score=351.88  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=202.9

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.+...||+|+||+||+|++     ..++..||+|+++...  .....+.+.+|+.+|..+ +||||+++++++...+..
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            44556899999999999974     3456789999986432  223456788999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC------------------------------------------------------------
Q psy10603         78 VLFMELCTEGTLESLVQSTE------------------------------------------------------------   97 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~------------------------------------------------------------   97 (407)
                      ++|||||++|+|.++++...                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999999886422                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         98 --------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        98 --------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                                    ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++......... .
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~-~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYV-V  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCccccc-c
Confidence                          136788899999999999999999999999999999999875 469999999997664322111 1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....++..|+|||++..   ..++.++|||||||++|||++ |..||............+..+..+..|...+.+++++
T Consensus       273 ~~~~~~~~~y~aPE~~~~---~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         273 KGNARLPVKWMAPESIFN---CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             cCCCCCCcceeChhHhcC---CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence            112335668999999854   346889999999999999998 8999976544444444444445555567788999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcC
Q psy10603        243 AELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..||+.||++|||+.|+++.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.5e-45  Score=350.12  Aligned_cols=248  Identities=28%  Similarity=0.385  Sum_probs=196.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l   79 (407)
                      ....||+|+||.||+|++..+++.||||++..... +....+.+.+|+.+++.++||||+++++++...      ..+|+
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l  106 (364)
T cd07875          28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  106 (364)
T ss_pred             EEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence            34489999999999999999999999999875432 333456788999999999999999999987543      35799


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++ +|...+..   .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus       107 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~-  180 (364)
T cd07875         107 VMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF-  180 (364)
T ss_pred             EEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCCC-
Confidence            9999975 67666643   388999999999999999999999999999999999998765 69999999997653321 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--------------  225 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--------------  225 (407)
                         ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...+... ....+..              
T Consensus       181 ---~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         181 ---MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ---cccCCcccCCcCCHHHHhC---CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhh
Confidence               1244678999999999854   346789999999999999999999997543221 1111100              


Q ss_pred             -------CCCCC--------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 -------GETPT--------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 -------~~~~~--------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                             ...|.                    .....++++++++.+||+.||.+|||+.|+|+|||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                   00010                    0112356789999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-44  Score=335.40  Aligned_cols=254  Identities=33%  Similarity=0.579  Sum_probs=210.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|++..+++.+|+|.+...   +....+.+.+|+.+++.++||||+++++.+..++.+|+||||++
T Consensus        16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (292)
T cd06644          16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP   92 (292)
T ss_pred             hhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence            344899999999999999999999999998643   34456778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|..++......+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++.......   ....
T Consensus        93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~---~~~~  168 (292)
T cd06644          93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTL---QRRD  168 (292)
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceeccccc---cccc
Confidence            9999988765556689999999999999999999999999999999999998754 69999999986643221   1223


Q ss_pred             ccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQA  241 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~  241 (407)
                      ...+++.|+|||++...  ....++.++|+|||||++|||++|+.||...... ....+......+  ..+..++.++.+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLSQPSKWSMEFRD  247 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCCccCCCCcccCHHHHH
Confidence            45688999999998532  1234577999999999999999999999754432 333333333333  235678899999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+||..||++||++.|+++|||+.
T Consensus       248 li~~~l~~~p~~Rp~~~~il~~~~~~  273 (292)
T cd06644         248 FLKTALDKHPETRPSAAQLLEHPFVS  273 (292)
T ss_pred             HHHHHhcCCcccCcCHHHHhcCcccc
Confidence            99999999999999999999999984

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-44  Score=337.42  Aligned_cols=258  Identities=31%  Similarity=0.567  Sum_probs=213.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|+||.||+|++..+++.||+|.+...  .+......+.+|+.++++++||||+++++.+...+.+|+|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            345666899999999999999999999999998643  233344678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         83 LCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+++++|..++...  ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.+ +.+||+|||++..+.... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCCc-
Confidence            99999999988653  2358999999999999999999997 599999999999999885 469999999987653221 


Q ss_pred             CCCcccccccCCcccccccccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHhCCCCCCCCCc
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTN---KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPES  234 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~  234 (407)
                          .....+++.|+|||++....   ...++.++|+|||||++|+|++|+.||......  ...+..+..+..+.++..
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence                13346888999999985422   123578999999999999999999999753322  122333444556677888


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +++++.+++.+||+.||++||++.++++|||+..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~  267 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK  267 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence            9999999999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.7e-44  Score=329.45  Aligned_cols=257  Identities=54%  Similarity=0.937  Sum_probs=217.5

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++.+...+.+++|+||+++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG   83 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence            45899999999999999999999999998765433 45678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc-cc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LN  165 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~-~~  165 (407)
                      ++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++............ ..
T Consensus        84 ~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~  161 (264)
T cd06626          84 GTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQ  161 (264)
T ss_pred             CcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCccccccc
Confidence            9999998653 448899999999999999999999999999999999999885 46999999998776543322211 23


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCcc--CHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL--SDEGQAFA  243 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~~i  243 (407)
                      ...+++.|+|||++........+.++||||||+++|+|++|+.||...+........+..+..+.+|...  +..+.+++
T Consensus       162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (264)
T cd06626         162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL  241 (264)
T ss_pred             CCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHH
Confidence            4567889999999865432346789999999999999999999998665555555555556666666654  89999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .+||+.||++|||+.|++.|||+
T Consensus       242 ~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         242 DRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-44  Score=332.67  Aligned_cols=251  Identities=19%  Similarity=0.294  Sum_probs=204.6

Q ss_pred             ccceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      .+.+...||+|+||.||+|.+.   ..+..||+|.++..  ........+.+|+.+|.+++||||+++++++..++..++
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            3456668999999999999865   44578999998753  223345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||++|++||||||+|||++.++ .+|++|||.+........
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccccch
Confidence            9999999999999876555689999999999999999999999999999999999998764 699999998755322111


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      .  ......++..|+|||++..   ..++.++|||||||++||+++ |..||.... .......+..+..++.|..++..
T Consensus       163 ~--~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd05064         163 Y--TTMSGKSPVLWAAPEAIQY---HHFSSASDVWSFGIVMWEVMSYGERPYWDMS-GQDVIKAVEDGFRLPAPRNCPNL  236 (266)
T ss_pred             h--cccCCCCceeecCHHHHhh---CCccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHHCCCCCCCCCCCCHH
Confidence            1  1112345678999999854   346789999999999999775 999998543 33444455555566677889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +.+++..||+.||++||++.|+++
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.2e-44  Score=328.30  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=214.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|.+..+++.+|+|.+...... ....+.+.+|+++|++++||||+++++.+...+..++||||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            4556899999999999999999999999999764333 334577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         85 TEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++..+||+|||++........    
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~----  157 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----  157 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc----
Confidence            9999999997643 34899999999999999999999999999999999999987666789999999977643321    


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      .....|+..|+|||.+..   ..++.++|+||||+++|+|++|+.||...+.. .....+..+..+.++..++.++++++
T Consensus       158 ~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li  233 (256)
T cd08220         158 AYTVVGTPCYISPELCEG---KPYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVLKIMSGTFAPISDRYSPDLRQLI  233 (256)
T ss_pred             ccccccCCcccCchhccC---CCCCcccchHHHHHHHHHHHhCCCCcccCchH-HHHHHHHhcCCCCCCCCcCHHHHHHH
Confidence            123568899999999854   33578999999999999999999999864433 33344444555566778999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ..||..||++|||+.|+++|||+
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4236|consensus

Probab=100.00  E-value=1.5e-46  Score=349.78  Aligned_cols=252  Identities=28%  Similarity=0.411  Sum_probs=214.8

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .+||.|.||+||-|+++.+|+.||||+|++.+....+ ...+.+|+.||+++.||.||.+.-.+++.+.+++|||-+.|.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            4899999999999999999999999999876554433 366889999999999999999999999999999999999876


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccCceecCCCCCCCCccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      .|.-.+.+..+.+++...++++.||+.||.|||.++|+|.||||+|||+.+..  -.+||||||+|+.+.+..-+    .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR----r  724 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR----R  724 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh----h
Confidence            66666666667799999999999999999999999999999999999997643  26999999999998765432    5


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      +.+|||.|+|||+|+.   .+|.+.-||||.|||+|.-++|.+||.+..+-.+.+.....=..|.-+..+|.++.|||..
T Consensus       725 sVVGTPAYLaPEVLrn---kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRN---KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhcCCccccCHHHHhh---ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            6799999999999965   4578899999999999999999999986443222222222223455567899999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +|+..-.+|.+.++.+.|||+.
T Consensus       802 LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  802 LLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             HHHHHHHHhcchHhhccchhhh
Confidence            9999999999999999999984

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.7e-45  Score=351.12  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=201.7

Q ss_pred             cceeeecccccCeEEEEEEECCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETG-----ELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.+...||+|+||.||+|++..+|     +.||+|.+.....  ......+.+|+.+|+.+ +||||+++++.+...+.+
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            334458999999999999865443     5799999875432  23356788999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC------------------------------------------------------------
Q psy10603         78 VLFMELCTEGTLESLVQSTE------------------------------------------------------------   97 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~------------------------------------------------------------   97 (407)
                      ++|||||++|+|.++++...                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885421                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         98 ---------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        98 ---------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                               ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++........ .......
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~-~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNY-VVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcce-eeccCCC
Confidence                     136788899999999999999999999999999999999875 47999999999765432211 0111223


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +++.|||||++..   ..++.++|||||||++|||++ |+.||...............+..+..|..+++++.+++.+||
T Consensus       276 ~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  352 (374)
T cd05106         276 LPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW  352 (374)
T ss_pred             CccceeCHHHhcC---CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence            5668999999854   346889999999999999997 999998654443333334444555667778999999999999


Q ss_pred             ccCCCCcCCHHHHhc
Q psy10603        248 RHDPAQRATIFELLQ  262 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~  262 (407)
                      +.||++|||+.++++
T Consensus       353 ~~dp~~RPs~~~l~~  367 (374)
T cd05106         353 NLEPTERPTFSQISQ  367 (374)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-44  Score=335.01  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHH---HHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVEL---RILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .||+|+||.||+|.+..+++.+|+|.+.............+.+|.   +++...+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998754333222222333444   34445689999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||++.......     ..
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~-----~~  153 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-----PH  153 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccC-----cc
Confidence            9999998865 34599999999999999999999999999999999999998764 69999999987654321     12


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ...||+.|+|||.+..  ...++.++|+||+||++|+|++|..||..... .............+.+|..+++++++++.
T Consensus       154 ~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         154 ASVGTHGYMAPEVLQK--GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE  231 (279)
T ss_pred             CcCCCcCccCHHHhcC--CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHH
Confidence            3478999999998753  23467899999999999999999999975332 22223333333455677889999999999


Q ss_pred             HhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        245 LCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +||..||++|+     ++.|+++||||.
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence            99999999999     699999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=334.62  Aligned_cols=255  Identities=35%  Similarity=0.598  Sum_probs=212.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|.+..+++.+|+|.+...   +....+.+.+|+.++++++||||+++++.+..++..|+||||++
T Consensus         9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            344799999999999999989999999998643   34455778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++........   ...
T Consensus        86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~---~~~  161 (280)
T cd06611          86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQ---KRD  161 (280)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhccccc---ccc
Confidence            9999999876556699999999999999999999999999999999999998765 699999999866432211   123


Q ss_pred             ccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--CCCccCHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQA  241 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~  241 (407)
                      ...||+.|+|||++...  ....++.++|+|||||++|+|++|+.||.... ..+.......+..+.  .+..++.++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-PMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-HHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            45789999999998532  12345779999999999999999999997643 333344444444333  35678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++.+||+.||++||++.++++|||+..
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-44  Score=337.06  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=202.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.||+|.+..... +....+.+.+|+.++++++||||+++++.+..++..|+||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3455689999999999999999999999999875432 222345677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        84 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++ ++|..++....  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......   
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~---  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV---  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc---
Confidence            98 58888875432  4589999999999999999999999999999999999998765 69999999987653221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC--------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG--------------  226 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~--------------  226 (407)
                      .......+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||.............. .+              
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCC--CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            112334678899999988543  3357899999999999999999999975432211111000 00              


Q ss_pred             ------------CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        227 ------------ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       227 ------------~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                  ........+++++++++.+||+.||++|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                        0001123478999999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.8e-44  Score=330.75  Aligned_cols=255  Identities=35%  Similarity=0.649  Sum_probs=208.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccC---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN---DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ....||+|+||+||+|.. .+++.+|+|.+......   ..+..+.+.+|+++|++++|+||+++++++...+.+++++|
T Consensus         4 ~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             ccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            345799999999999986 47889999998754221   23344668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC---C
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT---T  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~---~  159 (407)
                      |+++++|.+++.+. ..+++..+..++.|++.||.|||+.+|+|+||||+||++++++ .+||+|||++.......   .
T Consensus        83 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~  160 (265)
T cd06631          83 FVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGLHGT  160 (265)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhcccccc
Confidence            99999999999653 4589999999999999999999999999999999999998764 69999999987643211   1


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHH-HhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~s~~  238 (407)
                      .........|+..|+|||++..   ..++.++|+|||||++|+|++|..||...+........ ...+..+.++..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06631         161 HSNMLKSMHGTPYWMAPEVINE---SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA  237 (265)
T ss_pred             ccccccccCCCccccChhhhcC---CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence            1112234578999999999854   33578999999999999999999999754433222211 1223456677889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+++.+||.+||++||++.|+++||||
T Consensus       238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         238 AIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-44  Score=329.16  Aligned_cols=256  Identities=33%  Similarity=0.545  Sum_probs=210.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||.||+|.+..+++.+|+|++.....   ...+.+.+|+.++++++||||+++++.+...+.+|++||
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            45667799999999999999999999999999875432   245778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++......+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||++........   
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~---  156 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIA---  156 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhh---
Confidence            9999999999876546699999999999999999999999999999999999999765 699999999876543221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~  239 (407)
                      ......++..|+|||.+.......++.++|+|||||++|+|++|+.||..................+   ..+...+.++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            1234578889999999854322346789999999999999999999998654333322221111111   1234567889


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      ++++.+||..||.+|||+.+++.|+|
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.9e-44  Score=337.30  Aligned_cols=253  Identities=30%  Similarity=0.529  Sum_probs=207.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|.+..+++.+|+|.+...  .......++.+|++++++++||||+++++.+..++.+++|||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            355667899999999999999999999999988643  234455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.++++.. ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||++......    
T Consensus        80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~----  153 (308)
T cd06615          80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----  153 (308)
T ss_pred             ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc----
Confidence            99999999999754 558999999999999999999998 5899999999999998765 6999999998654322    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--------------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--------------------  221 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--------------------  221 (407)
                       .....+|++.|+|||++.+   ..++.++|+|||||++|+|++|+.||...+.. ....                    
T Consensus       154 -~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQG---THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             -ccccCCCCcCccChhHhcC---CCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccC
Confidence             1234678999999999754   33678999999999999999999999643211 1111                    


Q ss_pred             ----------------HHhCCCCCCCCC-ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        222 ----------------KVGMGETPTIPE-SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       222 ----------------~~~~~~~~~~~~-~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                      .......|..|. .++.++++++.+||..||++|||+.|+++|||+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                            011111222222 36889999999999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-44  Score=334.87  Aligned_cols=258  Identities=27%  Similarity=0.503  Sum_probs=208.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-LEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.+...||+|+||.||+|++..+|+.||+|++......+  ....+..|+.+ ++.++||||+++++.+..++.+|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            4566779999999999999999999999999987543222  23455667665 56789999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         82 ELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        82 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ||++ |+|.+++..   ....+++..+..++.|++.||.|||++ +++||||||+|||++.++ .+||+|||++......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  157 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccccc
Confidence            9997 688777654   234589999999999999999999998 999999999999998765 6999999998765432


Q ss_pred             CCCCCcccccccCCccccccccccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC-Ccc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESL  235 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~  235 (407)
                      .    ..+...|+..|+|||++..... ..++.++|+|||||++|+|++|+.||.......+.......+..+.++ ..+
T Consensus       158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd06617         158 V----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF  233 (283)
T ss_pred             c----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence            1    1133568899999998854222 346789999999999999999999997654444444444444445444 458


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |.++.+++.+||..||++||++.++++|||+..
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence            999999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0604|consensus

Probab=100.00  E-value=2.5e-46  Score=326.79  Aligned_cols=245  Identities=27%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEe----CceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIH----REEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~~~lv~E~   83 (407)
                      +||-|-.|+|-.|.++.||+++|+|++.-.        ....+|+++.-. -.|||||.+.+++.+    ...+.+|||.
T Consensus        69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   69 VLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            899999999999999999999999987521        234567776543 469999999998764    4578899999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |+||+|...++.+. ..|+|.++..+++||+.|+.|||+.+|.||||||+|+|....  +..+||+|||+|+.-..    
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~----  216 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE----  216 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC----
Confidence            99999999997653 359999999999999999999999999999999999999753  45799999999977542    


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc---hHHHHHHHhCCCC--C-CCCCc
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS---NYQIMFKVGMGET--P-TIPES  234 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~---~~~~~~~~~~~~~--~-~~~~~  234 (407)
                      +..+.+.|-||+|.|||++..   ..|+...|+||+||++|-|++|.+||.....   .-....++..|..  | +-+..
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~---eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             CccccCCcccccccCHHHhCc---hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            345677899999999999843   3478899999999999999999999974322   1111223333332  1 22456


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +|++++++|+.+|+.+|.+|.|+.|++.|||+..
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence            8999999999999999999999999999999863

>KOG4721|consensus

Probab=100.00  E-value=2.7e-46  Score=350.78  Aligned_cols=236  Identities=29%  Similarity=0.525  Sum_probs=201.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      =||.|+-|.||+|+..  ++.||||.++..        +  ..+|+-|++|+||||+.+.|+|.....+|||||||..|-
T Consensus       131 WlGSGaQGAVF~Grl~--netVAVKKV~el--------k--ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRLH--NETVAVKKVREL--------K--ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhccCcccceeeeecc--CceehhHHHhhh--------h--hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            5899999999999754  678999977521        1  236888999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |..+++. ...++......|..+|+.|+.|||.+.|||||||.-||||..+. .|||+|||.++......    ....|+
T Consensus       199 L~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~S----TkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKS----TKMSFA  272 (904)
T ss_pred             HHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhh----hhhhhh
Confidence            9999976 44588899999999999999999999999999999999999864 79999999998776543    346799


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCCccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      ||..|||||++..   .+.+.|+|||||||+||||+||..||.+-+.. .+++-++. ....++|..+++.++-|++.||
T Consensus       273 GTVaWMAPEvIrn---ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  273 GTVAWMAPEVIRN---EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCW  348 (904)
T ss_pred             hhHhhhCHHHhhc---CCcccccceehhHHHHHHHHhcCCCccccchh-eeEEeccCCcccccCcccCchHHHHHHHHHH
Confidence            9999999999964   56789999999999999999999999864432 33333322 2244578899999999999999


Q ss_pred             ccCCCCcCCHHHHhcCCee
Q psy10603        248 RHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~hp~~  266 (407)
                      +-.|..||++.+++.|.-+
T Consensus       349 ~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             hcCCCCCccHHHHHHHHhh
Confidence            9999999999999998754

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-45  Score=347.36  Aligned_cols=249  Identities=26%  Similarity=0.428  Sum_probs=198.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l   79 (407)
                      ....||+|+||+||+|.+..+++.||||.+..... .....+.+.+|+.+|++++||||+++++++...      ...|+
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   97 (343)
T cd07878          19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL   97 (343)
T ss_pred             hheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence            33489999999999999999999999999865322 223345677899999999999999999877533      35799


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ++|++ +++|..+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....  
T Consensus        98 ~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~--  171 (343)
T cd07878          98 VTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQADDE--  171 (343)
T ss_pred             EeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecCCC--
Confidence            99988 6799888753  3599999999999999999999999999999999999998765 6999999999765432  


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--CC-----------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--MG-----------  226 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--~~-----------  226 (407)
                          ....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||....... .+....  .+           
T Consensus       172 ----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         172 ----MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ----cCCccccccccCchHhcCC--ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhcc
Confidence                2446789999999998542  346789999999999999999999997543211 111110  00           


Q ss_pred             ---------CCCCC--------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        227 ---------ETPTI--------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       227 ---------~~~~~--------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                               ..+..        ....++.+.+++.+||..||.+|||+.|+++||||..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                     00111        1235677899999999999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-44  Score=358.39  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=189.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC------CCcceEEEEEEeC-ceE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ------KNLVKYYGVEIHR-EEM   77 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~-~~~   77 (407)
                      .....||+|+||+||+|.+..+++.||||+++...    .....+.+|+.+++.++|      ++++++++++... +.+
T Consensus       132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            34448999999999999999999999999986421    223345567777666554      4588888887754 478


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCC---------------
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGN---------------  141 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~---------------  141 (407)
                      |+|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ .|||||||||+|||++.++.               
T Consensus       208 ~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            9999998 6688888765 3459999999999999999999998 59999999999999986542               


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF  221 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~  221 (407)
                      .+||+|||++.....      .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||....+......
T Consensus       286 ~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        286 RVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG---LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             eEEECCCCccccCcc------ccccccCCccccCcHHhhc---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            499999998754321      1245689999999999865   3468899999999999999999999976443221110


Q ss_pred             -HHhCCCCC------------------------CC-C-------------C-ccCHHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        222 -KVGMGETP------------------------TI-P-------------E-SLSDEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       222 -~~~~~~~~------------------------~~-~-------------~-~~s~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                       ....+..|                        .. +             . .-++.+.+||.+||++||.+|||+.|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence             00011000                        00 0             0 0135577999999999999999999999


Q ss_pred             cCCeeee
Q psy10603        262 QHPFLIV  268 (407)
Q Consensus       262 ~hp~~~~  268 (407)
                      +||||..
T Consensus       437 ~Hp~~~~  443 (467)
T PTZ00284        437 THPYVLK  443 (467)
T ss_pred             cCccccc
Confidence            9999964

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7e-45  Score=338.18  Aligned_cols=254  Identities=27%  Similarity=0.483  Sum_probs=202.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|++..+|+.+|+|.+..... +......+.+|+.++++++||||+++++++.+.+.+++|+||+
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            345589999999999999999999999999875422 2223355778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++ +|..++......+++..+..++.||+.||.|||+++|+||||||+||+++.++ .+||+|||+++.......   ..
T Consensus        82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~---~~  156 (284)
T cd07839          82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVR---CY  156 (284)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCC---Cc
Confidence            74 78777765556699999999999999999999999999999999999998765 699999999976543221   12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-------------------
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-------------------  225 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-------------------  225 (407)
                      ....+++.|+|||++.+.  ..++.++|||||||++|+|++|..||....+.......+..                   
T Consensus       157 ~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CCCccccCCcChHHHhCC--cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            334678999999998543  33578999999999999999999987543332222111100                   


Q ss_pred             CCCCC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        226 GETPT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       226 ~~~~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ...+.         ....+++++++++.+||+.||.+|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00011         113478899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.9e-44  Score=330.11  Aligned_cols=249  Identities=28%  Similarity=0.450  Sum_probs=211.1

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||.|+||.||+|++..+++.+|+|++...........+.+.+|+.++++++||||+++++.+...+.+++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999999999865544445567889999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccccc
Q psy10603         90 ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG  169 (407)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~g  169 (407)
                      .+++.+. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||++.......    ......|
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~----~~~~~~~  154 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQ----KTWTFCG  154 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccc----ccccccC
Confidence            9999653 4489999999999999999999999999999999999998865 69999999997764332    1233578


Q ss_pred             CCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhC-CCCCCCCCccCHHHHHHHHHhc
Q psy10603        170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGM-GETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       170 t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~-~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      ++.|+|||.+..   ..++.++|+||||+++|+|++|..||..... .......+.. ...+..|...++++++++.+||
T Consensus       155 ~~~~~~PE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  231 (262)
T cd05572         155 TPEYVAPEIILN---KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL  231 (262)
T ss_pred             CcCccChhHhcC---CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence            899999999754   3357899999999999999999999986542 2222332222 3455667777999999999999


Q ss_pred             ccCCCCcCC-----HHHHhcCCeee
Q psy10603        248 RHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +.||++||+     +.|+++||||.
T Consensus       232 ~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         232 RRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             cCChhhCcCCcccCHHHHhcChhhh
Confidence            999999999     99999999984

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-44  Score=333.78  Aligned_cols=250  Identities=28%  Similarity=0.478  Sum_probs=207.5

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|+||+||+|.+..+|+.||+|.+...........+.+.+|+.+|+.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999998754333333445667899999999999999999999999999999999999999


Q ss_pred             HHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         90 ESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        90 ~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      .+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.......    ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~----~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGK----KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCC----cccccc
Confidence            99886543 3589999999999999999999999999999999999998765 69999999987654321    123346


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccCHHHHHHHHHh
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLSDEGQAFAELC  246 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~  246 (407)
                      ++..|+|||++.+.   .++.++|+|||||++|+|++|+.||.....  ....+...........+..+++++.+++.+|
T Consensus       156 ~~~~y~~PE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (277)
T cd05577         156 GTPGYMAPEVLQGE---VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL  232 (277)
T ss_pred             CCCCcCCHHHhcCC---CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHH
Confidence            78899999998542   267899999999999999999999975432  2222233333344456777899999999999


Q ss_pred             cccCCCCcC-----CHHHHhcCCeee
Q psy10603        247 LRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       247 l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      |+.||++||     ++.++++|||+.
T Consensus       233 l~~~p~~R~~~~~~~~~~ll~h~~~~  258 (277)
T cd05577         233 LQKDPEKRLGCRGGSADEVREHPLFK  258 (277)
T ss_pred             ccCChhHccCCCcccHHHHHhChhhh
Confidence            999999999     888899999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-44  Score=333.72  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=209.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG-----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.+...||+|+||.||+|.+...+     +.+|+|.+...  ........+.+|++++.+++||||+++++++...+..
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            5666779999999999999876555     68999988643  2334456788999999999999999999999988899


Q ss_pred             EEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCe
Q psy10603         78 VLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS  142 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~  142 (407)
                      +++|||+++|+|.+++....               ..+++..+..++.|++.||.|||+++++||||||+||++++++ .
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~-~  162 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-T  162 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC-c
Confidence            99999999999999986531               3478889999999999999999999999999999999998764 6


Q ss_pred             EEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHH
Q psy10603        143 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF  221 (407)
Q Consensus       143 vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~  221 (407)
                      +||+|||+++........ .......+++.|+|||.+..   ..++.++|||||||++|||++ |..||.+.. ..+...
T Consensus       163 ~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~slG~il~el~~~g~~p~~~~~-~~~~~~  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY---GKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-NQEVIE  237 (283)
T ss_pred             EEECCCcceeeccccccc-cccCCCcccccccCHHHhcc---CcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Confidence            999999999765332211 11233466889999998854   236789999999999999998 999998543 344555


Q ss_pred             HHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       222 ~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+..+..+..|..+++++.+++.+||+.||.+||++.|++++
T Consensus       238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            555666677788899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0607|consensus

Probab=100.00  E-value=1.4e-45  Score=324.62  Aligned_cols=255  Identities=26%  Similarity=0.353  Sum_probs=211.0

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+|+.|-.|....+|++||||+|.+..   ...+.+..+|++++.+++ |+||+++.++|+++..+|||||-|.||
T Consensus        85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            7999999999999999999999999998763   244678999999998875 899999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC--eEEEEcccCceecCCCCCC----C
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAVKISAHTTV----P  161 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~--~vkl~DFGla~~~~~~~~~----~  161 (407)
                      +|..+|++ +..|+|.++.++.++|+.||++||.+||.||||||+|||-.+.+.  -||||||-+...+..+...    .
T Consensus       162 plLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  162 PLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             hHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            99999976 556999999999999999999999999999999999999765432  4899999887543322111    2


Q ss_pred             CcccccccCCcccccccccc--cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------------chHHHHHHHhCC
Q psy10603        162 GELNGFVGTQAYMAPEVFMD--TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-------------SNYQIMFKVGMG  226 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-------------~~~~~~~~~~~~  226 (407)
                      .++.+.+|+..|||||+..-  .....|+.+.|.|||||++|-|++|.+||.+.=             .=++.++..+..
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence            34567899999999997531  233557899999999999999999999997421             112334444433


Q ss_pred             CCCCCCC----ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 ETPTIPE----SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 ~~~~~~~----~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ....+|+    .+|.+++++++.+|..|+.+|.++.++++|||+.
T Consensus       321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence            4444553    5899999999999999999999999999999985

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.6e-44  Score=341.10  Aligned_cols=250  Identities=25%  Similarity=0.402  Sum_probs=189.8

Q ss_pred             ecccccCeEEEEEEECC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEEEecC
Q psy10603          9 SPGQGRFGKVYTAVNNE--TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLFMELC   84 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~E~~   84 (407)
                      .||+|+||+||+|++..  +++.||+|.+.....     ...+.+|+.+|++++||||+++++++..  +...++||||+
T Consensus         8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             EeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            79999999999999653  568899998864321     2346789999999999999999998854  55789999998


Q ss_pred             CCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec---CCCeEEEEcccCcee
Q psy10603         85 TEGTLESLVQST--------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA---EGNSLKLGDFGSAVK  153 (407)
Q Consensus        85 ~~g~L~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~---~~~~vkl~DFGla~~  153 (407)
                      ++ +|.+++...        ...+++..+..++.|++.||.|||+++|+||||||+|||+..   +.+.+||+|||+++.
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            75 776666421        224889999999999999999999999999999999999942   234799999999987


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch---------HHHHHHHh
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN---------YQIMFKVG  224 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~---------~~~~~~~~  224 (407)
                      ...............||+.|+|||++.+.  ..++.++|||||||++|||++|++||......         .+......
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC--CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            65433222233456789999999998542  33578999999999999999999999643211         00000000


Q ss_pred             -CC-----------CCC------------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        225 -MG-----------ETP------------------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       225 -~~-----------~~~------------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                       .+           ..+                        ......+..+.+++.+||+.||.+|||+.|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00           000                        0011235568889999999999999999999999996

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0612|consensus

Probab=100.00  E-value=2.8e-46  Score=374.78  Aligned_cols=259  Identities=31%  Similarity=0.401  Sum_probs=214.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      |+...++||+|+||+|.+++++.|++.||+|++.+-.-.+.....-|..|..+|..-+.+=|++++.+|++..++|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            55666799999999999999999999999999876322223334557789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++||+|..++.+.. .+||.++++|+..|+.||+-||+.|.|||||||+|||+|..| ++||+|||.+.++..+.... 
T Consensus       156 Y~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~dG~V~-  232 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDADGTVR-  232 (1317)
T ss_pred             cccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCCCCcEE-
Confidence            999999999997655 799999999999999999999999999999999999999876 69999999998887654432 


Q ss_pred             cccccccCCccccccccccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCCCCCC--CccCH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNK--VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIP--ESLSD  237 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~--~~~s~  237 (407)
                       ....+|||-|+|||+|...+.  ..|++.+|.||+||++|||+.|..||... +-....-++. ....-.+|  ..+|.
T Consensus       233 -s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-slveTY~KIm~hk~~l~FP~~~~VSe  310 (1317)
T KOG0612|consen  233 -SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-SLVETYGKIMNHKESLSFPDETDVSE  310 (1317)
T ss_pred             -eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-HHHHHHHHHhchhhhcCCCcccccCH
Confidence             356799999999999964322  45899999999999999999999999843 2222111111 11222334  35999


Q ss_pred             HHHHHHHHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      ++++||.+.+. +|+.|..   ++++..||||.
T Consensus       311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~  342 (1317)
T KOG0612|consen  311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE  342 (1317)
T ss_pred             HHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence            99999999887 7889988   99999999995

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=326.96  Aligned_cols=258  Identities=33%  Similarity=0.621  Sum_probs=211.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~   78 (407)
                      ++.....||+|+||.||+|++..+++.||+|.+....  ....+..+.+.+|+.++++++||||+++++.+.+.  +.++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            4556679999999999999999999999999886432  12334556788999999999999999999988664  4689


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +++||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||+++......
T Consensus        83 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcccccccccccc
Confidence            999999999999998653 3489999999999999999999999999999999999998764 69999999997754322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      ..........|+..|+|||++..   ...+.++|+|||||++|+|++|+.||..................+.+|..++++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  237 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISG---EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA  237 (264)
T ss_pred             ccCccccccCCcccccCHhhhcC---CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence            11122234578999999999854   235789999999999999999999998654444444333344556788899999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +++++.+||. +|.+||++.+++.|||+
T Consensus       238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-44  Score=332.12  Aligned_cols=254  Identities=31%  Similarity=0.590  Sum_probs=215.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||.||+|.+..+++.+|+|.+....  .....+++.+|++++++++||||+++++.+...+..++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            3455668999999999999999999999999987543  23445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh--
Confidence            999999999997654668999999999999999999999 9999999999999999865 699999999866532211  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----chHHHHHHHhCCCCCCCCCc-cC
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD----SNYQIMFKVGMGETPTIPES-LS  236 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~-~s  236 (407)
                         ....++..|+|||.+.+.   .++.++||||||+++|+|++|+.||....    .....+........+.++.. ++
T Consensus       157 ---~~~~~~~~y~~PE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGN---DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS  230 (265)
T ss_pred             ---hcccCChhccCHHHHcCC---CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcC
Confidence               125788899999998543   46789999999999999999999997542    23334444445556666665 89


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++.++|.+||..||++|||+.|++.||||.
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            9999999999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-44  Score=330.69  Aligned_cols=254  Identities=32%  Similarity=0.605  Sum_probs=215.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||.|+||.||+|++..+++.+|+|.+....  .......+.+|+++++.++||||+++++.+.....+|+|+||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            344568999999999999999999999999987542  223346678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++...  .+++..+..++.|++.||.|||+++++||||+|+||+++.++ .++|+|||+++.+.....   .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~---~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMS---K  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeeccccc---c
Confidence            9999999998653  589999999999999999999999999999999999999865 699999999987754321   2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCc-cCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~~  242 (407)
                      .....|++.|+|||++.+.   .++.++|||||||++|+|++|+.||.... .......+..+..+.++.. ++.++.++
T Consensus       155 ~~~~~~~~~y~~PE~~~~~---~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQS---GYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             cccccCCccccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence            2445788999999998653   36789999999999999999999997543 3334444445556666655 89999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      +.+||..||++|||+.++++|||+...
T Consensus       231 l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            999999999999999999999999643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.4e-44  Score=334.88  Aligned_cols=252  Identities=32%  Similarity=0.563  Sum_probs=208.9

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||+||+|++..+++.||+|++........+..+.+.+|+.+++.++||||+++++.+...+..|+||||++ 
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence            3489999999999999999999999999875544444555778899999999999999999999999999999999997 


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |++.+++......+++..+..++.|++.||.|||+++|+||||+|+||++++++ .+||+|||++......       ..
T Consensus        99 g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~-------~~  170 (307)
T cd06607          99 GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA-------NS  170 (307)
T ss_pred             CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-------CC
Confidence            577777655455689999999999999999999999999999999999998865 6999999998654322       23


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC-CCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~~i~~  245 (407)
                      ..|++.|+|||++.......++.++||||||+++|||++|+.||.... .......+.....+.. +..++.++.+++.+
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  249 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSDYFRNFVDS  249 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence            568889999999854333446789999999999999999999997543 2233333433344443 34578899999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||..||++||++.+++.|||+..
T Consensus       250 ~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         250 CLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HhcCChhhCcCHHHHhcChhhcc
Confidence            99999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-44  Score=352.57  Aligned_cols=246  Identities=24%  Similarity=0.307  Sum_probs=194.6

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|.+..+++.||||....         ..+.+|+++|++++|||||++++++...+..++|||++. 
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            3489999999999999999999999995321         235679999999999999999999999999999999995 


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|..++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ .....
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~-~~~~~  321 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWST-PFHYG  321 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccc-ccccc
Confidence            688888765555699999999999999999999999999999999999998765 6999999999775432211 11234


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-------hHHHHHHHhCC-----CCC-----
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-------NYQIMFKVGMG-----ETP-----  229 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-------~~~~~~~~~~~-----~~~-----  229 (407)
                      .+||+.|+|||++.+   ..++.++|||||||++|||++|..|+.....       ..++...+...     ..+     
T Consensus       322 ~~GT~~Y~APE~~~~---~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        322 IAGTVDTNAPEVLAG---DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             cCCCcCCcCHHHHcC---CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            679999999999854   3467899999999999999998866532211       11111111110     000     


Q ss_pred             ----------------CC--C-----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 ----------------TI--P-----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ----------------~~--~-----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                      ..  +     ..++.++++|+.+||+.||.+|||+.|+|+||||.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~  459 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ  459 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence                            00  0     13456889999999999999999999999999984

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.5e-44  Score=329.16  Aligned_cols=257  Identities=32%  Similarity=0.621  Sum_probs=212.4

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccC---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN---DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ....||+|+||.||+|.+..+++.+|+|++......   ..+..+.+.+|+++|++++||||+++++.+...+.+++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            345899999999999999999999999998754322   22345778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC-C
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-P  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~-~  161 (407)
                      |+++++|.++++. ...+++..+..++.|++.||.|||++|++||||||+||+++.++..+||+|||++..+...... .
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  162 (268)
T cd06630          84 WMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG  162 (268)
T ss_pred             ccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCC
Confidence            9999999999865 3458999999999999999999999999999999999999876667999999998776533211 1


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHH-hCCCCCCCCCccCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKV-GMGETPTIPESLSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~-~~~~~~~~~~~~s~~  238 (407)
                      .......||..|+|||.+..   ..++.++|+|||||++|+|++|..||.....  ........ .....+.++..++++
T Consensus       163 ~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         163 EFQGQLLGTIAFMAPEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             ccccccccccceeCHhHhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence            11223568899999999854   3457899999999999999999999974332  22222222 233456677889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+++.+||..||++|||+.|+++||||
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-44  Score=325.37  Aligned_cols=253  Identities=38%  Similarity=0.695  Sum_probs=212.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ--NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      ....||+|+||+||+|.+..+++.||+|.+.....  ...+..+.+.+|+.+++.++||||+++++.+...+.+++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            34589999999999999998999999999875432  2234557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++.......    .
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~----~  157 (258)
T cd06632          84 VPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS----F  157 (258)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc----c
Confidence            9999999999754 3489999999999999999999999999999999999998765 69999999987654332    1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      .....|++.|+|||.+....  .++.++|+|||||++|+|++|+.||..................+.++..+++++.+++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~--~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQG--GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             ccccCCCcceeCHHHhcCCC--CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence            23456889999999985432  3578999999999999999999999865432222222222456677788999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .+||+.||++||++.+++.|||+
T Consensus       236 ~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         236 LKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHhhcCcccCcCHHHHhcCCCC
Confidence            99999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-44  Score=330.39  Aligned_cols=254  Identities=31%  Similarity=0.429  Sum_probs=215.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|.+..+++.||+|++......+.+..+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            34567999999999999999999999999999866555555677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|..++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++.......    .
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~----~  155 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDT----L  155 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCc----c
Confidence            9999999999764 4689999999999999999999999999999999999998865 69999999987654332    1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-HHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....|+..|+|||++...   .++.++|+||||+++|+|++|+.||...... ............+..|..++.++.++
T Consensus       156 ~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQ---GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA  232 (258)
T ss_pred             ccccCCChhhcCHHHHccc---CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH
Confidence            2345688899999998543   3578999999999999999999999865431 12222222225566778899999999


Q ss_pred             HHHhcccCCCCcCCH--HHHhcCCee
Q psy10603        243 AELCLRHDPAQRATI--FELLQHPFL  266 (407)
Q Consensus       243 i~~~l~~dp~~R~t~--~e~l~hp~~  266 (407)
                      +.+||+.||.+||++  .|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-44  Score=332.16  Aligned_cols=253  Identities=35%  Similarity=0.561  Sum_probs=203.8

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|++..+++.||+|++....... .......+|+.++++++||||+++++++......++||||++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            4568999999999999999999999999998664322 223344669999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|.+++.. ...+++..+..++.|++.||.+||+++|+||||||+||+++.+ +.++|+|||.+......   .....
T Consensus        82 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~---~~~~~  156 (260)
T PF00069_consen   82 GGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSEN---NENFN  156 (260)
T ss_dssp             TEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTST---TSEBS
T ss_pred             cccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc---ccccc
Confidence            9999999973 3458999999999999999999999999999999999999965 46999999999764211   12234


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--chHHHHHHHhCCCCC---CCCCccCHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIMFKVGMGETP---TIPESLSDEGQ  240 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~--~~~~~~~~~~~~~~~---~~~~~~s~~~~  240 (407)
                      ...+|+.|+|||++..  ...++.++|+||||+++|+|++|..||....  +.............+   ......+.++.
T Consensus       157 ~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQ--GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             SSSSSGGGSCHHHHTT--TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccc--cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            5678999999999851  2346789999999999999999999998652  111222211111100   11112248899


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +++..||+.||++||++.++++||||
T Consensus       235 ~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-44  Score=329.43  Aligned_cols=255  Identities=34%  Similarity=0.607  Sum_probs=206.0

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccC-------cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-------DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      ..||+|+||.||+|.+..+|+.+|+|.+......       .....+.+.+|+.++++++||||+++++.+...+..++|
T Consensus         7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   86 (272)
T cd06629           7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF   86 (272)
T ss_pred             ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence            4899999999999999999999999988642211       112345678899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++++|.++++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.+ +.+||+|||+++....... 
T Consensus        87 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~-  163 (272)
T cd06629          87 LEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYD-  163 (272)
T ss_pred             EecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccccccccc-
Confidence            9999999999998764 568999999999999999999999999999999999999875 4799999999876532211 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC----CccC
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP----ESLS  236 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~s  236 (407)
                      ........|+..|+|||++.... ..++.++|+||||+++|+|++|..||..................+.++    ..++
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06629         164 NDQNMSMQGSVFWMAPEVIHSYS-QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS  242 (272)
T ss_pred             ccccccccCCccccCHHHhcccc-CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCC
Confidence            11223456889999999986432 246789999999999999999999997544332222222222233333    3468


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .++++++.+||.+||++|||+.++++|||+
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         243 PVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=335.69  Aligned_cols=258  Identities=31%  Similarity=0.454  Sum_probs=211.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|.+..+++.||+|.+...........+.+.+|+++|..++||||+++++.+...+..|+||||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            45566899999999999999999999999999865544445567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC--
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--  160 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~--  160 (407)
                      +.+++|.++++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.........  
T Consensus        83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhcccccccccc
Confidence            9999999998653 24589999999999999999999999999999999999998765 6999999998654321110  


Q ss_pred             ------------------------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch
Q psy10603        161 ------------------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN  216 (407)
Q Consensus       161 ------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~  216 (407)
                                              ....+...||..|+|||++.+   ..++.++||||||+++|+|++|+.||...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG---DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC---CCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                    011234578999999999854   33578999999999999999999999765433


Q ss_pred             HHHHHHHhCCCCCCCCC--ccCHHHHHHHHHhcccCCCCcCC----HHHHhcCCeee
Q psy10603        217 YQIMFKVGMGETPTIPE--SLSDEGQAFAELCLRHDPAQRAT----IFELLQHPFLI  267 (407)
Q Consensus       217 ~~~~~~~~~~~~~~~~~--~~s~~~~~~i~~~l~~dp~~R~t----~~e~l~hp~~~  267 (407)
                      .. ...+. ...+..+.  .+++++++++.+||+.||++|||    +.|+++||||.
T Consensus       239 ~~-~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~  293 (316)
T cd05574         239 ET-FSNIL-KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR  293 (316)
T ss_pred             HH-HHHHh-cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence            22 22222 22222332  37899999999999999999999    99999999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-43  Score=325.82  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             ecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||.||+|.+.  .++..||+|++...  ......+.+.+|+.++++++||||+++++.+. .+..++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            5899999999999765  44567999988643  23445567889999999999999999999875 4578999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|.+++......+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++...............
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccCC
Confidence            999999876566799999999999999999999999999999999999998764 6999999999765433221111122


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..+++.|+|||++..   ..++.++|||||||++|||++ |..||.... .......+..+..+..|...++++.+++.+
T Consensus       158 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05115         158 GKWPLKWYAPECINF---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-GPEVMSFIEQGKRLDCPAECPPEMYALMKD  233 (257)
T ss_pred             CCCCcccCCHHHHcc---CCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            233578999998854   335789999999999999996 999998643 334455556666777788899999999999


Q ss_pred             hcccCCCCcCCHHHHhc
Q psy10603        246 CLRHDPAQRATIFELLQ  262 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~  262 (407)
                      ||..||++||++.++.+
T Consensus       234 c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         234 CWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.4e-44  Score=325.87  Aligned_cols=246  Identities=22%  Similarity=0.363  Sum_probs=202.3

Q ss_pred             ecccccCeEEEEEEE--CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVN--NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||+||+|.+  ..+++.+|+|++... ..+....+.+.+|+.+++.++||||+++++.+. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999964  466789999988644 234456678899999999999999999999874 5567999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++..+............
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCC
Confidence            999999865 34589999999999999999999999999999999999998764 6999999999776433221111122


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..+++.|+|||.+..   ..++.++|+|||||++|||++ |..||.... .......+..+..+..|..++++++++|.+
T Consensus       158 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05116         158 GKWPVKWYAPECMNY---YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-GNEVTQMIESGERMECPQRCPPEMYDLMKL  233 (257)
T ss_pred             CCCCccccCHhHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            344678999998843   346789999999999999998 999997543 344555566666777888899999999999


Q ss_pred             hcccCCCCcCCHHHHhc
Q psy10603        246 CLRHDPAQRATIFELLQ  262 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~  262 (407)
                      ||+.||++||++.++.+
T Consensus       234 ~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         234 CWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HhccCchhCcCHHHHHH
Confidence            99999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-43  Score=326.62  Aligned_cols=258  Identities=31%  Similarity=0.533  Sum_probs=211.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|+||+||+|.+..+++.+|+|++.......  ..+.+.+|+.+|+.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            4566779999999999999999899999999986543222  45678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ++++++|.++++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++ .+||+|||++..+......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDR  158 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCccc
Confidence            999999999986532  4589999999999999999999999999999999999998764 6999999998776543222


Q ss_pred             C-CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC-----Cc
Q psy10603        161 P-GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-----ES  234 (407)
Q Consensus       161 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-----~~  234 (407)
                      . .......|+..|+|||++...  ...+.++|+|||||++|+|++|+.||...... ...........+..+     ..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQV--HGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             cccccccccCChhhcChHHHccc--cCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCCCcCCcccccc
Confidence            1 122345789999999998643  24678999999999999999999999865433 223333223333222     35


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +++++.+++.+||++||++|||+.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78899999999999999999999999999996

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-43  Score=324.47  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=201.5

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|++..+++.+|+|.+...  ........+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            589999999999999999999999987533  234455678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......... .......
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~  157 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA-STGGMKQ  157 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCccccccccc-ccCCCCC
Confidence            9999876555689999999999999999999999999999999999998765 6999999998754322111 1011112


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      ++..|+|||.+...   .++.++|+|||||++|||++ |..||.... .......+.....+..+..++.++.+++.+||
T Consensus       158 ~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (252)
T cd05084         158 IPVKWTAPEALNYG---RYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRLPCPELCPDAVYRLMERCW  233 (252)
T ss_pred             CceeecCchhhcCC---CCChHHHHHHHHHHHHHHHhCCCCCccccC-HHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence            34569999998542   35789999999999999997 899997543 33333344444455667788999999999999


Q ss_pred             ccCCCCcCCHHHHhc
Q psy10603        248 RHDPAQRATIFELLQ  262 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~  262 (407)
                      +.||++|||+.|+++
T Consensus       234 ~~~p~~Rps~~~~~~  248 (252)
T cd05084         234 EYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-43  Score=322.50  Aligned_cols=253  Identities=32%  Similarity=0.482  Sum_probs=214.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||.+++..+++.+++|.+...... ....+++.+|+.+|++++|+||+++++++.+.+.++++|||+
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            4456899999999999999999999999998755332 344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         85 TEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++........   .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~---~  157 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS---M  157 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc---c
Confidence            999999998764 34589999999999999999999999999999999999998865 699999999977643321   2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      .....|++.|+|||++.+.   ..+.++|+||||+++|||++|..||... +..+....+..+..+..+..++.++.+++
T Consensus       158 ~~~~~~~~~y~ape~~~~~---~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd08221         158 AETVVGTPYYMSPELCQGV---KYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNYTPVVSVYSSELISLV  233 (256)
T ss_pred             ccccCCCccccCHhhcCCC---CCCCcchhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence            2345789999999998542   3567899999999999999999999753 33344445555555556677899999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .+||.+||++||++.++++|||+
T Consensus       234 ~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         234 HSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHcccCcccCCCHHHHhhCcCC
Confidence            99999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-43  Score=324.17  Aligned_cols=249  Identities=30%  Similarity=0.493  Sum_probs=209.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||++++..+++.+|+|.+....  .....+.+.+|+.++++++||||+++++.+...+.+|++|||
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            345679999999999999999999999999987542  233456788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||++++++ .++|+|||++..+.....   
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~---  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGA---  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeeccccc---
Confidence            9999999988653 34589999999999999999999999999999999999998764 699999999976643221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ......|++.|+|||++..   ..++.++|+||||+++|+|++|..||... +.......+..+..+.++..++.+++++
T Consensus       156 ~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (255)
T cd08219         156 YACTYVGTPYYVPPEIWEN---MPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVCQGSYKPLPSHYSYELRSL  231 (255)
T ss_pred             ccccccCCccccCHHHHcc---CCcCchhhhhhhchhheehhhccCCCCCC-CHHHHHHHHhcCCCCCCCcccCHHHHHH
Confidence            1234578899999999854   33678999999999999999999999853 3333444555556666778899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhc
Q psy10603        243 AELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +.+||+.||++|||+.|++.
T Consensus       232 i~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhh
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.6e-44  Score=330.94  Aligned_cols=251  Identities=29%  Similarity=0.557  Sum_probs=202.0

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe------CceEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIH------REEMVL   79 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------~~~~~l   79 (407)
                      ...||+|+||.||+|++..+++.+|+|++....    .....+..|+.++.++ +||||+++++.+..      .+.+|+
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            348999999999999999999999999886432    2235577899999888 69999999998853      457899


Q ss_pred             EEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         80 FMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +|||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus        97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~~~  175 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTV  175 (282)
T ss_pred             EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhccc
Confidence            999999999999986533 3488999999999999999999999999999999999998765 69999999987653221


Q ss_pred             CCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CCCCcc
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESL  235 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~  235 (407)
                         .......|++.|+|||++....  ...++.++|+|||||++|||++|..||.......... .......+ ..+..+
T Consensus       176 ---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  251 (282)
T cd06636         176 ---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPKLKSKKW  251 (282)
T ss_pred             ---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhhCCCCCCccccc
Confidence               1223467899999999985321  2346789999999999999999999997544332222 22222222 234468


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.++.+++.+||..||.+|||+.|+++||||
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-43  Score=331.85  Aligned_cols=249  Identities=34%  Similarity=0.539  Sum_probs=206.1

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|++..+++.+|+|.+......   ..+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            34799999999999999999999999998754332   235678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   ....
T Consensus       102 ~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~---~~~~  175 (296)
T cd06654         102 GSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS---KRST  175 (296)
T ss_pred             CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhcccccc---ccCc
Confidence            999999854  3478999999999999999999999999999999999998764 699999999876533221   1233


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQAFAE  244 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~~i~  244 (407)
                      ..|++.|+|||.+..   ..++.++|||||||++|+|++|+.||........... ......+  ..+..++..+.+++.
T Consensus       176 ~~~~~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         176 MVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             ccCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-HhcCCCCCCCCccccCHHHHHHHH
Confidence            578999999999854   3357899999999999999999999975443322222 2222222  235678899999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeeee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +||.+||++|||+.|+++|||+..
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhc
Confidence            999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-44  Score=342.99  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=192.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|++..+++.||+|+....         ....|+.+|++++||||+++++++...+..++|||++
T Consensus        69 ~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             EEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            3445999999999999999999999999975322         2346899999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      . ++|..++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......    ..
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~----~~  213 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAP----AF  213 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCc----cc
Confidence            6 588888766566799999999999999999999999999999999999998765 69999999986532211    12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-ch--------HHHHHHHh--CCCC-CCCC
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-SN--------YQIMFKVG--MGET-PTIP  232 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-~~--------~~~~~~~~--~~~~-~~~~  232 (407)
                      ....||+.|+|||++..   ..++.++|||||||++|||+++..|+.... ..        ...+....  .+.. ..++
T Consensus       214 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        214 LGLAGTVETNAPEVLAR---DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             ccccccccccCCeecCC---CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            34578999999999864   346889999999999999998655543211 11        00011000  0000 0011


Q ss_pred             ------------------------------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ------------------------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ------------------------------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                                    ..++.++.++|.+||+.||.+|||+.|+|+||||.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence                                          13567788899999999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-43  Score=333.24  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=196.4

Q ss_pred             ccceeeecccccCeEEEEEEECC----------------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcce
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNE----------------TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK   66 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   66 (407)
                      .+.+...||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.+|.+++||||++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            34556699999999999998543                34579999987532  3344567899999999999999999


Q ss_pred             EEEEEEeCceEEEEEecCCCCCHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy10603         67 YYGVEIHREEMVLFMELCTEGTLESLVQSTE------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRD  128 (407)
Q Consensus        67 ~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrd  128 (407)
                      +++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.||+.||.|||++||+|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999999999999999999999999885421                  2367788899999999999999999999999


Q ss_pred             CCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc--C
Q psy10603        129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS--G  206 (407)
Q Consensus       129 lKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~--g  206 (407)
                      |||+|||++.++ .+||+|||+++.+...... .......++..|+|||++..   ..++.++|||||||++|||++  +
T Consensus       164 lkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         164 LATRNCLVGENL-TIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM---GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cchhheEEcCCc-cEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc---CCCCchhhhHHHHHHHHHHHHccC
Confidence            999999998764 6999999999765432211 11123355788999999854   236889999999999999986  5


Q ss_pred             CCCCCCCCchHHHHHHHh-------CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        207 KRPWAEYDSNYQIMFKVG-------MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       207 ~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..||...... +......       ....+..+..++.++.+++.+||+.||++|||+.|+.+
T Consensus       239 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHH-HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            6788754322 2221111       11122345567889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-43  Score=325.67  Aligned_cols=255  Identities=33%  Similarity=0.548  Sum_probs=210.3

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.....||+|+||.||+|++..+++.||||.+......+.+....+.+|+.+++.++||||+++++.+...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            45667789999999999999999999999999987654455566677889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||+++|+|..++..   ....+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccchh
Confidence            99999999988753   234488999999999999999999999999999999999998765 69999999987654322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-HHHHHHHhCCCCCCC-CCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTI-PESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~-~~~~s  236 (407)
                      .   ......|++.|+|||.+..   ...+.++|+||||+++|||++|+.||...... ......+.....+.. +...+
T Consensus       161 ~---~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd08228         161 T---AAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS  234 (267)
T ss_pred             H---HHhcCCCCccccChhhhcc---CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence            1   1233568889999999854   23578999999999999999999999754332 333344333334433 34678


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ....+++.+||+.||++||++.|+++.
T Consensus       235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         235 EKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.8e-43  Score=323.53  Aligned_cols=253  Identities=27%  Similarity=0.491  Sum_probs=214.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||++++..+|+.||+|.+..... .....+++.+|+.++++++||||+++++.+...+..++|+||+
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            455689999999999999999999999999875432 2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         85 TEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+|||++.++ .++|+|||++.........   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~---  157 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVEL---  157 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchhh---
Confidence            9999999886533 3578999999999999999999999999999999999998764 6999999999765432211   


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      .....|++.|+|||++...   ..+.++|+|||||++++|++|+.||.... .......+..+..+..+..++.++.+++
T Consensus       158 ~~~~~~~~~~~~pe~~~~~---~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08218         158 ARTCIGTPYYLSPEICENR---PYNNKSDIWALGCVLYEMCTLKHAFEAGN-MKNLVLKIIRGSYPPVSSHYSYDLRNLV  233 (256)
T ss_pred             hhhccCCccccCHHHhCCC---CCCCccchhHHHHHHHHHHcCCCCccCCC-HHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence            1234688899999998542   35679999999999999999999998543 3444455566667777888999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .+||+.||++||++.++++||||
T Consensus       234 ~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         234 SQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHhhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-43  Score=330.05  Aligned_cols=256  Identities=27%  Similarity=0.490  Sum_probs=210.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|.+..+++.||+|++...  ......+.+.+|+++++.++||||+++++.+...+.+++|||
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            344556899999999999999999999999988654  234456778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++.......   
T Consensus        84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSI---  158 (284)
T ss_pred             cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhhc---
Confidence            9999999998865 3458999999999999999999997 5899999999999998764 69999999986543221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch----------HHHHHHHhCCCCCCC
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN----------YQIMFKVGMGETPTI  231 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~----------~~~~~~~~~~~~~~~  231 (407)
                        ....+|+..|+|||++...   .++.++|+|||||++|+|++|+.||......          ............+.+
T Consensus       159 --~~~~~~~~~~~aPE~~~~~---~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGG---KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL  233 (284)
T ss_pred             --cCccccCcccCCHHHHccC---CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence              1345789999999998542   4578999999999999999999999753321          122223333334444


Q ss_pred             CCc-cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeeec
Q psy10603        232 PES-LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSC  270 (407)
Q Consensus       232 ~~~-~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~  270 (407)
                      +.. ++.++.+++.+||++||++|||+.|+++|+|+....
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            443 788999999999999999999999999999987544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.5e-43  Score=329.93  Aligned_cols=251  Identities=34%  Similarity=0.560  Sum_probs=208.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||.|+||.||+|.+..+++.||+|.+......   ..+.+.+|+.+++.++||||+++++.+...+.+|+|+||+
T Consensus        22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3345899999999999999999999999998754322   2456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++++|..++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........   ..
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~---~~  172 (296)
T cd06655          99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQS---KR  172 (296)
T ss_pred             CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccc---cC
Confidence            99999998864  3489999999999999999999999999999999999998765 699999999876543221   12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~~  242 (407)
                      ....|++.|+|||.+..   ..++.++|+|||||++|+|++|+.||...+..... ..+.....+  ..+..+++.++++
T Consensus       173 ~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         173 STMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             CCcCCCccccCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCcccCCcccCCHHHHHH
Confidence            33468899999999854   33578999999999999999999999865433322 222222222  3456789999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+||..||++|||+.+++.|||+..
T Consensus       249 i~~~l~~dp~~Rpt~~~il~~~~~~~  274 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQHPFLKL  274 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhhChHhhh
Confidence            99999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-43  Score=329.19  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=202.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHH---HHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVE---LRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E---~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .||+|+||.||+|++..+++.||+|.+.............+..|   ++.++..+||||+.+++.+...+.+++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999875432222211222333   445566789999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++..+....     ..
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~~-----~~  153 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK-----PH  153 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCccC-----Cc
Confidence            9999988865 44589999999999999999999999999999999999998764 69999999987653221     13


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ...|+..|+|||++...  ..++.++||||+||++|+|++|+.||..... .............+.+|..+|.++.+++.
T Consensus       154 ~~~~~~~y~aPE~~~~~--~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  231 (278)
T cd05606         154 ASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE  231 (278)
T ss_pred             CcCCCcCCcCcHHhcCC--CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHH
Confidence            45789999999998532  3467899999999999999999999975422 11222333334456677788999999999


Q ss_pred             HhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        245 LCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +||..||++||     ++.++++|||+.
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            99999999999     999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.4e-43  Score=331.43  Aligned_cols=259  Identities=28%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            34566799999999999999999999999999876543334455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC---
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT---  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~---  159 (407)
                      |+++++|.++++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++.......   
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCccccc
Confidence            99999999999664 4589999999999999999999999999999999999998764 699999999864211000   


Q ss_pred             ---------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC--C
Q psy10603        160 ---------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE--T  228 (407)
Q Consensus       160 ---------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~--~  228 (407)
                               .........|+..|+|||.+..   ..++.++|+|||||++|||++|..||.+.. ..+.......+.  .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~~~~  235 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccCC
Confidence                     0001123467889999999854   346789999999999999999999997543 333333333322  2


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      |..+..+++++++++.+||++||++||+   +.|+++|||+.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~  277 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL  277 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcccc
Confidence            3333468899999999999999999998   79999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0696|consensus

Probab=100.00  E-value=1.1e-45  Score=335.22  Aligned_cols=256  Identities=29%  Similarity=0.415  Sum_probs=219.5

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv   80 (407)
                      .+++|..+||+|+||+|-+|..+.+.+.||||++++........++--+.|-++|.-. +.|.+++++..|++-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            5889999999999999999999999999999998765433222344556788887654 458999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+.||+|.-+++.. +.+.|..+..|+.+|+.||-+||++|||.||||.+||+++.+| ++||+|||+++.-..   .
T Consensus       429 MEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~---~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIF---D  503 (683)
T ss_pred             EEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeeccccccccc---C
Confidence            9999999999999764 4599999999999999999999999999999999999999986 699999999976322   1


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      .....++||||-|+|||.+..   .+|+.++|.||+||+||||+.|++||.+.+  ...+++.+....-..|+++|.|+.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~Y---qPYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI~ehnvsyPKslSkEAv  578 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQAIMEHNVSYPKSLSKEAV  578 (683)
T ss_pred             CcceeeecCCCcccccceEEe---cccccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHccCcCcccccHHHH
Confidence            233467999999999999854   568999999999999999999999998643  445666677777888999999999


Q ss_pred             HHHHHhcccCCCCcCCH-----HHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRATI-----FELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~-----~e~l~hp~~~  267 (407)
                      ++++..|.+.|.+|...     .++-.||||.
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR  610 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFR  610 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence            99999999999999753     5688899985

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2e-43  Score=324.77  Aligned_cols=249  Identities=22%  Similarity=0.371  Sum_probs=206.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||.||+|.+..+++.+|+|.+...    ......+.+|++++++++||||+++++.+...+.++++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            455667999999999999999999999999987632    1224568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+|||+++++ .+||+|||++......... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceee-
Confidence            999999999986533 3589999999999999999999999999999999999998764 6999999999776433211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......++..|+|||.+..   ..++.++|||||||++|||++ |..||.+. +..........+..+..+..++.++.
T Consensus       161 -~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKGYRMERPEGCPPKVY  235 (263)
T ss_pred             -ccCCCCCccccCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence             1122234668999998854   345789999999999999998 99999754 33344444444556677888999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++|||+.++++
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-43  Score=323.25  Aligned_cols=254  Identities=32%  Similarity=0.537  Sum_probs=213.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLFM   81 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~   81 (407)
                      +.....||.|+||.||+|.+..+++.+|+|.+..... .....+++..|++++++++||||+++++.+..  ....+++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            3456689999999999999999999999999875432 34445678899999999999999999997764  45689999


Q ss_pred             ecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         82 ELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALH-----ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        82 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH-----~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      ||+++++|..++...   ...+++..+..++.|++.||.|||     +.+++|+||||+||+++.++ .+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEeccccccc
Confidence            999999999998653   345899999999999999999999     89999999999999999764 699999999877


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE  233 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  233 (407)
                      ......   ......|++.|+|||++...   .++.++|+||||+++|+|++|+.||.... .......+..+..+.++.
T Consensus       160 ~~~~~~---~~~~~~~~~~~~~pE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  232 (265)
T cd08217         160 LGHDSS---FAKTYVGTPYYMSPEQLNHM---SYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEGKFRRIPY  232 (265)
T ss_pred             ccCCcc---cccccccCCCccChhhhcCC---CCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcCCCCCCcc
Confidence            643321   12345789999999998542   35789999999999999999999998643 444455556666677888


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .++.++.+++.+||+.||++|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            899999999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-43  Score=324.68  Aligned_cols=251  Identities=33%  Similarity=0.632  Sum_probs=209.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|++..+++.+|+|.+.....     .+.+.+|++++++++||||+++++.+......|+++|
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            34556689999999999999999899999999864321     5678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++......+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .+||+|||++........   
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~---  154 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMA---  154 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCcc---
Confidence            9999999999976566789999999999999999999999999999999999998865 699999999876643321   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQ  240 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~  240 (407)
                      ......|+..|+|||++.+   ..++.++|||||||++|+|++|+.||........ ...+.....+  ..+..++.++.
T Consensus       155 ~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQE---IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIPNKPPPTLSDPEKWSPEFN  230 (256)
T ss_pred             ccccccCCccccCHHHHhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhccCCCCCCCchhhcCHHHH
Confidence            1233567889999999854   3467899999999999999999999986443322 2222221222  23456788999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +++.+||+.||++|||+.|+++||||
T Consensus       231 ~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         231 DFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0194|consensus

Probab=100.00  E-value=1.4e-44  Score=345.39  Aligned_cols=253  Identities=25%  Similarity=0.455  Sum_probs=212.7

Q ss_pred             CccceeeecccccCeEEEEEEECCCCc---E-EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGE---L-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~---~-vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++++...+||+|+||+||+|.....+.   . ||+|.............+++++|.++|++++|||||++||+...+..+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            467888899999999999998765432   3 899988764445566788999999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ++|||+|+||+|.+++++....++..+...++.+.+.||+|||++++|||||-.+|+|++.+ +.+||+|||+++.-..-
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQY  315 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccCCcce
Confidence            99999999999999998877679999999999999999999999999999999999999875 45899999998664311


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH-hCCCCCCCCCcc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV-GMGETPTIPESL  235 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (407)
                      .... .  ...-...|+|||.+...   .++.++|||||||++||+++ |..||.+.. ..++..++ ..+.+...|...
T Consensus       316 ~~~~-~--~~klPirWLAPEtl~~~---~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  316 VMKK-F--LKKLPIRWLAPETLNTG---IFSFKTDVWSFGVLLWEIFENGAEPYPGMK-NYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             eecc-c--cccCcceecChhhhccC---ccccccchhheeeeEEeeeccCCCCCCCCC-HHHHHHHHHhcCccCCCCCCC
Confidence            1110 0  01124689999999643   57899999999999999998 889999754 44555555 667777888888


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++...++..||..||++|||+.++.+
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999999998765

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.3e-43  Score=330.34  Aligned_cols=250  Identities=33%  Similarity=0.589  Sum_probs=207.2

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      ..||+|+||+||+|++..+++.||+|.+...........+.+.+|++++++++|||++++++++...+..|+||||+. |
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            369999999999999999999999999976544444555678899999999999999999999999999999999996 5


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      ++.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....       ..+..
T Consensus       106 ~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~-------~~~~~  177 (313)
T cd06633         106 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS-------PANSF  177 (313)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC-------CCCCc
Confidence            77777765555689999999999999999999999999999999999998765 69999999885422       12345


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC-CCccCHHHHHHHHHh
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDEGQAFAELC  246 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~~i~~~  246 (407)
                      .|+..|+|||++.......++.++|||||||++|+|++|..||...... ...........+.. ...++..+++++.+|
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  256 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNDSPTLQSNEWTDSFRGFVDYC  256 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence            7899999999985432334678999999999999999999999765433 33333333333332 345788899999999


Q ss_pred             cccCCCCcCCHHHHhcCCeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+++|.+||++.++++|||+.
T Consensus       257 l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         257 LQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             ccCChhhCcCHHHHhcCcccC
Confidence            999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.5e-43  Score=327.83  Aligned_cols=255  Identities=30%  Similarity=0.492  Sum_probs=206.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            4456899999999999999999999999998764322 234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                       +++|.+++......+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++........  ...
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~--~~~  157 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEP--RLY  157 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCC--Ccc
Confidence             9999999876566699999999999999999999999999999999999998864 699999999876643321  122


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CC----------------
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GE----------------  227 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~----------------  227 (407)
                      ....|+..|+|||.+...  ..++.++|||||||++|||++|.+||....+.......... +.                
T Consensus       158 ~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         158 SHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccCcccccCceeeecc--ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            345789999999998542  33578999999999999999998888654332211111100 00                


Q ss_pred             ---CC--------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 ---TP--------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 ---~~--------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                         .+        ......+.++.+++.+||.+||.+|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence               00        0112457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-43  Score=322.67  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=204.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||.||+|.+.. +..+|+|.+..... .   ...+.+|+.+|++++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-S---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-c---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            45667799999999999998764 56799998763321 1   2467889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYT--  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCcee--
Confidence            9999999999876555689999999999999999999999999999999999998754 6999999998765332211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||++..   ..++.++|+||||+++|||++ |+.||... +..+....+..+..+..|...+.++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~s~G~~l~el~~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  232 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNF---SKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-SNYEVVEMISRGFRLYRPKLASMTVYE  232 (256)
T ss_pred             ccCCCCCchhhCChhhccc---CccchhhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            1122345668999999854   346789999999999999999 89999754 344555556556666667778899999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||+.||++||++.|+++
T Consensus       233 li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-43  Score=334.34  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=203.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcE----EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGEL----VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      ++.....||+|+||+||+|++..+++.    ||+|.+...  ......+++.+|+.+++.++||||+++++++... ..+
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            344455899999999999998766654    899988632  3344567788999999999999999999988754 578


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +++||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccccccCCC
Confidence            99999999999999977666689999999999999999999999999999999999998765 69999999998765332


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                      ... ......++..|+|||++..   ..++.++|||||||++|||++ |+.||.+.. ..+.......+..+..+..++.
T Consensus       164 ~~~-~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd05108         164 KEY-HAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTI  238 (316)
T ss_pred             cce-eccCCccceeecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhCCCCCCCCCCCCH
Confidence            211 1122334678999999854   346789999999999999997 999997543 3333333444455556677889


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++.+++.+||+.||++||++.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-43  Score=327.60  Aligned_cols=254  Identities=21%  Similarity=0.337  Sum_probs=207.1

Q ss_pred             CccceeeecccccCeEEEEEEEC----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNN----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      +++.+...||+|+||+||+|.+.    .+++.+|+|.+...  ........+.+|+.++++++||||+++++.+...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            45677789999999999999853    45678999998643  2334456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTE----------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN  141 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~----------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~  141 (407)
                      |+||||+++++|.+++....                ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ 
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~-  161 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL-  161 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC-
Confidence            99999999999999885321                2378889999999999999999999999999999999998764 


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM  220 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~  220 (407)
                      .+||+|||+++........ .......++..|+|||++.+   ..++.++|+|||||++|||++ |..||.+.. .....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMY---GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVI  236 (283)
T ss_pred             cEEeccccccccccCCcce-ecccCCCccceecChHHhcc---CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHH
Confidence            6999999999765432211 11233456778999999854   236789999999999999998 999997543 33445


Q ss_pred             HHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       221 ~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+.....+..+..+++++.+++.+||++||++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5555555566778899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.3e-44  Score=332.48  Aligned_cols=257  Identities=29%  Similarity=0.511  Sum_probs=205.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||.||++.+..+++.+|+|.+......  .....+.+|+.++.++. ||||+++++.+..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            344555899999999999999999999999998754322  34567889999999996 999999999999999999999


Q ss_pred             ecCCCCCHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         82 ELCTEGTLESLVQ----STEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        82 E~~~~g~L~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      ||+.. ++..+..    .....+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||+++....
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~  160 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD  160 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence            99874 5544332    1235589999999999999999999985 999999999999998764 699999999876543


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC----
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP----  232 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----  232 (407)
                      ...    .....|++.|+|||++.......++.++|||||||++|+|++|+.||.......+.+.+...+..+.++    
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         161 SIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE  236 (288)
T ss_pred             CCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence            211    133468899999999865322356889999999999999999999998654333333333333333332    


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..++.++.+|+.+||++||++|||+.+++.|||+.
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence            34789999999999999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=329.07  Aligned_cols=256  Identities=26%  Similarity=0.459  Sum_probs=202.2

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ..+.....||+|+||+||+|++..+++.||+|.+.......  ....+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            34566679999999999999999999999999987543221  1234668999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++ +|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.......  
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCCc--
Confidence            99985 89988876556789999999999999999999999999999999999998865 699999999865432111  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC-C----------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE-T----------  228 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~-~----------  228 (407)
                       ......++..|+|||++.+.  ..++.++||||+||++|+|++|+.||............+..  +. .          
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             -cccccccccccCCcHHhhcC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence             11233568899999988542  33578999999999999999999999754422222111100  00 0          


Q ss_pred             --------C--------CCCCccC--HHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        229 --------P--------TIPESLS--DEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       229 --------~--------~~~~~~s--~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                              +        .....++  .++.+++.+||+.||++|||+.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    0        0001234  788999999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.8e-43  Score=327.58  Aligned_cols=255  Identities=31%  Similarity=0.560  Sum_probs=204.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            4556689999999999999999999999999864432 222335578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|..++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++........   .
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~---~  156 (286)
T cd07847          82 CDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGD---D  156 (286)
T ss_pred             cCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCcc---c
Confidence            999888887654 44589999999999999999999999999999999999998765 699999999977643321   1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC----------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG----------------  226 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~----------------  226 (407)
                      .....++..|+|||++.+.  ..++.++|+|||||++|+|++|+.||.+..+......... .+                
T Consensus       157 ~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         157 YTDYVATRWYRAPELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccCcccccccCCHHHHhCC--CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence            2345678899999997542  3357899999999999999999999986443222111100 00                


Q ss_pred             --C-CCC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        227 --E-TPT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       227 --~-~~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                        . .|.         ....++..+.+|+.+||++||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0 000         012467889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG1989|consensus

Probab=100.00  E-value=1.8e-44  Score=356.92  Aligned_cols=254  Identities=29%  Similarity=0.463  Sum_probs=206.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEE-EEe------C
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGV-EIH------R   74 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~------~   74 (407)
                      .|+.+..|-+|||+.||+|++...|..||+|++-..   ++...+.+.+||++|++|+ |+|||.|++. ...      .
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            356677999999999999999998899999998643   6777889999999999998 9999999993 221      1


Q ss_pred             ceEEEEEecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         75 EEMVLFMELCTEGTLESLVQS-TEDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        75 ~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      -+++|.||||.||.|-+++.. ...+|+|.++.+|++|++.|+.+||...  |||||||-|||||+.+| ..||||||.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCccccc
Confidence            368899999999999888864 3455999999999999999999999987  99999999999999876 6999999998


Q ss_pred             eecCCCCCCCCcc------cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC
Q psy10603        152 VKISAHTTVPGEL------NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM  225 (407)
Q Consensus       152 ~~~~~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~  225 (407)
                      ...........+.      -....|+.|+|||.+.-.++.+++.|+|||+|||+||-|+....||++....     .+..
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIln  268 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILN  268 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEe
Confidence            6533222111100      0123589999999998778889999999999999999999999999864321     1222


Q ss_pred             CC--CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        226 GE--TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       226 ~~--~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.  .|.. +.+|+.+++||..||+.||++||++.|++.+-+.
T Consensus       269 g~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  269 GNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            22  2222 4789999999999999999999999998875543

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.8e-43  Score=342.92  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=201.5

Q ss_pred             eeeecccccCeEEEEEEECCC-----CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNET-----GELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l   79 (407)
                      +...||+|+||.||+|.+...     +..||||.+...  ......+.+.+|+++|.+++ ||||+++++++...+..||
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l  118 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI  118 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence            445899999999999987433     357999998643  23344567899999999996 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcC--------------------------------------------------------------
Q psy10603         80 FMELCTEGTLESLVQSTE--------------------------------------------------------------   97 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~--------------------------------------------------------------   97 (407)
                      |||||++|+|.+++....                                                              
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (400)
T cd05105         119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS  198 (400)
T ss_pred             EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence            999999999998875421                                                              


Q ss_pred             ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEE
Q psy10603         98 ---------------------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK  144 (407)
Q Consensus        98 ---------------------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vk  144 (407)
                                                       ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ ..+|
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~-~~~k  277 (400)
T cd05105         199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVK  277 (400)
T ss_pred             hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC-CEEE
Confidence                                             237788889999999999999999999999999999999875 4699


Q ss_pred             EEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH
Q psy10603        145 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV  223 (407)
Q Consensus       145 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~  223 (407)
                      |+|||+++........ .......+++.|+|||++.+   ..++.++|||||||++|||++ |..||............+
T Consensus       278 L~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         278 ICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD---NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             EEeCCcceeccccccc-cccCCcCCCcceEChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence            9999999765432211 11223456788999999854   346789999999999999997 999998654333333444


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+..+..+..++.++.+++.+||+.||++|||+.++.+
T Consensus       354 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            455556667788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-43  Score=331.10  Aligned_cols=250  Identities=35%  Similarity=0.548  Sum_probs=206.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      +....||+|+||.||+|++..+++.||+|.+......   ..+.+.+|+.+++.++||||+++++.+...+..|+||||+
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            3445899999999999999999999999998754322   2356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++++|.+++.+  ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++........   ..
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~---~~  172 (297)
T cd06656          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS---KR  172 (297)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCcc---Cc
Confidence            99999999854  3488999999999999999999999999999999999998764 699999999876543221   12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~~  242 (407)
                      ....+++.|+|||.+.+   ..++.++|+|||||++|+|++|..||...+..... ........+  ..+..++..++++
T Consensus       173 ~~~~~~~~y~aPE~~~~---~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l  248 (297)
T cd06656         173 STMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTPELQNPERLSAVFRDF  248 (297)
T ss_pred             CcccCCccccCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-eeeccCCCCCCCCccccCHHHHHH
Confidence            33568899999999854   33578999999999999999999999754433222 222222222  2456788999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+||.+||++||++.++++|||+.
T Consensus       249 i~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         249 LNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             HHHHccCChhhCcCHHHHhcCchhc
Confidence            9999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.9e-43  Score=331.53  Aligned_cols=258  Identities=29%  Similarity=0.472  Sum_probs=202.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLF   80 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv   80 (407)
                      ++.....||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++|+||+++++++...  +.+++|
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            4455568999999999999999999999999987543222 2223456799999999999999999998755  568999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+.+ +|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........ 
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~~-  163 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPAK-  163 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCccC-
Confidence            999975 88888866556689999999999999999999999999999999999998765 699999999987643221 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC------------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE------------  227 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~------------  227 (407)
                        ......+++.|+|||++.+.  ..++.++|||||||++|||++|+.||...+.......... .+.            
T Consensus       164 --~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         164 --PMTPKVVTLWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             --CCCcccccccccChhhhcCC--CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence              12233457889999998542  3457899999999999999999999986443322211111 000            


Q ss_pred             ----CCCC-----------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        228 ----TPTI-----------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       228 ----~~~~-----------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                          ...+           ....++++.++|.+||++||++|||+.|+++||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                0000           1235888999999999999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-43  Score=325.75  Aligned_cols=250  Identities=31%  Similarity=0.574  Sum_probs=210.9

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|+.++++++||||+++++.+.+.+.+++||||+++
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence            347999999999999999999999999987542  223456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.+++..  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++........   ....
T Consensus        87 ~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~---~~~~  160 (277)
T cd06640          87 GSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQI---KRNT  160 (277)
T ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCcc---cccc
Confidence            999999864  3589999999999999999999999999999999999998764 699999999976643221   1233


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHh
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC  246 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~  246 (407)
                      ..++..|+|||++..   ...+.++|+|||||++|||++|..||.... .......+..+..+.++..++.++.+++.+|
T Consensus       161 ~~~~~~y~apE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         161 FVGTPFWMAPEVIQQ---SAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccCcccccCHhHhcc---CCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            467889999999854   235789999999999999999999998543 3333333444456666777889999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |+.||++||++.++++|+|+..
T Consensus       237 l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         237 LNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             cccCcccCcCHHHHHhChHhhh
Confidence            9999999999999999999854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-43  Score=344.69  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             ceeeecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||.||+|...  .+++.||+|.+...        +...+|+++|++++||||+++++.+...+..|+|||
T Consensus        95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            34458999999999999754  45678999987532        124579999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++. ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........ .
T Consensus       167 ~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~-~  242 (392)
T PHA03207        167 KYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDT-P  242 (392)
T ss_pred             hcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCccccc-c
Confidence            996 588888743 45699999999999999999999999999999999999998765 6999999999776543221 1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHH-----------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKV-----------------  223 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~-----------------  223 (407)
                      ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.+....  ...+..+                 
T Consensus       243 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        243 QCYGWSGTLETNSPELLAL---DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             cccccccccCccCHhHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            2234679999999999854   34678999999999999999999999753321  1111000                 


Q ss_pred             ---------hCCCCCC--CC-----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        224 ---------GMGETPT--IP-----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       224 ---------~~~~~~~--~~-----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                               .....+.  +|     ..++.+++++|.+||..||++|||+.|++.||||..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                     0000111  11     235678899999999999999999999999999953

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-43  Score=322.92  Aligned_cols=254  Identities=29%  Similarity=0.495  Sum_probs=212.0

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|.++.+|+.+|+|.+...... ....+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            4566899999999999999999999999998754322 223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         85 TEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++..+||+|||.+.........   
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---  158 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL---  158 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc---
Confidence            9999999886533 247899999999999999999999999999999999999887666899999998765432211   


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      .....|++.|+|||++..   ..++.++|+|||||++++|++|..||.... ..+.......+..+..+..++.++++++
T Consensus       159 ~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         159 AYTCVGTPYYLSPEICQN---RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQGYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             ccccCCCccccCHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence            123468899999998754   235789999999999999999999997543 3334444445555556677899999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .+||..+|++|||+.|+++|||+
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.1e-43  Score=330.51  Aligned_cols=251  Identities=32%  Similarity=0.543  Sum_probs=207.5

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      ..||+|+||.||+|++..+++.+|+|.+........+..+.+.+|++++++++|||++++++++..++..++||||+++ 
T Consensus        31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-  109 (317)
T cd06635          31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-  109 (317)
T ss_pred             heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-
Confidence            3799999999999999999999999998755444445567788999999999999999999999999999999999975 


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++.....       ....
T Consensus       110 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~-------~~~~  181 (317)
T cd06635         110 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP-------ANSF  181 (317)
T ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC-------cccc
Confidence            77777755455689999999999999999999999999999999999998765 699999999865432       1335


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC-CCCCCccCHHHHHHHHHh
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELC  246 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~~i~~~  246 (407)
                      .|++.|+|||++.......++.++|+|||||++|||++|+.||..... ......+..+.. +..+..+++.+++++.+|
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            688999999997532233467899999999999999999999975432 233333333333 333456788999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |+.||.+||++.++++|+|+..
T Consensus       261 l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         261 LQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ccCCcccCcCHHHHHhChhhhc
Confidence            9999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-43  Score=325.92  Aligned_cols=250  Identities=32%  Similarity=0.543  Sum_probs=202.2

Q ss_pred             ceeeecccccCeEEEEEEEC----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNN----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +....||.|+||.||+|.+.    ..+..|+||.+..  ....+..+.+.+|++.+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence            45678999999999999987    4457899999854  23444568899999999999999999999999988889999


Q ss_pred             EecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         81 MELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      +||+++|+|.+++... ...+++.....++.|++.||.|||+++++|+||+|+|||++.++ .+||+|||++........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence            9999999999999875 45699999999999999999999999999999999999999865 799999999987632211


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      . .......+...|+|||.+....   ++.++||||||+++|||++ |+.||.+. +..+....+..+..+..+..++..
T Consensus       159 ~-~~~~~~~~~~~~~aPE~~~~~~---~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  159 Y-KNDSSQQLPLRYLAPEVLKDGE---YTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLPIPDNCPKD  233 (259)
T ss_dssp             E-EESTTSESGGGGS-HHHHHHSE---ESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETTSBTTSBHH
T ss_pred             c-cccccccccccccccccccccc---cccccccccccccccccccccccccccc-ccccccccccccccceeccchhHH
Confidence            1 1112234667899999986532   5789999999999999999 78999865 455556666666677778889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+++..||..||++|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0662|consensus

Probab=100.00  E-value=1.7e-44  Score=293.98  Aligned_cols=252  Identities=29%  Similarity=0.532  Sum_probs=208.9

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .+||+|.||+||+|++..+++.||+|.++... .++..-...++|+.+|+.++|.|||++++....+..+-+|+|||.. 
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            38999999999999999999999999998764 3444456788999999999999999999999999999999999975 


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|..+..+..+.+..+.++.++.|++.||.+||+++++|||+||.|+||+.+| .+||+|||+++.+.-...   .....
T Consensus        86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvr---cysae  161 (292)
T KOG0662|consen   86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVR---CYSAE  161 (292)
T ss_pred             HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceE---eeece
Confidence            89999888888899999999999999999999999999999999999999865 799999999988764432   22344


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHH--HH-hCCC---------------C
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF--KV-GMGE---------------T  228 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~--~~-~~~~---------------~  228 (407)
                      +-|.+|.+|.++.+..  -|+...|+||.|||+.|+.. |++.|++.+...+...  +. +...               .
T Consensus       162 vvtlwyrppdvlfgak--ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             eeeeeccCcceeeeee--hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            6799999999998754  36889999999999999986 7777776655444322  11 1110               0


Q ss_pred             CCCC---------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        229 PTIP---------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       229 ~~~~---------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |..|         +.++...++++.++|.-+|.+|.++++.++||||.
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~  287 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS  287 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence            1111         23455679999999999999999999999999985

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-43  Score=328.39  Aligned_cols=248  Identities=32%  Similarity=0.581  Sum_probs=208.3

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      ..||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|+.++++++||||+++++.+...+..|+||||++++
T Consensus        10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642          10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            37999999999999999999999999886442  2234567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|.+++..  ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||++..+.....   .....
T Consensus        88 ~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~---~~~~~  161 (277)
T cd06642          88 SALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQI---KRNTF  161 (277)
T ss_pred             cHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcch---hhhcc
Confidence            99998854  4589999999999999999999999999999999999998764 699999999876543221   12335


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      .|+..|+|||++..   ..++.++|+|||||++|||++|+.||..... ......+..+..+.++..++.++.+++.+||
T Consensus       162 ~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         162 VGTPFWMAPEVIKQ---SAYDFKADIWSLGITAIELAKGEPPNSDLHP-MRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             cCcccccCHHHhCc---CCCchhhhHHHHHHHHHHHHhCCCCCcccch-hhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            68889999999854   2457899999999999999999999975432 2233333444455566678899999999999


Q ss_pred             ccCCCCcCCHHHHhcCCeee
Q psy10603        248 RHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+|++||++.++++|||+.
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHH
Confidence            99999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.2e-43  Score=327.30  Aligned_cols=253  Identities=31%  Similarity=0.564  Sum_probs=201.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEE-----eCceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEI-----HREEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~-----~~~~~~   78 (407)
                      .....||+|+||+||+|.+..+++.+|+|++.....    ....+.+|+.+++++ +||||+++++.+.     ..+.++
T Consensus        21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            444599999999999999999999999998764321    124567899999998 6999999999874     345689


Q ss_pred             EEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         79 LFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      +||||+++++|.+++..   ....+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++...
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~  175 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLT  175 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeecc
Confidence            99999999999988753   234588999999999999999999999999999999999999875 59999999997764


Q ss_pred             CCCCCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CC
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TI  231 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~  231 (407)
                      ....   ......|++.|+|||++....  ...++.++|||||||++|||++|+.||........ .........+  ..
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~  251 (286)
T cd06638         176 STRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKIPRNPPPTLHQ  251 (286)
T ss_pred             cCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-HhhccccCCCcccC
Confidence            3221   123346899999999985321  23367899999999999999999999986543322 2222222222  23


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +..++.++.+++.+||+.||++|||+.|+++|+|+
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            45578899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.8e-43  Score=326.07  Aligned_cols=254  Identities=32%  Similarity=0.557  Sum_probs=203.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-----ceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR-----EEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-----~~~   77 (407)
                      +.....||+|+||.||+|.+..+++.+|+|++.....    ....+.+|+.++.++ +|||++++++++...     +.+
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            4455589999999999999999999999999864321    234567889999988 899999999988754     358


Q ss_pred             EEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceec
Q psy10603         78 VLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI  154 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~  154 (407)
                      ++||||+++++|.++++.   ....+++..+..++.|++.||+|||+.+++||||||+||+++.++ .+||+|||++...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            999999999999998753   234589999999999999999999999999999999999998765 5999999998765


Q ss_pred             CCCCCCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--
Q psy10603        155 SAHTTVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--  230 (407)
Q Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--  230 (407)
                      ......   .....|+..|+|||++....  ...++.++|||||||++|||++|+.||...... .....+..+..+.  
T Consensus       179 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~  254 (291)
T cd06639         179 TSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIPRNPPPTLL  254 (291)
T ss_pred             cccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHhcCCCCCCC
Confidence            432211   12346889999999985422  123578999999999999999999999854332 3333333333332  


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .++..+.++.+++.+||++||++||++.|+++||||
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence            245678899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.3e-43  Score=325.11  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             cceeeecccccCeEEEEEEECC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|.+..     ++..||+|.+...  ........+.+|+.++++++||||+++++++.+.+..+
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            3445589999999999999877     7788999987533  22333456889999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccC
Q psy10603         79 LFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGS  150 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGl  150 (407)
                      +||||+++++|.+++....      ..+++..+..++.||+.||.|||+++++||||||+|||++.++  ..+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999986543      2488999999999999999999999999999999999998653  3589999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETP  229 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~  229 (407)
                      ++........ ........+..|+|||++..   ..++.++|||||||++|||++ |..||.... .......+.....+
T Consensus       166 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~~  240 (277)
T cd05036         166 ARDIYRASYY-RKGGRAMLPIKWMPPEAFLD---GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-NQEVMEFVTGGGRL  240 (277)
T ss_pred             ccccCCccce-ecCCCCCccHhhCCHHHHhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCcC
Confidence            9776322111 11112234568999999854   336889999999999999997 999998543 33444444444555


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ..|..++.++.+++.+||+.||++||++.++++|-
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l  275 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI  275 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence            66778899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.7e-43  Score=326.63  Aligned_cols=255  Identities=26%  Similarity=0.434  Sum_probs=200.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|.+..+|+.||+|++.......  ....+.+|+.+|+.++|+||+++++++...+..|+|||
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            4556669999999999999999999999999986543222  22356789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+. +++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~---~  158 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPS---Q  158 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCC---C
Confidence            996 577666655445688899999999999999999999999999999999998765 69999999987543221   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC-----------CC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE-----------TP  229 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~-----------~~  229 (407)
                      ......+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||.......+.+.....  +.           .|
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCccccccccCCceeecC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            12334678999999998542  23567899999999999999999999765433222221100  00           00


Q ss_pred             ----C------------CCC--ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        230 ----T------------IPE--SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       230 ----~------------~~~--~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                          .            ...  ..+.++.+++.+||+.||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                0            001  125688999999999999999999999999996

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG1006|consensus

Probab=100.00  E-value=8.9e-46  Score=318.46  Aligned_cols=250  Identities=30%  Similarity=0.514  Sum_probs=212.8

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||.|+||+|++-.++.+|+..|||+|+....  .+..++++.|.... +.-+.||||++||+...++..||+||+|. -
T Consensus        71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            89999999999999999999999999987643  45567888898764 45577999999999999999999999996 4


Q ss_pred             CHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         88 TLESLVQS----TEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        88 ~L~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +|..+++.    ....+||..+-.++...+.||+||-.. .|||||+||+|||++..| .+||||||++..+.....   
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv~SiA---  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLVDSIA---  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHHHHHH---
Confidence            77766542    344599999999999999999999865 899999999999999876 599999999977654322   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC--C---ccCH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--E---SLSD  237 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~---~~s~  237 (407)
                       .+.-.|...|||||.+.... .+|+.++|+||||++|||++||+.||...++-.+.+.++..|..|.+.  .   ..|.
T Consensus       224 -kT~daGCrpYmAPERi~p~~-~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  224 -KTVDAGCRPYMAPERIDPSD-KGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             -hhhccCCccccChhccCCcc-CCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence             23347889999999996533 468899999999999999999999999888877778888888887653  2   3789


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+..||..||.+|-+.||...+++.+||..
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            999999999999999999999999999974

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-43  Score=322.16  Aligned_cols=253  Identities=22%  Similarity=0.328  Sum_probs=206.9

Q ss_pred             ccceeeecccccCeEEEEEEECCC---CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNET---GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +++....||+|+||+||+|.+..+   ...+|||.+....  .......+.+|+.++++++||||+++++.+...+..++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            456677999999999999998644   4579999886432  33445678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      +|||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhccccccc
Confidence            9999999999999976555689999999999999999999999999999999999998764 699999999987642111


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      . .......+++.|+|||.+..   ..++.++||||||+++|+|++ |..||.... ..+....+..+..+..+...++.
T Consensus       162 ~-~~~~~~~~~~~y~~Pe~~~~---~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd05033         162 T-YTTKGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRLPPPMDCPSA  236 (266)
T ss_pred             c-eeccCCCCCccccChhhhcc---CCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHH
Confidence            1 01112234678999998854   346789999999999999998 999997543 33444445444455556778999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++.+||+.||++||++.|++++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-43  Score=329.89  Aligned_cols=248  Identities=34%  Similarity=0.551  Sum_probs=205.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||++.+..+++.||||.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+||||+++++
T Consensus        29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             cccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            7999999999999999999999999986432   2334668899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.+++..  ..+++..+..++.||+.||.|||+++|+||||||+||+++.++ .+||+|||++.......   .......
T Consensus       106 L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~---~~~~~~~  179 (292)
T cd06658         106 LTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEV---PKRKSLV  179 (292)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhccccc---ccCceee
Confidence            9998854  3489999999999999999999999999999999999998764 69999999986543222   1223457


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHHHh
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC  246 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~~~  246 (407)
                      |++.|+|||.+..   ..++.++|+|||||++|||++|+.||..... ......+.....+.+  ....+..+++++.+|
T Consensus       180 ~~~~y~aPE~~~~---~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         180 GTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             cCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence            8999999999854   3457899999999999999999999975432 233333222222222  235788999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      |..||.+|||+.|+++|||+...
T Consensus       256 l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         256 LVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             ccCChhHCcCHHHHhhChhhhcc
Confidence            99999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-43  Score=331.23  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=201.1

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcE--EEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGEL--VAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   78 (407)
                      +++.+...||+|+||.||+|.+..++..  +|+|.+..  .........+.+|+.++.++ +||||+++++++...+.+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            3566677999999999999998877765  46666543  22334456788999999999 8999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         79 LFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      +||||+++|+|.+++....               ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~~  163 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA  163 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-cE
Confidence            9999999999999986432               2478999999999999999999999999999999999998765 69


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||++.......    ......++..|+|||++..   ..++.++|||||||++|||+| |..||.... ..+....
T Consensus       164 kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEK  235 (303)
T ss_pred             EeCccccCcccchhh----hcccCCCcccccCHHHHhc---cCCcccccchhhhhHHHHHHhcCCCCcccCC-hHHHHHH
Confidence            999999986432111    0111234567999998744   346789999999999999998 999997533 2333333


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ...+..+..+..+++++.+++.+||+.||++||++.+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            333444555667889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.1e-43  Score=359.76  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=200.9

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ........||+|+||+||+|++..+|+.||+|++...........+++.+|++++++++||||+++++++.+.+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            34455679999999999999999999999999997654445556678999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         82 ELCTEGTLESLVQST----------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        82 E~~~~g~L~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      ||++||+|.++++..          ...++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFGLA  160 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWGAA  160 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecCcc
Confidence            999999999988642          12245567888999999999999999999999999999998765 6999999999


Q ss_pred             eecCCCCCC---------------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch
Q psy10603        152 VKISAHTTV---------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN  216 (407)
Q Consensus       152 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~  216 (407)
                      +........               .......+||+.|||||++.+   ..++.++|||||||++|||++|+.||......
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g---~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG---VPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC---CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            876211100               001123579999999999854   34688999999999999999999999753322


Q ss_pred             HHHHHHHhCCCCCC--CCCccCHHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        217 YQIMFKVGMGETPT--IPESLSDEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       217 ~~~~~~~~~~~~~~--~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                       .............  ....+++.+.+++.+||+.||++|++..+.+
T Consensus       238 -ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        238 -KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             -hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence             2222111111111  1246788999999999999999998765544

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.7e-43  Score=320.54  Aligned_cols=254  Identities=34%  Similarity=0.585  Sum_probs=211.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .++.+...||+|+||.||+|.+..+|+.||+|.++.....+....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            35667789999999999999999999999999987654445555678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||+++|+|..++...   ...+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++..+....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccCCC
Confidence            999999999988542   34489999999999999999999999999999999999998765 69999999987654332


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-HHHHHHHhCCCCCCCCC-ccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIPE-SLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~-~~s  236 (407)
                      .   ......|++.|+|||.+.+   ..++.++|+|||||++|+|++|+.||...... .........+..+..|. .++
T Consensus       161 ~---~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd08224         161 T---AAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS  234 (267)
T ss_pred             c---ccceecCCccccCHHHhcc---CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence            1   1234568899999998854   34578999999999999999999999654332 23333444445555555 788


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..+++.+||..+|++|||+.++++
T Consensus       235 ~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         235 EELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-43  Score=325.47  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=206.1

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++++...||+|+||.||+|++.     .+++.||+|.+...  ...+..+.+.+|+++|++++||||+++++.+......
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3455668999999999999874     34678999988643  2233457889999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEE
Q psy10603         78 VLFMELCTEGTLESLVQSTE-------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK  144 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~-------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vk  144 (407)
                      ++||||+++++|.+++....             ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~k  162 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVK  162 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-eEE
Confidence            99999999999999986532             3478889999999999999999999999999999999998864 699


Q ss_pred             EEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH
Q psy10603        145 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV  223 (407)
Q Consensus       145 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~  223 (407)
                      |+|||+++........ .......+++.|+|||++..   ..++.++|||||||++|||++ |..||.... .......+
T Consensus       163 l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~~~  237 (280)
T cd05049         163 IGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIECI  237 (280)
T ss_pred             ECCcccceecccCcce-ecCCCCcccceecChhhhcc---CCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH
Confidence            9999999765322211 11123345788999999854   346789999999999999998 999997543 34445555


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+..+..+..++.++.+++.+||++||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            556666667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.1e-43  Score=328.74  Aligned_cols=250  Identities=31%  Similarity=0.560  Sum_probs=207.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|++..+++.+|+|.+...........+++.+|+++++.++|||++++++++...+..++||||+. |+
T Consensus        22 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~  100 (308)
T cd06634          22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS  100 (308)
T ss_pred             heeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CC
Confidence            79999999999999999999999999875433344455678899999999999999999999999999999999997 57


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      +.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||++......       ....
T Consensus       101 l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~-------~~~~  172 (308)
T cd06634         101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-------NXFV  172 (308)
T ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-------cccc
Confidence            8777655455689999999999999999999999999999999999998764 6999999998765322       2356


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC-CCCccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT-IPESLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~~i~~~l  247 (407)
                      |++.|+|||++.......++.++|||||||++|+|++|..||...... ........+..+. .+..++.++.+++.+||
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  251 (308)
T cd06634         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSEYFRNFVDSCL  251 (308)
T ss_pred             CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCCCcCcccccHHHHHHHHHHh
Confidence            889999999975322234578999999999999999999999754332 2233333334343 24468899999999999


Q ss_pred             ccCCCCcCCHHHHhcCCeeee
Q psy10603        248 RHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .++|++||++.++++|||+..
T Consensus       252 ~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         252 QKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             hCCcccCCCHHHHhhCccccc
Confidence            999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.2e-43  Score=334.93  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=201.5

Q ss_pred             ceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-ceE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR-EEM   77 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~   77 (407)
                      .....||+|+||.||+|.+.     .+++.||+|+++...  .....+.+.+|+.++.++ +||||+++++.+... ..+
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054          10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             hhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            34558999999999999743     345789999886432  223446778999999999 899999999987654 568


Q ss_pred             EEEEecCCCCCHHHHHhhcC------------------------------------------------------------
Q psy10603         78 VLFMELCTEGTLESLVQSTE------------------------------------------------------------   97 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~------------------------------------------------------------   97 (407)
                      +++|||+++++|.+++....                                                            
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999999885421                                                            


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccc
Q psy10603         98 DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE  177 (407)
Q Consensus        98 ~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE  177 (407)
                      ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+...... .......++..|+|||
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE  245 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPE  245 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcch-hhccCCCCCccccCcH
Confidence            2478899999999999999999999999999999999999764 6999999999775432211 1112335567899999


Q ss_pred             cccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCC
Q psy10603        178 VFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRAT  256 (407)
Q Consensus       178 ~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t  256 (407)
                      ++.+   ..++.++|||||||++|||++ |..||...............+..+..+...++++.+++.+||+.+|++||+
T Consensus       246 ~~~~---~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         246 SIFD---KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             HhcC---CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            9854   346889999999999999997 999997644333333444445566667788999999999999999999999


Q ss_pred             HHHHhcCC
Q psy10603        257 IFELLQHP  264 (407)
Q Consensus       257 ~~e~l~hp  264 (407)
                      +.|+++|.
T Consensus       323 ~~ell~~l  330 (337)
T cd05054         323 FSELVEIL  330 (337)
T ss_pred             HHHHHHHH
Confidence            99998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-43  Score=323.42  Aligned_cols=255  Identities=33%  Similarity=0.587  Sum_probs=205.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc------
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE------   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~------   75 (407)
                      .+.....||+|+||.||+|.+..+++.+|+|++.....    ....+.+|+.+++++ +||||+++++.+....      
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            34455699999999999999999999999999875422    235678999999998 7999999999987644      


Q ss_pred             eEEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         76 EMVLFMELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      .+++||||+++++|.++++..   ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||++.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~  161 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccce
Confidence            489999999999999988653   35689999999999999999999999999999999999998764 69999999987


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      .......   ......|++.|+|||++....  ...++.++|||||||++|+|++|+.||...... ....+...+..+.
T Consensus       162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~  237 (275)
T cd06608         162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNPPPT  237 (275)
T ss_pred             ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccCCCC
Confidence            6543221   223457899999999875321  234577899999999999999999999754332 2333333333333


Q ss_pred             C--CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        231 I--PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       231 ~--~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +  +..++.++++++.+||..||++|||+.|+++|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            2  23478899999999999999999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.8e-43  Score=327.04  Aligned_cols=259  Identities=26%  Similarity=0.422  Sum_probs=204.3

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +.+.....||+|++|+||+|.+..+|+.||+|.+..... .......+.+|++++++++||||+++++++...+..|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            455667799999999999999999999999999865432 2233456778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ||++ ++|..++..... .+++..+..++.||+.||+|||+++++||||||+||+++.++..+||+|||++.......  
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--  157 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--  157 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence            9996 477777654332 368889999999999999999999999999999999998766679999999997653221  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh---CC-----------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG---MG-----------  226 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~---~~-----------  226 (407)
                       .......+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||..............   ..           
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             -cccccCceeecccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence             112334678899999988542  2357899999999999999999999975433222111110   00           


Q ss_pred             -----CCCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 -----ETPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 -----~~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                           ..+.        ....+++++.+++.+||+.||++||++.++++||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                 0000        1235788899999999999999999999999999985

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-43  Score=323.73  Aligned_cols=251  Identities=30%  Similarity=0.536  Sum_probs=208.0

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN---QKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ....||+|+||.||+|.+..+++.||+|.+....  .....+.+.+|+.++++++   |||++++++.+...+..++|||
T Consensus         5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            4457999999999999999999999999986542  2233466778999998886   9999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.  ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||++........   
T Consensus        83 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~---  156 (277)
T cd06917          83 YAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSS---  156 (277)
T ss_pred             cCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcc---
Confidence            9999999999864  3589999999999999999999999999999999999999864 699999999987654331   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC-ccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~  241 (407)
                      ......|+..|+|||.+..  ...++.++|+|||||++|+|++|..||...... ...........+.++. .++.++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITE--GKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-RAMMLIPKSKPPRLEDNGYSKLLRE  233 (277)
T ss_pred             ccccccCCcceeCHHHhcc--CCccccchhHHHHHHHHHHHHhCCCCCCCCChh-hhhhccccCCCCCCCcccCCHHHHH
Confidence            2234578999999998854  234578999999999999999999999754332 2222222333444544 38899999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+||+.||++||++.|++.|+|+.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~  259 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIK  259 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhh
Confidence            99999999999999999999999984

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.2e-43  Score=320.03  Aligned_cols=255  Identities=33%  Similarity=0.584  Sum_probs=217.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|++|.||+|++..+++.||+|++......  ...+.+.+|+..+.+++||||+++++.+...+..++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            455667999999999999999999999999998754322  445778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++ .++|+|||++......... 
T Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc-
Confidence            99999999999754 558999999999999999999999 9999999999999998865 6999999998776433221 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--chHHHHHHHhCCCCCCCCCc-cCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIMFKVGMGETPTIPES-LSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~-~s~~  238 (407)
                        .....++..|+|||.+...   .++.++|+||||+++|+|++|+.||....  ...+....+.....+.++.. ++..
T Consensus       157 --~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGE---SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE  231 (264)
T ss_pred             --ccceeecccccCHhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence              1245688899999998542   46789999999999999999999998654  44455555555556666666 8999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+++..||.++|++||++.|+++|||+.
T Consensus       232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~  260 (264)
T cd06623         232 FRDFISACLQKDPKKRPSAAELLQHPFIK  260 (264)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence            99999999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.1e-43  Score=327.92  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=203.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLFM   81 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~   81 (407)
                      +.....||+|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++.+++||||+++++++...  +..|+||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            34455899999999999999999999999999754332 23344567899999999999999999998877  8899999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++ +|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||++.......   
T Consensus        86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~---  160 (293)
T cd07843          86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPL---  160 (293)
T ss_pred             hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCc---
Confidence            99985 99888876555689999999999999999999999999999999999998865 69999999997765332   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--C-------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--G-------------  226 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~-------------  226 (407)
                      .......+++.|+|||.+.+.  ...+.++|+||||+++|+|++|..||...... ....++..  +             
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             cccccccccccccCchhhcCC--ccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhcc
Confidence            112334678899999988543  23578999999999999999999999754322 11111100  0             


Q ss_pred             ---------------CCCCCCCc-cCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        227 ---------------ETPTIPES-LSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       227 ---------------~~~~~~~~-~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                     ....++.. +++.+.+++.+||+.||++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                           01112333 58889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-43  Score=319.84  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=209.2

Q ss_pred             ecccccCeEEEEEEECCC---CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNET---GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .||+|+||.||+|.+...   +..+|+|.+.......  ..+.+.+|++.+..++|+||+++++++.....+++||||++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            689999999999998866   8899999987543322  45778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         86 EGTLESLVQST--------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        86 ~g~L~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      +++|.++++..        ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||.+......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~  158 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccccc
Confidence            99999999765        36689999999999999999999999999999999999998864 6999999999776543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      .. ........+++.|+|||.+...   .++.++|||||||++|+|++ |..||... ...+.......+.....+..++
T Consensus       159 ~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd00192         159 DY-YRKKTGGKLPIRWMAPESLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRLPKPEYCP  233 (262)
T ss_pred             cc-cccccCCCcCccccCHHHhccC---CcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCCCCccCC
Confidence            21 1112345678899999988543   46789999999999999999 69999865 3444555555566667788899


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .++.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         234 DELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.4e-43  Score=324.73  Aligned_cols=251  Identities=24%  Similarity=0.421  Sum_probs=204.9

Q ss_pred             ccceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.....||+|+||+||++.+     ..++..+|+|.+...   .....+.+.+|+.++++++||||+++++.+...+.+
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            345566899999999999985     334567999988643   234456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEE
Q psy10603         78 VLFMELCTEGTLESLVQSTE------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKL  145 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl  145 (407)
                      ++||||+++++|.+++....            ..+++..+..++.|++.||+|||++|++||||||+|||+++++ .+||
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~kl  161 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKI  161 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cEEe
Confidence            99999999999999986432            2489999999999999999999999999999999999998765 6999


Q ss_pred             EcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHh
Q psy10603        146 GDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG  224 (407)
Q Consensus       146 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~  224 (407)
                      +|||+++........ .......+++.|+|||++..   ..++.++|+|||||++|+|++ |..||.... .......+.
T Consensus       162 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-~~~~~~~i~  236 (288)
T cd05093         162 GDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECIT  236 (288)
T ss_pred             ccCCccccccCCcee-ecCCCCCccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH
Confidence            999999765332111 11123345778999999854   346789999999999999998 999997543 334555555


Q ss_pred             CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       225 ~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..+..+..++.++.+++.+||+.||.+|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            66666667788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.6e-43  Score=322.36  Aligned_cols=254  Identities=33%  Similarity=0.569  Sum_probs=207.9

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++++....||+|+||.||+|++..+++.+|||.+......+....+++.+|+.+++.++||||+++++.+..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            34566678999999999999999999999999887654445555678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||+++++|.++++.   ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccccCC
Confidence            99999999998863   234589999999999999999999999999999999999998765 69999999987654322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH-HHHHHHhCCCCCCC-CCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QIMFKVGMGETPTI-PESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~-~~~~~~~~~~~~~~-~~~~s  236 (407)
                      .   ......|++.|+|||++..   ..++.++|+||||+++|+|++|..||....... .....+.....+.. +..++
T Consensus       161 ~---~~~~~~~~~~~~ape~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd08229         161 T---AAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS  234 (267)
T ss_pred             c---ccccccCCcCccCHHHhcC---CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence            1   1234578899999999854   335789999999999999999999997543332 22223322333333 35688


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++++++.+||+.||++|||+.++++
T Consensus       235 ~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         235 EELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.5e-43  Score=323.47  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=202.0

Q ss_pred             cceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|.+.     .+++.||+|.+...  .......++.+|+.+++.++||||+++++++......+
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            445568999999999999864     34568999987532  23334567889999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHhhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         79 LFMELCTEGTLESLVQSTED---------GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      +||||+++|+|.++++....         .+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~l~dfg  164 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFG  164 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEEECCCC
Confidence            99999999999999865322         246778899999999999999999999999999999999764 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCC
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET  228 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~  228 (407)
                      +++......... ......+++.|+|||++..   ..++.++|||||||++|||++ |..||.... .......+..+..
T Consensus       165 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~  239 (277)
T cd05062         165 MTRDIYETDYYR-KGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVLRFVMEGGL  239 (277)
T ss_pred             CccccCCcceee-cCCCCccCHhhcChhHhhc---CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCc
Confidence            987653322111 1112345778999999854   346789999999999999999 789997543 3344444445555


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..+..+++++++++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            66678889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-42  Score=322.32  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=203.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      ++.....||+|+||+||+|++..+++    .||+|.+...  ......+.+.+|+.++..++||||+++++.+.. ...+
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            45666799999999999999877776    4899988643  234445678899999999999999999998865 4578


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +++||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+++++ .+||+|||+++......
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeeccccc
Confidence            99999999999999976555689999999999999999999999999999999999998764 69999999998764322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                      .. .......+++.|+|||.+..   ..++.++|||||||++|||++ |..||.... .......+..+..+..+..+++
T Consensus       164 ~~-~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05109         164 TE-YHADGGKVPIKWMALESILH---RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREIPDLLEKGERLPQPPICTI  238 (279)
T ss_pred             ce-eecCCCccchhhCCHHHhcc---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHCCCcCCCCccCCH
Confidence            11 01112234678999999854   346789999999999999998 999997533 3333344445555566778899


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+++.+||+.||++||++.++++
T Consensus       239 ~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         239 DVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-42  Score=320.13  Aligned_cols=253  Identities=21%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +++....||+|+||.||+|.+..+++   .+|+|.+....  .....+.+.+|++++.+++||||+++.+++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            45667799999999999999876654   78999886432  23345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++++|.+++......+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++........
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceecccccc
Confidence            9999999999999976556689999999999999999999999999999999999998764 699999999976643221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      ..........++.|+|||++..   ..++.++|||||||++|||++ |+.||.... .......+..+.....+..++.+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~  238 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAY---RKFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVMKAINDGFRLPAPMDCPSA  238 (268)
T ss_pred             cceeccCCCcCceecCHHHhhc---CCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-HHHHHHHHhcCCCCCCCCCCCHH
Confidence            1111111223457999999854   235789999999999999997 999997543 33444444444444455678899


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +.+++.+||+.||++||++.++++
T Consensus       239 ~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         239 VYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-42  Score=323.04  Aligned_cols=250  Identities=30%  Similarity=0.455  Sum_probs=197.4

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--ceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHR--EEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~E   82 (407)
                      ....||+|+||.||+|.+..+++.||+|++........  .....+|+.++.++. ||||+++++.+.+.  +.+++|||
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45689999999999999999999999999865422221  123457999999885 99999999999887  88999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++ ++|.+.+......+++..+..++.|++.||.|||++|++||||||+||+++.  +.+||+|||+++.......   
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~---  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPP---  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCC---
Confidence            997 4777777655556899999999999999999999999999999999999988  4699999999977643221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--HH------------hCCC-
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--KV------------GMGE-  227 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--~~------------~~~~-  227 (407)
                       .....+++.|+|||++...  ..++.++|||||||++|||++|..||...+.......  ..            .... 
T Consensus       155 -~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         155 -YTEYISTRWYRAPECLLTD--GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             -cCCCCCCcccCChhHhhcC--CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence             1335678999999987432  2357899999999999999999999975432211100  00            0000 


Q ss_pred             -CCC-----------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 -TPT-----------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 -~~~-----------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                       ...           +...++.++.+++.+||.+||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence             000           113568899999999999999999999999999996

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.5e-43  Score=328.35  Aligned_cols=247  Identities=34%  Similarity=0.521  Sum_probs=205.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.++..++||||+++++.+...+..|++|||+++++
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            79999999999999999999999999865432   224567899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |..++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........   ......
T Consensus       105 L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~---~~~~~~  178 (297)
T cd06659         105 LTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVP---KRKSLV  178 (297)
T ss_pred             HHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccc---ccccee
Confidence            9998754  3489999999999999999999999999999999999998765 699999999865543221   123457


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC--CCCCCccCHHHHHHHHHh
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET--PTIPESLSDEGQAFAELC  246 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~i~~~  246 (407)
                      |++.|+|||++.+   ..++.++|||||||++|||++|+.||..... ...+..+.....  ...+..++.++.+++.+|
T Consensus       179 ~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         179 GTPYWMAPEVISR---TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-VQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             cCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            8999999999854   2357899999999999999999999975432 233333322221  223446788999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |+.||++||++.++++|||+..
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhcc
Confidence            9999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.8e-43  Score=326.48  Aligned_cols=254  Identities=30%  Similarity=0.498  Sum_probs=201.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|++..+++.||||.+...... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            4456899999999999999999999999988654322 223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         85 TEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      + ++|..++... ...+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|||++........   .
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~---~  156 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR---T  156 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc---c
Confidence            6 5888887543 34589999999999999999999999999999999999998865 699999999876532211   1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---------------  228 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---------------  228 (407)
                      .....+++.|+|||++.+.  ..++.++|||||||++|||+||+.||..................               
T Consensus       157 ~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccCCeEEecC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            2234578899999988543  23578899999999999999999999754322211111100000               


Q ss_pred             ----C--------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        229 ----P--------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       229 ----~--------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                          +        .....+++++++++.+||+.||++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                0        0123478889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-43  Score=319.09  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|+||.||+|.+. ++..+|+|.+......    ...+.+|+.++++++||||+++++++...+..|+|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            4566779999999999999876 4667999988643222    2357789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++........  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~--  156 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYT--  156 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceeccccccc--
Confidence            9999999999876555689999999999999999999999999999999999998765 6999999998765432211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||.+..   ..++.++|+|||||++|+|++ |+.||.... .......+..+..+..+...+.++.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDY---SRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-NSEVVESVSAGYRLYRPKLAPTEVYT  232 (256)
T ss_pred             ccCCCCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            1112234457999998854   346789999999999999999 899997543 34445555555556667788999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcC
Q psy10603        242 FAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++.+||..+|++|||+.|+++.
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=318.05  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=199.0

Q ss_pred             ecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .||+|+||.||+|....++   ..+|+|.+......  ...+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            6899999999999876554   78999998754332  34567889999999999999999999865 556899999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|.+++.... .+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||+++.............
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCccccccc
Confidence            999999997644 589999999999999999999999999999999999998865 699999999977643322111111


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ...++..|+|||.+..   ..++.++|||||||++|+|++ |..||...+ ..+....+........+..++..+++++.
T Consensus       157 ~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         157 AGRWPLKWYAPECINY---GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             CccccccccCHHHhcC---CCCCccchHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence            2223567999998854   336789999999999999998 999997644 33444444455555667788999999999


Q ss_pred             HhcccCCCCcCCHHHHhc
Q psy10603        245 LCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~  262 (407)
                      +||..||++||++.++++
T Consensus       233 ~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         233 SCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-43  Score=327.08  Aligned_cols=254  Identities=31%  Similarity=0.502  Sum_probs=204.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      ++....||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+++|+.++||||+++++++..++..|+||||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            455679999999999999999999999999886543322 3445678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|..+... ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .+||+|||++.......   ..
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~---~~  156 (286)
T cd07846          82 VDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG---EV  156 (286)
T ss_pred             CCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCc---cc
Confidence            999999887654 34589999999999999999999999999999999999998765 69999999987654322   12


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh---C---------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG---M---------------  225 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~---~---------------  225 (407)
                      .....++..|+|||++.+.  ..++.++|||||||++|||++|++||........ ...+.   .               
T Consensus       157 ~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         157 YTDYVATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             cCcccceeeccCcHHhccc--cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccchH
Confidence            2345688999999998542  2357899999999999999999999975432111 11000   0               


Q ss_pred             ---CCCCC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        226 ---GETPT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       226 ---~~~~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                         -..+.         ....++..+.+++.+||..||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence               00000         123578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-42  Score=320.94  Aligned_cols=252  Identities=20%  Similarity=0.329  Sum_probs=201.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCc--EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGE--LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~   76 (407)
                      .....||+|+||.||+|++..+++  .+|+|.+..... .....+.+.+|+.+++.++||||+++++.+...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            456789999999999999887775  689998865432 334457788999999999999999999976432      24


Q ss_pred             EEEEEecCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         77 MVLFMELCTEGTLESLVQS-----TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      .+++|||+++|+|..++..     ....+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence            7899999999999987642     123478999999999999999999999999999999999998764 6999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      +.+....... ......+++.|+|||++..   ..++.++|||||||++|||++ |+.||... ...+....+..+..+.
T Consensus       160 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~  234 (272)
T cd05075         160 KKIYNGDYYR-QGRIAKMPVKWIAIESLAD---RVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNRLK  234 (272)
T ss_pred             cccCccccee-cCCcccCCcccCCHHHccC---CCcChHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCCC
Confidence            8764332111 1122345678999999854   346789999999999999999 89999754 3444445555555556


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            677889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-43  Score=330.38  Aligned_cols=258  Identities=25%  Similarity=0.443  Sum_probs=200.6

Q ss_pred             ceeeecccccCeEEEEEEECC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNE--TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLF   80 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv   80 (407)
                      .....||+|+||.||+|.+..  +++.||+|.+...........+.+.+|+.++++++||||+++++.+...  +.+++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            345689999999999999988  8999999999764322333446678899999999999999999999988  789999


Q ss_pred             EecCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec----CCCeEEEEcccCce
Q psy10603         81 MELCTEGTLESLVQST----EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA----EGNSLKLGDFGSAV  152 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~----~~~~vkl~DFGla~  152 (407)
                      |||+++ +|..++...    ...+++..+..++.|++.||.|||+++|+||||||+||+++.    + +.+||+|||++.
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~~~  160 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGLAR  160 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcccc
Confidence            999985 666655322    225899999999999999999999999999999999999987    4 469999999998


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH--------HHHHHH-
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKV-  223 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~--------~~~~~~-  223 (407)
                      ................+|+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.......        ..+..+ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            764332212223456789999999987542  235789999999999999999999997533211        000000 


Q ss_pred             ---h---------------------CCCCCCCC-----------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        224 ---G---------------------MGETPTIP-----------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       224 ---~---------------------~~~~~~~~-----------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                         .                     .......+           ...+.++.+++.+||+.||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence               0                     00001111           1466789999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=320.85  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=203.2

Q ss_pred             eeeecccccCeEEEEEEECC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce------
Q psy10603          6 FSVSPGQGRFGKVYTAVNNE---TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE------   76 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------   76 (407)
                      ....||+|+||.||+|.+..   +++.||+|.+..... .......+.+|++.|+.++||||+++++.+...+.      
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            44579999999999998764   347899999875432 33445678999999999999999999998765543      


Q ss_pred             EEEEEecCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         77 MVLFMELCTEGTLESLVQST-----EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      .+++|||+++|+|..++...     ...+++..+..++.|++.||.|||+++++||||||+||++++++ .+||+|||++
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  160 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFGLS  160 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCccce
Confidence            79999999999999887442     23589999999999999999999999999999999999998764 6999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      +.+....... ......++..|+|||.+..   ..++.++|||||||++|||++ |..||.+.. ..+.......+..+.
T Consensus       161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~  235 (273)
T cd05035         161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-NHEIYDYLRHGNRLK  235 (273)
T ss_pred             eecccccccc-ccccccCCccccCHhhccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCC
Confidence            8764332211 1122334678999998843   346789999999999999999 899997543 445555555566677


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .|..+++++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-42  Score=318.50  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=204.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|+||+||+|.+.. +..+|+|.+......    ...+.+|+.++++++||||+++++++...+..++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            45677799999999999998754 446999988643221    2457889999999999999999999998889999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++......+++..+..++.|++.||.|||++|++|+||||+|||++.++ .+||+|||+++........  
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYT--  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCcee--
Confidence            9999999999976555689999999999999999999999999999999999998764 6999999998765432211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||++..   ..++.++|||||||++|+|++ |..||.... .......+..+..+..+...++++++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLY---SKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVEKVSQGLRLYRPHLASEKVYA  232 (256)
T ss_pred             ecCCCccChhhCCHHHHhc---CcccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            1122345678999999854   235789999999999999998 999997543 33344455555566667778999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcC
Q psy10603        242 FAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++.+||..||++|||+.+++.+
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-42  Score=325.39  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             CccceeeecccccCeEEEEEEECCCCc--EEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGE--LVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   78 (407)
                      +++.+...||+|+||.||+|+...++.  .+|+|.+...  ......+.+.+|++++.++ +||||+++++.+...+.+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            456777899999999999999877765  4688877532  2334456788999999999 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         79 LFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      +||||+++++|.+++....               ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence            9999999999999986532               2488899999999999999999999999999999999998754 69


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||++........    ......+..|+|||++..   ..++.++|||||||++|||++ |..||.... .......
T Consensus       159 kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-~~~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY---SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEK  230 (297)
T ss_pred             EECCcCCCccccceec----cCCCCcCccccCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Confidence            9999999864321110    111223457999998854   346789999999999999997 999997543 3344444


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ...+..+..+..+++++++++.+||+.||.+|||+.++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  272 (297)
T cd05089         231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL  272 (297)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            555555666778999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.5e-43  Score=324.86  Aligned_cols=252  Identities=20%  Similarity=0.332  Sum_probs=204.6

Q ss_pred             cceeeecccccCeEEEEEEECC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||+||+|.+..     .++.||+|.+...  .+....+.+.+|+.++.+++||||+++++.+...+..+
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            3444589999999999998754     3578999998643  23344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         79 LFMELCTEGTLESLVQST---------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      +++||+++++|..++...               ...+++..+..++.|++.||.|||++||+||||||+|||+++++ .+
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~  163 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL-NV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC-ce
Confidence            999999999999988421               12378888999999999999999999999999999999998764 69


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||+++........ .......+++.|+|||++..   ..++.++|||||||++|||++ |..||.+.. ..+....
T Consensus       164 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~  238 (283)
T cd05091         164 KISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY---GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEM  238 (283)
T ss_pred             Eecccccccccccchhe-eeccCccCCccccCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHH
Confidence            99999998765432211 11223456789999999854   235789999999999999998 888987543 3445555


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..+..+..+..++.++.+++..||+.||++||++.++++.
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            55666666778899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.9e-43  Score=332.19  Aligned_cols=257  Identities=21%  Similarity=0.355  Sum_probs=200.9

Q ss_pred             ecccc--cCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQG--RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G--~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|  +||+||+|++..+|+.||+|++...... .+..+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            56777  9999999999999999999998765333 34457788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC---
Q psy10603         87 GTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG---  162 (407)
Q Consensus        87 g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~---  162 (407)
                      ++|.++++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+|++||+.+...........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCccccccc
Confidence            9999988653 24589999999999999999999999999999999999998765 699999986543321111000   


Q ss_pred             -cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC--------------
Q psy10603        163 -ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE--------------  227 (407)
Q Consensus       163 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~--------------  227 (407)
                       ......++..|+|||++... ...++.++|||||||++|||++|+.||.................              
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQD-LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             cccccccCccCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence             00112346679999998642 23467899999999999999999999986543332222111000              


Q ss_pred             -------------------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        228 -------------------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       228 -------------------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                                     ....+..+++++.+|+.+||+.||++|||+.|+++|||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                           00112335678999999999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-42  Score=318.16  Aligned_cols=246  Identities=27%  Similarity=0.444  Sum_probs=199.8

Q ss_pred             ecccccCeEEEEEEECC-CC--cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNE-TG--ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .||+|+||.||+|.+.. .+  ..+|+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            58999999999999865 33  36899998754332  556788999999999999999999999888 88999999999


Q ss_pred             CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +++|.+.+.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++.+..........
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEeccccccccccccccceecc
Confidence            999999987654 4589999999999999999999999999999999999999874 69999999998764322111111


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHh-CCCCCCCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG-MGETPTIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~~  242 (407)
                      ....++..|+|||.+..   ..++.++|||||||++|||++ |+.||..... .+....+. .......+..++.++.++
T Consensus       158 ~~~~~~~~y~~pE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         158 EHLKVPFAWCAPESLRT---RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             cCCCCCceecCHHHhcc---cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence            23456788999998854   346789999999999999998 9999975433 23333222 333444566788999999


Q ss_pred             HHHhcccCCCCcCCHHHHhc
Q psy10603        243 AELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +.+||+.+|++||++.++++
T Consensus       234 i~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         234 MLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-42  Score=324.34  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=204.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||.||+|.+..+++.||+|.+......  .......+..|++++++++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            3455899999999999999999999999999755432  12344567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+ +|+|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++........   
T Consensus        83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~---  157 (298)
T cd07841          83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPNR---  157 (298)
T ss_pred             cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCCc---
Confidence            99 8999999976443699999999999999999999999999999999999999764 699999999977643221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC----------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG----------------  226 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~----------------  226 (407)
                      ......+++.|+|||.+...  ..++.++|+|||||++|||++|.+||...... ....+....                
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGA--RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             cccccccceeeeCHHHHhCC--CCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccccc
Confidence            12234568889999988532  34578999999999999999998888654322 211111100                


Q ss_pred             ------CCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        227 ------ETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       227 ------~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                            ..+.     .....+.++.+++.+||++||++|||+.|+++|+||..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence                  0000     12345788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-42  Score=320.98  Aligned_cols=251  Identities=31%  Similarity=0.569  Sum_probs=211.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|.+..+++.+|+|.+....  .....+.+.+|+.++.+++||||+++++.+...+..|+||||++
T Consensus         8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            4458999999999999999999999999876432  23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|..++..  ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++ .++|+|||++..+.....   ...
T Consensus        86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~---~~~  159 (277)
T cd06641          86 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQI---KRN  159 (277)
T ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchh---hhc
Confidence            9999998854  3489999999999999999999999999999999999998764 699999999876543211   123


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ...|+..|+|||.+..   ...+.++|+|||||++|+|++|..||.... .......+..+..+.++..++.++.+++.+
T Consensus       160 ~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         160 TFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             cccCCccccChhhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCccc-hHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            3568889999998854   235789999999999999999999997543 333344444455666777889999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||..||++||++.++++|||+..
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~  258 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVR  258 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhh
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-42  Score=325.31  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.+...||+|+||.||+|.+     ..++..+|+|.+....  .....+.+.+|+.+++++ +||||+++++.+...+..
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            34555899999999999975     3345689999886432  234456788999999999 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         78 VLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      ++||||+++|+|.++++... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.+ ..+||+|||+++....
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~  193 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLARDIMN  193 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcccccccC
Confidence            99999999999999986533 338999999999999999999999999999999999999865 4799999999976543


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCcc
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL  235 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (407)
                      .... .......+++.|+|||.+...   .++.++|||||||++|||++ |..||...............+..+..+...
T Consensus       194 ~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (302)
T cd05055         194 DSNY-VVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA  269 (302)
T ss_pred             CCce-eecCCCCcccccCCHhhhccC---CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence            3211 011223457789999998542   35789999999999999998 999998654433333333344445556678


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++++.+++.+||.+||++|||+.|+++
T Consensus       270 ~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         270 PAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-43  Score=333.10  Aligned_cols=258  Identities=26%  Similarity=0.449  Sum_probs=201.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~   77 (407)
                      .+.....||+|+||.||+|++..+|+.||+|++...  .......++.+|+.++++++||||+++++++...     ...
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            344555899999999999999999999999998642  2233456678899999999999999999876543     358


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |+|+||+++ +|..++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~  159 (336)
T cd07849          84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPE  159 (336)
T ss_pred             EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeecccc
Confidence            999999975 88877743  3589999999999999999999999999999999999998765 6999999999776433


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH--------------
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV--------------  223 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~--------------  223 (407)
                      ...........||+.|+|||++...  ..++.++|||||||++|+|++|+.||...+.........              
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNS--KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            2222223446789999999987542  345789999999999999999999997543211110000              


Q ss_pred             h----------CCCCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        224 G----------MGETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       224 ~----------~~~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .          ....+.     .....++++.+++.+||+.||++|||+.|+++|||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence            0          000011     11245788999999999999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.1e-43  Score=321.88  Aligned_cols=240  Identities=22%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             ecccccCeEEEEEEECCCCc-------EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          9 SPGQGRFGKVYTAVNNETGE-------LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +||+|+||.||+|.+..++.       .+|+|.+...   .....+.+..|+.+++.++||||+++++.+...+..++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            68999999999998865543       4888877532   2344567888999999999999999999999989999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCe-------EEEEcccCceec
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS-------LKLGDFGSAVKI  154 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~-------vkl~DFGla~~~  154 (407)
                      ||+++|+|..+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++..       +|++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999997655568999999999999999999999999999999999999876543       799999998654


Q ss_pred             CCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCchHHHHHHHhCCCCCCCCC
Q psy10603        155 SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK-RPWAEYDSNYQIMFKVGMGETPTIPE  233 (407)
Q Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~  233 (407)
                      ...       ....+++.|+|||++...  ..++.++|||||||++|||++|. .||........ ...  ....+.+|.
T Consensus       159 ~~~-------~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~--~~~~~~~~~  226 (258)
T cd05078         159 LPK-------EILLERIPWVPPECIENP--QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQF--YEDRHQLPA  226 (258)
T ss_pred             CCc-------hhccccCCccCchhccCC--CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHH--HHccccCCC
Confidence            321       234678899999998542  23578999999999999999995 66654332221 111  123445666


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+.++.+++.+||+.||++|||+.++++.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         227 PKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            778899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-42  Score=324.70  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=200.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCce-----E
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREE-----M   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~-----~   77 (407)
                      +.....||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++..++ ||||+++++.+...+.     .
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            34556899999999999999999999999988654322 223356788999999996 5999999999887665     8


Q ss_pred             EEEEecCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         78 VLFMELCTEGTLESLVQSTE----DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      |+||||+++ +|..++....    ..+++..+..++.||+.||.|||+++|+||||||+||+++.+++.+||+|||+++.
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            999999986 7888775432    34899999999999999999999999999999999999998556799999999876


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh---CCC---
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG---MGE---  227 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~---~~~---  227 (407)
                      ......   ......+++.|+|||++.+.  ..++.++|+|||||++|+|++|..||..............   ...   
T Consensus       161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         161 FSIPVK---SYTHEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cCCCcc---ccCCcccccCCCChHHhhCC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            533211   12233578899999988542  3357899999999999999999999975433222211100   000   


Q ss_pred             ------------CCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 ------------TPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 ------------~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                  .+.        ..+.++.++.+||.+||.+||.+||++.|++.|||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence                        000        013478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.1e-43  Score=320.66  Aligned_cols=251  Identities=33%  Similarity=0.519  Sum_probs=206.7

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|+||.||+|++..+|+.+|+|++...........+.+.+|++++++++||||+++++.+...+..|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999998755443445567788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC-----CCcc
Q psy10603         90 ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-----PGEL  164 (407)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~-----~~~~  164 (407)
                      .+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++ .+||+|||++.........     ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccccc
Confidence            99997644 589999999999999999999999999999999999999865 6999999998654322110     1122


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCc--cCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~~  242 (407)
                      ....++..|+|||.+...   ..+.++|+||||+++|+|++|..||.... ..........+. ...+..  +++++.++
T Consensus       159 ~~~~~~~~~~~Pe~~~~~---~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQ---GHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGK-IEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCC-cCCCccccCCHHHHHH
Confidence            345678899999998543   25789999999999999999999997543 333333333222 233444  48999999


Q ss_pred             HHHhcccCCCCcCCH---HHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATI---FELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~---~e~l~hp~~~  267 (407)
                      +.+||+.||++|||+   .++++||||.
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence            999999999999999   9999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-42  Score=320.05  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=201.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcE----EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGEL----VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|.+..+++.    +|+|.+...  .......++..|+.++.+++||||+++++++. ....++
T Consensus         9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            44455899999999999999877764    667766422  22344567788999999999999999999875 456789


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ++||+++|+|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.+ ..+||+|||+++.......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceeccCCCc
Confidence            999999999999997666678999999999999999999999999999999999999875 4699999999986543221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                       ........++..|+|||++..   ..++.++|||||||++|||++ |+.||.+.. .......+..+..+..+...+.+
T Consensus       165 -~~~~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         165 -KYFYSEHKTPIKWMALESILF---GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             -ccccCCCCCcccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHCCCcCCCCCCCCHH
Confidence             111233456778999999854   236789999999999999998 999997543 23333444555666666778889


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+++.+||..||++|||+.|+++
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4e-42  Score=320.06  Aligned_cols=248  Identities=34%  Similarity=0.541  Sum_probs=205.8

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      ..||+|++|.||+|.+..+++.+|+|++....   ....+.+.+|+.+++.++||||+++++.+...+..++++||++++
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~  101 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG  101 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence            48999999999999999999999999886432   233456789999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........   .....
T Consensus       102 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~---~~~~~  175 (285)
T cd06648         102 ALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVP---RRKSL  175 (285)
T ss_pred             CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCc---ccccc
Confidence            99999865  4589999999999999999999999999999999999998764 699999998865433221   12335


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHHH
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAEL  245 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~~  245 (407)
                      .|++.|+|||++.+   ..++.++|+|||||++|+|++|+.||.... .............+..  +..++.++.+++.+
T Consensus       176 ~~~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         176 VGTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             cCCccccCHHHhcC---CCCCCcccHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            68999999999854   236789999999999999999999997543 2333333333333332  33478999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||..||++|||+.++++|||+..
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             HcccChhhCcCHHHHccCccccc
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-42  Score=318.48  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +.....||+|+||.||+|++..++.   .+|+|.+....  .....+.+.+|+.++.+++||||+++++.+...+..|+|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            4455699999999999999865543   79999886432  233456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||++..+......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccccccccce
Confidence            999999999999976555689999999999999999999999999999999999998764 6999999999776433221


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      ........++..|+|||++..   ..++.++|+|||||++||+++ |..||.... ..+....+..+..+..+..+++++
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             eeecCCCccceeecCHhHhcc---CccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCCCcCCCCCCCCHHH
Confidence            111122233568999999854   335789999999999999886 999997543 333444444444445566788999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+++|.+||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.4e-42  Score=320.72  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             ccceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.....||+|+||.||+|..     ..++..+|+|.+...   .....+.+.+|+++++.++||||+++++++...+..
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            455666999999999999974     335678999987533   334456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         78 VLFMELCTEGTLESLVQSTE--------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~--------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      +++|||+++++|.+++....              ..+++..+..++.|++.||.|||++|++||||||+|||+++++ .+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~~  161 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-CE
Confidence            99999999999999986532              2478899999999999999999999999999999999998764 69


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||+++........ .......+++.|+|||++..   ..++.++|||||||++|||++ |..||.... .......
T Consensus       162 kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY---RKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIEC  236 (280)
T ss_pred             EECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc---CCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHH
Confidence            99999999765432211 11122345788999998854   336789999999999999998 999997543 3334444


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ...+..+..+..+++++.+++.+||+.||.+||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5555556667789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=318.05  Aligned_cols=247  Identities=30%  Similarity=0.459  Sum_probs=199.3

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..||+|+||.||+|.+..+++.||+|++.............+..|..++ ...+|||++++++.+...+.+|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            3689999999999999999999999998654322222334455565544 456899999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|..+++.. ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++ .+||+|||++.....       ...
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-------~~~  152 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-------NKK  152 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc-------ccc
Confidence            9999999653 4589999999999999999999999999999999999998764 699999999865432       123


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC---CCCCCCCccCHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG---ETPTIPESLSDEGQAFA  243 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~~~i  243 (407)
                      ..|++.|+|||.+.+.   .++.++|+||||+++|+|++|..||..... .+.......+   ..+..+..+++++.+++
T Consensus       153 ~~~~~~y~~pe~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  228 (260)
T cd05611         153 FVGTPDYLAPETILGV---GDDKMSDWWSLGCVIFEFLFGYPPFHAETP-DAVFDNILSRRINWPEEVKEFCSPEAVDLI  228 (260)
T ss_pred             CCCCcCccChhhhcCC---CCcchhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence            5688899999998643   257899999999999999999999975433 2322222222   12234456899999999


Q ss_pred             HHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      .+||+.||++||+   +.|++.|||+.
T Consensus       229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~  255 (260)
T cd05611         229 NRLLCMDPAKRLGANGYQEIKSHPFFK  255 (260)
T ss_pred             HHHccCCHHHccCCCcHHHHHcChHhh
Confidence            9999999999995   57999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5e-42  Score=313.61  Aligned_cols=255  Identities=43%  Similarity=0.783  Sum_probs=215.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~E   82 (407)
                      .....||+|++|.||+|.+..+++.+++|++...... ....+.+.+|+.++++++||||+++++.+...  +.+++++|
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            4456899999999999999999999999998755332 34567889999999999999999999999888  88999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .+||+|||.+......... .
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~-~  158 (260)
T cd06606          82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETG-E  158 (260)
T ss_pred             ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEeccccccc-c
Confidence            999999999997644 689999999999999999999999999999999999999854 6999999999876544321 0


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||.+...   ..+.++|+||||+++|+|++|..||....+.......... ...+.+|..++.++++
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGE---EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             cccCCCCCccccCHhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence            12345688899999998543   2578999999999999999999999876544444444433 4456677888999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ++.+||+.||++||++.|+++|||+
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-42  Score=322.38  Aligned_cols=254  Identities=27%  Similarity=0.477  Sum_probs=202.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|++|.||+|++..+|+.||||++......  .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            34556999999999999999999999999998754322  2234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        84 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........  
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~--  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN--  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc--
Confidence            985 8888775433  4589999999999999999999999999999999999998765 699999999976543221  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----------------  225 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----------------  225 (407)
                       ......+++.|+|||++...  ..++.++|+|||||++|+|++|+.||.+.............                
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             -ccccccccccccChHHhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence             12334678899999988543  23578999999999999999999999865433221111100                


Q ss_pred             ---CCCCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        226 ---GETPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       226 ---~~~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                         ...+.        +...++.++.+++.+||+.||++||++.|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence               00000        112457889999999999999999999999999996

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=322.76  Aligned_cols=256  Identities=34%  Similarity=0.564  Sum_probs=205.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|.+..+++.||+|+++.... +....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            4556689999999999999999999999998865432 334456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++++.+..+... ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++........  ..
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~--~~  157 (288)
T cd07833          82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPA--SP  157 (288)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCcc--cc
Confidence            998777766644 45589999999999999999999999999999999999998764 699999999877654322  12


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC----------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG----------------  226 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~----------------  226 (407)
                      .....++..|+|||++...  ..++.++|+||||+++|+|++|+.||.............. .+                
T Consensus       158 ~~~~~~~~~~~~PE~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         158 LTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccCcccccCCcCCchhcCC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            2346788999999998653  2467899999999999999999999975432211111000 00                


Q ss_pred             ---CCC----------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        227 ---ETP----------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       227 ---~~~----------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                         ..+          ..+..++.++.+++.+||..||++|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence               000          1233458899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-42  Score=331.83  Aligned_cols=256  Identities=29%  Similarity=0.467  Sum_probs=200.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC---------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR---------   74 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---------   74 (407)
                      +.....||.|+||.||+|++..+|+.||+|.+.....   ...+.+.+|+++|++++||||+++++.+...         
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            3445589999999999999999999999999865432   3346678899999999999999998765543         


Q ss_pred             -----ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         75 -----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        75 -----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                           ...|+||||++ ++|..++..  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++..+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                 35799999997 588887753  3589999999999999999999999999999999999998766679999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-----
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-----  224 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-----  224 (407)
                      ++.................++..|+|||++...  ..++.++|||||||++|+|++|+.||..............     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCc--cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            997654322211122334678899999987542  3467899999999999999999999975432221111000     


Q ss_pred             ------------------CCCCC-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 ------------------MGETP-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 ------------------~~~~~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                        ....+     .+...++.++.+|+.+||+.||++|||+.|+++|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence                              00011     01235788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG2345|consensus

Probab=100.00  E-value=4.3e-44  Score=305.32  Aligned_cols=254  Identities=27%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----CceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-----REEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~l   79 (407)
                      .+...+|+|||+.||++++..+++.||+|.+..+.   .+..+..++|++..++++|||++++++....     ....||
T Consensus        24 ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   24 RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             EEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            34558999999999999999999999999997554   3456788999999999999999999876543     335999


Q ss_pred             EEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCceec
Q psy10603         80 FMELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKI  154 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~  154 (407)
                      ++.|...|+|.+.++..   ...++|.++..|+.+++.||++||+..  ..||||||.|||+.+++ .++|.|||.+...
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQA  179 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccCcccc
Confidence            99999999999988653   335899999999999999999999998  99999999999998864 6999999998765


Q ss_pred             CCCCCCC------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---chHHHHHHHhC
Q psy10603        155 SAHTTVP------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGM  225 (407)
Q Consensus       155 ~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~---~~~~~~~~~~~  225 (407)
                      .-.....      ++...-..|..|.|||++.-......+.++|||||||++|+|+.|.-||+..-   ....+......
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q  259 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ  259 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence            3221110      11122345889999999987666778899999999999999999999996311   01010000000


Q ss_pred             CCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       226 ~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      -..|. ...+|+.+.++++.||+.||.+||++.+++.+
T Consensus       260 ~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  260 ISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            01122 12389999999999999999999999999864

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.6e-42  Score=319.33  Aligned_cols=253  Identities=29%  Similarity=0.508  Sum_probs=203.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLFM   81 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~   81 (407)
                      +.....||.|++|.||+|.+..+++.+|+|.+....  ......++.+|++++++++||||+++++.+..  .+.+|+||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            445669999999999999999999999999987542  22445678899999999999999999998765  34789999


Q ss_pred             ecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeeccccccccccc
Confidence            99999999987653   234588999999999999999999999999999999999998765 69999999986543221


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC----chHHHHHHHhCCCCCCCC--
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD----SNYQIMFKVGMGETPTIP--  232 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~----~~~~~~~~~~~~~~~~~~--  232 (407)
                           .....++..|+|||.+..   ..++.++|||||||++|+|++|+.||....    ...+..........+.++  
T Consensus       160 -----~~~~~~~~~y~~pE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd06621         160 -----AGTFTGTSFYMAPERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE  231 (287)
T ss_pred             -----cccccCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC
Confidence                 123457889999998854   345789999999999999999999998542    122222222222222222  


Q ss_pred             ----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                          ..+++++.+++.+||.+||++|||+.|+++|||+.
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence                23567899999999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-42  Score=331.44  Aligned_cols=250  Identities=28%  Similarity=0.416  Sum_probs=196.7

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l   79 (407)
                      ....||+|+||.||+|++..+++.||+|.+.... .+......+.+|+.+++.++||||+++++++...      ...|+
T Consensus        20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   98 (353)
T cd07850          20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL   98 (353)
T ss_pred             EEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence            3448999999999999999999999999986432 2333446678899999999999999999987643      35799


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+.+ +|.+.+...   +++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        99 v~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~  173 (353)
T cd07850          99 VMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM  173 (353)
T ss_pred             EEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCCC
Confidence            9999965 887777532   89999999999999999999999999999999999998865 699999999977543221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh---------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG---------------  224 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~---------------  224 (407)
                          .....+|+.|+|||++.+   ..++.++|||||||++|+|++|+.||...+..........               
T Consensus       174 ----~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         174 ----MTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             ----CCCCcccccccCHHHHhC---CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence                234568899999999854   3467899999999999999999999975432111100000               


Q ss_pred             -----CCCCCC---------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        225 -----MGETPT---------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       225 -----~~~~~~---------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                           ....+.                     .+...++++++++.+||+.||++|||+.|+|+|||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                 000000                     01134667899999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-42  Score=335.11  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             eeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv   80 (407)
                      ...||+|+||.||+|++.     .+++.||+|++....  .....+.+.+|+++|.+++ ||||+++++++...+..++|
T Consensus        42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv  119 (401)
T cd05107          42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII  119 (401)
T ss_pred             hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence            348999999999999864     345689999996432  2233457889999999998 99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcC---------------------------------------------------------------
Q psy10603         81 MELCTEGTLESLVQSTE---------------------------------------------------------------   97 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~---------------------------------------------------------------   97 (407)
                      ||||++|+|.++++...                                                               
T Consensus       120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (401)
T cd05107         120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV  199 (401)
T ss_pred             EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence            99999999999986421                                                               


Q ss_pred             ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         98 ----------------------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        98 ----------------------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                                                        ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ ..+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~-~~~  278 (401)
T cd05107         200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLV  278 (401)
T ss_pred             hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC-CEE
Confidence                                              135667788899999999999999999999999999999875 579


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||+++........ .......+++.|+|||++..   ..++.++|||||||++|||++ |..||............
T Consensus       279 kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~  354 (401)
T cd05107         279 KICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN---NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA  354 (401)
T ss_pred             EEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC---CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence            99999999765322211 11123457889999999854   346789999999999999998 89999765444444444


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..+..+..|..++.++.+++.+||..||.+||++.|+++.
T Consensus       355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            45555666778899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-42  Score=325.05  Aligned_cols=258  Identities=27%  Similarity=0.457  Sum_probs=198.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--------   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------   75 (407)
                      +.....||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++...+        
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            44455899999999999999999999999998654322 222345668999999999999999999876543        


Q ss_pred             eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      ..++||||+.+ +|..++......+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus        93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~  170 (310)
T cd07865          93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFS  170 (310)
T ss_pred             eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCccccc
Confidence            45999999975 88887766555689999999999999999999999999999999999998764 69999999997764


Q ss_pred             CCCCC-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCCC--
Q psy10603        156 AHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPT--  230 (407)
Q Consensus       156 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~~--  230 (407)
                      ..... ........++..|+|||++.+.  ..++.++||||||+++|||++|+.||.........  +........+.  
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCC--cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            33221 1122345678899999987542  23578999999999999999999999754332221  11111000000  


Q ss_pred             -------------C-------------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        231 -------------I-------------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       231 -------------~-------------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                   .             +...++.+.+++.+||..||++|||+.|+++||||
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                         0             11235678899999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-42  Score=321.66  Aligned_cols=251  Identities=24%  Similarity=0.398  Sum_probs=203.5

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.....||+|+||.||+|++.     .++..+|+|.+...   .....+.+.+|+.++++++||||+++++.+...+..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            3445568999999999999854     34566888887532   334446788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCe
Q psy10603         78 VLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS  142 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~  142 (407)
                      ++||||+++++|.+++....               ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-~  161 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-L  161 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-c
Confidence            99999999999999986432               2378999999999999999999999999999999999998765 6


Q ss_pred             EEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHH
Q psy10603        143 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF  221 (407)
Q Consensus       143 vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~  221 (407)
                      +||+|||+++....... ........+++.|+|||++..   ..++.++|||||||++|||++ |+.||.... ......
T Consensus       162 ~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY---RKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIE  236 (291)
T ss_pred             EEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence            99999999976543221 111223456789999998854   346789999999999999998 999997543 334444


Q ss_pred             HHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       222 ~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ....+..+..+...+.++.+++.+||++||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            45555566667778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.1e-42  Score=316.89  Aligned_cols=239  Identities=26%  Similarity=0.420  Sum_probs=194.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .+|+|+||.||++++..+++.+|+|.+........        |+.... ..+||||+++++.+...+..|+||||++++
T Consensus        23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~   94 (267)
T PHA03390         23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDG   94 (267)
T ss_pred             eecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCC
Confidence            36999999999999999999999999865322111        222221 127999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF  167 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  167 (407)
                      +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++..++|+|||++......       ...
T Consensus        95 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------~~~  166 (267)
T PHA03390         95 DLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------SCY  166 (267)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------ccC
Confidence            999999764 368999999999999999999999999999999999999987647999999998765422       224


Q ss_pred             ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH---HHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       168 ~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      .|+..|+|||++..   ..++.++|+|||||++|+|++|+.||.......   ....... ......+..+++.+.+|+.
T Consensus       167 ~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        167 DGTLDYFSPEKIKG---HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             CCCCcccChhhhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHH
Confidence            68899999999854   335789999999999999999999997433221   1122222 3334456679999999999


Q ss_pred             HhcccCCCCcCC-HHHHhcCCeee
Q psy10603        245 LCLRHDPAQRAT-IFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~t-~~e~l~hp~~~  267 (407)
                      +||+.||.+|++ ++|+++|||+.
T Consensus       243 ~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHhccChhhCCchHHHHhcCCccc
Confidence            999999999996 69999999984

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.5e-42  Score=312.15  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|... +++.+|+|.+....  ..+....+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus         2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             ccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            6899999999999865 67889999876432  33444568899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.........  ......
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~--~~~~~~  155 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS--SSGLKQ  155 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccc--cCCCCC
Confidence            9999876555689999999999999999999999999999999999998764 6999999998764332211  111223


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      +++.|+|||++..   ..++.++||||||+++|+|++ |..||.... .......+..+.....+..++.++.+++.+||
T Consensus       156 ~~~~y~aPE~~~~---~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         156 IPIKWTAPEALNY---GRYSSESDVWSYGILLWETFSLGVCPYPGMT-NQQAREQVEKGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             CcccccCHHHhcc---CCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            4567999999854   235789999999999999998 999997543 33444445555555667788999999999999


Q ss_pred             ccCCCCcCCHHHHhc
Q psy10603        248 RHDPAQRATIFELLQ  262 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~  262 (407)
                      +.||++||++.|+++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-42  Score=320.04  Aligned_cols=240  Identities=22%  Similarity=0.326  Sum_probs=191.4

Q ss_pred             ecccccCeEEEEEEECCC------------------------CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCc
Q psy10603          9 SPGQGRFGKVYTAVNNET------------------------GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL   64 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpni   64 (407)
                      .||+|+||.||+|....+                        ...||+|++...   ......++.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            589999999999975322                        235888887543   22344668889999999999999


Q ss_pred             ceEEEEEEeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC----
Q psy10603         65 VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG----  140 (407)
Q Consensus        65 v~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~----  140 (407)
                      +++++++...+..++||||+++|+|..++......+++..+..++.|++.||+|||+++|+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999999876556689999999999999999999999999999999999997543    


Q ss_pred             --CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHH-HcCCCCCCCCCchH
Q psy10603        141 --NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNY  217 (407)
Q Consensus       141 --~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em-~~g~~Pf~~~~~~~  217 (407)
                        ..+|++|||++......       ....++..|+|||.+...  ..++.++|||||||++||| ++|..||.......
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG--NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccceeeecCCccccccccc-------cccccCCcccCchhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence              13899999987543221       123578889999988542  3468899999999999998 57999997543322


Q ss_pred             HHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        218 QIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      . ....  ......|...++++.+++.+||+.||++|||+.+++++
T Consensus       230 ~-~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 K-ERFY--EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             H-HHHH--HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1 1111  12233455567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.2e-42  Score=326.13  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=202.4

Q ss_pred             eecccc--cCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          8 VSPGQG--RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         8 ~~iG~G--~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      +.||+|  ++|.||.+++..+++.||+|++.... ...+..+.+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            456665  67788888888899999999997642 233456778999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC----
Q psy10603         86 EGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV----  160 (407)
Q Consensus        86 ~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~----  160 (407)
                      +|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||.+.........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccc
Confidence            99999998753 34589999999999999999999999999999999999999765 6999999998765322111    


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC------------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET------------  228 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~------------  228 (407)
                      ........++..|+|||++... ...++.++|+|||||++|||++|+.||...........+......            
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQN-LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence            0111334577889999998542 234678999999999999999999999865433332222110000            


Q ss_pred             --------------------CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        229 --------------------PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       229 --------------------~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                          ...+..++.++.+++.+||+.||++|||+.|+++|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence                                001123456788999999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1187|consensus

Probab=100.00  E-value=9.6e-43  Score=330.48  Aligned_cols=247  Identities=29%  Similarity=0.447  Sum_probs=190.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-eEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-EMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~E   82 (407)
                      +...-.||+|+||.||+|.... |+.||||++.......   .++|.+|+.+|.+++|||+|+++|+|.+.+ ..+||+|
T Consensus        77 Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   77 FSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             CchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            3344599999999999998765 4889999876543321   345999999999999999999999999988 5999999


Q ss_pred             cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEecCCCeEEEEcccCceecCC-C
Q psy10603         83 LCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENT---IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-H  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~---iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~-~  157 (407)
                      |+++|+|.+++..... .++|....+|+.+++.||+|||...   ||||||||+|||+|.+ ...||+|||+|+.... .
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCccc
Confidence            9999999999977555 7899999999999999999999864   9999999999999965 5699999999965433 2


Q ss_pred             CCCCCccccc-ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--chHHHH----HHHhCCC---
Q psy10603        158 TTVPGELNGF-VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIM----FKVGMGE---  227 (407)
Q Consensus       158 ~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~--~~~~~~----~~~~~~~---  227 (407)
                      ..    .... .||.+|+|||++...   ..+.|+|||||||++.|++||+.|.....  ......    .....+.   
T Consensus       232 ~~----~~~~~~gt~gY~~PEy~~~g---~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e  304 (361)
T KOG1187|consen  232 TS----VSTTVMGTFGYLAPEYASTG---KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE  304 (361)
T ss_pred             cc----eeeecCCCCccCChhhhccC---CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence            11    1122 799999999998542   24789999999999999999998887432  111011    1111111   


Q ss_pred             --CCCCC-CccC--HHH---HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        228 --TPTIP-ESLS--DEG---QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       228 --~~~~~-~~~s--~~~---~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                        .|.+. ...+  .+.   ..+..+|++.+|.+||++.|+++
T Consensus       305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence              12222 2233  233   45677899999999999999754

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=311.19  Aligned_cols=252  Identities=35%  Similarity=0.663  Sum_probs=215.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|++|.||+|++..+++.||+|.+...... ......+.+|++++.+++|||++++++++...+..+++|||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            4566899999999999999999999999998765332 345678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.........   .
T Consensus        82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~---~  156 (254)
T cd06627          82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKD---D  156 (254)
T ss_pred             CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCccc---c
Confidence            999999998754 5589999999999999999999999999999999999998754 6999999999876543221   2


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ....++..|+|||.+...   ..+.++|+||||+++|+|++|..||.... .............+.++..+++++.+++.
T Consensus       157 ~~~~~~~~y~~pe~~~~~---~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQDDHPPLPEGISPELKDFLM  232 (254)
T ss_pred             cccccchhhcCHhhhcCC---CCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            345688899999988542   25789999999999999999999998654 33444444455667778889999999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.1e-42  Score=317.91  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=190.6

Q ss_pred             ecccccCeEEEEEEECC--CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNNE--TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||+||+|....  ....+|+|.+...  ........+.+|+.+++.++||||+++++.+...+.+++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999996432  3457888877543  2334456688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         87 GTLESLVQSTED----GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        87 g~L~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+|.+++.....    ..++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||++......... .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~-~  157 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYY-I  157 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhe-e
Confidence            999999865332    246778899999999999999999999999999999998865 6999999998654221111 0


Q ss_pred             cccccccCCccccccccccc----ccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCC-----CCCCC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT----NKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE-----TPTIP  232 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~-----~~~~~  232 (407)
                      ......+++.|+|||++...    ....++.++|||||||++|||++ |..||....+. ..........     .|.++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhccCccCCCCccc
Confidence            11223456789999997531    12345789999999999999999 78899754332 2322222222     23345


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+++...+++..|| .||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            578889999999999 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.4e-42  Score=322.21  Aligned_cols=258  Identities=30%  Similarity=0.527  Sum_probs=206.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|.+..+++.||||.+.....  ....+.+.+|+.++.+.. ||||+++++++......|+||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            45566799999999999999999999999999875422  223456677887666664 999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ||++ +++..++......+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .+||+|||++..+..... 
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~~-  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSKA-  170 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCCc-
Confidence            9986 47777776655668999999999999999999997 5999999999999998754 699999999876543221 


Q ss_pred             CCcccccccCCcccccccccccc-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC--ccCH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTN-KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE--SLSD  237 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~s~  237 (407)
                         .....+++.|+|||.+.... ...++.++|+||||+++|+|++|+.||.......+....+.....+..+.  .++.
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence               12345788999999985432 13367899999999999999999999976444444444444444444433  4789


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++.+++.+||..||++||++.++++|||+..
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            9999999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7e-42  Score=311.33  Aligned_cols=250  Identities=38%  Similarity=0.655  Sum_probs=209.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|++|.||+|.+..+++.+++|++.....   ...+.+.+|+..+++++||||+++++.+...+..++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            3455689999999999999999999999999875432   3456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++......+++..+..++.|++.||.|||++|++||||+|+||++++++ .+||+|||.+........    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~----  153 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKA----  153 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeecccccccccccc----
Confidence            999999999876545699999999999999999999999999999999999998764 699999999876643321    


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCc--cCHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQA  241 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~  241 (407)
                      .....|+..|+|||.+...   ..+.++|+||||+++|+|++|+.||...+.... .........+..+..  ++.++.+
T Consensus       154 ~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  229 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGK---PYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFKIATNGPPGLRNPEKWSDEFKD  229 (253)
T ss_pred             ccceecCCcccCHHHHcCC---CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcCCCCcCcccccCHHHHH
Confidence            2345788999999998543   357899999999999999999999986533332 222333334444433  3899999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      ++.+||+.||++|||+.|+++|||
T Consensus       230 ~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         230 FLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-42  Score=314.24  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=201.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|+||.||+|.+.. ++.||+|.++....    ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             heeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            45667799999999999998754 56799999864322    13567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........  
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~--  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIY--  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCcc--
Confidence            999999999986543 3589999999999999999999999999999999999998865 699999999987653211  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      ........+..|+|||++..   ..++.++|+||||+++|||++ |+.||.+.. .......+........+...+..+.
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALY---NRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-NAEVLQQVDQGYRMPCPPGCPKELY  234 (261)
T ss_pred             cccCCCcCceeccCcccccc---CCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            11112233457999998854   345789999999999999999 999997543 3334444444444455677899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++||++.++++
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.5e-42  Score=314.83  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=196.9

Q ss_pred             ecccccCeEEEEEEECC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCceEEEEEecC
Q psy10603          9 SPGQGRFGKVYTAVNNE---TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEI-HREEMVLFMELC   84 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~E~~   84 (407)
                      .||+|+||.||+|.+..   .+..+|+|.+...  .+....+.+.+|+.+++.++||||+++++.+. .++..+++|||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            58999999999998653   3457999987532  33445677889999999999999999999765 455689999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC-CCc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~-~~~  163 (407)
                      ++|+|.+++.......++..+..++.|++.||.|||+++++||||||+|||+++++ .+||+|||+++........ ...
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeecc
Confidence            99999999976555577888889999999999999999999999999999998765 6999999999765432111 111


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-KRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+++.|+|||.+..   ..++.++|||||||++|||++| .+||.. .+..........+..+..+..+++.+.++
T Consensus       159 ~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         159 HTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             cccCcCCccccChhHhcc---CccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            123345678999998854   3467899999999999999995 566654 33444444555555666677789999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcC
Q psy10603        243 AELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..||..||++||++.|+++.
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999998853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.4e-42  Score=312.08  Aligned_cols=253  Identities=34%  Similarity=0.582  Sum_probs=214.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||.|+||.||++.+..+++.+|+|++..... +.+..+.+.+|+++++.++|||++++.+.+...+..++|+||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            344589999999999999999999999999875432 3345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++++|.+++...   ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++........  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~--  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVD--  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccCcc--
Confidence            999999998764   26699999999999999999999999999999999999998764 699999999876544321  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       ......|++.|+|||.+..   ..++.++|+||+|+++++|++|+.||.... ..+..........+.++..++.++.+
T Consensus       159 -~~~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd08215         159 -LAKTVVGTPYYLSPELCQN---KPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKGQYPPIPSQYSSELRN  233 (258)
T ss_pred             -eecceeeeecccChhHhcc---CCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence             1234578899999998754   235789999999999999999999997543 34444444555566777889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ++..||..||++|||+.|+++||||
T Consensus       234 ~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         234 LVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4e-42  Score=315.69  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=201.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++....+||+|+||.||+|.+. +++.||+|.+....    ...+.+.+|+.++++++||||+++++.+...+..+++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            3455569999999999999865 56679999875432    124678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.++++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++......... 
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee-
Confidence            99999999998653 34588899999999999999999999999999999999998764 6999999999776432211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......++..|+|||++..   ..++.++|||||||++|+|++ |..||.... .......+..+...+.+..++.++.
T Consensus       160 -~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-NSDVMSALQRGYRMPRMENCPDELY  234 (261)
T ss_pred             -ccCCCccceecCCHHHhcc---CCCChhhhhhhhHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHH
Confidence             1123346778999999854   335789999999999999998 999997543 3344444444444445567899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||..||++||++.++.+
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         235 DIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-42  Score=318.23  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=205.1

Q ss_pred             ccceeeecccccCeEEEEEEECCC-----CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNET-----GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      +++....||+|+||.||+|.+...     ++.||+|.+...  ........+.+|+.+|..++||||+++++++......
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            445566999999999999987643     478999997543  2333456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcc
Q psy10603         78 VLFMELCTEGTLESLVQSTE---------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDF  148 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DF  148 (407)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+||
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl~df  163 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDF  163 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEEECCc
Confidence            99999999999999986422         2367888999999999999999999999999999999999865 6999999


Q ss_pred             cCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCC
Q psy10603        149 GSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE  227 (407)
Q Consensus       149 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~  227 (407)
                      |+++........ .......+|..|+|||.+..   ..++.++|||||||++|||++ |..||.... ..........+.
T Consensus       164 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~  238 (277)
T cd05032         164 GMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD---GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVIDGG  238 (277)
T ss_pred             ccchhhccCccc-ccCCCCCccccccCHHHHhc---CCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHhcCC
Confidence            998765432211 11223456789999998854   235789999999999999998 999997543 344444445555


Q ss_pred             CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       228 ~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..|..++.++.+++.+||+.+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            66778888999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-42  Score=316.93  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=205.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++++...||+|+||.||+|.+.. ++.+|+|.+...   .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34555689999999999999987 888999998643   22334568889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.++++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~~-  160 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYL-  160 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCcccc-
Confidence            999999999997533 3589999999999999999999999999999999999998764 6999999999765432211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                        .....++..|+|||++..   ..++.++||||||+++|+|++ |+.||.... ..+.......+..+..+..+++++.
T Consensus       161 --~~~~~~~~~~~~PE~~~~---~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASH---GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIY  234 (261)
T ss_pred             --ccCCCCceEecCHHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHhCCcCCCCCCCCHHHH
Confidence              123345678999998854   345789999999999999998 899997543 3344444555556666788999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++|||+.++++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5e-42  Score=316.53  Aligned_cols=253  Identities=21%  Similarity=0.353  Sum_probs=204.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      ++.....||+|+||.||+|.+..+++   .||+|.+...  .+....+++..|+.++++++||||+++++.+...+..++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            45667799999999999999887665   5999988643  234456788999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccCcc
Confidence            9999999999999976666689999999999999999999999999999999999998754 699999999876543221


Q ss_pred             CCCccccc--ccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        160 VPGELNGF--VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       160 ~~~~~~~~--~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      ........  ..+..|+|||.+..   ..++.++|||||||++|||++ |..||.... .......+........+..++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~  237 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIEQDYRLPPPMDCP  237 (269)
T ss_pred             ccccccccCCCcceeecCHhHhcc---CcccchhhhhhhHHHHHHHhcCCCCCCCCCC-HHHHHHHHHcCCcCCCcccCC
Confidence            11111111  12457999999854   345789999999999999886 999997543 333444444444444566788


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .++.+++..||+.+|++||++.+++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         238 TALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1026|consensus

Probab=100.00  E-value=2.3e-43  Score=347.63  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=213.2

Q ss_pred             CccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE   76 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   76 (407)
                      +++.+...||+|.||+||+|+..     .....||||.++..  .+.+..++|.||+++|..|+|||||+++|.+..++.
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            46677779999999999999753     33467999988643  444567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      +|||+|||..|||.++++...             ..++..+...++.||+.|++||-++..|||||-.+|+|+.. +..|
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge-~l~V  642 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE-NLVV  642 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc-ceEE
Confidence            999999999999999986421             12778899999999999999999999999999999999986 4689


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||+++..-.........++ .=..+|||||.++..   .++.++||||+||+|||+++ |+.||.+. .+.+++..
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t-~lPIRWMppEsIly~---kFTteSDVWs~GVvLWEIFsyG~QPy~gl-Sn~EVIe~  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNT-LLPIRWMPPESILYG---KFTTESDVWSFGVVLWEIFSYGKQPYYGL-SNQEVIEC  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCc-eeeeecCCHHHhhcC---cccchhhhhhhhhhhhhhhccccCccccc-chHHHHHH
Confidence            99999999876433322111111 225689999999763   47899999999999999997 89999875 46678888


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      +..|..-..|+.++.+..+++..||+.+|.+||++.||-
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            888888889999999999999999999999999999974

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-42  Score=329.41  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-ce
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR-EE   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~   76 (407)
                      +.+...||+|+||+||+|++     ..+++.||||.++...  .......+.+|+.+|.++ +||||+++++++... ..
T Consensus         9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            34556899999999999984     3567899999986432  223456788999999999 679999999987654 46


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-----------------------------------------------------------
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-----------------------------------------------------------   97 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-----------------------------------------------------------   97 (407)
                      ++++||||++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            899999999999999886421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccC
Q psy10603         98 -------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGT  170 (407)
Q Consensus        98 -------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt  170 (407)
                             ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++......... .......++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDY-VRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcch-hhcCCCCCC
Confidence                   1367788889999999999999999999999999999998764 6999999999765322111 011123456


Q ss_pred             CcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhccc
Q psy10603        171 QAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH  249 (407)
Q Consensus       171 ~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~  249 (407)
                      +.|+|||++..   ..++.++|||||||++|+|++ |..||...............+..+..|...++++.+++..||+.
T Consensus       245 ~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         245 LKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             cceECcHHhcC---CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            78999999854   346789999999999999996 99999865444444444555556666777889999999999999


Q ss_pred             CCCCcCCHHHHhcC
Q psy10603        250 DPAQRATIFELLQH  263 (407)
Q Consensus       250 dp~~R~t~~e~l~h  263 (407)
                      ||++|||+.|+++|
T Consensus       322 ~p~~Rps~~eil~~  335 (343)
T cd05103         322 EPSQRPTFSELVEH  335 (343)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-42  Score=319.37  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=198.4

Q ss_pred             eeecccccCeEEEEEEE----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVN----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv   80 (407)
                      ...||+|+||.||+|+.    ..+++.||+|.+...  ........+.+|+++|++++||||+++++++...  ...++|
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05079           9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI   86 (284)
T ss_pred             ceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence            34799999999999974    456889999998643  2344456789999999999999999999988765  568999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++........
T Consensus        87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  165 (284)
T cd05079          87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEY  165 (284)
T ss_pred             EEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCccccccccCccc
Confidence            999999999999876555689999999999999999999999999999999999998765 6999999999766433221


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--------------hHHHHHHHhCC
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--------------NYQIMFKVGMG  226 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--------------~~~~~~~~~~~  226 (407)
                      ........++..|+|||++..   ..++.++|||||||++|||++++.|+.....              ..........+
T Consensus       166 ~~~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         166 YTVKDDLDSPVFWYAPECLIQ---SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             eeecCCCCCCccccCHHHhcc---CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            111223456778999998854   2357899999999999999998776532110              01111222233


Q ss_pred             CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       227 ~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .....+..++.++.+|+.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            3444567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=319.60  Aligned_cols=253  Identities=29%  Similarity=0.480  Sum_probs=201.6

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|++|.||+|.+..+|+.||+|++..... .......+.+|+++++.++|||++++++++.+.+..|++|||++
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            34589999999999999999999999999875432 22233567789999999999999999999999999999999995


Q ss_pred             CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                       ++|..++.... ..+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.+||+|||++........   ..
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~---~~  156 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVR---TY  156 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCcc---cc
Confidence             68998886543 358999999999999999999999999999999999999885 4699999999976532211   12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-------------------
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-------------------  225 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-------------------  225 (407)
                      ....+++.|+|||++.+.  ..++.++|+||||+++|+|++|+.||.......+.......                   
T Consensus       157 ~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         157 THEVVTLWYRAPEILLGS--RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             CccccccCCCCCceeecC--cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            233568899999988542  23578999999999999999999999754332211110000                   


Q ss_pred             -----C---CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        226 -----G---ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       226 -----~---~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                           .   ........++.++.+++.+||+.||++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                 0   0011234577899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.9e-42  Score=321.25  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             cceeeecccccCeEEEEEEECCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETG-----ELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.....||+|+||.||+|.+...+     ..+|+|.+....  ..+....+.+|+.++.++ +||||+++++++...+.+
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            344558999999999999876443     689999886432  233456788999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCe
Q psy10603         78 VLFMELCTEGTLESLVQST---------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS  142 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~  142 (407)
                      +++|||+++|+|..+++..               ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~-~  170 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-V  170 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC-e
Confidence            9999999999999998642               23488999999999999999999999999999999999998764 6


Q ss_pred             EEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHH
Q psy10603        143 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF  221 (407)
Q Consensus       143 vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~  221 (407)
                      +||+|||+++.+....... ......++..|+|||++..   ..++.++|||||||++|||++ |..||.... ..+...
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~  245 (293)
T cd05053         171 MKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFK  245 (293)
T ss_pred             EEeCcccccccccccccee-ccCCCCCCccccCHHHhcc---CCcCcccceeehhhHHHHHhcCCCCCCCCCC-HHHHHH
Confidence            9999999997654322111 1112234678999998754   346789999999999999997 999997543 334444


Q ss_pred             HHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       222 ~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ....+..+..+...+.++.+++.+||..||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            444555566677889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0695|consensus

Probab=100.00  E-value=2.5e-43  Score=312.42  Aligned_cols=257  Identities=28%  Similarity=0.407  Sum_probs=223.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++....+||+|+|++|-++++..|.+.||+|+++++..++.+.+.....|..+.++ -+||.+|-+..+|++...+++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            34445599999999999999999999999999998877777777777788888766 47899999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||++||+|..+++..+ .+||+.++.|..+|+.||.|||++|||.||||.+|+|++.+| .+||+|+|+++.--...   
T Consensus       331 eyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~g---  405 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPG---  405 (593)
T ss_pred             EEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCC---
Confidence            9999999999987644 499999999999999999999999999999999999999986 69999999997643221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCC------CCchHHHHHHHhCCCCCCCCCcc
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE------YDSNYQIMFKVGMGETPTIPESL  235 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~------~~~~~~~~~~~~~~~~~~~~~~~  235 (407)
                      ....++||||.|+|||.+++   ..|+..+|.|+|||+++||+.|+.||.-      ..+....+++++....-.+|.++
T Consensus       406 d~tstfcgtpnyiapeilrg---eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl  482 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRG---EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL  482 (593)
T ss_pred             cccccccCCCcccchhhhcc---cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence            22467999999999999965   4578999999999999999999999962      22446678888888888899999


Q ss_pred             CHHHHHHHHHhcccCCCCcCC------HHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRAT------IFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t------~~e~l~hp~~~  267 (407)
                      |-.+..+++..|++||.+|..      +.++..|+||.
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence            999999999999999999963      57888999984

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.1e-42  Score=319.09  Aligned_cols=251  Identities=23%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             cceeeecccccCeEEEEEEECC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|++..     ..+.+|+|.+....  ......++.+|+.+++.++||||+++++.+...+..+
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            3455689999999999998753     23578888876432  3344567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy10603         79 LFMELCTEGTLESLVQSTE-----------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIF  135 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nil  135 (407)
                      +++||+++|+|.+++....                       ..+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999886421                       23778899999999999999999999999999999999


Q ss_pred             EecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q psy10603        136 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYD  214 (407)
Q Consensus       136 l~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~  214 (407)
                      +++++ .+||+|||+++......... ......++..|+|||.+..   ..++.++||||||+++|||++ |..||... 
T Consensus       160 l~~~~-~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~-  233 (290)
T cd05045         160 VAEGR-KMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-  233 (290)
T ss_pred             EcCCC-cEEeccccccccccCccchh-cccCCCCCccccCHHHHcc---CCcchHhHHHHHHHHHHHHHhcCCCCCCCC-
Confidence            98764 69999999997653322111 1122345678999998754   336789999999999999998 99999753 


Q ss_pred             chHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        215 SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ...........+..+..+..++.++.+++..||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            333444444444455667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.3e-42  Score=318.04  Aligned_cols=251  Identities=25%  Similarity=0.399  Sum_probs=199.6

Q ss_pred             cceeeecccccCeEEEEEEECC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|.+..     .+..||+|.+....  .......+.+|+.+++.++||||+++++.+...+..|
T Consensus         8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            3445589999999999997642     34579999876432  2233456788999999999999999999999889999


Q ss_pred             EEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         79 LFMELCTEGTLESLVQSTE---------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      +||||+++|+|.++++...         ...+...+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~L~Dfg  164 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFG  164 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEEECcCC
Confidence            9999999999999996532         1245678889999999999999999999999999999998764 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCC
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET  228 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~  228 (407)
                      +++......... ......++..|+|||.+..   ..++.++|+|||||++|||++ |..||.... ..+....+..+..
T Consensus       165 ~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~---~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~  239 (288)
T cd05061         165 MTRDIYETDYYR-KGGKGLLPVRWMAPESLKD---GVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVLKFVMDGGY  239 (288)
T ss_pred             cccccccccccc-ccCCCcccccccCHHHhcc---CCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC
Confidence            987654322111 1122345678999999854   235789999999999999998 788997543 3344444444555


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +..+...++++++++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  273 (288)
T cd05061         240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN  273 (288)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.6e-42  Score=315.35  Aligned_cols=249  Identities=23%  Similarity=0.374  Sum_probs=191.7

Q ss_pred             ecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||.||+|...  .++..+|+|.++....  ......+.+|+.++++++||||+++++.+.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            5899999999999754  4557899998865432  23345688899999999999999999999988899999999999


Q ss_pred             CCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         87 GTLESLVQSTE----DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        87 g~L~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+|.+++....    ...++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++....... ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~-~~  157 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDY-YV  157 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCcce-ee
Confidence            99999986422    2356778889999999999999999999999999999998764 699999999865432111 11


Q ss_pred             cccccccCCccccccccccccc----CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCC----CCCCCCC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNK----VGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG----ETPTIPE  233 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~----~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~----~~~~~~~  233 (407)
                      ......|++.|+|||++.....    ..++.++|+|||||++|||++ |+.||....+.......+...    ..|.+..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence            1233467889999999853211    134789999999999999996 999998654433222222111    1223334


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..++...+++.+|+ .||++|||+.|++.
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            57888999999999 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.9e-42  Score=315.53  Aligned_cols=240  Identities=23%  Similarity=0.356  Sum_probs=189.8

Q ss_pred             ecccccCeEEEEEEECCC------------CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce
Q psy10603          9 SPGQGRFGKVYTAVNNET------------GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE   76 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~------------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   76 (407)
                      .||+|+||.||+|+....            ...+|+|.+...   .....+.+..|+.++..++||||+++++++..+..
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            589999999999985422            235888887543   22344567889999999999999999999999889


Q ss_pred             EEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC------eEEEEcccC
Q psy10603         77 MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN------SLKLGDFGS  150 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~------~vkl~DFGl  150 (407)
                      .++||||+++|+|..++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.      .+|++|||+
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999988765566899999999999999999999999999999999999976542      389999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCchHHHHHHHhCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS-SGKRPWAEYDSNYQIMFKVGMGETP  229 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~-~g~~Pf~~~~~~~~~~~~~~~~~~~  229 (407)
                      +......       ....++..|+|||++...  ..++.++|||||||++|||+ +|..||.......  ......+.. 
T Consensus       159 ~~~~~~~-------~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~-  226 (262)
T cd05077         159 PITVLSR-------QECVERIPWIAPECVEDS--KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQC-  226 (262)
T ss_pred             CccccCc-------ccccccccccChhhhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcCc-
Confidence            8654321       234678899999988532  34678999999999999997 6888987533221  111111211 


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ......++++.+++.+||+.||.+||++.+++++
T Consensus       227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            1223356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-42  Score=312.19  Aligned_cols=247  Identities=37%  Similarity=0.536  Sum_probs=209.9

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|+||.||++.+..+++.+|+|++......+......+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            79999999999999989999999999876554444566788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccccc
Q psy10603         90 ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG  169 (407)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~g  169 (407)
                      .+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++........   ......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~  155 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGS---RTNTFCG  155 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCC---cccCCcC
Confidence            9999754 3589999999999999999999999999999999999998865 699999999877543311   1234567


Q ss_pred             CCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhccc
Q psy10603        170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH  249 (407)
Q Consensus       170 t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~  249 (407)
                      +..|+|||.+.+.   ..+.++|+||||+++|+|++|..||...+ ..+....+. .....+|..+++++.+++.+||..
T Consensus       156 ~~~~~~Pe~~~~~---~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         156 TPEYLAPEVLLGK---GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL-KDPLRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             CccccChHHhCCC---CCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcC
Confidence            8899999998542   35789999999999999999999997543 233333333 245667888899999999999999


Q ss_pred             CCCCcCCH---HHHhcCCee
Q psy10603        250 DPAQRATI---FELLQHPFL  266 (407)
Q Consensus       250 dp~~R~t~---~e~l~hp~~  266 (407)
                      ||++||++   .++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999996

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-42  Score=314.87  Aligned_cols=243  Identities=22%  Similarity=0.325  Sum_probs=195.5

Q ss_pred             ecccccCeEEEEEEECCCCc--EEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGE--LVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .||+|+||.||+|++..++.  .+|+|.+...  ......+.+.+|++++.++ +||||+++++.+...+..++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            58999999999999988876  4578877532  2334456788999999999 79999999999999999999999999


Q ss_pred             CCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccC
Q psy10603         86 EGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGS  150 (407)
Q Consensus        86 ~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGl  150 (407)
                      +|+|.+++....               ..+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCC
Confidence            999999986432               2478999999999999999999999999999999999998764 799999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETP  229 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~  229 (407)
                      +........    ......+..|+|||++..   ..++.++|||||||++|||++ |..||.... .......+..+..+
T Consensus       159 ~~~~~~~~~----~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~~  230 (270)
T cd05047         159 SRGQEVYVK----KTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRL  230 (270)
T ss_pred             ccccchhhh----ccCCCCccccCChHHHcc---CCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHHhCCCCC
Confidence            853221110    111233567999998854   346789999999999999997 999997533 33333444444455


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+..++.++.+++.+||..||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            566778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.3e-42  Score=317.13  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=195.1

Q ss_pred             ceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~   78 (407)
                      .....||+|+||+||++.    ...+++.||+|.+....  .......+.+|+++|++++||||+++++++...  ..++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            344589999999998865    34567899999986532  223456788999999999999999999987653  4689


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ++|||+++++|.+++..  ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++......
T Consensus        85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCcc
Confidence            99999999999999865  3499999999999999999999999999999999999998764 69999999997654322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--------------HHHHh
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--------------MFKVG  224 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--------------~~~~~  224 (407)
                      ..........++..|+|||.+..   ..++.++|||||||++|||++|..||.........              .....
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKE---NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcc---cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            11111122345667999998854   23578999999999999999999998643321111              11111


Q ss_pred             CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       225 ~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..+..+..++.++.+++..||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22333456778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1035|consensus

Probab=100.00  E-value=3.6e-43  Score=355.04  Aligned_cols=254  Identities=30%  Similarity=0.499  Sum_probs=199.9

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-------------
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-------------   74 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-------------   74 (407)
                      ..||+||||.||+++++-+|+.||||+|....  ..+....+.+|++.|.+|+|||||++|.++.+.             
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~  562 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD  562 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence            38999999999999999999999999998764  344557789999999999999999998543100             


Q ss_pred             --------------------------------------------------------------------------------
Q psy10603         75 --------------------------------------------------------------------------------   74 (407)
Q Consensus        75 --------------------------------------------------------------------------------   74 (407)
                                                                                                      
T Consensus       563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~  642 (1351)
T KOG1035|consen  563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL  642 (1351)
T ss_pred             hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence                                                                                            


Q ss_pred             --------------------------ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy10603         75 --------------------------EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD  128 (407)
Q Consensus        75 --------------------------~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrd  128 (407)
                                                ..+||-||||+.-++.++++.....-....++++++||++||.|+|++||||||
T Consensus       643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRD  722 (1351)
T KOG1035|consen  643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRD  722 (1351)
T ss_pred             CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeecc
Confidence                                      126888999999888888865432214678899999999999999999999999


Q ss_pred             CCCCCEEEecCCCeEEEEcccCceecC----------C-----CCCCCCcccccccCCcccccccccccccCCCCcchhH
Q psy10603        129 IKSANIFLTAEGNSLKLGDFGSAVKIS----------A-----HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDI  193 (407)
Q Consensus       129 lKp~Nill~~~~~~vkl~DFGla~~~~----------~-----~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~Di  193 (407)
                      |||.||+++.++ .|||+|||+|....          .     .....+..++.+||--|+|||++.+.....|+.|+||
T Consensus       723 LKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm  801 (1351)
T KOG1035|consen  723 LKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM  801 (1351)
T ss_pred             CCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence            999999999765 69999999997621          0     0011234578899999999999977654568999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC---CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        194 WSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI---PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       194 wSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |||||+++||+.   ||...-+...++.....+..|..   ...--+....+|..+|+.||.+|||+.|+|++.++-
T Consensus       802 YSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  802 YSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            999999999985   57644334444444444444432   222234567799999999999999999999988764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.5e-42  Score=318.91  Aligned_cols=257  Identities=28%  Similarity=0.497  Sum_probs=213.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||.||+|++..+++.||+|++...........+.+.+|..++.+++ ||||+++++.+...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            4556679999999999999999999999999987644334444567889999999999 999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC-
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~-  160 (407)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++......... 
T Consensus        82 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          82 EYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccccc
Confidence            999999999999764 4599999999999999999999999999999999999998765 6999999998765432210 


Q ss_pred             ----------------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh
Q psy10603        161 ----------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG  224 (407)
Q Consensus       161 ----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~  224 (407)
                                      ........|+..|+|||++...   ..+.++|+||||++++++++|+.||.... ..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~  235 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---PAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL  235 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCC---CCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH
Confidence                            0122345678999999987542   35789999999999999999999998644 223222222


Q ss_pred             CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCH----HHHhcCCee
Q psy10603        225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATI----FELLQHPFL  266 (407)
Q Consensus       225 ~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~----~e~l~hp~~  266 (407)
                       .....+|..+++.+.+++.+||+.||++||++    .++++||||
T Consensus       236 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 -KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             33445677889999999999999999999999    999999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0666|consensus

Probab=100.00  E-value=1.5e-43  Score=310.83  Aligned_cols=255  Identities=25%  Similarity=0.462  Sum_probs=199.7

Q ss_pred             ecccccCeEEEEEEECCCC----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETG----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~E~   83 (407)
                      .||+|+||.||+|....++    +.+|+|.++..+... .......||+.+++.++||||+.+..++.+ +..+++++||
T Consensus        31 ~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY  109 (438)
T KOG0666|consen   31 KIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY  109 (438)
T ss_pred             eecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence            7999999999999654332    379999887553322 234567899999999999999999999887 7789999999


Q ss_pred             CCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC---CeEEEEcccCceecCC
Q psy10603         84 CTEGTLESLVQST----EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISA  156 (407)
Q Consensus        84 ~~~g~L~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~---~~vkl~DFGla~~~~~  156 (407)
                      .+. +|.+.|+..    ...+|...++.++.||++|+.|||++-|+||||||.|||+..++   +.|||+|||+++.+..
T Consensus       110 AEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~  188 (438)
T KOG0666|consen  110 AEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNN  188 (438)
T ss_pred             hhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhc
Confidence            986 888887532    24589999999999999999999999999999999999998762   4799999999998865


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc------h-----HHHHHHHhC
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS------N-----YQIMFKVGM  225 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~------~-----~~~~~~~~~  225 (407)
                      ....-......+-|.+|.|||+|.+.  ..|+++.||||.|||+.||+|-.+-|.....      .     ...++.+ .
T Consensus       189 plkpl~s~d~VVVTiWYRAPELLLGa--~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~v-L  265 (438)
T KOG0666|consen  189 PLKPLASLDPVVVTIWYRAPELLLGA--RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEV-L  265 (438)
T ss_pred             cccccccCCceEEEEEecChHHhccc--ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHH-c
Confidence            44333344556789999999999875  4589999999999999999998887764221      1     1111111 1


Q ss_pred             CCC-----C---CCC--------------------------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        226 GET-----P---TIP--------------------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       226 ~~~-----~---~~~--------------------------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |..     |   ..|                          ..-++.+.+++.++|++||.+|.|+++.|+|+||..
T Consensus       266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            110     0   001                          112455789999999999999999999999999964

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.7e-42  Score=318.16  Aligned_cols=252  Identities=35%  Similarity=0.593  Sum_probs=208.5

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|.+..+++.+|+|++.....    ..+.+.+|++.+++++|+||+++++.+...+..|+++||+++
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            3489999999999999998999999999875432    346678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|.+++......+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++........   ....
T Consensus       100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~---~~~~  175 (286)
T cd06614         100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKS---KRNS  175 (286)
T ss_pred             CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchh---hhcc
Confidence            999999976543699999999999999999999999999999999999998764 699999999865432211   1233


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAE  244 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~  244 (407)
                      ..+++.|+|||.+..   ..++.++|+|||||++|+|++|+.||...... .....+.....+..  +..++.++++++.
T Consensus       176 ~~~~~~y~~PE~~~~---~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (286)
T cd06614         176 VVGTPYWMAPEVIKR---KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGIPPLKNPEKWSPEFKDFLN  251 (286)
T ss_pred             ccCCcccCCHhHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence            457889999998854   33578999999999999999999999854333 33333333333332  2347899999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeeeeec
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLIVSC  270 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~~~~  270 (407)
                      +||+.+|.+|||+.++++|+|+...+
T Consensus       252 ~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHhccChhhCcCHHHHhhChHhhccC
Confidence            99999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-41  Score=316.17  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=196.0

Q ss_pred             cceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~   77 (407)
                      +.+...||+|+||.||+|.    +..+++.||+|.+...   .....+.+.+|+++|++++||||+++++++..  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4455689999999999997    4567889999998643   33445678899999999999999999997654  3468


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ++||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccCC
Confidence            999999999999999976555689999999999999999999999999999999999998765 6999999999876432


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH---------------HHHHH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---------------QIMFK  222 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~---------------~~~~~  222 (407)
                      ...........++..|+|||++.+   ..++.++|||||||++|||++|..|+.......               .....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhcc---CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            211000111223456999999854   335789999999999999999987764321110               01111


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ...+..+..+..++.++.+++.+||..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2222333445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=310.32  Aligned_cols=245  Identities=23%  Similarity=0.343  Sum_probs=200.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|.+.. ++.||+|.+......  ...+.+.+|+.++++++||||+++++.+......++||||+++++
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            58999999999999887 999999988754332  345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||++......... .......
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~-~~~~~~~  156 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT-VSDGLKQ  156 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce-eccccCc
Confidence            9999976555689999999999999999999999999999999999998764 6999999998765422111 1111123


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhc
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL  247 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l  247 (407)
                      ++..|+|||.+.+   ..++.++|+|||||++|||++ |..||.... .......+..+..+..+..++.++.+++.+||
T Consensus       157 ~~~~y~~PE~~~~---~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  232 (251)
T cd05041         157 IPIKWTAPEALNY---GRYTSESDVWSYGILLWETFSLGDTPYPGMS-NQQTRERIESGYRMPAPQLCPEEIYRLMLQCW  232 (251)
T ss_pred             ceeccCChHhhcc---CCCCcchhHHHHHHHHHHHHhccCCCCccCC-HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence            3567999998854   236789999999999999999 889997543 22333334444445567788999999999999


Q ss_pred             ccCCCCcCCHHHHhc
Q psy10603        248 RHDPAQRATIFELLQ  262 (407)
Q Consensus       248 ~~dp~~R~t~~e~l~  262 (407)
                      +.+|++|||+.|+++
T Consensus       233 ~~~p~~Rp~~~ell~  247 (251)
T cd05041         233 AYDPENRPSFSEIYN  247 (251)
T ss_pred             ccChhhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.5e-42  Score=320.93  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=201.9

Q ss_pred             cceeeecccccCeEEEEEEECC-------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-------TGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~   75 (407)
                      +.....||+|+||.||+|++..       +...+|+|.+....  .......+.+|+.++.++ +||||+++++.+...+
T Consensus        20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            3455689999999999998643       23579999887532  233346788899999999 7999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      ..|+||||+++|+|.+++....               ..+++..+..++.|++.||+|||++|++||||||+|||++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999996532               2478889999999999999999999999999999999998764


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~  219 (407)
                       .+||+|||+++........ .......+++.|+|||++.+   ..++.++|+|||||++|||++ |..||... +..+.
T Consensus       178 -~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~~~~  251 (307)
T cd05098         178 -VMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL  251 (307)
T ss_pred             -cEEECCCcccccccccchh-hccccCCCccceeChHHhcc---CCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CHHHH
Confidence             6999999998765322111 11112234568999998854   335789999999999999998 88998743 33344


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ...+..+..+..+..++.++++++.+||..+|++|||+.+++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l  296 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  296 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            444444555567788899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-41  Score=310.55  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++++...||+|+||.||+|.+. .+..+|+|.+......    ...+.+|++++++++||||+++++.+......++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            46778889999999999999876 4678999988643322    245778999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+||+++.+ ..+||+|||++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~--  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQY--  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcc--
Confidence            9999999999987655568999999999999999999999999999999999999865 4699999999876533211  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      .......++..|+|||++..   ..++.++|+||||+++|||++ |+.||.... ..........+..+..+...+.++.
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSF---SKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETINAGFRLYKPRLASQSVY  231 (256)
T ss_pred             cccCCCccchhhcCHhHhcc---CCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            11122345678999998854   235789999999999999998 999997533 3344444444445555667889999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcC
Q psy10603        241 AFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++.+||+.+|++|||+.|++++
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-41  Score=312.04  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=198.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+++..+||+|+||.||+|++..++ .||+|.+......    .+.+.+|++++++++||||+++++.+. .+..++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   80 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence            3556779999999999999887654 5999998753321    246788999999999999999998864 456899999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++.+...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc-
Confidence            99999999999753 23478999999999999999999999999999999999998764 6999999999766433211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......++..|+|||++..   ..++.++|+|||||++|+|++ |..||.... ..+....+..+.....+..++..+.
T Consensus       159 -~~~~~~~~~~y~~PE~~~~---~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~  233 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESLH  233 (262)
T ss_pred             -cccCCcccceecCHhHhcc---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-hHHHHHHHhcCCCCCCccccCHHHH
Confidence             1122345678999998743   336789999999999999999 888997543 3344444444444455667889999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||++||++||++.++++
T Consensus       234 ~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         234 DLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=323.90  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=200.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHH-----------HHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR-----------FVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      .||.|+||+||+|.+..+++.||+|.+.........           ....+.+|+++++.++||||+++++++...+..
T Consensus        16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   95 (335)
T PTZ00024         16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI   95 (335)
T ss_pred             cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence            699999999999999999999999998654322110           112467899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus        96 ~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~dfg~~~~~~~~  172 (335)
T PTZ00024         96 NLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYP  172 (335)
T ss_pred             EEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEECCccceeecccc
Confidence            99999997 589888865 44589999999999999999999999999999999999998765 6999999999765411


Q ss_pred             CC-----------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--
Q psy10603        158 TT-----------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--  224 (407)
Q Consensus       158 ~~-----------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--  224 (407)
                      ..           .........+++.|+|||++.+.  ..++.++|+|||||++|||++|..||...++.........  
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~  250 (335)
T PTZ00024        173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL  250 (335)
T ss_pred             cccccccccccccccccccccccccCCCCChhcccC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            10           01112234568899999998643  2357899999999999999999999986543322211110  


Q ss_pred             -CCCCC-----------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        225 -MGETP-----------------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       225 -~~~~~-----------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                       .....                       ......++++.+++.+||+.||++|||+.|++.|||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence             00000                       011345788999999999999999999999999999963

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.5e-41  Score=316.91  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=208.6

Q ss_pred             ceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l   79 (407)
                      +....||+|+||.||+|++.   .+|+.||+|++...... .....+.+.+|+.+|+++ +|+||+++++.+..++.+|+
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            45568999999999999874   47899999998753221 223345678899999999 58999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++........
T Consensus        83 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          83 ILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceecccccc
Confidence            99999999999998653 4589999999999999999999999999999999999998764 699999999976543221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccCH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                        .......|+..|+|||.+.... ..++.++||||||+++|+|++|..||.....  ....+........+..|..+++
T Consensus       161 --~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T cd05613         161 --ERAYSFCGTIEYMAPDIVRGGD-GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  237 (290)
T ss_pred             --cccccccCCcccCChhhccCCC-CCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence              1123457899999999985422 2356789999999999999999999964221  2222223333344556778899


Q ss_pred             HHHHHHHHhcccCCCCcC-----CHHHHhcCCeeee
Q psy10603        238 EGQAFAELCLRHDPAQRA-----TIFELLQHPFLIV  268 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~-----t~~e~l~hp~~~~  268 (407)
                      .+.+++.+||+.||++|+     ++.+++.|||+..
T Consensus       238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  273 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK  273 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence            999999999999999997     8899999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-41  Score=311.12  Aligned_cols=242  Identities=23%  Similarity=0.390  Sum_probs=198.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEI-HREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~   81 (407)
                      ++.+...||+|+||.||+|...  |+.+|+|.+...     ...+.+.+|+.++++++|+|++++++++. ..+..+++|
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            4566679999999999999765  778999987532     12356889999999999999999999764 456789999


Q ss_pred             ecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ||+++++|.++++.... .+++..+..++.|++.||.|||++|++||||||+||++++++ .+||+|||++.......  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--
Confidence            99999999999876433 478999999999999999999999999999999999998765 69999999987653321  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                          ....++..|+|||++..   ..++.++|||||||++|||++ |+.||... +..+....+..+..+..+..+++.+
T Consensus       157 ----~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  228 (256)
T cd05082         157 ----DTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVV  228 (256)
T ss_pred             ----CCCccceeecCHHHHcc---CCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                12234568999998854   346789999999999999997 99999753 3334444455556667778899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+.||++|||+.++++
T Consensus       229 ~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         229 YDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0669|consensus

Probab=100.00  E-value=2.1e-44  Score=307.80  Aligned_cols=255  Identities=28%  Similarity=0.480  Sum_probs=203.7

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--------CceEEEE
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--------REEMVLF   80 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~~~~~lv   80 (407)
                      .||+|.||+||+|++..+|+.||+|++-... .+..+-...++|+++|..|+|+|++.+.+.+..        +..+|+|
T Consensus        24 kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   24 KIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             hcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            8999999999999999999999998764332 233344567899999999999999998876543        3459999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      +.+|+. +|.-++......++..++..++.++++||.|+|++.|+|||+||+|+||+.++ .+||+|||+++.++.....
T Consensus       103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~  180 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARAFSTSKNV  180 (376)
T ss_pred             HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccceeccccc
Confidence            999986 88888876656799999999999999999999999999999999999999875 7999999999887643322


Q ss_pred             -CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--HHhCCCCC--------
Q psy10603        161 -PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--KVGMGETP--------  229 (407)
Q Consensus       161 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--~~~~~~~~--------  229 (407)
                       ....+..+-|++|.+||.+.+.+  .|+++.|||..||++.||.+|.+-+.+..+..++..  .......+        
T Consensus       181 ~kprytnrvvTLwYrppEllLG~r--~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~  258 (376)
T KOG0669|consen  181 VKPRYTNRVVTLWYRPPELLLGDR--EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDN  258 (376)
T ss_pred             CCCCcccceeeeecCCHHHhhccc--ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCccc
Confidence             22245667799999999998754  478999999999999999999999986544333211  11111111        


Q ss_pred             ----------CCCC-------------ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        230 ----------TIPE-------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       230 ----------~~~~-------------~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                ++|+             .-.+++.+++..+|..||.+|+++.+++.|.||..
T Consensus       259 lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  259 LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence                      1121             12357889999999999999999999999999963

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.3e-42  Score=319.54  Aligned_cols=249  Identities=35%  Similarity=0.555  Sum_probs=205.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|.+..+++.+|+|.+.....   ...+.+.+|+.++++++||||+++++.+...+..|+|+||++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            34589999999999999998999999999864322   224567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|.+++.+  ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........   ...
T Consensus       100 ~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~---~~~  173 (293)
T cd06647         100 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS---KRS  173 (293)
T ss_pred             CCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceeccccccc---ccc
Confidence            9999999864  3478999999999999999999999999999999999998764 699999999876543221   223


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFA  243 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i  243 (407)
                      ...|++.|+|||.+..   ..++.++|+|||||++|+|++|+.||.......+ ......+..+..  +..++...++++
T Consensus       174 ~~~~~~~y~~PE~~~~---~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li  249 (293)
T cd06647         174 TMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGTPELQNPEKLSAIFRDFL  249 (293)
T ss_pred             cccCChhhcCchhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhcCCCCCCCCccccCHHHHHHH
Confidence            4568899999999854   2357899999999999999999999975443322 222222223322  345788999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+||+.||++||++.+++.|+|+.
T Consensus       250 ~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         250 NRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             HHHccCChhhCcCHHHHhcCHHHh
Confidence            999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0668|consensus

Probab=100.00  E-value=3.1e-43  Score=296.76  Aligned_cols=243  Identities=27%  Similarity=0.450  Sum_probs=204.1

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCc--eEEEEEecCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHRE--EMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~~~lv~E~~~   85 (407)
                      ++|+|.|++||.|.+..++++++||++++-+      .+.+.+|+.||++|+ ||||++++++..++.  ...|++||++
T Consensus        45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~  118 (338)
T KOG0668|consen   45 KVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN  118 (338)
T ss_pred             HHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence            7999999999999999999999999987542      356789999999998 899999999877654  5789999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +.+...+...    ++..+++.++.|++.||+||||.||+|||+||.|++|+.+...++|+|+|+|....+.    .+.+
T Consensus       119 n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~----~eYn  190 (338)
T KOG0668|consen  119 NTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG----KEYN  190 (338)
T ss_pred             cccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC----ceee
Confidence            9998887754    8889999999999999999999999999999999999998888999999999766543    3456


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----------------CCCC
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----------------GETP  229 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----------------~~~~  229 (407)
                      ..+.+..|.-||++.+.+.  |+.+-|+|||||++..|+..+.||....++...+.++..                ...|
T Consensus       191 VRVASRyfKGPELLVdy~~--YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQM--YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             eeeehhhcCCchheeechh--ccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence            6788999999999987643  677899999999999999999999866655444322210                1111


Q ss_pred             C----------------CC----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 T----------------IP----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ~----------------~~----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .                ++    .-.++++.||+.++|..|..+|+|+.|++.||||.
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence            1                00    12469999999999999999999999999999995

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-41  Score=318.53  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             ceeeecccccCeEEEEEEEC-------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNN-------ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~   76 (407)
                      .....||+|+||.||+|++.       .++..+|+|.+...  ......+.+.+|+.+++.+ +||||+++++.+...+.
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   95 (304)
T cd05101          18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   95 (304)
T ss_pred             eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence            44558999999999999753       23457999987643  2233456788999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN  141 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~  141 (407)
                      .|++|||+++|+|.+++....               ..++...+..++.|++.||.|||++||+||||||+|||++.++ 
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~-  174 (304)
T cd05101          96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN-  174 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC-
Confidence            999999999999999986532               2467888999999999999999999999999999999998764 


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM  220 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~  220 (407)
                      .+||+|||+++........ .......+++.|+|||++.+   ..++.++|||||||++|+|++ |..||... +..+..
T Consensus       175 ~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~  249 (304)
T cd05101         175 VMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF  249 (304)
T ss_pred             cEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHH
Confidence            6999999999876432211 11122345678999999854   346789999999999999998 78898754 344444


Q ss_pred             HHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       221 ~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+..+..+..+..++.++++++.+||..+|++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            4555555556677889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-41  Score=310.38  Aligned_cols=251  Identities=31%  Similarity=0.509  Sum_probs=213.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||++.+..+++.+|+|.+...... ......+.+|++++++++||||+++++.+......++||||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            4566899999999999999999999999998764333 234567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++++|..++...   ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.......   
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~~---  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKNM---  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccCC---
Confidence            999999988552   24589999999999999999999999999999999999999864 69999999987664431   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                        .....+++.|+|||.+.+   ..++.++|+||||+++|+|++|+.||...+ .......+..+..+.++..++.++++
T Consensus       158 --~~~~~~~~~~~~Pe~~~~---~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd08530         158 --AKTQIGTPHYMAPEVWKG---RPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQN  231 (256)
T ss_pred             --cccccCCccccCHHHHCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCCCCchhhCHHHHH
Confidence              123467889999999854   335789999999999999999999998643 33444555566667777889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ++.+||..+|++|||+.|+++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0603|consensus

Probab=100.00  E-value=7.9e-43  Score=333.82  Aligned_cols=242  Identities=31%  Similarity=0.396  Sum_probs=202.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +..+...+|.|+|+.|..+.+..+++..++|++......       ..+|+.++. .-+||||+++.+.+.+..+.|+||
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            345556899999999999999999999999999765222       224665544 457999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe-cCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT-AEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~-~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |.+.|+.+.+.+...+  .....+..|++||+.|++|||++|||||||||+|||++ .. ++++|+|||.++.....   
T Consensus       396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA-GHLRLTYFGFWSELERS---  469 (612)
T ss_pred             hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC-CcEEEEEechhhhCchh---
Confidence            9999999988876533  33378888999999999999999999999999999995 54 46999999999776543   


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                         ..+.+=|..|.|||++.   ..+|++++|+||||++||+|++|+.||.......++..++..   +.+...+|++++
T Consensus       470 ---~~tp~~t~~y~APEvl~---~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~---~~~s~~vS~~AK  540 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLA---IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM---PKFSECVSDEAK  540 (612)
T ss_pred             ---hcccchhhcccChhhhc---cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC---CccccccCHHHH
Confidence               23345688999999986   356899999999999999999999999876666566666554   334488999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ++++.||+.||.+|+++.++..|||+
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999998

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.3e-41  Score=319.33  Aligned_cols=252  Identities=21%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             cceeeecccccCeEEEEEEECC-------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-------TGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~   75 (407)
                      +.....||+|+||.||+|++..       ....+|+|.+....  .......+.+|+.+++++ +||||+++++++...+
T Consensus        14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            3456699999999999998642       34578999876432  234456788999999999 6999999999999888


Q ss_pred             eEEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      .+|++|||+++|+|.+++....               ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            9999999999999999986532               2478889999999999999999999999999999999998765


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~  219 (407)
                       .+||+|||+++......... ......++..|+|||++..   ..++.++|||||||++|||++ |..||... +....
T Consensus       172 -~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~~~~  245 (314)
T cd05099         172 -VMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD---RVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEEL  245 (314)
T ss_pred             -cEEEcccccccccccccccc-ccccCCCCccccCHHHHcc---CCcCccchhhHHHHHHHHHHhCCCCCCCCC-CHHHH
Confidence             69999999997654321111 1112234567999999854   346789999999999999999 89999753 33334


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ...+..+..+..+..++.++++++.+||..||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44444455556677889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-41  Score=310.87  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.++++++|||++++++.+. .+..+++|||
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            445568999999999999876 4567999998754322    245788999999999999999999874 5568999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++..+......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~--  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT--  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc--
Confidence            9999999998653 23489999999999999999999999999999999999998754 6999999999776433211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||++..   ..++.++|+||||+++|+|++ |..||.... .......+..+..+..+...+.++++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERGYRMPCPQDCPISLHE  234 (260)
T ss_pred             cccCCCCCccccChHHHhc---CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            1122345668999998754   335789999999999999999 899997543 33444555555566677888999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||.+||++|||+.++.+
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-41  Score=313.32  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=203.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      .+.....||+|+||+||+|.+..+|+    .+|+|.+....  .......+.+|+.++++++||||+++++.+.. ...+
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            34555689999999999999876665    58999876442  23455678899999999999999999999876 7899


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||+++......
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCcccccccCcc
Confidence            99999999999999977666699999999999999999999999999999999999998764 69999999997764322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                      .. .......++..|+|||.+..   ..++.++|+|||||++||+++ |+.||.... ..+....+..+.....|...+.
T Consensus       164 ~~-~~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05057         164 KE-YHAEGGKVPIKWMALESILH---RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVEIPDLLEKGERLPQPPICTI  238 (279)
T ss_pred             cc-eecCCCcccccccCHHHhhc---CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHhCCCCCCCCCCCCH
Confidence            11 01111223567999998743   345789999999999999998 999998543 3344445555555666777889


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+++.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         239 DVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.2e-42  Score=320.04  Aligned_cols=257  Identities=28%  Similarity=0.474  Sum_probs=201.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-------
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-------   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------   75 (407)
                      ++.....||+|+||.||+|.+..+|+.||+|+++.....+ .....+.+|++++++++||||+++++++....       
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            4455669999999999999999999999999987543222 22345678999999999999999999887654       


Q ss_pred             ---eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         76 ---EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        76 ---~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                         .+++|+||+++ ++...+......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~  164 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLAR  164 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcccccc
Confidence               79999999986 67677665455689999999999999999999999999999999999998764 69999999997


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCC-
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETP-  229 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~-  229 (407)
                      ........  ......++..|+|||++...  ..++.++|||||||++|||++|+.||.........  +.....+..+ 
T Consensus       165 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         165 LYNSEESR--PYTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccCCccc--ccccceeccCccChHHhcCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            66433211  11223567889999988532  23578999999999999999999999754332221  1111111110 


Q ss_pred             -------------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        230 -------------------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       230 -------------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                               .....+++.+.+++.+||..||++|||+.+++.|||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     0112468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-41  Score=309.63  Aligned_cols=243  Identities=23%  Similarity=0.383  Sum_probs=202.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||.||+|...  |+.||+|.+.....    ..+++.+|+.++.+++|+||+++++.+...+..++|||
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            4566779999999999999865  78899999864321    45678899999999999999999999998899999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.++++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||+++......   
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc---
Confidence            999999999987543 2589999999999999999999999999999999999998765 69999999997653221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                         .....+..|+|||.+..   ..++.++|+||||+++|||++ |+.||... +.......+..+..+..+..+++++.
T Consensus       157 ---~~~~~~~~~~ape~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05039         157 ---DSGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVY  229 (256)
T ss_pred             ---ccCCCcccccCchhhcC---CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCCCCccCCCHHHH
Confidence               12234567999998854   235789999999999999997 99999754 33444444444555666778899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||..+|++|||+.|+++
T Consensus       230 ~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         230 KVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG1095|consensus

Probab=100.00  E-value=2.8e-42  Score=351.43  Aligned_cols=252  Identities=24%  Similarity=0.408  Sum_probs=210.7

Q ss_pred             ccceeeecccccCeEEEEEEECCC-C----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNET-G----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~-~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      .+++...||+|.||+||.|..... |    ..||||.+..  ..+.+...+|++|..+|++++|||||++.|++.+....
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            466777999999999999985432 2    2488887754  45667788999999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         78 VLFMELCTEGTLESLVQST------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      +|++|||++|+|..+|++.      ...++..+...++.||++|++||++++.|||||-.+|+|++.. ..+||+|||+|
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaDFGlA  849 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIADFGLA  849 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcccchh
Confidence            9999999999999999886      5668999999999999999999999999999999999999986 57999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      +.+........... ..-...|||||.+.+   ..++.|+|||||||++||++| |..||.+. ++.+++.....+.+..
T Consensus       850 rDiy~~~yyr~~~~-a~lPvkWm~PEsl~d---~iFtskSDvWsFGVllWEifslG~~PY~~~-~n~~v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGE-AMLPVKWMPPESLKD---GIFTSKSDVWSFGVLLWEIFSLGATPYPSR-SNFEVLLDVLEGGRLD  924 (1025)
T ss_pred             HhhhhchheeccCc-cccceecCCHHHHhh---cccccccchhhhHHHHHHHHhCCCCCCCCc-chHHHHHHHHhCCccC
Confidence            95543322211111 122357999999976   347899999999999999998 88999865 4556655455555777


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .|..+++...+++..||+.+|++||++..+++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            78999999999999999999999999999886

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-41  Score=315.93  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=203.5

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.....||+|+||.||+|.+.     .++..+|+|.+...  ......+.+.+|+.++.+++||||+++++++...+..
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4455568999999999999874     36788999988643  2334456788999999999999999999999998899


Q ss_pred             EEEEecCCCCCHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy10603         78 VLFMELCTEGTLESLVQSTE---------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL  136 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~---------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill  136 (407)
                      +++|||+++|+|.+++....                     ..+++..+..++.|++.||.|||+++++||||||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~  163 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence            99999999999999986421                     236788899999999999999999999999999999999


Q ss_pred             ecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCc
Q psy10603        137 TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDS  215 (407)
Q Consensus       137 ~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~  215 (407)
                      +.++ .+||+|||++......... .......+++.|+|||++..   ..++.++|||||||++|||++ |..||.+.. 
T Consensus       164 ~~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-  237 (288)
T cd05050         164 GENM-VVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-  237 (288)
T ss_pred             cCCC-ceEECccccceecccCccc-cccCCCccChhhcCHHHHhc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            8765 6999999998765432211 11122234678999998754   346789999999999999997 888987543 


Q ss_pred             hHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        216 NYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+....+..+..+..+..++.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            33444555555556667788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.6e-41  Score=309.14  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             ceeeecccccCeEEEEEEECCCC----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETG----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +....||.|+||.||+|++..++    +.+|+|.+....  .....+.+..|+..+..++||||+++++.+...+..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            45568999999999999998766    899999986442  222457788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~-~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||+++++|.+++...... +++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||+|||++........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccccc
Confidence            9999999999998764444 89999999999999999999999999999999999998865 699999999977654322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      ...  ....+++.|+|||.+..   ..++.++|+||||+++|+|++ |..||.. .+.......+..+..+..+...+.+
T Consensus       159 ~~~--~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T smart00219      159 YKK--KGGKLPIRWMAPESLKD---GKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLPKPENCPPE  232 (258)
T ss_pred             ccc--ccCCCcccccChHHhcc---CCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCCCCCcCCHH
Confidence            111  11236789999998843   346789999999999999998 7888875 3344445555556666677789999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +.+++.+||..||++|||+.|+++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.9e-41  Score=309.87  Aligned_cols=246  Identities=24%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      ......||+|+||.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.++++++|||++++++.+. .+..+++|||
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            34556899999999999987665 4599998764322    2356788999999999999999998874 5568999999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.++++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++ .+||+|||++.........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~--  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYT--  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCccc--
Confidence            99999999986533 3478999999999999999999999999999999999998764 6999999999766432211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||++..   ..++.++|||||||++|||++ |..||.+.. ..........+..+..+..++.++++
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~---~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELVTKGRVPYPGMV-NREVLEQVERGYRMPCPQGCPESLHE  234 (260)
T ss_pred             ccCCCccchhhCCHHHhcc---CCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            1123345678999998754   335789999999999999999 999998643 33344444445555667788999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||++||++||++.++++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-41  Score=311.59  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=203.4

Q ss_pred             cceeeecccccCeEEEEEEECCC---CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNET---GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      ++....||+|+||.||+|.+...   ...+|||.....  .+....+.+.+|+.++++++||||+++++.+.. +..++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            45566999999999999987544   346899987543  224455678899999999999999999998764 557899


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++|+|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++ .+||+|||+++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeecccccce
Confidence            999999999999976555689999999999999999999999999999999999998764 6999999998765433211


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      .  .+...+++.|+|||.+..   ..++.++|||||||++|||++ |..||.... .......+..+..+..+..++.++
T Consensus       164 ~--~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         164 K--ASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMLGVKPFQGVK-NNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             e--cCCCCccccccChhhhcc---CCCCchhhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCcCCCCCCCCHHH
Confidence            1  112234568999998743   346789999999999999986 999997544 334445556666667788899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+++.+||..+|++|||+.+++..
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.2e-41  Score=316.15  Aligned_cols=248  Identities=33%  Similarity=0.521  Sum_probs=203.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||++.+..+++.||+|++...   .......+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus        27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            799999999999999999999999988533   22344668899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |.+++..  ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++........   ......
T Consensus       104 L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~---~~~~~~  177 (292)
T cd06657         104 LTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVP---RRKSLV  177 (292)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccc---cccccc
Confidence            9998743  3489999999999999999999999999999999999998764 699999999876543221   123456


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--CCCccCHHHHHHHHHh
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQAFAELC  246 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~~i~~~  246 (407)
                      |++.|+|||.+..   ..++.++|+||+|+++|+|++|..||..... ............+.  ....++.++.+++.+|
T Consensus       178 ~~~~y~~pE~~~~---~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         178 GTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             cCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhCCcccCCcccCCHHHHHHHHHH
Confidence            8899999998753   2357899999999999999999999975432 22222222222222  2345788999999999


Q ss_pred             cccCCCCcCCHHHHhcCCeeeee
Q psy10603        247 LRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       247 l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      |..||.+||++.++++|||+...
T Consensus       254 l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             HhCCcccCcCHHHHhcChHHhcc
Confidence            99999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=315.06  Aligned_cols=254  Identities=29%  Similarity=0.502  Sum_probs=203.0

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEEEec
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLFMEL   83 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~E~   83 (407)
                      ....||.|+||.||+|.+..+++.+|+|.+.... ......+.+.+|++++++++|||++++++.+...  +..++||||
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            4568999999999999999999999999998653 2334456788999999999999999999999887  789999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++ +|..++......+++..+..++.|++.||.|||++|++|+||||+||++++++ .+||+|||++........  ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~--~~  157 (287)
T cd07840          82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNS--AD  157 (287)
T ss_pred             ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCc--cc
Confidence            985 88888865545699999999999999999999999999999999999999865 699999999977654321  11


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-C-C--------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-G-E--------------  227 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~-~--------------  227 (407)
                      .....++..|+|||.+.+.  ..++.++||||||+++|||++|+.||............... + .              
T Consensus       158 ~~~~~~~~~y~~PE~~~~~--~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         158 YTNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccCCceeeEcc--ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            2334668899999987542  33578999999999999999999999764432221111100 0 0              


Q ss_pred             -----CCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 -----TPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 -----~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                           ...        +...+++++.+++.+||..||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                 000        011138889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.8e-42  Score=325.31  Aligned_cols=259  Identities=26%  Similarity=0.457  Sum_probs=202.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~l   79 (407)
                      +.....||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++..    ...+++
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            3444589999999999999999999999999875422 22345667889999999999999999987753    346899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+. ++|..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||++........
T Consensus        86 v~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          86 VMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeecccCc
Confidence            999996 588888864 34489999999999999999999999999999999999999865 699999999976543221


Q ss_pred             C-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH---------------
Q psy10603        160 V-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV---------------  223 (407)
Q Consensus       160 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~---------------  223 (407)
                      . ........|+..|+|||.+...  ..++.++|||||||++|||++|+.||...+...+.....               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSL--PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CCCcccccccccccccChHHhcCC--cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            1 1112345789999999997542  236789999999999999999999997543222111000               


Q ss_pred             ---------hCCCCCCC-----CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        224 ---------GMGETPTI-----PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       224 ---------~~~~~~~~-----~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                               .....+..     ....++++.+++.+||+.||++|||+.+++.|||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence                     00111111     1346889999999999999999999999999999963

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-41  Score=324.79  Aligned_cols=254  Identities=27%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~l   79 (407)
                      .....||+|+||+||+|++..+++.||||.+..... .......+.+|+.+|+.++||||+++++++...     ...|+
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            344589999999999999999999999999875422 222345677899999999999999999877643     34899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||+++...... 
T Consensus        87 v~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~-  162 (337)
T cd07858          87 VYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKG-  162 (337)
T ss_pred             EEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCCCc-
Confidence            999996 688888865 34599999999999999999999999999999999999998765 69999999997654321 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--HHHh-------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--FKVG-------------  224 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--~~~~-------------  224 (407)
                        .......++..|+|||++...  ..++.++|+|||||++|+|++|+.||...+......  ....             
T Consensus       163 --~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         163 --DFMTEYVVTRWYRAPELLLNC--SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             --ccccccccccCccChHHHhcC--CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence              112345678999999988542  236789999999999999999999997532111110  0000             


Q ss_pred             ---------CCCC--C---CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 ---------MGET--P---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 ---------~~~~--~---~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                               ....  +   .....+++++.+++.+||+.||++|||+.|+++|||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence                     0000  0   11245789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-41  Score=320.37  Aligned_cols=259  Identities=32%  Similarity=0.523  Sum_probs=198.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-------
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-------   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------   75 (407)
                      ++.....||+|+||.||+|.+..+++.+|+|++......+ .....+.+|+++++.++||||+++++.+....       
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            4555668999999999999999999999999987543322 12245678999999999999999998765433       


Q ss_pred             -eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceec
Q psy10603         76 -EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI  154 (407)
Q Consensus        76 -~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~  154 (407)
                       .+++||||+.+ ++...+......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  165 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARPY  165 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchhc
Confidence             47999999975 67766655455699999999999999999999999999999999999998865 6999999999765


Q ss_pred             CCCCCC--------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHh
Q psy10603        155 SAHTTV--------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVG  224 (407)
Q Consensus       155 ~~~~~~--------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~  224 (407)
                      ......        ....+...+++.|+|||++.+.  ..++.++|||||||++|||++|++||.........  +....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCC--CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            432211        1112344678899999987542  33578999999999999999999999754332211  11111


Q ss_pred             CCCC----------C---------CCC-------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        225 MGET----------P---------TIP-------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       225 ~~~~----------~---------~~~-------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ....          +         ..+       ..++.++.+++.+||+.||++|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            0000          0         000       2345678899999999999999999999999996

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-41  Score=313.36  Aligned_cols=247  Identities=25%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             ecccccCeEEEEEEECCCC------cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETG------ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .||+|+||.||+|++....      +.+|+|.+....  .......+.+|+.+|+.++||||+++++++...+..++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            5899999999999876544      689999875432  22335678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC----CeEEEEcccCce
Q psy10603         83 LCTEGTLESLVQST------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG----NSLKLGDFGSAV  152 (407)
Q Consensus        83 ~~~~g~L~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~----~~vkl~DFGla~  152 (407)
                      |+++++|.+++...      ...+++..+..++.|++.||.|||+++++|+||||+||+++.++    ..+||+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999998642      23478899999999999999999999999999999999998754    269999999987


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTI  231 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~  231 (407)
                      ........ .......++..|+|||++.+.   .++.++|||||||++|||++ |..||.... ..+....+..+..+..
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~~~  234 (269)
T cd05044         160 DIYKSDYY-RKEGEGLLPVRWMAPESLLDG---KFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAGGRLQK  234 (269)
T ss_pred             cccccccc-ccCcccCCCccccCHHHHccC---CcccchhHHHHHHHHHHHHHcCCCCCcccC-HHHHHHHHhcCCccCC
Confidence            65432211 111223457789999998542   35789999999999999998 999997543 3344444445555566


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +..++.++.+++.+||+++|++||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7788999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.2e-41  Score=308.80  Aligned_cols=246  Identities=22%  Similarity=0.386  Sum_probs=199.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.+...||+|+||.||+|... +++.||+|.+......    ...+.+|+.++++++||||+++++.+ ..+..+++|||
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           8 LKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             ceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            455669999999999999855 5678999998754322    24678899999999999999999886 45678999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||++++++ .++|+|||++.........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~--  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYT--  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcc--
Confidence            9999999988653 34589999999999999999999999999999999999998865 6999999999765422211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......++..|+|||++..   ..++.++||||||+++|||++ |+.||.... ..........+..+..+...+.++.+
T Consensus       159 ~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05067         159 AREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-NPEVIQNLERGYRMPRPDNCPEELYE  234 (260)
T ss_pred             cccCCcccccccCHHHhcc---CCcCcccchHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1123345678999998854   335789999999999999999 999998543 33444444455555667788999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||+.||++|||+.+++.
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4e-41  Score=314.83  Aligned_cols=253  Identities=21%  Similarity=0.307  Sum_probs=199.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCC----------------cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcce
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG----------------ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK   66 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   66 (407)
                      .+.....||+|+||.||+|.+..++                ..||+|.+....  .....+.+.+|++++.+++||||++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3455669999999999999876544                468999886442  2345677889999999999999999


Q ss_pred             EEEEEEeCceEEEEEecCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q psy10603         67 YYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL  136 (407)
Q Consensus        67 ~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill  136 (407)
                      +++++...+..+++|||+++++|..++....          ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili  163 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence            9999999999999999999999999986543          158999999999999999999999999999999999999


Q ss_pred             ecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc--CCCCCCCCC
Q psy10603        137 TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS--GKRPWAEYD  214 (407)
Q Consensus       137 ~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~--g~~Pf~~~~  214 (407)
                      +.++ .+||+|||+++........ .......+++.|+|||++..   ..++.++|||||||++|||++  |..||....
T Consensus       164 ~~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         164 GKNY-TIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL---GKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             cCCC-ceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc---CCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            8864 6999999998765332211 11123456788999999854   236789999999999999998  778887543


Q ss_pred             chHHHHHHHhCC-------CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        215 SNYQIMFKVGMG-------ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       215 ~~~~~~~~~~~~-------~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      . .+........       .....+..+++++.+++.+||+.||++|||+.|+++.
T Consensus       239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~  293 (296)
T cd05051         239 D-QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF  293 (296)
T ss_pred             h-HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence            2 2222222111       1122345678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-41  Score=311.77  Aligned_cols=253  Identities=28%  Similarity=0.491  Sum_probs=207.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||.||++++..++..+++|+++.....  .......+.+|+.++++++||||+++++.+......++|+|
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence            3456899999999999999888777777776532211  11223456689999999999999999999998889999999


Q ss_pred             cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         83 LCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+++++|..++..   ....+++..+..++.|++.||.|||++|++|+||||+||++++  +.+||+|||++........
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--CCEeecccCceeecCCCcc
Confidence            9999999988753   2345899999999999999999999999999999999999975  3599999999877643322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                         ......|++.|+|||.+..   ..++.++|+||||+++|+|++|..||... ...........+..+..+..++.++
T Consensus       161 ---~~~~~~~~~~~~~pe~~~~---~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (260)
T cd08222         161 ---LATTFTGTPYYMSPEALKH---QGYDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRIVEGPTPSLPETYSRQL  233 (260)
T ss_pred             ---cccCCCCCcCccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCCCCCcchhcHHH
Confidence               1234567889999998753   33567899999999999999999999743 3444445555666777788899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .+++.+||..||++||++.|+++|||+
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-42  Score=341.70  Aligned_cols=256  Identities=25%  Similarity=0.320  Sum_probs=185.3

Q ss_pred             ceeeecccccCeEEEEEEECCCC-cEEEEEE--------------EeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETG-ELVAMKE--------------IQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG   69 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~-~~vAvK~--------------i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   69 (407)
                      .....||+|+||+||+|..+... +..+.|.              +.+...........+.+|+.+|.+++||||+++++
T Consensus       151 ~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  230 (501)
T PHA03210        151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEE  230 (501)
T ss_pred             EEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeE
Confidence            33459999999999999765332 2222221              11111122234556789999999999999999999


Q ss_pred             EEEeCceEEEEEecCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEE
Q psy10603         70 VEIHREEMVLFMELCTEGTLESLVQST----EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKL  145 (407)
Q Consensus        70 ~~~~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl  145 (407)
                      ++...+..|+|+|++.+ +|..++...    ........+..++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus       231 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~-~vkL  308 (501)
T PHA03210        231 ILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-KIVL  308 (501)
T ss_pred             EEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEE
Confidence            99999999999999964 666665332    12234567888999999999999999999999999999998865 6999


Q ss_pred             EcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCC-CCCCC-chHHHHHHH
Q psy10603        146 GDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYD-SNYQIMFKV  223 (407)
Q Consensus       146 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~P-f~~~~-~~~~~~~~~  223 (407)
                      +|||+++.+.....  ......+||+.|+|||++..   ..++.++|||||||++|||++|..| +.... .....+.++
T Consensus       309 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        309 GDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG---DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             EeCCCceecCcccc--cccccccCCcCCCCchhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            99999987643221  11234679999999999864   3468899999999999999998754 43222 111111111


Q ss_pred             hCC------CCC--------------------CC-----CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        224 GMG------ETP--------------------TI-----PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       224 ~~~------~~~--------------------~~-----~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ...      ..|                    .+     ...++.++.+++.+||++||.+|||+.|+|.||||.
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            100      000                    00     013456778889999999999999999999999994

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-41  Score=322.55  Aligned_cols=257  Identities=28%  Similarity=0.459  Sum_probs=205.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-----eEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-----EMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l   79 (407)
                      .....||+|+||.||+|++..+++.+|+|.+.... .+....+.+.+|+.+++.++||||+++++++...+     .+|+
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            44568999999999999999999999999987542 22344567889999999999999999999987765     7899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      +|||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++........
T Consensus        82 v~e~~~~-~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          82 VTELMET-DLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDED  158 (330)
T ss_pred             Eecchhh-hHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeeccccc
Confidence            9999984 888888653 369999999999999999999999999999999999999886 4699999999987654332


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC----------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE----------  227 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~----------  227 (407)
                      .........+|+.|+|||++....  .++.++|+||||+++|+|++|+.||........ ...+..  +.          
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSS--RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccCcCCceeeeccc--CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhcc
Confidence            112234457899999999986532  468899999999999999999999975432211 111100  00          


Q ss_pred             -------------CC-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        228 -------------TP-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       228 -------------~~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                   ..     .....++.++.+++.+||++||++|||+.++++||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                         00     012346888999999999999999999999999999953

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4250|consensus

Probab=100.00  E-value=7.8e-43  Score=336.53  Aligned_cols=239  Identities=34%  Similarity=0.569  Sum_probs=192.5

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~lv~E   82 (407)
                      .||+|+||.||+++++++|+.||||..+....  .+-+++..+|+++|++|+|||||+++++-....      ...+|||
T Consensus        20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            89999999999999999999999999876543  233566789999999999999999999865543      5789999


Q ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec--CCC-eEEEEcccCceecCCC
Q psy10603         83 LCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA--EGN-SLKLGDFGSAVKISAH  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~--~~~-~vkl~DFGla~~~~~~  157 (407)
                      ||+||||...+++.  ..++||..+..++..+..||.|||++||+||||||.||++-.  +|. .-||+|||.|+.++.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~  177 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN  177 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence            99999999999753  457999999999999999999999999999999999999853  233 3599999999998776


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---chHHHHHHHhCCCCC-----
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGMGETP-----  229 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~---~~~~~~~~~~~~~~~-----  229 (407)
                      +    ..++.+||+.|.+||++..  ...|+..+|.|||||++|+++||..||....   ++++.+..+..+...     
T Consensus       178 s----~~~S~vGT~~YLhPel~E~--q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  178 S----LFTSLVGTEEYLHPELYER--QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             C----eeeeecCchhhcChHHHhh--ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            5    3577899999999999854  2457889999999999999999999996433   234455444332211     


Q ss_pred             ---------------CCCCccCHHH----HHHHHHhcccCCCCcC
Q psy10603        230 ---------------TIPESLSDEG----QAFAELCLRHDPAQRA  255 (407)
Q Consensus       230 ---------------~~~~~~s~~~----~~~i~~~l~~dp~~R~  255 (407)
                                     +.|-.++...    -..+..+|..+|.+|.
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                           1233444333    3467778999999998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-41  Score=308.66  Aligned_cols=229  Identities=26%  Similarity=0.376  Sum_probs=188.8

Q ss_pred             ccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCHHHH
Q psy10603         13 GRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESL   92 (407)
Q Consensus        13 G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L~~~   92 (407)
                      |.||+||+|++..+++.||+|.+....        ...+|...+....||||+++++.+...+..+++|||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999999999999999987542        122345555567799999999999999999999999999999999


Q ss_pred             HhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCc
Q psy10603         93 VQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA  172 (407)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~  172 (407)
                      +... ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++++|||++.......      ....++..
T Consensus        76 l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~~------~~~~~~~~  147 (237)
T cd05576          76 ISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDSC------DGEAVENM  147 (237)
T ss_pred             HHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhcccccc------ccCCcCcc
Confidence            8653 4589999999999999999999999999999999999999865 59999999876554321      22356778


Q ss_pred             ccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCC
Q psy10603        173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPA  252 (407)
Q Consensus       173 y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~  252 (407)
                      |+|||.+..   ..+++++|+||+||++|||++|+.|+......      ........+|..+++++++++.+||++||+
T Consensus       148 y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         148 YCAPEVGGI---SEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             ccCCcccCC---CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHH
Confidence            999998743   33578999999999999999999987642211      111122345678899999999999999999


Q ss_pred             CcCCH-----HHHhcCCee
Q psy10603        253 QRATI-----FELLQHPFL  266 (407)
Q Consensus       253 ~R~t~-----~e~l~hp~~  266 (407)
                      +|+++     .++++|||+
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            99986     899999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-41  Score=307.78  Aligned_cols=248  Identities=24%  Similarity=0.366  Sum_probs=202.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .++....||+|+||.||+|.+. .++.+|||.+......    .+++.+|+.++++++||||+++++.+......++|||
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            4556679999999999999876 4577999998743321    3567889999999999999999999988889999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++ .+||+|||++......... 
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~-  159 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEYT-  159 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhhh-
Confidence            999999999986543 4589999999999999999999999999999999999998865 6999999999776432111 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......++..|+|||.+.+   ..++.++|+|||||++|+|++ |+.||.... ..........+.....+...+.++.
T Consensus       160 -~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANY---GRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-NREVLEQVERGYRMPRPPNCPEELY  234 (261)
T ss_pred             -hhhccCCCccccCHHHhcc---CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHH
Confidence             1112234568999998854   335789999999999999998 999997543 3444555555555566777899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++||++.++.+
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0614|consensus

Probab=100.00  E-value=9.7e-44  Score=329.78  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=219.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||-|+||.|-++..+.....+|+|.+++...-+.+..+.+..|..||..++.|.||++|-.|.+...+|+.||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            33344899999999999987766666899999887777888888899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      |-||.|...++. ++.|.+.++++|+..+++|++|||++|||.|||||+|++++.+| -+||.|||+|+++....    .
T Consensus       502 ClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~----K  575 (732)
T KOG0614|consen  502 CLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGR----K  575 (732)
T ss_pred             hcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccCC----c
Confidence            999999999965 56699999999999999999999999999999999999999876 59999999999886543    3


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC-CCCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~~  242 (407)
                      ..++||||.|.|||++.+   .+++.++|.||||+++|||++|++||.+.+.... ...+..| ..-.+|..++..+.++
T Consensus       576 TwTFcGTpEYVAPEIILn---KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILN---KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             eeeecCCcccccchhhhc---cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhhhhhhhcccccchhHHHH
Confidence            468999999999999975   4568999999999999999999999997554322 2222222 2345688999999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      ++++...+|.+|..     +.++..|-||.
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            99999999999975     78999999984

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-41  Score=311.16  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=202.2

Q ss_pred             cceeeecccccCeEEEEEEECC----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~   78 (407)
                      +.....||+|+||.||+|.+..    +++.||+|.+...  .+....+.+.+|+.+|++++||||+++++++.. ....+
T Consensus         8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            3455689999999999999876    3578999987633  344456778899999999999999999998765 46789


Q ss_pred             EEEecCCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         79 LFMELCTEGTLESLVQSTE-------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      +++||+++++|.+++....       ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d~g~~  164 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITDNALS  164 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECCCCCc
Confidence            9999999999999986532       3488999999999999999999999999999999999998764 6999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      +.+....... ......++..|+|||++..   ..++.++|||||||++||+++ |+.||... +.......+..+..+.
T Consensus       165 ~~~~~~~~~~-~~~~~~~~~~y~apE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~  239 (280)
T cd05043         165 RDLFPMDYHC-LGDNENRPVKWMALESLVN---KEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLKDGYRLA  239 (280)
T ss_pred             ccccCCceEE-eCCCCCcchhccCHHHHhc---CCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHcCCCCC
Confidence            7654322110 0122345678999999854   346789999999999999999 99999754 3344444444455555


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..+++++.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            56678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=314.16  Aligned_cols=252  Identities=31%  Similarity=0.542  Sum_probs=203.2

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|++|.||+|.+..+++.+|+|.+..... .......+.+|+++|++++||||+++++.+...+..++|+||+++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            4579999999999999999999999999875432 223456788899999999999999999999999999999999975


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                       +|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++ .+||+|||.+.......   .....
T Consensus        83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~---~~~~~  157 (283)
T cd05118          83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPV---RPYTH  157 (283)
T ss_pred             -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCc---ccccC
Confidence             88888766555689999999999999999999999999999999999998764 69999999997765432   11233


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CC-C----------------
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GE-T----------------  228 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~-~----------------  228 (407)
                      ..++..|+|||.+...  ..++.++|+||||+++|+|++|+.||...+...+....... +. .                
T Consensus       158 ~~~~~~~~~PE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         158 YVVTRWYRAPELLLGD--KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             ccCcccccCcHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            4678899999998542  24678999999999999999999999754432221111000 00 0                


Q ss_pred             ----------CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        229 ----------PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       229 ----------~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                                +.+...++.++.+++..||++||.+||++.+++.|||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                      01123467899999999999999999999999999996

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-41  Score=319.16  Aligned_cols=252  Identities=21%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             ceeeecccccCeEEEEEEECCC-------CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNET-------GELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~   76 (407)
                      +....||+|+||.||+|++...       +..||+|.+...  ......+.+.+|+.+++++ +||||+++++.+...+.
T Consensus        15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            3445899999999999986432       236899987633  2334457788999999999 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN  141 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~  141 (407)
                      .+++|||+++|+|.+++....               ..++...+..++.|++.||.|||++|++||||||+|||++.++ 
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~-  171 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-  171 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-
Confidence            999999999999999986532               2367788899999999999999999999999999999998765 


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM  220 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~  220 (407)
                      .+||+|||+++........ .......++..|+|||++..   ..++.++|||||||++|||++ |..||... +.....
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~  246 (334)
T cd05100         172 VMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF  246 (334)
T ss_pred             cEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc---CCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHH
Confidence            6999999999765432211 11122234567999999854   335789999999999999998 88999754 333444


Q ss_pred             HHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       221 ~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ..+..+..+..+...+.++.+++.+||+.+|++|||+.|++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            44445556666778899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.9e-41  Score=307.78  Aligned_cols=238  Identities=24%  Similarity=0.387  Sum_probs=189.7

Q ss_pred             ecccccCeEEEEEEECCCC----------cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          9 SPGQGRFGKVYTAVNNETG----------ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      .||+|+||.||+|.+..++          ..+++|.+.....   . ...+.+|+.+|++++||||+++++.+.. +..+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            5899999999999998766          3577787653321   1 4678899999999999999999999887 7789


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC------eEEEEcccCce
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN------SLKLGDFGSAV  152 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~------~vkl~DFGla~  152 (407)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++.      .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999999765546899999999999999999999999999999999999987641      49999999987


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTI  231 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~  231 (407)
                      .....       ....++..|+|||++.... ..++.++|||||||++|||++ |..||........... ...  ....
T Consensus       157 ~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~~--~~~~  225 (259)
T cd05037         157 TVLSR-------EERVERIPWIAPECIRNGQ-ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQD--QHRL  225 (259)
T ss_pred             ccccc-------cccccCCCccChhhhcCCC-CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-Hhc--CCCC
Confidence            65431       2245677899999986531 346789999999999999999 5888875432221111 111  1112


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +...+.++.+++.+||..||.+|||+.++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2223478999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-41  Score=312.07  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=200.8

Q ss_pred             cceeeecccccCeEEEEEEEC----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~   77 (407)
                      +.+...||+|+||.||+|.+.    .+++.+|+|.+......  ...+.+.+|+++++.++||||+++++++..  ....
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            455568999999999999864    34789999998754332  455778999999999999999999998877  5579


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      +++|||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~  162 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPED  162 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccccccccC
Confidence            999999999999999976555689999999999999999999999999999999999998764 6999999999776532


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH--------------HHHHHH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------------QIMFKV  223 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~--------------~~~~~~  223 (407)
                      ...........++..|+|||.+..   ..++.++||||||+++|||++|..|+.......              ......
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRT---SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHcc---CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            211111112344567999998854   245789999999999999999999986432111              111222


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..+.....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            233334445677889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-41  Score=320.45  Aligned_cols=249  Identities=28%  Similarity=0.426  Sum_probs=199.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~lv   80 (407)
                      ...||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+|++++||||+++++++....      .+++|
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            348999999999999999999999999986432 23344567889999999999999999999887553      46899


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+ +++|..++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......   
T Consensus        99 ~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~---  171 (343)
T cd07880          99 MPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTDSE---  171 (343)
T ss_pred             EecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccccccccC---
Confidence            9999 6799888753  4589999999999999999999999999999999999998765 6999999998765322   


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC-------------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-------------  227 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~-------------  227 (407)
                         .....+++.|+|||++...  ..++.++|+|||||++|+|++|+.||.................             
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         172 ---MTGYVVTRWYRAPEVILNW--MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             ---ccccccCCcccCHHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence               2335678999999998542  2357899999999999999999999975433211111100000             


Q ss_pred             --------C--------CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        228 --------T--------PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       228 --------~--------~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                              .        ..+...+++++.+++.+||+.||++|||+.+++.||||..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence                    0        0122457888999999999999999999999999999863

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.7e-41  Score=314.58  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=199.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||.||+|.+..+|+    .+|+|.+...  ........+.+|+.++..++||||+++++.+... ..++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            3344589999999999999887776    4688877543  2233345688999999999999999999988654 4679


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ++||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEK  164 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccccccCccc
Confidence            9999999999999876555689999999999999999999999999999999999998754 699999999976643221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      . .......++..|+|||++..   ..++.++|||||||++|||++ |..||.+.. ..........+..+..+...+..
T Consensus       165 ~-~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         165 E-YNADGGKMPIKWMALECIHY---RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             c-cccCCCccccccCCHHHhcc---CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHCCCCCCCCCCCCHH
Confidence            1 11223345778999998854   346789999999999999997 999997532 22333333444455556678889


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++..||..||++||++.++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1151|consensus

Probab=100.00  E-value=1.8e-42  Score=316.77  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=211.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEecccc----CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ----NDARFVKDMLVELRILEGINQKNLVKYYGVEI-HREEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~E~   83 (407)
                      .||+|||++||+|.+....+.||||+-..++.    .++.+.+...+|.+|.+.|.||.||++|+++. +.+.+|-|+||
T Consensus       470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY  549 (775)
T KOG1151|consen  470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY  549 (775)
T ss_pred             HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence            78999999999999999999999998766543    24557788899999999999999999999986 45679999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEecCC--CeEEEEcccCceecCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN--TIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~~~  159 (407)
                      |+|.+|+.+++. +..++|.+++.++-||+.||.||...  .|||-||||.|||+.+.+  +.+||+|||+++.+.....
T Consensus       550 ceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy  628 (775)
T KOG1151|consen  550 CEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY  628 (775)
T ss_pred             cCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence            999999999965 56699999999999999999999875  699999999999996532  4699999999999875433


Q ss_pred             CC---Cc-ccccccCCccccccccccc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--CCCCCCC-
Q psy10603        160 VP---GE-LNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--MGETPTI-  231 (407)
Q Consensus       160 ~~---~~-~~~~~gt~~y~aPE~l~~~-~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~-  231 (407)
                      ..   -+ .....||.+|++||.+.-. ..+.++.|+||||.|||+|.++.|+.||.+......++....  ......+ 
T Consensus       629 ~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP  708 (775)
T KOG1151|consen  629 NSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP  708 (775)
T ss_pred             CcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence            21   11 2356899999999998643 334578899999999999999999999986554444443221  1111112 


Q ss_pred             -CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        232 -PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       232 -~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                       .+.+|.++++||++||++.-++|....++..||++.
T Consensus       709 ~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  709 PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence             246899999999999999999999999999999974

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.2e-41  Score=320.73  Aligned_cols=257  Identities=28%  Similarity=0.441  Sum_probs=201.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC--ceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR--EEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~lv   80 (407)
                      +.....||+|+||.||+|.+..+++.+|+|.+..... +......+.+|+.++.++ +||||+++++++...  ..+|+|
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            4445689999999999999999999999998864322 223345677899999999 999999999987653  368999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||++ ++|..+++..  .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.........
T Consensus        88 ~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          88 FEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN  163 (337)
T ss_pred             ecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence            99997 5998888653  588999999999999999999999999999999999998865 6999999999766433211


Q ss_pred             --CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--------------
Q psy10603        161 --PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--------------  224 (407)
Q Consensus       161 --~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--------------  224 (407)
                        ........||+.|+|||++...  ..++.++|+|||||++|+|++|+.||..............              
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccCcchhcccccccccCceeeecc--ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence              1123446789999999987542  3457899999999999999999999975432221110000              


Q ss_pred             ------------CCCCC---CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 ------------MGETP---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 ------------~~~~~---~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                  .....   .....++.++.+++.+||+.||++|||+.++++|||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~  299 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA  299 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhh
Confidence                        00000   11223788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0587|consensus

Probab=100.00  E-value=1.3e-41  Score=334.08  Aligned_cols=255  Identities=31%  Similarity=0.583  Sum_probs=214.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe-----CceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIH-----REEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-----~~~~   77 (407)
                      ..+..+||+|.+|.||++++..+++..|+|++......+    +++..|..+|+.. .|||++.+|+++..     ++.+
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            456679999999999999999999999999987654433    3455688888765 57999999999874     4689


Q ss_pred             EEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         78 VLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      |||||||.+|+..++++.. ...+.|+.+.-+++.++.||.+||.+.+||||||=.|||++.++ .|||+|||++.++..
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeeec
Confidence            9999999999999999764 34588999999999999999999999999999999999999876 599999999988754


Q ss_pred             CCCCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--C
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--P  232 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~  232 (407)
                      ..   +..++++|||.|||||++....  ...|+.++|+||||++..||..|.+|+.+.... ..++++....+|.+  |
T Consensus       176 T~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-raLF~IpRNPPPkLkrp  251 (953)
T KOG0587|consen  176 TV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-RALFLIPRNPPPKLKRP  251 (953)
T ss_pred             cc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-hhhccCCCCCCccccch
Confidence            32   3457789999999999996432  344667899999999999999999999876544 34555555455543  6


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.++.++.+||..||.+|-++||+..++++|||+.
T Consensus       252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             hhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            78999999999999999999999999999999985

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-41  Score=313.31  Aligned_cols=251  Identities=20%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             cceeeecccccCeEEEEEEECCCC--------------cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETG--------------ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG   69 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   69 (407)
                      +.....||+|+||.||+|++..++              ..||+|.+...  ........+.+|+++|.+++|||++++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            344558999999999999875432              35899998743  23344567889999999999999999999


Q ss_pred             EEEeCceEEEEEecCCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec
Q psy10603         70 VEIHREEMVLFMELCTEGTLESLVQSTE-----------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA  138 (407)
Q Consensus        70 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~  138 (407)
                      ++...+..++||||+++++|.+++....           ..+++..+..++.|++.||.|||+++++||||||+||++++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999885421           13678889999999999999999999999999999999987


Q ss_pred             CCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCch
Q psy10603        139 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS--GKRPWAEYDSN  216 (407)
Q Consensus       139 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~--g~~Pf~~~~~~  216 (407)
                      ++ .+||+|||++......... .......+++.|+|||++..   ..++.++|+|||||++|+|++  |..||......
T Consensus       165 ~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         165 HY-TIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL---GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             CC-cEEecccccccccccCcce-eccCcCcCceeecChhhhcc---CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            54 6999999998765322111 11122345678999998854   236789999999999999988  67788754322


Q ss_pred             HHHHHHH-------hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        217 YQIMFKV-------GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       217 ~~~~~~~-------~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                       +.....       ........+..+++.+.+++.+||+.||++||++.++++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 -QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             -HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             222111       111122335567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.5e-41  Score=309.25  Aligned_cols=252  Identities=20%  Similarity=0.359  Sum_probs=201.0

Q ss_pred             ccceeeecccccCeEEEEEEECC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNE-----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.....||+|+||+||+|+...     +.+.+|+|.+...  ......+.+.+|+++|++++||||+++++.+...+..
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            34455689999999999999654     3467999987543  2333567789999999999999999999999888899


Q ss_pred             EEEEecCCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         78 VLFMELCTEGTLESLVQSTE--------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      ++||||+++|+|.+++....        ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+|++|||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~~~~  162 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVSLLS  162 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEcccc
Confidence            99999999999999986543        1489999999999999999999999999999999999998865 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCC
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET  228 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~  228 (407)
                      ++........  .......+++.|+|||.+...   ..+.++||||||+++|+|++ |..||..... .........+..
T Consensus       163 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~---~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~~~~~~  236 (275)
T cd05046         163 LSKDVYNSEY--YKLRNALIPLRWLAPEAVQED---DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKL  236 (275)
T ss_pred             cccccCcccc--cccCCceeEEeecChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHHHcCCc
Confidence            9865432211  122344667889999988543   35689999999999999998 8899975432 233333332222


Q ss_pred             -CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        229 -PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       229 -~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                       ...+..++..+.+++.+||+.||++|||+.|++..
T Consensus       237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence             23356788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-40  Score=343.11  Aligned_cols=148  Identities=26%  Similarity=0.392  Sum_probs=133.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||||++......+....+.+.+|+.++..++||||+++++.+...+.+|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            45566799999999999999999999999999986555556666788899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      |+.+++|..++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++
T Consensus        85 y~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            9999999999865 34589999999999999999999999999999999999998765 69999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=310.23  Aligned_cols=250  Identities=28%  Similarity=0.489  Sum_probs=195.9

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc---CCCCCcceEEEEEEeCce-----E
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG---INQKNLVKYYGVEIHREE-----M   77 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~---l~hpniv~~~~~~~~~~~-----~   77 (407)
                      ....||+|+||.||+|++..+++.||+|.+..... +......+.+|+.++++   ++||||+++++.+...+.     +
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45589999999999999998999999999975433 22233456677776655   469999999999988776     9


Q ss_pred             EEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         78 VLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      +++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.+||+|||++.....
T Consensus        82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~~  159 (287)
T cd07838          82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYSF  159 (287)
T ss_pred             EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceeccC
Confidence            999999985 7888876533 358999999999999999999999999999999999999987 4699999999977643


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----CC-----
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GE-----  227 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----~~-----  227 (407)
                      ...    .....+++.|+|||++..   ..++.++|+|||||++|+|++|+.||........ ..++..    ..     
T Consensus       160 ~~~----~~~~~~~~~~~~PE~~~~---~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         160 EMA----LTSVVVTLWYRAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             Ccc----cccccccccccChHHhcc---CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcC
Confidence            321    233457889999999854   2357899999999999999999999975432211 111100    00     


Q ss_pred             ---------CC--------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 ---------TP--------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 ---------~~--------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                               .+        .....+++++.+++.+||+.||++||++.|+++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                     00        0112356788999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-40  Score=311.75  Aligned_cols=251  Identities=20%  Similarity=0.330  Sum_probs=195.0

Q ss_pred             cceeeecccccCeEEEEEEECC----------------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE----------------TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY   67 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   67 (407)
                      +++...||+|+||+||+|.+..                ++..+|+|.+...  ......+.+.+|+.+|+.++||||+++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4566689999999999986432                3457899988643  234455678899999999999999999


Q ss_pred             EEEEEeCceEEEEEecCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe
Q psy10603         68 YGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT  137 (407)
Q Consensus        68 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~  137 (407)
                      ++++...+..++||||+++|+|.+++....          ..+++..+..++.|++.||+|||++|++||||||+|||++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999999986532          1366788999999999999999999999999999999998


Q ss_pred             cCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCc
Q psy10603        138 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS--GKRPWAEYDS  215 (407)
Q Consensus       138 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~--g~~Pf~~~~~  215 (407)
                      .++ .+||+|||+++.+...... .......+++.|+|||+...   ..++.++|+|||||++|||++  |..||.....
T Consensus       165 ~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~---~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         165 KNY-TIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILL---GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             CCC-CEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhc---CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            754 6999999999765432211 11122344678999998754   236789999999999999998  7789875432


Q ss_pred             hHHHHHHH-------hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        216 NYQIMFKV-------GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       216 ~~~~~~~~-------~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      . +.....       ........+..+++.+.+++..||+.||.+||++.|+++
T Consensus       240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 E-QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             H-HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2 221111       111122335567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2e-40  Score=305.77  Aligned_cols=248  Identities=20%  Similarity=0.355  Sum_probs=188.8

Q ss_pred             ecccccCeEEEEEEECCC--CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNNET--GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||+||+|.....  ...+++|.+....  .....+.+.+|+.++..++||||+++++.+......|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999975433  2345666655332  233456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         87 GTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        87 g~L~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      |+|.++++...   ...++..+..++.||+.||+|||+++++||||||+|||++.++ .+||+|||++........ ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~-~~~  157 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY-IET  157 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchh-hhc
Confidence            99999986532   2366778889999999999999999999999999999998765 699999999854321111 111


Q ss_pred             ccccccCCcccccccccccc----cCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCC-----CCCCCC
Q psy10603        164 LNGFVGTQAYMAPEVFMDTN----KVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE-----TPTIPE  233 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~----~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~  233 (407)
                      .....+++.|+|||++....    ...++.++|||||||++|||++ |..||..... .........+.     .|.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhhcccccCCCccCC
Confidence            23457889999999974321    1234679999999999999996 5778865433 22222222221     244455


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++...+++..|| .||++||++.|+++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            68899999999999 68999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-41  Score=310.06  Aligned_cols=252  Identities=29%  Similarity=0.490  Sum_probs=199.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEec
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .+...||+|+||+||+|+...+++.||+|.+........  .....+|+..+.+++ ||||+++++.+...+..++||||
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            355689999999999999999999999999865432211  223457999999999 99999999999999999999999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      + +|+|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++++++ .++|+|||++........   
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~---  154 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPP---  154 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCC---
Confidence            9 789988886543 4589999999999999999999999999999999999998754 699999999976543221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CC--------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GE--------------  227 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~--------------  227 (407)
                       .....++..|+|||++...  ..++.++|+||||++++||++|+.||............... +.              
T Consensus       155 -~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRS--TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             -cCCCCCcccccCceeeecC--cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence             2345688899999988543  23578999999999999999999999754332221111100 00              


Q ss_pred             -----CC--------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        228 -----TP--------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       228 -----~~--------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                           .+        ......+.++.+++.+||+.||++|||+.|++.|||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                 00        0011236789999999999999999999999999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-41  Score=321.58  Aligned_cols=250  Identities=27%  Similarity=0.446  Sum_probs=200.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce------EE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE------MV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------~~   78 (407)
                      .....||+|+||.||+|++..+++.||+|++.... ......+.+.+|+.++++++||||+++.+.+...+.      .+
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY   96 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence            34459999999999999999999999999886432 223344667889999999999999999887765554      89


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +|+||+ +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...... 
T Consensus        97 lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          97 LVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTDDE-  171 (343)
T ss_pred             EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccccc-
Confidence            999999 5699998864  4589999999999999999999999999999999999998765 6999999998765432 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CCC--------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GET--------  228 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~~--------  228 (407)
                           .....+++.|+|||++...  ..++.++|||||||++|+|++|+.||....... ....+..  +..        
T Consensus       172 -----~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         172 -----MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             -----ccCCcccccccCHHHHhCC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhc
Confidence                 2345788999999987542  245789999999999999999999997543322 1111110  000        


Q ss_pred             -----------------C---CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        229 -----------------P---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       229 -----------------~---~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                       +   ......++++.+++.+||+.||++|||+.|+++|||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence                             0   111346889999999999999999999999999999963

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.6e-40  Score=303.54  Aligned_cols=247  Identities=24%  Similarity=0.394  Sum_probs=199.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||.||+|.+. .+..+|+|.+...    ....+.+.+|+.++++++|+||+++++.+.. ...+++||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            4566679999999999999865 4556999987632    2234678889999999999999999999877 77899999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++......... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~-  158 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT-  158 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc-
Confidence            99999999998653 33478889999999999999999999999999999999998764 6999999999765432211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......++..|+|||++..   ..++.++|+|||||++|+|++ |..||.... .......+..+.....+...+.++.
T Consensus       159 -~~~~~~~~~~y~~PE~~~~---~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEELY  233 (260)
T ss_pred             -cccCCcccccccCHhHhcc---CCcCccccchHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCCCCCcccCCHHHH
Confidence             1122345678999999854   335789999999999999998 999998543 3333444444545555677899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||++||++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999988764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-41  Score=319.96  Aligned_cols=247  Identities=29%  Similarity=0.446  Sum_probs=195.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~lv   80 (407)
                      ...||+|+||.||+|++..+|+.||+|++..... .......+.+|+.++++++||||+++++++...      ..+++|
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            3489999999999999999999999999865322 223345678999999999999999999988654      246999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      +||+.. +|..+.   ...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++....    
T Consensus        99 ~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~----  169 (342)
T cd07879          99 MPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA----  169 (342)
T ss_pred             eccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC----
Confidence            999974 776655   23489999999999999999999999999999999999999865 699999999865432    


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC---------------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM---------------  225 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~---------------  225 (407)
                        ......+|+.|+|||++.+.  ..++.++|||||||++|||++|+.||....... .+..+..               
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             --CCCCceeeecccChhhhcCc--cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcc
Confidence              12345788999999998542  235789999999999999999999998543221 1111100               


Q ss_pred             -------CCCCCC--------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        226 -------GETPTI--------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       226 -------~~~~~~--------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                             ...+..        ....++++.+++.+||+.||++||++.|++.||||..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence                   000111        1246788999999999999999999999999999953

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-40  Score=304.93  Aligned_cols=251  Identities=25%  Similarity=0.467  Sum_probs=202.1

Q ss_pred             cceeeecccccCeEEEEEEECC-CCcEEEEEEEecccc-------CcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeC
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-TGELVAMKEIQLHKQ-------NDARFVKDMLVELRILEG-INQKNLVKYYGVEIHR   74 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~   74 (407)
                      ++....||+|+||.||+|++.. +++.+|+|.+.....       .......++.+|+.++.+ ++||||+++++.+...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            3455689999999999999987 678999998864321       223445667889988865 8999999999999999


Q ss_pred             ceEEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccC
Q psy10603         75 EEMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGS  150 (407)
Q Consensus        75 ~~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGl  150 (407)
                      +..+++|||+++++|.+++..   ....+++..+..++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg~  160 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFGL  160 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEecccc
Confidence            999999999999999988743   23458999999999999999999996 6899999999999998865 699999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      +.......    ......|+..|+|||.+..   ..++.++|+||||+++|+|++|+.||.... .......+..+..++
T Consensus       161 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~---~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~  232 (269)
T cd08528         161 AKQKQPES----KLTSVVGTILYSCPEIVKN---EPYGEKADVWAFGCILYQMCTLQPPFYSTN-MLSLATKIVEAVYEP  232 (269)
T ss_pred             eeeccccc----ccccccCcccCcChhhhcC---CCCchHHHHHHHHHHHHHHHhCCCcccccC-HHHHHHHHhhccCCc
Confidence            97654332    2244578899999999854   235789999999999999999999997533 223333333333333


Q ss_pred             CC-CccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        231 IP-ESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       231 ~~-~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+ ...++++.+++.+||+.||++||++.|+..+
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            33 3678999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-40  Score=309.91  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=206.6

Q ss_pred             cceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|++.   .+++.||||.+...... ..+..+.+.+|+.++.++ +||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            345668999999999999864   46789999998753222 223445678999999999 5899999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|..++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||+|||+++.+....
T Consensus        82 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          82 LILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccccc
Confidence            99999999999998865 34589999999999999999999999999999999999998764 69999999987654332


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      ..  ......|++.|+|||.+.... ...+.++|+||||+++|||++|..||.....  ......+......+..|..++
T Consensus       160 ~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd05583         160 EE--RAYSFCGTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS  236 (288)
T ss_pred             cc--ccccccCCccccCHHHhcCCC-CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccC
Confidence            11  112356889999999975422 2356899999999999999999999964321  112222222334456677899


Q ss_pred             HHHHHHHHHhcccCCCCcCC---HHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQRAT---IFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t---~~e~l~hp~~~  267 (407)
                      .++.+++.+||+.||++|||   +.++++|||+.
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~  270 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ  270 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence            99999999999999999998   56789999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-40  Score=315.21  Aligned_cols=256  Identities=29%  Similarity=0.487  Sum_probs=199.1

Q ss_pred             ceeeecccccCeEEEEEEECCC--CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC----ceE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNET--GELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR----EEM   77 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~----~~~   77 (407)
                      .....||+|+||.||+|++..+  ++.||+|.+.... ......+.+.+|+.+++++ +||||+++++.....    ..+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            4556899999999999999888  8999999986432 2223456778999999999 599999999875432    457


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |+++||+. ++|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        82 ~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          82 YLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence            89999986 588888854 45589999999999999999999999999999999999998865 6999999999876532


Q ss_pred             CCC-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHH--------------
Q psy10603        158 TTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK--------------  222 (407)
Q Consensus       158 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~--------------  222 (407)
                      ... ........||+.|+|||++...  ..++.++|||||||++|+|++|+.||...+.. .....              
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSF--QSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            211 1122346789999999987532  34678999999999999999999999754311 11100              


Q ss_pred             -H----------hCCCCC-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        223 -V----------GMGETP-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       223 -~----------~~~~~~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                       .          .....+     ......+.++.+++.+||+.||++|||+.|++.|||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence             0          000011     11234678999999999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-40  Score=301.89  Aligned_cols=241  Identities=25%  Similarity=0.427  Sum_probs=195.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +++....||+|+||.||++.  .+++.+|+|.+....     ..+.+.+|+.++++++||||+++++.+.. +..+++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e   78 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVME   78 (254)
T ss_pred             HceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEE
Confidence            35566689999999999986  467889999885421     23567889999999999999999998865 45799999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.......   
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceeccccC---
Confidence            999999999986543 3488999999999999999999999999999999999998765 69999999987543211   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                         .....+..|+|||.+..   ..++.++|+|||||++|||++ |+.||.... .......+..+..+..+..+++++.
T Consensus       155 ---~~~~~~~~y~~pe~~~~---~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  227 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKH---KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPPEGCPADVY  227 (254)
T ss_pred             ---CCCCCCceecCHHHhcc---CCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHhCCCCCCCCCcCCHHHH
Confidence               12234567999998854   346789999999999999997 999997543 3333344444455555677899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.+|++||++.+++.
T Consensus       228 ~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         228 VLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=309.18  Aligned_cols=253  Identities=30%  Similarity=0.488  Sum_probs=202.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|++..+++.+|+|.+.... ......+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            4458999999999999999999999999987653 223344667889999999999999999999999999999999998


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                       ++|.+++......+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||++........   ...
T Consensus        82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~---~~~  156 (282)
T cd07829          82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLR---TYT  156 (282)
T ss_pred             -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCcc---ccC
Confidence             589999976545699999999999999999999999999999999999998864 699999999876543221   122


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-------------------CC
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-------------------MG  226 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-------------------~~  226 (407)
                      ...++..|+|||.+...  ..++.++|+|||||++|||++|+.||..............                   ..
T Consensus       157 ~~~~~~~~~aPE~~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         157 HEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             ccccCcCcCChHHhcCC--cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            34567889999998543  2467899999999999999999999975432211111000                   00


Q ss_pred             CCCC--------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        227 ETPT--------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       227 ~~~~--------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ..+.        ....++.++.+++.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000        012347889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0608|consensus

Probab=100.00  E-value=8.4e-42  Score=324.00  Aligned_cols=258  Identities=26%  Similarity=0.365  Sum_probs=205.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +...+.||-|+||+|++++...|...||+|.+++........+.....|..||..-..+=||+||..|++++.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            34456899999999999999999999999999876555556666778899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC-----
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-----  158 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~-----  158 (407)
                      ++||++..++-+ .+-|+|..+++|+.++.+|+++.|..|.|||||||+|||||.+| ++||+||||+.-+.-..     
T Consensus       711 IPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceeccccccc
Confidence            999999998865 45599999999999999999999999999999999999999986 69999999996542000     


Q ss_pred             ------C----C--------CC----------------cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHH
Q psy10603        159 ------T----V--------PG----------------ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS  204 (407)
Q Consensus       159 ------~----~--------~~----------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~  204 (407)
                            .    .        ..                .....+||+.|+|||+|..   .+|+..+|.||.|||||||+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r---~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR---TGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc---cCccccchhhHhhHHHHHHh
Confidence                  0    0        00                0013479999999999965   45778999999999999999


Q ss_pred             cCCCCCCCCCchHHHHHHHhCCCCCCCC--CccCHHHHHHHHHhcccCCCCcC---CHHHHhcCCeee
Q psy10603        205 SGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQAFAELCLRHDPAQRA---TIFELLQHPFLI  267 (407)
Q Consensus       205 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~~i~~~l~~dp~~R~---t~~e~l~hp~~~  267 (407)
                      .|++||............+.......++  ..+|+++.++|.++. -+++.|.   .++|+..||||.
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFk  932 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFK  932 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccc
Confidence            9999997543322111111111222222  468999999997744 3677886   467899999995

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-40  Score=315.37  Aligned_cols=249  Identities=26%  Similarity=0.438  Sum_probs=195.8

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~lv   80 (407)
                      ...||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++...      ...|++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  100 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  100 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence            3489999999999999999999999999865322 223345678899999999999999999987643      347888


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ++++ +++|.++++.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++....    
T Consensus       101 ~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~~----  172 (345)
T cd07877         101 THLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDD----  172 (345)
T ss_pred             ehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEecccccccccc----
Confidence            8887 6799888754  3489999999999999999999999999999999999998865 699999999875432    


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--HHh--------------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--KVG--------------  224 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--~~~--------------  224 (407)
                        ......||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||...........  ...              
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             --cccccccCCCccCHHHHhCc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence              12345788999999987542  3457899999999999999999999975432211110  000              


Q ss_pred             --------CCCCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        225 --------MGETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       225 --------~~~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                              ....+.     .....++++.+++.+||++||.+||++.++++||||..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                    000010     11245788999999999999999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-40  Score=311.37  Aligned_cols=251  Identities=28%  Similarity=0.440  Sum_probs=197.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEEEEEec
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMVLFMEL   83 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~E~   83 (407)
                      .....||+|+||.||+|++..+++.||+|.+..... .....+.+.+|+.++++++||||+++++++.. ....|+++||
T Consensus        13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            344599999999999999999999999998865322 22334667889999999999999999998876 4578999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      + +++|..+++.  ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++......      
T Consensus        92 ~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~~------  161 (328)
T cd07856          92 L-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDPQ------  161 (328)
T ss_pred             h-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCCC------
Confidence            8 4689888753  3488899999999999999999999999999999999998754 6999999998754321      


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHH------------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKV------------------  223 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~------------------  223 (407)
                      .....+++.|+|||++...  ..++.++|+|||||++|+|++|+.||.........  +...                  
T Consensus       162 ~~~~~~~~~y~aPE~~~~~--~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTW--QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             cCCCcccccccCceeeecc--CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence            2345678899999987532  34678999999999999999999999754321110  0000                  


Q ss_pred             ----hCCCCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        224 ----GMGETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       224 ----~~~~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                          .......     ....+++++++++.+||+.||++|||+.+++.|||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~  293 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP  293 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence                0000001     11346789999999999999999999999999999853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.8e-40  Score=302.03  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=196.8

Q ss_pred             eeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------e
Q psy10603          6 FSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------E   76 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~   76 (407)
                      ....||+|+||.||+|.+.   .+++.+|||++.... ......+++.+|+++|++++||||+++++++....      .
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            4458999999999999864   457899999986543 33344567889999999999999999999876532      2


Q ss_pred             EEEEEecCCCCCHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         77 MVLFMELCTEGTLESLVQST-----EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      .++++||+++|+|..++...     ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg~~  160 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLS  160 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccccc
Confidence            47899999999998876432     12478899999999999999999999999999999999998754 6999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT  230 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~  230 (407)
                      +......... ......+++.|++||.+..   ..++.++|||||||++|||++ |+.||.... .......+..+....
T Consensus       161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~---~~~~~~sDi~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~  235 (273)
T cd05074         161 KKIYSGDYYR-QGCASKLPVKWLALESLAD---NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIYNYLIKGNRLK  235 (273)
T ss_pred             ccccCCccee-cCCCccCchhhcCHhHHhc---CccchhhhhHHHHHHHHHHhhCCCCCCCCCC-HHHHHHHHHcCCcCC
Confidence            8654322111 1122345678999998854   335789999999999999999 899997543 333333344444445


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+...++++.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0576|consensus

Probab=100.00  E-value=4.2e-42  Score=328.17  Aligned_cols=364  Identities=29%  Similarity=0.454  Sum_probs=269.4

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .+|.|+||.||+|++..+++..|+|+++.....+-   +-+.+|+-+++..+|||||.+++.+..++.+|++||||.+|+
T Consensus        22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             eecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            89999999999999999999999999998765553   445579999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccc
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV  168 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~  168 (407)
                      |++..+- -+.++|.++....++.+.||+|||+.|-+|||||=.|||+++.+ .+|++|||.+-.+....   ....++.
T Consensus        99 lQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati---~Krksfi  173 (829)
T KOG0576|consen   99 LQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATI---AKRKSFI  173 (829)
T ss_pred             ccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhh---hhhhccc
Confidence            9998754 45589999999999999999999999999999999999999876 59999999987765433   2346789


Q ss_pred             cCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-C--CCCccCHHHHHHHHH
Q psy10603        169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-T--IPESLSDEGQAFAEL  245 (407)
Q Consensus       169 gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~--~~~~~s~~~~~~i~~  245 (407)
                      ||+.|||||+-.-....+|...+|||++|++..|+..-.+|.......+.....-..+..| .  -+...++.+.+|++.
T Consensus       174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~  253 (829)
T KOG0576|consen  174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKG  253 (829)
T ss_pred             CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHH
Confidence            9999999998765556678899999999999999999888876544433333333333333 2  245688999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeeeecC--------CcCCCCCC-----------CchhhHHhhhhcC---ccCCCCCcccc
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIVSCE--------EDVCNPRS-----------VPASVLQDYLKLG---IVLPPMSEDSV  303 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~~~~--------~~~~~~~~-----------~p~~~~~~~l~~~---~~~~~~s~~~i  303 (407)
                      +|.++|.+|||++.+|+|||+.....        +...+|..           ....+..++...+   ......++-..
T Consensus       254 altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~  333 (829)
T KOG0576|consen  254 ALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIAL  333 (829)
T ss_pred             HhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhh
Confidence            99999999999999999999853211        00011110           0000000100000   00000111111


Q ss_pred             c----------------------ccCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCc
Q psy10603        304 K----------------------VYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK  361 (407)
Q Consensus       304 ~----------------------~~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  361 (407)
                      .                      .+.+.|++.+. + ..+..||+....+....    ...+..+|+.++|||+..... 
T Consensus       334 ~~~~~~~~~r~et~~l~~l~~~~~~~~d~~l~s~-~-~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~-  406 (829)
T KOG0576|consen  334 EQYQFAYPLRKETRPLAELHSSYKVHRDNILGSE-E-EVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENT-  406 (829)
T ss_pred             hhhhhhhhhhhhcccccccccccccCcccccccc-c-ccccccccCCcccCccc----ccccCCCCCCCCCchhhcccc-
Confidence            1                      12233444433 2 47889999886654332    234568999999999886543 


Q ss_pred             CCCCccchHHhHHHHHHHHHhCCCCCCC
Q psy10603        362 VGHGRAVDIWSLGCVLVEMSSGKTNLSG  389 (407)
Q Consensus       362 ~~~~~~~Dvws~G~~~~e~~~g~~~~~~  389 (407)
                        +..+.|+||+|.-..+|..|-+|-.+
T Consensus       407 --~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  407 --IDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             --cccCCCccCCCcchhhcCCCCCCCCC
Confidence              34678999999988888888777654

>KOG0196|consensus

Probab=100.00  E-value=4e-41  Score=326.36  Aligned_cols=252  Identities=21%  Similarity=0.366  Sum_probs=218.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      -+..+.+||.|.||+||+|+.+..|   ..||||.++..  ..++...+|+.|..||.+++||||++|.|+......+.|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            4567779999999999999988776   46999998743  455667889999999999999999999999988888999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |.|||++|+|+.+++...+.|+..+...+++.|+.|++||-+.+.|||||-.+|||++.+ -.+|++|||+++.+..+. 
T Consensus       708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvledd~-  785 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-  785 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecccCC-
Confidence            999999999999999888889999999999999999999999999999999999999874 579999999999876554 


Q ss_pred             CCCcccccccC--CcccccccccccccCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        160 VPGELNGFVGT--QAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS-SGKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       160 ~~~~~~~~~gt--~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                       +...++.-|.  ..|.|||.+..   -.++.++||||+||++||.+ .|..||.+. ++++++..+..+.+-+-|-.++
T Consensus       786 -~~~ytt~GGKIPiRWTAPEAIa~---RKFTsASDVWSyGIVmWEVmSyGERPYWdm-SNQdVIkaIe~gyRLPpPmDCP  860 (996)
T KOG0196|consen  786 -EAAYTTLGGKIPIRWTAPEAIAY---RKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAIEQGYRLPPPMDCP  860 (996)
T ss_pred             -CccccccCCccceeecChhHhhh---cccCchhhccccceEEEEecccCCCccccc-chHHHHHHHHhccCCCCCCCCc
Confidence             2233344443  57999999954   33688999999999999955 599999976 4667888888888877788999


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+..|+..||++|..+||++.|++.+
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999998753

>KOG0671|consensus

Probab=100.00  E-value=5.4e-41  Score=302.70  Aligned_cols=246  Identities=30%  Similarity=0.477  Sum_probs=198.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC--CC----cceEEEEEEeCceEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ--KN----LVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--pn----iv~~~~~~~~~~~~~lv~E   82 (407)
                      .+|+|+||.|-.+.+++++..||+|+++.    -.++.++.+.|+++|+++++  |+    +|.+.++|...++.|||+|
T Consensus        96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe  171 (415)
T KOG0671|consen   96 LLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE  171 (415)
T ss_pred             hhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence            79999999999999999999999999863    34677888899999999954  33    7888899999999999999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-------------------CCe
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-------------------GNS  142 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-------------------~~~  142 (407)
                      .+ |-++.++++.. ...+|...++.+++|++.++.+||+.+++|-||||+|||+.+.                   +..
T Consensus       172 ll-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~  250 (415)
T KOG0671|consen  172 LL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTA  250 (415)
T ss_pred             cc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcc
Confidence            88 45888888653 3469999999999999999999999999999999999998542                   124


Q ss_pred             EEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH-HH
Q psy10603        143 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI-MF  221 (407)
Q Consensus       143 vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~-~~  221 (407)
                      |||+|||.|+......      ...+.|..|.|||++.+   .+++.++||||+||||+|+.+|...|...++..++ +.
T Consensus       251 I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg---LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM  321 (415)
T KOG0671|consen  251 IKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG---LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM  321 (415)
T ss_pred             eEEEecCCcceeccCc------ceeeeccccCCchheec---cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence            8999999997654322      45688999999999986   56789999999999999999999999876654433 22


Q ss_pred             HHhCCCCCC------------------CCCc----------------------cC---HHHHHHHHHhcccCCCCcCCHH
Q psy10603        222 KVGMGETPT------------------IPES----------------------LS---DEGQAFAELCLRHDPAQRATIF  258 (407)
Q Consensus       222 ~~~~~~~~~------------------~~~~----------------------~s---~~~~~~i~~~l~~dp~~R~t~~  258 (407)
                      +.+.|..|.                  .|+.                      -+   .++-||+++||.+||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            333332221                  0000                      01   2457899999999999999999


Q ss_pred             HHhcCCeeee
Q psy10603        259 ELLQHPFLIV  268 (407)
Q Consensus       259 e~l~hp~~~~  268 (407)
                      |+|.||||..
T Consensus       402 EAL~HpFF~~  411 (415)
T KOG0671|consen  402 EALSHPFFAR  411 (415)
T ss_pred             HHhcCHHhhc
Confidence            9999999963

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.8e-39  Score=300.10  Aligned_cols=249  Identities=19%  Similarity=0.265  Sum_probs=182.9

Q ss_pred             eeeecccccCeEEEEEEECCC---CcEEEEEEEeccccCc--HHH------HHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNET---GELVAMKEIQLHKQND--ARF------VKDMLVELRILEGINQKNLVKYYGVEIHR   74 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~---~~~vAvK~i~~~~~~~--~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~   74 (407)
                      ....||+|+||+||+|.+..+   ++.+|+|+........  +..      ......+...+..++|+||+++++.....
T Consensus        16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   95 (294)
T PHA02882         16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK   95 (294)
T ss_pred             EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence            344899999999999998877   6677877654332111  000      11223445566788999999999876554


Q ss_pred             c----eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccC
Q psy10603         75 E----EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGS  150 (407)
Q Consensus        75 ~----~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGl  150 (407)
                      .    ..++++|++.. ++.+.++.. ...++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+
T Consensus        96 ~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~DFGl  172 (294)
T PHA02882         96 RCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGYIIDYGI  172 (294)
T ss_pred             cCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEEEcCC
Confidence            3    45788888754 666666442 3368889999999999999999999999999999999998764 699999999


Q ss_pred             ceecCCCCCC----CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH------
Q psy10603        151 AVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM------  220 (407)
Q Consensus       151 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~------  220 (407)
                      |+.+......    ........||+.|+|||++.+   ..++.++|||||||++|||++|+.||..........      
T Consensus       173 a~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~---~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG---ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             ceeeccCCcccccccccccccCCCccccCHHHhCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            9876432111    112234579999999999854   346899999999999999999999998653322211      


Q ss_pred             --HHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        221 --FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       221 --~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                        .++..+.  ......++++.++++.|++.+|++||++.++++
T Consensus       250 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              1222111  113456889999999999999999999999875

>KOG0603|consensus

Probab=100.00  E-value=1.8e-41  Score=324.49  Aligned_cols=238  Identities=29%  Similarity=0.396  Sum_probs=197.9

Q ss_pred             ecccccCeEEEEEE---ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecC
Q psy10603          9 SPGQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         9 ~iG~G~~g~V~~~~---~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ++|+|+||.|++++   -...|..||+|+..+....... ......|..++..++ ||.+|++...++.+...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            47999999999875   3455778999998765432211 124566888888887 999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      .+|+|...+.. ...+.+...+.+...++.|++++|+.+|+|||+|++||+++.+| .+|+.|||+++..-....     
T Consensus        80 rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~-----  152 (612)
T KOG0603|consen   80 RGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI-----  152 (612)
T ss_pred             ccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh-----
Confidence            99999887754 45588999999999999999999999999999999999999876 699999999987643321     


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                        .|||..|||||++.     ++..++|.||||++++||+||..||..     . ..+.+....+..|..++.++++++.
T Consensus       153 --~cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~-----~-~~~~Il~~~~~~p~~l~~~a~~~~~  219 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGG-----D-TMKRILKAELEMPRELSAEARSLFR  219 (612)
T ss_pred             --cccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCch-----H-HHHHHhhhccCCchhhhHHHHHHHH
Confidence              28999999999985     356789999999999999999999985     2 2233344566778999999999999


Q ss_pred             HhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        245 LCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      .++..+|..|.-     ..|+++|+|+.
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~  247 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQHEFFQ  247 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhccchhe
Confidence            999999999964     57899999985

>KOG4257|consensus

Probab=100.00  E-value=4.9e-40  Score=311.64  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=205.8

Q ss_pred             cceeeecccccCeEEEEEEECC--CCc--EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE--TGE--LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~--~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      ++....||.|-||.||+|....  .|+  .||||.-+...  +....+.|+.|..+|++++|||||++.|++.+ ...||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            3444589999999999997542  344  46777654332  23336889999999999999999999999864 45899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||+++-|.|..+++.....++......|+.||+.||.|||+...|||||-..|||+... ..|||+|||+++-+.....
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhccccch
Confidence            999999999999999888889999999999999999999999999999999999999875 4699999999998875543


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      ....  ...-..-|||||.+.-   -.++.++|||-|||++||++. |..||.+-.+ ..++-.+..|.+++.|+++++.
T Consensus       547 YkaS--~~kLPIKWmaPESINf---RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-sDVI~~iEnGeRlP~P~nCPp~  620 (974)
T KOG4257|consen  547 YKAS--RGKLPIKWMAPESINF---RRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-SDVIGHIENGERLPCPPNCPPA  620 (974)
T ss_pred             hhcc--ccccceeecCccccch---hcccchhhHHHHHHHHHHHHHhcCCccccccc-cceEEEecCCCCCCCCCCCChH
Confidence            3211  1112346999999854   346889999999999999765 9999986543 3566677789999999999999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +..++.+||++||.+||++.|+..
T Consensus       621 LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  621 LYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHHhccCcccCCcHHHHHH
Confidence            999999999999999999988643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-39  Score=325.83  Aligned_cols=255  Identities=21%  Similarity=0.271  Sum_probs=173.2

Q ss_pred             ccceeeecccccCeEEEEEEECCC----CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEE------EE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNET----GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV------EI   72 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~   72 (407)
                      ++.....||+|+||+||+|++..+    +..||+|.+......     +....|  .+....+.++..+...      ..
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            445556999999999999999988    899999987532111     111111  1122222233222211      23


Q ss_pred             eCceEEEEEecCCCCCHHHHHhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy10603         73 HREEMVLFMELCTEGTLESLVQSTEDG-------------------LPEVLVRRYTKQLVDAISALHENTIVHRDIKSAN  133 (407)
Q Consensus        73 ~~~~~~lv~E~~~~g~L~~~~~~~~~~-------------------~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~N  133 (407)
                      ....+++|+||+++++|.++++.....                   ..+..+..++.|++.||.|||+++|+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            456799999999999999988643211                   1234567899999999999999999999999999


Q ss_pred             EEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccC-------------------CCCcchhHH
Q psy10603        134 IFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV-------------------GHGRAVDIW  194 (407)
Q Consensus       134 ill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-------------------~~~~~~Diw  194 (407)
                      ||++.++..+||+|||+|+.+......  ....+++|+.|||||.+......                   .++.++|||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~--~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             EEEeCCCCcEEEEeCCCcccccccccc--CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            999875567999999999765432211  22456889999999976432211                   133467999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-C-------------CCCC------CCCccCHHHHHHHHHhcccCCCCc
Q psy10603        195 SLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-G-------------ETPT------IPESLSDEGQAFAELCLRHDPAQR  254 (407)
Q Consensus       195 SlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~-------------~~~~------~~~~~s~~~~~~i~~~l~~dp~~R  254 (407)
                      ||||++|||+++..|+...  ..+....... +             ..+.      +.+..+..+.+|+.+||++||++|
T Consensus       364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            9999999999987775421  1111111100 0             0000      011123345689999999999999


Q ss_pred             CCHHHHhcCCeeee
Q psy10603        255 ATIFELLQHPFLIV  268 (407)
Q Consensus       255 ~t~~e~l~hp~~~~  268 (407)
                      ||+.|+|+||||..
T Consensus       442 ~ta~e~L~Hpff~~  455 (566)
T PLN03225        442 ISAKAALAHPYFDR  455 (566)
T ss_pred             CCHHHHhCCcCcCC
Confidence            99999999999953

>KOG0984|consensus

Probab=100.00  E-value=2.7e-39  Score=268.89  Aligned_cols=218  Identities=26%  Similarity=0.486  Sum_probs=183.4

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..||+|+||.|-+-++..+|...|+|.+...-  +.+..++.++|+.+..+ ...|.+|.+||........+++||.|..
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t  129 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT  129 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence            38999999999999999999999999997543  34556778899987654 5679999999999999999999999964


Q ss_pred             CCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         87 GTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        87 g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                       +|..+.++   ....+||..+-+++..++.||.|||++ .|||||+||+|||++.+| .+|+||||++-.+.....   
T Consensus       130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~dSiA---  204 (282)
T KOG0984|consen  130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVDSIA---  204 (282)
T ss_pred             -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeehhhhH---
Confidence             88776643   355699999999999999999999987 899999999999999986 599999999977654321   


Q ss_pred             cccccccCCccccccccccc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE  233 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~-~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  233 (407)
                       .+.-.|...|||||.+... +..+|+-++||||||+++.||++++.||.......+.+.++.....|.+|.
T Consensus       205 -kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~  275 (282)
T KOG0984|consen  205 -KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA  275 (282)
T ss_pred             -HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence             1224678899999998643 233788999999999999999999999999888888888888777777663

>KOG0199|consensus

Probab=100.00  E-value=3.7e-39  Score=309.13  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             ceeeecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ..-..||+|+||.|++|.+...+   ..||||.++.....  .....|++|+.+|.+|+|||+|++||+..+ ....|||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            33448999999999999886433   46899998754332  256789999999999999999999999876 6688999


Q ss_pred             ecCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQS-TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |+++.|+|.+.+++ ....|.......|+.||+.|+.||.+++.|||||-..|+|+... ..|||+||||.+.+..+...
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccCCCCcc
Confidence            99999999999976 44568888999999999999999999999999999999999875 57999999999887654432


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      =.......-...|.|||.|..   ..++-++|+|++||++|||++ |..||.+. ...+++..+..+++-.-|+.+|.++
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh---~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erLpRPk~csedI  344 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRH---RKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERLPRPKYCSEDI  344 (1039)
T ss_pred             eEecCCCcCcccccCHhHhcc---ccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccCCCCCCChHHH
Confidence            000000112346999999954   346789999999999999998 78999864 5678888888888888899999999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      .++++.||+.+|++|||+..+.+.-+
T Consensus       345 Y~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  345 YQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             HHHHHHhccCCccccccHHHHHHhHH
Confidence            99999999999999999988864433

>KOG1094|consensus

Probab=100.00  E-value=3.4e-39  Score=304.01  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=201.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+..+||+|.||+|.+|.-.. +.+||||.++...+.+  .+++|.+|+++|.+|+|||||.++++|..++.+++++|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            45667799999999999997553 6899999998765443  46889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++|+|.+++..... ....+...+++.||++|+.||.+.++||||+.+.|+|++.+. ++||+|||+++.+-......
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccccccCCcee
Confidence            9999999999976422 234455667999999999999999999999999999999864 69999999998664333221


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHH--cCCCCCCCCCchHHHHHHHh-------CCCCCCCC
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS--SGKRPWAEYDSNYQIMFKVG-------MGETPTIP  232 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~--~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~  232 (407)
                      . .-..+-...|||||.+...   .++.++|+|+||+++||++  +...||....+. +......       ....+..|
T Consensus       695 v-qgr~vlpiRwmawEsillg---kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  695 V-QGRAVLPIRWMAWESILLG---KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-QVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             e-ecceeeeeeehhHHHHHhc---cccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-HHHHhhhhhcCCCCcceeccCC
Confidence            1 1123446789999998653   3688999999999999975  578999865433 3322111       11233457


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .-++.++.+++.+||..|.++||+++++..|
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            7889999999999999999999999998543

>KOG4278|consensus

Probab=100.00  E-value=1.1e-38  Score=302.20  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=209.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +++-.-+||-|.||.||.|.++...-.||||.++-    |.-.+++|+.|..+|+.++|||+|++.|+|.....+|||.|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            45556699999999999999999999999998852    33346889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||..|+|.+|+++... .++-.....++-||.+|++||..++.|||||-..|.|+.. ++.||++||||++.+..++.. 
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgDTYT-  421 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGDTYT-  421 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc-cceEEeeccchhhhhcCCcee-
Confidence            9999999999987543 3666677788999999999999999999999999999976 468999999999998765432 


Q ss_pred             Cccccccc---CCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        162 GELNGFVG---TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       162 ~~~~~~~g---t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                          ...|   ..-|.|||-|..   ..++.|+|||+|||+|||++| |..||++.+ ..++......+.+..-|+++++
T Consensus       422 ----AHAGAKFPIKWTAPEsLAy---NtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSqVY~LLEkgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  422 ----AHAGAKFPIKWTAPESLAY---NTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYGLLEKGYRMDGPEGCPP  493 (1157)
T ss_pred             ----cccCccCcccccCcccccc---cccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHHHHhccccccCCCCCCH
Confidence                2233   356999998843   446889999999999999987 889999754 3455555567888888999999


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ...+|+..||+++|.+||++.|+-+
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHH
Confidence            9999999999999999999988643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-37  Score=280.67  Aligned_cols=242  Identities=40%  Similarity=0.662  Sum_probs=201.4

Q ss_pred             cCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCHHHHH
Q psy10603         14 RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLV   93 (407)
Q Consensus        14 ~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L~~~~   93 (407)
                      +||.||+|.+..+++.+|+|++........  .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999999999999999875433221  567889999999999999999999999999999999999999999998


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcc
Q psy10603         94 QSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY  173 (407)
Q Consensus        94 ~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y  173 (407)
                      ..... +++..+..++.+++.++.|||+.+++|+||+|+||+++.++ .++|+|||.+.......    ......++..|
T Consensus        79 ~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~----~~~~~~~~~~~  152 (244)
T smart00220       79 KKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGG----LLTTFVGTPEY  152 (244)
T ss_pred             HhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeecccc----ccccccCCcCC
Confidence            76443 89999999999999999999999999999999999998864 69999999997765432    22345678899


Q ss_pred             cccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCc--cCHHHHHHHHHhcccCC
Q psy10603        174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAELCLRHDP  251 (407)
Q Consensus       174 ~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~~~i~~~l~~dp  251 (407)
                      +|||.+..   ...+.++|+||||+++++|++|..||...............+..+..+..  ++.++.+++.+||..||
T Consensus       153 ~~pE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  229 (244)
T smart00220      153 MAPEVLLG---KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP  229 (244)
T ss_pred             CCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence            99998853   33577999999999999999999999764444444444443333332222  88999999999999999


Q ss_pred             CCcCCHHHHhcCCee
Q psy10603        252 AQRATIFELLQHPFL  266 (407)
Q Consensus       252 ~~R~t~~e~l~hp~~  266 (407)
                      ++||++.++++|||+
T Consensus       230 ~~Rp~~~~~~~~~~~  244 (244)
T smart00220      230 EKRLTAEEALQHPFF  244 (244)
T ss_pred             hhccCHHHHhhCCCC
Confidence            999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-37  Score=300.94  Aligned_cols=262  Identities=20%  Similarity=0.315  Sum_probs=182.2

Q ss_pred             ccceeeecccccCeEEEEEEEC----------------CCCcEEEEEEEeccccCcH-HH----------HHHHHHHHHH
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN----------------ETGELVAMKEIQLHKQNDA-RF----------VKDMLVELRI   55 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~----------------~~~~~vAvK~i~~~~~~~~-~~----------~~~~~~E~~~   55 (407)
                      ++.....||+|+||+||+|...                ..++.||||.+........ ++          .+....|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            4455569999999999999752                3356799999864322111 11          1223456777


Q ss_pred             HhcCCCCCc-----ceEEEEEE--------eCceEEEEEecCCCCCHHHHHhhcCC-----------------------C
Q psy10603         56 LEGINQKNL-----VKYYGVEI--------HREEMVLFMELCTEGTLESLVQSTED-----------------------G   99 (407)
Q Consensus        56 l~~l~hpni-----v~~~~~~~--------~~~~~~lv~E~~~~g~L~~~~~~~~~-----------------------~   99 (407)
                      +.+++|.|+     +++.+++.        .++..+||+||+++++|.++++....                       .
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777777654     55656553        24568999999999999998864211                       2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccc
Q psy10603        100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF  179 (407)
Q Consensus       100 ~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l  179 (407)
                      +++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++.+......  ......+|+.|+|||++
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINF--NPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCcc--CccccCCCcceeChhhh
Confidence            35667889999999999999999999999999999998765 6999999999765432211  11122347899999988


Q ss_pred             cccccC-------------------CCCcchhHHHHHHHHHHHHcCCC-CCCCCCchHHH---------HHHHhCCCC--
Q psy10603        180 MDTNKV-------------------GHGRAVDIWSLGCVLVEMSSGKR-PWAEYDSNYQI---------MFKVGMGET--  228 (407)
Q Consensus       180 ~~~~~~-------------------~~~~~~DiwSlGv~l~em~~g~~-Pf~~~~~~~~~---------~~~~~~~~~--  228 (407)
                      ......                   ....+.||||+||++|+|++|.. ||.........         .++...+..  
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            532110                   11235799999999999999986 77532111000         011111111  


Q ss_pred             CCCCCccCHHHHHHHHHhcccCC---CCcCCHHHHhcCCeee
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDP---AQRATIFELLQHPFLI  267 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp---~~R~t~~e~l~hp~~~  267 (407)
                      .......++++++++.++|.++|   .+|+|+.|+|+||||.
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            12345678999999999999866   6899999999999984

>KOG1027|consensus

Probab=100.00  E-value=2.9e-38  Score=309.12  Aligned_cols=248  Identities=27%  Similarity=0.452  Sum_probs=192.5

Q ss_pred             eeeecccccCeE-EEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEec
Q psy10603          6 FSVSPGQGRFGK-VYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         6 ~~~~iG~G~~g~-V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      -...+|.|+-|+ ||+|...  |+.||||.+...      ....+.+|+..|+.- +|||||++|+...++...||+.|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            344889999884 8999754  779999987532      334567899999765 699999999999999999999999


Q ss_pred             CCCCCHHHHHhhc--CCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC---C-CeEEEEcccCceecCC
Q psy10603         84 CTEGTLESLVQST--EDGL-PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE---G-NSLKLGDFGSAVKISA  156 (407)
Q Consensus        84 ~~~g~L~~~~~~~--~~~~-~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~---~-~~vkl~DFGla~~~~~  156 (407)
                      |.. +|.+++...  .... .....+..+.|+++||.+||+.+||||||||.||||+..   + ..++|+|||+++++..
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            976 999999763  1111 114567889999999999999999999999999999862   3 4689999999999876


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCchHHHHHHHhCCCCCCC--CC
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-KRPWAEYDSNYQIMFKVGMGETPTI--PE  233 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~--~~  233 (407)
                      ....-....+..||-+|+|||++.....   ..++||+||||++|..++| +.||...-   +....+..+..-..  ..
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~---~~avDiFslGCvfyYvltgG~HpFGd~~---~R~~NIl~~~~~L~~L~~  737 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRK---TQAVDIFSLGCVFYYVLTGGSHPFGDSL---ERQANILTGNYTLVHLEP  737 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhcccc---CcccchhhcCceEEEEecCCccCCCchH---HhhhhhhcCccceeeecc
Confidence            6554444667789999999999976443   5689999999999998886 99997422   21112222222111  11


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .-..++.++|.+|+.+||..||++.++|.||+|..
T Consensus       738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            11128999999999999999999999999999963

>KOG0664|consensus

Probab=100.00  E-value=4.1e-39  Score=278.41  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=199.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-----eE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-----EM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~   77 (407)
                      |+.-+..||-|+||.||.+.+..+|+.||.|.+..- ...-...+++.+|++.|..++|.|++...++.+-..     ++
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            344556899999999999999999999999987533 223344578999999999999999999998876443     57


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |++.|+|.. +|...+-+ ...++.+.++-+++||+.||+|||+.+|+||||||.|+|++.+ ..+||||||+++....+
T Consensus       133 YV~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchh
Confidence            888998864 78777744 5558899999999999999999999999999999999999874 67999999999876544


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH--------------
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV--------------  223 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~--------------  223 (407)
                      ..  ...+..+-|.+|.|||.+++.+  .|+.++||||.|||+.|++.++..|.....-.++-...              
T Consensus       210 ~~--~hMTqEVVTQYYRAPEiLMGaR--hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  210 DR--LNMTHEVVTQYYRAPELLMGAR--RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             hh--hhhHHHHHHHHhccHHHhhcch--hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            32  2334456788999999998764  47899999999999999999999997544332221100              


Q ss_pred             hCC----------CCCCCC--------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        224 GMG----------ETPTIP--------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       224 ~~~----------~~~~~~--------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ..|          ..|.++        ..-..++..++..+|.+||++|.+..+.+.|++.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            000          112211        1123466778888999999999999999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.9e-37  Score=329.78  Aligned_cols=236  Identities=19%  Similarity=0.227  Sum_probs=180.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.||||.+.......       ..|++.+++++|||||++++++.+.+..|+||||+
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            33458999999999999999999999999886432211       24688899999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH---ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++|+|.++++.    +++..+..++.|++.||+|||   +.+|+||||||+||+++.++ ..++. ||........    
T Consensus       766 ~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        766 EGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCTD----  835 (968)
T ss_pred             CCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccccC----
Confidence            99999999953    889999999999999999999   67999999999999998754 45554 6654332111    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch----HHHHHHHhCC------CCCCC
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN----YQIMFKVGMG------ETPTI  231 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~----~~~~~~~~~~------~~~~~  231 (407)
                         ....||+.|||||++..   ..++.++|||||||++|||++|+.||......    ..........      ..|.+
T Consensus       836 ---~~~~~t~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        836 ---TKCFISSAYVAPETRET---KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ---CCccccccccCcccccC---CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence               22368899999999854   34688999999999999999999998532111    1100000000      01111


Q ss_pred             C------CccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        232 P------ESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       232 ~------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .      .....+..+++.+||+.||++|||+.|+++.
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            1      1122356788999999999999999999864

>KOG0670|consensus

Probab=100.00  E-value=6.5e-38  Score=291.81  Aligned_cols=246  Identities=30%  Similarity=0.465  Sum_probs=201.4

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC------CCcceEEEEEEeCceEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ------KNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~~~~~~lv~E   82 (407)
                      -.|+|=|++|..|.+...|..||||+|+.+    +--.+.=++|++||++|+.      -|+++++-.|...+++|||+|
T Consensus       439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE  514 (752)
T KOG0670|consen  439 YTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFE  514 (752)
T ss_pred             ccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEeh
Confidence            579999999999999999999999999743    2333556789999999974      389999999999999999999


Q ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      -+. -+|.+++++..  -++....++.|+.|+..||..|-..||+|.||||+|||++...+.+||||||.|.....+.  
T Consensus       515 ~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene--  591 (752)
T KOG0670|consen  515 PLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE--  591 (752)
T ss_pred             hhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc--
Confidence            885 58999997643  4588899999999999999999999999999999999999877889999999997765543  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH-HHhCCCCCC---------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPT---------  230 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~-~~~~~~~~~---------  230 (407)
                         .+.+.-+..|.|||.+.+   .+|+...|+||.||+||||.||+..|++..++..+-. .-..|..|.         
T Consensus       592 ---itPYLVSRFYRaPEIiLG---~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~  665 (752)
T KOG0670|consen  592 ---ITPYLVSRFYRAPEIILG---LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK  665 (752)
T ss_pred             ---ccHHHHHHhccCcceeec---CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence               345666788999999976   5678899999999999999999999998766644321 111121110         


Q ss_pred             -----------------------------C-C-----------CccC-------HHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        231 -----------------------------I-P-----------ESLS-------DEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       231 -----------------------------~-~-----------~~~s-------~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                                                   + |           +.++       .++++|+..||..||++|.|..|+|.
T Consensus       666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                                         0 1           0122       24688999999999999999999999


Q ss_pred             CCeee
Q psy10603        263 HPFLI  267 (407)
Q Consensus       263 hp~~~  267 (407)
                      ||||+
T Consensus       746 HpFi~  750 (752)
T KOG0670|consen  746 HPFIT  750 (752)
T ss_pred             CCccc
Confidence            99985

>KOG0665|consensus

Probab=100.00  E-value=1.8e-37  Score=273.89  Aligned_cols=246  Identities=28%  Similarity=0.418  Sum_probs=193.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~lv~E   82 (407)
                      .+|.|.- .|..|.+.-+++.||+|.+...... ...-++..+|+.++..++|+||++++.++.-..      ..|+|||
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            6777776 7888999999999999988765333 344467789999999999999999999886432      5899999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +|. .+|...+..   .+..+++..++.|++.|++|||+.||+||||||+||+++.+ ..+||.|||+|+.-...    -
T Consensus       102 ~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~----~  172 (369)
T KOG0665|consen  102 LMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTD----F  172 (369)
T ss_pred             hhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccCcc----c
Confidence            996 488888763   27788999999999999999999999999999999999886 46999999999765432    1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH---HHHHhC--------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI---MFKVGM--------------  225 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~---~~~~~~--------------  225 (407)
                      ..+.++.|..|.|||++.+..   +...+||||+||++.||++|+.-|.+.+.-.+-   ....+.              
T Consensus       173 ~mtpyVvtRyyrapevil~~~---~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVILGMG---YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             ccCchhheeeccCchheeccC---CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            346788999999999997643   678999999999999999999999854311110   000000              


Q ss_pred             ---CCC---------CCCCC-----------ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        226 ---GET---------PTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       226 ---~~~---------~~~~~-----------~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                         ...         ..+|+           .-+..+++++.+||..||++|.+++++|+|||+.+
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v  315 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV  315 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence               000         01111           12356899999999999999999999999999863

>KOG2052|consensus

Probab=100.00  E-value=1.4e-36  Score=278.64  Aligned_cols=248  Identities=27%  Similarity=0.432  Sum_probs=191.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHh--cCCCCCcceEEEEEEeCc----e
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE--GINQKNLVKYYGVEIHRE----E   76 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~~~~~~~~~~----~   76 (407)
                      .++....||+|.||+||+|+++  |+.||||++...   ++   ....+|.+|.+  .|+|+||+.+.++...++    +
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEeccc---ch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            4556679999999999999876  789999998643   21   34556777765  589999999999876554    6


Q ss_pred             EEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEecCCCeEEEEcc
Q psy10603         77 MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN--------TIVHRDIKSANIFLTAEGNSLKLGDF  148 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--------~iiHrdlKp~Nill~~~~~~vkl~DF  148 (407)
                      +|||.+|-+.|||.+++..  ..++.+...+++..+++||.+||-.        .|.|||||..|||+..++ .+.|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADL  360 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  360 (513)
T ss_pred             EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeec
Confidence            9999999999999999965  5599999999999999999999953        499999999999998765 6999999


Q ss_pred             cCceecCCCC-CCCCcccccccCCcccccccccccccCCC---CcchhHHHHHHHHHHHHcC----------CCCCCC--
Q psy10603        149 GSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMSSG----------KRPWAE--  212 (407)
Q Consensus       149 Gla~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~---~~~~DiwSlGv~l~em~~g----------~~Pf~~--  212 (407)
                      |||....... ......+..+||.+|||||+|...-....   -..+||||||.++||++.+          .+||.+  
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998876542 33445678899999999999954211111   1369999999999999752          368864  


Q ss_pred             -CCchHHHHHHHh--CCCCCCCCCccC-----HHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        213 -YDSNYQIMFKVG--MGETPTIPESLS-----DEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       213 -~~~~~~~~~~~~--~~~~~~~~~~~s-----~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                       .+++.+.+.++.  ...+|.+|..++     ...-.+++.||..+|..|.|+..+.
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence             344555555442  344666665443     2345678999999999999986654

>KOG0200|consensus

Probab=100.00  E-value=1e-35  Score=301.76  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=207.9

Q ss_pred             ceeeecccccCeEEEEEEEC----C---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNN----E---TGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~----~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   76 (407)
                      .+.+.+|+|.||.|++|.-.    .   ....||||.+.....  ....+.+..|+.+|+.+. ||||+.+.|++..++.
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            34459999999999999732    1   145799998865432  255688999999999874 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN  141 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~  141 (407)
                      +++|+||+..|+|..+++..+               ..++..+...++.||+.|++||++.++|||||-.+|||+..+ .
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~-~  455 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN-K  455 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC-C
Confidence            999999999999999998766               348889999999999999999999999999999999999874 6


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccC--CcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGT--QAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQ  218 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt--~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~  218 (407)
                      .+||+|||+|+.........  .....|+  ..|||||.+.+   ..++.++||||+||+|||++| |..||.+......
T Consensus       456 ~~kIaDFGlar~~~~~~~y~--~~~~~~~LP~kWmApEsl~~---~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYR--TKSSAGTLPVKWMAPESLFD---RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             EEEEccccceeccCCCCceE--ecCCCCccceeecCHHHhcc---CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            89999999998654322221  0111222  34999999965   457899999999999999998 8899987554566


Q ss_pred             HHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       219 ~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +...+..|.+...|..++++..++++.||..+|++||++.|+.+
T Consensus       531 l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            66678889999999999999999999999999999999998764

>KOG1290|consensus

Probab=100.00  E-value=4.9e-36  Score=277.72  Aligned_cols=125  Identities=25%  Similarity=0.461  Sum_probs=107.6

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-----C---CCcceEEEEEEeC----c
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-----Q---KNLVKYYGVEIHR----E   75 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~~~~----~   75 (407)
                      .+||.|.|++||+|.+..+.+.||+|+++    ....+.+..+.||++|++++     |   ..||++++.|...    .
T Consensus        84 rKLGWGHFSTVWLawDtq~~r~VAlKVvK----SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~  159 (590)
T KOG1290|consen   84 RKLGWGHFSTVWLAWDTQNKRYVALKVVK----SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ  159 (590)
T ss_pred             EeccccccceeEEEeeccCCeEEEEEEEe----hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence            39999999999999999999999999986    34567788899999998764     3   3699999988754    4


Q ss_pred             eEEEEEecCCCCCHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEe
Q psy10603         76 EMVLFMELCTEGTLESLVQ-STEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLT  137 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~  137 (407)
                      ++|||+|++.. +|..+|+ ....++|...++.|++||+.||+|||++ ||||-||||+|||+.
T Consensus       160 HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  160 HVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             EEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            79999999955 5555554 4567899999999999999999999986 899999999999984

>KOG3653|consensus

Probab=100.00  E-value=3.9e-36  Score=277.75  Aligned_cols=244  Identities=27%  Similarity=0.415  Sum_probs=185.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHh--cCCCCCcceEEEEEEeCc----eEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE--GINQKNLVKYYGVEIHRE----EMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~~~~~~~~~~----~~~   78 (407)
                      ++...||+|+||.||+|+..  ++.||||++...      ..+.+.+|-.|.+  .++|+||++++++.....    +++
T Consensus       213 ~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             hhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34458999999999999765  589999998632      2355666766654  689999999999876554    899


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN---------TIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---------~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      ||+||.+.|+|.++++.  ..+++....+++.-++.||.|||+.         .|+|||||.+|||+..|. +..|+|||
T Consensus       285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            99999999999999964  4489999999999999999999963         599999999999998764 68999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCC---CCcchhHHHHHHHHHHHHcCCCCCC-CCCchHH-------
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG---HGRAVDIWSLGCVLVEMSSGKRPWA-EYDSNYQ-------  218 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~~~~DiwSlGv~l~em~~g~~Pf~-~~~~~~~-------  218 (407)
                      +|.++...... +..-..+||.+|||||+|.+.-...   .-.+.||||+|.++|||+++..-+. +....++       
T Consensus       362 LAl~~~p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  362 LALRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             eeEEecCCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            99998754432 3344579999999999996532211   1247899999999999998654331 1111111       


Q ss_pred             -------HH--HHHhCCCCCCCCCcc-----CHHHHHHHHHhcccCCCCcCCHHHH
Q psy10603        219 -------IM--FKVGMGETPTIPESL-----SDEGQAFAELCLRHDPAQRATIFEL  260 (407)
Q Consensus       219 -------~~--~~~~~~~~~~~~~~~-----s~~~~~~i~~~l~~dp~~R~t~~e~  260 (407)
                             .+  ..+....+|.+|..+     ...+++.+.-||..||+.|.|+.=+
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                   11  122334566666543     3457889999999999999997543

>KOG1025|consensus

Probab=100.00  E-value=1.2e-35  Score=289.48  Aligned_cols=245  Identities=24%  Similarity=0.340  Sum_probs=205.8

Q ss_pred             eeeecccccCeEEEEEEECCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ..++||+|+||+||+|.+...|+    +||+|++.....  .+...+++.|.-+|.+++|||++++.+++.... +-||+
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34599999999999999876665    678998865432  334577899999999999999999999988766 88999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      +|++.|.|.++++..+..+-......|..||++|+.|||.+.++||||-.+|+|+... +.+||+|||+++.+...... 
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~~e-  854 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDEKE-  854 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCccccc-
Confidence            9999999999999888889999999999999999999999999999999999999875 47999999999887654322 


Q ss_pred             Cccccccc--CCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        162 GELNGFVG--TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       162 ~~~~~~~g--t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                        .+...|  .+.|||-|.+..   ..|+.++|||||||++||++| |..|+.+. ...++-.....+.+-..|+.++-+
T Consensus       855 --y~~~~gK~pikwmale~i~~---~~~thqSDVWsfGVtiWElmTFGa~Py~gi-~~~eI~dlle~geRLsqPpiCtiD  928 (1177)
T KOG1025|consen  855 --YSAPGGKVPIKWMALESIRI---RKYTHQSDVWSFGVTIWELMTFGAKPYDGI-PAEEIPDLLEKGERLSQPPICTID  928 (1177)
T ss_pred             --ccccccccCcHHHHHHHhhc---cCCCchhhhhhhhhhHHHHHhcCCCccCCC-CHHHhhHHHhccccCCCCCCccHH
Confidence              222222  356999898854   457889999999999999988 89999864 344555556667778889999999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHh
Q psy10603        239 GQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      ..-++.+||..|++.||++.++.
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHH
Confidence            99999999999999999998864

>KOG1167|consensus

Probab=100.00  E-value=1.4e-35  Score=271.11  Aligned_cols=249  Identities=29%  Similarity=0.465  Sum_probs=196.8

Q ss_pred             eecccccCeEEEEEEECC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEec
Q psy10603          8 VSPGQGRFGKVYTAVNNE---TGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .+||+|+|++||+|.+..   .++.||+|.+......     .++.+|++.|..+. +-||+++.+++...+...+||||
T Consensus        42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~  116 (418)
T KOG1167|consen   42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY  116 (418)
T ss_pred             ccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence            389999999999998877   7889999998765332     45788999999885 68999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC-----
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-----  158 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~-----  158 (407)
                      ++.-+..+++..    ++...++.|++.++.||.++|++|||||||||+|+|.+...+.-.|+|||+|.......     
T Consensus       117 ~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  117 FEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             cCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999999999865    77889999999999999999999999999999999999887778899999996211000     


Q ss_pred             ------------------------------------CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHH
Q psy10603        159 ------------------------------------TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  202 (407)
Q Consensus       159 ------------------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~e  202 (407)
                                                          ..+...-...||++|.|||++...+  ..++++||||.|||+..
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~--~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP--RQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc--CcCCccceeeccceeeh
Confidence                                                0001111346999999999997643  35789999999999999


Q ss_pred             HHcCCCCCCCCCchHHHHHHH--------------hCCC--------CCCC----------------------------C
Q psy10603        203 MSSGKRPWAEYDSNYQIMFKV--------------GMGE--------TPTI----------------------------P  232 (407)
Q Consensus       203 m~~g~~Pf~~~~~~~~~~~~~--------------~~~~--------~~~~----------------------------~  232 (407)
                      +++++.||....++...+..+              ..|.        .+.+                            .
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            999999996543221111000              0000        0100                            1


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +..+..+.+++.+||+.||.+|.|+++.|.||||.
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            12345788999999999999999999999999995

>KOG1152|consensus

Probab=100.00  E-value=8.6e-35  Score=274.17  Aligned_cols=201  Identities=31%  Similarity=0.445  Sum_probs=170.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHH-----HHHHHHHHHhcCC---CCCcceEEEEEEeC
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVK-----DMLVELRILEGIN---QKNLVKYYGVEIHR   74 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~-----~~~~E~~~l~~l~---hpniv~~~~~~~~~   74 (407)
                      +++-..++|.|+||.|++|.++++...|+||.|.+.+......++     ..-.||+||..++   |+||+++.++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            455666999999999999999999999999999766543222221     2456999999998   99999999999999


Q ss_pred             ceEEEEEecC-CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         75 EEMVLFMELC-TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        75 ~~~~lv~E~~-~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      +.+||+||-- ++-+|.++|.. +..++|.++.-+++|++.|+++||++||||||||-+|+.++.+| .+||+|||.|..
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgsaa~  719 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGSAAY  719 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeeccchhh
Confidence            9999999975 46789999965 55599999999999999999999999999999999999999876 599999998844


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE  212 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~  212 (407)
                      ..     .+....++||..|.|||++.+.++  .+..-|||+||++||.++...-||.+
T Consensus       720 ~k-----sgpfd~f~gtv~~aapevl~g~~y--~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TK-----SGPFDVFVGTVDYAAPEVLGGEKY--LGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hc-----CCCcceeeeeccccchhhhCCCcc--CCCcchhhhhhheeeEEEeccCCCcC
Confidence            32     234467899999999999976443  47889999999999999999888863

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.2e-32  Score=241.10  Aligned_cols=215  Identities=37%  Similarity=0.626  Sum_probs=183.9

Q ss_pred             cccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCCH
Q psy10603         10 PGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL   89 (407)
Q Consensus        10 iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L   89 (407)
                      ||+|++|.||++....+++.+++|++.......  ..+.+.+|++.++.++|++|+++++.+......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999999889999999987543221  346788999999999999999999999998999999999999999


Q ss_pred             HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccccccc
Q psy10603         90 ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG  169 (407)
Q Consensus        90 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~g  169 (407)
                      .+++......++...+..++.+++.+|.+||+.|++|+||+|.||+++..+..++|+|||.+........   ......+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~  155 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVG  155 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccC
Confidence            9999765345899999999999999999999999999999999999987234699999999977644321   1233457


Q ss_pred             CCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhccc
Q psy10603        170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH  249 (407)
Q Consensus       170 t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~  249 (407)
                      ...|++||.+...  ...+.++|+||+|+++++|                                 +...+++..|++.
T Consensus       156 ~~~~~~pe~~~~~--~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         156 TPAYMAPEVLLGK--GYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             CCCccChhHhccc--CCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhC
Confidence            7889999988542  2457899999999999999                                 6778999999999


Q ss_pred             CCCCcCCHHHHhcCC
Q psy10603        250 DPAQRATIFELLQHP  264 (407)
Q Consensus       250 dp~~R~t~~e~l~hp  264 (407)
                      ||++||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345|consensus

Probab=100.00  E-value=3.3e-34  Score=247.77  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=191.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEE-EEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGV-EIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~~~~~~lv~E   82 (407)
                      +....+|+|.||.+-+|+|+.++..+++|.+....    ...++|.+|...--.|. |.||+..|+. |+..+.++++||
T Consensus        27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            33458999999999999999999999999886432    23467888887655554 6899998874 777888899999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe-cCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT-AEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~-~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |++.|+|..-+.  ..++-|.....++.|+++|++|+|++++||||||.+||||- .+...|||||||+.+.......  
T Consensus       103 ~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~--  178 (378)
T KOG1345|consen  103 FAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK--  178 (378)
T ss_pred             cCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh--
Confidence            999999988763  46689999999999999999999999999999999999985 3446899999999876532211  


Q ss_pred             CcccccccCCccccccccccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC---chHHHHHHHhCCCCCCCCC---
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNK--VGHGRAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGMGETPTIPE---  233 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~---~~~~~~~~~~~~~~~~~~~---  233 (407)
                          ..--+..|.+||++.....  ....+.+|+|.||+++|.++||.+||....   ..+-...+...+..+.+|+   
T Consensus       179 ----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~  254 (378)
T KOG1345|consen  179 ----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN  254 (378)
T ss_pred             ----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence                1123567899998743221  123578999999999999999999998432   2233334444555666665   


Q ss_pred             ccCHHHHHHHHHhcccCCCCcC---CHHHHhcCCee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRA---TIFELLQHPFL  266 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~---t~~e~l~hp~~  266 (407)
                      .+|+.+..+.++-|..+|++|-   ++.......|.
T Consensus       255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            4788999999999999999994   44444444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-31  Score=239.77  Aligned_cols=217  Identities=37%  Similarity=0.567  Sum_probs=177.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|++|.||+|.+..+++.+|+|.+......  +..+.+.+|++.+++++|+|++++++.+...+..++++||++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            456899999999999999988999999998754322  245778899999999999999999999998899999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|.+++......+++..+..++.|++.++.+||+++++|+|++|+||+++.+ ..++|+|||++.......  +....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~--~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL--AALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc--ccccc
Confidence            999999997644338899999999999999999999999999999999999876 469999999987765432  01223


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCC-CCchHHHHHHHhCCCCC
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE-YDSNYQIMFKVGMGETP  229 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~-~~~~~~~~~~~~~~~~~  229 (407)
                      ...++..|++||.+.  ....++.++|+||||+++++|++|+.||.. ..+.......+..+..+
T Consensus       158 ~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      158 TVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            457788999999874  234467799999999999999999999976 33333444444444433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=3.4e-33  Score=293.90  Aligned_cols=204  Identities=17%  Similarity=0.220  Sum_probs=147.6

Q ss_pred             cCCC-CCcceEEEEE-------EeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy10603         58 GINQ-KNLVKYYGVE-------IHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI  129 (407)
Q Consensus        58 ~l~h-pniv~~~~~~-------~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdl  129 (407)
                      .++| +||.++++++       .....+++++|++ +++|.+++......+++..+..+++||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4556 5777777776       2334678889987 56999999765556999999999999999999999999999999


Q ss_pred             CCCCEEEecC------------------CCeEEEEcccCceecCCCCC-------------CCCcccccccCCccccccc
Q psy10603        130 KSANIFLTAE------------------GNSLKLGDFGSAVKISAHTT-------------VPGELNGFVGTQAYMAPEV  178 (407)
Q Consensus       130 Kp~Nill~~~------------------~~~vkl~DFGla~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~  178 (407)
                      ||+|||++..                  ...+|++|||+++.......             .+......+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999542                  23467777777754321000             0001122468999999999


Q ss_pred             ccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHH
Q psy10603        179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIF  258 (407)
Q Consensus       179 l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~  258 (407)
                      +.+   ..++.++|||||||++|||++|..|+.....   .+........|..+..-.++..+++..||++||.+||++.
T Consensus       187 ~~~---~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        187 DNG---SSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             hcc---CCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence            865   3468899999999999999999998763221   1111111112211112245567899999999999999999


Q ss_pred             HHhcCCeeee
Q psy10603        259 ELLQHPFLIV  268 (407)
Q Consensus       259 e~l~hp~~~~  268 (407)
                      |+++|||+..
T Consensus       261 eil~h~~~~~  270 (793)
T PLN00181        261 ELLQSEFINE  270 (793)
T ss_pred             HHhhchhhhh
Confidence            9999999853

>KOG1024|consensus

Probab=99.97  E-value=2.9e-31  Score=240.07  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             ecccccCeEEEEEEECCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-ceEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETG-----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-EEMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~E   82 (407)
                      .+-+|.||.||.|.+++.+     +.|-+|.++.+  ..+-.+..++.|...|..+.|||+..+.++..++ ...+.++.
T Consensus       291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            6778999999999876543     33555665432  3344567789999999999999999999987654 46788899


Q ss_pred             cCCCCCHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         83 LCTEGTLESLVQST-------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      ++..|+|..+++-.       ...++..+...++.|++.|++|||+.+|||.||-.+|.+|++. -.+||+|=.+++.+.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltDsaLSRDLF  447 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTDSALSRDLF  447 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEeccchhccccC
Confidence            99999999999722       2336677888999999999999999999999999999999875 579999999998765


Q ss_pred             CCCCC-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCC
Q psy10603        156 AHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPE  233 (407)
Q Consensus       156 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  233 (407)
                      +.... -+..  --....||+||.+..   ..|+.++|+|||||++|||+| |+.||.+.+ ..+.-..+..|.+-..|-
T Consensus       448 P~DYhcLGDn--EnRPvkWMslEal~n---~~yssasDvWsfGVllWELmtlg~~PyaeID-PfEm~~ylkdGyRlaQP~  521 (563)
T KOG1024|consen  448 PGDYHCLGDN--ENRPVKWMSLEALQN---SHYSSASDVWSFGVLLWELMTLGKLPYAEID-PFEMEHYLKDGYRLAQPF  521 (563)
T ss_pred             cccccccCCC--CCCcccccCHHHHhh---hhhcchhhhHHHHHHHHHHHhcCCCCccccC-HHHHHHHHhccceecCCC
Confidence            43221 1111  012457999999964   447899999999999999987 899998654 445555566778888889


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++++++-.++..||+.+|++||++.|+..
T Consensus       522 NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  522 NCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            99999999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.3e-30  Score=224.78  Aligned_cols=161  Identities=27%  Similarity=0.280  Sum_probs=126.5

Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.++++.....+++..++.++.|++.||.|||+++      ||+|||++.++ .+|+  ||+++.....        .
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~--------~   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE--------Q   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc--------c
Confidence            7899999765666999999999999999999999998      99999998765 5888  9998765432        1


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC------CCCccCH--H
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT------IPESLSD--E  238 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~s~--~  238 (407)
                      ..||+.|||||++.+   ..++.++|||||||++|||++|+.||..................+.      .+..+++  +
T Consensus        64 ~~g~~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (176)
T smart00750       64 SRVDPYFMAPEVIQG---QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARS  140 (176)
T ss_pred             CCCcccccChHHhcC---CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhh
Confidence            268999999999965   3467899999999999999999999975433222222222111111      1223444  6


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++.+||..||++||++.|+++|+|+.
T Consensus       141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      141 FADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            89999999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2e-28  Score=231.18  Aligned_cols=186  Identities=16%  Similarity=0.176  Sum_probs=136.3

Q ss_pred             cceeeecccccCeEEEEEEECC-CCcEEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCcce-EEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-TGELVAMKEIQLHKQ--NDARFVKDMLVELRILEGINQKNLVK-YYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|++.. +++.+|||++.....  .+....+.+.+|+++|++++|+||+. +++.    +..|+
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L   95 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL   95 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence            4445589999999999999876 677789998753311  13334567899999999999999985 5442    46899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI-KSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdl-Kp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||||++|++|... .  .  ..   ...++.|++.||.|||++||+|||| ||+|||++.++ .+||+|||+|+.+....
T Consensus        96 VmE~~~G~~L~~~-~--~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~~~  166 (365)
T PRK09188         96 VRGWTEGVPLHLA-R--P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRRRG  166 (365)
T ss_pred             EEEccCCCCHHHh-C--c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceecccCc
Confidence            9999999999632 1  1  11   1467899999999999999999999 99999997654 69999999998765432


Q ss_pred             CCC-----CcccccccCCcccccccccccccCCC---CcchhHHHHHHHHHHHHcCCCCC
Q psy10603        159 TVP-----GELNGFVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMSSGKRPW  210 (407)
Q Consensus       159 ~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~---~~~~DiwSlGv~l~em~~g~~Pf  210 (407)
                      ...     ...+...+++.|+|||.+........   +..+|-|        +-||..-+
T Consensus       167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW--------~~TGDlg~  218 (365)
T PRK09188        167 ALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW--------LATGKKVY  218 (365)
T ss_pred             chhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE--------EeCCCEEE
Confidence            111     12245678899999999854322111   2346766        35676554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=8.8e-27  Score=219.27  Aligned_cols=259  Identities=31%  Similarity=0.446  Sum_probs=203.6

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCC-CcceEEEEEEeCceEEEEEecC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK-NLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ....||.|+||.||++.+.   ..+|+|.+.............+.+|+.++..+.|+ +|+++++.+......++++|++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            4458999999999999988   77999999866554444567899999999999998 7999999997777789999999


Q ss_pred             CCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC-
Q psy10603         85 TEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP-  161 (407)
Q Consensus        85 ~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~-  161 (407)
                      .++++.+++....  ..+++..+..++.|++.++.|+|+.+++|||+||+||+++..+..++++|||++..+....... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999997776543  2589999999999999999999999999999999999998765469999999997654332211 


Q ss_pred             --CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc---hHHHHHHHhCCCCC----CCC
Q psy10603        162 --GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS---NYQIMFKVGMGETP----TIP  232 (407)
Q Consensus       162 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~---~~~~~~~~~~~~~~----~~~  232 (407)
                        .......||..|+|||.+........+...|+||+|++++++++|..||.....   ..+....+.....+    ...
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS  240 (384)
T ss_pred             ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence              123567899999999998542102357899999999999999999999876543   23333333332322    111


Q ss_pred             Ccc----CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESL----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~----s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ...    .....+++..++..+|..|.+..+...+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~  279 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA  279 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence            111    25788999999999999999999988876543

>KOG0590|consensus

Probab=99.95  E-value=5.3e-29  Score=249.91  Aligned_cols=256  Identities=26%  Similarity=0.383  Sum_probs=194.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEec---cccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQL---HKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~---~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      ...+|.|++|.|+.+......+..+.|..+.   .......+...+..|..+-..++|||++.......+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            4489999999999888877777677665542   1122333344477788888899999998877766666655556999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC-CCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT-VPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~-~~~  162 (407)
                      |++ +|..++... ..++..++..+++|++.|++|+|+.||.|||+||+|++++..+ .+||+|||.+..+..... ...
T Consensus       403 ~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             ccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcchhhh
Confidence            999 999988543 3488889999999999999999999999999999999999865 799999999866543221 113


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH-hCC------CCCCCCCcc
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMG------ETPTIPESL  235 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~-~~~------~~~~~~~~~  235 (407)
                      .....+|+.+|+|||++....  ...+..||||.|++++.|.+|+.||.-.....+..... ...      ....+...+
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~--ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKE--YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhcCcccCCcCcCcccccccc--cCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence            456789999999999996543  23568999999999999999999997433221110110 000      011223457


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+.+.++.++|+.||.+|.|++++++.+|+.
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            78889999999999999999999999999985

>KOG0590|consensus

Probab=99.95  E-value=8.6e-30  Score=255.59  Aligned_cols=375  Identities=28%  Similarity=0.390  Sum_probs=264.4

Q ss_pred             eecccccCeEEEEEEECC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecCC
Q psy10603          8 VSPGQGRFGKVYTAVNNE-TGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ..||+|+|+.|-.+.... +...+|+|.+.... ...........|..+-..++ |+|++.+++...+.+..++++||..
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~  104 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD  104 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence            378999999998887643 34456777665432 23344556667888888887 9999999999999999999999999


Q ss_pred             CCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         86 EGTLESLV-QSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        86 ~g~L~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++++...+ .....+.+...+..++.|+..++.|+| ..++.|||+||+|.+++..+..+|+.|||+|..+.........
T Consensus       105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~  184 (601)
T KOG0590|consen  105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERS  184 (601)
T ss_pred             ccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCccee
Confidence            99999888 433226788899999999999999999 9999999999999999876536999999999877652222334


Q ss_pred             cccccc-CCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH-HHhC-CC-CCCCCCccCHHH
Q psy10603        164 LNGFVG-TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGM-GE-TPTIPESLSDEG  239 (407)
Q Consensus       164 ~~~~~g-t~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~-~~~~-~~-~~~~~~~~s~~~  239 (407)
                      ....+| ++.|+|||.+.+.  ...++..|+||.|+++.-|++|..|+........... .... +. ....+..++...
T Consensus       185 ~~~~~g~s~~y~a~E~~~~~--~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (601)
T KOG0590|consen  185 LKDRCGSSPPYGAPEHLSGK--AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQA  262 (601)
T ss_pred             eecccCCCCCCCCcccccch--hhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhh
Confidence            556788 9999999998652  2346789999999999999999999975433222111 1111 11 234467789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee-ecCCcC---CC----CCCC-------------------------------
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV-SCEEDV---CN----PRSV-------------------------------  280 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~-~~~~~~---~~----~~~~-------------------------------  280 (407)
                      .+++.+++..+|+.|.+..++..+||+.. ......   +.    ....                               
T Consensus       263 ~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~  342 (601)
T KOG0590|consen  263 HDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSD  342 (601)
T ss_pred             hhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccCCccceeeecccCceEEEEecCC
Confidence            99999999999999999999999999876 111000   00    0000                               


Q ss_pred             ----chhhH----------Hhhhh--------------cCc------------------cCCC-----------CCcccc
Q psy10603        281 ----PASVL----------QDYLK--------------LGI------------------VLPP-----------MSEDSV  303 (407)
Q Consensus       281 ----p~~~~----------~~~l~--------------~~~------------------~~~~-----------~s~~~i  303 (407)
                          +....          .++..              .++                  +.+.           +....+
T Consensus       343 ~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~  422 (601)
T KOG0590|consen  343 LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSNGKLTPLEA  422 (601)
T ss_pred             CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcccccchhhh
Confidence                00000          00000              000                  0000           000000


Q ss_pred             ccc---------------------CCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCc
Q psy10603        304 KVY---------------------ARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNK  361 (407)
Q Consensus       304 ~~~---------------------~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~  361 (407)
                      ..+                     ++.|+++...+. +||+|||.+.-+.-+... .......+|+..|+|||++.+..+
T Consensus       423 ~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~-lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~y  501 (601)
T KOG0590|consen  423 DCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI-LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEY  501 (601)
T ss_pred             hHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc-eEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccccc
Confidence            000                     135888888775 999999999755432221 122446789999999999976433


Q ss_pred             CCCCccchHHhHHHHHHHHHhCCCCCC
Q psy10603        362 VGHGRAVDIWSLGCVLVEMSSGKTNLS  388 (407)
Q Consensus       362 ~~~~~~~Dvws~G~~~~e~~~g~~~~~  388 (407)
                        .....||||.|+++..|.+|+-||+
T Consensus       502 --dpr~vDiwS~~ii~~~m~~~~~~Wk  526 (601)
T KOG0590|consen  502 --DPRAVDVWSCGIIYICMILGRFPWK  526 (601)
T ss_pred             --CcchhhhhhccceEEEEecCCCccc
Confidence              2467899999999999999999988

>KOG1164|consensus

Probab=99.95  E-value=4e-26  Score=215.64  Aligned_cols=250  Identities=22%  Similarity=0.285  Sum_probs=185.5

Q ss_pred             eeeecccccCeEEEEEEECCCC-cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC----CCcceEEEEE-EeCceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ----KNLVKYYGVE-IHREEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~~~l   79 (407)
                      ....||+|+||.||+|.+..++ +.+|+|..........   ..+..|..+|..+..    +++..+++.. ......|+
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            3449999999999999988775 6789998765432221   145668888877762    6888999888 47778999


Q ss_pred             EEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC----CeEEEEcccCce--
Q psy10603         80 FMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG----NSLKLGDFGSAV--  152 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~----~~vkl~DFGla~--  152 (407)
                      ||+.+ |.+|.++.+... +.++..++..++.|++.+|++||+.|++||||||+|+++....    ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99988 679999886554 6799999999999999999999999999999999999998653    469999999998  


Q ss_pred             ecCCCC----CCCCc-ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHhC
Q psy10603        153 KISAHT----TVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGM  225 (407)
Q Consensus       153 ~~~~~~----~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~~~  225 (407)
                      .+....    ..+.. ...+.||..|+++.+..+   ...+++.|+||++.++.|+..|..||......  .....+...
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~---~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG---IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCC---CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            432221    11111 234669999999998754   34589999999999999999999999765432  222222211


Q ss_pred             CCCCC-CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        226 GETPT-IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       226 ~~~~~-~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ..... .....+.+..++...+-..+...+|....+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            11111 23345567777777777788889998766654

>KOG1163|consensus

Probab=99.93  E-value=2.2e-25  Score=190.26  Aligned_cols=241  Identities=24%  Similarity=0.333  Sum_probs=183.6

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .+||.|+||.+|+|.+..+|++||||+=.... ..    -.+..|.++.+.|++ ..|..+..+..++..-.+||+++ |
T Consensus        21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   21 RKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G   94 (341)
T ss_pred             EeecCCchhheeeeeeccCCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence            48999999999999999999999999754332 22    235678888888887 67777777778888899999998 6


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCC---C
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTV---P  161 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~---~  161 (407)
                      .+|.++..-....++..++.-++-|++.-++|+|.++.|||||||+|+|..-.  .+.+-|+|||+|+++....+.   +
T Consensus        95 PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIp  174 (341)
T KOG1163|consen   95 PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIP  174 (341)
T ss_pred             ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCc
Confidence            79999998777779999999999999999999999999999999999997532  346899999999887543221   1


Q ss_pred             -CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH--HHHHHHhCCCCCC----CCCc
Q psy10603        162 -GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--QIMFKVGMGETPT----IPES  234 (407)
Q Consensus       162 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~--~~~~~~~~~~~~~----~~~~  234 (407)
                       .+-....||..|.+--...+   ...+++.|+-|+|.+|.....|+.||.+.....  |...++.......    +=++
T Consensus       175 yre~r~ltGTaRYASinAh~g---~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G  251 (341)
T KOG1163|consen  175 YREDRNLTGTARYASINAHLG---IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKG  251 (341)
T ss_pred             cccCCccceeeeehhhhhhhh---hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCC
Confidence             22345679999988554432   334789999999999998999999998754432  2222332222111    1256


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCH
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATI  257 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~  257 (407)
                      ++.|+--.+.-|-..--++-|.-
T Consensus       252 ~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  252 FPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CcHHHHHHHHHHhhcCCCCCCcH
Confidence            78888888888877666666653

>KOG0195|consensus

Probab=99.93  E-value=2e-26  Score=199.83  Aligned_cols=246  Identities=17%  Similarity=0.273  Sum_probs=195.1

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++++..+|.+...|+.|+|++..+  -++.|++..... ..+..+.|-.|.-.|+-+.||||+.+.+.+..+..+.++.
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            4667777899999999999998754  456687765433 3344466778888999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEE--EcccCceecCC
Q psy10603         82 ELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKL--GDFGSAVKISA  156 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl--~DFGla~~~~~  156 (407)
                      .||+.|+|..+++...+ .....++.+++.+++.|+.|||+..  |.---|....+++|.+ .+.+|  +|--++.+-  
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsfqe--  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSFQE--  343 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeeeec--
Confidence            99999999999976433 2567889999999999999999863  4445788888999865 23443  343332211  


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                              .+..-.|.||+||.++.......-+++|+|||.+++||+.|...||.+..+..--+.....|.++.+|+++|
T Consensus       344 --------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis  415 (448)
T KOG0195|consen  344 --------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS  415 (448)
T ss_pred             --------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence                    223457899999999765444345689999999999999999999998776655566666788999999999


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      .....+++.|+..||.+||.++.++
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999999987654

>KOG1165|consensus

Probab=99.93  E-value=1.5e-24  Score=193.03  Aligned_cols=240  Identities=24%  Similarity=0.330  Sum_probs=182.8

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .+||+|+||+++.|.+.-+++.||||.=... ...+    ++.-|.+..+.|.+ +.|...|.+..+..+-.||+|++ |
T Consensus        34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cccccCcceeeecccccccCceEEEEecccc-CCcc----hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            3999999999999999999999999964332 2222    23345555555544 89999998888888889999998 6


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC----CeEEEEcccCceecCCCCCCC-
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG----NSLKLGDFGSAVKISAHTTVP-  161 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~----~~vkl~DFGla~~~~~~~~~~-  161 (407)
                      .+|+++..-....|+..++..++.|++.-++|+|++.+|.|||||+|+||...+    +.|.++|||+|+......+.. 
T Consensus       108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH  187 (449)
T KOG1165|consen  108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH  187 (449)
T ss_pred             cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc
Confidence            799999988888899999999999999999999999999999999999996432    468999999999876443321 


Q ss_pred             ---CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CchHHHHHHHhCCCCCC----CC
Q psy10603        162 ---GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY--DSNYQIMFKVGMGETPT----IP  232 (407)
Q Consensus       162 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~--~~~~~~~~~~~~~~~~~----~~  232 (407)
                         .+..+..||..||+--...+   ...+++.|+-|||-++...+-|.+||.+.  +++.+...+++......    +-
T Consensus       188 IPYrE~KSLsGTARYMSINTHlG---rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc  264 (449)
T KOG1165|consen  188 IPYREHKSLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC  264 (449)
T ss_pred             CccccccccccceeeeEeecccc---chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence               34456789999999655444   23478999999999999999999999864  34455555665444322    12


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCC
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRAT  256 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t  256 (407)
                      ++++.++...+.-.-..+-.+-|.
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCC
Confidence            456667666665555555556665

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=4.4e-25  Score=191.88  Aligned_cols=140  Identities=21%  Similarity=0.220  Sum_probs=108.0

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcH----------HH-------------HHHHHHHHHHHhcCCCCCc
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA----------RF-------------VKDMLVELRILEGINQKNL   64 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~----------~~-------------~~~~~~E~~~l~~l~hpni   64 (407)
                      ..||+|+||.||+|.+. +|+.||||+++.......          ++             .....+|+++|.++.++++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36999999999999987 899999999976432110          00             1223459999999988776


Q ss_pred             ceEEEEEEeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCEEEecCCCeE
Q psy10603         65 VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL-HENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        65 v~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL-H~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      ........  ...+|||||++++++...... ...+++..+..++.|++.+|.|+ |+.||+||||||+|||+++  +.+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~v  156 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GKL  156 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--CcE
Confidence            44333222  223899999999877654322 34589999999999999999999 7999999999999999984  369


Q ss_pred             EEEcccCcee
Q psy10603        144 KLGDFGSAVK  153 (407)
Q Consensus       144 kl~DFGla~~  153 (407)
                      +|+|||+|..
T Consensus       157 ~LiDFG~a~~  166 (190)
T cd05147         157 YIIDVSQSVE  166 (190)
T ss_pred             EEEEcccccc
Confidence            9999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.2e-23  Score=183.50  Aligned_cols=141  Identities=20%  Similarity=0.224  Sum_probs=109.9

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCc---------------------H-H-HHHHHHHHHHHHhcCCCCCc
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND---------------------A-R-FVKDMLVELRILEGINQKNL   64 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~---------------------~-~-~~~~~~~E~~~l~~l~hpni   64 (407)
                      ..||+|+||.||+|++. +|+.||||+++......                     . . ....+.+|.+.+.++.|+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            47999999999999987 89999999998652210                     0 0 01234578999999999987


Q ss_pred             ceEEEEEEeCceEEEEEecCCCCCHHHH-HhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCe
Q psy10603         65 VKYYGVEIHREEMVLFMELCTEGTLESL-VQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNS  142 (407)
Q Consensus        65 v~~~~~~~~~~~~~lv~E~~~~g~L~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~  142 (407)
                      ..........  .||||||++|+++... +.  ...+++..+..++.|++.++.++|+ +||+||||||+|||++ + +.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CC
Confidence            5544433332  4899999998865433 32  2347888999999999999999999 9999999999999998 4 46


Q ss_pred             EEEEcccCceecC
Q psy10603        143 LKLGDFGSAVKIS  155 (407)
Q Consensus       143 vkl~DFGla~~~~  155 (407)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=2.8e-23  Score=182.28  Aligned_cols=139  Identities=19%  Similarity=0.209  Sum_probs=110.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEEeCc--
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-----NQKNLVKYYGVEIHRE--   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~--   75 (407)
                      +++-...||+|+||.||.  +..++.. +||++.....   ...+.+.+|+++++.+     +||||+++|++++++.  
T Consensus         3 ~L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          3 RLSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             ecCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            455667999999999995  7777766 6898875432   2235688999999999     6799999999998874  


Q ss_pred             -eEE-EEEec--CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEEecCC---CeEEEEc
Q psy10603         76 -EMV-LFMEL--CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAI-SALHENTIVHRDIKSANIFLTAEG---NSLKLGD  147 (407)
Q Consensus        76 -~~~-lv~E~--~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL-~yLH~~~iiHrdlKp~Nill~~~~---~~vkl~D  147 (407)
                       .++ +|+||  +.+|+|.++++..  .+++.  ..++.|++.++ +|||+++|+||||||+|||++..+   ..++|+|
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence             434 78999  5589999999652  36666  35688888888 999999999999999999997432   3699999


Q ss_pred             ccCc
Q psy10603        148 FGSA  151 (407)
Q Consensus       148 FGla  151 (407)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=6.9e-24  Score=186.67  Aligned_cols=167  Identities=14%  Similarity=0.159  Sum_probs=127.1

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHH------HHHHHHHHhcCCCCCcceEEEEEEeC------
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD------MLVELRILEGINQKNLVKYYGVEIHR------   74 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~E~~~l~~l~hpniv~~~~~~~~~------   74 (407)
                      ...+|+|+||.||++..  ++..+|+|+++......+...+.      +.+|+..+.+++||+|....+++...      
T Consensus        36 ~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~  113 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR  113 (232)
T ss_pred             EEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence            34899999999999754  46689999998766666666555      57899999999999999998886643      


Q ss_pred             --ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         75 --EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        75 --~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                        +..+|||||++|.+|.++..     +++.    ...+++.+|..||+.|++|||+||+||++++++  ++|+|||...
T Consensus       114 ~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg~~~  182 (232)
T PRK10359        114 YAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLSGKR  182 (232)
T ss_pred             ccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECCCcc
Confidence              35899999999999987742     3332    456999999999999999999999999998765  9999999875


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHH
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS  204 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~  204 (407)
                      .......        +.  .     +... .  .++.++|+||||+++.-..
T Consensus       183 ~~~e~~a--------~d--~-----~vle-r--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        183 CTAQRKA--------KD--R-----IDLE-R--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccchhh--------HH--H-----HHHH-h--HhcccccccceeEeehHHH
Confidence            5422110        00  0     1111 1  2457899999999877543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=2.8e-23  Score=188.22  Aligned_cols=234  Identities=23%  Similarity=0.306  Sum_probs=146.4

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC---C-------CcceEEEEE-----
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ---K-------NLVKYYGVE-----   71 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h---p-------niv~~~~~~-----   71 (407)
                      ...||.|+++.||.+++.+||+.+|+|+............+++.+|.-....+.+   |       .++.-++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            3489999999999999999999999999876554333445566666544333332   1       111111211     


Q ss_pred             ----EeC---c-----eEEEEEecCCCCCHHHHHhh---cCCC-CCHH--HHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q psy10603         72 ----IHR---E-----EMVLFMELCTEGTLESLVQS---TEDG-LPEV--LVRRYTKQLVDAISALHENTIVHRDIKSAN  133 (407)
Q Consensus        72 ----~~~---~-----~~~lv~E~~~~g~L~~~~~~---~~~~-~~~~--~~~~~~~qi~~aL~yLH~~~iiHrdlKp~N  133 (407)
                          ...   .     ..+++|+-+. ++|..++..   .... ....  ....+..|++..+.+||+.|++|+||||+|
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~n  175 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPEN  175 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred             CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceee
Confidence                111   1     2367787774 588887542   2221 1122  224556899999999999999999999999


Q ss_pred             EEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCccccccccccc-----ccCCCCcchhHHHHHHHHHHHHcCCC
Q psy10603        134 IFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-----NKVGHGRAVDIWSLGCVLVEMSSGKR  208 (407)
Q Consensus       134 ill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~~~DiwSlGv~l~em~~g~~  208 (407)
                      +|++.+| .++|+||+...........      ...+..|.+||+....     ....++.+.|.|+||+++|.|.+|+.
T Consensus       176 fll~~~G-~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  176 FLLDQDG-GVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             EEE-TTS--EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             EEEcCCC-CEEEcChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999876 6999999987665432211      2335679999977432     22346789999999999999999999


Q ss_pred             CCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCc
Q psy10603        209 PWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR  254 (407)
Q Consensus       209 Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R  254 (407)
                      ||...........     ....+. .+++..+++|..+|+.||.+|
T Consensus       249 Pf~~~~~~~~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9985322211000     112334 678899999999999999988

>KOG0606|consensus

Probab=99.90  E-value=6e-24  Score=214.01  Aligned_cols=221  Identities=32%  Similarity=0.438  Sum_probs=161.0

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++++-.+.|..|+||.||.++|+.+.+.+|+| +++++        .++|.  +|.....|.+|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~--------lilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN--------LILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc--------hhhhc--cccccCCccee----------------
Confidence            35667779999999999999999999999995 43221        12222  33333444444                


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC--
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT--  159 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~--  159 (407)
                           |+-..+++. .+.+|.+.        +.+++|||+-||+|||+||+|.||+.-| ++|++|||+++.......  
T Consensus       136 -----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccch
Confidence                 565555643 23355333        7889999999999999999999999865 699999999865321100  


Q ss_pred             ----------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC--C
Q psy10603        160 ----------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG--E  227 (407)
Q Consensus       160 ----------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~--~  227 (407)
                                ..-.-...||||.|+|||++..   .+|+..+|.|++|+|+||.+.|..||.+. ...+++-++...  .
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr---qgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~i~  276 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR---QGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIE  276 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhh---hccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhhcc
Confidence                      0011134589999999999965   45799999999999999999999999864 344444333322  2


Q ss_pred             CCCCCCccCHHHHHHHHHhcccCCCCcC---CHHHHhcCCeeee
Q psy10603        228 TPTIPESLSDEGQAFAELCLRHDPAQRA---TIFELLQHPFLIV  268 (407)
Q Consensus       228 ~~~~~~~~s~~~~~~i~~~l~~dp~~R~---t~~e~l~hp~~~~  268 (407)
                      .|.-.+.+++|+++++..+|+.+|..|.   .+.++.+|+||..
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            3333456889999999999999999994   5788899999863

>KOG1240|consensus

Probab=99.89  E-value=1.1e-23  Score=212.40  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=175.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ-NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.+...||.+.|=+|.+|++++ |. |+||++-++.. ..-+-.++.+.|++ ..-.++||++.+--+.+.+..-|||=+
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4455699999999999998875 54 88999875542 22222334455666 556789999998777666777788888


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |..+ +|.+.+.. +.-+...+-+.++.|++.||.-||..||+|+|||.+|||++.-+ -+.|+||..-+----....+.
T Consensus       102 yvkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  102 YVKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCcc
Confidence            8865 89888854 44477778888999999999999999999999999999999865 589999976533222222233


Q ss_pred             cccccccC----Ccccccccccccc-------cCC-CCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCC--
Q psy10603        163 ELNGFVGT----QAYMAPEVFMDTN-------KVG-HGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE--  227 (407)
Q Consensus       163 ~~~~~~gt----~~y~aPE~l~~~~-------~~~-~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~--  227 (407)
                      ..+-+-.|    ..|.|||.+....       ..+ .+++=||+|+||++.|+++ |++||.-    .|+ +....+.  
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL-~aYr~~~~~  253 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQL-LAYRSGNAD  253 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHH-HhHhccCcc
Confidence            33333333    3699999885421       111 4578899999999999987 6888852    111 1111111  


Q ss_pred             CCC--CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        228 TPT--IPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       228 ~~~--~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+.  +.+.-+...+.++..|++.||++|.++++.|+.
T Consensus       254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            110  001113357899999999999999999999874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.3e-22  Score=172.37  Aligned_cols=189  Identities=13%  Similarity=0.035  Sum_probs=133.6

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcH-HHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceEEEEEecCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-RFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ..|++|+||+||.+..  .+.+++.+.+........ -....+.+|+++|++|.| ++|++++++    +..+++|||+.
T Consensus         8 ~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          8 EPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             eeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            4799999999998754  567777776643221111 112257799999999965 789999886    44699999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEecCCCeEEEEcccCceecCCCCCC----
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI-KSANIFLTAEGNSLKLGDFGSAVKISAHTTV----  160 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdl-Kp~Nill~~~~~~vkl~DFGla~~~~~~~~~----  160 (407)
                      |.+|...+..       . ...++.|++.+|+++|++||+|||| ||+|||++.++ .++|+|||+|.........    
T Consensus        82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             CccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHH
Confidence            9998654321       1 1357889999999999999999999 79999998765 6999999999754432210    


Q ss_pred             C-Cccc-----ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q psy10603        161 P-GELN-----GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE  212 (407)
Q Consensus       161 ~-~~~~-----~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~  212 (407)
                      . ....     -...++.|++|+.-.-.... .-.+.+..+-|+-+|.++|++.|..+
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~-~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRT-SWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccc-hhHHHHHHHhcchHHHHHhccCCccc
Confidence            0 0000     01246778888754221111 12467888999999999999999864

>KOG4158|consensus

Probab=99.88  E-value=2.1e-22  Score=183.36  Aligned_cols=197  Identities=21%  Similarity=0.316  Sum_probs=146.3

Q ss_pred             CCCCCcceEEEEEEeC---------------------------ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHH
Q psy10603         59 INQKNLVKYYGVEIHR---------------------------EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQ  111 (407)
Q Consensus        59 l~hpniv~~~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~q  111 (407)
                      -+|||||++.++|.+.                           ..+|+||.-.+. +|..++....  .+....+-++.|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQ  349 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHH
Confidence            3599999998876532                           258999998875 9999986543  567778889999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCC---CeEEEEcccCceecCCCC---CCCCcccccccCCcccccccccccccC
Q psy10603        112 LVDAISALHENTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISAHT---TVPGELNGFVGTQAYMAPEVFMDTNKV  185 (407)
Q Consensus       112 i~~aL~yLH~~~iiHrdlKp~Nill~~~~---~~vkl~DFGla~~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~~  185 (407)
                      +++|+.|||++||.|||+|.+|||+.-+.   -.+.|+|||++-.-....   ...+.....-|.-.-||||+.....+.
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            99999999999999999999999985432   247899999874432211   111122334566778999987543221


Q ss_pred             C---CCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHH
Q psy10603        186 G---HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIF  258 (407)
Q Consensus       186 ~---~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~  258 (407)
                      .   .-.|+|.|+.|.+.||++...-||.......-..........|.+|+.+++.+++++..+|+.||++|++..
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            1   114899999999999999999999863322111222334567889999999999999999999999999854

>KOG1023|consensus

Probab=99.85  E-value=3e-21  Score=185.82  Aligned_cols=205  Identities=22%  Similarity=0.397  Sum_probs=156.8

Q ss_pred             HhcCCCCCcceEEEEEEeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCCE
Q psy10603         56 LEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI-VHRDIKSANI  134 (407)
Q Consensus        56 l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~i-iHrdlKp~Ni  134 (407)
                      |+.+.|.|+.+++|.+.+.+..++|.+||..|+|.+.+....-.++.--...+.++++.||.|||...| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999999999999997755567777788899999999999999876 9999999999


Q ss_pred             EEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCC----CCcchhHHHHHHHHHHHHcCCCCC
Q psy10603        135 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG----HGRAVDIWSLGCVLVEMSSGKRPW  210 (407)
Q Consensus       135 ll~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~----~~~~~DiwSlGv~l~em~~g~~Pf  210 (407)
                      +++.. ..+||+|||+....... ..........-..-|.|||++.......    -+.+.|+||+|++++|+++.+.||
T Consensus        81 lvd~~-w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSR-WVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeee-EEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            99875 57999999998655321 0001111112345699999997642222    356899999999999999999999


Q ss_pred             CCCCch---HHHHHHHhC-CCC---CCCCC--ccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        211 AEYDSN---YQIMFKVGM-GET---PTIPE--SLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       211 ~~~~~~---~~~~~~~~~-~~~---~~~~~--~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ......   .+++.++.. +..   |.++.  ...++...++..||..+|.+||++.++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            853322   234444444 332   33321  34557888999999999999999988643

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=6.8e-21  Score=171.21  Aligned_cols=142  Identities=18%  Similarity=0.192  Sum_probs=108.3

Q ss_pred             eeeecccccCeEEEEEE-ECCCCcEEEEEEEeccccC-------------------cH-H-HHHHHHHHHHHHhcCCCC-
Q psy10603          6 FSVSPGQGRFGKVYTAV-NNETGELVAMKEIQLHKQN-------------------DA-R-FVKDMLVELRILEGINQK-   62 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~-~~~~~~~vAvK~i~~~~~~-------------------~~-~-~~~~~~~E~~~l~~l~hp-   62 (407)
                      ....||+|+||.||+|. +..+|+.||+|+++.....                   +. + ....+.+|+.++.++.+. 
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34589999999999998 7788999999998754211                   00 0 113356899999999763 


Q ss_pred             -CcceEEEEEEeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEecCC
Q psy10603         63 -NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT-IVHRDIKSANIFLTAEG  140 (407)
Q Consensus        63 -niv~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~-iiHrdlKp~Nill~~~~  140 (407)
                       .+.+.++.    ...++||||+++++|...... ...+.+..+..++.|++.+|.+||++| |+||||||+||+++ + 
T Consensus       112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~-  184 (237)
T smart00090      112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D-  184 (237)
T ss_pred             CCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C-
Confidence             33444442    235899999999888765422 233566677899999999999999999 99999999999998 3 


Q ss_pred             CeEEEEcccCceec
Q psy10603        141 NSLKLGDFGSAVKI  154 (407)
Q Consensus       141 ~~vkl~DFGla~~~  154 (407)
                      +.++|+|||.+...
T Consensus       185 ~~i~LiDFg~a~~~  198 (237)
T smart00090      185 GKVVIIDVSQSVEL  198 (237)
T ss_pred             CCEEEEEChhhhcc
Confidence            46999999998543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.1e-20  Score=167.68  Aligned_cols=136  Identities=18%  Similarity=0.195  Sum_probs=111.5

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-----RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .||+|++|.||+|.+  .|..+++|+.........     ....++.+|+.++..++|++|.....++...+..+++|||
T Consensus         3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            689999999999987  577899997654322211     1224578899999999999987777666677788999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      ++|++|.+++...    .. ....++.+++.+|.++|+.+++|||++|+|||++ + +.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence            9999999988642    22 7788999999999999999999999999999998 3 4699999998854

>KOG1166|consensus

Probab=99.84  E-value=5.6e-21  Score=196.12  Aligned_cols=191  Identities=25%  Similarity=0.375  Sum_probs=152.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCceEEEEEe
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN---QKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ....||+|+||+||+|.+.. |+.||+|+=++....+      |..-.+++.+|+   -+-|..+..++...+.-+||+|
T Consensus       702 I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  702 ISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             EEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            34589999999999999887 9999999765543322      223345555665   2456666677778888999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC------CCeEEEEcccCceecCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE------GNSLKLGDFGSAVKISA  156 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~------~~~vkl~DFGla~~~~~  156 (407)
                      |.+.|+|.+++. ..+.+++..+..+..|++.-++.||..+|||+||||+|.||...      ...++|+|||.+..+..
T Consensus       775 y~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  775 YSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             ccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            999999999997 45669999999999999999999999999999999999998532      23599999999977653


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCC
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR  208 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~  208 (407)
                      .... ...+..++|-.+-.+|...+   .++++.+|.|.|..+++.|+.|+.
T Consensus       854 fp~~-~~F~~~~~td~f~C~EM~~g---rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  854 FPDG-TKFKAVWHTDLFDCIEMREG---RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cCCC-cEEeeeeccccchhHHHhcC---CCCchhhhhHHHHHHHHHHHHHHH
Confidence            3221 23456788999999998754   457889999999999999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=2.9e-20  Score=163.56  Aligned_cols=133  Identities=18%  Similarity=0.226  Sum_probs=104.7

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCc-----HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND-----ARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .||+|+||+||+|..  ++..+++|.........     .....++.+|++++..++|+++......+...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999984  56789999865332111     11235677899999999988765544445566678999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      ++|++|.+++....     .   .++.|++.+|.+||+.|++|||++|+||+++ + ..++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~-----~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-----H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence            99999998874421     1   7889999999999999999999999999998 3 4699999999855

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033|consensus

Probab=99.83  E-value=2.3e-21  Score=183.35  Aligned_cols=209  Identities=25%  Similarity=0.377  Sum_probs=147.0

Q ss_pred             HHHHHHHHHHHhcCCCCCcceEEE-------EEE-----eCceEEEEEecCCCCCHHHHHhhcC--CCCCHHHHHHHHHH
Q psy10603         46 VKDMLVELRILEGINQKNLVKYYG-------VEI-----HREEMVLFMELCTEGTLESLVQSTE--DGLPEVLVRRYTKQ  111 (407)
Q Consensus        46 ~~~~~~E~~~l~~l~hpniv~~~~-------~~~-----~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~~q  111 (407)
                      .....+++-.+....|-+..-+.+       ...     ....+||.|++|...+|.+++...+  ...+......++.|
T Consensus       288 ~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q  367 (516)
T KOG1033|consen  288 CKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQ  367 (516)
T ss_pred             hhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHh
Confidence            344555665555555544333333       111     1235899999999999999996432  33677788999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC---CCCcccccccCCcccccccccccccCCCC
Q psy10603        112 LVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT---VPGELNGFVGTQAYMAPEVFMDTNKVGHG  188 (407)
Q Consensus       112 i~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  188 (407)
                      +..|++|   ++.+|||+||.||+...+. .+||.|||+.........   .....+.-+||+.||+||.+.+   ..|+
T Consensus       368 ~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g---~~y~  440 (516)
T KOG1033|consen  368 IAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG---QQYS  440 (516)
T ss_pred             hccchhh---ccchhhhccccccccccch-hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh---hhhh
Confidence            9999999   9999999999999998764 699999999877654431   1223466789999999999965   3478


Q ss_pred             cchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCC-CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        189 RAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT-IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       189 ~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      .++||||||++|+|++. =..+|.    ....+..+..+..|+ +... -++...|+..+|.+.|.+||++.+.-.|+|.
T Consensus       441 ~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  441 EKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            99999999999999997 233332    122222333333332 1112 2345679999999999999988777666653

>KOG0601|consensus

Probab=99.82  E-value=1.8e-20  Score=180.43  Aligned_cols=345  Identities=27%  Similarity=0.265  Sum_probs=242.9

Q ss_pred             eeeccc--ccCeEEEEEEE--CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEE
Q psy10603          7 SVSPGQ--GRFGKVYTAVN--NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         7 ~~~iG~--G~~g~V~~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ...+|.  |.+|.||.+..  ..++..+|+|.-+... .......+=.+|+...++++ |+|.++.+..+...+..|+-+
T Consensus       119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt  197 (524)
T KOG0601|consen  119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT  197 (524)
T ss_pred             ccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence            347888  99999999998  8899999998732211 11111122346676666664 799999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD----AISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~----aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |+|. .+|..+.......+|+..++..+.+...    ||.++|+.+++|-|+||.||+...+...++++|||+...+...
T Consensus       198 E~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~  276 (524)
T KOG0601|consen  198 ELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDG  276 (524)
T ss_pred             cccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCC
Confidence            9996 6888887665556899999999999999    9999999999999999999999887567999999999887654


Q ss_pred             CCCC--CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CchHHHHHHHhCCC-CCCCC
Q psy10603        158 TTVP--GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY--DSNYQIMFKVGMGE-TPTIP  232 (407)
Q Consensus       158 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~--~~~~~~~~~~~~~~-~~~~~  232 (407)
                      ....  .......|...|++||++.+    -++.+.|++|+|-++.+..++..+....  ....+.    ..+. ...+-
T Consensus       277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~----l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~----r~~~ip~e~~  348 (524)
T KOG0601|consen  277 NFSSVFKVSKRPEGDCIYAAKELLNG----LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL----RQGYIPLEFC  348 (524)
T ss_pred             ccccceeeeecCCCCceEeChhhhcc----ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc----ccccCchhhh
Confidence            3211  11122256678999999854    2578999999999999999887766432  111111    0111 11122


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeeecCCcCCCCCCCchhhHHhhhhcCccCCCCCcccccc-cCCccE
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKV-YARANI  311 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~p~~~~~~~l~~~~~~~~~s~~~i~~-~~~~ni  311 (407)
                      ...+.++...+..+++.||-.|+++..++.|+++...                               .-++. -.+.|+
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~-------------------------------~~~~~d~~psni  397 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK-------------------------------LFVHLDVKPSNI  397 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch-------------------------------hhhcccccccce
Confidence            3445666678899999999999999999999986310                               01111 234577


Q ss_pred             EEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       312 ll~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      ++.+++...++.|||++..+.-..  ..   ...+.+.|-..|+++.  .+.+..++|++|+|..+.|..+|.++-...+
T Consensus       398 ~i~~~~~~~~~~~~~~~t~~~~~~--~~---~~~~~r~~p~~~~~~e--~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~  470 (524)
T KOG0601|consen  398 LISNDGFFSKLGDFGCWTRLAFSS--GV---FHHIDRLYPIAEILLE--DYPHLSKADIFSLGLSVDEAITGSPLSESGV  470 (524)
T ss_pred             eeccchhhhhccccccccccceec--cc---ccccccccccchhhcc--ccccccccccccccccccccccCcccCcccc
Confidence            777765558899999985421100  00   1123333413455442  2345788999999999999999999888766


Q ss_pred             eeeEEEec
Q psy10603        392 VSAEVFGS  399 (407)
Q Consensus       392 ~~~~~~~~  399 (407)
                      ....++-+
T Consensus       471 ~~~~i~~~  478 (524)
T KOG0601|consen  471 QSLTIRSG  478 (524)
T ss_pred             cceeeecc
Confidence            66666543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.5e-19  Score=157.46  Aligned_cols=136  Identities=18%  Similarity=0.196  Sum_probs=104.1

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH-------------------HHHHHHHHHHHHHhcCCCCC--cc
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-------------------RFVKDMLVELRILEGINQKN--LV   65 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hpn--iv   65 (407)
                      ...||+|+||.||+|.+. +|+.+|||++......-.                   .......+|..++..+.|++  +.
T Consensus        20 ~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~   98 (198)
T cd05144          20 GNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVP   98 (198)
T ss_pred             CCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCC
Confidence            347999999999999875 799999999765321100                   01123567889999888874  44


Q ss_pred             eEEEEEEeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEE
Q psy10603         66 KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKL  145 (407)
Q Consensus        66 ~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl  145 (407)
                      ..++    ....++||||++|++|..+...       .....++.+++.++.++|+.||+||||||+||+++.+ +.++|
T Consensus        99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~~~l  166 (198)
T cd05144          99 KPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EKIYI  166 (198)
T ss_pred             ceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-CcEEE
Confidence            4443    2456899999999999765421       3456788999999999999999999999999999875 47999


Q ss_pred             EcccCceecC
Q psy10603        146 GDFGSAVKIS  155 (407)
Q Consensus       146 ~DFGla~~~~  155 (407)
                      +|||++....
T Consensus       167 iDfg~~~~~~  176 (198)
T cd05144         167 IDWPQMVSTD  176 (198)
T ss_pred             EECCccccCC
Confidence            9999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=4.1e-19  Score=178.99  Aligned_cols=134  Identities=18%  Similarity=0.208  Sum_probs=106.7

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-----DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ..||+|+||+||+|.+...  .+++|+.......     +....+++.+|+++++.++|++++....++...+..++|||
T Consensus       339 ~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        339 HLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             ceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            4799999999999987544  3444443221111     11223568899999999999999887777777777899999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceec
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI  154 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~  154 (407)
                      |+++++|.+++.         ....++.|++.+|.|||+.|++||||||+|||++ + +.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence            999999998874         3467899999999999999999999999999994 3 46999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=2e-18  Score=150.24  Aligned_cols=138  Identities=22%  Similarity=0.269  Sum_probs=96.8

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHH---------------------HHHHHHHHHhcCCCCC--c
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVK---------------------DMLVELRILEGINQKN--L   64 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~E~~~l~~l~hpn--i   64 (407)
                      ..||+|+||+||+|.+. +++.||||++............                     ....|...+..+.+..  +
T Consensus         3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46999999999999877 8999999998754322111111                     0124555565554432  4


Q ss_pred             ceEEEEEEeCceEEEEEecCCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCe
Q psy10603         65 VKYYGVEIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNS  142 (407)
Q Consensus        65 v~~~~~~~~~~~~~lv~E~~~~g~L~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~  142 (407)
                      .+.++.    ...++||||++++.+.. .+....  . ...+..++.+++.++.++|+ .+|+||||||+||+++ + +.
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~  152 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GK  152 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-Cc
Confidence            444443    24689999999955421 121111  1 15678899999999999999 9999999999999998 4 46


Q ss_pred             EEEEcccCceecC
Q psy10603        143 LKLGDFGSAVKIS  155 (407)
Q Consensus       143 vkl~DFGla~~~~  155 (407)
                      ++|+|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=1.2e-17  Score=150.44  Aligned_cols=138  Identities=18%  Similarity=0.232  Sum_probs=104.4

Q ss_pred             eeecc-cccCeEEEEEEECCCCcEEEEEEEecccc----------CcHHHHHHHHHHHHHHhcCCCCCc--ceEEEEEEe
Q psy10603          7 SVSPG-QGRFGKVYTAVNNETGELVAMKEIQLHKQ----------NDARFVKDMLVELRILEGINQKNL--VKYYGVEIH   73 (407)
Q Consensus         7 ~~~iG-~G~~g~V~~~~~~~~~~~vAvK~i~~~~~----------~~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~   73 (407)
                      .+.|| .||.|+||.+...  +..+++|.+.....          .+.....++.+|+.++..++|++|  +..++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35788 8999999999764  67899998753210          011233567889999999998875  566665433


Q ss_pred             Cc----eEEEEEecCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcc
Q psy10603         74 RE----EMVLFMELCTE-GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDF  148 (407)
Q Consensus        74 ~~----~~~lv~E~~~~-g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DF  148 (407)
                      +.    ..++|||+++| .+|.+++..  ..+++..    +.|++.+|.+||++||+||||||+|||++.++ .++|+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDf  186 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDF  186 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEEC
Confidence            22    23599999997 689888854  2355543    56899999999999999999999999998754 6999999


Q ss_pred             cCcee
Q psy10603        149 GSAVK  153 (407)
Q Consensus       149 Gla~~  153 (407)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98744

>KOG0591|consensus

Probab=99.69  E-value=1.4e-17  Score=145.76  Aligned_cols=78  Identities=46%  Similarity=0.708  Sum_probs=66.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.+|. +|++||||++.+....+   .....+|||.||+||.++..   +|+.++||||+||++|||+.-++
T Consensus       154 IKPaNIFl~~~gv-vKLGDfGL~r~l~s~~t---fA~S~VGTPyYMSPE~i~~~---~Y~~kSDiWslGCllyEMcaL~~  226 (375)
T KOG0591|consen  154 IKPANIFLTANGV-VKLGDFGLGRFLSSKTT---FAHSLVGTPYYMSPERIHES---GYNFKSDIWSLGCLLYEMCALQS  226 (375)
T ss_pred             CcchheEEcCCCc-eeeccchhHhHhcchhH---HHHhhcCCCcccCHHHHhcC---CCCcchhHHHHHHHHHHHHhcCC
Confidence            5788999999886 99999999987754332   23467999999999999754   45789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.|-
T Consensus       227 PF~g~  231 (375)
T KOG0591|consen  227 PFYGD  231 (375)
T ss_pred             Ccccc
Confidence            99985

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2.7e-16  Score=131.27  Aligned_cols=130  Identities=21%  Similarity=0.190  Sum_probs=107.0

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCceEEEEEecCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ--KNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ..||+|.++.||++....  ..+++|.......     ...+.+|+.+++.++|  +++++++......+..+++|||++
T Consensus         4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             eecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            468999999999998754  6799998754322     3457789999998877  588999888887788999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN---TIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      ++.+..+        +......++.+++.+|.++|..   +++|+|+||+||+++.. +.++++|||.+..
T Consensus        77 g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence            8877543        4556677889999999999985   69999999999999874 5799999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0616|consensus

Probab=99.68  E-value=4.4e-17  Score=143.58  Aligned_cols=121  Identities=32%  Similarity=0.541  Sum_probs=85.3

Q ss_pred             HHHhcCCeeeeecCCcCCCC------CCCchhhHHhhhhcCccCCCCCcccccccC---------------------Ccc
Q psy10603        258 FELLQHPFLIVSCEEDVCNP------RSVPASVLQDYLKLGIVLPPMSEDSVKVYA---------------------RAN  310 (407)
Q Consensus       258 ~e~l~hp~~~~~~~~~~~~~------~~~p~~~~~~~l~~~~~~~~~s~~~i~~~~---------------------~~n  310 (407)
                      ...+.|||++.-.....+..      ..++...+..++..   ..++++..+++|+                     ++|
T Consensus        98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPEN  174 (355)
T KOG0616|consen   98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN  174 (355)
T ss_pred             HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence            44566888764332222211      11223333333332   2356677777764                     579


Q ss_pred             EEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCC
Q psy10603        311 IFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGV  390 (407)
Q Consensus       311 ill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~  390 (407)
                      +|++.+|. +||.|||+|++...      .+.+.||||.|+|||++...   +++.++|+||||+++|||+.|.+||.+-
T Consensus       175 iLlD~~G~-iKitDFGFAK~v~~------rT~TlCGTPeYLAPEii~sk---~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  175 LLLDQNGH-IKITDFGFAKRVSG------RTWTLCGTPEYLAPEIIQSK---GYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             eeeccCCc-EEEEeccceEEecC------cEEEecCCccccChHHhhcC---CCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            99999997 99999999987643      23457999999999999653   4688999999999999999999999864


Q ss_pred             c
Q psy10603        391 V  391 (407)
Q Consensus       391 ~  391 (407)
                      .
T Consensus       245 ~  245 (355)
T KOG0616|consen  245 N  245 (355)
T ss_pred             C
Confidence            3

>KOG0593|consensus

Probab=99.67  E-value=3.5e-17  Score=144.62  Aligned_cols=79  Identities=37%  Similarity=0.665  Sum_probs=67.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +|+||||+|+.+..+...   ++.++.|++|+|||++.+...  |+.++||||+||++.||++|++
T Consensus       127 IKPENILit~~gv-vKLCDFGFAR~L~~pgd~---YTDYVATRWYRaPELLvGDtq--YG~pVDiWAiGCv~aEl~~G~p  200 (396)
T KOG0593|consen  127 IKPENILITQNGV-VKLCDFGFARTLSAPGDN---YTDYVATRWYRAPELLVGDTQ--YGKPVDIWAIGCVFAELLTGEP  200 (396)
T ss_pred             CChhheEEecCCc-EEeccchhhHhhcCCcch---hhhhhhhhhccChhhhcccCc--CCCcccchhhhHHHHHHhcCCc
Confidence            5688999999987 999999999987654443   345799999999999987543  5899999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      +|+|-
T Consensus       201 L~PG~  205 (396)
T KOG0593|consen  201 LWPGR  205 (396)
T ss_pred             CCCCc
Confidence            99974

>KOG0598|consensus

Probab=99.66  E-value=6.1e-17  Score=147.14  Aligned_cols=77  Identities=39%  Similarity=0.645  Sum_probs=63.8

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|+|++.+|+ ++++||||++..-..   .....++|||+.|||||++++.   +++..+|+||+||++|||++|.+|
T Consensus       152 KPENILLd~~GH-i~LtDFgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~---gy~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  152 KPENILLDEQGH-IKLTDFGLCKEDLKD---GDATRTFCGTPEYMAPEILLGK---GYDKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             CHHHeeecCCCc-EEEeccccchhcccC---CCccccccCCccccChHHHhcC---CCCcccchHhHHHHHHHHhhCCCC
Confidence            468999999987 999999999743221   1224457999999999999865   467899999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |.+=
T Consensus       225 F~~~  228 (357)
T KOG0598|consen  225 FYAE  228 (357)
T ss_pred             CcCc
Confidence            9864

>KOG0658|consensus

Probab=99.63  E-value=2.1e-16  Score=143.38  Aligned_cols=89  Identities=27%  Similarity=0.514  Sum_probs=72.6

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|+|++.+.+.+||||||.|+.+..+..    ...+++|++|+|||++.+...  |+.++||||.|||+.||+-|+++
T Consensus       152 KPqNlLvD~~tg~LKicDFGSAK~L~~~ep----niSYicSRyYRaPELifga~~--Yt~~IDiWSaGCV~aELl~g~pl  225 (364)
T KOG0658|consen  152 KPQNLLVDPDTGVLKICDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVMAELLKGQPL  225 (364)
T ss_pred             ChheEEEcCCCCeEEeccCCcceeeccCCC----ceeEEEeccccCHHHHcCccc--cCceeEEhhhhHHHHHHhcCCcc
Confidence            578999999988899999999987754332    235789999999999987654  57899999999999999999999


Q ss_pred             CCCCc------eeeEEEecCc
Q psy10603        387 LSGVV------VSAEVFGSGG  401 (407)
Q Consensus       387 ~~~~~------~~~~~~~~~~  401 (407)
                      |+|-.      -++.+||+++
T Consensus       226 FpG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  226 FPGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             cCCCCHHHHHHHHHHHhCCCC
Confidence            99732      2445666653

>KOG0660|consensus

Probab=99.62  E-value=2.6e-16  Score=142.58  Aligned_cols=83  Identities=35%  Similarity=0.635  Sum_probs=68.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.+.. +||+|||+|+..... ......+.++.|++|+|||+++...  .|+.++||||+||++.||++|++
T Consensus       151 LKPsNll~n~~c~-lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~--~Yt~aiDiWSvGCI~AEmL~gkp  226 (359)
T KOG0660|consen  151 LKPSNLLLNADCD-LKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSS--EYTKAIDIWSVGCILAEMLTGKP  226 (359)
T ss_pred             cchhheeeccCCC-EEeccccceeecccc-CcccchhcceeeeeecCHHHHhccc--cccchhhhhhhhHHHHHHHcCCC
Confidence            4567999988876 999999999876543 2333446679999999999997654  46889999999999999999999


Q ss_pred             CCCCCce
Q psy10603        386 NLSGVVV  392 (407)
Q Consensus       386 ~~~~~~~  392 (407)
                      +|+|...
T Consensus       227 lFpG~d~  233 (359)
T KOG0660|consen  227 LFPGKDY  233 (359)
T ss_pred             CCCCCch
Confidence            9999764

>KOG1035|consensus

Probab=99.62  E-value=1.1e-14  Score=149.46  Aligned_cols=204  Identities=24%  Similarity=0.374  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEEeCce----EEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy10603         46 VKDMLVELRILEGINQKNLVKYYGVEIHREE----MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE  121 (407)
Q Consensus        46 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~  121 (407)
                      ......|+..+.+..|+|++.++.+...+..    ..+..|+|..-++...+++. ..++..+.+.+..++++||.|+|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHH
Confidence            3444567888899999999999988765432    23456889999998888763 448899999999999999999999


Q ss_pred             CCceecCCCCC---CEEEecCCCeEEEE--cccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHH
Q psy10603        122 NTIVHRDIKSA---NIFLTAEGNSLKLG--DFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL  196 (407)
Q Consensus       122 ~~iiHrdlKp~---Nill~~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSl  196 (407)
                      ....|.-+..+   +-..+.++ .+..+  ||+.++........    ....-+..+.+||.+... ....+...|+|.+
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKEN-TAKKSRLTDLWCL  378 (1351)
T ss_pred             hccceeEEecccccccccCccc-eeecchhhhcccccCCCcccc----hhhcCccccccccccccc-cchhhhhhHHHHH
Confidence            86555544443   22233332 34555  77776554432211    112334567788876432 2222445799999


Q ss_pred             HHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        197 GCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       197 Gv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |.....+..|..+-......           ...++.....+..+...+|+.-|+++|+.+.+++.|+|..
T Consensus       379 gll~~~~~~~~~i~~~~~~~-----------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAVP-----------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             HHHHhhhhhcCcccccccch-----------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            99999998886553211111           0011111222677888999999999999999999999864

>KOG4721|consensus

Probab=99.60  E-value=3.6e-16  Score=148.61  Aligned_cols=86  Identities=37%  Similarity=0.628  Sum_probs=73.1

Q ss_pred             CccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       308 ~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      .-|+|++.++- +||+|||.++....-.    ..+.++||..|||||+++..   +.+.++|||||||||+||+||+.||
T Consensus       240 SPNiLIs~~d~-VKIsDFGTS~e~~~~S----TkMSFaGTVaWMAPEvIrne---PcsEKVDIwSfGVVLWEmLT~EiPY  311 (904)
T KOG4721|consen  240 SPNILISYDDV-VKISDFGTSKELSDKS----TKMSFAGTVAWMAPEVIRNE---PCSEKVDIWSFGVVLWEMLTGEIPY  311 (904)
T ss_pred             CCceEeeccce-EEeccccchHhhhhhh----hhhhhhhhHhhhCHHHhhcC---CcccccceehhHHHHHHHHhcCCCc
Confidence            46999988775 9999999997554321    24568999999999999643   3578999999999999999999999


Q ss_pred             CCCceeeEEEecCc
Q psy10603        388 SGVVVSAEVFGSGG  401 (407)
Q Consensus       388 ~~~~~~~~~~~~~~  401 (407)
                      +.|++.|-+||++.
T Consensus       312 kdVdssAIIwGVGs  325 (904)
T KOG4721|consen  312 KDVDSSAIIWGVGS  325 (904)
T ss_pred             cccchheeEEeccC
Confidence            99999999999875

>KOG0661|consensus

Probab=99.60  E-value=3.3e-16  Score=146.25  Aligned_cols=89  Identities=28%  Similarity=0.559  Sum_probs=74.3

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|+|+..+.- +||+|||+||.+....    .++.++.|++|+|||++++...  |+.++|+||+||+++|+.+-+++
T Consensus       137 KPENiLi~~~~~-iKiaDFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~--Ys~pvD~wA~GcI~aEl~sLrPL  209 (538)
T KOG0661|consen  137 KPENILISGNDV-IKIADFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGY--YSSPVDMWAVGCIMAELYSLRPL  209 (538)
T ss_pred             ChhheEecccce-eEecccccccccccCC----CcchhhhcccccchHHhhhccc--cCCchHHHHHHHHHHHHHHhccc
Confidence            468999987654 9999999998765322    3456799999999999987654  57899999999999999999999


Q ss_pred             CCCCc------eeeEEEecCce
Q psy10603        387 LSGVV------VSAEVFGSGGW  402 (407)
Q Consensus       387 ~~~~~------~~~~~~~~~~~  402 (407)
                      |+|..      -+.+|+|+++|
T Consensus       210 FPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  210 FPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             CCCCcHHHHHHHHHHHhCCCcc
Confidence            99964      46788999887

>KOG0667|consensus

Probab=99.59  E-value=7.9e-16  Score=149.36  Aligned_cols=135  Identities=28%  Similarity=0.485  Sum_probs=91.9

Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeeeeecCCcCCCCCCCchhhHHhhhhcCccCCCCCccccccc---------------
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVY---------------  306 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~p~~~~~~~l~~~~~~~~~s~~~i~~~---------------  306 (407)
                      ++..+-+.||+.-..+-.++++-.+    ....|---.+....+.++++.+-..+ ++...++.+               
T Consensus       235 iL~~ln~~d~~~~~n~Vrm~d~F~f----r~HlciVfELL~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~  309 (586)
T KOG0667|consen  235 ILELLNKHDPDDKYNIVRMLDYFYF----RNHLCIVFELLSTNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG  309 (586)
T ss_pred             HHHHHhccCCCCCeeEEEeeecccc----ccceeeeehhhhhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4555556888877665555543332    22333334445566677766554333 333333332               


Q ss_pred             ------CCccEEEecC-CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        307 ------ARANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       307 ------~~~nill~~~-~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                            +++|||+-.. ...+|++|||+|......      ...++.+++|+|||++++..   |+.++|+||||||+.|
T Consensus       310 IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~------vytYiQSRfYRAPEVILGlp---Y~~~IDmWSLGCIlAE  380 (586)
T KOG0667|consen  310 IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR------VYTYIQSRFYRAPEVILGLP---YDTAIDMWSLGCILAE  380 (586)
T ss_pred             eeeccCChhheeeccCCcCceeEEecccccccCCc------ceeeeeccccccchhhccCC---CCCccceeehhhhHHh
Confidence                  4689988543 347999999999654321      23578999999999999764   5789999999999999


Q ss_pred             HHhCCCCCCCC
Q psy10603        380 MSSGKTNLSGV  390 (407)
Q Consensus       380 ~~~g~~~~~~~  390 (407)
                      |++|.++|+|-
T Consensus       381 L~tG~PLfpG~  391 (586)
T KOG0667|consen  381 LFTGEPLFPGD  391 (586)
T ss_pred             HhcCccccCCC
Confidence            99999999984

>KOG0606|consensus

Probab=99.58  E-value=4.8e-16  Score=157.61  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=182.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .+-.|+++.++.+.-..+|-..+.|+..+.........+...++-.++-...+|-++.....+......+|+++|+.+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            67778899999887777775556665432211111112233344444444556777766666666778999999999999


Q ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC------------
Q psy10603         89 LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA------------  156 (407)
Q Consensus        89 L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~------------  156 (407)
                      |...++.. +....+-++.+...+..+++|||+..+.|||+||.|+|+..++ ..+++|||.......            
T Consensus       891 ~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~  968 (1205)
T KOG0606|consen  891 LPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGLIPPTTDLSGPSS  968 (1205)
T ss_pred             chhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccccccccccccCcCCcccccc
Confidence            99988753 3477778888999999999999999999999999999998765 589999984432110            


Q ss_pred             ---------CCCCC-------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH
Q psy10603        157 ---------HTTVP-------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM  220 (407)
Q Consensus       157 ---------~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~  220 (407)
                               ....+       .......||+.|.+||.+.+.   ..+..+|.|+.|++++|.++|.+||... ...++.
T Consensus       969 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~---~hgs~ad~~~~g~~l~e~l~g~pp~na~-tpq~~f 1044 (1205)
T KOG0606|consen  969 SGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR---RHGSAADWWSSGVCLFEVLTGIPPFNAE-TPQQIF 1044 (1205)
T ss_pred             cCccccccccccccccccchhhccccccCCCcccCCcccccc---cCCCcchhhhhhhhhhhhhcCCCCCCCc-chhhhh
Confidence                     00000       011235689999999998663   3578999999999999999999999853 333333


Q ss_pred             HHHhCCC--CCCCCCccCHHHHHHHHHhcccCCCCcCCHH---HHhcCCeee
Q psy10603        221 FKVGMGE--TPTIPESLSDEGQAFAELCLRHDPAQRATIF---ELLQHPFLI  267 (407)
Q Consensus       221 ~~~~~~~--~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~---e~l~hp~~~  267 (407)
                      ..+..+.  .|..+...+.++++++.+.|..+|.+|..+.   ++..|+|+.
T Consensus      1045 ~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1045 ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQ 1096 (1205)
T ss_pred             hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccC
Confidence            3333322  2334567899999999999999999999887   888999985

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=2.6e-15  Score=148.47  Aligned_cols=142  Identities=19%  Similarity=0.203  Sum_probs=93.9

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccC--------------------------c-----HHHHHHHH------
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--------------------------D-----ARFVKDML------   50 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--------------------------~-----~~~~~~~~------   50 (407)
                      ..||.|++|.||+|+...+|+.||||++++....                          +     .++.+.+.      
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            3899999999999999988999999999754210                          0     01222233      


Q ss_pred             HHHHHHhcC----CCCCcceEEEEEEe-CceEEEEEecCCCCCHHHHHhhcCCC-----CCHHHHHHHHHHHHHHHHHHH
Q psy10603         51 VELRILEGI----NQKNLVKYYGVEIH-REEMVLFMELCTEGTLESLVQSTEDG-----LPEVLVRRYTKQLVDAISALH  120 (407)
Q Consensus        51 ~E~~~l~~l----~hpniv~~~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~~~~-----~~~~~~~~~~~qi~~aL~yLH  120 (407)
                      +|...+.++    .+.+.+.+-.++.+ ....+|||||+.|+.+.++-.-...+     +.+..+..++.|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            333333332    24333433333322 34578999999999998753211222     3344455555555       4


Q ss_pred             hCCceecCCCCCCEEEecCC---CeEEEEcccCceecCC
Q psy10603        121 ENTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISA  156 (407)
Q Consensus       121 ~~~iiHrdlKp~Nill~~~~---~~vkl~DFGla~~~~~  156 (407)
                      ..|++|+|+||.||+++.++   ..++++|||++..++.
T Consensus       278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            68999999999999998764   2699999999987654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=1.4e-14  Score=141.69  Aligned_cols=143  Identities=23%  Similarity=0.260  Sum_probs=95.1

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccC----cH---------------------------HHHH------HHH
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DA---------------------------RFVK------DML   50 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~----~~---------------------------~~~~------~~~   50 (407)
                      ..||.|++|.||+|+.. +|+.||||+.++....    |-                           ++..      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            48999999999999865 6899999998654210    00                           0000      133


Q ss_pred             HHHHHHhcC----CCCCcceEEEEEE-eCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q psy10603         51 VELRILEGI----NQKNLVKYYGVEI-HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD-AISALHENTI  124 (407)
Q Consensus        51 ~E~~~l~~l----~hpniv~~~~~~~-~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~-aL~yLH~~~i  124 (407)
                      +|.+.+.++    ++.+-+.+-..+. .....+|||||++|++|.++......+.+   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            454444433    3333233222221 23457999999999999887653222232   2345555555 4778999999


Q ss_pred             eecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603        125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus       125 iHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      +|+|+||.||+++.++ .++++|||++..+.
T Consensus       279 ~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            9999999999998764 69999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0694|consensus

Probab=99.56  E-value=3e-15  Score=145.74  Aligned_cols=76  Identities=36%  Similarity=0.615  Sum_probs=63.7

Q ss_pred             ccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCC
Q psy10603        309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLS  388 (407)
Q Consensus       309 ~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~  388 (407)
                      .|+|++.+|+ +||+|||+++.-   .-....+.++|||+.|||||++...   .|+.++|+|||||++|||+.|++||+
T Consensus       497 dNiLLD~eGh-~kiADFGlcKe~---m~~g~~TsTfCGTpey~aPEil~e~---~Yt~aVDWW~lGVLlyeML~Gq~PF~  569 (694)
T KOG0694|consen  497 DNLLLDTEGH-VKIADFGLCKEG---MGQGDRTSTFCGTPEFLAPEVLTEQ---SYTRAVDWWGLGVLLYEMLVGESPFP  569 (694)
T ss_pred             hheEEcccCc-EEeccccccccc---CCCCCccccccCChhhcChhhhccC---cccchhhHHHHHHHHHHHHcCCCCCC
Confidence            6999999987 999999999742   1112235678999999999999764   36789999999999999999999999


Q ss_pred             CCc
Q psy10603        389 GVV  391 (407)
Q Consensus       389 ~~~  391 (407)
                      |-+
T Consensus       570 gdd  572 (694)
T KOG0694|consen  570 GDD  572 (694)
T ss_pred             CCC
Confidence            864

>KOG0983|consensus

Probab=99.55  E-value=3.3e-15  Score=130.44  Aligned_cols=78  Identities=36%  Similarity=0.579  Sum_probs=66.1

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|||++..|+ +|+||||.+.++.....    ++...|++.|||||.+...+...|..++||||||++++|++||+-|
T Consensus       219 KPSNILlDe~Gn-iKlCDFGIsGrlvdSkA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yP  293 (391)
T KOG0983|consen  219 KPSNILLDERGN-IKLCDFGISGRLVDSKA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYP  293 (391)
T ss_pred             CccceEEccCCC-EEeecccccceeecccc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCC
Confidence            578999999987 99999999987653222    3345799999999999776566678899999999999999999999


Q ss_pred             CCC
Q psy10603        387 LSG  389 (407)
Q Consensus       387 ~~~  389 (407)
                      |+|
T Consensus       294 y~~  296 (391)
T KOG0983|consen  294 YKG  296 (391)
T ss_pred             CCC
Confidence            998

>KOG0601|consensus

Probab=99.55  E-value=3.7e-15  Score=144.02  Aligned_cols=249  Identities=22%  Similarity=0.261  Sum_probs=182.3

Q ss_pred             ccceeeecccccCeEEEEEEEC-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +++.-..||.|.|+.|+.+.-+ .++..|++|.+..........+ .-+.|+.+...+ .|.+++.++..+......|+-
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            3455569999999999988655 7788999998765443332222 234566665554 478999998888877788899


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      .|||.++++...+. ....+.+...+.+..|++.++.++|+...+|+|+||+||++..++...++.|||+...+....  
T Consensus       345 ~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--  421 (524)
T ss_pred             hhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec--
Confidence            99999999876653 233478888999999999999999999999999999999998765668999999986532211  


Q ss_pred             CCcccccccCCccc-ccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYM-APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                          ......-++. .+|.+..  ...+..++|++|||..+.|.+++..--....    ....+..+..|..+... .++
T Consensus       422 ----~~~~~~~r~~p~~~~~~e--~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~-~~~  490 (524)
T KOG0601|consen  422 ----GVFHHIDRLYPIAEILLE--DYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLK-LQL  490 (524)
T ss_pred             ----ccccccccccccchhhcc--ccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchH-Hhh
Confidence                1122333444 2555533  2456789999999999999998865433221    12233445566655444 888


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      +.+.+.+...|+..|+.+.++..|.-+
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchh
Confidence            999999999999999999998887754

>KOG1266|consensus

Probab=99.55  E-value=8.4e-16  Score=137.53  Aligned_cols=204  Identities=22%  Similarity=0.313  Sum_probs=136.0

Q ss_pred             HHhcCCCCCcceEEEEEEe-----CceEEEEEecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q psy10603         55 ILEGINQKNLVKYYGVEIH-----REEMVLFMELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHEN--TI  124 (407)
Q Consensus        55 ~l~~l~hpniv~~~~~~~~-----~~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~--~i  124 (407)
                      -|-++-|-|||+++.++.+     ..+..++.||+..|++..++++.   ...+......+|+-||++||.|||+.  .|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            3456779999998876543     44688999999999999999763   33477888899999999999999986  59


Q ss_pred             eecCCCCCCEEEecCCCeEEEEcccCc-eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHH
Q psy10603        125 VHRDIKSANIFLTAEGNSLKLGDFGSA-VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM  203 (407)
Q Consensus       125 iHrdlKp~Nill~~~~~~vkl~DFGla-~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em  203 (407)
                      +|+++.++-|++..+ +.+|+.--.-. .....+.....+.....+-++|.|||.=..   ...+.++|||+||....||
T Consensus       200 ihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~---tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT---TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             ccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc---cccccchhhhhhhHHHHHH
Confidence            999999999999865 45665411000 000111111111122235678999986321   2235689999999999999


Q ss_pred             HcCCCCCCCCCchHHHHHHHhCCCCCCCCCccC-HHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        204 SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS-DEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       204 ~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s-~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+..--.+.......-.. +..    .-..++ +-.++++.+||+..|..||++.+++.||...
T Consensus       276 ailEiq~tnseS~~~~ee~-ia~----~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEEN-IAN----VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             HHheeccCCCcceeehhhh-hhh----heeeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence            9887643322221111000 000    001111 1235688999999999999999999999764

>KOG0986|consensus

Probab=99.53  E-value=5.3e-15  Score=137.42  Aligned_cols=75  Identities=37%  Similarity=0.635  Sum_probs=63.4

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|||+++.|+ ++|+|+|||..+.....    +...+||.+|||||++....   |+.++|+||+||++|||+.|++|
T Consensus       314 KPeNILLDd~Gh-vRISDLGLAvei~~g~~----~~~rvGT~GYMAPEvl~ne~---Y~~s~Dwf~lGCllYemi~G~sP  385 (591)
T KOG0986|consen  314 KPENILLDDHGH-VRISDLGLAVEIPEGKP----IRGRVGTVGYMAPEVLQNEV---YDFSPDWFSLGCLLYEMIAGHSP  385 (591)
T ss_pred             ChhheeeccCCC-eEeeccceEEecCCCCc----cccccCcccccCHHHHcCCc---ccCCccHHHHHhHHHHHHcccCc
Confidence            368999999987 99999999987765443    33448999999999997543   57889999999999999999999


Q ss_pred             CCC
Q psy10603        387 LSG  389 (407)
Q Consensus       387 ~~~  389 (407)
                      |.+
T Consensus       386 Fr~  388 (591)
T KOG0986|consen  386 FRQ  388 (591)
T ss_pred             hhh
Confidence            974

>KOG0659|consensus

Probab=99.53  E-value=9.5e-15  Score=127.17  Aligned_cols=79  Identities=28%  Similarity=0.569  Sum_probs=65.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++.+|. +|++|||+|+.+.++....   ...+.|++|+|||++.+.+.  |+..+|+||.||++.||+-|.+
T Consensus       127 lKPnNLLis~~g~-lKiADFGLAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~--Yg~~VDmWavGCI~AELllr~P  200 (318)
T KOG0659|consen  127 LKPNNLLISSDGQ-LKIADFGLARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQ--YGTGVDMWAVGCIFAELLLRVP  200 (318)
T ss_pred             CCccceEEcCCCc-EEeecccchhccCCCCccc---ccceeeeeccChHHhccchh--cCCcchhhhHHHHHHHHHccCC
Confidence            3567888888876 9999999999887655432   23478999999999988765  4788999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      .|+|.
T Consensus       201 ~fpG~  205 (318)
T KOG0659|consen  201 FFPGD  205 (318)
T ss_pred             CCCCC
Confidence            99974

>KOG0663|consensus

Probab=99.53  E-value=7.4e-15  Score=131.69  Aligned_cols=79  Identities=32%  Similarity=0.571  Sum_probs=67.0

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +..|+|++..|. +||+|||+|+.++.+..   .....+.|.+|+|||++++...  |++++|+||+||++.||++++++
T Consensus       204 K~SNLLm~~~G~-lKiaDFGLAR~ygsp~k---~~T~lVVTLWYRaPELLLG~~t--yst~iDMWSvGCI~aE~l~~kPl  277 (419)
T KOG0663|consen  204 KTSNLLLSHKGI-LKIADFGLAREYGSPLK---PYTPLVVTLWYRAPELLLGAKT--YSTAVDMWSVGCIFAELLTQKPL  277 (419)
T ss_pred             chhheeeccCCc-EEecccchhhhhcCCcc---cCcceEEEeeecCHHHhcCCcc--cCcchhhhhHHHHHHHHHhcCCC
Confidence            456888988887 99999999998876533   2445689999999999998654  57899999999999999999999


Q ss_pred             CCCCc
Q psy10603        387 LSGVV  391 (407)
Q Consensus       387 ~~~~~  391 (407)
                      |+|--
T Consensus       278 f~G~s  282 (419)
T KOG0663|consen  278 FPGKS  282 (419)
T ss_pred             CCCCc
Confidence            99853

>KOG0600|consensus

Probab=99.52  E-value=7.3e-15  Score=138.29  Aligned_cols=78  Identities=36%  Similarity=0.605  Sum_probs=65.9

Q ss_pred             CccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       308 ~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      ..|+|++++|. +||+|||||+.+......  .++..+.|.+|+|||++++...  |+.++|+||.||++.||++|++.|
T Consensus       246 ~SNiLidn~G~-LKiaDFGLAr~y~~~~~~--~~T~rVvTLWYRpPELLLG~t~--Yg~aVDlWS~GCIl~El~~gkPI~  320 (560)
T KOG0600|consen  246 GSNILIDNNGV-LKIADFGLARFYTPSGSA--PYTSRVVTLWYRPPELLLGATS--YGTAVDLWSVGCILAELFLGKPIL  320 (560)
T ss_pred             ccceEEcCCCC-EEeccccceeeccCCCCc--ccccceEEeeccChHHhcCCcc--cccceeehhhhHHHHHHHcCCCCc
Confidence            36999999887 999999999876544332  2455689999999999998765  578999999999999999999999


Q ss_pred             CCC
Q psy10603        388 SGV  390 (407)
Q Consensus       388 ~~~  390 (407)
                      .|-
T Consensus       321 ~G~  323 (560)
T KOG0600|consen  321 QGR  323 (560)
T ss_pred             CCc
Confidence            974

>KOG0201|consensus

Probab=99.52  E-value=1.1e-14  Score=134.85  Aligned_cols=85  Identities=36%  Similarity=0.602  Sum_probs=68.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+.+|+++...+. +|++|||.+.+.......   ..+++||++|||||++...   .|+.++||||||++.+||++|++
T Consensus       137 IKaanil~s~~g~-vkl~DfgVa~ql~~~~~r---r~tfvGTPfwMAPEVI~~~---~Y~~KADIWSLGITaiEla~GeP  209 (467)
T KOG0201|consen  137 IKAANILLSESGD-VKLADFGVAGQLTNTVKR---RKTFVGTPFWMAPEVIKQS---GYDTKADIWSLGITAIELAKGEP  209 (467)
T ss_pred             ccccceeEeccCc-EEEEecceeeeeechhhc---cccccccccccchhhhccc---cccchhhhhhhhHHHHHHhcCCC
Confidence            4568999988865 999999999876532221   2567999999999999743   46789999999999999999999


Q ss_pred             CCCCCceeeEEE
Q psy10603        386 NLSGVVVSAEVF  397 (407)
Q Consensus       386 ~~~~~~~~~~~~  397 (407)
                      |++.....-..|
T Consensus       210 P~s~~hPmrvlf  221 (467)
T KOG0201|consen  210 PHSKLHPMRVLF  221 (467)
T ss_pred             CCcccCcceEEE
Confidence            999877655444

>KOG0575|consensus

Probab=99.52  E-value=7.1e-15  Score=141.48  Aligned_cols=75  Identities=39%  Similarity=0.720  Sum_probs=61.4

Q ss_pred             CccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       308 ~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      -+|++++.+-+ |||+|||||-++..+..   ...+.||||.|+|||++.+   .+++..+||||+||++|.|+.|+|||
T Consensus       146 LGNlfL~~~~~-VKIgDFGLAt~le~~~E---rk~TlCGTPNYIAPEVl~k---~gHsfEvDiWSlGcvmYtLL~G~PPF  218 (592)
T KOG0575|consen  146 LGNLFLNENMN-VKIGDFGLATQLEYDGE---RKKTLCGTPNYIAPEVLNK---SGHSFEVDIWSLGCVMYTLLVGRPPF  218 (592)
T ss_pred             hhheeecCcCc-EEecccceeeeecCccc---ccceecCCCcccChhHhcc---CCCCCchhhhhhhhHHHhhhhCCCCc
Confidence            35888877655 99999999977653322   3456799999999999964   35678899999999999999999999


Q ss_pred             CC
Q psy10603        388 SG  389 (407)
Q Consensus       388 ~~  389 (407)
                      ..
T Consensus       219 et  220 (592)
T KOG0575|consen  219 ET  220 (592)
T ss_pred             cc
Confidence            84

>KOG0595|consensus

Probab=99.51  E-value=8.1e-15  Score=134.78  Aligned_cols=76  Identities=32%  Similarity=0.550  Sum_probs=61.4

Q ss_pred             cCCccEEEecC-C----CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHH
Q psy10603        306 YARANIFLTAE-G----NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM  380 (407)
Q Consensus       306 ~~~~nill~~~-~----~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~  380 (407)
                      .++.|+|++.. +    -.+||+|||+|+.+...    ....+.|||+.|||||+++...   |+.|+|+||+|+++|+|
T Consensus       135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~---YdAKADLWSiG~Ilyq~  207 (429)
T KOG0595|consen  135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQ---YDAKADLWSIGTILYQC  207 (429)
T ss_pred             CCcceEEeccCCCCCCCceEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhcc---ccchhhHHHHHHHHHHH
Confidence            35678888764 2    35899999999876532    2345689999999999996543   57899999999999999


Q ss_pred             HhCCCCCC
Q psy10603        381 SSGKTNLS  388 (407)
Q Consensus       381 ~~g~~~~~  388 (407)
                      ++|++||.
T Consensus       208 l~g~~Pf~  215 (429)
T KOG0595|consen  208 LTGKPPFD  215 (429)
T ss_pred             HhCCCCcc
Confidence            99999998

>KOG0594|consensus

Probab=99.51  E-value=1.4e-14  Score=131.51  Aligned_cols=81  Identities=35%  Similarity=0.542  Sum_probs=67.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++..+. +|++|||+|+.+..+...   ..+.++|.+|+|||++++...  |+..+|+||+||+++||+++++
T Consensus       146 LKPQNlLi~~~G~-lKlaDFGlAra~~ip~~~---yt~evvTlWYRaPEvLlGs~~--Ys~~vDiWs~GcIfaEm~~~~~  219 (323)
T KOG0594|consen  146 LKPQNLLISSSGV-LKLADFGLARAFSIPMRT---YTPEVVTLWYRAPEVLLGSTS--YSTSVDIWSLGCIFAEMFTRRP  219 (323)
T ss_pred             CCcceEEECCCCc-EeeeccchHHHhcCCccc---ccccEEEeeccCHHHhcCCCc--CCCCcchHhHHHHHHHHHhCCC
Confidence            4678999999775 999999999866544432   445689999999999998755  5788999999999999999999


Q ss_pred             CCCCCce
Q psy10603        386 NLSGVVV  392 (407)
Q Consensus       386 ~~~~~~~  392 (407)
                      +|+|.-.
T Consensus       220 LFpG~se  226 (323)
T KOG0594|consen  220 LFPGDSE  226 (323)
T ss_pred             CCCCCcH
Confidence            9998643

>KOG0614|consensus

Probab=99.50  E-value=1.5e-14  Score=136.06  Aligned_cols=79  Identities=42%  Similarity=0.698  Sum_probs=68.4

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.+|. +|+.|||+|+++.....    +-++|||+.|.|||+++..   ++..++|.||||+++||+++|.||
T Consensus       547 KPENllLd~~Gy-~KLVDFGFAKki~~g~K----TwTFcGTpEYVAPEIILnK---GHD~avDyWaLGIli~ELL~G~pP  618 (732)
T KOG0614|consen  547 KPENLLLDNRGY-LKLVDFGFAKKIGSGRK----TWTFCGTPEYVAPEIILNK---GHDRAVDYWALGILIYELLTGSPP  618 (732)
T ss_pred             ChhheeeccCCc-eEEeehhhHHHhccCCc----eeeecCCcccccchhhhcc---CcchhhHHHHHHHHHHHHHcCCCC
Confidence            468999999998 99999999998865443    3468999999999999753   457899999999999999999999


Q ss_pred             CCCCcee
Q psy10603        387 LSGVVVS  393 (407)
Q Consensus       387 ~~~~~~~  393 (407)
                      |+|++..
T Consensus       619 Fs~~dpm  625 (732)
T KOG0614|consen  619 FSGVDPM  625 (732)
T ss_pred             CCCCchH
Confidence            9998753

>KOG0615|consensus

Probab=99.49  E-value=3.3e-15  Score=137.33  Aligned_cols=80  Identities=36%  Similarity=0.517  Sum_probs=64.8

Q ss_pred             cCCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|+|+..+.  -.+||.|||+|+..+..    ....+.|||+.|.|||++...+...+..++|+||+||++|-+++|
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG  377 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG  377 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence            357899997652  35999999999865422    224568999999999999876655555689999999999999999


Q ss_pred             CCCCCC
Q psy10603        384 KTNLSG  389 (407)
Q Consensus       384 ~~~~~~  389 (407)
                      .+||++
T Consensus       378 ~pPFS~  383 (475)
T KOG0615|consen  378 YPPFSE  383 (475)
T ss_pred             CCCccc
Confidence            999994

>KOG0581|consensus

Probab=99.48  E-value=1.4e-14  Score=131.84  Aligned_cols=76  Identities=33%  Similarity=0.553  Sum_probs=64.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|+..+|. +||||||.++.+...     ...+++||..|||||.+.+.   .|+.++||||||++++|+++|+-
T Consensus       205 IKPsNlLvNskGe-VKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~---~Ys~~sDIWSLGLsllE~a~Grf  275 (364)
T KOG0581|consen  205 IKPSNLLVNSKGE-VKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGE---SYSVKSDIWSLGLSLLELAIGRF  275 (364)
T ss_pred             CCHHHeeeccCCC-EEeccccccHHhhhh-----hcccccccccccChhhhcCC---cCCcccceecccHHHHHHhhCCC
Confidence            4678999998886 999999999765432     24568999999999999765   35788999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||...
T Consensus       276 P~~~~  280 (364)
T KOG0581|consen  276 PYPPP  280 (364)
T ss_pred             CCCCc
Confidence            99864

>KOG0696|consensus

Probab=99.48  E-value=3.9e-14  Score=130.25  Aligned_cols=76  Identities=33%  Similarity=0.593  Sum_probs=63.0

Q ss_pred             ccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCC
Q psy10603        309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLS  388 (407)
Q Consensus       309 ~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~  388 (407)
                      .|++++.+|+ +||+|||+++.-   ........+++||+-|+|||++.   +.+|+.++|+||+|+++|||+.|++||.
T Consensus       479 DNvmLd~eGH-iKi~DFGmcKEn---i~~~~TTkTFCGTPdYiAPEIi~---YqPYgksvDWWa~GVLLyEmlaGQpPFd  551 (683)
T KOG0696|consen  479 DNVMLDSEGH-IKIADFGMCKEN---IFDGVTTKTFCGTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFD  551 (683)
T ss_pred             cceEeccCCc-eEeeeccccccc---ccCCcceeeecCCCcccccceEE---ecccccchhHHHHHHHHHHHHcCCCCCC
Confidence            6999999987 999999999631   12222345789999999999984   4457899999999999999999999999


Q ss_pred             CCc
Q psy10603        389 GVV  391 (407)
Q Consensus       389 ~~~  391 (407)
                      |-+
T Consensus       552 GeD  554 (683)
T KOG0696|consen  552 GED  554 (683)
T ss_pred             CCC
Confidence            865

>KOG0597|consensus

Probab=99.46  E-value=2.9e-14  Score=135.84  Aligned_cols=76  Identities=41%  Similarity=0.691  Sum_probs=62.6

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.||++...+. +|+||||+|+.+...+..   ....-|||.|||||++...   +|+..+|.||+||++|||++|+||
T Consensus       127 kPqniLl~~~~~-~KlcdFg~Ar~m~~~t~v---ltsikGtPlYmAPElv~e~---pyd~~sDlWslGcilYE~~~G~PP  199 (808)
T KOG0597|consen  127 KPQNILLEKGGT-LKLCDFGLARAMSTNTSV---LTSIKGTPLYMAPELVEEQ---PYDHTSDLWSLGCILYELYVGQPP  199 (808)
T ss_pred             CcceeeecCCCc-eeechhhhhhhcccCcee---eeeccCcccccCHHHHcCC---CccchhhHHHHHHHHHHHhcCCCC
Confidence            467899988776 999999999987654433   2345799999999999743   456789999999999999999999


Q ss_pred             CCC
Q psy10603        387 LSG  389 (407)
Q Consensus       387 ~~~  389 (407)
                      |-.
T Consensus       200 F~a  202 (808)
T KOG0597|consen  200 FYA  202 (808)
T ss_pred             chH
Confidence            974

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=9.1e-13  Score=113.79  Aligned_cols=139  Identities=17%  Similarity=0.177  Sum_probs=99.6

Q ss_pred             eecccccCeEEEEEEECC------CCcEEEEEEEecccc----------CcHH-------------HHHHHHHHHHHHhc
Q psy10603          8 VSPGQGRFGKVYTAVNNE------TGELVAMKEIQLHKQ----------NDAR-------------FVKDMLVELRILEG   58 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~------~~~~vAvK~i~~~~~----------~~~~-------------~~~~~~~E~~~l~~   58 (407)
                      ..||.|.=+.||.|....      .+..+|||+.+....          .+.+             ......+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999997653      357899998753210          0111             11123489999988


Q ss_pred             CCC--CCcceEEEEEEeCceEEEEEecCCCCCHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCE
Q psy10603         59 INQ--KNLVKYYGVEIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAISAL-HENTIVHRDIKSANI  134 (407)
Q Consensus        59 l~h--pniv~~~~~~~~~~~~~lv~E~~~~g~L~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yL-H~~~iiHrdlKp~Ni  134 (407)
                      +..  -++...++.    ..-+|||||+.++.+.. .++.  ..+++..+..+..|++.+|..| |+.||+|+||+|.||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            764  456666654    45689999998754422 2322  2356667778889999999999 899999999999999


Q ss_pred             EEecCCCeEEEEcccCceec
Q psy10603        135 FLTAEGNSLKLGDFGSAVKI  154 (407)
Q Consensus       135 ll~~~~~~vkl~DFGla~~~  154 (407)
                      |+++ + .+.|+|||.+...
T Consensus       157 L~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         157 LWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             EEEC-C-cEEEEECCCceeC
Confidence            9974 3 5999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0578|consensus

Probab=99.46  E-value=4.4e-14  Score=134.98  Aligned_cols=74  Identities=42%  Similarity=0.651  Sum_probs=61.9

Q ss_pred             CccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       308 ~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      ..|+|++.++. +||.|||++.++......   -.+.+||++|||||++.+   ..|+.++||||||++++||+.|++||
T Consensus       397 SDnILL~~~g~-vKltDFGFcaqi~~~~~K---R~TmVGTPYWMAPEVvtr---k~YG~KVDIWSLGIMaIEMveGEPPY  469 (550)
T KOG0578|consen  397 SDNILLTMDGS-VKLTDFGFCAQISEEQSK---RSTMVGTPYWMAPEVVTR---KPYGPKVDIWSLGIMAIEMVEGEPPY  469 (550)
T ss_pred             cceeEeccCCc-EEEeeeeeeeccccccCc---cccccCCCCccchhhhhh---cccCccccchhhhhHHHHHhcCCCCc
Confidence            36899988876 999999999887654432   235689999999999953   35789999999999999999999998


Q ss_pred             C
Q psy10603        388 S  388 (407)
Q Consensus       388 ~  388 (407)
                      =
T Consensus       470 l  470 (550)
T KOG0578|consen  470 L  470 (550)
T ss_pred             c
Confidence            4

>KOG4645|consensus

Probab=99.46  E-value=1e-14  Score=150.52  Aligned_cols=85  Identities=53%  Similarity=0.880  Sum_probs=74.0

Q ss_pred             CCccEEEecCCCceEEecCCccccccccc-CCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      +++|++++.+| .+|++|||.|+.+..+. +.++..+...||+.|||||++.+....+++.++||||+|||++||+||+.
T Consensus      1361 K~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1361 KPANILLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred             CccceeeecCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence            56899999988 59999999999887664 55667778899999999999998877778889999999999999999999


Q ss_pred             CCCCCce
Q psy10603        386 NLSGVVV  392 (407)
Q Consensus       386 ~~~~~~~  392 (407)
                      |+...+.
T Consensus      1440 PW~~~dn 1446 (1509)
T KOG4645|consen 1440 PWAELDN 1446 (1509)
T ss_pred             chhhccc
Confidence            9986543

>KOG0198|consensus

Probab=99.46  E-value=1.9e-14  Score=132.57  Aligned_cols=82  Identities=41%  Similarity=0.624  Sum_probs=62.0

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|+|++..+..+||+|||+++................||+.|||||++..+..  .+.++||||+||++.||+||.+|
T Consensus       144 K~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~--~~~~sDiWSlGCtVvEM~Tg~~P  221 (313)
T KOG0198|consen  144 KPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV--ARRESDIWSLGCTVVEMLTGKPP  221 (313)
T ss_pred             ccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCc--CCccchhhhcCCEEEeccCCCCc
Confidence            4679999884335999999999876531222222335689999999999975211  23589999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |...
T Consensus       222 W~~~  225 (313)
T KOG0198|consen  222 WSEF  225 (313)
T ss_pred             chhh
Confidence            9974

>KOG0666|consensus

Probab=99.45  E-value=4.5e-14  Score=125.54  Aligned_cols=84  Identities=26%  Similarity=0.493  Sum_probs=69.5

Q ss_pred             cCCccEEEecCC---CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~---~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .+++||++..++   +.|||+|+|+++.+..+...-.....++.|.+|+|||++++.+.  |+.++||||+||++.||+|
T Consensus       158 LKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h--YT~AiDvWAiGCIfaElLt  235 (438)
T KOG0666|consen  158 LKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH--YTKAIDVWAIGCIFAELLT  235 (438)
T ss_pred             CCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccccc--ccchhhhHHHHHHHHHHHc
Confidence            567899997662   35999999999988765443334567899999999999998765  5789999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      -+++|.|-.
T Consensus       236 l~PlF~g~E  244 (438)
T KOG0666|consen  236 LEPLFKGRE  244 (438)
T ss_pred             cCccccchh
Confidence            999999753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.1e-13  Score=115.46  Aligned_cols=126  Identities=17%  Similarity=0.123  Sum_probs=91.7

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL-VKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..++.|.++.||++...  ++.|++|+.......    ...+.+|..+++.+.+.++ .+++...  ....++||||++|
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            36888999999999864  778999986543211    1234578888887765544 3455543  3335799999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI-----VHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~i-----iHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      .++....      .   .....+.+++.+|..||+.++     +|+|++|+||++++  +.++++|||.+.
T Consensus        76 ~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~--~~~~liDf~~a~  135 (170)
T cd05151          76 SELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD--GRLWLIDWEYAG  135 (170)
T ss_pred             Ccccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC--CeEEEEeccccc
Confidence            8875430      1   113456789999999999885     99999999999983  369999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0670|consensus

Probab=99.45  E-value=9.7e-15  Score=137.67  Aligned_cols=139  Identities=27%  Similarity=0.383  Sum_probs=93.0

Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeeeecCCcCCCCCCCchhhHHhhhhcCccCCCCCccccccc-------------
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVY-------------  306 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~p~~~~~~~l~~~~~~~~~s~~~i~~~-------------  306 (407)
                      .++++++-.-||+.+.-+.-++.|-+-    ....|.........+.+.++.--..-.+....++.|             
T Consensus       479 leiLkKL~~AD~Edk~Hclrl~r~F~h----knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~  554 (752)
T KOG0670|consen  479 LEILKKLNDADPEDKFHCLRLFRHFKH----KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK  554 (752)
T ss_pred             HHHHHHhhccCchhhhHHHHHHHHhhh----cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh
Confidence            457888889999999988777764321    111221111112223332221111112222333333             


Q ss_pred             --------CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHH
Q psy10603        307 --------ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  378 (407)
Q Consensus       307 --------~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~  378 (407)
                              ++.|+|+....+-+||||||.|...+.+     ...++..+++|.|||++++-.   |.++.|+||+||+||
T Consensus       555 c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en-----eitPYLVSRFYRaPEIiLG~~---yd~~iD~WSvgctLY  626 (752)
T KOG0670|consen  555 CGVLHADIKPDNILVNESKNILKLCDFGSASFASEN-----EITPYLVSRFYRAPEIILGLP---YDYPIDTWSVGCTLY  626 (752)
T ss_pred             cCeeecccCccceEeccCcceeeeccCccccccccc-----cccHHHHHHhccCcceeecCc---ccCCccceeeceeeE
Confidence                    4689999888888999999999655432     345678999999999998753   578899999999999


Q ss_pred             HHHhCCCCCCCC
Q psy10603        379 EMSSGKTNLSGV  390 (407)
Q Consensus       379 e~~~g~~~~~~~  390 (407)
                      |+.||+.+|+|-
T Consensus       627 ElYtGkIlFpG~  638 (752)
T KOG0670|consen  627 ELYTGKILFPGR  638 (752)
T ss_pred             EeeccceecCCC
Confidence            999999999984

>KOG0592|consensus

Probab=99.45  E-value=7.4e-14  Score=132.66  Aligned_cols=80  Identities=36%  Similarity=0.745  Sum_probs=63.8

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCC------C----CcccccccccccccCcccccCCcCCCCccchHHhHHHH
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTV------P----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV  376 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~  376 (407)
                      +++|+|++.+++ ++|.|||.|+.+.+....      .    .+...++||..|.+||+|.+.   ..++++|+|||||+
T Consensus       201 KPENILLd~dmh-ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~---~~~~~sDiWAlGCi  276 (604)
T KOG0592|consen  201 KPENILLDKDGH-IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS---PAGPSSDLWALGCI  276 (604)
T ss_pred             ChhheeEcCCCc-EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC---CCCcccchHHHHHH
Confidence            468999998886 999999999876533211      1    112458999999999999653   34688999999999


Q ss_pred             HHHHHhCCCCCCCC
Q psy10603        377 LVEMSSGKTNLSGV  390 (407)
Q Consensus       377 ~~e~~~g~~~~~~~  390 (407)
                      +|.|+.|.+||.|.
T Consensus       277 lyQmlaG~PPFra~  290 (604)
T KOG0592|consen  277 LYQMLAGQPPFRAA  290 (604)
T ss_pred             HHHHhcCCCCCccc
Confidence            99999999999974

>KOG0582|consensus

Probab=99.44  E-value=9e-14  Score=129.19  Aligned_cols=81  Identities=35%  Similarity=0.610  Sum_probs=65.1

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccC-CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      +.+|||++.+|. +||+|||.+-.+..+.. ...+..+++||+.|||||+++.. ..+|+.|+||||||++.+||++|+.
T Consensus       153 KAgnILi~~dG~-VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~-~~GYdfKaDIwSfGITA~ELA~G~a  230 (516)
T KOG0582|consen  153 KAGNILIDSDGT-VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ-LHGYDFKADIWSFGITACELAHGHA  230 (516)
T ss_pred             ccccEEEcCCCc-EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhc-ccCccchhhhhhhhHHHHHHhcCCC
Confidence            567999999887 99999999865543332 22233677999999999997653 3467899999999999999999999


Q ss_pred             CCCC
Q psy10603        386 NLSG  389 (407)
Q Consensus       386 ~~~~  389 (407)
                      ||+-
T Consensus       231 Pf~k  234 (516)
T KOG0582|consen  231 PFSK  234 (516)
T ss_pred             Cccc
Confidence            9973

>KOG1006|consensus

Probab=99.44  E-value=2e-14  Score=125.15  Aligned_cols=80  Identities=31%  Similarity=0.474  Sum_probs=64.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|+++.|. +|+||||.+.++...-.    .+.-.|++.|||||.+..... ++..++||||||++++|++||.-
T Consensus       194 vKPSNILldr~G~-vKLCDFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGITL~EvAtG~f  267 (361)
T KOG1006|consen  194 VKPSNILLDRHGD-VKLCDFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGITLYEVATGNF  267 (361)
T ss_pred             CChhheEEecCCC-EeeecccchHhHHHHHH----hhhccCCccccChhccCCccC-CcchhhhhhhhcceEeeeecCCC
Confidence            3578999999987 99999999976543211    223479999999999976554 56789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      |+.+-.
T Consensus       268 Pyr~w~  273 (361)
T KOG1006|consen  268 PYRKWD  273 (361)
T ss_pred             CcchHH
Confidence            998654

>KOG0605|consensus

Probab=99.43  E-value=8.9e-14  Score=132.04  Aligned_cols=81  Identities=35%  Similarity=0.684  Sum_probs=61.9

Q ss_pred             cCCccEEEecCCCceEEecCCccccccc---------------------ccCCC-----Cc------------------c
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISA---------------------HTTVP-----GE------------------L  341 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~---------------------~~~~~-----~~------------------~  341 (407)
                      .++.|+|++..|+ +|++||||+..+..                     +...+     ..                  .
T Consensus       267 IKPdNlLiD~~GH-iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a  345 (550)
T KOG0605|consen  267 IKPDNLLIDAKGH-IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA  345 (550)
T ss_pred             CChhheeecCCCC-EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence            4678999999987 99999999853210                     00001     00                  1


Q ss_pred             cccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCC
Q psy10603        342 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGV  390 (407)
Q Consensus       342 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~  390 (407)
                      ...+|||-|||||++++.   +|+..+|+|||||++|||+.|-|||.|-
T Consensus       346 ~StVGTPDYiAPEVll~k---gY~~~cDwWSLG~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  346 YSTVGTPDYIAPEVLLGK---GYGKECDWWSLGCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             hcccCCccccchHHHhcC---CCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            234899999999999864   3578899999999999999999999964

>KOG0596|consensus

Probab=99.42  E-value=7.1e-14  Score=132.93  Aligned_cols=82  Identities=41%  Similarity=0.649  Sum_probs=63.8

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcC--------CCCccchHHhHHHHHH
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV--------GHGRAVDIWSLGCVLV  378 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--------~~~~~~Dvws~G~~~~  378 (407)
                      +++|.|+ ..|. +||+|||.|..+..+++... ....+||+.||+||.+......        ..++++||||+||++|
T Consensus       487 KPANFLl-VkG~-LKLIDFGIA~aI~~DTTsI~-kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILY  563 (677)
T KOG0596|consen  487 KPANFLL-VKGR-LKLIDFGIANAIQPDTTSIV-KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILY  563 (677)
T ss_pred             CcccEEE-Eeee-EEeeeechhcccCcccccee-eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHH
Confidence            4567665 4454 99999999998887665433 3457899999999998653221        1367899999999999


Q ss_pred             HHHhCCCCCCCCc
Q psy10603        379 EMSSGKTNLSGVV  391 (407)
Q Consensus       379 e~~~g~~~~~~~~  391 (407)
                      +|+.|++||..+.
T Consensus       564 qMvYgktPf~~~~  576 (677)
T KOG0596|consen  564 QMVYGKTPFGQII  576 (677)
T ss_pred             HHHhcCCchHHHH
Confidence            9999999998664

>KOG0984|consensus

Probab=99.41  E-value=1.3e-13  Score=116.02  Aligned_cols=78  Identities=28%  Similarity=0.455  Sum_probs=61.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC-CcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      -++.|+|++..|+ +|+||||.+..+.....    .+...|+..|||||.+... +..+|+-++||||||++++||++++
T Consensus       175 vKPsNiLIn~~Gq-VKiCDFGIsG~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr  249 (282)
T KOG0984|consen  175 VKPSNILINYDGQ-VKICDFGISGYLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILR  249 (282)
T ss_pred             CCcceEEEccCCc-EEEcccccceeehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcc
Confidence            3578999999886 99999999965432211    1224699999999998653 3336788999999999999999999


Q ss_pred             CCCC
Q psy10603        385 TNLS  388 (407)
Q Consensus       385 ~~~~  388 (407)
                      -||.
T Consensus       250 ~PY~  253 (282)
T KOG0984|consen  250 FPYE  253 (282)
T ss_pred             cccc
Confidence            9987

>KOG4279|consensus

Probab=99.41  E-value=4.3e-14  Score=137.45  Aligned_cols=77  Identities=38%  Similarity=0.774  Sum_probs=62.0

Q ss_pred             CccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       308 ~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      ..|+|+..=.+-+||+|||.+++... -+ +. .+++.||..|||||++..+.. +|+.++|||||||++.||+||+|||
T Consensus       703 GDNVLvNTySGvlKISDFGTsKRLAg-in-P~-TETFTGTLQYMAPEvIDqG~R-GYG~aADIWS~GCT~vEMATGrPPF  778 (1226)
T KOG4279|consen  703 GDNVLVNTYSGVLKISDFGTSKRLAG-IN-PC-TETFTGTLQYMAPEVIDQGPR-GYGKAADIWSFGCTMVEMATGRPPF  778 (1226)
T ss_pred             CCcEEEeeccceEEecccccchhhcc-CC-cc-ccccccchhhhChHhhccCCc-CCCchhhhhhccceeEeeccCCCCe
Confidence            46888876556699999999987532 11 11 346789999999999976543 5789999999999999999999999


Q ss_pred             C
Q psy10603        388 S  388 (407)
Q Consensus       388 ~  388 (407)
                      -
T Consensus       779 ~  779 (1226)
T KOG4279|consen  779 V  779 (1226)
T ss_pred             e
Confidence            8

>KOG0574|consensus

Probab=99.39  E-value=6.4e-14  Score=123.94  Aligned_cols=85  Identities=35%  Similarity=0.619  Sum_probs=68.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+.+|+|+..+|. .|++|||.|.++....   ....+++||++|||||++..   -+|.+++||||||++..||+.|++
T Consensus       155 IKAGNILLNT~G~-AKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVI~E---IGY~~~ADIWSLGITaIEMAEG~P  227 (502)
T KOG0574|consen  155 IKAGNILLNTDGI-AKLADFGVAGQLTDTM---AKRNTVIGTPFWMAPEVIEE---IGYDTKADIWSLGITAIEMAEGRP  227 (502)
T ss_pred             cccccEEEcccch-hhhhhccccchhhhhH---HhhCccccCcccccHHHHHH---hccchhhhHhhhcchhhhhhcCCC
Confidence            4568999998887 9999999997764332   23356899999999999953   346789999999999999999999


Q ss_pred             CCCCCceeeEEE
Q psy10603        386 NLSGVVVSAEVF  397 (407)
Q Consensus       386 ~~~~~~~~~~~~  397 (407)
                      ||+.+--.-.+|
T Consensus       228 PYsDIHPMRAIF  239 (502)
T KOG0574|consen  228 PYSDIHPMRAIF  239 (502)
T ss_pred             CcccccccceeE
Confidence            999876544444

>KOG1243|consensus

Probab=99.39  E-value=5.4e-12  Score=123.53  Aligned_cols=187  Identities=20%  Similarity=0.341  Sum_probs=137.8

Q ss_pred             ccceeeecccccCeE--EE-EEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGK--VY-TAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~--V~-~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +..|.|.|=.+.++.  +| .|..+.++.+|.|.+.+....   .......+-++-|+.++||||+++++..+..+.+||
T Consensus        10 ~~~fpY~le~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~yl   86 (690)
T KOG1243|consen   10 SSQFPYDLEETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYL   86 (690)
T ss_pred             cccCCcccccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEE
Confidence            345666665555553  55 466778889999998875533   334556677889999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      |+|-+.  .|..+++.    +....+.--++||+.||.+|| +.+++|++|.-+.|+++..| .-||++|-++.......
T Consensus        87 vTErV~--Pl~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   87 VTERVR--PLETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN  159 (690)
T ss_pred             Eeeccc--cHHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence            999985  56667765    346667777899999999998 56899999999999999876 69999998876544322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  207 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~  207 (407)
                      . +.  ....---.|..|+.+..     .....|.|-|||+++|++.|.
T Consensus       160 ~-~~--~~~~~~~s~~~P~~~~~-----s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  160 A-PA--KSLYLIESFDDPEEIDP-----SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             c-cc--ccchhhhcccChhhcCc-----cccchhhhhHHHHHHHHhCcc
Confidence            1 00  01111124667775421     124679999999999999993

>KOG0192|consensus

Probab=99.38  E-value=5.1e-13  Score=126.64  Aligned_cols=83  Identities=28%  Similarity=0.464  Sum_probs=64.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+..|+|++.+...+||+|||+++......   .......||..|||||++... ...++.++||||||++++||+||+.
T Consensus       169 LK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~  244 (362)
T KOG0192|consen  169 LKSDNILVDLKGKTLKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEI  244 (362)
T ss_pred             cChhhEEEcCCCCEEEECCCccceeecccc---ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCC
Confidence            356799998886459999999997543211   112235799999999999743 2346899999999999999999999


Q ss_pred             CCCCCce
Q psy10603        386 NLSGVVV  392 (407)
Q Consensus       386 ~~~~~~~  392 (407)
                      ||.+...
T Consensus       245 Pf~~~~~  251 (362)
T KOG0192|consen  245 PFEDLAP  251 (362)
T ss_pred             CCCCCCH
Confidence            9998774

>KOG0610|consensus

Probab=99.37  E-value=8.1e-13  Score=121.90  Aligned_cols=48  Identities=50%  Similarity=0.842  Sum_probs=42.2

Q ss_pred             ccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        341 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       341 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      ...++||..|+|||++.+.   +++.++|+|+|||.+|||+.|.+||+|-.
T Consensus       292 SnSFVGThEYlAPEvI~G~---GHgsAVDWWtfGIflYEmLyG~TPFKG~~  339 (459)
T KOG0610|consen  292 SNSFVGTHEYLAPEVIRGE---GHGSAVDWWTFGIFLYEMLYGTTPFKGSN  339 (459)
T ss_pred             ccccccccccccceeeecC---CCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence            3567899999999999765   35789999999999999999999999853

>KOG0577|consensus

Probab=99.37  E-value=2.1e-13  Score=130.65  Aligned_cols=75  Identities=40%  Similarity=0.634  Sum_probs=63.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+.+|||++..|. ||++|||.|....       ....++|||+|||||+++..+..-|+-++||||||+++.|++..+|
T Consensus       152 iKAGNILLse~g~-VKLaDFGSAsi~~-------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkP  223 (948)
T KOG0577|consen  152 IKAGNILLSEPGL-VKLADFGSASIMA-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  223 (948)
T ss_pred             ccccceEecCCCe-eeeccccchhhcC-------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCC
Confidence            3568999999987 9999999995432       2345899999999999987666667889999999999999999888


Q ss_pred             CCC
Q psy10603        386 NLS  388 (407)
Q Consensus       386 ~~~  388 (407)
                      |+=
T Consensus       224 PlF  226 (948)
T KOG0577|consen  224 PLF  226 (948)
T ss_pred             Ccc
Confidence            753

>KOG0583|consensus

Probab=99.37  E-value=5.8e-13  Score=127.25  Aligned_cols=79  Identities=35%  Similarity=0.618  Sum_probs=63.2

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|++++.+...+||+|||++....   .......+.+||+.|+|||++.+...+ .+.++||||+|+++|.|++|+-|
T Consensus       147 K~ENilld~~~~~~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y-~g~~aDvWS~GViLy~ml~G~~P  222 (370)
T KOG0583|consen  147 KPENILLDGNEGNLKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTY-SGKAADVWSLGVILYVLLCGRLP  222 (370)
T ss_pred             CHHHEEecCCCCCEEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCc-CCchhhhhhhHHHHHHHHhCCCC
Confidence            45799999883449999999997653   112234567999999999999764422 36889999999999999999999


Q ss_pred             CCC
Q psy10603        387 LSG  389 (407)
Q Consensus       387 ~~~  389 (407)
                      |..
T Consensus       223 F~d  225 (370)
T KOG0583|consen  223 FDD  225 (370)
T ss_pred             CCC
Confidence            996

>KOG0690|consensus

Probab=99.37  E-value=3.7e-13  Score=120.43  Aligned_cols=74  Identities=36%  Similarity=0.667  Sum_probs=60.9

Q ss_pred             ccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCC
Q psy10603        309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLS  388 (407)
Q Consensus       309 ~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~  388 (407)
                      .|++++.+|+ +||.|||+++.-   -+......++||||.|+|||++.+.   .|+.++|+|.+|+++|||++|+-||.
T Consensus       297 ENLlLDkDGH-IKitDFGLCKE~---I~~g~t~kTFCGTPEYLAPEVleDn---DYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  297 ENLLLDKDGH-IKITDFGLCKEE---IKYGDTTKTFCGTPEYLAPEVLEDN---DYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             hhheeccCCc-eEeeecccchhc---ccccceeccccCChhhcCchhhccc---cccceeehhhhhHHHHHHHhccCccc
Confidence            5888888776 999999999642   2222345678999999999999653   46899999999999999999999997


Q ss_pred             C
Q psy10603        389 G  389 (407)
Q Consensus       389 ~  389 (407)
                      .
T Consensus       370 n  370 (516)
T KOG0690|consen  370 N  370 (516)
T ss_pred             c
Confidence            4

>KOG3087|consensus

Probab=99.36  E-value=1.1e-11  Score=103.09  Aligned_cols=142  Identities=24%  Similarity=0.303  Sum_probs=101.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccc----cCcHH-HHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHK----QNDAR-FVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~----~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .+-+|+=+.|+++..  .|+.+.||.--...    ..+.+ ..++..+|.++|.++.--.|.--.=++.+...-.|+|||
T Consensus        14 likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   14 LIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            567888888998865  47777787532221    11222 245678999999887654443333344555666789999


Q ss_pred             CCC-CCHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE--EEEcccCce
Q psy10603         84 CTE-GTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL--KLGDFGSAV  152 (407)
Q Consensus        84 ~~~-g~L~~~~~~~~~~-~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v--kl~DFGla~  152 (407)
                      ++| .++.+++.+.... ........++++|-..+.-||.++|||+||..+||++.++++.+  -++|||++.
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            987 4688887654322 23333378889999999999999999999999999999887655  899999973

>KOG2345|consensus

Probab=99.36  E-value=6.8e-13  Score=114.63  Aligned_cols=98  Identities=29%  Similarity=0.315  Sum_probs=71.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcc------cccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL------NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      .+++|++++..+. +++.|||.+.+....-....+.      ..-.+|..|+|||++.-......+.++|||||||++|+
T Consensus       155 iKP~NILls~~~~-~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa  233 (302)
T KOG2345|consen  155 IKPANILLSDSGL-PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYA  233 (302)
T ss_pred             CCcceeEecCCCc-eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHH
Confidence            4678999998765 9999999997654322211111      11247999999999854444445789999999999999


Q ss_pred             HHhCCCCCC------CCceeeEEEecCceee
Q psy10603        380 MSSGKTNLS------GVVVSAEVFGSGGWWF  404 (407)
Q Consensus       380 ~~~g~~~~~------~~~~~~~~~~~~~~~~  404 (407)
                      |+.|.+||.      |-.+.|..=|+=+||-
T Consensus       234 ~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~  264 (302)
T KOG2345|consen  234 MMFGESPFERIYQQGGSLALAVQNAQISIPN  264 (302)
T ss_pred             HHHcCCcchHHhhcCCeEEEeeeccccccCC
Confidence            999999997      4455666667777773

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.5e-11  Score=101.49  Aligned_cols=130  Identities=22%  Similarity=0.265  Sum_probs=93.9

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEecccc----CcHHH-HHHHHHHHHHHhcCCC--CCcceEEEEEEeCceEEEEE
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ----NDARF-VKDMLVELRILEGINQ--KNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~----~~~~~-~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~   81 (407)
                      .+++|+=+.+|.+..  -|..+++|.=.++.-    .|.+. ..+..+|.+++.+++-  -++..+|++  +.+...|+|
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~m   78 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVM   78 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEE
Confidence            467899999999855  344566665332211    12222 3456789999987654  344555554  566678999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      ||++|-.|.+.+...        ...+++.+-.-+.-||.+||+|+||.++||++...  .+.++||||+.
T Consensus        79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~  139 (204)
T COG3642          79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGE  139 (204)
T ss_pred             EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccc
Confidence            999999999888653        13456667777888999999999999999999864  38999999984

>KOG0612|consensus

Probab=99.33  E-value=7.3e-13  Score=135.45  Aligned_cols=80  Identities=40%  Similarity=0.639  Sum_probs=66.5

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC--CcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      +|.|+|++..|+ +|++|||.+-++....+.  .....+|||-|++||++...  ....|+.-+|+||+||++|||+.|.
T Consensus       202 KPDNvLld~~GH-ikLADFGsClkm~~dG~V--~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~  278 (1317)
T KOG0612|consen  202 KPDNVLLDKSGH-IKLADFGSCLKMDADGTV--RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGE  278 (1317)
T ss_pred             CcceeEecccCc-EeeccchhHHhcCCCCcE--EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCC
Confidence            578999999987 999999999888755543  23456899999999998542  2235688999999999999999999


Q ss_pred             CCCCC
Q psy10603        385 TNLSG  389 (407)
Q Consensus       385 ~~~~~  389 (407)
                      +||..
T Consensus       279 TPFYa  283 (1317)
T KOG0612|consen  279 TPFYA  283 (1317)
T ss_pred             CcchH
Confidence            99983

>KOG0588|consensus

Probab=99.32  E-value=9.7e-13  Score=127.82  Aligned_cols=77  Identities=30%  Similarity=0.512  Sum_probs=63.2

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|+|++.+.+ +||+|||.|..-..+    .-.++.||+++|.|||++++..+  .+.++||||.||++|.|+||+-|
T Consensus       139 KpENlLLd~~~n-IKIADFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pY--dG~~sDVWSCGVILfALLtG~LP  211 (786)
T KOG0588|consen  139 KPENLLLDVKNN-IKIADFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPY--DGRPSDVWSCGVILFALLTGKLP  211 (786)
T ss_pred             CchhhhhhcccC-EeeeccceeecccCC----ccccccCCCcccCCchhhcCCCC--CCCccccchhHHHHHHHHhCCCC
Confidence            457999999887 999999999532221    12456799999999999987654  47899999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |.+-
T Consensus       212 FdDd  215 (786)
T KOG0588|consen  212 FDDD  215 (786)
T ss_pred             CCCc
Confidence            9853

>KOG0695|consensus

Probab=99.32  E-value=9.7e-13  Score=118.17  Aligned_cols=73  Identities=34%  Similarity=0.682  Sum_probs=61.2

Q ss_pred             ccEEEecCCCceEEecCCcccc-cccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        309 ANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       309 ~nill~~~~~~~ki~dfGla~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      .|+|++.+|+ +|+.|+|.++. +.+..    ..+++||||.|+|||++++..   |+.++|+||+|++++||+.|++||
T Consensus       380 dnvlldaegh-ikltdygmcke~l~~gd----~tstfcgtpnyiapeilrgee---ygfsvdwwalgvlmfemmagrspf  451 (593)
T KOG0695|consen  380 DNVLLDAEGH-IKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEE---YGFSVDWWALGVLMFEMMAGRSPF  451 (593)
T ss_pred             cceEEccCCc-eeecccchhhcCCCCCc----ccccccCCCcccchhhhcccc---cCceehHHHHHHHHHHHHcCCCCc
Confidence            6899999987 99999999964 22222    245689999999999997653   578999999999999999999999


Q ss_pred             CC
Q psy10603        388 SG  389 (407)
Q Consensus       388 ~~  389 (407)
                      .=
T Consensus       452 di  453 (593)
T KOG0695|consen  452 DI  453 (593)
T ss_pred             ce
Confidence            83

>KOG0589|consensus

Probab=99.32  E-value=3.4e-13  Score=127.80  Aligned_cols=80  Identities=41%  Similarity=0.644  Sum_probs=66.8

Q ss_pred             CccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCC
Q psy10603        308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNL  387 (407)
Q Consensus       308 ~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~  387 (407)
                      ..|++++.++. +|++|||+|+.++.+..   ...+++||+.||+||++.+.   .|+.++|||||||++|||++-+++|
T Consensus       134 ~~Nifltk~~~-VkLgDfGlaK~l~~~~~---~a~tvvGTp~YmcPEil~d~---pYn~KSDiWsLGC~~yEm~~lk~aF  206 (426)
T KOG0589|consen  134 CANIFLTKDKK-VKLGDFGLAKILNPEDS---LASTVVGTPYYMCPEILSDI---PYNEKSDIWSLGCCLYEMCTLKPAF  206 (426)
T ss_pred             hhhhhccccCc-eeecchhhhhhcCCchh---hhheecCCCcccCHHHhCCC---CCCccCcchhhcchHHHHHhccccc
Confidence            46899988876 89999999998876541   24467999999999999654   4679999999999999999999999


Q ss_pred             CCCceee
Q psy10603        388 SGVVVSA  394 (407)
Q Consensus       388 ~~~~~~~  394 (407)
                      ++....+
T Consensus       207 ~a~~m~~  213 (426)
T KOG0589|consen  207 KASNMSE  213 (426)
T ss_pred             CccchHH
Confidence            9876543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.31  E-value=2.2e-12  Score=121.73  Aligned_cols=84  Identities=26%  Similarity=0.457  Sum_probs=61.9

Q ss_pred             cCCccEEEec---CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTA---EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~---~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|+++..   ....+||+|||+++.+.............+||+.|+|||++.+..  .++.++||||+||+++||++
T Consensus       134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~  211 (317)
T cd07868         134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLT  211 (317)
T ss_pred             CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCC--CcCchhhHHHHHHHHHHHHh
Confidence            3456888842   234599999999986644322222234567999999999987533  24678999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |+++|.+..
T Consensus       212 g~~~f~~~~  220 (317)
T cd07868         212 SEPIFHCRQ  220 (317)
T ss_pred             CCCCccCCc
Confidence            999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.30  E-value=2e-12  Score=127.51  Aligned_cols=79  Identities=32%  Similarity=0.599  Sum_probs=62.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++..+||+|||+|+.+.....    ....+||+.|||||++.+..  .++.++||||+||+++||++|.+
T Consensus       196 LKp~NILl~~~~~~vkL~DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlGvil~elltG~~  269 (440)
T PTZ00036        196 LKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR----SVSYICSRFYRAPELMLGAT--NYTTHIDLWSLGCIIAEMILGYP  269 (440)
T ss_pred             cCHHHEEEcCCCCceeeeccccchhccCCCC----cccCCCCcCccCHHHhcCCC--CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567899987766799999999986543221    22357899999999986532  24688999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.|-
T Consensus       270 pf~~~  274 (440)
T PTZ00036        270 IFSGQ  274 (440)
T ss_pred             CCCCC
Confidence            99874

>KOG0599|consensus

Probab=99.29  E-value=2.5e-12  Score=112.59  Aligned_cols=78  Identities=29%  Similarity=0.533  Sum_probs=64.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCccccc---CCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|+|++++-+ +||+|||+|.++..+.    .....||||+|+|||.+.-   .+..+|+.-+|.||.|+++|.++.
T Consensus       149 LKpENILlddn~~-i~isDFGFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa  223 (411)
T KOG0599|consen  149 LKPENILLDDNMN-IKISDFGFACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA  223 (411)
T ss_pred             cChhheeeccccc-eEEeccceeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc
Confidence            4567999988876 9999999998875433    3456799999999998842   345567788999999999999999


Q ss_pred             CCCCCC
Q psy10603        383 GKTNLS  388 (407)
Q Consensus       383 g~~~~~  388 (407)
                      |-+||-
T Consensus       224 GcpPFw  229 (411)
T KOG0599|consen  224 GCPPFW  229 (411)
T ss_pred             CCCchh
Confidence            999984

>KOG0664|consensus

Probab=99.29  E-value=1.1e-12  Score=114.80  Aligned_cols=90  Identities=29%  Similarity=0.499  Sum_probs=66.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|.++..+-- +||||||+++-........  ...-+.|.+|+|||++++.+.+  +.++||||+||++.|++-.+-
T Consensus       182 IKPGNLLVNSNCv-LKICDFGLARvee~d~~~h--MTqEVVTQYYRAPEiLMGaRhY--s~AvDiWSVGCIFaELLgRrI  256 (449)
T KOG0664|consen  182 IKPGNLLVNSNCI-LKICDFGLARTWDQRDRLN--MTHEVVTQYYRAPELLMGARRY--TGAVDIWSVGCIFAELLQRKI  256 (449)
T ss_pred             CCCccEEeccCce-EEecccccccccchhhhhh--hHHHHHHHHhccHHHhhcchhh--cCccceehhhHHHHHHHhhhh
Confidence            3578999988776 9999999997543322221  2223689999999999988764  678999999999999999888


Q ss_pred             CCCC------CceeeEEEecC
Q psy10603        386 NLSG------VVVSAEVFGSG  400 (407)
Q Consensus       386 ~~~~------~~~~~~~~~~~  400 (407)
                      +|-.      .+.|.+.+|++
T Consensus       257 LFQAq~PiqQL~lItdLLGTP  277 (449)
T KOG0664|consen  257 LFQAAGPIEQLQMIIDLLGTP  277 (449)
T ss_pred             hhhccChHHHHHHHHHHhCCC
Confidence            8752      33344555554

>KOG0033|consensus

Probab=99.29  E-value=3.3e-12  Score=110.25  Aligned_cols=76  Identities=32%  Similarity=0.635  Sum_probs=61.9

Q ss_pred             CCccEEEec--CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~~--~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      ++.|+++..  ++..+|++|||+|...+...    ...+.+|||.|||||++...   .++.++||||.|+++|-++.|.
T Consensus       137 kP~nllLASK~~~A~vKL~~FGvAi~l~~g~----~~~G~~GtP~fmaPEvvrkd---py~kpvDiW~cGViLfiLL~G~  209 (355)
T KOG0033|consen  137 KPENLLLASKAKGAAVKLADFGLAIEVNDGE----AWHGFAGTPGYLSPEVLKKD---PYSKPVDIWACGVILYILLVGY  209 (355)
T ss_pred             ChhheeeeeccCCCceeecccceEEEeCCcc----ccccccCCCcccCHHHhhcC---CCCCcchhhhhhHHHHHHHhCC
Confidence            467888854  34579999999998776322    23456899999999999654   3578999999999999999999


Q ss_pred             CCCCC
Q psy10603        385 TNLSG  389 (407)
Q Consensus       385 ~~~~~  389 (407)
                      +||.|
T Consensus       210 ~PF~~  214 (355)
T KOG0033|consen  210 PPFWD  214 (355)
T ss_pred             CCCCC
Confidence            99998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.28  E-value=3.1e-12  Score=123.19  Aligned_cols=82  Identities=34%  Similarity=0.566  Sum_probs=60.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC--------------------------------CCcccccccccccccC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV--------------------------------PGELNGFVGTQAYMAP  353 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~--------------------------------~~~~~~~~gt~~y~aP  353 (407)
                      .++.|++++.++. +||+|||+++.+......                                .......+||+.|+||
T Consensus       127 lKp~NILi~~~~~-vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP  205 (363)
T cd05628         127 IKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP  205 (363)
T ss_pred             CCHHHeEECCCCC-EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence            3567899987765 999999999754321100                                0001235799999999


Q ss_pred             cccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        354 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       354 E~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      |++.+.   .++.++||||+||++|||++|+.||.+..
T Consensus       206 E~~~~~---~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         206 EVFMQT---GYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             HHHcCC---CCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence            998653   34678999999999999999999998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.27  E-value=3.6e-12  Score=121.35  Aligned_cols=83  Identities=33%  Similarity=0.467  Sum_probs=61.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++...............+||+.|+|||++.+.. ..++.++||||+||+++||++|++
T Consensus       129 lkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         129 LKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             CCHHHeEECCCCc-EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc-cccCchhHHHHHHHHHHHHHcCCC
Confidence            3456888877765 99999999975432221111123457999999999985421 235678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      +|.+-
T Consensus       207 pf~~~  211 (338)
T cd07859         207 LFPGK  211 (338)
T ss_pred             CCCCC
Confidence            99864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	407
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-42
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-40
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-37
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-36
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-36
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-36
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-36
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-36
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-36
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-34
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-31
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-30
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-30
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-30
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-30
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-30
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-29
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-29
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-28
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-28
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-28
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-28
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-28
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-28
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-28
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-28
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-27
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-27
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-27
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-27
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-27
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-27
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-26
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-26
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-26
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-26
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-04
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-26
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-26
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-26
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-26
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-26
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-26
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-26
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-26
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-26
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-26
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-26
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-26
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-26
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-26
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-26
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-26
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-26
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-26
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-26
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-26
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-26
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-26
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-26
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-26
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-26
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-26
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-26
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-26
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-26
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-26
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-26
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-26
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-25
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-25
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-25
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-25
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-25
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-25
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-25
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-25
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-25
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-25
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-25
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-25
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-25
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-25
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-25
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-25
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-25
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-25
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-25
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-25
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-25
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-25
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-24
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-24
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-24
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-24
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-24
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-24
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-24
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-24
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-24
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-24
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-24
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-24
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-24
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-24
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-24
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-24
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-24
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-24
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-24
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-24
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-05
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-23
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-23
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-23
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-23
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-23
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-23
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-23
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-23
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-23
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-23
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-23
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-23
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-23
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-23
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-23
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-22
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-22
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-22
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-22
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-22
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-22
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-22
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-22
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-22
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-22
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-22
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-22
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-21
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-21
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-21
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-21
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-21
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-21
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-21
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-21
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-21
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-21
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-20
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-20
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-20
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-20
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-20
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-20
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-20
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-20
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-20
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-20
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-20
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-20
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-20
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-20
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-20
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-20
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-19
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-19
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-19
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-19
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-19
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-19
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-19
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-19
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-19
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-19
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-19
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-19
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-19
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-19
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-19
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-19
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-19
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-19
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-19
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-19
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-19
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-19
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-19
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-19
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-19
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-19
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-19
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-19
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-19
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-18
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-04
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-18
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-18
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-18
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-18
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-18
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-18
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-18
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
3soa_A	444	Full-Length Human Camkii Length = 444		1e-17
3soa_A	444	Full-Length Human Camkii Length = 444		1e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-17
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-17
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-17
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-17
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-17
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-17
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-17
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-17
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-17
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-17
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-17
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-17
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-17
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-16
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-16
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-16
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-16
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-16
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-16
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-16
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-16
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-16
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-16
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-16
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-15
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-15
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-15
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-15
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-15
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-15
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-14
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-04
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-04
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-12
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-11
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		6e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		7e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		7e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 151/271 (55%), Gaps = 10/271 (3%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY   +      +A+KEI    + D+R+ + +  E+ + + +  KN+V+Y G 
Sbjct: 31  GKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLP--EVLVRRYTKQLVDAISALHENTIVHRD 128
                 + +FME    G+L +L++S    L   E  +  YTKQ+++ +  LH+N IVHRD
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK  N+ +      LK+ DFG++ +++           F GT  YMAPE+ +D    G+G
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEI-IDKGPRGYG 203
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELCL 247
           +A DIWSLGC ++EM++GK P+ E       MFKVGM +  P IPES+S E +AF   C 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 248 RHDPAQRATIFELLQHPFLIVSCEEDVCNPR 278
             DP +RA   +LL   FL VS ++    P+
Sbjct: 264 EPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 45/75 (60%), Gaps = 4/75 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +      LK+ DFG++ +++           F GT  YMAPE+ +D    G+G+A D
Sbjct: 152 NVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEI-IDKGPRGYGKAAD 207
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLGC ++EM++GK
Sbjct: 208 IWSLGCTIIEMATGK 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 95/259 (36%), Positives = 145/259 (55%), Gaps = 10/259 (3%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY   +      +A+KEI    + D+R+ + +  E+ + + +  KN+V+Y G 
Sbjct: 17  GKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLP--EVLVRRYTKQLVDAISALHENTIVHRD 128
                 + +FME    G+L +L++S    L   E  +  YTKQ+++ +  LH+N IVHRD
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK  N+ +      LK+ DFG++ +++           F GT  YMAPE+ +D    G+G
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEI-IDKGPRGYG 189
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELCL 247
           +A DIWSLGC ++EM++GK P+ E       MFKVGM +  P IPES+S E +AF   C 
Sbjct: 190 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 249
Query: 248 RHDPAQRATIFELLQHPFL 266
             DP +RA   +LL   FL
Sbjct: 250 EPDPDKRACANDLLVDEFL 268

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 45/75 (60%), Gaps = 4/75 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +      LK+ DFG++ +++           F GT  YMAPE+ +D    G+G+A D
Sbjct: 138 NVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEI-IDKGPRGYGKAAD 193
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLGC ++EM++GK
Sbjct: 194 IWSLGCTIIEMATGK 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 143/263 (54%), Gaps = 12/263 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ET  L A K I    + +   ++D +VE+ IL   +  N+VK    
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDA 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             +   + + +E C  G +++++   E  L E  ++   KQ +DA++ LH+N I+HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   + 
Sbjct: 163 AGNILFTLDGD-IKLADFGVSAK---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              D+WSLG  L+EM+  + P  E +   +++ K+   E PT+  P   S   + F + C
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L  +   R T  +LLQHPF+ V 
Sbjct: 278 LEKNVDARWTTSQLLQHPFVTVD 300

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 44/74 (59%), Gaps = 6/74 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGRA 367
           NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   +   
Sbjct: 165 NILFTLDGD-IKLADFGVSAK---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 368 VDIWSLGCVLVEMS 381
            D+WSLG  L+EM+
Sbjct: 221 ADVWSLGITLIEMA 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 143/263 (54%), Gaps = 12/263 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ET  L A K I    + +   ++D +VE+ IL   +  N+VK    
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDA 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             +   + + +E C  G +++++   E  L E  ++   KQ +DA++ LH+N I+HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   + 
Sbjct: 163 AGNILFTLDGD-IKLADFGVSAK---NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              D+WSLG  L+EM+  + P  E +   +++ K+   E PT+  P   S   + F + C
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L  +   R T  +LLQHPF+ V 
Sbjct: 278 LEKNVDARWTTSQLLQHPFVTVD 300

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 44/74 (59%), Gaps = 6/74 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGRA 367
           NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   +   
Sbjct: 165 NILFTLDGD-IKLADFGVSAK---NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 368 VDIWSLGCVLVEMS 381
            D+WSLG  L+EM+
Sbjct: 221 ADVWSLGITLIEMA 234

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/263 (34%), Positives = 143/263 (54%), Gaps = 12/263 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ET  L A K I    + +   ++D +VE+ IL   +  N+VK    
Sbjct: 46  GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDA 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             +   + + +E C  G +++++   E  L E  ++   KQ +DA++ LH+N I+HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   + 
Sbjct: 163 AGNILFTLDGD-IKLADFGVSAK---NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              D+WSLG  L+EM+  + P  E +   +++ K+   E PT+  P   S   + F + C
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHELNP-MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 277
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L  +   R T  +LLQHPF+ V 
Sbjct: 278 LEKNVDARWTTSQLLQHPFVTVD 300

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 44/74 (59%), Gaps = 6/74 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGRA 367
           NI  T +G+ +KL DFG + K   +T      + F+GT  +MAPEV M +T+K   +   
Sbjct: 165 NILFTLDGD-IKLADFGVSAK---NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 368 VDIWSLGCVLVEMS 381
            D+WSLG  L+EM+
Sbjct: 221 ADVWSLGITLIEMA 234

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 141/258 (54%), Gaps = 15/258 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A++ ETG++VA+K++ +        +++++ E+ I++  +  ++VKYYG 
Sbjct: 38  GEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ + ME C  G++  +++     L E  +    +  +  +  LH    +HRDIK
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L  EG++ KL DFG A ++   T    + N  +GT  +MAPEV  +   +G+   
Sbjct: 153 AGNILLNTEGHA-KLADFGVAGQL---TDXMAKRNXVIGTPFWMAPEVIQE---IGYNCV 205
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
            DIWSLG   +EM+ GK P+A+     + +F +     PT   PE  SD    F + CL 
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHP-MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264
Query: 249 HDPAQRATIFELLQHPFL 266
             P QRAT  +LLQHPF+
Sbjct: 265 KSPEQRATATQLLQHPFV 282

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 282 ASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL 341
           A++LQ  LK    L  M +    + A  NI L  EG++ KL DFG A ++   T    + 
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDIKA-GNILLNTEGHA-KLADFGVAGQL---TDXMAKR 182
Query: 342 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVF 397
           N  +GT  +MAPEV  +   +G+    DIWSLG   +EM+ GK   + +     +F
Sbjct: 183 NXVIGTPFWMAPEVIQE---IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 147/260 (56%), Gaps = 12/260 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ETG L A K I+   + +   ++D +VE+ IL   +   +VK  G 
Sbjct: 20  GDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGA 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H  ++ + +E C  G +++++   + GL E  ++   +Q+++A++ LH   I+HRD+K
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + N+ +T EG+ ++L DFG + K   +     + + F+GT  +MAPEV M +T K   + 
Sbjct: 137 AGNVLMTLEGD-IRLADFGVSAK---NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              DIWSLG  L+EM+  + P  E +   +++ K+   + PT+  P   S E + F ++ 
Sbjct: 193 YKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIA 251
Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  +P  R +  +LL+HPF+
Sbjct: 252 LDKNPETRPSAAQLLEHPFV 271

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 44/75 (58%), Gaps = 6/75 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGRA 367
           N+ +T EG+ ++L DFG + K   +     + + F+GT  +MAPEV M +T K   +   
Sbjct: 139 NVLMTLEGD-IRLADFGVSAK---NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 194
Query: 368 VDIWSLGCVLVEMSS 382
            DIWSLG  L+EM+ 
Sbjct: 195 ADIWSLGITLIEMAQ 209

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 147/260 (56%), Gaps = 12/260 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ETG L A K I+   + +   ++D +VE+ IL   +   +VK  G 
Sbjct: 28  GDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGA 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H  ++ + +E C  G +++++   + GL E  ++   +Q+++A++ LH   I+HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHG 188
           + N+ +T EG+ ++L DFG + K   +     + + F+GT  +MAPEV M +T K   + 
Sbjct: 145 AGNVLMTLEGD-IRLADFGVSAK---NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              DIWSLG  L+EM+  + P  E +   +++ K+   + PT+  P   S E + F ++ 
Sbjct: 201 YKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIA 259
Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  +P  R +  +LL+HPF+
Sbjct: 260 LDKNPETRPSAAQLLEHPFV 279

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 44/75 (58%), Gaps = 6/75 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK-VGHGRA 367
           N+ +T EG+ ++L DFG + K   +     + + F+GT  +MAPEV M +T K   +   
Sbjct: 147 NVLMTLEGD-IRLADFGVSAK---NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 202
Query: 368 VDIWSLGCVLVEMSS 382
            DIWSLG  L+EM+ 
Sbjct: 203 ADIWSLGITLIEMAQ 217

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 85/252 (33%), Positives = 136/252 (53%), Gaps = 12/252 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+F +VY A     G  VA+K++Q+    DA+   D + E+ +L+ +N  N++KYY  
Sbjct: 41  GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 100
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
            I   E+ + +EL   G L  +++  +     +PE  V +Y  QL  A+  +H   ++HR
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK AN+F+TA G  +KLGD G     S+ TT    L   VGT  YM+PE   +    G+
Sbjct: 161 DIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHEN---GY 213
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIP-ESLSDEGQAFAEL 245
               DIWSLGC+L EM++ + P+     N Y +  K+   + P +P +  S+E +    +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273
Query: 246 CLRHDPAQRATI 257
           C+  DP +R  +
Sbjct: 274 CINPDPEKRPDV 285

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 46/81 (56%), Gaps = 7/81 (8%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+TA G  +KLGD G     S+ TT    L   VGT  YM+PE   +    G+    
Sbjct: 165 ANVFITATG-VVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHEN---GYNFKS 217
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWSLGC+L EM++ ++   G
Sbjct: 218 DIWSLGCLLYEMAALQSPFYG 238

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 140/261 (53%), Gaps = 15/261 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +   E+   VGT  +MAPEV     +  +G  
Sbjct: 144 SDNILLGMDG-SVKLTDFGFCAQITPEQSKRSEM---VGTPYWMAPEV---VTRKAYGPK 196
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 249 HDPAQRATIFELLQHPFLIVS 269
            D  +R +  ELLQH FL ++
Sbjct: 256 MDVEKRGSAKELLQHQFLKIA 276

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/75 (41%), Positives = 43/75 (57%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   E+   VGT  +MAPEV     +  +G  VD
Sbjct: 146 NILLGMDG-SVKLTDFGFCAQITPEQSKRSEM---VGTPYWMAPEV---VTRKAYGPKVD 198
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 199 IWSLGIMAIEMIEGE 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 140/261 (53%), Gaps = 15/261 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  
Sbjct: 144 SDNILLGMDG-SVKLTDFGFCAQITPEQS---KRSXMVGTPYWMAPEV---VTRKAYGPK 196
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 249 HDPAQRATIFELLQHPFLIVS 269
            D  +R +  ELLQH FL ++
Sbjct: 256 MDVEKRGSAKELLQHQFLKIA 276

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 146 NILLGMDG-SVKLTDFGFCAQITPEQS---KRSXMVGTPYWMAPEV---VTRKAYGPKVD 198
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 199 IWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 140/261 (53%), Gaps = 15/261 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  
Sbjct: 144 SDNILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPK 196
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 249 HDPAQRATIFELLQHPFLIVS 269
            D  +R +  ELLQH FL ++
Sbjct: 256 MDVEKRGSAKELLQHQFLKIA 276

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 146 NILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPKVD 198
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 199 IWSLGIMAIEMIEGE 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 141/281 (50%), Gaps = 21/281 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A +    E+VA+K++    +      +D++ E+R L+ +   N ++Y G 
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRD+K
Sbjct: 123 YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L+  G  +KLGDFGSA       ++    N FVGT  +MAPEV +  ++  +   
Sbjct: 182 AGNILLSEPG-LVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQAFAELCLRH 249
           VD+WSLG   +E++  K P    ++    ++ +   E+P +     S+  + F + CL+ 
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
            P  R T   LL+H F++          R  P +V+ D ++
Sbjct: 293 IPQDRPTSEVLLKHRFVL----------RERPPTVIMDLIQ 323

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           +A   L +E   +KLGDFGSA       ++    N FVGT  +MAPEV +  ++  +   
Sbjct: 181 KAGNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 368 VDIWSLGCVLVEMSSGKTNL 387
           VD+WSLG   +E++  K  L
Sbjct: 234 VDVWSLGITCIELAERKPPL 253

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 140/261 (53%), Gaps = 15/261 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 86
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 144
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  
Sbjct: 145 SDNILLGMDG-SVKLTDFGFCAQITPEQS---KRSXMVGTPYWMAPEV---VTRKAYGPK 197
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 249 HDPAQRATIFELLQHPFLIVS 269
            D  +R +  EL+QH FL ++
Sbjct: 257 MDVEKRGSAKELIQHQFLKIA 277

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 147 NILLGMDG-SVKLTDFGFCAQITPEQS---KRSXMVGTPYWMAPEV---VTRKAYGPKVD 199
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 200 IWSLGIMAIEMIEGE 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 141/281 (50%), Gaps = 21/281 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A +    E+VA+K++    +      +D++ E+R L+ +   N ++Y G 
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRD+K
Sbjct: 84  YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L+  G  +KLGDFGSA       ++    N FVGT  +MAPEV +  ++  +   
Sbjct: 143 AGNILLSEPG-LVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQAFAELCLRH 249
           VD+WSLG   +E++  K P    ++    ++ +   E+P +     S+  + F + CL+ 
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
            P  R T   LL+H F++          R  P +V+ D ++
Sbjct: 254 IPQDRPTSEVLLKHRFVL----------RERPPTVIMDLIQ 284

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           +A   L +E   +KLGDFGSA       ++    N FVGT  +MAPEV +  ++  +   
Sbjct: 142 KAGNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 368 VDIWSLGCVLVEMSSGKTNL 387
           VD+WSLG   +E++  K  L
Sbjct: 195 VDVWSLGITCIELAERKPPL 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 140/261 (53%), Gaps = 15/261 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     +   + E+ ++      N+V Y   
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDS 86
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  TE  + E  +    ++ + A+  LH N ++HR+IK
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIK 144
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  
Sbjct: 145 SDNILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPK 197
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 249 HDPAQRATIFELLQHPFLIVS 269
            D  +R +  EL+QH FL ++
Sbjct: 257 MDVEKRGSAKELIQHQFLKIA 277

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G S+KL DFG   +I+   +   + +  VGT  +MAPEV     +  +G  VD
Sbjct: 147 NILLGMDG-SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEV---VTRKAYGPKVD 199
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG + +EM  G+
Sbjct: 200 IWSLGIMAIEMIEGE 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 137/262 (52%), Gaps = 12/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D         E+ +L   +   + KYYG 
Sbjct: 32  GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ--EITVLSQCDSSYVTKYYGS 89
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L+++      E  +    K+++  +  LH    +HRDIK
Sbjct: 90  YLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 148 AANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIQQS---AYDSK 200
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P ++     +++F +     PT+    +   + F + CL  D
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHP-MRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKD 259
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P+ R T  ELL+H F++ + ++
Sbjct: 260 PSFRPTAKELLKHKFIVKNSKK 281

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 7/76 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 149 ANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIQQS---AYDSKA 201
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 202 DIWSLGITAIELAKGE 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 12/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D         E+ +L   +   + KYYG 
Sbjct: 31  GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--EITVLSQCDSPYVTKYYGS 88
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 147 AANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQS---AYDSK 199
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P +E     +++F +     PT+  + S   + F E CL  +
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHP-MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P+ R T  ELL+H F++ + ++
Sbjct: 259 PSFRPTAKELLKHKFILRNAKK 280

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 148 ANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQS---AYDSKA 200
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 201 DIWSLGITAIELARGE 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 12/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D         E+ +L   +   + KYYG 
Sbjct: 36  GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--EITVLSQCDSPYVTKYYGS 93
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 94  YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 152 AANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDSK 204
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P +E     +++F +     PT+  + S   + F E CL  +
Sbjct: 205 ADIWSLGITAIELARGEPPHSELHP-MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 263
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P+ R T  ELL+H F++ + ++
Sbjct: 264 PSFRPTAKELLKHKFILRNAKK 285

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 153 ANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDSKA 205
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 206 DIWSLGITAIELARGE 221

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    TG+ VA+K++ L KQ        +  E+ I+   +  N+V  Y  
Sbjct: 54  GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHDNVVDMYSS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT++G  +KL DFG   ++S    VP      VGT  +MAPEV    +++ +G  
Sbjct: 169 SDSILLTSDGR-IKLSDFGFCAQVSKE--VPKR-KXLVGTPYWMAPEVI---SRLPYGTE 221
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+   +   Q M ++     P + +   +S   + F +L L 
Sbjct: 222 VDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLV 280
Query: 249 HDPAQRATIFELLQHPFL 266
            +P+QRAT  ELL HPFL
Sbjct: 281 REPSQRATAQELLGHPFL 298

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/75 (41%), Positives = 46/75 (61%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT++G  +KL DFG   ++S    VP      VGT  +MAPEV    +++ +G  VD
Sbjct: 171 SILLTSDGR-IKLSDFGFCAQVSKE--VPKR-KXLVGTPYWMAPEVI---SRLPYGTEVD 223
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 224 IWSLGIMVIEMIDGE 238

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 132/256 (51%), Gaps = 12/256 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+VY  ++N T E+VA+K I L +  D         E+ +L   +   + +Y+G 
Sbjct: 28  GKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ--EITVLSQCDSPYITRYFGS 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 144 AANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQS---AYDFK 196
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P ++     +++F +     PT+    S   + F E CL  D
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHP-MRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKD 255
Query: 251 PAQRATIFELLQHPFL 266
           P  R T  ELL+H F+
Sbjct: 256 PRFRPTAKELLKHKFI 271

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 7/76 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+ +G+ +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 145 ANVLLSEQGD-VKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQS---AYDFKA 197
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 198 DIWSLGITAIELAKGE 213

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 12/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D         E+ +L   +   + KYYG 
Sbjct: 16  GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--EITVLSQCDSPYVTKYYGS 73
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 132 AANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQS---AYDSK 184
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P +E     +++F +     PT+  + S   + F E CL  +
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHP-MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 243
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P+ R T  ELL+H F++ + ++
Sbjct: 244 PSFRPTAKELLKHKFILRNAKK 265

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 133 ANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNXFVGTPFWMAPEVIKQS---AYDSKA 185
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 186 DIWSLGITAIELARGE 201

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 12/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D         E+ +L   +   + KYYG 
Sbjct: 16  GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--EITVLSQCDSPYVTKYYGS 73
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +   
Sbjct: 132 AANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDSK 184
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P +E     +++F +     PT+  + S   + F E CL  +
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHP-MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 243
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P+ R T  ELL+H F++ + ++
Sbjct: 244 PSFRPTAKELLKHKFILRNAKK 265

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+  G  +KL DFG A ++   T    + N FVGT  +MAPEV   +    +    
Sbjct: 133 ANVLLSEHGE-VKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQS---AYDSKA 185
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 186 DIWSLGITAIELARGE 201

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 134/258 (51%), Gaps = 15/258 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 29  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 144 SDSILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPE 196
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+   +   + M  +     P +     +S   + F +  L 
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 255
Query: 249 HDPAQRATIFELLQHPFL 266
            DPAQRAT  ELL+HPFL
Sbjct: 256 RDPAQRATAAELLKHPFL 273

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 146 SILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPEVD 198
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 199 IWSLGIMVIEMVDGE 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 134/258 (51%), Gaps = 15/258 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 33  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 89
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 148 SDSILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPE 200
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+   +   + M  +     P +     +S   + F +  L 
Sbjct: 201 VDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 259
Query: 249 HDPAQRATIFELLQHPFL 266
            DPAQRAT  ELL+HPFL
Sbjct: 260 RDPAQRATAAELLKHPFL 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 150 SILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPEVD 202
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 203 IWSLGIMVIEMVDGE 217

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 132/257 (51%), Gaps = 13/257 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 40  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 96
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 155 SDSILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPE 207
Query: 191 VDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           VDIWSLG +++EM  G+ P+  E       M +  +         +S   + F +  L  
Sbjct: 208 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 267
Query: 250 DPAQRATIFELLQHPFL 266
           DPAQRAT  ELL+HPFL
Sbjct: 268 DPAQRATAAELLKHPFL 284

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 157 SILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPEVD 209
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 210 IWSLGIMVIEMVDGE 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 134/258 (51%), Gaps = 15/258 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 38  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 94
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 153 SDSILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPE 205
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+   +   + M  +     P +     +S   + F +  L 
Sbjct: 206 VDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 264
Query: 249 HDPAQRATIFELLQHPFL 266
            DPAQRAT  ELL+HPFL
Sbjct: 265 RDPAQRATAAELLKHPFL 282

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 155 SILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPEVD 207
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 208 IWSLGIMVIEMVDGE 222

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 132/257 (51%), Gaps = 13/257 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 83  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 139
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 198 SDSILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPE 250
Query: 191 VDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           VDIWSLG +++EM  G+ P+  E       M +  +         +S   + F +  L  
Sbjct: 251 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310
Query: 250 DPAQRATIFELLQHPFL 266
           DPAQRAT  ELL+HPFL
Sbjct: 311 DPAQRATAAELLKHPFL 327

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 200 SILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPEVD 252
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 253 IWSLGIMVIEMVDGE 267

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 132/257 (51%), Gaps = 13/257 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G+LVA+K++ L KQ        +  E+ I+     +N+V+ Y  
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNS 216
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G L  +V  T   + E  +      ++ A+S LH   ++HRDIK
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  
Sbjct: 275 SDSILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPE 327
Query: 191 VDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           VDIWSLG +++EM  G+ P+  E       M +  +         +S   + F +  L  
Sbjct: 328 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387
Query: 250 DPAQRATIFELLQHPFL 266
           DPAQRAT  ELL+HPFL
Sbjct: 388 DPAQRATAAELLKHPFL 404

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 45/75 (60%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   ++S    VP      VGT  +MAPE+    +++ +G  VD
Sbjct: 277 SILLTHDGR-VKLSDFGFCAQVSKE--VPRR-KXLVGTPYWMAPELI---SRLPYGPEVD 329
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 330 IWSLGIMVIEMVDGE 344

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 131/262 (50%), Gaps = 15/262 (5%)
Query: 8   VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           V  G+G  G V  A    +G  VA+K + L KQ        +  E+ I+      N+V+ 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHFNVVEM 107
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y   +  EE+ + ME    G L  +V      L E  +    + ++ A++ LH   ++HR
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIKS +I LT +G  +KL DFG   +IS    VP      VGT  +MAPEV    ++  +
Sbjct: 166 DIKSDSILLTLDGR-VKLSDFGFCAQIS--KDVPKR-KXLVGTPYWMAPEVI---SRSLY 218
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAEL 245
              VDIWSLG +++EM  G+ P+   DS  Q M ++     P +  S  +S   + F E 
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 246 CLRHDPAQRATIFELLQHPFLI 267
            L  DP +RAT  ELL HPFL+
Sbjct: 278 MLVRDPQERATAQELLDHPFLL 299

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/75 (41%), Positives = 43/75 (57%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           +I LT +G  +KL DFG   +IS    VP      VGT  +MAPEV    ++  +   VD
Sbjct: 171 SILLTLDGR-VKLSDFGFCAQISK--DVPKR-KXLVGTPYWMAPEVI---SRSLYATEVD 223
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLG +++EM  G+
Sbjct: 224 IWSLGIMVIEMVDGE 238

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 153/290 (52%), Gaps = 26/290 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G G +G+VY   + +TG+L A+K + +    +    +++  E+ +L+   + +N+  YYG
Sbjct: 33  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYG 88
Query: 70  VEIHR------EEMVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHEN 122
             I +      +++ L ME C  G++  L+++T+ + L E  +    ++++  +S LH++
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-D 181
            ++HRDIK  N+ LT E   +KL DFG + ++    TV G  N F+GT  +MAPEV   D
Sbjct: 149 KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD--RTV-GRRNTFIGTPYWMAPEVIACD 204
Query: 182 TN-KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEG 239
            N    +    D+WSLG   +EM+ G  P  +     + +F +     P +  +  S + 
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPAPRLKSKKWSKKF 263
Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYL 289
           Q+F E CL  + +QR    +L++HPF+      D  N R V    L+D++
Sbjct: 264 QSFIESCLVKNHSQRPATEQLMKHPFI-----RDQPNERQVRIQ-LKDHI 307

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 43/80 (53%), Gaps = 6/80 (7%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTN-KVGHGRA 367
           N+ LT E   +KL DFG + ++    TV G  N F+GT  +MAPEV   D N    +   
Sbjct: 159 NVLLT-ENAEVKLVDFGVSAQLD--RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFK 214
Query: 368 VDIWSLGCVLVEMSSGKTNL 387
            D+WSLG   +EM+ G   L
Sbjct: 215 SDLWSLGITAIEMAEGAPPL 234

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 131/268 (48%), Gaps = 21/268 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G G +G+         G+++  KE+      +A   K MLV E+ +L  +   N+V+YY 
Sbjct: 15  GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE--KQMLVSEVNLLRELKHPNIVRYYD 72
Query: 70  VEIHREEMVLF--MELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE--- 121
             I R    L+  ME C  G L S++         L E  V R   QL  A+   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 122 --NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
             +T++HRD+K AN+FL  + N +KLGDFG A +I  H T   +   FVGT  YM+PE  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA-RILNHDTSFAK--AFVGTPYYMSPE-- 186
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
              N++ +    DIWSLGC+L E+ +   P+  + S  ++  K+  G+   IP   SDE 
Sbjct: 187 -QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRRIPYRYSDEL 244
Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLI 267
                  L      R ++ E+L++P ++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 7/74 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+FL  + N +KLGDFG A +I  H T   +   FVGT  YM+PE     N++ +    
Sbjct: 145 ANVFLDGKQN-VKLGDFGLA-RILNHDTSFAK--AFVGTPYYMSPE---QMNRMSYNEKS 197
Query: 369 DIWSLGCVLVEMSS 382
           DIWSLGC+L E+ +
Sbjct: 198 DIWSLGCLLYELCA 211

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  +S  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 131/268 (48%), Gaps = 21/268 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G G +G+         G+++  KE+      +A   K MLV E+ +L  +   N+V+YY 
Sbjct: 15  GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE--KQMLVSEVNLLRELKHPNIVRYYD 72
Query: 70  VEIHREEMVLF--MELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE--- 121
             I R    L+  ME C  G L S++         L E  V R   QL  A+   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 122 --NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
             +T++HRD+K AN+FL  + N +KLGDFG A +I  H T   +   FVGT  YM+PE  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA-RILNHDTSFAK--TFVGTPYYMSPE-- 186
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
              N++ +    DIWSLGC+L E+ +   P+  + S  ++  K+  G+   IP   SDE 
Sbjct: 187 -QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRRIPYRYSDEL 244
Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLI 267
                  L      R ++ E+L++P ++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 7/74 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+FL  + N +KLGDFG A +I  H T   +   FVGT  YM+PE     N++ +    
Sbjct: 145 ANVFLDGKQN-VKLGDFGLA-RILNHDTSFAK--TFVGTPYYMSPE---QMNRMSYNEKS 197
Query: 369 DIWSLGCVLVEMSS 382
           DIWSLGC+L E+ +
Sbjct: 198 DIWSLGCLLYELCA 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 142/274 (51%), Gaps = 17/274 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-LEGINQKNLVKYYG 69
           G+G +G V   V+  +G+++A+K I+     D +  K +L++L + +   +   +V++YG
Sbjct: 31  GRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 70  VEIHREEMVLFMELCT---EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIV 125
                 +  + MEL +   +   + +    +D +PE ++ + T   V A++ L EN  I+
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII 148
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNK 184
           HRDIK +NI L   GN +KL DFG    IS             G + YMAPE +    ++
Sbjct: 149 HRDIKPSNILLDRSGN-IKLCDFG----ISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA--- 241
            G+    D+WSLG  L E+++G+ P+ +++S +  + +V  G+ P +  S   E      
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263
Query: 242 -FAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
            F  LCL  D ++R    ELL+HPF+++  E  V
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNKVGHGRA 367
           +NI L   GN +KL DFG    IS             G + YMAPE +    ++ G+   
Sbjct: 155 SNILLDRSGN-IKLCDFG----ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR 209
Query: 368 VDIWSLGCVLVEMSSGK 384
            D+WSLG  L E+++G+
Sbjct: 210 SDVWSLGITLYELATGR 226

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 71
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 72  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 131 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 180
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 181 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 293
Query: 277 P 277
           P
Sbjct: 294 P 294

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 134 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 181
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGXK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGXKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 71
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 72  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 131 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 180
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 181 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 293
Query: 277 P 277
           P
Sbjct: 294 P 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 134 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 181
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 19  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 77
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 78  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 136
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 137 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGXK 186
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 187 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 299
Query: 277 P 277
           P
Sbjct: 300 P 300

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 140 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGXKY-- 187
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 16  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 74
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 75  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 133
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 134 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 183
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 184 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 296
Query: 277 P 277
           P
Sbjct: 297 P 297

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 137 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 184
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 74  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 183 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 295
Query: 277 P 277
           P
Sbjct: 296 P 296

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 136 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 183
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 72
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 73  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 132 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 181
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 182 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 294
Query: 277 P 277
           P
Sbjct: 295 P 295

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 135 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 182
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 72
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E  +    + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 73  -IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 132 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 181
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 182 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 294
Query: 277 P 277
           P
Sbjct: 295 P 295

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 135 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 182
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 74  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 183 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 295
Query: 277 P 277
           P
Sbjct: 296 P 296

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 136 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 183
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 19  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 77
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 78  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 136
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 137 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 186
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 187 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 299
Query: 277 P 277
           P
Sbjct: 300 P 300

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 140 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 187
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 141/286 (49%), Gaps = 39/286 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V    N +TG +VA+K+  L   +D    K  + E+++L+ +  +NLV    V
Sbjct: 34  GEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++   L  E      L+ L +   +GL   +V++Y  Q+++ I   H + I+HRDIK
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI ++  G  +KL DFG A  ++A    PGE+ +  V T+ Y APE+ +    V +G+
Sbjct: 152 PENILVSQSG-VVKLCDFGFARTLAA----PGEVYDDEVATRWYRAPELLV--GDVKYGK 204
Query: 190 AVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVG---------MGETPT-----IP 232
           AVD+W++GC++ EM  G+  +   ++ D  Y IM  +G           + P      +P
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 233 E------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           E             LS+     A+ CL  DP +R    ELL H F 
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 47/78 (60%), Gaps = 7/78 (8%)
Query: 313 LTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
           L ++   +KL DFG A  ++A    PGE+ +  V T+ Y APE+ +    V +G+AVD+W
Sbjct: 156 LVSQSGVVKLCDFGFARTLAA----PGEVYDDEVATRWYRAPELLV--GDVKYGKAVDVW 209
Query: 372 SLGCVLVEMSSGKTNLSG 389
           ++GC++ EM  G+    G
Sbjct: 210 AIGCLVTEMFMGEPLFPG 227

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 72
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 73  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 132 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 181
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 182 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 294
Query: 277 P 277
           P
Sbjct: 295 P 295

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 135 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 182
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 69
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 70  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 178
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 179 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 291
Query: 277 P 277
           P
Sbjct: 292 P 292

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 132 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 179
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 72
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 73  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 131
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 132 KPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 181
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 182 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 294
Query: 277 P 277
           P
Sbjct: 295 P 295

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 135 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 182
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 71
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 72  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 131 KPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 180
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 181 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 293
Query: 277 P 277
           P
Sbjct: 294 P 294

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 134 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 181
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 69
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 70  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 178
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 179 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 291
Query: 277 P 277
           P
Sbjct: 292 P 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 132 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 179
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 69
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 70  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 178
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 179 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 291
Query: 277 P 277
           P
Sbjct: 292 P 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 132 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 179
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E  +    + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 74  -IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 183 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 295
Query: 277 P 277
           P
Sbjct: 296 P 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 136 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 183
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 69
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 70  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 178
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 179 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 291
Query: 277 P 277
           P
Sbjct: 292 P 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 132 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 179
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 71
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 72  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 131 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 180
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 181 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 293
Query: 277 P 277
           P
Sbjct: 294 P 294

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 134 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 181
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E  +    + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 74  -IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 133 KPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 183 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 295
Query: 277 P 277
           P
Sbjct: 296 P 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 136 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 183
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 129/268 (48%), Gaps = 21/268 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G G +G+         G+++  KE+      +A   K MLV E+ +L  +   N+V+YY 
Sbjct: 15  GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE--KQMLVSEVNLLRELKHPNIVRYYD 72
Query: 70  VEIHREEMVLF--MELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE--- 121
             I R    L+  ME C  G L S++         L E  V R   QL  A+   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 122 --NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
             +T++HRD+K AN+FL  + N +KLGDFG A  ++       E   FVGT  YM+PE  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDEDFAKE---FVGTPYYMSPE-- 186
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
              N++ +    DIWSLGC+L E+ +   P+  + S  ++  K+  G+   IP   SDE 
Sbjct: 187 -QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRRIPYRYSDEL 244
Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLI 267
                  L      R ++ E+L++P ++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/74 (41%), Positives = 43/74 (58%), Gaps = 7/74 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+FL  + N +KLGDFG A  ++       E   FVGT  YM+PE     N++ +    
Sbjct: 145 ANVFLDGKQN-VKLGDFGLARILNHDEDFAKE---FVGTPYYMSPE---QMNRMSYNEKS 197
Query: 369 DIWSLGCVLVEMSS 382
           DIWSLGC+L E+ +
Sbjct: 198 DIWSLGCLLYELCA 211

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 141/306 (46%), Gaps = 40/306 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V+   N +TG++VA+K+  L  ++D    K  L E+R+L+ +   NLV    V
Sbjct: 12  GEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +  + L  E C    L  L    + G+PE LV+  T Q + A++  H++  +HRD+K
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK 129
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGR 189
             NI +T   + +KL DFG A  ++  +      +  V T+ Y +PE+ + DT    +G 
Sbjct: 130 PENILITKH-SVIKLCDFGFARLLTGPSDY---YDDEVATRWYRSPELLVGDTQ---YGP 182
Query: 190 AVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVG----------------MGETPT 230
            VD+W++GCV  E+ SG   W   ++ D  Y I   +G                 G    
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242
Query: 231 IPESLSDEGQAFAEL----------CLRHDPAQRATIFELLQHPFLIVSCE-EDVCNPRS 279
            PE +      F  +          CL  DP +R T  +LL HP+     E ED+     
Sbjct: 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD 302
Query: 280 VPASVL 285
            PA  L
Sbjct: 303 KPAENL 308

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGRAV 368
           NI +T   + +KL DFG A  ++  +      +  V T+ Y +PE+ + DT    +G  V
Sbjct: 132 NILITKH-SVIKLCDFGFARLLTGPSDY---YDDEVATRWYRSPELLVGDTQ---YGPPV 184
Query: 369 DIWSLGCVLVEMSSG 383
           D+W++GCV  E+ SG
Sbjct: 185 DVWAIGCVFAELLSG 199

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 71
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E  +    + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 72  -IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 130
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 131 KPENLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 180
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 181 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 293
Query: 277 P 277
           P
Sbjct: 294 P 294

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 134 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 181
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 16  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 74
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 75  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 133
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 134 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 183
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 184 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 296
Query: 277 P 277
           P
Sbjct: 297 P 297

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 137 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 184
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 141/301 (46%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +     +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 74  -IHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 183 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 295
Query: 277 P 277
           P
Sbjct: 296 P 296

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 136 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 183
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 142/301 (47%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 74  -IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 133 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 183 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 295
Query: 277 P 277
           P
Sbjct: 296 P 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 136 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 183
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 74  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 132 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YG 183
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YGRAV 186
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 138/290 (47%), Gaps = 48/290 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            P+ P+            L ++G++     L +DP +R +    L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYXHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 17  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 76
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 77  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 135 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YG 186
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 244
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 245 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 282

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 138 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YGRAV 189
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 190 DWWGLGVVMYEMMCGR 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 74  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 132 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YG 183
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YGRAV 186
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 139/273 (50%), Gaps = 32/273 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G F  V   +N ETG+  A+K + + K   +     +D+  E  I   +   ++V+  
Sbjct: 33  GKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL- 91
Query: 69  GVEIHREEMVLFM--------ELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISA 118
            +E +  + +L+M        +LC E     +V+  + G    E +   Y +Q+++A+  
Sbjct: 92  -LETYSSDGMLYMVFEFMDGADLCFE-----IVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
            H+N I+HRD+K  N+ L ++ NS  +KLGDFG A+++     V G   G VGT  +MAP
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG---GRVGTPHFMAP 202
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
           EV     +  +G+ VD+W  G +L  + SG  P+  Y +  ++   +  G+    P   S
Sbjct: 203 EV---VKREPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGKYKMNPRQWS 257
Query: 237 DEGQAFAELCLRH---DPAQRATIFELLQHPFL 266
              ++  +L  R    DPA+R T++E L HP+L
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 8/76 (10%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++ NS  +KLGDFG A+++     V G   G VGT  +MAPEV     +  +G+ 
Sbjct: 160 NVLLASKENSAPVKLGDFGVAIQLGESGLVAG---GRVGTPHFMAPEV---VKREPYGKP 213
Query: 368 VDIWSLGCVLVEMSSG 383
           VD+W  G +L  + SG
Sbjct: 214 VDVWGCGVILFILLSG 229

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 19  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 78
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 79  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 137 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YG 188
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 246
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 247 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 284

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 140 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YGRAV 191
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 192 DWWGLGVVMYEMMCGR 207

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 141/301 (46%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 69
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +     +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 70  -IHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 178
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 179 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 291
Query: 277 P 277
           P
Sbjct: 292 P 292

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 132 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 179
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 74  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 132 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YG 183
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLEDND---YGRAV 186
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 74  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 132 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YG 183
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YGRAV 186
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 133/278 (47%), Gaps = 19/278 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   + E R+L+      L    Y 
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH   +V+RDI
Sbjct: 74  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +G
Sbjct: 132 KLENLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YG 183
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           RAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 249 HDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVP 281
            DP QR     +   E+++H F +    +DV   + +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 279

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG   + IS   T    +  F GT  Y+APEV  D +   +GRAV
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGAT----MKXFCGTPEYLAPEVLEDND---YGRAV 186
Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 141/301 (46%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+ +I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALXKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 70
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 71  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 129
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 130 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 179
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 180 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 292
Query: 277 P 277
           P
Sbjct: 293 P 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 133 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 180
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 141/301 (46%), Gaps = 53/301 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+ +I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALXKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLDV 69
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            IH E ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+
Sbjct: 70  -IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128
Query: 130 KSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           K  N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +   
Sbjct: 129 KPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCK 178
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGE------------- 227
              +  AVDIWSLGC+  EM + +  +   +E D  ++I   +G  +             
Sbjct: 179 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 228 TPTIPE-----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
            P+ P+            L ++G++     L +DP +R +    L HPF      +DV  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-----QDVTK 291
Query: 277 P 277
           P
Sbjct: 292 P 292

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG ++KL DFG A      V+   H  V         T  Y APE+ +      
Sbjct: 132 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLGCKY-- 179
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +  AVDIWSLGC+  EM + +    G
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEIXINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 245 LVENPSARITIPDI 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 14/272 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDVCNPR 278
           L  +P+ R TI ++ +  +     ++    PR
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEIXINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 246 LVENPSARITIPDI 259

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 143/286 (50%), Gaps = 13/286 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG  VA+K I   + N     K +  E+RI++ +N  N+VK + V
Sbjct: 21  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKLFEV 79
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDL 137
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   TV G+L+ F G+  Y APE+F    K   G 
Sbjct: 138 KAENLLLDADMN-IKIADFG----FSNEFTVGGKLDTFCGSPPYAAPELF--QGKKYDGP 190
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 248
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVL 295
           +P +R T+ ++++  ++    EED   P   P   + D  ++ I++
Sbjct: 249 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMV 294

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 43/80 (53%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   TV G+L+ F G+  Y APE+F    K   G  VD
Sbjct: 141 NLLLDADMN-IKIADFG----FSNEFTVGGKLDTFCGSPPYAAPELF--QGKKYDGPEVD 193
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 194 VWSLGVILYTLVSGSLPFDG 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 151/294 (51%), Gaps = 31/294 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL--HKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G  G+V+     +TG ++A+K+++   +K+ + R + D+ V   +L+  +   +V+ +
Sbjct: 34  GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQCF 90
Query: 69  GVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVH 126
           G  I   ++ + MEL   GT  E L +  +  +PE ++ + T  +V A+  L E + ++H
Sbjct: 91  GTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 184
           RD+K +NI L   G  +KL DFG    IS         +   G  AYMAPE     D  K
Sbjct: 149 RDVKPSNILLDERGQ-IKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG--QAF 242
             +    D+WSLG  LVE+++G+ P+    ++++++ KV   E P +P  +   G  Q+F
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 243 AELCLRHDPAQRATIFELLQHPFL---------IVSCEEDVC----NPRSVPAS 283
            + CL  D  +R    +LL+H F+         + S  +DV     +PRS P+S
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSGPSS 317

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 40/91 (43%), Gaps = 7/91 (7%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGR 366
           +NI L   G  +KL DFG    IS         +   G  AYMAPE     D  K  +  
Sbjct: 154 SNILLDERGQ-IKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
Query: 367 AVDIWSLGCVLVEMSSGKTNLSGVVVSAEVF 397
             D+WSLG  LVE+++G+          EV 
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVL 239

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 14/272 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDVCNPR 278
           L  +P+ R TI ++ +  +     ++    PR
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKKGAKRPR 276

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 142/286 (49%), Gaps = 13/286 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG  VA+K I   + N     K +  E+RI++ +N  N+VK + V
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKLFEV 82
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   TV G+L+ F G   Y APE+F    K   G 
Sbjct: 141 KAENLLLDADMN-IKIADFG----FSNEFTVGGKLDAFCGAPPYAAPELF--QGKKYDGP 193
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVL 295
           +P +R T+ ++++  ++    EED   P   P   + D  ++ I++
Sbjct: 252 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMV 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/80 (40%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   TV G+L+ F G   Y APE+F    K   G  VD
Sbjct: 144 NLLLDADMN-IKIADFG----FSNEFTVGGKLDAFCGAPPYAAPELF--QGKKYDGPEVD 196
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 197 VWSLGVILYTLVSGSLPFDG 216

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 14/272 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEIXINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDVCNPR 278
           L  +P+ R TI ++ +  +     ++    PR
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKKGAKRPR 276

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATI 257
           L  +P+ R TI
Sbjct: 245 LVENPSARITI 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 246 LVENPSARITIPDI 259

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 246 LVENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 246 LVENPSARITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATI 257
           L  +P+ R TI
Sbjct: 246 LVENPSARITI 256

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 245 LVENPSARITIPDI 258

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATI 257
           L  +P+ R TI
Sbjct: 245 LVENPSARITI 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 245 LVENPSARITIPDI 258

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 14  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 70
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 71  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 128 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 183
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 244 LVENPSARITIPDI 257

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 134 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 190
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 191 SCGIVLTAMLAGE 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 245 LVENPSARITIPDI 258

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 246 LVENPSARITIPDI 259

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 140/278 (50%), Gaps = 32/278 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G    V  A      E VA+K I L K   +  + ++L E++ +   +  N+V YY  
Sbjct: 19  GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQST------EDG-LPEVLVRRYTKQLVDAISALHENT 123
            + ++E+ L M+L + G++  +++        + G L E  +    +++++ +  LH+N 
Sbjct: 77  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 136
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL------NGFVGTQAYMAPE 177
            +HRD+K+ NI L  +G S+++ DFG    +SA     G++        FVGT  +MAPE
Sbjct: 137 QIHRDVKAGNILLGEDG-SVQIADFG----VSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
           V       G+    DIWS G   +E+++G  P+ +Y     +M  +   + P++   + D
Sbjct: 192 VMEQVR--GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQD 248
Query: 238 E------GQAFAE---LCLRHDPAQRATIFELLQHPFL 266
           +      G++F +   LCL+ DP +R T  ELL+H F 
Sbjct: 249 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 12/82 (14%)
Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL------NGFVGTQAYMAPEVFMDTNK 361
           +A   L  E  S+++ DFG    +SA     G++        FVGT  +MAPEV      
Sbjct: 143 KAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR- 197
Query: 362 VGHGRAVDIWSLGCVLVEMSSG 383
            G+    DIWS G   +E+++G
Sbjct: 198 -GYDFKADIWSFGITAIELATG 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 14/272 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDVCNPR 278
           L  +P+ R TI ++ +  +     ++    PR
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKKGAKRPR 276

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATI 257
           L  +P+ R TI
Sbjct: 245 LVENPSARITI 255

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 245 LVENPSARITIPDI 258

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMXGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 140/278 (50%), Gaps = 32/278 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G    V  A      E VA+K I L K   +  + ++L E++ +   +  N+V YY  
Sbjct: 24  GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQST------EDG-LPEVLVRRYTKQLVDAISALHENT 123
            + ++E+ L M+L + G++  +++        + G L E  +    +++++ +  LH+N 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL------NGFVGTQAYMAPE 177
            +HRD+K+ NI L  +G S+++ DFG    +SA     G++        FVGT  +MAPE
Sbjct: 142 QIHRDVKAGNILLGEDG-SVQIADFG----VSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
           V       G+    DIWS G   +E+++G  P+ +Y     +M  +   + P++   + D
Sbjct: 197 VMEQVR--GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQD 253
Query: 238 E------GQAFAE---LCLRHDPAQRATIFELLQHPFL 266
           +      G++F +   LCL+ DP +R T  ELL+H F 
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 40/82 (48%), Gaps = 12/82 (14%)
Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL------NGFVGTQAYMAPEVFMDTNK 361
           +A   L  E  S+++ DFG    +SA     G++        FVGT  +MAPEV      
Sbjct: 148 KAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR- 202
Query: 362 VGHGRAVDIWSLGCVLVEMSSG 383
            G+    DIWS G   +E+++G
Sbjct: 203 -GYDFKADIWSFGITAIELATG 223

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGIN 60
            S + G G  G+V  A   +T + VA+K I   K       +A    ++  E+ IL+ +N
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LH
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 131
Query: 121 ENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMA 175
           EN I+HRD+K  N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+A
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLA 184
Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-- 233
           PEV +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 234 -SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +S++     +  L  DP  R T  E L+HP+L
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 12/79 (15%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMAPEVFMDTNKVGH 364
           N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+APEV +     G+
Sbjct: 144 NVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 365 GRAVDIWSLGCVLVEMSSG 383
            RAVD WSLG +L    SG
Sbjct: 197 NRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 16/271 (5%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGIN 60
            S + G G  G+V  A   +T + VA+K I   K       +A    ++  E+ IL+ +N
Sbjct: 20  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 79
Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LH
Sbjct: 80  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 137
Query: 121 ENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           EN I+HRD+K  N+ L+++     +K+ DFG + KI   T++   +    GT  Y+APEV
Sbjct: 138 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS-KILGETSL---MRTLCGTPTYLAPEV 193
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SL 235
            +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE    +
Sbjct: 194 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 253
Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           S++     +  L  DP  R T  E L+HP+L
Sbjct: 254 SEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++     +K+ DFG + KI   T++   +    GT  Y+APEV +     G+ RA
Sbjct: 150 NVLLSSQEEDCLIKITDFGHS-KILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRA 205
Query: 368 VDIWSLGCVLVEMSSG 383
           VD WSLG +L    SG
Sbjct: 206 VDCWSLGVILFICLSG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGIN 60
            S + G G  G+V  A   +T + VA+K I   K       +A    ++  E+ IL+ +N
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LH
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 131
Query: 121 ENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMA 175
           EN I+HRD+K  N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+A
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLA 184
Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-- 233
           PEV +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 234 -SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +S++     +  L  DP  R T  E L+HP+L
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 12/79 (15%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMAPEVFMDTNKVGH 364
           N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+APEV +     G+
Sbjct: 144 NVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 365 GRAVDIWSLGCVLVEMSSG 383
            RAVD WSLG +L    SG
Sbjct: 197 NRAVDCWSLGVILFICLSG 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/251 (33%), Positives = 125/251 (49%), Gaps = 14/251 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I   +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINAMLNHENVVKFYG- 72
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 73  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 130 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 185
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 247 LRHDPAQRATI 257
           L  +P+ R TI
Sbjct: 246 LVENPSARITI 256

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 136 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 192
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 193 SCGIVLTAMLAGE 205

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGIN 60
            S + G G  G+V  A   +T + VA+K I   K       +A    ++  E+ IL+ +N
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LH
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 131
Query: 121 ENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMA 175
           EN I+HRD+K  N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+A
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLA 184
Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-- 233
           PEV +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE  
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 234 -SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +S++     +  L  DP  R T  E L+HP+L
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 12/79 (15%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMAPEVFMDTNKVGH 364
           N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+APEV +     G+
Sbjct: 144 NVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 365 GRAVDIWSLGCVLVEMSSG 383
            RAVD WSLG +L    SG
Sbjct: 197 NRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGIN 60
            S + G G  G+V  A   +T + VA+K I   K       +A    ++  E+ IL+ +N
Sbjct: 13  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 72
Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LH
Sbjct: 73  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 130
Query: 121 ENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMA 175
           EN I+HRD+K  N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+A
Sbjct: 131 ENGIIHRDLKPENVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLA 183
Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-- 233
           PEV +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE  
Sbjct: 184 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 243
Query: 234 -SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +S++     +  L  DP  R T  E L+HP+L
Sbjct: 244 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 12/79 (15%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMAPEVFMDTNKVGH 364
           N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+APEV +     G+
Sbjct: 143 NVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 195
Query: 365 GRAVDIWSLGCVLVEMSSG 383
            RAVD WSLG +L    SG
Sbjct: 196 NRAVDCWSLGVILFICLSG 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 133/273 (48%), Gaps = 22/273 (8%)
Query: 7   SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGINQ 61
           S + G G  G+V  A   +T + VA++ I   K       +A    ++  E+ IL+ +N 
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
             ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LHE
Sbjct: 214 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE 271
Query: 122 NTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMAP 176
           N I+HRD+K  N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+AP
Sbjct: 272 NGIIHRDLKPENVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLAP 324
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE--- 233
           EV +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE   
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 384
Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            +S++     +  L  DP  R T  E L+HP+L
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 12/79 (15%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE---LNGFVGTQAYMAPEVFMDTNKVGH 364
           N+ L+++     +K+ DFG       H+ + GE   +    GT  Y+APEV +     G+
Sbjct: 283 NVLLSSQEEDCLIKITDFG-------HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 335
Query: 365 GRAVDIWSLGCVLVEMSSG 383
            RAVD WSLG +L    SG
Sbjct: 336 NRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 16/270 (5%)
Query: 7   SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGINQ 61
           S + G G  G+V  A   +T + VA++ I   K       +A    ++  E+ IL+ +N 
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
             ++K        E+  + +EL   G L   V   +  L E   + Y  Q++ A+  LHE
Sbjct: 200 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE 257
Query: 122 NTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           N I+HRD+K  N+ L+++     +K+ DFG + KI   T++   +    GT  Y+APEV 
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS-KILGETSL---MRTLCGTPTYLAPEVL 313
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLS 236
           +     G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE    +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           ++     +  L  DP  R T  E L+HP+L
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++     +K+ DFG + KI   T++   +    GT  Y+APEV +     G+ RA
Sbjct: 269 NVLLSSQEEDCLIKITDFGHS-KILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRA 324
Query: 368 VDIWSLGCVLVEMSSG 383
           VD WSLG +L    SG
Sbjct: 325 VDCWSLGVILFICLSG 340

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 140/278 (50%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA+K I   + N +   K +  E+RI++ +N  N+VK + V
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEV 81
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKFIVHRDL 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G 
Sbjct: 140 KAENLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELF--QGKKYDGP 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++++  ++ V  E+D   P   P    +D
Sbjct: 251 NPSKRGTLEQIMKDRWMNVGHEDDELKPYVAPLPDYKD 288

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G  VD
Sbjct: 143 NLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQ--GKKYDGPEVD 195
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 196 VWSLGVILYTLVSGSLPFDG 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 48  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 107
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +ELC   +L  L       L E   R Y +Q+V     LH N ++HRD+K
Sbjct: 108 FEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGR 189
             N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH  
Sbjct: 167 LGNLFLN-EDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIAPEVL---SKKGHSF 218
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WS+GC++  +  GK P+ E     +   ++   E  +IP+ ++    +  +  L+ 
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQT 276
Query: 250 DPAQRATIFELLQHPFL 266
           DP  R TI ELL   F 
Sbjct: 277 DPTARPTINELLNDEFF 293

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH   V
Sbjct: 169 NLFLN-EDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIAPEVL---SKKGHSFEV 220
Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 221 DVWSIGCIMYTLLVGK 236

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 30  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 89
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +ELC   +L  L       L E   R Y +Q+V     LH N ++HRD+K
Sbjct: 90  FEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGR 189
             N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH  
Sbjct: 149 LGNLFLN-EDLEVKIGDFGLATKVEYD----GERKKTLCGTPNYIAPEVL---SKKGHSF 200
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WS+GC++  +  GK P+ E     +   ++   E  +IP+ ++    +  +  L+ 
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQT 258
Query: 250 DPAQRATIFELLQHPFL 266
           DP  R TI ELL   F 
Sbjct: 259 DPTARPTINELLNDEFF 275

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH   V
Sbjct: 151 NLFLN-EDLEVKIGDFGLATKVEYD----GERKKTLCGTPNYIAPEVL---SKKGHSFEV 202
Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 203 DVWSIGCIMYTLLVGK 218

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/254 (32%), Positives = 127/254 (50%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 15  GEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG- 71
Query: 71  EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
             HR E     LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HR
Sbjct: 72  --HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 128
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H
Sbjct: 129 DIKPENLLLD-ERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFH 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ-AFAELC 246
              VD+WS G VL  M +G+ PW +   + Q        +T   P    D    A     
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 247 LRHDPAQRATIFEL 260
           L  +P+ R TI ++
Sbjct: 245 LVENPSARITIPDI 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E ++LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD+W
Sbjct: 135 LLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPELL--KRREFHAEPVDVW 191
Query: 372 SLGCVLVEMSSGK 384
           S G VL  M +G+
Sbjct: 192 SCGIVLTAMLAGE 204

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +ELC   +L  L       L E   R Y +Q+V     LH N ++HRD+K
Sbjct: 86  FEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGR 189
             N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH  
Sbjct: 145 LGNLFLN-EDLEVKIGDFGLATKVEYD----GERKKTLCGTPNYIAPEVL---SKKGHSF 196
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WS+GC++  +  GK P+ E     +   ++   E  +IP+ ++    +  +  L+ 
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQT 254
Query: 250 DPAQRATIFELLQHPFL 266
           DP  R TI ELL   F 
Sbjct: 255 DPTARPTINELLNDEFF 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH   V
Sbjct: 147 NLFLN-EDLEVKIGDFGLATKVEYD----GERKKTLCGTPNYIAPEVL---SKKGHSFEV 198
Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 199 DVWSIGCIMYTLLVGK 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +ELC   +L  L       L E   R Y +Q+V     LH N ++HRD+K
Sbjct: 110 FEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGR 189
             N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH  
Sbjct: 169 LGNLFLN-EDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIAPEVL---SKKGHSF 220
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WS+GC++  +  GK P+ E     +   ++   E  +IP+ ++    +  +  L+ 
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQT 278
Query: 250 DPAQRATIFELLQHPFL 266
           DP  R TI ELL   F 
Sbjct: 279 DPTARPTINELLNDEFF 295

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH   V
Sbjct: 171 NLFLN-EDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIAPEVL---SKKGHSFEV 222
Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 223 DVWSIGCIMYTLLVGK 238

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +ELC   +L  L       L E   R Y +Q+V     LH N ++HRD+K
Sbjct: 86  FEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGR 189
             N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH  
Sbjct: 145 LGNLFLN-EDLEVKIGDFGLATKVEYD----GERKKTLCGTPNYIAPEVL---SKKGHSF 196
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WS+GC++  +  GK P+ E     +   ++   E  +IP+ ++    +  +  L+ 
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQT 254
Query: 250 DPAQRATIFELLQHPFL 266
           DP  R TI ELL   F 
Sbjct: 255 DPTARPTINELLNDEFF 271

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH   V
Sbjct: 147 NLFLN-EDLEVKIGDFGLATKVEYD----GERKKTLCGTPNYIAPEVL---SKKGHSFEV 198
Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 199 DVWSIGCIMYTLLVGK 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 124/257 (48%), Gaps = 12/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +ELC   +L  L       L E   R Y +Q+V     LH N ++HRD+K
Sbjct: 84  FEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGR 189
             N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH  
Sbjct: 143 LGNLFLN-EDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIAPEVL---SKKGHSF 194
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WS+GC++  +  GK P+ E     +   ++   E  +IP+ ++    +  +  L+ 
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKMLQT 252
Query: 250 DPAQRATIFELLQHPFL 266
           DP  R TI ELL   F 
Sbjct: 253 DPTARPTINELLNDEFF 269

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 42/76 (55%), Gaps = 9/76 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  E   +K+GDFG A K+       GE      GT  Y+APEV    +K GH   V
Sbjct: 145 NLFLN-EDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIAPEVL---SKKGHSFEV 196
Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 197 DVWSIGCIMYTLLVGK 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 139/278 (50%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA+K I   + N +   K +  E+RI++ +N  N+VK + V
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEV 81
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKFIVHRDL 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G   Y APE+F    K   G 
Sbjct: 140 KAENLLLDADMN-IKIADFG----FSNEFTFGNKLDAFCGAPPYAAPELF--QGKKYDGP 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++++  ++ V  E+D   P   P    +D
Sbjct: 251 NPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKD 288

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G   Y APE+F    K   G  VD
Sbjct: 143 NLLLDADMN-IKIADFG----FSNEFTFGNKLDAFCGAPPYAAPELF--QGKKYDGPEVD 195
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 196 VWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 140/278 (50%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA+K I   + N +   K +  E+RI++ +N  N+VK + V
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEV 81
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKFIVHRDL 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G 
Sbjct: 140 KAENLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELF--QGKKYDGP 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++++  ++ V  E+D   P   P    +D
Sbjct: 251 NPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKD 288

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G  VD
Sbjct: 143 NLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQ--GKKYDGPEVD 195
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 196 VWSLGVILYTLVSGSLPFDG 215

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 127/257 (49%), Gaps = 11/257 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  VY A +  TG  VA+K I       A  V+ +  E++I   +   ++++ Y  
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E+C  G +   +++      E   R +  Q++  +  LH + I+HRD+ 
Sbjct: 80  FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLT 139
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGR 189
            +N+ LT   N +K+ DFG A ++     +P E +    GT  Y++PE+     +  HG 
Sbjct: 140 LSNLLLTRNMN-IKIADFGLATQLK----MPHEKHYTLCGTPNYISPEI---ATRSAHGL 191
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             D+WSLGC+   +  G+ P+ + D+    + KV + +   +P  LS E +      LR 
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADY-EMPSFLSIEAKDLIHQLLRR 249
Query: 250 DPAQRATIFELLQHPFL 266
           +PA R ++  +L HPF+
Sbjct: 250 NPADRLSLSSVLDHPFM 266

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 41/77 (53%), Gaps = 9/77 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRA 367
           +N+ LT   N +K+ DFG A ++     +P E +    GT  Y++PE+     +  HG  
Sbjct: 141 SNLLLTRNMN-IKIADFGLATQLK----MPHEKHYTLCGTPNYISPEI---ATRSAHGLE 192
Query: 368 VDIWSLGCVLVEMSSGK 384
            D+WSLGC+   +  G+
Sbjct: 193 SDVWSLGCMFYTLLIGR 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 10/256 (3%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K Y   + +T E+ A K +           + M  E+ I + ++  ++V ++G 
Sbjct: 35  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 94
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +E+C   +L  L       + E   R + +Q +  +  LH N ++HRD+K
Sbjct: 95  FEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 153
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+FL  + + +K+GDFG A KI        +L    GT  Y+APEV     K GH   
Sbjct: 154 LGNLFLNDDMD-VKIGDFGLATKIEFDGERKKDL---CGTPNYIAPEVLC---KKGHSFE 206
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VDIWSLGC+L  +  GK P+ E     +   ++   E  ++P  ++    A     L  D
Sbjct: 207 VDIWSLGCILYTLLVGKPPF-ETSCLKETYIRIKKNEY-SVPRHINPVASALIRRMLHAD 264
Query: 251 PAQRATIFELLQHPFL 266
           P  R ++ ELL   F 
Sbjct: 265 PTLRPSVAELLTDEFF 280

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/75 (44%), Positives = 42/75 (56%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+FL  + + +K+GDFG A KI        +L    GT  Y+APEV     K GH   VD
Sbjct: 156 NLFLNDDMD-VKIGDFGLATKIEFDGERKKDL---CGTPNYIAPEVLC---KKGHSFEVD 208
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLGC+L  +  GK
Sbjct: 209 IWSLGCILYTLLVGK 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 10/256 (3%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K Y   + +T E+ A K +           + M  E+ I + ++  ++V ++G 
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +E+C   +L  L       + E   R + +Q +  +  LH N ++HRD+K
Sbjct: 111 FEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+FL  + + +K+GDFG A KI        +L    GT  Y+APEV     K GH   
Sbjct: 170 LGNLFLNDDMD-VKIGDFGLATKIEFDGERKKDL---CGTPNYIAPEVLC---KKGHSFE 222
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VDIWSLGC+L  +  GK P+ E     +   ++   E  ++P  ++    A     L  D
Sbjct: 223 VDIWSLGCILYTLLVGKPPF-ETSCLKETYIRIKKNEY-SVPRHINPVASALIRRMLHAD 280
Query: 251 PAQRATIFELLQHPFL 266
           P  R ++ ELL   F 
Sbjct: 281 PTLRPSVAELLTDEFF 296

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/75 (44%), Positives = 42/75 (56%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+FL  + + +K+GDFG A KI        +L    GT  Y+APEV     K GH   VD
Sbjct: 172 NLFLNDDMD-VKIGDFGLATKIEFDGERKKDL---CGTPNYIAPEVLC---KKGHSFEVD 224
Query: 370 IWSLGCVLVEMSSGK 384
           IWSLGC+L  +  GK
Sbjct: 225 IWSLGCILYTLLVGK 239

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 140/278 (50%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA+K I   + N +   K +  E+RI++ +N  N+VK + V
Sbjct: 16  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEV 74
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLV--AHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G 
Sbjct: 133 KAENLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELF--QGKKYDGP 185
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 186 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 243
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++++  ++ V  E+D   P   P    +D
Sbjct: 244 NPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKD 281

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G  VD
Sbjct: 136 NLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELF--QGKKYDGPEVD 188
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 189 VWSLGVILYTLVSGSLPFDG 208

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 20/261 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K Y   + +T E+ A K +           + M  E+ I + ++  ++V ++G 
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +E+C   +L  L       + E   R + +Q +  +  LH N ++HRD+K
Sbjct: 111 FEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDTNKV 185
             N+FL  + + +K+GDFG A KI        E +G       GT  Y+APEV     K 
Sbjct: 170 LGNLFLNDDMD-VKIGDFGLATKI--------EFDGERKKTLCGTPNYIAPEVLC---KK 217
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
           GH   VDIWSLGC+L  +  GK P+ E     +   ++   E  ++P  ++    A    
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPF-ETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 246 CLRHDPAQRATIFELLQHPFL 266
            L  DP  R ++ ELL   F 
Sbjct: 276 MLHADPTLRPSVAELLTDEFF 296

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/80 (42%), Positives = 43/80 (53%), Gaps = 17/80 (21%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDTNKVGH 364
           N+FL  + + +K+GDFG A KI        E +G       GT  Y+APEV     K GH
Sbjct: 172 NLFLNDDMD-VKIGDFGLATKI--------EFDGERKKTLCGTPNYIAPEVLC---KKGH 219
Query: 365 GRAVDIWSLGCVLVEMSSGK 384
              VDIWSLGC+L  +  GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 20/261 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K Y   + +T E+ A K +           + M  E+ I + ++  ++V ++G 
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + + + +E+C   +L  L       + E   R + +Q +  +  LH N ++HRD+K
Sbjct: 111 FEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDTNKV 185
             N+FL  + + +K+GDFG A KI        E +G       GT  Y+APEV     K 
Sbjct: 170 LGNLFLNDDMD-VKIGDFGLATKI--------EFDGERKKXLCGTPNYIAPEVLC---KK 217
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
           GH   VDIWSLGC+L  +  GK P+ E     +   ++   E  ++P  ++    A    
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPF-ETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 246 CLRHDPAQRATIFELLQHPFL 266
            L  DP  R ++ ELL   F 
Sbjct: 276 MLHADPTLRPSVAELLTDEFF 296

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/80 (42%), Positives = 43/80 (53%), Gaps = 17/80 (21%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDTNKVGH 364
           N+FL  + + +K+GDFG A KI        E +G       GT  Y+APEV     K GH
Sbjct: 172 NLFLNDDMD-VKIGDFGLATKI--------EFDGERKKXLCGTPNYIAPEVLC---KKGH 219
Query: 365 GRAVDIWSLGCVLVEMSSGK 384
              VDIWSLGC+L  +  GK
Sbjct: 220 SFEVDIWSLGCILYTLLVGK 239

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 129/259 (49%), Gaps = 26/259 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V  A      + VA+K+I+   +  A      +VELR L  +N  N+VK YG 
Sbjct: 18  GRGAFGVVCKA--KWRAKDVAIKQIESESERKA-----FIVELRQLSRVNHPNIVKLYGA 70
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR---YTKQLVDAISALHE---NTI 124
            ++   + L ME    G+L +++   E  LP         +  Q    ++ LH      +
Sbjct: 71  CLN--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K  N+ L A G  LK+ DFG+A  I  H T         G+ A+MAPEVF  +N 
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSN- 180
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEY-DSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
             +    D++S G +L E+ + ++P+ E     ++IM+ V  G  P + ++L    ++  
Sbjct: 181 --YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 238
Query: 244 ELCLRHDPAQRATIFELLQ 262
             C   DP+QR ++ E+++
Sbjct: 239 TRCWSKDPSQRPSMEEIVK 257

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 9/71 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A G  LK+ DFG+A  I  H T         G+ A+MAPEVF  +N   +    D
Sbjct: 136 NLLLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSN---YSEKCD 186
Query: 370 IWSLGCVLVEM 380
           ++S G +L E+
Sbjct: 187 VFSWGIILWEV 197

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 141/275 (51%), Gaps = 23/275 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 132 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 182
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN---------YQIMFKVGMGETPTIPESL-SDEG 239
             DIWS+G  LVEM+ G+ P    D+          ++++  +     P +P  + S E 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 242
Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
           Q F   CL  +PA+RA + +L+ H F+  S  E+V
Sbjct: 243 QDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 277

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 134 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 184
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 129/259 (49%), Gaps = 26/259 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V  A      + VA+K+I+   +  A      +VELR L  +N  N+VK YG 
Sbjct: 17  GRGAFGVVCKA--KWRAKDVAIKQIESESERKA-----FIVELRQLSRVNHPNIVKLYGA 69
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR---YTKQLVDAISALHE---NTI 124
            ++   + L ME    G+L +++   E  LP         +  Q    ++ LH      +
Sbjct: 70  CLN--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K  N+ L A G  LK+ DFG+A  I  H T         G+ A+MAPEVF  +N 
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSN- 179
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEY-DSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
             +    D++S G +L E+ + ++P+ E     ++IM+ V  G  P + ++L    ++  
Sbjct: 180 --YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237
Query: 244 ELCLRHDPAQRATIFELLQ 262
             C   DP+QR ++ E+++
Sbjct: 238 TRCWSKDPSQRPSMEEIVK 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 9/71 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A G  LK+ DFG+A  I  H T         G+ A+MAPEVF  +N   +    D
Sbjct: 135 NLLLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSN---YSEKCD 185
Query: 370 IWSLGCVLVEM 380
           ++S G +L E+
Sbjct: 186 VFSWGIILWEV 196

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA++ I   + N +   K +  E+RI++ +N  N+VK + V
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEV 81
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKFIVHRDL 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G 
Sbjct: 140 KAENLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELF--QGKKYDGP 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++++  ++ V  E+D   P   P    +D
Sbjct: 251 NPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKD 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G  VD
Sbjct: 143 NLLLDADMN-IKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQ--GKKYDGPEVD 195
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 196 VWSLGVILYTLVSGSLPFDG 215

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 32/273 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G F  V   +N ETG+  A+K + + K   +     +D+  E  I   +   ++V+  
Sbjct: 35  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL- 93
Query: 69  GVEIHREEMVLFM--------ELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISA 118
            +E +  + +L+M        +LC E     +V+  + G    E +   Y +Q+++A+  
Sbjct: 94  -LETYSSDGMLYMVFEFMDGADLCFE-----IVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
            H+N I+HRD+K   + L ++ NS  +KLG FG A+++     V G   G VGT  +MAP
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAP 204
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
           EV     +  +G+ VD+W  G +L  + SG  P+  Y +  ++   +  G+    P   S
Sbjct: 205 EV---VKREPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGKYKMNPRQWS 259
Query: 237 DEGQAFAELCLRH---DPAQRATIFELLQHPFL 266
              ++  +L  R    DPA+R T++E L HP+L
Sbjct: 260 HISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 8/75 (10%)
Query: 311 IFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           + L ++ NS  +KLG FG A+++     V G   G VGT  +MAPEV     +  +G+ V
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAPEV---VKREPYGKPV 216
Query: 369 DIWSLGCVLVEMSSG 383
           D+W  G +L  + SG
Sbjct: 217 DVWGCGVILFILLSG 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 24/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGIN 60
           + F +  G+G F  VY  ++ ET   VA  E+Q   L K    RF +    E   L+G+ 
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE----EAEXLKGLQ 83
Query: 61  QKNLVKYY----GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAI 116
             N+V++Y         ++ +VL  EL T GTL++ ++  +    +VL R + +Q++  +
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVL-RSWCRQILKGL 142
Query: 117 SALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYM 174
             LH  T  I+HRD+K  NIF+T    S+K+GD G A    A           +GT  + 
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFX 197
Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
           APE + +     +  +VD+++ G   +E ++ + P++E  +  QI  +V  G  P   + 
Sbjct: 198 APEXYEEK----YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
Query: 235 LS-DEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           ++  E +   E C+R +  +R +I +LL H F 
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA++ I   + N +   K +  E+RI++ +N  N+VK + V
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEV 81
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKFIVHRDL 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G 
Sbjct: 140 KAENLLLDADMN-IKIADFG----FSNEFTFGNKLDEFCGSPPYAAPELF--QGKKYDGP 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++++  ++ V  E+D   P   P    +D
Sbjct: 251 NPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKD 288

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G+  Y APE+F    K   G  VD
Sbjct: 143 NLLLDADMN-IKIADFG----FSNEFTFGNKLDEFCGSPPYAAPELFQ--GKKYDGPEVD 195
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 196 VWSLGVILYTLVSGSLPFDG 215

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 32/273 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G F  V   +N ETG+  A+K + + K   +     +D+  E  I   +   ++V+  
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL- 91
Query: 69  GVEIHREEMVLFM--------ELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISA 118
            +E +  + +L+M        +LC E     +V+  + G    E +   Y +Q+++A+  
Sbjct: 92  -LETYSSDGMLYMVFEFMDGADLCFE-----IVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
            H+N I+HRD+K   + L ++ NS  +KLG FG A+++     V G   G VGT  +MAP
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAP 202
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
           EV     +  +G+ VD+W  G +L  + SG  P+  Y +  ++   +  G+    P   S
Sbjct: 203 EV---VKREPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGKYKMNPRQWS 257
Query: 237 DEGQAFAELCLRH---DPAQRATIFELLQHPFL 266
              ++  +L  R    DPA+R T++E L HP+L
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 311 IFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           + L ++ NS  +KLG FG A+++     V G   G VGT  +MAPEV     +  +G+ V
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFMAPEV---VKREPYGKPV 214
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+W  G +L  + SG     G
Sbjct: 215 DVWGCGVILFILLSGCLPFYG 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 133/289 (46%), Gaps = 48/289 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A NN  GE  A+K+I+L K+++       + E+ IL+ +   N+VK Y V
Sbjct: 11  GEGTYGVVYKAQNN-YGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ +VL  E   +  L+ L+   E GL  V  + +  QL++ I+  H+  ++HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 131 SANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
             N+ +  EG  LK+ DFG A      V+   H  V         T  Y AP+V M + K
Sbjct: 128 PQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVV---------TLWYRAPDVLMGSKK 177
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIP--------- 232
             +   +DIWS+GC+  EM +G   +   +E D   +I   +G   +   P         
Sbjct: 178 --YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 233 ---------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                          + L + G       L+ DP QR T  + L+H + 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 41/87 (47%), Gaps = 18/87 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG  LK+ DFG A      V+   H  V         T  Y AP+V M + K  
Sbjct: 130 NLLINREG-ELKIADFGLARAFGIPVRKYTHEVV---------TLWYRAPDVLMGSKK-- 177
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSGV 390
           +   +DIWS+GC+  EM +G     GV
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGV 204

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 140/266 (52%), Gaps = 15/266 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 18  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 75
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 134
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++          N FVGT++YM+PE    T+   +  
Sbjct: 135 KPSNILVNSRGE-IKLCDFGVSGQLIDEMA-----NEFVGTRSYMSPERLQGTH---YSV 185
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL-SDEGQAFAELCLR 248
             DIWS+G  LVEM+ G+ P     + ++++  +     P +P ++ S E Q F   CL 
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPM-AIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLI 244
Query: 249 HDPAQRATIFELLQHPFLIVSCEEDV 274
            +PA+RA + +L+ H F+  S  E+V
Sbjct: 245 KNPAERADLKQLMVHAFIKRSDAEEV 270

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++          N FVGT++YM+PE    T+   +    
Sbjct: 137 SNILVNSRGE-IKLCDFGVSGQLIDEMA-----NEFVGTRSYMSPERLQGTH---YSVQS 187
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 188 DIWSMGLSLVEMAVGR 203

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 133/289 (46%), Gaps = 48/289 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A NN  GE  A+K+I+L K+++       + E+ IL+ +   N+VK Y V
Sbjct: 11  GEGTYGVVYKAQNN-YGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ +VL  E   +  L+ L+   E GL  V  + +  QL++ I+  H+  ++HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 131 SANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
             N+ +  EG  LK+ DFG A      V+   H  V         T  Y AP+V M + K
Sbjct: 128 PQNLLINREG-ELKIADFGLARAFGIPVRKYTHEVV---------TLWYRAPDVLMGSKK 177
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIP--------- 232
             +   +DIWS+GC+  EM +G   +   +E D   +I   +G   +   P         
Sbjct: 178 --YSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 233 ---------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                          + L + G       L+ DP QR T  + L+H + 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 41/87 (47%), Gaps = 18/87 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG  LK+ DFG A      V+   H  V         T  Y AP+V M + K  
Sbjct: 130 NLLINREG-ELKIADFGLARAFGIPVRKYTHEVV---------TLWYRAPDVLMGSKK-- 177
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSGV 390
           +   +DIWS+GC+  EM +G     GV
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAPLFPGV 204

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 133/289 (46%), Gaps = 48/289 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A NN  GE  A+K+I+L K+++       + E+ IL+ +   N+VK Y V
Sbjct: 11  GEGTYGVVYKAQNN-YGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ +VL  E   +  L+ L+   E GL  V  + +  QL++ I+  H+  ++HRD+K
Sbjct: 69  IHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 131 SANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
             N+ +  EG  LK+ DFG A      V+   H  V         T  Y AP+V M + K
Sbjct: 128 PQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIV---------TLWYRAPDVLMGSKK 177
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIP--------- 232
             +   +DIWS+GC+  EM +G   +   +E D   +I   +G   +   P         
Sbjct: 178 --YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 233 ---------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                          + L + G       L+ DP QR T  + L+H + 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 41/87 (47%), Gaps = 18/87 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ +  EG  LK+ DFG A      V+   H  V         T  Y AP+V M + K  
Sbjct: 130 NLLINREG-ELKIADFGLARAFGIPVRKYTHEIV---------TLWYRAPDVLMGSKK-- 177
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSGV 390
           +   +DIWS+GC+  EM +G     GV
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGV 204

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 140/269 (52%), Gaps = 17/269 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 34  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 91
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 92  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 150
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 151 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 201
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN---YQIMFKVGMGETPTIPESL-SDEGQAFAEL 245
             DIWS+G  LVEM+ G+ P      +   ++++  +     P +P  + S E Q F   
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 261
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDV 274
           CL  +PA+RA + +L+ H F+  S  E+V
Sbjct: 262 CLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 153 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 203
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 204 DIWSMGLSLVEMAVGR 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 38/277 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 21  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 79  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 136
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +     
Sbjct: 137 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSREN 193
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 194 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 246
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            IPE    + Q   + CL+ DP QR +I ELL HP++
Sbjct: 247 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +           
Sbjct: 142 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 199
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 200 ISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 136/279 (48%), Gaps = 38/279 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 65  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 180
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +     
Sbjct: 181 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSREN 237
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 290
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
            IPE    + Q   + CL+ DP QR +I ELL HP++ +
Sbjct: 291 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +           
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 38/277 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 17  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 75  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 132
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +     
Sbjct: 133 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSREN 189
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 190 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 242
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            IPE    + Q   + CL+ DP QR +I ELL HP++
Sbjct: 243 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +           
Sbjct: 138 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 195
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 196 ISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 136/279 (48%), Gaps = 38/279 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 18  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 76  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 133
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +     
Sbjct: 134 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSREN 190
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 243
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
            IPE    + Q   + CL+ DP QR +I ELL HP++ +
Sbjct: 244 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +           
Sbjct: 139 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 197 ISPKSDVWSLGCILYYMTYGKTPFQQII 224

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 38/277 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 37  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 152
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +     
Sbjct: 153 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSREN 209
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 262
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            IPE    + Q   + CL+ DP QR +I ELL HP++
Sbjct: 263 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +           
Sbjct: 158 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 136/279 (48%), Gaps = 38/279 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 65  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 180
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +     
Sbjct: 181 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSREN 237
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 290
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
            IPE    + Q   + CL+ DP QR +I ELL HP++ +
Sbjct: 291 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VGT  YM PE   D +           
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 142/286 (49%), Gaps = 13/286 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG  VA+K I   + N     K +  E+RI++ +N  N+VK + V
Sbjct: 24  GKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKLFEV 82
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G   + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQKYIVHRDL 140
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L  + N +K+ DFG     S   TV  +L+ F G+  Y APE+F    K   G 
Sbjct: 141 KAENLLLDGDMN-IKIADFG----FSNEFTVGNKLDTFCGSPPYAAPELFQ--GKKYDGP 193
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVL 251
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVL 295
           +P +R ++ ++++  ++ V  EE+   P + P     D  ++ I++
Sbjct: 252 NPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPDPDFNDTKRIDIMV 297

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  + N +K+ DFG     S   TV  +L+ F G+  Y APE+F    K   G  VD
Sbjct: 144 NLLLDGDMN-IKIADFG----FSNEFTVGNKLDTFCGSPPYAAPELFQ--GKKYDGPEVD 196
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 197 VWSLGVILYTLVSGSLPFDG 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 135/263 (51%), Gaps = 15/263 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G V    +  +G+++A+K I+  ++ Q   R + D+ + +R    ++    V +Y
Sbjct: 16  GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT---VDCPFTVTFY 72
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHEN-TIV 125
           G      ++ + MEL      +   Q  + G  +PE ++ +    +V A+  LH   +++
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNK 184
           HRD+K +N+ + A G  +K+ DFG    IS +       +   G + YMAPE +  + N+
Sbjct: 133 HRDVKPSNVLINALGQ-VKMCDFG----ISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAFA 243
            G+    DIWSLG  ++E++  + P+  + + +Q + +V    +P +P +  S E   F 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
             CL+ +  +R T  EL+QHPF 
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFF 270

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 135/265 (50%), Gaps = 15/265 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G V    +  +G+++A+K I+  ++ Q   R + D+ + +R    ++    V +Y
Sbjct: 60  GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT---VDCPFTVTFY 116
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHEN-TIV 125
           G      ++ + MEL      +   Q  + G  +PE ++ +    +V A+  LH   +++
Sbjct: 117 GALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 176
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTNK 184
           HRD+K +N+ + A G  +K+ DFG    IS +           G + YMAPE +  + N+
Sbjct: 177 HRDVKPSNVLINALGQ-VKMCDFG----ISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAFA 243
            G+    DIWSLG  ++E++  + P+  + + +Q + +V    +P +P +  S E   F 
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 244 ELCLRHDPAQRATIFELLQHPFLIV 268
             CL+ +  +R T  EL+QHPF  +
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFFTL 316

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   L E R+L+      L    Y 
Sbjct: 18  GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 77
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH E  +V+RD
Sbjct: 78  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 135
Query: 129 IKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K  N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +  
Sbjct: 136 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA------TMKXFCGTPEYLAPEVLEDND-- 186
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +L  E ++    
Sbjct: 187 -YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 243
Query: 246 CLRHDPAQR-----ATIFELLQHPFL 266
            L+ DP QR         E++QH F 
Sbjct: 244 LLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +   +GR
Sbjct: 140 NLMLDKDGH-IKITDFGLCKEGIKDGA------TMKXFCGTPEYLAPEVLEDND---YGR 189
Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 190 AVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   L E R+L+      L    Y 
Sbjct: 17  GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 76
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH E  +V+RD
Sbjct: 77  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 134
Query: 129 IKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K  N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +  
Sbjct: 135 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA------TMKXFCGTPEYLAPEVLEDND-- 185
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +L  E ++    
Sbjct: 186 -YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 242
Query: 246 CLRHDPAQR-----ATIFELLQHPFL 266
            L+ DP QR         E++QH F 
Sbjct: 243 LLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +   +GR
Sbjct: 139 NLMLDKDGH-IKITDFGLCKEGIKDGA------TMKXFCGTPEYLAPEVLEDND---YGR 188
Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 189 AVDWWGLGVVMYEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   L E R+L+      L    Y 
Sbjct: 19  GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 78
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH E  +V+RD
Sbjct: 79  FQTH-DRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 136
Query: 129 IKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K  N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +  
Sbjct: 137 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA------TMKXFCGTPEYLAPEVLEDND-- 187
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +L  E ++    
Sbjct: 188 -YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 244
Query: 246 CLRHDPAQR-----ATIFELLQHPFL 266
            L+ DP QR         E++QH F 
Sbjct: 245 LLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +   +GR
Sbjct: 141 NLMLDKDGH-IKITDFGLCKEGIKDGA------TMKXFCGTPEYLAPEVLEDND---YGR 190
Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 191 AVDWWGLGVVMYEMMCGR 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   L E R+L+      L    Y 
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH E  +V+RD
Sbjct: 217 FQTH-DRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 129 IKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K  N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +  
Sbjct: 275 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA------TMKTFCGTPEYLAPEVLEDND-- 325
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +L  E ++    
Sbjct: 326 -YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382
Query: 246 CLRHDPAQR-----ATIFELLQHPFL 266
            L+ DP QR         E++QH F 
Sbjct: 383 LLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +   +GR
Sbjct: 279 NLMLDKDGH-IKITDFGLCKEGIKDGA------TMKTFCGTPEYLAPEVLEDND---YGR 328
Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 329 AVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FGKV       TG   AMK ++         V   L E R+L+      L    Y 
Sbjct: 160 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 219
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
            + H + +   ME    G L     S E    E   R Y  ++V A+  LH E  +V+RD
Sbjct: 220 FQTH-DRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 277
Query: 129 IKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K  N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +  
Sbjct: 278 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA------TMKTFCGTPEYLAPEVLEDND-- 328
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +L  E ++    
Sbjct: 329 -YGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 385
Query: 246 CLRHDPAQR-----ATIFELLQHPFL 266
            L+ DP QR         E++QH F 
Sbjct: 386 LLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 13/78 (16%)
Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +K  A       +  F GT  Y+APEV  D +   +GR
Sbjct: 282 NLMLDKDGH-IKITDFGLCKEGIKDGA------TMKTFCGTPEYLAPEVLEDND---YGR 331
Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 332 AVDWWGLGVVMYEMMCGR 349

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 11/267 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A +  TG+ VA+K I       +     +  E+  L  +   +++K Y V
Sbjct: 17  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++E+++ +E       + +VQ   D + E   RR+ +Q++ A+   H + IVHRD+K
Sbjct: 77  IKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 134
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L    N +K+ DFG    +S   T    L    G+  Y APEV   + K+  G  
Sbjct: 135 PENLLLDEHLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVI--SGKLYAGPE 187
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD+WS G +L  M   + P+   D +  ++FK       T+P+ LS       +  L  +
Sbjct: 188 VDVWSCGVILYVMLCRRLPFD--DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 245
Query: 251 PAQRATIFELLQHPFLIVSCEEDVCNP 277
           P  R +I E++Q  +  V   E +  P
Sbjct: 246 PLNRISIHEIMQDDWFKVDLPEYLLPP 272

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 11/267 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A +  TG+ VA+K I       +     +  E+  L  +   +++K Y V
Sbjct: 13  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++E+++ +E       + +VQ   D + E   RR+ +Q++ A+   H + IVHRD+K
Sbjct: 73  IKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 130
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L    N +K+ DFG    +S   T    L    G+  Y APEV   + K+  G  
Sbjct: 131 PENLLLDEHLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVI--SGKLYAGPE 183
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD+WS G +L  M   + P+   D +  ++FK       T+P+ LS       +  L  +
Sbjct: 184 VDVWSCGVILYVMLCRRLPFD--DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 241
Query: 251 PAQRATIFELLQHPFLIVSCEEDVCNP 277
           P  R +I E++Q  +  V   E +  P
Sbjct: 242 PLNRISIHEIMQDDWFKVDLPEYLLPP 268

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 17/279 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIV-SCEEDVCNPRSVPASVLQ 286
           H+P+QR  + E+L+HP++   S +   C  +   A+ L+
Sbjct: 243 HNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALE 281

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 38/279 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 65  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 180
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++   TT   + +  VG   YM PE   D +     
Sbjct: 181 LKPAN-FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGAVNYMPPEAIKDMSSSREN 237
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 290
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
            IPE    + Q   + CL+ DP QR +I ELL HP++ +
Sbjct: 291 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++   TT   + +  VG   YM PE   D +           
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQII 271

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +        +   GT  Y+ PE+        H   
Sbjct: 139 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRDDLCGTLDYLPPEMIEGRM---HDEK 189
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 245
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 246 HNPSQRPMLREVLEHPWITAN 266

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 11/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A +  TG+ VA+K I       +     +  E+  L  +   +++K Y V
Sbjct: 22  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++E+++ +E       + +VQ   D + E   RR+ +Q++ A+   H + IVHRD+K
Sbjct: 82  IKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 139
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L    N +K+ DFG    +S   T    L    G+  Y APEV   + K+  G  
Sbjct: 140 PENLLLDEHLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVI--SGKLYAGPE 192
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD+WS G +L  M   + P+   D +  ++FK       T+P+ LS       +  L  +
Sbjct: 193 VDVWSCGVILYVMLCRRLPFD--DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 250
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P  R +I E++Q  +  V   E
Sbjct: 251 PLNRISIHEIMQDDWFKVDLPE 272

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 11/262 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A +  TG+ VA+K I       +     +  E+  L  +   +++K Y V
Sbjct: 23  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 82
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++E+++ +E       + +VQ   D + E   RR+ +Q++ A+   H + IVHRD+K
Sbjct: 83  IKSKDEIIMVIEYAGNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 140
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L    N +K+ DFG    +S   T    L    G+  Y APEV   + K+  G  
Sbjct: 141 PENLLLDEHLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVI--SGKLYAGPE 193
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD+WS G +L  M   + P+   D +  ++FK       T+P+ LS       +  L  +
Sbjct: 194 VDVWSCGVILYVMLCRRLPFD--DESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 251
Query: 251 PAQRATIFELLQHPFLIVSCEE 272
           P  R +I E++Q  +  V   E
Sbjct: 252 PLNRISIHEIMQDDWFKVDLPE 273

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 21  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIK 139
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 140 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 188
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 244
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 245 LKHNPSQRPMLREVLEHPWITAN 267

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 133/279 (47%), Gaps = 14/279 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV     N+T ++ AMK +   K  +   V+++  EL+I++G+    LV  +  
Sbjct: 24  GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYS 83
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               E+M + ++L   G L   +Q       E  V+ +  +LV A+  L    I+HRD+K
Sbjct: 84  FQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L   G+ + + DF  A  +   T    ++    GT+ YMAPE+F      G+  A
Sbjct: 143 PDNILLDEHGH-VHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 191 VDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETP--TIPESLSDEGQAFAELC 246
           VD WSLG    E+  G+RP+      S+ +I   V   ET   T P + S E  +  +  
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHTFETTVVTYPSAWSQEMVSLLKKL 254
Query: 247 LRHDPAQRATIFELLQH-PFLIVSCEEDVCNPRSVPASV 284
           L  +P QR +    +Q+ P++     + V   R +P  +
Sbjct: 255 LEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFI 293

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 37/75 (49%), Gaps = 5/75 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ + + DF  A  +   T    ++    GT+ YMAPE+F      G+  AVD
Sbjct: 145 NILLDEHGH-VHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 370 IWSLGCVLVEMSSGK 384
            WSLG    E+  G+
Sbjct: 200 WWSLGVTAYELLRGR 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE         H 
Sbjct: 141 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEXIEGRX---HD 189
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 245
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 246 LKHNPSQRPXLREVLEHPWITAN 268

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 139 PENLLLGSAGE-LKIADFGWSVHAPSSRRA-----ALCGTLDYLPPEMIEGRM---HDEK 189
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 245
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 246 HNPSQRPMLREVLEHPWITAN 266

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 136 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 184
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 240
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 241 LKHNPSQRPMLREVLEHPWITAN 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 43  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 161
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +        +   GT  Y+ PE+        H   
Sbjct: 162 PENLLLGSAG-ELKIADFGWSVHAPS-----SRRDDLCGTLDYLPPEMIEGR---MHDEK 212
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 268
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 269 HNPSQRPMLREVLEHPWITAN 289

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +        +   GT  Y+ PE+        H   
Sbjct: 137 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRDTLCGTLDYLPPEMIEGRM---HDEK 187
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 243
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 244 HNPSQRPMLREVLEHPWITAN 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 16  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 75
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 76  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 134
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 135 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 183
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 239
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 240 LKHNPSQRPMLREVLEHPWITAN 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 141 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 189
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 245
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 246 LKHNPSQRPMLREVLEHPWITAN 268

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAGE-LKIADFGWSVHAPSSRRA-----ALCGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 243 HNPSQRPMLREVLEHPWITAN 263

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 139 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 187
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 243
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   A ++   EL    GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAGE-LKIADFGWSV--HAPSSRRTEL---CGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 243 HNPSQRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 141 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEGRM---HDEK 191
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 247
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 248 HNPSQRPMLREVLEHPWITAN 268

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 139 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 187
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 243
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 137 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEGRM---HDEK 187
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 243
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 244 HNPSQRPMLREVLEHPWITAN 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRTXLCGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 243 HNPSQRPMLREVLEHPWITAN 263

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 43  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 161
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+        GT  Y+ PE+        H 
Sbjct: 162 PENLLLGSAG-ELKIADFGWSVHAPSSRRTTL-------CGTLDYLPPEMIEGR---MHD 210
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 266
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 267 LKHNPSQRPMLREVLEHPWITAN 289

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 155/325 (47%), Gaps = 30/325 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V+      TG+L A K++   +    +  +  +VE +IL  ++ + +V   Y 
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVH 126
            E  + ++ L M +   G +   + + ++   G  E     YT Q+V  +  LH+  I++
Sbjct: 254 FET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L  +GN +++ D G AV++ A  T   +  G+ GT  +MAPE+ +      
Sbjct: 313 RDLKPENVLLDDDGN-VRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEE--- 365
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           +  +VD ++LG  L EM + + P+    E   N ++  +V + +  T P+  S   + F 
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASKDFC 424
Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSV 303
           E  L+ DP +R          F   SC+    +P     S  Q  L+ G++ PP   DS 
Sbjct: 425 EALLQKDPEKRLG--------FRDGSCDGLRTHPLFRDISWRQ--LEAGMLTPPFVPDSR 474
Query: 304 KVYARA----NIFLTAEGNSLKLGD 324
            VYA+       F T +G + +  D
Sbjct: 475 TVYAKCIQDVGAFSTVKGVAFEKAD 499

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 133/277 (48%), Gaps = 38/277 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYY 68
           G G   KV+  +N E  ++ A+K + L ++ D + +     E+  L  + Q +  +++ Y
Sbjct: 37  GSGGSSKVFQVLN-EKKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +   P    + Y K +++A+  +H++ IVH D
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER-KSYWKNMLEAVHTIHQHGIVHSD 152
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K AN FL  +G  LKL DFG A ++        + +  VGT  YM PE   D +     
Sbjct: 153 LKPAN-FLIVDG-MLKLIDFGIANQMQPDXXXVVK-DSQVGTVNYMPPEAIKDMSSSREN 209
Query: 189 --------RAVDIWSLGCVLVEMSSGKRPWAE-----------YDSNYQIMFKVGMGETP 229
                      D+WSLGC+L  M+ GK P+ +            D N++I F       P
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF-------P 262
Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            IPE    + Q   + CL+ DP QR +I ELL HP++
Sbjct: 263 DIPEK---DLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 40/88 (45%), Gaps = 10/88 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG------ 365
           FL  +G  LKL DFG A ++        + +  VGT  YM PE   D +           
Sbjct: 158 FLIVDG-MLKLIDFGIANQMQPDXXXVVK-DSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 366 --RAVDIWSLGCVLVEMSSGKTNLSGVV 391
                D+WSLGC+L  M+ GKT    ++
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTPFQQII 243

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAG-ELKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 243 HNPSQRPMLREVLEHPWITAN 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A    +  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKKVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAGE-LKIADFGWSVHAPSSRRA-----ALCGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 243 HNPSQRPMLREVLEHPWITAN 263

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 155/325 (47%), Gaps = 30/325 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V+      TG+L A K++   +    +  +  +VE +IL  ++ + +V   Y 
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVH 126
            E  + ++ L M +   G +   + + ++   G  E     YT Q+V  +  LH+  I++
Sbjct: 254 FET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L  +GN +++ D G AV++ A  T   +  G+ GT  +MAPE+ +      
Sbjct: 313 RDLKPENVLLDDDGN-VRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEE--- 365
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           +  +VD ++LG  L EM + + P+    E   N ++  +V + +  T P+  S   + F 
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASKDFC 424
Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSV 303
           E  L+ DP +R          F   SC+    +P     S  Q  L+ G++ PP   DS 
Sbjct: 425 EALLQKDPEKRLG--------FRDGSCDGLRTHPLFRDISWRQ--LEAGMLTPPFVPDSR 474
Query: 304 KVYAR----ANIFLTAEGNSLKLGD 324
            VYA+       F T +G + +  D
Sbjct: 475 TVYAKNIQDVGAFSTVKGVAFEKAD 499

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    G +   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 141 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 189
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 245
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 246 LKHNPSQRPMLREVLEHPWITAN 268

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 155/325 (47%), Gaps = 30/325 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V+      TG+L A K++   +    +  +  +VE +IL  ++ + +V   Y 
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVH 126
            E  + ++ L M +   G +   + + ++   G  E     YT Q+V  +  LH+  I++
Sbjct: 254 FET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L  +GN +++ D G AV++ A  T   +  G+ GT  +MAPE+ +      
Sbjct: 313 RDLKPENVLLDDDGN-VRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEE--- 365
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           +  +VD ++LG  L EM + + P+    E   N ++  +V + +  T P+  S   + F 
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASKDFC 424
Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSV 303
           E  L+ DP +R          F   SC+    +P     S  Q  L+ G++ PP   DS 
Sbjct: 425 EALLQKDPEKRLG--------FRDGSCDGLRTHPLFRDISWRQ--LEAGMLTPPFVPDSR 474
Query: 304 KVYAR----ANIFLTAEGNSLKLGD 324
            VYA+       F T +G + +  D
Sbjct: 475 TVYAKNIQDVGAFSTVKGVAFEKAD 499

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 155/325 (47%), Gaps = 30/325 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G FG+V+      TG+L A K++   +    +  +  +VE +IL  ++ + +V   Y 
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVH 126
            E  + ++ L M +   G +   + + ++   G  E     YT Q+V  +  LH+  I++
Sbjct: 254 FET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L  +GN +++ D G AV++ A  T   +  G+ GT  +MAPE+ +      
Sbjct: 313 RDLKPENVLLDDDGN-VRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEE--- 365
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           +  +VD ++LG  L EM + + P+    E   N ++  +V + +  T P+  S   + F 
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTYPDKFSPASKDFC 424
Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSV 303
           E  L+ DP +R          F   SC+    +P     S  Q  L+ G++ PP   DS 
Sbjct: 425 EALLQKDPEKRLG--------FRDGSCDGLRTHPLFRDISWRQ--LEAGMLTPPFVPDSR 474
Query: 304 KVYAR----ANIFLTAEGNSLKLGD 324
            VYA+       F T +G + +  D
Sbjct: 475 TVYAKNIQDVGAFSTVKGVAFEKAD 499

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIK 135
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 136 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRXXLCGTLDYLPPEMIEGRM---HDEK 186
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 242
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 243 HNPSQRPMLREVLEHPWITAN 263

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 34  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 93
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 94  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 152
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 153 PENLLLGSAG-ELKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGR---MHD 201
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 257
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 258 LKHNPSQRPMLREVLEHPWITAN 280

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 19  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 78
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 137
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 138 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRXXLCGTLDYLPPEMIEGRM---HDEK 188
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 244
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 245 HNPSQRPMLREVLEHPWITAN 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +     S  TT+ G L+       Y+ PE+        H 
Sbjct: 137 PENLLLGSAGE-LKIADFGWSCHAPSSRRTTLSGTLD-------YLPPEMIEGRM---HD 185
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 241
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 242 LKHNPSQRPMLREVLEHPWITAN 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   +   ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 14  GKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 73
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 74  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 132
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 133 PENLLLGSAGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 181
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 237
Query: 247 LRHDPAQRATIFELLQHPFL 266
           L+H+P+QR  + E+L+HP++
Sbjct: 238 LKHNPSQRPMLREVLEHPWI 257

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 120/258 (46%), Gaps = 16/258 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 139 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRXXLCGTLDYLPPEMIEGRM---HDEK 189
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 245
Query: 249 HDPAQRATIFELLQHPFL 266
           H+P+QR  + E+L+HP++
Sbjct: 246 HNPSQRPMLREVLEHPWI 263

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 45/297 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V+ A N ET E+VA+K ++L   +D       L E+ +L+ +  KN+V+ + V
Sbjct: 11  GEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               +++ L  E C +   +       D  PE+ V+ +  QL+  +   H   ++HRD+K
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI-VKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +   G  LKL DFG A             +  V T  Y  P+V        +  +
Sbjct: 129 PQNLLINRNG-ELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFGAKL--YSTS 182
Query: 191 VDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPT---------IPE----- 233
           +D+WS GC+  E+++  RP     + D   + +F++ +G TPT         +P+     
Sbjct: 183 IDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRL-LG-TPTEEQWPSMTKLPDYKPYP 240
Query: 234 -------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
                         L+  G+   +  L+ +P QR +  E LQHP+       D C P
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-----SDFCPP 292

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 133/278 (47%), Gaps = 13/278 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG+ VA+K I   + N +   K +  E+RI + +N  N+VK + V
Sbjct: 23  GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIXKVLNHPNIVKLFEV 81
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L  E  + G   + LV        E   R   +Q+V A+   H+  IVHRD+
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEA--RAKFRQIVSAVQYCHQKFIVHRDL 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   T   +L+ F G   Y APE+F    K   G 
Sbjct: 140 KAENLLLDADXN-IKIADFG----FSNEFTFGNKLDAFCGAPPYAAPELFQ--GKKYDGP 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP   S + +   +  L  
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLIL 250
Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +P++R T+ ++ +  +  V  E+D   P   P    +D
Sbjct: 251 NPSKRGTLEQIXKDRWXNVGHEDDELKPYVEPLPDYKD 288

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   T   +L+ F G   Y APE+F    K   G  VD
Sbjct: 143 NLLLDADXN-IKIADFG----FSNEFTFGNKLDAFCGAPPYAAPELFQ--GKKYDGPEVD 195
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WSLG +L  + SG     G
Sbjct: 196 VWSLGVILYTLVSGSLPFDG 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 16/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    G +   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 140
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 141 PENLLLGSAGE-LKIADFGWSVHAPS-----SRRXXLXGTLDYLPPEMIEGRM---HDEK 191
Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRLLK 247
Query: 249 HDPAQRATIFELLQHPFLIVS 269
           H+P+QR  + E+L+HP++  +
Sbjct: 248 HNPSQRPMLREVLEHPWITAN 268

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ +FG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 139 PENLLLGSAGE-LKIANFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 187
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 243
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 244 LKHNPSQRPMLREVLEHPWITAN 266

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 19  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 78
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIK 137
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ +FG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 138 PENLLLGSAGE-LKIANFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGR---MHD 186
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   GK P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----TFPDFVTEGARDLISRL 242
Query: 247 LRHDPAQRATIFELLQHPFLIVS 269
           L+H+P+QR  + E+L+HP++  +
Sbjct: 243 LKHNPSQRPMLREVLEHPWITAN 265

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 109/205 (53%), Gaps = 20/205 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +  VY  +N  TG  VA+KE++L  +         + E+ +++ +  +N+V+ Y V
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYDV 71
Query: 71  EIHREEMVL----FMELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            IH E  +     FM+   +  ++S  V +T  GL   LV+ +  QL+  ++  HEN I+
Sbjct: 72  -IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF---VGTQAYMAPEVFMDT 182
           HRD+K  N+ +   G  LKLGDFG A        +P  +N F   V T  Y AP+V M +
Sbjct: 131 HRDLKPQNLLINKRG-QLKLGDFGLARAFG----IP--VNTFSSEVVTLWYRAPDVLMGS 183
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGK 207
               +  ++DIWS GC+L EM +GK
Sbjct: 184 RT--YSTSIDIWSCGCILAEMITGK 206

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 43/84 (51%), Gaps = 12/84 (14%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF---VGTQAYMAPEVFMDTNKVGHGR 366
           N+ +   G  LKLGDFG A        +P  +N F   V T  Y AP+V M +    +  
Sbjct: 138 NLLINKRG-QLKLGDFGLARAFG----IP--VNTFSSEVVTLWYRAPDVLMGSRT--YST 188
Query: 367 AVDIWSLGCVLVEMSSGKTNLSGV 390
           ++DIWS GC+L EM +GK    G 
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGT 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 126/266 (47%), Gaps = 27/266 (10%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
            T  +  G+G FG+V+   + +TG   A+K+++L       F  +   EL    G+    
Sbjct: 95  ATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-----FRAE---ELMACAGLTSPR 146
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +V  YG       + +FMEL   G+L  LV+  +  LPE     Y  Q ++ +  LH   
Sbjct: 147 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKE-QGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMD 181
           I+H D+K+ N+ L+++G+   L DFG AV +         L G    GT+ +MAPEV + 
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL- 264
Query: 182 TNKVGHGRA----VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESL 235
                 GR+    VD+WS  C+++ M +G  PW ++     +  K+     P   IP S 
Sbjct: 265 ------GRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG-PLCLKIASEPPPVREIPPSC 317
Query: 236 SD-EGQAFAELCLRHDPAQRATIFEL 260
           +    QA  E  LR +P  R +  EL
Sbjct: 318 APLTAQAIQE-GLRKEPIHRVSAAEL 342

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 13/80 (16%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++G+   L DFG AV +         L G    GT+ +MAPEV +       GR+
Sbjct: 215 NVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL-------GRS 267
Query: 368 ----VDIWSLGCVLVEMSSG 383
               VD+WS  C+++ M +G
Sbjct: 268 CDAKVDVWSSCCMMLHMLNG 287

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 136/298 (45%), Gaps = 50/298 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V++AV+N+  + VA+K+I L    D + VK  L E++I+  ++  N+VK + +
Sbjct: 20  GCGGNGLVFSAVDNDCDKRVAIKKIVL---TDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 71  -------------EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
                         +     V  ++   E  L ++++  +  L E   R +  QL+  + 
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLK 134
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 177
            +H   ++HRD+K AN+F+  E   LK+GDFG A  +  H +  G L+  + T+ Y +P 
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA------------------------EY 213
           + +  N   + +A+D+W+ GC+  EM +GK  +A                        E 
Sbjct: 195 LLLSPN--NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQEL 252
Query: 214 DSNYQIMFKVGMGE-----TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            S   +  +  M E     T  +P  +S E   F E  L   P  R T  E L HP++
Sbjct: 253 LSVIPVYIRNDMTEPHKPLTQLLP-GISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 48/81 (59%), Gaps = 2/81 (2%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+  E   LK+GDFG A  +  H +  G L+  + T+ Y +P + +  N   + +A+
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN--NYTKAI 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+W+ GC+  EM +GKT  +G
Sbjct: 207 DMWAAGCIFAEMLTGKTLFAG 227

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 126/266 (47%), Gaps = 27/266 (10%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
            T  +  G+G FG+V+   + +TG   A+K+++L       F  +   EL    G+    
Sbjct: 76  ATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-----FRAE---ELMACAGLTSPR 127
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +V  YG       + +FMEL   G+L  LV+  +  LPE     Y  Q ++ +  LH   
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKE-QGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMD 181
           I+H D+K+ N+ L+++G+   L DFG AV +         L G    GT+ +MAPEV + 
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL- 245
Query: 182 TNKVGHGRA----VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESL 235
                 GR+    VD+WS  C+++ M +G  PW ++     +  K+     P   IP S 
Sbjct: 246 ------GRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG-PLCLKIASEPPPVREIPPSC 298
Query: 236 SD-EGQAFAELCLRHDPAQRATIFEL 260
           +    QA  E  LR +P  R +  EL
Sbjct: 299 APLTAQAIQE-GLRKEPIHRVSAAEL 323

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 13/80 (16%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++G+   L DFG AV +         L G    GT+ +MAPEV +       GR+
Sbjct: 196 NVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL-------GRS 248
Query: 368 ----VDIWSLGCVLVEMSSG 383
               VD+WS  C+++ M +G
Sbjct: 249 CDAKVDVWSSCCMMLHMLNG 268

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 133/297 (44%), Gaps = 45/297 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V+ A N ET E+VA+K ++L   +D       L E+ +L+ +  KN+V+ + V
Sbjct: 11  GEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               +++ L  E C +   +       D  PE+ V+ +  QL+  +   H   ++HRD+K
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI-VKSFLFQLLKGLGFCHSRNVLHRDLK 128
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +   G  LKL +FG A             +  V T  Y  P+V        +  +
Sbjct: 129 PQNLLINRNG-ELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFGAKL--YSTS 182
Query: 191 VDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPT---------IPE----- 233
           +D+WS GC+  E+++  RP     + D   + +F++ +G TPT         +P+     
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LG-TPTEEQWPSMTKLPDYKPYP 240
Query: 234 -------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
                         L+  G+   +  L+ +P QR +  E LQHP+       D C P
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-----SDFCPP 292

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 133/263 (50%), Gaps = 10/263 (3%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGK     + E G    +KEI + + + ++  ++   E+ +L  +   N+V+Y   
Sbjct: 33  GEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRES 91
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 + + M+ C  G L   + + +  L  E  +  +  Q+  A+  +H+  I+HRDI
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           KS NIFLT +G +++LGDFG A  +++   +       +GT  Y++PE+    NK  + +
Sbjct: 152 KSQNIFLTKDG-TVQLGDFGIARVLNSTVELA---RACIGTPYYLSPEIC--ENKPYNNK 205
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           + DIW+LGCVL E+ + K  + E  S   ++ K+  G  P +    S + ++      + 
Sbjct: 206 S-DIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKR 263
Query: 250 DPAQRATIFELLQHPFLIVSCEE 272
           +P  R ++  +L+  F+    E+
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEK 286

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 47/75 (62%), Gaps = 7/75 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NIFLT +G +++LGDFG A  +++   +       +GT  Y++PE+    NK  + ++ D
Sbjct: 155 NIFLTKDG-TVQLGDFGIARVLNSTVELA---RACIGTPYYLSPEIC--ENKPYNNKS-D 207
Query: 370 IWSLGCVLVEMSSGK 384
           IW+LGCVL E+ + K
Sbjct: 208 IWALGCVLYELCTLK 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 143/307 (46%), Gaps = 55/307 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 42  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 99
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 159 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 209
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF-----------------------KVGM 225
             DIWS+G  LVEM+ G+ P    D+   ++MF                       K GM
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 226 GETPTI-------------PESL-----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
              P +             P  L     S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 330 RSDAEEV 336

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 161 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 211
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 212 DIWSMGLSLVEMAVGR 227

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 19/269 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+V    +  TG   A+K I+            +L E+ +L+ ++  N++K Y  
Sbjct: 30  GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEF 89
Query: 71  EIHREEMVLFMELCTEGTL--ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              +    L ME+   G L  E +++       EV      KQ++   + LH++ IVHRD
Sbjct: 90  FEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+ L ++     +K+ DFG    +SAH  V G++   +GT  Y+APEV     +  
Sbjct: 147 LKPENLLLESKSRDALIKIVDFG----LSAHFEVGGKMKERLGTAYYIAPEVL----RKK 198
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP---ESLSDEGQAFA 243
           +    D+WS G +L  +  G  P+    ++ +I+ +V  G+    P     +SDE +   
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPPFGG-QTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 257
Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEE 272
           +L L ++P++R +  E L HP+++  C +
Sbjct: 258 KLMLTYEPSKRISAEEALNHPWIVKFCSQ 286

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 147/298 (49%), Gaps = 50/298 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +  TGE+VA+K+I+    +   F    L E++IL+    +N++  + +
Sbjct: 20  GEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 71  EI-----HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +      +  E+ +  EL  +  L  ++ +    L +  ++ +  Q + A+  LH + ++
Sbjct: 78  QRPDSFENFNEVYIIQEL-MQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKI---SAHTTVP-GELNG---FVGTQAYMAPEV 178
           HRD+K +N+ + +  + LK+ DFG A  I   +A  + P G+ +G   FV T+ Y APEV
Sbjct: 135 HRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------- 229
            + + K  + RA+D+WS GC+L E+   +  +   D  +Q++   G+  TP         
Sbjct: 194 MLTSAK--YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 230 ----------TIP-----------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                     ++P             ++ +G    +  L  DPA+R T  E L+HP+L
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 43/76 (56%), Gaps = 9/76 (11%)
Query: 312 FLTAEGNSLKLGDFGSAVKI---SAHTTVP-GELNG---FVGTQAYMAPEVFMDTNKVGH 364
            L      LK+ DFG A  I   +A  + P G+ +G   FV T+ Y APEV + + K  +
Sbjct: 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK--Y 200
Query: 365 GRAVDIWSLGCVLVEM 380
            RA+D+WS GC+L E+
Sbjct: 201 SRAMDVWSCGCILAEL 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 120/258 (46%), Gaps = 16/258 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 21  GKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCHSKRVIHRDIK 139
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +        +   GT  Y+ PE+        H   
Sbjct: 140 PENLLLGSNGE-LKIADFGWSVHAPS-----SRRDTLCGTLDYLPPEMIEGRM---HDEK 190
Query: 191 VDIWSLGCVLVEMSSGKRPWA--EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           VD+WSLG +  E   G  P+    Y   Y+ + +V      T P+ +++  +      L+
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF----TFPDFVTEGARDLISRLLK 246
Query: 249 HDPAQRATIFELLQHPFL 266
           H+ +QR T+ E+L+HP++
Sbjct: 247 HNASQRLTLAEVLEHPWI 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 21  GKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCHSKRVIHRDIK 139
Query: 131 SANIFLTAEGNSLKLGDFGSAVKI--SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L + G  LK+ DFG +V    S  TT+ G L+       Y+ PE+        H 
Sbjct: 140 PENLLLGSNGE-LKIADFGWSVHAPSSRRTTLCGTLD-------YLPPEMIEGRM---HD 188
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             VD+WSLG +  E   G  P+    Y   Y+ + +V      T P+ +++  +      
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF----TFPDFVTEGARDLISRL 244
Query: 247 LRHDPAQRATIFELLQHPFL 266
           L+H+ +QR T+ E+L+HP++
Sbjct: 245 LKHNASQRLTLAEVLEHPWI 264

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 21/203 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +++ G +VA+K I+L  +++       + E+ +L+ ++  N+V    V
Sbjct: 30  GEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHPNIVSLIDV 87
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH E  +  +    E  L+ ++   + GL +  ++ Y  QL+  ++  H++ I+HRD+K
Sbjct: 88  -IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 131 SANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
             N+ + ++G +LKL DFG A      V+   H  V         T  Y AP+V M + K
Sbjct: 147 PQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVV---------TLWYRAPDVLMGSKK 196
Query: 185 VGHGRAVDIWSLGCVLVEMSSGK 207
             +  +VDIWS+GC+  EM +GK
Sbjct: 197 --YSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 18/87 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ + ++G +LKL DFG A      V+   H  V         T  Y AP+V M + K  
Sbjct: 149 NLLINSDG-ALKLADFGLARAFGIPVRSYTHEVV---------TLWYRAPDVLMGSKK-- 196
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSGV 390
           +  +VDIWS+GC+  EM +GK    GV
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPGV 223

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 21/203 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +++ G +VA+K I+L  +++       + E+ +L+ ++  N+V    V
Sbjct: 30  GEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHPNIVSLIDV 87
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH E  +  +    E  L+ ++   + GL +  ++ Y  QL+  ++  H++ I+HRD+K
Sbjct: 88  -IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146
Query: 131 SANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
             N+ + ++G +LKL DFG A      V+   H  V         T  Y AP+V M + K
Sbjct: 147 PQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVV---------TLWYRAPDVLMGSKK 196
Query: 185 VGHGRAVDIWSLGCVLVEMSSGK 207
             +  +VDIWS+GC+  EM +GK
Sbjct: 197 --YSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 18/87 (20%)
Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ + ++G +LKL DFG A      V+   H  V         T  Y AP+V M + K  
Sbjct: 149 NLLINSDG-ALKLADFGLARAFGIPVRSYTHEVV---------TLWYRAPDVLMGSKK-- 196
Query: 364 HGRAVDIWSLGCVLVEMSSGKTNLSGV 390
           +  +VDIWS+GC+  EM +GK    GV
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKPLFPGV 223

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 55/307 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 132 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 182
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF-----------------------KVGM 225
             DIWS+G  LVEM+ G+ P    D+   ++MF                         GM
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 226 GETPTI-------------PESL-----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
              P +             P  L     S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 303 RSDAEEV 309

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 134 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 184
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 55/307 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 132 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 182
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF-----------------------KVGM 225
             DIWS+G  LVEM+ G+ P    D+   ++MF                         GM
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 226 GETPTI-------------PESL-----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
              P +             P  L     S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 303 RSDAEEV 309

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 134 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 184
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 55/307 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 77  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 134
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 193
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 194 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 244
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF-----------------------KVGM 225
             DIWS+G  LVEM+ G+ P    D+   ++MF                         GM
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 304
Query: 226 GETPTI-------------PESL-----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
              P +             P  L     S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 305 DSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 364
Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 365 RSDAEEV 371

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 196 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 246
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 247 DIWSMGLSLVEMAVGR 262

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 55/307 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 132 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 182
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF-----------------------KVGM 225
             DIWS+G  LVEM+ G+ P    D+   ++MF                         GM
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 226 GETPTI-------------PESL-----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
              P +             P  L     S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 303 RSDAEEV 309

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 134 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 184
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 142/307 (46%), Gaps = 55/307 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +  
Sbjct: 132 KPSNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSV 182
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF-----------------------KVGM 225
             DIWS+G  LVEM+ G+ P    D+   ++MF                         GM
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 226 GETPTI-------------PESL-----SDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
              P +             P  L     S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 303 RSDAEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YM+PE    T+   +    
Sbjct: 134 SNILVNSRGE-IKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQGTH---YSVQS 184
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVEM+ G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 132/269 (49%), Gaps = 19/269 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+V    +  TG   A+K I+            +L E+ +L+ ++  N++K Y  
Sbjct: 13  GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEF 72
Query: 71  EIHREEMVLFMELCTEGTL--ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              +    L ME+   G L  E +++       EV      KQ++   + LH++ IVHRD
Sbjct: 73  FEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+ L ++     +K+ DFG    +SAH  V G++   +GT  Y+APEV     +  
Sbjct: 130 LKPENLLLESKSRDALIKIVDFG----LSAHFEVGGKMKERLGTAYYIAPEVL----RKK 181
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP---ESLSDEGQAFA 243
           +    D+WS G +L  +  G  P+    ++ +I+ +V  G+    P     +SDE +   
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGG-QTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEE 272
           +L L ++P++R +  E L HP+++  C +
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWIVKFCSQ 269

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 130/264 (49%), Gaps = 21/264 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--QLHKQNDARFVKDMLVELRI--LEGINQKNLVK 66
           G+G FGKV  A + +T + VA+K I  QL K++D      M VE  I  L+ +   +++K
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMH----MRVEREISYLKLLRHPHIIK 73
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            Y V     ++V+ +E       + +V+     + E   RR+ +Q++ AI   H + IVH
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVH 131
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L    N +K+ DFG    +S   T    L    G+  Y APEV     K+ 
Sbjct: 132 RDLKPENLLLDDNLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVI--NGKLY 184
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            G  VD+WS G VL  M  G+ P+  E+  N   +FK        +P+ LS   Q+    
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---LFKKVNSCVYVMPDFLSPGAQSLIRR 241
Query: 246 CLRHDPAQRATIFELLQHPFLIVS 269
            +  DP QR TI E+ + P+  V+
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVN 265

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 120/254 (47%), Gaps = 12/254 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKV    +  TG  VA+K +   K      V  +  E++ L+     +++K Y V
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                +  + ME  + G L   +      + E+  RR  +Q++ A+   H + +VHRD+K
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ L A  N+ K+ DFG +  +S      GE L    G+  Y APEV   + ++  G 
Sbjct: 139 PENVLLDAHMNA-KIADFGLSNMMSD-----GEFLRDSCGSPNYAAPEVI--SGRLYAGP 190
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VDIWS G +L  +  G  P+   D +   +FK   G    IPE L+          L+ 
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD--DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQV 248
Query: 250 DPAQRATIFELLQH 263
           DP +RATI ++ +H
Sbjct: 249 DPLKRATIKDIREH 262

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 147/298 (49%), Gaps = 50/298 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +  TGE+VA+K+I+    +   F    L E++IL+    +N++  + +
Sbjct: 20  GEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 71  EI-----HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +      +  E+ +  EL  +  L  ++ +    L +  ++ +  Q + A+  LH + ++
Sbjct: 78  QRPDSFENFNEVYIIQEL-MQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKI---SAHTTVP-GELNG---FVGTQAYMAPEV 178
           HRD+K +N+ + +  + LK+ DFG A  I   +A  + P G+ +G   +V T+ Y APEV
Sbjct: 135 HRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEV 193
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------- 229
            + + K  + RA+D+WS GC+L E+   +  +   D  +Q++   G+  TP         
Sbjct: 194 MLTSAK--YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 230 ----------TIP-----------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                     ++P             ++ +G    +  L  DPA+R T  E L+HP+L
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 48/79 (60%), Gaps = 10/79 (12%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKI---SAHTTVP-GELNG---FVGTQAYMAPEVFMDTNK 361
           +N+ + +  + LK+ DFG A  I   +A  + P G+ +G   +V T+ Y APEV + + K
Sbjct: 141 SNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAK 199
Query: 362 VGHGRAVDIWSLGCVLVEM 380
             + RA+D+WS GC+L E+
Sbjct: 200 --YSRAMDVWSCGCILAEL 216

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 120/254 (47%), Gaps = 12/254 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKV    +  TG  VA+K +   K      V  +  E++ L+     +++K Y V
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                +  + ME  + G L   +      + E+  RR  +Q++ A+   H + +VHRD+K
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ L A  N+ K+ DFG +  +S      GE L    G+  Y APEV   + ++  G 
Sbjct: 139 PENVLLDAHMNA-KIADFGLSNMMSD-----GEFLRTSCGSPNYAAPEVI--SGRLYAGP 190
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VDIWS G +L  +  G  P+   D +   +FK   G    IPE L+          L+ 
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD--DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQV 248
Query: 250 DPAQRATIFELLQH 263
           DP +RATI ++ +H
Sbjct: 249 DPLKRATIKDIREH 262

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 33/290 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V  A N       A+K+I+  ++     +  +L E+ +L  +N + +V+YY  
Sbjct: 15  GQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLNHQYVVRYYAA 70
Query: 71  EIHREEMV-----------LF--MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
            + R   V           LF  ME C  GTL  L+ S           R  +Q+++A+S
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--------PG---ELNG 166
            +H   I+HRD+K  NIF+  E  ++K+GDFG A  +     +        PG    L  
Sbjct: 131 YIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 167 FVGTQAYMAPEVFMDTNKVGH-GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM 225
            +GT  Y+A EV   T   GH    +D++SLG +  EM        E  +  + +  V +
Sbjct: 190 AIGTAMYVATEVLDGT---GHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVC 275
              P   ++     +    L + HDP +R     LL   +L V  +++V 
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 11  GQGRFGKVYTAVN---NETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQK 62
           GQG FGKV+       ++  +L AMK      +++  +   +  +D+LVE      +N  
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE------VNHP 86
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            +VK +       ++ L ++    G L + + S E    E  V+ Y  +L  A+  LH  
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            I++RD+K  NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    
Sbjct: 146 GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEV---V 198
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQ 240
           N+ GH ++ D WS G ++ EM +G  P+   D      ++ K  +G    +P+ LS E Q
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ 254
Query: 241 AFAELCLRHDPAQR 254
           +   +  + +PA R
Sbjct: 255 SLLRMLFKRNPANR 268

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 15/123 (12%)
Query: 267 IVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFG 326
           ++  EEDV    +  A  L     LGI+   +  +        NI L  EG+ +KL DFG
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE--------NILLDEEGH-IKLTDFG 171
Query: 327 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN 386
            + +   H     +   F GT  YMAPEV    N+ GH ++ D WS G ++ EM +G   
Sbjct: 172 LSKESIDHEK---KAYSFCGTVEYMAPEV---VNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 387 LSG 389
             G
Sbjct: 226 FQG 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 11  GQGRFGKVYTAVN---NETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQK 62
           GQG FGKV+       ++  +L AMK      +++  +   +  +D+LVE      +N  
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE------VNHP 86
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            +VK +       ++ L ++    G L + + S E    E  V+ Y  +L  A+  LH  
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            I++RD+K  NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    
Sbjct: 146 GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEV---V 198
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQ 240
           N+ GH ++ D WS G ++ EM +G  P+   D      ++ K  +G    +P+ LS E Q
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ 254
Query: 241 AFAELCLRHDPAQR 254
           +   +  + +PA R
Sbjct: 255 SLLRMLFKRNPANR 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 15/123 (12%)
Query: 267 IVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFG 326
           ++  EEDV    +  A  L     LGI+   +  +        NI L  EG+ +KL DFG
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE--------NILLDEEGH-IKLTDFG 171
Query: 327 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN 386
            + +   H     +   F GT  YMAPEV    N+ GH ++ D WS G ++ EM +G   
Sbjct: 172 LSKESIDHEK---KAYSFCGTVEYMAPEV---VNRRGHTQSADWWSFGVLMFEMLTGTLP 225
Query: 387 LSG 389
             G
Sbjct: 226 FQG 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 11  GQGRFGKVYTAVN---NETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQK 62
           GQG FGKV+       ++  +L AMK      +++  +   +  +D+LVE      +N  
Sbjct: 34  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE------VNHP 87
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            +VK +       ++ L ++    G L + + S E    E  V+ Y  +L  A+  LH  
Sbjct: 88  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSL 146
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            I++RD+K  NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    
Sbjct: 147 GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEV---V 199
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQ 240
           N+ GH ++ D WS G ++ EM +G  P+   D      ++ K  +G    +P+ LS E Q
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ 255
Query: 241 AFAELCLRHDPAQR 254
           +   +  + +PA R
Sbjct: 256 SLLRMLFKRNPANR 269

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 15/123 (12%)
Query: 267 IVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFG 326
           ++  EEDV    +  A  L     LGI+   +  +        NI L  EG+ +KL DFG
Sbjct: 122 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE--------NILLDEEGH-IKLTDFG 172
Query: 327 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN 386
            + +   H     +   F GT  YMAPEV    N+ GH ++ D WS G ++ EM +G   
Sbjct: 173 LSKESIDHEK---KAYSFCGTVEYMAPEV---VNRRGHTQSADWWSFGVLMFEMLTGTLP 226
Query: 387 LSG 389
             G
Sbjct: 227 FQG 229

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR---ILEGINQKNLVKY 67
           GQG    V+   + +TG+L A+K       N+  F++ + V++R   +L+ +N KN+VK 
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVF-----NNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 68  YGVE--IHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENT 123
           + +E        VL ME C  G+L ++++  S   GLPE       + +V  ++ L EN 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 124 IVHRDIKSANIF--LTAEGNSL-KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE--- 177
           IVHR+IK  NI   +  +G S+ KL DFG+A ++        +     GT+ Y+ P+   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYE 188
Query: 178 --VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGMGE 227
             V    ++  +G  VD+WS+G      ++G  P+  ++    N ++M+K+  G+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 138/300 (46%), Gaps = 45/300 (15%)
Query: 11  GQGRFGKVYTAVN-NETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVK 66
           G+G +GKV+ A +    G  VA+K +++    +      ++++ V LR LE     N+V+
Sbjct: 20  GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVR 78
Query: 67  YYGV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            + V       RE ++ L  E   +     L +  E G+P   ++    QL+  +  LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           + +VHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APEV + 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQ 193
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK---RPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           ++   +   VD+WS+GC+  EM   K   R  ++ D   +I+  +G+      P  ++  
Sbjct: 194 SS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250
Query: 239 GQAF---------------AEL-------CLRHDPAQRATIFELLQHPFL--IVSCEEDV 274
            QAF                EL       CL  +PA+R + +  L HP+   +  C+E++
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENL 310

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 39/80 (48%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G  +KL DFG A   S        L   V T  Y APEV + ++   +   VD
Sbjct: 150 NILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSS---YATPVD 201
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 202 LWSVGCIFAEMFRRKPLFRG 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 19/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+   + +TG   A+K+++L            + EL    G++   +V  YG 
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGA 118
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + +FMEL   G+L  L++     LPE     Y  Q ++ +  LH   I+H D+K
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHG 188
           + N+ L+++G+   L DFG A+ +         L G    GT+ +MAPEV M        
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA-- 235
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQAFAEL 245
             VDIWS  C+++ M +G  PW +Y     +  K+     P      S      QA  E 
Sbjct: 236 -KVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTAQAIQE- 292
Query: 246 CLRHDPAQRATIFEL 260
            LR +P  RA+  EL
Sbjct: 293 GLRKEPVHRASAMEL 307

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 5/76 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++G+   L DFG A+ +         L G    GT+ +MAPEV M          
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA---K 236
Query: 368 VDIWSLGCVLVEMSSG 383
           VDIWS  C+++ M +G
Sbjct: 237 VDIWSSCCMMLHMLNG 252

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 121/235 (51%), Gaps = 27/235 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR---ILEGINQKNLVKY 67
           GQG    V+   + +TG+L A+K       N+  F++ + V++R   +L+ +N KN+VK 
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVF-----NNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 68  YGVE--IHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENT 123
           + +E        VL ME C  G+L ++++  S   GLPE       + +V  ++ L EN 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 124 IVHRDIKSANIF--LTAEGNSL-KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE--- 177
           IVHR+IK  NI   +  +G S+ KL DFG+A ++        +     GT+ Y+ P+   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVXLYGTEEYLHPDMYE 188
Query: 178 --VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGMGE 227
             V    ++  +G  VD+WS+G      ++G  P+  ++    N ++M+K+  G+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI------NQKNL 64
           G+G FG+V  A +++  + VA+K ++    N+ RF +    E+RILE +      N  N+
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +        R  + +  EL +    E + ++   G    LVR++   ++  + ALH+N I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 221
Query: 125 VHRDIKSANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +H D+K  NI L  +G S +K+ DFGS+     H  V       + ++ Y APEV +   
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRV----YTXIQSRFYRAPEVILGAR 275
Query: 184 KVGHGRAVDIWSLGCVLVEMSSG 206
              +G  +D+WSLGC+L E+ +G
Sbjct: 276 ---YGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 10/81 (12%)
Query: 310 NIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L  +G S +K+ DFGS+     H  V       + ++ Y APEV +      +G  +
Sbjct: 230 NILLKQQGRSGIKVIDFGSSC--YEHQRV----YTXIQSRFYRAPEVILGAR---YGMPI 280
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLGC+L E+ +G   L G
Sbjct: 281 DMWSLGCILAELLTGYPLLPG 301

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI------NQKNL 64
           G+G FG+V  A +++  + VA+K ++    N+ RF +    E+RILE +      N  N+
Sbjct: 106 GKGXFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +        R  + +  EL +    E + ++   G    LVR++   ++  + ALH+N I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 221
Query: 125 VHRDIKSANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +H D+K  NI L  +G S +K+ DFGS+     H  V       + ++ Y APEV +   
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRV----YXXIQSRFYRAPEVILGAR 275
Query: 184 KVGHGRAVDIWSLGCVLVEMSSG 206
              +G  +D+WSLGC+L E+ +G
Sbjct: 276 ---YGMPIDMWSLGCILAELLTG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 10/81 (12%)
Query: 310 NIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L  +G S +K+ DFGS+     H  V       + ++ Y APEV +      +G  +
Sbjct: 230 NILLKQQGRSGIKVIDFGSSC--YEHQRV----YXXIQSRFYRAPEVILGAR---YGMPI 280
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLGC+L E+ +G   L G
Sbjct: 281 DMWSLGCILAELLTGYPLLPG 301

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 146/298 (48%), Gaps = 50/298 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +  TGE+VA+K+I+    +   F    L E++IL+    +N++  + +
Sbjct: 20  GEGAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 71  EI-----HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +      +  E+ +  EL  +  L  ++ +    L +  ++ +  Q + A+  LH + ++
Sbjct: 78  QRPDSFENFNEVYIIQEL-MQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKI---SAHTTVP-GELNGF---VGTQAYMAPEV 178
           HRD+K +N+ + +  + LK+ DFG A  I   +A  + P G+ +G    V T+ Y APEV
Sbjct: 135 HRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEV 193
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------- 229
            + + K  + RA+D+WS GC+L E+   +  +   D  +Q++   G+  TP         
Sbjct: 194 MLTSAK--YSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 230 ----------TIP-----------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                     ++P             ++ +G    +  L  DPA+R T  E L+HP+L
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 47/79 (59%), Gaps = 10/79 (12%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKI---SAHTTVP-GELNGF---VGTQAYMAPEVFMDTNK 361
           +N+ + +  + LK+ DFG A  I   +A  + P G+ +G    V T+ Y APEV + + K
Sbjct: 141 SNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAK 199
Query: 362 VGHGRAVDIWSLGCVLVEM 380
             + RA+D+WS GC+L E+
Sbjct: 200 --YSRAMDVWSCGCILAEL 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI------NQKNL 64
           G+G FG+V  A +++  + VA+K ++    N+ RF +    E+RILE +      N  N+
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +        R  + +  EL +    E + ++   G    LVR++   ++  + ALH+N I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 221
Query: 125 VHRDIKSANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +H D+K  NI L  +G S +K+ DFGS+     H  V       + ++ Y APEV +   
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRV----YTXIQSRFYRAPEVILGAR 275
Query: 184 KVGHGRAVDIWSLGCVLVEMSSG 206
              +G  +D+WSLGC+L E+ +G
Sbjct: 276 ---YGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 10/81 (12%)
Query: 310 NIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L  +G S +K+ DFGS+     H  V       + ++ Y APEV +      +G  +
Sbjct: 230 NILLKQQGRSGIKVIDFGSSC--YEHQRV----YTXIQSRFYRAPEVILGAR---YGMPI 280
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLGC+L E+ +G   L G
Sbjct: 281 DMWSLGCILAELLTGYPLLPG 301

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 19/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+   + +TG   A+K+++L            + EL    G++   +V  YG 
Sbjct: 81  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGA 132
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + +FMEL   G+L  L++     LPE     Y  Q ++ +  LH   I+H D+K
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHG 188
           + N+ L+++G+   L DFG A+ +         L G    GT+ +MAPEV M        
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA-- 249
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQAFAEL 245
             VDIWS  C+++ M +G  PW +Y     +  K+     P      S      QA  E 
Sbjct: 250 -KVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTAQAIQE- 306
Query: 246 CLRHDPAQRATIFEL 260
            LR +P  RA+  EL
Sbjct: 307 GLRKEPVHRASAMEL 321

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 5/76 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++G+   L DFG A+ +         L G    GT+ +MAPEV M          
Sbjct: 194 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA---K 250
Query: 368 VDIWSLGCVLVEMSSG 383
           VDIWS  C+++ M +G
Sbjct: 251 VDIWSSCCMMLHMLNG 266

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 130/266 (48%), Gaps = 17/266 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G V    +  +G++ A+K I+  ++ Q   R + D+ +  R    ++    V +Y
Sbjct: 43  GRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRT---VDCPFTVTFY 99
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHEN-TI 124
           G  + RE  V       + +L+   +   D    +PE ++ +    +V A+  LH   ++
Sbjct: 100 GA-LFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE-VFMDTN 183
           +HRD+K +N+ + A G  +K  DFG    IS +       +   G + Y APE +  + N
Sbjct: 159 IHRDVKPSNVLINALGQ-VKXCDFG----ISGYLVDDVAKDIDAGCKPYXAPERINPELN 213
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAF 242
           + G+    DIWSLG   +E++  + P+  + + +Q + +V    +P +P +  S E   F
Sbjct: 214 QKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDF 273
Query: 243 AELCLRHDPAQRATIFELLQHPFLIV 268
              CL+ +  +R T  EL QHPF  +
Sbjct: 274 TSQCLKKNSKERPTYPELXQHPFFTL 299

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 137/298 (45%), Gaps = 45/298 (15%)
Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVK 66
           G+G +GKV+ A + + G   VA+K +++    +      ++++ V LR LE     N+V+
Sbjct: 20  GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVR 78
Query: 67  YYGV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            + V       RE ++ L  E   +     L +  E G+P   ++    QL+  +  LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           + +VHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APEV + 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQ 193
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK---RPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           ++   +   VD+WS+GC+  EM   K   R  ++ D   +I+  +G+      P  ++  
Sbjct: 194 SS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250
Query: 239 GQAF---------------AEL-------CLRHDPAQRATIFELLQHPFL--IVSCEE 272
            QAF                EL       CL  +PA+R + +  L HP+   +  C+E
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 39/80 (48%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G  +KL DFG A   S        L   V T  Y APEV + ++   +   VD
Sbjct: 150 NILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSS---YATPVD 201
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 202 LWSVGCIFAEMFRRKPLFRG 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 19/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+   + +TG   A+K+++L            + EL    G++   +V  YG 
Sbjct: 83  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGA 134
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + +FMEL   G+L  L++     LPE     Y  Q ++ +  LH   I+H D+K
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHG 188
           + N+ L+++G+   L DFG A+ +         L G    GT+ +MAPEV M        
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA-- 251
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQAFAEL 245
             VDIWS  C+++ M +G  PW +Y     +  K+     P      S      QA  E 
Sbjct: 252 -KVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTAQAIQE- 308
Query: 246 CLRHDPAQRATIFEL 260
            LR +P  RA+  EL
Sbjct: 309 GLRKEPVHRASAMEL 323

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 5/76 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG--FVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+++G+   L DFG A+ +         L G    GT+ +MAPEV M          
Sbjct: 196 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA---K 252
Query: 368 VDIWSLGCVLVEMSSG 383
           VDIWS  C+++ M +G
Sbjct: 253 VDIWSSCCMMLHMLNG 268

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 133/290 (45%), Gaps = 43/290 (14%)
Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVK 66
           G+G +GKV+ A + + G   VA+K +++    +      ++++ V LR LE     N+V+
Sbjct: 20  GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVR 78
Query: 67  YYGV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            + V       RE ++ L  E   +     L +  E G+P   ++    QL+  +  LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           + +VHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APEV + 
Sbjct: 139 HRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQ 193
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK---RPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           ++   +   VD+WS+GC+  EM   K   R  ++ D   +I+  +G+      P  ++  
Sbjct: 194 SS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250
Query: 239 GQAF---------------AEL-------CLRHDPAQRATIFELLQHPFL 266
            QAF                EL       CL  +PA+R + +  L HP+ 
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 39/80 (48%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G  +KL DFG A   S        L   V T  Y APEV + ++   +   VD
Sbjct: 150 NILVTSSGQ-IKLADFGLARIYSFQMA----LTSVVVTLWYRAPEVLLQSS---YATPVD 201
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 202 LWSVGCIFAEMFRRKPLFRG 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++ V+++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 119/252 (47%), Gaps = 24/252 (9%)
Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQLHKQNDARFVKDML---VELRILEGINQKNL 64
           GQG FGKV+        ++G L AMK ++         V+D +   +E  IL  +N   +
Sbjct: 37  GQGSFGKVFLVRKVTRPDSGHLYAMKVLK----KATLKVRDRVRTKMERDILADVNHPFV 92
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           VK +       ++ L ++    G L + + S E    E  V+ Y  +L   +  LH   I
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLHSLGI 151
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           ++RD+K  NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    N+
Sbjct: 152 IYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEK---KAYSFCGTVEYMAPEV---VNR 204
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSDEGQAF 242
            GH  + D WS G ++ EM +G  P+   D      ++ K  +G    +P+ LS E Q+ 
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG----MPQFLSTEAQSL 260
Query: 243 AELCLRHDPAQR 254
                + +PA R
Sbjct: 261 LRALFKRNPANR 272

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/80 (38%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  EG+ +KL DFG + +   H     +   F GT  YMAPEV    N+ GH  + D
Sbjct: 160 NILLDEEGH-IKLTDFGLSKEAIDHEK---KAYSFCGTVEYMAPEV---VNRQGHSHSAD 212
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WS G ++ EM +G     G
Sbjct: 213 WWSYGVLMFEMLTGSLPFQG 232

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 25/280 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V+  TG   A K I   K + AR  + +  E RI   +   N+V+ +  
Sbjct: 15  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q++++I+  H N IVHR++
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L   A+G ++KL DFG A++++         +GF GT  Y++PEV     K  +
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPY 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
            + VDIW+ G +L  +  G  P W E         K G  + P+ PE  +++ E ++  +
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLID 243
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASV 284
             L  +P +R T  + L+ P+        +CN   V +++
Sbjct: 244 SMLTVNPKKRITADQALKVPW--------ICNRERVASAI 275

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 315 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG 374
           A+G ++KL DFG A++++         +GF GT  Y++PEV     K  + + VDIW+ G
Sbjct: 142 AKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPYSKPVDIWACG 194
Query: 375 CVL 377
            +L
Sbjct: 195 VIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 25/280 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V+  TG   A K I   K + AR  + +  E RI   +   N+V+ +  
Sbjct: 14  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q++++I+  H N IVHR++
Sbjct: 73  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNL 130
Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L   A+G ++KL DFG A++++         +GF GT  Y++PEV     K  +
Sbjct: 131 KPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPY 183
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
            + VDIW+ G +L  +  G  P W E         K G  + P+ PE  +++ E ++  +
Sbjct: 184 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLID 242
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASV 284
             L  +P +R T  + L+ P+        +CN   V +++
Sbjct: 243 SMLTVNPKKRITADQALKVPW--------ICNRERVASAI 274

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 315 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG 374
           A+G ++KL DFG A++++         +GF GT  Y++PEV     K  + + VDIW+ G
Sbjct: 141 AKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPYSKPVDIWACG 193
Query: 375 CVL 377
            +L
Sbjct: 194 VIL 196

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM--LVELRILEGINQKNLVKYY 68
           G G +G VY A +  +G  VA+K +++    +   +  +  +  LR LE     N+V+  
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLM 72
Query: 69  GV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V       RE ++ L  E   +     L ++   GLP   ++   +Q +  +  LH N 
Sbjct: 73  DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 132
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           IVHRD+K  NI +T+ G ++KL DFG A +I ++      L+  V T  Y APEV + + 
Sbjct: 133 IVHRDLKPENILVTS-GGTVKLADFGLA-RIYSYQMA---LDPVVVTLWYRAPEVLLQST 187
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
              +   VD+WS+GC+  EM   K  +   +E D   +I   +G+      P  +S    
Sbjct: 188 ---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG 244
Query: 241 AF-------------------AELCLR---HDPAQRATIFELLQHPFL 266
           AF                   A+L L     +P +R + F  LQH +L
Sbjct: 245 AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G ++KL DFG A +I ++      L+  V T  Y APEV + +    +   VD
Sbjct: 142 NILVTS-GGTVKLADFGLA-RIYSYQMA---LDPVVVTLWYRAPEVLLQST---YATPVD 193
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 194 MWSVGCIFAEMFRRKPLFCG 213

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 57  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 109
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 169
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 170 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 223
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 224 -GATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 180 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 232
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 233 DVWSAGCVLAELLLGQPIFPG 253

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 42  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 94
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 154
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 155 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 208
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 209 -GATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 165 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 217
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 218 DVWSAGCVLAELLLGQPIFPG 238

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 34  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 86
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 146
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 147 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 200
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 201 -GATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 157 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 209
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 210 DVWSAGCVLAELLLGQPIFPG 230

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 115
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 229
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 230 -GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 238
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 239 DVWSAGCVLAELLLGQPIFPG 259

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 67  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 119
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 179
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 180 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 233
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 234 -GATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 190 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 242
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 243 DVWSAGCVLAELLLGQPIFPG 263

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 65  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 117
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 177
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 178 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 231
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 232 -GATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 188 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 240
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 241 DVWSAGCVLAELLLGQPIFPG 261

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 25/280 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V+  TG   A K I   K + AR  + +  E RI   +   N+V+ +  
Sbjct: 38  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q++++I+  H N IVHR++
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNL 154
Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L   A+G ++KL DFG A++++         +GF GT  Y++PEV     K  +
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPY 207
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
            + VDIW+ G +L  +  G  P W E         K G  + P+ PE  +++ E ++  +
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLID 266
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASV 284
             L  +P +R T  + L+ P+        +CN   V +++
Sbjct: 267 SMLTVNPKKRITADQALKVPW--------ICNRERVASAI 298

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 315 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG 374
           A+G ++KL DFG A++++         +GF GT  Y++PEV     K  + + VDIW+ G
Sbjct: 165 AKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPYSKPVDIWACG 217
Query: 375 CVL 377
            +L
Sbjct: 218 VIL 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 130/282 (46%), Gaps = 25/282 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V   TG   A K I   K+  AR  + +  E RI   +   N+V+ +  
Sbjct: 13  GKGAFSVVRRCVKLCTGHEYAAKIINT-KKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q+++A+   H+  +VHRD+
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQMGVVHRDL 129
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L +  +G ++KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 130 KPENLLLASKCKGAAVKLADFGLAIEVQGDQQA---WFGFAGTPGYLSPEVL---RKEAY 183
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           G+ VDIW+ G +L  +  G  P W E         K G  + P+ PE  +++ E +    
Sbjct: 184 GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS-PEWDTVTPEAKNLIN 242
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
             L  +PA+R T  E L+HP+        VC  RS  AS++ 
Sbjct: 243 QMLTINPAKRITAHEALKHPW--------VCQ-RSTVASMMH 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 8/70 (11%)
Query: 310 NIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 133 NLLLASKCKGAAVKLADFGLAIEVQGDQQA---WFGFAGTPGYLSPEVL---RKEAYGKP 186
Query: 368 VDIWSLGCVL 377
           VDIW+ G +L
Sbjct: 187 VDIWACGVIL 196

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 108 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 160
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 220
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 221 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 274
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 275 -GATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 231 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 283
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 284 DVWSAGCVLAELLLGQPIFPG 304

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+ A + +TG+ VA+K++ +  + +  F    L E++IL+ +  +N+V    +
Sbjct: 27  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNL--I 83
Query: 71  EIHREE----------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
           EI R +          + L  + C E  L  L+ +         ++R  + L++ +  +H
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVF 179
            N I+HRD+K+AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ 
Sbjct: 143 RNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
           +   +  +G  +D+W  GC++ EM
Sbjct: 202 L--GERDYGPPIDLWGAGCIMAEM 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ +   +  +G  
Sbjct: 154 ANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL--GERDYGPP 210
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+W  GC++ EM +    + G
Sbjct: 211 IDLWGAGCIMAEMWTRSPIMQG 232

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 123/259 (47%), Gaps = 13/259 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+  V   TG +   K I      D   VK+   E+ I+  ++   L+  +  
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDA 116
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              + EMVL +E  + G L   + + +  + E  V  Y +Q  + +  +HE++IVH DIK
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176
Query: 131 SANIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI   T + +S+K+ DFG A K++    V         T  + APE+ +D   VG   
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPEI-VDREPVGF-- 229
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
             D+W++G +   + SG  P+A  D     Q + +           S+S E + F +  L
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 248 RHDPAQRATIFELLQHPFL 266
           + +P +R T+ + L+HP+L
Sbjct: 290 QKEPRKRLTVHDALEHPWL 308

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   +   TG+  A K I   K+  AR  + +  E RI   +   N+V+ +  
Sbjct: 13  GKGAFSVVRRCMKIPTGQEYAAKIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q++++++  H N IVHRD+
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIQQILESVNHCHLNGIVHRDL 129
Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L   ++G ++KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLAIEVQGDQQA---WFGFAGTPGYLSPEVL---RKDPY 183
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           G+ VD+W+ G +L  +  G  P W E         K G  + P+ PE  +++ E +    
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS-PEWDTVTPEAKDLIN 242
Query: 245 LCLRHDPAQRATIFELLQHPFL 266
             L  +PA+R T  E L+HP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 39/70 (55%), Gaps = 8/70 (11%)
Query: 310 NIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQGDQQA---WFGFAGTPGYLSPEVL---RKDPYGKP 186
Query: 368 VDIWSLGCVL 377
           VD+W+ G +L
Sbjct: 187 VDMWACGVIL 196

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   +   TG+  A K I   K+  AR  + +  E RI   +   N+V+ +  
Sbjct: 13  GKGAFSVVRRCMKIPTGQEYAAKIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q++++++  H N IVHRD+
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIQQILESVNHCHLNGIVHRDL 129
Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L   ++G ++KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 130 KPENLLLASKSKGAAVKLADFGLAIEVQGDQQA---WFGFAGTPGYLSPEVL---RKDPY 183
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           G+ VD+W+ G +L  +  G  P W E         K G  + P+ PE  +++ E +    
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS-PEWDTVTPEAKDLIN 242
Query: 245 LCLRHDPAQRATIFELLQHPFL 266
             L  +PA+R T  E L+HP++
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 39/70 (55%), Gaps = 8/70 (11%)
Query: 310 NIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQGDQQA---WFGFAGTPGYLSPEVL---RKDPYGKP 186
Query: 368 VDIWSLGCVL 377
           VD+W+ G +L
Sbjct: 187 VDMWACGVIL 196

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 17/262 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V+  TG   A K I   K + AR  + +  E RI   +   N+V+ +  
Sbjct: 15  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q++++I+  H N IVHR++
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L   A+G ++KL DFG A++++         +GF GT  Y++PEV     K  +
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPY 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
            + VDIW+ G +L  +  G  P W E         K G  + P+ PE  +++ E ++  +
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-PEWDTVTPEAKSLID 243
Query: 245 LCLRHDPAQRATIFELLQHPFL 266
             L  +P +R T  + L+ P++
Sbjct: 244 SMLTVNPKKRITADQALKVPWI 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 7/63 (11%)
Query: 315 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG 374
           A+G ++KL DFG A++++         +GF GT  Y++PEV     K  + + VDIW+ G
Sbjct: 142 AKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVL---KKDPYSKPVDIWACG 194
Query: 375 CVL 377
            +L
Sbjct: 195 VIL 197

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+ A + +TG+ VA+K++ +  + +  F    L E++IL+ +  +N+V    +
Sbjct: 26  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNL--I 82
Query: 71  EIHREE----------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
           EI R +          + L  + C E  L  L+ +         ++R  + L++ +  +H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVF 179
            N I+HRD+K+AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ 
Sbjct: 142 RNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 200
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
           +   +  +G  +D+W  GC++ EM
Sbjct: 201 L--GERDYGPPIDLWGAGCIMAEM 222

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ +   +  +G  
Sbjct: 153 ANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL--GERDYGPP 209
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+W  GC++ EM +    + G
Sbjct: 210 IDLWGAGCIMAEMWTRSPIMQG 231

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 141/310 (45%), Gaps = 30/310 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+V         ++ AMK +     L +   A F ++  V   ++ G ++     
Sbjct: 83  GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV---LVNGDSKWITTL 139
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +     + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   VH
Sbjct: 140 HYAFQ-DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 184
           RDIK  NI +   G+ ++L DFGS +K+    TV   +   VGT  Y++PE+   M+  K
Sbjct: 199 RDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGGK 255
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRP-WAE--YDSNYQIMFKVGMGETPTIPESLSDEGQA 241
             +G   D WSLG  + EM  G+ P +AE   ++  +IM      + PT    +S+  + 
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 242 FAE--LCLRHDPAQRATIFELLQHPFL-------IVSCEEDVCNPRSVPA-----SVLQD 287
                +C R     +  I +  +HPF        I +CE       S P       V  D
Sbjct: 316 LIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDD 375
Query: 288 YLKLGIVLPP 297
            LK    +PP
Sbjct: 376 CLKNSETMPP 385

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           NI +   G+ ++L DFGS +K+    TV   +   VGT  Y++PE+   M+  K  +G  
Sbjct: 205 NILMDMNGH-IRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGGKGRYGPE 261
Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 262 CDWWSLGVCMYEMLYGET 279

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+ A + +TG+ VA+K++ +  + +  F    L E++IL+ +  +N+V    +
Sbjct: 27  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNL--I 83
Query: 71  EIHREE----------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
           EI R +          + L  + C E  L  L+ +         ++R  + L++ +  +H
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVF 179
            N I+HRD+K+AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ 
Sbjct: 143 RNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
           +   +  +G  +D+W  GC++ EM
Sbjct: 202 L--GERDYGPPIDLWGAGCIMAEM 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ +   +  +G  
Sbjct: 154 ANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL--GERDYGPP 210
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+W  GC++ EM +    + G
Sbjct: 211 IDLWGAGCIMAEMWTRSPIMQG 232

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+ A + +TG+ VA+K++ +  + +  F    L E++IL+ +  +N+V    +
Sbjct: 27  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNL--I 83
Query: 71  EIHREE----------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
           EI R +          + L  + C E  L  L+ +         ++R  + L++ +  +H
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVF 179
            N I+HRD+K+AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ 
Sbjct: 143 RNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
           +   +  +G  +D+W  GC++ EM
Sbjct: 202 L--GERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 4/82 (4%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ +   +  +G  
Sbjct: 154 ANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLL--GERDYGPP 210
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+W  GC++ EM +    + G
Sbjct: 211 IDLWGAGCIMAEMWTRSPIMQG 232

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 129/290 (44%), Gaps = 33/290 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V  A N       A+K+I+  ++     +  +L E+ +L  +N + +V+YY  
Sbjct: 15  GQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLNHQYVVRYYAA 70
Query: 71  EIHREEMV-----------LF--MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
            + R   V           LF  ME C   TL  L+ S           R  +Q+++A+S
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--------PG---ELNG 166
            +H   I+HRD+K  NIF+  E  ++K+GDFG A  +     +        PG    L  
Sbjct: 131 YIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 167 FVGTQAYMAPEVFMDTNKVGH-GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM 225
            +GT  Y+A EV   T   GH    +D++SLG +  EM        E  +  + +  V +
Sbjct: 190 AIGTAMYVATEVLDGT---GHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVC 275
              P   ++     +    L + HDP +R     LL   +L V  +++V 
Sbjct: 247 EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM--LVELRILEGINQKNLVKYY 68
           G G +G VY A +  +G  VA+K +++    +   +  +  +  LR LE     N+V+  
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLM 72
Query: 69  GV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V       RE ++ L  E   +     L ++   GLP   ++   +Q +  +  LH N 
Sbjct: 73  DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 132
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           IVHRD+K  NI +T+ G ++KL DFG A +I ++      L   V T  Y APEV + + 
Sbjct: 133 IVHRDLKPENILVTS-GGTVKLADFGLA-RIYSYQMA---LAPVVVTLWYRAPEVLLQST 187
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
              +   VD+WS+GC+  EM   K  +   +E D   +I   +G+      P  +S    
Sbjct: 188 ---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG 244
Query: 241 AF-------------------AELCLR---HDPAQRATIFELLQHPFL 266
           AF                   A+L L     +P +R + F  LQH +L
Sbjct: 245 AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G ++KL DFG A +I ++      L   V T  Y APEV + +    +   VD
Sbjct: 142 NILVTS-GGTVKLADFGLA-RIYSYQMA---LAPVVVTLWYRAPEVLLQST---YATPVD 193
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 194 MWSVGCIFAEMFRRKPLFCG 213

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K    R       EL+I+  ++  N+V+  Y+
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K    R       EL+I+  ++  N+V+  Y+
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N  ++ ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM--LVELRILEGINQKNLVKYY 68
           G G +G VY A +  +G  VA+K +++    +   +  +  +  LR LE     N+V+  
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLM 72
Query: 69  GV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V       RE ++ L  E   +     L ++   GLP   ++   +Q +  +  LH N 
Sbjct: 73  DVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 132
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           IVHRD+K  NI +T+ G ++KL DFG A +I ++      L   V T  Y APEV + + 
Sbjct: 133 IVHRDLKPENILVTS-GGTVKLADFGLA-RIYSYQMA---LFPVVVTLWYRAPEVLLQST 187
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
              +   VD+WS+GC+  EM   K  +   +E D   +I   +G+      P  +S    
Sbjct: 188 ---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG 244
Query: 241 AF-------------------AELCLR---HDPAQRATIFELLQHPFL 266
           AF                   A+L L     +P +R + F  LQH +L
Sbjct: 245 AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G ++KL DFG A +I ++      L   V T  Y APEV + +    +   VD
Sbjct: 142 NILVTS-GGTVKLADFGLA-RIYSYQMA---LFPVVVTLWYRAPEVLLQST---YATPVD 193
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 194 MWSVGCIFAEMFRRKPLFCG 213

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/350 (25%), Positives = 149/350 (42%), Gaps = 81/350 (23%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-- 68
           G G FG V    + E+G+  A+K++      D R+    L  +++L+ +N   LV Y+  
Sbjct: 16  GTGSFGIVCEVFDIESGKRFALKKVL----QDPRYKNRELDIMKVLDHVNIIKLVDYFYT 71
Query: 69  -----------------------GVEIHREEMVL----------FMELCTE---GTLESL 92
                                  GV  H + +++           ME   +     L+S 
Sbjct: 72  TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 93  VQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV 152
           ++S    +P  L+  Y  QL  A+  +H   I HRDIK  N+ + ++ N+LKL DFGSA 
Sbjct: 132 IRSGR-SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190
Query: 153 KISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA 211
           K+     +P E +   + ++ Y APE+ +   +  +  ++D+WS+GCV  E+  GK  ++
Sbjct: 191 KL-----IPSEPSVAXICSRFYRAPELMLGATE--YTPSIDLWSIGCVFGELILGKPLFS 243
Query: 212 EYDSNYQIMFKVGMGETPT---------------------------IPESLSDEGQAFAE 244
              S  Q++  + +  TPT                           +PE          E
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303
Query: 245 LCLRHDPAQRATIFELLQHPF---LIVSCEEDVCNPRSVPASVLQDYLKL 291
             LR++P  R   +E + HPF   L  S E +V N  + P  V Q+  +L
Sbjct: 304 QILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 48/81 (59%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ + ++ N+LKL DFGSA K+     +P E +   + ++ Y APE+ +   +  +  ++
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL-----IPSEPSVAXICSRFYRAPELMLGATE--YTPSI 223
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS+GCV  E+  GK   SG
Sbjct: 224 DLWSIGCVFGELILGKPLFSG 244

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 30  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 82
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 142
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 143 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 196
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 197 -GATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 153 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 205
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 206 DVWSAGCVLAELLLGQPIFPG 226

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 33  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 85
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 145
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 146 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 199
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 200 -GATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 156 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 208
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 209 DVWSAGCVLAELLLGQPIFPG 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 48  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 100
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 160
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 161 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 214
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 215 -GATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 171 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 223
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 224 DVWSAGCVLAELLLGQPIFPG 244

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 41  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 93
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 154 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 207
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 208 -GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 164 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 216
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 217 DVWSAGCVLAELLLGQPIFPG 237

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 37  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 89
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 149
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 150 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 203
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 204 -GATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 160 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 212
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 213 DVWSAGCVLAELLLGQPIFPG 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 115
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 229
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 230 -GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 238
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 239 DVWSAGCVLAELLLGQPIFPG 259

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK--YY 68
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+  Y+
Sbjct: 41  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 93
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQ------STEDGLPEVLVRRYTKQLVDAISALHEN 122
                 ++  +++ L  +   E++ +        +  LP + V+ Y  QL  +++ +H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 154 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 207
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 208 -GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 164 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 216
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 217 DVWSAGCVLAELLLGQPIFPG 237

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 131/282 (46%), Gaps = 25/282 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V     +  A K I   K+  AR  + +  E RI   +   N+V+ +  
Sbjct: 40  GKGAFSVVRRCVKKTPTQEYAAKIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E        Q++++++ +H++ IVHRD+
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIV--AREYYSEADASHCIHQILESVNHIHQHDIVHRDL 156
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L +  +G ++KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 157 KPENLLLASKCKGAAVKLADFGLAIEVQGEQQA---WFGFAGTPGYLSPEVL---RKDPY 210
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           G+ VDIW+ G +L  +  G  P W E         K G  + P+ PE  +++ E +    
Sbjct: 211 GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS-PEWDTVTPEAKNLIN 269
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
             L  +PA+R T  + L+HP+        VC  RS  AS++ 
Sbjct: 270 QMLTINPAKRITADQALKHPW--------VCQ-RSTVASMMH 302

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/70 (35%), Positives = 39/70 (55%), Gaps = 8/70 (11%)
Query: 310 NIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 160 NLLLASKCKGAAVKLADFGLAIEVQGEQQA---WFGFAGTPGYLSPEVL---RKDPYGKP 213
Query: 368 VDIWSLGCVL 377
           VDIW+ G +L
Sbjct: 214 VDIWACGVIL 223

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 30/312 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+V       T  + AMK +     L +   A F ++  V   ++ G  Q     
Sbjct: 99  GRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV---LVNGDCQWITAL 155
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +     + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   VH
Sbjct: 156 HYAFQ-DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 214
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 184
           RDIK  N+ L   G+ ++L DFGS +K++   TV   +   VGT  Y++PE+   M+   
Sbjct: 215 RDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGM 271
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRP-WAE--YDSNYQIMFKVGMGETPTIPESLSDEGQA 241
             +G   D WSLG  + EM  G+ P +AE   ++  +IM      + P+    +S+E + 
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 242 FAE--LCLRHDPAQRATIFELLQHPFL-------IVSCEE----DVCNPRSVPA-SVLQD 287
             +  +C R     +  I +  +H F        I + E     DV +P       V  D
Sbjct: 332 LIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDD 391
Query: 288 YLKLGIVLPPMS 299
            L+   +LPP S
Sbjct: 392 VLRNTEILPPGS 403

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           N+ L   G+ ++L DFGS +K++   TV   +   VGT  Y++PE+   M+     +G  
Sbjct: 221 NVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGMGKYGPE 277
Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 278 CDWWSLGVCMYEMLYGET 295

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF------VKDMLVELRILEGINQKNL 64
           G G +G VY A +  +G  VA+K +++              V+++ + LR LE     N+
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLEAFEHPNV 76
Query: 65  VKYYGV----EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           V+   V       RE ++ L  E   +     L ++   GLP   ++   +Q +  +  L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H N IVHRD+K  NI +T+ G ++KL DFG A +I ++      L   V T  Y APEV 
Sbjct: 137 HANCIVHRDLKPENILVTS-GGTVKLADFGLA-RIYSYQMA---LTPVVVTLWYRAPEVL 191
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLS 236
           + +    +   VD+WS+GC+  EM   K  +   +E D   +I   +G+      P  +S
Sbjct: 192 LQST---YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 248
Query: 237 DEGQAF-------------------AELCLR---HDPAQRATIFELLQHPFL 266
               AF                   A+L L     +P +R + F  LQH +L
Sbjct: 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +T+ G ++KL DFG A +I ++      L   V T  Y APEV + +    +   VD
Sbjct: 150 NILVTS-GGTVKLADFGLA-RIYSYQMA---LTPVVVTLWYRAPEVLLQST---YATPVD 201
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           +WS+GC+  EM   K    G
Sbjct: 202 MWSVGCIFAEMFRRKPLFCG 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 132/269 (49%), Gaps = 15/269 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  TG+  A+K I   +       + +L E+++L+ ++  N++K Y  
Sbjct: 58  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 117
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +    L  E+ T G L   + S +    EV   R  +Q++  I+ +H+N IVHRD+K
Sbjct: 118 FEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 176
Query: 131 SANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L ++    ++++ DFG    +S H     ++   +GT  Y+APEV   T    + 
Sbjct: 177 PENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTAYYIAPEVLHGT----YD 228
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPE--SLSDEGQAFAEL 245
              D+WS G +L  + SG  P+   +  Y I+ KV  G+ T  +P+   +S+  +     
Sbjct: 229 EKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 287
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDV 274
            L + P+ R +  + L H ++    +E +
Sbjct: 288 MLTYVPSMRISARDALDHEWIQTYTKEQI 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 132/269 (49%), Gaps = 15/269 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  TG+  A+K I   +       + +L E+++L+ ++  N++K Y  
Sbjct: 59  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 118
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +    L  E+ T G L   + S +    EV   R  +Q++  I+ +H+N IVHRD+K
Sbjct: 119 FEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 177
Query: 131 SANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L ++    ++++ DFG    +S H     ++   +GT  Y+APEV   T    + 
Sbjct: 178 PENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTAYYIAPEVLHGT----YD 229
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPE--SLSDEGQAFAEL 245
              D+WS G +L  + SG  P+   +  Y I+ KV  G+ T  +P+   +S+  +     
Sbjct: 230 EKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 288
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDV 274
            L + P+ R +  + L H ++    +E +
Sbjct: 289 MLTYVPSMRISARDALDHEWIQTYTKEQI 317

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 21/271 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V    G+  A K I   K+  AR  + +  E RI   +   N+V+ +  
Sbjct: 31  GKGAFSVVRRCVKVLAGQEYAAKIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q+++A+   H+  +VHRD+
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQMGVVHRDL 147
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L +  +G ++KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 148 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVL---RKDPY 201
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           G+ VD+W+ G +L  +  G  P W E         K G  + P+ PE  +++ E +    
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS-PEWDTVTPEAKDLIN 260
Query: 245 LCLRHDPAQRATIFELLQHPFL-----IVSC 270
             L  +P++R T  E L+HP++     + SC
Sbjct: 261 KMLTINPSKRITAAEALKHPWISHRSTVASC 291

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 39/70 (55%), Gaps = 8/70 (11%)
Query: 310 NIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 151 NLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVL---RKDPYGKP 204
Query: 368 VDIWSLGCVL 377
           VD+W+ G +L
Sbjct: 205 VDLWACGVIL 214

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 30/312 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG+V       T  + AMK +     L +   A F ++  V   ++ G  Q     
Sbjct: 83  GRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV---LVNGDCQWITAL 139
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +     + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   VH
Sbjct: 140 HYAFQ-DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 184
           RDIK  N+ L   G+ ++L DFGS +K++   TV   +   VGT  Y++PE+   M+   
Sbjct: 199 RDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGM 255
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRP-WAE--YDSNYQIMFKVGMGETPTIPESLSDEGQA 241
             +G   D WSLG  + EM  G+ P +AE   ++  +IM      + P+    +S+E + 
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 242 FAE--LCLRHDPAQRATIFELLQHPFL-------IVSCEE----DVCNPRSVPA-SVLQD 287
             +  +C R     +  I +  +H F        I + E     DV +P       V  D
Sbjct: 316 LIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDD 375
Query: 288 YLKLGIVLPPMS 299
            L+   +LPP S
Sbjct: 376 VLRNTEILPPGS 387

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           N+ L   G+ ++L DFGS +K++   TV   +   VGT  Y++PE+   M+     +G  
Sbjct: 205 NVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVA--VGTPDYISPEILQAMEDGMGKYGPE 261
Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 262 CDWWSLGVCMYEMLYGET 279

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 132/269 (49%), Gaps = 15/269 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  TG+  A+K I   +       + +L E+++L+ ++  N++K Y  
Sbjct: 35  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +    L  E+ T G L   + S +    EV   R  +Q++  I+ +H+N IVHRD+K
Sbjct: 95  FEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 131 SANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L ++    ++++ DFG    +S H     ++   +GT  Y+APEV   T    + 
Sbjct: 154 PENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTAYYIAPEVLHGT----YD 205
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPE--SLSDEGQAFAEL 245
              D+WS G +L  + SG  P+   +  Y I+ KV  G+ T  +P+   +S+  +     
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDV 274
            L + P+ R +  + L H ++    +E +
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQI 293

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G+G + KV      +T  + AMK ++    ND   +  +  E  + E   N   LV  + 
Sbjct: 14  GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  +   +E    G L   +Q     LPE   R Y+ ++  A++ LHE  I++RD+
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDL 132
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G
Sbjct: 133 KLDNVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRGED---YG 184
Query: 189 RAVDIWSLGCVLVEMSSGKRPW------AEYDSNYQ-IMFKVGMGETPTIPESLSDEGQA 241
            +VD W+LG ++ EM +G+ P+         D N +  +F+V + +   IP SLS +  +
Sbjct: 185 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 244
Query: 242 FAELCLRHDPAQR-----ATIFELLQ-HPFL 266
             +  L  DP +R      T F  +Q HPF 
Sbjct: 245 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 275

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 9/77 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G +V
Sbjct: 136 NVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRGED---YGFSV 187
Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 188 DWWALGVLMFEMMAGRS 204

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G+G + KV      +T  + AMK ++    ND   +  +  E  + E   N   LV  + 
Sbjct: 18  GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 77
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  +   +E    G L   +Q     LPE   R Y+ ++  A++ LHE  I++RD+
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G
Sbjct: 137 KLDNVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRGED---YG 188
Query: 189 RAVDIWSLGCVLVEMSSGKRPW------AEYDSNYQ-IMFKVGMGETPTIPESLSDEGQA 241
            +VD W+LG ++ EM +G+ P+         D N +  +F+V + +   IP SLS +  +
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 248
Query: 242 FAELCLRHDPAQR-----ATIFELLQ-HPFL 266
             +  L  DP +R      T F  +Q HPF 
Sbjct: 249 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 9/77 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G +V
Sbjct: 140 NVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRGED---YGFSV 191
Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 192 DWWALGVLMFEMMAGRS 208

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---- 66
           G G FG VY A   ++GELVA+K++   K    R       EL+I+  ++  N+V+    
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCNIVRLRYF 81
Query: 67  YYGVEIHREEMVLFMEL----CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           +Y     ++E+ L + L     T   +       +  LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMD 181
            I HRDIK  N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+   
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF- 195
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
                +  ++D+WS GCVL E+  G+
Sbjct: 196 -GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +   LKL DFGSA ++     V GE N   + ++ Y APE+        +  ++
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSXICSRYYRAPELIF--GATDYTSSI 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS GCVL E+  G+    G
Sbjct: 205 DVWSAGCVLAELLLGQPIFPG 225

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 131/267 (49%), Gaps = 15/267 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  TG+  A+K I   +       + +L E+++L+ ++  N++K Y  
Sbjct: 41  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 100
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +    L  E+ T G L   + S +    EV   R  +Q++  I+ +H+N IVHRD+K
Sbjct: 101 FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDLK 159
Query: 131 SANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L ++    ++++ DFG    +S H     ++   +GT  Y+APEV   T    + 
Sbjct: 160 PENLLLESKSKDANIRIIDFG----LSTHFEASKKMKDKIGTAYYIAPEVLHGT----YD 211
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPE--SLSDEGQAFAEL 245
              D+WS G +L  + SG  P+   +  Y I+ KV  G+ T  +P+   +S+  +     
Sbjct: 212 EKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 270
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEE 272
            L + P+ R +  + L H ++    +E
Sbjct: 271 MLTYVPSMRISARDALDHEWIQTYTKE 297

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 131/292 (44%), Gaps = 48/292 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+VY A++  T E VA+K I+L  + +       + E+ +L+ +  +N+++   V
Sbjct: 43  GEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-VPGTAIREVSLLKELQHRNIIELKSV 101
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEV---LVRRYTKQLVDAISALHENTIVHR 127
             H   + L  E       E+ ++   D  P+V   +++ +  QL++ ++  H    +HR
Sbjct: 102 IHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR 156
Query: 128 DIKSANIFLT----AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           D+K  N+ L+    +E   LK+GDFG A    A      +    + T  Y  PE+ + + 
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGIPIRQFTHEIITLWYRPPEILLGSR 213
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV----GMGETPTIP--ESLSD 237
              +  +VDIWS+ C+  EM   K P    DS    +FK+    G+ +  T P   +L D
Sbjct: 214 H--YSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270
Query: 238 EGQAFAEL-----------------------CLRHDPAQRATIFELLQHPFL 266
             Q+F +                         L  DP +R +    L+HP+ 
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G+G + KV      +T  + AMK ++    ND   +  +  E  + E   N   LV  + 
Sbjct: 29  GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 88
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  +   +E    G L   +Q  +  LPE   R Y+ ++  A++ LHE  I++RD+
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDL 147
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G
Sbjct: 148 KLDNVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRGED---YG 199
Query: 189 RAVDIWSLGCVLVEMSSGKRPW------AEYDSNYQ-IMFKVGMGETPTIPESLSDEGQA 241
            +VD W+LG ++ EM +G+ P+         D N +  +F+V + +   IP S+S +  +
Sbjct: 200 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAAS 259
Query: 242 FAELCLRHDPAQR-----ATIFELLQ-HPFL 266
             +  L  DP +R      T F  +Q HPF 
Sbjct: 260 VLKSFLNKDPKERLGCLPQTGFADIQGHPFF 290

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 9/77 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G +V
Sbjct: 151 NVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSXFCGTPNYIAPEILRGED---YGFSV 202
Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 203 DWWALGVLMFEMMAGRS 219

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G+G + KV      +T  + AM+ ++    ND   +  +  E  + E   N   LV  + 
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  +   +E    G L   +Q  +  LPE   R Y+ ++  A++ LHE  I++RD+
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G
Sbjct: 180 KLDNVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YG 231
Query: 189 RAVDIWSLGCVLVEMSSGKRPW------AEYDSNYQ-IMFKVGMGETPTIPESLSDEGQA 241
            +VD W+LG ++ EM +G+ P+         D N +  +F+V + +   IP SLS +  +
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 291
Query: 242 FAELCLRHDPAQR-----ATIFELLQ-HPFL 266
             +  L  DP +R      T F  +Q HPF 
Sbjct: 292 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 9/77 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +KL D+G    +      PG+    F GT  Y+APE+    +   +G +V
Sbjct: 183 NVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGED---YGFSV 234
Query: 369 DIWSLGCVLVEMSSGKT 385
           D W+LG ++ EM +G++
Sbjct: 235 DWWALGVLMFEMMAGRS 251

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 113/259 (43%), Gaps = 13/259 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+      TG   A K +    ++D   V+    E++ +  +    LV  +  
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDA 222
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                EMV+  E  + G L   V    + + E     Y +Q+   +  +HEN  VH D+K
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 131 SANI-FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI F T   N LKL DFG    ++AH      +    GT  + APEV  +   VG+  
Sbjct: 283 PENIMFTTKRSNELKLIDFG----LTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPVGY-- 335
Query: 190 AVDIWSLGCVLVEMSSGKRPWA--EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
             D+WS+G +   + SG  P+     D   + +         +    +S++G+ F    L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 248 RHDPAQRATIFELLQHPFL 266
             DP  R TI + L+HP+L
Sbjct: 396 LADPNTRMTIHQALEHPWL 414

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 133/298 (44%), Gaps = 53/298 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---Y 67
           GQG FG V       TG  VA+K++      D RF    L  ++ L  ++  N+V+   Y
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVI----QDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTED------GLPEVLVRRYTKQLVDAISALHE 121
           +     R+   +++ +  E   ++L +   +        P +L++ +  QL+ +I  LH 
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 122 NTI--VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEV 178
            ++   HRDIK  N+ +     +LKL DFGSA K+S     P E N  ++ ++ Y APE+
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-----PSEPNVAYICSRYYRAPEL 202
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT-------- 230
                   +  AVDIWS+GC+  EM  G+  +   +S  Q+   V +   P+        
Sbjct: 203 IFGNQH--YTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260
Query: 231 -------------IP-------ESLSDEGQAFAELC--LRHDPAQRATIFELLQHPFL 266
                        IP        SL D  +A+  L   L++ P +R   +E L HP+ 
Sbjct: 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +     +LKL DFGSA K+S     P E N  ++ ++ Y APE+        +  AV
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLS-----PSEPNVAYICSRYYRAPELIFGNQH--YTTAV 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+  EM  G+    G
Sbjct: 214 DIWSVGCIFAEMMLGEPIFRG 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 31/270 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILE-GINQKNLVKY 67
           G+G FGKV  A   ETG+L A+K ++  +  Q+D   V+  + E RIL    N   L + 
Sbjct: 32  GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD--VECTMTEKRILSLARNHPFLTQL 89
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +      + +   ME    G L   +Q +     E   R Y  +++ A+  LH+  I++R
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDT 182
           D+K  N+ L  EG+  KL DFG   +        G  NG     F GT  Y+APE+    
Sbjct: 149 DLKLDNVLLDHEGHC-KLADFGMCKE--------GICNGVTTATFCGTPDYIAPEIL--- 196
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
            ++ +G AVD W++G +L EM  G  P+     N   +F+  + +    P  L ++    
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEA--ENEDDLFEAILNDEVVYPTWLHEDATGI 254
Query: 243 AELCLRHDPAQRATIF------ELLQHPFL 266
            +  +  +P  R           +L+HPF 
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 40/79 (50%), Gaps = 17/79 (21%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----FVGTQAYMAPEVFMDTNKVGH 364
           N+ L  EG+  KL DFG   +        G  NG     F GT  Y+APE+     ++ +
Sbjct: 154 NVLLDHEGHC-KLADFGMCKE--------GICNGVTTATFCGTPDYIAPEIL---QEMLY 201
Query: 365 GRAVDIWSLGCVLVEMSSG 383
           G AVD W++G +L EM  G
Sbjct: 202 GPAVDWWAMGVLLYEMLCG 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 119/254 (46%), Gaps = 12/254 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKV    +  TG  VA+K +   K      V  +  E++ L+     +++K Y V
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ + ME  + G L   +      L E   RR  +Q++  +   H + +VHRD+K
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ L A  N+ K+ DFG +  +S      GE L    G+  Y APEV   + ++  G 
Sbjct: 144 PENVLLDAHMNA-KIADFGLSNMMSD-----GEFLRXSCGSPNYAAPEVI--SGRLYAGP 195
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VDIWS G +L  +  G  P+   D +   +FK         P+ L+    +  +  L+ 
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD--DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQV 253
Query: 250 DPAQRATIFELLQH 263
           DP +RATI ++ +H
Sbjct: 254 DPMKRATIKDIREH 267

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 113/259 (43%), Gaps = 13/259 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+      TG   A K +    ++D   V+    E++ +  +    LV  +  
Sbjct: 60  GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDA 116
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                EMV+  E  + G L   V    + + E     Y +Q+   +  +HEN  VH D+K
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 176
Query: 131 SANI-FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI F T   N LKL DFG    ++AH      +    GT  + APEV  +   VG+  
Sbjct: 177 PENIMFTTKRSNELKLIDFG----LTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPVGY-- 229
Query: 190 AVDIWSLGCVLVEMSSGKRPWA--EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
             D+WS+G +   + SG  P+     D   + +         +    +S++G+ F    L
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 289
Query: 248 RHDPAQRATIFELLQHPFL 266
             DP  R TI + L+HP+L
Sbjct: 290 LADPNTRMTIHQALEHPWL 308

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVK- 66
           G+G FG+V    +  T ++ AMK   + ++ K++D+ F  +   E  I+   N   +V+ 
Sbjct: 78  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQL 134
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +  R  + + ME    G L +L+ + +  +PE   R YT ++V A+ A+H    +H
Sbjct: 135 FYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIH 191
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G
Sbjct: 192 RDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDG 248
Query: 187 -HGRAVDIWSLGCVLVEMSSGKRPW 210
            +GR  D WS+G  L EM  G  P+
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 4/77 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH-GRAV 368
           N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G+ GR  
Sbjct: 198 NMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 254
Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 255 DWWSVGVFLYEMLVGDT 271

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVK- 66
           G+G FG+V    +  T ++ AMK   + ++ K++D+ F  +   E  I+   N   +V+ 
Sbjct: 83  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQL 139
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +  R  + + ME    G L +L+ + +  +PE   R YT ++V A+ A+H    +H
Sbjct: 140 FYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIH 196
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G
Sbjct: 197 RDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDG 253
Query: 187 -HGRAVDIWSLGCVLVEMSSGKRPW 210
            +GR  D WS+G  L EM  G  P+
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 4/77 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH-GRAV 368
           N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G+ GR  
Sbjct: 203 NMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 259
Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 260 DWWSVGVFLYEMLVGDT 276

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVK- 66
           G+G FG+V    +  T ++ AMK   + ++ K++D+ F  +   E  I+   N   +V+ 
Sbjct: 83  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQL 139
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           +Y  +  R  + + ME    G L +L+ + +  +PE   R YT ++V A+ A+H    +H
Sbjct: 140 FYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMGFIH 196
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G
Sbjct: 197 RDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDG 253
Query: 187 -HGRAVDIWSLGCVLVEMSSGKRPW 210
            +GR  D WS+G  L EM  G  P+
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 4/77 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH-GRAV 368
           N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G+ GR  
Sbjct: 203 NMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 259
Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 260 DWWSVGVFLYEMLVGDT 276

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 123/264 (46%), Gaps = 24/264 (9%)
Query: 11  GQGRFGKVYTAVNNET----GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G +GKV   +++ET       +  K+      N    VK    E+++L  +  KN+++
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKNVIQ 70
Query: 67  YYGVEIHREE--MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
              V  + E+  M + ME C  G  E L    E   P      Y  QL+D +  LH   I
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDT 182
           VH+DIK  N+ LT  G +LK+   G A  +              G+ A+  PE+   +DT
Sbjct: 131 VHKDIKPGNLLLTT-GGTLKISALGVAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDT 188
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
                G  VDIWS G  L  +++G  P+ E D+ Y++   +G G    IP    D G   
Sbjct: 189 FS---GFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSY-AIP---GDCGPPL 240
Query: 243 AELC---LRHDPAQRATIFELLQH 263
           ++L    L ++PA+R +I ++ QH
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQH 264

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 89/358 (24%), Positives = 151/358 (42%), Gaps = 35/358 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V       TG++ A K+++  +    +     L E +ILE +N + +V     
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252
Query: 71  EIHREEMVLFMELCTEGTLE-SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
              ++ + L + L   G L+  +    + G PE     Y  ++   +  LH   IV+RD+
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  NI L   G+ +++ D G AV +    T+ G     VGT  YMAPEV  +     +  
Sbjct: 313 KPENILLDDHGH-IRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER---YTF 364
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQI-MFKVGMGETP-TIPESLSDEGQAFAELCL 247
           + D W+LGC+L EM +G+ P+ +     +    +  + E P    E  S + ++     L
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 248 RHDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDS 302
             DPA+R      +  E+ +HP                   +    L  G++ PP   D 
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLF---------------KKLNFKRLGAGMLEPPFKPDP 469
Query: 303 VKVYARANI----FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 356
             +Y +  +    F T +G  L+  D     K +  +      N  V T+ +    VF
Sbjct: 470 QAIYCKDVLDIEQFSTVKGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQELNVF 527

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 8/76 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AV +    T+ G     VGT  YMAPEV  +     +  + D
Sbjct: 316 NILLDDHGH-IRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER---YTFSPD 367
Query: 370 IWSLGCVLVEMSSGKT 385
            W+LGC+L EM +G++
Sbjct: 368 WWALGCLLYEMIAGQS 383

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 89/358 (24%), Positives = 151/358 (42%), Gaps = 35/358 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V       TG++ A K+++  +    +     L E +ILE +N + +V     
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252
Query: 71  EIHREEMVLFMELCTEGTLE-SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
              ++ + L + L   G L+  +    + G PE     Y  ++   +  LH   IV+RD+
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  NI L   G+ +++ D G AV +    T+ G     VGT  YMAPEV  +     +  
Sbjct: 313 KPENILLDDHGH-IRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER---YTF 364
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQI-MFKVGMGETP-TIPESLSDEGQAFAELCL 247
           + D W+LGC+L EM +G+ P+ +     +    +  + E P    E  S + ++     L
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLL 424
Query: 248 RHDPAQR-----ATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDS 302
             DPA+R      +  E+ +HP                   +    L  G++ PP   D 
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLF---------------KKLNFKRLGAGMLEPPFKPDP 469
Query: 303 VKVYARANI----FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 356
             +Y +  +    F T +G  L+  D     K +  +      N  V T+ +    VF
Sbjct: 470 QAIYCKDVLDIEQFSTVKGVELEPTDQDFYQKFATGSVPIPWQNEMVETECFQELNVF 527

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 8/76 (10%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AV +    T+ G     VGT  YMAPEV  +     +  + D
Sbjct: 316 NILLDDHGH-IRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER---YTFSPD 367
Query: 370 IWSLGCVLVEMSSGKT 385
            W+LGC+L EM +G++
Sbjct: 368 WWALGCLLYEMIAGQS 383

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 77  MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL 136
           M L  +L  +G L   + + +  L E   R   + L++A+S LH N IVHRD+K  NI L
Sbjct: 175 MFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL 233
Query: 137 TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHGRAVD 192
             +   ++L DFG +  +      PGE L    GT  Y+APE+    MD    G+G+ VD
Sbjct: 234 D-DNMQIRLSDFGFSCHLE-----PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 193 IWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFAEL---CLR 248
           +W+ G +L  + +G  P+  +     +M ++ M G+         D      +L    L+
Sbjct: 288 LWACGVILFTLLAGSPPF--WHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQ 345
Query: 249 HDPAQRATIFELLQHPFL 266
            DP  R T  + LQHPF 
Sbjct: 346 VDPEARLTAEQALQHPFF 363

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 10/78 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHG 365
           NI L  +   ++L DFG +  +      PGE L    GT  Y+APE+    MD    G+G
Sbjct: 230 NILLD-DNMQIRLSDFGFSCHLE-----PGEKLRELCGTPGYLAPEILKCSMDETHPGYG 283
Query: 366 RAVDIWSLGCVLVEMSSG 383
           + VD+W+ G +L  + +G
Sbjct: 284 KEVDLWACGVILFTLLAG 301

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 71  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 131 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 190 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 239
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 297
Query: 251 PAQR 254
             +R
Sbjct: 298 LTKR 301

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 192 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 241
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 242 WWALGVLIYEMAAG 255

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 43  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 103 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 162 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 211
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 269
Query: 251 PAQR 254
             +R
Sbjct: 270 LTKR 273

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 164 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 213
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 214 WWALGVLIYEMAAG 227

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 43  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 103 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 162 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 211
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 269
Query: 251 PAQR 254
             +R
Sbjct: 270 LTKR 273

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 164 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 213
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 214 WWALGVLIYEMAAG 227

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V  A N       A+K+I+  ++     +  +L E+ +L  +N + +V+YY  
Sbjct: 15  GQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVXLLASLNHQYVVRYYAA 70
Query: 71  EIHREEMV-----------LFM--ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
            + R   V           LF+  E C   TL  L+ S           R  +Q+++A+S
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--------PG---ELNG 166
            +H   I+HR++K  NIF+  E  ++K+GDFG A  +     +        PG    L  
Sbjct: 131 YIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 167 FVGTQAYMAPEVFMDTNKVGH-GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK--- 222
            +GT  Y+A EV   T   GH    +D +SLG +  E      P++       I+ K   
Sbjct: 190 AIGTAXYVATEVLDGT---GHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKKLRS 243
Query: 223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVC 275
           V +   P   ++     +    L + HDP +R     LL   +L V  +++V 
Sbjct: 244 VSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLMIDQQG-YIKVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLMIDQQG-YIKVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 15/269 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  TG+  A+K I   +       + +L E+++L+ ++  N+ K Y  
Sbjct: 35  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEF 94
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +    L  E+ T G L   + S +    EV   R  +Q++  I+  H+N IVHRD+K
Sbjct: 95  FEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYXHKNKIVHRDLK 153
Query: 131 SANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+ L ++    ++++ DFG    +S H     +    +GT  Y+APEV   T    + 
Sbjct: 154 PENLLLESKSKDANIRIIDFG----LSTHFEASKKXKDKIGTAYYIAPEVLHGT----YD 205
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPE--SLSDEGQAFAEL 245
              D+WS G +L  + SG  P+    + Y I+ KV  G+ T  +P+   +S+  +     
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDV 274
            L + P+ R +  + L H ++    +E +
Sbjct: 265 XLTYVPSXRISARDALDHEWIQTYTKEQI 293

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 71
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 132 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 185
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 186 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V    +  + ++ AMK   + ++ K++D+ F  +   E  I+   N   +V+ 
Sbjct: 84  GRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQL 140
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +      + + + ME    G L +L+ + +  +PE   + YT ++V A+ A+H   ++HR
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMGLIHR 198
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG- 186
           D+K  N+ L   G+ LKL DFG+ +K+     V    +  VGT  Y++PEV       G 
Sbjct: 199 DVKPDNMLLDKHGH-LKLADFGTCMKMDETGMV--HCDTAVGTPDYISPEVLKSQGGDGY 255
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDEGQAFAEL 245
           +GR  D WS+G  L EM  G  P+   DS      K+     +   PE       A   +
Sbjct: 256 YGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI 314
Query: 246 CL----RHDPAQRATIFELLQHPFL 266
           C     R     R  + E+ QHPF 
Sbjct: 315 CAFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 40/77 (51%), Gaps = 4/77 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH-GRAV 368
           N+ L   G+ LKL DFG+ +K+     V    +  VGT  Y++PEV       G+ GR  
Sbjct: 204 NMLLDKHGH-LKLADFGTCMKMDETGMV--HCDTAVGTPDYISPEVLKSQGGDGYYGREC 260
Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 261 DWWSVGVFLFEMLVGDT 277

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AV   T    A K+I  +   D    K    E+ I++ ++  N+++ Y  
Sbjct: 18  GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHPNIIRLYET 74
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                ++ L MELCT G L E +V   +    E    R  K ++ A++  H+  + HRD+
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 132
Query: 130 KSAN-IFLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N +FLT   +S LKL DFG A +       PG+ +   VGT  Y++P+V        
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFK-----PGKMMRTKVGTPYYVSPQVLEGL---- 183
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE----SLSDEGQAF 242
           +G   D WS G ++  +  G  P++   ++ ++M K+  G T T PE    ++S + ++ 
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSA-PTDXEVMLKIREG-TFTFPEKDWLNVSPQAESL 241
Query: 243 AELCLRHDPAQRATIFELLQH 263
               L   P QR T  + L+H
Sbjct: 242 IRRLLTKSPKQRITSLQALEH 262

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 75
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 76  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 135
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 136 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 189
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 190 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 231

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 66
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 67  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 126
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 127 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 180
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 181 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 222

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 74
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 75  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 134
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 135 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 188
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 189 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 72
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 73  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 132
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 133 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 186
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 187 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 228

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +   N+VK
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   +  L     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           +HRD+ + NI +  E N +K+GDFG        K       PGE   F     + APE  
Sbjct: 167 IHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESL 220
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
            ++       A D+WS G VL E+       K P AE+
Sbjct: 221 TESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 255

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 73
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 74  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 133
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 134 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 187
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 188 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 229

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AV   T    A K+I  +   D    K    E+ I++ ++  N+++ Y  
Sbjct: 35  GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHPNIIRLYET 91
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                ++ L MELCT G L E +V   +    E    R  K ++ A++  H+  + HRD+
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 149
Query: 130 KSAN-IFLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N +FLT   +S LKL DFG A +       PG+ +   VGT  Y++P+V        
Sbjct: 150 KPENFLFLTDSPDSPLKLIDFGLAARFK-----PGKMMRTKVGTPYYVSPQVLEGL---- 200
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE----SLSDEGQAF 242
           +G   D WS G ++  +  G  P++   ++ ++M K+  G T T PE    ++S + ++ 
Sbjct: 201 YGPECDEWSAGVMMYVLLCGYPPFSA-PTDXEVMLKIREG-TFTFPEKDWLNVSPQAESL 258
Query: 243 AELCLRHDPAQRATIFELLQH 263
               L   P QR T  + L+H
Sbjct: 259 IRRLLTKSPKQRITSLQALEH 279

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 68
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 129 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 182
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 183 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 36  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 95
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 96  FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 155 PENLLIDQQG-YIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSK---GYNKA 204
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 262
Query: 251 PAQR 254
             +R
Sbjct: 263 LTKR 266

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 157 NLLIDQQG-YIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSK---GYNKAVD 206
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 207 WWALGVLIYEMAAG 220

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 71
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 132 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 185
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 186 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 86
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 147 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 200
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY------DSNYQ-IMF 221
           + APE   ++       A D+WS G VL E+       K P AE+      D   Q I+F
Sbjct: 201 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 257
Query: 222 KV-----GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
            +       G  P  P+   DE       C  ++  QR +  +L
Sbjct: 258 HLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 40/284 (14%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 86
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 147 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 200
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY------DSNYQ-IMF 221
           + APE   ++       A D+WS G VL E+       K P AE+      D   Q I+F
Sbjct: 201 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 257
Query: 222 KV-----GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
            +       G  P  P+   DE       C  ++  QR +  +L
Sbjct: 258 HLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 87/333 (26%), Positives = 148/333 (44%), Gaps = 22/333 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V    G+  A   I   K+  AR  + +  E RI   +   N+V+ +  
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V    +   E       +Q+++A+   H+  +VHR++
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136
Query: 130 KSANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVL---RKDPY 190
Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           G+ VD+W+ G +L  +  G  P W E         K G  + P+ PE  +++ E +    
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS-PEWDTVTPEAKDLIN 249
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDY-----LKLGIVLPPMS 299
             L  +P++R T  E L+HP++        C  R      L+ +     LK  I+   ++
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLA 309
Query: 300 EDSVKVYARANIFLTAEG-NSLKLGDFGSAVKI 331
             +  V  +  I +T +   ++  GDF S  K+
Sbjct: 310 TRNFSVRKQEIIKVTEQLIEAISNGDFESYTKM 342

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 39/70 (55%), Gaps = 8/70 (11%)
Query: 310 NIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L ++  G ++KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVL---RKDPYGKP 193
Query: 368 VDIWSLGCVL 377
           VD+W+ G +L
Sbjct: 194 VDLWACGVIL 203

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 67
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 68  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 127
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 128 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 181
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 182 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 223

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 68
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 129 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 182
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 183 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 121/267 (45%), Gaps = 30/267 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G    VY      T +  A+K   L K  D + V+    E+ +L  ++  N++K   +
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVR---TEIGVLLRLSHPNIIKLKEI 116
Query: 71  EIHREEMVLFMELCTEGTL-----ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
                E+ L +EL T G L     E    S  D    V      KQ+++A++ LHEN IV
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV------KQILEAVAYLHENGIV 170
Query: 126 HRDIKSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           HRD+K  N+     A    LK+ DFG + KI  H  +   +    GT  Y APE+     
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLS-KIVEHQVL---MKTVCGTPGYCAPEIL---R 223
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
              +G  VD+WS+G +   +  G  P+ +   + Q MF+  +           DE    A
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNA 282
Query: 244 ELCLRH----DPAQRATIFELLQHPFL 266
           +  +R     DP +R T F+ LQHP++
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 18/222 (8%)
Query: 52  ELRILEGINQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYT 109
           E+ IL+ ++  N+VK   V  + + + + +  EL  +G +  +   T   L E   R Y 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSEDQARFYF 143
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
           + L+  I  LH   I+HRDIK +N+ +  +G+ +K+ DFG + +      +   L+  VG
Sbjct: 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDAL---LSNTVG 199
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM-----FKVG 224
           T A+MAPE   +T K+  G+A+D+W++G  L     G+ P+     + +IM      K  
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM----DERIMCLHSKIKSQ 255
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             E P  P+   D       + L  +P  R  + E+  HP++
Sbjct: 256 ALEFPDQPDIAEDLKDLITRM-LDKNPESRIVVPEIKLHPWV 296

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 29/150 (19%)
Query: 253 QRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIV-----LPPMSEDSVKVYA 307
           Q   I + L HP  +V   E + +P      ++ + +  G V     L P+SED  + Y 
Sbjct: 85  QEIAILKKLDHPN-VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF 143
Query: 308 RANI--------------------FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGT 347
           +  I                     L  E   +K+ DFG + +      +   L+  VGT
Sbjct: 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVGT 200
Query: 348 QAYMAPEVFMDTNKVGHGRAVDIWSLGCVL 377
            A+MAPE   +T K+  G+A+D+W++G  L
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 22/206 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL-VKYYG 69
           G+G FG+V  A +    E VA+K I+    N   F+    +E+R+LE +N+ +  +KYY 
Sbjct: 63  GKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 70  VEIHREEM-----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS--ALHEN 122
           V + R  M      L  E+ +    + L  +   G+   L R++ +Q+  A+   A  E 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 123 TIVHRDIKSANIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           +I+H D+K  NI L   + +++K+ DFGS+ ++         +   + ++ Y +PEV + 
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ------RIYQXIQSRFYRSPEVLLG 232
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
              + +  A+D+WSLGC+LVEM +G+
Sbjct: 233 ---MPYDLAIDMWSLGCILVEMHTGE 255

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 47/81 (58%), Gaps = 10/81 (12%)
Query: 310 NIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L   + +++K+ DFGS+ ++         +   + ++ Y +PEV +    + +  A+
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQ------RIYQXIQSRFYRSPEVLLG---MPYDLAI 239
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLGC+LVEM +G+   SG
Sbjct: 240 DMWSLGCILVEMHTGEPLFSG 260

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LAGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LAGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 71
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q+  + +  + + +YT Q+   + 
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGME 131
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HRD+ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 132 YLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF----- 185
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 186 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR--FVKDMLVELRILEGINQKNLVKYY 68
           G+G+F  VY A +  T ++VA+K+I+L  +++A+    +  L E+++L+ ++  N++   
Sbjct: 19  GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
               H+  + L  +   E  LE +++     L    ++ Y    +  +  LH++ I+HRD
Sbjct: 79  DAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ L   G  LKL DFG A    +           V T+ Y APE+       G G
Sbjct: 138 LKPNNLLLDENG-VLKLADFGLAKSFGSPNRA---YXHQVVTRWYRAPELLFGARMYGVG 193
Query: 189 RAVDIWSLGCVLVEM 203
             VD+W++GC+L E+
Sbjct: 194 --VDMWAVGCILAEL 206

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--QLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V   ++ +TGE VA+K+   +L  +N  R+     +E++I++ +N  N+V   
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC----LEIQIMKKLNHPNVVSAR 78
Query: 69  GVEIHREEM------VLFMELCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALH 120
            V    +++      +L ME C  G L   +   E+  GL E  +R     +  A+  LH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 121 ENTIVHRDIKSANIFLTAEGNSL--KLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPE 177
           EN I+HRD+K  NI L      L  K+ D G A ++       GEL   FVGT  Y+APE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-----GELCTEFVGTLQYLAPE 193
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
           +     +  +   VD WS G +  E  +G RP+
Sbjct: 194 LL---EQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--QLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V   ++ +TGE VA+K+   +L  +N  R+     +E++I++ +N  N+V   
Sbjct: 24  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC----LEIQIMKKLNHPNVVSAR 79
Query: 69  GVEIHREEM------VLFMELCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALH 120
            V    +++      +L ME C  G L   +   E+  GL E  +R     +  A+  LH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 121 ENTIVHRDIKSANIFLTAEGNSL--KLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPE 177
           EN I+HRD+K  NI L      L  K+ D G A ++       GEL   FVGT  Y+APE
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-----GELCTEFVGTLQYLAPE 194
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
           +     +  +   VD WS G +  E  +G RP+
Sbjct: 195 LL---EQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 22/206 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL-VKYYG 69
           G+G FG+V  A +    E VA+K I+    N   F+    +E+R+LE +N+ +  +KYY 
Sbjct: 44  GKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 99
Query: 70  VEIHREEM-----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS--ALHEN 122
           V + R  M      L  E+ +    + L  +   G+   L R++ +Q+  A+   A  E 
Sbjct: 100 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 159
Query: 123 TIVHRDIKSANIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           +I+H D+K  NI L   + +++K+ DFGS+ ++         +   + ++ Y +PEV + 
Sbjct: 160 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ------RIYQXIQSRFYRSPEVLLG 213
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
              + +  A+D+WSLGC+LVEM +G+
Sbjct: 214 ---MPYDLAIDMWSLGCILVEMHTGE 236

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 47/81 (58%), Gaps = 10/81 (12%)
Query: 310 NIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L   + +++K+ DFGS+ ++         +   + ++ Y +PEV +    + +  A+
Sbjct: 170 NILLCNPKRSAIKIVDFGSSCQLGQ------RIYQXIQSRFYRSPEVLLG---MPYDLAI 220
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLGC+LVEM +G+   SG
Sbjct: 221 DMWSLGCILVEMHTGEPLFSG 241

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 71  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 131 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 190 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 239
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 297
Query: 251 PAQR 254
             +R
Sbjct: 298 LTKR 301

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 192 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 241
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 242 WWALGVLIYEMAAG 255

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLMIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLMIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +   N+VK
Sbjct: 19  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   +  L     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-----PGELNGFVGTQAYMAPEVF 179
           +HRD+ + NI +  E N +K+GDFG    +           PGE   F     + APE  
Sbjct: 136 IHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-----WYAPESL 189
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
            ++       A D+WS G VL E+       K P AE+
Sbjct: 190 TESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 139/311 (44%), Gaps = 59/311 (18%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V    +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 25  GAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 82
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++  +  +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKHQIMHRDV 141
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++     +    N FVGT++YMAPE    T+   +  
Sbjct: 142 KPSNILVNSRG-EIKLCDFGVSGQL-----IDSMANSFVGTRSYMAPERLQGTH---YSV 192
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN--------------------------------- 216
             DIWS+G  LVE++ G+ P    D+                                  
Sbjct: 193 QSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS 252
Query: 217 ------------YQIMFKVGMGETPTIPESL-SDEGQAFAELCLRHDPAQRATIFELLQH 263
                       ++++  +     P +P  + + + Q F   CL  +PA+RA +  L  H
Sbjct: 253 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNH 312
Query: 264 PFLIVSCEEDV 274
            F+  S  E+V
Sbjct: 313 TFIKRSEVEEV 323

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 9/76 (11%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++     +    N FVGT++YMAPE    T+   +    
Sbjct: 144 SNILVNSRG-EIKLCDFGVSGQL-----IDSMANSFVGTRSYMAPERLQGTH---YSVQS 194
Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+G  LVE++ G+
Sbjct: 195 DIWSMGLSLVELAVGR 210

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 37  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 96
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 97  FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 155
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 156 PENLLIDEQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 205
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 263
Query: 251 PAQR 254
             +R
Sbjct: 264 LTKR 267

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/71 (32%), Positives = 38/71 (53%), Gaps = 9/71 (12%)
Query: 313 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWS 372
           L  E   +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD W+
Sbjct: 160 LIDEQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVDWWA 210
Query: 373 LGCVLVEMSSG 383
           LG ++ EM++G
Sbjct: 211 LGVLIYEMAAG 221

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   L K    
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   L K    
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V+      TG+L A+K I   K++ A     +  E+ +L+ I  +N+V    +
Sbjct: 18  GSGAFSEVFLVKQRLTGKLFALKCI---KKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L M+L + G L   +   E G+  E       +Q++ A+  LHEN IVHRD+
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 130 KSAN-IFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N ++LT E NS + + DFG + K+  +    G ++   GT  Y+APEV        +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLS-KMEQN----GIMSTACGTPGYVAPEVLAQK---PY 184
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQAFA 243
            +AVD WS+G +   +  G  P+ E ++  ++  K+  G    E+P   + +S+  + F 
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESP-FWDDISESAKDFI 242
Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L  DP +R T  + L HP++
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWI 265

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DEPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LXGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LXGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 86/326 (26%)
Query: 11  GQGRFGKVYTAVNNETGE-LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------ 63
           G+G FGKV   +++  G+  VA+K I+    N  ++ +   +E+ +L+ I +K+      
Sbjct: 28  GEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 64  ---LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              +  ++    H   M +  EL  + T E L ++     P   VR    QL  A+  LH
Sbjct: 84  CVLMSDWFNFHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140
Query: 121 ENTIVHRDIKSANIFL------------------TAEGNSLKLGDFGSAVKISAHTTVPG 162
           EN + H D+K  NI                    + +  S+++ DFGSA     H T   
Sbjct: 141 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT-- 198
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF 221
                V T+ Y  PEV ++   +G  +  D+WS+GC+L E   G   +  +++  + +M 
Sbjct: 199 ----IVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251
Query: 222 KVGMGETPT-----------------IPESLSDEGQAFAELC------------------ 246
           +  +G  P+                 + +  S +G+   E C                  
Sbjct: 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311
Query: 247 ------LRHDPAQRATIFELLQHPFL 266
                 L  DPAQR T+ E L HPF 
Sbjct: 312 DLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 9/72 (12%)
Query: 314 TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
           + +  S+++ DFGSA     H T        V T+ Y  PEV ++   +G  +  D+WS+
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTT------IVATRHYRPPEVILE---LGWAQPCDVWSI 225
Query: 374 GCVLVEMSSGKT 385
           GC+L E   G T
Sbjct: 226 GCILFEYYRGFT 237

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 86/326 (26%)
Query: 11  GQGRFGKVYTAVNNETGE-LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------ 63
           G+G FGKV   +++  G+  VA+K I+    N  ++ +   +E+ +L+ I +K+      
Sbjct: 37  GEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFL 92
Query: 64  ---LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              +  ++    H   M +  EL  + T E L ++     P   VR    QL  A+  LH
Sbjct: 93  CVLMSDWFNFHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 149
Query: 121 ENTIVHRDIKSANIFL------------------TAEGNSLKLGDFGSAVKISAHTTVPG 162
           EN + H D+K  NI                    + +  S+++ DFGSA     H T   
Sbjct: 150 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT-- 207
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF 221
                V T+ Y  PEV ++   +G  +  D+WS+GC+L E   G   +  +++  + +M 
Sbjct: 208 ----IVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 260
Query: 222 KVGMGETPT-----------------IPESLSDEGQAFAELC------------------ 246
           +  +G  P+                 + +  S +G+   E C                  
Sbjct: 261 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 320
Query: 247 ------LRHDPAQRATIFELLQHPFL 266
                 L  DPAQR T+ E L HPF 
Sbjct: 321 DLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 9/72 (12%)
Query: 314 TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
           + +  S+++ DFGSA     H T        V T+ Y  PEV ++   +G  +  D+WS+
Sbjct: 184 SVKNTSIRVADFGSATFDHEHHTT------IVATRHYRPPEVILE---LGWAQPCDVWSI 234
Query: 374 GCVLVEMSSGKT 385
           GC+L E   G T
Sbjct: 235 GCILFEYYRGFT 246

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 71  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 130
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 131 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 190 PENLLIDQQG-YIQVTDFGFAKRVKGATWT------LCGTPEYLAPEIILSK---GYNKA 239
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 297
Query: 251 PAQR 254
             +R
Sbjct: 298 LTKR 301

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 192 NLLIDQQG-YIQVTDFGFAKRVKGATWT------LCGTPEYLAPEIILSK---GYNKAVD 241
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 242 WWALGVLIYEMAAG 255

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 133/326 (40%), Gaps = 86/326 (26%)
Query: 11  GQGRFGKVYTAVNNETGE-LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------ 63
           G+G FGKV   +++  G+  VA+K I+    N  ++ +   +E+ +L+ I +K+      
Sbjct: 60  GEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFL 115
Query: 64  ---LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              +  ++    H   M +  EL  + T E L ++     P   VR    QL  A+  LH
Sbjct: 116 CVLMSDWFNFHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 172
Query: 121 ENTIVHRDIKSANIFL------------------TAEGNSLKLGDFGSAVKISAHTTVPG 162
           EN + H D+K  NI                    + +  S+++ DFGSA     H T   
Sbjct: 173 ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT-- 230
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMF 221
                V T+ Y  PEV ++   +G  +  D+WS+GC+L E   G   +  +++  + +M 
Sbjct: 231 ----IVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 283
Query: 222 KVGMGETPT-----------------IPESLSDEGQAFAELC------------------ 246
           +  +G  P+                 + +  S +G+   E C                  
Sbjct: 284 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 343
Query: 247 ------LRHDPAQRATIFELLQHPFL 266
                 L  DPAQR T+ E L HPF 
Sbjct: 344 DLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 9/72 (12%)
Query: 314 TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
           + +  S+++ DFGSA     H T        V T+ Y  PEV ++   +G  +  D+WS+
Sbjct: 207 SVKNTSIRVADFGSATFDHEHHTT------IVATRHYRPPEVILE---LGWAQPCDVWSI 257
Query: 374 GCVLVEMSSGKT 385
           GC+L E   G T
Sbjct: 258 GCILFEYYRGFT 269

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 118/248 (47%), Gaps = 29/248 (11%)
Query: 45  FVKDMLVELRIL-EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGL 100
           F    L+E+++L E  +  N+++YY  E     + + +ELC    L+ LV+S   +++ L
Sbjct: 69  FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENL 127
Query: 101 PEVLVRRYT-----KQLVDAISALHENTIVHRDIKSANIFLT------------AEGNSL 143
              L + Y      +Q+   ++ LH   I+HRD+K  NI ++            AE   +
Sbjct: 128 K--LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 185
Query: 144 KLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 202
            + DFG   K+ S        LN   GT  + APE+  ++ K    R++DI+S+GCV   
Sbjct: 186 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYY 245
Query: 203 -MSSGKRPWAE-YDSNYQIMFKV-GMGETPTIPE-SLSDEGQAFAELCLRHDPAQRATIF 258
            +S GK P+ + Y     I+  +  + E   + + SL  E        + HDP +R T  
Sbjct: 246 ILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 259 ELLQHPFL 266
           ++L+HP  
Sbjct: 306 KVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 315 AEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
           AE   + + DFG   K+ S        LN   GT  + APE+  ++ K    R++DI+S+
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSM 239
Query: 374 GCVLVE-MSSGK 384
           GCV    +S GK
Sbjct: 240 GCVFYYILSKGK 251

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   L K    
Sbjct: 51  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLMIDQQG-YIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLMIDQQG-YIQVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLMIDQQG-YIQVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 22/206 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL-VKYYG 69
           G+G FG+V  A +    E VA+K I+    N   F+    +E+R+LE +N+ +  +KYY 
Sbjct: 63  GKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 70  VEIHREEM-----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS--ALHEN 122
           V + R  M      L  E+ +    + L  +   G+   L R++ +Q+  A+   A  E 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 123 TIVHRDIKSANIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           +I+H D+K  NI L   +  ++K+ DFGS+ ++         +   + ++ Y +PEV + 
Sbjct: 179 SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ------RIYQXIQSRFYRSPEVLLG 232
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
              + +  A+D+WSLGC+LVEM +G+
Sbjct: 233 ---MPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 46/81 (56%), Gaps = 10/81 (12%)
Query: 310 NIFL-TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L   +  ++K+ DFGS+ ++         +   + ++ Y +PEV +    + +  A+
Sbjct: 189 NILLCNPKRXAIKIVDFGSSCQLGQ------RIYQXIQSRFYRSPEVLLG---MPYDLAI 239
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLGC+LVEM +G+   SG
Sbjct: 240 DMWSLGCILVEMHTGEPLFSG 260

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + ETG   AMK +   K    + ++  L E RI + +N   LVK    
Sbjct: 51  GTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFS 110
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + +E    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 111 FKDNSNLYMVLEYAPGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 170 PENLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 219
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 277
Query: 251 PAQR 254
             +R
Sbjct: 278 LTKR 281

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +K+ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 172 NLLIDQQG-YIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 128/263 (48%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  T +  A+K I      + +    +L E+ +L+ ++  N++K + +
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  EL T G L + +++       E    R  KQ+   I+ +H++ IVHRD+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 130 KSANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  NI L ++     +K+ DFG +     +T    ++   +GT  Y+APEV   T    +
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRGT----Y 199
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETP-TIPE--SLSDEGQAFA 243
               D+WS G +L  + SG  P+  Y  N Y I+ +V  G+    +P+  ++SD+ +   
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L   P+ R T  + L+HP++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWI 280

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 117/254 (46%), Gaps = 33/254 (12%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL------ 64
           G G FG+V+   +   G   AMK ++          K+++V L+ +E  N + L      
Sbjct: 15  GTGSFGRVHLIRSRHNGRYYAMKVLK----------KEIVVRLKQVEHTNDERLMLSIVT 64
Query: 65  ----VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               ++ +G     +++ + M+    G L SL++ ++   P  + + Y  ++  A+  LH
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH 123
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I++RD+K  NI L   G+ +K+ DFG A        VP       GT  Y+APEV  
Sbjct: 124 SKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYXLCGTPDYIAPEV-- 174
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
             +   + +++D WS G ++ EM +G  P+  YDSN    ++  +      P   +++ +
Sbjct: 175 -VSTKPYNKSIDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPFFNEDVK 231
Query: 241 AFAELCLRHDPAQR 254
                 +  D +QR
Sbjct: 232 DLLSRLITRDLSQR 245

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 45  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 104
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 105 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 163
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 164 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 213
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 271
Query: 251 PAQR 254
             +R
Sbjct: 272 LTKR 275

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 166 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 215
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 216 WWALGVLIYEMAAG 229

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 128/263 (48%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  T +  A+K I      + +    +L E+ +L+ ++  N++K + +
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  EL T G L + +++       E    R  KQ+   I+ +H++ IVHRD+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 130 KSANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  NI L ++     +K+ DFG +     +T    ++   +GT  Y+APEV   T    +
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRGT----Y 199
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETP-TIPE--SLSDEGQAFA 243
               D+WS G +L  + SG  P+  Y  N Y I+ +V  G+    +P+  ++SD+ +   
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L   P+ R T  + L+HP++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWI 280

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 118/248 (47%), Gaps = 29/248 (11%)
Query: 45  FVKDMLVELRIL-EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGL 100
           F    L+E+++L E  +  N+++YY  E     + + +ELC    L+ LV+S   +++ L
Sbjct: 69  FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENL 127
Query: 101 PEVLVRRYT-----KQLVDAISALHENTIVHRDIKSANIFLT------------AEGNSL 143
              L + Y      +Q+   ++ LH   I+HRD+K  NI ++            AE   +
Sbjct: 128 K--LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 185
Query: 144 KLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE 202
            + DFG   K+ S        LN   GT  + APE+  ++ K    R++DI+S+GCV   
Sbjct: 186 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYY 245
Query: 203 -MSSGKRPWAE-YDSNYQIMFKV-GMGETPTIPE-SLSDEGQAFAELCLRHDPAQRATIF 258
            +S GK P+ + Y     I+  +  + E   + + SL  E        + HDP +R T  
Sbjct: 246 ILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 305
Query: 259 ELLQHPFL 266
           ++L+HP  
Sbjct: 306 KVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 315 AEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
           AE   + + DFG   K+ S        LN   GT  + APE+  ++ K    R++DI+S+
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSM 239
Query: 374 GCVLVE-MSSGK 384
           GCV    +S GK
Sbjct: 240 GCVFYYILSKGK 251

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+ A   E+ E+   K +Q     D RF    L  +RI++  N  +L  ++  
Sbjct: 49  GNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQST------EDGLPEVLVRRYTKQLVDAISALHENTI 124
              +++ V F+ L  E   E++ +++      +  +P +L++ Y  QL+ +++ +H   I
Sbjct: 104 NGDKKDEV-FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI 162
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPE-VFMDT 182
            HRDIK  N+ L      LKL DFGSA  + A     GE N   + ++ Y APE +F  T
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-----GEPNVSXICSRYYRAPELIFGAT 217
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGK 207
           N   +   +DIWS GCV+ E+  G+
Sbjct: 218 N---YTTNIDIWSTGCVMAELMQGQ 239

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 42/82 (51%), Gaps = 10/82 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPE-VFMDTNKVGHGRA 367
           N+ L      LKL DFGSA  + A     GE N   + ++ Y APE +F  TN   +   
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIA-----GEPNVSXICSRYYRAPELIFGATN---YTTN 222
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +DIWS GCV+ E+  G+    G
Sbjct: 223 IDIWSTGCVMAELMQGQPLFPG 244

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLIIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIIISK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLIIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIIISK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L E   R+  + L++ I ALH+  IVHRD+K  NI L  + N +KL DFG + ++     
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLD---- 175
Query: 160 VPGE-LNGFVGTQAYMAPEVF---MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS 215
            PGE L    GT +Y+APE+    M+ N  G+G+ VD+WS G ++  + +G  P+  +  
Sbjct: 176 -PGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHR 232
Query: 216 NYQIMFKVGMGETPTI--PE--SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
              +M ++ M        PE    SD  +      L   P +R T  E L HPF 
Sbjct: 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 10/78 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHG 365
           NI L  + N +KL DFG + ++      PGE L    GT +Y+APE+    M+ N  G+G
Sbjct: 154 NILLDDDMN-IKLTDFGFSCQLD-----PGEKLRSVCGTPSYLAPEIIECSMNDNHPGYG 207
Query: 366 RAVDIWSLGCVLVEMSSG 383
           + VD+WS G ++  + +G
Sbjct: 208 KEVDMWSTGVIMYTLLAG 225

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 22/261 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG VY A   +   ++A+K +   QL K+     ++    E+ I   +   N+++ 
Sbjct: 24  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSHLRHPNILRM 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y     R+ + L +E    G L   +Q       E     + ++L DA+   HE  ++HR
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHR 139
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ +  +G  LK+ DFG +V   +            GT  Y+ PE+        H
Sbjct: 140 DIKPENLLMGYKG-ELKIADFGWSVHAPSLRR-----RXMCGTLDYLPPEMIEGKT---H 190
Query: 188 GRAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
              VD+W  G +  E   G  P+    +   ++ +  V +      P  LSD  +     
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----KFPPFLSDGSKDLISK 246
Query: 246 CLRHDPAQRATIFELLQHPFL 266
            LR+ P QR  +  +++HP++
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWV 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 22/261 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG VY A   +   ++A+K +   QL K+     ++    E+ I   +   N+++ 
Sbjct: 23  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSHLRHPNILRM 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y     R+ + L +E    G L   +Q       E     + ++L DA+   HE  ++HR
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHR 138
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  N+ +  +G  LK+ DFG +V   +            GT  Y+ PE+        H
Sbjct: 139 DIKPENLLMGYKG-ELKIADFGWSVHAPSLRR-----RXMCGTLDYLPPEMIEGKT---H 189
Query: 188 GRAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
              VD+W  G +  E   G  P+    +   ++ +  V +      P  LSD  +     
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----KFPPFLSDGSKDLISK 245
Query: 246 CLRHDPAQRATIFELLQHPFL 266
            LR+ P QR  +  +++HP++
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWV 266

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ +M++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/74 (29%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ +M++G
Sbjct: 221 WWALGVLIYQMAAG 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 18/272 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      + ++ ELVA+K I+  ++ D   VK  ++  R    +   N+V++  V
Sbjct: 27  GSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN-VKREIINHR---SLRHPNIVRFKEV 82
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    + + ME  + G L E +  +      E   R + +QL+  +S  H   + HRD+
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDL 140
Query: 130 KSANIFLT-AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N  L  +    LK+ DFG     S  + +  +    VGT AY+APEV +   K   G
Sbjct: 141 KLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDG 194
Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           +  D+WS G  L  M  G  P+   E   N++      +     IP+   +S E +    
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 254
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
                DPA+R +I E+  H + + +   D+ N
Sbjct: 255 RIFVADPAKRISIPEIRNHEWFLKNLPADLMN 286

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 13/228 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSD 264

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 41/74 (55%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 18/272 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      + +  ELVA+K I+  ++ D   VK  ++  R    +   N+V++  V
Sbjct: 28  GAGNFGVARLMRDKQANELVAVKYIERGEKIDEN-VKREIINHR---SLRHPNIVRFKEV 83
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    + + ME  + G L E +  +      E   R + +QL+  +S  H   + HRD+
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYAHAMQVAHRDL 141
Query: 130 KSANIFLT-AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N  L  +    LK+ DFG     S  + +  +    VGT AY+APEV +   K   G
Sbjct: 142 KLENTLLDGSPAPRLKIADFG----YSKASVLHSQPKSAVGTPAYIAPEVLL--KKEYDG 195
Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           +  D+WS G  L  M  G  P+   E   N++      +     IP+   +S E +    
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
                DPA+R +I E+  H + + +   D+ N
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLPADLMN 287

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L E   R+  + L++ I ALH+  IVHRD+K  NI L  + N +KL DFG + ++     
Sbjct: 108 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLD---- 162
Query: 160 VPGE-LNGFVGTQAYMAPEVF---MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS 215
            PGE L    GT +Y+APE+    M+ N  G+G+ VD+WS G ++  + +G  P+  +  
Sbjct: 163 -PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHR 219
Query: 216 NYQIMFKVGMGETPTI--PE--SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
              +M ++ M        PE    SD  +      L   P +R T  E L HPF 
Sbjct: 220 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 10/78 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHG 365
           NI L  + N +KL DFG + ++      PGE L    GT +Y+APE+    M+ N  G+G
Sbjct: 141 NILLDDDMN-IKLTDFGFSCQLD-----PGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 194
Query: 366 RAVDIWSLGCVLVEMSSG 383
           + VD+WS G ++  + +G
Sbjct: 195 KEVDMWSTGVIMYTLLAG 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 56/299 (18%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +A    TG+ VA+K+I  +  +     K  L EL+IL+     N++    +
Sbjct: 64  GNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 71  --------EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVL--VRRYTKQLVDAISALH 120
                   E     +VL +    E  L  ++ S++   P  L  VR +  QL+  +  +H
Sbjct: 123 LRPTVPYGEFKSVYVVLDL---MESDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH 176
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE----LNGFVGTQAYMAP 176
              ++HRD+K +N+ L  E   LK+GDFG A  +    T P E    +  +V T+ Y AP
Sbjct: 177 SAQVIHRDLKPSNL-LVNENCELKIGDFGMARGL---CTSPAEHQYFMTEYVATRWYRAP 232
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKVGMGETPTIPES 234
           E+ +  ++  + +A+D+WS+GC+  EM + ++  P   Y    Q++  V    +P + ++
Sbjct: 233 ELMLSLHE--YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 290
Query: 235 LSDE-------------------------GQAFAEL--CLRHDPAQRATIFELLQHPFL 266
           +  E                          QA + L   LR +P+ R +    L+HPFL
Sbjct: 291 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 349

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 9/82 (10%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGE----LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
            L  E   LK+GDFG A  +    T P E    +  +V T+ Y APE+ +  ++  + +A
Sbjct: 190 LLVNENCELKIGDFGMARGL---CTSPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQA 244
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+WS+GC+  EM + +    G
Sbjct: 245 IDLWSVGCIFGEMLARRQLFPG 266

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L E   R+  + L++ I ALH+  IVHRD+K  NI L  + N +KL DFG + ++     
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLD---- 175
Query: 160 VPGE-LNGFVGTQAYMAPEVF---MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS 215
            PGE L    GT +Y+APE+    M+ N  G+G+ VD+WS G ++  + +G  P+  +  
Sbjct: 176 -PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHR 232
Query: 216 NYQIMFKVGMGETPTI--PE--SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
              +M ++ M        PE    SD  +      L   P +R T  E L HPF 
Sbjct: 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 10/78 (12%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHG 365
           NI L  + N +KL DFG + ++      PGE L    GT +Y+APE+    M+ N  G+G
Sbjct: 154 NILLDDDMN-IKLTDFGFSCQLD-----PGEKLREVCGTPSYLAPEIIECSMNDNHPGYG 207
Query: 366 RAVDIWSLGCVLVEMSSG 383
           + VD+WS G ++  + +G
Sbjct: 208 KEVDMWSTGVIMYTLLAG 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 56/299 (18%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +A    TG+ VA+K+I  +  +     K  L EL+IL+     N++    +
Sbjct: 63  GNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 71  --------EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVL--VRRYTKQLVDAISALH 120
                   E     +VL +    E  L  ++ S++   P  L  VR +  QL+  +  +H
Sbjct: 122 LRPTVPYGEFKSVYVVLDL---MESDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH 175
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE----LNGFVGTQAYMAP 176
              ++HRD+K +N+ L  E   LK+GDFG A  +    T P E    +  +V T+ Y AP
Sbjct: 176 SAQVIHRDLKPSNL-LVNENCELKIGDFGMARGL---CTSPAEHQYFMTEYVATRWYRAP 231
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKVGMGETPTIPES 234
           E+ +  ++  + +A+D+WS+GC+  EM + ++  P   Y    Q++  V    +P + ++
Sbjct: 232 ELMLSLHE--YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289
Query: 235 LSDE-------------------------GQAFAEL--CLRHDPAQRATIFELLQHPFL 266
           +  E                          QA + L   LR +P+ R +    L+HPFL
Sbjct: 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 44/82 (53%), Gaps = 9/82 (10%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGE----LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
            L  E   LK+GDFG A  +    T P E    +  +V T+ Y APE+ +  ++  + +A
Sbjct: 189 LLVNENCELKIGDFGMARGL---CTSPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQA 243
Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+WS+GC+  EM + +    G
Sbjct: 244 IDLWSVGCIFGEMLARRQLFPG 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 127/263 (48%), Gaps = 20/263 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  T +  A+K I      + +    +L E+ +L+ ++  N++K + +
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  EL T G L + +++       E    R  KQ+   I+ +H++ IVHRD+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 130 KSANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  NI L ++     +K+ DFG +     +T +       +GT  Y+APEV   T    +
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR----IGTAYYIAPEVLRGT----Y 199
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETP-TIPE--SLSDEGQAFA 243
               D+WS G +L  + SG  P+  Y  N Y I+ +V  G+    +P+  ++SD+ +   
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257
Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L   P+ R T  + L+HP++
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWI 280

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 123/252 (48%), Gaps = 14/252 (5%)
Query: 11  GQGRFGKVYTAVN---NETGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKNLVK 66
           G G +GKV+       ++TG+L AMK ++       A+  +    E ++LE I Q   + 
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 67  YYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
                   E ++ L ++    G L + + S  +   E  V+ Y  ++V A+  LH+  I+
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RDIK  NI L + G+ + L DFG + +  A  T       F GT  YMAP++    +  
Sbjct: 182 YRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERA--YDFCGTIEYMAPDIVRGGDS- 237
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPW---AEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
           GH +AVD WSLG ++ E+ +G  P+    E +S  +I  ++   E P  P+ +S   +  
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSALAKDL 296
Query: 243 AELCLRHDPAQR 254
            +  L  DP +R
Sbjct: 297 IQRLLMKDPKKR 308

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 4/79 (5%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L + G+ + L DFG + +  A  T       F GT  YMAP++    +  GH +AVD
Sbjct: 189 NILLDSNGHVV-LTDFGLSKEFVADETERA--YDFCGTIEYMAPDIVRGGDS-GHDKAVD 244
Query: 370 IWSLGCVLVEMSSGKTNLS 388
            WSLG ++ E+ +G +  +
Sbjct: 245 WWSLGVLMYELLTGASPFT 263

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 4   VTFSVSPGQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           + F    G+G FG V    Y  + + TGE+VA+K++Q    +    ++D   E+ IL+ +
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSL 69
Query: 60  NQKNLVKYYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
              N+VKY GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   + 
Sbjct: 70  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 129
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-----SAVKISAHTTVPGELNGFVGTQA 172
            L     +HR++ + NI +  E N +K+GDFG        K       PGE   F     
Sbjct: 130 YLGTKRYIHRNLATRNILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----- 183
Query: 173 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM----SSGKRPWAEY 213
           + APE   ++       A D+WS G VL E+       K P AE+
Sbjct: 184 WYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEF 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 121/252 (48%), Gaps = 33/252 (13%)
Query: 45  FVKDMLVELRIL-EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGL 100
           F    L+E+++L E  +  N+++YY  E     + + +ELC    L+ LV+S   +++ L
Sbjct: 51  FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENL 109
Query: 101 PEVLVRRYT-----KQLVDAISALHENTIVHRDIKSANIFLT------------AEGNSL 143
              L + Y      +Q+   ++ LH   I+HRD+K  NI ++            AE   +
Sbjct: 110 K--LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 144 KLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN----KVGHGRAVDIWSLGC 198
            + DFG   K+ S  ++    LN   GT  + APE+  ++N    K    R++DI+S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 199 VLVE-MSSGKRPWAE-YDSNYQIMFKV-GMGETPTIPE-SLSDEGQAFAELCLRHDPAQR 254
           V    +S GK P+ + Y     I+  +  + E   + + SL  E        + HDP +R
Sbjct: 228 VFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287
Query: 255 ATIFELLQHPFL 266
            T  ++L+HP  
Sbjct: 288 PTAMKVLRHPLF 299

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 122/272 (44%), Gaps = 18/272 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      + ++ ELVA+K I+  ++  A  VK  ++  R L      N+V++  V
Sbjct: 28  GSGNFGVARLMRDKQSNELVAVKYIERGEKIAAN-VKREIINHRSLR---HPNIVRFKEV 83
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    + + ME  + G L E +  +      E   R + +QL+  +S  H   + HRD+
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 130 KSANIFLT-AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N  L  +    LK+ DFG +     H+    +    VGT AY+APEV +   K   G
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLL--KKEYDG 195
Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           +  D+WS G  L  M  G  P+   E   N++      +     IP+   +S E +    
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
                DPA+R +I E+  H + + +   D+ N
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLPADLMN 287

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 22/288 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V  A +  T +LVA+K I   K+        M  E+ +L  I   N+V    +
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIA--KKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 + L M+L + G L   +   E G   E    R   Q++DA+  LH+  IVHRD+
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+   +  E + + + DFG      +    PG  L+   GT  Y+APEV     +  
Sbjct: 143 KPENLLYYSLDEDSKIMISDFG-----LSKMEDPGSVLSTACGTPGYVAPEVLA---QKP 194
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSN----YQIMFKVGMGETPTIPESLSDEGQAF 242
           + +AVD WS+G +   +  G  P+  YD N    ++ + K          + +SD  + F
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
               +  DP +R T  + LQHP++      D    +SV   + +++ K
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAK 300

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT  Y+AP + +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPAIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/74 (29%), Positives = 40/74 (54%), Gaps = 10/74 (13%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT  Y+AP + +     G+ +AVD
Sbjct: 171 NLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEYLAPAIILSK---GYNKAVD 220
Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 22/288 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V  A +  T +LVA+K I   K+        M  E+ +L  I   N+V    +
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIA--KEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 + L M+L + G L   +   E G   E    R   Q++DA+  LH+  IVHRD+
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+   +  E + + + DFG      +    PG  L+   GT  Y+APEV     +  
Sbjct: 143 KPENLLYYSLDEDSKIMISDFG-----LSKMEDPGSVLSTACGTPGYVAPEVLA---QKP 194
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSN----YQIMFKVGMGETPTIPESLSDEGQAF 242
           + +AVD WS+G +   +  G  P+  YD N    ++ + K          + +SD  + F
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
               +  DP +R T  + LQHP++      D    +SV   + +++ K
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAK 300

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 123/267 (46%), Gaps = 23/267 (8%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD-----MLVELRILEGIN 60
           ++SP G G FG V+TAV+ E  + V +K I+  K  +  +++D     + +E+ IL  + 
Sbjct: 28  TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
             N++K   +  ++    L ME    G            L E L     +QLV A+  L 
Sbjct: 88  HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVF 179
              I+HRDIK  NI + AE  ++KL DFGSA  +       G+L   F GT  Y APEV 
Sbjct: 148 LKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLER-----GKLFYTFCGTIEYCAPEVL 201
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
           M       G  +++WSLG  L  +   + P+ E +   +             P  +S E 
Sbjct: 202 MGNPY--RGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP--------PYLVSKEL 251
Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
            +     L+  P +R T+ +L+  P++
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 24/279 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-ELRILEGINQKNLVKYYG 69
           G+G+FG VY A   ++  +VA+K +    Q +   V+  L  E+ I   ++  N+++ Y 
Sbjct: 32  GKGKFGNVYLAREKKSHFIVALK-VLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               R  + L +E    G L   +Q +     E       ++L DA+   H   ++HRDI
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCHGKKVIHRDI 149
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L      LK+ DFG +V   +            GT  Y+ PE+        H  
Sbjct: 150 KPENL-LLGLKGELKIADFGWSVHAPSLRR-----KTMCGTLDYLPPEMIEGR---MHNE 200
Query: 190 AVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            VD+W +G +  E+  G  P+  A ++  Y+ + KV +      P S+    Q      L
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL----KFPASVPTGAQDLISKLL 256
Query: 248 RHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
           RH+P++R  + ++  HP++  +        R +P S LQ
Sbjct: 257 RHNPSERLPLAQVSAHPWVRANSR------RVLPPSALQ 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 105 SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 214
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 215 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 263
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 264 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 22/288 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V  A +  T +LVA+K I   K+        M  E+ +L  I   N+V    +
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIA--KEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 + L M+L + G L   +   E G   E    R   Q++DA+  LH+  IVHRD+
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+   +  E + + + DFG      +    PG  L+   GT  Y+APEV     +  
Sbjct: 143 KPENLLYYSLDEDSKIMISDFG-----LSKMEDPGSVLSTACGTPGYVAPEVLA---QKP 194
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSN----YQIMFKVGMGETPTIPESLSDEGQAF 242
           + +AVD WS+G +   +  G  P+  YD N    ++ + K          + +SD  + F
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
               +  DP +R T  + LQHP++      D    +SV   + +++ K
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAK 300

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 41  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 97
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 157 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSA--- 211
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 269
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 162 NILLN-EDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSA---SKSSD 216
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 217 LWALGCIIYQLVAG 230

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT A++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPAFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 120/264 (45%), Gaps = 22/264 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V  A +  T +LVA+K I   K+        M  E+ +L  I   N+V    +
Sbjct: 27  GTGAFSEVILAEDKRTQKLVAIKCIA--KEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 + L M+L + G L   +   E G   E    R   Q++DA+  LH+  IVHRD+
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 130 KSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+   +  E + + + DFG      +    PG  L+   GT  Y+APEV     +  
Sbjct: 143 KPENLLYYSLDEDSKIMISDFG-----LSKMEDPGSVLSTACGTPGYVAPEVLA---QKP 194
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSN----YQIMFKVGMGETPTIPESLSDEGQAF 242
           + +AVD WS+G +   +  G  P+  YD N    ++ + K          + +SD  + F
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
               +  DP +R T  + LQHP++
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 86  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 142
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 195
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 196 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 244
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 245 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 123/270 (45%), Gaps = 29/270 (10%)
Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQLHKQNDARFVKDML---VELRILEGINQKNL 64
           G+G +GKV+         TG++ AMK   L K    R  KD      E  ILE +    +
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMK--VLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENT 123
           V          ++ L +E  + G L   +Q   +G+  E     Y  ++  A+  LH+  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I++RD+K  NI L  +G+ +KL DFG   +     TV    + F GT  YMAPE+ M   
Sbjct: 142 IIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV---THXFCGTIEYMAPEILM--- 194
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTIPESLSDEGQA 241
           + GH RAVD WSLG ++ +M +G  P+   +    I  + K  +     +P  L+ E + 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----NLPPYLTQEARD 250
Query: 242 FAELCLRHDPAQR-----ATIFELLQHPFL 266
             +  L+ + A R         E+  HPF 
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/80 (41%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G+ +KL DFG   +     TV    + F GT  YMAPE+ M   + GH RAVD
Sbjct: 151 NIMLNHQGH-VKLTDFGLCKESIHDGTV---THXFCGTIEYMAPEILM---RSGHNRAVD 203
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WSLG ++ +M +G    +G
Sbjct: 204 WWSLGALMYDMLTGAPPFTG 223

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 99  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 155
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 208
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 209 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 257
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 258 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 98  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 154
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 207
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 208 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 256
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 39  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 95
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 155 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANAFVGTAQYVSPELLTEKSAC-- 210
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 211 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 267
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 160 NILLN-EDMHIQITDFGTA-KVLSPESKQARANAFVGTAQYVSPELLTEKSAC---KSSD 214
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 215 LWALGCIIYQLVAG 228

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 123/270 (45%), Gaps = 29/270 (10%)
Query: 11  GQGRFGKVY---TAVNNETGELVAMKEIQLHKQNDARFVKDML---VELRILEGINQKNL 64
           G+G +GKV+         TG++ AMK   L K    R  KD      E  ILE +    +
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMK--VLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENT 123
           V          ++ L +E  + G L   +Q   +G+  E     Y  ++  A+  LH+  
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I++RD+K  NI L  +G+ +KL DFG   +     TV    + F GT  YMAPE+ M   
Sbjct: 142 IIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILM--- 194
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTIPESLSDEGQA 241
           + GH RAVD WSLG ++ +M +G  P+   +    I  + K  +     +P  L+ E + 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----NLPPYLTQEARD 250
Query: 242 FAELCLRHDPAQR-----ATIFELLQHPFL 266
             +  L+ + A R         E+  HPF 
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/80 (41%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G+ +KL DFG   +     TV    + F GT  YMAPE+ M   + GH RAVD
Sbjct: 151 NIMLNHQGH-VKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILM---RSGHNRAVD 203
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WSLG ++ +M +G    +G
Sbjct: 204 WWSLGALMYDMLTGAPPFTG 223

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 42  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 98
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 157
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 158 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSAC-- 213
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 214 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 270
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 271 VLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 163 NILLN-EDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSAC---KSSD 217
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 218 LWALGCIIYQLVAG 231

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 113 SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 169
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 222
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 223 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 271
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 272 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 98  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 154
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 207
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 208 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 256
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           S V  S   G G FG VY       G+ VA+K +++      +F +    E+ +L     
Sbjct: 36  SEVMLSTRIGSGSFGTVYKG--KWHGD-VAVKILKVVDPTPEQF-QAFRNEVAVLRKTRH 91
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            N++ + G  + ++ + +  + C   +L   +   E       +    +Q    +  LH 
Sbjct: 92  VNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
             I+HRD+KS NIFL  EG ++K+GDFG A  + +  +   ++    G+  +MAPEV   
Sbjct: 151 KNIIHRDMKSNNIFL-HEGLTVKIGDFGLAT-VKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIPESLSDEGQ 240
            +        D++S G VL E+ +G+ P++  ++  QI+F VG G  +P + +   +  +
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268
Query: 241 AFAEL---CLRHDPAQRATI------FELLQH 263
           A   L   C++    +R          ELLQH
Sbjct: 269 AMKRLVADCVKKVKEERPLFPQILSSIELLQH 300

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 99  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 155
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 208
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 209 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 257
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 258 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 85  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 141
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 194
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 195 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 243
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 244 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 66  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 176 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 224
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 71  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 127
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 180
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 181 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 229
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 230 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 71  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 127
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 180
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 181 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 229
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 230 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 70  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 126
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 179
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 180 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 228
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 229 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 66  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 176 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 224
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 71  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 127
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 128 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 180
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 181 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 229
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 230 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 98  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 154
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 207
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 208 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 256
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 86  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 142
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 195
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 196 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 244
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 245 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 99  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 155
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 208
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 209 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 257
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 258 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 70  SGFS--GVIRLLDWFERPDSFVLILER-MEPVQDLFDFITERGALQEELARSFFWQVLEA 126
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 127 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 179
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 180 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 228
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 229 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 99  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 155
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 156 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 208
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 209 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 257
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 258 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 98  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 154
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 155 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 207
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 208 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVFFR-------- 256
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 257 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 46  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 102
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 161
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 162 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 217
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 218 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 274
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 275 VLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 167 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 221
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 222 LWALGCIIYQLVAG 235

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 85  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 141
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 142 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 194
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 195 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 243
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 244 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 118 SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 174
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 175 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 227
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 228 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 276
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 277 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 66  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 176 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 224
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 225 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +AV+  TG  VA+K++    Q++  F K    ELR+L+ +  +N++    V
Sbjct: 34  GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 71  EIHREEMVLFME----LCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
               E +  F +    +   GT L  L++  + G  E  ++    Q++  +  +H   I+
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG--EDRIQFLVYQMLKGLRYIHAAGII 150
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K  N+ +  E   LK+ DFG A +  +      E+ G V T+ Y APEV +  N +
Sbjct: 151 HRDLKPGNLAVN-EDCELKILDFGLARQADS------EMXGXVVTRWYRAPEVIL--NWM 201
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
            + + VDIWS+GC++ EM +GK  +      D   +IM   G      +    SDE + +
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 243 A--------------------------ELCLRHDPAQRATIFELLQHPFL 266
                                      E  L  D  QR T  E L HP+ 
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 43/74 (58%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG A +  +      E+ G V T+ Y APEV +  N + + + VDIWS+GC
Sbjct: 163 EDCELKILDFGLARQADS------EMXGXVVTRWYRAPEVIL--NWMRYTQTVDIWSVGC 214
Query: 376 VLVEMSSGKTNLSG 389
           ++ EM +GKT   G
Sbjct: 215 IMAEMITGKTLFKG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 39  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 95
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 155 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 210
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 211 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 267
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 160 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 214
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 215 LWALGCIIYQLVAG 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 23/255 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F      V+ ++ +  A+K I   K+ +A   K+ +  L++ EG    N+VK + V
Sbjct: 20  GEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKE-ITALKLCEG--HPNIVKLHEV 74
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +    L MEL   G L   ++  +    E       ++LV A+S +H+  +VHRD+K
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 131 SANIFLTAEGNSL--KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+  T E ++L  K+ DFG A ++      P +   F  T  Y APE+    N+ G+ 
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFA-RLKPPDNQPLKTPCF--TLHYAAPELL---NQNGYD 187
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYD------SNYQIMFKVGMGETPTIPES---LSDEG 239
            + D+WSLG +L  M SG+ P+  +D      S  +IM K+  G+     E+   +S E 
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA 247
Query: 240 QAFAELCLRHDPAQR 254
           +   +  L  DP +R
Sbjct: 248 KDLIQGLLTVDPNKR 262

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 119/252 (47%), Gaps = 33/252 (13%)
Query: 45  FVKDMLVELRIL-EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQS---TEDGL 100
           F    L+E+++L E  +  N+++YY  E     + + +ELC    L+ LV+S   +++ L
Sbjct: 51  FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENL 109
Query: 101 PEVLVRRYT-----KQLVDAISALHENTIVHRDIKSANIFLT------------AEGNSL 143
              L + Y      +Q+   ++ LH   I+HRD+K  NI ++            AE   +
Sbjct: 110 K--LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 144 KLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN----KVGHGRAVDIWSLGC 198
            + DFG   K+ S        LN   GT  + APE+  ++N    K    R++DI+S+GC
Sbjct: 168 LISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 199 VLVE-MSSGKRPWAE-YDSNYQIMFKV-GMGETPTIPE-SLSDEGQAFAELCLRHDPAQR 254
           V    +S GK P+ + Y     I+  +  + E   + + SL  E        + HDP +R
Sbjct: 228 VFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287
Query: 255 ATIFELLQHPFL 266
            T  ++L+HP  
Sbjct: 288 PTAMKVLRHPLF 299

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 93  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 149
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 150 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 202
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 203 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 251
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 252 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 41  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 97
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 157 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 212
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 213 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 269
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 162 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 216
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 217 LWALGCIIYQLVAG 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 38  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 94
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 153
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 154 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSAC-- 209
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 210 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 266
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 267 VLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 159 NILLN-EDMHIQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEKSAC---KSSD 213
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 214 LWALGCIIYQLVAG 227

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 113 SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 169
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 170 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 222
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 223 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 271
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 272 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 41  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 97
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 157 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 212
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 213 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 269
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 162 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 216
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 217 LWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 41  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 97
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 157 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 212
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 213 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 269
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 162 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 216
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 217 LWALGCIIYQLVAG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 39  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 95
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 155 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 210
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 211 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 267
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 160 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 214
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 215 LWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 42  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 98
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 157
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 158 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 213
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 214 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 270
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 271 VLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 163 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 217
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 218 LWALGCIIYQLVAG 231

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 69  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 125
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 178
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 179 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 227
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 228 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKE-IQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG+     + ETGE++ MKE I+  ++    F+K    E++++  +   N++K+ G
Sbjct: 19  GKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK----EVKVMRCLEHPNVLKFIG 74
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           V    + +    E    GTL  +++S +   P      + K +   ++ LH   I+HRD+
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF-----------VGTQAYMAPEV 178
            S N  L  E  ++ + DFG A  +    T P  L              VG   +MAPE+
Sbjct: 135 NSHNC-LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEM 203
               N   +   VD++S G VL E+
Sbjct: 194 I---NGRSYDEKVDVFSFGIVLCEI 215

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 13/244 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT   +APE+ +     G+ +A
Sbjct: 169 PENLLIDQQG-YIQVTDFGFAKRVKGRTWX------LCGTPEALAPEIILSK---GYNKA 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+   D   QI  K+  G+    P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276
Query: 251 PAQR 254
             +R
Sbjct: 277 LTKR 280

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 38/276 (13%)
Query: 6   FSVSP--GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-------ARFVKDMLVELRIL 56
           + V P  G G FG VY+ +       VA+K ++  + +D        R   ++++  ++ 
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDA 115
            G +   +++        +  VL +E   E   +     TE G L E L R +  Q+++A
Sbjct: 86  SGFS--GVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEA 142
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAY 173
           +   H   ++HRDIK  NI +      LKL DFGS   +K + +T        F GT+ Y
Sbjct: 143 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 195
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGETPT 230
             PE ++  ++  HGR+  +WSLG +L +M  G  P+ E+D      Q+ F+        
Sbjct: 196 SPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFR-------- 244
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + +S E Q     CL   P  R T  E+  HP++
Sbjct: 245 --QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 23  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 138
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 139 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 194
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 195 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 251
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 252 VLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 144 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 198
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 199 LWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 38  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 94
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 153
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 154 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 209
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 210 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 266
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 267 VLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 159 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 213
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 214 LWALGCIIYQLVAG 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 19  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 75
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 134
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 135 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 190
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 191 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 247
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 248 VLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 140 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 194
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 195 LWALGCIIYQLVAG 208

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 34  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLAFRHENIIGINDI 91
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 150 RDLKPSNLLLNTTSD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 206
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 155 SNLLLNTTSD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 211
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 212 DIWSVGCILAEMLSNRPIFPG 232

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 16  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 72
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 131
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 132 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 187
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 188 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 244
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 245 VLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 137 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 191
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 192 LWALGCIIYQLVAG 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 18  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 74
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 133
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 134 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 189
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 190 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 246
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 247 VLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 139 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 193
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 194 LWALGCIIYQLVAG 207

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 80
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 138
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ GFV T+ Y APE+ +
Sbjct: 139 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMAGFVATRWYRAPEIML 191
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ GFV T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 156 EDCELKILDFG----LARHTD--DEMAGFVATRWYRAPEIML--NWMHYNQTVDIWSVGC 207
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 208 IMAELLTGRTLFPG 221

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 17  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 73
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 133 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 188
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 245
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 246 VLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 138 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 192
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 193 LWALGCIIYQLVAG 206

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 18/272 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      + ++ ELVA+K I+  ++ D   VK  ++  R    +   N+V++  V
Sbjct: 28  GSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN-VKREIINHR---SLRHPNIVRFKEV 83
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    + + ME  + G L E +  +      E   R + +QL+  +S  H   + HRD+
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 130 KSANIFLT-AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N  L  +    LK+  FG +     H+    +    VGT AY+APEV +   K   G
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHS----QPKSTVGTPAYIAPEVLL--KKEYDG 195
Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           +  D+WS G  L  M  G  P+   E   N++      +     IP+   +S E +    
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
                DPA+R +I E+  H + + +   D+ N
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLPADLMN 287

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 119/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+S +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E + LK+ DFG    +  HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDSELKILDFG----LCRHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E + LK+ DFG    +  HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDSELKILDFG----LCRHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 12  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 67
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 68  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 127 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 244
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 245 KRLMAECLKKKRDERPLFPQIL 266

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ GFV T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMAGFVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ GFV T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMAGFVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 15  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 70
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 71  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 130 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 248 KRLMAECLKKKRDERPLFPQIL 269

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 80
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK--LTDDHVQFLIYQILRGLKYIH 138
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 139 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 191
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 156 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 207
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 208 IMAELLTGRTLFPG 221

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 10  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 65
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 66  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 125 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 243 KRLMAECLKKKRDERPLFPQIL 264

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 34  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLAFRHENIIGINDI 91
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 150 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 206
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 155 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 211
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 212 DIWSVGCILAEMLSNRPIFPG 232

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ GFV T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMAGFVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ GFV T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMAGFVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 41  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 97
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 157 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 212
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F   +      PE    + +   E  L
Sbjct: 213 -KSSDLWALGCIIYQLVAGLPPFRA--GNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLL 269
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 162 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 216
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 217 LWALGCIIYQLVAG 230

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 15  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 70
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 71  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 130 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 248 KRLMAECLKKKRDERPLFPQIL 269

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 18/272 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      + ++ ELVA+K I+  ++ D   VK  ++  R    +   N+V++  V
Sbjct: 28  GSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN-VKREIINHR---SLRHPNIVRFKEV 83
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    + + ME  + G L E +  +      E   R + +QL+  +S  H   + HRD+
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 130 KSANIFLT-AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N  L  +    LK+  FG +     H+    +    VGT AY+APEV +   K   G
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHS----QPKDTVGTPAYIAPEVLL--KKEYDG 195
Query: 189 RAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPE--SLSDEGQAFAE 244
           +  D+WS G  L  M  G  P+   E   N++      +     IP+   +S E +    
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
                DPA+R +I E+  H + + +   D+ N
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLPADLMN 287

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 19  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 78
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 79  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 190
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 19  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 78
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 79  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 190
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TG LVA+K++Q H   D +  +D   E++IL+ ++   +VK
Sbjct: 16  GKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQ--RDFQREIQILKALHSDFIVK 72
Query: 67  YYGVEIH--REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R E+ L ME    G L   +Q     L    +  Y+ Q+   +  L     
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 132
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSA--VKISAHTTV---PGELNGFVGTQAYMAPEVF 179
           VHRD+ + NI + +E + +K+ DFG A  + +     V   PG+   F     + APE  
Sbjct: 133 VHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPIF-----WYAPESL 186
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
            D       R  D+WS G VL E+
Sbjct: 187 SDNI---FSRQSDVWSFGVVLYEL 207

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 80
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 138
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 139 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 191
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 156 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 207
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 208 IMAELLTGRTLFPG 221

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 41  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 97
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 156
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 157 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAX-- 212
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F   +      PE    + +   E  L
Sbjct: 213 -KSSDLWALGCIIYQLVAGLPPFRA--GNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLL 269
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 270 VLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 162 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAX---KSSD 216
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 217 LWALGCIIYQLVAG 230

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 21/269 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD----MLVELRILEGINQKNLVK 66
           G+G FGKV+ A   +T +  A+K ++     D   + D     +VE R+L    +   + 
Sbjct: 26  GKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 67  YYGVEIHREEMVLF-MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +       +E + F ME    G L   +QS            Y  +++  +  LH   IV
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K  NI L  +G+ +K+ DFG       +     + N F GT  Y+APE+ +   K 
Sbjct: 141 YRDLKLDNILLDKDGH-IKIADFGMC---KENMLGDAKTNXFCGTPDYIAPEILL-GQKY 195
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            H  +VD WS G +L EM  G+ P+   D   + +F     + P  P  L  E +     
Sbjct: 196 NH--SVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 246 CLRHDPAQRATIF-ELLQHP-FLIVSCEE 272
               +P +R  +  ++ QHP F  ++ EE
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFREINWEE 280

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G+ +K+ DFG       +     + N F GT  Y+APE+ +   K  H  +VD
Sbjct: 148 NILLDKDGH-IKIADFGMC---KENMLGDAKTNXFCGTPDYIAPEILL-GQKYNH--SVD 200
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WS G +L EM  G++   G
Sbjct: 201 WWSFGVLLYEMLIGQSPFHG 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 116/269 (43%), Gaps = 39/269 (14%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+V+   + E G L A+K       +  R  KD     R L  +     V  +  
Sbjct: 66  GHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKD---RARKLAEVGSHEKVGQHPC 118
Query: 71  EIHREE-------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            +  E+       + L  ELC   +L+   ++    LPE  V  Y +  + A++ LH   
Sbjct: 119 CVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +VH D+K ANIFL   G   KLGDFG  V++   T   GE+    G   YMAPE+   + 
Sbjct: 178 LVHLDVKPANIFLGPRGRC-KLGDFGLLVELG--TAGAGEVQ--EGDPRYMAPELLQGS- 231
Query: 184 KVGHGRAVDIWSLGCVLVEMSS------GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
              +G A D++SLG  ++E++       G   W +    Y           P     LS 
Sbjct: 232 ---YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------PPEFTAGLSS 279
Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           E ++   + L  DP  RAT   LL  P L
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVL 308

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 38  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 93
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 94  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 153 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 270
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 271 KRLMAECLKKKRDERPLFPQIL 292

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 116/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 45  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 103
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 161
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 162 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 214
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 215 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 261

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 179 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 230
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 231 IMAELLTGRTLFPG 244

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F     A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 39  GEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 95
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 154
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 155 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 210
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E  L
Sbjct: 211 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL 267
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 268 VLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 160 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 214
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 215 LWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F  V  A    T    A+K ++   + K+N   +V     E  ++  ++    VK 
Sbjct: 44  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKL 100
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+HR
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR 159
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +    
Sbjct: 160 DLKPENILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC-- 215
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
            ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      P +   + +   E  L
Sbjct: 216 -KSSDLWALGCIIYQLVAGLPPFRA--GNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLL 272
Query: 248 RHDPAQRATIFE------LLQHPFL 266
             D  +R    E      L  HPF 
Sbjct: 273 VLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 44/74 (59%), Gaps = 5/74 (6%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  E   +++ DFG+A K+ +  +     N FVGT  Y++PE+  + +     ++ D
Sbjct: 165 NILLN-EDMHIQITDFGTA-KVLSPESKQARANXFVGTAQYVSPELLTEKSAC---KSSD 219
Query: 370 IWSLGCVLVEMSSG 383
           +W+LGC++ ++ +G
Sbjct: 220 LWALGCIIYQLVAG 233

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 46  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 104
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 162
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 163 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 215
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 216 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 262

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 180 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 231
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 232 IMAELLTGRTLFPG 245

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 10  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 65
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 66  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A + S  +    +     G+  +MAPEV    +
Sbjct: 125 IIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQD 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 243 KRLMAECLKKKRDERPLFPQIL 264

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 37  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 92
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 93  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 152 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 269
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 270 KRLMAECLKKKRDERPLFPQIL 291

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 41  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 96
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 97  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 156
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 157 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 209
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG--------ETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+ +    GM         E P  PE   +S
Sbjct: 210 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 265
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 266 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 32  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 90
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 148
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 149 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 201
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 248

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 166 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 217
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 218 IMAELLTGRTLFPG 231

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 33  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 88
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 89  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 148
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 149 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 201
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 202 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 257
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 258 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 119/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 32  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 90
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 148
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E + LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 149 SADIIHRDLKPSNLAVN-EDSELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 201
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 248

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E + LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 166 EDSELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 217
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 218 IMAELLTGRTLFPG 231

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 32  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 87
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 88  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 147
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 148 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 200
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 201 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 256
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 257 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 26  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 81
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 82  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 141
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 142 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 194
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 195 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 250
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 251 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 30  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 87
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 146 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 202
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 151 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 207
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 208 DIWSVGCILAEMLSNRPIFPG 228

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 119/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 28  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 86
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 144
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E + LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 145 SADIIHRDLKPSNLAVN-EDSELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 244

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 46/74 (62%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E + LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 162 EDSELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 213
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 214 IMAELLTGRTLFPG 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 34  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 91
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 150 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 206
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 207 YTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 155 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 211
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 212 DIWSVGCILAEMLSNRPIFPG 232

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 8   VSP---GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL 64
           VSP   G G +G V +A++  +GE VA+K++    Q++  F K    EL +L+ +  +N+
Sbjct: 45  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHMQHENV 103
Query: 65  VKYYGVEIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           +    V      +  F +  L        L +       E  ++    Q++  +  +H  
Sbjct: 104 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            +VHRD+K  N+ +  E   LK+ DFG A    A      E+ G+V T+ Y APEV +  
Sbjct: 164 GVVHRDLKPGNLAVN-EDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVIL-- 214
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGK 207
           + + + + VDIWS+GC++ EM +GK
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 43/74 (58%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG A    A      E+ G+V T+ Y APEV +  + + + + VDIWS+GC
Sbjct: 179 EDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVIL--SWMHYNQTVDIWSVGC 230
Query: 376 VLVEMSSGKTNLSG 389
           ++ EM +GKT   G
Sbjct: 231 IMAEMLTGKTLFKG 244

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 25  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 80
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 141 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 193
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 194 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 249
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 250 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 118/255 (46%), Gaps = 11/255 (4%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           ++   F +  G+G FGKV  A    T EL A+K ++         V+  +VE R+L  ++
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 61  QKN-LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +   L + +      + +   ME    G L   +Q       E     Y  ++   +  L
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISIGLFFL 136
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H+  I++RD+K  N+ L +EG+ +K+ DFG       H         F GT  Y+APE+ 
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGH-IKIADFGMC---KEHMMDGVTTREFCGTPDYIAPEII 192
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
                  +G++VD W+ G +L EM +G+ P+   D +   +F+  M    + P+SLS E 
Sbjct: 193 AYQP---YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSIMEHNVSYPKSLSKEA 247
Query: 240 QAFAELCLRHDPAQR 254
            +  +  +   PA+R
Sbjct: 248 VSICKGLMTKHPAKR 262

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L +EG+ +K+ DFG       H         F GT  Y+APE+        +G++VD
Sbjct: 150 NVMLDSEGH-IKIADFGMC---KEHMMDGVTTREFCGTPDYIAPEIIAYQP---YGKSVD 202
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            W+ G +L EM +G+    G
Sbjct: 203 WWAYGVLLYEMLAGQPPFDG 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-ARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FGKVY A     G+ VA+K  +     D ++ ++++  E ++   +   N++   G
Sbjct: 16  GIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV---H 126
           V +    + L ME    G L   V S +   P++LV  +  Q+   ++ LH+  IV   H
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVN-WAVQIARGMNYLHDEAIVPIIH 131
Query: 127 RDIKSANIFLTAE-------GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           RD+KS+NI +  +          LK+ DFG A +    T +        G  A+MAPEV 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-----AGAYAWMAPEVI 186
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSDE 238
             +      +  D+WS G +L E+ +G+ P+   D    + + V M +    IP +  + 
Sbjct: 187 RASM---FSKGSDVWSYGVLLWELLTGEVPFRGIDG-LAVAYGVAMNKLALPIPSTCPEP 242
Query: 239 GQAFAELCLRHDPAQRATIFELLQH 263
                E C   DP  R +   +L  
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 31  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 86
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 87  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 146
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 147 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 199
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 200 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 255
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 256 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 40  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 97
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 155
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 156 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 212
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 213 YTKSIDIWSVGCILAEMLSNR 233

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 161 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 217
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 218 DIWSVGCILAEMLSNRPIFPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 32  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 148 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 204
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 153 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 209
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 210 DIWSVGCILAEMLSNRPIFPG 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 37  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 94
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 153 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 209
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 158 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 214
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 215 DIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 38  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 95
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 153
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 154 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 210
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 211 YTKSIDIWSVGCILAEMLSNR 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 159 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 215
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 216 DIWSVGCILAEMLSNRPIFPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 29  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 86
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 144
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 145 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 201
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 202 YTKSIDIWSVGCILAEMLSNR 222

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 150 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 207 DIWSVGCILAEMLSNRPIFPG 227

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 152 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 208
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 157 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 214 DIWSVGCILAEMLSNRPIFPG 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 8   VSP---GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL 64
           VSP   G G +G V +A++  +GE VA+K++    Q++  F K    EL +L+ +  +N+
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHMQHENV 85
Query: 65  VKYYGVEIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           +    V      +  F +  L        L +       E  ++    Q++  +  +H  
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA 145
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            +VHRD+K  N+ +  E   LK+ DFG A    A      E+ G+V T+ Y APEV +  
Sbjct: 146 GVVHRDLKPGNLAVN-EDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVIL-- 196
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGK 207
           + + + + VDIWS+GC++ EM +GK
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/74 (40%), Positives = 43/74 (58%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG A    A      E+ G+V T+ Y APEV +  + + + + VDIWS+GC
Sbjct: 161 EDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVIL--SWMHYNQTVDIWSVGC 212
Query: 376 VLVEMSSGKTNLSG 389
           ++ EM +GKT   G
Sbjct: 213 IMAEMLTGKTLFKG 226

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 120/269 (44%), Gaps = 21/269 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD----MLVELRILEGINQKNLVK 66
           G+G FGKV+ A   +T +  A+K ++     D   + D     +VE R+L    +   + 
Sbjct: 27  GKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 82
Query: 67  YYGVEIHREEMVLF-MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +       +E + F ME    G L   +QS            Y  +++  +  LH   IV
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIV 141
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K  NI L  +G+ +K+ DFG       +     + N F GT  Y+APE+ +   K 
Sbjct: 142 YRDLKLDNILLDKDGH-IKIADFGMC---KENMLGDAKTNEFCGTPDYIAPEILL-GQKY 196
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            H  +VD WS G +L EM  G+ P+   D   + +F     + P  P  L  E +     
Sbjct: 197 NH--SVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDNPFYPRWLEKEAKDLLVK 252
Query: 246 CLRHDPAQRATIF-ELLQHP-FLIVSCEE 272
               +P +R  +  ++ QHP F  ++ EE
Sbjct: 253 LFVREPEKRLGVRGDIRQHPLFREINWEE 281

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  +G+ +K+ DFG       +     + N F GT  Y+APE+ +   K  H  +VD
Sbjct: 149 NILLDKDGH-IKIADFGMC---KENMLGDAKTNEFCGTPDYIAPEILL-GQKYNH--SVD 201
Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WS G +L EM  G++   G
Sbjct: 202 WWSFGVLLYEMLIGQSPFHG 221

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 52  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 109
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 168 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 224
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 173 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 229
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 230 DIWSVGCILAEMLSNRPIFPG 250

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 152 RDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 208
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 157 SNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 214 DIWSVGCILAEMLSNRPIFPG 234

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 30  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 87
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 146 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 202
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 203 YTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 151 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 207
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 208 DIWSVGCILAEMLSNRPIFPG 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 32  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 148 RDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 204
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 153 SNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 209
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 210 DIWSVGCILAEMLSNRPIFPG 230

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 195
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 196 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 251
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 30  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 85
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 86  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A + S  +    +     G+  +MAPEV    +
Sbjct: 145 IIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQD 202
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 262
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 263 KRLMAECLKKKRDERPLFPQIL 284

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 32  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 148 RDLKPSNLLLNTTXD-LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 204
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 153 SNLLLNTTXD-LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 209
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 210 DIWSVGCILAEMLSNRPIFPG 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 32  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 148 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 204
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 153 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 209
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 210 DIWSVGCILAEMLSNRPIFPG 230

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NAMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 32  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 89
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 148 RDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 204
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 205 YTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 153 SNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 209
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 210 DIWSVGCILAEMLSNRPIFPG 230

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++    V
Sbjct: 41  GSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVIGLLDV 99
Query: 71  EIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
                 +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H   I+
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADII 157
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N +
Sbjct: 158 HRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWM 208
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
            + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 252

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 170 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 221
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 222 IMAELLTGRTLFPG 235

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 117/219 (53%), Gaps = 30/219 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DA-RFVKDMLVELRILEGINQKNLVKY 67
           G+G +G V+ +++  TGE+VA+K+I    QN  DA R  +++++   +    N  NL+  
Sbjct: 18  GKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYT-KQLVDAISALHENTIVH 126
              +  R+  ++F  + T+  L +++++    + E + ++Y   QL+  I  LH   ++H
Sbjct: 78  LRADNDRDVYLVFDYMETD--LHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLH 132
Query: 127 RDIKSANIFLTAEGNSLKLGDFG---SAVKISAHT-TVPGELN--------------GFV 168
           RD+K +NI L AE + +K+ DFG   S V I   T  +P  +N               +V
Sbjct: 133 RDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 207
            T+ Y APE+ + + K   G  +D+WSLGC+L E+  GK
Sbjct: 192 ATRWYRAPEILLGSTKYTKG--IDMWSLGCILGEILCGK 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 21/99 (21%)
Query: 309 ANIFLTAEGNSLKLGDFG---SAVKISAHTT-VPGELN--------------GFVGTQAY 350
           +NI L AE + +K+ DFG   S V I   T  +P  +N               +V T+ Y
Sbjct: 138 SNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196
Query: 351 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
            APE+ + + K   G  +D+WSLGC+L E+  GK    G
Sbjct: 197 RAPEILLGSTKYTKG--IDMWSLGCILGEILCGKPIFPG 233

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 25  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 80
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 141 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTEPCYTPYYVAPEVL---GPEK 193
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 194 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 249
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 250 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 239
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 295
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYXQRTLREIKILLRFRHENIIGINDI 93
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 152 RDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 208
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 157 SNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 214 DIWSVGCILAEMLSNRPIFPG 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L++     L    +  +  Q++  +  +H   ++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 152 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 208
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 157 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 214 DIWSVGCILAEMLSNRPIFPG 234

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 24  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 82
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 83  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 140
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 141 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 193
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 194 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 158 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 209
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 210 IMAELLTGRTLFPG 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 31  NLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 89
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 147
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 148 SADIIHRDLKPSNLAVN-EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 200
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 247

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 165 EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 216
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 217 IMAELLTGRTLFPG 230

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TG LVA+K++Q H   D +  +D   E++IL+ ++   +VK
Sbjct: 19  GKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQ--RDFQREIQILKALHSDFIVK 75
Query: 67  YYGVEIH--REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R+ + L ME    G L   +Q     L    +  Y+ Q+   +  L     
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 135
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-----PGELNGFVGTQAYMAPEVF 179
           VHRD+ + NI + +E + +K+ DFG A  +           PG+   F     + APE  
Sbjct: 136 VHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESL 189
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
            D       R  D+WS G VL E+
Sbjct: 190 SDNI---FSRQSDVWSFGVVLYEL 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 123/262 (46%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 10  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 65
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G      ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 66  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 125 IIHRDLKSNNIFL-HEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 243 KRLMAECLKKKRDERPLFPQIL 264

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 31  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 89
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 147
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 148 SADIIHRDLKPSNLAVN-EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 200
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 247

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 165 EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 216
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 217 IMAELLTGRTLFPG 230

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 16/271 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      +  T ELVA+K I+     D    ++++        +   N+V++  V
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH----RSLRHPNIVRFKEV 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +    + + ME  + G L   +        E   R + +QL+  +S  H   I HRD+K
Sbjct: 85  ILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143
Query: 131 SANIFLT-AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N  L  +    LK+ DFG +     H+    +    VGT AY+APEV +   +   G+
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLL--RQEYDGK 197
Query: 190 AVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPES--LSDEGQAFAEL 245
             D+WS G  L  M  G  P+   E   +Y+   +  +    +IP+   +S E       
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257
Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDVCN 276
               DPA R +I E+  H + + +   D+ N
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLPADLMN 288

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 195
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 196 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 251
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 77  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 132
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 133 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 192
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 193 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEK 245
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 246 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 301
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 302 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 334

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 80
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 138
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 139 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 191
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 192 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 156 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 207
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 208 IMAELLTGRTLFPG 221

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 38  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 93
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   +   E     + +    +Q    +  LH  +
Sbjct: 94  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E  ++K+GDFG A + S  +    +     G+  +MAPEV    +
Sbjct: 153 IIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQD 210
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
           K  +    D+++ G VL E+ +G+ P++  ++  QI+F VG G  +P + +  S+  +A 
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 270
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R    ++L
Sbjct: 271 KRLMAECLKKKRDERPLFPQIL 292

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 31  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 89
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 147
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 148 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 200
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 247

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 165 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 216
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 217 IMAELLTGRTLFPG 230

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 33  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 91
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 149
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 150 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTA--DEMTGYVATRWYRAPEIML 202
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 167 EDCELKILDFG----LARHTA--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 218
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 219 IMAELLTGRTLFPG 232

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 33  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 91
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 149
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 150 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTA--DEMTGYVATRWYRAPEIML 202
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 167 EDCELKILDFG----LARHTA--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 218
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 219 IMAELLTGRTLFPG 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 23  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 81
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 139
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 140 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 192
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 193 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 157 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 208
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 209 IMAELLTGRTLFPG 222

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TG LVA+K++Q H   D +  +D   E++IL+ ++   +VK
Sbjct: 20  GKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQ--RDFQREIQILKALHSDFIVK 76
Query: 67  YYGVEIH--REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R+ + L ME    G L   +Q     L    +  Y+ Q+   +  L     
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 136
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-----PGELNGFVGTQAYMAPEVF 179
           VHRD+ + NI + +E + +K+ DFG A  +           PG+   F     + APE  
Sbjct: 137 VHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESL 190
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
            D       R  D+WS G VL E+
Sbjct: 191 SDNI---FSRQSDVWSFGVVLYEL 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V    Y  + + TG LVA+K++Q H   D +  +D   E++IL+ ++   +VK
Sbjct: 32  GKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQ--RDFQREIQILKALHSDFIVK 88
Query: 67  YYGVEIH--REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R+ + L ME    G L   +Q     L    +  Y+ Q+   +  L     
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-----PGELNGFVGTQAYMAPEVF 179
           VHRD+ + NI + +E + +K+ DFG A  +           PG+   F     + APE  
Sbjct: 149 VHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESL 202
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEM 203
            D       R  D+WS G VL E+
Sbjct: 203 SDNI---FSRQSDVWSFGVVLYEL 223

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 119/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG+  A K I+  + + +R     +++  E+ IL  I   N++  
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + +  ++ ++VL +EL + G L   +   E  L E    ++ KQ++D +  LH   I H 
Sbjct: 74  HDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +KL DFG A KI A      E     GT  ++APE+    N 
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA----GNEFKNIFGTPEFVAPEI---VNY 185
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   ++  + +  +         E  S+     + 
Sbjct: 186 EPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKD 244
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + L+H ++
Sbjct: 245 FIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 33  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 91
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 149
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 150 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTA--DEMTGYVATRWYRAPEIML 202
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 167 EDCELKILDFG----LARHTA--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 218
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 219 IMAELLTGRTLFPG 232

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 37  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 95
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 153
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 154 SADIIHRDLKPSNLAVN-EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 206
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 207 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 253

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 171 EDXELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 222
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 223 IMAELLTGRTLFPG 236

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV  A +       A+K +Q    L K+ +   + +  V   +L+ +    LV 
Sbjct: 47  GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV---LLKNVKHPFLVG 103
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            +      +++   ++    G L   +Q  E    E   R Y  ++  A+  LH   IV+
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVY 162
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  NI L ++G+ + L DFG   +   H +     + F GT  Y+APEV    +K  
Sbjct: 163 RDLKPENILLDSQGH-IVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVL---HKQP 215
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           + R VD W LG VL EM  G  P+  Y  N   M+   + +   +  ++++  +   E  
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 273
Query: 247 LRHDPAQRA----TIFELLQHPFLIVSCEEDVCNPRSVP 281
           L+ D  +R        E+  H F  +   +D+ N +  P
Sbjct: 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP 312

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/74 (39%), Positives = 39/74 (52%), Gaps = 7/74 (9%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L ++G+ + L DFG   +   H +     + F GT  Y+APEV    +K  + R VD
Sbjct: 169 NILLDSQGH-IVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVL---HKQPYDRTVD 221
Query: 370 IWSLGCVLVEMSSG 383
            W LG VL EM  G
Sbjct: 222 WWCLGAVLYEMLYG 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 23  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 81
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 139
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 140 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 192
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 193 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 157 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 208
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 209 IMAELLTGRTLFPG 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 49  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 107
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 165
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 166 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 218
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 219 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 265

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 183 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 234
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 235 IMAELLTGRTLFPG 248

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 28  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 86
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 144
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 145 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 244

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 162 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 213
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 214 IMAELLTGRTLFPG 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 33  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 91
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 149
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 150 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 202
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 203 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 167 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 218
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 219 IMAELLTGRTLFPG 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 38  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 96
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 154
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 155 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 207
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 208 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 254

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 172 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 223
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 224 IMAELLTGRTLFPG 237

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 28  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 86
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 144
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 145 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 244

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 162 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 213
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 214 IMAELLTGRTLFPG 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 38  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 96
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 154
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 155 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 207
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 208 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 254

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 172 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 223
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 224 IMAELLTGRTLFPG 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 31  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 89
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 147
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 148 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 200
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 201 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 247

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 165 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 216
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 217 IMAELLTGRTLFPG 230

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 25  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 83
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 84  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 141
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 142 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 194
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 195 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 241

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 159 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 210
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 211 IMAELLTGRTLFPG 224

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+++I   +     + +  L E++IL     +N++    +
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIRKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 152 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 208
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 157 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 214 DIWSVGCILAEMLSNRPIFPG 234

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 28  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 86
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 144
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 145 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 198 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 244

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 162 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 213
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 214 IMAELLTGRTLFPG 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 45  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 103
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 161
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 162 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 214
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 215 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 261

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 179 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 230
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 231 IMAELLTGRTLFPG 244

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 46  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 104
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 162
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 163 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 215
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 216 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 262

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 180 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 231
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 232 IMAELLTGRTLFPG 245

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 20/270 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK---EIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G F +V      +TG++ AMK   +  + K+ +    ++   E  +L   +++ + + 
Sbjct: 70  GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE---ERDVLVNGDRRWITQL 126
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +        + L ME    G L +L+    + +P  + R Y  ++V AI ++H    VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK  NI L   G+ ++L DFGS +K+ A  TV   +   VGT  Y++PE+         
Sbjct: 187 DIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVA--VGTPDYLSPEILQAVGGGPG 243
Query: 188 GRA----VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET----PTIPESLSDEG 239
             +     D W+LG    EM  G+ P+   DS  +   K+   +     P + E + +E 
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 240 QAFAE--LCLRHDPAQRATIFELLQHPFLI 267
           + F +  LC       R    +   HPF  
Sbjct: 303 RDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 17  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 74
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 75  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 134
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 135 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 193
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 194 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 248
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 249 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 37  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 95
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 153
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 154 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 206
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 207 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 253

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 171 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 222
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 223 IMAELLTGRTLFPG 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 38  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIH-AKRTYRELRLLKHMKHENVI 96
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 154
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 155 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 207
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 208 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 254

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 172 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 223
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 224 IMAELLTGRTLFPG 237

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 32  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 90
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 148
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 149 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 201
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 248

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 166 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 217
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 218 IMAELLTGRTLFPG 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 32  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 90
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 148
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 149 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 201
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 202 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 248

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 166 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 217
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 218 IMAELLTGRTLFPG 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 23/274 (8%)
Query: 3   SVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILE 57
            +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++
Sbjct: 11  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 68
Query: 58  GINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RY 108
             N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  + 
Sbjct: 69  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 128
Query: 109 TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV 168
             ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G +
Sbjct: 129 AGEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 187
Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE 227
             + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G 
Sbjct: 188 PVR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGG 242
Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
               P++  D       +C +++P  R +  E++
Sbjct: 243 LLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 21  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 78
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 139 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 198 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 252
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 253 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/323 (23%), Positives = 132/323 (40%), Gaps = 80/323 (24%)
Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------ 63
           G+G FG+V   V++  G   VA+K I+    N  ++ +   +E+ +LE IN+K+      
Sbjct: 42  GEGTFGRVVQCVDHRRGGARVALKIIK----NVEKYKEAARLEINVLEKINEKDPDNKNL 97
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V+ +    +   M +  EL    T + L  +     P   VR    QL  A+  LH+N 
Sbjct: 98  CVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNK 157
Query: 124 IVHRDIKSANIFL------------------TAEGNSLKLGDFGSAVKISAHTTVPGELN 165
           + H D+K  NI                    + +  ++++ DFGSA     H +      
Sbjct: 158 LTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHST----- 212
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI-MFKVG 224
             V T+ Y APEV ++   +G  +  D+WS+GC++ E   G   +  +D+   + M +  
Sbjct: 213 -IVSTRHYRAPEVILE---LGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERI 268
Query: 225 MGETPT-----------------------------------IPESLSDEGQAFAEL---- 245
           +G  P+                                   +   L+ E +   +L    
Sbjct: 269 LGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLI 328
Query: 246 --CLRHDPAQRATIFELLQHPFL 266
              L ++PA+R T+ E LQHPF 
Sbjct: 329 ESMLEYEPAKRLTLGEALQHPFF 351

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/72 (30%), Positives = 38/72 (52%), Gaps = 9/72 (12%)
Query: 314 TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
           + +  ++++ DFGSA     H +        V T+ Y APEV ++   +G  +  D+WS+
Sbjct: 189 SVKSTAVRVVDFGSATFDHEHHST------IVSTRHYRAPEVILE---LGWSQPCDVWSI 239
Query: 374 GCVLVEMSSGKT 385
           GC++ E   G T
Sbjct: 240 GCIIFEYYVGFT 251

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           F    G G FG V+      +G    +K I  +K      ++ +  E+ +L+ ++  N++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 66  KYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDG--LPEVLVRRYTKQLVDAISALHEN 122
           K + V      M + ME C  G L E +V +   G  L E  V    KQ+++A++  H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 123 TIVHRDIKSANIFL--TAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAYMAPEV 178
            +VH+D+K  NI    T+  + +K+ DFG A   K   H+T         GT  YMAPEV
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST------NAAGTALYMAPEV 197
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW-----------AEY-DSNYQIMFKVGMG 226
           F    K       DIWS G V+  + +G  P+           A Y + NY +  +    
Sbjct: 198 F----KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR---- 249
Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             P  P+++        +  L  DP +R +  ++L H
Sbjct: 250 --PLTPQAVD-----LLKQMLTKDPERRPSAAQVLHH 279

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 49  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 107
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 165
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 166 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMXGYVATRWYRAPEIML 218
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 219 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 265

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 183 EDCELKILDFG----LARHTD--DEMXGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 234
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 235 IMAELLTGRTLFPG 248

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 27  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 84
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 204 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 258
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L  EL   G L   +   E  L E     + KQ+++ +  LH   I H 
Sbjct: 80  HEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+    N 
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFKNIFGTPEFVAPEI---VNY 191
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V         E  S+     + 
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 121/240 (50%), Gaps = 36/240 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQKNL 64
           G G +G V +A +    + VA+K++       +H +   R       ELR+L+ +  +N+
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-------ELRLLKHLKHENV 89
Query: 65  VKYYGVEIHREEMVLFMELCTEGTL-----ESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +    V      +  F E+    TL      ++V+S    L +  V+    QL+  +  +
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS--QALSDEHVQFLVYQLLRGLKYI 147
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H   I+HRD+K +N+ +  E + L++ DFG A +         E+ G+V T+ Y APE+ 
Sbjct: 148 HSAGIIHRDLKPSNVAVN-EDSELRILDFGLARQADE------EMTGYVATRWYRAPEIM 200
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEY-DSNYQIMFKVGMGETPTIPESLS 236
           +  N + + + VDIWS+GC++ E+  GK   P ++Y D   +IM  VG   TP+ PE L+
Sbjct: 201 L--NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVG---TPS-PEVLA 254

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E + L++ DFG A +         E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 166 EDSELRILDFGLARQADE------EMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 217
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+  GK    G
Sbjct: 218 IMAELLQGKALFPG 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 15/260 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G GRFG+V+      TG  +A K I+     D   VK+   E+ ++  ++  NL++ Y  
Sbjct: 98  GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN---EISVMNQLDHANLIQLYDA 154
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              + ++VL ME    G L   +      L E+    + KQ+ + I  +H+  I+H D+K
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 131 SANIF-LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI  +  +   +K+ DFG A +         +L    GT  ++APEV    N      
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEV---VNYDFVSF 267
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEGQAFAELC 246
             D+WS+G +   + SG  P+   D++ + +  +         E    +S+E + F    
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLG-DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326
Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  + + R +  E L+HP+L
Sbjct: 327 LIKEKSWRISASEALKHPWL 346

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 88/177 (49%), Gaps = 26/177 (14%)
Query: 96  TEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--V 152
           TE G L E L R +  Q+++A+   H   ++HRDIK  NI +      LKL DFGS   +
Sbjct: 149 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 208
Query: 153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE 212
           K + +T        F GT+ Y  PE ++  ++  HGR+  +WSLG +L +M  G  P+ E
Sbjct: 209 KDTVYTD-------FDGTRVYSPPE-WIRYHRY-HGRSAAVWSLGILLYDMVCGDIPF-E 258
Query: 213 YDSNY---QIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           +D      Q+ F+          + +S E Q     CL   P+ R T  E+  HP++
Sbjct: 259 HDEEIIRGQVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 128/304 (42%), Gaps = 52/304 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYY 68
           GQG +G V  A+ N+T  + A+K +  +K  Q + + V+ +  E+R+++ ++  N+ + Y
Sbjct: 35  GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94
Query: 69  GVEIHREEMVLFMELC---------------------------------------TEGTL 89
            V    + + L MELC                                         G++
Sbjct: 95  EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 90  ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSAN-IFLTAEGNSLKLGDF 148
               +S +    E L+    +Q+  A+  LH   I HRDIK  N +F T +   +KL DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 149 GSAVKISAHTTVPGELNGFV---GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS 205
           G + +   +    GE  G     GT  ++APEV   TN+  +G   D WS G +L  +  
Sbjct: 215 GLSKEF--YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE-SYGPKCDAWSAGVLLHLLLM 271
Query: 206 GKRPWA---EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           G  P+    + D+  Q++ K    E P     LS   +      L  +  +R      LQ
Sbjct: 272 GAVPFPGVNDADTISQVLNKKLCFENPNY-NVLSPLARDLLSNLLNRNVDERFDAMRALQ 330
Query: 263 HPFL 266
           HP++
Sbjct: 331 HPWI 334

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 46  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 104
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 162
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G V T+ Y APE+ +
Sbjct: 163 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMXGXVATRWYRAPEIML 215
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 216 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 262

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 180 EDCELKILDFG----LARHTD--DEMXGXVATRWYRAPEIML--NWMHYNQTVDIWSVGC 231
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 232 IMAELLTGRTLFPG 245

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 126/260 (48%), Gaps = 19/260 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+ A     G  VA+K I + +   A  V + L E+ I++ +   N+V + G 
Sbjct: 46  GAGSFGTVHRA--EWHGSDVAVK-ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDAISALHENT--IVH 126
                 + +  E  + G+L  L+  +   + L E         +   ++ LH     IVH
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           R++KS N+ L  +  ++K+ DFG + ++ A T +  +     GT  +MAPEV  D     
Sbjct: 163 RNLKSPNL-LVDKKYTVKVCDFGLS-RLKASTFLSSK--SAAGTPEWMAPEVLRDE---P 215
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIPESLSDEGQAFAEL 245
                D++S G +L E+++ ++PW   +   Q++  VG   +   IP +L+ +  A  E 
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 246 CLRHDPAQR---ATIFELLQ 262
           C  ++P +R   ATI +LL+
Sbjct: 275 CWTNEPWKRPSFATIMDLLR 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 123/261 (47%), Gaps = 21/261 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+ A     G  VA+K I + +   A  V + L E+ I++ +   N+V + G 
Sbjct: 46  GAGSFGTVHRA--EWHGSDVAVK-ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDAISALHENT--IVH 126
                 + +  E  + G+L  L+  +   + L E         +   ++ LH     IVH
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 127 RDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           RD+KS N+ L  +  ++K+ DFG S +K S             GT  +MAPEV  D    
Sbjct: 163 RDLKSPNL-LVDKKYTVKVCDFGLSRLKASXFLXS----KXAAGTPEWMAPEVLRDE--- 214
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-ETPTIPESLSDEGQAFAE 244
                 D++S G +L E+++ ++PW   +   Q++  VG   +   IP +L+ +  A  E
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNP-AQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 245 LCLRHDPAQR---ATIFELLQ 262
            C  ++P +R   ATI +LL+
Sbjct: 274 GCWTNEPWKRPSFATIMDLLR 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 14  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 71
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 72  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 131
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 132 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 191 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 245
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 246 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 18  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 75
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 76  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 135
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 136 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 195 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 249
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 250 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 21  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 78
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 79  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 138
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 139 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 198 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 252
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 253 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 20  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 77
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 138 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 197 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 251
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 252 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 49  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 106
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 107 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 166
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 167 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 225
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 226 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 280
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 281 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 20  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 77
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 78  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 137
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 138 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 197 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 251
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 252 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 118/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ D+G    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDYG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 45/74 (60%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ D+G    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDYG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 93
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L   V T+ Y APE+ +  N  G
Sbjct: 152 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML--NSKG 208
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L   V T+ Y APE+ +  N  G+ +++
Sbjct: 157 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML--NSKGYTKSI 213
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 214 DIWSVGCILAEMLSNRPIFPG 234

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 37  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDI 94
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  ++   E  L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L   V T+ Y APE+ +  N  G
Sbjct: 153 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML--NSKG 209
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 210 YTKSIDIWSVGCILAEMLSNR 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L   V T+ Y APE+ +  N  G+ +++
Sbjct: 158 SNLLLNTTCD-LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML--NSKGYTKSI 214
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 215 DIWSVGCILAEMLSNRPIFPG 235

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 4   VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++ 
Sbjct: 27  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKE 84
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RYT 109
            N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  +  
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMA 144
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G + 
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G  
Sbjct: 204 VR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL 258
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
              P++  D       +C +++P  R +  E++
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGXVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDFG----LARHTD--DEMTGXVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG+  A K I+  + + +R     +++  E+ IL  I   N++  
Sbjct: 21  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + +  ++ ++VL +EL + G L   +   E  L E    ++ KQ++D +  LH   I H 
Sbjct: 81  HDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHF 139
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +KL DFG A KI A      E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA----GNEFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   ++  + +  +         E  S+     + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R  I + L+H ++
Sbjct: 252 FIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 116/251 (46%), Gaps = 19/251 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +  VY   +  T  LVA+KEI+L  +  A      + E+ +L+ +   N+V  + +
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--AIREVSLLKDLKHANIVTLHDI 68
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            IH E+ +  +    +  L+  +    + +    V+ +  QL+  ++  H   ++HRD+K
Sbjct: 69  -IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +   G  LKL DFG A   S  T      +  V T  Y  P++ + +    +   
Sbjct: 128 PQNLLINERG-ELKLADFGLARAKSIPTKT---YDNEVVTLWYRPPDILLGS--TDYSTQ 181
Query: 191 VDIWSLGCVLVEMSSGKR--PWAEYDSNYQIMFKV-GMGETPTIPESLSDE-------GQ 240
           +D+W +GC+  EM++G+   P +  +     +F++ G     T P  LS+E        +
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241
Query: 241 AFAELCLRHDP 251
             AE  L H P
Sbjct: 242 YRAEALLSHAP 252

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 5/85 (5%)
Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIW 371
            L  E   LKL DFG A   S  T      +  V T  Y  P++ + +    +   +D+W
Sbjct: 131 LLINERGELKLADFGLARAKSIPTKT---YDNEVVTLWYRPPDILLGS--TDYSTQIDMW 185
Query: 372 SLGCVLVEMSSGKTNLSGVVVSAEV 396
            +GC+  EM++G+    G  V  ++
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEEQL 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DF     ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDF----YLARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DF     ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDF----YLARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I   +     + +  L E++IL     +N++    +
Sbjct: 52  GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLRFRHENIIGINDI 109
Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  +       L  L+++    L    +  +  Q++  +  +H   ++H
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 168 RDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 224
Query: 187 HGRAVDIWSLGCVLVEMSSGK 207
           + +++DIWS+GC+L EM S +
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++
Sbjct: 173 SNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSI 229
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC+L EM S +    G
Sbjct: 230 DIWSVGCILAEMLSNRPIFPG 250

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 23/274 (8%)
Query: 3   SVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILE 57
            +T S   GQG FG VY  V      +E    VA+K +        R   + L E  +++
Sbjct: 13  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 70
Query: 58  GINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-------PEVLVR--RY 108
             N  ++V+  GV    +  ++ MEL T G L+S ++S    +       P  L +  + 
Sbjct: 71  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 109 TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV 168
             ++ D ++ L+ N  VHRD+ + N  + AE  ++K+GDFG    I           G +
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCXV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE 227
             + +M+PE   D     +    D+WS G VL E+++  ++P+    SN Q++  V  G 
Sbjct: 190 PVR-WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGG 244
Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELL 261
               P++  D       +C +++P  R +  E++
Sbjct: 245 LLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 22/293 (7%)
Query: 6   FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           F  + G G F +V  A    TG+L A+K I   K+        +  E+ +L  I  +N+V
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIP--KKALKGKESSIENEIAVLRKIKHENIV 83
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL-PEVLVRRYTKQLVDAISALHENTI 124
               +      + L M+L + G L   +   E G   E       +Q++DA+  LH   I
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 125 VHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           VHRD+K  N+   +  E + + + DFG + K+     V   ++   GT  Y+APEV    
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLS-KMEGKGDV---MSTACGTPGYVAPEVLAQK 197
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG-----ETPTIPESLSD 237
               + +AVD WS+G +   +  G  P+  YD N   +F+  +      ++P   + +SD
Sbjct: 198 ---PYSKAVDCWSIGVIAYILLCGYPPF--YDENDSKLFEQILKAEYEFDSPYW-DDISD 251
Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
             + F    +  DP +R T  +  +HP++      +     SV A + +++ K
Sbjct: 252 SAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQIRKNFAK 304

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 134/286 (46%), Gaps = 28/286 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQ-NDARFVKDMLVELRILE-GINQKNLVKYY 68
           G+G+F  V   ++  TG+  A K ++  ++  D R   ++L E+ +LE   +   ++  +
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR--AEILHEIAVLELAKSCPRVINLH 95
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVL-------VRRYTKQLVDAISALHE 121
            V  +  E++L +E    G + SL       LPE+        V R  KQ+++ +  LH+
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 122 NTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           N IVH D+K  NI L++      +K+ DFG + KI  H     EL   +GT  Y+APE+ 
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHAC---ELREIMGTPEYLAPEIL 205
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVGMGETPTIPESLSD 237
              N      A D+W++G +   + +   P+   D+   Y  + +V +  +     S+S 
Sbjct: 206 ---NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262
Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPAS 283
               F +  L  +P +R T    L H +L     E++ +P    +S
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSS 308

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 123/262 (46%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 14  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 69
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G    + ++ +  + C   +L   + ++E       +    +Q    +  LH  +
Sbjct: 70  ILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 128
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E N++K+GDFG A  + +  +   +     G+  +MAPEV    +
Sbjct: 129 IIHRDLKSNNIFL-HEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
              +    D+++ G VL E+ +G+ P++  ++  QI+  VG G  +P + +  S+  +  
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 246
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R +   +L
Sbjct: 247 KRLMAECLKKKRDERPSFPRIL 268

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NIFL  E N++K+GDFG A  + +  +   +     G+  +MAPEV    +   +    D
Sbjct: 138 NIFL-HEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 370 IWSLGCVLVEMSSGKTNLSGV 390
           +++ G VL E+ +G+   S +
Sbjct: 196 VYAFGIVLYELMTGQLPYSNI 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG+  A K I+  +   +R     +++  E+ IL  I   N++  
Sbjct: 35  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITL 94
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + +  ++ ++VL +EL + G L   +   E  L E    ++ KQ++D +  LH   I H 
Sbjct: 95  HDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHF 153
Query: 128 DIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +KL DFG A KI A      E     GT  ++APE+    N 
Sbjct: 154 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA----GNEFKNIFGTPEFVAPEI---VNY 206
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE---GQA 241
              G   D+WS+G +   + SG  P+   ++  + +  +         E  S+     + 
Sbjct: 207 EPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKD 265
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R  I + L+H ++
Sbjct: 266 FIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 120/240 (50%), Gaps = 36/240 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQKNL 64
           G G +G V +A +    + VA+K++       +H +   R       ELR+L+ +  +N+
Sbjct: 37  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-------ELRLLKHLKHENV 89
Query: 65  VKYYGVEIHREEMVLFMELCTEGTL-----ESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +    V      +  F E+    TL      ++V+     L +  V+    QL+  +  +
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLLRGLKYI 147
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H   I+HRD+K +N+ +  E + L++ DFG A +         E+ G+V T+ Y APE+ 
Sbjct: 148 HSAGIIHRDLKPSNVAVN-EDSELRILDFGLARQADE------EMTGYVATRWYRAPEIM 200
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEY-DSNYQIMFKVGMGETPTIPESLS 236
           +  N + + + VDIWS+GC++ E+  GK   P ++Y D   +IM  VG   TP+ PE L+
Sbjct: 201 L--NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVG---TPS-PEVLA 254

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E + L++ DFG A +         E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 166 EDSELRILDFGLARQADE------EMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 217
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+  GK    G
Sbjct: 218 IMAELLQGKALFPG 231

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI-----QLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G +G V +A ++     VA+K+I     Q + Q   R ++ +L+  R    I  ++++
Sbjct: 52  GEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQ-ILLRFRHENVIGIRDIL 110
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +   +E  R+  V  ++   E  L  L++S +  L    +  +  Q++  +  +H   ++
Sbjct: 111 RASTLEAMRD--VYIVQDLMETDLYKLLKSQQ--LSNDHICYFLYQILRGLKYIHSANVL 166
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K +N+ +    + LK+ DFG A          G L   V T+ Y APE+ +  N  
Sbjct: 167 HRDLKPSNLLINTTCD-LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML--NSK 223
Query: 186 GHGRAVDIWSLGCVLVEMSSGK 207
           G+ +++DIWS+GC+L EM S +
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 2/71 (2%)
Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
            LK+ DFG A          G L   V T+ Y APE+ +  N  G+ +++DIWS+GC+L 
Sbjct: 182 DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML--NSKGYTKSIDIWSVGCILA 239
Query: 379 EMSSGKTNLSG 389
           EM S +    G
Sbjct: 240 EMLSNRPIFPG 250

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 119/240 (49%), Gaps = 36/240 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQKNL 64
           G G +G V +A +    + VA+K++       +H +   R       ELR+L+ +  +N+
Sbjct: 29  GSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-------ELRLLKHLKHENV 81
Query: 65  VKYYGVEIHREEMVLFMELCTEGTL-----ESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +    V      +  F E+    TL      ++V+     L +  V+    QL+  +  +
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC--QALSDEHVQFLVYQLLRGLKYI 139
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H   I+HRD+K +N+ +  E   L++ DFG A +         E+ G+V T+ Y APE+ 
Sbjct: 140 HSAGIIHRDLKPSNVAVN-EDCELRILDFGLARQADE------EMTGYVATRWYRAPEIM 192
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKR--PWAEY-DSNYQIMFKVGMGETPTIPESLS 236
           +  N + + + VDIWS+GC++ E+  GK   P ++Y D   +IM  VG   TP+ PE L+
Sbjct: 193 L--NWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVG---TPS-PEVLA 246

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   L++ DFG A +         E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 158 EDCELRILDFGLARQADE------EMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 209
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+  GK    G
Sbjct: 210 IMAELLQGKALFPG 223

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 7/214 (3%)
Query: 52  ELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQ 111
           E+ +L      N++ + G    + ++ +  + C   +L   + ++E       +    +Q
Sbjct: 70  EVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128
Query: 112 LVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
               +  LH  +I+HRD+KS NIFL  E N++K+GDFG A + S  +    +     G+ 
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSI 186
Query: 172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPT 230
            +MAPEV    +   +    D+++ G VL E+ +G+ P++  ++  QI+  VG G  +P 
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246
Query: 231 IPESLSDEGQAFAEL---CLRHDPAQRATIFELL 261
           + +  S+  +    L   CL+    +R +   +L
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+  FG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILGFG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+  FG    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILGFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 22/168 (13%)
Query: 112 LVDAISALHENTIVHRDIKSANIFLTAE-GN--SLKLGDFGSAVKISAHTTVPGELNGFV 168
           +   +  LH   +VHRD+K +NI    E GN  S+++ DFG A ++ A        NG +
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-------NGLL 177
Query: 169 GTQAY----MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFK 222
            T  Y    +APEV     + G+  A DIWSLG +L  M +G  P+A    D+  +I+ +
Sbjct: 178 MTPCYTANFVAPEVL---ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 223 VGMGE---TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
           +G G+   +     S+SD  +      L  DP QR T   +L+HP+++
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 27/113 (23%)
Query: 311 IFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAY----MAPEVFMDTNKVGH 364
           +++   GN  S+++ DFG A ++ A        NG + T  Y    +APEV     + G+
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAE-------NGLLMTPCYTANFVAPEVL---ERQGY 197
Query: 365 GRAVDIWSLGCVLVEMSSGKTNLS-----------GVVVSAEVFGSGGWWFQV 406
             A DIWSLG +L  M +G T  +             + S +   SGG+W  V
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ D G    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDAG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ D G    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDAG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ D G    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDRG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ D G    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDRG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 114/233 (48%), Gaps = 17/233 (7%)
Query: 40  QNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL-ESLVQSTED 98
           +N  +F +++  E+ +L+ ++  N++K + V   ++   L  E    G L E ++   + 
Sbjct: 84  KNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK- 142
Query: 99  GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAVKISA 156
              E       KQ++  I  LH++ IVHRDIK  NI L  + +  ++K+ DFG    +S+
Sbjct: 143 -FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG----LSS 197
Query: 157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN 216
             +   +L   +GT  Y+APEV     K  +    D+WS G ++  +  G  P+    ++
Sbjct: 198 FFSKDYKLRDRLGTAYYIAPEVL----KKKYNEKCDVWSCGVIMYILLCGYPPFGG-QND 252
Query: 217 YQIMFKVGMGETP---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             I+ KV  G+        +++SDE +   +L L +D  +R T  E L   ++
Sbjct: 253 QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 26  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 84
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 142
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ D G    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 143 SADIIHRDLKPSNLAVN-EDCELKILDGG----LARHTD--DEMTGYVATRWYRAPEIML 195
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
             N + + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP
Sbjct: 196 --NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 242

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 44/74 (59%), Gaps = 8/74 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ D G    ++ HT    E+ G+V T+ Y APE+ +  N + + + VDIWS+GC
Sbjct: 160 EDCELKILDGG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGC 211
Query: 376 VLVEMSSGKTNLSG 389
           ++ E+ +G+T   G
Sbjct: 212 IMAELLTGRTLFPG 225

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + + ME  ++G L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 43/273 (15%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+ A        +   LVA+K ++    ++AR  KD   E  +L  +  +++V
Sbjct: 22  GEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNAR--KDFHREAELLTNLQHEHIV 78
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS--------TEDGLPEVLVRRYTKQLVDAIS 117
           K+YGV +  + +++  E    G L   +++         E   P  L +     +   I+
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 118 A----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA--------VKISAHTTVPGELN 165
           A    L     VHRD+ + N  L  E   +K+GDFG +         ++  HT +P    
Sbjct: 139 AGMVYLASQHFVHRDLATRNC-LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-- 195
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVG 224
                  +M PE  M           D+WSLG VL E+ + GK+PW +  SN +++  + 
Sbjct: 196 -------WMPPESIMYRKFTTES---DVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 244
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATI 257
            G     P +   E       C + +P  R  I
Sbjct: 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNI 277

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V+ A +   G+   +K ++ + +   R       E++ L  ++  N+V Y G 
Sbjct: 20  GSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-------EVKALAKLDHVNIVHYNGC 72
Query: 71  --------------EIHREEMVLF--MELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLV 113
                             +   LF  ME C +GTLE  ++    + L +VL     +Q+ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 114 DAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY 173
             +  +H   +++RD+K +NIFL  +   +K+GDFG    +       G+     GT  Y
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKN----DGKRXRSKGTLRY 187
Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
           M+PE     +   +G+ VD+++LG +L E+
Sbjct: 188 MSPEQISSQD---YGKEVDLYALGLILAEL 214

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 59/297 (19%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE----GINQKNLVK 66
           G+G++ +V+ A+N    E V +K ++  K+N  +       E++ILE    G N   L  
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK------REIKILENLRGGPNIITLAD 99
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+H
Sbjct: 100 IVKDPVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMH 154
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKV 185
           RD+K  N+ +  E   L+L D+G      A    PG E N  V ++ +  PE+ +D    
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWG-----LAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 209
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETP 229
            +  ++D+WSLGC+L  M   K P+     NY  + ++                 +   P
Sbjct: 210 DY--SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 230 TIPESL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
              + L                    S E   F +  LR+D   R T  E ++HP+ 
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLA-----EFYHPGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV--NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +  + E   L VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 47  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 104
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 105 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 163
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 164 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 217
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 218 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 276
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 277 WAYDPSRRPRFTEL 290

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 122/262 (46%), Gaps = 11/262 (4%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           +T     G G FG VY       G+ VA+K + +      + ++    E+ +L      N
Sbjct: 26  ITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVN 81
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           ++ + G      ++ +  + C   +L   + ++E       +    +Q    +  LH  +
Sbjct: 82  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+KS NIFL  E N++K+GDFG A + S  +    +     G+  +MAPEV    +
Sbjct: 141 IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQD 198
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF 242
              +    D+++ G VL E+ +G+ P++  ++  QI+  VG G  +P + +  S+  +  
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 243 AEL---CLRHDPAQRATIFELL 261
             L   CL+    +R +   +L
Sbjct: 259 KRLMAECLKKKRDERPSFPRIL 280

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV--NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +  + E   L VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 24  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 81
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 82  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 141 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 194
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 253
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 254 WAYDPSRRPRFTEL 267

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV--NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +  + E   L VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 19  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 76
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 136 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 189
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 249 WAYDPSRRPRFTEL 262

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 47/303 (15%)
Query: 11  GQGRFGKV--------YTAVNNETGELVAMKEIQLHKQNDARFVK----DMLVELRILEG 58
            QG+F K+        + A+      L+  K       ND   +K    D   EL+I+  
Sbjct: 40  NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLES-------LVQSTEDGLPEVLVRRYTKQ 111
           I  +  +   G+  + +E+ +  E     ++         L ++    +P  +++   K 
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159
Query: 112 LVDAISALH-ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGT 170
           ++++ S +H E  I HRD+K +NI +   G  +KL DFG +        V  ++ G  GT
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGES-----EYMVDKKIKGSRGT 213
Query: 171 QAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA-----------------EY 213
             +M PE F + +    G  VDIWSLG  L  M     P++                 EY
Sbjct: 214 YEFMPPEFFSNESSYN-GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272
Query: 214 --DSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCE 271
             D N+  ++ +   ++      LS+E   F +L LR +PA+R T  + L+H +L  +  
Sbjct: 273 PLDRNH-FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331
Query: 272 EDV 274
           ED+
Sbjct: 332 EDL 334

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI +   G  +KL DFG +        V  ++ G  GT  +M PE F + +    G  V
Sbjct: 181 SNILMDKNG-RVKLSDFGES-----EYMVDKKIKGSRGTYEFMPPEFFSNESSYN-GAKV 233
Query: 369 DIWSLGCVLVEMSSGKTNLSGVVVSAEVFGS 399
           DIWSLG  L  M       S  +   E+F +
Sbjct: 234 DIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + +++ + D     D L+E  I+   N +N+
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL---DFLMEALIISKFNHQNI 110
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I   +         +  + +M P
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 229
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 230 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 282
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 283 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 320

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +          VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 19  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 76
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ ++A  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 136 DIAARNVLVSA-TDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 189
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 249 WAYDPSRRPRFTEL 262

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV--NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +  + E   L VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 22  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 79
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 80  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 138
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 139 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 192
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 251
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 252 WAYDPSRRPRFTEL 265

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +          VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 19  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 76
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 136 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 189
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 249 WAYDPSRRPRFTEL 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV--NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +  + E   L VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 16  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 73
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 74  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 133 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 186
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 245
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 246 WAYDPSRRPRFTEL 259

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +          VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 19  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 76
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 77  IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 136 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTXXKAS-KGKLPIK-WMAPE---SINFRRF 189
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 248
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 249 WAYDPSRRPRFTEL 262

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV--NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +  + E   L VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 21  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 78
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 79  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 137
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 138 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 191
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 192 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 250
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 251 WAYDPSRRPRFTEL 264

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 122/272 (44%), Gaps = 24/272 (8%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKE----IQLHKQNDARFVKDMLVELRILEG 58
            + F+ S GQG F K++  V  E G+   + E    +++  +    + +       ++  
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           ++ K+LV  YGV +  +E +L  E    G+L++ ++  ++ +  +      KQL  A+  
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 119 LHENTIVHRDIKSANIFLTAE-----GNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
           L ENT++H ++ + NI L  E     GN   +KL D G ++     T +P ++       
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVLPKDI--LQERI 181
Query: 172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT 230
            ++ PE     N      A D WS G  L E+ S G +P +  DS  ++ F     +   
Sbjct: 182 PWVPPECI--ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---YEDRHQ 236
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +P   + E       C+ ++P  R +   +++
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 95
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + MEL   G L+S ++ T         L  + +    + +      
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I   +         +  + +M P
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 214
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 215 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 267
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 305

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 7   SVSP-GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           ++SP G G +G V ++ + ++G  +A+K++    Q+     K    ELR+L+ +  +N++
Sbjct: 55  TLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVI 113
Query: 66  KYYGVEIHREEMVLFME--LCTE---GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
               V      +  F +  L T      L ++V+  +  L +  V+    Q++  +  +H
Sbjct: 114 GLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH 171
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
              I+HRD+K +N+ +  E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +
Sbjct: 172 SADIIHRDLKPSNLAVN-EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML 224
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGK 207
             N + +   VDIWS+GC++ E+ +G+
Sbjct: 225 --NWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 8/75 (10%)
Query: 316 EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGC 375
           E   LK+ DFG    ++ HT    E+ G+V T+ Y APE+ +  N + +   VDIWS+GC
Sbjct: 189 EDCELKILDFG----LARHTD--DEMTGYVATRWYRAPEIML--NWMHYNMTVDIWSVGC 240
Query: 376 VLVEMSSGKTNLSGV 390
           ++ E+ +G+T   G 
Sbjct: 241 IMAELLTGRTLFPGT 255

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 110
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + MEL   G L+S ++ T         L  + +    + +      
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I   +         +  + +M P
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 229
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 230 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 282
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 283 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 320

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ I  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKIRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + + +E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 133/266 (50%), Gaps = 18/266 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+V    +  T    A+K I+    + +   K +L E+ +L+ ++  N++K Y  
Sbjct: 46  GSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDF 104
Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
              +    L ME    G L + ++   +    EV      KQ++  ++ LH++ IVHRD+
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162
Query: 130 KSANIFL-TAEGNSL-KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ L + E ++L K+ DFG    +SA      ++   +GT  Y+APEV     +  +
Sbjct: 163 KPENLLLESKEKDALIKIVDFG----LSAVFENQKKMKERLGTAYYIAPEVL----RKKY 214
Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPE--SLSDEGQAFAE 244
               D+WS+G +L  + +G  P+    ++ +I+ KV  G+ T   PE  ++S+  +   +
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 245 LCLRHDPAQRATIFELLQHPFLIVSC 270
             L+ D  +R +  + L+HP++   C
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKEMC 299

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 85/168 (50%), Gaps = 22/168 (13%)
Query: 112 LVDAISALHENTIVHRDIKSANIFLTAE-GN--SLKLGDFGSAVKISAHTTVPGELNGFV 168
           +   +  LH   +VHRD+K +NI    E GN  S+++ DFG A ++ A        NG +
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-------NGLL 177
Query: 169 GTQAY----MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFK 222
            T  Y    +APEV     + G+  A DIWSLG +L    +G  P+A    D+  +I+ +
Sbjct: 178 XTPCYTANFVAPEVL---ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILAR 234
Query: 223 VGMGE---TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
           +G G+   +     S+SD  +      L  DP QR T   +L+HP+++
Sbjct: 235 IGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKXLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++  E    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 127 LYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRD 186
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A + ++H +    L     T  Y+APEV        
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPEK--- 239
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D WSLG +   +  G  P   + SN+        +   + G  E P  PE   +S
Sbjct: 240 YDKSCDXWSLGVIXYILLCGYPP---FYSNHGLAISPGXKTRIRXGQYEFPN-PEWSEVS 295
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E   HP++  S
Sbjct: 296 EEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQS 328

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 84/165 (50%), Gaps = 24/165 (14%)
Query: 115 AISALHENTIVHRDIKSANIFLTAE-GN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
            +  LH   +VHRD+K +NI    E GN   L++ DFG A ++ A        NG + T 
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE-------NGLLMTP 185
Query: 172 AY----MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGM 225
            Y    +APEV     + G+    DIWSLG +L  M +G  P+A    D+  +I+ ++G 
Sbjct: 186 CYTANFVAPEVL---KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGS 242
Query: 226 GETPTIP----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           G+  T+      ++S+  +      L  DP QR T  ++LQHP++
Sbjct: 243 GKF-TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 126/306 (41%), Gaps = 63/306 (20%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +   G  VA+K++    QN     K    EL +L+ +N KN++    V
Sbjct: 31  GSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNHKNIISLLNV 89
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q     L    +     Q++  I  LH   I+HRD
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 149
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   S +      +  +V T+ Y APEV +    +G+ 
Sbjct: 150 LKPSNIVVKSDC-TLKILDFGLARTASTNFM----MTPYVVTRYYRAPEVILG---MGYK 201
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFKVGMGET 228
             VDIWS+GC++ E+  G                      P AE+ +  Q   +  +   
Sbjct: 202 ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENR 261
Query: 229 PTIPESLSDEGQAFAEL--------------------------CLRHDPAQRATIFELLQ 262
           P  P      G AF EL                           L  DP +R ++ E L+
Sbjct: 262 PAYP------GIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALR 315
Query: 263 HPFLIV 268
           HP++ V
Sbjct: 316 HPYITV 321

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   S +      +  +V T+ Y APEV +    +G+   V
Sbjct: 153 SNIVVKSDC-TLKILDFGLARTASTNFM----MTPYVVTRYYRAPEVILG---MGYKENV 204
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ E+  G     G
Sbjct: 205 DIWSVGCIMGELVKGSVIFQG 225

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 31  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 87
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I   +         +  + +M P
Sbjct: 148 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 206
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 207 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 259
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 260 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 297

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 84/165 (50%), Gaps = 24/165 (14%)
Query: 115 AISALHENTIVHRDIKSANIFLTAE-GN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
            +  LH   +VHRD+K +NI    E GN   L++ DFG A ++ A        NG + T 
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE-------NGLLMTP 185
Query: 172 AY----MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGM 225
            Y    +APEV     + G+    DIWSLG +L  M +G  P+A    D+  +I+ ++G 
Sbjct: 186 CYTANFVAPEVL---KRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGS 242
Query: 226 GETPTIP----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           G+  T+      ++S+  +      L  DP QR T  ++LQHP++
Sbjct: 243 GKF-TLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+  +N +N+
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKLNHQNI 110
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I   +         +  + +M P
Sbjct: 171 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 229
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 230 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 282
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 283 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 320

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  +R ++VL +EL + G L   +   E  L E     + KQ++D ++ LH   I H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L  +      +KL DFG A +I        E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  +         E     S+  + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  +  +R TI E L+HP++
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+  +N +N+
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKLNHQNI 96
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 119 LHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT    G   K+GDFG A  I   +         +  + +M P
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 215
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 216 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 268
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 269 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 306

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 62
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 63  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 118
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 119 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 169
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 170 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 228
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 229 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 255

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  +R ++VL +EL + G L   +   E  L E     + KQ++D ++ LH   I H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L  +      +KL DFG A +I        E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL---SDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  +         E     S+  + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  +  +R TI E L+HP++
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 120/261 (45%), Gaps = 18/261 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V+  V   + +    K +++ K  D   VK    E+ IL     +N++  +  
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKK---EISILNIARHRNILHLHES 69
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               EE+V+  E  +   +   + ++   L E  +  Y  Q+ +A+  LH + I H DI+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 131 SAN-IFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ-AYMAPEVFMDTNKVGHG 188
             N I+ T   +++K+ +FG A ++      PG+    + T   Y APEV          
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLK-----PGDNFRLLFTAPEYYAPEVHQHDVV---S 181
Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES---LSDEGQAFAEL 245
            A D+WSLG ++  + SG  P+   ++N QI+  +   E     E+   +S E   F + 
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 246 CLRHDPAQRATIFELLQHPFL 266
            L  +   R T  E LQHP+L
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 120/256 (46%), Gaps = 19/256 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N + + VA+K ++    +    V+  L E  +++ +    LV+ Y V
Sbjct: 22  GAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
               E + +  E   +G+L   ++S E G   LP+++   ++ Q+ + ++ +     +HR
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHR 134
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++AN+ L +E    K+ DFG A  I  +     E   F     + APE     N    
Sbjct: 135 DLRAANV-LVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI---NFGCF 188
Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L E+ + GK P+    +N  +M  +  G      E+  DE     ++C
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPG-RTNADVMTALSQGYRMPRVENCPDELYDIMKMC 247
Query: 247 LRHDPAQRATIFELLQ 262
            +    +R T F+ LQ
Sbjct: 248 WKEKAEERPT-FDYLQ 262

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 64
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 65  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 120
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 121 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 171
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 230
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 231 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 257

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  +R ++VL +EL + G L   +   E  L E     + KQ++D ++ LH   I H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L  +      +KL DFG A +I        E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  +         E     S+  + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  +  +R TI E L+HP++
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  +R ++VL +EL + G L   +   E  L E     + KQ++D ++ LH   I H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L  +      +KL DFG A +I        E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL---SDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  +         E     S+  + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  +  +R TI E L+HP++
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 34/276 (12%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y    + TGE VA+K   L  ++    + D+  E+ IL  +  +N+VK
Sbjct: 30  GEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G+  E     + L ME    G+L+  +   ++ +      +Y  Q+   +  L     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 147
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           VHRD+ + N+ + +E + +K+GDFG    I          +       + APE  M +  
Sbjct: 148 VHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK- 205
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------------- 229
                A D+WS G  L E+ +    + + DS+   +F   +G T                
Sbjct: 206 --FYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259
Query: 230 ---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
                P +  DE       C    P+ R +   L++
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 34/276 (12%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y    + TGE VA+K   L  ++    + D+  E+ IL  +  +N+VK
Sbjct: 18  GEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G+  E     + L ME    G+L+  +   ++ +      +Y  Q+   +  L     
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 135
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           VHRD+ + N+ + +E + +K+GDFG    I          +       + APE  M +  
Sbjct: 136 VHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK- 193
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------------- 229
                A D+WS G  L E+ +    + + DS+   +F   +G T                
Sbjct: 194 --FYIASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 247
Query: 230 ---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
                P +  DE       C    P+ R +   L++
Sbjct: 248 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR---FVKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  +R ++VL +EL + G L   +   E  L E     + KQ++D ++ LH   I H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L  +      +KL DFG A +I        E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  +         E     S+  + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  +  +R TI E L+HP++
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 96
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 119 LHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT    G   K+GDFG A  I   +         +  + +M P
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 215
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 216 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 268
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 269 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 306

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 95
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I   +         +  + +M P
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 214
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 215 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 267
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 305

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+ A  N+  + VA+K ++    +    V+  L E  +++ +    LVK + V
Sbjct: 24  GAGQFGEVWMATYNKHTK-VAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            + +E + +  E   +G+L   ++S E     LP+++   ++ Q+ + ++ + +   +HR
Sbjct: 79  -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHR 135
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++ANI ++A     K+ DFG A  I  +     E   F     + APE     N    
Sbjct: 136 DLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI---NFGSF 189
Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L+E+ + G+ P+    SN +++  +  G     PE+  +E       C
Sbjct: 190 TIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRPENCPEELYNIMMRC 248
Query: 247 LRHDPAQRATIFELLQ 262
            ++ P +R T FE +Q
Sbjct: 249 WKNRPEERPT-FEYIQ 263

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 96
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 119 LHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT    G   K+GDFG A  I   +         +  + +M P
Sbjct: 157 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK-WMPP 215
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 216 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 268
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 269 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 306

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 18/265 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARF---VKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  +R ++VL +EL + G L   +   E  L E     + KQ++D ++ LH   I H 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 128 DIKSANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L  +      +KL DFG A +I        E     GT  ++APE+    N 
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI---VNY 192
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL---SDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  +         E     S+  + 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKD 251
Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  +  +R TI E L+HP++
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 45/223 (20%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY--- 67
           G G FG+V+ A +   G+   ++ ++ + +   R       E++ L  ++  N+V Y   
Sbjct: 21  GSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER-------EVKALAKLDHVNIVHYNGC 73
Query: 68  -----YGVEIHREEM-------------------VLF--MELCTEGTLESLVQSTE-DGL 100
                Y  E   + +                    LF  ME C +GTLE  ++    + L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
            +VL     +Q+   +  +H   ++HRD+K +NIFL  +   +K+GDFG    +      
Sbjct: 134 DKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKN---- 188
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
            G+     GT  YM+PE     +   +G+ VD+++LG +L E+
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQD---YGKEVDLYALGLILAEL 228

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 121/272 (44%), Gaps = 24/272 (8%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKE----IQLHKQNDARFVKDMLVELRILEG 58
            + F+ S GQG F K++  V  E G+   + E    +++  +    + +       ++  
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           ++ K+LV  YGV    +E +L  E    G+L++ ++  ++ +  +      KQL  A+  
Sbjct: 69  LSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHF 128
Query: 119 LHENTIVHRDIKSANIFLTAE-----GNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
           L ENT++H ++ + NI L  E     GN   +KL D G ++     T +P ++       
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVLPKDI--LQERI 181
Query: 172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPT 230
            ++ PE     N      A D WS G  L E+ S G +P +  DS  ++ F     +   
Sbjct: 182 PWVPPECI--ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---YEDRHQ 236
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +P   + E       C+ ++P  R +   +++
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 46  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 102
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 119 LHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT    G   K+GDFG A  I   +         +  + +M P
Sbjct: 163 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 221
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 222 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 274
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 275 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 312

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +          VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 456
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ ++A  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 516 DIAARNVLVSA-TDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 569
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 628
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 629 WAYDPSRRPRFTEL 642

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+ A  N+  + VA+K ++    +    V+  L E  +++ +    LVK + V
Sbjct: 197 GAGQFGEVWMATYNKHTK-VAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            + +E + +  E   +G+L   ++S E     LP+++   ++ Q+ + ++ + +   +HR
Sbjct: 252 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHR 308
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++ANI ++A     K+ DFG A  I  +     E   F     + APE     N    
Sbjct: 309 DLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI---NFGSF 362
Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L+E+ + G+ P+    SN +++  +  G     PE+  +E       C
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRPENCPEELYNIMMRC 421
Query: 247 LRHDPAQRATIFELLQ 262
            ++ P +R T FE +Q
Sbjct: 422 WKNRPEERPT-FEYIQ 436

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 129
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 190 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 241
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 193 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 244
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 245 DIWSVGCIMGEMVRHKILFPG 265

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 56  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 112
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 119 LHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT    G   K+GDFG A  I   +         +  + +M P
Sbjct: 173 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 231
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 232 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 284
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 285 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 322

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + + +E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N     Q    P  
Sbjct: 130 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEXTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 14/254 (5%)
Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +          VA+K  +    +  R  +  L E   +   +  ++VK 
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL 456
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ L +  + +KLGDFG +  +   T       G +  + +MAPE     N    
Sbjct: 516 DIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK-WMAPE---SINFRRF 569
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             A D+W  G  + E +  G +P+    +N  ++ ++  GE   +P +      +    C
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKC 628
Query: 247 LRHDPAQRATIFEL 260
             +DP++R    EL
Sbjct: 629 WAYDPSRRPRFTEL 642

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 66
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 67  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLV--DMAAQIASGMAY 122
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 123 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 173
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 174 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 232
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 233 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 259

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E   +G+L   ++  E G    LP+++    + Q+   ++ 
Sbjct: 71  KLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKG-ETGKYLRLPQLV--DMSAQIASGMAY 126
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 127 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 177
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 236
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 237 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 263

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 17/250 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+VY     +TG++ AMK      I++ KQ +   + + ++   +  G     + 
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y      +++   ++L   G L   + S      E  +R Y  +++  +  +H   +V
Sbjct: 257 MSYAFHTP-DKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V
Sbjct: 315 YRDLKPANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGV 366
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE 244
            +  + D +SLGC+L ++  G  P+ ++ + +   + ++ +     +P+S S E ++  E
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 245 LCLRHDPAQR 254
             L+ D  +R
Sbjct: 427 GLLQRDVNRR 436

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V +  + 
Sbjct: 321 ANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGVAYDSSA 372
Query: 369 DIWSLGCVLVEMSSGKT 385
           D +SLGC+L ++  G +
Sbjct: 373 DWFSLGCMLFKLLRGHS 389

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/329 (23%), Positives = 134/329 (40%), Gaps = 92/329 (27%)
Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------ 63
           G+G FGKV   ++++ G   VA+K ++    N  R+ +    E+++LE +N  +      
Sbjct: 23  GEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 64  ---LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVL--VRRYTKQLVDAIS 117
              +++++    H   + +  EL    T + +    E+G LP  L  +R+   Q+  +++
Sbjct: 79  CVQMLEWFE---HHGHICIVFELLGLSTYDFI---KENGFLPFRLDHIRKMAYQICKSVN 132
Query: 118 ALHENTIVHRDIKSANIFL------------------TAEGNSLKLGDFGSAVKISAHTT 159
            LH N + H D+K  NI                    T     +K+ DFGSA     H +
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS 192
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI 219
                   V T+ Y APEV +    +G  +  D+WS+GC+L+E   G   +  +DS   +
Sbjct: 193 T------LVSTRHYRAPEVIL---ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 220 -MFKVGMGETPTIP-----------------ESLSDEGQAFAELC--------------- 246
            M +  +G  P                    +  S  G+  +  C               
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 247 ---------LRHDPAQRATIFELLQHPFL 266
                    L +DPA+R T+ E L+HPF 
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 9/67 (13%)
Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
            +K+ DFGSA     H +        V T+ Y APEV +    +G  +  D+WS+GC+L+
Sbjct: 175 DIKVVDFGSATYDDEHHST------LVSTRHYRAPEVIL---ALGWSQPCDVWSIGCILI 225
Query: 379 EMSSGKT 385
           E   G T
Sbjct: 226 EYYLGFT 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 17/250 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+VY     +TG++ AMK      I++ KQ +   + + ++   +  G     + 
Sbjct: 197 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y      +++   ++L   G L   + S      E  +R Y  +++  +  +H   +V
Sbjct: 256 MSYAFHTP-DKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRFVV 313
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V
Sbjct: 314 YRDLKPANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGV 365
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE 244
            +  + D +SLGC+L ++  G  P+ ++ + +   + ++ +     +P+S S E ++  E
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 425
Query: 245 LCLRHDPAQR 254
             L+ D  +R
Sbjct: 426 GLLQRDVNRR 435

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V +  + 
Sbjct: 320 ANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGVAYDSSA 371
Query: 369 DIWSLGCVLVEMSSGKT 385
           D +SLGC+L ++  G +
Sbjct: 372 DWFSLGCMLFKLLRGHS 388

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 129
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+ +ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 130 VERMNYVHRDLAAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 180
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 181 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 239
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 240 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 266

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 17/250 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+VY     +TG++ AMK      I++ KQ +   + + ++   +  G     + 
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y      +++   ++L   G L   + S      E  +R Y  +++  +  +H   +V
Sbjct: 257 MSYAFHTP-DKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V
Sbjct: 315 YRDLKPANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGV 366
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE 244
            +  + D +SLGC+L ++  G  P+ ++ + +   + ++ +     +P+S S E ++  E
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 245 LCLRHDPAQR 254
             L+ D  +R
Sbjct: 427 GLLQRDVNRR 436

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V +  + 
Sbjct: 321 ANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGVAYDSSA 372
Query: 369 DIWSLGCVLVEMSSGKT 385
           D +SLGC+L ++  G +
Sbjct: 373 DWFSLGCMLFKLLRGHS 389

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 17/250 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+VY     +TG++ AMK      I++ KQ +   + + ++   +  G     + 
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             Y      +++   ++L   G L   + S      E  +R Y  +++  +  +H   +V
Sbjct: 257 MSYAFHTP-DKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V
Sbjct: 315 YRDLKPANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGV 366
Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQAFAE 244
            +  + D +SLGC+L ++  G  P+ ++ + +   + ++ +     +P+S S E ++  E
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 245 LCLRHDPAQR 254
             L+ D  +R
Sbjct: 427 GLLQRDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L   G+ +++ D G A   S         +  VGT  YMAPEV      V +  + 
Sbjct: 321 ANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVL--QKGVAYDSSA 372
Query: 369 DIWSLGCVLVEMSSGKT 385
           D +SLGC+L ++  G +
Sbjct: 373 DWFSLGCMLFKLLRGHS 389

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 129
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 190 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 241
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 193 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 244
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 245 DIWSVGCIMGEMVRHKILFPG 265

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 66  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 122
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 119 LHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT    G   K+GDFG A  I   +         +  + +M P
Sbjct: 183 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMPP 241
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 242 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 294
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 295 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 332

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 32  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 90
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 150
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 151 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 202
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 203 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 262
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 263 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 154 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 205
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 206 DIWSVGCIMGEMVRHKILFPG 226

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 84
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRD 144
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 145 LKPSNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 196
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 148 SNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 199
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 200 DIWSVGCIMGEMVRHKILFPG 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 207 DIWSVGCIMGEMVRHKILFPG 227

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 207 DIWSVGCIMGEMVRHKILFPG 227

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 11  GQGRFGKVYTA-VNNET---GELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKN 63
           G+G FG VY   VNN T    +L AM +I   +L +Q D         E++++     +N
Sbjct: 40  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ--------EIKVMAKCQHEN 91
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEV---LVRRYTKQLVDAISALH 120
           LV+  G     +++ L       G+L   + S  DG P +   +  +  +   + I+ LH
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFG--SAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           EN  +HRDIKSANI L  E  + K+ DFG   A +  A T +   +   VGT AYMAPE 
Sbjct: 151 ENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRI---VGTTAYMAPEA 206
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSSG 206
                    G      DI+S G VL+E+ +G
Sbjct: 207 L-------RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F    L E ++++ +  +
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF----LQEAQVMKKLRHE 322
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLV--DMAAQIASGMAY 378
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 379 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 429
Query: 179 FMDTNKVGHGR---AVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 488
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 489 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 515

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 34  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 92
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 152
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 153 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 204
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 205 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 265 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 324

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 156 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 207
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 208 DIWSVGCIMGEMVRHKILFPG 228

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKXVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 207 DIWSVGCIMGEMVRHKILFPG 227

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 34  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 92
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 152
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 153 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 204
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 205 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 265 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 324

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 156 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 207
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 208 DIWSVGCIMGEMVRHKILFPG 228

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLV--DMAAQIASGMAY 295
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 296 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 346
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET----PT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 405
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 406 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 432

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 207 DIWSVGCIMGEMVRHKILFPG 227

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLV--DMAAQIASGMAY 295
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 296 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 346
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET----PT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 405
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 406 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 432

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 84
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 145 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 196
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 148 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 199
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 200 DIWSVGCIMGEMVRHKILFPG 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 27  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 85
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 145
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 146 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 197
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 198 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 258 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 317

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 149 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 200
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 201 DIWSVGCIMGEMVRHKILFPG 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E   +G+L   ++  E G    LP+++    + Q+   ++ 
Sbjct: 71  KLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKG-ETGKYLRLPQLV--DMSAQIASGMAY 126
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 127 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEWTARQGAKFPIK 177
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 178 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 236
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 237 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 263

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKXVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 207 DIWSVGCIMGEMVRHKILFPG 227

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 120/256 (46%), Gaps = 19/256 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N + + VA+K ++    +    V+  L E  +++ +    LV+ Y V
Sbjct: 21  GAGQFGEVWMGYYNNSTK-VAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVHR 127
               E + +  E   +G+L   ++S E G   LP+++   ++ Q+ + ++ +     +HR
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIERKNYIHR 133
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++AN+ L +E    K+ DFG A  I  +     E   F     + APE     N    
Sbjct: 134 DLRAANV-LVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAI---NFGCF 187
Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               ++WS G +L E+ + GK P+    +N  +M  +  G      E+  DE     ++C
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIPYPG-RTNADVMSALSQGYRMPRMENCPDELYDIMKMC 246
Query: 247 LRHDPAQRATIFELLQ 262
            +    +R T F+ LQ
Sbjct: 247 WKEKAEERPT-FDYLQ 261

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 57  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 113
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I             +  + +M P
Sbjct: 174 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WMPP 232
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 233 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 285
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 286 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 323

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKXVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 204 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 323

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDX-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 207 DIWSVGCIMGEMVRHKILFPG 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 27  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV 85
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 145
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 146 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 197
Query: 189 RAVDIWSLGCVLVEMSSGK--------------------RPWAEYDSNYQIMFK------ 222
             VDIWS+GC++ EM   K                     P  E+    Q   +      
Sbjct: 198 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257
Query: 223 ---VGMGETPTIPESL-----------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
               G+      P+SL           + + +      L  DPA+R ++ + LQHP++ V
Sbjct: 258 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 317

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 149 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 200
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ EM   K    G
Sbjct: 201 DIWSVGCIMGEMVRHKILFPG 221

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 32/281 (11%)
Query: 11  GQGRFGKVY----TAVNNETGEL-VAMKEI-QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG+VY    + + N+   L VA+K + ++  + D     D L+E  I+   N +N+
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL---DFLMEALIISKFNHQNI 136
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISA 118
           V+  GV +      + +EL   G L+S ++ T         L  + +    + +      
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 119 LHENTIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           L EN  +HRDI + N  LT  G     K+GDFG A  I             +  + +M P
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WMPP 255
Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E FM+   T+K       D WS G +L E+ S G  P+    SN +++  V  G     P
Sbjct: 256 EAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRMDPP 308
Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           ++           C +H P  R     +L+    I  C +D
Sbjct: 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILER---IEYCTQD 346

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQ----EAQVMKKLRHE 240
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 241 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLV--DMAAQIASGMAY 296
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG    I        E N +   Q    P  
Sbjct: 297 VERMNYVHRDLRAANI-LVGENLVCKVADFGLGRLI--------EDNEYTARQGAKFPIK 347
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET----PT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 348 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 406
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R DP +R T FE LQ
Sbjct: 407 CPESLHD----LMCQCWRKDPEERPT-FEYLQ 433

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 11  GQGRFGKVYTA-VNNET---GELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKN 63
           G+G FG VY   VNN T    +L AM +I   +L +Q D         E++++     +N
Sbjct: 40  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ--------EIKVMAKCQHEN 91
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEV---LVRRYTKQLVDAISALH 120
           LV+  G     +++ L       G+L   + S  DG P +   +  +  +   + I+ LH
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH 150
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFG--SAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           EN  +HRDIKSANI L  E  + K+ DFG   A +  A T +   +   VGT AYMAPE 
Sbjct: 151 ENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRI---VGTTAYMAPEA 206
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSSG 206
                    G      DI+S G VL+E+ +G
Sbjct: 207 L-------RGEITPKSDIYSFGVVLLEIITG 230

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 51/300 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +   G  VA+K++    QN     K    EL +L+ +N KN++    V
Sbjct: 33  GSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNHKNIISLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  L  E    +L Q     L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A     +      +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLARTACTNFM----MTPYVVTRYYRAPEVILG---MGYA 203
Query: 189 RAVDIWSLGCVLVEMSSG--------------------KRPWAEYDSNYQIMFKVGMGET 228
             VDIWS+GC++ E+  G                      P AE+ +  Q   +  +   
Sbjct: 204 ANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENR 263
Query: 229 PTIP---------------ESLSD-----EGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
           P  P               ES  D     + +      L  DP +R ++ E L+HP++ V
Sbjct: 264 PKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 323

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A     +      +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDC-TLKILDFGLARTACTNFM----MTPYVVTRYYRAPEVILG---MGYAANV 206
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWS+GC++ E+  G     G
Sbjct: 207 DIWSVGCIMGELVKGCVIFQG 227

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 13/256 (5%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           ++   F +  G+G FGKV  +    T EL A+K ++         V+  +VE R+L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 61  QKN-LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +   L + +      + +   ME    G L   +Q       E     Y  ++   +  L
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFL 137
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEV 178
               I++RD+K  N+ L +EG+ +K+ DFG   + I    T       F GT  Y+APE+
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTT----KXFCGTPDYIAPEI 192
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
                   +G++VD W+ G +L EM +G+ P+   D +   +F+  M      P+S+S E
Sbjct: 193 IAYQ---PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHNVAYPKSMSKE 247
Query: 239 GQAFAELCLRHDPAQR 254
             A  +  +   P +R
Sbjct: 248 AVAICKGLMTKHPGKR 263

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +K+ DFG   + I    T       F GT  Y+APE+        +G++V
Sbjct: 151 NVMLDSEGH-IKIADFGMCKENIWDGVTT----KXFCGTPDYIAPEIIAYQ---PYGKSV 202
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D W+ G +L EM +G+    G
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEG 223

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 14/268 (5%)
Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG+VY  V  N  GE + +      K       +  + E  I++ ++  ++VK  G
Sbjct: 33  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 92
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           + I  E   + MEL   G L   ++  ++ L  + +  Y+ Q+  A++ L     VHRDI
Sbjct: 93  I-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 151
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              NI L A    +KLGDFG +  I         +        +M+PE     N      
Sbjct: 152 AVRNI-LVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPE---SINFRRFTT 205
Query: 190 AVDIWSLGCVLVE-MSSGKRP--WAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           A D+W     + E +S GK+P  W E   N  ++  +  G+    P+            C
Sbjct: 206 ASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLEKGDRLPKPDLCPPVLYTLMTRC 262
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDV 274
             +DP+ R    EL+     +   E+D+
Sbjct: 263 WDYDPSDRPRFTELVCSLSDVYQMEKDI 290

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 13  GRFGKVYTAVNNETGELVAMKEI--------QLHKQNDARFVKDMLVELRILEGINQKNL 64
           G +G V   V++E G  VA+K +         ++  +D+   K +L E+R+L   +  N+
Sbjct: 33  GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 65  VKYYGVEIHREEMVLF-MELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALH 120
           +    + +H EE  +  + L TE     L Q   D    +    ++ +   ++  +  LH
Sbjct: 92  LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH 151
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           E  +VHRD+   NI L A+ N + + DF     ++   T       +V  + Y APE+ M
Sbjct: 152 EAGVVHRDLHPGNILL-ADNNDITICDFN----LAREDTADANKTHYVTHRWYRAPELVM 206
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGK 207
                G  + VD+WS GCV+ EM + K
Sbjct: 207 QFK--GFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 36/77 (46%), Gaps = 6/77 (7%)
Query: 313 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWS 372
           L A+ N + + DF     ++   T       +V  + Y APE+ M     G  + VD+WS
Sbjct: 166 LLADNNDITICDFN----LAREDTADANKTHYVTHRWYRAPELVMQFK--GFTKLVDMWS 219
Query: 373 LGCVLVEMSSGKTNLSG 389
            GCV+ EM + K    G
Sbjct: 220 AGCVMAEMFNRKALFRG 236

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--------QLHKQNDARFVKDMLVELRILEGINQK 62
             G +G V   V++E G  VA+K +         ++  +D+   K +L E+R+L   +  
Sbjct: 31  SSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 63  NLVKYYGVEIHREEMVLF-MELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISA 118
           N++    + +H EE  +  + L TE     L Q   D    +    ++ +   ++  +  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           LHE  +VHRD+   NI L A+ N + + DF     ++   T       +V  + Y APE+
Sbjct: 150 LHEAGVVHRDLHPGNILL-ADNNDITICDFN----LAREDTADANKTHYVTHRWYRAPEL 204
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGK 207
            M     G  + VD+WS GCV+ EM + K
Sbjct: 205 VMQFK--GFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 36/77 (46%), Gaps = 6/77 (7%)
Query: 313 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWS 372
           L A+ N + + DF     ++   T       +V  + Y APE+ M     G  + VD+WS
Sbjct: 166 LLADNNDITICDFN----LAREDTADANKTHYVTHRWYRAPELVMQFK--GFTKLVDMWS 219
Query: 373 LGCVLVEMSSGKTNLSG 389
            GCV+ EM + K    G
Sbjct: 220 AGCVMAEMFNRKALFRG 236

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 240 KLVQLYAV-VSEEPIYIVGEYMSKGSLLDFLKG-ETGKYLRLPQLV--DMAAQIASGMAY 295
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N +   Q    P  
Sbjct: 296 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEYTARQGAKFPIK 346
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET----PT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 405
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 406 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 432

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 11  GQGRFGKVYTA-VNNET---GELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKN 63
           G+G FG VY   VNN T    +L AM +I   +L +Q D         E++++     +N
Sbjct: 34  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ--------EIKVMAKCQHEN 85
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEV---LVRRYTKQLVDAISALH 120
           LV+  G     +++ L       G+L   + S  DG P +   +  +  +   + I+ LH
Sbjct: 86  LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH 144
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           EN  +HRDIKSANI L  E  + K+ DFG A + S            VGT AYMAPE   
Sbjct: 145 ENHHIHRDIKSANILLD-EAFTAKISDFGLA-RASEKFAQXVMXXRIVGTTAYMAPEAL- 201
Query: 181 DTNKVGHGRAV---DIWSLGCVLVEMSSG 206
                  G      DI+S G VL+E+ +G
Sbjct: 202 ------RGEITPKSDIYSFGVVLLEIITG 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 14/268 (5%)
Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG+VY  V  N  GE + +      K       +  + E  I++ ++  ++VK  G
Sbjct: 21  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           + I  E   + MEL   G L   ++  ++ L  + +  Y+ Q+  A++ L     VHRDI
Sbjct: 81  I-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 139
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              NI L A    +KLGDFG +  I         +        +M+PE     N      
Sbjct: 140 AVRNI-LVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPE---SINFRRFTT 193
Query: 190 AVDIWSLGCVLVE-MSSGKRP--WAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           A D+W     + E +S GK+P  W E   N  ++  +  G+    P+            C
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLEKGDRLPKPDLCPPVLYTLMTRC 250
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDV 274
             +DP+ R    EL+     +   E+D+
Sbjct: 251 WDYDPSDRPRFTELVCSLSDVYQMEKDI 278

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 118/258 (45%), Gaps = 25/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL-HKQNDARFV---KDMLVELRILEGINQKNLVK 66
           G+G FG V+     +   +VA+K + L   + +   +   ++   E+ I+  +N  N+VK
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--I 124
            YG+  +   MV  ME    G L   +      +   +  R    +   I  +      I
Sbjct: 88  LYGLMHNPPRMV--MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 125 VHRDIKSANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           VHRD++S NIFL +   +     K+ DFG++ + S H+     ++G +G   +MAPE  +
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ-SVHS-----VSGLLGNFQWMAPET-I 198
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GETPTIPESLS 236
              +  +    D +S   +L  + +G+ P+ EY S  +I F + M    G  PTIPE   
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKIKF-INMIREEGLRPTIPEDCP 256
Query: 237 DEGQAFAELCLRHDPAQR 254
              +   ELC   DP +R
Sbjct: 257 PRLRNVIELCWSGDPKKR 274

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 13/256 (5%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           ++   F +  G+G FGKV  +    T EL A+K ++         V+  +VE R+L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 61  QKN-LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +   L + +      + +   ME    G L   +Q       E     Y  ++   +  L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFL 458
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEV 178
               I++RD+K  N+ L +EG+ +K+ DFG   + I    T       F GT  Y+APE+
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTT----KXFCGTPDYIAPEI 513
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
                   +G++VD W+ G +L EM +G+ P+   D +   +F+  M      P+S+S E
Sbjct: 514 IAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIMEHNVAYPKSMSKE 568
Query: 239 GQAFAELCLRHDPAQR 254
             A  +  +   P +R
Sbjct: 569 AVAICKGLMTKHPGKR 584

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 310 NIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +K+ DFG   + I    T       F GT  Y+APE+        +G++V
Sbjct: 472 NVMLDSEGH-IKIADFGMCKENIWDGVTT----KXFCGTPDYIAPEIIAYQP---YGKSV 523
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D W+ G +L EM +G+    G
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEG 544

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 48  DMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVL 104
           D  V+L + E     N+++Y+  E  R+   + +ELC   TL+  V+  +    GL  + 
Sbjct: 65  DREVQL-LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT 122
Query: 105 VRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKL----GDFGSAVKISAHTTV 160
           +    +Q    ++ LH   IVHRD+K  NI ++      K+     DFG   K++     
Sbjct: 123 L---LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQI 219
               +G  GT+ ++APE+  +  K      VDI+S GCV    +S G  P+ +     Q 
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-SLQRQA 238
Query: 220 MFKVGMGETPTI-PESLSDE-GQAFAELCLRHDPAQRATIFELLQHPFL 266
              +G      + PE   D   +   E  +  DP +R +   +L+HPF 
Sbjct: 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V+ A N       A+K I+L  +  AR  + ++ E++ L  +    +V+Y+  
Sbjct: 14  GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPGIVRYFNA 71
Query: 71  EIHREE------------MVLFMELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDA 115
            + +              + + M+LC +  L+  +    + E+    V +  +  Q+ +A
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QIAEA 130
Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH-------TTVP--GELNG 166
           +  LH   ++HRD+K +NIF T + + +K+GDFG    +          T +P      G
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
            VGT+ YM+PE  +  N   H   VDI+SLG +L E+
Sbjct: 190 QVGTKLYMSPEQ-IHGNSYSH--KVDIFSLGLILFEL 223

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 14/268 (5%)
Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG+VY  V  N  GE + +      K       +  + E  I++ ++  ++VK  G
Sbjct: 17  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 76
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           + I  E   + MEL   G L   ++  ++ L  + +  Y+ Q+  A++ L     VHRDI
Sbjct: 77  I-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 135
Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
              NI L A    +KLGDFG +  I         +        +M+PE     N      
Sbjct: 136 AVRNI-LVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPE---SINFRRFTT 189
Query: 190 AVDIWSLGCVLVE-MSSGKRP--WAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
           A D+W     + E +S GK+P  W E   N  ++  +  G+    P+            C
Sbjct: 190 ASDVWMFAVCMWEILSFGKQPFFWLE---NKDVIGVLEKGDRLPKPDLCPPVLYTLMTRC 246
Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDV 274
             +DP+ R    EL+     +   E+D+
Sbjct: 247 WDYDPSDRPRFTELVCSLSDVYQMEKDI 274

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           S+   V  GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  +
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 63
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG----LPEVLVRRYTKQLVDAISA 118
            LV+ Y V +  E + +  E  ++G+L   ++  E G    LP+++      Q+   ++ 
Sbjct: 64  KLVQLYAV-VSEEPIXIVTEYMSKGSLLDFLKG-ETGKYLRLPQLV--DMAAQIASGMAY 119
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           +     VHRD+++ANI L  E    K+ DFG A  I        E N     Q    P  
Sbjct: 120 VERMNYVHRDLRAANI-LVGENLVCKVADFGLARLI--------EDNEXTARQGAKFPIK 170
Query: 179 FMDTNKVGHGRAV---DIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGE----TPT 230
           +       +GR     D+WS G +L E+++ G+ P+     N +++ +V  G      P 
Sbjct: 171 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPE 229
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            PESL D        C R +P +R T FE LQ
Sbjct: 230 CPESLHD----LMCQCWRKEPEERPT-FEYLQ 256

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 111/259 (42%), Gaps = 18/259 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G FG+V++        LVA+K  +  L     A+F++    E RIL+  +  N+V+  
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ----EARILKQYSHPNIVRLI 178
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV   ++ + + MEL   G   + +++    L    + +        +  L     +HRD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 129 IKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           + + N  +T E N LK+ DFG S  +        G L        + APE     N   +
Sbjct: 239 LAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPEAL---NYGRY 292
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L E  S G  P+    SN Q    V  G     PE   D      E C
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 247 LRHDPAQR---ATIFELLQ 262
             ++P QR   +TI++ LQ
Sbjct: 352 WAYEPGQRPSFSTIYQELQ 370

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 126/256 (49%), Gaps = 30/256 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+ A  N+  + VA+K ++    +    V+  L E  +++ +    LVK + V
Sbjct: 191 GAGQFGEVWMATYNKHTK-VAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            + +E + +  E   +G+L   ++S E     LP+++   ++ Q+ + ++ + +   +HR
Sbjct: 246 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHR 302
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+++ANI ++A     K+ DFG A ++ A   +            + APE     N    
Sbjct: 303 DLRAANILVSA-SLVCKIADFGLA-RVGAKFPI-----------KWTAPEAI---NFGSF 346
Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L+E+ + G+ P+    SN +++  +  G     PE+  +E       C
Sbjct: 347 TIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRPENCPEELYNIMMRC 405
Query: 247 LRHDPAQRATIFELLQ 262
            ++ P +R T FE +Q
Sbjct: 406 WKNRPEERPT-FEYIQ 420

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY       +  E    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 26  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTK---QLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 144 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAP 201
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D        + D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 202 ESLKDGV---FTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 257
Query: 236 SDEGQAFAELCLRHDPAQRATIFELL 261
            +       +C + +P  R T  E++
Sbjct: 258 PERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 21  GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYAT 80
Query: 71  EIHREEM----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL---HENT 123
                       + ME     TL  +V +     P    +R  + + DA  AL   H+N 
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP----KRAIEVIADACQALNFSHQNG 136
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE      
Sbjct: 137 IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------ 189
Query: 184 KVGHGRAV----DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               G +V    D++SLGCVL E+ +G+ P+   DS   + ++  + E P IP S   EG
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQ-HVREDP-IPPSARHEG 245

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE          G +V
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ-------ARGDSV 196
Query: 369 D----IWSLGCVLVEMSSGKTNLSG 389
           D    ++SLGCVL E+ +G+   +G
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY       +  E    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 23  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTK---QLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 141 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAP 198
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D        + D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 199 ESLKDGV---FTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 254
Query: 236 SDEGQAFAELCLRHDPAQRATIFELL 261
            +       +C + +P  R T  E++
Sbjct: 255 PERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 111/259 (42%), Gaps = 18/259 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G FG+V++        LVA+K  +  L     A+F++    E RIL+  +  N+V+  
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ----EARILKQYSHPNIVRLI 178
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV   ++ + + MEL   G   + +++    L    + +        +  L     +HRD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 129 IKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           + + N  +T E N LK+ DFG S  +        G L        + APE     N   +
Sbjct: 239 LAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEAL---NYGRY 292
Query: 188 GRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
               D+WS G +L E  S G  P+    SN Q    V  G     PE   D      E C
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 247 LRHDPAQR---ATIFELLQ 262
             ++P QR   +TI++ LQ
Sbjct: 352 WAYEPGQRPSFSTIYQELQ 370

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/329 (23%), Positives = 133/329 (40%), Gaps = 92/329 (27%)
Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------ 63
           G+G FGKV   ++++ G   VA+K ++    N  R+ +    E+++LE +N  +      
Sbjct: 23  GEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 64  ---LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVL--VRRYTKQLVDAIS 117
              +++++    H   + +  EL    T + +    E+G LP  L  +R+   Q+  +++
Sbjct: 79  CVQMLEWFE---HHGHICIVFELLGLSTYDFI---KENGFLPFRLDHIRKMAYQICKSVN 132
Query: 118 ALHENTIVHRDIKSANIFL------------------TAEGNSLKLGDFGSAVKISAHTT 159
            LH N + H D+K  NI                    T     +K+ DFGSA     H +
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS 192
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI 219
                   V  + Y APEV +    +G  +  D+WS+GC+L+E   G   +  +DS   +
Sbjct: 193 T------LVXXRHYRAPEVIL---ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 220 -MFKVGMGETPTIP-----------------ESLSDEGQAFAELC--------------- 246
            M +  +G  P                    +  S  G+  +  C               
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 247 ---------LRHDPAQRATIFELLQHPFL 266
                    L +DPA+R T+ E L+HPF 
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/67 (34%), Positives = 34/67 (50%), Gaps = 9/67 (13%)
Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
            +K+ DFGSA     H +        V  + Y APEV +    +G  +  D+WS+GC+L+
Sbjct: 175 DIKVVDFGSATYDDEHHST------LVXXRHYRAPEVIL---ALGWSQPCDVWSIGCILI 225
Query: 379 EMSSGKT 385
           E   G T
Sbjct: 226 EYYLGFT 232

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY       +  E    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 26  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTK---QLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 144 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR-WMAP 201
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D        + D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 202 ESLKDGV---FTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 257
Query: 236 SDEGQAFAELCLRHDPAQRATIFELL 261
            +       +C + +P  R T  E++
Sbjct: 258 PERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 35  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 94  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 153
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           +K +NI + ++  +LK+ DFG A    ++   VP     FV T+ Y APEV +    +G+
Sbjct: 154 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVP-----FVVTRYYRAPEVILG---MGY 204
Query: 188 GRAVDIWSLGCVLVEMSSG 206
              VDIWS+GC++ EM  G
Sbjct: 205 KENVDIWSVGCIMGEMIKG 223

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 10/76 (13%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           +NI + ++  +LK+ DFG A    ++   VP     FV T+ Y APEV +    +G+   
Sbjct: 157 SNIVVKSDC-TLKILDFGLARTAGTSFMMVP-----FVVTRYYRAPEVILG---MGYKEN 207
Query: 368 VDIWSLGCVLVEMSSG 383
           VDIWS+GC++ EM  G
Sbjct: 208 VDIWSVGCIMGEMIKG 223

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY       +  E    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 26  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTK---QLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 144 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAP 201
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D        + D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 202 ESLKDG---VFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 257
Query: 236 SDEGQAFAELCLRHDPAQRATIFELL 261
            +       +C + +P  R T  E++
Sbjct: 258 PERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 71  EIHREEM----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL---HENT 123
                       + ME     TL  +V +     P    +R  + + DA  AL   H+N 
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP----KRAIEVIADACQALNFSHQNG 136
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE      
Sbjct: 137 IIHRDVKPANILISAT-NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE------ 189
Query: 184 KVGHGRAV----DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               G +V    D++SLGCVL E+ +G+ P+   DS   + ++  + E P IP S   EG
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQ-HVREDP-IPPSARHEG 245

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE          G +V
Sbjct: 145 ANILISAT-NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ-------ARGDSV 196
Query: 369 D----IWSLGCVLVEMSSGKTNLSG 389
           D    ++SLGCVL E+ +G+   +G
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 71  EIHREEM----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL---HENT 123
                       + ME     TL  +V +     P    +R  + + DA  AL   H+N 
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP----KRAIEVIADACQALNFSHQNG 136
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE      
Sbjct: 137 IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------ 189
Query: 184 KVGHGRAV----DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               G +V    D++SLGCVL E+ +G+ P+   DS   + ++  + E P IP S   EG
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQ-HVREDP-IPPSARHEG 245

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE          G +V
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ-------ARGDSV 196
Query: 369 D----IWSLGCVLVEMSSGKTNLSG 389
           D    ++SLGCVL E+ +G+   +G
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 38  GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 97
Query: 71  EIHREEM----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL---HENT 123
                       + ME     TL  +V +     P    +R  + + DA  AL   H+N 
Sbjct: 98  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP----KRAIEVIADACQALNFSHQNG 153
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE      
Sbjct: 154 IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------ 206
Query: 184 KVGHGRAV----DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               G +V    D++SLGCVL E+ +G+ P+   DS   + ++  + E P IP S   EG
Sbjct: 207 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQ-HVREDP-IPPSARHEG 262

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE          G +V
Sbjct: 162 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ-------ARGDSV 213
Query: 369 D----IWSLGCVLVEMSSGKTNLSG 389
           D    ++SLGCVL E+ +G+   +G
Sbjct: 214 DARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 117/258 (45%), Gaps = 25/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL-HKQNDARFV---KDMLVELRILEGINQKNLVK 66
           G+G FG V+     +   +VA+K + L   + +   +   ++   E+ I+  +N  N+VK
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--I 124
            YG+  +   MV  ME    G L   +      +   +  R    +   I  +      I
Sbjct: 88  LYGLMHNPPRMV--MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 125 VHRDIKSANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           VHRD++S NIFL +   +     K+ DFG + + S H+     ++G +G   +MAPE  +
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHS-----VSGLLGNFQWMAPET-I 198
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GETPTIPESLS 236
              +  +    D +S   +L  + +G+ P+ EY S  +I F + M    G  PTIPE   
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKIKF-INMIREEGLRPTIPEDCP 256
Query: 237 DEGQAFAELCLRHDPAQR 254
              +   ELC   DP +R
Sbjct: 257 PRLRNVIELCWSGDPKKR 274

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 5/107 (4%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG---NSLKLGDFGSAVKISA 156
           LP  +V+    Q++D I  LH N ++HRD+K ANI +  EG     +K+ D G A   ++
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
                 +L+  V T  Y APE+ +      + +A+DIW++GC+  E+
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAEL 229

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 309 ANIFLTAEG---NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           ANI +  EG     +K+ D G A   ++      +L+  V T  Y APE+ +      + 
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YT 214
Query: 366 RAVDIWSLGCVLVEM 380
           +A+DIW++GC+  E+
Sbjct: 215 KAIDIWAIGCIFAEL 229

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY       +  E    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 26  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTK---QLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 144 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WMAP 201
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D        + D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 202 ESLKDG---VFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 257
Query: 236 SDEGQAFAELCLRHDPAQRATIFELL 261
            +       +C + +P  R T  E++
Sbjct: 258 PERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 21  GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 71  EIHREEM----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL---HENT 123
                       + ME     TL  +V +     P    +R  + + DA  AL   H+N 
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP----KRAIEVIADACQALNFSHQNG 136
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE      
Sbjct: 137 IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------ 189
Query: 184 KVGHGRAV----DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               G +V    D++SLGCVL E+ +G+ P+   DS   + ++  + E P IP S   EG
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQ-HVREDP-IPPSARHEG 245

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE          G +V
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ-------ARGDSV 196
Query: 369 D----IWSLGCVLVEMSSGKTNLSG 389
           D    ++SLGCVL E+ +G+   +G
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 132/292 (45%), Gaps = 33/292 (11%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +++ F  + G G FGKV  A     G+      VA+K ++     D +  + ++ EL+I+
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIM 95
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQ-------STEDGLPEVL--VR 106
             + Q +N+V   G   H   +++  E C  G L + ++         EDG P  L  + 
Sbjct: 96  SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLL 155
Query: 107 RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG 166
            ++ Q+   ++ L     +HRD+ + N+ LT  G+  K+GDFG A  I   +    + N 
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEY--DSNYQIMFKV 223
            +  + +MAPE   D     +    D+WS G +L E+ S G  P+     +S +  + K 
Sbjct: 215 RLPVK-WMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 270
Query: 224 G--MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           G  M +    P+++    QA    C   +P  R T  ++    FL    +ED
Sbjct: 271 GYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS--FLQEQAQED 316

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  GKV    +  TG+  A+K   L+    AR  +++    +   G +   ++  Y  
Sbjct: 38  GLGVNGKVLECFHRRTGQKCALK--LLYDSPKAR--QEVDHHWQASGGPHIVCILDVYEN 93
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             H +  +L +  C EG  L S +Q   D    E       + +  AI  LH + I HRD
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++     LKL DFG A +     T    L     T  Y+APEV        
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKE-----TTQNALQTPCYTPYYVAPEVL---GPEK 205
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM-------FKVGMGETPTIPE--SLSD 237
           + ++ D+WSLG ++  +  G  P+  Y +  Q +        ++G    P  PE   +S+
Sbjct: 206 YDKSCDMWSLGVIMYILLCGFPPF--YSNTGQAISPGMKRRIRLGQYGFPN-PEWSEVSE 262
Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           + +    L L+ DP +R TI + + HP++
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 25/262 (9%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 17  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ------AYMAPEVFM 180
           RD+ + N+ L A  + +K+GDFG          +P   + +V  +      A+ APE  +
Sbjct: 135 RDLAARNLLL-ATRDLVKIGDFGLM------RALPQNDDHYVMQEHRKVPFAWCAPES-L 186
Query: 181 DTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDE 238
            T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE    +
Sbjct: 187 KTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQD 243
Query: 239 GQAFAELCLRHDPAQRATIFEL 260
                  C  H P  R T   L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVAL 265

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 25/262 (9%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 21  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ------AYMAPEVFM 180
           RD+ + N+ L A  + +K+GDFG          +P   + +V  +      A+ APE  +
Sbjct: 139 RDLAARNLLL-ATRDLVKIGDFGLM------RALPQNDDHYVMQEHRKVPFAWCAPES-L 190
Query: 181 DTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDE 238
            T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE    +
Sbjct: 191 KTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQD 247
Query: 239 GQAFAELCLRHDPAQRATIFEL 260
                  C  H P  R T   L
Sbjct: 248 IYNVMVQCWAHKPEDRPTFVAL 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 31/265 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 17  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 127 RDIKSANIFLTAEGNSLKLGDFG---------SAVKISAHTTVPGELNGFVGTQAYMAPE 177
           RD+ + N+ L A  + +K+GDFG             +  H  VP          A+ APE
Sbjct: 135 RDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---------AWCAPE 184
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESL 235
             + T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE  
Sbjct: 185 S-LKTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDC 240
Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
             +       C  H P  R T   L
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 31/265 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 27  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 127 RDIKSANIFLTAEGNSLKLGDFG---------SAVKISAHTTVPGELNGFVGTQAYMAPE 177
           RD+ + N+ L A  + +K+GDFG             +  H  VP          A+ APE
Sbjct: 145 RDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---------AWCAPE 194
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESL 235
             + T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE  
Sbjct: 195 S-LKTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDC 250
Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
             +       C  H P  R T   L
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 132/292 (45%), Gaps = 33/292 (11%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +++ F  + G G FGKV  A     G+      VA+K ++     D +  + ++ EL+I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIM 103
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQ-------STEDGLPEVL--VR 106
             + Q +N+V   G   H   +++  E C  G L + ++         EDG P  L  + 
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLL 163
Query: 107 RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG 166
            ++ Q+   ++ L     +HRD+ + N+ LT  G+  K+GDFG A  I   +    + N 
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEY--DSNYQIMFKV 223
            +  + +MAPE   D     +    D+WS G +L E+ S G  P+     +S +  + K 
Sbjct: 223 RLPVK-WMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 278
Query: 224 G--MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           G  M +    P+++    QA    C   +P  R T  ++    FL    +ED
Sbjct: 279 GYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS--FLQEQAQED 324

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 28/269 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  GKV    +  TG+  A+K   L+    AR  +++    +   G +   ++  Y  
Sbjct: 19  GLGVNGKVLECFHRRTGQKCALK--LLYDSPKAR--QEVDHHWQASGGPHIVCILDVYEN 74
Query: 71  EIHREEMVLFMELCTEG-TLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             H +  +L +  C EG  L S +Q   D    E       + +  AI  LH + I HRD
Sbjct: 75  MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 134
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++     LKL DFG A +     T    L     T  Y+APEV        
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAKE-----TTQNALQTPCYTPYYVAPEVL---GPEK 186
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM-------FKVGMGETPTIPE--SLSD 237
           + ++ D+WSLG ++  +  G  P+  Y +  Q +        ++G    P  PE   +S+
Sbjct: 187 YDKSCDMWSLGVIMYILLCGFPPF--YSNTGQAISPGMKRRIRLGQYGFPN-PEWSEVSE 243
Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           + +    L L+ DP +R TI + + HP++
Sbjct: 244 DAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 31/265 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 21  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 127 RDIKSANIFLTAEGNSLKLGDFG---------SAVKISAHTTVPGELNGFVGTQAYMAPE 177
           RD+ + N+ L A  + +K+GDFG             +  H  VP          A+ APE
Sbjct: 139 RDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---------AWCAPE 188
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESL 235
             + T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE  
Sbjct: 189 S-LKTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDC 244
Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
             +       C  H P  R T   L
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY       +  E    VA+K +  ++    R   + L E  +++G    ++V
Sbjct: 25  GQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTK---QLVDAI 116
           +  GV    +  ++ MEL   G L+S ++S         G P   ++   +   ++ D +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+    VHRD+ + N  + A   ++K+GDFG    I           G +  + +MAP
Sbjct: 143 AYLNAKKFVHRDLAARNC-MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WMAP 200
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           E   D        + D+WS G VL E++S  ++P+    SN Q++  V  G     P++ 
Sbjct: 201 ESLKDGV---FTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGGYLDQPDNC 256
Query: 236 SDEGQAFAELCLRHDPAQRATIFELL 261
            +       +C + +P  R T  E++
Sbjct: 257 PERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 26/240 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80
Query: 71  EIHREEM----VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL---HENT 123
                       + ME     TL  +V +     P    +R  + + DA  AL   H+N 
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP----KRAIEVIADACQALNFSHQNG 136
Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRD+K ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE      
Sbjct: 137 IIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------ 189
Query: 184 KVGHGRAV----DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
               G +V    D++SLGCVL E+ +G+ P+   DS   + ++  + E P IP S   EG
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPDSVAYQ-HVREDP-IPPSARHEG 245

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++A  N++K+ DFG A  I+       +    +GT  Y++PE          G +V
Sbjct: 145 ANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ-------ARGDSV 196
Query: 369 D----IWSLGCVLVEMSSGKTNLSG 389
           D    ++SLGCVL E+ +G+   +G
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A +  T + VA+K++    + D    K +L E+ IL  +    +++ Y +
Sbjct: 35  GRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 71  EIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            I  ++++ F EL       +  L+ L + T   L E  ++     L+   + +HE+ I+
Sbjct: 94  II-PDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGII 151
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-----------PG--------ELNG 166
           HRD+K AN  L  +  S+K+ DFG A  I++               PG        +L  
Sbjct: 152 HRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
            V T+ Y APE+ +   +  + +++DIWS GC+  E+
Sbjct: 211 HVVTRWYRAPELIL--LQENYTKSIDIWSTGCIFAEL 245

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 25/262 (9%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 17  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ------AYMAPEVFM 180
           RD+ + N+ L A  + +K+GDFG          +P   + +V  +      A+ APE  +
Sbjct: 135 RDLAARNLLL-ATRDLVKIGDFGLM------RALPQNDDHYVMQEHRKVPFAWCAPES-L 186
Query: 181 DTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDE 238
            T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE    +
Sbjct: 187 KTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQD 243
Query: 239 GQAFAELCLRHDPAQRATIFEL 260
                  C  H P  R T   L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVAL 265

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 31/265 (11%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG V    + A + +T   VA+K ++    +    + D + E+  +  ++ +NL++
Sbjct: 27  GDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +H
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 127 RDIKSANIFLTAEGNSLKLGDFG---------SAVKISAHTTVPGELNGFVGTQAYMAPE 177
           RD+ + N+ L A  + +K+GDFG             +  H  VP          A+ APE
Sbjct: 145 RDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---------AWCAPE 194
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESL 235
             + T    H  A D W  G  L EM + G+ PW   + + QI+ K+   GE    PE  
Sbjct: 195 S-LKTRTFSH--ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDC 250
Query: 236 SDEGQAFAELCLRHDPAQRATIFEL 260
             +       C  H P  R T   L
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 123/299 (41%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E VA+K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVLIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVLIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 34  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 152
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 153 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 204
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 205 ENVDIWSVGCIMGEMIKG 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 156 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 207
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 208 DIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 43/225 (19%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY-YG 69
           G+G +G VY A +    + VA+K++        R  +D++   RIL  I   N +K  Y 
Sbjct: 37  GRGSYGYVYLAYDKNANKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSDYI 89
Query: 70  VEIHR----EEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
           + +H     E+++ F EL       +  L+ L + T   L E  V+     L+     +H
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEQHVKTILYNLLLGEKFIH 148
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV--------------PG---- 162
           E+ I+HRD+K AN  L  +  S+K+ DFG A  I++   +              PG    
Sbjct: 149 ESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNK 207
Query: 163 ----ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
               +L   V T+ Y APE+ +      +  ++DIWS GC+  E+
Sbjct: 208 NLKKQLTSHVVTRWYRAPELILLQE--NYTNSIDIWSTGCIFAEL 250

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 109/253 (43%), Gaps = 9/253 (3%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G    VY A +      VA+K I +  +     +K    E+     ++ +N+V    V
Sbjct: 20  GGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
           +   +   L ME     TL   ++S    L       +T Q++D I   H+  IVHRDIK
Sbjct: 80  DEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIK 138
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI + +   +LK+ DFG A  +S   T   + N  +GT  Y +PE             
Sbjct: 139 PQNILIDS-NKTLKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSPE---QAKGEATDEC 192
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL-SDEGQAFAELCLRH 249
            DI+S+G VL EM  G+ P+   ++   I  K      P +   +  D  Q+ + + LR 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRA 251
Query: 250 DPAQRATIFELLQ 262
               +A  ++ +Q
Sbjct: 252 TEKDKANRYKTIQ 264

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 15/172 (8%)
Query: 106 RRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
           R +  Q+V AI   H   +VHRDIK  NI +       KL DFGS   +           
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-----YT 196
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM 225
            F GT+ Y  PE    +    H     +WSLG +L +M  G  P   ++ + +I+     
Sbjct: 197 DFDGTRVYSPPEWI--SRHQYHALPATVWSLGILLYDMVCGDIP---FERDQEIL----E 247
Query: 226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
            E    P  +S +  A    CL   P+ R ++ E+L  P++    E+   NP
Sbjct: 248 AEL-HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 116/258 (44%), Gaps = 25/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL-HKQNDARFV---KDMLVELRILEGINQKNLVK 66
           G+G FG V+     +   +VA+K + L   + +   +   ++   E+ I+  +N  N+VK
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--I 124
            YG+  +   MV  ME    G L   +      +   +  R    +   I  +      I
Sbjct: 88  LYGLMHNPPRMV--MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 125 VHRDIKSANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           VHRD++S NIFL +   +     K+ DF S  + S H+     ++G +G   +MAPE  +
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADF-SLSQQSVHS-----VSGLLGNFQWMAPET-I 198
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GETPTIPESLS 236
              +  +    D +S   +L  + +G+ P+ EY S  +I F + M    G  PTIPE   
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEY-SYGKIKF-INMIREEGLRPTIPEDCP 256
Query: 237 DEGQAFAELCLRHDPAQR 254
              +   ELC   DP +R
Sbjct: 257 PRLRNVIELCWSGDPKKR 274

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y   N+ TGE+VA+K ++       R       E+ IL  +  ++++K
Sbjct: 40  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEHIIK 97
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G   +     + L ME    G+L   +     GL ++L+  + +Q+ + ++ LH    
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHAQHY 155
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HRD+ + N+ L  +   +K+GDFG A  +   H       +G      Y APE   +  
Sbjct: 156 IHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYK 213
Query: 184 KVGHGRAVDIWSLGCVLVEM 203
                 A D+WS G  L E+
Sbjct: 214 FY---YASDVWSFGVTLYEL 230

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/75 (37%), Positives = 45/75 (60%), Gaps = 8/75 (10%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 155 SNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 206
Query: 369 DIWSLGCVLVEMSSG 383
           DIWS+GC++ EM  G
Sbjct: 207 DIWSVGCIMGEMIKG 221

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G+FG+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 127 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPES-L 182
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 183 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 241 ELMRA----CWQWNPSDRPSFAEIHQ 262

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        + +E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 127 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPES-L 182
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 183 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 241 ELMRA----CWQWNPSDRPSFAEIHQ 262

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 11  GQGRFGKVYTA-VNNET---GELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKN 63
           G+G FG VY   VNN T    +L AM +I   +L +Q D         E+++      +N
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQ--------EIKVXAKCQHEN 82
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR---RYTKQLVDAISALH 120
           LV+  G     +++ L       G+L   + S  DG P +      +  +   + I+ LH
Sbjct: 83  LVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           EN  +HRDIKSANI L  E  + K+ DFG A + S         +  VGT AY APE   
Sbjct: 142 ENHHIHRDIKSANILLD-EAFTAKISDFGLA-RASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 181 D--TNKVGHGRAVDIWSLGCVLVEMSSG 206
              T K       DI+S G VL+E+ +G
Sbjct: 200 GEITPK------SDIYSFGVVLLEIITG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A        +  E    V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPE----VVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+GC++ EM  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVF 179
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T T P    G      + APE  
Sbjct: 131 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAPA---GAKFPIKWTAPES- 185
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESL 235
           +  NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE +
Sbjct: 186 LAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 243
Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQ 262
            +  +A    C + +P+ R +  E+ Q
Sbjct: 244 YELMRA----CWQWNPSDRPSFAEIHQ 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 122/267 (45%), Gaps = 21/267 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 69
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 70  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVF 179
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T T P    G      + APE  
Sbjct: 130 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAPA---GAKFPIKWTAPES- 184
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESL 235
           +  NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE +
Sbjct: 185 LAYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 242
Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQ 262
            +  +A    C + +P+ R +  E+ Q
Sbjct: 243 YELMRA----CWQWNPSDRPSFAEIHQ 265

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 38  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 97  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 156
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 157 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 208
Query: 189 RAVDIWSLGCVLVEMSSGK 207
             VD+WS+GC++ EM   K
Sbjct: 209 ENVDLWSVGCIMGEMVCHK 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 160 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 211
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS+GC++ EM   K    G
Sbjct: 212 DLWSVGCIMGEMVCHKILFPG 232

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 100/226 (44%), Gaps = 44/226 (19%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL-----V 65
           G G FG+V    + +  +  A+K ++    N  ++ +   +E  IL+ I   ++     V
Sbjct: 44  GDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           KY+G  ++ + M L  E       E + ++  +G     ++ Y  +++ A++ L + ++ 
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLT 159
Query: 126 HRDIKSANIFL------------------------TAEGNSLKLGDFGSAVKISAHTTVP 161
           H D+K  NI L                          +   +KL DFG A       T  
Sbjct: 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-------TFK 212
Query: 162 GELNG-FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 206
            + +G  + T+ Y APEV ++   +G   + D+WS GCVL E+ +G
Sbjct: 213 SDYHGSIINTRQYRAPEVILN---LGWDVSSDMWSFGCVLAELYTG 255

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 37/70 (52%), Gaps = 11/70 (15%)
Query: 315 AEGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAVDIWSL 373
            +   +KL DFG A       T   + +G  + T+ Y APEV ++   +G   + D+WS 
Sbjct: 196 TKSTGIKLIDFGCA-------TFKSDYHGSIINTRQYRAPEVILN---LGWDVSSDMWSF 245
Query: 374 GCVLVEMSSG 383
           GCVL E+ +G
Sbjct: 246 GCVLAELYTG 255

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 116/284 (40%), Gaps = 52/284 (18%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+ A        +   LVA+K +   K       KD   E  +L  +  +++V
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQST-----------------EDGLPEVLVRRY 108
           K+YGV    + +++  E    G L   +++                  E GL ++L    
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML--HI 138
Query: 109 TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL-KLGDFGSA--------VKISAHTT 159
             Q+   +  L     VHRD+ + N  + A  N L K+GDFG +         ++  HT 
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQ 218
           +P           +M PE  M           D+WS G +L E+ + GK+PW +  SN +
Sbjct: 197 LPIR---------WMPPESIMYRKFTTES---DVWSFGVILWEIFTYGKQPWFQL-SNTE 243
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           ++  +  G     P     E       C + +P QR  I E+ +
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 27  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 86  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 145
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 146 LKPSNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 197
Query: 189 RAVDIWSLGCVLVEMSSGK 207
             VD+WS+GC++ EM   K
Sbjct: 198 ENVDLWSVGCIMGEMVCHK 216

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 46/81 (56%), Gaps = 8/81 (9%)
Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+   V
Sbjct: 149 SNIVVKSDC-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYKENV 200
Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS+GC++ EM   K    G
Sbjct: 201 DLWSVGCIMGEMVCHKILFPG 221

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 129/314 (41%), Gaps = 53/314 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFL--IVSCE 271
            L                    S E   F +  LR+D   R T  E ++HP+   +V  +
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQ 331
Query: 272 EDVCNPRSVPASVL 285
              C   +V +S L
Sbjct: 332 SQPCADNAVLSSGL 345

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        + +E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 129 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 184
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 185 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 243 ELMRA----CWQWNPSDRPSFAEIHQ 264

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 104/267 (38%), Gaps = 22/267 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V        G   A+K I  H+Q D    +      R+    N   LV Y   
Sbjct: 38  GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97
Query: 71  EI-HREEMVLFMELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHENTIVH 126
           E   + E  L +     GTL + ++  +D    L E  +      +   + A+H     H
Sbjct: 98  ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV--------GTQAYMAPEV 178
           RD+K  NI L  EG  + L D GS  +   H  V G               T +Y APE+
Sbjct: 158 RDLKPTNILLGDEGQPV-LMDLGSMNQACIH--VEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG--ETPTIPESLS 236
           F   +        D+WSLGCVL  M  G+ P   YD  +Q    V +      +IP+S  
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGP---YDMVFQKGDSVALAVQNQLSIPQSPR 271
Query: 237 DEGQAFAEL--CLRHDPAQRATIFELL 261
                +  L   +  DP QR  I  LL
Sbjct: 272 HSSALWQLLNSMMTVDPHQRPHIPLLL 298

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        + +E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 69  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 129 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 184
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 185 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 243 ELMRA----CWQWNPSDRPSFAEIHQ 264

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 120/260 (46%), Gaps = 16/260 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GRFG+VY       GE VA++ I + + N+ + +K    E+        +N+V + G 
Sbjct: 42  GKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQ-LKAFKREVMAYRQTRHENVVLFMGA 97
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +    + +   LC   TL S+V+  +  L     R+  +++V  +  LH   I+H+D+K
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 131 SANIFLTAEGNSLKLGDFG--SAVKISAHTTVPGELNGFVGTQAYMAPEVF------MDT 182
           S N+F   +   + + DFG  S   +        +L    G   ++APE+        + 
Sbjct: 158 SKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQA 241
           +K+   +  D+++LG +  E+ + + P+    +   I++++G G  P + +  +  E   
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-AIIWQMGTGMKPNLSQIGMGKEISD 274
Query: 242 FAELCLRHDPAQRATIFELL 261
               C   +  +R T  +L+
Sbjct: 275 ILLFCWAFEQEERPTFTKLM 294

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG++Y   N +T E VA+K   +  ++     +  +   RIL+G      V+++GV
Sbjct: 16  GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI--YRILQGGTGIPNVRWFGV 73
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
           E   +  VL M+L    +LE L       L    V     Q+++ +  +H  + +HRDIK
Sbjct: 74  E--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
Query: 131 SANIF--LTAEGNSLKLGDFGSAVK---ISAHTTVPGELN-GFVGTQAYMAPEVFMDTNK 184
             N    L    N + + DFG A K    S H  +P   N    GT  Y +    +    
Sbjct: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--- 187
Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPW 210
           +   R  D+ SLG VL+    G  PW
Sbjct: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 69
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        + +E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 70  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 130 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPES-L 185
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 186 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 243
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 244 ELMRA----CWQWNPSDRPSFAEIHQ 265

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 121/269 (44%), Gaps = 25/269 (9%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPE 177
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T          G +    + APE
Sbjct: 127 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDT-----FTAHAGAKFPIKWTAPE 180
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPE 233
             +  NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE
Sbjct: 181 S-LAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPE 237
Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            + +  +A    C + +P+ R +  E+ Q
Sbjct: 238 KVYELMRA----CWQWNPSDRPSFAEIHQ 262

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        + +E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 74  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 134 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 189
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 190 AYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 248 ELMRA----CWQWNPSDRPSFAEIHQ 269

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A        +  E    V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPE----VVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK 207
             VDIWS+GC++ EM   K
Sbjct: 204 ENVDIWSVGCIMGEMVCHK 222

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 114/268 (42%), Gaps = 23/268 (8%)
Query: 2   SSVTFSVSPGQGRFGKVYTA--VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI 59
           S +TF    G G+FG V+    +N +    VA+K I+    ++  F++    E  ++  +
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK---VAIKTIREGAMSEEDFIE----EAEVMMKL 59
Query: 60  NQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +   LV+ YGV + +  + L  E    G L   +++         +      + + ++ L
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAP 176
            E +++HRD+ + N  L  E   +K+ DFG          +  +     GT+    + +P
Sbjct: 120 EEASVIHRDLAARNC-LVGENQVIKVSDFG-----MTRFVLDDQYTSSTGTKFPVKWASP 173
Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESL 235
           EVF  +    +    D+WS G ++ E+ S GK P+ E  SN +++  +  G     P   
Sbjct: 174 EVFSFSR---YSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKPRLA 229
Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQH 263
           S         C +  P  R     LL+ 
Sbjct: 230 STHVYQIMNHCWKERPEDRPAFSRLLRQ 257

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 129 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 184
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 185 AYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 243 ELMRA----CWQWNPSDRPSFAEIHQ 264

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 134 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPES-L 189
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 190 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 248 ELMRA----CWQWNPSDRPSFAEIHQ 269

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 21/263 (7%)
Query: 4   VTFSVSPGQGRFGKVYTAVNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           +T     G G+FG V   +    G+  VA+K I+    ++  F +    E + +  ++  
Sbjct: 10  ITLLKELGSGQFGVV--KLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHP 63
Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            LVK+YGV      + +  E  + G L + ++S   GL    +      + + ++ L  +
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVF 179
             +HRD+ + N  L      +K+ DFG    +     V       VGT+    + APEVF
Sbjct: 124 QFIHRDLAARNC-LVDRDLCVKVSDFGMTRYVLDDQYVSS-----VGTKFPVKWSAPEVF 177
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
              +   +    D+W+ G ++ E+ S GK P+  Y +N +++ KV  G     P   SD 
Sbjct: 178 ---HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQGHRLYRPHLASDT 233
Query: 239 GQAFAELCLRHDPAQRATIFELL 261
                  C    P +R T  +LL
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLL 256

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 129 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 184
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 185 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 243 ELMRA----CWQWNPSDRPSFAEIHQ 264

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y   N+ TGE+VA+K ++       R       E+ IL  +  ++++K
Sbjct: 23  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEHIIK 80
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G   +   + + L ME    G+L   +     GL ++L+  + +Q+ + ++ LH    
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHSQHY 138
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HR++ + N+ L  +   +K+GDFG A  +   H       +G      Y APE   +  
Sbjct: 139 IHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYK 196
Query: 184 KVGHGRAVDIWSLGCVLVEM 203
                 A D+WS G  L E+
Sbjct: 197 FY---YASDVWSFGVTLYEL 213

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 134 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 189
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 190 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 248 ELMRA----CWQWNPSDRPSFAEIHQ 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 72
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 133 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 188
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 189 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 247 ELMRA----CWQWNPSDRPSFAEIHQ 268

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 26/259 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E +I++ +    LV+ Y V
Sbjct: 18  GNGQFGEVWMGTWNGNTK-VAIKTLKPGTMSPESF----LEEAQIMKKLKHDKLVQLYAV 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENTIVHR 127
            +  E + +  E   +G+L   ++  E     LP ++      Q+   ++ +     +HR
Sbjct: 73  -VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIERMNYIHR 129
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D++SANI L   G   K+ DFG A  I  +     +   F     + APE  +      +
Sbjct: 130 DLRSANI-LVGNGLICKIADFGLARLIEDNEXTARQGAKF--PIKWTAPEAAL------Y 180
Query: 188 GRAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
           GR     D+WS G +L E+ + G+ P+   + N +++ +V  G     P+          
Sbjct: 181 GRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERGYRMPCPQDCPISLHELM 239
Query: 244 ELCLRHDPAQRATIFELLQ 262
             C + DP +R T FE LQ
Sbjct: 240 IHCWKKDPEERPT-FEYLQ 257

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 51  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 108
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 109 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 163
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 164 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 216
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 217 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 276
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 277 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 335

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 129 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 184
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 185 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 243 ELMRA----CWQWNPSDRPSFAEIHQ 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 129 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 184
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 185 AYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 243 ELMRA----CWQWNPSDRPSFAEIHQ 264

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y   N+ TGE+VA+K ++       R       E+ IL  +  ++++K
Sbjct: 23  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEHIIK 80
Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G   +   + + L ME    G+L   +     GL ++L+  + +Q+ + ++ LH    
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--FAQQICEGMAYLHAQHY 138
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HR++ + N+ L  +   +K+GDFG A  +   H       +G      Y APE   +  
Sbjct: 139 IHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYK 196
Query: 184 KVGHGRAVDIWSLGCVLVEM 203
                 A D+WS G  L E+
Sbjct: 197 FY---YASDVWSFGVTLYEL 213

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 45  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 103 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 210
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 212
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 134 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 189
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 190 AYNKFSIKS--DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 248 ELMRA----CWQWNPSDRPSFAEIHQ 269

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 51/293 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            L                    S E   F +  LR+D   R T  E ++HP+ 
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 131 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 186
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 187 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 245 ELMRA----CWQWNPSDRPSFAEIHQ 266

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 45  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 102
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 103 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 210
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 212
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 71  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 131 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 186
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 187 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 244
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 245 ELMRA----CWQWNPSDRPSFAEIHQ 266

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 81
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 82  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 141
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 142 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 198 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 255
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 256 ELMRA----CWQWNPSDRPSFAEIHQ 277

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 44  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 101
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 102 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 156
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 157 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 209
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 211
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 212 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 132/305 (43%), Gaps = 46/305 (15%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +++ F  + G G FGKV  A     G+      VA+K ++     D +  + ++ EL+I+
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIM 88
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQ--------------------S 95
             + Q +N+V   G   H   +++  E C  G L + ++                     
Sbjct: 89  SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLD 148
Query: 96  TEDGLPEVL--VRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK 153
            EDG P  L  +  ++ Q+   ++ L     +HRD+ + N+ LT  G+  K+GDFG A  
Sbjct: 149 KEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARD 207
Query: 154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAE 212
           I   +    + N  +  + +MAPE   D     +    D+WS G +L E+ S G  P+  
Sbjct: 208 IMNDSNYIVKGNARLPVK-WMAPESIFDCV---YTVQSDVWSYGILLWEIFSLGLNPYPG 263
Query: 213 Y--DSNYQIMFKVG--MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
              +S +  + K G  M +    P+++    QA    C   +P  R T  ++    FL  
Sbjct: 264 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS--FLQE 317
Query: 269 SCEED 273
             +ED
Sbjct: 318 QAQED 322

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 74  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 134 KKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 189
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 190 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 247
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 248 ELMRA----CWQWNPSDRPSFAEIHQ 269

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A        +  E    V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPE----VVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSGK 207
             VD+WS+GC++ EM   K
Sbjct: 204 ENVDLWSVGCIMGEMVCHK 222

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 51/299 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L      
Sbjct: 46  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNIITLADIVKD 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + R   ++F E       + L Q+    L +  +R Y  +++ A+   H   I+HRD+K
Sbjct: 104 PVSRTPALVF-EHVNNTDFKQLRQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVK 158
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  
Sbjct: 159 PHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY-- 211
Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPE 233
           ++D+WSLGC+L  M   K P+     NY  + ++                 +   P   +
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 234 SL--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
            L                    S E   F +  LR+D   R T  E ++HP+     ++
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 330

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLVDYQMYDY--SL 213
Query: 369 DIWSLGCVLVEM-------SSGKTNLSGVVVSAEVFGS 399
           D+WSLGC+L  M         G  N   +V  A+V G+
Sbjct: 214 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 251

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 22  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 135 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 188
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 248 KERPEDRPT-FDYLR 261

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 44/293 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V  A +     +VA+K+I L    D    K +L E+ IL  +N  ++VK   +
Sbjct: 62  GTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 71  EIHRE-----EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            I ++     E+ + +E+  +   + L + T   L E+ ++     L+  +  +H   I+
Sbjct: 121 VIPKDVEKFDELYVVLEI-ADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGIL 178
Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKIS-----------------------AHT-TVP 161
           HRD+K AN  L  +  S+K+ DFG A  +                         HT  + 
Sbjct: 179 HRDLKPANC-LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF 221
            +L G V T+ Y APE+ +   +  +  A+D+WS+GC+  E+ +  +    Y ++   +F
Sbjct: 238 RQLTGHVVTRWYRAPELIL--LQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295
Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
             G    P  P+  +  G  F +   R +  Q   IF +L  P      EED+
Sbjct: 296 P-GSSCFPLSPDQKA--GNDF-KFHTRGNRDQLNVIFNILGTP-----SEEDI 339

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 22  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E N +   +    P  +     + +G
Sbjct: 135 LRAANI-LVSDTLSCKIADFGLARLI--------EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 189 RAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                 D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMR 244
Query: 245 LCLRHDPAQRATIFELLQ 262
           LC +  P  R T F+ L+
Sbjct: 245 LCWKERPEDRPT-FDYLR 261

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 176
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 177 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 234
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 235 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 294
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 295 LDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 176
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 177 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 234
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 235 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 294
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 295 LDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 24  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 78
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 79  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 137 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 190
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 249
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 250 KERPEDRPT-FDYLR 263

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 124 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 178
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 179 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 236
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 237 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 296
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 297 LDKLLRYDHQERLTALEAMTHPYF 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 177
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 178 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 235
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 236 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 295
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 296 LDKLLRYDHQERLTALEAMTHPYF 319

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 176
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 177 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 234
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 235 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 294
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 295 LDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 143 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 197
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 198 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 255
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 256 QLVKIAKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 315
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 316 LDKLLRYDHQERLTALEAMTHPYF 339

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 176
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 177 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 234
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 235 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 294
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 295 LDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 123 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 177
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 178 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 235
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 236 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 295
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 296 LDKLLRYDHQERLTALEAMTHPYF 319

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 17  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 71
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 72  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E N +   +    P  +     + +G
Sbjct: 130 LRAANI-LVSDTLSCKIADFGLARLI--------EDNEYTAREGAKFPIKWTAPEAINYG 180
Query: 189 RAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                 D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      
Sbjct: 181 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMR 239
Query: 245 LCLRHDPAQRATIFELLQ 262
           LC +  P  R T F+ L+
Sbjct: 240 LCWKERPEDRPT-FDYLR 256

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 176
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 177 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 234
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 235 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 294
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 295 LDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 23  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 77
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 78  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 136 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 189
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 248
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 249 KERPEDRPT-FDYLR 262

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+G ++ EM  G
Sbjct: 204 ENVDIWSVGVIMGEMIKG 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 31  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 85
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 86  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 144 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 197
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 256
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 257 KERPEDRPT-FDYLR 270

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 28  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 82
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 83  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E N +   +    P  +     + +G
Sbjct: 141 LRAANI-LVSDTLSCKIADFGLARLI--------EDNEYTAREGAKFPIKWTAPEAINYG 191
Query: 189 RAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                 D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMR 250
Query: 245 LCLRHDPAQRATIFELLQ 262
           LC +  P  R T F+ L+
Sbjct: 251 LCWKERPEDRPT-FDYLR 267

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 32  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 86
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 87  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E N +   +    P  +     + +G
Sbjct: 145 LRAANI-LVSDTLSCKIADFGLARLI--------EDNEYTAREGAKFPIKWTAPEAINYG 195
Query: 189 RAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                 D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMR 254
Query: 245 LCLRHDPAQRATIFELLQ 262
           LC +  P  R T F+ L+
Sbjct: 255 LCWKERPEDRPT-FDYLR 271

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 121/298 (40%), Gaps = 49/298 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L+     
Sbjct: 47  GRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR--GGTNIIKLIDTVKD 104
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + +   ++F E       + L Q     L +  +R Y  +L+ A+   H   I+HRD+K
Sbjct: 105 PVSKTPALVF-EYINNTDFKQLYQI----LTDFDIRFYMYELLKALDYCHSKGIMHRDVK 159
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +   L+L D+G    ++       E N  V ++ +  PE+ +D     +  +
Sbjct: 160 PHNVMIDHQQKKLRLIDWG----LAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY--S 213
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPES 234
           +D+WSLGC+L  M   + P+     NY  + ++                 +   P   + 
Sbjct: 214 LDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDI 273
Query: 235 L--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
           L                    S E     +  LR+D  QR T  E ++HP+     +E
Sbjct: 274 LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKE 331

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 44/204 (21%)
Query: 100 LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT 159
           L +  +R Y  +L+ A+   H   I+HRD+K  N+ +  E   L+L D+G      A   
Sbjct: 122 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-----LAEFY 176
Query: 160 VPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
            PG E N  V ++ +  PE+ +D     +  ++D+WSLGC+   M   K P+     N+ 
Sbjct: 177 HPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGMIFRKEPFFYGHDNHD 234
Query: 219 IMFKVG--------------------------MGETPTIP----------ESLSDEGQAF 242
            + K+                           +G     P            +S E   F
Sbjct: 235 QLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDF 294
Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  LR+D  +R T  E + HP+ 
Sbjct: 295 LDKLLRYDHQERLTALEAMTHPYF 318

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 27  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 81
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 82  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E N +   +    P  +     + +G
Sbjct: 140 LRAANI-LVSDTLSCKIADFGLARLI--------EDNEYTAREGAKFPIKWTAPEAINYG 190
Query: 189 RAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                 D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      
Sbjct: 191 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMR 249
Query: 245 LCLRHDPAQRATIFELLQ 262
           LC +  P  R T F+ L+
Sbjct: 250 LCWKERPEDRPT-FDYLR 266

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G + KV  AV+ + G+  A+K I+     + +R  +++    +     N   L++++ 
Sbjct: 22  GEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFE 81
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +       L  E    G++ + +Q  +    E    R  + +  A+  LH   I HRD+
Sbjct: 82  DDTR---FYLVFEKLQGGSILAHIQK-QKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 130 KSANIFLTA--EGNSLKLGDF--GSAVKISAHTT--VPGELNGFVGTQAYMAP---EVFM 180
           K  NI   +  + + +K+ DF  GS +K++   T     EL    G+  YMAP   EVF 
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY---DSNY----------QIMFKVGMGE 227
           D     + +  D+WSLG VL  M SG  P+  +   D  +            +F+     
Sbjct: 198 DQATF-YDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 256
Query: 228 TPTIPES----LSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
               P+     +S E +      L  D  QR +  ++LQHP++
Sbjct: 257 KYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 30  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 84
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 85  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 143 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 196
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 255
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 256 KERPEDRPT-FDYLR 269

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 22  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 135 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 188
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 248 KERPEDRPT-FDYLR 261

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y   N+ TGE+VA+K ++  +    +       E+ IL  +  +++VK
Sbjct: 18  GEGHFGKVSLYCYDPTNDGTGEMVAVKALK--EGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 67  YYGV-EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G  E   E+ V L ME    G+L   +     GL ++L+  + +Q+ + ++ LH    
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHAQHY 133
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HR + + N+ L  +   +K+GDFG A  +   H       +G      Y APE   +  
Sbjct: 134 IHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECK 191
Query: 184 KVGHGRAVDIWSLGCVLVEM 203
                 A D+WS G  L E+
Sbjct: 192 FY---YASDVWSFGVTLYEL 208

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 121/298 (40%), Gaps = 49/298 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G++ +V+ A+N    E V +K ++  K+   +    +L  LR   G N   L+     
Sbjct: 52  GRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR--GGTNIIKLIDTVKD 109
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + +   ++F E       + L Q     L +  +R Y  +L+ A+   H   I+HRD+K
Sbjct: 110 PVSKTPALVF-EYINNTDFKQLYQI----LTDFDIRFYMYELLKALDYCHSKGIMHRDVK 164
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +   L+L D+G    ++       E N  V ++ +  PE+ +D     +  +
Sbjct: 165 PHNVMIDHQQKKLRLIDWG----LAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY--S 218
Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------MGETPTIPES 234
           +D+WSLGC+L  M   + P+     NY  + ++                 +   P   + 
Sbjct: 219 LDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDI 278
Query: 235 L--------------------SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
           L                    S E     +  LR+D  QR T  E ++HP+     +E
Sbjct: 279 LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKE 336

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 71  EIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
              ++ +  F +  +  E    +L Q  +  L    +     Q++  I  LH   I+HRD
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRD 151
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI + ++  +LK+ DFG A   +A T+    +  +V T+ Y APEV +    +G+ 
Sbjct: 152 LKPSNIVVKSDA-TLKILDFGLAR--TAGTSF--MMTPYVVTRYYRAPEVILG---MGYK 203
Query: 189 RAVDIWSLGCVLVEMSSG 206
             VDIWS+G ++ EM  G
Sbjct: 204 ENVDIWSVGVIMGEMIKG 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 51  VELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQ---STEDGLPEVLVRR 107
           V++R ++  + KN V        +  + + M+LC +  L+  +    S ED    V +  
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH-------TTV 160
           +  Q+ +A+  LH   ++HRD+K +NIF T + + +K+GDFG    +          T +
Sbjct: 170 FI-QIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 161 PGELN--GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 203
           P      G VGT+ YM+PE     N   +   VDI+SLG +L E+
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGNN---YSHKVDIFSLGLILFEL 269

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 50/273 (18%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R  +  +   +V  Y  
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           +   R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 129 IKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+  T++  +  LKL DFG A                             +T    
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFA----------------------------KETTGEK 174
Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--------QIMFKVGMGETPTIPE--SLS 236
           + ++ D+WSLG ++  +  G  P   + SN+        +   ++G  E P  PE   +S
Sbjct: 175 YDKSCDMWSLGVIMYILLCGYPP---FYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEVS 230
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
           +E +      L+ +P QR TI E + HP+++ S
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 11  GQGRFGKV----YTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV    Y   N+ TGE+VA+K ++  +    +       E+ IL  +  +++VK
Sbjct: 17  GEGHFGKVSLYCYDPTNDGTGEMVAVKALK--EGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 67  YYGV-EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G  E   E+ V L ME    G+L   +     GL ++L+  + +Q+ + ++ LH    
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--FAQQICEGMAYLHAQHY 132
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HR + + N+ L  +   +K+GDFG A  +   H       +G      Y APE   +  
Sbjct: 133 IHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECK 190
Query: 184 KVGHGRAVDIWSLGCVLVEM 203
                 A D+WS G  L E+
Sbjct: 191 FY---YASDVWSFGVTLYEL 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 28  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 82
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 83  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I  +     E   F     + APE     N     
Sbjct: 141 LRAANI-LVSDTLSCKIADFGLARLIEDNEXTAREGAKF--PIKWTAPEAI---NYGTFT 194
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 253
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 254 KERPEDRPT-FDYLR 267

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 131/298 (43%), Gaps = 39/298 (13%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +++ F  + G G FGKV  A     G+      VA+K ++     D +  + ++ EL+I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIM 103
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQ---------------STEDGL 100
             + Q +N+V   G   H   +++  E C  G L + ++               + E+ L
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQL 163
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
               +  ++ Q+   ++ L     +HRD+ + N+ LT  G+  K+GDFG A  I   +  
Sbjct: 164 SSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 222
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEY--DSNY 217
             + N  +  + +MAPE   D     +    D+WS G +L E+ S G  P+     +S +
Sbjct: 223 IVKGNARLPVK-WMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 278
Query: 218 QIMFKVG--MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
             + K G  M +    P+++    QA    C   +P  R T  ++    FL    +ED
Sbjct: 279 YKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS--FLQEQAQED 330

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-G 69
            +G F  VY A +  +G   A+K +  +++   R +   +  ++ L G    N+V++   
Sbjct: 37  AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG--HPNIVQFCSA 94
Query: 70  VEIHREE-------MVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHE 121
             I +EE        +L  ELC    +E L +    G L    V +   Q   A+  +H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 122 NT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT--TVPGELNGFV-------GT 170
               I+HRD+K  N+ L+ +G ++KL DFGSA  IS +   +   +    V        T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 171 QAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAE 212
             Y  PE+    +    G   DIW+LGC+L  +   + P+ +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 29/241 (12%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            +GRFG V+ A      + VA+K   L  +   +  +++        G+  +NL+++   
Sbjct: 24  ARGRFGCVWKA--QLMNDFVAVKIFPLQDKQSWQSEREIFS----TPGMKHENLLQFIAA 77
Query: 71  EIHRE----EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN---- 122
           E        E+ L      +G+L   ++       E+      + +   +S LHE+    
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELC--HVAETMSRGLSYLHEDVPWC 135
Query: 123 -------TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMA 175
                  +I HRD KS N+ L ++  ++ L DFG AV+       PG+ +G VGT+ YMA
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKP-PGDTHGQVGTRRYMA 193
Query: 176 PEVF---MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
           PEV    ++  +    R +D++++G VL E+ S  +        Y + F+  +G+ P++ 
Sbjct: 194 PEVLEGAINFQRDAFLR-IDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLE 252
Query: 233 E 233
           E
Sbjct: 253 E 253

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 275
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HR++ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 336 KKNFIHRNLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 391
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 392 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 450 ELMRA----CWQWNPSDRPSFAEIHQ 471

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 37/279 (13%)
Query: 11  GQGRFGKVYTA----VNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV  A    +    G   VA+K   L +      ++D+L E  +L+ +N  +++
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR------------------ 107
           K YG       ++L +E    G+L   ++ +    P  L                     
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 108 -----YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
                +  Q+   +  L E ++VHRD+ + NI L AEG  +K+ DFG +  +    +   
Sbjct: 150 GDLISFAWQISQGMQYLAEMSLVHRDLAARNI-LVAEGRKMKISDFGLSRDVYEEDSXVK 208
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF 221
              G +  + +MA E   D          D+WS G +L E+ + G  P+       ++  
Sbjct: 209 RSQGRIPVK-WMAIESLFDHIYTTQS---DVWSFGVLLWEIVTLGGNPYPGIPPE-RLFN 263
Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
            +  G     P++ S+E       C + +P +R    ++
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 120/266 (45%), Gaps = 19/266 (7%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 259 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 314
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E  T G  L+ L +     +  V++     Q+  A+  L 
Sbjct: 315 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           +   +HR++ + N  L  E + +K+ DFG +  ++  T        F     + APE  +
Sbjct: 375 KKNFIHRNLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPES-L 430
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN--YQIMFKVGMGETPT-IPESLS 236
             NK       D+W+ G +L E+++ G  P+   D +  Y+++ K    E P   PE + 
Sbjct: 431 AYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 488
Query: 237 DEGQAFAELCLRHDPAQRATIFELLQ 262
           +  +A    C + +P+ R +  E+ Q
Sbjct: 489 ELMRA----CWQWNPSDRPSFAEIHQ 510

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 34/277 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 38  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 92
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL----PEVLVR---------R 107
            N+V   G        +++ +E C  G L + ++S  +      PE L +          
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G
Sbjct: 212 LPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P+  + E       C   +P+QR T  EL++H
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 119/258 (46%), Gaps = 24/258 (9%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 18  GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 72
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HR+
Sbjct: 73  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E N +   +    P  +     + +G
Sbjct: 131 LRAANI-LVSDTLSCKIADFGLARLI--------EDNEYTAREGAKFPIKWTAPEAINYG 181
Query: 189 RAV---DIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                 D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMR 240
Query: 245 LCLRHDPAQRATIFELLQ 262
           LC +  P  R T F+ L+
Sbjct: 241 LCWKERPEDRPT-FDYLR 257

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 37/279 (13%)
Query: 11  GQGRFGKVYTA----VNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV  A    +    G   VA+K   L +      ++D+L E  +L+ +N  +++
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR------------------ 107
           K YG       ++L +E    G+L   ++ +    P  L                     
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 108 -----YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
                +  Q+   +  L E  +VHRD+ + NI L AEG  +K+ DFG +  +    +   
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNI-LVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF 221
              G +  + +MA E   D          D+WS G +L E+ + G  P+       ++  
Sbjct: 209 RSQGRIPVK-WMAIESLFDHIYTTQS---DVWSFGVLLWEIVTLGGNPYPGIPPE-RLFN 263
Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
            +  G     P++ S+E       C + +P +R    ++
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 37/279 (13%)
Query: 11  GQGRFGKVYTA----VNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV  A    +    G   VA+K   L +      ++D+L E  +L+ +N  +++
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRR------------------ 107
           K YG       ++L +E    G+L   ++ +    P  L                     
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 108 -----YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
                +  Q+   +  L E  +VHRD+ + NI L AEG  +K+ DFG +  +    +   
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNI-LVAEGRKMKISDFGLSRDVYEEDSXVK 208
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF 221
              G +  + +MA E   D          D+WS G +L E+ + G  P+       ++  
Sbjct: 209 RSQGRIPVK-WMAIESLFDHIYTTQS---DVWSFGVLLWEIVTLGGNPYPGIPPE-RLFN 263
Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFEL 260
            +  G     P++ S+E       C + +P +R    ++
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 37/296 (12%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +++ F  + G G FGKV  A     G+      VA+K ++     D +  + ++ EL+I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIM 103
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTL------ESLVQSTEDGLP---EVLVR 106
             + Q +N+V   G   H   +++  E C  G L      +S V  T+         L  
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLST 163
Query: 107 R----YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
           R    ++ Q+   ++ L     +HRD+ + N+ LT  G+  K+GDFG A  I   +    
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIV 222
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEY--DSNYQI 219
           + N  +  + +MAPE   D     +    D+WS G +L E+ S G  P+     +S +  
Sbjct: 223 KGNARLPVK-WMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 220 MFKVG--MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           + K G  M +    P+++    QA    C   +P  R T  ++    FL    +ED
Sbjct: 279 LVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS--FLQEQAQED 328

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 48/285 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQ-KN 63
           G G FG V+  V    G + A+K  +      + +QN  R V    V       + Q  +
Sbjct: 18  GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV-------LGQHSH 70
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALH 120
           +V+Y+      + M++  E C  G+L   +           E  ++    Q+   +  +H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 121 ENTIVHRDIKSANIFLTA---------EGNS---------LKLGDFGSAVKISAHTTVPG 162
             ++VH DIK +NIF++          EG+           K+GD G   +IS+     G
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEG 190
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK 222
           +         ++A EV  +     H    DI++L   +V  ++G  P       +    +
Sbjct: 191 D-------SRFLANEVLQEN--YTHLPKADIFALALTVV-CAAGAEPLPRNGDQWH---E 237
Query: 223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
           +  G  P IP+ LS E     ++ +  DP +R +   L++H  L+
Sbjct: 238 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 37/296 (12%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRIL 56
           +++ F  + G G FGKV  A     G+      VA+K ++     D +  + ++ EL+I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EALMSELKIM 103
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL---PEVLVR------ 106
             + Q +N+V   G   H   +++  E C  G L + ++     L   P   +       
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 107 ----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
                ++ Q+   ++ L     +HRD+ + N+ LT  G+  K+GDFG A  I   +    
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIV 222
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEY--DSNYQI 219
           + N  +  + +MAPE   D     +    D+WS G +L E+ S G  P+     +S +  
Sbjct: 223 KGNARLPVK-WMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 220 MFKVG--MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEED 273
           + K G  M +    P+++    QA    C   +P  R T  ++    FL    +ED
Sbjct: 279 LVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICS--FLQEQAQED 328

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 46/284 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG V+  V    G + A+K  +      + +QN  R V    V  +        ++
Sbjct: 20  GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ------HSHV 73
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHE 121
           V+Y+      + M++  E C  G+L   +           E  ++    Q+   +  +H 
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 122 NTIVHRDIKSANIFLTA---------EGNS---------LKLGDFGSAVKISAHTTVPGE 163
            ++VH DIK +NIF++          EG+           K+GD G   +IS+     G+
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGD 193
Query: 164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV 223
                    ++A EV  +     H    DI++L   +V  ++G  P       +    ++
Sbjct: 194 -------SRFLANEVLQEN--YTHLPKADIFALALTVV-CAAGAEPLPRNGDQWH---EI 240
Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
             G  P IP+ LS E     ++ +  DP +R +   L++H  L+
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 81
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++ +E C  G L + ++S  +        PE L +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 201 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 35/278 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 37  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 91
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL-----PEVLVRR-------- 107
            N+V   G        +++ +E C  G L + ++S  +       PE L +         
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 108 -YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG 166
            Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + + 
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGM 225
            +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  
Sbjct: 211 RLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           G     P+  + E       C   +P+QR T  EL++H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 46/284 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQKNL 64
           G G FG V+  V    G + A+K  +      + +QN  R V    V  +        ++
Sbjct: 16  GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ------HSHV 69
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHE 121
           V+Y+      + M++  E C  G+L   +           E  ++    Q+   +  +H 
Sbjct: 70  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 129
Query: 122 NTIVHRDIKSANIFLT---------AEGNS---------LKLGDFGSAVKISAHTTVPGE 163
            ++VH DIK +NIF++          EG+           K+GD G   +IS+     G+
Sbjct: 130 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGD 189
Query: 164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV 223
                    ++A EV  +     H    DI++L   +V  ++G  P       +    ++
Sbjct: 190 -------SRFLANEVLQEN--YTHLPKADIFALALTVV-XAAGAEPLPRNGDQWH---EI 236
Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
             G  P IP+ LS E     ++ +  DP +R +   L++H  L+
Sbjct: 237 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 48/285 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ------LHKQNDARFVKDMLVELRILEGINQ-KN 63
           G G FG V+  V    G + A+K  +      + +QN  R V    V       + Q  +
Sbjct: 18  GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV-------LGQHSH 70
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALH 120
           +V+Y+      + M++  E C  G+L   +           E  ++    Q+   +  +H
Sbjct: 71  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 121 ENTIVHRDIKSANIFLT---------AEGNS---------LKLGDFGSAVKISAHTTVPG 162
             ++VH DIK +NIF++          EG+           K+GD G   +IS+     G
Sbjct: 131 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEG 190
Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK 222
           +         ++A EV  +     H    DI++L   +V  ++G  P       +    +
Sbjct: 191 D-------SRFLANEVLQEN--YTHLPKADIFALALTVV-CAAGAEPLPRNGDQWH---E 237
Query: 223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
           +  G  P IP+ LS E     ++ +  DP +R +   L++H  L+
Sbjct: 238 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 90
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++ +E C  G L + ++S  +        PE L +        
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 210 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 28/240 (11%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            +GRFG V+ A      E VA+K   +  Q+   +  +   E+  L G+  +N++++ G 
Sbjct: 33  ARGRFGCVWKA--QLLNEYVAVKIFPI--QDKQSWQNE--YEVYSLPGMKHENILQFIGA 86
Query: 71  EIHREEMVLFMELCT----EGTLESLVQSTEDG------LPEVLVR--RYTKQLVDAISA 118
           E     + + + L T    +G+L   +++          + E + R   Y  + +  +  
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLK--LGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
            H+  I HRDIKS N+ L    N+L   + DFG A+K  A  +  G+ +G VGT+ YMAP
Sbjct: 147 GHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAP 202
Query: 177 EVF---MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           EV    ++  +    R +D++++G VL E++S           Y + F+  +G+ P++ +
Sbjct: 203 EVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 52/290 (17%)
Query: 26  TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT 85
           TGE V ++ I L   ++   V  +  EL + +  N  N+V Y    I   E+ +      
Sbjct: 35  TGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 93
Query: 86  EGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK 144
            G+ + L+ +   DG+ E+ +    + ++ A+  +H    VHR +K+++I ++ +G  + 
Sbjct: 94  YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VY 152
Query: 145 LGDFGSAVKISAHTTVPGELNGF----VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL 200
           L    S + + +H      ++ F    V    +++PEV +  N  G+    DI+S+G   
Sbjct: 153 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-LQQNLQGYDAKSDIYSVGITA 211
Query: 201 VEMSSGKRPWAEYDSNYQIMFKVG-----MGETPTIP----------------------- 232
            E+++G  P+ +  +   ++ K+      + +T TIP                       
Sbjct: 212 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 271
Query: 233 ----------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                            + S     F E CL+ +P  R +   LL H F 
Sbjct: 272 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 321

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 52/290 (17%)
Query: 26  TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT 85
           TGE V ++ I L   ++   V  +  EL + +  N  N+V Y    I   E+ +      
Sbjct: 51  TGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109
Query: 86  EGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK 144
            G+ + L+ +   DG+ E+ +    + ++ A+  +H    VHR +K+++I ++ +G  + 
Sbjct: 110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VY 168
Query: 145 LGDFGSAVKISAHTTVPGELNGF----VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL 200
           L    S + + +H      ++ F    V    +++PEV +  N  G+    DI+S+G   
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-LQQNLQGYDAKSDIYSVGITA 227
Query: 201 VEMSSGKRPWAEYDSNYQIMFKVG-----MGETPTIP----------------------- 232
            E+++G  P+ +  +   ++ K+      + +T TIP                       
Sbjct: 228 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTT 287
Query: 233 ----------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                            + S     F E CL+ +P  R +   LL H F 
Sbjct: 288 STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 81
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++  E C  G L + ++S  +        PE L +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 201 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 73  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 127
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++ +E C  G L + ++S  +        PE L +        
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 247 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 303 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 90
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++ +E C  G L + ++S  +        PE L +        
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 210 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 90
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++ +E C  G L + ++S  +        PE L +        
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 210 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 38  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 92
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++ +E C  G L + ++S  +        PE L +        
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 212 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 267
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 268 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 15/264 (5%)
Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K +    + D   V++ L E  +++ I  
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKH 87
Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            NLV+  GV        +  E    G  L+ L +   + +  V++     Q+  A+  L 
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF- 179
           +   +HRD+ + N  L  E + +K+ DFG +  ++  T        F     + APE   
Sbjct: 148 KKNFIHRDLAARNC-LVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 204
Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
            +T  +      D+W+ G +L E+++ G  P+   D + Q+   +  G     PE    +
Sbjct: 205 YNTFSI----KSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYDLLEKGYRMEQPEGCPPK 259
Query: 239 GQAFAELCLRHDPAQRATIFELLQ 262
                  C +  PA R +  E  Q
Sbjct: 260 VYELMRACWKWSPADRPSFAETHQ 283

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 81
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++  E C  G L + ++S  +        PE L +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 201 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 36/279 (12%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 81
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGL------PEVLVRR------- 107
            N+V   G        +++  E C  G L + ++S  +        PE L +        
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 108 --YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 165
             Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +
Sbjct: 142 ICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
             +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++ 
Sbjct: 201 ARLPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 256
Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P+  + E       C   +P+QR T  EL++H
Sbjct: 257 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 32/275 (11%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 36  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 90
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQST-----------EDGLPEVLVRRYT 109
            N+V   G        +++ +E C  G L + ++S            +D L    +  Y+
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  + 
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G  
Sbjct: 210 LK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTR 265
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
              P+  + E       C   +P+QR T  EL++H
Sbjct: 266 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---------------LHKQNDARFVK-DMLVELR 54
           G G F  V+ A +      VAMK ++               L + NDA   K D +    
Sbjct: 28  GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87
Query: 55  ILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD 114
           IL+ ++  N     GV +     V+  E+  E  L  + +    G+P + V++ +KQL+ 
Sbjct: 88  ILKLLDHFNHKGPNGVHV-----VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 115 AISALHENT-IVHRDIKSANIFLTAEGN-----SLKLGDFGSAVKISAHTTVPGELNGFV 168
            +  +H    I+H DIK  N+ +    +      +K+ D G+A     H T        +
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT------NSI 196
Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 206
            T+ Y +PEV +       G   DIWS  C++ E+ +G
Sbjct: 197 QTREYRSPEVLL---GAPWGCGADIWSTACLIFELITG 231

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---------------LHKQNDARFVK-DMLVELR 54
           G G F  V+ A +      VAMK ++               L + NDA   K D +    
Sbjct: 28  GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87
Query: 55  ILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD 114
           IL+ ++  N     GV +     V+  E+  E  L  + +    G+P + V++ +KQL+ 
Sbjct: 88  ILKLLDHFNHKGPNGVHV-----VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 115 AISALHENT-IVHRDIKSANIFLTAEGN-----SLKLGDFGSAVKISAHTTVPGELNGFV 168
            +  +H    I+H DIK  N+ +    +      +K+ D G+A     H T        +
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT------NSI 196
Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG 206
            T+ Y +PEV +       G   DIWS  C++ E+ +G
Sbjct: 197 QTREYRSPEVLL---GAPWGCGADIWSTACLIFELITG 231

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 41/292 (14%)
Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+V+ A     +  E   +VA+K   L ++  A    D   E  ++   +  N+V
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS--------------------TEDGLPEVLV 105
           K  GV    + M L  E    G L   ++S                    +  G P +  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 106 RR---YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
                  +Q+   ++ L E   VHRD+ + N  L  E   +K+ DFG +  I +      
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNC-LVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 163 ELNGFVGTQAYMAPE-VFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIM 220
           + N  +  + +M PE +F +     +    D+W+ G VL E+ S G +P+    ++ +++
Sbjct: 233 DGNDAIPIR-WMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGLQPYYGM-AHEEVI 286
Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEE 272
           + V  G     PE+   E      LC    PA R +   +  H  L   CE 
Sbjct: 287 YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI--HRILQRMCER 336

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 47/287 (16%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G+V+  +    GE VA+K        +A + ++  +   +L  +  +N++ +   
Sbjct: 46  GKGRYGEVW--MGKWRGEKVAVK--VFFTTEEASWFRETEIYQTVL--MRHENILGFIAA 99
Query: 71  EIH----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH------ 120
           +I       ++ L  +    G+L   ++ST      +L   Y+   V  +  LH      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS--VSGLCHLHTEIFST 157
Query: 121 --ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNGFVGTQAYMAPE 177
             +  I HRD+KS NI +   G    + D G AVK IS    V    N  VGT+ YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 178 VFMDTNKVGHGRA---VDIWSLGCVLVEMS----SG------KRPWAEY---DSNYQIMF 221
           V  ++    H ++    D++S G +L E++    SG      + P+ +    D +Y+ M 
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 222 KVGMGET--PTIP------ESLSDEGQAFAELCLRHDPAQRATIFEL 260
           ++   +   P+ P      E L   G+   E C  H+PA R T   +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTE-CWAHNPASRLTALRV 322

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 116/255 (45%), Gaps = 18/255 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+ G+V+    N   + VA+K ++    +   F    L E  +++ +  + LV+ Y V
Sbjct: 22  GAGQAGEVWMGYYNGHTK-VAVKSLKQGSMSPDAF----LAEANLMKQLQHQRLVRLYAV 76
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVR--RYTKQLVDAISALHENTIVHRD 128
            + +E + +  E    G+L   ++ T  G+   + +      Q+ + ++ + E   +HRD
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +++ANI L ++  S K+ DFG A  I        E   F     + APE     N     
Sbjct: 135 LRAANI-LVSDTLSCKIADFGLARLIEDAEXTAREGAKF--PIKWTAPEAI---NYGTFT 188
Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G +L E+ + G+ P+    +N +++  +  G     P++  +E      LC 
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 248 RHDPAQRATIFELLQ 262
           +  P  R T F+ L+
Sbjct: 248 KERPEDRPT-FDYLR 261

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 32/275 (11%)
Query: 11  GQGRFGKVYTA--------VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK 62
           G+G FG+V  A            T  +  +KE   H ++ A     ++ EL+IL  I   
Sbjct: 36  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA-----LMSELKILIHIGHH 90
Query: 63  -NLVKYYGVEIHRE-EMVLFMELCTEGTLESLVQST-------EDGLPEVLVRR----YT 109
            N+V   G        +++ +E C  G L + ++S        +D   + L       Y+
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  + 
Sbjct: 151 FQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET 228
            + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G  
Sbjct: 210 LK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 265
Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
              P+  + E       C   +P+QR T  EL++H
Sbjct: 266 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KNTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDXX 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDXX 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYPGI--PVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 106/267 (39%), Gaps = 41/267 (15%)
Query: 11  GQGRFGKVYTAVNNETGELV--AMKEIQ-----LHKQNDARFVKDMLVELRILEGINQKN 63
           G+G FG VY       GE +  A   IQ     L +  + + V+  L E  ++ G+N  N
Sbjct: 30  GKGHFGVVYH------GEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 64  LVKYYGVEIHREEM--VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
           ++   G+ +  E +  VL   +C  G L   ++S +       +  +  Q+   +  L E
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMC-HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSA----------VKISAHTTVPGELNGFVGTQ 171
              VHRD+ + N  L  E  ++K+ DFG A          V+   H  +P +       Q
Sbjct: 143 QKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPT 230
            Y        T K       D+WS G +L E ++ G  P+   D  + +   +  G    
Sbjct: 202 TYRF------TTKS------DVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLP 248
Query: 231 IPESLSDEGQAFAELCLRHDPAQRATI 257
            PE   D      + C   DPA R T 
Sbjct: 249 QPEYCPDSLYQVMQQCWEADPAVRPTF 275

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 11  GQGRFGKVYTAVNNETGELVAM-------KEIQLHKQNDARFVKDMLVELRILEGINQKN 63
           G G FG +Y   N  +GE VA+       K  QLH +  ++F K       +++G     
Sbjct: 18  GSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIE--SKFYK-------MMQGGVGIP 68
Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            +K+ G E     MV  MEL    +LE L            V     Q++  I  +H   
Sbjct: 69  SIKWCGAEGDYNVMV--MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 124 IVHRDIKSANIF--LTAEGNSLKLGDFGSAVKI---SAHTTVPGELN-GFVGTQAYMAPE 177
            +HRD+K  N    L  +GN + + DFG A K      H  +P   N    GT  Y +  
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
             +    +   R  D+ SLG VL+  + G  PW
Sbjct: 186 THLG---IEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           M  +    + G+G FG V   + +  G  VA+K I+    NDA   +  L E  ++  + 
Sbjct: 192 MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK----NDAT-AQAFLAEASVMTQLR 244
Query: 61  QKNLVKYYGVEIHREE-MVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISA 118
             NLV+  GV +  +  + +  E   +G+L   ++S     L    + +++  + +A+  
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           L  N  VHRD+ + N+ L +E N  K+ DFG   K ++ T   G+L        + APE 
Sbjct: 305 LEGNNFVHRDLAARNV-LVSEDNVAKVSDFG-LTKEASSTQDTGKL-----PVKWTAPEA 357
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
             +          D+WS G +L E+ S G+ P+        ++ +V  G     P+    
Sbjct: 358 LREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPP 413
Query: 238 EGQAFAELCLRHDPAQRATIFELLQH 263
                 + C   D A R T  +L + 
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQ 439

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 202
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 203 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEE 256
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 257 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT-ENNVMKIADFGLARDINNIDYY 200
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 201 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEE 254
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 255 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 205
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 206 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 259
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 260 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           M  +    + G+G FG V   + +  G  VA+K I+    NDA   +  L E  ++  + 
Sbjct: 11  MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK----NDAT-AQAFLAEASVMTQLR 63
Query: 61  QKNLVKYYGVEIHREE-MVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISA 118
             NLV+  GV +  +  + +  E   +G+L   ++S     L    + +++  + +A+  
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           L  N  VHRD+ + N+ L +E N  K+ DFG   K ++ T   G+L        + APE 
Sbjct: 124 LEGNNFVHRDLAARNV-LVSEDNVAKVSDFG-LTKEASSTQDTGKL-----PVKWTAPEA 176
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
                +       D+WS G +L E+ S G+ P+        ++ +V  G     P+    
Sbjct: 177 L---REAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPP 232
Query: 238 EGQAFAELCLRHDPAQRATIFELLQH 263
                 + C   D A R +  +L + 
Sbjct: 233 AVYEVMKNCWHLDAAMRPSFLQLREQ 258

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A       ++  E V +    L      + + D++ E+ +++ I + KN+
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLVR-----RYT 109
           +   G       + + +E  ++G L   +++            + +PE  +        T
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 110 KQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
            QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+         NG + 
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFK-VGMGE 227
            + +MAPE   D     +    D+WS G ++ E+ + G  P+       + +FK +  G 
Sbjct: 269 VK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEELFKLLKEGH 322
Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
               P + ++E       C    P+QR T  +L++
Sbjct: 323 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           M  +    + G+G FG V   + +  G  VA+K I+    NDA   +  L E  ++  + 
Sbjct: 5   MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK----NDAT-AQAFLAEASVMTQLR 57
Query: 61  QKNLVKYYGVEIHREE-MVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISA 118
             NLV+  GV +  +  + +  E   +G+L   ++S     L    + +++  + +A+  
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           L  N  VHRD+ + N+ L +E N  K+ DFG   K ++ T   G+L        + APE 
Sbjct: 118 LEGNNFVHRDLAARNV-LVSEDNVAKVSDFG-LTKEASSTQDTGKL-----PVKWTAPEA 170
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
             +          D+WS G +L E+ S G+ P+        ++ +V  G     P+    
Sbjct: 171 LREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPP 226
Query: 238 EGQAFAELCLRHDPAQRATIFELLQH 263
                 + C   D A R +  +L + 
Sbjct: 227 AVYEVMKNCWHLDAAMRPSFLQLREQ 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L        + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 1   MSSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
           M  +    + G+G FG V   + +  G  VA+K I+    NDA   +  L E  ++  + 
Sbjct: 20  MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK----NDAT-AQAFLAEASVMTQLR 72
Query: 61  QKNLVKYYGVEIHREE-MVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISA 118
             NLV+  GV +  +  + +  E   +G+L   ++S     L    + +++  + +A+  
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           L  N  VHRD+ + N+ L +E N  K+ DFG   K ++ T   G+L        + APE 
Sbjct: 133 LEGNNFVHRDLAARNV-LVSEDNVAKVSDFG-LTKEASSTQDTGKL-----PVKWTAPEA 185
Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
             +          D+WS G +L E+ S G+ P+        ++ +V  G     P+    
Sbjct: 186 LREKK---FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPP 241
Query: 238 EGQAFAELCLRHDPAQRATIFELLQH 263
                 + C   D A R +  +L + 
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQ 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 120/284 (42%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +E  ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +++ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMRIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 51/289 (17%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G+V+    +  GE VA+K I   +   + F +  L    +L     +N++ +   
Sbjct: 46  GKGRYGEVWRG--SWQGENVAVK-IFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 99
Query: 71  EIHREEMVLFMELCTE----GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH------ 120
           ++        + L T     G+L   +Q T   L  V   R    +   ++ LH      
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 121 --ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL----NGFVGTQAYM 174
             +  I HRD+KS NI +   G    + D G AV    H+    +L    N  VGT+ YM
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCC-IADLGLAV---MHSQSTNQLDVGNNPRVGTKRYM 213
Query: 175 APEVFMDTNKV---GHGRAVDIWSLGCVLVE-----MSSG-----KRPWAEY---DSNYQ 218
           APEV  +T +V      + VDIW+ G VL E     +S+G     K P+ +    D +++
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 273
Query: 219 IMFKVGM--GETPTIPES-LSDEG-QAFAEL---CLRHDPAQRATIFEL 260
            M KV     + P IP    SD    + A+L   C   +P+ R T   +
Sbjct: 274 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 322

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 7/237 (2%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V   V     + + +    L +  +    ++M+ E +I+  ++   +V+  GV
Sbjct: 19  GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               E ++L ME+   G L   +    + +P   V     Q+   +  L E   VHRD+ 
Sbjct: 79  -CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + N+ L    +  K+ DFG +  + A  +     +       + APE     N       
Sbjct: 138 ARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI---NFRKFSSR 193
Query: 191 VDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
            D+WS G  + E +S G++P+ +     ++M  +  G+    P     E  A    C
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDC 249

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 45/286 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G+V+    +  GE VA+K I   +   + F +  L    +L   N    +     
Sbjct: 17  GKGRYGEVWRG--SWQGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH--------E 121
             H   ++ L       G+L   +Q T   L  V   R    +   ++ LH        +
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL----NGFVGTQAYMAPE 177
             I HRD+KS NI +   G    + D G AV    H+    +L    N  VGT+ YMAPE
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCC-IADLGLAV---MHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 178 VFMDTNKV---GHGRAVDIWSLGCVLVE-----MSSG-----KRPWAEY---DSNYQIMF 221
           V  +T +V      + VDIW+ G VL E     +S+G     K P+ +    D +++ M 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 222 KVGM--GETPTIPES-LSDEG-QAFAEL---CLRHDPAQRATIFEL 260
           KV     + P IP    SD    + A+L   C   +P+ R T   +
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 45/286 (15%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G+V+    +  GE VA+K I   +   + F +  L    +L   N    +     
Sbjct: 17  GKGRYGEVWRG--SWQGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 71  EIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH--------E 121
             H   ++ L       G+L   +Q T   L  V   R    +   ++ LH        +
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL----NGFVGTQAYMAPE 177
             I HRD+KS NI +   G    + D G AV    H+    +L    N  VGT+ YMAPE
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCC-IADLGLAV---MHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 178 VFMDTNKV---GHGRAVDIWSLGCVLVE-----MSSG-----KRPWAEY---DSNYQIMF 221
           V  +T +V      + VDIW+ G VL E     +S+G     K P+ +    D +++ M 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 222 KVGM--GETPTIPES-LSDEG-QAFAEL---CLRHDPAQRATIFEL 260
           KV     + P IP    SD    + A+L   C   +P+ R T   +
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G
Sbjct: 262 LPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 317
Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P+  + E       C   +P+QR T  EL++H
Sbjct: 318 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G
Sbjct: 255 LPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 310
Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P+  + E       C   +P+QR T  EL++H
Sbjct: 311 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +   ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G
Sbjct: 264 LPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 319
Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P+  + E       C   +P+QR T  EL++H
Sbjct: 320 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           Y+ Q+   +  L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
           +  + +MAPE   D          D+WS G +L E+ S G  P+     + +   ++  G
Sbjct: 257 LPLK-WMAPETIFDRVYTIQS---DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P+  + E       C   +P+QR T  EL++H
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKVY       G LVA+K ++  +            E+ ++     +NL++  G 
Sbjct: 39  GRGGFGKVYKG-RLADGXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGF 95
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEV---LVRRYTKQLVDAISALHEN---TI 124
            +   E +L       G++ S ++   +  P +     +R        ++ LH++    I
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTN 183
           +HRD+K+ANI L  E  ++ +GDFG A  +      V   + G +G   ++APE ++ T 
Sbjct: 156 IHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIG---HIAPE-YLSTG 210
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW 210
           K       D++  G +L+E+ +G+R +
Sbjct: 211 KSSE--KTDVFGYGVMLLELITGQRAF 235

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 12/265 (4%)
Query: 2   SSVTFSVSPGQGRFGKVYTA-VNNETGEL---VAMKEIQLHKQNDARFVKDMLVELRILE 57
           S VT     G G FG+VY   +   +G+    VA+K ++       R   D L E  I+ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMG 101
Query: 58  GINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
             +  N+++  GV    + M++  E    G L+  ++  +     + +    + +   + 
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 177
            L     VHRD+ + NI + +     K+ DFG +  +          +G      + APE
Sbjct: 162 YLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
                +      A D+WS G V+ E M+ G+RP+ E  SN+++M  +  G     P    
Sbjct: 221 AI---SYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRLPTPMDCP 276
Query: 237 DEGQAFAELCLRHDPAQRATIFELL 261
                    C + + A+R    +++
Sbjct: 277 SAIYQLMMQCWQQERARRPKFADIV 301

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKVY       G LVA+K ++  +            E+ ++     +NL++  G 
Sbjct: 47  GRGGFGKVYKG-RLADGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRGF 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEV---LVRRYTKQLVDAISALHEN---TI 124
            +   E +L       G++ S ++   +  P +     +R        ++ LH++    I
Sbjct: 104 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 163
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           +HRD+K+ANI L  E  ++ +GDFG A  +      V   + G +G   ++APE ++ T 
Sbjct: 164 IHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIG---HIAPE-YLSTG 218
Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPW 210
           K       D++  G +L+E+ +G+R +
Sbjct: 219 KSSE--KTDVFGYGVMLLELITGQRAF 243

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 30/284 (10%)
Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +T     G+G FG+V  A       ++  E V +    L      + + D++ E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 57  EGINQ-KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTE----------DGLPEVLV 105
           + I + KN++   G       + + +   ++G L   +++            + +PE  +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 R-----RYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV 160
                   T QL   +  L     +HRD+ + N+ +T E N +K+ DFG A  I+     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYY 213
Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI 219
               NG +  + +MAPE   D     +    D+WS G ++ E+ + G  P+       + 
Sbjct: 214 KKTTNGRLPVK-WMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPYP--GIPVEE 267
Query: 220 MFK-VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           +FK +  G     P + ++E       C    P+QR T  +L++
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DARFVKDMLVE----LR 54
           ++    S G+GRFG+V+       GE VA+K     ++     +A   + +++     L 
Sbjct: 7   TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 64
Query: 55  ILEGINQKN--LVKYYGVEIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRR 107
            +   N+ N    + + V  + E   LF  L       EG ++ L  ST  GL  + +  
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM-- 121
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNG 166
                 + +    +  I HRD+KS NI +   G    + D G AV+  SA  T+    N 
Sbjct: 122 ------EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNH 174
Query: 167 FVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS 204
            VGT+ YMAPEV  D+  + H    +  DI+++G V  E++
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DARFVKDMLVE----LR 54
           ++    S G+GRFG+V+       GE VA+K     ++     +A   + +++     L 
Sbjct: 5   TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 62
Query: 55  ILEGINQKN--LVKYYGVEIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRR 107
            +   N+ N    + + V  + E   LF  L       EG ++ L  ST  GL  + +  
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM-- 119
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNG 166
                 + +    +  I HRD+KS NI +   G    + D G AV+  SA  T+    N 
Sbjct: 120 ------EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNH 172
Query: 167 FVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS 204
            VGT+ YMAPEV  D+  + H    +  DI+++G V  E++
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DARFVKDMLVE----LR 54
           ++    S G+GRFG+V+       GE VA+K     ++     +A   + +++     L 
Sbjct: 30  TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 87
Query: 55  ILEGINQKN--LVKYYGVEIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRR 107
            +   N+ N    + + V  + E   LF  L       EG ++ L  ST  GL  + +  
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM-- 144
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNG 166
                 + +    +  I HRD+KS NI +   G    + D G AV+  SA  T+    N 
Sbjct: 145 ------EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNH 197
Query: 167 FVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS 204
            VGT+ YMAPEV  D+  + H    +  DI+++G V  E++
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DARFVKDMLVE----LR 54
           ++    S G+GRFG+V+       GE VA+K     ++     +A   + +++     L 
Sbjct: 4   TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 55  ILEGINQKN--LVKYYGVEIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRR 107
            +   N+ N    + + V  + E   LF  L       EG ++ L  ST  GL  + +  
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM-- 118
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNG 166
                 + +    +  I HRD+KS NI +   G    + D G AV+  SA  T+    N 
Sbjct: 119 ------EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNH 171
Query: 167 FVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS 204
            VGT+ YMAPEV  D+  + H    +  DI+++G V  E++
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DARFVKDMLVE----LR 54
           ++    S G+GRFG+V+       GE VA+K     ++     +A   + +++     L 
Sbjct: 10  TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 67
Query: 55  ILEGINQKN--LVKYYGVEIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRR 107
            +   N+ N    + + V  + E   LF  L       EG ++ L  ST  GL  + +  
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM-- 124
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNG 166
                 + +    +  I HRD+KS NI +   G    + D G AV+  SA  T+    N 
Sbjct: 125 ------EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNH 177
Query: 167 FVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS 204
            VGT+ YMAPEV  D+  + H    +  DI+++G V  E++
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 3   SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN----DARFVKDMLVE----LR 54
           ++    S G+GRFG+V+       GE VA+K     ++     +A   + +++     L 
Sbjct: 43  TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 55  ILEGINQKN--LVKYYGVEIHREEMVLFMEL-----CTEGTLESLVQSTEDGLPEVLVRR 107
            +   N+ N    + + V  + E   LF  L       EG ++ L  ST  GL  + +  
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHM-- 157
Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK-ISAHTTVPGELNG 166
                 + +    +  I HRD+KS NI +   G    + D G AV+  SA  T+    N 
Sbjct: 158 ------EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNH 210
Query: 167 FVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS 204
            VGT+ YMAPEV  D+  + H    +  DI+++G V  E++
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG +Y   +   GE VA+K   +  ++    ++  +   ++++G      +++ G 
Sbjct: 16  GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIY--KMMQGGVGIPTIRWCGA 73
Query: 71  EIHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           E     MV  MEL    +LE L    S +  L  VL+     Q++  I  +H    +HRD
Sbjct: 74  EGDYNVMV--MELLGP-SLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIHSKNFIHRD 128
Query: 129 IKSANIF--LTAEGNSLKLGDFGSAVKI---SAHTTVPGELN-GFVGTQAYMAPEVFMDT 182
           +K  N    L  +GN + + DFG A K      H  +P   N    GT  Y +    +  
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG- 187
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
             +   R  D+ SLG VL+  + G  PW
Sbjct: 188 --IEQSRRDDLESLGYVLMYFNLGSLPW 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +      G+    VA+K ++       R  +D L E  I+   +  N++  
Sbjct: 42  GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNVIHL 99
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV      +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 159
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA--YMAPEVFMDTNKV 185
           D+ + NI + +     K+ DFG +  +   T+ P   +   G     + APE        
Sbjct: 160 DLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 218
Query: 186 GHGRAVDIWSLGCVLVE-MSSGKRPW 210
               A D+WS G V+ E MS G+RP+
Sbjct: 219 S---ASDVWSYGIVMWEVMSYGERPY 241

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG +Y   +   GE VA+K   +  ++    ++  +   ++++G      +++ G 
Sbjct: 18  GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIY--KMMQGGVGIPTIRWCGA 75
Query: 71  EIHREEMVLFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           E     MV  MEL    +LE L    S +  L  VL+     Q++  I  +H    +HRD
Sbjct: 76  EGDYNVMV--MELLGP-SLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIHSKNFIHRD 130
Query: 129 IKSANIF--LTAEGNSLKLGDFGSAVKI---SAHTTVPGELN-GFVGTQAYMAPEVFMDT 182
           +K  N    L  +GN + + DFG A K      H  +P   N    GT  Y +    +  
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG- 189
Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
             +   R  D+ SLG VL+  + G  PW
Sbjct: 190 --IEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG A  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLARVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 84  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 143 RDLAARNV-LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 197
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM 225
           G +   A++APE      +  + R+ D+WS   +L E+ + + P+A+  SN +I  KV +
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVAL 225
Query: 226 -GETPTIPESLSDEGQAFAELCLRHDPAQR 254
            G  PTIP  +S       ++C+  DPA+R
Sbjct: 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKR 255

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 84  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 143 RDLAARNV-LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 197
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 28  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 86  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 145 RDLAARNV-LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 199
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 51  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 109
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 110 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENX 167
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 168 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 222
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 223 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 258

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 47  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 105
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 106 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 163
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 164 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 218
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 219 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 51  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 109
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 110 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 167
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 168 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 222
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 223 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 258

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 45  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 103
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 104 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 161
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 162 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 216
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 217 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 252

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 57  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 115
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 116 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 173
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 174 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 228
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 85  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 144 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 198
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 65  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 123
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 124 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 181
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 182 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 236
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 237 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 272

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 28  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 86  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 145 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 199
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 84  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 143 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 197
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 82  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 141 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 195
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 67  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 125
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 126 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 183
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 184 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 238
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 239 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 274

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q      
Sbjct: 67  NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVK 125
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            + ++     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 126 DKNIIE-LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 183
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 184 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 238
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 239 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 274

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 17/235 (7%)
Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V        G+    VA+K ++       R  ++ L E  I+      N+++ 
Sbjct: 25  GAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIRL 82
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV  +   +++  E    G L+S ++  +     + +    + +   +  L E + VHR
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA--YMAPEVFMDTNKV 185
           D+ + NI + +     K+ DFG +  +  +++ P E +   G     + APE        
Sbjct: 143 DLAARNILVNS-NLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201
Query: 186 GHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKV----GMGETPTIPESL 235
               A D WS G V+ E MS G+RP+ +  SN  ++  +     +   P  P SL
Sbjct: 202 S---ASDAWSYGIVMWEVMSFGERPYWDM-SNQDVINAIEQDYRLPPPPDCPTSL 252

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 25  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 83  LLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 142 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 196
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 42  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 99
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 159
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 160 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 213
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 214 K---FTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 254

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 25  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 83  LLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 142 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 196
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 41/281 (14%)
Query: 1   MSSVTFSVSPGQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDAR--FVKDMLVEL 53
           +S+V F    G+ RFGKVY          E  + VA+K ++   +   R  F  + ++  
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA 67
Query: 54  RILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTL---------ESLVQSTEDGL---- 100
           R    +   N+V   GV    + + +    C+ G L          S V ST+D      
Sbjct: 68  R----LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 101 ---PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH 157
              P   V     Q+   +  L  + +VH+D+ + N+ +  + N +K+ D G   ++ A 
Sbjct: 124 ALEPPDFV-HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLGLFREVYAA 181
Query: 158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEM-SSGKRPWAEY 213
                  N  +  + +MAPE  M      +G+     DIWS G VL E+ S G +P+  Y
Sbjct: 182 DYYKLLGNSLLPIR-WMAPEAIM------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 214 DSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
            SN  ++  +   +    P+       A    C    P++R
Sbjct: 235 -SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 274

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 70/178 (39%), Gaps = 36/178 (20%)
Query: 105 VRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG--------------- 149
           VR Y   L  A+  +H+  IVHRD+K +N           L DFG               
Sbjct: 119 VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF 178
Query: 150 ----------SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV 199
                     S  K S   +   ++    GT  + APEV   T       A+D+WS G +
Sbjct: 179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL--TKCPNQTTAIDMWSAGVI 236
Query: 200 LVEMSSGKRPWAEYDSNY----QIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQ 253
            + + SG+ P+ +   +     QIM   G  ET    ++    G++   LC +  PAQ
Sbjct: 237 FLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTF---GKSI--LCSKEVPAQ 289

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q     +
Sbjct: 410 NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH-V 467
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            +  +     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 468 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 526
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 527 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 581
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 582 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 617

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G+G   +V T +N  T +  A+K I+   +        +  E+ +L +    +N+++   
Sbjct: 22  GEGAHARVQTCINLITSQEYAVKIIE---KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                +   L  E    G++ S +        E+      + +  A+  LH   I HRD+
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 130 KSANIFLTAEG--NSLKLGDF--GSAVKISAHTT--VPGELNGFVGTQAYMAPEV---FM 180
           K  NI        + +K+ DF  GS +K++   +     EL    G+  YMAPEV   F 
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
           +   + + +  D+WSLG +L  + SG  P+
Sbjct: 198 EEASI-YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 10/216 (4%)
Query: 41  NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL 100
           ND     ++L E  +++ ++   +V+  G+    E  +L ME+   G L   +Q     +
Sbjct: 409 NDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH-V 466
Query: 101 PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-HTT 159
            +  +     Q+   +  L E+  VHRD+ + N+ L  + +  K+ DFG +  + A    
Sbjct: 467 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY 525
Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQ 218
              + +G    + Y APE     N        D+WS G ++ E  S G++P+     + +
Sbjct: 526 YKAQTHGKWPVKWY-APECI---NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E 580
Query: 219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
           +   +  GE    P     E      LC  +D   R
Sbjct: 581 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 616

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 25  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 82
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 143 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 196
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 197 K---FTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 237

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G+G   +V T +N  T +  A+K I+   +        +  E+ +L +    +N+++   
Sbjct: 22  GEGAHARVQTCINLITSQEYAVKIIE---KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                +   L  E    G++ S +        E+      + +  A+  LH   I HRD+
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 130 KSANIFLTAEG--NSLKLGDF--GSAVKISAHTT--VPGELNGFVGTQAYMAPEV---FM 180
           K  NI        + +K+ DF  GS +K++   +     EL    G+  YMAPEV   F 
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPW 210
           +   + + +  D+WSLG +L  + SG  P+
Sbjct: 198 EEASI-YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 25  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 82
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 142
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 143 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 196
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 197 K---FTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 237

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 52  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 109
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 169
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 170 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 223
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 224 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 264

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQ-LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG VY  +    GE V +   I+ L++    +   + + E  I+  ++  +LV+  
Sbjct: 47  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 106
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV +    + L  +L   G L   V   +D +   L+  +  Q+   +  L E  +VHRD
Sbjct: 107 GVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 165
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA--YMAPEVFMDTNKVG 186
           + + N+ L    N +K+ DFG A  +        E N   G     +MA E  +   K  
Sbjct: 166 LAARNV-LVKSPNHVKITDFGLARLLEGDEK---EYNADGGKMPIKWMALEC-IHYRKFT 220
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           H    D+WS G  + E M+ G +P+
Sbjct: 221 H--QSDVWSYGVTIWELMTFGGKPY 243

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +    + ++    VA+K +++      R  +D L E  I+   +  N+++ 
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIRL 111
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR 171
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG    +     +A+TT  G++        + +PE     
Sbjct: 172 DLAARNILINS-NLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYR 225
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMG 226
                  A D+WS G VL E MS G+RP+ E  SN  ++  V  G
Sbjct: 226 KFTS---ASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEG 266

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 114/281 (40%), Gaps = 41/281 (14%)
Query: 1   MSSVTFSVSPGQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDAR--FVKDMLVEL 53
           +S+V F    G+ RFGKVY          E  + VA+K ++   +   R  F  + ++  
Sbjct: 25  LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRA 84
Query: 54  RILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESL---------VQSTEDGL---- 100
           R    +   N+V   GV    + + +    C+ G L            V ST+D      
Sbjct: 85  R----LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 101 ---PEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH 157
              P   V     Q+   +  L  + +VH+D+ + N+ +  + N +K+ D G   ++ A 
Sbjct: 141 ALEPPDFV-HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLGLFREVYAA 198
Query: 158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEM-SSGKRPWAEY 213
                  N  +  + +MAPE  M      +G+     DIWS G VL E+ S G +P+  Y
Sbjct: 199 DYYKLLGNSLLPIR-WMAPEAIM------YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251
Query: 214 DSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR 254
            SN  ++  +   +    P+       A    C    P++R
Sbjct: 252 -SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 291

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQ-LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG VY  +    GE V +   I+ L++    +   + + E  I+  ++  +LV+  
Sbjct: 24  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 83
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV +    + L  +L   G L   V   +D +   L+  +  Q+   +  L E  +VHRD
Sbjct: 84  GVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 142
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA--YMAPEVFMDTNKVG 186
           + + N+ L    N +K+ DFG A  +        E N   G     +MA E  +   K  
Sbjct: 143 LAARNV-LVKSPNHVKITDFGLARLLEGDEK---EYNADGGKMPIKWMALEC-IHYRKFT 197
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           H    D+WS G  + E M+ G +P+
Sbjct: 198 H--QSDVWSYGVTIWELMTFGGKPY 220

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +      G+    VA+K +++      R  +D L E  I+   +  N+V  
Sbjct: 52  GAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR--RDFLCEASIMGQFDHPNVVHL 109
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++ +E    G L++ ++  +     + +    + +   +  L +   VHR
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHR 169
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  I     + +TT  G++        + APE     
Sbjct: 170 DLAARNILVNS-NLVCKVSDFGLSRVIEDDPEAVYTTTGGKI-----PVRWTAPEAIQYR 223
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFK 222
                  A D+WS G V+ E MS G+RP+  +D + Q + K
Sbjct: 224 KFTS---ASDVWSYGIVMWEVMSYGERPY--WDMSNQDVIK 259

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L  +L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 84  LLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +  +++ 
Sbjct: 143 RDLAARNV-LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESIL--HRI- 197
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +      G+    VA+K ++    +  R  +D L E  I+   +  N++  
Sbjct: 17  GVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHPNIIHL 74
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L++ ++  +     + +    + +   +  L + + VHR
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 134
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + APE     
Sbjct: 135 DLAARNILVNS-NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI-----PIRWTAPEAIAYR 188
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFK 222
                  A D+WS G V+ E MS G+RP+  +D + Q + K
Sbjct: 189 K---FTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVIK 224

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L  +L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 82  LLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 141 RDLAARNV-LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 195
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +      G+    VA+K ++    +  R  +D L E  I+   +  N++  
Sbjct: 38  GVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHPNIIHL 95
Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV    + +++  E    G+L++ ++  +     + +    + +   +  L + + VHR
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHR 155
Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           D+ + NI + +     K+ DFG +  +     +A+TT  G++        + APE     
Sbjct: 156 DLAARNILVNS-NLVCKVSDFGMSRVLEDDPEAAYTTRGGKI-----PIRWTAPEAIAYR 209
Query: 183 NKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFK 222
                  A D+WS G V+ E MS G+RP+  +D + Q + K
Sbjct: 210 K---FTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVIK 245

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY  V  + G  VA+K         ++ +++   E+  L      +LV   G 
Sbjct: 48  GHGVFGKVYKGVLRD-GAKVALKR---RTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA------LHENTI 124
              R EM+L  +    G L+  +  ++  LP  +   + ++L   I A      LH   I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSD--LP-TMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE--LNGFV-GTQAYMAPEVFMD 181
           +HRD+KS NI L  E    K+ DFG    IS   T  G+  L   V GT  Y+ PE F+ 
Sbjct: 161 IHRDVKSINILLD-ENFVPKITDFG----ISKKGTELGQTHLXXVVKGTLGYIDPEYFIK 215
Query: 182 TNKVGHGRAV---DIWSLGCVLVEM 203
                 GR     D++S G VL E+
Sbjct: 216 ------GRLTEKSDVYSFGVVLFEV 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 31  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L  +L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 89  LLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 148 RDLAARNV-LVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 202
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 11  GQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +
Sbjct: 21  GSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+ +    + L  +L   G L   V+  +D +    +  +  Q+ + ++ L +  +VH
Sbjct: 79  LLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + N+ L      +K+ DFG A  + A         G V  + +MA E  +      
Sbjct: 138 RDLAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI--- 192
Query: 187 HGRAVDIWSLGCVLVE-MSSGKRPW 210
           +    D+WS G  + E M+ G +P+
Sbjct: 193 YTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 13  GRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G FG VY  +    GE V    A+KE  L +    +  K++L E  ++  ++  ++ +  
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G+ +    + L M+L   G L   V+  +D +    +  +  Q+   ++ L +  +VHRD
Sbjct: 91  GICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 149
Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           + + N+ L      +K+ DFG A  + A         G V  + +MA E  +      + 
Sbjct: 150 LAARNV-LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK-WMALESILHRI---YT 204
Query: 189 RAVDIWSLGCVLVE-MSSGKRPW 210
              D+WS G  + E M+ G +P+
Sbjct: 205 HQSDVWSYGVTVWELMTFGSKPY 227
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	407
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-104
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-22
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-91
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-83
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-18
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-82
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-18
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-81
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-80
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-18
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-80
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-18
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-80
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-80
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-20
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-77
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-72
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-69
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-18
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-69
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-67
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-15
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-67
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-67
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-12
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-64
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-64
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-63
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-13
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-63
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-63
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-14
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-62
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-62
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-62
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-13
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-62
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-62
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-61
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-61
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-13
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-61
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-61
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-59
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-59
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-57
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-56
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-10
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-55
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-54
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-54
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-10
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-53
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-53
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-53
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-14
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-53
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-53
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-13
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-53
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-52
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-52
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-51
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-10
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-51
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-10
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-51
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-51
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-51
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-51
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-10
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-51
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-10
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-51
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-10
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-50
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-11
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-50
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-10
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-50
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-50
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-09
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-50
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-09
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-49
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-11
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-49
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-09
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-49
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-09
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-10
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-49
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-10
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-48
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-48
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-48
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-11
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-48
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-09
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-47
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-47
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-47
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-10
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-47
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-47
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-47
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-47
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-47
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-08
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-46
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-08
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-46
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-09
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-46
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-46
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-08
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-46
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-10
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-45
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-45
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-45
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-45
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-17
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-09
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-44
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-44
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-44
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-10
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-11
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-43
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-43
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-16
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-42
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-42
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-41
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-41
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-41
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-40
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-09
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-05
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-40
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-40
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-40
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-40
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-39
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-39
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-39
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-39
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-38
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-38
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-38
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-38
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-38
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-13
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-38
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-38
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-38
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-38
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-09
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-11
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-37
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-37
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-37
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-37
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-11
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-36
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-36
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-36
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-36
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-36
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-36
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-36
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-35
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-35
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-32
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-09
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-30
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-10
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-30
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-30
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-12
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-29
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-10
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-28
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-28
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-26
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-26
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-08
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-20
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-20
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-20
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-04
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-19
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-19
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-18
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  310 bits (796), Expect = e-104
 Identities = 96/271 (35%), Positives = 146/271 (53%), Gaps = 10/271 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY   +      +A+KEI           + +  E+ + + +  KN+V+Y G 
Sbjct: 31  GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLP--EVLVRRYTKQLVDAISALHENTIVHRD 128
                 + +FME    G+L +L++S    L   E  +  YTKQ+++ +  LH+N IVHRD
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           IK  N+ +      LK+ DFG++ +++           F GT  YMAPE+ +D    G+G
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEI-IDKGPRGYG 203

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-PTIPESLSDEGQAFAELCL 247
           +A DIWSLGC ++EM++GK P+ E       MFKVGM +  P IPES+S E +AF   C 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263

Query: 248 RHDPAQRATIFELLQHPFLIVSCEEDVCNPR 278
             DP +RA   +LL   FL VS ++    P+
Sbjct: 264 EPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 4/76 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +      LK+ DFG++ +++           F GT  YMAPE+ +D    G+G+A 
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEI-IDKGPRGYGKAA 206

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLGC ++EM++GK
Sbjct: 207 DIWSLGCTIIEMATGK 222

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  278 bits (713), Expect = 1e-91
 Identities = 74/260 (28%), Positives = 119/260 (45%), Gaps = 17/260 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+   + +TG   A+K+++L              EL    G++   +V  YG 
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGA 118

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + +FMEL   G+L  L++     LPE     Y  Q ++ +  LH   I+H D+K
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL--NGFVGTQAYMAPEVFMDTNKVGHG 188
           + N+ L+++G+   L DFG A+ +         L  +   GT+ +MAPEV M        
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK---PCD 234

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQAFAELC 246
             VDIWS  C+++ M +G  PW +Y     +  K+     P   IP S +       +  
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293

Query: 247 LRHDPAQRATIFELLQHPFL 266
           LR +P  RA+  EL +    
Sbjct: 294 LRKEPVHRASAMELRRKVGK 313

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 28/111 (25%), Positives = 43/111 (38%), Gaps = 26/111 (23%)

Query: 297 PMSEDSVKVYAR---------------------ANIFLTAEGNSLKLGDFGSAVKISAHT 335
            + ED    Y                        N+ L+++G+   L DFG A+ +    
Sbjct: 146 CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205

Query: 336 TVPGEL--NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
                L  +   GT+ +MAPEV M          VDIWS  C+++ M +G 
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGK---PCDAKVDIWSSCCMMLHMLNGC 253

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  256 bits (655), Expect = 2e-83
 Identities = 75/263 (28%), Positives = 135/263 (51%), Gaps = 18/263 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  VY  ++ ET   VA  E+Q  K   +   +    E  +L+G+   N+V++Y  
Sbjct: 35  GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 71  EI----HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--I 124
                  ++ +VL  EL T GTL++ ++  +  +   ++R + +Q++  +  LH  T  I
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K  NIF+T    S+K+GD G A    A           +GT  +MAPE++    +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEMY----E 203

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSDEGQAFA 243
             +  +VD+++ G  ++EM++ + P++E  +  QI  +V  G  P +  +    E +   
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
           E C+R +  +R +I +LL H F 
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 82.4 bits (204), Expect = 6e-18
 Identities = 28/123 (22%), Positives = 50/123 (40%), Gaps = 35/123 (28%)

Query: 285 LQDYLKLGIVLPPMSEDSVKVYAR-----------------------ANIFLTAEGNSLK 321
           L+ YLK       M    ++ + R                        NIF+T    S+K
Sbjct: 116 LKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172

Query: 322 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS 381
           +GD G A    A           +GT  +MAPE++    +  +  +VD+++ G  ++EM+
Sbjct: 173 IGDLGLATLKRASFA-----KAVIGTPEFMAPEMY----EEKYDESVDVYAFGMCMLEMA 223

Query: 382 SGK 384
           + +
Sbjct: 224 TSE 226

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  253 bits (647), Expect = 3e-82
 Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 36/278 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G G FG V+  V    G + A+K  +          ++ L E+     + Q  ++V+Y+ 
Sbjct: 20  GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFS 78

Query: 70  VEIHREEMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                + M++  E C  G+L   +           E  ++    Q+   +  +H  ++VH
Sbjct: 79  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 138

Query: 127 RDIKSANIFLTAEGNS------------------LKLGDFGSAVKISAHTTVPGELNGFV 168
            DIK +NIF++                        K+GD G   +IS+            
Sbjct: 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-------EE 191

Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET 228
           G   ++A EV  +     H    DI++L   +V  +  +        N     ++  G  
Sbjct: 192 GDSRFLANEVLQENY--THLPKADIFALALTVVCAAGAEPLP----RNGDQWHEIRQGRL 245

Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           P IP+ LS E     ++ +  DP +R +   L++H  L
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 30/177 (16%), Positives = 52/177 (29%), Gaps = 65/177 (36%)

Query: 259 ELLQHPFLIV----SCEEDV--------CNPRSVPASVLQDYLKLGIVLPPMSEDSVKVY 306
            L QH   +V    +  ED         CN  S+ A  + +  ++        E  +K  
Sbjct: 66  VLGQHSH-VVRYFSAWAEDDHMLIQNEYCNGGSL-ADAISENYRIM---SYFKEAELKDL 120

Query: 307 AR---------------------ANIFLTAEGNS------------------LKLGDFGS 327
                                  +NIF++                        K+GD G 
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 328 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
             +IS+            G   ++A EV  +     H    DI++L   +V  +  +
Sbjct: 181 VTRISSPQV-------EEGDSRFLANEVLQENY--THLPKADIFALALTVVCAAGAE 228

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  252 bits (645), Expect = 1e-81
 Identities = 84/265 (31%), Positives = 141/265 (53%), Gaps = 12/265 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+F +VY A     G  VA+K++Q+    DA+   D + E+ +L+ +N  N++KYY  
Sbjct: 41  GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 100

Query: 71  EIHREEMVLFMELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            I   E+ + +EL   G L  +++     +  +PE  V +Y  QL  A+  +H   ++HR
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DIK AN+F+TA G  +KLGD G     S+ TT     +  VGT  YM+PE   +    G+
Sbjct: 161 DIKPANVFITATGV-VKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPERIHEN---GY 213

Query: 188 GRAVDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAFAEL 245
               DIWSLGC+L EM++ + P+  +  + Y +  K+   + P +P +  S+E +    +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273

Query: 246 CLRHDPAQRATIFELLQHPFLIVSC 270
           C+  DP +R  +  +      + +C
Sbjct: 274 CINPDPEKRPDVTYVYDVAKRMHAC 298

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 32/76 (42%), Positives = 44/76 (57%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+TA G  +KLGD G     S+ TT     +  VGT  YM+PE   +    G+    
Sbjct: 165 ANVFITATGV-VKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPERIHEN---GYNFKS 217

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLGC+L EM++ +
Sbjct: 218 DIWSLGCLLYEMAALQ 233

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  252 bits (645), Expect = 1e-80
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 18/267 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL--VKYY 68
           G G   KV+  +N E  ++ A+K + L + ++   +     E+  L  + Q +   ++ Y
Sbjct: 65  GSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +  +     + Y K +++A+  +H++ IVH D
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN----- 183
           +K AN FL  +G  LKL DFG A ++   TT     +  VG   YM PE   D +     
Sbjct: 181 LKPAN-FLIVDGM-LKLIDFGIANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 184 ---KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDEG 239
              K       D+WSLGC+L  M+ GK P+ +  +    +   +        P+    + 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
           Q   + CL+ DP QR +I ELL HP++
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYV 324

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 33/85 (38%), Positives = 41/85 (48%), Gaps = 11/85 (12%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN-------- 360
           AN FL  +G  LKL DFG A ++   TT     +  VG   YM PE   D +        
Sbjct: 184 AN-FLIVDGM-LKLIDFGIANQMQPDTT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240

Query: 361 KVGHGRAVDIWSLGCVLVEMSSGKT 385
           K       D+WSLGC+L  M+ GKT
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKT 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  247 bits (634), Expect = 5e-80
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 18/267 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL--VKYY 68
           G G   KV+  +N E  ++ A+K + L + ++   +     E+  L  + Q +   ++ Y
Sbjct: 37  GSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +  +     + Y K +++A+  +H++ IVH D
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 152

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN----- 183
           +K AN  L  +G  LKL DFG A ++   TT     +  VGT  YM PE   D +     
Sbjct: 153 LKPANF-LIVDGM-LKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSREN 209

Query: 184 ---KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDEG 239
              K       D+WSLGC+L  M+ GK P+ +  +    +   +        P+    + 
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 269

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
           Q   + CL+ DP QR +I ELL HP++
Sbjct: 270 QDVLKCCLKRDPKQRISIPELLAHPYV 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 33/85 (38%), Positives = 41/85 (48%), Gaps = 11/85 (12%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN-------- 360
           AN  L  +G  LKL DFG A ++   TT     +  VGT  YM PE   D +        
Sbjct: 156 ANF-LIVDGM-LKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212

Query: 361 KVGHGRAVDIWSLGCVLVEMSSGKT 385
           K       D+WSLGC+L  M+ GKT
Sbjct: 213 KSKISPKSDVWSLGCILYYMTYGKT 237

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  248 bits (636), Expect = 6e-80
 Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 18/267 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL--VKYY 68
           G G   KV+  +N E  ++ A+K + L + ++   +     E+  L  + Q +   ++ Y
Sbjct: 18  GSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
             EI  + + + ME C    L S ++  +  +     + Y K +++A+  +H++ IVH D
Sbjct: 76  DYEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN----- 183
           +K AN  L  +G  LKL DFG A ++   TT     +  VGT  YM PE   D +     
Sbjct: 134 LKPANF-LIVDGM-LKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSREN 190

Query: 184 ---KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDEG 239
              K       D+WSLGC+L  M+ GK P+ +  +    +   +        P+    + 
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 250

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
           Q   + CL+ DP QR +I ELL HP++
Sbjct: 251 QDVLKCCLKRDPKQRISIPELLAHPYV 277

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 33/85 (38%), Positives = 41/85 (48%), Gaps = 11/85 (12%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN-------- 360
           AN  L  +G  LKL DFG A ++   TT     +  VGT  YM PE   D +        
Sbjct: 137 ANF-LIVDGM-LKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193

Query: 361 KVGHGRAVDIWSLGCVLVEMSSGKT 385
           K       D+WSLGC+L  M+ GKT
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKT 218

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  247 bits (633), Expect = 7e-80
 Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 15/257 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G G +G+V+   + E G L A+K      +   +     L E+   E + Q    V+   
Sbjct: 66  GHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQ 124

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  + L  ELC   +L+   ++    LPE  V  Y +  + A++ LH   +VH D+
Sbjct: 125 AWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K ANIFL   G   KLGDFG  V++       G      G   YMAPE+        +G 
Sbjct: 184 KPANIFLGPRGR-CKLGDFGLLVELGT----AGAGEVQEGDPRYMAPELLQG----SYGT 234

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           A D++SLG  ++E++         +   Q+         P     LS E ++   + L  
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQGY---LPPEFTAGLSSELRSVLVMMLEP 291

Query: 250 DPAQRATIFELLQHPFL 266
           DP  RAT   LL  P L
Sbjct: 292 DPKLRATAEALLALPVL 308

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 27/76 (35%), Positives = 37/76 (48%), Gaps = 9/76 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANIFL   G   KLGDFG  V++       G      G   YMAPE+        +G A 
Sbjct: 186 ANIFLGPRGR-CKLGDFGLLVELGT----AGAGEVQEGDPRYMAPELLQG----SYGTAA 236

Query: 369 DIWSLGCVLVEMSSGK 384
           D++SLG  ++E++   
Sbjct: 237 DVFSLGLTILEVACNM 252

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  241 bits (616), Expect = 8e-77
 Identities = 67/257 (26%), Positives = 125/257 (48%), Gaps = 10/257 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGK     + E G    +KEI + + +  +  ++   E+ +L  +   N+V+Y   
Sbjct: 33  GEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRES 91

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 + + M+ C  G L   + + +     E  +  +  Q+  A+  +H+  I+HRDI
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           KS NIFLT +G  ++LGDFG A  +++   +       +GT  Y++PE+  +     +  
Sbjct: 152 KSQNIFLTKDGT-VQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEICENK---PYNN 204

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             DIW+LGCVL E+ + K  + E  S   ++ K+  G  P +    S + ++      + 
Sbjct: 205 KSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKR 263

Query: 250 DPAQRATIFELLQHPFL 266
           +P  R ++  +L+  F+
Sbjct: 264 NPRDRPSVNSILEKGFI 280

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NIFLT +G  ++LGDFG A  +++   +       +GT  Y++PE+  +     +    
Sbjct: 154 QNIFLTKDGT-VQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEICENK---PYNNKS 206

Query: 369 DIWSLGCVLVEMSSGK 384
           DIW+LGCVL E+ + K
Sbjct: 207 DIWALGCVLYELCTLK 222

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  227 bits (582), Expect = 1e-72
 Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 19/266 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+         G+++  KE+      +    + ++ E+ +L  +   N+V+YY  
Sbjct: 15  GTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDR 73

Query: 71  EIHREEMVLF--MELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE---- 121
            I R    L+  ME C  G L S++         L E  V R   QL  A+   H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133

Query: 122 -NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
            +T++HRD+K AN+FL  + N +KLGDFG A  ++  T+       FVGT  YM+PE   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSF---AKTFVGTPYYMSPEQMN 189

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
                 +    DIWSLGC+L E+ +   P+    S  ++  K+  G+   IP   SDE  
Sbjct: 190 RM---SYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRYSDELN 245

Query: 241 AFAELCLRHDPAQRATIFELLQHPFL 266
                 L      R ++ E+L++P +
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLI 271

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 30/76 (39%), Positives = 41/76 (53%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+FL  + N +KLGDFG A  ++  T+       FVGT  YM+PE         +    
Sbjct: 145 ANVFLDGKQN-VKLGDFGLARILNHDTSF---AKTFVGTPYYMSPEQMNRM---SYNEKS 197

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLGC+L E+ +  
Sbjct: 198 DIWSLGCLLYELCALM 213

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  220 bits (563), Expect = 2e-69
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 31/288 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V  A N       A+K+I+  ++     +  +L E+ +L  +N + +V+YY  
Sbjct: 15  GQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLNHQYVVRYYAA 70

Query: 71  EIHREEMV-------------LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
            + R   V             + ME C  GTL  L+ S           R  +Q+++A+S
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP-----------GELNG 166
            +H   I+HRD+K  NIF+    N +K+GDFG A  +     +              L  
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189

Query: 167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG 226
            +GT  Y+A EV        +   +D++SLG +  EM        E  +  + +  V + 
Sbjct: 190 AIGTAMYVATEVL--DGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIE 247

Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
             P   ++     +    L + HDP +R     LL   +L V  +++V
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 14/83 (16%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVP-----------GELNGFVGTQAYMAPEVFM 357
            NIF+    N +K+GDFG A  +     +              L   +GT  Y+A EV  
Sbjct: 145 MNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL- 202

Query: 358 DTNKVGHGRAVDIWSLGCVLVEM 380
                 +   +D++SLG +  EM
Sbjct: 203 -DGTGHYNEKIDMYSLGIIFFEM 224

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  218 bits (558), Expect = 5e-69
 Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 38/273 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG- 69
           G G FG+V+ A +   G+   +K ++ + +   R       E++ L  ++  N+V Y G 
Sbjct: 20  GSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-------EVKALAKLDHVNIVHYNGC 72

Query: 70  ---------------VEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLV 113
                               + + + ME C +GTLE  ++      L +VL     +Q+ 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 114 DAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY 173
             +  +H   +++RD+K +NIFL      +K+GDFG    +        +     GT  Y
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGDFGLVTSLKNDG----KRTRSKGTLRY 187

Query: 174 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           M+PE         +G+ VD+++LG +L E+        E    +  +          I +
Sbjct: 188 MSPEQISSQ---DYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD------GIISD 238

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
               + +   +  L   P  R    E+L+   +
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 8/72 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NIFL      +K+GDFG    +        +     GT  YM+PE         +G+ V
Sbjct: 151 SNIFLVDTKQ-VKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQ---DYGKEV 202

Query: 369 DIWSLGCVLVEM 380
           D+++LG +L E+
Sbjct: 203 DLYALGLILAEL 214

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  216 bits (551), Expect = 3e-67
 Identities = 77/257 (29%), Positives = 132/257 (51%), Gaps = 11/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A +    E+VA+K++    +      +D++ E+R L+ +   N ++Y G 
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRD+K
Sbjct: 123 YLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L+  G  +KLGDFGSA  ++   +       FVGT  +MAPEV +  ++  +   
Sbjct: 182 AGNILLSEPGL-VKLGDFGSASIMAPANS-------FVGTPYWMAPEVILAMDEGQYDGK 233

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDEGQAFAELCLRH 249
           VD+WSLG   +E++  K P    ++    ++ +   E+P +     S+  + F + CL+ 
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292

Query: 250 DPAQRATIFELLQHPFL 266
            P  R T   LL+H F+
Sbjct: 293 IPQDRPTSEVLLKHRFV 309

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 29/76 (38%), Positives = 43/76 (56%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI L+  G  +KLGDFGSA  ++   +       FVGT  +MAPEV +  ++  +   V
Sbjct: 183 GNILLSEPGL-VKLGDFGSASIMAPANS-------FVGTPYWMAPEVILAMDEGQYDGKV 234

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WSLG   +E++  K
Sbjct: 235 DVWSLGITCIELAERK 250

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  213 bits (545), Expect = 7e-67
 Identities = 62/279 (22%), Positives = 116/279 (41%), Gaps = 32/279 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V+ A N       A+K I+L  +  AR  + ++ E++ L  +    +V+Y+  
Sbjct: 14  GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPGIVRYFNA 71

Query: 71  EIHREEM----------VLF--MELCTEGTLESLV--QSTEDGLPEVLVRRYTKQLVDAI 116
            + +              L+  M+LC +  L+  +  + T +     +      Q+ +A+
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA---------VKISAHTTVPGELNGF 167
             LH   ++HRD+K +NIF T +   +K+GDFG             +           G 
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE 227
           VGT+ YM+PE     +   +   VDI+SLG +L E+     P++      + +  V   +
Sbjct: 191 VGTKLYMSPEQI---HGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLK 244

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            P +            +  L   P +R     ++++   
Sbjct: 245 FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 25/81 (30%), Positives = 37/81 (45%), Gaps = 13/81 (16%)

Query: 309 ANIFLTAEGNSLKLGDFGSA---------VKISAHTTVPGELNGFVGTQAYMAPEVFMDT 359
           +NIF T +   +K+GDFG             +           G VGT+ YM+PE     
Sbjct: 147 SNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI--- 202

Query: 360 NKVGHGRAVDIWSLGCVLVEM 380
           +   +   VDI+SLG +L E+
Sbjct: 203 HGNSYSHKVDIFSLGLILFEL 223

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  213 bits (545), Expect = 7e-67
 Identities = 84/260 (32%), Positives = 143/260 (55%), Gaps = 12/260 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ETG L A K I+   + +   ++D +VE+ IL   +   +VK  G 
Sbjct: 28  GDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGA 84

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H  ++ + +E C  G +++++   + GL E  ++   +Q+++A++ LH   I+HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM--DTNKVGHG 188
           + N+ +T EG+ ++L DFG + K         + + F+GT  +MAPEV M        + 
Sbjct: 145 AGNVLMTLEGD-IRLADFGVSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYD 200

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              DIWSLG  L+EM+  + P  E +   +++ K+   + PT+  P   S E + F ++ 
Sbjct: 201 YKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIA 259

Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  +P  R +  +LL+HPF+
Sbjct: 260 LDKNPETRPSAAQLLEHPFV 279

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 6/78 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM--DTNKVGHGR 366
            N+ +T EG+ ++L DFG + K         + + F+GT  +MAPEV M        +  
Sbjct: 146 GNVLMTLEGD-IRLADFGVSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDY 201

Query: 367 AVDIWSLGCVLVEMSSGK 384
             DIWSLG  L+EM+  +
Sbjct: 202 KADIWSLGITLIEMAQIE 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  207 bits (530), Expect = 2e-64
 Identities = 85/258 (32%), Positives = 139/258 (53%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A++ ETG++VA+K++ +        +++++ E+ I++  +  ++VKYYG 
Sbjct: 38  GEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGS 92

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ + ME C  G++  +++     L E  +    +  +  +  LH    +HRDIK
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L  EG+  KL DFG A +++       + N  +GT  +MAPEV  +    G+   
Sbjct: 153 AGNILLNTEGH-AKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEI---GYNCV 205

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
            DIWSLG   +EM+ GK P+A+     + +F +     PT   PE  SD    F + CL 
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHP-MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264

Query: 249 HDPAQRATIFELLQHPFL 266
             P QRAT  +LLQHPF+
Sbjct: 265 KSPEQRATATQLLQHPFV 282

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 30/76 (39%), Positives = 41/76 (53%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI L  EG+  KL DFG A +++       + N  +GT  +MAPEV  +    G+    
Sbjct: 154 GNILLNTEGH-AKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEI---GYNCVA 206

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +EM+ GK
Sbjct: 207 DIWSLGITAIEMAEGK 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  207 bits (528), Expect = 2e-64
 Identities = 87/282 (30%), Positives = 142/282 (50%), Gaps = 25/282 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q      + ++ E+ ++      N+V Y   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDS 85

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V  T   + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G+ +KL DFG   +I+   +   + +  VGT  +MAPEV        +G  
Sbjct: 144 SDNILLGMDGS-VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK---AYGPK 196

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   +   + ++ +    TP +  PE LS   + F   CL 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 249 HDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
            D  +R +  ELLQH FL ++           P S L   + 
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAK----------PLSSLTPLIA 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI L  +G+ +KL DFG   +I+   +   + +  VGT  +MAPEV        +G  V
Sbjct: 145 DNILLGMDGS-VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK---AYGPKV 197

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG + +EM  G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  204 bits (522), Expect = 2e-63
 Identities = 79/256 (30%), Positives = 136/256 (53%), Gaps = 12/256 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V+  ++N T ++VA+K I L +  D   ++D+  E+ +L   +   + KYYG 
Sbjct: 31  GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +   ++ + ME    G+   L++     L E  +    ++++  +  LH    +HRDIK
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIK 146

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           +AN+ L+  G  +KL DFG A +++       + N FVGT  +MAPEV   +    +   
Sbjct: 147 AANVLLSEHGE-VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQS---AYDSK 199

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIWSLG   +E++ G+ P +E     +++F +     PT+  + S   + F E CL  +
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHP-MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258

Query: 251 PAQRATIFELLQHPFL 266
           P+ R T  ELL+H F+
Sbjct: 259 PSFRPTAKELLKHKFI 274

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+ L+  G  +KL DFG A +++       + N FVGT  +MAPEV   +    +    
Sbjct: 148 ANVLLSEHGE-VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQS---AYDSKA 200

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG   +E++ G+
Sbjct: 201 DIWSLGITAIELARGE 216

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  205 bits (523), Expect = 2e-63
 Identities = 84/258 (32%), Positives = 125/258 (48%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G V  A    +G  VA+K + L KQ      + +  E+ I+      N+V+ Y  
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  EE+ + ME    G L  +V      L E  +    + ++ A++ LH   ++HRDIK
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S +I LT +G  +KL DFG   +IS       +    VGT  +MAPEV   +    +   
Sbjct: 169 SDSILLTLDGR-VKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRS---LYATE 221

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG +++EM  G+ P+       Q M ++     P +     +S   + F E  L 
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSP-VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 249 HDPAQRATIFELLQHPFL 266
            DP +RAT  ELL HPFL
Sbjct: 281 RDPQERATAQELLDHPFL 298

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 29/76 (38%), Positives = 41/76 (53%), Gaps = 7/76 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            +I LT +G  +KL DFG   +IS       +    VGT  +MAPEV   +    +   V
Sbjct: 170 DSILLTLDGR-VKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRS---LYATEV 222

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWSLG +++EM  G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  204 bits (521), Expect = 4e-63
 Identities = 74/270 (27%), Positives = 137/270 (50%), Gaps = 14/270 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G G  G+V+     +TG ++A+K+++     +    K +L++L ++ +  +   +V+ +G
Sbjct: 34  GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN--KRILMDLDVVLKSHDCPYIVQCFG 91

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRD 128
             I   ++ + MEL      E L +  +  +PE ++ + T  +V A+  L  ++ ++HRD
Sbjct: 92  TFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K +NI L   G  +KL DFG    IS         +   G  AYMAPE     +     
Sbjct: 151 VKPSNILLDERGQ-IKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 189 RAV--DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL--SDEGQAFAE 244
             +  D+WSLG  LVE+++G+ P+    ++++++ KV   E P +P  +  S + Q+F +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
            CL  D  +R    +LL+H F+      +V
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 27/78 (34%), Positives = 37/78 (47%), Gaps = 7/78 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI L   G  +KL DFG    IS         +   G  AYMAPE     +       +
Sbjct: 154 SNILLDERGQ-IKLCDFG----ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208

Query: 369 --DIWSLGCVLVEMSSGK 384
             D+WSLG  LVE+++G+
Sbjct: 209 RADVWSLGISLVELATGQ 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  205 bits (524), Expect = 3e-62
 Identities = 60/263 (22%), Positives = 104/263 (39%), Gaps = 15/263 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G G  G +           VA+K I                E+++L   ++  N+++Y+ 
Sbjct: 33  GHGAEGTIV-YRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHPNVIRYFC 85

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            E  R+   + +ELC   TL+  V+  +     +      +Q    ++ LH   IVHRD+
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144

Query: 130 KSANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           K  NI ++           + DFG   K++         +G  GT+ ++APE+  +  K 
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204

Query: 186 GHGRAVDIWSLGCVLVEM-SSGKRP-WAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
                VDI+S GCV   + S G  P          I+      +     +      +   
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELI 264

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
           E  +  DP +R +   +L+HPF 
Sbjct: 265 EKMIAMDPQKRPSAKHVLKHPFF 287

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 21/79 (26%), Positives = 34/79 (43%), Gaps = 4/79 (5%)

Query: 309 ANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 364
            NI ++           + DFG   K++         +G  GT+ ++APE+  +  K   
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206

Query: 365 GRAVDIWSLGCVLVEMSSG 383
              VDI+S GCV   + S 
Sbjct: 207 TYTVDIFSAGCVFYYVISE 225

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  200 bits (512), Expect = 4e-62
 Identities = 72/271 (26%), Positives = 136/271 (50%), Gaps = 15/271 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-LEGINQKNLVKYYG 69
           G+G +G V    +  +G+++A+K I+    +  +  K +L++L I +  ++    V +YG
Sbjct: 16  GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ--KRLLMDLDISMRTVDCPFTVTFYG 73

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTED---GLPEVLVRRYTKQLVDAISALHENT-IV 125
                 ++ + MEL  + +L+   +   D    +PE ++ +    +V A+  LH    ++
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVI 132

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNK 184
           HRD+K +N+ + A G  +K+ DFG    IS +       +   G + YMAPE    + N+
Sbjct: 133 HRDVKPSNVLINALGQ-VKMCDFG----ISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL-SDEGQAFA 243
            G+    DIWSLG  ++E++  + P+  + + +Q + +V    +P +P    S E   F 
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247

Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
             CL+ +  +R T  EL+QHPF  +   +  
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESKGT 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 70.7 bits (174), Expect = 6e-14
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 6/77 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGRA 367
           +N+ + A G  +K+ DFG    IS +       +   G + YMAPE    + N+ G+   
Sbjct: 139 SNVLINALGQ-VKMCDFG----ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVK 193

Query: 368 VDIWSLGCVLVEMSSGK 384
            DIWSLG  ++E++  +
Sbjct: 194 SDIWSLGITMIELAILR 210

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  202 bits (515), Expect = 4e-62
 Identities = 82/291 (28%), Positives = 148/291 (50%), Gaps = 26/291 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G G +G+VY   + +TG+L A+K + +    +    +++  E+ +L +  + +N+  YYG
Sbjct: 33  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYG 88

Query: 70  ------VEIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHEN 122
                      +++ L ME C  G++  L+++T+   L E  +    ++++  +S LH++
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV--FM 180
            ++HRDIK  N+ LT     +KL DFG + ++    TV G  N F+GT  +MAPEV    
Sbjct: 149 KVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDR--TV-GRRNTFIGTPYWMAPEVIACD 204

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSDEG 239
           +     +    D+WSLG   +EM+ G  P  +     + +F +     P +  +  S + 
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPAPRLKSKKWSKKF 263

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
           Q+F E CL  + +QR    +L++HPF+      D  N R V    L+D++ 
Sbjct: 264 QSFIESCLVKNHSQRPATEQLMKHPFI-----RDQPNERQV-RIQLKDHID 308

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 28/78 (35%), Positives = 40/78 (51%), Gaps = 6/78 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV--FMDTNKVGHGR 366
            N+ LT     +KL DFG + ++    TV G  N F+GT  +MAPEV    +     +  
Sbjct: 158 QNVLLTENAE-VKLVDFGVSAQLDR--TV-GRRNTFIGTPYWMAPEVIACDENPDATYDF 213

Query: 367 AVDIWSLGCVLVEMSSGK 384
             D+WSLG   +EM+ G 
Sbjct: 214 KSDLWSLGITAIEMAEGA 231

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  201 bits (514), Expect = 4e-62
 Identities = 63/271 (23%), Positives = 95/271 (35%), Gaps = 18/271 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V        G   A+K I  H+Q D    ++   E  +    N  N+++    
Sbjct: 38  GEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNHPNILRLVAY 94

Query: 71  EIHRE----EMVLFMELCTEGTLESL---VQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            +       E  L +     GTL +    ++   + L E  +      +   + A+H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG------FVGTQAYMAPE 177
             HRD+K  NI L  EG    L D GS  +   H     +            T +Y APE
Sbjct: 155 YAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPESLS 236
           +F   +        D+WSLGCVL  M  G+ P    +     +   V    +       S
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273

Query: 237 DEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
                     +  DP QR  I  LL     +
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 26/83 (31%), Positives = 33/83 (39%), Gaps = 7/83 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG------FVGTQAYMAPEVFMDTNKV 362
            NI L  EG    L D GS  +   H     +            T +Y APE+F   +  
Sbjct: 163 TNILLGDEGQ-PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC 221

Query: 363 GHGRAVDIWSLGCVLVEMSSGKT 385
                 D+WSLGCVL  M  G+ 
Sbjct: 222 VIDERTDVWSLGCVLYAMMFGEG 244

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  200 bits (510), Expect = 6e-62
 Identities = 71/258 (27%), Positives = 121/258 (46%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  VY A +  TG  VA+K I       A  V+ +  E++I   +   ++++ Y  
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 71  EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  V L +E+C  G +   +++      E   R +  Q++  +  LH + I+HRD+
Sbjct: 80  -FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
             +N+ LT   N +K+ DFG    ++    +P E      GT  Y++PE+     +  HG
Sbjct: 139 TLSNLLLTRNMN-IKIADFG----LATQLKMPHEKHYTLCGTPNYISPEIA---TRSAHG 190

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCL 247
              D+WSLGC+   +  G+ P+       +    KV + +   +P  LS E +      L
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPF--DTDTVKNTLNKVVLADY-EMPSFLSIEAKDLIHQLL 247

Query: 248 RHDPAQRATIFELLQHPF 265
           R +PA R ++  +L HPF
Sbjct: 248 RRNPADRLSLSSVLDHPF 265

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 74.1 bits (183), Expect = 3e-15
 Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ LT   N +K+ DFG    ++    +P E      GT  Y++PE+     +  HG   
Sbjct: 142 NLLLTRNMN-IKIADFG----LATQLKMPHEKHYTLCGTPNYISPEIA---TRSAHGLES 193

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WSLGC+   +  G+
Sbjct: 194 DVWSLGCMFYTLLIGR 209

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  199 bits (509), Expect = 4e-61
 Identities = 81/275 (29%), Positives = 138/275 (50%), Gaps = 19/275 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-LEGINQKNLVKYYG 69
           G+G +G V   V+  +G+++A+K I+       +  K +L++L + +   +   +V++YG
Sbjct: 31  GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ--KQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 70  VEIHREEMVLFMELCTEGTLESLV----QSTEDGLPEVLVRRYTKQLVDAISALHENT-I 124
                 +  + MEL    + +          +D +PE ++ + T   V A++ L EN  I
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTN 183
           +HRDIK +NI L   GN +KL DFG    IS             G + YMAPE      +
Sbjct: 148 IHRDIKPSNILLDRSGN-IKLCDFG----ISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL----SDEG 239
           + G+    D+WSLG  L E+++G+ P+ +++S +  + +V  G+ P +  S     S   
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
             F  LCL  D ++R    ELL+HPF+++  E  V
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 27/77 (35%), Positives = 38/77 (49%), Gaps = 6/77 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM-DTNKVGHGRA 367
           +NI L   GN +KL DFG    IS             G + YMAPE      ++ G+   
Sbjct: 155 SNILLDRSGN-IKLCDFG----ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR 209

Query: 368 VDIWSLGCVLVEMSSGK 384
            D+WSLG  L E+++G+
Sbjct: 210 SDVWSLGITLYELATGR 226

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  199 bits (509), Expect = 5e-61
 Identities = 80/297 (26%), Positives = 135/297 (45%), Gaps = 21/297 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109

Query: 71  EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                + V + +ELC   +L  L +     L E   R Y +Q+V     LH N ++HRD+
Sbjct: 110 -FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+FL  +   +K+GDFG    ++      GE      GT  Y+APEV    +K GH 
Sbjct: 168 KLGNLFLNEDLE-VKIGDFG----LATKVEYDGERKKVLCGTPNYIAPEVL---SKKGHS 219

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCL 247
             VD+WS+GC++  +  GK P+    S  +  + ++   E  +IP+ ++    +  +  L
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 276

Query: 248 RHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVK 304
           + DP  R TI ELL   F           P  +P + L    +  I    +   + K
Sbjct: 277 QTDPTARPTINELLNDEFFTSGYI-----PARLPITCLTIPPRFSIAPSSLDPSNRK 328

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 28/76 (36%), Positives = 41/76 (53%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  +   +K+GDFG    ++      GE      GT  Y+APEV    +K GH   V
Sbjct: 171 NLFLNEDLE-VKIGDFG----LATKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFEV 222

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 223 DVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  198 bits (505), Expect = 7e-61
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 21/279 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F K +   + +T E+ A K +           + M +E+ I   +  +++V ++G 
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83

Query: 71  EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                + V + +ELC   +L  L +     L E   R Y +Q+V     LH N ++HRD+
Sbjct: 84  -FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+FL  +   +K+GDFG    ++      GE      GT  Y+APEV    +K GH 
Sbjct: 142 KLGNLFLNEDLE-VKIGDFG----LATKVEYDGERKKVLCGTPNYIAPEVL---SKKGHS 193

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCL 247
             VD+WS+GC++  +  GK P+    S  +  + ++   E  +IP+ ++    +  +  L
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 250

Query: 248 RHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
           + DP  R TI ELL   F           P  +P + L 
Sbjct: 251 QTDPTARPTINELLNDEFFTSGYI-----PARLPITCLT 284

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 28/76 (36%), Positives = 41/76 (53%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+FL  +   +K+GDFG    ++      GE      GT  Y+APEV    +K GH   V
Sbjct: 145 NLFLNEDLE-VKIGDFG----LATKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFEV 196

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC++  +  GK
Sbjct: 197 DVWSIGCIMYTLLVGK 212

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  196 bits (500), Expect = 4e-59
 Identities = 61/306 (19%), Positives = 115/306 (37%), Gaps = 54/306 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G      V  A    TGE V ++ I L   ++      +  EL + +  N  N+V Y   
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV-TFLQGELHVSKLFNHPNIVPYRAT 94

Query: 71  EIHREEMVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            I   E+ +       G+ + L+ +   DG+ E+ +    + ++ A+  +H    VHR +
Sbjct: 95  FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSV 154

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAH----TTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           K+++I ++ +G  + L    S + + +H      V       V    +++PEV +  N  
Sbjct: 155 KASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-LQQNLQ 212

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-------------- 231
           G+    DI+S+G    E+++G  P+ +  +  Q++ +   G  P +              
Sbjct: 213 GYDAKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKLNGTVPCLLDTSTIPAEELTMS 271

Query: 232 -------------------------------PESLSDEGQAFAELCLRHDPAQRATIFEL 260
                                            + S     F E CL+ +P  R +   L
Sbjct: 272 PSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331

Query: 261 LQHPFL 266
           L H F 
Sbjct: 332 LNHSFF 337

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 18/80 (22%), Positives = 37/80 (46%), Gaps = 6/80 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAH----TTVPGELNGFVGTQAYMAPEVFMDTNKVGH 364
           ++I ++ +G  + L    S + + +H      V       V    +++PEV +  N  G+
Sbjct: 157 SHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-LQQNLQGY 214

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
               DI+S+G    E+++G 
Sbjct: 215 DAKSDIYSVGITACELANGH 234

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  193 bits (492), Expect = 7e-59
 Identities = 71/274 (25%), Positives = 131/274 (47%), Gaps = 24/274 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G    V  A      E VA+K I L K   +  + ++L E++ +   +  N+V YY  
Sbjct: 24  GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-------LPEVLVRRYTKQLVDAISALHENT 123
            + ++E+ L M+L + G++  +++            L E  +    +++++ +  LH+N 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL--NGFVGTQAYMAPEVFMD 181
            +HRD+K+ NI L  +G+ +++ DFG +  ++    +        FVGT  +MAPEV   
Sbjct: 142 QIHRDVKAGNILLGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
               G+    DIWS G   +E+++G  P+ +Y    +++      + P++   + D+   
Sbjct: 201 VR--GYDFKADIWSFGITAIELATGAAPYHKYPPM-KVLMLTLQNDPPSLETGVQDKEML 257

Query: 242 ---------FAELCLRHDPAQRATIFELLQHPFL 266
                       LCL+ DP +R T  ELL+H F 
Sbjct: 258 KKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL--NGFVGTQAYMAPEVFMDTNKVGHGR 366
            NI L  +G+ +++ DFG +  ++    +        FVGT  +MAPEV       G+  
Sbjct: 150 GNILLGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR--GYDF 206

Query: 367 AVDIWSLGCVLVEMSSGK 384
             DIWS G   +E+++G 
Sbjct: 207 KADIWSFGITAIELATGA 224

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  188 bits (481), Expect = 1e-57
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 18/265 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 71  EIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             H    V L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDI
Sbjct: 78  -FHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDI 135

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N+ L + G  LK+ DFG     S H   P        GT  Y+ PE+        H 
Sbjct: 136 KPENLLLGSAGE-LKIADFG----WSVHA--PSSRRTDLCGTLDYLPPEMI---EGRMHD 185

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCL 247
             VD+WSLG +  E   GK P+    + YQ  + ++   E  T P+ +++  +      L
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVE-FTFPDFVTEGARDLISRLL 242

Query: 248 RHDPAQRATIFELLQHPFLIVSCEE 272
           +H+P+QR  + E+L+HP++  +  +
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSK 267

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 26/77 (33%), Positives = 33/77 (42%), Gaps = 11/77 (14%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L + G  LK+ DFG     S H   P        GT  Y+ PE+        H   V
Sbjct: 139 NLLLGSAGE-LKIADFG----WSVHA--PSSRRTDLCGTLDYLPPEMI---EGRMHDEKV 188

Query: 369 DIWSLGCVLVEMSSGKT 385
           D+WSLG +  E   GK 
Sbjct: 189 DLWSLGVLCYEFLVGKP 205

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  186 bits (473), Expect = 5e-56
 Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG    V+   + +TG+L A+K    +  +  R V   + E  +L+ +N KN+VK + +
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 71  --EIHREEMVLFMELCTEGTLESLVQS--TEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             E      VL ME C  G+L ++++      GLPE       + +V  ++ L EN IVH
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 127 RDIKSANIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF---- 179
           R+IK  NI      +     KL DFG+A ++              GT+ Y+ P+++    
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAV 191

Query: 180 -MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY---DSNYQIMFKVGMGE-------- 227
               ++  +G  VD+WS+G      ++G  P+  +     N ++M+K+  G+        
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251

Query: 228 ----------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
                           + ++   L           L  D  +     +       I+ 
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 12/83 (14%)

Query: 310 NIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF-----MDTNK 361
           NI      +     KL DFG+A ++              GT+ Y+ P+++        ++
Sbjct: 142 NIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 362 VGHGRAVDIWSLGCVLVEMSSGK 384
             +G  VD+WS+G      ++G 
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGS 220

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  183 bits (467), Expect = 2e-55
 Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 24/261 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG VY A   +   ++A+K +   QL K+     ++    E+ I   +   N+++ 
Sbjct: 23  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR---EIEIQSHLRHPNILRM 79

Query: 68  YGVEIHREEMV-LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           Y    H  + + L +E    G L   +Q       E     + ++L DA+   HE  ++H
Sbjct: 80  YNY-FHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIH 137

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKV 185
           RDIK  N+ +  +G  LK+ DFG     S H   P        GT  Y+ PE+       
Sbjct: 138 RDIKPENLLMGYKGE-LKIADFG----WSVHA--PSLRRRTMCGTLDYLPPEMI---EGK 187

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAE 244
            H   VD+W  G +  E   G  P+     ++     ++   +    P  LSD  +    
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPF--DSPSHTETHRRIVNVD-LKFPPFLSDGSKDLIS 244

Query: 245 LCLRHDPAQRATIFELLQHPF 265
             LR+ P QR  +  +++HP+
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPW 265

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 22/77 (28%), Positives = 30/77 (38%), Gaps = 11/77 (14%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  +G  LK+ DFG     S H   P        GT  Y+ PE+        H   V
Sbjct: 144 NLLMGYKGE-LKIADFG----WSVHA--PSLRRRTMCGTLDYLPPEMI---EGKTHDEKV 193

Query: 369 DIWSLGCVLVEMSSGKT 385
           D+W  G +  E   G  
Sbjct: 194 DLWCAGVLCYEFLVGMP 210

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  185 bits (471), Expect = 1e-54
 Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 18/267 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGINQKNLV 65
           G G  G+V  A   +T + VA++ I   K       +A    ++  E+ IL+ +N   ++
Sbjct: 144 GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 203

Query: 66  KYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           K        E+  + +EL   G L + +V +    L E   + Y  Q++ A+  LHEN I
Sbjct: 204 KIKNF-FDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGI 260

Query: 125 VHRDIKSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
           +HRD+K  N+ L+   E   +K+ DFG +  +   +     +    GT  Y+APEV +  
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSV 316

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEG 239
              G+ RAVD WSLG +L    SG  P++E+ +   +  ++  G+   IPE    +S++ 
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA 376

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
               +  L  DP  R T  E L+HP+L
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHPWL 403

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 24/70 (34%), Positives = 36/70 (51%), Gaps = 6/70 (8%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ L+   E   +K+ DFG +  +   +     +    GT  Y+APEV +     G+ RA
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRA 324

Query: 368 VDIWSLGCVL 377
           VD WSLG +L
Sbjct: 325 VDCWSLGVIL 334

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  183 bits (465), Expect = 3e-54
 Identities = 46/295 (15%), Positives = 81/295 (27%), Gaps = 48/295 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
             G    V+   + E  E  A+K   +  +N    ++ +         +  ++  +    
Sbjct: 71  RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130

Query: 71  E--------------------------IHREEMVLFMELCTEGTLESLVQ-----STEDG 99
                                            +L M       LE L           G
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRG 189

Query: 100 LPEVLVRRY-TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT 158
              +L     T QL+   + L    +VH      N+F+  +G  L LGD  +  K     
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSALWK----- 243

Query: 159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
              G            AP  F++ +      A++ W LG  +  +     P+       +
Sbjct: 244 --VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 219 IMFKVGMGETPTIPE-------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +K      P            L D  +      L  D  +R    E ++ P  
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+F+  +G  L LGD  +  K        G            AP  F++ +      A+
Sbjct: 223 DNLFIMPDGR-LMLGDVSALWK-------VGTRGPASSVPVTYAPREFLNASTATFTHAL 274

Query: 369 DIWSLGCVLVEMSSGK 384
           + W LG  +  +    
Sbjct: 275 NAWQLGLSIYRVWCLF 290

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  183 bits (466), Expect = 1e-53
 Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 38/285 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G G  G V     +  G  VA+K + +   + A       +E+++L E  +  N+++YY 
Sbjct: 24  GYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL------MEIKLLTESDDHPNVIRYYC 76

Query: 70  VEIHREEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTKQLVDAISALHENT 123
            E     + + +ELC    L+ LV+S            E       +Q+   ++ LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135

Query: 124 IVHRDIKSANIFLTAEGNS------------LKLGDFGSAVKISA-HTTVPGELNGFVGT 170
           I+HRD+K  NI ++                 + + DFG   K+ +  ++    LN   GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195

Query: 171 QAYMAPEVFMDTN----KVGHGRAVDIWSLGCVLVEM-SSGKRP-WAEYDSNYQIM---F 221
             + APE+  ++N    K    R++DI+S+GCV   + S GK P   +Y     I+   F
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 255

Query: 222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            +   +      SL  E        + HDP +R T  ++L+HP  
Sbjct: 256 SLDEMKCL-HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 29/152 (19%)

Query: 244 ELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD------YL-KLGIV-- 294
           ELC          + +L++     VS E         P S+L+       +L  L I+  
Sbjct: 89  ELC-------NLNLQDLVESK--NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR 139

Query: 295 -LPPMSED---SVKVYARANIFLTAEGNSLKLGDFGSAVKISA-HTTVPGELNGFVGTQA 349
            L P  ++   S      A+    AE   + + DFG   K+ +  ++    LN   GT  
Sbjct: 140 DLKP--QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197

Query: 350 YMAPEVFMDTN----KVGHGRAVDIWSLGCVL 377
           + APE+  ++N    K    R++DI+S+GCV 
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  184 bits (469), Expect = 1e-53
 Identities = 66/284 (23%), Positives = 127/284 (44%), Gaps = 21/284 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  TG+  A+K I   +       + +L E+++L+ ++  N++K Y  
Sbjct: 35  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
              +    L  E+ T G L + ++        EV   R  +Q++  I+ +H+N IVHRD+
Sbjct: 95  FEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 152

Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+ L   ++  ++++ DFG +           + +   +GT  Y+APEV        
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFE-----ASKKMKDKIGTAYYIAPEVL----HGT 203

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGE--TPTIP-ESLSDEGQAF 242
           +    D+WS G +L  + SG  P      + Y I+ KV  G+        + +S+  +  
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGA--NEYDILKKVEKGKYTFELPQWKKVSESAKDL 261

Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
               L + P+ R +  + L H ++    +E +        + + 
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAIL 305

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 19/77 (24%), Positives = 35/77 (45%), Gaps = 12/77 (15%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L   ++  ++++ DFG +           + +   +GT  Y+APEV        +  
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFE-----ASKKMKDKIGTAYYIAPEVL----HGTYDE 206

Query: 367 AVDIWSLGCVLVEMSSG 383
             D+WS G +L  + SG
Sbjct: 207 KCDVWSTGVILYILLSG 223

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  181 bits (460), Expect = 2e-53
 Identities = 43/297 (14%), Positives = 91/297 (30%), Gaps = 56/297 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM--------------------- 49
           GQ        A + ETGE   +      ++  +  +K M                     
Sbjct: 82  GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141

Query: 50  ----LVELRILEGINQKNLVKYYGVEIHREEMVLF--MELCTEGTLESLVQ-----STED 98
               +    +++   +K +++    E     +  F       +  L++  +     S+  
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTH 200

Query: 99  GLPEVLVRRY-TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH 157
                  R   T Q++  +++LH   +VH  ++  +I L   G  + L  F   V+  A 
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDGAR 259

Query: 158 TTVPGELNGFVGTQAYMAPEV--------FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP 209
                       ++ +  PE+        +    +     + D W+LG V+  +     P
Sbjct: 260 VV-------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 210 WAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                       +        IP+ +        E  LR+    R    + ++ P  
Sbjct: 313 I--TKDAALGGSEWIFRSCKNIPQPVRA----LLEGFLRYPKEDRLLPLQAMETPEY 363

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 14/84 (16%), Positives = 27/84 (32%), Gaps = 16/84 (19%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV--------FMDTNK 361
           +I L   G  + L  F   V+  A             ++ +  PE+        +    +
Sbjct: 236 DIVLDQRGG-VFLTGFEHLVRDGARVV-------SSVSRGFEPPELEARRATISYHRDRR 287

Query: 362 VGHGRAVDIWSLGCVLVEMSSGKT 385
                + D W+LG V+  +     
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADL 311

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  180 bits (457), Expect = 3e-53
 Identities = 82/312 (26%), Positives = 139/312 (44%), Gaps = 65/312 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I L  +   R    ++ EL++L   N   +V +YG 
Sbjct: 42  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSPYIVGFYGA 99

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E   I+HRD+
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 158

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNK 184
           K +NI + + G  +KL DFG          V G+L     N FVGT++YM+PE    T  
Sbjct: 159 KPSNILVNSRGE-IKLCDFG----------VSGQLIDSMANSFVGTRSYMSPERLQGT-- 205

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN---------------------------- 216
             +    DIWS+G  LVEM+ G+ P    D+                             
Sbjct: 206 -HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 217 -------------YQIMFKVGMGETPTIPESL-SDEGQAFAELCLRHDPAQRATIFELLQ 262
                        ++++  +     P +P  + S E Q F   CL  +PA+RA + +L+ 
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

Query: 263 HPFLIVSCEEDV 274
           H F+  S  E+V
Sbjct: 325 HAFIKRSDAEEV 336

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 31/81 (38%), Positives = 43/81 (53%), Gaps = 19/81 (23%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-----NGFVGTQAYMAPEVFMDTNKVG 363
           +NI + + G  +KL DFG          V G+L     N FVGT++YM+PE    T    
Sbjct: 161 SNILVNSRGE-IKLCDFG----------VSGQLIDSMANSFVGTRSYMSPERLQGT---H 206

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
           +    DIWS+G  LVEM+ G+
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGR 227

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  179 bits (455), Expect = 5e-53
 Identities = 71/312 (22%), Positives = 121/312 (38%), Gaps = 35/312 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
            +G F  VY A +  +G   A+K +  +++   R +     E+  ++ +    N+V++  
Sbjct: 37  AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHPNIVQFCS 93

Query: 70  VEIHR--------EEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALH 120
                         E +L  ELC    +E L +    G L    V +   Q   A+  +H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 121 ENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG---------ELNGFVG 169
                I+HRD+K  N+ L+ +G  +KL DFGSA  IS +              E      
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGT-IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP 229
           T  Y  PE+    +    G   DIW+LGC+L  +   + P+   D       ++  G+  
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGA---KLRIVNGK-Y 266

Query: 230 TIPESL--SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
           +IP          +     L+ +P +R +I E++     I        NP+S    +L+ 
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI--AAARNVNPKSPITELLEQ 324

Query: 288 YLKLGIVLPPMS 299
               G       
Sbjct: 325 NGGYGSATLSRG 336

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 10/85 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG---------ELNGFVGTQAYMAPEVFMDTN 360
           N+ L+ +G  +KL DFGSA  IS +              E      T  Y  PE+    +
Sbjct: 168 NLLLSNQGT-IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226

Query: 361 KVGHGRAVDIWSLGCVLVEMSSGKT 385
               G   DIW+LGC+L  +   + 
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQH 251

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  178 bits (454), Expect = 5e-53
 Identities = 59/322 (18%), Positives = 113/322 (35%), Gaps = 73/322 (22%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK----------------EIQLHKQNDARFV-------- 46
           G+G FG V+ A N       A+K                E++   + +   +        
Sbjct: 15  GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74

Query: 47  -------------------------------KDMLVELRILEGINQKNLVKYYGVEIHRE 75
                                              V++R ++  + KN V        + 
Sbjct: 75  ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKV 134

Query: 76  EMVLFMELCTEGTLESLV--QSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSAN 133
            + + M+LC +  L+  +  + + +     +      Q+ +A+  LH   ++HRD+K +N
Sbjct: 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN 194

Query: 134 IFLTAEGNSLKLGDFGSA---------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           IF T +   +K+GDFG             +           G VGT+ YM+PE     + 
Sbjct: 195 IFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI---HG 250

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
             +   VDI+SLG +L E+        E     +I+  V   + P +      +     +
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQ 307

Query: 245 LCLRHDPAQRATIFELLQHPFL 266
             L   P +R    +++++   
Sbjct: 308 DMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 83.0 bits (205), Expect = 7e-18
 Identities = 25/81 (30%), Positives = 37/81 (45%), Gaps = 13/81 (16%)

Query: 309 ANIFLTAEGNSLKLGDFGSA---------VKISAHTTVPGELNGFVGTQAYMAPEVFMDT 359
           +NIF T +   +K+GDFG             +           G VGT+ YM+PE     
Sbjct: 193 SNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI--- 248

Query: 360 NKVGHGRAVDIWSLGCVLVEM 380
           +   +   VDI+SLG +L E+
Sbjct: 249 HGNNYSHKVDIFSLGLILFEL 269

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  178 bits (454), Expect = 6e-53
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 52/304 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYY 68
           GQG +G V  A+ N+T  + A+K +  +K  Q + + V+ +  E+R+++ ++  N+ + Y
Sbjct: 35  GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY 94

Query: 69  GVEIHREEMVLFMELCTEGTL--------------------------------------- 89
            V    + + L MELC  G L                                       
Sbjct: 95  EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154

Query: 90  ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANI-FLTAEGNSLKLGDF 148
               +S +    E L+    +Q+  A+  LH   I HRDIK  N  F T +   +KL DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214

Query: 149 GSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 207
           G + +           +    GT  ++APEV   TN+  +G   D WS G +L  +  G 
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE-SYGPKCDAWSAGVLLHLLLMGA 273

Query: 208 RP-WAEYDSNYQIMFKVGMGETPTIPE----SLSDEGQAFAELCLRHDPAQRATIFELLQ 262
            P     D+    + +V   +           LS   +      L  +  +R      LQ
Sbjct: 274 VPFPGVNDA--DTISQVLNKK-LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330

Query: 263 HPFL 266
           HP++
Sbjct: 331 HPWI 334

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 23/77 (29%), Positives = 34/77 (44%), Gaps = 3/77 (3%)

Query: 310 NI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N  F T +   +KL DFG + +           +    GT  ++APEV   TN+  +G  
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE-SYGPK 256

Query: 368 VDIWSLGCVLVEMSSGK 384
            D WS G +L  +  G 
Sbjct: 257 CDAWSAGVLLHLLLMGA 273

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  180 bits (457), Expect = 9e-53
 Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG    V+   + +TG+L A+K    +  +  R V   + E  +L+ +N KN+VK + +
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 71  --EIHREEMVLFMELCTEGTLESLVQS--TEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             E      VL ME C  G+L ++++      GLPE       + +V  ++ L EN IVH
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 127 RDIKSANIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF---- 179
           R+IK  NI      +     KL DFG+A ++              GT+ Y+ P+++    
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAV 191

Query: 180 -MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY---DSNYQIMFKVGMGE-------- 227
               ++  +G  VD+WS+G      ++G  P+  +     N ++M+K+  G+        
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251

Query: 228 ----------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS 269
                           + ++   L           L  D  +     +       I+ 
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 12/83 (14%)

Query: 310 NIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF-----MDTNK 361
           NI      +     KL DFG+A ++              GT+ Y+ P+++        ++
Sbjct: 142 NIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQ 197

Query: 362 VGHGRAVDIWSLGCVLVEMSSGK 384
             +G  VD+WS+G      ++G 
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGS 220

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  176 bits (448), Expect = 2e-52
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 14/296 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK-QNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G +GKV   +++ET    A+K ++  K +       ++  E+++L  +  KN+++   
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73

Query: 70  VEIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           V ++ EE   M + ME C  G  E L    E   P      Y  QL+D +  LH   IVH
Sbjct: 74  V-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132

Query: 127 RDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +DIK  N+ LT  G  LK+   G +                  G+ A+  PE+       
Sbjct: 133 KDIKPGNLLLTTGGT-LKISALGVAE--ALHPFAADDTCRTSQGSPAFQPPEIANG-LDT 188

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAE 244
             G  VDIWS G  L  +++G  P+     N   +F  +G G    IP           +
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPF--EGDNIYKLFENIGKGSY-AIPGDCGPPLSDLLK 245

Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSE 300
             L ++PA+R +I ++ QH +               P+   +D  +   V+P + +
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLED 301

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 20/76 (26%), Positives = 29/76 (38%), Gaps = 5/76 (6%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ LT  G  LK+   G +                  G+ A+  PE+         G  V
Sbjct: 139 NLLLTTGGT-LKISALGVAE--ALHPFAADDTCRTSQGSPAFQPPEIANG-LDTFSGFKV 194

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS G  L  +++G 
Sbjct: 195 DIWSAGVTLYNITTGL 210

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  176 bits (449), Expect = 3e-52
 Identities = 87/285 (30%), Positives = 142/285 (49%), Gaps = 13/285 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F KV  A +  TG  VA+K I   + N     K +  E+RI++ +N  N+VK + V
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKLFEV 82

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               + + L ME  + G + + LV      + E   R   +Q+V A+   H+  IVHRD+
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K+ N+ L A+ N +K+ DFG     S   TV G+L+ F G   Y APE+F    K   G 
Sbjct: 141 KAENLLLDADMN-IKIADFG----FSNEFTVGGKLDAFCGAPPYAAPELFQ--GKKYDGP 193

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
            VD+WSLG +L  + SG  P+     N + + +  +     IP  +S + +   +  L  
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD--GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251

Query: 250 DPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIV 294
           +P +R T+ ++++  ++    EED   P   P   + D  ++ I+
Sbjct: 252 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIM 296

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 31/75 (41%), Positives = 41/75 (54%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A+ N +K+ DFG     S   TV G+L+ F G   Y APE+F    K   G  VD
Sbjct: 144 NLLLDADMN-IKIADFG----FSNEFTVGGKLDAFCGAPPYAAPELFQ--GKKYDGPEVD 196

Query: 370 IWSLGCVLVEMSSGK 384
           +WSLG +L  + SG 
Sbjct: 197 VWSLGVILYTLVSGS 211

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  176 bits (449), Expect = 1e-51
 Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 22/286 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+  V   TG +   K I      D      +  E+ I+  ++   L+  +  
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDA 116

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              + EMVL +E  + G L   + + +  + E  V  Y +Q  + +  +HE++IVH DIK
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176

Query: 131 SANI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
             NI   T + +S+K+ DFG A K++     P E +     T  + APE+    ++   G
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLN-----PDEIVKVTTATAEFAAPEIV---DREPVG 228

Query: 189 RAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFAE 244
              D+W++G +   + SG  P   E   + + +  V   +         S+S E + F +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGE--DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286

Query: 245 LCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
             L+ +P +R T+ + L+HP+L     +       +P+S      +
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWL---KGDHSNLTSRIPSSRYNKIRQ 329

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 10/70 (14%)

Query: 310 NI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           NI   T + +S+K+ DFG A K++     P E +     T  + APE+    ++   G  
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLN-----PDEIVKVTTATAEFAAPEIV---DREPVGFY 230

Query: 368 VDIWSLGCVL 377
            D+W++G + 
Sbjct: 231 TDMWAIGVLG 240

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  174 bits (444), Expect = 1e-51
 Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 24/264 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V+  V   + +    K +++   +       +  E+ IL     +N++  +  
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHES 69

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               EE+V+  E  +   + E +  S    L E  +  Y  Q+ +A+  LH + I H DI
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128

Query: 130 KSANI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGH 187
           +  NI + T   +++K+ +FG A ++      PG+          Y APEV         
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLK-----PGDNFRLLFTAPEYYAPEVH---QHDVV 180

Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE----SLSDEGQAF 242
             A D+WSLG ++  + SG  P  AE  +N QI+  +   E  T  E     +S E   F
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAE--TNQQIIENIMNAE-YTFDEEAFKEISIEAMDF 237

Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
            +  L  +   R T  E LQHP+L
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWL 261

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 20/70 (28%), Positives = 32/70 (45%), Gaps = 10/70 (14%)

Query: 310 NI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           NI + T   +++K+ +FG A ++      PG+          Y APEV           A
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLK-----PGDNFRLLFTAPEYYAPEVH---QHDVVSTA 183

Query: 368 VDIWSLGCVL 377
            D+WSLG ++
Sbjct: 184 TDMWSLGTLV 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  173 bits (441), Expect = 1e-51
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 26/269 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG+  A K I   +L         +++  E+ IL  I   N++  
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 68  YGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           + +  ++ ++VL +EL + G L + L +  ++ L E    ++ KQ++D +  LH   I H
Sbjct: 74  HDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAH 131

Query: 127 RDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDT 182
            D+K  NI L         +KL DFG A KI       G       GT  ++APE+    
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----AGNEFKNIFGTPEFVAPEIV--- 183

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSD 237
           N    G   D+WS+G +   + SG  P   E  +  + +  +       +      + S+
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGE--TKQETLTNISAVNYDFDEEYFS-NTSE 240

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + F    L  DP +R TI + L+H ++
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 59.1 bits (144), Expect = 5e-10
 Identities = 23/72 (31%), Positives = 30/72 (41%), Gaps = 12/72 (16%)

Query: 310 NIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 365
           NI L         +KL DFG A KI       G       GT  ++APE+    N    G
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIE-----AGNEFKNIFGTPEFVAPEIV---NYEPLG 189

Query: 366 RAVDIWSLGCVL 377
              D+WS+G + 
Sbjct: 190 LEADMWSIGVIT 201

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  174 bits (443), Expect = 2e-51
 Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 10/279 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYGH 73

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   LF+E C+ G L + +      G+PE   +R+  QL+  +  LH   I HRDI
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L    N LK+ DFG A  +  +      LN   GT  Y+APE+     +  H  
Sbjct: 132 KPENLLLDERDN-LKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLK--RREFHAE 187

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAFAELCLR 248
            VD+WS G VL  M +G+ PW +   + Q        +T   P + +     A     L 
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247

Query: 249 HDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
            +P+ R TI ++ +  +     ++    PR     V + 
Sbjct: 248 ENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSES 286

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 27/74 (36%), Positives = 36/74 (48%), Gaps = 4/74 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L    N LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD
Sbjct: 135 NLLLDERDN-LKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLK--RREFHAEPVD 190

Query: 370 IWSLGCVLVEMSSG 383
           +WS G VL  M +G
Sbjct: 191 VWSCGIVLTAMLAG 204

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  173 bits (440), Expect = 2e-51
 Identities = 80/269 (29%), Positives = 128/269 (47%), Gaps = 10/269 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K + + +  D    +++  E+ I + +N +N+VK+YG 
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYGH 73

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   LF+E C+ G L + +      G+PE   +R+  QL+  +  LH   I HRDI
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L    N LK+ DFG A  +  +      LN   GT  Y+APE+     +  H  
Sbjct: 132 KPENLLLDERDN-LKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLK--RREFHAE 187

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ESLSDEGQAFAELCLR 248
            VD+WS G VL  M +G+ PW +   + Q        +T   P + +     A     L 
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247

Query: 249 HDPAQRATIFELLQHPFLIVSCEEDVCNP 277
            +P+ R TI ++ +  +     ++    P
Sbjct: 248 ENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 59.1 bits (144), Expect = 4e-10
 Identities = 27/74 (36%), Positives = 36/74 (48%), Gaps = 4/74 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L    N LK+ DFG A  +  +      LN   GT  Y+APE+     +  H   VD
Sbjct: 135 NLLLDERDN-LKISDFGLA-TVFRYNNRERLLNKMCGTLPYVAPELLK--RREFHAEPVD 190

Query: 370 IWSLGCVLVEMSSG 383
           +WS G VL  M +G
Sbjct: 191 VWSCGIVLTAMLAG 204

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  178 bits (453), Expect = 3e-51
 Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 33/295 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK----------QNDARFVKDMLVELRILEGIN 60
           G G +G+V            A+K I+  +          +N  +F +++  E+ +L+ ++
Sbjct: 45  GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104

Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
             N++K + V   ++   L  E    G L E ++        E       KQ++  I  L
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYL 162

Query: 120 HENTIVHRDIKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAP 176
           H++ IVHRDIK  NI          +K+ DFG +   S         L   +GT  Y+AP
Sbjct: 163 HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-----KDYKLRDRLGTAYYIAP 217

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE-- 233
           EV     K  +    D+WS G ++  +  G  P   +  ++  I+ KV  G+        
Sbjct: 218 EVL----KKKYNEKCDVWSCGVIMYILLCGYPPFGGQ--NDQDIIKKVEKGK-YYFDFND 270

Query: 234 --SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
             ++SDE +   +L L +D  +R T  E L   ++         + +      L 
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALS 325

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 21/77 (27%), Positives = 31/77 (40%), Gaps = 12/77 (15%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI          +K+ DFG +   S         L   +GT  Y+APEV     K  +  
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFS-----KDYKLRDRLGTAYYIAPEVL----KKKYNE 226

Query: 367 AVDIWSLGCVLVEMSSG 383
             D+WS G ++  +  G
Sbjct: 227 KCDVWSCGVIMYILLCG 243

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  173 bits (441), Expect = 4e-51
 Identities = 77/269 (28%), Positives = 123/269 (45%), Gaps = 22/269 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLVELRILEGINQKNLV 65
           G G  G+V  A   +T + VA+K I   K       +A    ++  E+ IL+ +N   ++
Sbjct: 19  GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 66  KYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           K        E+  + +EL   G L + +V +    L E   + Y  Q++ A+  LHEN I
Sbjct: 79  KIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGI 135

Query: 125 VHRDIKSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMD 181
           +HRD+K  N+ L+   E   +K+ DFG +  +          +    GT  Y+APEV + 
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRTLCGTPTYLAPEVLVS 190

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGE---TPTIPESLSD 237
               G+ RAVD WSLG +L    SG  P          +  ++  G+    P +   +S+
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYNFIPEVWAEVSE 249

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           +     +  L  DP  R T  E L+HP+L
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 8/71 (11%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L+   E   +K+ DFG +  +          +    GT  Y+APEV +     G+ R
Sbjct: 144 NVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198

Query: 367 AVDIWSLGCVL 377
           AVD WSLG +L
Sbjct: 199 AVDCWSLGVIL 209

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  177 bits (451), Expect = 5e-51
 Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 22/275 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  T +  A+K I      +      +L E+ +L+ ++  N++K + +
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEI 89

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  EL T G L + +++       E    R  KQ+   I+ +H++ IVHRD+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147

Query: 130 KSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  NI   + E +  +K+ DFG +             +   +GT  Y+APEV   T    
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKDRIGTAYYIAPEVLRGT---- 198

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGE--TPTIP-ESLSDEGQAF 242
           +    D+WS G +L  + SG  P + +  + Y I+ +V  G+         ++SD+ +  
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
               L   P+ R T  + L+HP++     E     
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 12/77 (15%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI   + E +  +K+ DFG +             +   +GT  Y+APEV   T    +  
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKDRIGTAYYIAPEVLRGT----YDE 201

Query: 367 AVDIWSLGCVLVEMSSG 383
             D+WS G +L  + SG
Sbjct: 202 KCDVWSAGVILYILLSG 218

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  172 bits (437), Expect = 6e-51
 Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 22/265 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+      +G    +K I  +K      ++ +  E+ +L+ ++  N++K + V
Sbjct: 31  GSGAFGDVHLVEERSSGLERVIKTI--NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDG--LPEVLVRRYTKQLVDAISALHENTIVHR 127
                 M + ME C  G L E +V +   G  L E  V    KQ+++A++  H   +VH+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148

Query: 128 DIKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI F     +S +K+ DFG A           E      GT  YMAPEVF    K
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFK-----SDEHSTNAAGTALYMAPEVF----K 199

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGE--TPTIPESLSDEGQA 241
                  DIWS G V+  + +G  P         ++  K    E         L+ +   
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATYKEPNYAVECRPLTPQAVD 257

Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
             +  L  DP +R +  ++L H + 
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWF 282

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 26/71 (36%), Positives = 30/71 (42%), Gaps = 12/71 (16%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI F     +S +K+ DFG A           E      GT  YMAPEVF    K     
Sbjct: 154 NILFQDTSPHSPIKIIDFGLAELFK-----SDEHSTNAAGTALYMAPEVF----KRDVTF 204

Query: 367 AVDIWSLGCVL 377
             DIWS G V+
Sbjct: 205 KCDIWSAGVVM 215

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  171 bits (436), Expect = 1e-50
 Identities = 72/267 (26%), Positives = 122/267 (45%), Gaps = 30/267 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V+      TG+L A+K I+         +++   E+ +L+ I  +N+V    +
Sbjct: 18  GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHENIVTLEDI 74

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L M+L + G L + +++       E       +Q++ A+  LHEN IVHRD+
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDL 132

Query: 130 KSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+ +LT E NS + + DFG +          G ++   GT  Y+APEV     +  +
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQ-----NGIMSTACGTPGYVAPEVL---AQKPY 184

Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGET-------PTIPESLSDEG 239
            +AVD WS+G +   +  G  P + E  +  ++  K+  G           I    S+  
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDI----SESA 238

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFL 266
           + F    L  DP +R T  + L HP++
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWI 265

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 23/70 (32%), Positives = 36/70 (51%), Gaps = 10/70 (14%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ +LT E NS + + DFG +          G ++   GT  Y+APEV     +  + +A
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQ-----NGIMSTACGTPGYVAPEVL---AQKPYSKA 187

Query: 368 VDIWSLGCVL 377
           VD WS+G + 
Sbjct: 188 VDCWSIGVIT 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  172 bits (438), Expect = 2e-50
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 23/287 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK--QNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G F  V   +N ETG+  A+K + + K   +     +D+  E  I   +   ++V+  
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 69  GVEIHREEMVLFMELCTEGTL-ESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIV 125
                   + +  E      L   +V+         E +   Y +Q+++A+   H+N I+
Sbjct: 93  ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNII 152

Query: 126 HRDIKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDT 182
           HRD+K   +   + E ++ +KLG FG A+++       G    G VGT  +MAPEV    
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVAGGRVGTPHFMAPEVV--- 205

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE---SLSDEG 239
            +  +G+ VD+W  G +L  + SG  P+  Y +  ++   +  G+    P     +S+  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGKYKMNPRQWSHISESA 263

Query: 240 QAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
           +      L  DPA+R T++E L HP+L    E D    +      ++
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWL---KERDRYAYKIHLPETVE 307

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 23/71 (32%), Positives = 37/71 (52%), Gaps = 10/71 (14%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
            +   + E ++ +KLG FG A+++       G    G VGT  +MAPEV     +  +G+
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGE----SGLVAGGRVGTPHFMAPEVV---KREPYGK 212

Query: 367 AVDIWSLGCVL 377
            VD+W  G +L
Sbjct: 213 PVDVWGCGVIL 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  172 bits (438), Expect = 3e-50
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 21/263 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G GRFG+V+      TG  +A K I+     D    +++  E+ ++  ++  NL++ Y  
Sbjct: 98  GGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDA 154

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              + ++VL ME    G L   +      L E+    + KQ+ + I  +H+  I+H D+K
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214

Query: 131 SANI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
             NI  +  +   +K+ DFG A +       P E L    GT  ++APEV    N     
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYK-----PREKLKVNFGTPEFLAPEVV---NYDFVS 266

Query: 189 RAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQAFA 243
              D+WS+G +   + SG  P   + D+  + +  +       E       +S+E + F 
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRWDLEDEEFQ-DISEEAKEFI 323

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L  + + R +  E L+HP+L
Sbjct: 324 SKLLIKEKSWRISASEALKHPWL 346

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 21/67 (31%), Positives = 30/67 (44%), Gaps = 10/67 (14%)

Query: 310 NI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           NI  +  +   +K+ DFG A +       P E L    GT  ++APEV    N       
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYK-----PREKLKVNFGTPEFLAPEVV---NYDFVSFP 268

Query: 368 VDIWSLG 374
            D+WS+G
Sbjct: 269 TDMWSVG 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  175 bits (445), Expect = 4e-50
 Identities = 63/265 (23%), Positives = 126/265 (47%), Gaps = 24/265 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+V    +  T    A+K I+    + +     +L E+ +L+ ++  N++K Y  
Sbjct: 46  GSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
              +    L ME    G L + ++        EV      KQ++  ++ LH++ IVHRD+
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162

Query: 130 KSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+   + E ++ +K+ DFG +           + +   +GT  Y+APEV     +  
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFE-----NQKKMKERLGTAYYIAPEVL----RKK 213

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGE----TPTIPESLSDEGQA 241
           +    D+WS+G +L  + +G  P   +  ++ +I+ KV  G+    +P    ++S+  + 
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQ--TDQEILRKVEKGKYTFDSPEWK-NVSEGAKD 270

Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
             +  L+ D  +R +  + L+HP++
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWI 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 19/78 (24%), Positives = 37/78 (47%), Gaps = 12/78 (15%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+   + E ++ +K+ DFG +           + +   +GT  Y+APEV     +  +  
Sbjct: 166 NLLLESKEKDALIKIVDFGLSAVFE-----NQKKMKERLGTAYYIAPEVL----RKKYDE 216

Query: 367 AVDIWSLGCVLVEMSSGK 384
             D+WS+G +L  + +G 
Sbjct: 217 KCDVWSIGVILFILLAGY 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  178 bits (452), Expect = 4e-50
 Identities = 77/289 (26%), Positives = 111/289 (38%), Gaps = 43/289 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V   ++ +TGE VA+K+    ++   +  +   +E++I++ +N  N+V    V
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 71  E------IHREEMVLFMELCTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHEN 122
                     +  +L ME C  G L   +   E   GL E  +R     +  A+  LHEN
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 123 TIVHRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF 179
            I+HRD+K  NI L         K+ D G A ++       GE    FVGT  Y+APE+ 
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-----QGELCTEFVGTLQYLAPELL 195

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-------- 231
               K  +   VD WS G +  E  +G RP+       Q   KV       I        
Sbjct: 196 E--QK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 232 ----------PESLSDEGQAFAE----LCLRHDPAQRATIFELLQHPFL 266
                     P  LS       E      L     QR T  +       
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 25/78 (32%), Positives = 33/78 (42%), Gaps = 11/78 (14%)

Query: 310 NIFLTAEGNS--LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L         K+ D G A ++       GE    FVGT  Y+APE+     K  +  
Sbjct: 151 NIVLQPGPQRLIHKIIDLGYAKELD-----QGELCTEFVGTLQYLAPELLE--QK-KYTV 202

Query: 367 AVDIWSLGCVLVEMSSGK 384
            VD WS G +  E  +G 
Sbjct: 203 TVDYWSFGTLAFECITGF 220

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  170 bits (432), Expect = 9e-50
 Identities = 71/269 (26%), Positives = 115/269 (42%), Gaps = 26/269 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I   +          +D+  E+ IL+ I   N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 68  YGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           + V  ++ +++L +EL   G L + L +  ++ L E     + KQ+++ +  LH   I H
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAH 137

Query: 127 RDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDT 182
            D+K  NI L         +K+ DFG A KI       G       GT  ++APE+    
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----FGNEFKNIFGTPEFVAPEIV--- 189

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSD 237
           N    G   D+WS+G +   + SG  P   +  +  + +  V       E      + S 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANVSAVNYEFEDEYFS-NTSA 246

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
             + F    L  DP +R TI + LQHP++
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 22/72 (30%), Positives = 30/72 (41%), Gaps = 12/72 (16%)

Query: 310 NIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 365
           NI L         +K+ DFG A KI       G       GT  ++APE+    N    G
Sbjct: 144 NIMLLDRNVPKPRIKIIDFGLAHKID-----FGNEFKNIFGTPEFVAPEIV---NYEPLG 195

Query: 366 RAVDIWSLGCVL 377
              D+WS+G + 
Sbjct: 196 LEADMWSIGVIT 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  175 bits (446), Expect = 9e-50
 Identities = 71/263 (26%), Positives = 111/263 (42%), Gaps = 21/263 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+      TG   A K +    ++D    + +  E++ +  +    LV  +  
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                EMV+  E  + G L   V    + + E     Y +Q+   +  +HEN  VH D+K
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282

Query: 131 SANI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
             NI F T   N LKL DFG    +      P + +    GT  + APEV         G
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLD-----PKQSVKVTTGTAEFAAPEVA---EGKPVG 334

Query: 189 RAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQAFA 243
              D+WS+G +   + SG  P   E  ++ + +  V       +       +S++G+ F 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSG-ISEDGKDFI 391

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L  DP  R TI + L+HP+L
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWL 414

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 23/70 (32%), Positives = 30/70 (42%), Gaps = 10/70 (14%)

Query: 310 NI-FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           NI F T   N LKL DFG    +      P + +    GT  + APEV         G  
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLD-----PKQSVKVTTGTAEFAAPEVA---EGKPVGYY 336

Query: 368 VDIWSLGCVL 377
            D+WS+G + 
Sbjct: 337 TDMWSVGVLS 346

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  170 bits (434), Expect = 1e-49
 Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 26/289 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I   Q          +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 68  YGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           + V  +R ++VL +EL + G L + L Q  ++ L E     + KQ++D ++ LH   I H
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAH 138

Query: 127 RDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDT 182
            D+K  NI L         +KL DFG A +I       G       GT  ++APE+    
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-----DGVEFKNIFGTPEFVAPEIV--- 190

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSD 237
           N    G   D+WS+G +   + SG  P   +  +  + +  +       +        S+
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITAVSYDFDEEFFS-QTSE 247

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
             + F    L  +  +R TI E L+HP++     +     R    ++  
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 22/72 (30%), Positives = 30/72 (41%), Gaps = 12/72 (16%)

Query: 310 NIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 365
           NI L         +KL DFG A +I       G       GT  ++APE+    N    G
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIE-----DGVEFKNIFGTPEFVAPEIV---NYEPLG 196

Query: 366 RAVDIWSLGCVL 377
              D+WS+G + 
Sbjct: 197 LEADMWSIGVIT 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  168 bits (428), Expect = 1e-49
 Identities = 74/265 (27%), Positives = 126/265 (47%), Gaps = 23/265 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V+  TG   A K I   K + AR  + +  E RI   +   N+V+ +  
Sbjct: 15  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V        E       +Q++++I+  H N IVHR++
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNL 131

Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+ L   A+G ++KL DFG A++++       E  +GF GT  Y++PEV     K  
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVN-----DSEAWHGFAGTPGYLSPEVL---KKDP 183

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE----SLSDEGQA 241
           + + VDIW+ G +L  +  G  P W E    +++  ++  G     P     +++ E ++
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGA-YDYPSPEWDTVTPEAKS 240

Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
             +  L  +P +R T  + L+ P++
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWI 265

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 63.7 bits (156), Expect = 1e-11
 Identities = 26/71 (36%), Positives = 41/71 (57%), Gaps = 11/71 (15%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L   A+G ++KL DFG A++++       E  +GF GT  Y++PEV     K  + +
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVN-----DSEAWHGFAGTPGYLSPEVL---KKDPYSK 186

Query: 367 AVDIWSLGCVL 377
            VDIW+ G +L
Sbjct: 187 PVDIWACGVIL 197

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  168 bits (428), Expect = 1e-49
 Identities = 73/285 (25%), Positives = 124/285 (43%), Gaps = 39/285 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFV----------------KDMLV 51
           G+G +G V  A N       AMK +   +L +Q                      +  + 
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 52  ----ELRILEGINQKNLVKYYGVEIHREEMVLF--MELCTEGTLESLVQSTEDGLPEVLV 105
               E+ IL+ ++  N+VK   V     E  L+   EL  +G +  +   T   L E   
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQA 139

Query: 106 RRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGEL 164
           R Y + L+  I  LH   I+HRDIK +N+ +  +G+ +K+ DFG S     +       L
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSD----ALL 194

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KV 223
           +  VGT A+MAPE   +T K+  G+A+D+W++G  L     G+ P+   D     +  K+
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF--MDERIMCLHSKI 252

Query: 224 GMGETPTIPE--SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                   P+   ++++ +      L  +P  R  + E+  HP++
Sbjct: 253 KSQA-LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 25/76 (32%), Positives = 42/76 (55%), Gaps = 6/76 (7%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  +G+ +K+ DFG S     +       L+  VGT A+MAPE   +T K+  G+A+
Sbjct: 167 NLLVGEDGH-IKIADFGVSNEFKGSD----ALLSNTVGTPAFMAPESLSETRKIFSGKAL 221

Query: 369 DIWSLGCVLVEMSSGK 384
           D+W++G  L     G+
Sbjct: 222 DVWAMGVTLYCFVFGQ 237

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  168 bits (429), Expect = 2e-49
 Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 26/286 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I   Q          +++  E+ IL  +   N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 68  YGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           + V  +R ++VL +EL + G L + L Q  ++ L E     + KQ++D ++ LH   I H
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAH 138

Query: 127 RDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDT 182
            D+K  NI L         +KL DFG A +I       G       GT  ++APE+    
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-----DGVEFKNIFGTPEFVAPEIV--- 190

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSD 237
           N    G   D+WS+G +   + SG  P   +  +  + +  +       +        S+
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGD--TKQETLANITSVSYDFDEEFFS-HTSE 247

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPAS 283
             + F    L  +  +R TI E L+HP++     +     R    +
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVN 293

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 22/72 (30%), Positives = 30/72 (41%), Gaps = 12/72 (16%)

Query: 310 NIFL---TAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 365
           NI L         +KL DFG A +I       G       GT  ++APE+    N    G
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLAHEIE-----DGVEFKNIFGTPEFVAPEIV---NYEPLG 196

Query: 366 RAVDIWSLGCVL 377
              D+WS+G + 
Sbjct: 197 LEADMWSIGVIT 208

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  168 bits (427), Expect = 5e-49
 Identities = 67/277 (24%), Positives = 120/277 (43%), Gaps = 22/277 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYG 69
           G+G+F  V   ++  TG+  A K ++  ++       ++L E+ +LE       ++  + 
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLHE 96

Query: 70  VEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           V  +  E++L +E    G +    +    + + E  V R  KQ+++ +  LH+N IVH D
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156

Query: 129 IKSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKV 185
           +K  NI L+       +K+ DFG + KI          L   +GT  Y+APE+    N  
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIG-----HACELREIMGTPEYLAPEIL---NYD 208

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQ 240
               A D+W++G +   + +   P   E   N +    +          T   S+S    
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFS-SVSQLAT 265

Query: 241 AFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
            F +  L  +P +R T    L H +L     E++ +P
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 11/68 (16%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L+       +K+ DFG + KI          L   +GT  Y+APE+    N      
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIG-----HACELREIMGTPEYLAPEIL---NYDPITT 212

Query: 367 AVDIWSLG 374
           A D+W++G
Sbjct: 213 ATDMWNIG 220

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  166 bits (423), Expect = 6e-49
 Identities = 66/264 (25%), Positives = 119/264 (45%), Gaps = 22/264 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V    +  T +  A+K I        +    +L E+ +L+ ++  N++K + +
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  EL T G L + +++       E    R  KQ+   I+ +H++ IVHRD+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDL 147

Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  NI L    +   +K+ DFG +             +   +GT  Y+APEV     +  
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKDRIGTAYYIAPEVL----RGT 198

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG--ETPTIP-ESLSDEGQAF 242
           +    D+WS G +L  + SG  P + +  + Y I+ +V  G          ++SD+ +  
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
               L   P+ R T  + L+HP++
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWI 280

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 12/71 (16%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L    +   +K+ DFG +             +   +GT  Y+APEV     +  +  
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQ-----QNTKMKDRIGTAYYIAPEVL----RGTYDE 201

Query: 367 AVDIWSLGCVL 377
             D+WS G +L
Sbjct: 202 KCDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  166 bits (422), Expect = 8e-49
 Identities = 75/265 (28%), Positives = 123/265 (46%), Gaps = 26/265 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AV   T    A K+I  +   D   V     E+ I++ ++  N+++ Y  
Sbjct: 18  GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                ++ L MELCT G L E +V   +    E    R  K ++ A++  H+  + HRD+
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 132

Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N      +  + LKL DFG A +       PG+ +   VGT  Y++P+V     +  
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFK-----PGKMMRTKVGTPYYVSPQVL----EGL 183

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE----SLSDEGQA 241
           +G   D WS G ++  +  G  P  A  DS  ++M K+  G   T PE    ++S + ++
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGT-FTFPEKDWLNVSPQAES 240

Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
                L   P QR T  + L+H + 
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWF 265

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 12/71 (16%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N      +  + LKL DFG A +       PG+ +   VGT  Y++P+V     +  +G 
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFK-----PGKMMRTKVGTPYYVSPQVL----EGLYGP 186

Query: 367 AVDIWSLGCVL 377
             D WS G ++
Sbjct: 187 ECDEWSAGVMM 197

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  167 bits (425), Expect = 1e-48
 Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 53/306 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLV-----------ELRIL 56
            QG+F K+      +  +  A+K+     L K+ D     +  +           EL+I+
Sbjct: 40  NQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 57  EGINQKNLVKYYGVEIH-REEMVLFMELCTEGTL-------ESLVQSTEDGLPEVLVRRY 108
             I  +  +   G+ I   +E+ +  E     ++         L ++    +P  +++  
Sbjct: 98  TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 109 TKQLVDAISALH-ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
            K ++++ S +H E  I HRD+K +NI +   G  +KL DFG     S +     ++ G 
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFG----ESEYMV-DKKIKGS 210

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK----- 222
            GT  +M PE F       +G  VDIWSLG  L  M     P+     +   +F      
Sbjct: 211 RGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELFNNIRTK 268

Query: 223 --------------VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV 268
                         +   ++      LS+E   F +L LR +PA+R T  + L+H +L  
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328

Query: 269 SCEEDV 274
           +  ED+
Sbjct: 329 TNIEDL 334

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 26/76 (34%), Positives = 33/76 (43%), Gaps = 7/76 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +   G  +KL DFG     S +     ++ G  GT  +M PE F       +G  VD
Sbjct: 182 NILMDKNGR-VKLSDFG----ESEYMV-DKKIKGSRGTYEFMPPEFFS-NESSYNGAKVD 234

Query: 370 IWSLGCVLVEMSSGKT 385
           IWSLG  L  M     
Sbjct: 235 IWSLGICLYVMFYNVV 250

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  165 bits (421), Expect = 2e-48
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK-----QNDARFVKDMLV-ELRILEGIN-QKN 63
           G+G    V   ++  T +  A+K I +         + + +++  + E+ IL  ++   N
Sbjct: 26  GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           +++            L  +L  +G L + L +     L E   R+  + L++ I ALH+ 
Sbjct: 86  IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL 143

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF-- 179
            IVHRD+K  N  L  +  ++KL DFG + ++      PGE L    GT +Y+APE+   
Sbjct: 144 NIVHRDLKPEN-ILLDDDMNIKLTDFGFSCQLD-----PGEKLREVCGTPSYLAPEIIEC 197

Query: 180 -MDTNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE---- 233
            M+ N  G+G+ VD+WS G ++  + +G  P W        ++  +  G           
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--KQMLMLRMIMSGN-YQFGSPEWD 254

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
             SD  +      L   P +R T  E L HPF 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 25/70 (35%), Positives = 40/70 (57%), Gaps = 9/70 (12%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHGRA 367
            L  +  ++KL DFG + ++      PGE L    GT +Y+APE+    M+ N  G+G+ 
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLD-----PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE 209

Query: 368 VDIWSLGCVL 377
           VD+WS G ++
Sbjct: 210 VDMWSTGVIM 219

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  168 bits (427), Expect = 2e-48
 Identities = 73/261 (27%), Positives = 125/261 (47%), Gaps = 14/261 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV     N+T ++ AMK +   +  ++N+   V+++  EL+I++G+    LV  
Sbjct: 24  GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE---VRNVFKELQIMQGLEHPFLVNL 80

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +      E+M + ++L   G L   +Q       E  V+ +  +LV A+  L    I+HR
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHR 139

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  NI L   G+ + + DF  A  +   T     +    GT+ YMAPE+F      G+
Sbjct: 140 DMKPDNILLDEHGH-VHITDFNIAAMLPRETQ----ITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             AVD WSLG    E+  G+RP      ++ + +         T P + S E  +  +  
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 254

Query: 247 LRHDPAQR-ATIFELLQHPFL 266
           L  +P QR + + ++   P++
Sbjct: 255 LEPNPDQRFSQLSDVQNFPYM 275

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 5/76 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ + + DF  A  +   T     +    GT+ YMAPE+F      G+  AVD
Sbjct: 145 NILLDEHGH-VHITDFNIAAMLPRETQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVD 199

Query: 370 IWSLGCVLVEMSSGKT 385
            WSLG    E+  G+ 
Sbjct: 200 WWSLGVTAYELLRGRR 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  164 bits (417), Expect = 8e-48
 Identities = 67/285 (23%), Positives = 107/285 (37%), Gaps = 26/285 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQK----N 63
           G+G FG V+          VA+K I   ++   +         +E+ +L  +        
Sbjct: 40  GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99

Query: 64  LVKYYGVEIHREEMVLFMELCTEGT--LESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
           +++       +E  +L +E         + + +     L E   R +  Q+V AI   H 
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHS 157

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
             +VHRDIK  NI +       KL DFGS     A          F GT+ Y  PE    
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGS----GALLH-DEPYTDFDGTRVYSPPEWIS- 211

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
                H     +WSLG +L +M  G  P+           ++   E    P  +S +  A
Sbjct: 212 -RHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAEL-HFPAHVSPDCCA 262

Query: 242 FAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQ 286
               CL   P+ R ++ E+L  P++    E+   NP     + L 
Sbjct: 263 LIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 23/74 (31%), Positives = 28/74 (37%), Gaps = 7/74 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +       KL DFGS     A          F GT+ Y  PE         H     
Sbjct: 169 NILIDLRRGCAKLIDFGS----GALLH-DEPYTDFDGTRVYSPPEWIS--RHQYHALPAT 221

Query: 370 IWSLGCVLVEMSSG 383
           +WSLG +L +M  G
Sbjct: 222 VWSLGILLYDMVCG 235

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  164 bits (418), Expect = 9e-48
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 49/290 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM-LVELRILEGINQKNLVKYYG 69
           G+G +G V    N +TG +VA+K+      +    VK + + E+++L+ +  +NLV    
Sbjct: 34  GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM--VKKIAMREIKLLKQLRHENLVNLLE 91

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           V   ++   L  E   + T+   ++   +GL   +V++Y  Q+++ I   H + I+HRDI
Sbjct: 92  VCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  NI ++  G  +KL DFG A  ++     PGE  +  V T+ Y APE+ +   K  +G
Sbjct: 151 KPENILVSQSGV-VKLCDFGFARTLA----APGEVYDDEVATRWYRAPELLVGDVK--YG 203

Query: 189 RAVDIWSLGCVLVEMSSGKRPW----AEYDSNYQIMFKVGMGETPT-------------- 230
           +AVD+W++GC++ EM  G  P     ++ D  Y I     +G                  
Sbjct: 204 KAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHI-MMC-LG-NLIPRHQELFNKNPVFA 259

Query: 231 ---IPE------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              +PE             LS+     A+ CL  DP +R    ELL H F
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 29/76 (38%), Positives = 46/76 (60%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI ++  G  +KL DFG A  ++     PGE  +  V T+ Y APE+ +   K  +G+AV
Sbjct: 154 NILVSQSGV-VKLCDFGFARTLA----APGEVYDDEVATRWYRAPELLVGDVK--YGKAV 206

Query: 369 DIWSLGCVLVEMSSGK 384
           D+W++GC++ EM  G+
Sbjct: 207 DVWAIGCLVTEMFMGE 222

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  165 bits (420), Expect = 1e-47
 Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 25/288 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V+  TG   A K I   K + AR  + +  E RI   +   N+V+ +  
Sbjct: 38  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V        E       +Q++++I+  H N IVHR++
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNL 154

Query: 130 KSANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+ L   A+G ++KL DFG A++++       E  +GF GT  Y++PEV     K  
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVN-----DSEAWHGFAGTPGYLSPEVL---KKDP 206

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG--ETPTIP-ESLSDEGQAF 242
           + + VDIW+ G +L  +  G  P W E    +++  ++  G  + P+   ++++ E ++ 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDE--DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
            +  L  +P +R T  + L+ P++            ++      D LK
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWI----CNRERVASAIHRQDTVDCLK 308

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 26/71 (36%), Positives = 41/71 (57%), Gaps = 11/71 (15%)

Query: 310 NIFLT--AEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L   A+G ++KL DFG A++++       E  +GF GT  Y++PEV     K  + +
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVN-----DSEAWHGFAGTPGYLSPEVL---KKDPYSK 209

Query: 367 AVDIWSLGCVL 377
            VDIW+ G +L
Sbjct: 210 PVDIWACGVIL 220

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  165 bits (419), Expect = 1e-47
 Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 24/264 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G    VY      T +  A+K +   K  D    K +  E+ +L  ++  N++K   +
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVL--KKTVD---KKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                E+ L +EL T G L + +V+       E       KQ+++A++ LHEN IVHRD+
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDL 174

Query: 130 KSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVG 186
           K  N+ + T   ++ LK+ DFG +  +          +    GT  Y APE+        
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVE-----HQVLMKTVCGTPGYCAPEIL---RGCA 226

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE---SLSDEGQAF 242
           +G  VD+WS+G +   +  G  P + E   +  +  ++   E   I      +S   +  
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDE-RGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285

Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
               +  DP +R T F+ LQHP++
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPWV 309

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 19/71 (26%), Positives = 32/71 (45%), Gaps = 11/71 (15%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ + T   ++ LK+ DFG +  +          +    GT  Y APE+        +G 
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVE-----HQVLMKTVCGTPGYCAPEIL---RGCAYGP 229

Query: 367 AVDIWSLGCVL 377
            VD+WS+G + 
Sbjct: 230 EVDMWSVGIIT 240

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  164 bits (418), Expect = 1e-47
 Identities = 72/263 (27%), Positives = 116/263 (44%), Gaps = 24/263 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV-----ELRILEGINQKNLV 65
           G G FG V+TAV+ E  + V +K I+  K  +  +++D  +     E+ IL  +   N++
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92

Query: 66  KYYGVEIHREEMVLFMELCTEGT--LESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           K   +  ++    L ME    G      + +     L E L     +QLV A+  L    
Sbjct: 93  KVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD 150

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           I+HRDIK  NI +  +   +KL DFGS    +A+         F GT  Y APEV M   
Sbjct: 151 IIHRDIKDENIVIAEDFT-IKLIDFGS----AAYLERGKLFYTFCGTIEYCAPEVLM--G 203

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
               G  +++WSLG  L  +   + P+ E +       +         P  +S E  +  
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELE-------ETVEAAI-HPPYLVSKELMSLV 255

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L+  P +R T+ +L+  P++
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWV 278

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 24/68 (35%), Positives = 32/68 (47%), Gaps = 7/68 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +  +   +KL DFGS    +A+         F GT  Y APEV M       G  ++
Sbjct: 160 NIVIAEDFT-IKLIDFGS----AAYLERGKLFYTFCGTIEYCAPEVLM--GNPYRGPELE 212

Query: 370 IWSLGCVL 377
           +WSLG  L
Sbjct: 213 MWSLGVTL 220

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  166 bits (421), Expect = 2e-47
 Identities = 46/290 (15%), Positives = 89/290 (30%), Gaps = 43/290 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-------------- 56
           GQ        A + ETGE   +      ++  +  +K M  E+  L              
Sbjct: 87  GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 57  --------EGINQKNLVKYYGVEIHREE----MVLFMELCTEGTLESLVQS-----TEDG 99
                   + +      K   V +   +       F+    +  L++  +      +   
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 100 -LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT 158
            L      + T Q++  +++LH   +VH  ++  +I L   G  + L  F   V+  A  
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDGASA 265

Query: 159 TVPGELNGFVGTQAYMAPEV--FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN 216
             P             A  +  F   +      A D W+LG  +  +     P  + D+ 
Sbjct: 266 VSPI--GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAA 322

Query: 217 YQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                 +       IP+ +        E  LR+    R    + ++ P  
Sbjct: 323 LGGSEWI-FRSCKNIPQPVRA----LLEGFLRYPKEDRLLPLQAMETPEY 367

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 15/79 (18%), Positives = 23/79 (29%), Gaps = 5/79 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV--FMDTNKVGHGR 366
            +I L   G  + L  F   V+  A    P             A  +  F   +      
Sbjct: 240 VDIVLDQRGG-VFLTGFEHLVRDGASAVSPI--GRGFAPPETTAERMLPFGQHHPTLMTF 296

Query: 367 AVDIWSLGCVLVEMSSGKT 385
           A D W+LG  +  +     
Sbjct: 297 AFDTWTLGLAIYWIWCADL 315

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  166 bits (423), Expect = 2e-47
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 18/263 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V   V    G+  A   I   K +     + +  E RI   +   N+V+ +  
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHDS 78

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   L  +L T G L E +V        E       +Q+++A+   H+  +VHR++
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNL 136

Query: 130 KSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           K  N+   +    + +KL DFG A+++           GF GT  Y++PEV     K  +
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVL---RKDPY 190

Query: 188 GRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMG--ETPTIP-ESLSDEGQAFA 243
           G+ VD+W+ G +L  +  G  P W E    +++  ++  G  + P+   ++++ E +   
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDE--DQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L  +P++R T  E L+HP++
Sbjct: 249 NKMLTINPSKRITAAEALKHPWI 271

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 8/70 (11%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+   +    + +KL DFG A+++           GF GT  Y++PEV     K  +G+ 
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPEVL---RKDPYGKP 193

Query: 368 VDIWSLGCVL 377
           VD+W+ G +L
Sbjct: 194 VDLWACGVIL 203

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  164 bits (416), Expect = 2e-47
 Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 32/271 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G G  GKV    +  TG+  A+K +       AR       E+          ++V    
Sbjct: 38  GLGVNGKVLECFHRRTGQKCALKLLY--DSPKAR------QEVDHHWQASGGPHIVCILD 89

Query: 70  V---EIHREEMV-LFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           V     H +  + + ME    G L   + +  +    E       + +  AI  LH + I
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149

Query: 125 VHRDIKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            HRD+K  N+ + + E ++ LKL DFG A + +        L     T  Y+APEV    
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-----QNALQTPCYTPYYVAPEVL--- 201

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQ--IMFKVGMGETPTIPE----SL 235
               + ++ D+WSLG ++  +  G  P ++         +  ++ +G+    P      +
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPNPEWSEV 260

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           S++ +    L L+ DP +R TI + + HP++
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 21/70 (30%), Positives = 35/70 (50%), Gaps = 10/70 (14%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ + + E ++ LKL DFG A + +        L     T  Y+APEV        + ++
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETT-----QNALQTPCYTPYYVAPEVL---GPEKYDKS 209

Query: 368 VDIWSLGCVL 377
            D+WSLG ++
Sbjct: 210 CDMWSLGVIM 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  164 bits (416), Expect = 4e-47
 Identities = 73/272 (26%), Positives = 115/272 (42%), Gaps = 27/272 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHK----QNDARFVKDMLV-ELRILEGI-NQKNL 64
           G+G    V   V+  TG   A+K +++            V++    E  IL  +    ++
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162

Query: 65  VKYYGVEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +           M L  +L  +G L + L +     L E   R   + L++A+S LH N 
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANN 220

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF--- 179
           IVHRD+K  N  L  +   ++L DFG +  +      PGE L    GT  Y+APE+    
Sbjct: 221 IVHRDLKPEN-ILLDDNMQIRLSDFGFSCHLE-----PGEKLRELCGTPGYLAPEILKCS 274

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPE----S 234
           MD    G+G+ VD+W+ G +L  + +G  P W        ++  +  G+           
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--RQILMLRMIMEGQ-YQFSSPEWDD 331

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            S   +      L+ DP  R T  + LQHPF 
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 24/70 (34%), Positives = 36/70 (51%), Gaps = 9/70 (12%)

Query: 312 FLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVF---MDTNKVGHGRA 367
            L  +   ++L DFG +  +      PGE L    GT  Y+APE+    MD    G+G+ 
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLE-----PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285

Query: 368 VDIWSLGCVL 377
           VD+W+ G +L
Sbjct: 286 VDLWACGVIL 295

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  161 bits (409), Expect = 5e-47
 Identities = 75/258 (29%), Positives = 120/258 (46%), Gaps = 14/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKV    +  TG  VA+K +   K      V  +  E++ L+     +++K Y V
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                +  + ME  + G L + + +     + E+  RR  +Q++ A+   H + +VHRD+
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L A  N  K+ DFG    +S   +    L    G+  Y APEV     ++  G 
Sbjct: 138 KPENVLLDAHMN-AKIADFG----LSNMMSDGEFLRTSCGSPNYAAPEVIS--GRLYAGP 190

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCLR 248
            VDIWS G +L  +  G  P+   D +   +F K+  G    IPE L+          L+
Sbjct: 191 EVDIWSCGVILYALLCGTLPF--DDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHMLQ 247

Query: 249 HDPAQRATIFELLQHPFL 266
            DP +RATI ++ +H + 
Sbjct: 248 VDPLKRATIKDIREHEWF 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 25/75 (33%), Positives = 34/75 (45%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A  N  K+ DFG    +S   +    L    G+  Y APEV     ++  G  VD
Sbjct: 141 NVLLDAHMN-AKIADFG----LSNMMSDGEFLRTSCGSPNYAAPEVIS--GRLYAGPEVD 193

Query: 370 IWSLGCVLVEMSSGK 384
           IWS G +L  +  G 
Sbjct: 194 IWSCGVILYALLCGT 208

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  162 bits (411), Expect = 6e-47
 Identities = 77/262 (29%), Positives = 127/262 (48%), Gaps = 27/262 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V  A      + VA+K  Q+  +++    K  +VELR L  +N  N+VK YG 
Sbjct: 17  GRGAFGVVCKAKWR--AKDVAIK--QIESESE---RKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHE---NTIV 125
            ++   +V  ME    G+L +++   E            +  Q    ++ LH      ++
Sbjct: 70  CLNPVCLV--MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K  N+ L A G  LK+ DFG+A  I  H T         G+ A+MAPEVF  +N  
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSN-- 179

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTIPESLSDEGQAFAE 244
            +    D++S G +L E+ + ++P+ E     ++IM+ V  G  P + ++L    ++   
Sbjct: 180 -YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 238

Query: 245 LCLRHDPAQR---ATIFELLQH 263
            C   DP+QR     I +++ H
Sbjct: 239 RCWSKDPSQRPSMEEIVKIMTH 260

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 9/77 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ L A G  LK+ DFG+A  I  H T         G+ A+MAPEVF  +N   +    
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDIQTHMT------NNKGSAAWMAPEVFEGSN---YSEKC 184

Query: 369 DIWSLGCVLVEMSSGKT 385
           D++S G +L E+ + + 
Sbjct: 185 DVFSWGIILWEVITRRK 201

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  161 bits (409), Expect = 1e-46
 Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 47/289 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM-LVELRILEGINQKNLVKYYG 69
           G+G +G V+   N +TG++VA+K+    + +    +K + L E+R+L+ +   NLV    
Sbjct: 12  GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV--IKKIALREIRMLKQLKHPNLVNLLE 69

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           V   +  + L  E C + T+   +   + G+PE LV+  T Q + A++  H++  +HRD+
Sbjct: 70  VFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  NI +T     +KL DFG A  ++     P +  +  V T+ Y +PE+ +   +  +G
Sbjct: 129 KPENILITKHSV-IKLCDFGFARLLT----GPSDYYDDEVATRWYRSPELLVGDTQ--YG 181

Query: 189 RAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPT--------------- 230
             VD+W++GCV  E+ SG   W    + D  Y I  K  +G                   
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI-RKT-LG-DLIPRHQQVFSTNQYFSG 238

Query: 231 --IPE------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
             IP+            ++S       + CL  DP +R T  +LL HP+
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 53.7 bits (130), Expect = 3e-08
 Identities = 25/76 (32%), Positives = 41/76 (53%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGE-LNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI +T     +KL DFG A  ++     P +  +  V T+ Y +PE+ +   +  +G  V
Sbjct: 132 NILITKHSV-IKLCDFGFARLLT----GPSDYYDDEVATRWYRSPELLVGDTQ--YGPPV 184

Query: 369 DIWSLGCVLVEMSSGK 384
           D+W++GCV  E+ SG 
Sbjct: 185 DVWAIGCVFAELLSGV 200

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 2e-46
 Identities = 55/268 (20%), Positives = 119/268 (44%), Gaps = 25/268 (9%)

Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+GRFG+VY    + E    VA++ I + ++++   +K    E+        +N+V + G
Sbjct: 42  GKGRFGQVYHGRWHGE----VAIRLIDI-ERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
             +    + +   LC   TL S+V+  +  L     R+  +++V  +  LH   I+H+D+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156

Query: 130 KSANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           KS N+F   +   + + DFG      +        +L    G   ++APE+    +    
Sbjct: 157 KSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 188 G------RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
                  +  D+++LG +  E+ + + P+        I++++G G  P + +     G+ 
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-AEAIIWQMGTGMKPNLSQ--IGMGKE 271

Query: 242 FAEL---CLRHDPAQR---ATIFELLQH 263
            +++   C   +  +R     + ++L+ 
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMDMLEK 299

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 10/84 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSA--VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG- 365
            N+F   +   + + DFG      +        +L    G   ++APE+    +      
Sbjct: 159 KNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEED 216

Query: 366 -----RAVDIWSLGCVLVEMSSGK 384
                +  D+++LG +  E+ + +
Sbjct: 217 KLPFSKHSDVFALGTIWYELHARE 240

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  160 bits (406), Expect = 2e-46
 Identities = 59/258 (22%), Positives = 115/258 (44%), Gaps = 13/258 (5%)

Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG VY    + +    VA+K + +      + ++    E+ +L      N++ + G
Sbjct: 33  GSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMG 87

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                 ++ +  + C   +L   + ++E       +    +Q    +  LH  +I+HRD+
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           KS NIFL  E N++K+GDFG A    +  +   +     G+  +MAPEV    +   +  
Sbjct: 147 KSNNIFLH-EDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQAFAEL 245
             D+++ G VL E+ +G+ P++  ++  QI+  VG G    +   +  +     +     
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 264

Query: 246 CLRHDPAQRATIFELLQH 263
           CL+    +R +   +L  
Sbjct: 265 CLKKKRDERPSFPRILAE 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 2/76 (2%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NIFL  E N++K+GDFG A    +  +   +     G+  +MAPEV    +   +    
Sbjct: 149 NNIFLH-EDNTVKIGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206

Query: 369 DIWSLGCVLVEMSSGK 384
           D+++ G VL E+ +G+
Sbjct: 207 DVYAFGIVLYELMTGQ 222

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  164 bits (416), Expect = 5e-46
 Identities = 73/258 (28%), Positives = 121/258 (46%), Gaps = 14/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKV    +  TG  VA+K +   K      V  +  E++ L+     +++K Y V
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                ++ + ME  + G L + + ++    L E   RR  +Q++  +   H + +VHRD+
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L A  N  K+ DFG    +S   +    L    G+  Y APEV     ++  G 
Sbjct: 143 KPENVLLDAHMN-AKIADFG----LSNMMSDGEFLRTSCGSPNYAAPEVIS--GRLYAGP 195

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCLR 248
            VDIWS G +L  +  G  P+   D +   +F K+  G     P+ L+    +  +  L+
Sbjct: 196 EVDIWSSGVILYALLCGTLPF--DDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKHMLQ 252

Query: 249 HDPAQRATIFELLQHPFL 266
            DP +RATI ++ +H + 
Sbjct: 253 VDPMKRATIKDIREHEWF 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 24/68 (35%), Positives = 32/68 (47%), Gaps = 7/68 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L A  N  K+ DFG    +S   +    L    G+  Y APEV     ++  G  VD
Sbjct: 146 NVLLDAHMN-AKIADFG----LSNMMSDGEFLRTSCGSPNYAAPEVIS--GRLYAGPEVD 198

Query: 370 IWSLGCVL 377
           IWS G +L
Sbjct: 199 IWSSGVIL 206

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  160 bits (405), Expect = 1e-45
 Identities = 46/274 (16%), Positives = 89/274 (32%), Gaps = 32/274 (11%)

Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G F +VY A      + +  +   +K  +     +          +  L+   Q   +
Sbjct: 74  GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLKPSMQHMFM 130

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQS----TEDGLPEVLVRRYTKQLVDAISALHE 121
           K+Y   + +   VL  EL + GTL + +       E  +P+ LV  +  +++  I  +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 122 NTIVHRDIKSANIFLTAEGN----------SLKLGDFGSAVKISAHTTVPGELNGFVGTQ 171
             I+H DIK  N  L                L L D G ++ +               T 
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG-TIFTAKCETS 249

Query: 172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI 231
            +   E+    +       +D + +   +  M  G     + +   +   +      P  
Sbjct: 250 GFQCVEML---SNKPWNYQIDYFGVAATVYCMLFGTYMKVK-NEGGECKPEGLFRRLPH- 304

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                D    F  + L           +LL+   
Sbjct: 305 ----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 9/66 (13%), Positives = 19/66 (28%), Gaps = 4/66 (6%)

Query: 319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV 378
            L L D G ++ +               T  +   E+    +       +D + +   + 
Sbjct: 221 GLALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEML---SNKPWNYQIDYFGVAATVY 276

Query: 379 EMSSGK 384
            M  G 
Sbjct: 277 CMLFGT 282

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  158 bits (402), Expect = 1e-45
 Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 24/263 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQK--NLV 65
           G G FG VY+ +       VA+K +   ++    +      + +E+ +L+ ++     ++
Sbjct: 52  GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111

Query: 66  KYYGVEIHREEMVLFMELCT-EGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENT 123
           +        +  VL +E       L   +  TE G L E L R +  Q+++A+   H   
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHNCG 169

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           ++HRDIK  NI +      LKL DFGS     A          F GT+ Y  PE      
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGS----GALLK-DTVYTDFDGTRVYSPPEWIR--Y 222

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA 243
              HGR+  +WSLG +L +M  G  P+           ++  G+     + +S E Q   
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPF--EHDE-----EIIRGQV-FFRQRVSSECQHLI 274

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
             CL   P+ R T  E+  HP++
Sbjct: 275 RWCLALRPSDRPTFEEIQNHPWM 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 26/75 (34%), Positives = 32/75 (42%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI +      LKL DFGS     A          F GT+ Y  PE         HGR+  
Sbjct: 179 NILIDLNRGELKLIDFGS----GALLK-DTVYTDFDGTRVYSPPEWIR--YHRYHGRSAA 231

Query: 370 IWSLGCVLVEMSSGK 384
           +WSLG +L +M  G 
Sbjct: 232 VWSLGILLYDMVCGD 246

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  158 bits (401), Expect = 3e-45
 Identities = 70/269 (26%), Positives = 116/269 (43%), Gaps = 27/269 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G+G F      V+ ++ +  A+K I    + + +       E+  L+      N+VK + 
Sbjct: 20  GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKLHE 73

Query: 70  VEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           V   +    L MEL   G L E + +       E       ++LV A+S +H+  +VHRD
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRD 131

Query: 129 IKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           +K  N+ F     N  +K+ DFG A            L     T  Y APE+    N+ G
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYAAPELL---NQNG 185

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-WAE-----YDSNYQIMFKVGMGE---TPTIPESLSD 237
           +  + D+WSLG +L  M SG+ P  +        S  +IM K+  G+        +++S 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           E +   +  L  DP +R  +  L  + +L
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 8/78 (10%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ F     N  +K+ DFG A            L     T  Y APE+    N+ G+  +
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYAAPELL---NQNGYDES 189

Query: 368 VDIWSLGCVLVEMSSGKT 385
            D+WSLG +L  M SG+ 
Sbjct: 190 CDLWSLGVILYTMLSGQV 207

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  157 bits (400), Expect = 3e-45
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 24/266 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G F  V  A    T    A+K      I    +     V  +  E  ++  ++    V
Sbjct: 39  GEGSFSTVVLARELATSREYAIKILEKRHIIKENK-----VPYVTRERDVMSRLDHPFFV 93

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           K Y      E++   +     G L   ++       E   R YT ++V A+  LH   I+
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGII 152

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K  NI L  + + +++ DFG+A K+ +  +     N FVGT  Y++PE+  +    
Sbjct: 153 HRDLKPENILLNEDMH-IQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEK--- 207

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
              ++ D+W+LGC++ ++ +G  P+     N  ++F+  +      PE    + +   E 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265

Query: 246 CLRHDPAQRATIF------ELLQHPF 265
            L  D  +R           L  HPF
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPF 291

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 22/76 (28%), Positives = 44/76 (57%), Gaps = 5/76 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L  + + +++ DFG+A K+ +  +     N FVGT  Y++PE+  +       ++ D
Sbjct: 160 NILLNEDMH-IQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEK---SACKSSD 214

Query: 370 IWSLGCVLVEMSSGKT 385
           +W+LGC++ ++ +G  
Sbjct: 215 LWALGCIIYQLVAGLP 230

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  156 bits (397), Expect = 4e-45
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 24/268 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND----ARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V+     +   +VA+K + L             ++   E+ I+  +N  N+VK
Sbjct: 28  GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--I 124
            YG+        + ME    G L   +      +   +  R    +   I  +      I
Sbjct: 88  LYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145

Query: 125 VHRDIKSANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
           VHRD++S NIFL +   +     K+ DFG + + S H+      +G +G   +MAPE   
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSV-----SGLLGNFQWMAPETIG 199

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGM-GETPTIPESLSDE 238
              +  +    D +S   +L  + +G+ P+ EY     + +  +   G  PTIPE     
Sbjct: 200 AEEES-YTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPR 258

Query: 239 GQAFAELCLRHDPAQR---ATIFELLQH 263
            +   ELC   DP +R   + I + L  
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKELSE 286

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 20/80 (25%), Positives = 36/80 (45%), Gaps = 11/80 (13%)

Query: 309 ANIFLTAEGNS----LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 364
            NIFL +   +     K+ DFG + + S H+      +G +G   +MAPE      +  +
Sbjct: 153 PNIFLQSLDENAPVCAKVADFGLS-QQSVHSV-----SGLLGNFQWMAPETIGAEEES-Y 205

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
               D +S   +L  + +G+
Sbjct: 206 TEKADTYSFAMILYTILTGE 225

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  156 bits (396), Expect = 9e-45
 Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 25/264 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+ A  +  G  VA+K + + +   A  V + L E+ I++ +   N+V + G 
Sbjct: 46  GAGSFGTVHRAEWH--GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHENT--IVH 126
                 + +  E  + G+L  L+  +     L E         +   ++ LH     IVH
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           R++KS N+ +  +  ++K+ DFG + ++ A T +        GT  +MAPEV  D     
Sbjct: 163 RNLKSPNLLVD-KKYTVKVCDFGLS-RLKASTFL--SSKSAAGTPEWMAPEVLRDEP--- 215

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFAEL 245
                D++S G +L E+++ ++PW   +   Q++  VG   +   IP +L+      A +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLN-PAQVVAAVGFKCKRLEIPRNLN---PQVAAI 271

Query: 246 ---CLRHDPAQR---ATIFELLQH 263
              C  ++P +R   ATI +LL+ 
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRP 295

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 25/91 (27%), Positives = 44/91 (48%), Gaps = 10/91 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +  +  ++K+ DFG + ++ A T +        GT  +MAPEV  D          
Sbjct: 168 PNLLVD-KKYTVKVCDFGLS-RLKASTFL--SSKSAAGTPEWMAPEVLRDEP---SNEKS 220

Query: 369 DIWSLGCVLVEMSSGKT---NLSGVVVSAEV 396
           D++S G +L E+++ +    NL+   V A V
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  157 bits (398), Expect = 1e-44
 Identities = 79/258 (30%), Positives = 124/258 (48%), Gaps = 15/258 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV  A + +T + VA+K I       +     +  E+  L+ +   +++K Y V
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                ++V+ +E    G L + +V+  +  + E   RR+ +Q++ AI   H + IVHRD+
Sbjct: 78  ITTPTDIVMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  N+ L    N +K+ DFG    +S   T    L    G+  Y APEV     K+  G 
Sbjct: 135 KPENLLLDDNLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVIN--GKLYAGP 187

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF-KVGMGETPTIPESLSDEGQAFAELCLR 248
            VD+WS G VL  M  G+ P+   D     +F KV       +P+ LS   Q+     + 
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPF--DDEFIPNLFKKVNSCV-YVMPDFLSPGAQSLIRRMIV 244

Query: 249 HDPAQRATIFELLQHPFL 266
            DP QR TI E+ + P+ 
Sbjct: 245 ADPMQRITIQEIRRDPWF 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 27/75 (36%), Positives = 35/75 (46%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L    N +K+ DFG    +S   T    L    G+  Y APEV     K+  G  VD
Sbjct: 138 NLLLDDNLN-VKIADFG----LSNIMTDGNFLKTSCGSPNYAAPEVIN--GKLYAGPEVD 190

Query: 370 IWSLGCVLVEMSSGK 384
           +WS G VL  M  G+
Sbjct: 191 VWSCGIVLYVMLVGR 205

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  159 bits (405), Expect = 7e-44
 Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 22/266 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V       TG++ A K+++   + K+         L E +ILE +N + +V  
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---EAMALNEKQILEKVNSRFVVSL 249

Query: 68  YGVEIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                 ++ + L + L   G L+  +    + G PE     Y  ++   +  LH   IV+
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K  NI L   G+ +++ D G AV +    T+     G VGT  YMAPEV  +     
Sbjct: 310 RDLKPENILLDDHGH-IRISDLGLAVHVPEGQTI----KGRVGTVGYMAPEVVKNE---R 361

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTIPESLSDEGQAFAE 244
           +  + D W+LGC+L EM +G+ P+ +     +   + ++         E  S + ++   
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421

Query: 245 LCLRHDPAQR-----ATIFELLQHPF 265
             L  DPA+R      +  E+ +HP 
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPL 447

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 28/75 (37%), Positives = 41/75 (54%), Gaps = 8/75 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G AV +    T+     G VGT  YMAPEV  +     +  + D
Sbjct: 316 NILLDDHGH-IRISDLGLAVHVPEGQTI----KGRVGTVGYMAPEVVKNE---RYTFSPD 367

Query: 370 IWSLGCVLVEMSSGK 384
            W+LGC+L EM +G+
Sbjct: 368 WWALGCLLYEMIAGQ 382

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  156 bits (395), Expect = 9e-44
 Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 31/271 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G G  GKV    N  T E  A+K +Q      AR       E+ +        ++V+   
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKMLQ--DCPKAR------REVELHWRASQCPHIVRIVD 122

Query: 70  V----EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           V       R+ +++ ME    G L   +    +    E       K + +AI  LH   I
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182

Query: 125 VHRDIKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            HRD+K  N+ + +   N+ LKL DFG A + ++H +    L     T  Y+APEV    
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL--- 235

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQ--IMFKVGMGETPTIPE----SL 235
               + ++ D+WSLG ++  +  G  P ++ +       +  ++ MG+    P      +
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEV 294

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           S+E +      L+ +P QR TI E + HP++
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 9/70 (12%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           N+ + +   N+ LKL DFG A + ++H +    L     T  Y+APEV        + ++
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVL---GPEKYDKS 243

Query: 368 VDIWSLGCVL 377
            D+WSLG ++
Sbjct: 244 CDMWSLGVIM 253

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  154 bits (391), Expect = 1e-43
 Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 28/293 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYG 69
           G G +      ++  T    A+K I   K++          E+ IL       N++    
Sbjct: 31  GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYGQHPNIITLKD 83

Query: 70  VEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           V    + + +  EL   G L + +++       E         +   +  LH   +VHRD
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHRD 141

Query: 129 IKSANI-FLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +K +NI ++   GN  S+++ DFG A ++ A   +   L     T  ++APEV     + 
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTANFVAPEVL---ERQ 195

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMF-KVGMGE-TPTIPE--SLSDEGQ 240
           G+  A DIWSLG +L  M +G  P     D   + +  ++G G+ + +     S+SD  +
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 241 AFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGI 293
                 L  DP QR T   +L+HP++      D      +        +K  +
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWI---VHWDQLPQYQLNRQDAPHLVKGAM 305

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 25/71 (35%), Positives = 38/71 (53%), Gaps = 9/71 (12%)

Query: 310 NI-FLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI ++   GN  S+++ DFG A ++ A   +   L     T  ++APEV     + G+  
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTANFVAPEVL---ERQGYDA 199

Query: 367 AVDIWSLGCVL 377
           A DIWSLG +L
Sbjct: 200 ACDIWSLGVLL 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  151 bits (384), Expect = 2e-43
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 28/268 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-ARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FGKVY A     G+ VA+K  +     D ++ ++++  E ++   +   N++   G
Sbjct: 16  GIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN---TIVH 126
           V +    + L ME    G L  ++      +P  ++  +  Q+   ++ LH+     I+H
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 127 RDIKSANIFLT-------AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           RD+KS+NI +             LK+ DFG A +    TT         G  A+MAPEV 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTK----MSAAGAYAWMAPEVI 186

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDE 238
             +      +  D+WS G +L E+ +G+ P+   D    + + V M      IP +  + 
Sbjct: 187 RASM---FSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLALPIPSTCPEP 242

Query: 239 GQAFAELCLRHDPAQR---ATIFELLQH 263
                E C   DP  R     I + L  
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 11/85 (12%)

Query: 315 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG 374
                LK+ DFG A +    TT         G  A+MAPEV   +      +  D+WS G
Sbjct: 150 LSNKILKITDFGLA-REWHRTTK----MSAAGAYAWMAPEVIRASM---FSKGSDVWSYG 201

Query: 375 CVLVEMSSGKT---NLSGVVVSAEV 396
            +L E+ +G+     + G+ V+  V
Sbjct: 202 VLLWELLTGEVPFRGIDGLAVAYGV 226

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  151 bits (383), Expect = 6e-43
 Identities = 74/294 (25%), Positives = 134/294 (45%), Gaps = 58/294 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-----ARFVKDMLVELRILEGINQKNLV 65
           G+G +G V+ A N ET E+VA+K ++L   ++     A      L E+ +L+ +  KN+V
Sbjct: 11  GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHKNIV 64

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           + + V    +++ L  E C +  L+    S    L   +V+ +  QL+  +   H   ++
Sbjct: 65  RLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           HRD+K  N+ +   G  LKL +FG A    + +  ++         V T  Y  P+V   
Sbjct: 124 HRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAE-------VVTLWYRPPDVLFG 175

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT-------- 230
                +  ++D+WS GC+  E+++  RP    +    Q+  +F++ +G TPT        
Sbjct: 176 AKL--YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL-LG-TPTEEQWPSMT 231

Query: 231 -IPE------------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
            +P+                   L+  G+   +  L+ +P QR +  E LQHP+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 50.2 bits (121), Expect = 4e-07
 Identities = 19/75 (25%), Positives = 33/75 (44%), Gaps = 14/75 (18%)

Query: 310 NIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           N+ +   G  LKL +FG A    + +  ++         V T  Y  P+V        + 
Sbjct: 131 NLLINRNGE-LKLANFGLARAFGIPVRCYSAE-------VVTLWYRPPDVLFGAKL--YS 180

Query: 366 RAVDIWSLGCVLVEM 380
            ++D+WS GC+  E+
Sbjct: 181 TSIDMWSAGCIFAEL 195

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  158 bits (402), Expect = 6e-43
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 30/270 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD-----MLVELRILEGINQKN-- 63
           G+G FG+VY     +TG++ AMK   L K    R          L E  +L  ++  +  
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMK--CLDK---KRIKMKQGETLALNERIMLSLVSTGDCP 252

Query: 64  -LVK-YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            +V   Y      +++   ++L   G L   +        E  +R Y  +++  +  +H 
Sbjct: 253 FIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 310

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
             +V+RD+K ANI L   G+ +++ D G A   S         +  VGT  YMAPEV   
Sbjct: 311 RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQK 364

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
              V +  + D +SLGC+L ++  G  P       +   + ++ +     +P+S S E +
Sbjct: 365 --GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422

Query: 241 AFAELCLRHDPAQR-----ATIFELLQHPF 265
           +  E  L+ D  +R         E+ + PF
Sbjct: 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +++ D G A   S         +  VGT  YMAPEV      V +  + D
Sbjct: 322 NILLDEHGH-VRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQK--GVAYDSSAD 373

Query: 370 IWSLGCVLVEMSSGKT 385
            +SLGC+L ++  G +
Sbjct: 374 WFSLGCMLFKLLRGHS 389

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  149 bits (378), Expect = 2e-42
 Identities = 52/262 (19%), Positives = 108/262 (41%), Gaps = 22/262 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            +   G+++       G  + +K +++ +    R  +D   E   L   +  N++   G 
Sbjct: 19  NENHSGELWKGRWQ--GNDIVVKVLKV-RDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 71  --EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALH--ENTIV 125
                     L       G+L +++    +  + +    ++   +   ++ LH  E  I 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
              + S ++ +  E  + ++      VK S  +       G +   A++APE      + 
Sbjct: 136 RHALNSRSVMID-EDMTARISMAD--VKFSFQSP------GRMYAPAWVAPEALQKKPED 186

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFAE 244
            + R+ D+WS   +L E+ + + P+A+  SN +I  KV + G  PTIP  +S       +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245

Query: 245 LCLRHDPAQR---ATIFELLQH 263
           +C+  DPA+R     I  +L+ 
Sbjct: 246 ICMNEDPAKRPKFDMIVPILEK 267

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 55.7 bits (135), Expect = 5e-09
 Identities = 18/91 (19%), Positives = 40/91 (43%), Gaps = 12/91 (13%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            ++ +  E  + ++      VK S  +       G +   A++APE      +  + R+ 
Sbjct: 142 RSVMID-EDMTARISMAD--VKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSA 192

Query: 369 DIWSLGCVLVEMSSGKT---NLSGVVVSAEV 396
           D+WS   +L E+ + +    +LS + +  +V
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  154 bits (392), Expect = 3e-42
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 23/268 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V+      TG+L A K++    L K+      +  +VE +IL  ++ + +V  
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG---YQGAMVEKKILAKVHSRFIVSL 250

Query: 68  YGVEIHREEMVLFMELCTEGTLE---SLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
                 + ++ L M +   G +      V     G  E     YT Q+V  +  LH+  I
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           ++RD+K  N+ L  +GN +++ D G AV++ A  T      G+ GT  +MAPE+ +    
Sbjct: 311 IYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKT---KGYAGTPGFMAPELLLGE-- 364

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTIPESLSDEGQAF 242
             +  +VD ++LG  L EM + + P+       +   + +  + +  T P+  S   + F
Sbjct: 365 -EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423

Query: 243 AELCLRHDPAQR-----ATIFELLQHPF 265
            E  L+ DP +R      +   L  HP 
Sbjct: 424 CEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 7/75 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L  +GN +++ D G AV++ A  T      G+ GT  +MAPE+ +      +  +VD
Sbjct: 319 NVLLDDDGN-VRISDLGLAVELKAGQTKT---KGYAGTPGFMAPELLLGE---EYDFSVD 371

Query: 370 IWSLGCVLVEMSSGK 384
            ++LG  L EM + +
Sbjct: 372 YFALGVTLYEMIAAR 386

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  151 bits (384), Expect = 5e-42
 Identities = 71/271 (26%), Positives = 120/271 (44%), Gaps = 26/271 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVK- 66
           G+G F +V      +TG++ AMK +    + K+ +   V     E  +L   +++ + + 
Sbjct: 70  GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE---VSCFREERDVLVNGDRRWITQL 126

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
           ++  +     + L ME    G L +L+    + +P  + R Y  ++V AI ++H    VH
Sbjct: 127 HFAFQ-DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVH 185

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD----T 182
           RDIK  NI L   G+ ++L DFGS +K+ A  TV       VGT  Y++PE+        
Sbjct: 186 RDIKPDNILLDRCGH-IRLADFGSCLKLRADGTV--RSLVAVGTPDYLSPEILQAVGGGP 242

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-----PTIPESLSD 237
               +G   D W+LG    EM  G+ P+  Y  +    +   +        P + E + +
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPF--YADSTAETYGKIVHYKEHLSLPLVDEGVPE 300

Query: 238 EGQAFAELCLRHDPAQR---ATIFELLQHPF 265
           E + F +  L   P  R       +   HPF
Sbjct: 301 EARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 28/80 (35%), Positives = 39/80 (48%), Gaps = 7/80 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD----TNKVGHG 365
           NI L   G+ ++L DFGS +K+ A  TV       VGT  Y++PE+            +G
Sbjct: 192 NILLDRCGH-IRLADFGSCLKLRADGTV--RSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248

Query: 366 RAVDIWSLGCVLVEMSSGKT 385
              D W+LG    EM  G+T
Sbjct: 249 PECDWWALGVFAYEMFYGQT 268

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  149 bits (379), Expect = 1e-41
 Identities = 68/342 (19%), Positives = 124/342 (36%), Gaps = 82/342 (23%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ--------- 61
           G G F  V+ A +      VAMK ++     D  + +    E+++L+ +N          
Sbjct: 28  GWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 62  --KNLVKYYGVEIHREE----MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDA 115
              +++K      H+      +V+  E+  E  L  + +    G+P + V++ +KQL+  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 116 ISALH-ENTIVHRDIKSANIFLTAEG-----NSLKLGDFGSAVKISAHTTVPGELNGFVG 169
           +  +H    I+H DIK  N+ +           +K+ D G+A                + 
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------CWYDEHYTNSIQ 197

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-------------------------- 203
           T+ Y +PEV +       G   DIWS  C++ E+                          
Sbjct: 198 TREYRSPEVLL---GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 204 -----------SSGKRPWAEYDSNYQIMFKVGMGETP---TIPESLS---DEGQAFAEL- 245
                       +GK     ++S   +     +   P    + E      DE +  ++  
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 246 --CLRHDPAQRATIFELLQHPFL--IVSCEEDVCNPRSVPAS 283
              L+ DP +RA    L+ HP+L   +  EE     R +  S
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 356

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 9/68 (13%)

Query: 318 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL 377
             +K+ D G+A                + T+ Y +PEV +       G   DIWS  C++
Sbjct: 175 IQIKIADLGNA------CWYDEHYTNSIQTREYRSPEVLL---GAPWGCGADIWSTACLI 225

Query: 378 VEMSSGKT 385
            E+ +G  
Sbjct: 226 FELITGDF 233

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  148 bits (376), Expect = 2e-41
 Identities = 72/290 (24%), Positives = 132/290 (45%), Gaps = 49/290 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR--FVKDMLVELRILEGINQKNLVKYY 68
           G+G+F  VY A +  T ++VA+K+I+L  +++A+    +  L E+++L+ ++  N++   
Sbjct: 19  GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
               H+  + L  +   E  LE +++     L    ++ Y    +  +  LH++ I+HRD
Sbjct: 79  DAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137

Query: 129 IKSANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +K  N+ L   G  LKL DFG A        A+T         V T+ Y APE+      
Sbjct: 138 LKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQ-------VVTRWYRAPELLFGARM 189

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT---------IP 232
             +G  VD+W++GC+L E+     P+   DS+  Q+  +F+  +G TPT         +P
Sbjct: 190 --YGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFET-LG-TPTEEQWPDMCSLP 244

Query: 233 E-----------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
           +                 +  D+     +     +P  R T  + L+  +
Sbjct: 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 52.6 bits (127), Expect = 8e-08
 Identities = 26/80 (32%), Positives = 36/80 (45%), Gaps = 14/80 (17%)

Query: 309 ANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 364
            N+ L   G  LKL DFG A        A+T         V T+ Y APE+        +
Sbjct: 141 NNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQ-------VVTRWYRAPELLFGARM--Y 190

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
           G  VD+W++GC+L E+    
Sbjct: 191 GVGVDMWAVGCILAELLLRV 210

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  149 bits (377), Expect = 8e-41
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 22/268 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+V         ++ AMK +   ++ K+ +    ++   E  +L   + K +   
Sbjct: 83  GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSKWITTL 139

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +        + L M+    G L +L+   ED LPE + R Y  ++V AI ++H+   VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKV 185
           DIK  NI +   G+ ++L DFGS +K+    TV  + +  VGT  Y++PE+   M+  K 
Sbjct: 200 DIKPDNILMDMNGH-IRLADFGSCLKLMEDGTV--QSSVAVGTPDYISPEILQAMEGGKG 256

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET-----PTIPESLSDEGQ 240
            +G   D WSLG  + EM  G+ P+  Y  +    +   M        PT    +S+  +
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF--YAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314

Query: 241 AFAELCLRHDPAQR---ATIFELLQHPF 265
                 +      R     I +  +HPF
Sbjct: 315 DLIRRLIC-SREHRLGQNGIEDFKKHPF 341

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 29/78 (37%), Positives = 44/78 (56%), Gaps = 5/78 (6%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF--MDTNKVGHGRA 367
           NI +   G+ ++L DFGS +K+    TV  + +  VGT  Y++PE+   M+  K  +G  
Sbjct: 205 NILMDMNGH-IRLADFGSCLKLMEDGTV--QSSVAVGTPDYISPEILQAMEGGKGRYGPE 261

Query: 368 VDIWSLGCVLVEMSSGKT 385
            D WSLG  + EM  G+T
Sbjct: 262 CDWWSLGVCMYEMLYGET 279

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  147 bits (372), Expect = 1e-40
 Identities = 72/285 (25%), Positives = 117/285 (41%), Gaps = 22/285 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG      +  T ELVA+K I+     D    +    E+     +   N+V++  V
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFKEV 84

Query: 71  EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            +    + + ME  + G L E +  +      E   R + +QL+  +S  H   I HRD+
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142

Query: 130 KSANIFLTA-EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  N  L       LK+ DFG     S  + +  +    VGT AY+APEV +   +   G
Sbjct: 143 KLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL--RQEYDG 196

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE----TPTIPES--LSDEGQAF 242
           +  D+WS G  L  M  G  P+   D      ++  +        +IP+   +S E    
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPF--EDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 243 AELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQD 287
                  DPA R +I E+  H + + +   D+ N  +  +   + 
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 25/75 (33%), Positives = 34/75 (45%), Gaps = 7/75 (9%)

Query: 310 NIFLTA-EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N  L       LK+ DFG     S  + +  +    VGT AY+APEV +   +   G+  
Sbjct: 146 NTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL--RQEYDGKIA 199

Query: 369 DIWSLGCVLVEMSSG 383
           D+WS G  L  M  G
Sbjct: 200 DVWSCGVTLYVMLVG 214

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  145 bits (367), Expect = 2e-40
 Identities = 64/286 (22%), Positives = 111/286 (38%), Gaps = 24/286 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+     + ETGE++ MKE+    + D    +  L E++++  +   N++K+ GV
Sbjct: 19  GKGCFGQAIKVTHRETGEVMVMKEL---IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + +    E    GTL  +++S +   P      + K +   ++ LH   I+HRD+ 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----------FVGTQAYMAPEVF 179
           S N  L  E  ++ + DFG A  +    T P  L              VG   +MAPE+ 
Sbjct: 136 SHNC-LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-SNYQIMFKVGMGETPTIPESLSDE 238
              +   +   VD++S G VL E+        +Y          V        P +    
Sbjct: 195 NGRS---YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPS 251

Query: 239 GQAFAELCLRHDPAQR---ATIFELLQHPFLIVSCEEDVCNPRSVP 281
                  C   DP +R     +   L+   L +     +     + 
Sbjct: 252 FFPITVRCCDLDPEKRPSFVKLEHWLET--LRMHLAGHLPLGPQLE 295

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 15/87 (17%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG-----------FVGTQAYMAPEVFM 357
            N  L  E  ++ + DFG A  +    T P  L              VG   +MAPE+  
Sbjct: 137 HNC-LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195

Query: 358 DTNKVGHGRAVDIWSLGCVLVEMSSGK 384
             +   +   VD++S G VL E+    
Sbjct: 196 GRS---YDEKVDVFSFGIVLCEIIGRV 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  144 bits (365), Expect = 4e-40
 Identities = 59/283 (20%), Positives = 100/283 (35%), Gaps = 32/283 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G+G   +V T +N  T +  A+K I+    +       +  E+ +L      +N+++   
Sbjct: 22  GEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIE 78

Query: 70  VEIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
                +   L  E    G++   + +       E+      + +  A+  LH   I HRD
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRD 136

Query: 129 IKSANI-FLTAEGNS-LKLGDFGSAVKI----SAHTTVPGELNGFVGTQAYMAPEVF--M 180
           +K  NI        S +K+ DF     I            EL    G+  YMAPEV    
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQIMFKVGMGETP---------- 229
                 + +  D+WSLG +L  + SG  P      S+                       
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256

Query: 230 ----TIPE--SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                  +   +S   +      L  D  QR +  ++LQHP++
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 24/82 (29%), Positives = 32/82 (39%), Gaps = 8/82 (9%)

Query: 310 NI-FLTAEGNS-LKLGDFGSAVKI----SAHTTVPGELNGFVGTQAYMAPEVF--MDTNK 361
           NI        S +K+ DF     I            EL    G+  YMAPEV        
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200

Query: 362 VGHGRAVDIWSLGCVLVEMSSG 383
             + +  D+WSLG +L  + SG
Sbjct: 201 SIYDKRCDLWSLGVILYILLSG 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  143 bits (364), Expect = 6e-40
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 54/294 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+VY A++  T E VA+K I+L  + +       + E+ +L+ +  +N+++   V
Sbjct: 43  GEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-VPGTAIREVSLLKELQHRNIIELKSV 101

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             H   + L  E   E  L+  +      +   +++ +  QL++ ++  H    +HRD+K
Sbjct: 102 IHHNHRLHLIFEYA-ENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159

Query: 131 SANIFLTAEGNS----LKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
             N+ L+    S    LK+GDFG A    + I   T         + T  Y  PE+ + +
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-------IITLWYRPPEILLGS 212

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT--------- 230
               +  +VDIWS+ C+  EM     P    DS   Q+  +F+V +G  P          
Sbjct: 213 RH--YSTSVDIWSIACIWAEMLMKT-PLFPGDSEIDQLFKIFEV-LG-LPDDTTWPGVTA 267

Query: 231 -------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                              +   L DEG       L  DP +R +    L+HP+
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 24/83 (28%), Positives = 36/83 (43%), Gaps = 17/83 (20%)

Query: 310 NIFLTAEGNS----LKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 361
           N+ L+    S    LK+GDFG A    + I   T         + T  Y  PE+ + +  
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-------IITLWYRPPEILLGSRH 214

Query: 362 VGHGRAVDIWSLGCVLVEMSSGK 384
             +  +VDIWS+ C+  EM    
Sbjct: 215 --YSTSVDIWSIACIWAEMLMKT 235

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  143 bits (364), Expect = 6e-40
 Identities = 65/295 (22%), Positives = 121/295 (41%), Gaps = 61/295 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-----RFVKDMLVELRILEGINQKNLV 65
           G+G +  VY   +  T  LVA+KEI+L  +  A     R       E+ +L+ +   N+V
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHANIV 63

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             + +    + + L  E   +  L+  +    + +    V+ +  QL+  ++  H   ++
Sbjct: 64  TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           HRD+K  N+ +   G  LKL DFG A    +    +          V T  Y  P++ + 
Sbjct: 123 HRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNE-------VVTLWYRPPDILLG 174

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT-------- 230
           +    +   +D+W +GC+  EM++G RP     +   Q+  +F++ +G TPT        
Sbjct: 175 STD--YSTQIDMWGVGCIFYEMATG-RPLFPGSTVEEQLHFIFRI-LG-TPTEETWPGIL 229

Query: 231 -IPE-------------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              E                    L  +G       L+ +   R +  + ++HPF
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 20/80 (25%), Positives = 36/80 (45%), Gaps = 14/80 (17%)

Query: 309 ANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 364
            N+ +   G  LKL DFG A    +    +          V T  Y  P++ + +    +
Sbjct: 129 QNLLINERGE-LKLADFGLARAKSIPTKTYDNE-------VVTLWYRPPDILLGSTD--Y 178

Query: 365 GRAVDIWSLGCVLVEMSSGK 384
              +D+W +GC+  EM++G+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  146 bits (370), Expect = 6e-40
 Identities = 86/318 (27%), Positives = 141/318 (44%), Gaps = 58/318 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---- 66
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+    
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 115

Query: 67  YYGVEIHREEMVLF--MELCTEGTLESLVQSTEDG---LPEVLVRRYTKQLVDAISALHE 121
           +Y     ++E+ L   ++   E T+  + +        LP + V+ Y  QL  +++ +H 
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEV-F 179
             I HRDIK  N+ L  +   LKL DFG     SA   V GE N  ++ ++ Y APE+ F
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFG-----SAKQLVRGEPNVSYICSRYYRAPELIF 229

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPT---IPES 234
             T+   +  ++D+WS GCVL E+  G+  +       Q+  + KV +G TPT   I E 
Sbjct: 230 GATD---YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV-LG-TPTREQIREM 284

Query: 235 LSD---------EGQAFAEL---------------CLRHDPAQRATIFELLQHPFLIVSC 270
             +         +   + ++                L + P  R T  E   H F     
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

Query: 271 EEDVCNPRSVPASVLQDY 288
           + +V  P       L ++
Sbjct: 345 DPNVKLPNGRDTPALFNF 362

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 10/77 (12%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEV-FMDTNKVGHGRA 367
           N+ L  +   LKL DFGSA        V GE N  ++ ++ Y APE+ F  T+   +  +
Sbjct: 186 NLLLDPDTAVLKLCDFGSA-----KQLVRGEPNVSYICSRYYRAPELIFGATD---YTSS 237

Query: 368 VDIWSLGCVLVEMSSGK 384
           +D+WS GCVL E+  G+
Sbjct: 238 IDVWSAGCVLAELLLGQ 254

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  142 bits (361), Expect = 1e-39
 Identities = 78/297 (26%), Positives = 134/297 (45%), Gaps = 65/297 (21%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-----ARFVKDMLVELRILEGINQKNLV 65
           G+G +G VY A ++  G +VA+K I+L  +++     A      + E+ +L+ ++  N+V
Sbjct: 30  GEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPNIV 82

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
               V      + L  E   E  L+ ++   + GL +  ++ Y  QL+  ++  H++ I+
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVF 179
           HRD+K  N+ + ++G  LKL DFG A      V+   H  V         T  Y AP+V 
Sbjct: 142 HRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVV---------TLWYRAPDVL 191

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT------ 230
           M + K  +  +VDIWS+GC+  EM +GK P     ++  Q+  +F + +G TP       
Sbjct: 192 MGSKK--YSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSI-LG-TPNPREWPQ 246

Query: 231 ---IPE-------------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              +P                        EG       L  DP +R +  + + HP+
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 30/81 (37%), Positives = 42/81 (51%), Gaps = 18/81 (22%)

Query: 310 NIFLTAEGNSLKLGDFGSA------VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N+ + ++G  LKL DFG A      V+   H  V         T  Y AP+V M + K  
Sbjct: 149 NLLINSDGA-LKLADFGLARAFGIPVRSYTHEVV---------TLWYRAPDVLMGSKK-- 196

Query: 364 HGRAVDIWSLGCVLVEMSSGK 384
           +  +VDIWS+GC+  EM +GK
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  141 bits (358), Expect = 2e-39
 Identities = 84/294 (28%), Positives = 138/294 (46%), Gaps = 60/294 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQND-----ARFVKDMLVELRILEGINQKNLV 65
           G+G +G VY A NN  GE  A+K+I+L K+++            + E+ IL+ +   N+V
Sbjct: 11  GEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTT------IREISILKELKHSNIV 63

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           K Y V   ++ +VL  E   +  L+ L+   E GL  V  + +  QL++ I+  H+  ++
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           HRD+K  N+ +  EG  LK+ DFG A    + +  +T         + T  Y AP+V M 
Sbjct: 123 HRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHE-------IVTLWYRAPDVLMG 174

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT-------- 230
           + K  +   +DIWS+GC+  EM +G  P     S   Q+  +F++ +G TP         
Sbjct: 175 SKK--YSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMRIFRI-LG-TPNSKNWPNVT 229

Query: 231 -IPE------------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
            +P+                   L + G       L+ DP QR T  + L+H +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 14/79 (17%)

Query: 310 NIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           N+ +  EG  LK+ DFG A    + +  +T         + T  Y AP+V M + K  + 
Sbjct: 130 NLLINREGE-LKIADFGLARAFGIPVRKYTHE-------IVTLWYRAPDVLMGSKK--YS 179

Query: 366 RAVDIWSLGCVLVEMSSGK 384
             +DIWS+GC+  EM +G 
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  142 bits (361), Expect = 2e-39
 Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 37/273 (13%)

Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQ----LHKQNDARFVKDMLVELRILEGINQKN 63
           G+G +GKV+         TG++ AMK ++    +    D         E  ILE +    
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD---TAHTKAERNILEEVKHPF 82

Query: 64  LVKYYGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           +V      +        ++ L +E  + G L   ++  E    E     Y  ++  A+  
Sbjct: 83  IVD-----LIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLAEISMALGH 136

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPE 177
           LH+  I++RD+K  NI L  +G+ +KL DFG     I   T      + F GT  YMAPE
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVT----HTFCGTIEYMAPE 191

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
           + M +   GH RAVD WSLG ++ +M +G  P+     N +      +     +P  L+ 
Sbjct: 192 ILMRS---GHNRAVDWWSLGALMYDMLTGAPPF--TGENRKKTIDKILKCKLNLPPYLTQ 246

Query: 238 EGQAFAELCLRHDPAQR-----ATIFELLQHPF 265
           E +   +  L+ + A R         E+  HPF
Sbjct: 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 32/76 (42%), Positives = 42/76 (55%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L  +G+ +KL DFG     I   T      + F GT  YMAPE+ M +   GH RAV
Sbjct: 151 NIMLNHQGH-VKLTDFGLCKESIHDGTVT----HTFCGTIEYMAPEILMRS---GHNRAV 202

Query: 369 DIWSLGCVLVEMSSGK 384
           D WSLG ++ +M +G 
Sbjct: 203 DWWSLGALMYDMLTGA 218

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  142 bits (361), Expect = 2e-39
 Identities = 78/271 (28%), Positives = 124/271 (45%), Gaps = 37/271 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV       TG   AMK ++   +  +++   V   + E R+L+      L   
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---VAHTVTESRVLQNTRHPFLTA- 69

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
               +       + +   ME    G L   +   E    E   R Y  ++V A+  LH  
Sbjct: 70  ----LKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR 124

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            +V+RDIK  N+ L  +G+ +K+ DFG     +   A          F GT  Y+APEV 
Sbjct: 125 DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATM------KTFCGTPEYLAPEVL 177

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
            D     +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E 
Sbjct: 178 EDN---DYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEA 232

Query: 240 QAFAELCLRHDPAQR-----ATIFELLQHPF 265
           ++     L+ DP QR     +   E+++H F
Sbjct: 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 29/78 (37%), Positives = 39/78 (50%), Gaps = 13/78 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L  +G+ +K+ DFG     +   A          F GT  Y+APEV  D     +GR
Sbjct: 135 NLMLDKDGH-IKITDFGLCKEGISDGATM------KTFCGTPEYLAPEVLEDN---DYGR 184

Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD W LG V+ EM  G+
Sbjct: 185 AVDWWGLGVVMYEMMCGR 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  143 bits (363), Expect = 8e-39
 Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 26/266 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVK- 66
           G+G FGKV       TG   AMK ++   +  +++   V   L E R+L+      L   
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE---VAHTLTENRVLQNSRHPFLTAL 213

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIV 125
            Y  + H + +   ME    G L   +   E    E   R Y  ++V A+  LH E  +V
Sbjct: 214 KYSFQTH-DRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVV 271

Query: 126 HRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +RD+K  N+ L  +G+ +K+ DFG     I    T+      F GT  Y+APEV  D   
Sbjct: 272 YRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATM----KTFCGTPEYLAPEVLEDN-- 324

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
             +GRAVD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +L  E ++   
Sbjct: 325 -DYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381

Query: 245 LCLRHDPAQR-----ATIFELLQHPF 265
             L+ DP QR         E++QH F
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRF 407

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 30/76 (39%), Positives = 40/76 (52%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  +G+ +K+ DFG     I    T+      F GT  Y+APEV  D     +GRAV
Sbjct: 279 NLMLDKDGH-IKITDFGLCKEGIKDGATM----KTFCGTPEYLAPEVLEDN---DYGRAV 330

Query: 369 DIWSLGCVLVEMSSGK 384
           D W LG V+ EM  G+
Sbjct: 331 DWWGLGVVMYEMMCGR 346

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  141 bits (357), Expect = 1e-38
 Identities = 72/327 (22%), Positives = 131/327 (40%), Gaps = 60/327 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM-LVELRILEGINQKNLVKYYG 69
           GQG FG+V+ A + +TG+ VA+K++ +  + +        L E++IL+ +  +N+V    
Sbjct: 26  GQGTFGEVFKARHRKTGQKVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIE 83

Query: 70  V--------EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
           +           +  + L  + C E  L  L+ +         ++R  + L++ +  +H 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFM 180
           N I+HRD+K+AN+ +T +G  LKL DFG A   S    + P      V T  Y  PE+ +
Sbjct: 143 NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 201

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPW----AEYDSNYQI--MFKVGMGETPT---- 230
                 +G  +D+W  GC++ EM +   P      E     Q+  + ++  G + T    
Sbjct: 202 GERD--YGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQH---QLALISQL-CG-SITPEVW 253

Query: 231 -----IPE---------------------SLSDEGQAFAELCLRHDPAQRATIFELLQHP 264
                                                  +  L  DPAQR    + L H 
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 265 FLIVSCEEDVCNPRSVPASVLQDYLKL 291
           F     +    + + + ++ L    + 
Sbjct: 314 FF--WSDPMPSDLKGMLSTHLTSMFEY 338

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 4/77 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ +T +G  LKL DFG A   S    + P      V T  Y  PE+ +      +G  
Sbjct: 153 ANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD--YGPP 209

Query: 368 VDIWSLGCVLVEMSSGK 384
           +D+W  GC++ EM +  
Sbjct: 210 IDLWGAGCIMAEMWTRS 226

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  140 bits (354), Expect = 1e-38
 Identities = 77/294 (26%), Positives = 119/294 (40%), Gaps = 51/294 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDM--LVE---LRILEGINQKNLV 65
           G G +G VY A +  +G  VA+K +++           +  + E   LR LE     N+V
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77

Query: 66  KYYGVEIHREE-----MVLFMELCTEGTLESLVQS-TEDGLPEVLVRRYTKQLVDAISAL 119
           +   V           + L  E   +  L + +      GLP   ++   +Q +  +  L
Sbjct: 78  RLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           H N IVHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APEV 
Sbjct: 137 HANCIVHRDLKPENILVTSGGT-VKLADFGLARIYS----YQMALTPVVVTLWYRAPEVL 191

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT------ 230
           + +    +   VD+WS+GC+  EM   K P    +S   Q+  +F + +G  P       
Sbjct: 192 LQST---YATPVDMWSVGCIFAEMFRRK-PLFCGNSEADQLGKIFDL-IG-LPPEDDWPR 245

Query: 231 ---IPES----------------LSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              +P                  + + G       L  +P +R + F  LQH +
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 28/76 (36%), Positives = 37/76 (48%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI +T+ G  +KL DFG A   S        L   V T  Y APEV + +    +   V
Sbjct: 149 ENILVTSGGT-VKLADFGLARIYS----YQMALTPVVVTLWYRAPEVLLQST---YATPV 200

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC+  EM   K
Sbjct: 201 DMWSVGCIFAEMFRRK 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  142 bits (359), Expect = 2e-38
 Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 26/268 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+V    +  T ++ AMK     E+                E  I+   N   +V
Sbjct: 78  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD-----SAFFWEERDIMAFANSPWVV 132

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           + +        + + ME    G L +L+      +PE   R YT ++V A+ A+H    +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFI 190

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K  N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       
Sbjct: 191 HRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGD 247

Query: 186 G-HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK--VGMGETPTIPES--LSDEGQ 240
           G +GR  D WS+G  L EM  G  P+  Y  +    +   +    + T P+   +S E +
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305

Query: 241 AFAELCLRHDPAQR---ATIFELLQHPF 265
                 L  D   R     + E+ +H F
Sbjct: 306 NLICAFLT-DREVRLGRNGVEEIKRHLF 332

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 4/77 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG-HGRAV 368
           N+ L   G+ LKL DFG+ +K++    V    +  VGT  Y++PEV       G +GR  
Sbjct: 198 NMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGREC 254

Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS+G  L EM  G T
Sbjct: 255 DWWSVGVFLYEMLVGDT 271

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  139 bits (354), Expect = 2e-38
 Identities = 78/270 (28%), Positives = 119/270 (44%), Gaps = 33/270 (12%)

Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGINQKNLVK 66
           GQG FGKV+       ++  +L AMK   L K     R      +E  IL  +N   +VK
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMK--VLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 67  YYGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
                +H       ++ L ++    G L + +   E    E  V+ Y  +L  A+  LH 
Sbjct: 91  -----LHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS 144

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
             I++RD+K  NI L  EG+ +KL DFG S   I            F GT  YMAPEV  
Sbjct: 145 LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKA----YSFCGTVEYMAPEVVN 199

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
                GH ++ D WS G ++ EM +G  P+     + +    + +     +P+ LS E Q
Sbjct: 200 RR---GHTQSADWWSFGVLMFEMLTGTLPF--QGKDRKETMTMILKAKLGMPQFLSPEAQ 254

Query: 241 AFAELCLRHDPAQR-----ATIFELLQHPF 265
           +   +  + +PA R       + E+ +H F
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 30/76 (39%), Positives = 37/76 (48%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L  EG+ +KL DFG S   I            F GT  YMAPEV       GH ++ 
Sbjct: 156 NILLDEEGH-IKLTDFGLSKESIDHEKKA----YSFCGTVEYMAPEVVNRR---GHTQSA 207

Query: 369 DIWSLGCVLVEMSSGK 384
           D WS G ++ EM +G 
Sbjct: 208 DWWSFGVLMFEMLTGT 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  140 bits (356), Expect = 2e-38
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 35/276 (12%)

Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQNDARFVKD---MLVELRILEGINQKNL 64
           G G +GKV+       ++TG+L AMK   L K    +  K       E ++LE I Q   
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMK--VLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 65  VKYYGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           +    V +H       ++ L ++    G L + +    +   E  V+ Y  ++V A+  L
Sbjct: 121 L----VTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 175

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAP 176
           H+  I++RDIK  NI L + G+ + L DFG     V              F GT  YMAP
Sbjct: 176 HKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERA-----YDFCGTIEYMAP 229

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW--AEYDSNYQIMFKVGMGETPTIPES 234
           ++       GH +AVD WSLG ++ E+ +G  P+      ++   + +  +   P  P+ 
Sbjct: 230 DIVRG-GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288

Query: 235 LSDEGQAFAELCLRHDPAQR-----ATIFELLQHPF 265
           +S   +   +  L  DP +R         E+ +H F
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 27/78 (34%), Positives = 37/78 (47%), Gaps = 10/78 (12%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L + G+ + L DFG     V              F GT  YMAP++       GH +
Sbjct: 189 NILLDSNGH-VVLTDFGLSKEFVADETERA-----YDFCGTIEYMAPDIVRG-GDSGHDK 241

Query: 367 AVDIWSLGCVLVEMSSGK 384
           AVD WSLG ++ E+ +G 
Sbjct: 242 AVDWWSLGVLMYELLTGA 259

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  139 bits (351), Expect = 3e-38
 Identities = 66/288 (22%), Positives = 118/288 (40%), Gaps = 45/288 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G+V+       GE VA+K      +++  + ++   EL     +  +N++ +   
Sbjct: 17  GKGRYGEVWRGSWQ--GENVAVK--IFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS 70

Query: 71  EIH----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--- 123
           ++       ++ L       G+L   +Q T   L  V   R    +   ++ LH      
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 124 -----IVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPE 177
                I HRD+KS NI +   G    + D G + +   +   +    N  VGT+ YMAPE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 178 VF---MDTNKVGHGRAVDIWSLGCVLVEMSSG----------KRPWAEY---DSNYQIMF 221
           V    +  +     + VDIW+ G VL E++            K P+ +    D +++ M 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 222 K--VGMGETPTIPESLSDEG--QAFAEL---CLRHDPAQRATIFELLQ 262
           K      + P IP     +    + A+L   C   +P+ R T   + +
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 5/86 (5%)

Query: 309 ANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVF---MDTNKVGH 364
            NI +   G    + D G + +   +   +    N  VGT+ YMAPEV    +  +    
Sbjct: 142 KNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200

Query: 365 GRAVDIWSLGCVLVEMSSGKTNLSGV 390
            + VDIW+ G VL E++    +   V
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIV 226

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  140 bits (354), Expect = 3e-38
 Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 22/262 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG+V    + E+G   AMK   L KQ     + ++  L E RIL+ +N   LVK  
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMK--ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
                   + + ME    G + S ++       E   R Y  Q+V     LH   +++RD
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ +  +G  +++ DFG A ++   T          GT   +APE+ +     G+ 
Sbjct: 167 LKPENLLIDQQGY-IQVTDFGFAKRVKGRT------WTLCGTPEALAPEIILSK---GYN 216

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
           +AVD W+LG ++ EM++G  P+  +      +++  +      P   S + +      L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274

Query: 249 HDPAQR-----ATIFELLQHPF 265
            D  +R       + ++  H +
Sbjct: 275 VDLTKRFGNLKNGVNDIKNHKW 296

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 22/74 (29%), Positives = 40/74 (54%), Gaps = 10/74 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +G  +++ DFG A ++   T          GT   +APE+ +     G+ +AVD
Sbjct: 171 NLLIDQQGY-IQVTDFGFAKRVKGRT------WTLCGTPEALAPEIILSK---GYNKAVD 220

Query: 370 IWSLGCVLVEMSSG 383
            W+LG ++ EM++G
Sbjct: 221 WWALGVLIYEMAAG 234

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  140 bits (356), Expect = 4e-38
 Identities = 84/318 (26%), Positives = 137/318 (43%), Gaps = 59/318 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---- 66
           G G FG V+ A   E+ E VA+K++   K+   R       EL+I+  +   N+V     
Sbjct: 49  GNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAF 100

Query: 67  YYGVEIHREEMVLF--MELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE 121
           +Y     ++E+ L   +E   E T+    +     +  +P +L++ Y  QL+ +++ +H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEV-F 179
             I HRDIK  N+ L      LKL DFG     SA   + GE N  ++ ++ Y APE+ F
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFG-----SAKILIAGEPNVSYICSRYYRAPELIF 214

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPT---IPES 234
             TN   +   +DIWS GCV+ E+  G+  +       Q+  + KV +G TP+   I   
Sbjct: 215 GATN---YTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV-LG-TPSREQIKTM 269

Query: 235 LSD---------EGQAFAEL---------------CLRHDPAQRATIFELLQHPFLIVSC 270
             +             F+++                L + P+ R T  E L HPF     
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329

Query: 271 EEDVCNPRSVPASVLQDY 288
             +   P       L ++
Sbjct: 330 TGEARMPNGRELPPLFNW 347

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 29/77 (37%), Positives = 41/77 (53%), Gaps = 10/77 (12%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEV-FMDTNKVGHGRA 367
           N+ L      LKL DFGSA        + GE N  ++ ++ Y APE+ F  TN   +   
Sbjct: 171 NLLLDPPSGVLKLIDFGSA-----KILIAGEPNVSYICSRYYRAPELIFGATN---YTTN 222

Query: 368 VDIWSLGCVLVEMSSGK 384
           +DIWS GCV+ E+  G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  141 bits (356), Expect = 6e-38
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK------NL 64
           G+G FG+V  A +++  + VA+K ++    N+ RF +    E+RILE + ++      N+
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +        R  + +  EL +    E + ++   G    LVR++   ++  + ALH+N I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI 221

Query: 125 VHRDIKSANIFLTAEGNS-LKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDT 182
           +H D+K  NI L  +G S +K+ DFGS+        T        + ++ Y APEV +  
Sbjct: 222 IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY-------IQSRFYRAPEVILG- 273

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGK 207
               +G  +D+WSLGC+L E+ +G 
Sbjct: 274 --ARYGMPIDMWSLGCILAELLTGY 296

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 12/78 (15%)

Query: 310 NIFLTAEGNS-LKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           NI L  +G S +K+ DFGS+        T        + ++ Y APEV +      +G  
Sbjct: 230 NILLKQQGRSGIKVIDFGSSCYEHQRVYTY-------IQSRFYRAPEVILG---ARYGMP 279

Query: 368 VDIWSLGCVLVEMSSGKT 385
           +D+WSLGC+L E+ +G  
Sbjct: 280 IDMWSLGCILAELLTGYP 297

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  139 bits (352), Expect = 8e-38
 Identities = 69/330 (20%), Positives = 126/330 (38%), Gaps = 88/330 (26%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-----KNLV 65
           G G FG+V    + +  +  A+K ++    N  ++ +   +E  IL+ I        N+V
Sbjct: 44  GDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           KY+G  ++ + M L  E       E + ++  +G     ++ Y  +++ A++ L + ++ 
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLT 159

Query: 126 HRDIKSANIFLTAEG------------------------NSLKLGDFGSAVKIS-AHTTV 160
           H D+K  NI L                              +KL DFG A   S  H ++
Sbjct: 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSI 219

Query: 161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-------------- 206
                  + T+ Y APEV ++   +G   + D+WS GCVL E+ +G              
Sbjct: 220 -------INTRQYRAPEVILN---LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269

Query: 207 ------------------KRPWAEYDSNYQIMFKVGMGETP---------TIPESLSDEG 239
                             K   ++Y +  ++        +           +P     + 
Sbjct: 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329

Query: 240 QAFAEL---CLRHDPAQRATIFELLQHPFL 266
           + F +     L+ DP  R +  ELL+H FL
Sbjct: 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 11/69 (15%)

Query: 318 NSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV 376
             +KL DFG A   S  H ++       + T+ Y APEV ++   +G   + D+WS GCV
Sbjct: 199 TGIKLIDFGCATFKSDYHGSI-------INTRQYRAPEVILN---LGWDVSSDMWSFGCV 248

Query: 377 LVEMSSGKT 385
           L E+ +G  
Sbjct: 249 LAELYTGSL 257

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  138 bits (350), Expect = 8e-38
 Identities = 60/289 (20%), Positives = 112/289 (38%), Gaps = 47/289 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GRFG+V+       GE VA+K      + +  + ++   E+     +  +N++ +   
Sbjct: 51  GKGRFGEVWRGKWR--GEEVAVKI--FSSREERSWFRE--AEIYQTVMLRHENILGFIAA 104

Query: 71  EIHRE----EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--- 123
           +        ++ L  +    G+L   +      +    + +        ++ LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 124 -----IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPE 177
                I HRD+KS NI +   G    + D G AV+  + T T+    N  VGT+ YMAPE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 178 VFMDTNKVGHGRA---VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK------------ 222
           V  D+  + H  +    DI+++G V  E++        ++  YQ+ +             
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVPSDPSVEEM 280

Query: 223 ----VGMGETPTIPESLS--DEGQAFAEL---CLRHDPAQRATIFELLQ 262
                     P IP      +  +  A++   C   + A R T   + +
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 5/79 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
            NI +   G    + D G AV+  + T T+    N  VGT+ YMAPEV  D+  + H  +
Sbjct: 176 KNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 368 ---VDIWSLGCVLVEMSSG 383
               DI+++G V  E++  
Sbjct: 235 FKRADIYAMGLVFWEIARR 253

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  137 bits (348), Expect = 2e-37
 Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 32/267 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKN--LV 65
           G+G FGKV+ A   +T +  A+K ++   +   +D   V+  +VE R+L  +  ++  L 
Sbjct: 26  GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLS-LAWEHPFLT 81

Query: 66  KYYGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
                 +      +E +   ME    G L   +Q +           Y  +++  +  LH
Sbjct: 82  H-----MFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLH 135

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
              IV+RD+K  NI L  +G+ +K+ DFG     +          N F GT  Y+APE+ 
Sbjct: 136 SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAK----TNTFCGTPDYIAPEIL 190

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
           +      +  +VD WS G +L EM  G+ P+  +  + + +F     + P  P  L  E 
Sbjct: 191 LGQ---KYNHSVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWLEKEA 245

Query: 240 QAFAELCLRHDPAQR-ATIFELLQHPF 265
           +         +P +R     ++ QHP 
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPL 272

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 25/75 (33%), Positives = 36/75 (48%), Gaps = 9/75 (12%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L  +G+ +K+ DFG     +          N F GT  Y+APE+ +      +  +V
Sbjct: 148 NILLDKDGH-IKIADFGMCKENMLGDAK----TNTFCGTPDYIAPEILLGQ---KYNHSV 199

Query: 369 DIWSLGCVLVEMSSG 383
           D WS G +L EM  G
Sbjct: 200 DWWSFGVLLYEMLIG 214

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  136 bits (345), Expect = 3e-37
 Identities = 65/265 (24%), Positives = 115/265 (43%), Gaps = 28/265 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-----EIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G G FG+V+   +   G   AMK      +   KQ     V+    E  +L  +    ++
Sbjct: 15  GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-----VEHTNDERLMLSIVTHPFII 69

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           + +G     +++ + M+    G L SL++      P  + + Y  ++  A+  LH   I+
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDII 128

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RD+K  NI L   G+ +K+ DFG A K     T         GT  Y+APEV       
Sbjct: 129 YRDLKPENILLDKNGH-IKITDFGFA-KYVPDVT-----YTLCGTPDYIAPEVVSTK--- 178

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            + +++D WS G ++ EM +G  P+  YDSN    ++  +      P   +++ +     
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236

Query: 246 CLRHDPAQR-----ATIFELLQHPF 265
            +  D +QR         ++  HP+
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPW 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 25/74 (33%), Positives = 36/74 (48%), Gaps = 10/74 (13%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L   G+ +K+ DFG A K     T         GT  Y+APEV        + +++D
Sbjct: 136 NILLDKNGH-IKITDFGFA-KYVPDVT-----YTLCGTPDYIAPEVVSTK---PYNKSID 185

Query: 370 IWSLGCVLVEMSSG 383
            WS G ++ EM +G
Sbjct: 186 WWSFGILIYEMLAG 199

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  136 bits (345), Expect = 3e-37
 Identities = 77/300 (25%), Positives = 124/300 (41%), Gaps = 62/300 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-----RFVKDMLVELRILEGINQKNLV 65
           G G +  VY  +N  TG  VA+KE++L  +        R       E+ +++ +  +N+V
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLMKELKHENIV 66

Query: 66  KYYGVEIHREEMVLFMELCT---EGTLESL-VQSTEDGLPEVLVRRYTKQLVDAISALHE 121
           + Y V     ++ L  E      +  ++S  V +T  GL   LV+ +  QL+  ++  HE
Sbjct: 67  RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPE 177
           N I+HRD+K  N+ +   G  LKLGDFG A    + ++  ++        V T  Y AP+
Sbjct: 127 NKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSE-------VVTLWYRAPD 178

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGK------------------------RPWAEY 213
           V M +    +  ++DIWS GC+L EM +GK                          W   
Sbjct: 179 VLMGSRT--YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236

Query: 214 DS--NYQIMFKVGMGE------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                Y    +            P   E L      F    L+ +P  R +  + L HP+
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 14/79 (17%)

Query: 310 NIFLTAEGNSLKLGDFGSA----VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           N+ +   G  LKLGDFG A    + ++  ++        V T  Y AP+V M +    + 
Sbjct: 138 NLLINKRGQ-LKLGDFGLARAFGIPVNTFSSE-------VVTLWYRAPDVLMGSRT--YS 187

Query: 366 RAVDIWSLGCVLVEMSSGK 384
            ++DIWS GC+L EM +GK
Sbjct: 188 TSIDIWSCGCILAEMITGK 206

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  136 bits (345), Expect = 6e-37
 Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 33/270 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV  A   ETG+L A+K ++   + + +D   V+  + E RIL        +  
Sbjct: 32  GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD---VECTMTEKRILSLARNHPFL-- 86

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
              ++       + +   ME    G L   +Q       E   R Y  +++ A+  LH+ 
Sbjct: 87  --TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDK 143

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
            I++RD+K  N+ L  EG+  KL DFG     I    T       F GT  Y+APE+  +
Sbjct: 144 GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTT----ATFCGTPDYIAPEILQE 198

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
                +G AVD W++G +L EM  G  P+     N   +F+  + +    P  L ++   
Sbjct: 199 M---LYGPAVDWWAMGVLLYEMLCGHAPF--EAENEDDLFEAILNDEVVYPTWLHEDATG 253

Query: 242 FAELCLRHDPAQR------ATIFELLQHPF 265
             +  +  +P  R           +L+HPF
Sbjct: 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 28/76 (36%), Positives = 37/76 (48%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L  EG+  KL DFG     I    T       F GT  Y+APE+  +     +G AV
Sbjct: 154 NVLLDHEGH-CKLADFGMCKEGICNGVTT----ATFCGTPDYIAPEILQEM---LYGPAV 205

Query: 369 DIWSLGCVLVEMSSGK 384
           D W++G +L EM  G 
Sbjct: 206 DWWAMGVLLYEMLCGH 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  137 bits (346), Expect = 7e-37
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 37/271 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV  A +       A+K +Q   + K+ +    K ++ E  +L        VK+
Sbjct: 47  GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE---EKHIMSERNVLL-----KNVKH 98

Query: 68  -YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
            + V +H      +++   ++    G L   +Q  E    E   R Y  ++  A+  LH 
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS 157

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEV 178
             IV+RD+K  NI L ++G+ + L DFG     ++ ++ T      + F GT  Y+APEV
Sbjct: 158 LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTT------STFCGTPEYLAPEV 210

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
                   + R VD W LG VL EM  G  P+  Y  N   M+   + +   +  ++++ 
Sbjct: 211 LHKQ---PYDRTVDWWCLGAVLYEMLYGLPPF--YSRNTAEMYDNILNKPLQLKPNITNS 265

Query: 239 GQAFAELCLRHDPAQR----ATIFELLQHPF 265
            +   E  L+ D  +R        E+  H F
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 13/78 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L ++G+ + L DFG     ++ ++ T      + F GT  Y+APEV        + R
Sbjct: 169 NILLDSQGH-IVLTDFGLCKENIEHNSTT------STFCGTPEYLAPEVLHKQ---PYDR 218

Query: 367 AVDIWSLGCVLVEMSSGK 384
            VD W LG VL EM  G 
Sbjct: 219 TVDWWCLGAVLYEMLYGL 236

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  135 bits (342), Expect = 1e-36
 Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 45/288 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G+V+       GE VA+K        +A + ++   E+     +  +N++ +   
Sbjct: 46  GKGRYGEVWMGKWR--GEKVAVK--VFFTTEEASWFRE--TEIYQTVLMRHENILGFIAA 99

Query: 71  EIH----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--- 123
           +I       ++ L  +    G+L   ++ST   L    + +     V  +  LH      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 124 -----IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPE 177
                I HRD+KS NI +   G    + D G AVK  + T  V    N  VGT+ YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 178 VFMDTNKVGHGRA---VDIWSLGCVLVEMSSG----------KRPWAEY---DSNYQIMF 221
           V  ++    H ++    D++S G +L E++            + P+ +    D +Y+ M 
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 222 K--VGMGETPTIPESLSDEG--QAFAEL---CLRHDPAQRATIFELLQ 262
           +        P+ P   S +   +   +L   C  H+PA R T   + +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 5/86 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
            NI +   G    + D G AVK  + T  V    N  VGT+ YM PEV  ++    H ++
Sbjct: 171 KNILVKKNGT-CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229

Query: 368 ---VDIWSLGCVLVEMSSGKTNLSGV 390
               D++S G +L E++    +   V
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIV 255

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  135 bits (343), Expect = 1e-36
 Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 38/277 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G + KV      +T  + AMK ++   ++   D   +  +  E  + E  +    +  
Sbjct: 18  GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED---IDWVQTEKHVFEQASNHPFL-- 72

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
             V +H        +   +E    G L   +Q  +  LPE   R Y+ ++  A++ LHE 
Sbjct: 73  --VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHER 129

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMD 181
            I++RD+K  N+ L +EG+ +KL D+G    +      PG+  + F GT  Y+APE+   
Sbjct: 130 GIIYRDLKLDNVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRG 184

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPW-------AEYDSNYQIMFKVGMGETPTIPES 234
                +G +VD W+LG ++ EM +G+ P+           +    +F+V + +   IP S
Sbjct: 185 E---DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241

Query: 235 LSDEGQAFAELCLRHDPAQR------ATIFELLQHPF 265
           LS +  +  +  L  DP +R          ++  HPF
Sbjct: 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL-NGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +KL D+G    +      PG+  + F GT  Y+APE+        +G +V
Sbjct: 140 NVLLDSEGH-IKLTDYG----MCKEGLRPGDTTSTFCGTPNYIAPEILRGE---DYGFSV 191

Query: 369 DIWSLGCVLVEMSSGK 384
           D W+LG ++ EM +G+
Sbjct: 192 DWWALGVLMFEMMAGR 207

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  133 bits (338), Expect = 2e-36
 Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 52/271 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYG 69
           G G  GKV    N  T E  A+K +Q      AR       E+ +        ++V+   
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQ--DCPKAR------REVELHWRASQCPHIVRIVD 78

Query: 70  V----EIHREEMVLFMELCTEGTL-ESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           V       R+ +++ ME    G L   +    +    E       K + +AI  LH   I
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138

Query: 125 VHRDIKSANI-FLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            HRD+K  N+ + +   N+ LKL DFG                         A E     
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFG------------------------FAKETT--- 171

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRP-WAEYDSNYQ--IMFKVGMGETPTIPE----SL 235
               + ++ D+WSLG ++  +  G  P ++ +       +  ++ MG+    P      +
Sbjct: 172 -GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEV 229

Query: 236 SDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           S+E +      L+ +P QR TI E + HP++
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  135 bits (341), Expect = 2e-36
 Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 32/269 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV  +    T EL A+K ++   + + +D   V+  +VE R+L    +   +  
Sbjct: 29  GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMVEKRVLALPGKPPFL-- 83

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
              ++H      + +   ME    G L   +Q       E     Y  ++   +  L   
Sbjct: 84  --TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
            I++RD+K  N+ L +EG+ +K+ DFG     I    T       F GT  Y+APE+   
Sbjct: 141 GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTT----KTFCGTPDYIAPEIIAY 195

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
                +G++VD W+ G +L EM +G+ P+     +   +F+  M      P+S+S E  A
Sbjct: 196 Q---PYGKSVDWWAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPKSMSKEAVA 250

Query: 242 FAELCLRHDPAQR-----ATIFELLQHPF 265
             +  +   P +R         ++ +H F
Sbjct: 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFG-SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ L +EG+ +K+ DFG     I    T       F GT  Y+APE+        +G++V
Sbjct: 151 NVMLDSEGH-IKIADFGMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQ---PYGKSV 202

Query: 369 DIWSLGCVLVEMSSGK 384
           D W+ G +L EM +G+
Sbjct: 203 DWWAFGVLLYEMLAGQ 218

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  134 bits (340), Expect = 3e-36
 Identities = 78/324 (24%), Positives = 120/324 (37%), Gaps = 82/324 (25%)

Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK------N 63
           G+G FGKV   +++  G   VA+K I+    N  ++ +   +E+ +L+ I +K       
Sbjct: 28  GEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V           M +  EL  + T E L ++     P   VR    QL  A+  LHEN 
Sbjct: 84  CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143

Query: 124 IVHRDIKSANIFLT------------------AEGNSLKLGDFGSAVKIS-AHTTVPGEL 164
           + H D+K  NI                      +  S+++ DFGSA      HTT+    
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTI---- 199

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK----------------- 207
              V T+ Y  PEV ++   +G  +  D+WS+GC+L E   G                  
Sbjct: 200 ---VATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 208 -----------------------RPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA--F 242
                                    W E  S+ + + +        + +   +  Q    
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 243 AELCLRHDPAQRATIFELLQHPFL 266
               L  DPAQR T+ E L HPF 
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFF 337

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 11/94 (11%)

Query: 293 IVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYM 351
           I+      +++    ++    + +  S+++ DFGSA      HTT+       V T+ Y 
Sbjct: 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTI-------VATRHYR 206

Query: 352 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
            PEV ++   +G  +  D+WS+GC+L E   G T
Sbjct: 207 PPEVILE---LGWAQPCDVWSIGCILFEYYRGFT 237

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  139 bits (351), Expect = 3e-36
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 36/271 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FGKV  +    T EL A+K ++   + + +D   V+  +VE R+L    +   +  
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMVEKRVLALPGKPPFL-- 404

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
              ++H      + +   ME    G L   +Q       E     Y  ++   +  L   
Sbjct: 405 --TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            I++RD+K  N+ L +EG+ +K+ DFG     +     T        F GT  Y+APE+ 
Sbjct: 462 GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTT------KTFCGTPDYIAPEII 514

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG 239
                  +G++VD W+ G +L EM +G+ P+     +   +F+  M      P+S+S E 
Sbjct: 515 AYQ---PYGKSVDWWAFGVLLYEMLAGQAPF--EGEDEDELFQSIMEHNVAYPKSMSKEA 569

Query: 240 QAFAELCLRHDPAQR-----ATIFELLQHPF 265
            A  +  +   P +R         ++ +H F
Sbjct: 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 13/78 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L +EG+ +K+ DFG     +     T        F GT  Y+APE+        +G+
Sbjct: 472 NVMLDSEGH-IKIADFGMCKENIWDGVTT------KTFCGTPDYIAPEIIAYQ---PYGK 521

Query: 367 AVDIWSLGCVLVEMSSGK 384
           +VD W+ G +L EM +G+
Sbjct: 522 SVDWWAFGVLLYEMLAGQ 539

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  133 bits (337), Expect = 5e-36
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 57/296 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G+G++ +V+ A+N    E V +K ++  K+      K +  E++ILE +    N++    
Sbjct: 45  GRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLAD 98

Query: 70  VEIHREEM--VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +          L  E       + L Q+    L +  +R Y  +++ A+   H   I+HR
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 154

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVG 186
           D+K  N+ +  E   L+L D+G      A    PG E N  V ++ +  PE+ +D     
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWG-----LAEFYHPGQEYNVRVASRYFKGPELLVDYQM-- 207

Query: 187 HGRAVDIWSLGCVLVEMSSGKRP-------------------------WAE-YDSNYQIM 220
           +  ++D+WSLGC+L  M   K P                         + + Y+      
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267

Query: 221 FKVGMGETPTIP----------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
           F   +G                  +S E   F +  LR+D   R T  E ++HP+ 
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 8/77 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPG-ELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +  E   L+L D+G A         PG E N  V ++ +  PE+ +D     +  ++
Sbjct: 160 NVMIDHEHRKLRLIDWGLA-----EFYHPGQEYNVRVASRYFKGPELLVDYQM--YDYSL 212

Query: 369 DIWSLGCVLVEMSSGKT 385
           D+WSLGC+L  M   K 
Sbjct: 213 DMWSLGCMLASMIFRKE 229

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  134 bits (340), Expect = 6e-36
 Identities = 69/279 (24%), Positives = 125/279 (44%), Gaps = 42/279 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ---LHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G + KV      +T  + AM+ ++   ++   D   +  +  E  + E  +    +  
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED---IDWVQTEKHVFEQASNHPFL-- 115

Query: 68  YGVEIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
             V +H        +   +E    G L   +Q  +  LPE   R Y+ ++  A++ LHE 
Sbjct: 116 --VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHER 172

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            I++RD+K  N+ L +EG+ +KL D+G     ++    T      + F GT  Y+APE+ 
Sbjct: 173 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTT------STFCGTPNYIAPEIL 225

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW-------AEYDSNYQIMFKVGMGETPTIP 232
                  +G +VD W+LG ++ EM +G+ P+           +    +F+V + +   IP
Sbjct: 226 RGE---DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282

Query: 233 ESLSDEGQAFAELCLRHDPAQR------ATIFELLQHPF 265
            SLS +  +  +  L  DP +R          ++  HPF
Sbjct: 283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 13/78 (16%)

Query: 310 NIFLTAEGNSLKLGDFG---SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           N+ L +EG+ +KL D+G     ++    T      + F GT  Y+APE+        +G 
Sbjct: 183 NVLLDSEGH-IKLTDYGMCKEGLRPGDTT------STFCGTPNYIAPEILRGE---DYGF 232

Query: 367 AVDIWSLGCVLVEMSSGK 384
           +VD W+LG ++ EM +G+
Sbjct: 233 SVDWWALGVLMFEMMAGR 250

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  133 bits (337), Expect = 7e-36
 Identities = 72/325 (22%), Positives = 124/325 (38%), Gaps = 84/325 (25%)

Query: 11  GQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQK------N 63
           G+G FGKV   ++++ G   VA+K ++    N  R+ +    E+++LE +N         
Sbjct: 23  GEGAFGKVVECIDHKAGGRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V+      H   + +  EL    T + + ++         +R+   Q+  +++ LH N 
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138

Query: 124 IVHRDIKSANIFLTAEGN------------------SLKLGDFGSAVKIS-AHTTVPGEL 164
           + H D+K  NI                          +K+ DFGSA      H+T+    
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL---- 194

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG------------------ 206
              V T+ Y APEV +    +G  +  D+WS+GC+L+E   G                  
Sbjct: 195 ---VSTRHYRAPEVILA---LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248

Query: 207 ----------------------KRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE 244
                                 +  W E+ S  + + +           S   E +   +
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR-ACKPLKEFMLSQDVEHERLFD 307

Query: 245 L---CLRHDPAQRATIFELLQHPFL 266
           L    L +DPA+R T+ E L+HPF 
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.7 bits (135), Expect = 7e-09
 Identities = 27/94 (28%), Positives = 40/94 (42%), Gaps = 11/94 (11%)

Query: 293 IVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYM 351
           I+                   T     +K+ DFGSA      H+T+       V T+ Y 
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL-------VSTRHYR 201

Query: 352 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           APEV +    +G  +  D+WS+GC+L+E   G T
Sbjct: 202 APEVILA---LGWSQPCDVWSIGCILIEYYLGFT 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  134 bits (338), Expect = 8e-36
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ------KNL 64
           G+G FG+V  A +    E VA+K I+    N   F+    +E+R+LE +N+        +
Sbjct: 63  GKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-- 122
           V      + R  + L  E+ +    + L  +   G+   L R++ +Q+  A+  L     
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178

Query: 123 TIVHRDIKSANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD 181
           +I+H D+K  NI L     S +K+ DFGS+ ++            ++ ++ Y +PEV + 
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ------YIQSRFYRSPEVLLG 232

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGK 207
              + +  A+D+WSLGC+LVEM +G+
Sbjct: 233 ---MPYDLAIDMWSLGCILVEMHTGE 255

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 25/77 (32%), Positives = 43/77 (55%), Gaps = 10/77 (12%)

Query: 310 NIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           NI L     S +K+ DFGS+ ++            ++ ++ Y +PEV +    + +  A+
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIYQ------YIQSRFYRSPEVLLG---MPYDLAI 239

Query: 369 DIWSLGCVLVEMSSGKT 385
           D+WSLGC+LVEM +G+ 
Sbjct: 240 DMWSLGCILVEMHTGEP 256

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  132 bits (335), Expect = 1e-35
 Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 57/296 (19%)

Query: 11  GQGRFGKVYTAVN-NETGELVAMKEIQLHKQNDA------RFVKDMLVELRILEGINQKN 63
           G+G +GKV+ A +    G  VA+K +++    +       R V      LR LE     N
Sbjct: 20  GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA----VLRHLETFEHPN 75

Query: 64  LVKYYGVEIHREE-----MVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAIS 117
           +V+ + V           + L  E   +  L + +    E G+P   ++    QL+  + 
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 177
            LH + +VHRD+K  NI +T+ G  +KL DFG A   S        L   V T  Y APE
Sbjct: 135 FLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYS----FQMALTSVVVTLWYRAPE 189

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-QI--MFKVGMGETPT---- 230
           V + ++   +   VD+WS+GC+  EM   K P     S+  Q+  +  V +G  P     
Sbjct: 190 VLLQSS---YATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDV-IG-LPGEEDW 243

Query: 231 ---------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                                    + + G+     CL  +PA+R + +  L HP+
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 28/76 (36%), Positives = 38/76 (50%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI +T+ G  +KL DFG A   S        L   V T  Y APEV + ++   +   V
Sbjct: 149 QNILVTSSGQ-IKLADFGLARIYS----FQMALTSVVVTLWYRAPEVLLQSS---YATPV 200

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC+  EM   K
Sbjct: 201 DLWSVGCIFAEMFRRK 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  133 bits (336), Expect = 1e-35
 Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 57/300 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---- 66
           GQG FG V       TG  VA+K++        RF    L  ++ L  ++  N+V+    
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSY 87

Query: 67  -YYGVEIHREEMVLF--MELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALH 120
            Y   E  R ++ L   ME   + TL    ++    +   P +L++ +  QL+ +I  LH
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146

Query: 121 ENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPE 177
             +  + HRDIK  N+ +     +LKL DFG     SA    P E N  ++ ++ Y APE
Sbjct: 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-----SAKKLSPSEPNVAYICSRYYRAPE 201

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP-------------------------WAE 212
           +        +  AVDIWS+GC+  EM  G+ P                           +
Sbjct: 202 LIFGNQH--YTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVLRK 258

Query: 213 YDSNY------QIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
            + ++                        + E        L++ P +R   +E L HP+ 
Sbjct: 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ +     +LKL DFGSA         P E N  ++ ++ Y APE+        +  AV
Sbjct: 161 NVLVNEADGTLKLCDFGSA-----KKLSPSEPNVAYICSRYYRAPELIFGNQH--YTTAV 213

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+GC+  EM  G+
Sbjct: 214 DIWSVGCIFAEMMLGE 229

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  130 bits (330), Expect = 4e-35
 Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 47/281 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
            +GRFG V+ A      E VA+K      Q+   +  +   E+  L G+  +N++++ G 
Sbjct: 33  ARGRFGCVWKAQLL--NEYVAVK--IFPIQDKQSWQNE--YEVYSLPGMKHENILQFIGA 86

Query: 71  EIHREEMVLFMELCTE----GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--- 123
           E     + + + L T     G+L   +++    +    +    + +   ++ LHE+    
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGL 144

Query: 124 -------IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
                  I HRDIKS N+ L     +  + DFG A+K  A  +  G+ +G VGT+ YMAP
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTA-CIADFGLALKFEAGKS-AGDTHGQVGTRRYMAP 202

Query: 177 EVFMDTNKVGHG--RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK------------ 222
           EV              +D++++G VL E++S           Y + F+            
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262

Query: 223 ----VGMGETPTIPES-LSDEG-QAFAEL---CLRHDPAQR 254
               V   + P + +      G     E    C  HD   R
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 4/85 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG--R 366
            N+ L     +  + DFG A+K  A  +  G+ +G VGT+ YMAPEV             
Sbjct: 160 KNVLLKNNLTA-CIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217

Query: 367 AVDIWSLGCVLVEMSSGKTNLSGVV 391
            +D++++G VL E++S  T   G V
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPV 242

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  130 bits (329), Expect = 2e-34
 Identities = 65/316 (20%), Positives = 119/316 (37%), Gaps = 70/316 (22%)

Query: 11  GQGRFGKVYTAVN--NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G VY A     +  +  A+K+I                E+ +L  +   N++   
Sbjct: 30  GRGTYGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSACREIALLRELKHPNVISLQ 84

Query: 69  GVEIHREEMVLFM--ELCT-------EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
            V +   +  +++  +          +    S        LP  +V+    Q++D I  L
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 120 HENTIVHRDIKSANIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           H N ++HRD+K ANI +  EG     +K+ D G A   ++      +L+  V T  Y AP
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK---------RPWAEYDSNYQI--MFKVGM 225
           E+ +      + +A+DIW++GC+  E+ + +            +    + Q+  +F V M
Sbjct: 205 ELLLGARH--YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV-M 261

Query: 226 GETPT---------IPE---------------------------SLSDEGQAFAELCLRH 249
           G  P          +PE                               +     +  L  
Sbjct: 262 G-FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320

Query: 250 DPAQRATIFELLQHPF 265
           DP +R T  + +Q P+
Sbjct: 321 DPIKRITSEQAMQDPY 336

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 5/79 (6%)

Query: 309 ANIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 365
           ANI +  EG     +K+ D G A   ++      +L+  V T  Y APE+ +      + 
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YT 214

Query: 366 RAVDIWSLGCVLVEMSSGK 384
           +A+DIW++GC+  E+ + +
Sbjct: 215 KAIDIWAIGCIFAELLTSE 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  128 bits (324), Expect = 9e-34
 Identities = 76/354 (21%), Positives = 139/354 (39%), Gaps = 89/354 (25%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---- 66
           G G FG V    + E+G+  A+K++    +   R       EL I++ ++  N++K    
Sbjct: 16  GTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------ELDIMKVLDHVNIIKLVDY 68

Query: 67  YYGVEIHREEMVLFMELCTEGTLES---------------------LVQ----------- 94
           +Y       +     +   +   ++                     ++            
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 95  ----STEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGS 150
                +   +P  L+  Y  QL  A+  +H   I HRDIK  N+ + ++ N+LKL DFG 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG- 187

Query: 151 AVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR- 208
               SA   +P E +  ++ ++ Y APE+ +   +  +  ++D+WS+GCV  E+  GK  
Sbjct: 188 ----SAKKLIPSEPSVAYICSRFYRAPELMLGATE--YTPSIDLWSIGCVFGELILGKPL 241

Query: 209 -PWAEYDSNYQIMFKVGMGETPT---IPESLSD---------EGQAFAEL---------- 245
                       + ++ MG TPT   +               + + + ++          
Sbjct: 242 FSGETSIDQLVRIIQI-MG-TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 246 -----CLRHDPAQRATIFELLQHPF---LIVSCEEDVCNPRSVPASVLQDYLKL 291
                 LR++P  R   +E + HPF   L  S E +V N  + P  V Q+  +L
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 25/76 (32%), Positives = 45/76 (59%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN-GFVGTQAYMAPEVFMDTNKVGHGRAV 368
           N+ + ++ N+LKL DFGSA        +P E +  ++ ++ Y APE+ +   +  +  ++
Sbjct: 171 NLLVNSKDNTLKLCDFGSA-----KKLIPSEPSVAYICSRFYRAPELMLGATE--YTPSI 223

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GCV  E+  GK
Sbjct: 224 DLWSIGCVFGELILGK 239

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  124 bits (313), Expect = 1e-32
 Identities = 72/301 (23%), Positives = 128/301 (42%), Gaps = 56/301 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V++AV+N+  + VA+K+I L         K  L E++I+  ++  N+VK + +
Sbjct: 20  GCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKVFEI 76

Query: 71  --------------EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAI 116
                               + +  E   E  L ++++     L E   R +  QL+  +
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLEQGP--LLEEHARLFMYQLLRGL 133

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
             +H   ++HRD+K AN+F+  E   LK+GDFG A  +  H +  G L+  + T+ Y +P
Sbjct: 134 KYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPT--- 230
            + +  N   + +A+D+W+ GC+  EM +GK  +A      Q   I+  +          
Sbjct: 194 RLLLSPNN--YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP---VVHEED 248

Query: 231 -----------IPESLSDEGQAFAEL--------------CLRHDPAQRATIFELLQHPF 265
                      I   +++  +   +L               L   P  R T  E L HP+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308

Query: 266 L 266
           +
Sbjct: 309 M 309

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 2/77 (2%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+F+  E   LK+GDFG A  +  H +  G L+  + T+ Y +P + +  N   + +A+
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNN--YTKAI 206

Query: 369 DIWSLGCVLVEMSSGKT 385
           D+W+ GC+  EM +GKT
Sbjct: 207 DMWAAGCIFAEMLTGKT 223

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  122 bits (307), Expect = 9e-32
 Identities = 58/291 (19%), Positives = 99/291 (34%), Gaps = 56/291 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GR+G VY    +     VA+K       N   F+ +    +  +  +   N+ ++   
Sbjct: 22  GRGRYGAVYKGSLD--ERPVAVK--VFSFANRQNFINE--KNIYRVPLMEHDNIARFIVG 75

Query: 71  EIH-----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT-- 123
           +       R E +L ME    G+L   +             R    +   ++ LH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC--RLAHSVTRGLAYLHTELPR 133

Query: 124 -------IVHRDIKSANIFLTAEGNSLKLGDFGSAV-----KISAHTTVPGELNGFVGTQ 171
                  I HRD+ S N+ +  +G    + DFG ++     ++             VGT 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192

Query: 172 AYMAPEVFMDTNKVGHG----RAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFK--- 222
            YMAPEV      +       + VD+++LG +  E+          +S   YQ+ F+   
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252

Query: 223 -------------VGMGETPTIPESLSDEGQAFAEL------CLRHDPAQR 254
                            + P  PE+  +   A   L      C   D   R
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 10/88 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAV-----KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 363
            N+ +  +G    + DFG ++     ++             VGT  YMAPEV      + 
Sbjct: 149 RNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207

Query: 364 HG----RAVDIWSLGCVLVEMSSGKTNL 387
                 + VD+++LG +  E+    T+L
Sbjct: 208 DXESALKQVDMYALGLIYWEIFMRCTDL 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (294), Expect = 4e-30
 Identities = 64/257 (24%), Positives = 102/257 (39%), Gaps = 15/257 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G  G VY A +     +VA+K +     +D  F   M  E R    + + ++V  +  
Sbjct: 43  GRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF 102

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                ++ + M L     L ++++    G L         +Q+  A+ A H     HRD+
Sbjct: 103 GEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDV 160

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  NI ++A+     L DFG A   +       +L   VGT  YMAPE F ++    +  
Sbjct: 161 KPENILVSADDF-AYLVDFGIASATTDEKLT--QLGNTVGTLYYMAPERFSES-HATY-- 214

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR- 248
             DI++L CVL E  +G  P+        +M        P           AF  +  R 
Sbjct: 215 RADIYALTCVLYECLTGSPPYQ--GDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG 272

Query: 249 --HDPAQR-ATIFELLQ 262
              +P  R  T  +L  
Sbjct: 273 MAKNPEDRYVTCGDLSA 289

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 6/77 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI ++A+     L DFG A   +       +L   VGT  YMAPE F ++    +    
Sbjct: 163 ENILVSADDF-AYLVDFGIASATTDEKLT--QLGNTVGTLYYMAPERFSES-HATY--RA 216

Query: 369 DIWSLGCVLVEMSSGKT 385
           DI++L CVL E  +G  
Sbjct: 217 DIYALTCVLYECLTGSP 233

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  118 bits (297), Expect = 5e-30
 Identities = 82/311 (26%), Positives = 130/311 (41%), Gaps = 63/311 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G +G V +AV+  TG  VA+K++      +  A   K    ELR+L+ +  +N++   
Sbjct: 34  GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYRELRLLKHMRHENVIGLL 90

Query: 69  GVEIHREEMVLF------MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            V    E +  F      M       L  L++   + L E  ++    Q++  +  +H  
Sbjct: 91  DVFTPDETLDDFTDFYLVMPF-MGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            I+HRD+K  N+ +  +   LK+ DFG A +  +  T      G+V T+ Y APEV +  
Sbjct: 148 GIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMT------GYVVTRWYRAPEVIL-- 198

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD-- 237
           N + + + VDIWS+GC++ EM +GK  +   D   Q   IM   G   TP   E +    
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG---TPP-AEFVQRLQ 254

Query: 238 --------------EGQAFAEL--------------CLRHDPAQRATIFELLQHPFLIV- 268
                         E + FA +               L  D  QR T  E L HP+    
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

Query: 269 --SCEEDVCNP 277
             + +E     
Sbjct: 315 HDTEDEPQVQK 325

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +   LK+ DFG A +  +  T      G+V T+ Y APEV +  N + + + VD
Sbjct: 158 NLAVNEDC-ELKILDFGLARQADSEMT------GYVVTRWYRAPEVIL--NWMRYTQTVD 208

Query: 370 IWSLGCVLVEMSSGKT 385
           IWS+GC++ EM +GKT
Sbjct: 209 IWSVGCIMAEMITGKT 224

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (304), Expect = 6e-30
 Identities = 57/259 (22%), Positives = 93/259 (35%), Gaps = 50/259 (19%)

Query: 11  GQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
             G  G +Y A+  N  G  V +K   L    DA      + E + L  +   ++V+ + 
Sbjct: 89  AHGGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 70  VEIHREEMV-----LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
              H +        + ME     +L+         LP      Y  +++ A+S LH   +
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGL 203

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           V+ D+K  NI LT E   LKL D G+  +I++   +        GT  + APE+      
Sbjct: 204 VYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYL-------YGTPGFQAPEIVR---- 250

Query: 185 VGHGRAV---DIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSDEG- 239
                     DI+++G  L  ++                     G     +PE       
Sbjct: 251 ---TGPTVATDIYTVGRTLAALTLDLPTRN--------------GRYVDGLPEDDPVLKT 293

Query: 240 -QAFAELCLR---HDPAQR 254
             ++  L  R    DP QR
Sbjct: 294 YDSYGRLLRRAIDPDPRQR 312

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 22/89 (24%), Positives = 35/89 (39%), Gaps = 19/89 (21%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI LT E   LKL D G+  +I++   +        GT  + APE+             
Sbjct: 211 ENIMLTEEQ--LKLIDLGAVSRINSFGYL-------YGTPGFQAPEIVR-------TGPT 254

Query: 369 ---DIWSLGCVLVEMSSGKTNLSGVVVSA 394
              DI+++G  L  ++      +G  V  
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNGRYVDG 283

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  117 bits (295), Expect = 6e-30
 Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 64/311 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G +G V +A++  +GE VA+K++      +  A   K    EL +L+ +  +N++   
Sbjct: 33  GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYRELLLLKHMQHENVIGLL 89

Query: 69  GVEIHREEMVLF------MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            V      +  F      M    +  L+ ++        E  ++    Q++  +  +H  
Sbjct: 90  DVFTPASSLRNFYDFYLVMPF-MQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSA 145

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            +VHRD+K  N+ +  +   LK+ DFG A    A  T      G+V T+ Y APEV +  
Sbjct: 146 GVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMT------GYVVTRWYRAPEVILSW 198

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD-- 237
               + + VDIWS+GC++ EM +GK  +   D   Q   I+   G    P   E +    
Sbjct: 199 MH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG---VPG-TEFVQKLN 252

Query: 238 --------------EGQAFAEL--------------CLRHDPAQRATIFELLQHPFLIV- 268
                           + F +L               L  D  +R T  + L HPF    
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

Query: 269 --SCEEDVCNP 277
               EE     
Sbjct: 313 RDPEEETEAQQ 323

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +   LK+ DFG A    A  T      G+V T+ Y APEV +      + + VD
Sbjct: 156 NLAVNEDCE-LKILDFGLARHADAEMT------GYVVTRWYRAPEVILSWMH--YNQTVD 206

Query: 370 IWSLGCVLVEMSSGKT 385
           IWS+GC++ EM +GKT
Sbjct: 207 IWSVGCIMAEMLTGKT 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  117 bits (296), Expect = 7e-30
 Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 52/295 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ-LHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G +G V +A +N     VA+K+I     Q      +  L E++IL     +N++    
Sbjct: 36  GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC---QRTLREIKILLRFRHENIIGIND 92

Query: 70  VEI--HREEMV---LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           +      E+M    +  +L  E  L  L+++    L    +  +  Q++  +  +H   +
Sbjct: 93  IIRAPTIEQMKDVYIVQDL-METDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANV 149

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K +N+ L      LK+ DFG A          G L  +V T+ Y APE+ +++  
Sbjct: 150 LHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD---- 237
             + +++DIWS+GC+L EM S +  +       Q   I+  +G   +P+  E L+     
Sbjct: 209 --YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG---SPS-QEDLNCIINL 262

Query: 238 ------------EGQAFAEL--------------CLRHDPAQRATIFELLQHPFL 266
                           +  L               L  +P +R  + + L HP+L
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 26/77 (33%), Positives = 42/77 (54%), Gaps = 3/77 (3%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +N+ L      LK+ DFG A          G L  +V T+ Y APE+ +++    + +++
Sbjct: 157 SNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG--YTKSI 213

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWS+GC+L EM S + 
Sbjct: 214 DIWSVGCILAEMLSNRP 230

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (291), Expect = 9e-30
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 23/262 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G    VY A +      VA+K I +  +     +K    E+     ++ +N+V    V
Sbjct: 20  GGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDI 129
           +   +   L ME     TL   ++    G L       +T Q++D I   H+  IVHRDI
Sbjct: 80  DEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDI 137

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           K  NI + +    LK+ DFG A  +S  + T    +   +GT  Y +PE      +    
Sbjct: 138 KPQNILIDSNKT-LKIFDFGIAKALSETSLTQTNHV---LGTVQYFSPE------QAKGE 187

Query: 189 RA---VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE-GQAFAE 244
                 DI+S+G VL EM  G+ P+   ++   I  K      P +   +  +  Q+ + 
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246

Query: 245 L---CLRHDPAQR-ATIFELLQ 262
           +       D A R  TI E+  
Sbjct: 247 VILRATEKDKANRYKTIQEMKD 268

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 24/80 (30%), Positives = 36/80 (45%), Gaps = 14/80 (17%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHT-TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
            NI + +    LK+ DFG A  +S  + T    +   +GT  Y +PE      +      
Sbjct: 140 QNILIDSNKT-LKIFDFGIAKALSETSLTQTNHV---LGTVQYFSPE------QAKGEAT 189

Query: 368 ---VDIWSLGCVLVEMSSGK 384
               DI+S+G VL EM  G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  115 bits (290), Expect = 5e-29
 Identities = 76/309 (24%), Positives = 130/309 (42%), Gaps = 59/309 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++    V
Sbjct: 38  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 71  EI------HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
                      ++ L   L     L ++V+  +  L +  V+    Q++  +  +H   I
Sbjct: 97  FTPARSLEEFNDVYLVTHL-MGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADI 153

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K +N+ +  +   LK+ DFG A   +   T      G+V T+ Y APE+ +  N 
Sbjct: 154 IHRDLKPSNLAVNED-CELKILDFGLARHTADEMT------GYVATRWYRAPEIML--NW 204

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD---- 237
           + + + VDIWS+GC++ E+ +G+  +   D   Q   I+  VG   TP   E L      
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG---TPG-AELLKKISSE 260

Query: 238 ------------EGQAFAEL--------------CLRHDPAQRATIFELLQHPFLIV--- 268
                           FA +               L  D  +R T  + L H +      
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320

Query: 269 SCEEDVCNP 277
             +E V +P
Sbjct: 321 PDDEPVADP 329

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 9/76 (11%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  +   LK+ DFG A   +   T      G+V T+ Y APE+ +  N + + + VD
Sbjct: 162 NLAVNED-CELKILDFGLARHTADEMT------GYVATRWYRAPEIML--NWMHYNQTVD 212

Query: 370 IWSLGCVLVEMSSGKT 385
           IWS+GC++ E+ +G+T
Sbjct: 213 IWSVGCIMAELLTGRT 228

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  114 bits (288), Expect = 7e-29
 Identities = 67/325 (20%), Positives = 124/325 (38%), Gaps = 65/325 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQN--------DARFVKDMLVELRILEGINQK 62
             G +G V   V++  G  VA+K +     +        D+   K +L E+R+L   +  
Sbjct: 31  SSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 63  NLVKYYGVEIHR-----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
           N++    + +H       ++ L  EL     L  ++      +    ++ +   ++  + 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 177
            LHE  +VHRD+   NI L    N + + DF  A + +A          +V  + Y APE
Sbjct: 149 VLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTA----DANKTHYVTHRWYRAPE 203

Query: 178 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPES 234
           + M        + VD+WS GCV+ EM + K  +       Q   I+  VG   TP   E 
Sbjct: 204 LVMQFKG--FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG---TPK-IED 257

Query: 235 LSD-----------------EGQAFAEL--------------CLRHDPAQRATIFELLQH 263
           +                     +A+  +               L  +P +R +  + L+H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317

Query: 264 PFLIVSCEEDVCNPRSVPASVLQDY 288
           P+      E + +P  +   + + +
Sbjct: 318 PYF-----ESLFDPLDLTEGLSERF 337

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 24/76 (31%), Positives = 35/76 (46%), Gaps = 7/76 (9%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI L    N + + DF  A + +A          +V  + Y APE+ M        + VD
Sbjct: 164 NILLADN-NDITICDFNLAREDTA----DANKTHYVTHRWYRAPELVMQFKG--FTKLVD 216

Query: 370 IWSLGCVLVEMSSGKT 385
           +WS GCV+ EM + K 
Sbjct: 217 MWSAGCVMAEMFNRKA 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (280), Expect = 5e-28
 Identities = 60/264 (22%), Positives = 102/264 (38%), Gaps = 22/264 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY-- 68
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 80

Query: 69  GVEIHREEMVLF--MELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIV 125
           G        + +  ME     TL  +V    +G +              A++  H+N I+
Sbjct: 81  GEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQNGII 138

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K ANI ++A    +K+ DFG A  I+       +    +GT  Y++PE      + 
Sbjct: 139 HRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------QA 191

Query: 186 GHGRA---VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
                    D++SLGCVL E+ +G+ P+   DS   + ++    +               
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGLSADL 250

Query: 243 AEL---CLRHDPAQR-ATIFELLQ 262
             +    L  +P  R  T  E+  
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRA 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 10/79 (12%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA- 367
           ANI ++A    +K+ DFG A  I+       +    +GT  Y++PE      +       
Sbjct: 145 ANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE------QARGDSVD 197

Query: 368 --VDIWSLGCVLVEMSSGK 384
              D++SLGCVL E+ +G+
Sbjct: 198 ARSDVYSLGCVLYEVLTGE 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  111 bits (280), Expect = 8e-28
 Identities = 81/335 (24%), Positives = 140/335 (41%), Gaps = 70/335 (20%)

Query: 1   MSS-VTFSVSP--------GQGRFGKVYTAVNNETGELVAMKEIQ-LHKQNDARFVKDML 50
           M   + +++S         G+G +G V +A +  TGE+VA+K+I+   K   A      L
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---LRTL 57

Query: 51  VELRILEGINQKNLVKYYGVEI--HREEMV---LFMELCTEGTLESLVQSTEDGLPEVLV 105
            E++IL+    +N++  + ++     E      +  EL  +  L  ++ +    L +  +
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQTDLHRVISTQM--LSDDHI 114

Query: 106 RRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG-------SAVKISAHT 158
           + +  Q + A+  LH + ++HRD+K +N+ + +    LK+ DFG       SA   S  T
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPT 173

Query: 159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ 218
                +  FV T+ Y APEV +      + RA+D+WS GC+L E+   +  +   D  +Q
Sbjct: 174 GQQSGMVEFVATRWYRAPEVML--TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231

Query: 219 ---IMFKVGMGETPTIPESLSD----------------EGQAFAEL-------------- 245
              I   +G   TP     L                        ++              
Sbjct: 232 LLLIFGIIG---TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288

Query: 246 CLRHDPAQRATIFELLQHPFLIV---SCEEDVCNP 277
            L  DPA+R T  E L+HP+L       +E    P
Sbjct: 289 MLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 10/83 (12%)

Query: 309 ANIFLTAEGNSLKLGDFG-------SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 361
           +N+ + +    LK+ DFG       SA   S  T     +  FV T+ Y APEV +    
Sbjct: 141 SNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML--TS 197

Query: 362 VGHGRAVDIWSLGCVLVEMSSGK 384
             + RA+D+WS GC+L E+   +
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRR 220

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  113 bits (284), Expect = 8e-28
 Identities = 71/311 (22%), Positives = 129/311 (41%), Gaps = 51/311 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQL--HKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G +G V  A +     +VA+K+I        D    K +L E+ IL  +N  ++VK  
Sbjct: 62  GTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILREIAILNRLNHDHVVKVL 118

Query: 69  GVEIHR-----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            + I +     +E+ + +E+  +   + L ++    L E+ ++     L+  +  +H   
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY-LTELHIKTLLYNLLVGVKYVHSAG 176

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSA------------------------VKISAHTT 159
           I+HRD+K AN  +  +  S+K+ DFG A                        V       
Sbjct: 177 ILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235

Query: 160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI 219
           +  +L G V T+ Y APE+ +      +  A+D+WS+GC+  E+ +  +    Y ++   
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

Query: 220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRS 279
           +F  G    P  P+  +     F     R    Q   IF +L  P      EED+    +
Sbjct: 294 LFP-GSSCFPLSPDQKAGNDFKFHTRGNRD---QLNVIFNILGTP-----SEEDI---EA 341

Query: 280 VPASVLQDYLK 290
           +     + Y++
Sbjct: 342 LEKEDAKRYIR 352

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 27/96 (28%)

Query: 309 ANIFLTAEGNSLKLGDFGSA------------------------VKISAHTTVPGELNGF 344
           AN  +  +  S+K+ DFG A                        V       +  +L G 
Sbjct: 185 ANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243

Query: 345 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM 380
           V T+ Y APE+ +      +  A+D+WS+GC+  E+
Sbjct: 244 VVTRWYRAPELILLQEN--YTEAIDVWSIGCIFAEL 277

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  110 bits (276), Expect = 4e-27
 Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 74/323 (22%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G  G V  A +      VA+K++      Q  A   K    EL +++ +N KN++   
Sbjct: 34  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIIGLL 90

Query: 69  GV---EIHREEMV---LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
            V   +   EE     + MEL  +  L  ++Q     L    +     Q++  I  LH  
Sbjct: 91  NVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 146

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            I+HRD+K +NI + ++  +LK+ DFG A            +  +V T+ Y APEV +  
Sbjct: 147 GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGM 201

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD-- 237
               +   VDIWS+GC++ EM  G   +   D   Q   ++ ++G   TP  PE +    
Sbjct: 202 G---YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG---TPC-PEFMKKLQ 254

Query: 238 -------------EGQAFAEL--------------------------CLRHDPAQRATIF 258
                         G +F +L                           L  D ++R ++ 
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 259 ELLQHPFLIV---SCEEDVCNPR 278
           E LQHP++ V     E +   P+
Sbjct: 315 EALQHPYINVWYDPSEAEAPPPK 337

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 8/77 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A            +  +V T+ Y APEV +      +   V
Sbjct: 156 SNIVVKSD-CTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG---YKENV 207

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWS+GC++ EM  G  
Sbjct: 208 DIWSVGCIMGEMIKGGV 224

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  111 bits (278), Expect = 5e-27
 Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 63/304 (20%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G  G V  A +      VA+K++      Q  A   K    EL +++ +N KN++   
Sbjct: 71  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIISLL 127

Query: 69  GVEIHREEMVLFME--LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            V   ++ +  F +  L  E    +L Q  +  L    +     Q++  I  LH   I+H
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 187

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +NI + ++  +LK+ DFG A            +  +V T+ Y APEV +      
Sbjct: 188 RDLKPSNIVVKSD-CTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG--- 239

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVGMGETPTIPESLSD------ 237
           +   VDIWS+GC++ EM   K  +   D   Q   ++ ++G   TP  PE +        
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG---TPC-PEFMKKLQPTVR 295

Query: 238 ---------EGQAFAEL--------------------------CLRHDPAQRATIFELLQ 262
                     G  F +L                           L  DPA+R ++ + LQ
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355

Query: 263 HPFL 266
           HP++
Sbjct: 356 HPYI 359

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 8/77 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + ++  +LK+ DFG A            +  +V T+ Y APEV +      +   V
Sbjct: 193 SNIVVKSD-CTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMG---YKENV 244

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWS+GC++ EM   K 
Sbjct: 245 DIWSVGCIMGEMVRHKI 261

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  108 bits (273), Expect = 1e-26
 Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 23/260 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG+V++        LVA+K     +          L E RIL+  +  N+V+  GV
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ + + MEL   G   + +++    L    + +        +  L     +HRD+ 
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY----MAPEVFMD---TN 183
           + N  L  E N LK+ DFG + + +             G +       APE       ++
Sbjct: 241 ARNC-LVTEKNVLKISDFGMSREEADGVYAASG-----GLRQVPVKWTAPEALNYGRYSS 294

Query: 184 KVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
           +       D+WS G +L E  S G  P+    SN Q    V  G     PE   D     
Sbjct: 295 E------SDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRLPCPELCPDAVFRL 347

Query: 243 AELCLRHDPAQRATIFELLQ 262
            E C  ++P QR +   + Q
Sbjct: 348 MEQCWAYEPGQRPSFSTIYQ 367

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (263), Expect = 6e-26
 Identities = 39/263 (14%), Positives = 78/263 (29%), Gaps = 52/263 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G     + + A++      VA+  +          +++ L     L  I++  + +   V
Sbjct: 40  GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV 99

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              R   ++  E    G+L+ +    +     V   R  + L  A  A H   +      
Sbjct: 100 VHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDH 156

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
            + + ++ +G+ + L                            M                
Sbjct: 157 PSRVRVSIDGD-VVLAYPA-----------------------TMPDA----------NPQ 182

Query: 191 VDIWSLGCVLVEMSSGKRPWAE--YDSNYQIMFKVGMGE-------TPTIPESLSDEGQA 241
            DI  +G  L  +   + P  E    S      +   G+          IP  +S    A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS----A 238

Query: 242 FAELCLRHDPAQR--ATIFELLQ 262
            A   ++ D   R  +T+  L+Q
Sbjct: 239 VAARSVQGDGGIRSASTLLNLMQ 261

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  107 bits (269), Expect = 6e-26
 Identities = 69/306 (22%), Positives = 127/306 (41%), Gaps = 49/306 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G+G +G VY A +  T + VA+K++        D    K +L E+ IL  +    +++ Y
Sbjct: 35  GRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYIIRLY 91

Query: 69  GVEI--HREEMV---LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            + I     +     + +E+  +  L+ L ++    L E  ++     L+   + +HE+ 
Sbjct: 92  DLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF-LTEEHIKTILYNLLLGENFIHESG 149

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSA-------------------VKISAHTTVPGEL 164
           I+HRD+K AN  L  +  S+K+ DFG A                        +  +  +L
Sbjct: 150 IIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG 224
              V T+ Y APE+ +      + +++DIWS GC+  E+ +  +      +N   +F  G
Sbjct: 209 TSHVVTRWYRAPELILLQEN--YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP-G 265

Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASV 284
               P  P+  S +         + +  Q   IF ++  P      E+D+ N        
Sbjct: 266 SSCFPLSPDRNSKKVHE------KSNRDQLNIIFNIIGTP-----TEDDLKNINKPEV-- 312

Query: 285 LQDYLK 290
              Y+K
Sbjct: 313 -IKYIK 317

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 23/96 (23%), Positives = 39/96 (40%), Gaps = 22/96 (22%)

Query: 309 ANIFLTAEGNSLKLGDFGSA-------------------VKISAHTTVPGELNGFVGTQA 349
           AN  L  +  S+K+ DFG A                        +  +  +L   V T+ 
Sbjct: 158 ANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRW 216

Query: 350 YMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           Y APE+ +      + +++DIWS GC+  E+ +   
Sbjct: 217 YRAPELILLQEN--YTKSIDIWSTGCIFAELLNMLQ 250

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 98.2 bits (245), Expect = 8e-23
 Identities = 77/353 (21%), Positives = 136/353 (38%), Gaps = 88/353 (24%)

Query: 4   VTFSVSP--------GQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVEL 53
           V   V          G+G +G V+ +++  TGE+VA+K+I        DA   +    E+
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFREI 59

Query: 54  RILEGINQ-KNLVKYYGVEI--HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTK 110
            IL  ++  +N+V    V    +  ++ L  +   E  L +++++    L  V  +    
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI--LEPVHKQYVVY 116

Query: 111 QLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA------------------V 152
           QL+  I  LH   ++HRD+K +NI L AE   +K+ DFG +                   
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK----- 207
                      L  +V T+ Y APE+ + + K  + + +D+WSLGC+L E+  GK     
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTK--YTKGIDMWSLGCILGEILCGKPIFPG 233

Query: 208 ---------------RPWAE----YDSNYQIMFKVGMGETPTIP-----ESLSDEGQAFA 243
                           P  E      S +       + E   I      +  +       
Sbjct: 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL 293

Query: 244 EL----------------CLRHDPAQRATIFELLQHPFLIV---SCEEDVCNP 277
           ++                 L+ +P +R +  + L+HPF+ +     EE  C+ 
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDH 346

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 27/94 (28%), Positives = 42/94 (44%), Gaps = 21/94 (22%)

Query: 309 ANIFLTAEGNSLKLGDFGSA------------------VKISAHTTVPGELNGFVGTQAY 350
           +NI L AE   +K+ DFG +                              L  +V T+ Y
Sbjct: 138 SNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196

Query: 351 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
            APE+ + + K  + + +D+WSLGC+L E+  GK
Sbjct: 197 RAPEILLGSTK--YTKGIDMWSLGCILGEILCGK 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 97.7 bits (243), Expect = 1e-22
 Identities = 63/363 (17%), Positives = 119/363 (32%), Gaps = 120/363 (33%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------- 63
           G G F  V+ + + +  + VAMK +    ++   + +  L E+R+L+ +   +       
Sbjct: 46  GWGHFSTVWLSWDIQGKKFVAMK-VV---KSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 64  -LVKYYGV-EIHREE---MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +V+     +I       + +  E+     L+ +++S   GLP   V++  +Q++  +  
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 119 LH-ENTIVHRDIKSANIFLTAEGNSL---------------------------------- 143
           LH +  I+H DIK  NI L+     +                                  
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 144 --------------KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
                         K+ D G+A  +  H          + T+ Y + EV +     G+  
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIG---SGYNT 272

Query: 190 AVDIWSLGCVLVEMSSGK-----------------------------RPWAE-------- 212
             DIWS  C+  E+++G                              R            
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 213 YDSNYQIMFKVGMGETP---TIPESLS---DEGQAFAEL---CLRHDPAQRATIFELLQH 263
           +     +     +        + E      +E   F +     L   P +RAT  E L+H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 264 PFL 266
           P+L
Sbjct: 393 PWL 395

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 20/121 (16%), Positives = 37/121 (30%), Gaps = 9/121 (7%)

Query: 265 FLIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGD 324
             +           +            G  +      +            AE   +K+ D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 325 FGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
            G+A  +  H          + T+ Y + EV +     G+    DIWS  C+  E+++G 
Sbjct: 240 LGNACWVHKH------FTEDIQTRQYRSLEVLIG---SGYNTPADIWSTACMAFELATGD 290

Query: 385 T 385
            
Sbjct: 291 Y 291

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 55/289 (19%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGEL-------VAMKEIQLHKQNDARFVKDMLVELR 54
             + F+ S GQG F K++  V  E G+        V +K +    +    + +       
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAAS 64

Query: 55  ILEGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVD 114
           ++  ++ K+LV  YGV +  +E +L  E    G+L++ ++  ++ +  +      KQL  
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124

Query: 115 AISALHENTIVHRDIKSANIFLTA-------EGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           A+  L ENT++H ++ + NI L             +KL D G ++ +             
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------------- 171

Query: 168 VGTQAY------MAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIM 220
           +           + PE   +   +    A D WS G  L E  S G +P +    + + +
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNL--ATDKWSFGTTLWEICSGGDKPLSAL-DSQRKL 228

Query: 221 FKVGMG---ETPTIPESLSDEGQAFAEL---CLRHDPAQRATIFELLQH 263
                      P   E         A L   C+ ++P  R + F  +  
Sbjct: 229 QFYEDRHQLPAPKAAE--------LANLINNCMDYEPDHRPS-FRAIIR 268

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 18/267 (6%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
            S+   V  GQG FG+V+    N T   VA+K ++          +  L E ++++ +  
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK----PGTMSPEAFLQEAQVMKKLRH 238

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISAL 119
           + LV+ Y V +  E + +  E  ++G+L   ++           LV     Q+   ++ +
Sbjct: 239 EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 296

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
                VHRD+++ANI L  E    K+ DFG A  I  +     +   F     + APE  
Sbjct: 297 ERMNYVHRDLRAANI-LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAA 353

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           +           D+WS G +L E  + G+ P+     N +++ +V  G     P    + 
Sbjct: 354 LYGR---FTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECPES 409

Query: 239 GQAFAELCLRHDPAQRATIFELLQHPF 265
                  C R +P +R T FE LQ   
Sbjct: 410 LHDLMCQCWRKEPEERPT-FEYLQAFL 435

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 96.8 bits (241), Expect = 6e-22
 Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 21/269 (7%)

Query: 2   SSVTFSVSPGQGRFGKVY--TAVNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEG 58
             +      G+G+FG V+    ++ E   + VA+K             +  L E   +  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQ 447

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +  ++VK  GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ 
Sbjct: 448 FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMA 175
           L     VHRDI + N+ L +  + +KLGDFG +  +   T            +    +MA
Sbjct: 507 LESKRFVHRDIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-----KGKLPIKWMA 560

Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPES 234
           PE      +     A D+W  G  + E+   G +P+     N  ++ ++  GE   +P +
Sbjct: 561 PESINF-RRFTS--ASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERLPMPPN 616

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQH 263
                 +    C  +DP++R   F  L+ 
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPR-FTELKA 644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 96.4 bits (240), Expect = 7e-22
 Identities = 60/279 (21%), Positives = 110/279 (39%), Gaps = 18/279 (6%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K ++     D   V++ L E  +++ I  
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKH 275

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISAL 119
            NLV+  GV        +  E  T G L   ++          VL+     Q+  A+  L
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL-YMATQISSAMEYL 334

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
            +   +HR++ + N  L  E + +K+ DFG +  ++  T        F     + APE  
Sbjct: 335 EKKNFIHRNLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESL 391

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
                       D+W+ G +L E  + G  P+       Q+   +        PE   ++
Sbjct: 392 AYNKF---SIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERPEGCPEK 447

Query: 239 GQAFAELCLRHDPAQRAT---IFELLQHPFLIVSCEEDV 274
                  C + +P+ R +   I +  +  F   S  ++V
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.5 bits (240), Expect = 8e-22
 Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 18/267 (6%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
            S+   V  GQG FG+V+    N T   VA+K ++          +  L E ++++ +  
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK----PGTMSPEAFLQEAQVMKKLRH 321

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISAL 119
           + LV+ Y V +  E + +  E  ++G+L   ++           LV     Q+   ++ +
Sbjct: 322 EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 379

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
                VHRD+++ANI L  E    K+ DFG A  I  +     +   F     + APE  
Sbjct: 380 ERMNYVHRDLRAANI-LVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAA 436

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
           +           D+WS G +L E  + G+ P+     N +++ +V  G     P    + 
Sbjct: 437 LYGR---FTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECPES 492

Query: 239 GQAFAELCLRHDPAQRATIFELLQHPF 265
                  C R +P +R T FE LQ   
Sbjct: 493 LHDLMCQCWRKEPEERPT-FEYLQAFL 518

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 27/272 (9%)

Query: 2   SSVTFSVSPGQGRFGKVY--TAVNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEG 58
             +      G+G+FG V+    ++ E   L VA+K             +  L E   +  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQ 72

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +  ++VK  GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ 
Sbjct: 73  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMA 175
           L     VHRDI + N+ L +  + +KLGDFG +  +   T            +    +MA
Sbjct: 132 LESKRFVHRDIAARNV-LVSSNDCVKLGDFGLSRYMEDSTYYKAS-----KGKLPIKWMA 185

Query: 176 PEVFMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTI 231
           PE           R   A D+W  G  + E +  G +P+     N  ++ ++  GE   +
Sbjct: 186 PESIN------FRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERLPM 238

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           P +      +    C  +DP++R   F  L+ 
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPR-FTELKA 269

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 67/280 (23%), Positives = 105/280 (37%), Gaps = 38/280 (13%)

Query: 11  GQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V         + TG LVA+K++   + +     +D   E++IL+ ++   +VK
Sbjct: 32  GKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R+ + L ME    G L   +Q     L    +  Y+ Q+   +  L     
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH-----TTVPGELNGFVGTQAYMAPEVF 179
           VHRD+ + NI L      +K+ DFG A  +           PG+   F     + APE  
Sbjct: 149 VHRDLAARNI-LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESL 202

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTI------- 231
            D N        D+WS G VL E  +   +  +      ++M         +        
Sbjct: 203 SD-NIFSR--QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 232 ------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                 P +   E     +LC    P  R + F  L    
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPS-FSALGPQL 298

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 27/272 (9%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV-NNETGE--LVAMKEIQLHKQNDARFVKDMLVELRILEG 58
             V  +   G+G FG+VY  V  N  GE   VA+K     K       +  + E  I++ 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKN 69

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           ++  ++VK  G+ I  E   + MEL   G L   ++  ++ L  + +  Y+ Q+  A++ 
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMA 175
           L     VHRDI   NI L A    +KLGDFG +  I               T+    +M+
Sbjct: 129 LESINCVHRDIAVRNI-LVASPECVKLGDFGLSRYIEDEDYYKAS-----VTRLPIKWMS 182

Query: 176 PEVFMDTNKVGHGR---AVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTI 231
           PE           R   A D+W     + E+ S GK+P+     N  ++  +  G+    
Sbjct: 183 PESIN------FRRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDRLPK 235

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           P+            C  +DP+ R   F  L  
Sbjct: 236 PDLCPPVLYTLMTRCWDYDPSDRPR-FTELVC 266

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 41/282 (14%)

Query: 11  GQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V         + TGE+VA+K++   + +    ++D   E+ IL+ +   N+VK
Sbjct: 19  GKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   +  L     
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-----HTTVPGELNGFVGTQAYMAPEVF 179
           +HRD+ + NI L    N +K+GDFG    +           PGE   F     + APE  
Sbjct: 136 IHRDLATRNI-LVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-----WYAPESL 189

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS----------------GKRPWAEYDSNYQIMFKV 223
            + +K     A D+WS G VL E+ +                G     +    + ++  +
Sbjct: 190 TE-SKFSV--ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHLIELL 245

Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                   P+   DE       C  ++  QR + F  L    
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-FRDLALRV 286

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 65/280 (23%), Positives = 112/280 (40%), Gaps = 39/280 (13%)

Query: 11  GQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV        N+ TGE+VA+K ++       R       E+ IL  +  ++++K
Sbjct: 40  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEHIIK 97

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G   +     + L ME    G+L   +     GL ++L   + +Q+ + ++ LH    
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL--LFAQQICEGMAYLHAQHY 155

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-----HTTVPGELNGFVGTQAYMAPEVF 179
           +HRD+ + N+ L      +K+GDFG A  +            G+   F     + APE  
Sbjct: 156 IHRDLAARNV-LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECL 209

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYD-------------SNYQIMFKVGM 225
            +  K  +  A D+WS G  L E+ +      +                +  ++   +  
Sbjct: 210 KE-YKFYY--ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
           GE    P+    E     + C   + + R T FE L    
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPT-FENLIPIL 305

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 41/282 (14%)

Query: 11  GQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V         + TGE+VA+K++   + +    ++D   E+ IL+ +   N+VK
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y GV     R  + L ME    G+L   +Q  ++ +  + + +YT Q+   +  L     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-----HTTVPGELNGFVGTQAYMAPEVF 179
           +HRD+ + NI L    N +K+GDFG    +           PGE   F     + APE  
Sbjct: 167 IHRDLATRNI-LVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-----WYAPESL 220

Query: 180 MDTNKVGHGRAVDIWSLGCVLVEMSS----------------GKRPWAEYDSNYQIMFKV 223
            + +K     A D+WS G VL E+ +                G     +    + ++  +
Sbjct: 221 TE-SKFSV--ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHLIELL 276

Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                   P+   DE       C  ++  QR + F  L    
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-FRDLALRV 317

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 90.7 bits (226), Expect = 5e-21
 Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 26/269 (9%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           S +TF    G G+FG V+        + VA+K I+      A   +D + E  ++  ++ 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIR----EGAMSEEDFIEEAEVMMKLSH 62

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE 121
             LV+ YGV + +  + L  E    G L   +++         +      + + ++ L E
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMAPEV 178
             ++HRD+ + N  L  E   +K+ DFG    +              GT+    + +PEV
Sbjct: 123 ACVIHRDLAARNC-LVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPVKWASPEV 176

Query: 179 FMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
           F         R     D+WS G ++ E  S GK P+    SN +++  +  G     P  
Sbjct: 177 FS------FSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYKPRL 229

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQH 263
            S         C R  P  R   F  L  
Sbjct: 230 ASTHVYQIMNHCWRERPEDRPA-FSRLLR 257

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 90.8 bits (226), Expect = 7e-21
 Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 24/262 (9%)

Query: 11  GQGRFGKVYTAV-NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V   V      ++ VA+K   L +  +    ++M+ E +I+  ++   +V+  
Sbjct: 19  GCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV    E ++L ME+   G L   +    + +P   V     Q+   +  L E   VHRD
Sbjct: 77  GV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVFMDTNKV 185
           + + N+ L    +  K+ DFG +  + A              +    + APE        
Sbjct: 136 LAARNV-LLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECIN----- 186

Query: 186 GHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
              +     D+WS G  + E +S G++P+ +     ++M  +  G+    P     E  A
Sbjct: 187 -FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRMECPPECPPELYA 244

Query: 242 FAELCLRHDPAQRATIFELLQH 263
               C  +    R   F  ++ 
Sbjct: 245 LMSDCWIYKWEDRPD-FLTVEQ 265

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.5 bits (228), Expect = 8e-21
 Identities = 58/271 (21%), Positives = 104/271 (38%), Gaps = 37/271 (13%)

Query: 11  GQGRFGKVYTAV---NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +     E  ++ VA+K  +L +    +  K++L E  ++  ++  ++ +
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+      + L  +L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 82  LLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY-----------MA 175
           RD+ + N+ L      +K+ DFG A  + A              + Y           MA
Sbjct: 141 RDLAARNV-LVKTPQHVKITDFGLAKLLGA------------EEKEYHAEGGKVPIKWMA 187

Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
            E  +      H    D+WS G  + E M+ G +P+       +I   +  GE    P  
Sbjct: 188 LESILH-RIYTH--QSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPI 243

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
            + +       C   D   R   F  L   F
Sbjct: 244 CTIDVYMIMRKCWMIDADSRPK-FRELIIEF 273

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 60/266 (22%), Positives = 103/266 (38%), Gaps = 28/266 (10%)

Query: 11  GQGRFGKVY--TAVNNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG VY    ++     +  A+K   L +  + + V+  L E  ++ G+N  N++  
Sbjct: 30  GKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 68  YGVEIHREEMVLF-MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            G+ +  E +    +     G L   ++S +       +  +  Q+   +  L E   VH
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA-----YMAPEVFMD 181
           RD+ + N  +  E  ++K+ DFG A  I        +        A     + A E    
Sbjct: 148 RDLAARNC-MLDESFTVKVADFGLARDILDREYYSVQ----QHRHARLPVKWTALESLQT 202

Query: 182 ---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD 237
              T K       D+WS G +L E ++ G  P+      + +   +  G     PE   D
Sbjct: 203 YRFTTK------SDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLAQGRRLPQPEYCPD 255

Query: 238 EGQAFAELCLRHDPAQRATIFELLQH 263
                 + C   DPA R T F +L  
Sbjct: 256 SLYQVMQQCWEADPAVRPT-FRVLVG 280

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 24/266 (9%)

Query: 11  GQGRFGKVYTAV-NNETGEL--VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG V     +  +G+   VA+K ++    +    + D + E+  +  ++ +NL++ 
Sbjct: 27  GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +HR
Sbjct: 87  YGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 145

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVFMDTNK 184
           D+ + N+ L A  + +K+GDFG    +  +             +   A+ APE       
Sbjct: 146 DLAARNL-LLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCAPESLK---- 197

Query: 185 VGHGR---AVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDEG 239
                   A D W  G  L EM + G+ PW    +  QI+ K+   GE    PE    + 
Sbjct: 198 --TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDI 254

Query: 240 QAFAELCLRHDPAQRATIFELLQHPF 265
                 C  H P  R T F  L+   
Sbjct: 255 YNVMVQCWAHKPEDRPT-FVALRDFL 279

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 56/262 (21%), Positives = 103/262 (39%), Gaps = 24/262 (9%)

Query: 11  GQGRFGKVYTAV-NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V   V      ++ VA+K   L +  +    ++M+ E +I+  ++   +V+  
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV    E ++L ME+   G L   +    + +P   V     Q+   +  L E   VHR+
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVFMDTNKV 185
           + + N+ L    +  K+ DFG +  + A              +    + APE        
Sbjct: 462 LAARNV-LLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECIN----- 512

Query: 186 GHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
              +     D+WS G  + E +S G++P+ +     ++M  +  G+    P     E  A
Sbjct: 513 -FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRMECPPECPPELYA 570

Query: 242 FAELCLRHDPAQRATIFELLQH 263
               C  +    R   F  ++ 
Sbjct: 571 LMSDCWIYKWEDRPD-FLTVEQ 591

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 25/275 (9%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV-NNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILE 57
           S VT     G G FG+VY  +    +G+    VA+K   L      +   D L E  I+ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK--TLKAGYTEKQRVDFLGEAGIMG 101

Query: 58  GINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
             +  N+++  GV    + M++  E    G L+  ++  +     + +    + +   + 
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YM 174
            L     VHRD+ + NI L       K+ DFG +  +      P       G +    + 
Sbjct: 162 YLANMNYVHRDLAARNI-LVNSNLVCKVSDFGLSRVLEDD---PEATYTTSGGKIPIRWT 217

Query: 175 APEVFMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPT 230
           APE         + +   A D+WS G V+ E M+ G+RP+ E  SN+++M  +  G    
Sbjct: 218 APEAIS------YRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRLP 270

Query: 231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
            P             C + + A+R   F  +    
Sbjct: 271 TPMDCPSAIYQLMMQCWQQERARRPK-FADIVSIL 304

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 28/270 (10%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
             +T     G G+FG V       +    VA+K I+      +    +   E + +  ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIK----EGSMSEDEFFQEAQTMMKLS 61

Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
              LVK+YGV      + +  E  + G L + ++S   GL    +      + + ++ L 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMAPE 177
            +  +HRD+ + N  L      +K+ DFG    +     V        GT+    + APE
Sbjct: 122 SHQFIHRDLAARNC-LVDRDLCVKVSDFGMTRYVLDDQYVSSV-----GTKFPVKWSAPE 175

Query: 178 VFMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           VF       + +     D+W+ G ++ E  S GK P+  Y +N +++ KV  G     P 
Sbjct: 176 VFH------YFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQGHRLYRPH 228

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             SD        C    P +R T F+ L  
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPT-FQQLLS 257

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 28/271 (10%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
           + +T     G G++G+VY  V  +    VA+K ++     D   V++ L E  +++ I  
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKH 68

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISAL 119
            NLV+  GV        +  E  T G L   ++          VL+     Q+  A+  L
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL-YMATQISSAMEYL 127

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMAP 176
            +   +HRD+ + N  L  E + +K+ DFG +  ++  T          G +    + AP
Sbjct: 128 EKKNFIHRDLAARNC-LVGENHLVKVADFGLSRLMTGDTYTAHA-----GAKFPIKWTAP 181

Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E       + K       D+W+ G +L E  + G  P+       Q+   +        P
Sbjct: 182 ESLAYNKFSIK------SDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRMERP 234

Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           E   ++       C + +P+ R + F  +  
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPS-FAEIHQ 264

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 56/270 (20%), Positives = 107/270 (39%), Gaps = 28/270 (10%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV-NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN 60
             +TF    G G+FG V       +    VA+K I+      +    + + E +++  ++
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMIK----EGSMSEDEFIEEAKVMMNLS 77

Query: 61  QKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH 120
            + LV+ YGV   +  + +  E    G L + ++          +    K + +A+  L 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMAPE 177
               +HRD+ + N  L  +   +K+ DFG +  +              G++    +  PE
Sbjct: 138 SKQFLHRDLAARNC-LVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFPVRWSPPE 191

Query: 178 VFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPE 233
           V M    ++K       DIW+ G ++ E  S GK P+  + +N +    +  G     P 
Sbjct: 192 VLMYSKFSSK------SDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRLYRPH 244

Query: 234 SLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             S++       C      +R T F++L  
Sbjct: 245 LASEKVYTIMYSCWHEKADERPT-FKILLS 273

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 37/280 (13%)

Query: 11  GQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G+G FGKV         + TGE VA+K ++     +     D+  E+ IL  +  +N+VK
Sbjct: 30  GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVK 87

Query: 67  YYGV--EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
           Y G+  E     + L ME    G+L+  +   ++ +      +Y  Q+   +  L     
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY 147

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISA-----HTTVPGELNGFVGTQAYMAPEVF 179
           VHRD+ + N+ L    + +K+GDFG    I             +   F     + APE  
Sbjct: 148 VHRDLAARNV-LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF-----WYAPECL 201

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYD-------------SNYQIMFKVGM 225
           M  +K     A D+WS G  L E ++      +                +  +++  +  
Sbjct: 202 MQ-SKFYI--ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258

Query: 226 GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
           G+    P +  DE       C    P+ R + F+ L   F
Sbjct: 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS-FQNLIEGF 297

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 47/259 (18%), Positives = 95/259 (36%), Gaps = 34/259 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKE---IQLHKQND------ARFVKDMLVELRILEGINQ 61
           GQG FG +Y A +  + E V       +++   ++       +F +      +I + I  
Sbjct: 44  GQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 62  KNL-------VKYYGVEIHREEM--VLFMELCTEGT-LESLVQSTEDGLPEVLVRRYTKQ 111
           + L           G+     +    + M+    G+ L+ + ++         V + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 112 LVDAISALHENTIVHRDIKSANIFL-TAEGNSLKLGDFGSAVK-ISAHTTVP---GELNG 166
           ++D +  +HE+  VH DIK++N+ L     + + L D+G A +                 
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220

Query: 167 FVGTQAYMAPEVFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPWAEY--DSNYQIMFKV 223
             GT  + +    +D +  V   R  D+  LG  +++  +G  PW +   D  Y    K+
Sbjct: 221 HDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKI 276

Query: 224 GMGETPTIPESLSDEGQAF 242
              E               
Sbjct: 277 RYRENIASLMDKCFPAANA 295

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 28/274 (10%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           ++++     G G FG+V +       +    VA+K   L      +  +D L E  I+  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK--TLKVGYTEKQRRDFLGEASIMGQ 102

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +  N+++  GV    + +++  E    G+L+S ++  +     + +    + +   +  
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-----SAHTTVPGELNGFVGTQAY 173
           L +   VHRD+ + NI L       K+ DFG    +     +A+TT  G++        +
Sbjct: 163 LSDMGYVHRDLAARNI-LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-----PIRW 216

Query: 174 MAPEVFMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETP 229
            +PE         + +   A D+WS G VL E MS G+RP+ E  SN  ++  V  G   
Sbjct: 217 TSPEAIA------YRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEGYRL 269

Query: 230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             P             C + D   R   FE +  
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPK-FEQIVS 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 71/283 (25%), Positives = 100/283 (35%), Gaps = 69/283 (24%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY  V  + G  VA+K  +      ++ +++   E+  L      +LV   G 
Sbjct: 48  GHGVFGKVYKGVLRD-GAKVALK--RR-TPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103

Query: 71  EIHREEMVL---FMELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAISA------LH 120
              R EM+L   +ME    G L+  L  S    +     +R    L   I A      LH
Sbjct: 104 CDERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQR----LEICIGAARGLHYLH 156

Query: 121 ENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV-----GTQAYMA 175
              I+HRD+KS NI L       K+ DFG + K              +     GT  Y+ 
Sbjct: 157 TRAIIHRDVKSINILLDENFVP-KITDFGIS-K-----KGTELDQTHLSTVVKGTLGYID 209

Query: 176 PEVFMD---TNKVGHGRAVDIWSLGCVLVEMSSGKRP--------------WAEYDSNYQ 218
           PE F+    T K       D++S G VL E+   +                WA       
Sbjct: 210 PEYFIKGRLTEK------SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA------V 257

Query: 219 IMFKVGMGET---PTIPESLSDEG----QAFAELCLRHDPAQR 254
                G  E    P + + +  E        A  CL      R
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 74/285 (25%), Positives = 109/285 (38%), Gaps = 68/285 (23%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFV---KDMLVELRILEGINQKNLVKY 67
           G+G FG VY    N T   VA+K  +L    D       +    E++++     +NLV+ 
Sbjct: 40  GEGGFGVVYKGYVNNT--TVAVK--KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 68  YGVEIHREEMVL---FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDA---ISALHE 121
            G     +++ L   +M     G+L   +   +   P     R  K    A   I+ LHE
Sbjct: 96  LGFSSDGDDLCLVYVYMPN---GSLLDRLSCLDGTPPLSWHMRC-KIAQGAANGINFLHE 151

Query: 122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH-------TTVPGELNGFVGTQAYM 174
           N  +HRDIKSANI L     + K+ DFG A + S         + +       VGT AYM
Sbjct: 152 NHHIHRDIKSANILLDEAFTA-KISDFGLA-RASEKFAQTVMTSRI-------VGTTAYM 202

Query: 175 APEVFMD---TNKVGHGRAVDIWSLGCVLVEMSSGKRP------------WAEY----DS 215
           APE  +    T K       DI+S G VL+E+ +G                 E     + 
Sbjct: 203 APE-ALRGEITPK------SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255

Query: 216 NYQIMFKVGMGETPTIPESLSDEGQAFAEL---CLRHDPAQRATI 257
             +      M +        S   +A   +   CL     +R  I
Sbjct: 256 TIEDYIDKKMNDAD------STSVEAMYSVASQCLHEKKNKRPDI 294

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 40.2 bits (95), Expect = 8e-04
 Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 26/89 (29%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAH-------TTVPGELNGFVGTQAYMAPEVFMD--- 358
           ANI L     + K+ DFG A + S         + +       VGT AYMAPE  +    
Sbjct: 162 ANILLDEAFTA-KISDFGLA-RASEKFAQTVMTSRI-------VGTTAYMAPE-ALRGEI 211

Query: 359 TNKVGHGRAVDIWSLGCVLVEMSSGKTNL 387
           T K       DI+S G VL+E+ +G   +
Sbjct: 212 TPK------SDIYSFGVVLLEIITGLPAV 234

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 41/277 (14%)

Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY  V      +E    VA+K   +++    R   + L E  +++  N  ++V
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDA---ISA-- 118
           +  GV    +  ++ MEL T G L+S ++S         VL      +++     I+   
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 119 --LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAY-- 173
             L+ N  VHRD+ + N  + AE  ++K+GDFG    I               G +    
Sbjct: 152 AYLNANKFVHRDLAARNC-MVAEDFTVKIGDFGMTRDIYETDYYR-------KGGKGLLP 203

Query: 174 ---MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMG 226
              M+PE   D   T         D+WS G VL E+++  ++P+    SN Q++  V  G
Sbjct: 204 VRWMSPESLKDGVFTTY------SDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEG 256

Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                P++  D       +C +++P  R +  E++  
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 56/277 (20%), Positives = 100/277 (36%), Gaps = 30/277 (10%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEG 58
           S +      G G  G+V        G+    VA+K   L      R  +D L E  I+  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--ALKAGYTERQRRDFLSEASIMGQ 106

Query: 59  INQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
            +  N+++  GV       ++  E    G+L++ +++ +     + +    + +   +  
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA------ 172
           L +   VHRD+ + N+ L       K+ DFG +  +        + +    T        
Sbjct: 167 LSDLGYVHRDLAARNV-LVDSNLVCKVSDFGLSRVLE------DDPDAAYTTTGGKIPIR 219

Query: 173 YMAPEVFMDTNKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGET 228
           + APE               A D+WS G V+ E ++ G+RP+    +N  ++  V  G  
Sbjct: 220 WTAPEAIA------FRTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSVEEGYR 272

Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              P             C   D AQR   F  +    
Sbjct: 273 LPAPMGCPHALHQLMLDCWHKDRAQRPR-FSQIVSVL 308

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 67/271 (24%), Positives = 127/271 (46%), Gaps = 30/271 (11%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
            S+      G G+FG+V+ A  N+  + VA+K ++      +  V+  L E  +++ +  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK----PGSMSVEAFLAEANVMKTLQH 242

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEV--LVRRYTKQLVDAISAL 119
             LVK + V + +E + +  E   +G+L   ++S E     +  L+  ++ Q+ + ++ +
Sbjct: 243 DKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAFI 300

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAP 176
            +   +HRD+++ANI L +     K+ DFG A  I  +     E     G +    + AP
Sbjct: 301 EQRNYIHRDLRAANI-LVSASLVCKIADFGLARVIEDNEYTARE-----GAKFPIKWTAP 354

Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E       T K       D+WS G +L+E ++ G+ P+    SN +++  +  G     P
Sbjct: 355 EAINFGSFTIK------SDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMPRP 407

Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           E+  +E       C ++ P +R T FE +Q 
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPT-FEYIQS 437

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 57/208 (27%), Positives = 84/208 (40%), Gaps = 18/208 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG +Y   +   GE VA+K E    K         +   ++   GI     +++ G
Sbjct: 18  GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT---IRWCG 74

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            E     MV  MEL    +LE L            V     Q++  I  +H    +HRD+
Sbjct: 75  AEGDYNVMV--MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 131

Query: 130 KSANIFL--TAEGNSLKLGDFGSAVK-ISAHTTV---PGELNGFVGTQAYMAPEVFMDTN 183
           K  N  +    +GN + + DFG A K   A T       E     GT  Y +    ++T+
Sbjct: 132 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS----INTH 187

Query: 184 K-VGHGRAVDIWSLGCVLVEMSSGKRPW 210
             +   R  D+ SLG VL+  + G  PW
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 20/210 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G G FG++    N  T E VA+K E    +            +L   +GI Q   V Y+G
Sbjct: 18  GCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQ---VYYFG 74

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                  MV  +EL    +LE L    +       V     QL+  +  +H   +++RD+
Sbjct: 75  PCGKYNAMV--LELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDV 131

Query: 130 KSANIFL----TAEGNSLKLGDFGSAVK-ISAHTTV---PGELNGFVGTQAYMAPEVFMD 181
           K  N  +          + + DF  A + I   T       E     GT  YM+    ++
Sbjct: 132 KPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS----IN 187

Query: 182 TNK-VGHGRAVDIWSLGCVLVEMSSGKRPW 210
           T+      R  D+ +LG + +    G  PW
Sbjct: 188 THLGKEQSRRDDLEALGHMFMYFLRGSLPW 217

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 56/265 (21%), Positives = 102/265 (38%), Gaps = 25/265 (9%)

Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG VY      N+      A+K   L++  D   V   L E  I++  +  N++  
Sbjct: 34  GRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 68  YGVEIHREE--MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            G+ +  E   +V+ +     G L + +++         +  +  Q+   +  L     V
Sbjct: 92  LGICLRSEGSPLVV-LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMAPEVFMDT 182
           HRD+ + N  +  E  ++K+ DFG A  +  +      ++   G +    +MA E     
Sbjct: 151 HRDLAARNC-MLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALESLQT- 206

Query: 183 NKVGHGR---AVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE 238
                 +     D+WS G +L E M+ G  P+ +  + + I   +  G     PE   D 
Sbjct: 207 -----QKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQPEYCPDP 260

Query: 239 GQAFAELCLRHDPAQRATIFELLQH 263
                  C       R +  EL+  
Sbjct: 261 LYEVMLKCWHPKAEMRPSFSELVSR 285

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 31/223 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK----EIQLHKQ--NDARFVKDMLVELRILEGINQKNL 64
           G G FG +Y A      E  A      E Q +    ++ +F + +  +  I + I +K L
Sbjct: 46  GSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105

Query: 65  -------VKYYGVEIHREEM--VLFMELCTEGT-LESLVQSTEDG-LPEVLVRRYTKQLV 113
                      G+   +      + ME    G  L+ +    ++G   +  V +   +++
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG--QNGTFKKSTVLQLGIRML 161

Query: 114 DAISALHENTIVHRDIKSANIFL-TAEGNSLKLGDFGSAVK-ISAHTTVP---GELNGFV 168
           D +  +HEN  VH DIK+AN+ L     + + L D+G + +                G  
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221

Query: 169 GTQAYMAPEVFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPW 210
           GT  + +    +D +K V   R  D+  LG  ++    GK PW
Sbjct: 222 GTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 59/267 (22%), Positives = 100/267 (37%), Gaps = 29/267 (10%)

Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG VY      N+      A+K   L++  D   V   L E  I++  +  N++  
Sbjct: 98  GRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 68  YGVEIHREE--MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
            G+ +  E   +V+ +     G L + +++         +  +  Q+   +  L     V
Sbjct: 156 LGICLRSEGSPLVV-LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA-----YMAPEVFM 180
           HRD+ + N  +  E  ++K+ DFG A  +               T A     +MA E   
Sbjct: 215 HRDLAARNC-MLDEKFTVKVADFGLARDMYDKEFDSVH----NKTGAKLPVKWMALESLQ 269

Query: 181 D---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
               T K       D+WS G +L E M+ G  P+ +  + + I   +  G     PE   
Sbjct: 270 TQKFTTK------SDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQPEYCP 322

Query: 237 DEGQAFAELCLRHDPAQRATIFELLQH 263
           D        C       R +  EL+  
Sbjct: 323 DPLYEVMLKCWHPKAEMRPSFSELVSR 349

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 76/279 (27%), Positives = 110/279 (39%), Gaps = 45/279 (16%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G G FG+VY        N+ +   VA+K +            D L+E  I+   N +N+V
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE--LDFLMEALIISKFNHQNIV 137

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQST--EDGLPEVLVRRYTKQLVDA---ISA-- 118
           +  GV +      + +EL   G L+S ++ T      P  L       L+     I+   
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA---MLDLLHVARDIACGC 194

Query: 119 --LHENTIVHRDIKSANIFLT--AEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAY 173
             L EN  +HRDI + N  LT    G   K+GDFG A  I  A            G  A 
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-------KGGCAM 247

Query: 174 -----MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG 224
                M PE FM+   T+K       D WS G +L E+ S G  P+    SN +++  V 
Sbjct: 248 LPVKWMPPEAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVT 300

Query: 225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            G     P++           C +H P  R     +L+ 
Sbjct: 301 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 79/288 (27%), Positives = 115/288 (39%), Gaps = 45/288 (15%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
            ++T     G G FG+VY        N+ +   VA+K   L +    +   D L+E  I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCSEQDELDFLMEALII 87

Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQST--EDGLPEVLVRRYTKQLVD 114
              N +N+V+  GV +      + MEL   G L+S ++ T      P  L       L+ 
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA---MLDLLH 144

Query: 115 A---ISA----LHENTIVHRDIKSANIFLT--AEGNSLKLGDFGSAVKI-SAHTTVPGEL 164
               I+     L EN  +HRDI + N  LT    G   K+GDFG A  I  A        
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---- 200

Query: 165 NGFVGTQAY-----MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDS 215
               G  A      M PE FM+   T+K       D WS G +L E+ S G  P+    S
Sbjct: 201 ---KGGCAMLPVKWMPPEAFMEGIFTSK------TDTWSFGVLLWEIFSLGYMPYPSK-S 250

Query: 216 NYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           N +++  V  G     P++           C +H P  R     +L+ 
Sbjct: 251 NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 58/271 (21%), Positives = 104/271 (38%), Gaps = 37/271 (13%)

Query: 11  GQGRFGKVYTAV---NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG VY  +     E  ++ VA+K  +L +    +  K++L E  ++  ++  ++ +
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             G+      + L  +L   G L   V+  +D +    +  +  Q+   ++ L +  +VH
Sbjct: 82  LLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY-----------MA 175
           RD+ + N+ L      +K+ DFG A  + A              + Y           MA
Sbjct: 141 RDLAARNV-LVKTPQHVKITDFGLAKLLGA------------EEKEYHAEGGKVPIKWMA 187

Query: 176 PEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
            E  +      H    D+WS G  + E M+ G +P+       +I   +  GE    P  
Sbjct: 188 LESILH-RIYTH--QSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPI 243

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
            + +       C   D   R   F  L   F
Sbjct: 244 CTIDVYMIMVKCWMIDADSRPK-FRELIIEF 273

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 68/289 (23%), Positives = 104/289 (35%), Gaps = 59/289 (20%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G G FGKV  A        +    VA+K   L     A   + ++ EL+I+  + Q +N+
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 65  VKYYGVEIHREEMVLFMELCTEGTL------ESLVQSTEDGLPEVLVRRYTKQLVDAISA 118
           V   G   H   +++  E C  G L      +S V  T+           T+ L+   S+
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH-FSS 171

Query: 119 --------LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGT 170
                   L     +HRD+ + N+ L   G+  K+GDFG A  I             +  
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNV-LLTNGHVAKIGDFGLARDI-------------MND 217

Query: 171 QAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYD 214
             Y            MAPE   D   T +       D+WS G +L E+ S G  P+    
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQ------SDVWSYGILLWEIFSLGLNPYPGIL 271

Query: 215 SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            N +    V  G     P        +  + C   +P  R T  ++   
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 58/300 (19%), Positives = 106/300 (35%), Gaps = 55/300 (18%)

Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG V  A     + +   VA+K ++      +  +++ L E   ++  +  ++ K 
Sbjct: 32  GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKL 90

Query: 68  YGV------EIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRR----YTKQLVDAI 116
            GV      +      ++ +     G L + L+ S     P  L  +    +   +   +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY--- 173
             L     +HRD+ + N  + AE  ++ + DFG + KI                  Y   
Sbjct: 151 EYLSSRNFIHRDLAARNC-MLAEDMTVCVADFGLSRKI-------------YSGDYYRQG 196

Query: 174 ---------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIM 220
                    +A E   D   T         D+W+ G  + E M+ G+ P+A    N +I 
Sbjct: 197 CASKLPVKWLALESLADNLYTVH------SDVWAFGVTMWEIMTRGQTPYAGI-ENAEIY 249

Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR---ATIFELLQHPFLIVSCEEDVCNP 277
             +  G     P    +E       C   DP QR     +   L++    +S      +P
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 55/262 (20%), Positives = 103/262 (39%), Gaps = 24/262 (9%)

Query: 11  GQGRFGKVYTAV-NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V       +     VA+K ++ ++ ND     ++L E  +++ ++   +V+  
Sbjct: 26  GSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G+    E  +L ME+   G L   +Q       + ++     Q+   +  L E+  VHRD
Sbjct: 85  GI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHRD 142

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ---AYMAPEVFMDTNKV 185
           + + N+ L    +  K+ DFG +  + A              +    + APE        
Sbjct: 143 LAARNV-LLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAPECIN----- 193

Query: 186 GHGR---AVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA 241
            + +     D+WS G ++ E  S G++P+       ++   +  GE    P     E   
Sbjct: 194 -YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKGERMGCPAGCPREMYD 251

Query: 242 FAELCLRHDPAQRATIFELLQH 263
              LC  +D   R   F  ++ 
Sbjct: 252 LMNLCWTYDVENRPG-FAAVEL 272

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.1 bits (211), Expect = 8e-19
 Identities = 54/211 (25%), Positives = 84/211 (39%), Gaps = 22/211 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-EIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYG 69
           G+G FG ++   N    + VA+K E +       R        L    GI     V Y+G
Sbjct: 19  GEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN---VYYFG 75

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
            E     +V  ++L    +LE L+           V    KQ++  + ++HE ++V+RDI
Sbjct: 76  QEGLHNVLV--IDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 132

Query: 130 KSANIFL-----TAEGNSLKLGDFGSAVK-ISAHTTV---PGELNGFVGTQAYMAPEVFM 180
           K  N FL     +   N + + DFG         T       E     GT  YM+    +
Sbjct: 133 KPDN-FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS----I 187

Query: 181 DTNK-VGHGRAVDIWSLGCVLVEMSSGKRPW 210
           +T+      R  D+ +LG V +    G  PW
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMK-------EIQLHKQNDARFVKDMLVELRILEGINQKN 63
           G G FG++Y   N +T E VA+K         QL  +  ++         RIL+G     
Sbjct: 16  GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKI-------YRILQGGTGIP 66

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
            V+++GVE     +V  M+L    +LE L       L    V     Q+++ +  +H  +
Sbjct: 67  NVRWFGVEGDYNVLV--MDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 124 IVHRDIKSANIFL--TAEGNSLKLGDFGSAVK-ISAHTTV---PGELNGFVGTQAYMAPE 177
            +HRDIK  N  +      N + + DFG A K     T       E     GT  Y +  
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS-- 181

Query: 178 VFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPW 210
             ++T+  +   R  D+ SLG VL+    G  PW
Sbjct: 182 --VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 85.0 bits (211), Expect = 8e-19
 Identities = 62/271 (22%), Positives = 119/271 (43%), Gaps = 30/271 (11%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
            ++      G G+FG+V+    N   + VA+K ++      +      L E  +++ +  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK----QGSMSPDAFLAEANLMKQLQH 67

Query: 62  KNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISAL 119
           + LV+ Y V + +E + +  E    G+L   +++          L+     Q+ + ++ +
Sbjct: 68  QRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFI 125

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMAP 176
            E   +HRD+++ANI L ++  S K+ DFG A  I  +     E     G +    + AP
Sbjct: 126 EERNYIHRDLRAANI-LVSDTLSCKIADFGLARLIEDNEYTARE-----GAKFPIKWTAP 179

Query: 177 EVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIP 232
           E       T K       D+WS G +L E ++ G+ P+    +N +++  +  G     P
Sbjct: 180 EAINYGTFTIK------SDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRMVRP 232

Query: 233 ESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           ++  +E      LC +  P  R T F+ L+ 
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPT-FDYLRS 262

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 70/303 (23%), Positives = 115/303 (37%), Gaps = 62/303 (20%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A         T   VA+K   L +       + ++ EL+IL  I    N+
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 65  VKYYGVEIHREE-MVLFMELCTEGTLESLVQSTEDGLPEVLVRRY--------TKQLVDA 115
           V   G        +++ +E C  G L + ++S  +      V            + L+  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 116 ---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV 168
              ++     L     +HRD+ + NI L +E N +K+ DFG A  I              
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNI-LLSEKNVVKICDFGLARDIYK------------ 200

Query: 169 GTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAE 212
               Y            MAPE   D   T +       D+WS G +L E+ S G  P+  
Sbjct: 201 -DPDYVRKGDARLPLKWMAPETIFDRVYTIQ------SDVWSFGVLLWEIFSLGASPYPG 253

Query: 213 YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH--PFLIVSC 270
              + +   ++  G     P+  + E       C   +P+QR T  EL++H    L  + 
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

Query: 271 EED 273
           ++D
Sbjct: 314 QQD 316

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 50/251 (19%), Positives = 98/251 (39%), Gaps = 32/251 (12%)

Query: 11  GQGRFGKVYTAVNNETG--------ELVAMK----EIQLHKQND--ARFVK-DMLVELRI 55
            +   G +Y A    T         +  ++K    + +L  + +   R  K   + + + 
Sbjct: 51  TRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKK 110

Query: 56  LEGINQKNLVKYYGVEIHREEM-VLFMELCTEGT-LESLVQSTEDG-LPEVLVRRYTKQL 112
           L       +    G  +H+++   L +     G  L+S +  +    L E  V +   +L
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRL 168

Query: 113 VDAISALHENTIVHRDIKSANIFL-TAEGNSLKLGDFGSAVK-ISAHTTVP---GELNGF 167
           +DA+  LHEN  VH ++ + NIF+   + + + L  +G A +   +   V    G  +  
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228

Query: 168 VGTQAYMAPEVFMDTNK-VGHGRAVDIWSLGCVLVEMSSGKRPWAEY--DSNYQIMFKVG 224
            G   +++    MD +K  G  R  D+ SLG  +++   G  PW     ++   +  K  
Sbjct: 229 EGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQK 284

Query: 225 MGETPTIPESL 235
             + P      
Sbjct: 285 FVDKPGPFVGP 295

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 60/295 (20%), Positives = 108/295 (36%), Gaps = 55/295 (18%)

Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGINQKNLVK 66
           G+G FG V        + T   VA+K   +   N   R +++ L E   ++  +  N+++
Sbjct: 43  GEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 67  YYGV------EIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRR----YTKQLVDA 115
             GV      +   + MV+ +     G L + L+ S  +  P+ +  +    +   +   
Sbjct: 101 LLGVCIEMSSQGIPKPMVI-LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 116 ISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY-- 173
           +  L     +HRD+ + N  +  +  ++ + DFG + KI                  Y  
Sbjct: 160 MEYLSNRNFLHRDLAARNC-MLRDDMTVCVADFGLSKKI-------------YSGDYYRQ 205

Query: 174 ----------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQI 219
                     +A E   D   T+K       D+W+ G  + E  + G  P+     N+++
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSK------SDVWAFGVTMWEIATRGMTPYPGV-QNHEM 258

Query: 220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDV 274
              +  G     PE   DE       C R DP  R T   L      ++    DV
Sbjct: 259 YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV 313

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 64/293 (21%), Positives = 98/293 (33%), Gaps = 63/293 (21%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G G FGKV  A     + ++    VA+K   L         + ++ EL++L  +    N+
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 65  VKYYGVEIHREEMVLFMELCTEGTL---------ESLVQSTEDGLPEVLVRRYT-KQLVD 114
           V   G        ++  E C  G L           +   T   + E        + L+ 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 115 AISA--------LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG 166
             S         L     +HRD+ + NI L   G   K+ DFG A  I            
Sbjct: 150 -FSYQVAKGMAFLASKNCIHRDLAARNI-LLTHGRITKICDFGLARDI------------ 195

Query: 167 FVGTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPW 210
                 Y            MAPE   +   T +       D+WS G  L E+ S G  P+
Sbjct: 196 -KNDSNYVVKGNARLPVKWMAPESIFNCVYTFE------SDVWSYGIFLWELFSLGSSPY 248

Query: 211 AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                + +    +  G     PE    E     + C   DP +R T  +++Q 
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 54/277 (19%), Positives = 108/277 (38%), Gaps = 31/277 (11%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV---NNETGEL-VAMKEIQLHKQNDARFVKDMLVELRILE 57
           + +      G G FG V+  V     E+ ++ V +K   +  ++  +  + +   +  + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSFQAVTDHMLAIG 70

Query: 58  GINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAIS 117
            ++  ++V+  G+      + L  +    G+L   V+     L   L+  +  Q+   + 
Sbjct: 71  SLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 118 ALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI--------SAHTTVPGELNGFVG 169
            L E+ +VHR++ + N+ L    + +++ DFG A  +         +    P        
Sbjct: 130 YLEEHGMVHRNLAARNV-LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP-------- 180

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGET 228
              +MA E      K  H    D+WS G  + E M+ G  P+A      ++   +  GE 
Sbjct: 181 -IKWMALESIHF-GKYTH--QSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGER 235

Query: 229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
              P+  + +       C   D   R T F+ L + F
Sbjct: 236 LAQPQICTIDVYMVMVKCWMIDENIRPT-FKELANEF 271

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 84.9 bits (211), Expect = 1e-18
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 39/217 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKVY       G LVA+K  +L ++           E+ ++     +NL++  G 
Sbjct: 39  GRGGFGKVYKGR-LADGTLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95

Query: 71  EIHREEMVL---FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDA---ISALHENT- 123
            +   E +L   +M     G++ S ++   +  P +   +  +  + +   ++ LH++  
Sbjct: 96  CMTPTERLLVYPYMAN---GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152

Query: 124 --IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH------TTVPGELNGFVGTQAYMA 175
             I+HRD+K+ANI L  E  +  +GDFG A K+  +      T V        GT  ++A
Sbjct: 153 PKIIHRDVKAANILLDEEFEA-VVGDFGLA-KLMDYKDTHVTTAV-------RGTIGHIA 203

Query: 176 PEVFMDTNKVGHGRA---VDIWSLGCVLVEMSSGKRP 209
           PE          G++    D++  G +L+E+ +G+R 
Sbjct: 204 PEYLS------TGKSSEKTDVFGYGVMLLELITGQRA 234

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 66/282 (23%), Positives = 110/282 (39%), Gaps = 48/282 (17%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV+ A        +   LVA+K +   K       KD   E  +L  +  +++V
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 66  KYYGVEIHREEMVLFMELCTEGTLES--------LVQSTEDGLPEVLVRRYTKQLVDA-- 115
           K+YGV    + +++  E    G L           +   +    +        Q++    
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 116 -ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVG 169
            I++    L     VHRD+ + N  L      +K+GDFG +  + S            VG
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNC-LVGANLLVKIGDFGMSRDVYSTDYYR-------VG 192

Query: 170 TQA-----YMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM 220
                   +M PE  M        +     D+WS G +L E+ + GK+PW +  SN +++
Sbjct: 193 GHTMLPIRWMPPESIMY------RKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVI 245

Query: 221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
             +  G     P     E       C + +P QR  I E+ +
Sbjct: 246 ECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 47/291 (16%)

Query: 2   SSVTFSVSPGQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
             +      G+G FGKV+ A     +  +   LVA+K +   K+      +D   E  +L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELL 97

Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYT------- 109
             +  +++V+++GV      +++  E    G L   ++S       +             
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 110 KQLVDA---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVP 161
            QL+     ++A    L     VHRD+ + N  L  +G  +K+GDFG +  I S      
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNC-LVGQGLVVKIGDFGMSRDIYSTDYYR- 215

Query: 162 GELNGFVGTQA-----YMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEMSS-GKRPWAE 212
                 VG +      +M PE  +        +     D+WS G VL E+ + GK+PW +
Sbjct: 216 ------VGGRTMLPIRWMPPESILY------RKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263

Query: 213 YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             SN + +  +  G     P +   E  A    C + +P QR +I ++   
Sbjct: 264 L-SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 61/298 (20%), Positives = 101/298 (33%), Gaps = 68/298 (22%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G G FGKV  A             VA+K   L ++ D+   + ++ EL+++  +   +N+
Sbjct: 54  GSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 65  VKYYGVEIHREEMVLFMELCTEGTL--------ESLVQSTEDGLPEVLVRRYT------- 109
           V   G       + L  E C  G L        E   +   +   +  +           
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 110 KQLVDAISA--------LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP 161
           + L+   +         L   + VHRD+ + N+ L   G  +K+ DFG A  I +     
Sbjct: 172 EDLLC-FAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKVVKICDFGLARDIMS----- 224

Query: 162 GELNGFVGTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS- 205
                      Y            MAPE   +   T K       D+WS G +L E+ S 
Sbjct: 225 --------DSNYVVRGNARLPVKWMAPESLFEGIYTIK------SDVWSYGILLWEIFSL 270

Query: 206 GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           G  P+     +      +  G     P   ++E     + C   D  +R +   L   
Sbjct: 271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 64/304 (21%)

Query: 11  GQGRFGKVYTAV-------NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-K 62
           G+G FG+V  A          +    VA+K   L      + + D++ E+ +++ I + K
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLES-------LVQSTEDGLPEVLVRRYT-KQLVD 114
           N++   G       + + +E  ++G L                 +  V   + T K LV 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 115 A---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
               ++     L     +HRD+ + N+ L  E N +K+ DFG A  I+            
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNV-LVTENNVMKIADFGLARDIN------------ 254

Query: 168 VGTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWA 211
                Y            MAPE   D   T++       D+WS G ++ E+ + G  P+ 
Sbjct: 255 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ------SDVWSFGVLMWEIFTLGGSPYP 307

Query: 212 EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH--PFLIVS 269
                 ++   +  G     P + ++E       C    P+QR T  +L++     L ++
Sbjct: 308 GI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366

Query: 270 CEED 273
             E+
Sbjct: 367 TNEE 370

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 44/278 (15%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
             +    + G+G FG V        G  VA+K I   K +     +  L E  ++  +  
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI---KNDATA--QAFLAEASVMTQLRH 245

Query: 62  KNLVKYYGVEIHREEMV-LFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISA 118
            NLV+  GV +  +  + +  E   +G+L   ++S    +   + L+ +++  + +A+  
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL-KFSLDVCEAMEY 304

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA---VKISAHTTVPGELNGFVGTQAYMA 175
           L  N  VHRD+ + N+ L +E N  K+ DFG             +P +         + A
Sbjct: 305 LEGNNFVHRDLAARNV-LVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---------WTA 354

Query: 176 PEVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTI 231
           PE   +   + K       D+WS G +L E  S G+ P+        ++ +V  G     
Sbjct: 355 PEALREKKFSTK------SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDA 407

Query: 232 PESLSDEGQAFAEL---CLRHDPAQR---ATIFELLQH 263
           P+          ++   C   D A R     + E L+H
Sbjct: 408 PDGCPPA---VYDVMKNCWHLDAATRPTFLQLREQLEH 442

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 36/272 (13%)

Query: 2   SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ 61
             +    + G+G FG V        G  VA+K I   K +     +  L E  ++  +  
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI---KNDATA--QAFLAEASVMTQLRH 73

Query: 62  KNLVKYYGVEIHREEMV-LFMELCTEGTLESLVQSTEDGL--PEVLVRRYTKQLVDAISA 118
            NLV+  GV +  +  + +  E   +G+L   ++S    +   + L+ +++  + +A+  
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL-KFSLDVCEAMEY 132

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA---YMA 175
           L  N  VHRD+ + N+ L +E N  K+ DFG   + S+              +    + A
Sbjct: 133 LEGNNFVHRDLAARNV-LVSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWTA 182

Query: 176 PEVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTI 231
           PE   +   + K       D+WS G +L E  S G+ P+        ++ +V  G     
Sbjct: 183 PEALREKKFSTK------SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDA 235

Query: 232 PESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           P+          + C   D A R + F  L+ 
Sbjct: 236 PDGCPPAVYEVMKNCWHLDAAMRPS-FLQLRE 266

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 64/307 (20%)

Query: 11  GQGRFGKVYTAV-------NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-K 62
           G+G FG+V  A          +    VA+K   L      + + D++ E+ +++ I + K
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRRYT-------KQLVD 114
           N++   G       + + +E  ++G L   L      G+                K LV 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 115 A---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
               ++     L     +HRD+ + N+ L  E N +K+ DFG A  I+            
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNV-LVTENNVMKIADFGLARDIN------------ 208

Query: 168 VGTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWA 211
                Y            MAPE   D   T++       D+WS G ++ E+ + G  P+ 
Sbjct: 209 -NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ------SDVWSFGVLMWEIFTLGGSPYP 261

Query: 212 EYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH--PFLIVS 269
                 ++   +  G     P + ++E       C    P+QR T  +L++     L ++
Sbjct: 262 GI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320

Query: 270 CEEDVCN 276
             E+  +
Sbjct: 321 TNEEYLD 327

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 62/299 (20%), Positives = 114/299 (38%), Gaps = 55/299 (18%)

Query: 11  GQGRFGKVYTAV-------NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-K 62
           G+G FG+V  A               VA+K   L      + + D++ E+ +++ I + K
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLES--------LVQSTEDGLPEVLVRRYTKQLVD 114
           N++   G       + + +E  ++G L           ++ + +       +  +K LV 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 115 A---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
               ++     L     +HRD+ + N+ L  E N +K+ DFG A  I            +
Sbjct: 196 CAYQVARGMEYLASKKCIHRDLAARNV-LVTEDNVMKIADFGLARDI--------HHIDY 246

Query: 168 --VGTQA-----YMAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSN 216
               T       +MAPE   D   T++       D+WS G +L E+ + G  P+      
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQ------SDVWSFGVLLWEIFTLGGSPYPGV-PV 299

Query: 217 YQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR---ATIFELLQHPFLIVSCEE 272
            ++   +  G     P + ++E       C    P+QR     + E L     + S +E
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 67/297 (22%), Positives = 110/297 (37%), Gaps = 67/297 (22%)

Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FGKV  A             VA+K   L +      ++D+L E  +L+ +N  +++
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVK--MLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 66  KYYGVEIHREEMVLFMELCTEGTL---------------ESLVQSTEDGLPEVLVRRYT- 109
           K YG       ++L +E    G+L                S        L     R  T 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 110 KQLVDA---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
             L+     IS     L E  +VHRD+ + NI L AEG  +K+ DFG +  +        
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNI-LVAEGRKMKISDFGLSRDV-------- 200

Query: 163 ELNGFVGTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-G 206
                    +Y            MA E   D   T +       D+WS G +L E+ + G
Sbjct: 201 -----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ------SDVWSFGVLLWEIVTLG 249

Query: 207 KRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             P+       ++   +  G     P++ S+E       C + +P +R    ++ + 
Sbjct: 250 GNPYPGI-PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 63/291 (21%), Positives = 108/291 (37%), Gaps = 45/291 (15%)

Query: 2   SSVTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRIL 56
           S+V F    G+ RFGKVY          E  + VA+K   L  + +    ++   E  + 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK--TLKDKAEGPLREEFRHEAMLR 66

Query: 57  EGINQKNLVKYYGVEIHREEMVLFMELCTEGTLES--------LVQSTEDGLPEVLVRRY 108
             +   N+V   GV    + + +    C+ G L              + D    V     
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 109 TKQLVDA---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP 161
               V     I+A    L  + +VH+D+ + N+ L  +  ++K+ D G   ++ A     
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV-LVYDKLNVKISDLGLFREVYAADYYK 185

Query: 162 GELNGFVGTQA-----YMAPEVFMDTNKVGHGR---AVDIWSLGCVLVEMSS-GKRPWAE 212
                 +   +     +MAPE  M       G+     DIWS G VL E+ S G +P+  
Sbjct: 186 ------LLGNSLLPIRWMAPEAIMY------GKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233

Query: 213 YDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
           Y SN  ++  +   +    P+       A    C    P++R    ++   
Sbjct: 234 Y-SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 64/297 (21%), Positives = 106/297 (35%), Gaps = 67/297 (22%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+V+ A     +  E   +VA+K   L ++  A    D   E  ++   +  N+V
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 66  KYYGVEIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRRYT--------------- 109
           K  GV    + M L  E    G L   L   +   +  +     +               
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 110 KQLVDA---ISA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
            + +     ++A    L E   VHRD+ + N  L  E   +K+ DFG +  I        
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNC-LVGENMVVKIADFGLSRNI-------- 224

Query: 163 ELNGFVGTQAY------------MAPEVFMD---TNKVGHGRAVDIWSLGCVLVEMSS-G 206
                     Y            M PE       T +       D+W+ G VL E+ S G
Sbjct: 225 -----YSADYYKADGNDAIPIRWMPPESIFYNRYTTE------SDVWAYGVVLWEIFSYG 273

Query: 207 KRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
            +P+    ++ ++++ V  G     PE+   E      LC    PA R +   + + 
Sbjct: 274 LQPYYGM-AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 62/280 (22%), Positives = 103/280 (36%), Gaps = 46/280 (16%)

Query: 11  GQGRFGKVYTAV--NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKY 67
           G+G FG+V  A    +      A+K  ++ +       +D   EL +L  +    N++  
Sbjct: 34  GEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 68  YGVEIHREEMVLFMELCTEGTL-----ESLVQSTEDGLPEVLVRRYT---KQLVDA---I 116
            G   HR  + L +E    G L     +S V  T+           T   +QL+     +
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 117 SA----LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQA 172
           +     L +   +HRD+ + NI L  E    K+ DFG +     +            T  
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNI-LVGENYVAKIADFGLSRGQEVYVK---------KTMG 201

Query: 173 -----YMAPEVFMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKV 223
                +MA E       T         D+WS G +L E +S G  P+    +  ++  K+
Sbjct: 202 RLPVRWMAIESLNYSVYTTN------SDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKL 254

Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             G     P +  DE       C R  P +R +  ++L  
Sbjct: 255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.3 bits (132), Expect = 1e-08
 Identities = 49/319 (15%), Positives = 93/319 (29%), Gaps = 76/319 (23%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-----RFVKDMLVELRILEGINQ---- 61
           G+G FG+V+  + +     VA+K I +   +       +  +++L E+ I + ++     
Sbjct: 29  GEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 62  -----KNLVKYYGVEIHR------------------------------EEMVLFMELCTE 86
                +  +    V   +                              +++ + +E    
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 87  GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTA------- 138
           G    L Q           +    QL  +++    +    HRD+   N+ L         
Sbjct: 147 GI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204

Query: 139 ---EGNSLKLGDFGSAVKISAHTTVPGELNG-FVGTQAYMAPEVFMDTNKVGHGRAVDIW 194
               G S  +   G  V I  +T    E +G  V     M  ++F            DI+
Sbjct: 205 YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD----GDYQFDIY 260

Query: 195 SL-GCVLVEMSSGKRP-----WAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAFAELCL 247
            L             P     W  Y ++  +       +  T     +  + Q F    L
Sbjct: 261 RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML 320

Query: 248 RHDPAQRATIFELLQHPFL 266
               A      +LL    L
Sbjct: 321 NFSSA-----TDLLCQHSL 334

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 12/149 (8%)

Query: 119 LHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           L     +HRD+ + NI L+ E N +K+ DFG A  I        + +  +  + +MAPE 
Sbjct: 209 LASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WMAPET 266

Query: 179 FMD---TNKVGHGRAVDIWSLGCVLVE-MSSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
             D   T +       D+WS G +L E  S G  P+     + +   ++  G     P+ 
Sbjct: 267 IFDRVYTIQ------SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQH 263
            + E       C   +P+QR T  EL++H
Sbjct: 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 9/92 (9%)

Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A         T   VA+K   L +       + ++ EL+IL  I    N+
Sbjct: 31  GRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 65  VKYYGV-EIHREEMVLFMELCTEGTLESLVQS 95
           V   G        +++ +E C  G L + ++S
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 2e-06
 Identities = 58/378 (15%), Positives = 107/378 (28%), Gaps = 118/378 (31%)

Query: 22  VNNETGEL-VAMKEIQLHKQNDARFVKDMLVE--LRILEGINQKNLVKYYGVEIHREEMV 78
           ++ ETGE     K+I    ++   FV +   +    + + I  K  + +  +        
Sbjct: 7   MDFETGEHQYQYKDILSVFEDA--FVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64

Query: 79  --LFMELCTEGT------LESLVQ----------STEDGLPEVLVRRYTKQL------VD 114
             LF  L ++        +E +++           TE   P ++ R Y +Q         
Sbjct: 65  LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124

Query: 115 AISALHENTIVHR-----DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 169
             +  +    V R      ++ A + L    N L  G  GS  K    T V  ++     
Sbjct: 125 VFAKYN----VSRLQPYLKLRQALLELRPAKNVLIDGVLGSG-K----TWVALDVCLSYK 175

Query: 170 TQAYMAPEVFMDTNKVGHGRAVDIW-SLGCV-----LVEMSSGKRPWAEYDSNYQIMFKV 223
            Q  M  ++F              W +L        ++EM   ++   + D N+      
Sbjct: 176 VQCKMDFKIF--------------WLNLKNCNSPETVLEML--QKLLYQIDPNWTSRSD- 218

Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP--FLIVSCEEDVCNPRSVP 281
                     S+  E        LR        + +   +    L++    +V N ++  
Sbjct: 219 HSSNIKLRIHSIQAE--------LRR-------LLKSKPYENCLLVL---LNVQNAKAWN 260

Query: 282 A--------------SVLQDYLKLGIVLPPMSEDSVKVYARANIFLTAEGNSLKLGDFGS 327
           A               V  D+L          +            LT       L     
Sbjct: 261 AFNLSCKILLTTRFKQVT-DFLSAATTTHISLDHHSMT-------LT-PDEVKSL--LLK 309

Query: 328 AVKIS-------AHTTVP 338
            +            TT P
Sbjct: 310 YLDCRPQDLPREVLTTNP 327

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	407
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.68
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.68
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.68
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.67
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.67
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.66
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.65
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.65
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.64
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.61
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.59
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.59
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.58
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.57
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.57
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.56
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.55
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.52
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.44
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.38
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.38
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.36
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.35
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.35
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.35
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.35
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.34
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.34
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.34
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.34
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.33
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.33
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.32
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.32
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.32
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.32
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.31
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.3
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.3
3niz_A	311	Rhodanese family protein; structural genomics, str	99.3
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.3
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.3
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.3
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.3
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.29
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.29
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.29
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.29
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.27
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.27
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.27
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.26
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.26
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.24
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.24
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.23
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.23
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.23
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.22
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.21
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.2
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.2
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.2
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.2
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.2
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.2
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.2
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.2
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.2
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.2
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.2
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.19
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.19
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.18
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.17
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.17
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.17
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.14
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.13
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.13
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.13
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.13
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.12
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.11
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.11
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.11
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.1
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.1
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.1
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.1
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.1
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.1
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.1
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.1
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.09
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.09
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.09
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.09
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.09
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.09
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.09
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.08
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.08
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.07
3bhy_A	283	Death-associated protein kinase 3; death associate	99.07
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.07
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.07
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.07
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.06
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.06
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.06
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.06
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.06
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.06
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.06
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.06
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.05
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.05
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.05
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.05
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.05
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.04
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.04
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.03
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.03
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.03
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.03
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.03
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.02
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.02
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.02
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.02
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.02
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.01
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.01
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.99
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	98.99
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	98.98

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.3e-67  Score=483.96  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=221.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+++|++++|||||++++++++++.+|||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45566699999999999999999999999999986543333345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||+||+|.+++++. +.++|..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+..... ..
T Consensus       113 y~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~-~~  189 (311)
T 4aw0_A          113 YAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK-QA  189 (311)
T ss_dssp             CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTT-CC
T ss_pred             cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCC-cc
Confidence            99999999999764 4599999999999999999999999999999999999998875 699999999988754322 12


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ...+.+||+.|||||++.+   .+|+.++|||||||++|||++|+.||.+. +..++..++..+ .+.+|+.+|+++++|
T Consensus       190 ~~~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~-~~~~p~~~s~~~~dl  264 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTE---KSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKL-EYDFPEKFFPKARDL  264 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHH---SCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHT-CCCCCTTCCHHHHHH
T ss_pred             cccCcccCcccCCHHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcC-CCCCCcccCHHHHHH
Confidence            3456899999999999965   45789999999999999999999999853 444444444443 456788999999999


Q ss_pred             HHHhcccCCCCcCCHHH------HhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFE------LLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e------~l~hp~~~  267 (407)
                      |.+||++||++|||+.|      +++||||.
T Consensus       265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~  295 (311)
T 4aw0_A          265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE  295 (311)
T ss_dssp             HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred             HHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence            99999999999999988      57899984

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-66  Score=488.23  Aligned_cols=255  Identities=26%  Similarity=0.461  Sum_probs=218.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||++.+... +....+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            3445589999999999999999999999999986543 344567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+||+|.+++.... ..++|..++.|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.....   
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~---  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVE---  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHHHH---
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCCcc---
Confidence            99999999997543 3479999999999999999999999999999999999999875 699999999987643211   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ..++.+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+ .+..+.+.++..+..|.++..+|+++++|
T Consensus       181 ~~~~~~GT~~YmAPE~l~~---~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICEN---KPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence            1245689999999999964   4578999999999999999999999985 45566677777777888889999999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |.+||++||++|||+.|+|+|||+.
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHccCChhHCcCHHHHhcCHHhh
Confidence            9999999999999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-65  Score=471.05  Aligned_cols=252  Identities=30%  Similarity=0.520  Sum_probs=216.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVLF   80 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv   80 (407)
                      .++..||+|+||+||+|++..+++.||+|++..... .....+++.+|+++|++++|||||++++++.+    ++.+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            345589999999999999999999999999986543 34456789999999999999999999999875    3568999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||||++|+|.+++++. ..+++..++.++.||+.||+|||+++  ||||||||+|||++.+++.+||+|||+|+....  
T Consensus       108 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  184 (290)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence            9999999999999764 45999999999999999999999998  999999999999986445799999999975432  


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~  237 (407)
                         ....+.+||+.|||||++.+    .|+.++|||||||++|||+||+.||.+..+...+...+..+..| .++..+++
T Consensus       185 ---~~~~~~~GTp~YmAPE~~~~----~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  257 (290)
T 3fpq_A          185 ---SFAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ---CccCCcccCccccCHHHcCC----CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence               12356799999999999843    37899999999999999999999998766666666666555544 45667899


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++||.+||++||++|||+.|+++||||.
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~  287 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence            999999999999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-65  Score=481.20  Aligned_cols=250  Identities=33%  Similarity=0.521  Sum_probs=216.7

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ...+||+|+||+||+|++..+|+.||||++.......   .+.+.+|+.+|++++|||||++++++.+++.+|||||||+
T Consensus        78 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           78 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            3448999999999999999999999999998654433   2457899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      ||+|.++++.  ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.....   ..+
T Consensus       155 gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~---~~~  228 (346)
T 4fih_A          155 GGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVP---RRK  228 (346)
T ss_dssp             TEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSC---CBC
T ss_pred             CCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCC---ccc
Confidence            9999999975  3599999999999999999999999999999999999999875 699999999988754322   235


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--CCCccCHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQAFA  243 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~~i  243 (407)
                      +.+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. +..+.+..+..+..+.  .+..+|+++++||
T Consensus       229 ~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          229 SLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             CCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             ccccCcCcCCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            6799999999999854   45789999999999999999999999854 4445555554444443  3457999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+||++||++|||+.|+|+||||..
T Consensus       305 ~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          305 DRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhcC
Confidence            9999999999999999999999964

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-65  Score=470.19  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=204.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||||++.+....+....+++.+|+++|++++|||||++++++.+++.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            44556699999999999999999999999999987655555556778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      || +|+|.+++.. .+.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......    
T Consensus        94 y~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~----  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGN----  166 (275)
T ss_dssp             CC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC-----------
T ss_pred             CC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCC----
Confidence            99 6799999876 45699999999999999999999999999999999999998865 69999999997754322    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ...+.+||+.|||||++.+.  ..++.++|||||||++|||++|+.||.+. +.......+.. ..+.+|..+|+++++|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~--~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~-~~~~~p~~~s~~~~~l  242 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISN-GVYTLPKFLSPGAAGL  242 (275)
T ss_dssp             --------CTTSCHHHHSSS--SCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH-TCCCCCTTSCHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCC--CCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHc-CCCCCCCCCCHHHHHH
Confidence            23567999999999999653  23468999999999999999999999853 33344444433 4556788999999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+||++||++|||+.|+++||||.
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             HHHHccCChhHCcCHHHHHcCcccc
Confidence            9999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.6e-64  Score=482.44  Aligned_cols=251  Identities=33%  Similarity=0.519  Sum_probs=217.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+|+.||||++.......   .+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus       154 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            34458999999999999999999999999998654433   245789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +||+|.++++.  ..+++..++.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.....   ..
T Consensus       231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~---~~  304 (423)
T 4fie_A          231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVP---RR  304 (423)
T ss_dssp             TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCC---CB
T ss_pred             CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCc---cc
Confidence            99999999965  3499999999999999999999999999999999999999875 699999999988754322   23


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--CCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~~  242 (407)
                      .+.+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. +..+.+..+..+..+.  .+..+|+++++|
T Consensus       305 ~~~~GTp~YmAPEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          305 KSLVGTPYWMAPELISR---LPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             CCCEECTTTCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             cccccCcCcCCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence            56899999999999854   45789999999999999999999999854 4445555554444333  356799999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |.+||++||++|||+.|+|+||||..
T Consensus       381 i~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          381 LDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            99999999999999999999999964

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.6e-64  Score=470.22  Aligned_cols=244  Identities=30%  Similarity=0.467  Sum_probs=204.3

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+|+.||||+++....        ..+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            344579999999999999999999999999986432        246999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC--C
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP--G  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~--~  162 (407)
                      +||+|.++++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++..+||+|||+|+.+.......  .
T Consensus       133 ~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          133 EGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             TTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            999999999764 4599999999999999999999999999999999999999877679999999998875432111  1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC--CCCCCccCHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET--PTIPESLSDEGQ  240 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~  240 (407)
                      .....+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+.... ....++..+..  +.+|..+|++++
T Consensus       212 ~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMG---KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cCCccccCccccCHHHHCC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHcCCCCchhcCccCCHHHH
Confidence            1234689999999999965   45789999999999999999999999854332 23333333333  246788999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHh
Q psy10603        241 AFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      +||.+||++||++|||+.|++
T Consensus       288 ~li~~~L~~dP~~R~sa~el~  308 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELR  308 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHH
Confidence            999999999999999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-64  Score=465.78  Aligned_cols=254  Identities=29%  Similarity=0.413  Sum_probs=208.3

Q ss_pred             ccceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      ++.....||+|+||+||+|++.   .+++.||||++++...... ...++.+|+++|++++|||||++++++.+++.+||
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            3455569999999999999874   4688999999975432211 12357789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||+||+|.+++++. +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus       104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccCCCc
Confidence            99999999999999764 4599999999999999999999999999999999999999875 699999999986543321


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                         ...+.+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. +..+.+..+..+ .+.+|..+|+++
T Consensus       182 ---~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~-~~~~p~~~s~~~  253 (304)
T 3ubd_A          182 ---KAYSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKA-KLGMPQFLSPEA  253 (304)
T ss_dssp             ---CCCSCCCCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC-CCCCCTTSCHHH
T ss_pred             ---cccccccCcccCCHHHhcc---CCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHcC-CCCCCCcCCHHH
Confidence               2356799999999999864   45789999999999999999999999853 344444444443 456788999999


Q ss_pred             HHHHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      ++||.+||++||++|||     ++|+++||||.
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~  286 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS  286 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence            99999999999999998     57999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-61  Score=450.32  Aligned_cols=254  Identities=24%  Similarity=0.407  Sum_probs=208.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||+||+|++..   .||||+++... ...+..++|.+|+++|++++|||||++++++. ++.+|||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE  111 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ  111 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence            56677899999999999998653   59999987543 34456788999999999999999999999864 567899999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||++|+|.+++......+++..+..++.||+.||+|||+++||||||||+|||++.+ ..+||+|||+|+....... ..
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~-~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSG-SQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC---------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccCCc-ce
Confidence            999999999997766779999999999999999999999999999999999999876 4799999999987543221 12


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC----CCCCCccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET----PTIPESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~s~~  238 (407)
                      .....+||+.|||||++.......|+.++|||||||++|||+||+.||.+..+.......+..+..    +.++..++++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            235578999999999997544445789999999999999999999999876655555555544432    2456789999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++.+||++||++|||+.|++++
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999988654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-61  Score=450.70  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-------
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-------   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------   75 (407)
                      ++.....||+|+||+||+|++..+|+.||||+++...  .....+.+.+|+++|++++|||||++++++.+.+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            4455669999999999999999999999999997543  4445678899999999999999999999987654       


Q ss_pred             -----eEEEEEecCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcc
Q psy10603         76 -----EMVLFMELCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDF  148 (407)
Q Consensus        76 -----~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DF  148 (407)
                           .+|+|||||++|+|.++++....  ..++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence                 37999999999999999975322  245667899999999999999999999999999999999875 6999999


Q ss_pred             cCceecCCCCCC---------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH
Q psy10603        149 GSAVKISAHTTV---------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI  219 (407)
Q Consensus       149 Gla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~  219 (407)
                      |+|+.+......         ....++.+||+.|||||++.+   ..|+.++|||||||++|||++   ||....+....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~---~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG---NSYSHKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT---CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC---CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            999876543211         112345689999999999864   457899999999999999996   88643333344


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +..+.....|..+...++++.+|+.+||++||++|||+.|+++||||.
T Consensus       237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            445555555555556778899999999999999999999999999984

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.5e-61  Score=447.20  Aligned_cols=250  Identities=24%  Similarity=0.419  Sum_probs=213.0

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.+...||+|+||+||+|++.     .+++.||||+++..   .....++|.+|+++|++++|||||++++++.+++.+
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            5667779999999999999875     45789999998643   345567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEE
Q psy10603         78 VLFMELCTEGTLESLVQST------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKL  145 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl  145 (407)
                      |||||||++|+|.++++..            ...+++..+..++.||+.||.|||+++||||||||+|||++.++ .+||
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~~Ki  169 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKI  169 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-cEEE
Confidence            9999999999999999653            23599999999999999999999999999999999999998864 6999


Q ss_pred             EcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHh
Q psy10603        146 GDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVG  224 (407)
Q Consensus       146 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~  224 (407)
                      +|||+|+........ ......+||+.|||||++..   ..++.++|||||||++|||+| |+.||.+. +..+++..+.
T Consensus       170 ~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~---~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY---RKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT  244 (299)
T ss_dssp             CCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHH
T ss_pred             CCcccceecCCCCce-eecCceecChhhcCHHHHcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH
Confidence            999999876433211 11234579999999999965   347899999999999999998 89999864 4556777777


Q ss_pred             CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       225 ~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      .+..+..|..+|+++.+++.+||+.||++|||+.|++
T Consensus       245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            7888888999999999999999999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-60  Score=449.04  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=208.9

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.+..+||+|+||+||+|++.     .+++.||||+++..   +....++|.+|+++|++++|||||++++++.+.+.+
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            5667779999999999999865     46889999998642   445567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeE
Q psy10603         78 VLFMELCTEGTLESLVQSTE--------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSL  143 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~--------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~v  143 (407)
                      |||||||++|+|.++++...              ..+++.++..++.||+.||.|||+++||||||||+|||++.+ ..+
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-~~~  197 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVV  197 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-CcE
Confidence            99999999999999986532              348999999999999999999999999999999999999876 579


Q ss_pred             EEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHH
Q psy10603        144 KLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       144 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~  222 (407)
                      ||+|||+|+........ ......+||+.|||||++.+   ..++.++|||||||++|||+| |+.||.+. +..+.+..
T Consensus       198 Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~---~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY---RKFTTESDVWSFGVVLWEIFTYGKQPWYQL-SNTEAIDC  272 (329)
T ss_dssp             EECCCC-----------------CCCCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-CHHHHHHH
T ss_pred             EEcccccceeccCCCcc-eecCcccccccccChhhhcC---CCCCccccccchHHHHHHHHcCCCCCCCCC-CHHHHHHH
Confidence            99999999876433211 12234679999999999864   357899999999999999999 89999864 45566667


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..+..+..|..+++++.+++.+||++||++|||+.|++++
T Consensus       273 i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            77778888899999999999999999999999999999865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-60  Score=444.83  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=215.5

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.+...||+|+||+||+|+..     .+++.||||+++...  +....++|.+|+.+|++++|||||+++|++.+++.+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            5667789999999999999863     467899999986442  223457799999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCe
Q psy10603         78 VLFMELCTEGTLESLVQST---------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS  142 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~  142 (407)
                      +||||||++|+|.+++...               ...+++..+..++.||+.||+|||+++||||||||+|||++.++ .
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-~  183 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-N  183 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-C
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC-C
Confidence            9999999999999999643               13489999999999999999999999999999999999999865 6


Q ss_pred             EEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHH
Q psy10603        143 LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF  221 (407)
Q Consensus       143 vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~  221 (407)
                      +||+|||+|+........ ......+||+.|||||++.+   ..++.++|||||||++|||+| |+.||.+. +..++..
T Consensus       184 ~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~---~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-~~~~~~~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY---GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVVE  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-CHHHHHH
T ss_pred             EEECCcccceeccCCCce-eEecccccCCcccCHHHHhC---CCCCccchhhhHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence            999999999876433221 22345689999999999965   347899999999999999998 89999864 4556777


Q ss_pred             HHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       222 ~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+..+..++.|..+++++.+++.+||+.||++|||+.|++++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            777788888899999999999999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-60  Score=454.53  Aligned_cols=257  Identities=25%  Similarity=0.429  Sum_probs=208.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~   78 (407)
                      .....||+|+||+||+|++..+|+.||||++.... ......+++.+|+++|++++|||||++++++...      +.+|
T Consensus        57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            33449999999999999999999999999997543 3445567889999999999999999999987643      5799


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||||||+ |+|.+++.. .+.+++..++.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+....
T Consensus       136 ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC----
T ss_pred             EEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeecccCc
Confidence            9999996 679999865 45699999999999999999999999999999999999999865 69999999998764322


Q ss_pred             C-CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--CCCC-------
Q psy10603        159 T-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--MGET-------  228 (407)
Q Consensus       159 ~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--~~~~-------  228 (407)
                      . ......+.+||+.|||||++.+.  ..++.++||||+||++|||++|++||.+.+.. ..+..+.  .+..       
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~--~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSL--HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGGTC-
T ss_pred             cccccccccceeChHhcCHHHhcCC--CCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhh
Confidence            1 12234578999999999998653  34689999999999999999999999864433 2222211  1110       


Q ss_pred             --------------CC-------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        229 --------------PT-------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       229 --------------~~-------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                    +.       +...+|+++++||.+||++||++|||+.|+|+||||..
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence                          00       11357899999999999999999999999999999963

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-59  Score=472.17  Aligned_cols=257  Identities=24%  Similarity=0.407  Sum_probs=217.2

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ---NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +++.....||+|+||+||+|++..+|+.||||++.+...   ..........+++.+++.++|||||++++++++++.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            356677799999999999999999999999999975422   22233334455678888999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||||||+||+|..+++.. +.+++..++.|++||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.+... 
T Consensus       269 lVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~~~-  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeecCCC-
Confidence            999999999999999764 4599999999999999999999999999999999999999876 6999999999876543 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                          ...+.+||+.|||||++..  ..+|+.++|||||||++|||++|+.||.+... ....+........+.+|..+|+
T Consensus       346 ----~~~t~~GTp~YmAPEvl~~--~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~  419 (689)
T 3v5w_A          346 ----KPHASVGTHGYMAPEVLQK--GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  419 (689)
T ss_dssp             ----CCCSCCSCGGGCCHHHHST--TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ----CCCCccCCcCccCHHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence                2356799999999999853  24578999999999999999999999975322 2222333333455677889999


Q ss_pred             HHHHHHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      ++++||.+||++||.+|++     +.|+++||||.
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence            9999999999999999998     79999999995

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.1e-59  Score=444.55  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             cceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|+++   .+++.||+|.+....  .   ..++.+|+++|+.+ +|||||++++++.+++.+|+
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            344559999999999999874   467899999986542  2   24577899999988 69999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||++|+|.++++.    +++.+++.+++||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.......
T Consensus        98 vmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            9999999999999843    899999999999999999999999999999999999988756899999999986542210


Q ss_pred             -------------------------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q psy10603        160 -------------------------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD  214 (407)
Q Consensus       160 -------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~  214 (407)
                                               ......+.+||+.|||||++.+.  ..|+.++||||+||++|||++|+.||....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC--PNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                     01123456899999999998653  347899999999999999999999997655


Q ss_pred             chHHHHHHHhC-------------------------------------C---CCC-------------CCCCccCHHHHH
Q psy10603        215 SNYQIMFKVGM-------------------------------------G---ETP-------------TIPESLSDEGQA  241 (407)
Q Consensus       215 ~~~~~~~~~~~-------------------------------------~---~~~-------------~~~~~~s~~~~~  241 (407)
                      +....+..+..                                     +   ..|             .....+|+++++
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            44333221110                                     0   000             113457899999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+.+||++||++|+|+.|+|+||||.
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccC
Confidence            99999999999999999999999984

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.5e-59  Score=440.41  Aligned_cols=255  Identities=25%  Similarity=0.361  Sum_probs=215.8

Q ss_pred             ccceeeecccccCeEEEEEEECCC-----CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeC-c
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNET-----GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHR-E   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~-~   75 (407)
                      ++.+...||+|+||+||+|++..+     ++.||||.+...  ......+.+.+|+++|.+++| ||||++++++..+ +
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            345566999999999999987654     368999998643  233445789999999999977 8999999998764 5


Q ss_pred             eEEEEEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         76 EMVLFMELCTEGTLESLVQST---------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      .+|||||||++|+|.++++..               ...+++..+..++.||+.||+|||+++||||||||+|||++.++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence            689999999999999999753               23488999999999999999999999999999999999999865


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~  219 (407)
                       .+||+|||+|+.+...... ......+||+.|||||++.+   ..|+.++|||||||++|||+| |+.||.+.......
T Consensus       223 -~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~---~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          223 -VVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             -CEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             -CEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc---CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             6999999999876543221 12245689999999999965   357899999999999999998 99999876666666


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ...+..+..+..|+.+++++.+++.+||+.||++|||+.|+++|.
T Consensus       298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L  342 (353)
T 4ase_A          298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  342 (353)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            666777888889999999999999999999999999999999873

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-57  Score=460.15  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=218.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            345568999999999999999999999999997543   23346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-CCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-GNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+||+|.+++......+++..++.+++||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.+....    
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~----  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS----
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC----
Confidence            99999999997656679999999999999999999999999999999999999864 3579999999998875432    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~  239 (407)
                      .....+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. +..+.+..+.....   +..+..+|+++
T Consensus       312 ~~~~~~GT~~y~APEv~~~---~~y~~~~DiWSlGvilyeml~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEG---KPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             ceeeeEECccccCHHHhCC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            2356789999999999965   45789999999999999999999999864 34444444444332   22345789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++||.+||++||.+|||+.|+|+||||..
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence            99999999999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-55  Score=412.62  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=193.3

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc----eE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE----EM   77 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~   77 (407)
                      .++.....||+|+||+||+|++  +|+.||||++....  ..  .....+|+..+.+++|||||++++++..++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4567788999999999999987  58899999986432  11  122335666778899999999999988654    68


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN--------TIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--------~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      |||||||++|+|.++++.  ..++++.+..++.|++.||.|||++        +||||||||+|||++.++ .+||+|||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            999999999999999975  3489999999999999999999987        999999999999998865 69999999


Q ss_pred             CceecCCCCCC-CCcccccccCCcccccccccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----------
Q psy10603        150 SAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTN---KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-----------  214 (407)
Q Consensus       150 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-----------  214 (407)
                      +|+........ .......+||+.|||||++.+..   ...++.++|||||||++|||+||+.||....           
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876543221 12234568999999999986431   1124679999999999999999987664211           


Q ss_pred             --chHHHHHH-H-hCCCCCCCCCcc-----CHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        215 --SNYQIMFK-V-GMGETPTIPESL-----SDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       215 --~~~~~~~~-~-~~~~~~~~~~~~-----s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                        .....+.. + ..+..|.+|...     ++.+.+++.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              11222222 2 234456666543     3467899999999999999999998863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-53  Score=404.17  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=217.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||++..... +....+++.+|+++|+.++||||+++++++...+.+|+||||
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            4455699999999999999999999999999976543 445567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......    .
T Consensus        96 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~----~  169 (328)
T 3fe3_A           96 ASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGG----K  169 (328)
T ss_dssp             CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSC----G
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCC----c
Confidence            9999999998664 4599999999999999999999999999999999999998865 69999999997664332    2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      ....+||+.|+|||++.+.  ...+.++|||||||++|+|++|+.||.+.. .......+.. ....+|..+|+++.+++
T Consensus       170 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~p~~~s~~~~~li  245 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLR-GKYRIPFYMSTDCENLL  245 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTC--CCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-CCCCCCTTSCHHHHHHH
T ss_pred             cccccCCcceeCcccccCC--CcCCchhhhhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-CCCCCCCCCCHHHHHHH
Confidence            3567899999999998653  223579999999999999999999998543 3333333333 34456788999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+||+.||.+|||+.|+++|||+..
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcC
Confidence            9999999999999999999999863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-53  Score=402.38  Aligned_cols=256  Identities=30%  Similarity=0.449  Sum_probs=216.8

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.....||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|++++||||+++++++...+.+|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            35566779999999999999999999999999997543222223456789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        85 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~---  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG---  159 (337)
T ss_dssp             ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT---
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC---
Confidence            999999999998753 4599999999999999999999999999999999999998865 69999999997643221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+ .......+.. ....+|..+|+++++
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~s~~~~~  234 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILM-EEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS---SCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-CCCCCCTTSCHHHHH
T ss_pred             CcccccccChhhCChhhhcC---CCCCchhhcccchhHHHHHhcCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCHHHHH
Confidence            12356789999999999854   346889999999999999999999998543 3333333332 345578889999999


Q ss_pred             HHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +|.+||++||++||     ++.|+++||||.
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence            99999999999999     899999999984

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.2e-53  Score=409.68  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=216.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.+....+....+.+.+|..+|.++ +||||+++++++.+.+.+|+||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            345556999999999999999999999999999876555555556688899999876 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus       133 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~---  207 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG---  207 (396)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT---
T ss_pred             EcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCC---
Confidence            999999999998764 4599999999999999999999999999999999999999875 69999999997633221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------chHHHHHHHhCCCCCCCCCc
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-------SNYQIMFKVGMGETPTIPES  234 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~  234 (407)
                      ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||....       .....+........+.+|..
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~---~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             CccccccCCcccCCchhhcC---CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            22356799999999999865   346899999999999999999999996321       12233444444456677889


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCH------HHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATI------FELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~------~e~l~hp~~~  267 (407)
                      +|++++++|.+||++||.+||++      .|+++||||.
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence            99999999999999999999985      7999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=406.14  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=212.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+|..+ +||||+++++++.+.+.+|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            455666999999999999999999999999999764333333456678999999987 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||++|+|..+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus       104 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~---  178 (353)
T 3txo_A          104 EFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNG---  178 (353)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC-----
T ss_pred             eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCC---
Confidence            999999999999764 4599999999999999999999999999999999999998875 69999999997543221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... .......+.. ....+|..+++++++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~~~~  253 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILN-DEVVYPTWLHEDATG  253 (353)
T ss_dssp             -------CCGGGCCHHHHHH---HHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-CCCCCCTTSCHHHHH
T ss_pred             ccccccCCCcCeEChhhcCC---CCcCCccCCCcchHHHHHHHhCCCCCCCCC-HHHHHHHHHc-CCCCCCCCCCHHHHH
Confidence            12345789999999999865   346889999999999999999999998543 3344444333 345567889999999


Q ss_pred             HHHHhcccCCCCcCCH------HHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATI------FELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~------~e~l~hp~~~  267 (407)
                      ++.+||++||.+||++      .|+++||||.
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence            9999999999999998      8999999994

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-52  Score=398.18  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=218.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.+....+....+.+.+|+.+|.++ +||||+++++++.+.+.+|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            455666999999999999999999999999999876666666677888999999987 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        90 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~---  164 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG---  164 (345)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTT---
T ss_pred             eCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCC---
Confidence            999999999999764 4599999999999999999999999999999999999998865 69999999997643221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------chHHHHHHHhCCCCCCCCCc
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-------SNYQIMFKVGMGETPTIPES  234 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~  234 (407)
                      ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||....       .....+........+.+|..
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             CcccccCCCccccCccccCC---CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            12355789999999999864   346889999999999999999999996421       12222333333345667889


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCH------HHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATI------FELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~------~e~l~hp~~~  267 (407)
                      +|.++++++.+||++||.+||++      .|+++||||.
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence            99999999999999999999995      7999999984

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=404.47  Aligned_cols=259  Identities=29%  Similarity=0.455  Sum_probs=218.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++...........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            34455699999999999999999999999999975433233335678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|..+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......    
T Consensus        96 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~----  169 (384)
T 4fr4_A           96 LLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET----  169 (384)
T ss_dssp             CCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC----
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC----
Confidence            9999999999975 45599999999999999999999999999999999999998865 69999999998765332    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      .....+||+.|+|||++.......++.++|||||||++|||++|+.||..... ....+...........|..+++++.+
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~  249 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS  249 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence            23567899999999999654445578899999999999999999999974322 22222222233455667889999999


Q ss_pred             HHHHhcccCCCCcCC-HHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRAT-IFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t-~~e~l~hp~~~  267 (407)
                      +|.+||++||.+||+ +.++++||||.
T Consensus       250 li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          250 LLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             HHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             HHHHHhcCCHhHhcccHHHHHcChhhh
Confidence            999999999999998 89999999984

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.1e-52  Score=387.07  Aligned_cols=252  Identities=33%  Similarity=0.514  Sum_probs=213.3

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.||+|++........   +.+.+|+.++++++||||+++++++...+.+|+||||+
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            334489999999999999999999999999976544432   55788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++|+|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   ..
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~---~~  173 (297)
T 3fxz_A          100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS---KR  173 (297)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTC---CB
T ss_pred             CCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCccc---cc
Confidence            999999999753  489999999999999999999999999999999999998765 699999999987654322   23


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCCccCHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFA  243 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~~i  243 (407)
                      ...+||+.|+|||++.+   ..++.++|||||||++|||++|+.||............... ......+..+++++++++
T Consensus       174 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CCCCSCGGGCCHHHHHC---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             CCccCCcCccChhhhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            45689999999999864   34688999999999999999999999865433322222221 223344678999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+||+.||++|||+.|+++|||+..
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHccCChhHCcCHHHHhhChhhcc
Confidence            9999999999999999999999963

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.7e-52  Score=397.13  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=214.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +.....||+|+||+||+|++..+|+.||+|++........   ...+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            3445599999999999999999999999999986543211   1245688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC---eEEEEcccCceecCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAH  157 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~---~vkl~DFGla~~~~~~  157 (407)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.   .+||+|||+++.....
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~  172 (361)
T 2yab_A           94 LELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (361)
T ss_dssp             EECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred             EEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence            999999999999965 456999999999999999999999999999999999999987653   6999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPES  234 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  234 (407)
                      .    .....+||+.|+|||++..   ..++.++|||||||++|+|++|..||.+. +.......+..+...   ..+..
T Consensus       173 ~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          173 V----EFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             C----CCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             C----ccccCCCCccEECchHHcC---CCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCchhccC
Confidence            2    2345689999999999854   34689999999999999999999999854 333444444433322   22357


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +|+++++||.+||.+||.+|||+.|+++||||.
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            899999999999999999999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-52  Score=393.28  Aligned_cols=252  Identities=23%  Similarity=0.391  Sum_probs=215.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            45566799999999999999999999999999975432222234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....     
T Consensus        87 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~~-----  159 (318)
T 1fot_A           87 YIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDV-----  159 (318)
T ss_dssp             CCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSC-----
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCCc-----
Confidence            9999999999976 44599999999999999999999999999999999999998765 6999999999875432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       ....+||+.|+|||++..   ..++.++|||||||++|||++|+.||.... .......+.. ....+|..++++++++
T Consensus       160 -~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~~~~l  233 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILN-AELRFPPFFNEDVKDL  233 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred             -cccccCCccccCHhHhcC---CCCCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-CCCCCCCCCCHHHHHH
Confidence             235689999999999854   346889999999999999999999998543 3333333333 3455678899999999


Q ss_pred             HHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +.+||+.||++|+     ++.|+++||||.
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence            9999999999999     899999999995

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.7e-53  Score=399.99  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=215.6

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +++.....||+|+||+||+|++..+|+.||||++...........+.+.+|..+|..+ +||||+++++++.+.+.+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            3556667999999999999999999999999999754221122245677899999876 999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++|+|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......  
T Consensus        97 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~--  172 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD--  172 (345)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--
T ss_pred             EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC--
Confidence            9999999999999764 4599999999999999999999999999999999999998875 69999999997643221  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......+||+.|+|||++.+   ..++.++|+|||||++|||++|+.||...+ .......+.. ..+.+|..++++++
T Consensus       173 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~s~~~~  246 (345)
T 1xjd_A          173 -AKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRM-DNPFYPRWLEKEAK  246 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-CCCCCCTTSCHHHH
T ss_pred             -CcccCCCCCcccCChhhhcC---CCCCChhhhHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHh-CCCCCCcccCHHHH
Confidence             12356789999999999865   346899999999999999999999998543 3333333333 34567888999999


Q ss_pred             HHHHHhcccCCCCcCCHH-HHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRATIF-ELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~-e~l~hp~~~  267 (407)
                      +++.+||+.||++||++. |+++||||.
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~  274 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFR  274 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence            999999999999999998 999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4e-52  Score=396.79  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=216.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||+|++...........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            34555699999999999999999999999999975432222334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....     
T Consensus       122 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~-----  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR-----  194 (350)
T ss_dssp             CCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-----
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC-----
Confidence            99999999999764 4599999999999999999999999999999999999998865 6999999999876432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||... +..+....+..+ .+.+|..++++++++
T Consensus       195 -~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~~~~~~~l  268 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSG-KVRFPSHFSSDLKDL  268 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC-CCCCCTTCCHHHHHH
T ss_pred             -cccccCCccccCHHHhcC---CCCCCcCCEecccHhHhHHhhCCCCCCCC-CHHHHHHHHHcC-CCCCCCCCCHHHHHH
Confidence             245689999999999864   34688999999999999999999999854 333444444433 455678899999999


Q ss_pred             HHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      |.+||+.||.+||+     +.|+++||||.
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence            99999999999998     99999999984

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.3e-52  Score=396.77  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=215.5

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +++.....||+|+||+||+|++..+++.||||++.+.........+.+.+|..+|..+ +||||+++++++.+.+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            3556667999999999999999999999999999764322222346678899999987 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++|+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......  
T Consensus       100 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~--  175 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG--  175 (353)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC--
Confidence            9999999999999764 4599999999999999999999999999999999999998875 69999999997643221  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||... +.......+.. ..+.+|..+|++++
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~-~~~~~~~~i~~-~~~~~p~~~s~~~~  249 (353)
T 2i0e_A          176 -VTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIME-HNVAYPKSMSKEAV  249 (353)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTT---CCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH-CCCCCCTTSCHHHH
T ss_pred             -cccccccCCccccChhhhcC---CCcCCcccccchHHHHHHHHcCCCCCCCC-CHHHHHHHHHh-CCCCCCCCCCHHHH
Confidence             12356789999999999854   34688999999999999999999999854 33333333333 34567889999999


Q ss_pred             HHHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +++.+||++||.+||+     +.|+++||||.
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~  281 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  281 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence            9999999999999995     69999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-52  Score=397.70  Aligned_cols=255  Identities=29%  Similarity=0.412  Sum_probs=211.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|++......+....+.+.+|+.+|+.++||||+++++++...+..++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            34455699999999999999999999999999975432222223567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+ +|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......    
T Consensus        90 ~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~----  162 (336)
T 3h4j_B           90 YA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN----  162 (336)
T ss_dssp             CC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB----
T ss_pred             CC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc----
Confidence            99 67888888654 4599999999999999999999999999999999999998765 69999999997654332    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+||+.|+|||++.+..  ..++++|||||||++|+|++|+.||...... . ...........+|..+|++++++
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~-~~~~i~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKL--YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-N-LFKKVNSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSG--GGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-T-CBCCCCSSCCCCCTTSCHHHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCC--CCCCccchhHHHHHHHHHHhCCCCCCCccHH-H-HHHHHHcCCCCCcccCCHHHHHH
Confidence            234568999999999986432  2368999999999999999999999753221 1 11112223445678899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+||+.||.+|||+.|+++||||..
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhcc
Confidence            99999999999999999999999953

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-52  Score=410.83  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=214.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+|..++||||+++++++.+.+.+|+|||
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E  154 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD  154 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence            34555699999999999999999999999999975322111122347789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+........  
T Consensus       155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~--  231 (437)
T 4aw2_A          155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGTV--  231 (437)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSCE--
T ss_pred             cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccCCCc--
Confidence            9999999999977566799999999999999999999999999999999999998865 6999999999876543221  


Q ss_pred             cccccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----CCCCCCCCccC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GETPTIPESLS  236 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~s  236 (407)
                      .....+||+.|+|||++...  ....++.++|||||||++|||++|+.||.... ..+....+..    -..|..+..+|
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhhccccccCCcccccCC
Confidence            22346899999999998621  12346889999999999999999999998643 3333333321    22344445689


Q ss_pred             HHHHHHHHHhcccCCCC--cCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQ--RATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~--R~t~~e~l~hp~~~  267 (407)
                      +++++||.+||+.+|++  |+++.|+++||||.
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             HHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            99999999999988888  99999999999995

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.8e-51  Score=401.44  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=213.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++.+.+..|+|||||
T Consensus        14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   92 (444)
T 3soa_A           14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV   92 (444)
T ss_dssp             EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence            345589999999999999999999999999986543 3344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++|+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+  +..+||+|||+++......   .
T Consensus        93 ~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~---~  168 (444)
T 3soa_A           93 TGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ---Q  168 (444)
T ss_dssp             BCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC---C
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC---c
Confidence            99999999876 4559999999999999999999999999999999999999852  3579999999997765432   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~  239 (407)
                      .....+||+.|+|||++..   ..++.++|||||||++|+|++|..||.... .......+..+..   ......+|+++
T Consensus       169 ~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED-QHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             eeecccCCcccCCHHHhcC---CCCCCccccHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhCCCCCCccccccCCHHH
Confidence            2345789999999999854   346889999999999999999999998543 3344444433322   22235789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++|+.+||+.||++|||+.|+|+|||+..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            99999999999999999999999999853

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.9e-51  Score=390.77  Aligned_cols=252  Identities=31%  Similarity=0.549  Sum_probs=214.5

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||+||+|++..+++.||||++...........+.+.+|+++|++++||||+++++++...+..++||||+. 
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence            3489999999999999999999999999986655555566789999999999999999999999999999999999998 


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....       ..
T Consensus       138 g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~-------~~  209 (348)
T 1u5q_A          138 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-------NS  209 (348)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB-------CC
T ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCCC-------Cc
Confidence            578887765566799999999999999999999999999999999999998764 7999999999765422       34


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~~i~~  245 (407)
                      .+||+.|+|||++.......++.++|||||||++|||++|+.||...... .....+..+..+ ..+..+++++++++.+
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~  288 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSEYFRNFVDS  288 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            68999999999986433345688999999999999999999999865433 333333333333 3456789999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||+.||++|||+.|+++|||+..
T Consensus       289 ~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          289 CLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HcccChhhCcCHHHHhhChhhhc
Confidence            99999999999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.4e-51  Score=378.64  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=211.0

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ..+.....||+|+||+||+|++..+++.||+|++..... .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            445667799999999999999999999999999986543 3344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++ ++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......  
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCS--
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCccc--
Confidence            99986 55555555566799999999999999999999999999999999999998865 699999999987653322  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE------------  227 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~------------  227 (407)
                       ......||+.|+|||++.+.  ..++.++|||||||++|+|++|..||....+....+..+..  +.            
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cccCCccccCCcChHHHcCC--CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence             23456789999999998643  33688999999999999999998886544444333322210  00            


Q ss_pred             --------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 --------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 --------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                    .......+++++++|+.+||+.||++|||+.|+++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence                          0012235789999999999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-52  Score=406.60  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=212.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+|..++||||+++++++.+.+.+|+|||
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE  141 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME  141 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence            44556699999999999999999999999999975322222223457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........  
T Consensus       142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~~~~~--  218 (412)
T 2vd5_A          142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRADGTV--  218 (412)
T ss_dssp             CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSCE--
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccCCCcc--
Confidence            9999999999977555699999999999999999999999999999999999999865 6999999999876543221  


Q ss_pred             cccccccCCcccccccccccc----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----CCCCCCCCc
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTN----KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----GETPTIPES  234 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~----~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~  234 (407)
                      .....+||+.|+|||++....    ...++.++|||||||++|||++|+.||.... ..+...++..    -..|..+..
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHCCCC----C
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccCcCCCccccC
Confidence            123468999999999986311    2346889999999999999999999998643 3333333222    123444568


Q ss_pred             cCHHHHHHHHHhcccCCCCc---CCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQR---ATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R---~t~~e~l~hp~~~  267 (407)
                      +|+++++||.+||+ ||.+|   +++.|+++||||.
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            99999999999999 99998   5999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-52  Score=406.80  Aligned_cols=259  Identities=27%  Similarity=0.367  Sum_probs=211.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+|..++||||+++++++.+.+.+|+|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            34555699999999999999999999999999975321111112346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||++|+|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........  
T Consensus       150 ~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~~--  224 (410)
T 3v8s_A          150 YMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMV--  224 (410)
T ss_dssp             CCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSEE--
T ss_pred             CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCCcc--
Confidence            9999999999965  3499999999999999999999999999999999999998875 6999999999876543211  


Q ss_pred             cccccccCCcccccccccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC-CCCC--CCccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKV-GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTI--PESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~-~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~~s~~  238 (407)
                      ...+.+||+.|+|||++...... .++.++|||||||++|||++|+.||.... ......++..+. ...+  +..+|++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-hhhHHHHHHhccccccCCCcccccHH
Confidence            12457899999999998653211 15789999999999999999999998543 333333333221 1122  3478999


Q ss_pred             HHHHHHHhcccCCCC--cCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQ--RATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~--R~t~~e~l~hp~~~  267 (407)
                      +++||.+||+.+|.+  |+++.|+++||||.
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            999999999999988  99999999999995

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-51  Score=384.17  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCc-----------------------HHHHHHHHHHHHHHhcC
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND-----------------------ARFVKDMLVELRILEGI   59 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~~E~~~l~~l   59 (407)
                      .+.....||+|+||+||+|++..+++.||||++.......                       ....+.+.+|+++|+++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            3455669999999999999999999999999997543211                       11235688999999999


Q ss_pred             CCCCcceEEEEEEe--CceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe
Q psy10603         60 NQKNLVKYYGVEIH--REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT  137 (407)
Q Consensus        60 ~hpniv~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~  137 (407)
                      +||||+++++++..  .+.+|+||||+++++|.+++.  ...+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  171 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG  171 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence            99999999999886  568999999999999988653  34599999999999999999999999999999999999998


Q ss_pred             cCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH
Q psy10603        138 AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY  217 (407)
Q Consensus       138 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~  217 (407)
                      .++ .+||+|||+++.......   ......||+.|+|||++.......++.++|||||||++|+|++|+.||.... ..
T Consensus       172 ~~~-~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~  246 (298)
T 2zv2_A          172 EDG-HIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IM  246 (298)
T ss_dssp             TTS-CEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-HH
T ss_pred             CCC-CEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-HH
Confidence            765 699999999987654321   2244689999999999865432224678999999999999999999998543 22


Q ss_pred             HHHHHHhCCC-CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        218 QIMFKVGMGE-TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       218 ~~~~~~~~~~-~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .....+.... ....+..+++++++++.+||+.||++|||+.|+++||||.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            2222222222 2222357899999999999999999999999999999973

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5e-51  Score=391.20  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=213.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+|++++||||+++++++.+.+..|+||||+
T Consensus        32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~  110 (362)
T 2bdw_A           32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV  110 (362)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            344589999999999999999999999999986543 3445577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccCceecCCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++  ..+||+|||++.......    
T Consensus       111 ~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~----  185 (362)
T 2bdw_A          111 TGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----  185 (362)
T ss_dssp             CSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC----
T ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc----
Confidence            99999998865 44589999999999999999999999999999999999998643  369999999997765322    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~  239 (407)
                      .....+||+.|+|||++..   ..++.++|||||||++|+|++|..||...+ .......+..+...   .....+++++
T Consensus       186 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED-QHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             ccccCCCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            2345689999999999854   346889999999999999999999998543 33333333333221   1224689999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++.+||++||++|||+.|+++|||+.
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence            9999999999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-51  Score=388.01  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=214.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|.+....    .....+.+|+.+|+.++||||+++++++.+.+.+++|||
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            3455669999999999999999999999999986432    233567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-CCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-GNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.+ +..+||+|||+++......   
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence            999999999997655569999999999999999999999999999999999999863 3579999999998765432   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC---CCCccCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT---IPESLSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~s~~  238 (407)
                       ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.... ..+....+..+....   .+..+|++
T Consensus       159 -~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~  233 (321)
T 1tki_A          159 -NFRLLFTAPEYYAPEVHQH---DVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIE  233 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHTT---CEECHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             -ccccccCChhhcCcHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHcCCCCCChhhhccCCHH
Confidence             2245679999999999854   235789999999999999999999998643 334444443333222   12468999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +++++.+||..||.+|||+.|+++|||+..
T Consensus       234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          234 AMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            999999999999999999999999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.4e-51  Score=386.51  Aligned_cols=259  Identities=29%  Similarity=0.442  Sum_probs=212.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            445566999999999999999999999999999754322  233567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++. ...+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+..... ..
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~-~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNR-ER  162 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTE-EC
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCc-cc
Confidence            9999999999864 44599999999999999999999999999999999999998765 699999999986543221 12


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~  241 (407)
                      .....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||............... .........+++++.+
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             ccCCCccCcCccCcHHhccC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence            23456899999999998643  22467899999999999999999999865544333332222 2222334678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++.+||+.||++|||+.|+++|||+..
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhcc
Confidence            999999999999999999999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-51  Score=394.49  Aligned_cols=255  Identities=26%  Similarity=0.375  Sum_probs=206.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHH-HhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-LEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|++..+++.||||++.+.........+.+.+|..+ ++.++||||+++++++.+.+.+|+||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            45566799999999999999999999999999987654444455667788877 57799999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus       119 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~---  193 (373)
T 2r5t_A          119 DYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN---  193 (373)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCCC---
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccCC---
Confidence            999999999999763 4599999999999999999999999999999999999998875 69999999997643221   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|+|||++.+   ..++.++|+|||||++|||++|..||.... ..+....+.. ....++..+++++++
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~-~~~~~~~~~~~~~~~  268 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILN-KPLQLKPNITNSARH  268 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHHHHHH-SCCCCCSSSCHHHHH
T ss_pred             CccccccCCccccCHHHhCC---CCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh-cccCCCCCCCHHHHH
Confidence            12356789999999999864   347899999999999999999999998543 3333333333 344567889999999


Q ss_pred             HHHHhcccCCCCcCCH----HHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATI----FELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~----~e~l~hp~~~  267 (407)
                      ++.+||++||.+||++    .|+++||||.
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~  298 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFS  298 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence            9999999999999986    6899999984

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-51  Score=411.05  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=215.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|++++||||+++++++.+.+.+|+||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            44455999999999999999999999999999754322222345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......    
T Consensus       266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~~~~----  340 (576)
T 2acx_A          266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ----  340 (576)
T ss_dssp             CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCTTC----
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecccCc----
Confidence            99999999986543 3499999999999999999999999999999999999998865 69999999998765432    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....  ....+........+.+|..+|++++
T Consensus       341 ~~~~~~GT~~Y~APEvl~~---~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~  417 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKN---ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR  417 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTT---CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cccccCCCccccCHHHHcC---CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence            2245689999999999864   3468899999999999999999999986432  2223333333345566788999999


Q ss_pred             HHHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++|.+||++||.+||     ++.|+++||||.
T Consensus       418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             HHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence            999999999999999     789999999995

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-51  Score=384.57  Aligned_cols=254  Identities=27%  Similarity=0.395  Sum_probs=211.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .....||+|+||+||+|++..+|+.||+|++........   ...+.+.+|+.+|++++||||+++++++...+..++||
T Consensus        14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   93 (326)
T 2y0a_A           14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL   93 (326)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            344589999999999999999999999999976533211   12466889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC---eEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~---~vkl~DFGla~~~~~~~  158 (407)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.   .+||+|||+++......
T Consensus        94 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~  172 (326)
T 2y0a_A           94 ELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  172 (326)
T ss_dssp             ECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred             EcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence            99999999999965 455999999999999999999999999999999999999987642   69999999998765332


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCcc
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESL  235 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (407)
                          .....+||+.|+|||++..   ..++.++|||||||++|+|++|..||.... .......+......   ..+..+
T Consensus       173 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          173 ----EFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             ----CCCCCCSCTTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             ----ccccccCCcCcCCceeecC---CCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHhcCCCcCccccccC
Confidence                2345689999999999854   346889999999999999999999997543 33333333222211   123568


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++++|+.+||+.||++|||+.|+++||||.
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence            99999999999999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.4e-51  Score=390.99  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=210.0

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||+||+|++..+|+.||||++......  .....+.+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus        27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  106 (351)
T 3c0i_A           27 ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE  106 (351)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            3445899999999999999999999999999753211  11123568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccCceecCCC
Q psy10603         83 LCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAH  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~  157 (407)
                      ||++|+|.+.+...   ...+++..+..++.||+.||.|||++||+||||||+|||++.++  ..+||+|||+++.....
T Consensus       107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~  186 (351)
T 3c0i_A          107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES  186 (351)
T ss_dssp             CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC
Confidence            99999998877542   23489999999999999999999999999999999999998653  34999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC---CCc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI---PES  234 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~  234 (407)
                      ..   .....+||+.|+|||++..   ..++.++|||||||++|+|++|+.||...  .......+..+.....   +..
T Consensus       187 ~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          187 GL---VAGGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             SC---BCCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             Ce---eecCCcCCcCccCHHHHcC---CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCcccccc
Confidence            22   1245689999999999854   34688999999999999999999999753  3333333333332222   256


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++++++.+||++||++|||+.|+++|||+.
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence            899999999999999999999999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-50  Score=380.87  Aligned_cols=255  Identities=28%  Similarity=0.506  Sum_probs=204.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++. +|+.||+|++.... .+....+.+.+|+++|++++||||+++++++.+.+.+++||||
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            344559999999999999985 58999999997543 2333456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++ +|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......   .
T Consensus       101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~---~  175 (311)
T 3niz_A          101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPVR---S  175 (311)
T ss_dssp             CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCCC----
T ss_pred             CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCcc---c
Confidence            985 88888776666799999999999999999999999999999999999998865 699999999987643221   2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCCC-----------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPT-----------  230 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~~-----------  230 (407)
                      ....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.........  +........+.           
T Consensus       176 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccCCcccCCcCCHHHhcCC--CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            3445789999999998542  34688999999999999999999999865443222  11111111110           


Q ss_pred             ---------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        231 ---------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       231 ---------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                     +...+++++.+|+.+||++||++|||+.|+++||||.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                           1234788999999999999999999999999999984

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.3e-51  Score=407.20  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=214.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+.+.+|+||||+
T Consensus       188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            34458999999999999999999999999997543322233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      +||+|..++...   ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+.....  
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~~~~~~~--  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQT--  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCTTCC--
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeeeccCCCc--
Confidence            999999998653   23599999999999999999999999999999999999999865 699999999987654322  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                       .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....  ....+........+.+|..+|+++
T Consensus       345 -~~~~~~GT~~Y~APE~l~~---~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~  420 (543)
T 3c4z_A          345 -KTKGYAGTPGFMAPELLLG---EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS  420 (543)
T ss_dssp             -CBCCCCSCTTTSCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             -ccccccCCccccChhhhcC---CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence             1244689999999999864   3468999999999999999999999975432  122222222334556678899999


Q ss_pred             HHHHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      +++|.+||++||++||+     +.++++||||.
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~  453 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR  453 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence            99999999999999996     48999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.3e-51  Score=404.60  Aligned_cols=254  Identities=30%  Similarity=0.443  Sum_probs=205.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+|+.||||++.............+.+|+.+|+.++||||+++++++...+.+|+||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            34455999999999999999999999999999865333444456778999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++|+|.+++... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++......   .
T Consensus       230 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~---~  304 (446)
T 4ejn_A          230 ANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG---A  304 (446)
T ss_dssp             CSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC------
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCCC---c
Confidence            9999999998664 459999999999999999999998 9999999999999998865 69999999997543221   1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.... .......+.. ....+|..++++++++
T Consensus       305 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~~~~l  379 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELILM-EEIRFPRTLGPEAKSL  379 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHT---SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-CCCCCCTTSCHHHHHH
T ss_pred             ccccccCCccccCHhhcCC---CCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHHHHHh-CCCCCCccCCHHHHHH
Confidence            2355789999999999854   346899999999999999999999998543 3333333332 3445678899999999


Q ss_pred             HHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      |.+||++||.+||     ++.|+++||||.
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence            9999999999999     999999999995

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-51  Score=404.23  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=216.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|+.++||||+++++++...+.+|+||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~   97 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY   97 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            44556999999999999999999999999999754322222346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......    .
T Consensus        98 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~----~  171 (476)
T 2y94_A           98 VSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE----F  171 (476)
T ss_dssp             CSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC----C
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc----c
Confidence            999999999965 45599999999999999999999999999999999999998765 69999999998765432    2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      ....+||+.|+|||++.+.  ...+.++|||||||++|+|++|+.||.... .......+..+ ....|..+++++++++
T Consensus       172 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~-~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGR--LYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDG-IFYTPQYLNPSVISLL  247 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-SHHHHHHHHTT-CCCCCTTCCHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCC--CCCCCcceehhhHHHHHHHhhCCCCCCCCC-HHHHHHHHhcC-CcCCCccCCHHHHHHH
Confidence            3456899999999998653  224689999999999999999999998543 33334444433 3456778999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+||+.||.+|||+.|+++||||..
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhh
Confidence            9999999999999999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-50  Score=387.32  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=212.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|.+..+|+.||+|++....   ......+.+|+.+|++++||||+++++++.+.+.+++||||++
T Consensus        55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            3448999999999999999999999999987542   2234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-CCeEEEEcccCceecCCCCCCCCcc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      +|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+++......    ..
T Consensus       132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~  207 (387)
T 1kob_A          132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IV  207 (387)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CE
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc----ce
Confidence            999999997655569999999999999999999999999999999999999753 3469999999998765432    12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC---CCCCCCccCHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQA  241 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~~  241 (407)
                      ...+||+.|+|||++..   ..++.++|||||||++|||++|..||.... .......+....   .+..+..+++++++
T Consensus       208 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDR---EPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWEFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             EEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             eeeccCCCccCchhccC---CCCCCcccEeeHhHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence            34579999999999854   346889999999999999999999998643 333333333222   23344678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||.+||+.||.+|||+.|+++|||+..
T Consensus       284 li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVHDALEHPWLKG  310 (387)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             HHHHHcCCChhHCcCHHHHhhCccccC
Confidence            999999999999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.6e-51  Score=378.27  Aligned_cols=257  Identities=30%  Similarity=0.519  Sum_probs=206.1

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ..+.....||+|+||+||+|++ .+|+.||+|++..... +....+.+.+|+++|++++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            3456677999999999999998 6789999999975432 2223356789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++ +|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~---  154 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPV---  154 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC-----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCccc---
Confidence            99986 99998877667799999999999999999999999999999999999998765 69999999997654321   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH---hCCCC----------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV---GMGET----------  228 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~---~~~~~----------  228 (407)
                      .......||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.............   .....          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             -------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccCchheeCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence            122345789999999998542  346889999999999999999999998654332222111   11000          


Q ss_pred             ---C-----------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        229 ---P-----------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       229 ---~-----------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                         +           .....+++++.+++.+||+.||++|||+.|+++||||.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  285 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence               0           11245789999999999999999999999999999984

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-50  Score=389.70  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=210.8

Q ss_pred             cceeeecccc--cCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          4 VTFSVSPGQG--RFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         4 ~~~~~~iG~G--~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +.....||+|  +||+||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            4455599999  999999999999999999999986543 3455677889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~~~~~~~  184 (389)
T 3gni_B          106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMISHGQR  184 (389)
T ss_dssp             ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEECEETTEE
T ss_pred             EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceeecccccc
Confidence            999999999998764 25599999999999999999999999999999999999998765 6999999998765322111


Q ss_pred             ----CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC---------
Q psy10603        161 ----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---------  227 (407)
Q Consensus       161 ----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~---------  227 (407)
                          .......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+........... .+.         
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~  262 (389)
T 3gni_B          185 QRVVHDFPKYSVKVLPWLSPEVLQQN-LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLDTST  262 (389)
T ss_dssp             CSCBCCCCTTCTTTGGGSCHHHHSTT-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             ccccccccccccccccccCHHHHhcc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCccccccc
Confidence                1112345789999999998652 1346889999999999999999999998644332222111 110         


Q ss_pred             ------------------------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 ------------------------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 ------------------------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                                          ....+..+++++++|+.+||+.||++|||+.|+++||||.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                0113456889999999999999999999999999999995

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.4e-50  Score=376.69  Aligned_cols=249  Identities=34%  Similarity=0.516  Sum_probs=211.6

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||.||+|++..+|+.||||++.......   .+.+.+|+.+|++++||||+++++++...+..++||||+++
T Consensus        50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            348999999999999999999999999997654332   35678999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   ....
T Consensus       127 ~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~---~~~~  200 (321)
T 2c30_A          127 GALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVP---KRKS  200 (321)
T ss_dssp             CBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSC---CBCC
T ss_pred             CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCcc---cccc
Confidence            999999854  4599999999999999999999999999999999999998765 699999999987654322   2245


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC--CCccCHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAE  244 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~~i~  244 (407)
                      ..||+.|+|||++..   ..++.++|||||||++|||++|+.||.... ..+....+.....+.+  +..+++++++++.
T Consensus       201 ~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          201 LVGTPYWMAPEVISR---SLYATEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             CCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCHhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            689999999999854   346789999999999999999999998543 3344444443333332  3468999999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeeee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +||+.||++|||+.|+++|||+..
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             HHccCChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999963

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=388.49  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=205.0

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      ..||+|+||.||+|++..+|+.||+|++....   ....+.+.+|+++|++++||||+++++++...+.+++||||++++
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            47999999999999999999999999997542   234467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec-CCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA-EGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~-~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. ++..+||+|||+++.......    ...
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----~~~  247 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----LKV  247 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB----CCC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc----ccc
Confidence            999988765556999999999999999999999999999999999999953 345799999999987654322    234


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEGQAFA  243 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~~~i  243 (407)
                      .+||+.|+|||++..   ..++.++|||||||++|||++|+.||..... ...+..+.....   +.....+++++++|+
T Consensus       248 ~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CCSSCTTCCHHHHTT---CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccCCCcEeChhhccC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            579999999999854   3468899999999999999999999986443 333333332221   122356899999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+||++||.+|||+.|+++||||.
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcC
Confidence            999999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.4e-50  Score=386.45  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=198.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+++.||+|++.......    +.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            445559999999999999999999999999997644333    4567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC-eEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN-SLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~-~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. .+||+|||+++......    
T Consensus        98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~----  172 (361)
T 3uc3_A           98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----  172 (361)
T ss_dssp             CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC----
Confidence            9999999998653 45999999999999999999999999999999999999986532 49999999997543221    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc---hHHHHHHHhCCC-CCCCCCccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS---NYQIMFKVGMGE-TPTIPESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~---~~~~~~~~~~~~-~~~~~~~~s~~  238 (407)
                      .....+||+.|+|||++.+..  ..+.++|||||||++|+|++|+.||.....   .......+.... ....+..++++
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             --------CTTSCHHHHHCSS--CCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             CCCCCcCCCCcCChhhhcCCC--CCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence            224467999999999986532  224459999999999999999999975432   122222222221 22223368999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +++|+.+||++||++|||+.|+++||||..
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            999999999999999999999999999953

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-50  Score=380.86  Aligned_cols=255  Identities=30%  Similarity=0.515  Sum_probs=198.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||+|++......  ...+.+.+|+.+|++++||||+++++++..++.+++||||
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             ------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            44455999999999999999999999999999754322  2235677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         84 CTEGTLESLVQSTE-----DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ++ |+|.+++....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEETTSCC
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceecCCCc
Confidence            98 59998886432     3589999999999999999999999999999999999998865 69999999998764322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCC---------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGET---------  228 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~---------  228 (407)
                      .   .....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.............. .+..         
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          163 N---TFSSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             C---CCCCCCSCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             c---cCCCCcccccccCchHhhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            1   22445789999999998542  3468899999999999999999999986543322211100 0000         


Q ss_pred             ----------------------CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        229 ----------------------PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       229 ----------------------~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                            +..+..+++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence                                  011235789999999999999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-50  Score=383.79  Aligned_cols=249  Identities=27%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEec
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .....||+|+||+||+|++..+|+.||||++......       ..+|+++|.++ +||||+++++++.+.+.+|+||||
T Consensus        25 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            3445899999999999999999999999999765332       24578888777 799999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC---eEEEEcccCceecCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~---~vkl~DFGla~~~~~~~~~  160 (407)
                      |++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+.++++   .+||+|||+++....... 
T Consensus        98 ~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~-  175 (342)
T 2qr7_A           98 MKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-  175 (342)
T ss_dssp             CCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC-
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC-
Confidence            999999999865 455999999999999999999999999999999999999865432   499999999987654321 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC--CchHHHHHHHhCCCCC---CCCCcc
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY--DSNYQIMFKVGMGETP---TIPESL  235 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~--~~~~~~~~~~~~~~~~---~~~~~~  235 (407)
                        .....+||+.|+|||++.+.   .++.++|||||||++|||++|..||...  ....+....+..+..+   ..+..+
T Consensus       176 --~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          176 --LLMTPCYTANFVAPEVLERQ---GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             --CBCCSSCCSSCCCHHHHHHH---HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             --ceeccCCCccccCHHHhcCC---CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence              23456899999999998642   3578999999999999999999999753  2333444444444332   234678


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+++++++.+||..||++|||+.|+++|||+.
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            99999999999999999999999999999995

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.8e-50  Score=380.55  Aligned_cols=248  Identities=27%  Similarity=0.383  Sum_probs=190.7

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..||+|+||+||+|++..+++.||||++...      ....+.+|+.+|+.++ ||||+++++++.+.+..|+||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            3699999999999999999999999998643      1245678999999997 99999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC--eEEEEcccCceecCCCCCCCCcc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~--~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.  .+||+|||+++......   ...
T Consensus        91 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~  166 (325)
T 3kn6_A           91 GELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPL  166 (325)
T ss_dssp             CBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC---Ccc
Confidence            999999976 456999999999999999999999999999999999999986542  69999999998654322   123


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc------hHHHHHHHhCCCCCCCC---Ccc
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS------NYQIMFKVGMGETPTIP---ESL  235 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~------~~~~~~~~~~~~~~~~~---~~~  235 (407)
                      ...+||+.|+|||++..   ..++.++|||||||++|+|++|+.||.....      ..+....+..+..+..+   ..+
T Consensus       167 ~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV  243 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred             cccCCCcCccCHHHhcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence            45678999999999854   3468899999999999999999999975332      23344444444332211   358


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      |+++++++.+||+.||.+|||+.|+++|||+..
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            999999999999999999999999999999963

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-50  Score=414.41  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=216.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      ++.....||+|+||+||+|++..+++.||||++.+.........+.+.+|..+|..+ +||||+++++++.+.+.+||||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            456667999999999999999999999999999754322222345678899999987 6899999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus       422 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~---  496 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG---  496 (674)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCTT---
T ss_pred             eCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccCC---
Confidence            999999999999764 4599999999999999999999999999999999999999875 69999999998643222   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|+|||++..   ..++.++|||||||++|||++|+.||.+. +..+....+. ...+.+|..+|+++++
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~---~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~-~~~~~~p~~~s~~~~~  571 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIM-EHNVAYPKSMSKEAVA  571 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTC---CCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHH-SSCCCCCTTSCHHHHH
T ss_pred             cccccccCCCcccCHhhhcC---CCCCccceEechHHHHHHHHcCCCCCCCC-CHHHHHHHHH-hCCCCCCccCCHHHHH
Confidence            12356789999999999854   34689999999999999999999999864 3334444443 3456678899999999


Q ss_pred             HHHHhcccCCCCcCCH-----HHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATI-----FELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~-----~e~l~hp~~~  267 (407)
                      ||.+||++||++|+++     .|+++||||.
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~  602 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  602 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence            9999999999999997     9999999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-50  Score=380.43  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=202.7

Q ss_pred             cceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|++.   .+++.||+|++...... +......+.+|+.+|++++||||+++++++...+.+|+
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            445569999999999999985   68999999999754321 22334567889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        99 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~  176 (327)
T 3a62_A           99 ILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGT  176 (327)
T ss_dssp             EEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC--------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccccccCCc
Confidence            99999999999999753 4589999999999999999999999999999999999998765 699999999976432221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                         .....+||+.|+|||++..   ..++.++|||||||++|+|++|+.||.... .......+.. ....+|..+++++
T Consensus       177 ---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~-~~~~~p~~~~~~~  248 (327)
T 3a62_A          177 ---VTHTFCGTIEYMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKILK-CKLNLPPYLTQEA  248 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHH-TCCCCCTTSCHHH
T ss_pred             ---cccccCCCcCccCHhhCcC---CCCCCcccchhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHh-CCCCCCCCCCHHH
Confidence               2245689999999999854   346889999999999999999999998543 3333333332 3445678899999


Q ss_pred             HHHHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++++.+||+.||++||     ++.|+++||||.
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence            9999999999999999     889999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-50  Score=388.74  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=198.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCc--eEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHRE--EMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~~~lv   80 (407)
                      +.....||+|+||+||+|.+..+|+.||||++.... ......+++.+|+.+|.+++ ||||+++++++...+  .+|+|
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            445569999999999999999999999999986442 34455677889999999997 999999999997654  69999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC-
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT-  159 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~-  159 (407)
                      ||||+ ++|..+++.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+..... 
T Consensus        90 ~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           90 FDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCC
T ss_pred             ecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccccccccccc
Confidence            99998 589988865  3589999999999999999999999999999999999998865 699999999987643111 


Q ss_pred             -----------------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Q psy10603        160 -----------------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK  222 (407)
Q Consensus       160 -----------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~  222 (407)
                                       ........+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+...+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCC--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                             01123456899999999998642  34789999999999999999999999865433222111


Q ss_pred             HhCCCCCC---------------------------------------------CCCccCHHHHHHHHHhcccCCCCcCCH
Q psy10603        223 VGMGETPT---------------------------------------------IPESLSDEGQAFAELCLRHDPAQRATI  257 (407)
Q Consensus       223 ~~~~~~~~---------------------------------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~  257 (407)
                      ......|.                                             .+..+++++.+|+.+||+.||++|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            11000110                                             122678999999999999999999999


Q ss_pred             HHHhcCCeee
Q psy10603        258 FELLQHPFLI  267 (407)
Q Consensus       258 ~e~l~hp~~~  267 (407)
                      .|+++|||+.
T Consensus       324 ~e~l~Hp~~~  333 (388)
T 3oz6_A          324 NDALKHPFVS  333 (388)
T ss_dssp             HHHTTSTTTT
T ss_pred             HHHhCCHHHH
Confidence            9999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.9e-51  Score=381.30  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=207.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc----eEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE----EMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l   79 (407)
                      +.....||+|+||+||+|++..+++.||+|++......+....+.+.+|+.++.+++||||+++++++....    ..|+
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            445569999999999999999999999999998766666677788999999999999999999999987654    3599


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++++|.++++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        94 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~  171 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGN  171 (311)
T ss_dssp             EEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC--------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCccccccccc
Confidence            99999999999999764 4599999999999999999999999999999999999998865 699999999987654322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--CCCccCH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSD  237 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~  237 (407)
                      ........+||+.|+|||++.+   ..++.++|||||||++|||++|+.||..................+.  .+..+++
T Consensus       172 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (311)
T 3ork_A          172 SVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA  248 (311)
T ss_dssp             ----------CCTTCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred             ccccccccCcCcccCCHHHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence            2222345679999999999854   3468899999999999999999999986543332222222222221  2356899


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++.+++.+||+.||++||++.+++.|+|+..
T Consensus       249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          249 DLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            9999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-50  Score=395.24  Aligned_cols=257  Identities=30%  Similarity=0.440  Sum_probs=201.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-----DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      .....||+|+||+||+|.+..+++.||||++......     .......+.+|+.+|++++||||+++++++. .+..|+
T Consensus       138 ~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~l  216 (419)
T 3i6u_A          138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYI  216 (419)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEE
T ss_pred             EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEE
Confidence            3445899999999999999999999999999764321     1122335789999999999999999999874 556899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccCceecCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAH  157 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~  157 (407)
                      ||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++  ..+||+|||+++.....
T Consensus       217 v~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  295 (419)
T 3i6u_A          217 VLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  295 (419)
T ss_dssp             EEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--
T ss_pred             EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC
Confidence            9999999999998864 45599999999999999999999999999999999999997543  35999999999776432


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC---CCc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI---PES  234 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~  234 (407)
                      .    .....+||+.|+|||++.......++.++|||||||++|+|++|+.||............+..+..+..   +..
T Consensus       296 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          296 S----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             -------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             c----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            2    234568999999999986433445678999999999999999999999865443333333333333322   356


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++.+++.+||+.||++|||+.|+++||||.
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence            899999999999999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=373.89  Aligned_cols=247  Identities=29%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ....||+|+||+||+|++..+|+.||||++....... .......+|+..+.+ .+||||+++++++.+.+.+|+||||+
T Consensus        61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~  139 (311)
T 3p1a_A           61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC  139 (311)
T ss_dssp             EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence            3348999999999999999999999999986543333 334455566666555 49999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                       +++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+++......    ..
T Consensus       140 -~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~----~~  213 (311)
T 3p1a_A          140 -GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAG----AG  213 (311)
T ss_dssp             -CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC---------
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCC----CC
Confidence             6689888877666799999999999999999999999999999999999998865 69999999998764332    12


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC-CCCCCCccCHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAFA  243 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~~i  243 (407)
                      ....||+.|+|||++.+    .++.++|||||||++|||++|..|+.... .   ......+. .+.++..+++++.+++
T Consensus       214 ~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~el~~g~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMELPHGGE-G---WQQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT----CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-H---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             cccCCCccccCHhHhcC----CCCchhhHHHHHHHHHHHHhCCCCCCCcc-H---HHHHhccCCCcccccCCCHHHHHHH
Confidence            34579999999999853    36889999999999999999977765322 1   11222222 2334567899999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+||+.||++|||+.|+++||||.
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          286 VMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             HHHcCCChhhCcCHHHHHhCcccc
Confidence            999999999999999999999984

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.3e-50  Score=381.82  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=197.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.||||++....     ..+.+.+|+.+|++++||||+++++++...+..++||||+
T Consensus        56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            34458999999999999999999999999987532     1245778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec--CCCeEEEEcccCceecCCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~--~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.  ++..+||+|||+++......    
T Consensus       131 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~----  205 (349)
T 2w4o_A          131 TGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----  205 (349)
T ss_dssp             CSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc----
Confidence            99999999865 445899999999999999999999999999999999999974  23579999999997654322    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~  239 (407)
                      .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||............+......   .....++.++
T Consensus       206 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             -------CGGGSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             ccccccCCCCccCHHHhcC---CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            1244679999999999864   346889999999999999999999998655554444444433322   2345789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++++.+||+.||++|||+.|+++|||+..
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4e-50  Score=399.92  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=214.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|++++||||+++++++...+.+|+|||||.
T Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  109 (484)
T 3nyv_A           30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT  109 (484)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            34489999999999999999999999999976544333345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec--CCCeEEEEcccCceecCCCCCCCCc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~--~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.  .+..+||+|||+++......    .
T Consensus       110 ~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~  184 (484)
T 3nyv_A          110 GGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----K  184 (484)
T ss_dssp             SCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----S
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----c
Confidence            9999998865 455999999999999999999999999999999999999952  23579999999997764332    2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CC--CCccCHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TI--PESLSDEGQ  240 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~--~~~~s~~~~  240 (407)
                      ....+||+.|+|||++.+    .++.++|||||||++|+|++|..||.... .......+..+... ..  +..+|++++
T Consensus       185 ~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             cccCCCCccccCceeecC----CCCCcceeHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence            345679999999999853    36889999999999999999999998643 44444444443322 22  356899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      +|+.+||++||.+|||+.|+++|||+...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.8e-50  Score=371.31  Aligned_cols=254  Identities=26%  Similarity=0.476  Sum_probs=210.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+++.||+|++......+......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            34455699999999999999999999999999975433333334668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......     
T Consensus        90 ~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~-----  162 (279)
T 3fdn_A           90 YAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS-----  162 (279)
T ss_dssp             CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC--------
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCcc-----
Confidence            99999999998764 4499999999999999999999999999999999999998765 6999999998554322     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||.... .......+. ......|..++++++++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEG---RMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRIS-RVEFTFPDFVTEGARDL  237 (279)
T ss_dssp             -----CCCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHH-HTCCCCCTTSCHHHHHH
T ss_pred             cccccCCCCCccCHhHhcc---CCCCccchhHhHHHHHHHHHHCCCCCCCCc-HHHHHHHHH-hCCCCCCCcCCHHHHHH
Confidence            1234578999999999854   345789999999999999999999998543 223322222 23445678899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+||+.||++|||+.|+++|||+..
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHhccChhhCCCHHHHhhCccccC
Confidence            99999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4e-50  Score=380.18  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=199.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+|++++||||+++++++...+.+++||||
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            344559999999999999999999999999997543 2333456678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC----CCeEEEEcccCceecCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE----GNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~----~~~vkl~DFGla~~~~~~~~  159 (407)
                      +++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+    ...+||+|||+++.......
T Consensus       115 ~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~  192 (329)
T 3gbz_A          115 AEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR  192 (329)
T ss_dssp             CSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred             CCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence            985 999998764 459999999999999999999999999999999999999633    23599999999977643221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCC--CC------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGET--PT------  230 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~--~~------  230 (407)
                         .....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.............. .+..  ..      
T Consensus       193 ---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          193 ---QFTHEIITLWYRPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             ----------CCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ---ccCCCcCCccccCHHHhcCC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence               23445789999999998643  3468899999999999999999999986543322221111 0100  00      


Q ss_pred             -------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        231 -------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       231 -------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                         ++..+++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence                               0112789999999999999999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=371.08  Aligned_cols=257  Identities=26%  Similarity=0.466  Sum_probs=195.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++..+|+.||+|++......+....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            34555699999999999999999999999999975432222334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~---  167 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHE---  167 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC-------
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCCC---
Confidence            9999999999987656799999999999999999999999999999999999998765 699999999987643221   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ......||+.|+|||++..   ..++.++|||||||++|+|++|+.||...... ....... ......|..++.+++++
T Consensus       168 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~l  242 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATR---SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVV-LADYEMPSFLSIEAKDL  242 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC-SSCCCCCTTSCHHHHHH
T ss_pred             cceeccCCCCcCCcchhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHh-hcccCCccccCHHHHHH
Confidence            1234578999999999854   34578999999999999999999999854332 2222222 22334577899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+||+.||++|||+.|+++|||+..
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccC
Confidence            99999999999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-50  Score=380.36  Aligned_cols=259  Identities=23%  Similarity=0.402  Sum_probs=203.0

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +.+.....||+|+||+||+|++..+++.||+|++.....  ......+.+|+.+|++++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            345566799999999999999999999999999864422  112224567999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||++ |+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~---  154 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT---  154 (324)
T ss_dssp             ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC-------
T ss_pred             cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCc---
Confidence            9998 589888877666799999999999999999999999999999999999998865 69999999997654322   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--HHHhCCC-CCC--------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--FKVGMGE-TPT--------  230 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--~~~~~~~-~~~--------  230 (407)
                      ......+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||..........  ....... ...        
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             --------CGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             cccccccCcccccChhhhcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence            122445789999999998542  346889999999999999999999998654332221  1111111 000        


Q ss_pred             -----------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        231 -----------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       231 -----------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                                       .+..+++++.+|+.+||+.||++|||+.|+++||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                             123478899999999999999999999999999999643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5e-49  Score=364.52  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=213.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   86 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   86 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence            4455699999999999999999999999999976543 344557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccCceecCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~~~~~  161 (407)
                      +++++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++  ..+||+|||++.......   
T Consensus        87 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---  162 (284)
T 3kk8_A           87 VTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---  162 (284)
T ss_dssp             CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC---
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc---
Confidence            9999999888654 4599999999999999999999999999999999999997643  349999999997765432   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC---CCCCCCccCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~~  238 (407)
                       ......||+.|+|||++..   ..++.++||||||+++|+|++|+.||..... ......+..+.   .......++++
T Consensus       163 -~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 3kk8_A          163 -AWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWDTVTPE  237 (284)
T ss_dssp             -BCCCSCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             -cccCCCCCcCCcCchhhcC---CCCCcccchHHHHHHHHHHHHCCCCCCCCch-hHHHHHHHhccccCCchhhcccCHH
Confidence             2244679999999999854   3467899999999999999999999986443 33333332222   22223578999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+++.+||+.||++|||+.|+++|||+..
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          238 AKSLIDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence            999999999999999999999999999853

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.8e-49  Score=365.97  Aligned_cols=252  Identities=30%  Similarity=0.519  Sum_probs=213.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVLF   80 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv   80 (407)
                      .+...||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+|++++||||+++++++..    ...+++|
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            344589999999999999999999999999976543 34456788999999999999999999998875    3568999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      |||+++|+|.++++.. ..+++..+..++.|++.||.|||+++  |+||||||+|||++.+++.+||+|||++...... 
T Consensus       108 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-  185 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999999764 45899999999999999999999999  9999999999999844557999999999654322 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~  237 (407)
                          ......||+.|+|||++.+    .++.++|||||||++|+|++|+.||....+..........+..+ ..+...++
T Consensus       186 ----~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          186 ----FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ----ccccccCCcCcCCHHHHhc----cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence                1234579999999998853    36889999999999999999999998766665555555544433 34566789


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+++.+||+.||.+|||+.|+++||||.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~  287 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence            999999999999999999999999999984

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.9e-50  Score=378.19  Aligned_cols=255  Identities=23%  Similarity=0.363  Sum_probs=205.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--------   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------   75 (407)
                      +.....||+|+||+||+|++..+|+.||||++....  .....+.+.+|+.+|++++||||+++++++.+.+        
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            345568999999999999999999999999997543  2334577899999999999999999999986543        


Q ss_pred             -------------------------------------------------eEEEEEecCCCCCHHHHHhhcCC--CCCHHH
Q psy10603         76 -------------------------------------------------EMVLFMELCTEGTLESLVQSTED--GLPEVL  104 (407)
Q Consensus        76 -------------------------------------------------~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~  104 (407)
                                                                       ..++|||||++|+|.++++....  ..++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999976432  256667


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC---------CCcccccccCCcccc
Q psy10603        105 VRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV---------PGELNGFVGTQAYMA  175 (407)
Q Consensus       105 ~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~---------~~~~~~~~gt~~y~a  175 (407)
                      +..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........         .......+||+.|+|
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            899999999999999999999999999999998765 6999999999887543211         012245679999999


Q ss_pred             cccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcC
Q psy10603        176 PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRA  255 (407)
Q Consensus       176 PE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~  255 (407)
                      ||++.+   ..++.++|||||||++|||++|..|+.   ..............|..+...++++.+++.+||+.||++||
T Consensus       245 PE~~~~---~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          245 PEQIHG---NNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             HHHHHC---CCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             hHHhcC---CCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            999864   346899999999999999999987763   22333344444444444556788899999999999999999


Q ss_pred             CHHHHhcCCeee
Q psy10603        256 TIFELLQHPFLI  267 (407)
Q Consensus       256 t~~e~l~hp~~~  267 (407)
                      |+.|+++||||.
T Consensus       319 s~~~~l~~~~f~  330 (332)
T 3qd2_B          319 EATDIIENAIFE  330 (332)
T ss_dssp             CHHHHHHSTTCC
T ss_pred             CHHHHhhchhhh
Confidence            999999999984

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-49  Score=366.19  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=203.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.+|+|++.......  ..+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            44559999999999999999999999999997654322  2456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCC
Q psy10603         85 TEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        85 ~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~  159 (407)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||++||+||||||+|||++.+  +..+||+|||++....... 
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-  181 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-  181 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-
Confidence            999999988542   3569999999999999999999999999999999999999542  3469999999997654332 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC--CCCCCCccCH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE--TPTIPESLSD  237 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~  237 (407)
                         ......||+.|+|||++..    .++.++|||||||++|+|++|+.||..... ...........  .+.....+++
T Consensus       182 ---~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T 3is5_A          182 ---HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQQKATYKEPNYAVECRPLTP  253 (285)
T ss_dssp             --------CTTGGGCCHHHHTT----CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCCCCC--CCCCH
T ss_pred             ---cCcCcccccCcCChHHhcc----CCCcccCeehHHHHHHHHHhCCCCCCCCCH-HHHHhhhccCCcccccccCcCCH
Confidence               1244678999999999842    367899999999999999999999986433 23222222222  2222345799


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+++.+||+.||++|||+.|+++||||.
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            999999999999999999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-49  Score=385.65  Aligned_cols=246  Identities=28%  Similarity=0.391  Sum_probs=194.5

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe----CceEEEEEe
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYGVEIH----REEMVLFME   82 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~~lv~E   82 (407)
                      ..||+|+||+||+|++..+|+.||||++...        ..+.+|+.++ +..+||||+++++++..    .+.+|+|||
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            3799999999999999999999999998632        2356788876 45689999999999876    567999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+  +..+||+|||+++...... 
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-  218 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  218 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence            999999999997643 359999999999999999999999999999999999999863  3569999999998764322 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH---HHHHHHhCCC---CCCCCC
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVGMGE---TPTIPE  233 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~---~~~~~~~~~~---~~~~~~  233 (407)
                         .....+||+.|+|||++..   ..++.++|||||||++|||++|+.||.......   .....+..+.   ......
T Consensus       219 ---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  292 (400)
T 1nxk_A          219 ---SLTTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  292 (400)
T ss_dssp             -----------CTTCCGGGSCC---CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred             ---ccccCCCCCCccCHhhcCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence               2345789999999999854   346889999999999999999999997533210   1111222221   112235


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+++++++||.+||+.||++|||+.|+++||||..
T Consensus       293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            78999999999999999999999999999999963

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=371.05  Aligned_cols=257  Identities=30%  Similarity=0.498  Sum_probs=206.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+|+.||+|++... ..+....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC-CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc-ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            455667999999999999999999999999998654 3344556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|..+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   
T Consensus        83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~---  157 (311)
T 4agu_A           83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSD---  157 (311)
T ss_dssp             CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-------
T ss_pred             eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCccc---
Confidence            9999999998865 45599999999999999999999999999999999999998765 699999999987653321   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--HHhCC--------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--KVGMG--------------  226 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--~~~~~--------------  226 (407)
                      .....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||...........  .....              
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             --------GGGCCHHHHHTC--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccCCCcCCccccChHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            12345789999999998542  3468899999999999999999999986543322211  11000              


Q ss_pred             ----CCCCC---------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 ----ETPTI---------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 ----~~~~~---------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                          ..+..         ...+++++.+++.+||+.||++|||+.|+++||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence                00100         135788999999999999999999999999999995

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.6e-49  Score=372.32  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=212.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .....||+|+||.||+|++..+|+.||+|++........   ...+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (321)
T 2a2a_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL   94 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            345589999999999999999999999999976543221   12466889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC---eEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~---~vkl~DFGla~~~~~~~  158 (407)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.   .+||+|||++.......
T Consensus        95 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~  173 (321)
T 2a2a_A           95 ELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV  173 (321)
T ss_dssp             CCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence            99999999999965 455899999999999999999999999999999999999987653   69999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCcc
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESL  235 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (407)
                          ......||+.|+|||++..   ..++.++|||||||++|+|++|+.||.... .......+......   ..+..+
T Consensus       174 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          174 ----EFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             ----CCCCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ----cccccCCCCCccCcccccC---CCCCCccccHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcccccChhhhccc
Confidence                2244679999999999854   346889999999999999999999998543 33333333332221   123568


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++++++.+||+.||++|||+.|+++|||+.
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            99999999999999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.4e-49  Score=365.07  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=211.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.....||+|+||+||+|++..+++.||+|++....... .....+.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            344559999999999999999999999999998654333 3356788999999998 99999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC------------------CC
Q psy10603         83 LCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE------------------GN  141 (407)
Q Consensus        83 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~------------------~~  141 (407)
                      |+++++|.+++...   ...+++..+..++.||+.||.|||++||+||||||+|||++.+                  ..
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CC
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            99999999998653   2558999999999999999999999999999999999999743                  23


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF  221 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~  221 (407)
                      .+||+|||++......       ....||+.|+|||++.+.  ..++.++|||||||++|+|++|.+|+....    ...
T Consensus       172 ~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~  238 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN--YTHLPKADIFALALTVVCAAGAEPLPRNGD----QWH  238 (289)
T ss_dssp             CEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC--CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHH
T ss_pred             EEEEcccccccccCCc-------cccCCCccccChhHhcCC--CCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHH
Confidence            6999999999876532       224689999999998642  245679999999999999999998875332    233


Q ss_pred             HHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       222 ~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+..+..+.+|..+++++.+++.+||+.||++|||+.|+++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            44456677788899999999999999999999999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.2e-50  Score=396.75  Aligned_cols=248  Identities=29%  Similarity=0.435  Sum_probs=195.3

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~lv   80 (407)
                      ...||+|+||+||+|++..+++.||||++.... ......+++.+|+.+|+.++||||+++++++...      ..+|+|
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv  145 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV  145 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence            448999999999999999999999999997543 3445567889999999999999999999998654      367999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||++++ |...+..   .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......  
T Consensus       146 ~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~--  218 (464)
T 3ttj_A          146 MELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF--  218 (464)
T ss_dssp             EECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----CC--
T ss_pred             EeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCCc--
Confidence            9999864 6555532   389999999999999999999999999999999999999865 69999999997764322  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC-------------
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG-------------  226 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~-------------  226 (407)
                        ..+..+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.+.+...+...... .+             
T Consensus       219 --~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          219 --MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             --CC----CCCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             --ccCCCcccccccCHHHHcC---CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence              2355789999999999965   3578999999999999999999999986543322211110 00             


Q ss_pred             ------CCCC---------CCCc-----------cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 ------ETPT---------IPES-----------LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 ------~~~~---------~~~~-----------~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                            ..+.         +|..           .++++++|+.+||++||++|||+.|+|+||||.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                  0010         0111           156799999999999999999999999999996

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.3e-49  Score=372.59  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=201.3

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEeCceEEEEEecCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIHREEMVLFMELCTEG   87 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~E~~~~g   87 (407)
                      .||+|+||+||+|++..+++.||||++......   ..+.+.+|+.+|.+ ++||||+++++++.+.+.+|+||||+++|
T Consensus        20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   96 (316)
T 2ac3_A           20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG   96 (316)
T ss_dssp             CCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence            689999999999999999999999999755322   23567899999988 57999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC--eEEEEcccCceecCCCCC----CC
Q psy10603         88 TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAVKISAHTT----VP  161 (407)
Q Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~--~vkl~DFGla~~~~~~~~----~~  161 (407)
                      +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.  .+||+|||++........    ..
T Consensus        97 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  175 (316)
T 2ac3_A           97 SILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST  175 (316)
T ss_dssp             BHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------
T ss_pred             cHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccc
Confidence            999999764 45999999999999999999999999999999999999987643  399999999876542211    11


Q ss_pred             CcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--------------HHHHHHHhC
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--------------YQIMFKVGM  225 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--------------~~~~~~~~~  225 (407)
                      ......+||+.|+|||++....  ...++.++|||||||++|||++|+.||......              ......+..
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  255 (316)
T 2ac3_A          176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE  255 (316)
T ss_dssp             ------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH
T ss_pred             cccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc
Confidence            1223457999999999985311  123578999999999999999999999754321              112222222


Q ss_pred             CCCCCCC----CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 GETPTIP----ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 ~~~~~~~----~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      + ...+|    ..+++++++++.+||+.||++|||+.|+++||||.
T Consensus       256 ~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          256 G-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             C-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             c-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence            2 22333    45899999999999999999999999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-49  Score=396.09  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=210.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH----------HHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA----------RFVKDMLVELRILEGINQKNLVKYYGVEIHR   74 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   74 (407)
                      .....||+|+||+||+|++..+++.||+|++........          ...+.+.+|+.+|++++||||+++++++.+.
T Consensus        39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  118 (504)
T 3q5i_A           39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK  118 (504)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344599999999999999999999999999976432211          2346788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC--eEEEEcccCce
Q psy10603         75 EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAV  152 (407)
Q Consensus        75 ~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~--~vkl~DFGla~  152 (407)
                      +.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  .+||+|||+++
T Consensus       119 ~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  197 (504)
T 3q5i_A          119 KYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS  197 (504)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCE
Confidence            9999999999999999988654 45999999999999999999999999999999999999987653  59999999998


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--  230 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--  230 (407)
                      ......    .....+||+.|+|||++..    .++.++|||||||++|+|++|..||.... .......+..+....  
T Consensus       198 ~~~~~~----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          198 FFSKDY----KLRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQN-DQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             ECCTTS----CBCCCCSCTTTCCHHHHTT----CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCH
T ss_pred             EcCCCC----ccccccCCcCCCCHHHhcc----CCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCc
Confidence            765432    2345689999999999852    36889999999999999999999998643 444444444433221  


Q ss_pred             -CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        231 -IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       231 -~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                       .+..+|+++++|+.+||++||.+|||+.|+++|||+..
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence             12578999999999999999999999999999999963

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.5e-49  Score=362.12  Aligned_cols=249  Identities=27%  Similarity=0.424  Sum_probs=209.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|.+..+++.+|+|.+......+   .+.+.+|+++|++++||||+++++++...+..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A           12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            34458999999999999999999999999997654433   356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---ecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill---~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+   +.+ ..+||+|||++.......   
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~---  163 (277)
T 3f3z_A           89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK---  163 (277)
T ss_dssp             CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS---
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc---
Confidence            999999988664 448999999999999999999999999999999999999   443 569999999998765432   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC---CccCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP---ESLSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~s~~  238 (407)
                       ......||+.|+|||++.+    .++.++||||||+++|+|++|+.||.... .......+..+..+...   ..++++
T Consensus       164 -~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          164 -MMRTKVGTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT-DSEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             -CBCCCCSCTTTCCHHHHTT----CBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             -chhccCCCCCccChHHhcc----cCCchhhehhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCchhhhcCCHH
Confidence             2245679999999999853    25789999999999999999999998644 33344444333322211   268999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+++.+||++||++|||+.|+++||||.
T Consensus       238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~  266 (277)
T 3f3z_A          238 AESLIRRLLTKSPKQRITSLQALEHEWFE  266 (277)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            99999999999999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=371.58  Aligned_cols=256  Identities=27%  Similarity=0.462  Sum_probs=199.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcC---CCCCcceEEEEEEeCc---
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGI---NQKNLVKYYGVEIHRE---   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~---   75 (407)
                      +.....||+|+||+||+|++..+++.||+|++......  .......+.+|+.+++.+   +||||+++++++....   
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~   90 (308)
T 3g33_A           11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR   90 (308)
T ss_dssp             CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence            44455999999999999999999999999999754321  111113345566665554   5999999999988755   


Q ss_pred             --eEEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         76 --EMVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        76 --~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                        .+++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus        91 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~  168 (308)
T 3g33_A           91 EIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLAR  168 (308)
T ss_dssp             EEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCSCTT
T ss_pred             ceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCcccc
Confidence              5899999997 59999987643 3499999999999999999999999999999999999998765 69999999997


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHH---HhCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK---VGMGETP  229 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~---~~~~~~~  229 (407)
                      ......    .....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||............   .......
T Consensus       169 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          169 IYSYQM----ALTPVVVTLWYRAPEVLLQ---STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             TSTTCC----CSGGGGCCCSSCCHHHHHT---SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccCCCc----ccCCccccccccCchHHcC---CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            654322    2345689999999999864   34688999999999999999999999865433222111   1111000


Q ss_pred             C----------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        230 T----------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       230 ~----------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .                      ....+++++.+++.+||++||++|||+.|+++||||..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            0                      12357899999999999999999999999999999963

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=373.48  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=211.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +.....||+|+||+||+|++..+++   .||||++...  ......+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus        51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            3445689999999999999986655   4999998743  2445567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++|+|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC----C
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcccccccCccc
Confidence            999999999999976666799999999999999999999999999999999999998764 6999999999876543322


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      ........+|+.|+|||++..   ..++.++|||||||++|||++ |..||... ........+..+..+..+..+++++
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l  283 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAF---RTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSVEEGYRLPAPMGCPHAL  283 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             eeeccCCCCcccccCHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCCCCCCCCcCHHH
Confidence            222233456788999999854   236789999999999999999 99999864 3445556666666777788999999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+++..||..||++|||+.|+++.
T Consensus       284 ~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          284 HQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999998863

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.8e-49  Score=366.92  Aligned_cols=254  Identities=25%  Similarity=0.343  Sum_probs=206.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.||+|++......+....+.+.+|+.++.+++||||+++++++...+.+|+||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            34455999999999999999999999999999876666677778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......  ..
T Consensus        93 ~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~  168 (294)
T 4eqm_A           93 IEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSL--TQ  168 (294)
T ss_dssp             CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC---------
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccccccc--cc
Confidence            9999999999764 4599999999999999999999999999999999999998765 699999999976543221  12


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC----CCCccCHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT----IPESLSDEG  239 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~  239 (407)
                      ....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...... ...........+.    .+..+++.+
T Consensus       169 ~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKG---EATDECTDIYSIGIVLYEMLVGEPPFNGETAV-SIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ------CCSSCCHHHHHT---CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-HHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             cCccccCccccCHhHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhhccCCCcchhcccCCCHHH
Confidence            234679999999999864   34678999999999999999999999865433 3333333333332    356789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      .+++.+||++||.+||+..+.+.+.+
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHH
Confidence            99999999999999995555555544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-49  Score=378.48  Aligned_cols=261  Identities=26%  Similarity=0.373  Sum_probs=206.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ--NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||+||+|++..+++.||+|++.....  .+....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus        29 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  108 (345)
T 3hko_A           29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVME  108 (345)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEe
Confidence            344589999999999999999999999999975421  123345778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy10603         83 LCTEGTLESLVQST---------------------------------------EDGLPEVLVRRYTKQLVDAISALHENT  123 (407)
Q Consensus        83 ~~~~g~L~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~aL~yLH~~~  123 (407)
                      ||++|+|.+++...                                       ...+++..+..++.|++.||.|||++|
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  188 (345)
T 3hko_A          109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG  188 (345)
T ss_dssp             CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999988420                                       112367788999999999999999999


Q ss_pred             ceecCCCCCCEEEecCCC-eEEEEcccCceecCCCCCC-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHH
Q psy10603        124 IVHRDIKSANIFLTAEGN-SLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  201 (407)
Q Consensus       124 iiHrdlKp~Nill~~~~~-~vkl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~  201 (407)
                      |+||||||+|||++.++. .+||+|||+++.+...... ........||+.|+|||++.... ..++.++|||||||++|
T Consensus       189 ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~  267 (345)
T 3hko_A          189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN-ESYGPKCDAWSAGVLLH  267 (345)
T ss_dssp             EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS-SCCCTHHHHHHHHHHHH
T ss_pred             ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC-CCCCcHHHHHHHHHHHH
Confidence            999999999999986542 6999999999876432211 11234567999999999986422 34688999999999999


Q ss_pred             HHHcCCCCCCCCCchHHHHHHHhCCCC-CCC--CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        202 EMSSGKRPWAEYDSNYQIMFKVGMGET-PTI--PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       202 em~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~--~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ||++|+.||...... .....+..+.. ...  ...+++++++++.+||+.||.+|||+.|+++||||.
T Consensus       268 el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~  335 (345)
T 3hko_A          268 LLLMGAVPFPGVNDA-DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS  335 (345)
T ss_dssp             HHHHSSCSSCCSSHH-HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred             HHHHCCCCCCCCChH-HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence            999999999865443 33333322222 222  234899999999999999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.8e-49  Score=365.50  Aligned_cols=254  Identities=36%  Similarity=0.599  Sum_probs=211.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCCCC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            7999999999999999999999999987542   2345678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         89 LESLVQSTED--GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        89 L~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |.+++.....  .+++..+..++.|++.||.|||++||+||||||+|||++..++.+||+|||++........   ....
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~  182 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTET  182 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--------CC
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC---cccc
Confidence            9999976432  4678999999999999999999999999999999999987445799999999987643221   1234


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHH-HhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..||+.|+|||++.... ..++.++||||||+++|+|++|+.||............ ......+.++..+++++.+++.+
T Consensus       183 ~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  261 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGP-RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK  261 (295)
T ss_dssp             CCCCGGGCCHHHHHHGG-GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred             cCCCccccChhhhcCCC-CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence            67899999999986432 23678999999999999999999999765444333222 23345667788999999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      ||+.||++|||+.|+++|||+...
T Consensus       262 ~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          262 CFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             TTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HccCChhhCCCHHHHhcChhhhhc
Confidence            999999999999999999999643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-49  Score=366.52  Aligned_cols=254  Identities=24%  Similarity=0.437  Sum_probs=213.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++..+++.||+|++......+....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            34455699999999999999999999999999875432222234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......    
T Consensus        95 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~----  168 (284)
T 2vgo_A           95 FAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLR----  168 (284)
T ss_dssp             CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSSC----
T ss_pred             eCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcccc----
Confidence            99999999998764 4599999999999999999999999999999999999998765 69999999987654321    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                       .....||+.|+|||++.+   ..++.++||||||+++|+|++|..||.... .......+. .....+|..++++++++
T Consensus       169 -~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~l  242 (284)
T 2vgo_A          169 -RRTMCGTLDYLPPEMIEG---KTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-HTETHRRIV-NVDLKFPPFLSDGSKDL  242 (284)
T ss_dssp             -BCCCCSCGGGCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHH-TTCCCCCTTSCHHHHHH
T ss_pred             -cccccCCCCcCCHHHhcc---CCCCcccchhhHHHHHHHHHHCCCCCCCCC-HhHHHHHHh-ccccCCCCcCCHHHHHH
Confidence             234678999999999864   345789999999999999999999998543 323333332 23445678899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+||+.||.+|||+.|+++|||+..
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence            99999999999999999999999963

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.8e-49  Score=393.69  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=207.0

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|++..+++.||+|++....... .....+.+|+.+|+.++||||+++++++.+.+.+|+|||||+
T Consensus        41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  119 (494)
T 3lij_A           41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK  119 (494)
T ss_dssp             EEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence            3448999999999999999999999999997543221 123567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCCCCc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++..  ...+||+|||+++......    .
T Consensus       120 ~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~  194 (494)
T 3lij_A          120 GGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----K  194 (494)
T ss_dssp             SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB----C
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc----c
Confidence            99999988654 459999999999999999999999999999999999999754  2359999999998765432    2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCccCHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESLSDEGQ  240 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~  240 (407)
                      ....+||+.|+|||++..    .++.++|||||||++|+|++|..||.... .......+..+...   .....+|++++
T Consensus       195 ~~~~~gt~~y~aPE~l~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRK----KYDEKCDVWSIGVILFILLAGYPPFGGQT-DQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTT----CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             ccccCCCcCeeCHHHHcc----cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            345689999999999842    36889999999999999999999998643 34444444433322   12356899999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +|+.+||+.||.+|||+.|+++|||+..
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCccccc
Confidence            9999999999999999999999999963

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-49  Score=391.43  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=190.0

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~l   79 (407)
                      .....||+|+||+||+|++..+++.||||++... ..+....+++.+|+++|+.++||||+++++++...     ..+|+
T Consensus        56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            3444899999999999999999999999999654 33455567899999999999999999999998543     56999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+. ++|..+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus       135 v~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          135 VLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTSCTT
T ss_pred             EEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccCccc
Confidence            999985 689998865 45599999999999999999999999999999999999999865 699999999987643211


Q ss_pred             C------------------------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc----------
Q psy10603        160 V------------------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS----------  205 (407)
Q Consensus       160 ~------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~----------  205 (407)
                      .                        ....+..+||+.|+|||++...  ..++.++|||||||++|||++          
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ--ENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCC--CCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                        0123567899999999987432  347899999999999999999          


Q ss_pred             -CCCCCCCCCc-------------------hHHH---HHHHhCCCC--------------------C--------CCCCc
Q psy10603        206 -GKRPWAEYDS-------------------NYQI---MFKVGMGET--------------------P--------TIPES  234 (407)
Q Consensus       206 -g~~Pf~~~~~-------------------~~~~---~~~~~~~~~--------------------~--------~~~~~  234 (407)
                       |+++|.+...                   ....   +..+. +..                    +        .....
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL-GTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHH-CCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHc-CCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence             6777754321                   0000   11000 000                    0        01234


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++.+|+.+||++||++|||+.|+|+||||.
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~  401 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFK  401 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence            689999999999999999999999999999995

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.7e-49  Score=381.29  Aligned_cols=257  Identities=28%  Similarity=0.491  Sum_probs=208.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN--QKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||+||+|.+.. ++.||||++..... +....+.+.+|+.+|.+++  ||||+++++++...+.+|+|||
T Consensus        59 ~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           59 SILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            344599999999999999865 89999999976543 4456678899999999997  4999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                       +.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+++  +.+||+|||+++.+...... .
T Consensus       137 -~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~~~-~  211 (390)
T 2zmd_A          137 -CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTS-V  211 (390)
T ss_dssp             -CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC--------
T ss_pred             -cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccccccCCCcc-c
Confidence             6788999999764 46899999999999999999999999999999999999964  46999999999876433211 1


Q ss_pred             cccccccCCcccccccccccc--------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTN--------KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPE  233 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~--------~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~  233 (407)
                      .....+||+.|+|||++....        ...++.++|||||||++|||++|+.||....+....+..+.. ......|.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence            124568999999999985421        124688999999999999999999999865544444443333 33445677


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ..++++++++.+||+.||.+|||+.|+++|||+..
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence            78999999999999999999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-49  Score=380.07  Aligned_cols=251  Identities=28%  Similarity=0.478  Sum_probs=202.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--------
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--------   74 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------   74 (407)
                      .+.....||+|+||+||+|++..+|+.||||++......       ..+|+++|+.++||||+++++++...        
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            345556999999999999999999999999998754322       23699999999999999999998543        


Q ss_pred             ------------------------------ceEEEEEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy10603         75 ------------------------------EEMVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE  121 (407)
Q Consensus        75 ------------------------------~~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~  121 (407)
                                                    ..+++||||+++ +|.+.+..   ....+++..+..++.||+.||.|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                          348999999985 77766642   34569999999999999999999999


Q ss_pred             CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHH
Q psy10603        122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  201 (407)
Q Consensus       122 ~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~  201 (407)
                      +||+||||||+|||++.+++.+||+|||+++.+....    ......||+.|+|||++.+.  ..++.++|||||||++|
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTC--SSCCTHHHHHHHHHHHH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCC--CCCCcchhhhhHHHHHH
Confidence            9999999999999998655689999999998765432    22456789999999998642  34688999999999999


Q ss_pred             HHHcCCCCCCCCCchHHHHHHHhC-C-----------------CCC---------CCCCccCHHHHHHHHHhcccCCCCc
Q psy10603        202 EMSSGKRPWAEYDSNYQIMFKVGM-G-----------------ETP---------TIPESLSDEGQAFAELCLRHDPAQR  254 (407)
Q Consensus       202 em~~g~~Pf~~~~~~~~~~~~~~~-~-----------------~~~---------~~~~~~s~~~~~~i~~~l~~dp~~R  254 (407)
                      ||++|+.||.+.....+....+.. +                 ..|         .++..+++++.+|+.+||+.||++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999865443332221110 0                 001         1356689999999999999999999


Q ss_pred             CCHHHHhcCCeee
Q psy10603        255 ATIFELLQHPFLI  267 (407)
Q Consensus       255 ~t~~e~l~hp~~~  267 (407)
                      ||+.|+++||||.
T Consensus       314 ~t~~e~l~hp~f~  326 (383)
T 3eb0_A          314 INPYEAMAHPFFD  326 (383)
T ss_dssp             CCHHHHHTSGGGH
T ss_pred             CCHHHHhcCHHHH
Confidence            9999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-49  Score=379.38  Aligned_cols=249  Identities=30%  Similarity=0.440  Sum_probs=200.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~l   79 (407)
                      ....||+|+||.||+|++..+|+.||||++.... .+....+++.+|+++|++++||||+++++++...+      .+|+
T Consensus        29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l  107 (367)
T 1cm8_A           29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL  107 (367)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence            3448999999999999999999999999986543 34456678899999999999999999999987653      4699


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+ +++|.++++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....  
T Consensus       108 v~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~--  181 (367)
T 1cm8_A          108 VMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSE--  181 (367)
T ss_dssp             EEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSS--
T ss_pred             EEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccccccc--
Confidence            99999 7899999875  3599999999999999999999999999999999999998865 6999999999875432  


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC-----------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE-----------  227 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~-----------  227 (407)
                          ....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+...+...... .+.           
T Consensus       182 ----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          182 ----MTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             ----CCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ----cCcCcCCCCcCCHHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence                3456899999999998642  3468899999999999999999999986543322211100 000           


Q ss_pred             -----------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 -----------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 -----------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                       ...+....++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence                             0112346789999999999999999999999999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-48  Score=364.09  Aligned_cols=253  Identities=28%  Similarity=0.480  Sum_probs=216.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.+|+|++......+....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   97 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC   97 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence            34458999999999999999999999999998765555666778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   ..
T Consensus        98 ~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~---~~  172 (294)
T 2rku_A           98 RRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE---RK  172 (294)
T ss_dssp             TTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSTTC---CB
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecccCcc---cc
Confidence            999999988653 4599999999999999999999999999999999999998765 699999999987643221   22


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ....||+.|+|||++..   ..++.++||||||+++|+|++|+.||..... ......+. .....+|..+++++.+++.
T Consensus       173 ~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSK---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-KETYLRIK-KNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CCCCSCCSSCCHHHHTT---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHH-TTCCCCCTTSCHHHHHHHH
T ss_pred             ccccCCCCcCCcchhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh-hccCCCccccCHHHHHHHH
Confidence            44678999999999854   3457899999999999999999999985432 23333333 2344567889999999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +||+.||++|||+.|+++|||+.
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~  270 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFT  270 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             HHcccChhhCcCHHHHhhChhee
Confidence            99999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.7e-49  Score=376.11  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--------Cc
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--------RE   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~~   75 (407)
                      +.....||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++..        .+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            34455899999999999999999999999998654332 2223567789999999999999999999887        34


Q ss_pred             eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      .+|+||||+++ +|...+......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFS  175 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhccccc
Confidence            68999999986 77777766556799999999999999999999999999999999999998765 69999999998765


Q ss_pred             CCCC-CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--HHHhCCCCCCCC
Q psy10603        156 AHTT-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--FKVGMGETPTIP  232 (407)
Q Consensus       156 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--~~~~~~~~~~~~  232 (407)
                      .... ........+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||..........  ........+...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccCCcccccCccCchhhcCC--CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            3222 12233556889999999998542  346889999999999999999999998654332221  121111222111


Q ss_pred             Cc----------------------------cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ES----------------------------LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~----------------------------~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..                            .++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            11                            277899999999999999999999999999995

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.7e-49  Score=394.00  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=210.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.||||++....... .....+.+|+.+|++++||||+++++++...+.+|+|||||
T Consensus        25 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  103 (486)
T 3mwu_A           25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY  103 (486)
T ss_dssp             EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence            34459999999999999999999999999997543221 12366889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++..  +..+||+|||+++......    
T Consensus       104 ~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----  178 (486)
T 3mwu_A          104 TGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----  178 (486)
T ss_dssp             CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC----
Confidence            999999988654 459999999999999999999999999999999999999643  3469999999997654332    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-C--CCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-T--IPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~--~~~~~s~~~  239 (407)
                      .....+||+.|+|||++.+    .++.++|||||||++|+|++|+.||.+. +.......+..+..+ .  .+..+|+++
T Consensus       179 ~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGK-NEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             ccCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            2345689999999999853    3688999999999999999999999864 344444444443322 2  235689999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++|+.+||+.||.+|||+.|+++|||+..
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            99999999999999999999999999963

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.9e-49  Score=372.24  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=216.6

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|++..+++.||+|++......+....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus        45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence            34589999999999999999999999999987655566667788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......   ...
T Consensus       125 ~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~---~~~  199 (335)
T 2owb_A          125 RRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE---RKK  199 (335)
T ss_dssp             TCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSTTC---CBC
T ss_pred             CCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecccCcc---ccc
Confidence            99999998653 4599999999999999999999999999999999999998765 699999999987643221   224


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ...||+.|+|||++.+   ..++.++|||||||++|+|++|+.||..... ......+.. ....++..+++++.+++.+
T Consensus       200 ~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          200 VLCGTPNYIAPEVLSK---KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-KETYLRIKK-NEYSIPKHINPVAASLIQK  274 (335)
T ss_dssp             CCCSCCSSCCHHHHHT---SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHH-TCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCCccccCHHHhcc---CCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHhc-CCCCCCccCCHHHHHHHHH
Confidence            4679999999999854   3457899999999999999999999985432 233232222 2345677899999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||+.||++|||+.|+++||||..
T Consensus       275 ~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          275 MLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999853

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=373.87  Aligned_cols=257  Identities=29%  Similarity=0.497  Sum_probs=207.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ--KNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||+||+|.+. +++.||||++.... .+....+.+.+|+.+|.+++|  |||+++++++...+.+|+|||
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e   89 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME   89 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence            34459999999999999874 68899999997653 344556788999999999987  999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                       +.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+++  +.+||+|||+++.+...... .
T Consensus        90 -~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~~~~~-~  164 (343)
T 3dbq_A           90 -CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTS-V  164 (343)
T ss_dssp             -CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCCC--------
T ss_pred             -CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccccCccccc-c
Confidence             567899999976 456999999999999999999999999999999999999974  46999999999876533211 1


Q ss_pred             cccccccCCccccccccccc--------ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCCCCCCC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT--------NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIPE  233 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~--------~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~  233 (407)
                      .....+||+.|+|||++...        ....++.++|||||||++|||++|+.||....+......... .......|.
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  244 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc
Confidence            22356899999999998541        113467899999999999999999999986555444443333 334455677


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ..++++.+++.+||+.||.+|||+.|+++|||+..
T Consensus       245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            88899999999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.6e-49  Score=376.63  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=211.2

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-----DARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv   80 (407)
                      ...||+|+||.||+|++..+|+.||||++......     .....+.+.+|+.++.++ +||||+++++++...+..|+|
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            35899999999999999999999999999765321     123456788999999998 899999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++..+....  
T Consensus       179 ~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~~~~~--  254 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGE--  254 (365)
T ss_dssp             ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTTC--
T ss_pred             EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCcccccCCCc--
Confidence            9999999999999753 4599999999999999999999999999999999999998765 69999999998765432  


Q ss_pred             CCcccccccCCccccccccccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC---CCCc
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDT---NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT---IPES  234 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~  234 (407)
                        .....+||+.|+|||++...   ....++.++|||||||++|+|++|+.||.... .......+..+....   .+..
T Consensus       255 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          255 --KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-QILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             --CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCHHHHSS
T ss_pred             --ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCCccccc
Confidence              23456899999999998532   12246789999999999999999999998543 333333333332221   1246


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++.+++.+||+.||++|||+.|+++||||.
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            889999999999999999999999999999983

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=377.10  Aligned_cols=246  Identities=29%  Similarity=0.429  Sum_probs=207.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-----RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      ....||+|+||+||+|++..+++.||||++........     ...+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus        28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  107 (335)
T 3dls_A           28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV  107 (335)
T ss_dssp             EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence            44589999999999999999999999999986542211     1234567899999999999999999999999999999


Q ss_pred             EecCCCC-CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         81 MELCTEG-TLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        81 ~E~~~~g-~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||+.+| +|..+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++...... 
T Consensus       108 ~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~-  184 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGK-  184 (335)
T ss_dssp             EECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTC-
T ss_pred             EEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceECCCCC-
Confidence            9999777 99999865 44599999999999999999999999999999999999998864 69999999998765432 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                         .....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||......        .......|..+++++
T Consensus       185 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~l  251 (335)
T 3dls_A          185 ---LFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKEL  251 (335)
T ss_dssp             ---CBCEECSCGGGCCHHHHTTC--CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHHH
T ss_pred             ---ceeccCCCccccChhhhcCC--CCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHHH
Confidence               22456799999999998653  22378999999999999999999999753211        122334466789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+++.+||++||++|||+.|+++|||+.
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~~~  279 (335)
T 3dls_A          252 MSLVSGLLQPVPERRTTLEKLVTDPWVT  279 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccc
Confidence            9999999999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7e-49  Score=383.73  Aligned_cols=249  Identities=28%  Similarity=0.426  Sum_probs=199.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l   79 (407)
                      ....||+|+||+||+|++..+|+.||||++.....       ...+|+++|+.++||||+++++++...      ..+++
T Consensus        58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            34489999999999999999999999999865322       123699999999999999999988542      24779


Q ss_pred             EEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         80 FMELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        80 v~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      ||||+++ +|..++.   .....+++..+..++.||+.||.|||++||+||||||+|||++.++..+||+|||+++.+..
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            9999986 5555543   23456999999999999999999999999999999999999997767799999999987643


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-C---------
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-G---------  226 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~---------  226 (407)
                      ..    .....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.....+....+.. +         
T Consensus       210 ~~----~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          210 GE----PNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             TC----CCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             CC----CceeeeeCCCcCCHHHHcCC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32    12456899999999998642  34788999999999999999999999865433222211110 0         


Q ss_pred             --------CCCC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        227 --------ETPT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       227 --------~~~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                              ..|.         ++..+++++++|+.+||++||.+|||+.|+++||||..
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence                    0111         23457899999999999999999999999999999953

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-48  Score=383.10  Aligned_cols=258  Identities=29%  Similarity=0.466  Sum_probs=200.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~   78 (407)
                      +.....||+|+||+||+|++..+++.||||++... ..+....+++.+|+++|++++||||+++++++...     +.+|
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            44455999999999999999999999999999754 23445567899999999999999999999998766     5799


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||++ |+|.++++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus       107 lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEK  183 (432)
T ss_dssp             EEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC----
T ss_pred             EEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcccccccc
Confidence            9999997 599999865 45599999999999999999999999999999999999998865 69999999998765322


Q ss_pred             CC-------------------CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCC---------
Q psy10603        159 TV-------------------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW---------  210 (407)
Q Consensus       159 ~~-------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf---------  210 (407)
                      ..                   ....+..+||+.|+|||++...  ..++.++|||||||++|||++|..||         
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ--ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTTC--SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhcC--CCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            11                   0123567899999999987432  34789999999999999999854443         


Q ss_pred             --CCCCc----------------hHHHH---HHH-h---------------------CCCCCCC-----CCccCHHHHHH
Q psy10603        211 --AEYDS----------------NYQIM---FKV-G---------------------MGETPTI-----PESLSDEGQAF  242 (407)
Q Consensus       211 --~~~~~----------------~~~~~---~~~-~---------------------~~~~~~~-----~~~~s~~~~~~  242 (407)
                        .+...                ....+   ... +                     .......     ...+++++.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence              32110                00000   000 0                     0001111     14589999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+||+.||++|||+.|+|+||||.
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhh
Confidence            9999999999999999999999995

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.2e-49  Score=368.76  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=200.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++  +|+.||||++.... ......+.+.+|+++|++++||||+++++++...+.+++||||
T Consensus        39 y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             ceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            44556899999999999987  57889999987543 3445567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         84 CTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      +++|+|.+++.....  .+++..+..++.|++.||.|||++|  |+||||||+|||++.++ .+||+|||+++.......
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCcccccccc
Confidence            999999999965321  2899999999999999999999999  99999999999998764 699999999975433211


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                         ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||..................+.+|..+++++
T Consensus       195 ---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          195 ---SSKSAAGTPEWMAPEVLRD---EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             ----------CCTTSCHHHHTT---CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ---ccccCCCCccccChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence               1244689999999999864   3467899999999999999999999986544333333333455667788999999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+.||.+|||+.|+++
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-48  Score=360.14  Aligned_cols=258  Identities=29%  Similarity=0.443  Sum_probs=212.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            34556899999999999999999999999999755332  2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......... ..
T Consensus        87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~-~~  163 (276)
T 2yex_A           87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE-RL  163 (276)
T ss_dssp             CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE-CC
T ss_pred             cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcch-hc
Confidence            999999998864 44599999999999999999999999999999999999998765 6999999999765432211 12


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC-CCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~~  242 (407)
                      .....||+.|+|||++...  ..++.++|||||||++|+|++|+.||................. ....+..++++++++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCS--SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccCCccccCccChHHHhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            3456799999999998542  2236789999999999999999999986544333322222222 222235789999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +.+||+.||++|||+.|+++||||..
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~  267 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNK  267 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccC
Confidence            99999999999999999999999853

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.2e-49  Score=373.95  Aligned_cols=257  Identities=30%  Similarity=0.439  Sum_probs=206.0

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEecccc-----CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ-----NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      .....||+|+||.||+|++..+++.||||++.....     .+......+.+|+++|++++||||+++++++...+ .|+
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~l   91 (322)
T 2ycf_A           13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYI   91 (322)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEE
Confidence            445589999999999999999999999999875422     11222345789999999999999999999986655 899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC--eEEEEcccCceecCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAVKISAH  157 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~--~vkl~DFGla~~~~~~  157 (407)
                      ||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  .+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  170 (322)
T 2ycf_A           92 VLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET  170 (322)
T ss_dssp             EEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC
T ss_pred             EEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc
Confidence            9999999999998864 456999999999999999999999999999999999999986542  4999999999876432


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC---CCCc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT---IPES  234 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~  234 (407)
                      .    ......||+.|+|||++.......++.++|||||||++|+|++|..||............+..+....   .+..
T Consensus       171 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (322)
T 2ycf_A          171 S----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  246 (322)
T ss_dssp             H----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred             c----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence            1    12345789999999998543334578899999999999999999999976543322323333333222   2356


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++.+++.+||+.||++|||+.|+++|||+.
T Consensus       247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~  279 (322)
T 2ycf_A          247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  279 (322)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence            899999999999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.1e-49  Score=365.42  Aligned_cols=259  Identities=25%  Similarity=0.457  Sum_probs=199.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++..+|+.||+|++..... .....+.+..+...++.++||||+++++++...+..++|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            34556699999999999999999999999999875422 22333344455566888999999999999999999999999


Q ss_pred             cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         83 LCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        83 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      |+++ +|.+++..   ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccccccc
Confidence            9985 88776643   345699999999999999999999998 999999999999998765 69999999997764432


Q ss_pred             CCCCcccccccCCccccccccccc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC-CCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~s  236 (407)
                      .    .....||+.|+|||++... ....++.++|||||||++|+|++|+.||..................+.. +..++
T Consensus       165 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          165 A----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             c----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            1    2334789999999997321 2234688999999999999999999999865555555444444444433 45789


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +++.+++.+||+.||++|||+.|+++||||..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            99999999999999999999999999999963

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.2e-49  Score=370.69  Aligned_cols=248  Identities=26%  Similarity=0.421  Sum_probs=205.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEe--CceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIH--REEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv   80 (407)
                      +.....||+|+||+||+|++..+++.||+|++....      .+.+.+|+.+|++++ ||||+++++++..  ....++|
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            344559999999999999999999999999986432      256789999999997 9999999999987  5679999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++++|.++++.    +++..+..++.|++.||.|||++||+||||||+|||++.++..+||+|||+++......  
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--  185 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--  185 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence            999999999998854    89999999999999999999999999999999999999776689999999998765432  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-------------CC
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-------------GE  227 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-------------~~  227 (407)
                        ......||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.........+..+..             ..
T Consensus       186 --~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          186 --EYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             --ccccccccccccChhhhcCC--CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence              23456789999999998542  34688999999999999999999999654443322211100             00


Q ss_pred             -----------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 -----------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 -----------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                             ....+..+++++.+|+.+||++||++|||+.|+++||||.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence                                   0111233799999999999999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.7e-49  Score=376.84  Aligned_cols=252  Identities=22%  Similarity=0.360  Sum_probs=211.8

Q ss_pred             cceeeecccccCeEEEEEEEC-------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-------ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~   75 (407)
                      +.....||+|+||+||+|++.       .++..||+|++...  ......+.+.+|+.+|+.+ +||||+++++++...+
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            344558999999999999874       34567999998654  3445567899999999999 8999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      .+|+||||+++|+|.++++...               ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999997643               2478999999999999999999999999999999999998765


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~  219 (407)
                       .+||+|||+++........ .......+|+.|+|||++.+   ..++.++|||||||++|||++ |..||.... ..+.
T Consensus       241 -~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~  314 (370)
T 2psq_A          241 -VMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL  314 (370)
T ss_dssp             -CEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGH
T ss_pred             -CEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC---CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHH
Confidence             6999999999876543221 12234467889999999864   346899999999999999999 999998643 3445


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ...+..+..+..|..+++++.+++.+||+.||++|||+.|++++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            55566667777888999999999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-48  Score=374.87  Aligned_cols=255  Identities=24%  Similarity=0.426  Sum_probs=208.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEMVL   79 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~l   79 (407)
                      .....||+|+||+||+|++..+++.||||++...  ......+.+.+|+++|.+++||||+++++++...     ...|+
T Consensus        30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            3445999999999999999999999999998743  3445567889999999999999999999998765     36899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++ +|.++++.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus       108 v~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          108 VQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred             EEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCCC
Confidence            9999984 89998865  3499999999999999999999999999999999999998765 699999999987754433


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh---------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG---------------  224 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~---------------  224 (407)
                      ........+||+.|+|||++...  ..++.++|||||||++|+|++|+.||..............               
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  261 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  261 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTB--CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             ccccccccccccCCCCCHHhcCC--CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            33334566899999999987543  3468899999999999999999999986543322211110               


Q ss_pred             ---------CCCCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 ---------MGETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 ---------~~~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                               ......     +...+++++.+|+.+||++||++|||+.|+++||||.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                     000001     1245789999999999999999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-48  Score=374.01  Aligned_cols=249  Identities=27%  Similarity=0.429  Sum_probs=201.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-----CCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-----QKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||+||+|++..+++.||||++..    .....+.+.+|+.+|+.++     ||||+++++++...+..+
T Consensus        37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             EEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            3445599999999999999999999999999863    2334566778999999886     999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec-------------------
Q psy10603         79 LFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA-------------------  138 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~-------------------  138 (407)
                      +||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.                   
T Consensus       113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            999999 899999987643 35999999999999999999999999999999999999974                   


Q ss_pred             -----CCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy10603        139 -----EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY  213 (407)
Q Consensus       139 -----~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~  213 (407)
                           ....+||+|||+++.....      .....||+.|+|||++.+   ..++.++|||||||++|+|++|+.||...
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN---LGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC---CCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                 2456999999999765432      234679999999999864   34689999999999999999999999864


Q ss_pred             CchHHHHHH-HhCCCCC-----------------------CCC--------------------CccCHHHHHHHHHhccc
Q psy10603        214 DSNYQIMFK-VGMGETP-----------------------TIP--------------------ESLSDEGQAFAELCLRH  249 (407)
Q Consensus       214 ~~~~~~~~~-~~~~~~~-----------------------~~~--------------------~~~s~~~~~~i~~~l~~  249 (407)
                      ......... ...+..|                       ..|                    ...++++.+|+.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            432221111 1111111                       001                    11247788999999999


Q ss_pred             CCCCcCCHHHHhcCCee
Q psy10603        250 DPAQRATIFELLQHPFL  266 (407)
Q Consensus       250 dp~~R~t~~e~l~hp~~  266 (407)
                      ||++|||+.|+|+||||
T Consensus       343 dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             SGGGSCCHHHHTTSGGG
T ss_pred             ChhhCCCHHHHhcCccc
Confidence            99999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-49  Score=374.68  Aligned_cols=257  Identities=24%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND--ARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +.....||+|+||+||+|++..+|+.||+|++.......  ....+.+.+|+.+|++++||||+++++++...+..++||
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   91 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence            344559999999999999999999999999987543221  122346789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++ +|..++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   
T Consensus        92 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~---  166 (346)
T 1ua2_A           92 DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPN---  166 (346)
T ss_dssp             ECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCC---
T ss_pred             EcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceeccCCc---
Confidence            99986 88888876556689999999999999999999999999999999999998865 69999999997764322   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC--C---------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE--T---------  228 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~--~---------  228 (407)
                      ......+||+.|+|||++.+.  ..++.++|||||||++|||++|..||........ +..+..  +.  .         
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSS
T ss_pred             ccCCcccccccccCchHhhCC--CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHcCCCChhhhhhhccC
Confidence            123456889999999998542  3468899999999999999999999986543322 221110  10  0         


Q ss_pred             ---------CCC-----CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        229 ---------PTI-----PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       229 ---------~~~-----~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                               +..     ...+++++++++.+||+.||++|||+.|+++||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence                     011     1456789999999999999999999999999999963

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.2e-49  Score=362.90  Aligned_cols=254  Identities=28%  Similarity=0.410  Sum_probs=205.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+|+.||+|++......+....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            44556999999999999999999999999999754322223346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......    .
T Consensus        93 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~----~  166 (276)
T 2h6d_A           93 VSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE----F  166 (276)
T ss_dssp             CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC-------
T ss_pred             cCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc----c
Confidence            9999999999764 4589999999999999999999999999999999999998765 69999999997654322    1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      .....||+.|+|||++.+.  ...+.++||||||+++|+|++|+.||.... .......+.. ....+|..++.++.+++
T Consensus       167 ~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGR--LYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRG-GVFYIPEYLNRSVATLL  242 (276)
T ss_dssp             ----------CCTGGGTTS--CCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHH-CCCCCCTTSCHHHHHHH
T ss_pred             eecccCCccccCHHHHcCC--CCCCccchHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhc-CcccCchhcCHHHHHHH
Confidence            2345789999999998642  223579999999999999999999997543 3333333332 34456788999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+||+.||++|||+.|+++||||.
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~  266 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFK  266 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHccCChhhCCCHHHHHhChhhc
Confidence            999999999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=379.39  Aligned_cols=257  Identities=27%  Similarity=0.396  Sum_probs=213.4

Q ss_pred             cceeeecccccCeEEEEEE-----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||+||+|+     +..+++.||||++...  ........+.+|+.+|++++||||+++++++...+..+
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            3445589999999999999     4567789999998643  23444567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccC
Q psy10603         79 LFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGS  150 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGl  150 (407)
                      +|||||++|+|.++++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ..+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999999997643      3489999999999999999999999999999999999998533  3699999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETP  229 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~  229 (407)
                      ++........ .......||+.|+|||++.+   ..++.++|||||||++|||++ |..||... +.......+..+..+
T Consensus       231 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~ellt~g~~pf~~~-~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          231 ARDIYRAGYY-RKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVTSGGRM  305 (367)
T ss_dssp             HHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHTTCCC
T ss_pred             cccccccccc-ccCCCcCCcccEECHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC
Confidence            9765322211 12234578999999999864   346889999999999999998 99999854 445566666666777


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+..+++++.+++.+||+.||++|||+.|++++.+..
T Consensus       306 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            77889999999999999999999999999999988764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-48  Score=370.05  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=206.3

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..||+|+||+||+|++..+++.||+|++....... .....+.+|+.++..++ ||||+++++++...+..++||||+++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~  113 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG  113 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence            47999999999999999999999999997643322 23456889999999985 59999999999999999999999999


Q ss_pred             CCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec--CCCeEEEEcccCceecCCCCCCCCc
Q psy10603         87 GTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        87 g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~--~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      |+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.  +.+.+||+|||+++......    .
T Consensus       114 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~  189 (327)
T 3lm5_A          114 GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----E  189 (327)
T ss_dssp             EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------
T ss_pred             CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc----c
Confidence            9999988543 356999999999999999999999999999999999999986  13469999999998765332    1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH--HHhCCCCCCCCCccCHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF--KVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~~  241 (407)
                      .....||+.|+|||++..   ..++.++|||||||++|+|++|+.||...........  .......+..+..+++++++
T Consensus       190 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          190 LREIMGTPEYLAPEILNY---DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             ----CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             cccccCCcCccCCeeecC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            244679999999999854   3468899999999999999999999986543322221  22222333445678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++.+||+.||++|||+.|+++|||+..
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             HHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence            999999999999999999999999863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-48  Score=374.79  Aligned_cols=253  Identities=29%  Similarity=0.505  Sum_probs=209.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+++.||+|++...  .+....+.+.+|+.+|++++||||+++++++...+..++||||
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            34455999999999999999999999999999754  3445567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.++++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++.......    
T Consensus       113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~----  186 (360)
T 3eqc_A          113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSM----  186 (360)
T ss_dssp             CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHHC----
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCccccccc----
Confidence            9999999999764 4599999999999999999999996 999999999999998865 69999999987653221    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHH------------------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ------------------------  218 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~------------------------  218 (407)
                       .....||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........                        
T Consensus       187 -~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          187 -ANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             -----CCCCTTCCHHHHTT---CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             -ccCCCCCCCeECHHHHcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence             234579999999999854   3468899999999999999999999975432211                        


Q ss_pred             -----------------HHHHHhCCCCCCCC-CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        219 -----------------IMFKVGMGETPTIP-ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       219 -----------------~~~~~~~~~~~~~~-~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                       ....+.....+..+ ..+++++++|+.+||+.||++|||+.|+++||||..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                             11111222223332 357999999999999999999999999999999964

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-49  Score=368.32  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=205.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||+|++..   .+....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            45566699999999999999999999999998853   344566789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC-
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP-  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~-  161 (407)
                      |+++|+|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......... 
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC-------
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceeccccccccc
Confidence            9999999999987667799999999999999999999999999999999999998765 69999999998764332211 


Q ss_pred             ----------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH----HHHHhCCC
Q psy10603        162 ----------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI----MFKVGMGE  227 (407)
Q Consensus       162 ----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~----~~~~~~~~  227 (407)
                                ......+||+.|+|||++.+   ..++.++|||||||++|||++|..||.........    ....   .
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~---~  240 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF---L  240 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH---H
T ss_pred             ccccccccccccccccCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc---c
Confidence                      01125689999999999854   34688999999999999999999998753221100    0000   0


Q ss_pred             CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       228 ~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ....+..+++++.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11235678888999999999999999999999886

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-49  Score=378.15  Aligned_cols=259  Identities=28%  Similarity=0.421  Sum_probs=209.8

Q ss_pred             cceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||+||+|++.   .+++.||||++...... .....+.+.+|+++|+++ +||||+++++++...+.++
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            344558999999999999984   58899999998643211 111224466799999999 6999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus       136 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  213 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADE  213 (355)
T ss_dssp             EEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECCGGG
T ss_pred             EEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeecccCC
Confidence            999999999999999764 4599999999999999999999999999999999999998765 69999999998764322


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCCCCCccC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      .  ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.....  ....+........+..|..++
T Consensus       214 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (355)
T 1vzo_A          214 T--ERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  290 (355)
T ss_dssp             G--GGGCGGGSCCTTCCHHHHTTC-C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             C--CcccCcccCcCccChhhhcCC-CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence            1  122456899999999998642 23467899999999999999999999974321  222222223334566788899


Q ss_pred             HHHHHHHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      +.+++++.+||++||.+||     |+.|+++||||.
T Consensus       291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence            9999999999999999999     999999999985

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.5e-49  Score=371.04  Aligned_cols=256  Identities=30%  Similarity=0.483  Sum_probs=205.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+|+.||+|++.... .+....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            344559999999999999999999999999987543 3445566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......   .
T Consensus       106 ~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~---~  180 (331)
T 4aaa_A          106 VDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGE---V  180 (331)
T ss_dssp             CSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC------------
T ss_pred             CCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCcc---c
Confidence            999999888754 45699999999999999999999999999999999999998765 699999999976543221   2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC----------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG----------------  226 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~----------------  226 (407)
                      .....||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.............. .+                
T Consensus       181 ~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cCCCcCCccccCcccccCC--CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            2345789999999998542  3468899999999999999999999986543322211110 00                


Q ss_pred             ---CCCC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 ---ETPT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 ---~~~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                         ..+.         ....+++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~  311 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ  311 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence               0111         1135789999999999999999999999999999995

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.9e-48  Score=360.35  Aligned_cols=257  Identities=26%  Similarity=0.393  Sum_probs=212.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC------cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCce
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN------DARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREE   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   76 (407)
                      +.....||+|+||.||+|++..+|+.||+|++......      .....+.+.+|+.+|++++ ||||+++++++...+.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   98 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence            44455899999999999999999999999999754311      1234567889999999995 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      .++||||+++++|.++++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        99 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~  176 (298)
T 1phk_A           99 FFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDP  176 (298)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT
T ss_pred             EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchhhcCC
Confidence            99999999999999999763 4599999999999999999999999999999999999998765 699999999987654


Q ss_pred             CCCCCCcccccccCCccccccccccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---C
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDT---NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---T  230 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~  230 (407)
                      ..    ......||+.|+|||++...   ....++.++||||||+++|+|++|+.||.... .......+..+...   .
T Consensus       177 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          177 GE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             TC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTT
T ss_pred             Cc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-HHHHHHHHhcCCcccCcc
Confidence            32    22446789999999998531   12346789999999999999999999997543 33333333222221   1


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ....+++++.+++.+||+.||.+|||+.|+++||||.
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  288 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence            2246899999999999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-48  Score=357.51  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=211.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++. +++.||+|++.......    +.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            3445569999999999999987 46789999997543322    457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........  
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~--  162 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYT--  162 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHH--
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEeccccccccccccccc--
Confidence            9999999999977666799999999999999999999999999999999999998764 6999999999765432211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++||||||+++|+|++ |+.||... ........+..+..+..|..+++++.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYKPRLASTHVYQ  238 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             cccCcccccccCCHHHhcC---CCCCchhhhHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence            1234467888999999854   346889999999999999999 99999854 444555666666677778889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCC
Q psy10603        242 FAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ++.+||+.||++|||+.|+++|.
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~l  261 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQL  261 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHHH
Confidence            99999999999999999998763

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.8e-49  Score=378.64  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=212.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||||++...  ......+.+.+|+++|++++||||+++++++...+.+|+|||
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            345566999999999999999999999999998643  334455678899999999999999999999998899999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++|+|.++++.....+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++........ .
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~~-~  270 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYA-A  270 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEEE-C
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCcee-e
Confidence            9999999999976555699999999999999999999999999999999999998765 6999999999865432211 1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+++.|+|||++...   .++.++|||||||++|||++ |..||.... ..+....+..+..+..|..+++++.+
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  346 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLS-NQQTREFVEKGGRLPCPELCPDAVFR  346 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-HHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cCCCCCCCcCcCCHhHhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            11123457789999998642   35789999999999999998 999998654 44455555666677778899999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||+.||++|||+.++++
T Consensus       347 li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          347 LMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=368.81  Aligned_cols=254  Identities=26%  Similarity=0.456  Sum_probs=203.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--eEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--EMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~E   82 (407)
                      .....||+|+||+||+|++..+++.||||++.......  ..+.+.+|+++|++++||||+++++++...+  ..++|||
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            33449999999999999999999999999997543222  2456789999999999999999999988765  7899999


Q ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----ecCCCeEEEEcccCceecCC
Q psy10603         83 LCTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL----TAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill----~~~~~~vkl~DFGla~~~~~  156 (407)
                      |+++++|.++++...  ..+++..+..++.|++.||.|||++||+||||||+|||+    +.+ ..+||+|||+++....
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAARELED  168 (319)
T ss_dssp             CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTCEECCT
T ss_pred             CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCceecCC
Confidence            999999999997533  238999999999999999999999999999999999998    433 4699999999987654


Q ss_pred             CCCCCCcccccccCCccccccccccc-----ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc---hHHHHHHHhCCCC
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDT-----NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS---NYQIMFKVGMGET  228 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~---~~~~~~~~~~~~~  228 (407)
                      ..    ......||+.|+|||++...     ....++.++|||||||++|||++|+.||.....   ....+..+..+..
T Consensus       169 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          169 DE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             TC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            32    22446799999999998521     124468899999999999999999999964322   2333333322221


Q ss_pred             C------------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        229 P------------------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       229 ~------------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      +                        .++..+++.+.+++.+||+.||++|||+.|+++||-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            1                        122345677899999999999999999999999984

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.3e-49  Score=375.31  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=212.1

Q ss_pred             cceeeecccccCeEEEEEE-----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCce-
Q psy10603          4 VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREE-   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~-   76 (407)
                      +.....||+|+||.||+|+     +..+++.||||++...  ......+.+.+|+++|.++ +||||+++++++...+. 
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            4455699999999999998     5667789999999743  3344457789999999999 78999999999887654 


Q ss_pred             EEEEEecCCCCCHHHHHhhcCC----------------------------------------------------------
Q psy10603         77 MVLFMELCTEGTLESLVQSTED----------------------------------------------------------   98 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~----------------------------------------------------------   98 (407)
                      +++|||||++|+|.++++....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999975432                                                          


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCC
Q psy10603         99 -------GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ  171 (407)
Q Consensus        99 -------~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~  171 (407)
                             .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ .......||+
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~  259 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDY-VRKGDARLPL  259 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTC-EEC--CEECG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccc-hhccccCCCc
Confidence                   189999999999999999999999999999999999998765 6999999999766433211 1223457899


Q ss_pred             cccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccC
Q psy10603        172 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD  250 (407)
Q Consensus       172 ~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~d  250 (407)
                      .|+|||++.+   ..++.++|||||||++|||++ |+.||...............+..+..|..+++++.+++.+||+.|
T Consensus       260 ~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          260 KWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             GGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             eeEChhhhcC---CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            9999999864   346899999999999999998 999998766555555566666677788889999999999999999


Q ss_pred             CCCcCCHHHHhcCC
Q psy10603        251 PAQRATIFELLQHP  264 (407)
Q Consensus       251 p~~R~t~~e~l~hp  264 (407)
                      |++|||+.|+++|.
T Consensus       337 P~~Rps~~ell~~L  350 (359)
T 3vhe_A          337 PSQRPTFSELVEHL  350 (359)
T ss_dssp             GGGSCCHHHHHHHH
T ss_pred             hhhCCCHHHHHHHH
Confidence            99999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-48  Score=375.53  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=196.5

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~l   79 (407)
                      ....||+|+||+||+|++..+++ +|+|++......       ..+|+++|+.++||||+++++++...+      .+++
T Consensus        44 ~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           44 NCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            34489999999999999987776 888887643222       136999999999999999999986544      3889


Q ss_pred             EEecCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         80 FMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        80 v~E~~~~g~L~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ||||++++.+.....  .....+++..++.++.||+.||.|||++||+||||||+|||++.+++.+||+|||+++.....
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            999999765544332  234569999999999999999999999999999999999999854568999999999876443


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC------------
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM------------  225 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~------------  225 (407)
                      ..    ....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.....+.......            
T Consensus       196 ~~----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          196 EP----NVSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CC----CCSSCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CC----CcccccCcCccCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            22    2456889999999998543  34689999999999999999999999865433322211110            


Q ss_pred             ------CCCC---------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 ------GETP---------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 ------~~~~---------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                            ...|         .++..+++++.+|+.+||++||.+|||+.|+++||||.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence                  0011         12345889999999999999999999999999999995

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.4e-48  Score=359.82  Aligned_cols=251  Identities=31%  Similarity=0.570  Sum_probs=216.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||.||+|++..+++.||+|++......  ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            344899999999999999999999999999765332  234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   ...
T Consensus       104 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~---~~~  177 (303)
T 3a7i_A          104 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQI---KRN  177 (303)
T ss_dssp             TEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBC---CBC
T ss_pred             CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcccc---ccC
Confidence            9999999854  4599999999999999999999999999999999999998765 699999999987654321   224


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ...||+.|+|||++..   ..++.++|||||||++|+|++|+.||.... .......+..+..+.++..++.++.+++.+
T Consensus       178 ~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQ---SAYDSKADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             ccCCCcCccCHHHHhc---CCCCchhhhHHHHHHHHHHccCCCCCCCcC-HHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence            5679999999999854   345789999999999999999999998643 334444444556677788899999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCeeee
Q psy10603        246 CLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ||+.||++|||+.|+++|||+..
T Consensus       254 ~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             HcCCChhhCcCHHHHhhChhhhc
Confidence            99999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-49  Score=380.84  Aligned_cols=253  Identities=17%  Similarity=0.178  Sum_probs=188.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHH---HHHHhcCCCCCcceEE-------EEEEeC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVE---LRILEGINQKNLVKYY-------GVEIHR   74 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E---~~~l~~l~hpniv~~~-------~~~~~~   74 (407)
                      .....||+|+||+||+|++..+|+.||||++...........+.+.+|   +++|+. +||||++++       +.+..+
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEET
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecC
Confidence            344589999999999999999999999999987655455556667777   556666 799988765       444433


Q ss_pred             -----------------ceEEEEEecCCCCCHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecCCCC
Q psy10603         75 -----------------EEMVLFMELCTEGTLESLVQSTEDGLPEVLV------RRYTKQLVDAISALHENTIVHRDIKS  131 (407)
Q Consensus        75 -----------------~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~------~~~~~qi~~aL~yLH~~~iiHrdlKp  131 (407)
                                       ..+|+|||||+ |+|.++++.....+++...      ..++.||+.||.|||++||+||||||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp  222 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP  222 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence                             34899999999 8999999764444555555      56779999999999999999999999


Q ss_pred             CCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy10603        132 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA  211 (407)
Q Consensus       132 ~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~  211 (407)
                      +|||++.++ .+||+|||+++......      ....+|+.|+|||++.+. ...++.++|||||||++|||++|+.||.
T Consensus       223 ~NIll~~~~-~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          223 DNLFIMPDG-RLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNAS-TATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             GGEEECTTS-CEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCS-EEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             HHEEECCCC-CEEEEecceeeecCCCc------cCccCCcCCcChhhccCC-CCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999865 69999999998764321      134677999999998542 1346899999999999999999999998


Q ss_pred             CCCchHHHHH-----HHhCCCCC--CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        212 EYDSNYQIMF-----KVGMGETP--TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       212 ~~~~~~~~~~-----~~~~~~~~--~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..........     ........  ..+..+++++.+++.+||++||++|||+.|+++||||.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            6532211000     00001111  22357899999999999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.5e-48  Score=378.92  Aligned_cols=250  Identities=30%  Similarity=0.513  Sum_probs=201.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC------CCCCcceEEEEEEeCceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI------NQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~~~   78 (407)
                      .....||+|+||+||+|++..+++.||||++...    ....+.+.+|+++++.+      +|+||+++++.+...+.++
T Consensus       100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A          100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             EEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            3345999999999999999999999999998642    33445667788877765      6789999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC-eEEEEcccCceecCC
Q psy10603         79 LFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN-SLKLGDFGSAVKISA  156 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~-~vkl~DFGla~~~~~  156 (407)
                      +||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++....
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            9999997 58888886643 45999999999999999999999999999999999999987653 399999999976532


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCC-------
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GET-------  228 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~-------  228 (407)
                      .      ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+........... +..       
T Consensus       255 ~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          255 R------VYTYIQSRFYRAPEVILG---ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             C------CCSSCSCGGGCCHHHHHT---BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             c------ccccCCCCCccChHHHhC---CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            2      244689999999999865   34689999999999999999999999865443222111100 000       


Q ss_pred             -------------C------------------------------------CCCCccCHHHHHHHHHhcccCCCCcCCHHH
Q psy10603        229 -------------P------------------------------------TIPESLSDEGQAFAELCLRHDPAQRATIFE  259 (407)
Q Consensus       229 -------------~------------------------------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e  259 (407)
                                   |                                    .++...++++.+|+.+||++||++|||+.|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence                         0                                    012234788999999999999999999999


Q ss_pred             HhcCCeeee
Q psy10603        260 LLQHPFLIV  268 (407)
Q Consensus       260 ~l~hp~~~~  268 (407)
                      +|+||||..
T Consensus       406 ~L~Hpw~~~  414 (429)
T 3kvw_A          406 ALRHPWLRR  414 (429)
T ss_dssp             HHTSTTTC-
T ss_pred             HhCChhhcc
Confidence            999999963

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.9e-48  Score=357.50  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=207.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHH----HHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFV----KDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      .+.....||+|+||+||+|++..+++.||+|++...........    +.+.+|+.++++++||||+++++++.+..  +
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   97 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R   97 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence            34556699999999999999999999999999875443322221    67889999999999999999999986655  7


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCC----eEEEEcccCce
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGN----SLKLGDFGSAV  152 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~----~vkl~DFGla~  152 (407)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||++|  |+||||||+|||++.++.    .+||+|||+++
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            999999999999988766667999999999999999999999999  999999999999986542    39999999997


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHH--HHHHHhCCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ--IMFKVGMGETPT  230 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~--~~~~~~~~~~~~  230 (407)
                      ....      ......||+.|+|||++... ...++.++|||||||++|+|++|+.||........  .......+..+.
T Consensus       178 ~~~~------~~~~~~g~~~y~aPE~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 4f0f_A          178 QSVH------SVSGLLGNFQWMAPETIGAE-EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT  250 (287)
T ss_dssp             CCSS------CEECCCCCCTTSCGGGSSCS-SCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred             cccc------cccccCCCccccCchhhccC-CCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence            5432      22446799999999998432 23457899999999999999999999986543322  222334556677


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++..+++++.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            88899999999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.7e-48  Score=358.47  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=208.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .....||+|+||+||+|++..+++.||+|++........   ...+.+.+|+.+|++++||||+++++++...+..++||
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   87 (283)
T 3bhy_A            8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL   87 (283)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence            445599999999999999999999999999976533211   12467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC---eEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~---~vkl~DFGla~~~~~~~  158 (407)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.   .+||+|||++.......
T Consensus        88 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~  166 (283)
T 3bhy_A           88 ELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN  166 (283)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred             eecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence            999999999999753 45999999999999999999999999999999999999987542   69999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCcc
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESL  235 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (407)
                          ......||+.|+|||++..   ..++.++||||||+++|+|++|+.||.... .......+......   ..+..+
T Consensus       167 ----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          167 ----EFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGET-KQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             ---------CCCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ----cccccCCCcCccCcceecC---CCCCcchhhhhHHHHHHHHHHCCCCCCCcc-hHHHHHHhHhcccCCcchhcccC
Confidence                1234578999999999854   346789999999999999999999998643 33333333322221   123567


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++++.+++.+||+.||++|||+.|+++|||+.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  270 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK  270 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence            89999999999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-48  Score=362.62  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=203.2

Q ss_pred             cceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~   77 (407)
                      +.....||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|+++|++++||||+++++++...  ..+
T Consensus        12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            4455699999999999998    5678999999998643   445567789999999999999999999998654  458


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ++||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccCC
Confidence            999999999999999977655699999999999999999999999999999999999999864 7999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch---------------HHHHHH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN---------------YQIMFK  222 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~---------------~~~~~~  222 (407)
                      ...........+|+.|+|||++.+   ..++.++|||||||++|||++|..||......               ......
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTE---SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cceeeeccCCCCccceeCcHHhcC---CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            222222234457788999999864   34688999999999999999999998642111               122233


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ...+..+..|..+++++.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4445566678889999999999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.5e-48  Score=359.72  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+|+.||+|++.....   ...+.+.+|+.+|++++||||+++++++...+..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A           12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            345589999999999999999999999999975432   12356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---ecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill---~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+   +. +..+||+|||++......    
T Consensus        89 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg~~~~~~~~----  162 (304)
T 2jam_A           89 SGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE-NSKIMITDFGLSKMEQNG----  162 (304)
T ss_dssp             CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSST-TCCEEBCSCSTTCCCCCB----
T ss_pred             CCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCC-CCCEEEccCCcceecCCC----
Confidence            999999988654 458999999999999999999999999999999999999   44 356999999998654321    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC---CCCCCCccCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~s~~  238 (407)
                       ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.... .......+..+.   ....+..++++
T Consensus       163 -~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          163 -IMSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVITYILLCGYPPFYEET-ESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             -TTHHHHSCCCBCCTTTBSS---CSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             -ccccccCCCCccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCCCCccccccCCHH
Confidence             1234578999999999854   346889999999999999999999998543 333333333332   22345678999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+++.+||+.||++|||+.|+++|||+.
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence            99999999999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-48  Score=373.40  Aligned_cols=249  Identities=28%  Similarity=0.392  Sum_probs=193.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~   78 (407)
                      .....||+|+||+||+|++..+++.||||++.... .+....+.+.+|+.+|+.++||||+++++++...+      ..|
T Consensus        28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            34448999999999999999999999999997543 34455677889999999999999999999987655      789


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++ +|.++++.   .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus       107 lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          107 IVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF  181 (371)
T ss_dssp             EEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC--------
T ss_pred             EEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccccc
Confidence            99999985 78777742   389999999999999999999999999999999999998765 69999999997654321


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC----------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET----------  228 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~----------  228 (407)
                          .....+||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.+.+.. .....+.....          
T Consensus       182 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          182 ----MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ------------CTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTTS
T ss_pred             ----ccCCceecCCccCHHHhcC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHh
Confidence                2245689999999999865   34688999999999999999999999865432 22222221110          


Q ss_pred             -----------CCC--------------C------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        229 -----------PTI--------------P------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       229 -----------~~~--------------~------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                 +..              |      ...++++++|+.+||+.||++|||+.|+++||||.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                       110              0      01256889999999999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.1e-48  Score=358.29  Aligned_cols=256  Identities=29%  Similarity=0.502  Sum_probs=214.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLF   80 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv   80 (407)
                      .+.....||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++..  .+..++|
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            34556699999999999999999999999999976543 34456778999999999999999999998754  5689999


Q ss_pred             EecCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         81 MELCTEGTLESLVQST---EDGLPEVLVRRYTKQLVDAISALHENT-----IVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~-----iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+++     |+||||||+|||++.++ .+||+|||+++
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~~~  164 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLAR  164 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCchhe
Confidence            9999999999998653   234899999999999999999999999     99999999999998765 69999999997


Q ss_pred             ecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC
Q psy10603        153 KISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP  232 (407)
Q Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  232 (407)
                      .......   ......||+.|+|||++..   ..++.++||||||+++|+|++|+.||.... .......+..+..+.++
T Consensus       165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~  237 (279)
T 2w5a_A          165 ILNHDTS---FAKTFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKFRRIP  237 (279)
T ss_dssp             HC---CH---HHHHHHSCCTTCCHHHHHC---C-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCC
T ss_pred             eeccccc---cccccCCCccccChHHhcc---CCCCchhhHHHHHHHHHHHHHCCCCCcccC-HHHHHHHHhhcccccCC
Confidence            6543211   1234578999999999854   346789999999999999999999998643 44455556666677788


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+++++.+++.+||+.||.+|||+.|+++|+|+.
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            89999999999999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.3e-48  Score=362.89  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=199.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE------------
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEI------------   72 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------------   72 (407)
                      .....||+|+||.||+|++..+++.||+|++...   +....+.+.+|++++++++||||+++++++.            
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            3445899999999999999999999999998743   3455678899999999999999999999873            


Q ss_pred             --eCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccC
Q psy10603         73 --HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGS  150 (407)
Q Consensus        73 --~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGl  150 (407)
                        ..+..|+||||++ |+|.++++.  ..+++..+..++.|++.||+|||++||+||||||+|||++.++..+||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence              3467899999998 599999854  45899999999999999999999999999999999999986666899999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCC----
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG----  226 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~----  226 (407)
                      ++................+|+.|+|||++...  ..++.++|||||||++|||++|+.||....... ....+...    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  244 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP--NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIPVV  244 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSCCC
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCc--ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence            98765332222233456789999999988542  346889999999999999999999998654322 21111100    


Q ss_pred             --------------------CCC-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 --------------------ETP-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 --------------------~~~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                          ..+     ..+..+++++++++.+||+.||++|||+.|+++||||.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence                                001     11346899999999999999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-48  Score=362.76  Aligned_cols=254  Identities=33%  Similarity=0.600  Sum_probs=206.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|++..+++.||+|++......   ..+.+.+|+.++..++||||+++++++...+..++||||++
T Consensus        23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (302)
T 2j7t_A           23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP   99 (302)
T ss_dssp             EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred             ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence            344899999999999999999999999998654322   24678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........   ...
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~---~~~  175 (302)
T 2j7t_A          100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQ---KRD  175 (302)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHHH---C--
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCcccccccc---ccc
Confidence            9999999876666799999999999999999999999999999999999998765 699999999754322111   123


Q ss_pred             ccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQA  241 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~  241 (407)
                      ...||+.|+|||++...  ....++.++|||||||++|+|++|..||...... ...........+  ..+..++.++.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHhccCCcccCCccccCHHHHH
Confidence            45789999999998421  1234678999999999999999999999865433 333333333333  235678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+||+.||++|||+.|+++|||+.
T Consensus       255 li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             HHHHHcccChhhCCCHHHHhcChHHh
Confidence            99999999999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=358.69  Aligned_cols=250  Identities=34%  Similarity=0.626  Sum_probs=207.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|++..+|+.||+|++.....     .+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        32 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             EEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            344589999999999999999999999999975432     246788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........   ..
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~---~~  182 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMA---KR  182 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBS---CB
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhcc---cc
Confidence            99999999976566799999999999999999999999999999999999998765 699999999987653321   22


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC--CCCCccCHHHHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--TIPESLSDEGQAF  242 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~~  242 (407)
                      ....||+.|+|||++..   ..++.++|||||||++|+|++|+.||...... ...........+  ..+..+++++.++
T Consensus       183 ~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQE---IGYNCVADIWSLGITAIEMAEGKPPYADIHPM-RAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             CCCCSCGGGCCHHHHSS---SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             CccCCCCCccChhhcCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCcccCCcccCCHHHHHH
Confidence            45678999999999854   34678999999999999999999999865433 222222222222  2356789999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+||..||.+|||+.|+++|||+.
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHh
Confidence            9999999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.8e-48  Score=373.62  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=198.5

Q ss_pred             cceeeecccccCeEEEEEEEC---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN---ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +.....||+|+||+||+|++.   .++..||||++...  ......+.+.+|+.+|++++||||+++++++...+..++|
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            445569999999999999876   56778999998653  2445567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++|+|.++++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC------------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccccccccCCcc
Confidence            999999999999987666799999999999999999999999999999999999998765 6999999999876543221


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      ........+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.... .......+..+..+..+..++.++
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l  279 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAY---RKFTSASDVWSYGIVLWEVMSYGERPYWEMS-NQDVIKAVDEGYRLPPPMDCPAAL  279 (373)
T ss_dssp             ----------CTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-HHHHHHHHHTTEECCCCTTCBHHH
T ss_pred             ceeccCCCcCCCccChhhhcc---CCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCccccHHH
Confidence            111223345788999999854   346889999999999999998 999998643 444555555555556677889999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+.||.+||++.|+++
T Consensus       280 ~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          280 YQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999886

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=362.78  Aligned_cols=255  Identities=29%  Similarity=0.553  Sum_probs=202.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEe------Cce
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIH------REE   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~------~~~   76 (407)
                      +.....||+|+||.||+|++..+|+.||+|++......    .+.+.+|+.+++++ +||||+++++++..      .+.
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            34455999999999999999999999999999754322    24577899999998 79999999999987      468


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      +++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecC
Confidence            999999999999999997642 4589999999999999999999999999999999999998765 69999999997654


Q ss_pred             CCCCCCCcccccccCCcccccccccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC-CCCCC
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE-TPTIP  232 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~  232 (407)
                      ....   ......||+.|+|||++....  ...++.++|||||||++|+|++|+.||...... .....+.... ....+
T Consensus       181 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          181 RTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-RALFLIPRNPAPRLKS  256 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSC
T ss_pred             cCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCccccCCc
Confidence            3221   224467999999999985321  234678999999999999999999999865433 3333333222 33345


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+++++++++.+||..||.+|||+.|+++||||.
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            67899999999999999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.5e-50  Score=384.69  Aligned_cols=245  Identities=18%  Similarity=0.203  Sum_probs=193.8

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHH---HHHhcCCCCCcceEE-------EEEEeCc-
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVEL---RILEGINQKNLVKYY-------GVEIHRE-   75 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~~~-------~~~~~~~-   75 (407)
                      ...||+|+||+||+|++..+|+.||||++...........+.+.+|+   ++|++++|||||+++       +++..++ 
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            45899999999999999999999999999865444445567788999   566677899999998       6665553 


Q ss_pred             ----------------eEEEEEecCCCCCHHHHHhhcCCCCCH-------HHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy10603         76 ----------------EMVLFMELCTEGTLESLVQSTEDGLPE-------VLVRRYTKQLVDAISALHENTIVHRDIKSA  132 (407)
Q Consensus        76 ----------------~~~lv~E~~~~g~L~~~~~~~~~~~~~-------~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~  132 (407)
                                      ..|+||||+ +|+|.++++... .+++       ..+..++.||+.||+|||++||+||||||+
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~  235 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV  235 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence                            289999999 579999997532 2444       788889999999999999999999999999


Q ss_pred             CEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCccccccccccc--------ccCCCCcchhHHHHHHHHHHHH
Q psy10603        133 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--------NKVGHGRAVDIWSLGCVLVEMS  204 (407)
Q Consensus       133 Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--------~~~~~~~~~DiwSlGv~l~em~  204 (407)
                      |||++.++ .+||+|||+++....      .....+| +.|+|||++...        ....++.++|||||||++|||+
T Consensus       236 NIll~~~~-~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          236 DIVLDQRG-GVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             GEEECTTC-CEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             HEEEcCCC-CEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            99999765 699999999986432      2244577 999999998653        0114689999999999999999


Q ss_pred             cCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        205 SGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       205 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +|+.||...... .....+     ...+..+++++.+++.+||+.||++|||+.|+++||||.
T Consensus       308 tg~~Pf~~~~~~-~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  364 (377)
T 3byv_A          308 CADLPITKDAAL-GGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  364 (377)
T ss_dssp             HSSCCC-------CCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred             HCCCCCcccccc-cchhhh-----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence            999999753221 111111     112357899999999999999999999999999999984

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-48  Score=374.64  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=187.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~   78 (407)
                      .....||+|+||.||+|++..+|+.||||++.... .+....+++.+|+++|+.++||||+++++++...      ...|
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~  110 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY  110 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence            33448999999999999999999999999986543 3445567788999999999999999999998654      5689


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +|||++ +++|.++++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... 
T Consensus       111 lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~-  185 (367)
T 2fst_X          111 LVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADE-  185 (367)
T ss_dssp             EEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC-----------
T ss_pred             EEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccccccccc-
Confidence            999999 6799988864  4599999999999999999999999999999999999998765 6999999999765322 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC-----------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG-----------  226 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~-----------  226 (407)
                           ....+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+...+...... .+           
T Consensus       186 -----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          186 -----MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ----------CCCTTCCHHHHTTC--CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             -----CCCcCcCcCccChHHHcCC--cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence                 2456899999999998642  3468899999999999999999999986543322211100 00           


Q ss_pred             ------------CCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 ------------ETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 ------------~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                  ..+.     .....++++.+|+.+||+.||++|||+.|+|+||||.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence                        0111     1135688999999999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=362.41  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=208.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-DARFVKDMLVELRILEGINQKNLVKYYGVEI--HREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv   80 (407)
                      +.....||+|+||.||+|.+..+++.||+|++...... .....+.+.+|++++++++||||+++++++.  ..+..++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            44556999999999999999999999999999754211 1223467889999999999999999999984  45579999


Q ss_pred             EecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         81 MELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||++++ |.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus        87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPFAA  164 (305)
T ss_dssp             EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTTCS
T ss_pred             ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCcccc
Confidence            9999987 66666543 45699999999999999999999999999999999999998765 699999999987643221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      . .......||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||... +.......+..+ ...++..+++++
T Consensus       165 ~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~~-~~~~~~~~~~~l  240 (305)
T 2wtk_C          165 D-DTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYPFEGD-NIYKLFENIGKG-SYAIPGDCGPPL  240 (305)
T ss_dssp             S-CEECCCCSCGGGCCHHHHTCCS-CEESHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHC-CCCCCSSSCHHH
T ss_pred             c-cccccCCCCCCCcChhhccCcc-cCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHHHHhcC-CCCCCCccCHHH
Confidence            1 1224567899999999985422 22367999999999999999999999854 333333333333 345677899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      .+++.+||+.||.+|||+.|+++|||+..
T Consensus       241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            99999999999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.5e-48  Score=353.01  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=210.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|.+. ++..||+|++.......    +++.+|++++.+++||||+++++++...+..++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             heeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            3455569999999999999876 56779999997543322    457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.........  
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~--  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYV--  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEE--
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhh--
Confidence            9999999999977655699999999999999999999999999999999999998765 6999999999876443221  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++||||||+++|+|++ |+.||.... ..........+..+..|...++++.+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHY---FKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRLYRPHLASDTIYQ  236 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHH---SEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             cccCCCcCcccCCHHHHhc---cCCchhhhhHHHHHHHHHHHcCCCCCccccC-hHHHHHHHHcCCCCCCCCcChHHHHH
Confidence            1233456788999999854   235789999999999999999 999998543 44555556666667778889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCC
Q psy10603        242 FAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ++..||+.||++|||+.|++++.
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-47  Score=365.55  Aligned_cols=258  Identities=28%  Similarity=0.515  Sum_probs=205.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~   77 (407)
                      .+.....||+|+||+||+|++..+|+.||||++...  ........+.+|+++|++++||||+++++++...     ...
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            344556999999999999999999999999998643  3445567788999999999999999999987654     679


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |+||||++ ++|.+++..  ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus        90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred             EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccc
Confidence            99999997 589998865  3599999999999999999999999999999999999998765 6999999999876532


Q ss_pred             CCCC-------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC--
Q psy10603        158 TTVP-------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE--  227 (407)
Q Consensus       158 ~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~--  227 (407)
                      ....       ......+||+.|+|||++...  ..++.++|||||||++|+|++|+.||.............. .+.  
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTS--AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSC--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccCccccccchhhccccccccCCeeeccC--CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            2110       112346789999999987542  3468899999999999999999999986543322211110 000  


Q ss_pred             ----------------------CCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        228 ----------------------TPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       228 ----------------------~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                            .+.     .+..+++++.+++.+||+.||++|||+.|+++||||..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                                  000     12468899999999999999999999999999999963

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.9e-48  Score=353.97  Aligned_cols=248  Identities=17%  Similarity=0.289  Sum_probs=209.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMVLF   80 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv   80 (407)
                      .+.....||+|+||+||+|++.  ++.||+|++.... ......+.+.+|+.+|++++||||+++++++...  +..++|
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            4556669999999999999985  8889999997653 3344557799999999999999999999999877  788999


Q ss_pred             EecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         81 MELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |||+++|+|.+++..... .+++..+..++.|++.||.|||+++  |+||||||+|||++.++ .+||+|||++..... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQS-  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTTSC-
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeeecc-
Confidence            999999999999976443 4899999999999999999999999  99999999999998764 589999888644221 


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                             ....||+.|+|||++.+.....++.++|||||||++|||++|+.||...............+..+.+|..+++
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence                   3357899999999987644443455899999999999999999999866544444444556667788899999


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999885

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=356.03  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=211.4

Q ss_pred             ecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||.||+|.+.  .+++.||+|++...  ......+.+.+|+++|++++||||+++++++ ..+..++||||+++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~   93 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG   93 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence            8999999999999854  46788999998754  3445567889999999999999999999998 56679999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..............
T Consensus        94 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~  172 (287)
T 1u59_A           94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSA  172 (287)
T ss_dssp             EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCS
T ss_pred             CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeeccCcceeecccc
Confidence            999999976666799999999999999999999999999999999999999764 7999999999876543322122233


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..||+.|+|||++..   ..++.++|||||||++|||++ |+.||.... .......+..+..+..|..+++++.+++..
T Consensus       173 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  248 (287)
T 1u59_A          173 GKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSD  248 (287)
T ss_dssp             SCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccccccccCHHHhcc---CCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHhcCCcCCCCCCcCHHHHHHHHH
Confidence            457899999999854   235789999999999999998 999998644 344555666667777888999999999999


Q ss_pred             hcccCCCCcCCHHHHhcCCee
Q psy10603        246 CLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ||+.||++||++.|++++.+-
T Consensus       249 ~l~~~p~~Rps~~~l~~~l~~  269 (287)
T 1u59_A          249 CWIYKWEDRPDFLTVEQRMRA  269 (287)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHHHHH
Confidence            999999999999999987653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.5e-48  Score=362.72  Aligned_cols=259  Identities=20%  Similarity=0.323  Sum_probs=193.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE---
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM---   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~---   77 (407)
                      +.....||+|+||+||+|++..+++   .||+|++....... ...+.+.+|++++++++||||+++++++...+..   
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            4455699999999999999887775   89999987543222 3457789999999999999999999999877654   


Q ss_pred             ---EEEEecCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         78 ---VLFMELCTEGTLESLVQSTE-----DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        78 ---~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                         ++||||+++|+|.+++....     ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl~Dfg  182 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFG  182 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEEeecc
Confidence               99999999999999985432     1489999999999999999999999999999999999998765 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCC
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET  228 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~  228 (407)
                      +++........ .......+|+.|+|||++.+   ..++.++|||||||++|||++ |..||.... .......+..+..
T Consensus       183 ~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~-~~~~~~~~~~~~~  257 (323)
T 3qup_A          183 LSRKIYSGDYY-RQGCASKLPVKWLALESLAD---NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-NAEIYNYLIGGNR  257 (323)
T ss_dssp             C------------------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCC
T ss_pred             ccccccccccc-cccccccCcccccCchhhcC---CCCCCccchhhHHHHHHHHHhCCCCCccccC-hHHHHHHHhcCCC
Confidence            99776433211 11233456789999999854   346889999999999999999 999998644 3344455555666


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCC-------HHHHhcCCeeeee
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRAT-------IFELLQHPFLIVS  269 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t-------~~e~l~hp~~~~~  269 (407)
                      +..+..+++++.+++.+||+.||++|||       +.++++|||+...
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            6778889999999999999999999999       6667889998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.7e-48  Score=361.77  Aligned_cols=260  Identities=28%  Similarity=0.503  Sum_probs=190.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++..+++.||+|++.....  ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            34455699999999999999999999999998865422  2334668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         83 LCTEGTLESLVQS-------TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        83 ~~~~g~L~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      |+++++|.+++..       ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLA  172 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHHHCC
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchheec
Confidence            9999999999864       234589999999999999999999999999999999999998765 69999999987654


Q ss_pred             CCCCC--CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC----
Q psy10603        156 AHTTV--PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP----  229 (407)
Q Consensus       156 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~----  229 (407)
                      .....  ........||+.|+|||++...  ..++.++|||||||++|+|++|+.||............. ....+    
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~  249 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQV--RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPSLET  249 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHH--HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TSSCCCTTC
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccc--cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-ccCCCcccc
Confidence            32111  1122346799999999998542  235789999999999999999999998655443332222 22222    


Q ss_pred             -----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        230 -----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       230 -----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                           .....+++++.+++.+||+.||.+|||+.|+++||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence                 233567899999999999999999999999999999963

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.6e-48  Score=353.44  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=196.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND-ARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .+.....||+|+||.||+|++.  ++.||+|++....... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            4566679999999999999975  7899999987543222 233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEecC-------CCeEEEEcccCc
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT---IVHRDIKSANIFLTAE-------GNSLKLGDFGSA  151 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---iiHrdlKp~Nill~~~-------~~~vkl~DFGla  151 (407)
                      ||+++++|.++++.  ..+++..+..++.|++.||.|||++|   |+||||||+|||++.+       +..+||+|||++
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           86 EFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             ECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            99999999999853  45999999999999999999999999   8999999999999852       346999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI  231 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  231 (407)
                      +......     .....||+.|+|||++.+   ..++.++||||||+++|+|++|+.||..................+..
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          164 REWHRTT-----KMSAAGAYAWMAPEVIRA---SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             -----------------CCGGGSCHHHHHH---CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             ccccccc-----ccCCCCccceeCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            7654322     124578999999999854   34688999999999999999999999865544333333344445667


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +..+++++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            78899999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-47  Score=365.00  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=211.9

Q ss_pred             cceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|++.     .+++.||+|++...  ......+.+.+|+.+|++++||||+++++++...+..+
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            445558999999999999987     45589999998743  24455678899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy10603         79 LFMELCTEGTLESLVQSTE-----------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIF  135 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nil  135 (407)
                      +||||+++|+|.++++...                       ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            9999999999999997632                       45899999999999999999999999999999999999


Q ss_pred             EecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q psy10603        136 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYD  214 (407)
Q Consensus       136 l~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~  214 (407)
                      ++.++ .+||+|||+++........ .......||+.|+|||++..   ..++.++|||||||++|||++ |..||... 
T Consensus       207 ~~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~-  280 (343)
T 1luf_A          207 VGENM-VVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  280 (343)
T ss_dssp             ECGGG-CEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             ECCCC-eEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc---CCcCcccccHHHHHHHHHHHhcCCCcCCCC-
Confidence            98765 6999999999765432211 11234568899999999864   346889999999999999999 99999854 


Q ss_pred             chHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        215 SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.......+..+..+..|..+++++.+++.+||+.||++|||+.|++++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            3445556666677777888999999999999999999999999998864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.3e-48  Score=363.99  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=201.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEE----EEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|++..+++.+    |+|.+...  ......+++.+|+.+|++++||||+++++++.... .++
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            444559999999999999998888755    66766432  22234567889999999999999999999987654 789


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHTTTCC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEccCCcc
Confidence            9999999999999987677799999999999999999999999999999999999999865 799999999987654322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      . .......||+.|+|||++.+   ..++.++|||||||++|||++ |+.||.... .......+..+..+..+..++.+
T Consensus       173 ~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          173 E-YHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             --------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             c-ccccCCCccccccChHHhcc---CCCCchhhhhhhHHHHHHHHhcCCCCccCCC-HHHHHHHHHcCCCCCCCccCCHH
Confidence            1 12233456889999999864   346899999999999999999 999998643 33344455555666677889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +.+++.+||+.||++|||+.|++++.
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~l  273 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            99999999999999999999998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=376.73  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=182.7

Q ss_pred             ecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEEEEecC
Q psy10603          9 SPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVLFMELC   84 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~E~~   84 (407)
                      .||+|+||+||+|++.  .+++.||||++......     ..+.+|+.+|++++||||+++++++..  ...+|+||||+
T Consensus        28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~  102 (405)
T 3rgf_A           28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA  102 (405)
T ss_dssp             CCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred             EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence            7999999999999966  57889999998644221     356789999999999999999999965  66899999999


Q ss_pred             CCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe---cCCCeEEEEcccCcee
Q psy10603         85 TEGTLESLVQST--------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT---AEGNSLKLGDFGSAVK  153 (407)
Q Consensus        85 ~~g~L~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~---~~~~~vkl~DFGla~~  153 (407)
                      ++ +|.+++...        ...+++..++.++.||+.||.|||++||+||||||+|||+.   ++...+||+|||+++.
T Consensus       103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  181 (405)
T 3rgf_A          103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  181 (405)
T ss_dssp             SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred             CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence            75 777776421        12489999999999999999999999999999999999993   2235799999999987


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--------HHHHHHH--
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--------YQIMFKV--  223 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--------~~~~~~~--  223 (407)
                      ..............+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||......        ...+..+  
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          182 FNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             ---------------CCCTTCCHHHHTTC--CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             cCCCCcccccCCCceecCcccCchhhcCC--CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            65432222334557899999999998642  34688999999999999999999999753321        1111111  


Q ss_pred             hCCCCC-CC----------------------------------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        224 GMGETP-TI----------------------------------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       224 ~~~~~~-~~----------------------------------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ..+..+ ..                                  ....++++.+||.+||++||.+|||+.|+|+||||..
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~  339 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE  339 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTS
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhcc
Confidence            011110 00                                  0112678899999999999999999999999999963

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-47  Score=354.83  Aligned_cols=249  Identities=25%  Similarity=0.383  Sum_probs=197.7

Q ss_pred             ceeeecccccCeEEEEEEECCC---CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNET---GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .....||+|+||+||+|++..+   +..||+|.+...  ......+.+.+|+.++++++||||+++++++ ..+..|+||
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   94 (281)
T 1mp8_A           18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIM   94 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             EEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEE
Confidence            4455899999999999998654   457999987643  3445567789999999999999999999987 456789999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++++|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~-  172 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYY-  172 (281)
T ss_dssp             ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC--------------
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCccccc-
Confidence            99999999999987666799999999999999999999999999999999999999764 7999999999776433211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......+|+.|+|||++..   ..++.++|||||||++|||++ |..||..... ......+..+..+..+..+++++.
T Consensus       173 -~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~  247 (281)
T 1mp8_A          173 -KASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTLY  247 (281)
T ss_dssp             -------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             -ccccCCCcccccChhhccc---CCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-HHHHHHHHcCCCCCCCCCCCHHHH
Confidence             1223456789999999854   346789999999999999996 9999986443 344455555666777889999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcC
Q psy10603        241 AFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++.+||+.||++|||+.|++++
T Consensus       248 ~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          248 SLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-48  Score=366.22  Aligned_cols=256  Identities=23%  Similarity=0.309  Sum_probs=210.4

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.....||+|+||+||+|++     ..+++.||+|++....  .....+.+.+|+.+|.++ +||||+++++++...+..
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            34455999999999999997     3456789999997432  233456788999999999 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy10603         78 VLFMELCTEGTLESLVQSTED----------------------GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIF  135 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~----------------------~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nil  135 (407)
                      ++||||+++|+|.+++.....                      .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            999999999999999976432                      2789999999999999999999999999999999999


Q ss_pred             EecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q psy10603        136 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYD  214 (407)
Q Consensus       136 l~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~  214 (407)
                      ++.++ .+||+|||++......... .......||+.|+|||++.+   ..++.++|||||||++|+|++ |..||....
T Consensus       205 l~~~~-~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          205 VTHGK-VVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             EETTT-EEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             EcCCC-cEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc---CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            98764 7999999999766433211 11234567889999999854   346889999999999999998 999998765


Q ss_pred             chHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        215 SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ...........+..+..+..+++++.+++.+||+.||.+|||+.|+++|..-
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  331 (344)
T 1rjb_A          280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  331 (344)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            5544445555566667788899999999999999999999999999987643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-47  Score=355.17  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=210.2

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus        25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  103 (287)
T 2wei_A           25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY  103 (287)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEcc
Confidence            34558999999999999999999999999997543322 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC--CeEEEEcccCceecCCCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG--NSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~--~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++  ..+||+|||++.......    
T Consensus       104 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~----  178 (287)
T 2wei_A          104 TGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----  178 (287)
T ss_dssp             CSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS----
T ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC----
Confidence            999999888654 3599999999999999999999999999999999999997643  369999999987654332    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CC--CCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TI--PESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~--~~~~s~~~  239 (407)
                      ......||+.|+|||++.+    .++.++||||||+++|+|++|+.||.... .......+..+..+ ..  ...+++++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT----CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             ccccccCcccccChHHhcC----CCCCchhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            2234578999999999853    26789999999999999999999998643 33444444333322 22  25689999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+++.+||+.||++|||+.|+++||||.
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~  281 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence            9999999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.7e-47  Score=354.20  Aligned_cols=249  Identities=22%  Similarity=0.360  Sum_probs=207.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|.+. +++.||+|++.......    +++.+|++++.+++||||+++++++...+..++||||
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             EEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            444569999999999999876 57789999997543322    4578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........  .
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~--~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYT--S  177 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHH--S
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEccccccccccccccc--c
Confidence            999999999976556699999999999999999999999999999999999998765 6999999999765432211  1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      .....+|+.|+|||++..   ..++.++||||||+++|+|++ |+.||.... .......+..+..+..+...++++.++
T Consensus       178 ~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l  253 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRPHLASEKVYTI  253 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccCCccCcccCCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCccccC-hhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence            233456888999999864   346889999999999999998 999998643 445555566666677788899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCC
Q psy10603        243 AELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +.+||+.||++|||+.|+++|.
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          254 MYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHHHH
Confidence            9999999999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=367.75  Aligned_cols=252  Identities=22%  Similarity=0.353  Sum_probs=212.6

Q ss_pred             ceeeecccccCeEEEEEEECCC-------CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNET-------GELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~   76 (407)
                      .....||+|+||+||+|++..+       ++.||+|++...  ......+++.+|+++++++ +||||+++++++...+.
T Consensus        72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  149 (382)
T 3tt0_A           72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP  149 (382)
T ss_dssp             EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence            3445899999999999997543       357999998754  3445567889999999999 99999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN  141 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~  141 (407)
                      .++||||+++|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-  228 (382)
T 3tt0_A          150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-  228 (382)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-
T ss_pred             eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC-
Confidence            999999999999999997643               3489999999999999999999999999999999999998765 


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM  220 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~  220 (407)
                      .+||+|||+++........ .......||+.|+|||++.+   ..++.++|||||||++|+|++ |..||... +..+..
T Consensus       229 ~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwslG~il~ellt~g~~p~~~~-~~~~~~  303 (382)
T 3tt0_A          229 VMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELF  303 (382)
T ss_dssp             CEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHH
T ss_pred             cEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHH
Confidence            6999999999876433211 12234567889999999864   346889999999999999999 99999854 344555


Q ss_pred             HHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       221 ~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ..+..+..+..+..+++++.+++.+||+.||++|||+.|++++.
T Consensus       304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            66666677777889999999999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-47  Score=368.69  Aligned_cols=248  Identities=28%  Similarity=0.447  Sum_probs=199.8

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE------EE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM------VL   79 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~------~l   79 (407)
                      ....||+|+||+||+|++..+|+.||||++.... ......+++.+|+.+|+.++||||+++++++...+..      |+
T Consensus        46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  124 (371)
T 4exu_A           46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  124 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred             EEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence            3448999999999999999999999999997543 3445567889999999999999999999999876654      99


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+. ++|..++.   ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....  
T Consensus       125 v~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~--  197 (371)
T 4exu_A          125 VMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAE--  197 (371)
T ss_dssp             EEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC--------
T ss_pred             EEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcccccccC--
Confidence            999998 58877763   3499999999999999999999999999999999999998765 6999999999765432  


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--------------
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--------------  225 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--------------  225 (407)
                          ....+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.+.............              
T Consensus       198 ----~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          198 ----MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ----cCCcccCccccCHHHhcCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence                2446789999999998542  34688999999999999999999999864432221111100              


Q ss_pred             ----------CCCC-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 ----------GETP-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 ----------~~~~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                ...+     ..+..+++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                      0000     11245789999999999999999999999999999995

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-47  Score=357.31  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=201.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----------   73 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------   73 (407)
                      +.....||+|+||.||+|++..+++.||||++..    .....+.+.+|+.++++++||||+++++++..          
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            3455699999999999999999999999999864    23445778899999999999999999998765          


Q ss_pred             ---CceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccC
Q psy10603         74 ---REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGS  150 (407)
Q Consensus        74 ---~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGl  150 (407)
                         .+..|+||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcc
Confidence               4578999999999999999987666688999999999999999999999999999999999998765 699999999


Q ss_pred             ceecCCCCC-----------CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH
Q psy10603        151 AVKISAHTT-----------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI  219 (407)
Q Consensus       151 a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~  219 (407)
                      +........           .........||+.|+|||++.+.  ..++.++|||||||++|+|++   ||....+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT--GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSC--SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCC--CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            976542210           01123456799999999998642  246789999999999999998   66533223333


Q ss_pred             HHHHhC---CCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        220 MFKVGM---GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       220 ~~~~~~---~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ...+..   ...+.++...++.+++++.+||+.||.+|||+.|+++|||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence            333322   223345566788899999999999999999999999999995

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-47  Score=358.63  Aligned_cols=252  Identities=22%  Similarity=0.383  Sum_probs=210.3

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|.+     ..+++.||+|++...  ......+.+.+|+++|++++||||+++++++...+..+
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            34445899999999999987     345689999998743  34455678899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q psy10603         79 LFMELCTEGTLESLVQSTE-----------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIF  135 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nil  135 (407)
                      +||||+++|+|.+++....                       ..+++..+..++.|++.||.|||++||+||||||+|||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            9999999999999997632                       23889999999999999999999999999999999999


Q ss_pred             EecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q psy10603        136 LTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYD  214 (407)
Q Consensus       136 l~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~  214 (407)
                      ++.++ .+||+|||+++........ .......+|+.|+|||++.+   ..++.++|||||||++|||++ |..||....
T Consensus       183 i~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          183 VAEGR-KMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD---HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             EETTT-EEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EcCCC-CEEEccccccccccccccc-eeccCCCCcccccChhhhcC---CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            98764 7999999999876433211 11233467889999999864   335789999999999999999 999998643


Q ss_pred             chHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        215 SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                       .......+..+..+..+..+++++.+++.+||+.||++|||+.|++++
T Consensus       258 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          258 -PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             -GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             334445555566677788999999999999999999999999999865

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=360.22  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=204.1

Q ss_pred             cceeeecccccCeEEEEEEECCCC----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETG----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|.+..++    ..||+|++...  ........+.+|+.++++++||||+++++++...+..++
T Consensus        46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            444568999999999999876553    45999998743  234455678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhhccccc
Confidence            9999999999999987666799999999999999999999999999999999999998765 699999999987654322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      .........+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.... .......+..+..+..+..++++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  278 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPMDCPSA  278 (333)
T ss_dssp             --------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             cccccCCCCccccccCchhccc---CCCCchhhhHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHCCCcCCCcccCCHH
Confidence            1111223456788999999854   346889999999999999999 999998543 44555555666666677889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +.+++.+||+.||++||++.|++++.
T Consensus       279 l~~li~~~l~~~p~~Rps~~~l~~~L  304 (333)
T 1mqb_A          279 IYQLMMQCWQQERARRPKFADIVSIL  304 (333)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999999988653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=357.28  Aligned_cols=257  Identities=28%  Similarity=0.470  Sum_probs=195.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..+|+.||||++..... .....+.+..+..+++.++||||+++++++...+..++||||
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~  105 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL  105 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence            3445589999999999999999999999999975432 223333344555678889999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      + ++.+..+.......+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++.......    
T Consensus       106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~----  179 (318)
T 2dyl_A          106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDDK----  179 (318)
T ss_dssp             C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC-----------
T ss_pred             c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCCc----
Confidence            9 5567666655556699999999999999999999995 999999999999998765 69999999997654322    


Q ss_pred             cccccccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC--CccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP--ESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~s~~  238 (407)
                      ......||+.|+|||++...  ....++.++|||||||++|+|++|+.||...............+..+.++  ..++++
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD  259 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHH
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHH
Confidence            12345789999999998532  12346789999999999999999999998765565555555555555554  358999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+++.+||+.||.+|||+.|+++|||+.
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            99999999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-47  Score=358.42  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=210.9

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.....||+|+||+||+|++     ..+++.||+|++...  ......+.+.+|+.+|+++ +||||+++++++...+..
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            44556899999999999985     467789999999754  2334457789999999999 999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         78 VLFMELCTEGTLESLVQSTED-----------------GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~-----------------~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      ++||||+++|+|.+++.....                 .+++..+..++.|++.||.|||++||+||||||+|||++.+ 
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-  181 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-  181 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT-
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC-
Confidence            999999999999999976432                 38999999999999999999999999999999999999876 


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~  219 (407)
                      +.+||+|||+++........ .......||+.|+|||++..   ..++.++|||||||++|+|++ |+.||.........
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             CCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            47999999999776543221 11234567889999999854   346889999999999999999 99999866544444


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ......+..+..+..+++++.+++.+||+.||.+|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            44444455566677899999999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.4e-48  Score=373.00  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=197.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC--------CCCcceEEEEEE---
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN--------QKNLVKYYGVEI---   72 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~~~~~~~---   72 (407)
                      +.....||+|+||+||+|++..+++.||||++...    ....+.+.+|+.+|+.++        ||||+++++.+.   
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            34445899999999999999999999999998632    344567889999998885        788999999987   


Q ss_pred             -eCceEEEEEecCCCCCHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCC---------
Q psy10603         73 -HREEMVLFMELCTEGTLESLV-QSTEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEG---------  140 (407)
Q Consensus        73 -~~~~~~lv~E~~~~g~L~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~---------  140 (407)
                       ....+|+||||+.+ +|.+.+ +.....+++..+..++.||+.||.|||++ ||+||||||+|||++.++         
T Consensus       115 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          115 VNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             TTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence             45679999999955 555544 43335699999999999999999999999 999999999999998653         


Q ss_pred             ---------------------------------------CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccc
Q psy10603        141 ---------------------------------------NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMD  181 (407)
Q Consensus       141 ---------------------------------------~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  181 (407)
                                                             ..+||+|||+++.....      ....+||+.|+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHT
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcC
Confidence                                                   26999999999876432      234579999999999865


Q ss_pred             cccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-----hHHHHHHH--hCCCCC-------------------------
Q psy10603        182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-----NYQIMFKV--GMGETP-------------------------  229 (407)
Q Consensus       182 ~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-----~~~~~~~~--~~~~~~-------------------------  229 (407)
                         ..++.++|||||||++|||++|+.||.....     ....+..+  ..+..|                         
T Consensus       268 ---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          268 ---SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             ---SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             ---CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence               3468899999999999999999999975331     11111100  011110                         


Q ss_pred             --------------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 --------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 --------------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                    ..+...++++.+|+.+||+.||++|||+.|+++||||.
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                          11233456788999999999999999999999999984

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3e-47  Score=355.76  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=205.9

Q ss_pred             ceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~   78 (407)
                      .....||+|+||.||+|+    +..+++.||+|++.....  ....+.+.+|+.+|++++||||+++++++...  +.++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             EEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            334589999999999998    577899999999975432  22346788999999999999999999999876  6689


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  180 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDK  180 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTC
T ss_pred             EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcccccccccCCC
Confidence            99999999999999976666799999999999999999999999999999999999998865 79999999998775443


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC--------------CchHHHHHHHh
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY--------------DSNYQIMFKVG  224 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~--------------~~~~~~~~~~~  224 (407)
                      ..........||+.|+|||++.+.   .++.++|||||||++|+|++|..|+...              ...........
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          181 EYYTVKDDRDSPVFWYAPECLMQS---KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             CEEECCCCTTCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             cceeccCCCCCCccccCCeeecCC---CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            221223445788899999998653   3568999999999999999999986421              11222334445


Q ss_pred             CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       225 ~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+.....+..+++++.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            55666678889999999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-47  Score=365.38  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=190.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce-------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE-------   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-------   76 (407)
                      +.....||+|+||+||+|++..+|+.||||++.......    ..+.+|++.+..++||||+++++++...+.       
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             EEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            445558999999999999999999999999986543222    345678888889999999999999876443       


Q ss_pred             EEEEEecCCCCCHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         77 MVLFMELCTEGTLESLVQ---STEDGLPEVLVRRYTKQLVDAISALH--ENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      +++||||++++ |...+.   .....+++..+..++.|++.||.|||  ++||+||||||+|||++..++.+||+|||++
T Consensus       101 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            89999999874 443332   23456899999999999999999999  9999999999999999874568999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCC---
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGE---  227 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~---  227 (407)
                      +......    ......||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.............. .+.   
T Consensus       180 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          180 KKLSPSE----PNVAYICSRYYRAPELIFGN--QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             BCCCTTS----CCCSTTSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             eecCCCC----CcccccCCcceeCHHHHcCC--CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            8765432    22456789999999998542  3468899999999999999999999986543322211110 000   


Q ss_pred             --------------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        228 --------------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       228 --------------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                                .+..+...++++.+|+.+||+.||.+|||+.|+++||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence                                      01122235789999999999999999999999999999964

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-47  Score=359.82  Aligned_cols=257  Identities=30%  Similarity=0.557  Sum_probs=187.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELR-ILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.....||+|+||.||+|.+..+|+.||||++....  ......++.+|+. +++.++||||+++++++...+..++|||
T Consensus        24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            334458999999999999999999999999997542  3334455666766 7788999999999999999999999999


Q ss_pred             cCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         83 LCTEGTLESLVQS----TEDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |+++ +|.+++..    ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++.....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC----
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceecccc
Confidence            9986 77777653    245689999999999999999999999 999999999999998764 7999999999776433


Q ss_pred             CCCCCcccccccCCccccccccccc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC----
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP----  232 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----  232 (407)
                      ..    .....||+.|+|||++... ....++.++|||||||++|+|++|+.||...............+..+.++    
T Consensus       180 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3aln_A          180 IA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE  255 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSS
T ss_pred             cc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccc
Confidence            21    2334799999999998421 12346789999999999999999999998644333333333333344333    


Q ss_pred             CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        233 ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       233 ~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ..+++++.+++.+||+.||++|||+.|+++|||+..
T Consensus       256 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            468999999999999999999999999999999863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.1e-47  Score=352.03  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=203.9

Q ss_pred             ecccccCeEEEEEE--ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAV--NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||+||+|.  +..+++.||||++.... .+....+++.+|+.++++++||||+++++++ ..+..++||||+++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~  101 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL  101 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence            89999999999995  46677899999987543 2334567889999999999999999999998 66778999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      ++|.++++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...............
T Consensus       102 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~  179 (291)
T 1xbb_A          102 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTH  179 (291)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC---
T ss_pred             CCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeeccCCCccccccc
Confidence            999999976 44599999999999999999999999999999999999999865 7999999999876543322111223


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..+|+.|+|||++...   .++.++||||||+++|+|++ |+.||.... ..+....+..+..+..+..+++++.+++.+
T Consensus       180 ~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (291)
T 1xbb_A          180 GKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-GSEVTAMLEKGERMGCPAGCPREMYDLMNL  255 (291)
T ss_dssp             -CCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCCCceeeChHHhccC---CCChhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            4567899999998542   35789999999999999999 999998643 445555666667777888999999999999


Q ss_pred             hcccCCCCcCCHHHHhc
Q psy10603        246 CLRHDPAQRATIFELLQ  262 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~  262 (407)
                      ||+.||++|||+.|+++
T Consensus       256 ~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          256 CWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-47  Score=360.63  Aligned_cols=254  Identities=25%  Similarity=0.382  Sum_probs=210.1

Q ss_pred             cceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE--eCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEI--HREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~   77 (407)
                      +.....||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|+++|++++||||+++++++.  ..+.+
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4455699999999999998    5678899999998643   3445577899999999999999999999887  45679


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ++||||+++++|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECCTT
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceecccC
Confidence            999999999999999976555699999999999999999999999999999999999998865 7999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--------------HHHHHHH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--------------YQIMFKV  223 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--------------~~~~~~~  223 (407)
                      ...........||+.|+|||++.+.   .++.++|||||||++|+|++|..||......              .......
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDN---IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             CccceeeccCCccccccCHHHhccC---CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            3221222345688899999998542   3578999999999999999999998642211              2233344


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ..+..+..+..+++++.+++.+||+.||++|||+.|++++.
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  298 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL  298 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            45566667888999999999999999999999999997654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.1e-47  Score=352.24  Aligned_cols=252  Identities=23%  Similarity=0.423  Sum_probs=194.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..   .+|+|++.... ......+.+.+|+.+|++++||||++++++. ..+..++||||
T Consensus        26 y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           26 ITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             CEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             eeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            4455699999999999998653   59999987553 3445567889999999999999999999964 56678999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....... ...
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~  178 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSG-SHQ  178 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--------------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccccccc-ccc
Confidence            999999999976666799999999999999999999999999999999999998864 799999999976543211 112


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC----CCCCCccCHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET----PTIPESLSDEG  239 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~  239 (407)
                      .....||+.|+|||++.......++.++|||||||++|+|++|+.||...............+..    +.++..+++++
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM  258 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHH
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHH
Confidence            34467999999999986433455688999999999999999999999876655554444433332    22345789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+.||++|||+.|+++
T Consensus       259 ~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          259 KRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999885

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-47  Score=365.52  Aligned_cols=256  Identities=24%  Similarity=0.399  Sum_probs=196.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEecccc--------CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ--------NDARFVKDMLVELRILEGINQKNLVKYYGVEIHR   74 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   74 (407)
                      .+.....||+|+||.||+|.+.. |+.||||++.....        .+....+.+.+|+.+|++++||||+++++++...
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            34555699999999999999865 89999999864322        2344557889999999999999999999998542


Q ss_pred             -----ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         75 -----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        75 -----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                           ..+|+||||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  179 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFN  179 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCTT
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEEecC
Confidence                 36899999998 588888876566799999999999999999999999999999999999998765 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC----
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM----  225 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~----  225 (407)
                      +++......    ......||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||...............    
T Consensus       180 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          180 LAREDTADA----NKTHYVTHRWYRAPELVMQF--KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             C-------------------CGGGCCHHHHTTC--TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccc----ccceecccceecCcHHhcCC--CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            997544322    22446789999999998642  34688999999999999999999999864422221111000    


Q ss_pred             ------------------CC---CC-----CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 ------------------GE---TP-----TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 ------------------~~---~~-----~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                        ..   .+     ..+...++++.+++.+||+.||++|||+.|+++||||.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  321 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE  321 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence                              00   00     11245688999999999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-47  Score=355.77  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=203.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCC-------cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG-------ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   75 (407)
                      .+.....||+|+||+||+|++..++       +.||+|++....   ....+.+.+|+.+|++++||||+++++++...+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4455669999999999999998877       479999986532   233467889999999999999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCe-------EEEEcc
Q psy10603         76 EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNS-------LKLGDF  148 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~-------vkl~DF  148 (407)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++..       +||+||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            9999999999999999998765559999999999999999999999999999999999999886532       999999


Q ss_pred             cCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC
Q psy10603        149 GSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET  228 (407)
Q Consensus       149 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~  228 (407)
                      |++......       ....||+.|+|||++.+.  ..++.++|||||||++|||++|..|+..............  ..
T Consensus       166 g~~~~~~~~-------~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--~~  234 (289)
T 4fvq_A          166 GISITVLPK-------DILQERIPWVPPECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--DR  234 (289)
T ss_dssp             CSCTTTSCH-------HHHHHTTTTSCHHHHHCG--GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TT
T ss_pred             cccccccCc-------cccCCcCcccCHHHhCCC--CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--cc
Confidence            998654321       234689999999998642  3468899999999999999996544443333333322222  24


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +..+...++++.+++.+||+.||++|||+.|+++|.
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            445666788899999999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=361.58  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=200.3

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce------EE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE------MV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------~~   78 (407)
                      .....||+|+||.||+|++..+|+.||||++.... ......+++.+|+.+|++++||||+++++++...+.      +|
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            33448999999999999999999999999997543 344556788999999999999999999999887653      59


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||++ ++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... 
T Consensus       106 lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~-  179 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAE-  179 (353)
T ss_dssp             EEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC-----
T ss_pred             EEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCCC-
Confidence            9999998 58877763   3499999999999999999999999999999999999998765 6999999999764322 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--------------
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--------------  224 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--------------  224 (407)
                           .....||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.+...... +..+.              
T Consensus       180 -----~~~~~~t~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          180 -----MTGYVVTRWYRAPEVILSW--MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCC--SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHTTC
T ss_pred             -----ccccccCcCcCCHHHHhCc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHH
Confidence                 2346789999999998542  3467899999999999999999999986443221 11110              


Q ss_pred             -------------C---CCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 -------------M---GETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 -------------~---~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                   .   ...+..+..+++++.+++.+||+.||++|||+.|+++||||.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                         0   011123456799999999999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-47  Score=363.00  Aligned_cols=253  Identities=20%  Similarity=0.256  Sum_probs=204.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcE----EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGEL----VAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      .+.....||+|+||+||+|++..+++.    ||+|.+.....  ....+.+.+|+.++.+++||||+++++++. .+..+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            344556999999999999999888876    67776643321  122345678999999999999999999875 56689


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSCCCT
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccccCccc
Confidence            99999999999999976555699999999999999999999999999999999999998765 69999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                      .. .......||+.|+|||++..   ..++.++|||||||++|+|++ |+.||.... .......+..+..+..+..++.
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          170 KQ-LLYSEAKTPIKWMALESIHF---GKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTI  244 (325)
T ss_dssp             TC-CC-----CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-TTHHHHHHHTTCBCCCCTTBCT
T ss_pred             cc-ccccCCCCcccccChHHhcc---CCCChhhHhHHhHHHHHHHHhCCCCCccccC-HHHHHHHHHcCCCCCCCCcCcH
Confidence            21 12244567889999999854   346889999999999999999 999998643 3344455555666677788899


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ++.+++.+||+.||.+|||+.|++++.
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~l  271 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANEF  271 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999999998863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-47  Score=379.28  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=210.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+++.||||++.....    ..+.+.+|+.+|++++||||+++++++...+.+|+|||
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34556699999999999999999999999999875432    14678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++|+|.++++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~-  374 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYT-  374 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCEE-
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCcee-
Confidence            99999999999763 34589999999999999999999999999999999999998764 6999999999876433211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......+|+.|+|||++..   ..++.++|||||||++|||++ |..||..... .+....+..+..+..|..+++++.
T Consensus       375 -~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~  449 (495)
T 1opk_A          375 -AHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVY  449 (495)
T ss_dssp             -CCTTCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             -ecCCCcCCcceeCHhHHhc---CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHH
Confidence             1223456788999999864   236789999999999999999 9999986543 344445555666777889999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++|||+.|+++
T Consensus       450 ~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          450 ELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCcChhHCcCHHHHHH
Confidence            9999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-47  Score=346.82  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=210.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++. +++.||+|++......    .+.+.+|++++++++||||+++++++...+..++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            3455569999999999999987 5778999999754332    2467889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.....+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.........  
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~--  160 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYT--  160 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHH--
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEccccccccccccccc--
Confidence            9999999999987666799999999999999999999999999999999999998765 6999999999765432111  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++||||||+++|+|++ |+.||... ........+..+..+..|..+++++.+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~l~~  236 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTGFRLYKPRLASTHVYQ  236 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             ccccccccccccChhhhcC---CCccchhchhhhHHHHHHHhccCCCCCCCC-CHHHHHHHHhcCCcCCCCccCcHHHHH
Confidence            1233467889999999854   346789999999999999999 89999854 344555566666666778889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcC
Q psy10603        242 FAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++.+||+.||++|||+.|++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          237 IMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=350.90  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=208.0

Q ss_pred             eecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE-EEEEec
Q psy10603          8 VSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM-VLFMEL   83 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~lv~E~   83 (407)
                      ..||+|+||+||+|++..+++   .+|+|.+..  .......+.+.+|+.+|++++||||+++++++...+.. ++||||
T Consensus        27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEETTEEEEEEEEECSSSCEEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             ceeccCCCceEEEEEEecCCCceeeeeeeeccc--cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            589999999999999765554   799999864  33445567889999999999999999999999876655 999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC-CCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT-VPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~-~~~  162 (407)
                      +.+|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++....... ...
T Consensus       105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~  183 (298)
T 3pls_A          105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQ  183 (298)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTGGGGCSC
T ss_pred             ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCCcccccc
Confidence            999999999977666799999999999999999999999999999999999998765 699999999976543221 112


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ......+|+.|+|||.+.+   ..++.++|||||||++|+|++|..|+....+.......+..+..+..+..+++++.++
T Consensus       184 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  260 (298)
T 3pls_A          184 QHRHARLPVKWTALESLQT---YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV  260 (298)
T ss_dssp             CSSCTTCGGGGSCHHHHTT---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cCcCCCCCccccChhhhcc---CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHH
Confidence            2344578899999999854   3468899999999999999996666554455555555666666677788899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcC
Q psy10603        243 AELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+||+.||.+|||+.|+++.
T Consensus       261 i~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          261 MQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999998863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-47  Score=364.76  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=209.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH--------------HHHHHHHHHHHHHhcCCCCCcceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA--------------RFVKDMLVELRILEGINQKNLVKYY   68 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~~~   68 (407)
                      .+.....||+|+||.||+|++  +++.||+|++........              ...+.+.+|+.++++++||||++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            344555999999999999998  899999999975432211              1126788999999999999999999


Q ss_pred             EEEEeCceEEEEEecCCCCCHHHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCC
Q psy10603         69 GVEIHREEMVLFMELCTEGTLESL------VQST-EDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        69 ~~~~~~~~~~lv~E~~~~g~L~~~------~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~  140 (407)
                      +++.+.+..++||||+++|+|.++      +... ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence            999999999999999999999988      5432 4569999999999999999999999 9999999999999998765


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR-AVDIWSLGCVLVEMSSGKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~-~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~  219 (407)
                       .+||+|||++......     ......||+.|+|||++.+..  .++. ++|||||||++|||++|+.||.........
T Consensus       190 -~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          190 -RVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNES--SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             -CEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCC--CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             -cEEEeccccccccccc-----cccCCCCCcCccCchhhcCCC--CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence             6999999999876432     224467899999999986431  2344 899999999999999999999865553454


Q ss_pred             HHHHhCCCCCCCC-------------------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        220 MFKVGMGETPTIP-------------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       220 ~~~~~~~~~~~~~-------------------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ...+..+. +..|                   ..+++++.+++.+||+.||.+|||+.|+++||||.
T Consensus       262 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          262 FNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             HHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            44444332 2333                   56899999999999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-46  Score=351.23  Aligned_cols=253  Identities=33%  Similarity=0.575  Sum_probs=200.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|.+..+|+.||+|++......+....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            44556999999999999999999999999999865555666778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         84 CTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        84 ~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      +++++|.+++..   ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........ 
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~-  191 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTT-  191 (310)
T ss_dssp             CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------------
T ss_pred             CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeeecCCCc-
Confidence            999999998864   345589999999999999999999999999999999999998765 699999999876543221 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-HHHHHHHhCCCCCCC-CCccCHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-YQIMFKVGMGETPTI-PESLSDE  238 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-~~~~~~~~~~~~~~~-~~~~s~~  238 (407)
                        ......||+.|+|||++..   ..++.++|||||||++|+|++|+.||...... ......+.....+.. +..++++
T Consensus       192 --~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          192 --AAHSLVGTPYYMSPERIHE---NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ---------CCSSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             --cccccCCCeeEeChHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence              1234578999999999854   34678999999999999999999999754332 333344444444443 3678999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++.+||..||++|||+.|++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.1e-47  Score=359.25  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCc-----EEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~   77 (407)
                      +.....||+|+||+||+|.+..+++     .||+|.+...  ......+.+.+|+.+|+++ +||||+++++++...+..
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            4455699999999999999977664     7999998754  2344557789999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEE
Q psy10603         78 VLFMELCTEGTLESLVQST-------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK  144 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~-------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vk  144 (407)
                      ++||||+++|+|.+++...             ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~k  204 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAK  204 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-EEE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC-eEE
Confidence            9999999999999998653             23479999999999999999999999999999999999998764 799


Q ss_pred             EEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH
Q psy10603        145 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV  223 (407)
Q Consensus       145 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~  223 (407)
                      |+|||+++........ .......||+.|+|||++.+   ..++.++|||||||++|||++ |..||.............
T Consensus       205 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD---CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             BCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             ECccccccccccccce-eecCCCCCCccccCHHHhcc---CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            9999999765433211 11234567889999999864   346889999999999999998 999998655444444444


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+..+..+...++++.+++..||+.||.+|||+.|++++
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            4455566677889999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-46  Score=352.54  Aligned_cols=252  Identities=24%  Similarity=0.306  Sum_probs=200.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||.||+|++..+++.||+|++......+....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            34556699999999999999999999999999986655566667889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........  .
T Consensus       115 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~--~  190 (309)
T 2h34_A          115 LINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEKL--T  190 (309)
T ss_dssp             CCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC------------
T ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccccc--c
Confidence            99999999999764 4599999999999999999999999999999999999998765 699999999876543221  1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC--CCCCCCccCHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE--TPTIPESLSDEGQ  240 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  240 (407)
                      ......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||...... .....+....  ....+..+++++.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSE---SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             ------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             cccccCCCcCccCHHHHcC---CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHH
Confidence            2234578999999999854   34578999999999999999999999854322 2222222221  1234567899999


Q ss_pred             HHHHHhcccCCCCcC-CHHHHhc
Q psy10603        241 AFAELCLRHDPAQRA-TIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~-t~~e~l~  262 (407)
                      +++.+||+.||++|| ++.++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7888764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-47  Score=357.30  Aligned_cols=254  Identities=25%  Similarity=0.375  Sum_probs=210.9

Q ss_pred             cceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc-e
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE-E   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~-~   76 (407)
                      +.....||+|+||+||+|++     ..+++.||+|++...  ......+.+.+|+.+|.++ +||||+++++++...+ .
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            34455899999999999985     456789999998754  2334456789999999999 6899999999987755 4


Q ss_pred             EEEEEecCCCCCHHHHHhhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTEDG---------------LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN  141 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~~---------------~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~  141 (407)
                      +++||||+++|+|.+++......               +++..+..++.|++.||.|||++||+||||||+|||++.++ 
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-  185 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-  185 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-
Confidence            89999999999999999764332               78999999999999999999999999999999999998765 


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIM  220 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~  220 (407)
                      .+||+|||+++........ .......||+.|+|||++.+   ..++.++|||||||++|+|++ |..||..........
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CEEECCCccccccccCccc-eeccCCCcceeecCchhhcc---ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            6999999999766433211 11234568899999999854   346889999999999999998 999998765555555


Q ss_pred             HHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        221 FKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       221 ~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      .....+..+..+..+++++.+++..||+.||.+|||+.|+++|.
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            55555666677888999999999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=373.33  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=192.1

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      ....||+|+||+|+. ....+++.||||++......      .+.+|+++|+.+ +|||||++++++.+.+..|+|||||
T Consensus        28 ~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           28 PKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            345899999999764 34567899999998654321      245799999998 7999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC----CeEEEEcccCceecCCCCCC
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG----NSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~----~~vkl~DFGla~~~~~~~~~  160 (407)
                      + |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++    ..+||+|||+++........
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            7 599999976655566777889999999999999999999999999999995321    25889999999876543222


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCC--CCCCccCH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETP--TIPESLSD  237 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~s~  237 (407)
                      .......+||+.|+|||++.......++.++|||||||++|||++ |..||........ .........+  ..+...+.
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  258 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLHPEKHEDV  258 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSCTTCHHHH
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccCccccccH
Confidence            223345689999999999965333456789999999999999999 9999975433222 1111111111  11234566


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+++++.+||+.||.+|||+.|+++||||.
T Consensus       259 ~~~~li~~~L~~dP~~Rps~~evl~hp~f~  288 (432)
T 3p23_A          259 IARELIEKMIAMDPQKRPSAKHVLKHPFFW  288 (432)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred             HHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence            789999999999999999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-46  Score=348.84  Aligned_cols=251  Identities=20%  Similarity=0.247  Sum_probs=204.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.....||+|+||+||+|++..+++.||+|++......     +.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            44555999999999999999999999999998654322     3467799999999 79999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC----eEEEEcccCceecCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN----SLKLGDFGSAVKISAHT  158 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~----~vkl~DFGla~~~~~~~  158 (407)
                      |+ +++|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.    .+||+|||+++......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 99999999876666999999999999999999999999999999999999976532    39999999998765432


Q ss_pred             CCC----CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhC----CCC
Q psy10603        159 TVP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGM----GET  228 (407)
Q Consensus       159 ~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~----~~~  228 (407)
                      ...    .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....  ..+....+..    ...
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             ccccccccCccCCCCCcccCCchhhcC---CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            211    12345689999999999854   3468899999999999999999999986432  2222222111    112


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.....+++++.+++.+||+.||++|||+.++++.
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            22345789999999999999999999999998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=370.82  Aligned_cols=242  Identities=23%  Similarity=0.391  Sum_probs=204.0

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-eEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-EMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~   81 (407)
                      ++.....||+|+||+||+|.+.  |+.||||+++...     ..+.+.+|+.+|++++||||+++++++...+ .+|+||
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             HeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            3455669999999999999875  7799999987542     2356889999999999999999999987665 799999


Q ss_pred             ecCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ||+++|+|.++++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......  
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcccccccc--
Confidence            99999999999976543 379999999999999999999999999999999999998765 69999999998643221  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                          ....+|+.|+|||++..   ..++.++|||||||++|||++ |+.||..... .+....+..+..+..|..+++++
T Consensus       344 ----~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l  415 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAV  415 (450)
T ss_dssp             -------CCCTTTSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-TTHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ----cCCCCCcceeCHHHhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCcCCHHH
Confidence                22357889999999854   346899999999999999998 9999986543 34455566677778889999999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+.||++|||+.|+++
T Consensus       416 ~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          416 YDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=355.71  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=200.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEE----EEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELV----AMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~v----AvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      +.....||+|+||+||+|++..+++.+    |+|.+....  .....+.+.+|+.+|++++||||+++++++.... .++
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            444559999999999999998888765    566554322  2223467889999999999999999999987655 889


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+||+.+|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC---------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEccCccc
Confidence            9999999999999987667799999999999999999999999999999999999998865 799999999987643322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      . .......+|+.|+|||++.+   ..++.++|||||||++|||++ |+.||.... .......+..+..+..+..++.+
T Consensus       173 ~-~~~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          173 E-YHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             --------CCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             c-ccccCCCccccccCHHHHcC---CCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCCCCCccCCHH
Confidence            1 11233456889999999864   346889999999999999999 999998643 33444455556666778889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++.+||+.||.+|||+.|+++.
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.8e-47  Score=356.06  Aligned_cols=254  Identities=27%  Similarity=0.490  Sum_probs=199.9

Q ss_pred             cceeeecccccCeEEEEEEEC-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc---CCCCCcceEEEEEE-----eC
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-ETGELVAMKEIQLHKQNDARFVKDMLVELRILEG---INQKNLVKYYGVEI-----HR   74 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~---l~hpniv~~~~~~~-----~~   74 (407)
                      +.....||+|+||+||+|++. .+|+.||+|++....... .....+.+|+.+++.   ++||||+++++++.     ..
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            445559999999999999995 678999999997543221 111234456666554   58999999999987     45


Q ss_pred             ceEEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCcee
Q psy10603         75 EEMVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVK  153 (407)
Q Consensus        75 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~  153 (407)
                      ...++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  169 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARI  169 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCccccc
Confidence            67999999998 59999987643 3499999999999999999999999999999999999998765 699999999976


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH---hCCC---
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV---GMGE---  227 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~---~~~~---  227 (407)
                      .....    ......||+.|+|||++..   ..++.++|||||||++|+|++|+.||.............   ....   
T Consensus       170 ~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          170 YSFQM----ALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCGGG----GGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ccCCC----CccccccccceeCHHHHhc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            54322    2245678999999999854   346889999999999999999999998654332221111   0000   


Q ss_pred             -------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 -------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 -------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                         ...++..+++++++++.+||+.||++|||+.|+++||||.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  301 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  301 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence                               0112356889999999999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-46  Score=356.23  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=206.7

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEE--EEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELV--AMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~v--AvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l   79 (407)
                      ++.....||+|+||.||+|++..+++.+  |+|.+...  ......+.+.+|+++|.++ +||||+++++++...+..|+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            4555669999999999999999888865  99988643  2233456788999999999 99999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEE
Q psy10603         80 FMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK  144 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vk  144 (407)
                      ||||+++|+|.+++....               ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~k  182 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAK  182 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-eEE
Confidence            999999999999997543               3589999999999999999999999999999999999998765 699


Q ss_pred             EEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH
Q psy10603        145 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV  223 (407)
Q Consensus       145 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~  223 (407)
                      |+|||+++......    ......+|+.|+|||++..   ..++.++|||||||++|||++ |+.||... ........+
T Consensus       183 L~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~~~  254 (327)
T 1fvr_A          183 IADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKL  254 (327)
T ss_dssp             ECCTTCEESSCEEC----CC----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHG
T ss_pred             EcccCcCccccccc----cccCCCCCccccChhhhcc---ccCCchhcchHHHHHHHHHHcCCCCCCCCC-cHHHHHHHh
Confidence            99999997543221    1133456889999999854   335789999999999999998 99999854 344455555


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ..+..+..+..+++++.+++.+||+.||.+|||+.|++++.
T Consensus       255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            55666677888999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.5e-47  Score=357.46  Aligned_cols=249  Identities=21%  Similarity=0.287  Sum_probs=200.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.....||+|+||+||+|++..+|+.||||++......     +.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            44556999999999999999999999999998754322     3467899999999 99999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC----eEEEEcccCceecCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN----SLKLGDFGSAVKISAHT  158 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~----~vkl~DFGla~~~~~~~  158 (407)
                      |+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.    .+||+|||+++.+....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99 89999999876667999999999999999999999999999999999999987542    29999999998764332


Q ss_pred             CCC----CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHhCCCCCC--
Q psy10603        159 TVP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVGMGETPT--  230 (407)
Q Consensus       159 ~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~~~~~~~--  230 (407)
                      ...    ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....  ..+....+.....+.  
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLG---KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccCCcCCCccccChHHHcC---CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            211    12245789999999999865   3468999999999999999999999986432  222222221111111  


Q ss_pred             --CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        231 --IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       231 --~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                        ....++ ++.+++..||+.||.+||++.++++
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              112344 8999999999999999999998875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.8e-47  Score=363.03  Aligned_cols=254  Identities=18%  Similarity=0.255  Sum_probs=196.1

Q ss_pred             cceeeecccccCeEEEEEEECCC-----CcEEEEEEEeccccCcHH---HH-----HHHHHHHHHHhcCCCCCcceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNET-----GELVAMKEIQLHKQNDAR---FV-----KDMLVELRILEGINQKNLVKYYGV   70 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~-----~~~vAvK~i~~~~~~~~~---~~-----~~~~~E~~~l~~l~hpniv~~~~~   70 (407)
                      +.....||+|+||+||+|.+..+     ++.||||++.........   ..     ..+..|+..+..++||||++++++
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~  116 (364)
T 3op5_A           37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS  116 (364)
T ss_dssp             EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred             EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence            34455899999999999998765     588999998754321111   11     124456777889999999999999


Q ss_pred             EEeC----ceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe--cCCCeEE
Q psy10603         71 EIHR----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT--AEGNSLK  144 (407)
Q Consensus        71 ~~~~----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~--~~~~~vk  144 (407)
                      +...    ...|+||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++  .+ +.+|
T Consensus       117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~-~~~k  194 (364)
T 3op5_A          117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP-DQVY  194 (364)
T ss_dssp             EEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT-TCEE
T ss_pred             eeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC-CeEE
Confidence            8765    4589999999 9999999987666799999999999999999999999999999999999998  54 5799


Q ss_pred             EEcccCceecCCCCCC----CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH
Q psy10603        145 LGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM  220 (407)
Q Consensus       145 l~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~  220 (407)
                      |+|||+++.+......    .......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||..........
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG---VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC---CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            9999999876543211    111244569999999999854   346899999999999999999999998533322221


Q ss_pred             HHHhCCCCCC---------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        221 FKVGMGETPT---------IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       221 ~~~~~~~~~~---------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ........+.         .+..+++++.+++..||+.||.+||++.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1111100000         12567899999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-46  Score=350.34  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             eeeecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEE-eCceEEEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEI-HREEMVLFM   81 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~   81 (407)
                      +...||+|+||+||+|++..++   ..+|+|.+..  ..+....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEC-----CEEEEEEEETT--CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hcceeeecCCceEEEEEEecCCCceeEEEEEeccc--CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            3459999999999999975443   3589998864  344556678899999999999999999999854 456789999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC-
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~-  160 (407)
                      ||+++|+|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~  185 (298)
T 3f66_A          107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYS  185 (298)
T ss_dssp             ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCGGGCB
T ss_pred             eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccccccccccchhc
Confidence            99999999999976666789999999999999999999999999999999999998764 6999999999876433211 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      ........||+.|+|||++.+   ..++.++|||||||++|+|++ |.+||.. .+..........+..+..|..+++++
T Consensus       186 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l  261 (298)
T 3f66_A          186 VHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRLLQPEYCPDPL  261 (298)
T ss_dssp             C-----CCBCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccCCCCCccccChHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCCCCCccCCHHH
Confidence            122344567889999999854   346889999999999999999 5566654 33444455555666667788899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhc
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+++.+||+.||++|||+.|+++
T Consensus       262 ~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          262 YEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999886

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.7e-47  Score=358.14  Aligned_cols=257  Identities=27%  Similarity=0.401  Sum_probs=208.9

Q ss_pred             cceeeecccccCeEEEEEE-----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~-----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|+     +..+++.||||++...  .......++.+|+.++++++||||+++++++...+..|
T Consensus        32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            4445599999999999999     5677889999998633  23445567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccC
Q psy10603         79 LFMELCTEGTLESLVQSTE------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGS  150 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGl  150 (407)
                      +||||+++++|.+++....      ..+++..+..++.|++.||.|||++||+||||||+|||++.+  +..+||+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999999999999997643      348999999999999999999999999999999999999843  34699999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETP  229 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~  229 (407)
                      ++........ .......||+.|+|||++..   ..++.++|||||||++|+|++ |..||... ........+..+..+
T Consensus       190 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          190 ARDIYRASYY-RKGGCAMLPVKWMPPEAFME---GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-SNQEVLEFVTSGGRM  264 (327)
T ss_dssp             HHHHHC-------CCGGGSCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHTTCCC
T ss_pred             cccccccccc-ccCCCcCCCcceeCHhHhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCc-CHHHHHHHHhcCCCC
Confidence            9765332211 11234567899999999854   346889999999999999998 99999854 344555566666677


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+..+++++.+++.+||+.||.+|||+.|+++|++..
T Consensus       265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            77888999999999999999999999999999998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.9e-47  Score=364.21  Aligned_cols=249  Identities=29%  Similarity=0.481  Sum_probs=197.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CC-----CcceEEEEEEeCceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QK-----NLVKYYGVEIHREEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~~~~~~~~   78 (407)
                      .....||+|+||+||+|++..+++.||||++..    .....+.+.+|+.+++.++ |+     +|+++++.+...+..|
T Consensus        57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            344589999999999999999999999999863    2344566778888888775 44     4999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEec-CCCeEEEEcccCceec
Q psy10603         79 LFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALH--ENTIVHRDIKSANIFLTA-EGNSLKLGDFGSAVKI  154 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH--~~~iiHrdlKp~Nill~~-~~~~vkl~DFGla~~~  154 (407)
                      +||||++ |+|.+++.... ..+++..+..++.|++.||.|||  +.||+||||||+|||++. ....+||+|||+++..
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9999997 49999887643 45999999999999999999999  479999999999999964 2346999999999876


Q ss_pred             CCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CCCC---
Q psy10603        155 SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GETP---  229 (407)
Q Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~~~---  229 (407)
                      ...      ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........ +..+..  +..+   
T Consensus       212 ~~~------~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          212 GQR------IYQYIQSRFYRSPEVLLG---MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ-MNKIVEVLGIPPAHI  281 (382)
T ss_dssp             TCC------CCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHH
T ss_pred             ccc------cccccCCccccChHHHcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence            432      234689999999999865   3468999999999999999999999986543322 211110  0000   


Q ss_pred             -----C-------CC------------------C---c-------------------------cCHHHHHHHHHhcccCC
Q psy10603        230 -----T-------IP------------------E---S-------------------------LSDEGQAFAELCLRHDP  251 (407)
Q Consensus       230 -----~-------~~------------------~---~-------------------------~s~~~~~~i~~~l~~dp  251 (407)
                           .       +|                  .   .                         .++++++||.+||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                 0       00                  0   0                         01478999999999999


Q ss_pred             CCcCCHHHHhcCCeeee
Q psy10603        252 AQRATIFELLQHPFLIV  268 (407)
Q Consensus       252 ~~R~t~~e~l~hp~~~~  268 (407)
                      ++|||+.|+|+||||..
T Consensus       362 ~~Rpta~e~L~hp~f~~  378 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKK  378 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC
T ss_pred             hhCCCHHHHhcCccccc
Confidence            99999999999999953

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.2e-47  Score=350.00  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=210.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|.+..+++.||+|++....    ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            445569999999999999999999999999986432    2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.++++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++........  .
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~--~  167 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY--T  167 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSS--E
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCcc--c
Confidence            9999999999763 34589999999999999999999999999999999999998765 699999999976543321  1


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++||||||+++|+|++ |..||.... .......+.....+..+..+++++.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYRMERPEGCPEKVYE  243 (288)
T ss_dssp             EETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccCCccccCcCChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhccCCCCCCCCCCHHHHH
Confidence            2234567889999999854   346889999999999999999 999998644 33344444555566678889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcC
Q psy10603        242 FAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++..||+.||.+|||+.|+++.
T Consensus       244 li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          244 LMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCChhhCcCHHHHHHH
Confidence            9999999999999999999763

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=384.52  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=202.9

Q ss_pred             ecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||+||+|.+.  .++..||||+++...  .....+.+.+|+++|++++|||||++++++.. +.+++|||||++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999875  355679999987542  22235678999999999999999999999865 569999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+............
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC-----------
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccCCCceeeeccC
Confidence            999999976666799999999999999999999999999999999999999865 7999999999876433221111122


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.... ..+....+..+..+..|..+++++.+++..
T Consensus       499 ~~~~~~y~APE~~~~---~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  574 (613)
T 2ozo_A          499 GKWPLKWYAPECINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSD  574 (613)
T ss_dssp             ---CCTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-SHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCCccceeCHhhhcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            345789999999854   346899999999999999998 999998654 445566667777788889999999999999


Q ss_pred             hcccCCCCcCCHHHHhc
Q psy10603        246 CLRHDPAQRATIFELLQ  262 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~  262 (407)
                      ||+.||++||++.++++
T Consensus       575 cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          575 CWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TTCSSTTTSCCHHHHHH
T ss_pred             HcCCChhHCcCHHHHHH
Confidence            99999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-46  Score=351.09  Aligned_cols=257  Identities=29%  Similarity=0.496  Sum_probs=205.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCceEEEEEe
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ--KNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~E   82 (407)
                      .....||+|+||.||+|++. +++.||+|++.... .+....+.+.+|+.+|.+++|  |||+++++++...+..++|||
T Consensus        31 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           31 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            34459999999999999885 58899999997653 344556788999999999984  999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                       +.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+++  +.+||+|||+++........ .
T Consensus       109 -~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~~~~-~  183 (313)
T 3cek_A          109 -CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTS-V  183 (313)
T ss_dssp             -CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC---------
T ss_pred             -cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccccccccCcccc-c
Confidence             6678999999764 45899999999999999999999999999999999999964  47999999999776433211 1


Q ss_pred             cccccccCCccccccccccc--------ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCCCCCCC
Q psy10603        163 ELNGFVGTQAYMAPEVFMDT--------NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETPTIPE  233 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~--------~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~~~~~~  233 (407)
                      ......||+.|+|||++...        ....++.++|||||||++|+|++|+.||.............. ......++.
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  263 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  263 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc
Confidence            12345789999999998541        113467899999999999999999999986554444333333 333445677


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ..++++.+++.+||+.||.+|||+.|+++|||+..
T Consensus       264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             cchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            78999999999999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-46  Score=355.66  Aligned_cols=250  Identities=27%  Similarity=0.445  Sum_probs=200.4

Q ss_pred             cceeeecccccCeEEEEEEE-CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC------cceEEEEEEeCce
Q psy10603          4 VTFSVSPGQGRFGKVYTAVN-NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------LVKYYGVEIHREE   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~~   76 (407)
                      +.....||+|+||+||+|.+ ..+++.||+|++...    ....+.+.+|+++++.++|+|      |+++++++...+.
T Consensus        16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            34455999999999999998 567899999998632    344567788999998877654      9999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC----------------
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE----------------  139 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~----------------  139 (407)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++..                
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            99999999 789999887643 358999999999999999999999999999999999999763                


Q ss_pred             --CCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH
Q psy10603        140 --GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY  217 (407)
Q Consensus       140 --~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~  217 (407)
                        +..+||+|||+++.....      .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||...+...
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA---LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccCCCceEeeCcccccCccc------cccccCCccccChHHhhC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence              235999999999764332      234679999999999864   346889999999999999999999998654332


Q ss_pred             HHHH-HHhCCCCC-----------------------------------------CCCCccCHHHHHHHHHhcccCCCCcC
Q psy10603        218 QIMF-KVGMGETP-----------------------------------------TIPESLSDEGQAFAELCLRHDPAQRA  255 (407)
Q Consensus       218 ~~~~-~~~~~~~~-----------------------------------------~~~~~~s~~~~~~i~~~l~~dp~~R~  255 (407)
                      .... ....+..|                                         ..+...++++.+++.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            2111 11111110                                         01223457789999999999999999


Q ss_pred             CHHHHhcCCeee
Q psy10603        256 TIFELLQHPFLI  267 (407)
Q Consensus       256 t~~e~l~hp~~~  267 (407)
                      |+.|+++||||.
T Consensus       322 t~~ell~hp~f~  333 (339)
T 1z57_A          322 TLREALKHPFFD  333 (339)
T ss_dssp             CHHHHTTSGGGG
T ss_pred             CHHHHhcCHHHH
Confidence            999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.1e-47  Score=352.13  Aligned_cols=254  Identities=24%  Similarity=0.421  Sum_probs=196.4

Q ss_pred             cceeeecccccCeEEEEEEECC-CCc--EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE-TGE--LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      +.....||+|+||+||+|++.. +++  .||+|++......+....+.+.+|++++++++||||+++++++...+ .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            3445589999999999998643 333  68999987654444456678999999999999999999999987655 8999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  177 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH  177 (291)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCE
T ss_pred             EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccccccccc
Confidence            999999999999976556699999999999999999999999999999999999998764 7999999999876543221


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH-hCCCCCCCCCccCHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV-GMGETPTIPESLSDE  238 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~s~~  238 (407)
                      ........+|+.|+|||++...   .++.++||||||+++|+|++ |+.||...... +....+ .....+..+..++++
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  253 (291)
T 1u46_A          178 YVMQEHRKVPFAWCAPESLKTR---TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPEDCPQD  253 (291)
T ss_dssp             EEC-----CCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTSCCCCCCCTTCCHH
T ss_pred             hhhhccCCCCceeeCchhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHccCCCCCCCcCcCHH
Confidence            1122345678899999998542   35789999999999999999 99999865433 333333 333455567789999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++.+||+.||++|||+.+++++
T Consensus       254 l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          254 IYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-46  Score=385.24  Aligned_cols=246  Identities=22%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             ecccccCeEEEEEEE--CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVN--NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      .||+|+||+||+|.+  ..+++.||||+++... .+....+++.+|+++|++++|||||++++++. .+..++|||||++
T Consensus       376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             EeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            799999999999954  4667899999997543 23344577899999999999999999999885 4568999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.++++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+............
T Consensus       454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCccccccccC
Confidence            999999975 45599999999999999999999999999999999999999865 7999999999876543322222234


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.+. +..+....+..+..+..|..+++++.+++..
T Consensus       532 ~~~t~~y~APE~~~~---~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  607 (635)
T 4fl3_A          532 GKWPVKWYAPECINY---YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKGERMGCPAGCPREMYDLMNL  607 (635)
T ss_dssp             ---CGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCCceeeeChhhhcC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            457889999999854   346899999999999999998 99999864 3445666666777788889999999999999


Q ss_pred             hcccCCCCcCCHHHHhc
Q psy10603        246 CLRHDPAQRATIFELLQ  262 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~l~  262 (407)
                      ||+.||++|||+.++++
T Consensus       608 cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          608 CWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HTCSSTTTSCCHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHH
Confidence            99999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-46  Score=347.64  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=204.3

Q ss_pred             ccceeeecccccCeEEEEEEECC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNE---TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      .+.....||+|+||+||+|++..   ++..||+|.+...  ......+.+.+|+.++++++||||+++++++.. +..++
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            34556699999999999998653   3456999998754  234455778999999999999999999999764 45789


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC-----
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCcccccccc
Confidence            9999999999999977666799999999999999999999999999999999999999865 799999999976543221


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      .  ......+|+.|+|||++..   ..++.++|||||||++|+|++ |+.||...... .....+..+..+..+..++++
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          169 Y--KASVTRLPIKWMSPESINF---RRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKGDRLPKPDLCPPV  242 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHHTCCCCCCTTCCHH
T ss_pred             c--ccccCCCCcceeCchhhcc---CCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhcCCCCCCCCCCCHH
Confidence            1  1233457889999999854   346889999999999999998 99999754333 333444445566667889999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +.+++.+||..||++|||+.|++++.
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~L  268 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCSL  268 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHHH
Confidence            99999999999999999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.2e-47  Score=372.45  Aligned_cols=247  Identities=24%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|.+.. +..||||++.....    ..+.+.+|+.+|++++||||+++++++. .+..|+|||
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             HeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            34556699999999999999864 67899999975432    2467889999999999999999999875 667899999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++|+|.++++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++........ 
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~-  340 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT-  340 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHH-
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCcee-
Confidence            999999999997432 2589999999999999999999999999999999999998764 6999999999776432211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.+.. ..+....+..+..+..|..+++++.
T Consensus       341 -~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~  415 (454)
T 1qcf_A          341 -AREGAKFPIKWTAPEAINF---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMPRPENCPEELY  415 (454)
T ss_dssp             -TTCSSSSCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             -ccCCCcccccccCHHHhcc---CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHH
Confidence             1123456788999999854   346899999999999999999 999998643 4455555556667777889999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++|||+.++++
T Consensus       416 ~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          416 NIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-46  Score=355.22  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=210.4

Q ss_pred             cceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|++.     .+++.||+|.+...  ...+....+.+|+.+|++++||||+++++++.+.+..+
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            344558999999999999876     46788999998643  33445567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         79 LFMELCTEGTLESLVQSTE---------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      +||||+++|+|.++++...         ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~kl~Dfg  183 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFG  183 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEECCTT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEEECcCc
Confidence            9999999999999986522         3478999999999999999999999999999999999998765 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCC
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGET  228 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~  228 (407)
                      +++........ .......||+.|+|||++.+   ..++.++|||||||++|+|++ |+.||... +..+....+..+..
T Consensus       184 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          184 MTRDIYETDYY-RKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVLRFVMEGGL  258 (322)
T ss_dssp             CCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHHHHHHTTCC
T ss_pred             ccccccccccc-ccccCCCCCCCccChhhhcc---CCCCchhhHHHHHHHHHHHHhcCCCccccC-CHHHHHHHHHcCCc
Confidence            99765432211 11233467889999999854   346889999999999999999 89999854 34455555556666


Q ss_pred             CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        229 PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       229 ~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +..+..+++++.+++.+||+.||.+|||+.|+++|.
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L  294 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  294 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            677888999999999999999999999999998763

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.2e-47  Score=356.78  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc----eEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE----EMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l   79 (407)
                      +.....||+|+||+||+|++.  ++.||||++....    .......+|+.+|.+++||||+++++++....    .+++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            445559999999999999876  7899999986432    22344567999999999999999999988743    4799


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN----------TIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----------~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      ||||+++|+|.++++..  .+++..+..++.|++.||.|||+.          ||+||||||+|||++.++ .+||+|||
T Consensus       100 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg  176 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFG  176 (322)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCT
T ss_pred             EEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCC
Confidence            99999999999999753  499999999999999999999999          999999999999998764 69999999


Q ss_pred             CceecCCCCCCCCcccccccCCccccccccccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCc------------
Q psy10603        150 SAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK--VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS------------  215 (407)
Q Consensus       150 la~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~------------  215 (407)
                      +++........ ......+||+.|+|||++.+...  ..++.++|||||||++|||++|+.||.....            
T Consensus       177 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          177 LALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             cccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99876543322 22345689999999999864211  1245688999999999999999999975321            


Q ss_pred             ---hHHHHHHH-hCCCCCCCCCc-----cCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        216 ---NYQIMFKV-GMGETPTIPES-----LSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       216 ---~~~~~~~~-~~~~~~~~~~~-----~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                         ........ .....|.++..     .++++.+++.+||+.||++|||+.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               11111111 22233333332     34568999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-46  Score=355.31  Aligned_cols=253  Identities=22%  Similarity=0.359  Sum_probs=209.0

Q ss_pred             cceeeecccccCeEEEEEEEC-------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCc
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNN-------ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHRE   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~   75 (407)
                      +.....||+|+||+||+|++.       .+++.||+|++...  ......+.+.+|+.+|+++ +||||+++++++...+
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            445569999999999999975       45678999998743  3445567889999999999 8999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      ..++||||+++|+|.+++....               ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            9999999999999999997543               2389999999999999999999999999999999999998765


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~  219 (407)
                       .+||+|||+++........ .......+|+.|+|||++.+   ..++.++|||||||++|+|++ |..||... +....
T Consensus       195 -~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~  268 (334)
T 2pvf_A          195 -VMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD---RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEEL  268 (334)
T ss_dssp             -CEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHH
T ss_pred             -CEEEccccccccccccccc-cccCCCCcccceeChHHhcC---CCcChHHHHHHHHHHHHHHHhCCCCCcCcC-CHHHH
Confidence             6999999999876543211 11233467889999999854   235789999999999999999 99999854 34444


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ...+..+..+..+..+++++.+++.+||+.||.+|||+.|++++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  313 (334)
T 2pvf_A          269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  313 (334)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            455555666677888999999999999999999999999998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-47  Score=359.01  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=205.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCceEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGIN--QKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~   78 (407)
                      +.....||+|+||.||+|++..+++.||||++......+.   ...+.+.+|+.++++++  ||||+++++++...+..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            4455599999999999999999999999999976532211   11234567999999986  499999999999999999


Q ss_pred             EEEecCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         79 LFMELCTE-GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        79 lv~E~~~~-g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      +|||++.+ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+++.+||+|||+++.....
T Consensus       125 lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~  203 (320)
T 3a99_A          125 LILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT  203 (320)
T ss_dssp             EEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS
T ss_pred             EEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc
Confidence            99999986 8999998763 459999999999999999999999999999999999999854568999999999876532


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                      .     .....||+.|+|||++...  ..++.++|||||||++|||++|+.||...   .....     .....+..+++
T Consensus       204 ~-----~~~~~gt~~y~aPE~~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~---~~~~~-----~~~~~~~~~~~  268 (320)
T 3a99_A          204 V-----YTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHD---EEIIR-----GQVFFRQRVSS  268 (320)
T ss_dssp             C-----BCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHHH-----CCCCCSSCCCH
T ss_pred             c-----ccCCCCCccCCChHHhccC--CCCCccchHHhHHHHHHHHHHCCCCCCCh---hhhhc-----ccccccccCCH
Confidence            2     2345799999999998543  22367899999999999999999999742   11111     23345678899


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+++.+||+.||++|||+.|+++||||.
T Consensus       269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence            999999999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=351.69  Aligned_cols=243  Identities=30%  Similarity=0.528  Sum_probs=198.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+.....||+|+||+||+|++.  ++.||+|++...     ...+.+.+|+++|++++||||+++++++.  +..++|||
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e   79 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVME   79 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEE
T ss_pred             HeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEE
Confidence            3455669999999999999875  788999988532     23467889999999999999999999875  44799999


Q ss_pred             cCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         83 LCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALHE---NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~---~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |+++|+|.+++.....  .+++..+..++.|++.||.|||+   +||+||||||+|||++.++..+||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999975432  37889999999999999999999   899999999999999987766899999999765432


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCCCCCCccC
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s  236 (407)
                            .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||..... ..........+..+..+..++
T Consensus       160 ------~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (307)
T 2eva_A          160 ------MTNNKGSAAWMAPEVFEG---SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP  230 (307)
T ss_dssp             -----------CCTTSSCHHHHTC---CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred             ------cccCCCCCceEChhhhCC---CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence                  133468999999999854   3468899999999999999999999985433 334445556667777788899


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++.+++.+||+.||++|||+.|++++
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-46  Score=356.78  Aligned_cols=245  Identities=25%  Similarity=0.366  Sum_probs=176.2

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEEEEecC
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVLFMELC   84 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~E~~   84 (407)
                      .||+|+||+||+|++..+|+.||||++...    ....++   ....++.++||||+++++++..    ...+++||||+
T Consensus        36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~  108 (336)
T 3fhr_A           36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM  108 (336)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence            599999999999999999999999998642    222222   2233567899999999999876    45689999999


Q ss_pred             CCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.+  +..+||+|||+++......   
T Consensus       109 ~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~---  185 (336)
T 3fhr_A          109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---  185 (336)
T ss_dssp             TTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc---
Confidence            9999999997643 359999999999999999999999999999999999999753  2359999999997654321   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHH---HHHHHh---CCCCCCCCCcc
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQ---IMFKVG---MGETPTIPESL  235 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~---~~~~~~---~~~~~~~~~~~  235 (407)
                        ....+||+.|+|||++..   ..++.++|||||||++|+|++|+.||........   ....+.   ..........+
T Consensus       186 --~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (336)
T 3fhr_A          186 --LQTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV  260 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred             --cccCCCCcCccChhhhCC---CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence              234578999999999854   2357899999999999999999999975432211   011111   11122233578


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++++++++.+||+.||.+|||+.|+++||||..
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            999999999999999999999999999999963

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-47  Score=363.08  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=196.8

Q ss_pred             eeeecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEEEEE
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMVLFM   81 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~   81 (407)
                      +...||+|+||+||+|++..++   ..||+|.+...  .+....+++.+|+.+|++++||||+++++++.. ++..++||
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            4458999999999999875433   46899988643  334456789999999999999999999998654 55789999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC-
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV-  160 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~-  160 (407)
                      ||+++|+|.++++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~  249 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDS  249 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-------------
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccccccc
Confidence            99999999999977666789999999999999999999999999999999999998765 6999999999865432211 


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEG  239 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  239 (407)
                      ........+|+.|+|||++..   ..++.++|||||||++|||++ |.+||.... ..+....+..+..+..|..+++++
T Consensus       250 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          250 VHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             --------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccCCCCCcccccChHHhcC---CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHH
Confidence            112234567889999999864   346889999999999999999 678887543 333444455566667788899999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      .+++.+||+.||++|||+.|++++.
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~L  350 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSRI  350 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.5e-47  Score=359.72  Aligned_cols=254  Identities=19%  Similarity=0.253  Sum_probs=194.1

Q ss_pred             cceeeecccccCeEEEEEEECC---CCcEEEEEEEeccccCcHH---H-----HHHHHHHHHHHhcCCCCCcceEEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE---TGELVAMKEIQLHKQNDAR---F-----VKDMLVELRILEGINQKNLVKYYGVEI   72 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~---~~~~vAvK~i~~~~~~~~~---~-----~~~~~~E~~~l~~l~hpniv~~~~~~~   72 (407)
                      +.....||+|+||+||+|++..   ++..+|+|++.........   .     .+.+.+|+.++..++||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~  118 (345)
T 2v62_A           39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL  118 (345)
T ss_dssp             EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred             EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence            3445599999999999999987   7889999998754321111   1     123668899999999999999999998


Q ss_pred             e----CceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC-CeEEEEc
Q psy10603         73 H----REEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG-NSLKLGD  147 (407)
Q Consensus        73 ~----~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~-~~vkl~D  147 (407)
                      .    ....|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||+|
T Consensus       119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~D  196 (345)
T 2v62_A          119 TEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD  196 (345)
T ss_dssp             EESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECC
T ss_pred             cccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEe
Confidence            8    67899999999 999999997544 699999999999999999999999999999999999998754 2699999


Q ss_pred             ccCceecCCCCCC----CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Q psy10603        148 FGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV  223 (407)
Q Consensus       148 FGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~  223 (407)
                      ||+++.+......    ........||+.|+|||++.+   ..++.++|||||||++|||++|+.||.............
T Consensus       197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG---VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             CCCceecccccccccchhccccccCCCccccCHHHhcC---CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999876533211    112245689999999999864   346899999999999999999999996432222222111


Q ss_pred             hCCCCCCCC---------CccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        224 GMGETPTIP---------ESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       224 ~~~~~~~~~---------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .....+.++         ..+++++.+++..||+.||++|||+.++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            111111122         278899999999999999999999999876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=354.07  Aligned_cols=258  Identities=24%  Similarity=0.297  Sum_probs=202.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~l   79 (407)
                      +.....||+|+||.||+|++..+++.||+|++...   +....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            34455999999999999999999999999998653   33456778899999999999999999999873    347899


Q ss_pred             EEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         80 FMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      ||||+++|+|.+++..   ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACI  186 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEESCE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhccc
Confidence            9999999999998865   245699999999999999999999999999999999999998765 699999999876532


Q ss_pred             CCCCC------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCC
Q psy10603        157 HTTVP------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETP  229 (407)
Q Consensus       157 ~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~  229 (407)
                      .....      .......||+.|+|||++.......++.++|||||||++|+|++|+.||..... ..............
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  266 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI  266 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence            11100      011234679999999998654333357899999999999999999999963110 00111222223333


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      ..+..+++++.+++.+||+.||.+|||+.|++++..
T Consensus       267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            345678999999999999999999999999998643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.5e-46  Score=359.92  Aligned_cols=251  Identities=25%  Similarity=0.433  Sum_probs=199.5

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-----------CCCcceEEEEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-----------QKNLVKYYGVEI   72 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~   72 (407)
                      +.....||+|+||+||+|++..+++.||||++..    +....+.+.+|+.++++++           ||||+++++++.
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            4455699999999999999999999999999863    2234466788999988876           899999999988


Q ss_pred             eCc----eEEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEecCC-----C
Q psy10603         73 HRE----EMVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHEN-TIVHRDIKSANIFLTAEG-----N  141 (407)
Q Consensus        73 ~~~----~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~-~iiHrdlKp~Nill~~~~-----~  141 (407)
                      ..+    .+++||||+ +++|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++     .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            654    789999999 88999998763 34599999999999999999999998 999999999999996432     2


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-----h
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-----N  216 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-----~  216 (407)
                      .+||+|||+++.....      .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....     .
T Consensus       176 ~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             EEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             eEEEcccccccccCCC------CCCCCCCccccCcHHHhC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence            6999999999876432      234578999999999865   3468999999999999999999999975321     1


Q ss_pred             HHHHHHH--hCCC---------------------------------------CCCCCCccCHHHHHHHHHhcccCCCCcC
Q psy10603        217 YQIMFKV--GMGE---------------------------------------TPTIPESLSDEGQAFAELCLRHDPAQRA  255 (407)
Q Consensus       217 ~~~~~~~--~~~~---------------------------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~  255 (407)
                      ...+..+  ..+.                                       ...++..+++++.+||.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            1111110  0011                                       1123345677899999999999999999


Q ss_pred             CHHHHhcCCeeee
Q psy10603        256 TIFELLQHPFLIV  268 (407)
Q Consensus       256 t~~e~l~hp~~~~  268 (407)
                      |+.|+++||||..
T Consensus       327 t~~ell~hp~f~~  339 (373)
T 1q8y_A          327 DAGGLVNHPWLKD  339 (373)
T ss_dssp             CHHHHHTCGGGTT
T ss_pred             CHHHHhhChhhhc
Confidence            9999999999963

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-47  Score=354.67  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=201.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcC----CCCCcceEEEEEEeCce
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGI----NQKNLVKYYGVEIHREE   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l----~hpniv~~~~~~~~~~~   76 (407)
                      +.....||+|+||.||+|++..+++.||+|++........   .....+.+|+.++.++    +||||+++++++...+.
T Consensus        33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~  112 (312)
T 2iwi_A           33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG  112 (312)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----
T ss_pred             eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCe
Confidence            4445589999999999999999999999999875433221   1223456788888888    89999999999999999


Q ss_pred             EEEEEec-CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         77 MVLFMEL-CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        77 ~~lv~E~-~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      .++|||+ +.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+++.+||+|||+++...
T Consensus       113 ~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~  191 (312)
T 2iwi_A          113 FMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH  191 (312)
T ss_dssp             CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECC
T ss_pred             EEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcc
Confidence            9999999 7899999999764 4599999999999999999999999999999999999998445689999999998765


Q ss_pred             CCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCcc
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESL  235 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (407)
                      ...     .....||+.|+|||++....  ..+.++|||||||++|+|++|+.||...   ....     .....++..+
T Consensus       192 ~~~-----~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~-----~~~~~~~~~~  256 (312)
T 2iwi_A          192 DEP-----YTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIPFERD---QEIL-----EAELHFPAHV  256 (312)
T ss_dssp             SSC-----BCCCCSCTTTSCHHHHHHSC--BCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHH-----HTCCCCCTTS
T ss_pred             cCc-----ccccCCcccccCceeeecCC--CCCccchHHHHHHHHHHHHHCCCCCCCh---HHHh-----hhccCCcccC
Confidence            432     24467899999999986432  2345899999999999999999999742   1211     1234466789


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      ++++.+++.+||+.||++|||+.|+++|||+...
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            9999999999999999999999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.4e-46  Score=353.79  Aligned_cols=250  Identities=28%  Similarity=0.452  Sum_probs=197.2

Q ss_pred             cceeeecccccCeEEEEEEECCCC-cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC------cceEEEEEEeCce
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETG-ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN------LVKYYGVEIHREE   76 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~~   76 (407)
                      +.....||+|+||+||+|++..++ +.||+|++...    ....+.+.+|+.+++.++|+|      ++.+++++...+.
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            344558999999999999998877 68999998632    334566788999998887765      8999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec-----------------
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA-----------------  138 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~-----------------  138 (407)
                      .++||||+ ++++.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.                 
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence            99999999 456666654433 46999999999999999999999999999999999999932                 


Q ss_pred             -CCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH
Q psy10603        139 -EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY  217 (407)
Q Consensus       139 -~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~  217 (407)
                       .+..+||+|||+++.....      .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE---LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             ESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec---CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence             2357999999999764332      234689999999999864   346889999999999999999999998654332


Q ss_pred             HHHH-HHhCCCCCC-----------------------------------------CCCccCHHHHHHHHHhcccCCCCcC
Q psy10603        218 QIMF-KVGMGETPT-----------------------------------------IPESLSDEGQAFAELCLRHDPAQRA  255 (407)
Q Consensus       218 ~~~~-~~~~~~~~~-----------------------------------------~~~~~s~~~~~~i~~~l~~dp~~R~  255 (407)
                      .... ....+..|.                                         .....++++.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            2111 111111110                                         0112345788999999999999999


Q ss_pred             CHHHHhcCCeee
Q psy10603        256 TIFELLQHPFLI  267 (407)
Q Consensus       256 t~~e~l~hp~~~  267 (407)
                      |+.|+++||||.
T Consensus       327 t~~e~l~hp~f~  338 (355)
T 2eu9_A          327 TLAEALLHPFFA  338 (355)
T ss_dssp             CHHHHTTSGGGG
T ss_pred             CHHHHhcChhhc
Confidence            999999999995

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.1e-46  Score=348.36  Aligned_cols=253  Identities=21%  Similarity=0.324  Sum_probs=198.0

Q ss_pred             cceeeecccccCeEEEEEEECC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc-----
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNE---TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE-----   75 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----   75 (407)
                      +.....||+|+||+||+|.+..   +++.||+|++.... ......+.+.+|+.++++++||||+++++++...+     
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            3445589999999999998764   55689999987543 33455677899999999999999999999987655     


Q ss_pred             eEEEEEecCCCCCHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccC
Q psy10603         76 EMVLFMELCTEGTLESLVQS-----TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGS  150 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGl  150 (407)
                      ..++||||+++|+|.+++..     ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~Dfg~  193 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGL  193 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEECSCSC
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEeecCc
Confidence            35999999999999999843     234599999999999999999999999999999999999998765 699999999


Q ss_pred             ceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCC
Q psy10603        151 AVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETP  229 (407)
Q Consensus       151 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~  229 (407)
                      ++........ .......+++.|+|||++.+   ..++.++|||||||++|+|++ |..||.... ..........+..+
T Consensus       194 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~  268 (313)
T 3brb_A          194 SKKIYSGDYY-RQGRIAKMPVKWIAIESLAD---RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-NHEMYDYLLHGHRL  268 (313)
T ss_dssp             C-----------------CCGGGSCHHHHHS---SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHHHTTCCC
T ss_pred             ceeccccccc-CcccccCCCccccCchhhcC---CCccchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHHHHHcCCCC
Confidence            9776433211 11233457889999999854   346889999999999999999 899998644 33444455556677


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+..+++++.+++.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7788899999999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-45  Score=342.88  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=199.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEE-EEeCceEEEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV-EIHREEMVLFM   81 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~-~~~~~~~~lv~   81 (407)
                      .+.....||+|+||+||+|++..+++.||+|++......     +.+.+|+.+++.++|++++..+.. ....+..++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            344556999999999999999999999999998754332     246789999999999886665554 45677889999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe--cCCCeEEEEcccCceecCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT--AEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~--~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      ||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++  ++++.+||+|||+++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999 8999999976666799999999999999999999999999999999999995  2345799999999987654322


Q ss_pred             CC----CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-----HHHH-HHHhCCCCC
Q psy10603        160 VP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-----YQIM-FKVGMGETP  229 (407)
Q Consensus       160 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-----~~~~-~~~~~~~~~  229 (407)
                      ..    .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||......     ...+ ........+
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             ccccccccccccccccccCChhhhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            11    11245689999999999864   34688999999999999999999999853221     1111 111111112


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .++..+++++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            234678999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.1e-46  Score=367.50  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|.+.. +..||||++......    .+.+.+|+++|++++||||+++++++.. +..++||||
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4455689999999999999875 466999998754322    2568899999999999999999999865 678999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++|+|.++++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........  
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~--  336 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT--  336 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC----------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCcee--
Confidence            9999999999653 24589999999999999999999999999999999999998764 6999999999776432211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.+.. ..+....+..+..+..|..+++++.+
T Consensus       337 ~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             ------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             cccCCcccccccCHhHHhc---CCCCccccHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1223456789999999864   346889999999999999999 999998643 44556666677777778899999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||+.||++|||+.++++
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-46  Score=353.85  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=200.0

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++. +++.||+|++.....   ...+.+.+|+.+|+.++||||+++++++...+..++||||+
T Consensus        42 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           42 DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             CccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            34448999999999999964 689999998865422   23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         85 TEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        85 ~~g~L~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ++|+|.+++....   ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~-  195 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQT-  195 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSSSSCC-
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccccccccc-
Confidence            9999999886432   2489999999999999999999999999999999999998765 6999999999875432211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH-----HH-HHHHhCCC--------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY-----QI-MFKVGMGE--------  227 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~-----~~-~~~~~~~~--------  227 (407)
                      .......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......     .. ......+.        
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIK---GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHH---CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             ccccccCCCccccCHHHhcC---CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            12244578999999999864   346889999999999999999999997533211     00 01111111        


Q ss_pred             -CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        228 -TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       228 -~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                       ...++...+.++.+++.+||+.||++|||+.|++++..
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence             11223345577899999999999999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-45  Score=343.55  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=197.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEE-EeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVE-IHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~E   82 (407)
                      +.....||+|+||+||+|++..+++.||+|++......     +.+.+|+.+++.++|+|++..+..+ ...+..++|||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            44555999999999999999999999999987644322     3467899999999998877665554 66778999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE---ecCCCeEEEEcccCceecCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL---TAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill---~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+   +.+ ..+||+|||+++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCTTT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCccc
Confidence            99 899999998666679999999999999999999999999999999999999   454 5699999999987654322


Q ss_pred             CC----CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHH----HHhCCCCC
Q psy10603        160 VP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMF----KVGMGETP  229 (407)
Q Consensus       160 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~----~~~~~~~~  229 (407)
                      ..    .......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||......  .+...    .......+
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             CccCCCCcccccCCCccccchHHhcC---CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            11    12245689999999999864   34688999999999999999999999753321  11111    11111111


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .....+++++.+++..||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            233668999999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.7e-46  Score=343.72  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=202.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-----------
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-----------   73 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----------   73 (407)
                      .....||+|+||.||+|++..+++.||+|++....       +.+.+|++++++++||||+++++++..           
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            34458999999999999999999999999997542       235689999999999999999998754           


Q ss_pred             -----CceEEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEc
Q psy10603         74 -----REEMVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGD  147 (407)
Q Consensus        74 -----~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~D  147 (407)
                           ...+++||||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECc
Confidence                 44589999999999999999754 34589999999999999999999999999999999999999864 799999


Q ss_pred             ccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCC
Q psy10603        148 FGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE  227 (407)
Q Consensus       148 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~  227 (407)
                      ||++.......    ......||+.|+|||++..   ..++.++|||||||++|+|++|..|+...   .........  
T Consensus       166 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~--  233 (284)
T 2a19_B          166 FGLVTSLKNDG----KRTRSKGTLRYMSPEQISS---QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRD--  233 (284)
T ss_dssp             CTTCEESSCCS----CCCCCCSCCTTSCHHHHHC---SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHT--
T ss_pred             chhheeccccc----cccccCCcccccChhhhcc---CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhc--
Confidence            99998765432    1234579999999999854   34688999999999999999999998532   122222222  


Q ss_pred             CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 ~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                       ..++..+++++++++.+||+.||.+|||+.|+++|++..
T Consensus       234 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          234 -GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             -TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             234567899999999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-46  Score=350.84  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=204.8

Q ss_pred             cceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--eE
Q psy10603          4 VTFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--EM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~   77 (407)
                      +.....||+|+||.||+|+    +..+++.||+|++...   .....+.+.+|+++|++++||||+++++++...+  .+
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            3445599999999999998    4678999999998653   3344577899999999999999999999886644  68


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCSS
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhcccc
Confidence            999999999999999987666799999999999999999999999999999999999999864 7999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch---------------HHHHHH
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN---------------YQIMFK  222 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~---------------~~~~~~  222 (407)
                      ...........+|+.|+|||++.+.   .++.++|||||||++|||++|..||......               ......
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTES---KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             ccccccccCCCCceeEECchhhcCC---CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            2211112334577889999998643   3578999999999999999999998632100               012223


Q ss_pred             HhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       223 ~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ...+..+..+..+++++.+++.+||+.||++|||+.|+++
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3344455667889999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.3e-46  Score=350.20  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=203.1

Q ss_pred             ceeeecccccCeEEEEEE----ECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC--ceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAV----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR--EEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~   78 (407)
                      .....||+|+||+||+|.    +..+++.||||++...  ......+.+.+|+++|++++||||+++++++.+.  ..++
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            344589999999998875    4457899999999754  3445567789999999999999999999999874  6799


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +||||+++|+|.+++...  .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       112 lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTC
T ss_pred             EEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccccc
Confidence            999999999999999653  399999999999999999999999999999999999998764 69999999998775433


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--------------HHHHHHHh
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--------------YQIMFKVG  224 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--------------~~~~~~~~  224 (407)
                      ..........||+.|+|||++.+.   .++.++|||||||++|+|++|+.||......              ........
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKEY---KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccCCCCCceeeChHHhcCC---CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            221122345688899999998643   3568999999999999999999999742111              11223334


Q ss_pred             CCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        225 MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       225 ~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..+..+..+++++.+++.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            45566678889999999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.3e-46  Score=345.64  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=192.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeC----ce
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG--INQKNLVKYYGVEIHR----EE   76 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~----~~   76 (407)
                      .+.....||+|+||+||+|++  +++.||||++....      .+.+.+|.+++..  ++||||+++++++...    ..
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            455566999999999999987  58899999986431      1334556666655  8999999999986543    46


Q ss_pred             EEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEecCCCeEEEEcc
Q psy10603         77 MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH--------ENTIVHRDIKSANIFLTAEGNSLKLGDF  148 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--------~~~iiHrdlKp~Nill~~~~~~vkl~DF  148 (407)
                      +++||||+++|+|.++++.  ..+++..+..++.|++.||.|||        +++|+||||||+|||++.++ .+||+||
T Consensus        81 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df  157 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADL  157 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             eEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeC
Confidence            8999999999999999954  45999999999999999999999        99999999999999998765 6999999


Q ss_pred             cCceecCCCCCC-CCcccccccCCcccccccccccccC---CCCcchhHHHHHHHHHHHHcC----------CCCCCCCC
Q psy10603        149 GSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKV---GHGRAVDIWSLGCVLVEMSSG----------KRPWAEYD  214 (407)
Q Consensus       149 Gla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~---~~~~~~DiwSlGv~l~em~~g----------~~Pf~~~~  214 (407)
                      |+++........ ........||+.|+|||++......   .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999776433221 1112345899999999998653211   234689999999999999999          88986432


Q ss_pred             c---hHHHHHHH--hCCCCCCCCC-----ccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        215 S---NYQIMFKV--GMGETPTIPE-----SLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       215 ~---~~~~~~~~--~~~~~~~~~~-----~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .   ........  .....+.+|.     ..++++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            1   22222221  2233444443     35678999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-45  Score=339.34  Aligned_cols=246  Identities=23%  Similarity=0.390  Sum_probs=203.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++. +++.||+|.+......    .+.+.+|+++|++++||||+++++++. .+..++||||
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             hhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            445569999999999999976 5678999998754322    356789999999999999999999875 5568999999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.........  
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~--  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT--  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE--
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccc--
Confidence            99999999986432 2589999999999999999999999999999999999998764 6999999999876543211  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.... ..+....+..+..+..+..+++++.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINY---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHH---CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccCCCCccCccChhhhcc---CCCCchhhhHHHHHHHHHHHhCCCCCCcccC-HHHHHHHHhcccCCCCcccccHHHHH
Confidence            1233457889999999854   235789999999999999999 999998643 44455555566666778889999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++.+||..||++|||+.++++
T Consensus       242 li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=361.30  Aligned_cols=250  Identities=27%  Similarity=0.457  Sum_probs=199.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc--eEEEEEec
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE--EMVLFMEL   83 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~E~   83 (407)
                      ....||+|+||+||+|++..+|+.||||++.......  ..+.+.+|+++|++++||||+++++++...+  ..++||||
T Consensus        13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            3449999999999999999999999999997543222  2456789999999999999999999988765  78999999


Q ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE----ecCCCeEEEEcccCceecCCC
Q psy10603         84 CTEGTLESLVQSTE--DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFL----TAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        84 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill----~~~~~~vkl~DFGla~~~~~~  157 (407)
                      |++|+|.++++...  ..+++..+..++.|++.||.|||++||+||||||+|||+    +.+ ..+||+|||+++.....
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAARELEDD  169 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGCEECCCG
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCceEccCC
Confidence            99999999986532  238999999999999999999999999999999999998    433 46999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---chHHHHHHHhCCCCC
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTN-----KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD---SNYQIMFKVGMGETP  229 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~---~~~~~~~~~~~~~~~  229 (407)
                      ..    .....||+.|+|||++....     ...++.++|||||||++|||++|+.||....   .....+..+..+..+
T Consensus       170 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          170 EQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             GG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             Cc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            22    24467999999999985310     1234679999999999999999999996432   233444444333322


Q ss_pred             C------------------------CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        230 T------------------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       230 ~------------------------~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .                        ++..+++.+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            1                        12335567889999999999999999999854

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.4e-46  Score=363.10  Aligned_cols=252  Identities=27%  Similarity=0.441  Sum_probs=188.9

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ...||+|+||+||.+ ...+|+.||||++....      .+.+.+|+.+|.++ +||||+++++++.+.+.+|+|||||+
T Consensus        20 ~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           20 EKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             cCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            347999999999875 45579999999986432      24567899999875 89999999999999999999999996


Q ss_pred             CCCHHHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC------------CCeEEEEc
Q psy10603         86 EGTLESLVQSTEDG------LPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE------------GNSLKLGD  147 (407)
Q Consensus        86 ~g~L~~~~~~~~~~------~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~------------~~~vkl~D  147 (407)
                       |+|.+++......      .++..+..++.||+.||+|||++||+||||||+|||++.+            +..+||+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence             5999999753321      1233457799999999999999999999999999999753            24799999


Q ss_pred             ccCceecCCCCCC-CCcccccccCCcccccccccccc----cCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHH
Q psy10603        148 FGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTN----KVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMF  221 (407)
Q Consensus       148 FGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~  221 (407)
                      ||+++........ .......+||+.|+|||++.+..    ...++.++|||||||++|||++ |+.||.........+.
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~  251 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII  251 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHH
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHh
Confidence            9999887543221 11234568999999999986421    2346889999999999999999 9999975433322222


Q ss_pred             HHhCCCCCCC----CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        222 KVGMGETPTI----PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       222 ~~~~~~~~~~----~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ... ...+..    +..+++++++++.+||+.||.+|||+.|+++||||.
T Consensus       252 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          252 RGI-FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             HTC-CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             cCC-CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            111 111111    234568899999999999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-45  Score=340.38  Aligned_cols=241  Identities=23%  Similarity=0.386  Sum_probs=195.4

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-ceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-EEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~E   82 (407)
                      +.....||+|+||+||+|.+.  |+.||+|++....     ..+.+.+|++++++++||||+++++++... +..++|||
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             ceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            445558999999999999874  7899999986432     246688999999999999999999987654 47899999


Q ss_pred             cCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+++++|.+++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.......   
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeeccccccccccc---
Confidence            9999999999865332 278999999999999999999999999999999999998765 69999999987654321   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                         ....+|+.|+|||++..   ..++.++||||||+++|+|++ |+.||.... .......+..+..+..+..+++++.
T Consensus       172 ---~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~  244 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKMDAPDGCPPAVY  244 (278)
T ss_dssp             -------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred             ---cCCCccccccCHHHhCC---CCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhcCCCCCCcccCCHHHH
Confidence               23467889999999854   346889999999999999998 999998643 3344455555666777889999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhc
Q psy10603        241 AFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +++.+||+.||++|||+.|+++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-46  Score=354.65  Aligned_cols=252  Identities=23%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++. +|+.||||++.......  ....+.+|+.++++++||||+++++++...+..++||||+
T Consensus        33 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  109 (326)
T 3uim_A           33 SNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM  109 (326)
T ss_dssp             CSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECC
T ss_pred             ccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEec
Confidence            33448999999999999754 68899999987543211  1235788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         85 TEGTLESLVQSTE---DGLPEVLVRRYTKQLVDAISALHEN---TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        85 ~~g~L~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ++|+|.++++...   ..+++..+..++.|++.||.|||++   ||+||||||+|||++.++ .+||+|||+++......
T Consensus       110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  188 (326)
T 3uim_A          110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKD  188 (326)
T ss_dssp             TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCEECCSSS
T ss_pred             cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccccccCccc
Confidence            9999999997533   2389999999999999999999999   999999999999998764 69999999998764332


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC----Cch---HHHHHHHhCC-----
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY----DSN---YQIMFKVGMG-----  226 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~----~~~---~~~~~~~~~~-----  226 (407)
                      .  .......||+.|+|||++...   .++.++|||||||++|+|++|+.||...    ...   ..........     
T Consensus       189 ~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          189 T--HVTTAVRGTIGHIAPEYLSTG---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             S--CEECCCCSCGGGCCHHHHHHS---EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             c--cccccccCCcCccCHHHhccC---CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            2  123445699999999998543   3578999999999999999999999521    110   0111000000     


Q ss_pred             -----CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        227 -----ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       227 -----~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                           ..+..+...++++.+++.+||+.||.+|||+.|+++|..
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                 011122334477899999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=347.11  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=184.4

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEE--------eCce
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEI--------HREE   76 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--------~~~~   76 (407)
                      ....||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.++.++. ||||+++++++.        ....
T Consensus        32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             EEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            345999999999999999999999999998643   3344567889999999996 999999999984        3446


Q ss_pred             EEEEEecCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603         77 MVLFMELCTEGTLESLVQS--TEDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                      +++||||++ |+|.+++..  ....+++..+..++.||+.||.|||++|  |+||||||+|||++.++ .+||+|||+++
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~  186 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSAT  186 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTTCB
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCccce
Confidence            899999996 688888754  3445999999999999999999999999  99999999999998865 69999999998


Q ss_pred             ecCCCCCCC---------CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Q psy10603        153 KISAHTTVP---------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV  223 (407)
Q Consensus       153 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~  223 (407)
                      .........         .......||+.|+|||++.......++.++|||||||++|+|++|+.||...... ....  
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~--  263 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-RIVN--  263 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-Hhhc--
Confidence            765332110         1112456899999999985333455688999999999999999999999753221 1111  


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                       .......+...++++.+++.+||+.||++|||+.|+++|..-
T Consensus       264 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          264 -GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             -CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             112223345677889999999999999999999999987654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-45  Score=369.80  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=205.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|.+.. +..||||++......    .+.+.+|+++|++++||||+++++++.. +.+||||||
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4556689999999999999875 467999999754322    2568899999999999999999999865 678999999


Q ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      +++|+|.++++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++........  
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~--  419 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT--  419 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHH--
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCcee--
Confidence            9999999999653 24589999999999999999999999999999999999998764 6999999999765432111  


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+|+.|+|||++..   ..++.++|||||||++|||++ |+.||.+. ...+....+..+.....+..+++++.+
T Consensus       420 ~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMPCPPECPESLHD  495 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-CHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccCCcCcccccCHHHhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1123456788999999864   346889999999999999999 99999864 344556666667777778899999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +|.+||+.||++|||+.++++
T Consensus       496 li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999876

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.9e-45  Score=342.29  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=199.1

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ-NDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ..||+|+||+||+|++  +++.||+|++..... ......+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        37 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           37 NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             CEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             CccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            5799999999999986  578999999875432 2334567788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         87 GTLESLVQST--EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        87 g~L~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++|.+++...  ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ ...
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~-~~~  192 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQT-VMT  192 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSSC-EEC
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeeccccccccccccc-ccc
Confidence            9999998643  34589999999999999999999999999999999999998764 6999999999776432211 112


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH---HHHHHHh----------CCCCCCC
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY---QIMFKVG----------MGETPTI  231 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~---~~~~~~~----------~~~~~~~  231 (407)
                      ....||+.|+|||++.+    .++.++|||||||++|+|++|..||.......   .......          ....+..
T Consensus       193 ~~~~g~~~y~aPE~~~~----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             SSCCSCGGGCCHHHHTT----EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccCCCcCcCChHHhcC----CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            34579999999998853    25789999999999999999999997543221   1111111          1112223


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +...++.+.+++.+||+.||.+|||+.|++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44556788999999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=352.58  Aligned_cols=248  Identities=19%  Similarity=0.270  Sum_probs=195.8

Q ss_pred             cceeeecccccCeEEEEEEECCC--------CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcce---------
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNET--------GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK---------   66 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~--------~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------   66 (407)
                      +.....||+|+||+||+|++..+        ++.||+|++...        +.+.+|++++++++||||++         
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            34445999999999999999874        889999998743        34678999999999999987         


Q ss_pred             ------EEEEEEe-CceEEEEEecCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec
Q psy10603         67 ------YYGVEIH-REEMVLFMELCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA  138 (407)
Q Consensus        67 ------~~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~  138 (407)
                            +++++.. .+..|+||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP  194 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence                  5677766 67899999999 99999999764 256999999999999999999999999999999999999987


Q ss_pred             CC-CeEEEEcccCceecCCCCCC----CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q psy10603        139 EG-NSLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEY  213 (407)
Q Consensus       139 ~~-~~vkl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~  213 (407)
                      ++ ..+||+|||+++.+......    ........||+.|+|||++.+   ..++.++|||||||++|||++|+.||...
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG---CGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc---CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            54 16999999999876533211    112244589999999999854   34688999999999999999999999865


Q ss_pred             CchHHHHHHHh---CCCCCCCC------CccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        214 DSNYQIMFKVG---MGETPTIP------ESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       214 ~~~~~~~~~~~---~~~~~~~~------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ......+....   ....+.++      ..+++++.+++.+||+.||++|||+.|+++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            42222221111   11222221      2578999999999999999999999998763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-44  Score=370.32  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=205.1

Q ss_pred             ceeeecccccCeEEEEEEECCC---CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNET---GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .....||+|+||+||+|++..+   +..||+|.+...  ......+.+.+|+.+|++++||||+++++++ ..+..|+||
T Consensus       393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~lv~  469 (656)
T 2j0j_A          393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIM  469 (656)
T ss_dssp             EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEEEE
Confidence            3445899999999999998654   457999987643  3445567889999999999999999999987 456789999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|.++++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~~~~~-  547 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYY-  547 (656)
T ss_dssp             ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC-----
T ss_pred             EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecCCCcce-
Confidence            99999999999987666699999999999999999999999999999999999999865 7999999999876433211 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ......+|+.|+|||++..   ..++.++|||||||++|||++ |..||.+.. .......+..+..+..|..+++++.
T Consensus       548 -~~~~~~~t~~y~aPE~~~~---~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          548 -KASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             -------CCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             -eccCCCCCcceeCHHHhcC---CCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHcCCCCCCCccccHHHH
Confidence             1223456789999999854   346889999999999999997 999998643 4455555666667778889999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcC
Q psy10603        241 AFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++.+||..||++|||+.|+++.
T Consensus       623 ~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999998863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=353.47  Aligned_cols=243  Identities=19%  Similarity=0.290  Sum_probs=189.0

Q ss_pred             ceeeecccccCeEEEEE-----EECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCce
Q psy10603          5 TFSVSPGQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN---QKNLVKYYGVEIHREE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~-----~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~   76 (407)
                      .....||+|+||+||+|     .+..+++.||+|++...   .   ...+.+|+++++.++   |+||+++++++...+.
T Consensus        68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---N---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---C---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---C---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            34458999999999999     46788999999998643   2   234566777777776   8999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec-----------CCC
Q psy10603         77 MVLFMELCTEGTLESLVQS----TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA-----------EGN  141 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~-----------~~~  141 (407)
                      .|+|||||++|+|.++++.    ....+++..+..++.||+.||+|||++||+||||||+|||++.           + .
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~-~  220 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS-A  220 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C-T
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc-C
Confidence            9999999999999999964    2456999999999999999999999999999999999999987           4 4


Q ss_pred             eEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Q psy10603        142 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMF  221 (407)
Q Consensus       142 ~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~  221 (407)
                      .+||+|||+|+.+..... .......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........   
T Consensus       221 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             TEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT---CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             CEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC---CCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence            699999999977542211 122355689999999999865   3368999999999999999999999964322100   


Q ss_pred             HHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        222 KVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       222 ~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      . .....+..  ..++...+++..||+.+|.+|++..+.+.+.
T Consensus       294 ~-~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          294 K-PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             E-ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             e-echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            0 00111111  2467788999999999999997655554433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-44  Score=355.57  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=199.6

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceEEEEEe
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~E   82 (407)
                      +.....||+|+||+||+|++..+++.||||++......     ..+.+|+++++.++| ++|..+..++...+..+||||
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            44455999999999999999999999999988754332     236789999999988 556666667778889999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEe--cCCCeEEEEcccCceecCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLT--AEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~--~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++  ++++.+||+|||+++.+......
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            99 8999999986666799999999999999999999999999999999999994  23457999999999876543221


Q ss_pred             C----CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch--HHHHHHHh----CCCCCC
Q psy10603        161 P----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN--YQIMFKVG----MGETPT  230 (407)
Q Consensus       161 ~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~--~~~~~~~~----~~~~~~  230 (407)
                      .    ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||......  .+....+.    ......
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccccCCCccccCHHHhcC---CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            1    12235789999999999865   34688999999999999999999999864331  22222111    111222


Q ss_pred             CCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        231 IPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       231 ~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++..+++++.+++..||+.||++||++.++++
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            34578999999999999999999999988754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-44  Score=338.97  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=190.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeC----ceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG--INQKNLVKYYGVEIHR----EEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~----~~~   77 (407)
                      +.....||+|+||+||+|++.  ++.||||++....      .....+|.+++..  ++||||+++++++...    ..+
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           39 IQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             CEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             eEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            345569999999999999875  8899999986431      1234455566554  5999999999999887    789


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN--------TIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--------~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      ++||||+++|+|.++++..  .+++..+..++.|++.||.|||++        ||+||||||+|||++.++ .+||+|||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg  187 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  187 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCC
Confidence            9999999999999999653  489999999999999999999999        999999999999998765 69999999


Q ss_pred             CceecCCCCCC-CCcccccccCCcccccccccccccCCC---CcchhHHHHHHHHHHHHcC----------CCCCCCCC-
Q psy10603        150 SAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMSSG----------KRPWAEYD-  214 (407)
Q Consensus       150 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~---~~~~DiwSlGv~l~em~~g----------~~Pf~~~~-  214 (407)
                      +++.+...... .......+||+.|+|||++........   +.++|||||||++|||++|          ..||.... 
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~  267 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP  267 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence            99876543221 111235689999999999864321110   1149999999999999999          77776432 


Q ss_pred             --chHHHHHH--HhCCCCCCCCC-----ccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        215 --SNYQIMFK--VGMGETPTIPE-----SLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       215 --~~~~~~~~--~~~~~~~~~~~-----~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                        ........  ......+.++.     .+++++.+++.+||+.||++|||+.|+++|.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence              12222221  12233444443     4567799999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=343.68  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=187.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHH--HHHHHhcCCCCCcceEEEEEEe-----Cc
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLV--ELRILEGINQKNLVKYYGVEIH-----RE   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~--E~~~l~~l~hpniv~~~~~~~~-----~~   75 (407)
                      .+.....||+|+||+||+|++  +++.||||++.....      ..+..  |+..+..++||||+++++.+..     ..
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            455667999999999999976  688999999874321      22333  4444556999999999986542     33


Q ss_pred             eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEEecCCCeEEEE
Q psy10603         76 EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN---------TIVHRDIKSANIFLTAEGNSLKLG  146 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---------~iiHrdlKp~Nill~~~~~~vkl~  146 (407)
                      .+++||||+++|+|.++++..  ..++..+..++.|++.||.|||++         ||+||||||+|||++.++ .+||+
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~  162 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVIS  162 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEEC
T ss_pred             eEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEe
Confidence            679999999999999999653  368999999999999999999999         999999999999998765 69999


Q ss_pred             cccCceecCCCCCC-----CCcccccccCCccccccccccccc----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-
Q psy10603        147 DFGSAVKISAHTTV-----PGELNGFVGTQAYMAPEVFMDTNK----VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-  216 (407)
Q Consensus       147 DFGla~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~----~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-  216 (407)
                      |||+++.+......     .......+||+.|+|||++.+...    ..++.++|||||||++|||++|..||...... 
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            99999876533211     112235679999999999864211    22457899999999999999997776432210 


Q ss_pred             ---------------HHH--HHHHhCCCCCCCCCc------cCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        217 ---------------YQI--MFKVGMGETPTIPES------LSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       217 ---------------~~~--~~~~~~~~~~~~~~~------~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                                     ...  .........+.+|..      +++++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                           011  111222334455544      4458999999999999999999999965

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=345.17  Aligned_cols=253  Identities=23%  Similarity=0.396  Sum_probs=201.3

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||.||+|++..   .+|+|++....... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             eEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            4445599999999999998864   49999987543221 2234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC--CC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT--VP  161 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~--~~  161 (407)
                      +++++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+++  +.+||+|||+++.......  ..
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~--~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----------C
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC--CCEEEeecCCccccccccccccc
Confidence            9999999999765556999999999999999999999999999999999999973  3699999999865432111  11


Q ss_pred             CcccccccCCcccccccccccc------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCC-Cc
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTN------KVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIP-ES  234 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~------~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~  234 (407)
                      .......||+.|+|||++....      ...++.++|||||||++|||++|+.||.... .......+..+..+..+ ..
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~  267 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-AEAIIWQMGTGMKPNLSQIG  267 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-HHHHHHHHHTTCCCCCCCSS
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhccCCCCCCCcCC
Confidence            2233456899999999986421      2346789999999999999999999998543 44445555555555443 46


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++++.+++.+||..||++|||+.|+++.
T Consensus       268 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          268 MGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            88999999999999999999999999863

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.1e-44  Score=333.17  Aligned_cols=226  Identities=27%  Similarity=0.364  Sum_probs=182.4

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHH-hcCCCCCcceEEEEEEe----CceEEEEEe
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYGVEIH----REEMVLFME   82 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~~lv~E   82 (407)
                      ..||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++ +.++||||+++++++..    ...+++|||
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e   95 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   95 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence            3699999999999999999999999998632        2456788887 66799999999999887    678999999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~  159 (407)
                      |+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.+  +..+||+|||++.....   
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---  172 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---  172 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---
Confidence            999999999997643 359999999999999999999999999999999999999873  34699999999854321   


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCCCCC----C
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTIP----E  233 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~----~  233 (407)
                                               ..++.++|||||||++|||++|+.||.........  ............+    .
T Consensus       173 -------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (299)
T 3m2w_A          173 -------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS  227 (299)
T ss_dssp             -------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred             -------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence                                     12357899999999999999999999753221110  0000011111222    5


Q ss_pred             ccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeeee
Q psy10603        234 SLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVS  269 (407)
Q Consensus       234 ~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~~  269 (407)
                      .+++++++++.+||+.||++|||+.|+++||||...
T Consensus       228 ~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            689999999999999999999999999999999643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-45  Score=371.22  Aligned_cols=255  Identities=27%  Similarity=0.360  Sum_probs=202.7

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CceE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH------REEM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~   77 (407)
                      +.....||+|+||+||+|.+..+|+.||||++...  ......+.+.+|+++|++++||||+++++++..      .+..
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            34445999999999999999999999999988643  344556788999999999999999999998655      6678


Q ss_pred             EEEEecCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC--eEEEEcccCcee
Q psy10603         78 VLFMELCTEGTLESLVQSTED--GLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN--SLKLGDFGSAVK  153 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~--~vkl~DFGla~~  153 (407)
                      ++|||||++|+|.+++.....  .+++..+..++.|++.||.|||++||+||||||+|||++.++.  .+||+|||++..
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            999999999999999976432  5899999999999999999999999999999999999986543  489999999987


Q ss_pred             cCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--------HHH--
Q psy10603        154 ISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--------FKV--  223 (407)
Q Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--------~~~--  223 (407)
                      .....    ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||..........        ...  
T Consensus       174 ~~~~~----~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          174 LDQGE----LCTEFVGTLQYLAPELLEQ---KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             TTSCC----CCCCCCSCCTTCSSCSSCC---SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccc----ccccccCCcccCChHHhcc---CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            65432    2245689999999999854   346889999999999999999999997532211100        000  


Q ss_pred             ---hCC-----C----CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        224 ---GMG-----E----TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       224 ---~~~-----~----~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                         ..+     .    ...++..+++++.+++.+||.+||++|||+.|+++||||.
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence               000     0    0112334678999999999999999999999999999974

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.8e-44  Score=338.86  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=196.0

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc--CCCCCcceEEEEEEeCc----eE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG--INQKNLVKYYGVEIHRE----EM   77 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~----~~   77 (407)
                      +.....||+|+||+||+|++  +|+.||||++....      .+.+.+|.+++..  ++||||+++++++...+    ..
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           44 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             CEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             EEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            34556999999999999988  48899999986431      2456778888876  89999999999998776    79


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH--------ENTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--------~~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      ++||||+++|+|.++++.  ..+++..+..++.|++.||.|||        +++|+||||||+|||++.++ .+||+|||
T Consensus       116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg  192 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  192 (342)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCT
T ss_pred             EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECC
Confidence            999999999999999965  34899999999999999999999        89999999999999998765 69999999


Q ss_pred             CceecCCCCCC-CCcccccccCCcccccccccccccC---CCCcchhHHHHHHHHHHHHcC----------CCCCCCCCc
Q psy10603        150 SAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKV---GHGRAVDIWSLGCVLVEMSSG----------KRPWAEYDS  215 (407)
Q Consensus       150 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~---~~~~~~DiwSlGv~l~em~~g----------~~Pf~~~~~  215 (407)
                      +++........ ........||+.|+|||++......   .++.++|||||||++|||++|          ..||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            99776543211 0112445799999999998643111   123689999999999999999          789875321


Q ss_pred             ---hHHH-HHHH-hCCCCCCCCC-----ccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        216 ---NYQI-MFKV-GMGETPTIPE-----SLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       216 ---~~~~-~~~~-~~~~~~~~~~-----~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                         .... ...+ .....+.++.     ..++.+.+++.+||+.||++|||+.|+++|.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence               1222 2222 2233444543     2346788999999999999999999998763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-44  Score=352.88  Aligned_cols=248  Identities=18%  Similarity=0.192  Sum_probs=186.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcce-----------------
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVK-----------------   66 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~-----------------   66 (407)
                      .....||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++| +|...                 
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            344589999999999999999999999999875444444445678899999999987 32111                 


Q ss_pred             ----EEEEEEe-----CceEEEEEecCCCCCHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy10603         67 ----YYGVEIH-----REEMVLFMELCTEGTLESLVQS------TEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKS  131 (407)
Q Consensus        67 ----~~~~~~~-----~~~~~lv~E~~~~g~L~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp  131 (407)
                          +...+..     ...++++|+++ +++|.++++.      ....+++..+..++.||+.||.|||++||+||||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp  239 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP  239 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCccc
Confidence                1111111     22467778866 5799988842      133477888899999999999999999999999999


Q ss_pred             CCEEEecCCCeEEEEcccCceecCCCCCCCCcccccccCCccccccccccc-------ccCCCCcchhHHHHHHHHHHHH
Q psy10603        132 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-------NKVGHGRAVDIWSLGCVLVEMS  204 (407)
Q Consensus       132 ~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~~~DiwSlGv~l~em~  204 (407)
                      +|||++.++ .+||+|||+++.....      ....+| +.|+|||++...       ....++.++|||||||++|||+
T Consensus       240 ~NILl~~~~-~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          240 VDIVLDQRG-GVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             GGEEECTTC-CEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             ceEEEecCC-eEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999875 5999999999775432      244578 999999998421       2234678999999999999999


Q ss_pred             cCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        205 SGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       205 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +|+.||...... .....+ ..    ....+++++++++.+||++||++|||+.|+++||||.
T Consensus       312 tg~~Pf~~~~~~-~~~~~~-~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          312 CADLPNTDDAAL-GGSEWI-FR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             HSSCCCCTTGGG-SCSGGG-GS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             HCCCCCCCcchh-hhHHHH-Hh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence            999999754321 111111 11    1235789999999999999999999999999999984

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-45  Score=349.34  Aligned_cols=241  Identities=16%  Similarity=0.207  Sum_probs=185.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHhcCC---------CCCcceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN-----DARFVKDMLVELRILEGIN---------QKNLVKYYGV   70 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hpniv~~~~~   70 (407)
                      .....||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+|+.++         ||||+++.+.
T Consensus        23 ~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~  100 (336)
T 2vuw_A           23 QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV  100 (336)
T ss_dssp             HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred             hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence            3445899999999999998  6899999999865321     2223456778888888775         8888888776


Q ss_pred             EE------------------------------eCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q psy10603         71 EI------------------------------HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALH  120 (407)
Q Consensus        71 ~~------------------------------~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH  120 (407)
                      +.                              ..+.+|+|||||++|++.+.+..  ..+++..++.++.||+.||.|||
T Consensus       101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH  178 (336)
T 2vuw_A          101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAE  178 (336)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH
Confidence            53                              26789999999999976666533  45899999999999999999999


Q ss_pred             -hCCceecCCCCCCEEEecCC-------------------CeEEEEcccCceecCCCCCCCCcccccccCCccccccccc
Q psy10603        121 -ENTIVHRDIKSANIFLTAEG-------------------NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM  180 (407)
Q Consensus       121 -~~~iiHrdlKp~Nill~~~~-------------------~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  180 (407)
                       ++||+||||||+|||++.++                   ..+||+|||+|+.....        ..+||+.|+|||++.
T Consensus       179 ~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCSGGGC
T ss_pred             HhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccChhhhc
Confidence             99999999999999999864                   27999999999876432        348999999999996


Q ss_pred             ccccCCCCcchhHHHHHHH-HHHHHcCCCCCCCCCchHHHHHHHh----CCCC--CCCCCccCHHHHHHHHHhcccCCCC
Q psy10603        181 DTNKVGHGRAVDIWSLGCV-LVEMSSGKRPWAEYDSNYQIMFKVG----MGET--PTIPESLSDEGQAFAELCLRHDPAQ  253 (407)
Q Consensus       181 ~~~~~~~~~~~DiwSlGv~-l~em~~g~~Pf~~~~~~~~~~~~~~----~~~~--~~~~~~~s~~~~~~i~~~l~~dp~~  253 (407)
                      +.   . +.++|||||+++ .+++++|..||..............    ....  +..+..+|+++++||.+||++|   
T Consensus       251 g~---~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          251 GD---G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             CC---S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred             CC---C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence            43   2 679999998776 7889999999953210011111111    1111  1123457899999999999977   


Q ss_pred             cCCHHHHh-cCCee
Q psy10603        254 RATIFELL-QHPFL  266 (407)
Q Consensus       254 R~t~~e~l-~hp~~  266 (407)
                        |+.|+| +||||
T Consensus       324 --sa~e~l~~Hp~f  335 (336)
T 2vuw_A          324 --SATDLLCQHSLF  335 (336)
T ss_dssp             --SHHHHHHHCGGG
T ss_pred             --CHHHHHhcCCCc
Confidence              999999 99997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-42  Score=321.68  Aligned_cols=221  Identities=16%  Similarity=0.153  Sum_probs=182.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||.||+|++..+++.||||++......+....+.+.+|+.++.+++||||+++++++...+..|+||||+
T Consensus        34 ~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  113 (286)
T 3uqc_A           34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWI  113 (286)
T ss_dssp             EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEec
Confidence            44459999999999999999999999999998766666677788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL  164 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~  164 (407)
                      ++++|.++++.  + .....+..++.|++.||+|||++||+||||||+|||++.++ .+||+++|               
T Consensus       114 ~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~---------------  174 (286)
T 3uqc_A          114 RGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA---------------  174 (286)
T ss_dssp             CEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC---------------
T ss_pred             CCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc---------------
Confidence            99999999853  2 46667889999999999999999999999999999999865 58887442               


Q ss_pred             cccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCC---CCCCccCHHH
Q psy10603        165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETP---TIPESLSDEG  239 (407)
Q Consensus       165 ~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~---~~~~~~s~~~  239 (407)
                              |++|          ++.++|||||||++|||++|+.||.........  ..+...+..+   ..+..+++++
T Consensus       175 --------~~~~----------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 --------TMPD----------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             --------CCTT----------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             --------ccCC----------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                    3333          468999999999999999999999864432110  0011111111   1235789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++++.+||++||++| |+.|+++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999864

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.2e-43  Score=360.34  Aligned_cols=236  Identities=23%  Similarity=0.296  Sum_probs=193.0

Q ss_pred             ceeeecccccCeEEEEEEECC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCce-----EE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNE-TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREE-----MV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----~~   78 (407)
                      .....||+|+||+||+|++.. +|+.||||++...  .+....+.+.+|+++|.+++||||+++++++...+.     .|
T Consensus        83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            344489999999999999976 7899999988643  344556778999999999999999999999987665     79


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      |||||+++++|.+++..   .+++..+..++.||+.||.|||++||+||||||+|||++.+  .+||+|||+++..... 
T Consensus       161 lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~-  234 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF-  234 (681)
T ss_dssp             EEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred             EEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence            99999999999987743   59999999999999999999999999999999999999864  6999999999876432 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC-CCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI-PESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~s~  237 (407)
                            ...+||+.|+|||++...    ++.++|||||||++|+|++|..||......         +..... ....++
T Consensus       235 ------~~~~gt~~y~aPE~~~~~----~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~  295 (681)
T 2pzi_A          235 ------GYLYGTPGFQAPEIVRTG----PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYD  295 (681)
T ss_dssp             ------SCCCCCTTTSCTTHHHHC----SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCH
T ss_pred             ------CccCCCccccCHHHHcCC----CCCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCH
Confidence                  345799999999998542    378999999999999999999998642110         000000 113467


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ++.+++.+||++||++||+..+.+.|+|..
T Consensus       296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            899999999999999999998988888763

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.4e-36  Score=306.48  Aligned_cols=191  Identities=15%  Similarity=0.102  Sum_probs=136.5

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEecccc-------CcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQ-------NDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~   78 (407)
                      ....+.|++|.+..++....|+.||||++.+...       ..+...+++.+|+++|+++ +|+||+++++++++++.+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            3467788888888888888999999999975421       1233456799999999999 6999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||||||+|++|.++++. .+.+++.   .++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus       319 LVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---
T ss_pred             EEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCC
Confidence            99999999999999976 3447654   4789999999999999999999999999999875 69999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCC
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRP  209 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~P  209 (407)
                      .   ...+.+||+.|||||++.+.    +..++|+||+|+++++|.++..|
T Consensus       394 ~---~~~t~vGTp~YmAPE~l~g~----~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 S---WPTNLVQSFFVFVNELFAEN----KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C---CSHHHHHHHHHHHHHHC---------------------CCCCTTHHH
T ss_pred             c---cccCceechhhccHHHhCCC----CCCcccccccccchhhhccccch
Confidence            2   23567899999999998642    35689999999998887666444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=6.3e-32  Score=270.97  Aligned_cols=189  Identities=14%  Similarity=0.148  Sum_probs=145.8

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA-----RFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ..||+|+||+||+|.  ..++.+|+|..........     ...+++.+|+++|++++||||+++..++...+..|+|||
T Consensus       342 ~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          342 HLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             ------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            379999999999994  4578899998765433222     224568999999999999999955555557777899999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+++++|.++++.         +..++.|++.||+|||++||+||||||+|||++.   .+||+|||+++..........
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccccc
Confidence            9999999999854         5689999999999999999999999999999986   699999999988754321100


Q ss_pred             ----cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy10603        163 ----ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA  211 (407)
Q Consensus       163 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~  211 (407)
                          .....+||+.|||||++... ...|+..+|+||...-..+.+.++.+|.
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~-~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERF-LEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHH-HHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHH-HHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                11357899999999998642 1335678899999999888888887774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.8e-26  Score=211.41  Aligned_cols=143  Identities=17%  Similarity=0.190  Sum_probs=112.8

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---------------HHHHHHHHHHHHHhcCCCCCcceEEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---------------RFVKDMLVELRILEGINQKNLVKYYGVE   71 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---------------~~~~~~~~E~~~l~~l~hpniv~~~~~~   71 (407)
                      ...||+|+||.||+|.+ .+|+.||+|+++.......               .....+.+|+.+|++++|   +++++.+
T Consensus        95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~  170 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY  170 (282)
T ss_dssp             EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred             cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence            36899999999999999 8899999999864321110               235678899999999984   5555544


Q ss_pred             EeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         72 IHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        72 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      . .+..|+||||++||+|.+ +..       .....++.|++.||.|||++||+||||||+|||++ + +.+||+|||+|
T Consensus       171 ~-~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~DFG~a  239 (282)
T 1zar_A          171 A-WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDFPQS  239 (282)
T ss_dssp             E-EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCCTTC
T ss_pred             e-ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEECCCC
Confidence            3 355799999999999987 421       23457999999999999999999999999999999 4 57999999998


Q ss_pred             eecCCCCCCCCcccccccCCccccccccc
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFM  180 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  180 (407)
                      +.                +..++|||++.
T Consensus       240 ~~----------------~~~~~a~e~l~  252 (282)
T 1zar_A          240 VE----------------VGEEGWREILE  252 (282)
T ss_dssp             EE----------------TTSTTHHHHHH
T ss_pred             eE----------------CCCCCHHHHHH
Confidence            53                34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=5e-23  Score=187.33  Aligned_cols=137  Identities=25%  Similarity=0.291  Sum_probs=105.6

Q ss_pred             eeecccccCeEEEEEEECCCCcE--EEEEEEeccccC---------------------cHHHHHHHHHHHHHHhcCCCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGEL--VAMKEIQLHKQN---------------------DARFVKDMLVELRILEGINQKN   63 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~--vAvK~i~~~~~~---------------------~~~~~~~~~~E~~~l~~l~hpn   63 (407)
                      ...||+|+||.||+|.+..+|+.  ||||+++.....                     .......+.+|+.+|..++|++
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  131 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG  131 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence            45899999999999998778999  999987543211                     0111236788999999998875


Q ss_pred             c--ceEEEEEEeCceEEEEEecCCC-C----CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEE
Q psy10603         64 L--VKYYGVEIHREEMVLFMELCTE-G----TLESLVQSTEDGLPEVLVRRYTKQLVDAISALH-ENTIVHRDIKSANIF  135 (407)
Q Consensus        64 i--v~~~~~~~~~~~~~lv~E~~~~-g----~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~iiHrdlKp~Nil  135 (407)
                      +  ...++.    +..+|||||+.+ |    +|.++...    .++..+..++.|++.||.||| +.||+||||||+|||
T Consensus       132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NIL  203 (258)
T 1zth_A          132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIM  203 (258)
T ss_dssp             CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEE
T ss_pred             CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEE
Confidence            4  344432    356899999942 3    67666432    335567889999999999999 999999999999999


Q ss_pred             EecCCCeEEEEcccCceec
Q psy10603        136 LTAEGNSLKLGDFGSAVKI  154 (407)
Q Consensus       136 l~~~~~~vkl~DFGla~~~  154 (407)
                      ++.   .++|+|||+|...
T Consensus       204 l~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          204 YID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ESS---SEEECCCTTCEET
T ss_pred             EcC---cEEEEECcccccC
Confidence            986   5999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.1e-18  Score=165.35  Aligned_cols=137  Identities=14%  Similarity=0.218  Sum_probs=96.5

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccC---------------cHH--H--HHHHHHHHHHHhcCCCCCcceE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN---------------DAR--F--VKDMLVELRILEGINQKNLVKY   67 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~---------------~~~--~--~~~~~~E~~~l~~l~hpniv~~   67 (407)
                      ...||+|+||.||+|.+. +|+.||||+++.....               ...  .  .....+|...|.++.+.++...
T Consensus       100 ~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp  178 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP  178 (397)
T ss_dssp             EEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred             cCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            348999999999999875 6999999987642110               000  0  1123456777777755444322


Q ss_pred             EEEEEeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC------
Q psy10603         68 YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN------  141 (407)
Q Consensus        68 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~------  141 (407)
                      .-+....  .+|||||++|++|..+..     .  ..+..++.|++.+|.|||++|||||||||.|||++.++.      
T Consensus       179 ~p~~~~~--~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~  249 (397)
T 4gyi_A          179 EPIAQSR--HTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSS  249 (397)
T ss_dssp             CEEEEET--TEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTS
T ss_pred             eeeeccC--ceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccc
Confidence            2222222  379999999988865431     1  234678899999999999999999999999999987642      


Q ss_pred             ---eEEEEcccCcee
Q psy10603        142 ---SLKLGDFGSAVK  153 (407)
Q Consensus       142 ---~vkl~DFGla~~  153 (407)
                         .+.|+||+-+..
T Consensus       250 ~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          250 ITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEEECCCTTCEE
T ss_pred             cccceEEEEeCCccc
Confidence               378999997754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.68  E-value=1.9e-17  Score=153.26  Aligned_cols=80  Identities=28%  Similarity=0.640  Sum_probs=64.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+.+..... .....+.+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       158 lKPeNILl~~~g~-vKl~DFGla~~~~~~~~-~~~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~  232 (311)
T 4aw0_A          158 LKPENILLNEDMH-IQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLP  232 (311)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCTTTT-CCCBCCCCSCGGGCCHHHHHHS---CBCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHeEEcCCCC-EEEEEcCCceecCCCCC-cccccCcccCcccCCHHHHcCC---CCCcHHHHHHHHHHHHHHHhCCC
Confidence            4678999988776 99999999987643222 2223457899999999999753   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.|-
T Consensus       233 PF~~~  237 (311)
T 4aw0_A          233 PFRAG  237 (311)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.68  E-value=2.6e-17  Score=154.58  Aligned_cols=78  Identities=36%  Similarity=0.611  Sum_probs=63.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+.+.....   .....+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       196 lKp~NILl~~~g~-vKl~DFGla~~~~~~~~---~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~  268 (346)
T 4fih_A          196 IKSDSILLTHDGR-VKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIMVIEMVDGEP  268 (346)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEecCcCceecCCCCC---cccccccCcCcCCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCCC
Confidence            3568999988876 99999999987643322   23356899999999998653   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       269 PF~~~  273 (346)
T 4fih_A          269 PYFNE  273 (346)
T ss_dssp             TTTTS
T ss_pred             CCCCc
Confidence            99874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.68  E-value=1.9e-17  Score=153.39  Aligned_cols=84  Identities=30%  Similarity=0.414  Sum_probs=61.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++.++. +||+|||+|+....... .......+||+.|||||++.......++.++|||||||++|||+||+.
T Consensus       158 lKp~NILl~~~~~-~Ki~DFGla~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~  235 (307)
T 3omv_A          158 MKSNNIFLHEGLT-VKIGDFGLATVKSRWSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL  235 (307)
T ss_dssp             CCSSSEEEETTEE-EEECCCSSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEECCCCc-EEEeeccCceecccCCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCC
Confidence            4678999988765 99999999976543221 122334689999999999975443446789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       236 Pf~~~~  241 (307)
T 3omv_A          236 PYSHIN  241 (307)
T ss_dssp             TTTTCC
T ss_pred             CCCCCC
Confidence            998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.67  E-value=5.4e-17  Score=149.19  Aligned_cols=77  Identities=30%  Similarity=0.520  Sum_probs=61.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.....+||+|||+|+....     ....+.+||+.|||||++.+    .++.++||||+||++|||+||+.
T Consensus       157 lKp~NILl~~~~g~vKl~DFGla~~~~~-----~~~~~~~GTp~YmAPE~~~~----~y~~~~DiwSlGvilyelltg~~  227 (290)
T 3fpq_A          157 LKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEY  227 (290)
T ss_dssp             CCGGGEEESSTTSCEEECCTTGGGGCCT-----TSBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cChhheeEECCCCCEEEEeCcCCEeCCC-----CccCCcccCccccCHHHcCC----CCCcHHHHHHHHHHHHHHHHCCC
Confidence            4578999986444599999999974322     12335689999999999853    25789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       228 Pf~~~~  233 (290)
T 3fpq_A          228 PYSECQ  233 (290)
T ss_dssp             TTTTCS
T ss_pred             CCCCCC
Confidence            998654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.67  E-value=3.3e-17  Score=153.32  Aligned_cols=84  Identities=29%  Similarity=0.412  Sum_probs=63.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC--CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV--PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .+++|+|++.++..+||+|||+|+.+......  .......+||+.|||||++.+.   .++.++||||+||++|||++|
T Consensus       176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvilyemltG  252 (336)
T 4g3f_A          176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK---PCDAKVDIWSSCCMMLHMLNG  252 (336)
T ss_dssp             CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC---CCCcHHHHHHHHHHHHHHHHC
Confidence            35789999988767999999999876432211  1122345799999999999753   357899999999999999999


Q ss_pred             CCCCCCCce
Q psy10603        384 KTNLSGVVV  392 (407)
Q Consensus       384 ~~~~~~~~~  392 (407)
                      ++||.+...
T Consensus       253 ~~Pf~~~~~  261 (336)
T 4g3f_A          253 CHPWTQYFR  261 (336)
T ss_dssp             SCSSTTTCC
T ss_pred             cCCCCCCCH
Confidence            999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.66  E-value=3.3e-17  Score=151.42  Aligned_cols=79  Identities=38%  Similarity=0.653  Sum_probs=62.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+.......   ...+.+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       152 lKp~NILl~~~g~-vKl~DFGla~~~~~~~~---~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvilyemltG~~  224 (304)
T 3ubd_A          152 LKPENILLDEEGH-IKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRR---GHTQSADWWSFGVLMFEMLTGTL  224 (304)
T ss_dssp             CCGGGEEECTTSC-EEEESSEEEEC-----C---CCCSCCCCGGGCCHHHHHTS---CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHeEEcCCCC-EEecccccceeccCCCc---cccccccCcccCCHHHhccC---CCCCCCcccchHHHHHHHHhCCC
Confidence            4567999988876 99999999986543222   23346899999999999654   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       225 PF~~~~  230 (304)
T 3ubd_A          225 PFQGKD  230 (304)
T ss_dssp             SSCCSS
T ss_pred             CCCCcC
Confidence            999753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.65  E-value=5.9e-17  Score=147.68  Aligned_cols=78  Identities=28%  Similarity=0.440  Sum_probs=55.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +||+|||+|+......    ...+.+||+.|||||++.+...  ++.++||||+||++|||++|+.
T Consensus       138 iKP~NILl~~~~~-vkl~DFGla~~~~~~~----~~~~~~GT~~Y~APE~~~~~~y--~~~~~DiwSlGvily~lltg~~  210 (275)
T 3hyh_A          138 LKPENLLLDEHLN-VKIADFGLSNIMTDGN----FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYVMLCRRL  210 (275)
T ss_dssp             CCTTTEEECTTCC-EEECCSSCC-------------------CTTSCHHHHSSSSC--CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHHeEECCCCC-EEEeecCCCeecCCCC----ccCCeeECcccCChhhhcCCCC--CCChhhhHHHHHHHHHHHHCCC
Confidence            4678999988775 9999999997654322    1234689999999999975432  3578999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       211 PF~~~  215 (275)
T 3hyh_A          211 PFDDE  215 (275)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.65  E-value=8e-17  Score=155.02  Aligned_cols=77  Identities=36%  Similarity=0.622  Sum_probs=63.5

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|+|++.++. +||+|||+|+.+.....   .....+||+.|||||++.+.   .|+.++||||+||++|||++|++|
T Consensus       274 Kp~NILl~~~g~-vKl~DFGla~~~~~~~~---~~~~~~GTp~YmAPEvl~~~---~y~~~~DiWSlGvilyeml~G~~P  346 (423)
T 4fie_A          274 KSDSILLTHDGR-VKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPELISRL---PYGPEVDIWSLGIMVIEMVDGEPP  346 (423)
T ss_dssp             STTTEEECTTCC-EEECCCTTCEECCSSCC---CBCCCEECTTTCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CHHHEEEcCCCC-EEEecCccceECCCCCc---cccccccCcCcCCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            468999998876 99999999987643322   23456899999999998653   357899999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |.+-
T Consensus       347 F~~~  350 (423)
T 4fie_A          347 YFNE  350 (423)
T ss_dssp             TTTS
T ss_pred             CCCc
Confidence            9874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.64  E-value=3.5e-17  Score=153.92  Aligned_cols=79  Identities=34%  Similarity=0.619  Sum_probs=63.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+.+.....   .....+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       151 lKp~NILl~~~g~-vKl~DFGla~~~~~~~~---~~~~~~GT~~YmAPE~l~~~---~y~~~~DiwSlGvilyemltG~~  223 (350)
T 4b9d_A          151 IKSQNIFLTKDGT-VQLGDFGIARVLNSTVE---LARACIGTPYYLSPEICENK---PYNNKSDIWALGCVLYELCTLKH  223 (350)
T ss_dssp             CCGGGEEECTTCC-EEECSTTEESCCCHHHH---HHHHHHSCCTTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEcccccceeecCCcc---cccccCCCccccCHHHHCCC---CCCcHHHHHHHHHHHHHHHHCCC
Confidence            4578999988776 99999999986543221   12346899999999999653   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|-.
T Consensus       224 PF~~~~  229 (350)
T 4b9d_A          224 AFEAGS  229 (350)
T ss_dssp             SCCCSS
T ss_pred             CCCCcC
Confidence            998753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.61  E-value=3.6e-16  Score=150.32  Aligned_cols=82  Identities=28%  Similarity=0.565  Sum_probs=63.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .+++|+|++.++. +||+|||+|+.+..... ......+.+||+.|||||++.+...  ++.++||||+||++|||++|+
T Consensus       184 lKP~NIl~~~~~~-~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~--~~~~~DiWSlG~il~ell~G~  260 (398)
T 4b99_A          184 LKPSNLLVNENCE-LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE--YTQAIDLWSVGCIFGEMLARR  260 (398)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC--CCTHHHHHHHHHHHHHHHHTS
T ss_pred             cCccccccCCCCC-EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCC--CCChhheehhHHHHHHHHHCC
Confidence            4677999988876 99999999987643221 1223345789999999999876433  478999999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      +||.|-
T Consensus       261 ~pF~g~  266 (398)
T 4b99_A          261 QLFPGK  266 (398)
T ss_dssp             CSSCCS
T ss_pred             CCCCCC
Confidence            999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.59  E-value=6.3e-16  Score=146.93  Aligned_cols=81  Identities=23%  Similarity=0.386  Sum_probs=60.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-------------------------CCCcccccccccccccCcccccCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-------------------------VPGELNGFVGTQAYMAPEVFMDTN  360 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~  360 (407)
                      .+++|+|++.+...+||+|||+|+.......                         ......+.+||+.|||||++.+..
T Consensus       143 iKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~  222 (361)
T 4f9c_A          143 VKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP  222 (361)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred             CCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence            4678999988766799999999975432110                         011123458999999999997643


Q ss_pred             cCCCCccchHHhHHHHHHHHHhCCCCCC
Q psy10603        361 KVGHGRAVDIWSLGCVLVEMSSGKTNLS  388 (407)
Q Consensus       361 ~~~~~~~~Dvws~G~~~~e~~~g~~~~~  388 (407)
                      .  ++.++||||+||++|||++|+.||.
T Consensus       223 ~--y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          223 N--QTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             C--CCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             C--CCCccchhhhHHHHHHHHHCCCCCC
Confidence            2  5788999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.59  E-value=6.7e-16  Score=155.67  Aligned_cols=76  Identities=33%  Similarity=0.574  Sum_probs=62.7

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      +++|+|++.++. +||+|||+|+.+....     ..+.+||+.|||||++.+..  .++.++||||+||++|||++|++|
T Consensus       319 KPeNILld~~G~-vKL~DFGlA~~~~~~~-----~~t~~GTp~YmAPEvl~~~~--~y~~~vDiWSLGvilYEmLtG~~P  390 (689)
T 3v5w_A          319 KPANILLDEHGH-VRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGV--AYDSSADWFSLGCMLFKLLRGHSP  390 (689)
T ss_dssp             SGGGEEECTTSC-EEECCCTTCEECSSCC-----CCSCCSCGGGCCHHHHSTTC--CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             chHHeEEeCCCC-EEecccceeeecCCCC-----CCCccCCcCccCHHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            468999998886 9999999998664322     23468999999999996432  357899999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |.+-
T Consensus       391 F~~~  394 (689)
T 3v5w_A          391 FRQH  394 (689)
T ss_dssp             TCGG
T ss_pred             CCCC
Confidence            9863

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.58  E-value=7.2e-16  Score=143.17  Aligned_cols=81  Identities=30%  Similarity=0.364  Sum_probs=64.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|+|++.++. +||+|||+|+........ ......+||+.|||||++.+.   .++.++|||||||++|||+| |+
T Consensus       171 LK~~NILl~~~~~-~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~---~~s~ksDVwSfGvvl~El~t~g~  245 (308)
T 4gt4_A          171 LATRNVLVYDKLN-VKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGL  245 (308)
T ss_dssp             CSGGGEEECGGGC-EEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccccceEECCCCC-EEECCcccceeccCCCce-eEecccccCCcccCHHHHhCC---CCCccchhhhHHHHHHHHHhCCC
Confidence            4567999988776 999999999866433221 122345799999999999754   35789999999999999998 89


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.|..
T Consensus       246 ~Pf~~~~  252 (308)
T 4gt4_A          246 QPYCGYS  252 (308)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCC
Confidence            9999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.57  E-value=5.7e-16  Score=146.49  Aligned_cols=82  Identities=30%  Similarity=0.423  Sum_probs=64.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|+|++.++. +||+|||+|+.+...... ......+||+.|||||++.+.   .++.++|||||||++|||+| |+
T Consensus       211 LK~~NILl~~~~~-vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~---~y~~ksDVwS~Gv~l~El~t~G~  285 (353)
T 4ase_A          211 LAARNILLSEKNV-VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGA  285 (353)
T ss_dssp             CSGGGEEECGGGC-EEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             cCccceeeCCCCC-EEECcchhhhhcccCCCc-eeeccccccccccCHHHHhcC---CCCCcccEeehHHHHHHHHhCCC
Confidence            4567999988775 999999999866433221 122345799999999999754   35789999999999999998 99


Q ss_pred             CCCCCCce
Q psy10603        385 TNLSGVVV  392 (407)
Q Consensus       385 ~~~~~~~~  392 (407)
                      +||.|...
T Consensus       286 ~Pf~~~~~  293 (353)
T 4ase_A          286 SPYPGVKI  293 (353)
T ss_dssp             CSSTTCCC
T ss_pred             CCCCCCCH
Confidence            99998643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.57  E-value=3.6e-16  Score=145.22  Aligned_cols=83  Identities=29%  Similarity=0.361  Sum_probs=59.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCc---CCCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNK---VGHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|+|++.++. +||+|||+|+........ .......+||+.|||||++.+...   ..++.++|||||||++|||+
T Consensus       134 lKp~NILl~~~~~-~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~  212 (303)
T 3hmm_A          134 LKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  212 (303)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCcccEEECCCCC-EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence            4678999988876 999999999865433221 122334589999999999865321   12356899999999999999


Q ss_pred             hCCCCCCC
Q psy10603        382 SGKTNLSG  389 (407)
Q Consensus       382 ~g~~~~~~  389 (407)
                      ||+++|.+
T Consensus       213 tg~~~~~~  220 (303)
T 3hmm_A          213 RRCSIGGI  220 (303)
T ss_dssp             HTBCBTTB
T ss_pred             HCCCCCCc
Confidence            99887753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.56  E-value=7.3e-16  Score=142.52  Aligned_cols=81  Identities=26%  Similarity=0.343  Sum_probs=63.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|+|++.++. +||+|||+|+........ .......||+.|||||++.+.   .++.++||||+||++|||+| |+
T Consensus       154 lKp~NILl~~~~~-~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~---~~~~k~DVwS~Gvvl~Ellt~G~  228 (299)
T 4asz_A          154 LATRNCLVGENLL-VKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYR---KFTTESDVWSLGVVLWEIFTYGK  228 (299)
T ss_dssp             CSGGGEEECGGGC-EEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cCHhhEEECCCCc-EEECCcccceecCCCCce-eecCceecChhhcCHHHHcCC---CCCchhhHHHHHHHHHHHHcCCC
Confidence            4567999988775 999999999865432221 112234699999999999754   35789999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       229 ~Pf~~~~  235 (299)
T 4asz_A          229 QPWYQLS  235 (299)
T ss_dssp             CTTTTSC
T ss_pred             CCCCCCC
Confidence            9999753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.55  E-value=1.8e-15  Score=141.88  Aligned_cols=81  Identities=25%  Similarity=0.329  Sum_probs=56.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|+|++.++. +||+|||+|+........ ......+||+.|||||++.+.   .++.++|||||||++|||+| |+
T Consensus       184 LKp~NILl~~~~~-~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~~---~~~~~sDvwS~Gvvl~Ellt~G~  258 (329)
T 4aoj_A          184 LATRNCLVGQGLV-VKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGK  258 (329)
T ss_dssp             CCGGGEEEETTTE-EEECCCC-----------------CCCCGGGCCHHHHTTC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccHhhEEECCCCc-EEEcccccceeccCCCcc-eecCcccccccccChhhhcCC---CCCccccccchHHHHHHHHcCCC
Confidence            4567999988765 999999999865432221 112345799999999998654   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       259 ~Pf~~~~  265 (329)
T 4aoj_A          259 QPWYQLS  265 (329)
T ss_dssp             CTTCSSC
T ss_pred             CCCCCCC
Confidence            9998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.52  E-value=4.6e-15  Score=137.25  Aligned_cols=77  Identities=34%  Similarity=0.535  Sum_probs=52.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC---------CCcccccccccccccCcccccCCcCCCCccchHHhHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV---------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV  376 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~  376 (407)
                      .+++|+|++.++. +||+|||+|+.+......         .....+.+||+.|||||++.+.   .++.++||||+||+
T Consensus       144 lKp~NILl~~~~~-vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~---~y~~~~DiwSlGvi  219 (299)
T 4g31_A          144 LKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN---SYSHKVDIFSLGLI  219 (299)
T ss_dssp             CCGGGEEECTTCC-EEECCCCCC--------------------------CCCTTSCHHHHTTC---CCCTHHHHHHHHHH
T ss_pred             CcHHHeEECCCCc-EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC---CCCCHHHHHHHHHH
Confidence            4678999988775 999999999876432211         1123446899999999999653   35789999999999


Q ss_pred             HHHHHhCCCCCCC
Q psy10603        377 LVEMSSGKTNLSG  389 (407)
Q Consensus       377 ~~e~~~g~~~~~~  389 (407)
                      +|||++   ||.+
T Consensus       220 lyell~---Pf~~  229 (299)
T 4g31_A          220 LFELLY---PFST  229 (299)
T ss_dssp             HHHHHS---CCSS
T ss_pred             HHHHcc---CCCC
Confidence            999996   6654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.44  E-value=3.9e-14  Score=142.68  Aligned_cols=78  Identities=31%  Similarity=0.473  Sum_probs=62.9

Q ss_pred             CCccEEEecC-CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        307 ARANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       307 ~~~nill~~~-~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      ++.|+|++.+ ...+||+|||+|+.+....    .....+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       282 Kp~Nill~~~~~~~vKl~DFG~a~~~~~~~----~~~~~~GT~~y~APEv~~~~---~y~~~~DiWSlGvilyeml~G~~  354 (573)
T 3uto_A          282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGLS  354 (573)
T ss_dssp             CGGGEEESSSSCCCEEECCCSSCEECCTTS----EEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             ChhhccccCCCCCCEEEeeccceeEccCCC----ceeeeEECccccCHHHhCCC---CCCcHHHHHHHHHHHHHHHHCCC
Confidence            5689999764 3469999999998764322    23346899999999999754   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       355 Pf~~~~  360 (573)
T 3uto_A          355 PFGGEN  360 (573)
T ss_dssp             SSCCSS
T ss_pred             CCCCcC
Confidence            998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=9.4e-13  Score=119.45  Aligned_cols=135  Identities=18%  Similarity=0.159  Sum_probs=103.1

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEec
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .+...+|.|+.+.||++...  ++.+++|+........   ...+.+|+.+|+.+. +.++.+++++....+..|+||||
T Consensus        17 ~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           17 RCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             EEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             eeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            44557788888999999743  6789999886421111   124677888888774 57788899988888899999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE------------------------------------------  121 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~------------------------------------------  121 (407)
                      ++|.+|.+...      +......++.++..+|..||+                                          
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99999976531      112234678899999999998                                          


Q ss_pred             -----------------CCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603        122 -----------------NTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus       122 -----------------~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                                       ..++|+|++|.|||+++ +..+.|+||+.+
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a  211 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRS  211 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTC
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhc
Confidence                             44899999999999975 444579999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.38  E-value=4.1e-13  Score=128.70  Aligned_cols=79  Identities=33%  Similarity=0.563  Sum_probs=62.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+....    .....+||+.|+|||++.......++.++||||+||++|||++|+.
T Consensus       141 lkp~NIll~~~g~-vkL~DFG~a~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~  215 (384)
T 4fr4_A          141 MKPDNILLDEHGH-VHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR  215 (384)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CcHHHeEECCCCC-EEEeccceeeeccCCC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence            3567999988775 9999999997654322    2334689999999999865333345789999999999999999999


Q ss_pred             CCCC
Q psy10603        386 NLSG  389 (407)
Q Consensus       386 ~~~~  389 (407)
                      ||.+
T Consensus       216 Pf~~  219 (384)
T 4fr4_A          216 PYHI  219 (384)
T ss_dssp             SSCC
T ss_pred             CCCC
Confidence            9975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.38  E-value=2.5e-13  Score=130.65  Aligned_cols=83  Identities=33%  Similarity=0.582  Sum_probs=61.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC------------------CCCcccccccccccccCcccccCCcCCCCcc
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT------------------VPGELNGFVGTQAYMAPEVFMDTNKVGHGRA  367 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  367 (407)
                      .++.|++++.++. +||+|||+|+.+.....                  ........+||+.|+|||++.+..  .++.+
T Consensus       135 lkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~  211 (388)
T 3oz6_A          135 MKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST--KYTKG  211 (388)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCC--CCCTH
T ss_pred             CCHHHeEEcCCCC-EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCC--CCCCh
Confidence            3567999988775 99999999976532110                  011123458999999999987533  35789


Q ss_pred             chHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        368 VDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       368 ~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      +||||+||+++||++|++||.|..
T Consensus       212 ~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          212 IDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.36  E-value=4.8e-13  Score=128.70  Aligned_cols=78  Identities=32%  Similarity=0.584  Sum_probs=62.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+.   .++.++||||+||++|||++|++
T Consensus       179 LKp~NILl~~~g~-ikL~DFGla~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~---~~~~~~DiwslGvllyell~G~~  251 (396)
T 4dc2_A          179 LKLDNVLLDSEGH-IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRS  251 (396)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCCCCTT---CCBCCCCBCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEeecceeeecccCC---CccccccCCcccCCchhhcCC---CCChHHHHHHHHHHHHHHHhCCC
Confidence            3567999988876 9999999997532211   123456899999999999654   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       252 Pf~~~  256 (396)
T 4dc2_A          252 PFDIV  256 (396)
T ss_dssp             SSTTT
T ss_pred             CCccc
Confidence            99764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.36  E-value=7.4e-13  Score=124.81  Aligned_cols=78  Identities=36%  Similarity=0.639  Sum_probs=61.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+.   .++.++||||+||++|||++|+.
T Consensus       131 lkp~NIll~~~g~-vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  203 (337)
T 1o6l_A          131 IKLENLMLDKDGH-IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRL  203 (337)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSS---CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEeeccchhhcccCC---CcccccccChhhCChhhhcCC---CCCchhhcccchhHHHHHhcCCC
Confidence            3567999988775 9999999997533221   123346899999999998653   34789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       204 Pf~~~  208 (337)
T 1o6l_A          204 PFYNQ  208 (337)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.35  E-value=6.6e-13  Score=129.06  Aligned_cols=80  Identities=30%  Similarity=0.552  Sum_probs=63.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++..+||+|||+++.+.....    ....+||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       182 lkp~NILl~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~G~~  255 (420)
T 1j1b_A          182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGAT--DYTSSIDVWSAGCVLAELLLGQP  255 (420)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSCCSCTTSCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChhhEEEeCCCCeEEeccchhhhhcccCCC----ceeeeeCCCcCCHHHHcCCC--CCCchhhhHHHHHHHHHHHhCCC
Confidence            4567999987766689999999986543221    22357999999999986532  25789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       256 pf~~~~  261 (420)
T 1j1b_A          256 IFPGDS  261 (420)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            999754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.35  E-value=3.8e-13  Score=130.10  Aligned_cols=83  Identities=35%  Similarity=0.556  Sum_probs=63.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcC-CCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV-GHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. +||+|||+++.+......  .....+||+.|+|||++...... .++.++||||+||++|||++|+
T Consensus       194 LKp~NILl~~~g~-ikL~DFG~a~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  270 (410)
T 3v8s_A          194 VKPDNMLLDKSGH-LKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  270 (410)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCTTSEE--ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHeeECCCCC-EEEeccceeEeeccCCcc--cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCC
Confidence            3567999988876 999999999765432211  12346899999999998753211 1467899999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+-.
T Consensus       271 ~Pf~~~~  277 (410)
T 3v8s_A          271 TPFYADS  277 (410)
T ss_dssp             CTTCCSS
T ss_pred             CCCCCCC
Confidence            9998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.35  E-value=6.5e-13  Score=125.97  Aligned_cols=79  Identities=32%  Similarity=0.569  Sum_probs=62.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+.   .++.++||||+||++|||++|++
T Consensus       147 lkp~NIll~~~g~-vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~  219 (353)
T 2i0e_A          147 LKLDNVMLDSEGH-IKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQA  219 (353)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTC---CBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCc-EEEEeCCcccccccCC---cccccccCCccccChhhhcCC---CcCCcccccchHHHHHHHHcCCC
Confidence            3567999988775 9999999997532211   123346899999999998653   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       220 Pf~~~~  225 (353)
T 2i0e_A          220 PFEGED  225 (353)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.35  E-value=3.2e-13  Score=128.11  Aligned_cols=78  Identities=33%  Similarity=0.555  Sum_probs=58.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+..   ++.++||||+||++|||++|++
T Consensus       150 lkp~NILl~~~g~-ikL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~G~~  222 (353)
T 3txo_A          150 LKLDNVLLDHEGH-CKLADFGMCKEGICNG---VTTATFCGTPDYIAPEILQEML---YGPAVDWWAMGVLLYEMLCGHA  222 (353)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCSCC------------CCGGGCCHHHHHHHH---CTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEccccceeecccCC---ccccccCCCcCeEChhhcCCCC---cCCccCCCcchHHHHHHHhCCC
Confidence            3567999988876 9999999997533221   1233468999999999986542   4689999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       223 Pf~~~  227 (353)
T 3txo_A          223 PFEAE  227 (353)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.34  E-value=6.6e-13  Score=124.70  Aligned_cols=79  Identities=34%  Similarity=0.657  Sum_probs=62.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......    .....+||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       140 lkp~NIll~~~~~-~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~  212 (328)
T 3fe3_A          140 LKAENLLLDADMN-IKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELFQGKKY--DGPEVDVWSLGVILYTLVSGSL  212 (328)
T ss_dssp             CCGGGEEECTTSC-EEECSTTCCGGGSSSC----GGGTTSSSGGGCCHHHHHTCCC--CSHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEeeccCceecCCCC----ccccccCCcceeCcccccCCCc--CCchhhhhhhHHHHHHHHhCCC
Confidence            3567999988775 9999999997654322    2345689999999999875432  2578999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       213 pf~~~~  218 (328)
T 3fe3_A          213 PFDGQN  218 (328)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.34  E-value=8.1e-13  Score=124.93  Aligned_cols=79  Identities=33%  Similarity=0.602  Sum_probs=62.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+.   .++.++||||+||++|||++|++
T Consensus       144 lkp~NIll~~~g~-vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  216 (345)
T 1xjd_A          144 LKLDNILLDKDGH-IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQS  216 (345)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChhhEEECCCCC-EEEeEChhhhhcccCC---CcccCCCCCcccCChhhhcCC---CCCChhhhHHHHHHHHHHhcCCC
Confidence            3567999988775 9999999997543211   123346899999999998654   34789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       217 Pf~~~~  222 (345)
T 1xjd_A          217 PFHGQD  222 (345)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.34  E-value=8.6e-13  Score=129.71  Aligned_cols=83  Identities=28%  Similarity=0.494  Sum_probs=58.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC------------------------CCcccccccccccccCcccccCCc
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV------------------------PGELNGFVGTQAYMAPEVFMDTNK  361 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~  361 (407)
                      .++.|+|++.++. +||+|||+++........                        .......+||+.|+|||++.... 
T Consensus       182 lKp~NILl~~~~~-~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-  259 (458)
T 3rp9_A          182 LKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE-  259 (458)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC-
T ss_pred             CChhhEEECCCCC-EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC-
Confidence            3567999988775 999999999865422110                        01234568999999999875433 


Q ss_pred             CCCCccchHHhHHHHHHHHHh-----------CCCCCCCCc
Q psy10603        362 VGHGRAVDIWSLGCVLVEMSS-----------GKTNLSGVV  391 (407)
Q Consensus       362 ~~~~~~~Dvws~G~~~~e~~~-----------g~~~~~~~~  391 (407)
                       .++.++||||+||+++||++           |+++|+|..
T Consensus       260 -~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          260 -NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS  299 (458)
T ss_dssp             -CCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred             -CCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence             35789999999999999999           899998754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.34  E-value=5.6e-13  Score=129.90  Aligned_cols=83  Identities=34%  Similarity=0.559  Sum_probs=62.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC--CcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +||+|||+|+........  .....+||+.|||||++...  ....++.++||||+||++|||++|
T Consensus       201 LKp~NILl~~~g~-vkL~DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG  277 (437)
T 4aw2_A          201 IKPDNILMDMNGH-IRLADFGSCLKLMEDGTV--QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG  277 (437)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCTTSCE--ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred             cCHHHeeEcCCCC-EEEcchhhhhhcccCCCc--ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence            3568999988875 999999999765432221  12335799999999998621  112246899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      ++||.+..
T Consensus       278 ~~Pf~~~~  285 (437)
T 4aw2_A          278 ETPFYAES  285 (437)
T ss_dssp             SCTTCCSS
T ss_pred             CCCCCCCC
Confidence            99998643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.33  E-value=1e-12  Score=125.60  Aligned_cols=78  Identities=36%  Similarity=0.575  Sum_probs=62.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+.   .++.++||||+||++|||++|++
T Consensus       165 lkp~NIll~~~g~-ikL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~G~~  237 (373)
T 2r5t_A          165 LKPENILLDSQGH-IVLTDFGLCKENIEHN---STTSTFCGTPEYLAPEVLHKQ---PYDRTVDWWCLGAVLYEMLYGLP  237 (373)
T ss_dssp             CCGGGEEECTTSC-EEECCCCBCGGGBCCC---CCCCSBSCCCCCCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEeeCccccccccCC---CccccccCCccccCHHHhCCC---CCCchhhhHHHHHHHHHHHcCCC
Confidence            3567999988775 9999999997533221   123346899999999998653   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       238 Pf~~~  242 (373)
T 2r5t_A          238 PFYSR  242 (373)
T ss_dssp             TTCCS
T ss_pred             CCCCC
Confidence            99864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.33  E-value=9.2e-13  Score=129.64  Aligned_cols=78  Identities=35%  Similarity=0.550  Sum_probs=58.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......    .....+||+.|+|||++.+.   .++.++||||+||+++||++|++
T Consensus       190 lkp~NIll~~~~~-~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~  261 (464)
T 3ttj_A          190 LKPSNIVVKSDCT-LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMVRHKI  261 (464)
T ss_dssp             CCGGGEEECTTSC-EEECCCCCC-----CC----CC----CCCTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CChHhEEEeCCCC-EEEEEEEeeeecCCCc----ccCCCcccccccCHHHHcCC---CCCHHHHHHHHHHHHHHHHhCCC
Confidence            3567999988775 9999999997654321    23346899999999999764   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       262 pF~g~~  267 (464)
T 3ttj_A          262 LFPGRD  267 (464)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            999854

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.32  E-value=8e-13  Score=127.80  Aligned_cols=84  Identities=26%  Similarity=0.456  Sum_probs=55.9

Q ss_pred             cCCccEEEe---cCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLT---AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~---~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|+++.   .....+||+|||+++.+.............+||+.|+|||++.+..  .++.++||||+||+++||++
T Consensus       154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~  231 (405)
T 3rgf_A          154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLT  231 (405)
T ss_dssp             CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCC--SCCHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC--cccchhhhHHHHHHHHHHHh
Confidence            356788883   2234599999999987654322222334568999999999987533  25789999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |++||.+..
T Consensus       232 g~~pf~~~~  240 (405)
T 3rgf_A          232 SEPIFHCRQ  240 (405)
T ss_dssp             SSCTTCCCC
T ss_pred             CCCCCCCcc
Confidence            999998653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.32  E-value=5.3e-13  Score=129.14  Aligned_cols=83  Identities=34%  Similarity=0.513  Sum_probs=63.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCC----cCCCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN----KVGHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++.++. +||+|||+++........  .....+||+.|+|||++....    ...++.++||||+||++|||+
T Consensus       188 LKp~NILld~~g~-vkL~DFGla~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell  264 (412)
T 2vd5_A          188 IKPDNILLDRCGH-IRLADFGSCLKLRADGTV--RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF  264 (412)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCTTSCE--ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred             cCHHHeeecCCCC-EEEeechhheeccCCCcc--ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence            3567999988776 999999999765432221  122358999999999986310    122468899999999999999


Q ss_pred             hCCCCCCCCc
Q psy10603        382 SGKTNLSGVV  391 (407)
Q Consensus       382 ~g~~~~~~~~  391 (407)
                      +|++||.+..
T Consensus       265 tG~~Pf~~~~  274 (412)
T 2vd5_A          265 YGQTPFYADS  274 (412)
T ss_dssp             HSSCTTCCSS
T ss_pred             hCCCCCCCCC
Confidence            9999998753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.32  E-value=1.1e-12  Score=124.00  Aligned_cols=78  Identities=32%  Similarity=0.584  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......   ......+||+.|+|||++.+.   .++.++||||+||++|||++|++
T Consensus       136 lkp~NIll~~~g~-~kL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  208 (345)
T 3a8x_A          136 LKLDNVLLDSEGH-IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGE---DYGFSVDWWALGVLMFEMMAGRS  208 (345)
T ss_dssp             CCGGGEEECTTSC-EEECCGGGCBCSCCTT---CCBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEEeccccccccCCC---CcccccCCCccccCccccCCC---CCChHHhHHHHHHHHHHHHhCCC
Confidence            3567999988775 9999999997532211   123346899999999998653   34789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       209 pf~~~  213 (345)
T 3a8x_A          209 PFDIV  213 (345)
T ss_dssp             TTTTT
T ss_pred             CcCCc
Confidence            99764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.32  E-value=1.3e-12  Score=122.03  Aligned_cols=75  Identities=32%  Similarity=0.546  Sum_probs=60.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....      ....+||+.|+|||++.+.   .++.++||||+||+++||++|++
T Consensus       132 lkp~NIll~~~g~-~kL~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  201 (318)
T 1fot_A          132 LKPENILLDKNGH-IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTK---PYNKSIDWWSFGILIYEMLAGYT  201 (318)
T ss_dssp             CCGGGEEECTTSC-EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTC---CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CChheEEEcCCCC-EEEeecCcceecCCc------cccccCCccccCHhHhcCC---CCCcccchhhhHHHHHHHHhCCC
Confidence            3567999988775 999999999765321      2235799999999998653   34688999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       202 pf~~~  206 (318)
T 1fot_A          202 PFYDS  206 (318)
T ss_dssp             TTCCS
T ss_pred             CCCCC
Confidence            99864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.32  E-value=1e-12  Score=125.17  Aligned_cols=79  Identities=14%  Similarity=0.186  Sum_probs=60.2

Q ss_pred             cCCccEEEec-----------CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHH
Q psy10603        306 YARANIFLTA-----------EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG  374 (407)
Q Consensus       306 ~~~~nill~~-----------~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G  374 (407)
                      .++.|++++.           .+ .+||+|||+|+.+..... .......+||+.|||||++.+..   ++.++||||+|
T Consensus       198 iKp~NIll~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG  272 (365)
T 3e7e_A          198 IKPDNFILGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKP---WNYQIDYFGVA  272 (365)
T ss_dssp             CSGGGEEECGGGTCC------CT-TEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCC---BSTHHHHHHHH
T ss_pred             CCHHHEEecccccCccccccccC-CEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCC---CCccccHHHHH
Confidence            3567888876           44 599999999975432111 11233457999999999996543   57899999999


Q ss_pred             HHHHHHHhCCCCCCC
Q psy10603        375 CVLVEMSSGKTNLSG  389 (407)
Q Consensus       375 ~~~~e~~~g~~~~~~  389 (407)
                      |+++||++|+.||.+
T Consensus       273 ~il~elltg~~pf~~  287 (365)
T 3e7e_A          273 ATVYCMLFGTYMKVK  287 (365)
T ss_dssp             HHHHHHHHSSCCCEE
T ss_pred             HHHHHHHhCCCcccc
Confidence            999999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.31  E-value=1.5e-12  Score=121.51  Aligned_cols=80  Identities=36%  Similarity=0.626  Sum_probs=62.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   .....+||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       134 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~  207 (317)
T 2pmi_A          134 LKPQNLLINKRGQ-LKLGDFGLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSR--TYSTSIDIWSCGCILAEMITGKP  207 (317)
T ss_dssp             CCGGGEEECTTCC-EEECCCSSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHHeEEcCCCC-EEECcCccceecCCCcc---cCCCCcccccccCchHhhCCC--CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999988775 99999999976543222   122347899999999986532  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       208 pf~~~~  213 (317)
T 2pmi_A          208 LFPGTN  213 (317)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.31  E-value=1.5e-12  Score=125.49  Aligned_cols=80  Identities=31%  Similarity=0.541  Sum_probs=62.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.....+||+|||+++.......    ....+||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       167 lkp~Nill~~~~~~~kL~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~  240 (394)
T 4e7w_A          167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEP----NVSYICSRYYRAPELIFGAT--NYTTNIDIWSTGCVMAELMQGQP  240 (394)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSSCSCGGGCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCCcEEEeeCCCcccccCCCC----CcccccCcCccCHHHHcCCC--CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999985555699999999976543222    22357899999999986533  25789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       241 pf~~~~  246 (394)
T 4e7w_A          241 LFPGES  246 (394)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            999753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.31  E-value=1.3e-12  Score=130.32  Aligned_cols=77  Identities=31%  Similarity=0.596  Sum_probs=62.5

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. +||+|||+++.+.....   .....+||+.|+|||++.+.   .++.++||||+||++|||++|++|
T Consensus       316 KP~NILl~~~g~-vkL~DFGla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~---~~~~~~DiwSlGvilyelltG~~P  388 (543)
T 3c4z_A          316 KPENVLLDDDGN-VRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGE---EYDFSVDYFALGVTLYEMIAARGP  388 (543)
T ss_dssp             CGGGEEECTTSC-EEECCCTTCEECCTTCC---CBCCCCSCTTTSCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ChHHEEEeCCCC-EEEeecceeeeccCCCc---ccccccCCccccChhhhcCC---CCChHHhcCcchHHHHHHHhCCCC
Confidence            568999988876 99999999986543222   12345899999999999653   357899999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |.+.
T Consensus       389 F~~~  392 (543)
T 3c4z_A          389 FRAR  392 (543)
T ss_dssp             SCCT
T ss_pred             CCCC
Confidence            9874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.30  E-value=1.5e-12  Score=120.53  Aligned_cols=79  Identities=37%  Similarity=0.598  Sum_probs=62.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++........   .....+||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       142 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  214 (297)
T 3fxz_A          142 IKSDNILLGMDGS-VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIMAIEMIEGEP  214 (297)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHHCS---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEeeCCCceecCCccc---ccCCccCCcCccChhhhcCC---CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999988775 99999999976543322   12345799999999998654   34689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       215 pf~~~~  220 (297)
T 3fxz_A          215 PYLNEN  220 (297)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            998653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.30  E-value=1.7e-12  Score=123.69  Aligned_cols=83  Identities=34%  Similarity=0.636  Sum_probs=64.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++...............+||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       154 ikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~  230 (364)
T 3qyz_A          154 LKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCILAEMLSNRP  230 (364)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC--SCSTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHhEEECCCCC-EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC--CCCcchhHHHHHHHHHHHHHCCC
Confidence            3467999988765 99999999986654333222234458999999999876443  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       231 pf~~~~  236 (364)
T 3qyz_A          231 IFPGKH  236 (364)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.30  E-value=1.9e-12  Score=120.60  Aligned_cols=80  Identities=36%  Similarity=0.629  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   .....+||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       145 ikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~  218 (311)
T 3niz_A          145 LKPQNLLINSDGA-LKLADFGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGSK--KYSTSVDIWSIGCIFAEMITGKP  218 (311)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEETTSCCC------CCCCCCTTCCHHHHTTCC--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CchHhEEECCCCC-EEEccCcCceecCCCcc---cccCCcccCCcCCHHHhcCCC--CCCchHHhHHHHHHHHHHHhCCC
Confidence            3567999988775 99999999976543222   123347899999999986533  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       219 pf~~~~  224 (311)
T 3niz_A          219 LFPGVT  224 (311)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.30  E-value=2.4e-12  Score=121.27  Aligned_cols=78  Identities=31%  Similarity=0.469  Sum_probs=61.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++........    ....+||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       134 lkp~NIll~~~~~-~kl~DFG~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~  206 (336)
T 3h4j_B          134 LKPENLLLDDNLN-VKIADFGLSNIMTDGNF----LKTSCGSPNYAAPEVINGKLY--AGPEVDVWSCGIVLYVMLVGRL  206 (336)
T ss_dssp             CSTTTEEECTTCC-EEECCSSCTBTTTTSBT----TCCCTTSTTTSCGGGSCCSGG--GCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CchhhEEEcCCCC-EEEEEeccceeccCCcc----cccccCCcCcCCHHHHcCCCC--CCCccchhHHHHHHHHHHhCCC
Confidence            3567999988765 99999999976543221    234579999999999865432  2578999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       207 Pf~~~  211 (336)
T 3h4j_B          207 PFDDE  211 (336)
T ss_dssp             SSBCS
T ss_pred             CCCCc
Confidence            99864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.30  E-value=1.7e-12  Score=133.41  Aligned_cols=78  Identities=32%  Similarity=0.590  Sum_probs=62.7

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|+|++.++. +||+|||+++.......   .....+||+.|||||++.+.   .++.++||||+||++|||++|++|
T Consensus       469 Kp~NILl~~~g~-ikL~DFGla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~---~~~~~~DvwSlGvilyelltG~~P  541 (674)
T 3pfq_A          469 KLDNVMLDSEGH-IKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQAP  541 (674)
T ss_dssp             CSTTEEECSSSC-EEECCCTTCEECCCTTC---CBCCCCSCSSSCCHHHHTCC---CBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ChhhEEEcCCCc-EEEeecceeeccccCCc---ccccccCCCcccCHhhhcCC---CCCccceEechHHHHHHHHcCCCC
Confidence            468999988876 99999999975332211   23356899999999998654   357899999999999999999999


Q ss_pred             CCCCc
Q psy10603        387 LSGVV  391 (407)
Q Consensus       387 ~~~~~  391 (407)
                      |.+..
T Consensus       542 f~~~~  546 (674)
T 3pfq_A          542 FEGED  546 (674)
T ss_dssp             SCCSS
T ss_pred             CCCCC
Confidence            98753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.30  E-value=1.3e-12  Score=121.64  Aligned_cols=82  Identities=30%  Similarity=0.499  Sum_probs=55.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+.............+||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       142 lkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~g~~  217 (311)
T 3ork_A          142 VKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---SVDARSDVYSLGCVLYEVLTGEP  217 (311)
T ss_dssp             CCGGGEEEETTSC-EEECCCSCC------------------CCTTCCHHHHHTC---CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEeeccCcccccccccccccccccCcCcccCCHHHhcCC---CCCchHhHHHHHHHHHHHHhCCC
Confidence            3567999988775 9999999997654433222223345799999999998654   35689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       218 pf~~~~  223 (311)
T 3ork_A          218 PFTGDS  223 (311)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.29  E-value=2.4e-12  Score=122.80  Aligned_cols=77  Identities=36%  Similarity=0.629  Sum_probs=62.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....      ....+||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       154 lkp~NIll~~~~~-~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~  224 (367)
T 1cm8_A          154 LKPGNLAVNEDCE-LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWM--RYTQTVDIWSVGCIMAEMITGKT  224 (367)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTT--CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEEcCCCC-EEEEeeecccccccc------cCcCcCCCCcCCHHHHhCCC--CCChhhhHHHHHHHHHHHHhCCC
Confidence            3567999988775 999999999765332      22357999999999987532  35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       225 pf~~~~  230 (367)
T 1cm8_A          225 LFKGSD  230 (367)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            999754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.29  E-value=2e-12  Score=120.10  Aligned_cols=78  Identities=37%  Similarity=0.580  Sum_probs=62.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......    .....+||+.|+|||++.+..   ++.++||||+||+++||++|++
T Consensus       146 lkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~  217 (308)
T 3g33_A          146 LKPENILVTSGGT-VKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQST---YATPVDMWSVGCIFAEMFRRKP  217 (308)
T ss_dssp             CCTTTEEECTTSC-EEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSC---CCSTHHHHHHHHHHHHTTTSSC
T ss_pred             CCHHHEEEcCCCC-EEEeeCccccccCCCc----ccCCccccccccCchHHcCCC---CCchHHHHHHHHHHHHHHhCCC
Confidence            3567999987765 9999999997654322    123457999999999986543   4689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       218 pf~~~~  223 (308)
T 3g33_A          218 LFCGNS  223 (308)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.29  E-value=2.1e-12  Score=119.34  Aligned_cols=81  Identities=30%  Similarity=0.580  Sum_probs=61.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+.....   ......||+.|+|||++.+......+.++||||+||+++||++|+.
T Consensus       163 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          163 IKPSNLLVGEDGH-IKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            3567999987775 99999999976543221   1234579999999999865432112578999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       239 pf~~~  243 (298)
T 2zv2_A          239 PFMDE  243 (298)
T ss_dssp             SSCCS
T ss_pred             CCCCc
Confidence            99864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.29  E-value=2e-12  Score=122.57  Aligned_cols=75  Identities=28%  Similarity=0.569  Sum_probs=61.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....      ....+||+.|+|||++.+.   .++.++||||+||+++||++|++
T Consensus       167 lkp~NIll~~~g~-~kL~DFg~a~~~~~~------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  236 (350)
T 1rdq_E          167 LKPENLLIDQQGY-IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSK---GYNKAVDWWALGVLIYEMAAGYP  236 (350)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccceEEECCCCC-EEEcccccceeccCC------cccccCCccccCHHHhcCC---CCCCcCCEecccHhHhHHhhCCC
Confidence            3567999988775 999999999765432      2235799999999998653   34689999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       237 Pf~~~  241 (350)
T 1rdq_E          237 PFFAD  241 (350)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.29  E-value=2.1e-12  Score=122.97  Aligned_cols=81  Identities=16%  Similarity=0.216  Sum_probs=61.6

Q ss_pred             cCCccEEEe--cCCCceEEecCCcccccccccCC----CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        306 YARANIFLT--AEGNSLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       306 ~~~~nill~--~~~~~~ki~dfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      .++.|++++  ..+ .+||+|||+++.+......    .......+||+.|+|||++.+.   .++.++||||+||+++|
T Consensus       178 lkp~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~e  253 (364)
T 3op5_A          178 IKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV---APSRRGDLEILGYCMIQ  253 (364)
T ss_dssp             CCGGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC---CCCchhhHHHHHHHHHH
Confidence            356799998  444 5999999999765432211    1112345699999999998653   35789999999999999


Q ss_pred             HHhCCCCCCCC
Q psy10603        380 MSSGKTNLSGV  390 (407)
Q Consensus       380 ~~~g~~~~~~~  390 (407)
                      |++|+.||.+.
T Consensus       254 l~~g~~Pf~~~  264 (364)
T 3op5_A          254 WLTGHLPWEDN  264 (364)
T ss_dssp             HHHSCCTTGGG
T ss_pred             HHhCCCCcccc
Confidence            99999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.28  E-value=3e-12  Score=121.24  Aligned_cols=83  Identities=31%  Similarity=0.563  Sum_probs=63.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. +||+|||+++.+..... ........+||+.|+|||++.+..  .++.++||||+||+++||++|+
T Consensus       150 lkp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~  226 (351)
T 3mi9_A          150 MKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWTRS  226 (351)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC--SCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHEEEcCCCC-EEEccchhcccccccccccccccCCcccccCccCchhhcCCC--CCCcHhHHHHHHHHHHHHHhCC
Confidence            3567999988775 99999999976542221 122234457899999999986533  2468999999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      ++|.+..
T Consensus       227 ~pf~~~~  233 (351)
T 3mi9_A          227 PIMQGNT  233 (351)
T ss_dssp             CSCCCSS
T ss_pred             CCCCCCC
Confidence            9998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.28  E-value=1.6e-12  Score=119.63  Aligned_cols=80  Identities=33%  Similarity=0.605  Sum_probs=59.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   ......||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       126 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~  199 (288)
T 1ob3_A          126 LKPQNLLINREGE-LKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSK--KYSTTIDIWSVGCIFAEMVNGTP  199 (288)
T ss_dssp             CCGGGEEECTTSC-EEECCTTHHHHHCC------------CCCTTCCHHHHTTCC--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEeECccccccCcccc---ccccccccccccCchheeCCC--CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999988775 99999999976543221   122347899999999986533  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       200 pf~~~~  205 (288)
T 1ob3_A          200 LFPGVS  205 (288)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.28  E-value=2.3e-12  Score=122.95  Aligned_cols=77  Identities=32%  Similarity=0.643  Sum_probs=53.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....      ....+||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       158 lkp~NIll~~~~~-~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~  228 (367)
T 2fst_X          158 LKPSNLAVNEDCE-LKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWM--HYNQTVDIWSVGCIMAELLTGRT  228 (367)
T ss_dssp             CCGGGEEECTTCC-EEECC---------------------CCCTTCCHHHHTTCC--SCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHhhEEECCCCC-EEEeecccccccccc------CCCcCcCcCccChHHHcCCc--CCCchhhHHHHHHHHHHHHhCCC
Confidence            3567999987765 999999999764322      22357999999999987532  35688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       229 pf~~~~  234 (367)
T 2fst_X          229 LFPGTD  234 (367)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            999865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.27  E-value=3.5e-12  Score=121.31  Aligned_cols=78  Identities=29%  Similarity=0.478  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCC---ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~---~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|++++..+.   .+||+|||+++.+.....    ....+||+.|+|||++...   .++.++||||+||++|||++
T Consensus       141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvil~~ll~  213 (361)
T 2yab_A          141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVITYILLS  213 (361)
T ss_dssp             CSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC----CCCCCSCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc----cccCCCCccEECchHHcCC---CCCccccHHHHHHHHHHHHh
Confidence            3567888877653   599999999976543221    2345799999999998643   35789999999999999999


Q ss_pred             CCCCCCCC
Q psy10603        383 GKTNLSGV  390 (407)
Q Consensus       383 g~~~~~~~  390 (407)
                      |.+||.|.
T Consensus       214 g~~Pf~~~  221 (361)
T 2yab_A          214 GASPFLGD  221 (361)
T ss_dssp             SCCSSCCS
T ss_pred             CCCCCCCC
Confidence            99999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.27  E-value=2.9e-12  Score=121.35  Aligned_cols=78  Identities=40%  Similarity=0.638  Sum_probs=61.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....       ...+||+.|+|||++.......++.++||||+||+++||++|++
T Consensus       180 lkp~NIll~~~~~-~kL~DfG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~  251 (348)
T 1u5q_A          180 VKAGNILLSEPGL-VKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  251 (348)
T ss_dssp             CSGGGEEEETTTE-EEECCCTTCBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEeeccCceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999987765 999999999765321       23579999999999864322345778999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       252 p~~~~~  257 (348)
T 1u5q_A          252 PLFNMN  257 (348)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            998653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.27  E-value=2.7e-12  Score=125.20  Aligned_cols=82  Identities=29%  Similarity=0.506  Sum_probs=58.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-------------------CCcccccccccccccCcccccCCcCCCCc
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-------------------PGELNGFVGTQAYMAPEVFMDTNKVGHGR  366 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  366 (407)
                      .++.|++++.++. +||+|||+++........                   .......+||+.|+|||++....  .++.
T Consensus       155 lkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~~~  231 (432)
T 3n9x_A          155 LKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE--NYTK  231 (432)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCS--CCCT
T ss_pred             CCHHHeEECCCCC-EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC--CCCc
Confidence            3567999988765 999999999865432211                   01234568999999999875433  3578


Q ss_pred             cchHHhHHHHHHHHHh-----------CCCCCCCC
Q psy10603        367 AVDIWSLGCVLVEMSS-----------GKTNLSGV  390 (407)
Q Consensus       367 ~~Dvws~G~~~~e~~~-----------g~~~~~~~  390 (407)
                      ++||||+||+++||++           |.++|+|.
T Consensus       232 ~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~  266 (432)
T 3n9x_A          232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS  266 (432)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCS
T ss_pred             ccccchHHHHHHHHHhcccccccccccccccCCCc
Confidence            9999999999999998           67777764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.27  E-value=3.6e-12  Score=123.01  Aligned_cols=79  Identities=29%  Similarity=0.436  Sum_probs=56.2

Q ss_pred             cCCccEEEecC--CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~--~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++..  ...+||+|||+++......    .....+||+.|+|||++.+.   .++.++||||+||++|||++|
T Consensus       187 lkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g  259 (400)
T 1nxk_A          187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCG  259 (400)
T ss_dssp             CCGGGEEESSSSTTCCEEECCCTTCEECC---------------CTTCCGGGSCCC---CSSSHHHHHHHHHHHHHHHHS
T ss_pred             cCcceEEEecCCCCccEEEEecccccccCCCC----ccccCCCCCCccCHhhcCCC---CCCCcccHHHHHHHHHHHHhC
Confidence            35678999863  3459999999997654322    12345799999999998643   357899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       260 ~~pf~~~~  267 (400)
T 1nxk_A          260 YPPFYSNH  267 (400)
T ss_dssp             SCSCCCCT
T ss_pred             CCCCCCCc
Confidence            99998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.27  E-value=2.6e-12  Score=125.89  Aligned_cols=78  Identities=36%  Similarity=0.636  Sum_probs=60.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   .....+||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       275 lkp~NIll~~~~~-~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~  347 (446)
T 4ejn_A          275 LKLENLMLDKDGH-IKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRL  347 (446)
T ss_dssp             CCGGGEEECSSSC-EEECCCCCCCTTCC--------CCSSSCGGGCCHHHHHTS---CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEccCCCceeccCCCc---ccccccCCccccCHhhcCCC---CCCCccchhhhHHHHHHHhhCCC
Confidence            3567999988775 99999999975432221   22346899999999998653   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       348 Pf~~~  352 (446)
T 4ejn_A          348 PFYNQ  352 (446)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.26  E-value=1.5e-12  Score=121.83  Aligned_cols=83  Identities=33%  Similarity=0.478  Sum_probs=62.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCc--CCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK--VGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +||+|||+++.+...... ......+||+.|+|||++.+...  ..++.++||||+||+++||++|
T Consensus       157 lkp~Nill~~~~~-~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg  234 (322)
T 3soc_A          157 IKSKNVLLKNNLT-ACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR  234 (322)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CChHhEEECCCCe-EEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence            3567999988765 999999999766543322 12234579999999999865211  1124578999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       235 ~~pf~~~  241 (322)
T 3soc_A          235 CTAADGP  241 (322)
T ss_dssp             BTTSSSC
T ss_pred             CCCCCCC
Confidence            9999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.26  E-value=4.3e-12  Score=121.70  Aligned_cols=80  Identities=33%  Similarity=0.608  Sum_probs=62.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++..+||+|||+++.......    .....||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       167 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGAT--EYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             CCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCC--CCCcchhhhhHHHHHHHHHhCCC
Confidence            3567999986555799999999986543222    22357899999999986533  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       241 pf~~~~  246 (383)
T 3eb0_A          241 LFSGET  246 (383)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.26  E-value=3.2e-12  Score=124.53  Aligned_cols=77  Identities=34%  Similarity=0.647  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCC-ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGN-SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~-~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. .+||+|||++......      ....+||+.|+|||++.+..   ++.++||||+||+++||++|+
T Consensus       226 lKp~NILl~~~~~~~vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltG~  296 (429)
T 3kvw_A          226 LKPENILLKQQGRSGIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGAR---YGMPIDMWSLGCILAELLTGY  296 (429)
T ss_dssp             CSGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBC---CCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHeEEccCCCcceEEeecccceecCCc------ccccCCCCCccChHHHhCCC---CCchHHHHhHHHHHHHHHhCC
Confidence            3567999987764 3999999999654321      22357999999999997543   578999999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       297 ~pf~~~~  303 (429)
T 3kvw_A          297 PLLPGED  303 (429)
T ss_dssp             CSSCCSS
T ss_pred             CCCCCCC
Confidence            9998764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.26  E-value=4.4e-12  Score=120.35  Aligned_cols=80  Identities=34%  Similarity=0.587  Sum_probs=62.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++..+..+||+|||+++.......    .....||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       157 lkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~~Di~slG~il~ell~g~~  230 (360)
T 3e3p_A          157 IKPHNVLVNEADGTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQ--HYTTAVDIWSVGCIFAEMMLGEP  230 (360)
T ss_dssp             CCGGGEEEETTTTEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEeCCCCcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCC--CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999987455699999999976543222    22357899999999986533  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       231 pf~~~~  236 (360)
T 3e3p_A          231 IFRGDN  236 (360)
T ss_dssp             SSCCSS
T ss_pred             CcCCCC
Confidence            998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.26  E-value=3.1e-12  Score=118.09  Aligned_cols=80  Identities=31%  Similarity=0.481  Sum_probs=57.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......  .......||+.|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       137 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~~l~~ll~g~~  210 (294)
T 4eqm_A          137 IKPQNILIDSNKT-LKIFDFGIAKALSETSL--TQTNHVLGTVQYFSPEQAKGEA---TDECTDIYSIGIVLYEMLVGEP  210 (294)
T ss_dssp             CCGGGEEECTTSC-EEECCCSSSTTC---------------CCSSCCHHHHHTCC---CCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEEeCCCccccccccc--cccCccccCccccCHhHhcCCC---CCchHhHHHHHHHHHHHHhCCC
Confidence            3567999988775 99999999976543221  1223457999999999986542   4678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       211 pf~~~~  216 (294)
T 4eqm_A          211 PFNGET  216 (294)
T ss_dssp             SSCSSC
T ss_pred             CCCCCC
Confidence            998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.26  E-value=4.1e-12  Score=121.84  Aligned_cols=77  Identities=34%  Similarity=0.689  Sum_probs=60.8

Q ss_pred             cCCccEEEec-CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTA-EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~-~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++. ....+||+|||+++.....      ....+||+.|+|||++.+.   .++.++||||+||+++||++|+
T Consensus       185 lkp~NIll~~~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~  255 (382)
T 2vx3_A          185 LKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGM---PYDLAIDMWSLGCILVEMHTGE  255 (382)
T ss_dssp             CSGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCcccEEEecCCCCcEEEEeccCceecccc------cccccCCccccChHHHcCC---CCCcHHHHHHHHHHHHHHHhCC
Confidence            3567999964 2345999999999765432      2235799999999999754   3578999999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       256 ~pf~~~~  262 (382)
T 2vx3_A          256 PLFSGAN  262 (382)
T ss_dssp             CSSCCSS
T ss_pred             CCCCCCC
Confidence            9999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.26  E-value=4e-12  Score=119.29  Aligned_cols=79  Identities=41%  Similarity=0.698  Sum_probs=58.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   .....+||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       147 lkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~  219 (327)
T 3a62_A          147 LKPENIMLNHQGH-VKLTDFGLCKESIHDGT---VTHTFCGTIEYMAPEILMRS---GHNRAVDWWSLGALMYDMLTGAP  219 (327)
T ss_dssp             CCTTTEEECTTSC-EEECCCSCC-------------CTTSSCCTTSCHHHHTTS---CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHeEECCCCc-EEEEeCCcccccccCCc---cccccCCCcCccCHhhCcCC---CCCCcccchhHHHHHHHHHHCCC
Confidence            4567999988775 99999999975432221   12345799999999998653   34689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       220 pf~~~~  225 (327)
T 3a62_A          220 PFTGEN  225 (327)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.25  E-value=4.8e-12  Score=123.68  Aligned_cols=79  Identities=30%  Similarity=0.614  Sum_probs=61.4

Q ss_pred             cCCccEEEecC--CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~--~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.+  +..+||+|||+++.......   .....+||+.|+|||++.+.   .++.++||||+||++|+|++|
T Consensus       136 lKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~---~~~~~~DIwSlGvilyell~G  209 (444)
T 3soa_A          136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKD---PYGKPVDLWACGVILYILLVG  209 (444)
T ss_dssp             CSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC---BCCCSCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEeccCCCCcEEEccCceeEEecCCCc---eeecccCCcccCCHHHhcCC---CCCCccccHHHHHHHHHHHhC
Confidence            45679999752  34699999999976543322   12345799999999998653   357899999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      ++||.+-
T Consensus       210 ~~Pf~~~  216 (444)
T 3soa_A          210 YPPFWDE  216 (444)
T ss_dssp             SCSCCCS
T ss_pred             CCCCCCc
Confidence            9999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.25  E-value=3.2e-12  Score=128.09  Aligned_cols=76  Identities=37%  Similarity=0.671  Sum_probs=62.0

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. +||+|||+++.+.....    ....+||+.|+|||++.+..   ++.++||||+||++|||++|++|
T Consensus       313 KPeNILld~~g~-vKL~DFGla~~~~~~~~----~~~~~GT~~Y~APEvl~~~~---~~~~~DiwSLGvilyeLltG~~P  384 (576)
T 2acx_A          313 KPENILLDDHGH-IRISDLGLAVHVPEGQT----IKGRVGTVGYMAPEVVKNER---YTFSPDWWALGCLLYEMIAGQSP  384 (576)
T ss_dssp             CGGGEEECTTSC-EEECCCTTCEECCTTCC----EECCCSCGGGCCHHHHTTCE---ESSHHHHHHHHHHHHHHHHSSCS
T ss_pred             chheEEEeCCCC-eEEEecccceecccCcc----ccccCCCccccCHHHHcCCC---CCccchHHHHHHHHHHHHhCCCC
Confidence            568999988775 99999999976543221    23458999999999986532   46899999999999999999999


Q ss_pred             CCCC
Q psy10603        387 LSGV  390 (407)
Q Consensus       387 ~~~~  390 (407)
                      |.+.
T Consensus       385 F~~~  388 (576)
T 2acx_A          385 FQQR  388 (576)
T ss_dssp             SSCS
T ss_pred             Cccc
Confidence            9874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.25  E-value=3.5e-12  Score=119.49  Aligned_cols=80  Identities=29%  Similarity=0.589  Sum_probs=57.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   .....+||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       126 ikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~  199 (324)
T 3mtl_A          126 LKPQNLLINERGE-LKLADFGLARAKSIPTK---TYDNEVVTLWYRPPDILLGST--DYSTQIDMWGVGCIFYEMATGRP  199 (324)
T ss_dssp             CCGGGEEECTTCC-EEECSSSEEECC---------------CGGGCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEECCCCC-EEEccCcccccccCCcc---ccccccCcccccChhhhcCCC--CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3567999988775 99999999975443221   123357899999999986533  34688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       200 pf~~~~  205 (324)
T 3mtl_A          200 LFPGST  205 (324)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.25  E-value=1.9e-12  Score=123.58  Aligned_cols=77  Identities=19%  Similarity=0.324  Sum_probs=60.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......      ....+|+.|+|||++.+.. ..++.++||||+||+++||++|+.
T Consensus       220 ikp~NIll~~~~~-~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~-~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          220 FTPDNLFIMPDGR-LMLGDVSALWKVGTRG------PASSVPVTYAPREFLNAST-ATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             CSGGGEEECTTSC-EEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSE-EECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCC-EEEEecceeeecCCCc------cCccCCcCCcChhhccCCC-CCcCccccHHHHHHHHHHHHhCCC
Confidence            4567999988775 9999999997653221      1346779999999996421 235789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       292 Pf~~~  296 (371)
T 3q60_A          292 PFGLV  296 (371)
T ss_dssp             STTBC
T ss_pred             CCCCc
Confidence            99876

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.24  E-value=6.6e-12  Score=119.51  Aligned_cols=79  Identities=29%  Similarity=0.573  Sum_probs=61.4

Q ss_pred             cCCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++  ..+||+|||++........    ....+||+.|+|||++.+.   .++.++||||+||++|||++|
T Consensus       154 lkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g  226 (362)
T 2bdw_A          154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVLKKD---PYSKPVDIWACGVILYILLVG  226 (362)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS----CCCSCSCTTTCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CchHHEEEecCCCCCCEEEeecCcceEecCCcc----cccCCCCccccCHHHHccC---CCCchhhHHHHHHHHHHHHHC
Confidence            356788997643  3599999999976543221    2345799999999998653   357899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      ++||.+..
T Consensus       227 ~~Pf~~~~  234 (362)
T 2bdw_A          227 YPPFWDED  234 (362)
T ss_dssp             SCSSCCSS
T ss_pred             CCCCCCCC
Confidence            99998643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.24  E-value=4.5e-12  Score=118.98  Aligned_cols=82  Identities=22%  Similarity=0.319  Sum_probs=62.3

Q ss_pred             cCCccEEEecCCC----ceEEecCCcccccccccCC----CCcccccccccccccCcccccCCcCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGN----SLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~----~~ki~dfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++.++.    .+||+|||+++.+......    .......+||+.|+|||++.+.   .++.++||||+||++
T Consensus       131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il  207 (330)
T 2izr_A          131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK---EQSRRDDLEALGHMF  207 (330)
T ss_dssp             CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHH
T ss_pred             CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC---CCCchhHHHHHHHHH
Confidence            3567889976553    2999999999865432221    1112356799999999998653   357899999999999


Q ss_pred             HHHHhCCCCCCCC
Q psy10603        378 VEMSSGKTNLSGV  390 (407)
Q Consensus       378 ~e~~~g~~~~~~~  390 (407)
                      +||++|+.||.+.
T Consensus       208 ~ell~g~~Pf~~~  220 (330)
T 2izr_A          208 MYFLRGSLPWQGL  220 (330)
T ss_dssp             HHHHHSSCTTTTC
T ss_pred             HHHhcCCCCcccc
Confidence            9999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.24  E-value=4.4e-12  Score=121.12  Aligned_cols=78  Identities=35%  Similarity=0.575  Sum_probs=53.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......    .....+||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       153 lkp~NIl~~~~~~-~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~~g~~  224 (371)
T 2xrw_A          153 LKPSNIVVKSDCT-LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMIKGGV  224 (371)
T ss_dssp             CCGGGEEECTTSC-EEECCCCC--------------------CTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEEEeeccccccccc----ccCCceecCCccCHHHhcCC---CCCchHhHHHHHHHHHHHHhCCC
Confidence            3567999987765 9999999997654321    12345799999999999753   35689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       225 pf~~~~  230 (371)
T 2xrw_A          225 LFPGTD  230 (371)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.24  E-value=5.5e-12  Score=117.34  Aligned_cols=79  Identities=23%  Similarity=0.374  Sum_probs=53.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   ......||+.|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       165 ikp~NIll~~~~~-~kL~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~  237 (309)
T 3p86_A          165 LKSPNLLVDKKYT-VKVCDFGLSRLKASTFL---SSKSAAGTPEWMAPEVLRDEP---SNEKSDVYSFGVILWELATLQQ  237 (309)
T ss_dssp             CCGGGEEECTTCC-EEECCCC--------------------CCTTSCHHHHTTCC---CCTTHHHHHHHHHHHHHHHCCC
T ss_pred             CChhhEEEeCCCc-EEECCCCCCcccccccc---ccccCCCCccccChhhhcCCC---CCchhhHHHHHHHHHHHHhCCC
Confidence            3567999987765 99999999975432211   123457999999999986542   4688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       238 Pf~~~~  243 (309)
T 3p86_A          238 PWGNLN  243 (309)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            998754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.24  E-value=5.5e-12  Score=122.93  Aligned_cols=85  Identities=26%  Similarity=0.417  Sum_probs=56.8

Q ss_pred             cCCccEEEecCC----CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEG----NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~----~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++..+    ..+||+|||+++...............+||+.|+|||++.......++.++||||+||+++||+
T Consensus       144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell  223 (432)
T 3p23_A          144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI  223 (432)
T ss_dssp             CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence            356788985322    2478999999987654332222234467999999999987532334567899999999999999


Q ss_pred             h-CCCCCCCC
Q psy10603        382 S-GKTNLSGV  390 (407)
Q Consensus       382 ~-g~~~~~~~  390 (407)
                      + |..||.+.
T Consensus       224 t~g~~pf~~~  233 (432)
T 3p23_A          224 SEGSHPFGKS  233 (432)
T ss_dssp             TTSCBTTBST
T ss_pred             cCCCCCcchh
Confidence            9 99999643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.23  E-value=4.5e-12  Score=121.90  Aligned_cols=82  Identities=38%  Similarity=0.586  Sum_probs=57.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCC--------cCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN--------KVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++. + .+||+|||+++.+...... ......+||+.|+|||++.+..        ...++.++||||+||++
T Consensus       181 lkp~NIll~~-~-~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil  257 (390)
T 2zmd_A          181 LKPANFLIVD-G-MLKLIDFGIANQMQPDTTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  257 (390)
T ss_dssp             CCGGGEEESS-S-CEEECCCSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHH
T ss_pred             CCHHHEEEEC-C-eEEEEecCccccccCCCcc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHH
Confidence            3567888853 3 5999999999876433221 1123457999999999986421        11357889999999999


Q ss_pred             HHHHhCCCCCCCC
Q psy10603        378 VEMSSGKTNLSGV  390 (407)
Q Consensus       378 ~e~~~g~~~~~~~  390 (407)
                      |||++|++||.+.
T Consensus       258 ~ell~G~~Pf~~~  270 (390)
T 2zmd_A          258 YYMTYGKTPFQQI  270 (390)
T ss_dssp             HHHHHSSCTTTTC
T ss_pred             HHHHHCCCcchhh
Confidence            9999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.23  E-value=6.2e-12  Score=120.09  Aligned_cols=81  Identities=26%  Similarity=0.425  Sum_probs=62.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.+....... ......+|+.|+|||++.+.   .++.++||||+||++|||++ |+
T Consensus       229 lkp~NIll~~~~~-~kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslG~il~ellt~g~  303 (370)
T 2psq_A          229 LAARNVLVTENNV-MKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGG  303 (370)
T ss_dssp             CCGGGEEECTTCC-EEECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHTC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cchhhEEECCCCC-EEEccccCCcccCccccee-cccCCCcccceECHhHhcCC---CCCcHHHHHHHHHHHHHHHcCCC
Confidence            4567999987775 9999999998654322211 12234578899999998653   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       304 ~p~~~~~  310 (370)
T 2psq_A          304 SPYPGIP  310 (370)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.23  E-value=6.3e-12  Score=118.81  Aligned_cols=80  Identities=33%  Similarity=0.525  Sum_probs=62.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+.....   .....+||+.|+|||++.+..  .++.++||||+||+++||++|.+
T Consensus       138 lkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~  211 (346)
T 1ua2_A          138 LKPNNLLLDENGV-LKLADFGLAKSFGSPNR---AYTHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAELLLRVP  211 (346)
T ss_dssp             CCGGGEEECTTCC-EEECCCGGGSTTTSCCC---CCCCSCCCCTTCCHHHHTTCS--CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEEecccceeccCCcc---cCCcccccccccCchHhhCCC--CCCchhhhHhHHHHHHHHHHCCC
Confidence            3567899988775 99999999976543221   123457999999999986433  24688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      +|.+..
T Consensus       212 ~~~~~~  217 (346)
T 1ua2_A          212 FLPGDS  217 (346)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.23  E-value=7.2e-12  Score=115.32  Aligned_cols=82  Identities=24%  Similarity=0.306  Sum_probs=61.6

Q ss_pred             cCCccEEE---ecCCCceEEecCCcccccccccCCC----CcccccccccccccCcccccCCcCCCCccchHHhHHHHHH
Q psy10603        306 YARANIFL---TAEGNSLKLGDFGSAVKISAHTTVP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  378 (407)
Q Consensus       306 ~~~~nill---~~~~~~~ki~dfGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~  378 (407)
                      .++.|+++   +..+ .+||+|||+++.........    .......||+.|+|||++.+.   .++.++||||+||+++
T Consensus       131 lkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~  206 (296)
T 4hgt_A          131 VKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYVLM  206 (296)
T ss_dssp             CSGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC---CCCHHHHHHHHHHHHH
T ss_pred             CCHHHeeeeccCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC---CCCchhHHHHHHHHHH
Confidence            34678888   4444 59999999998654332211    112345799999999998653   3578999999999999


Q ss_pred             HHHhCCCCCCCCc
Q psy10603        379 EMSSGKTNLSGVV  391 (407)
Q Consensus       379 e~~~g~~~~~~~~  391 (407)
                      ||++|+.||.+..
T Consensus       207 ~l~~g~~pf~~~~  219 (296)
T 4hgt_A          207 YFNLGSLPWQGLK  219 (296)
T ss_dssp             HHHHSSCTTSSCC
T ss_pred             HHhcCCCCCcccc
Confidence            9999999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=2.7e-11  Score=115.05  Aligned_cols=139  Identities=17%  Similarity=0.212  Sum_probs=102.0

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEe--ccccCcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeC---ceEEEE
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQ--LHKQNDARFVKDMLVELRILEGINQ--KNLVKYYGVEIHR---EEMVLF   80 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~--~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~---~~~~lv   80 (407)
                      ..++.|.++.||++...  +..+++|+..  .....  .....+.+|..+|+.+..  .++.+++..+.+.   +..|+|
T Consensus        44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            37899999999998754  4578888764  22111  112456789999888774  5678888887665   458999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE---------------------------------------  121 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---------------------------------------  121 (407)
                      |||++|..+.+..   ...+++.....++.+++..|..||+                                       
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999998874311   2237788888999999999999997                                       


Q ss_pred             -------------------CCceecCCCCCCEEEecCCC-eEEEEcccCcee
Q psy10603        122 -------------------NTIVHRDIKSANIFLTAEGN-SLKLGDFGSAVK  153 (407)
Q Consensus       122 -------------------~~iiHrdlKp~Nill~~~~~-~vkl~DFGla~~  153 (407)
                                         ..++|+|++|.|||++.++. .+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               35899999999999987643 368999998864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.23  E-value=7e-12  Score=117.28  Aligned_cols=78  Identities=37%  Similarity=0.583  Sum_probs=61.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++.........   .....||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       167 lkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~il~el~~g~~  239 (321)
T 2c30_A          167 IKSDSILLTLDGR-VKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRS---LYATEVDIWSLGIMVIEMVDGEP  239 (321)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCSSSCC---BCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCc-EEEeeeeeeeecccCccc---cccccCCccccCHhhhcCC---CCCchhhHHHHHHHHHHHHhCCC
Confidence            3567999987765 999999999765432211   2345799999999998653   24678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       240 pf~~~  244 (321)
T 2c30_A          240 PYFSD  244 (321)
T ss_dssp             TTTTS
T ss_pred             CCCCC
Confidence            99864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.23  E-value=6.4e-12  Score=116.96  Aligned_cols=84  Identities=35%  Similarity=0.639  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++..+||+|||+++................+|+.|+|||++....  .++.++||||+||+++||++|+.
T Consensus       146 lkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~el~~g~~  223 (320)
T 2i6l_A          146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN--NYTKAIDMWAAGCIFAEMLTGKT  223 (320)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT--CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcc--cCCchhhhHhHHHHHHHHHhCCC
Confidence            3567999986666799999999986543322222233456899999999986532  35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       224 pf~~~~  229 (320)
T 2i6l_A          224 LFAGAH  229 (320)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.23  E-value=6e-12  Score=119.47  Aligned_cols=81  Identities=35%  Similarity=0.603  Sum_probs=61.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+......  .....+||+.|+|||++.+.. ..++.++||||+||+++||++|+.
T Consensus       185 lkp~NIll~~~~~-~kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DvwslG~il~ell~g~~  260 (355)
T 1vzo_A          185 IKLENILLDSNGH-VVLTDFGLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGD-SGHDKAVDWWSLGVLMYELLTGAS  260 (355)
T ss_dssp             CCGGGEEECTTSC-EEESCSSEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEECCCCc-EEEeeCCCCeecccCCCC--cccCcccCcCccChhhhcCCC-CCCCchhhHHHHHHHHHHHHHCCC
Confidence            3567999987775 999999999765432221  123457999999999987532 234678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       261 pf~~~  265 (355)
T 1vzo_A          261 PFTVD  265 (355)
T ss_dssp             TTSCT
T ss_pred             CCccC
Confidence            99743

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=2.6e-11  Score=109.47  Aligned_cols=127  Identities=14%  Similarity=0.072  Sum_probs=90.6

Q ss_pred             ecc-cccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC--cceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPG-QGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKN--LVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG-~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .++ .|..+.||++.. .+|+.+++|+.....      ...+.+|+.+|+.+.+.+  +.++++.....+..++||||++
T Consensus        26 ~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             ecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            344 556689999954 457789999865431      133567888887775544  5668888877788999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT------------------------------------------  123 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~------------------------------------------  123 (407)
                      |.+|.  ...    ..   ...++.+++..|..||+..                                          
T Consensus        99 G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           99 GQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            98884  211    11   1245667777777777643                                          


Q ss_pred             ----------------ceecCCCCCCEEEecCCCeEEEEcccCce
Q psy10603        124 ----------------IVHRDIKSANIFLTAEGNSLKLGDFGSAV  152 (407)
Q Consensus       124 ----------------iiHrdlKp~Nill~~~~~~vkl~DFGla~  152 (407)
                                      ++|+|++|.|||++++ ..+.|+|||.+.
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~  213 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence                            9999999999999753 445699999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.23  E-value=4.4e-12  Score=118.75  Aligned_cols=82  Identities=33%  Similarity=0.514  Sum_probs=62.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+...... ......+||+.|+|||++.+...  ++.++||||+||+++||++|+.
T Consensus       131 lkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~  206 (323)
T 3tki_A          131 IKPENLLLDERDN-LKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGEL  206 (323)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECEETTEE-CCBCSCCSCGGGSCHHHHHCSSB--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             cchHHEEEeCCCC-EEEEEeeccceeccCCcc-cccCCCccCcCccCcHHhccCCC--CCCcccHHHHHHHHHHHHhCCC
Confidence            3567999988775 999999999765422211 11234579999999999865432  2568999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       207 pf~~~~  212 (323)
T 3tki_A          207 PWDQPS  212 (323)
T ss_dssp             SCSSSC
T ss_pred             CCCCCc
Confidence            998643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.23  E-value=5.9e-12  Score=122.25  Aligned_cols=81  Identities=32%  Similarity=0.562  Sum_probs=55.4

Q ss_pred             cCCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++..+  ..+||+|||+++......    .....+||+.|+|||++.......++.++||||+||+++||++|
T Consensus       265 lkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg  340 (419)
T 3i6u_A          265 LKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG  340 (419)
T ss_dssp             CCGGGEEESSSSSSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHS
T ss_pred             CChHhEEEecCCCcceEEEeecccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            356899997543  259999999997654322    12345799999999998643333456799999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       341 ~~pf~~~  347 (419)
T 3i6u_A          341 YPPFSEH  347 (419)
T ss_dssp             SCSSCCC
T ss_pred             CCCCCCC
Confidence            9999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.23  E-value=8.3e-12  Score=115.07  Aligned_cols=82  Identities=21%  Similarity=0.291  Sum_probs=62.0

Q ss_pred             cCCccEEEecCCC----ceEEecCCcccccccccCCC----CcccccccccccccCcccccCCcCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGN----SLKLGDFGSAVKISAHTTVP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~----~~ki~dfGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++.++.    .+||+|||+++.........    .......||+.|+|||++.+.   .++.++||||+||++
T Consensus       132 lkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il  208 (298)
T 1csn_A          132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---EQSRRDDLEALGHVF  208 (298)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHH
T ss_pred             CCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC---CCChHHHHHHHHHHH
Confidence            3467888875542    39999999998654332210    123345799999999998653   347899999999999


Q ss_pred             HHHHhCCCCCCCC
Q psy10603        378 VEMSSGKTNLSGV  390 (407)
Q Consensus       378 ~e~~~g~~~~~~~  390 (407)
                      +||++|+.||.+.
T Consensus       209 ~el~~g~~pf~~~  221 (298)
T 1csn_A          209 MYFLRGSLPWQGL  221 (298)
T ss_dssp             HHHHHSSCTTSSC
T ss_pred             HHHHcCCCCcchh
Confidence            9999999999974

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.22  E-value=7.3e-12  Score=118.67  Aligned_cols=79  Identities=33%  Similarity=0.573  Sum_probs=61.3

Q ss_pred             cCCccEEEecCCC--ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~--~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++.  .+|++|||+++.......   .....+||+.|+|||++.+.   .++.++||||+||+++||++|
T Consensus       156 lkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g  229 (351)
T 3c0i_A          156 VKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKRE---PYGKPVDVWGCGVILFILLSG  229 (351)
T ss_dssp             CSGGGEEECSSSTTCCEEECCCTTCEECCTTSC---BCCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHS
T ss_pred             CChHHeEEecCCCCCcEEEecCcceeEecCCCe---eecCCcCCcCccCHHHHcCC---CCCchHhhHHHHHHHHHHHHC
Confidence            3567889976542  499999999976643221   12345799999999998653   246899999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       230 ~~pf~~~  236 (351)
T 3c0i_A          230 CLPFYGT  236 (351)
T ss_dssp             SCSSCSS
T ss_pred             CCCCCCc
Confidence            9999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.22  E-value=8.1e-12  Score=115.04  Aligned_cols=82  Identities=27%  Similarity=0.364  Sum_probs=61.4

Q ss_pred             cCCccEEEe--cCCCceEEecCCcccccccccCCC----CcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        306 YARANIFLT--AEGNSLKLGDFGSAVKISAHTTVP----GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       306 ~~~~nill~--~~~~~~ki~dfGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      .++.|++++  .++..+||+|||+++.........    .......||+.|+|||++.+..   ++.++||||+||+++|
T Consensus       131 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~  207 (296)
T 3uzp_A          131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE---QSRRDDLESLGYVLMY  207 (296)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC---CCHHHHHHHHHHHHHH
T ss_pred             CCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC---CCcchhhHHHHHHHHH
Confidence            356788885  334459999999997654332210    1123457999999999986532   5689999999999999


Q ss_pred             HHhCCCCCCCC
Q psy10603        380 MSSGKTNLSGV  390 (407)
Q Consensus       380 ~~~g~~~~~~~  390 (407)
                      |++|+.||.+.
T Consensus       208 l~~g~~pf~~~  218 (296)
T 3uzp_A          208 FNLGSLPWQGL  218 (296)
T ss_dssp             HHHSSCTTSSC
T ss_pred             HHhCCCCCCCc
Confidence            99999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.22  E-value=9.2e-12  Score=116.73  Aligned_cols=78  Identities=29%  Similarity=0.476  Sum_probs=60.8

Q ss_pred             cCCccEEEecCCC---ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~---~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|++++.++.   .+||+|||+++.+.....    ....+||+.|+|||++...   .++.++||||+||+++||++
T Consensus       140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~  212 (326)
T 2y0a_A          140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVITYILLS  212 (326)
T ss_dssp             CCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC----CCCCCSCTTTCCHHHHTTC---CCCTHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc----cccccCCcCcCCceeecCC---CCCcHHHHHHHHHHHHHHHH
Confidence            3467888876652   599999999976543221    2335799999999998543   35789999999999999999


Q ss_pred             CCCCCCCC
Q psy10603        383 GKTNLSGV  390 (407)
Q Consensus       383 g~~~~~~~  390 (407)
                      |+.||.+.
T Consensus       213 g~~pf~~~  220 (326)
T 2y0a_A          213 GASPFLGD  220 (326)
T ss_dssp             SCCSSCCS
T ss_pred             CcCCCCCC
Confidence            99999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.22  E-value=8.7e-12  Score=116.04  Aligned_cols=74  Identities=36%  Similarity=0.562  Sum_probs=57.3

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. +||+|||+++.......    .....||+.|+|||++.+    .++.++||||+||+++||++|..+
T Consensus       184 kp~NIll~~~~~-~kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~el~~g~~~  254 (311)
T 3p1a_A          184 KPANIFLGPRGR-CKLGDFGLLVELGTAGA----GEVQEGDPRYMAPELLQG----SYGTAADVFSLGLTILEVACNMEL  254 (311)
T ss_dssp             SGGGEEECGGGC-EEECCCTTCEECC----------CCCCCGGGCCGGGGGT----CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred             CHHHEEECCCCC-EEEccceeeeecccCCC----CcccCCCccccCHhHhcC----CCCchhhHHHHHHHHHHHHhCCCC
Confidence            567999988775 99999999976543221    223469999999999864    257899999999999999999877


Q ss_pred             CCC
Q psy10603        387 LSG  389 (407)
Q Consensus       387 ~~~  389 (407)
                      |.+
T Consensus       255 ~~~  257 (311)
T 3p1a_A          255 PHG  257 (311)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.21  E-value=7.9e-12  Score=117.64  Aligned_cols=79  Identities=30%  Similarity=0.502  Sum_probs=62.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......    ....+||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       156 lkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~el~~g~~  228 (335)
T 3dls_A          156 IKDENIVIAEDFT-IKLIDFGSAAYLERGKL----FYTFCGTIEYCAPEVLMGNPY--RGPELEMWSLGVTLYTLVFEEN  228 (335)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCTTCC----BCEECSCGGGCCHHHHTTCCB--CSHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEEcCCCc-EEEeecccceECCCCCc----eeccCCCccccChhhhcCCCC--CCCcccchhHHHHHHHHHhCCC
Confidence            3567999988765 99999999976543221    234579999999999875432  2678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       229 pf~~~~  234 (335)
T 3dls_A          229 PFCELE  234 (335)
T ss_dssp             SCSSGG
T ss_pred             chhhHH
Confidence            998644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.21  E-value=1.1e-11  Score=117.82  Aligned_cols=65  Identities=35%  Similarity=0.612  Sum_probs=52.3

Q ss_pred             CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCC
Q psy10603        317 GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGV  390 (407)
Q Consensus       317 ~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~  390 (407)
                      ...+||+|||+++.....      ....+||+.|+|||++.+.   .++.++||||+||+++||++|+.||.+.
T Consensus       198 ~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          198 STGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCC---CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence            345999999999754321      1235799999999999754   3578999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.21  E-value=7.9e-12  Score=118.11  Aligned_cols=81  Identities=19%  Similarity=0.288  Sum_probs=61.8

Q ss_pred             cCCccEEEecCC-CceEEecCCcccccccccCC----CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHH
Q psy10603        306 YARANIFLTAEG-NSLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM  380 (407)
Q Consensus       306 ~~~~nill~~~~-~~~ki~dfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~  380 (407)
                      .++.|++++.++ ..+||+|||+++.+......    ........||+.|+|||++.+.   .++.++||||+||+++||
T Consensus       177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el  253 (345)
T 2v62_A          177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV---ALSRRSDVEILGYCMLRW  253 (345)
T ss_dssp             CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC---CCCHHHHHHHHHHHHHHH
T ss_pred             cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC---CCCchhhHHHHHHHHHHH
Confidence            356799998765 25999999999766432211    1112345799999999998753   357899999999999999


Q ss_pred             HhCCCCCCC
Q psy10603        381 SSGKTNLSG  389 (407)
Q Consensus       381 ~~g~~~~~~  389 (407)
                      ++|+.||.+
T Consensus       254 l~g~~pf~~  262 (345)
T 2v62_A          254 LCGKLPWEQ  262 (345)
T ss_dssp             HHSSCTTGG
T ss_pred             HhCCCCccc
Confidence            999999964

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.21  E-value=6.3e-12  Score=115.64  Aligned_cols=83  Identities=29%  Similarity=0.491  Sum_probs=53.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++........ ........||+.|+|||++.......++.++||||+||+++||++|+.
T Consensus       146 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  223 (289)
T 3og7_A          146 LKSNNIFLHEDNT-VKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL  223 (289)
T ss_dssp             CCGGGEEEETTTE-EEECCCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccceEEECCCCC-EEEccceeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCC
Confidence            3467899988764 99999999975432211 112234579999999999863333345678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       224 p~~~~  228 (289)
T 3og7_A          224 PYSNI  228 (289)
T ss_dssp             TTSSC
T ss_pred             Ccccc
Confidence            99864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.21  E-value=1.1e-11  Score=116.86  Aligned_cols=85  Identities=27%  Similarity=0.387  Sum_probs=60.6

Q ss_pred             cCCccEEEecCCC-ceEEecCCcccccccccCC-CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGN-SLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~-~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. .+||+|||+++.+...... ........||+.|+|||++.+.. ..++.++||||+||+++||++|
T Consensus       194 lkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~el~~g  272 (345)
T 3hko_A          194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN-ESYGPKCDAWSAGVLLHLLLMG  272 (345)
T ss_dssp             CCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS-SCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC-CCCCcHHHHHHHHHHHHHHHHC
Confidence            3567899976552 5999999999765432111 11123457999999999986432 2357899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       273 ~~pf~~~~  280 (345)
T 3hko_A          273 AVPFPGVN  280 (345)
T ss_dssp             SCSSCCSS
T ss_pred             CCCCCCCC
Confidence            99998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.20  E-value=9.7e-12  Score=116.44  Aligned_cols=81  Identities=21%  Similarity=0.313  Sum_probs=60.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.+...... .......||..|+|||++....   ++.++||||+||+++||++ |+
T Consensus       141 ikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~~g~  215 (325)
T 3kex_A          141 LAARNVLLKSPSQ-VQVADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGK---YTHQSDVWSYGVTVWELMTFGA  215 (325)
T ss_dssp             CSSTTEEESSSSC-EEECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cchheEEECCCCe-EEECCCCcccccCccccc-ccccCCCCcccccChHHhccCC---CChhhHhHHhHHHHHHHHhCCC
Confidence            3567999987765 999999999876433221 1123456888999999986532   5789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       216 ~p~~~~~  222 (325)
T 3kex_A          216 EPYAGLR  222 (325)
T ss_dssp             CTTTTSC
T ss_pred             CCccccC
Confidence            9998753

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.20  E-value=3.7e-12  Score=123.51  Aligned_cols=78  Identities=19%  Similarity=0.263  Sum_probs=60.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC-------CcCCCCccchHHhHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-------NKVGHGRAVDIWSLGCVLV  378 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~Dvws~G~~~~  378 (407)
                      .++.|++++.++. +||+|||+++.....      ....+| +.|+|||++...       ....++.++||||+||++|
T Consensus       237 iKp~NILl~~~~~-~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          237 LRPVDIVLDQRGG-VFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CCGGGEEECTTCC-EEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCe-EEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            4578999998876 999999999765432      223467 999999998421       1112467899999999999


Q ss_pred             HHHhCCCCCCCCc
Q psy10603        379 EMSSGKTNLSGVV  391 (407)
Q Consensus       379 e~~~g~~~~~~~~  391 (407)
                      ||++|+.||.+..
T Consensus       309 elltg~~Pf~~~~  321 (413)
T 3dzo_A          309 WIWCADLPNTDDA  321 (413)
T ss_dssp             HHHHSSCCCCTTG
T ss_pred             HHHHCCCCCCCcc
Confidence            9999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.20  E-value=1.1e-11  Score=114.19  Aligned_cols=78  Identities=26%  Similarity=0.510  Sum_probs=59.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   ......||+.|+|||++.+..  .++.++||||+||+++||++|..
T Consensus       127 ikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~~~~  200 (292)
T 3o0g_A          127 LKPQNLLINRNGE-LKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAK--LYSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCS--CCCTHHHHHHHHHHHHHHTTTSC
T ss_pred             CCHHHEEEcCCCC-EEEeecccceecCCccc---cccCCccccCCcChHHHcCCC--CcCchHHHHHHHHHHHHHHHcCC
Confidence            3567999988775 99999999976543222   123457899999999986543  24789999999999999998777


Q ss_pred             C-CCC
Q psy10603        386 N-LSG  389 (407)
Q Consensus       386 ~-~~~  389 (407)
                      | |.+
T Consensus       201 p~~~~  205 (292)
T 3o0g_A          201 PLFPG  205 (292)
T ss_dssp             CSCCC
T ss_pred             CCcCC
Confidence            6 444

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.20  E-value=1.1e-11  Score=118.19  Aligned_cols=79  Identities=28%  Similarity=0.569  Sum_probs=61.5

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC---CcCCCCccchHHhHHHHHHHHHhC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT---NKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      ++.|++++.++. ++++|||++..+.....    ....+||+.|+|||++.+.   ....++.++||||+||+++||++|
T Consensus       227 kp~NIl~~~~~~-ikl~DfG~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g  301 (365)
T 2y7j_A          227 KPENILLDDNMQ-IRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG  301 (365)
T ss_dssp             SGGGEEECTTCC-EEECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             CHHHEEECCCCC-EEEEecCcccccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence            567999988775 99999999976643222    2345799999999998532   112356789999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       302 ~~pf~~~  308 (365)
T 2y7j_A          302 SPPFWHR  308 (365)
T ss_dssp             SCSSCCS
T ss_pred             CCCCCCC
Confidence            9999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.20  E-value=8.5e-12  Score=116.91  Aligned_cols=79  Identities=30%  Similarity=0.474  Sum_probs=43.7

Q ss_pred             cCCccEEEecCCC--ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~--~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++.  .+||+|||+++.......   .....+||+.|+|||++.+.   .++.++||||+||+++||++|
T Consensus       132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g  205 (325)
T 3kn6_A          132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---PLKTPCFTLHYAAPELLNQN---GYDESCDLWSLGVILYTMLSG  205 (325)
T ss_dssp             CCGGGEEEEC----CEEEECCCTTCEECCC-------------------------C---CCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEecCCCcccEEEeccccceecCCCCC---cccccCCCcCccCHHHhcCC---CCCCccchHHHHHHHHHHHhC
Confidence            3567899976552  599999999975543221   12345789999999998643   357899999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       206 ~~pf~~~  212 (325)
T 3kn6_A          206 QVPFQSH  212 (325)
T ss_dssp             SCTTC--
T ss_pred             CCCCCCC
Confidence            9999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.20  E-value=1.1e-11  Score=122.03  Aligned_cols=79  Identities=32%  Similarity=0.449  Sum_probs=62.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......    .....+||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       142 Lkp~NIll~~~~~-vkL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~elltG~~  214 (476)
T 2y94_A          142 LKPENVLLDAHMN-AKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLY--AGPEVDIWSSGVILYALLCGTL  214 (476)
T ss_dssp             CSGGGEEECTTCC-EEECCCSSCEECCTTC----CBCCCCSCSTTCCHHHHTTCCB--CSHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccHHHEEEecCCC-eEEEeccchhhccccc----cccccCCCcCeEChhhccCCCC--CCCcceehhhHHHHHHHhhCCC
Confidence            3567999988775 9999999997654322    1234579999999999875432  2578999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       215 Pf~~~~  220 (476)
T 2y94_A          215 PFDDDH  220 (476)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.20  E-value=5e-12  Score=116.72  Aligned_cols=84  Identities=37%  Similarity=0.487  Sum_probs=60.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCcC---CCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKV---GHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++.++. +||+|||+++........ ........||+.|+|||++.+....   .++.++||||+||+++||+
T Consensus       139 lkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~  217 (301)
T 3q4u_A          139 LKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA  217 (301)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CChHhEEEcCCCC-EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence            3567999987765 999999999755432211 1112334799999999998653211   1236899999999999999


Q ss_pred             hC----------CCCCCCC
Q psy10603        382 SG----------KTNLSGV  390 (407)
Q Consensus       382 ~g----------~~~~~~~  390 (407)
                      +|          +.||.+.
T Consensus       218 tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          218 RRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             TTBCBTTBCCCCCCTTTTT
T ss_pred             hhhcCcccccccccccccc
Confidence            99          8888754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.20  E-value=7.5e-12  Score=118.16  Aligned_cols=82  Identities=39%  Similarity=0.593  Sum_probs=56.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC--------CcCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--------NKVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++. + .+||+|||+++.+...... ......+||+.|+|||++.+.        ....++.++||||+||++
T Consensus       134 ikp~NIll~~-~-~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il  210 (343)
T 3dbq_A          134 LKPANFLIVD-G-MLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  210 (343)
T ss_dssp             CCGGGEEEET-T-EEEECCCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred             CCcceEEEEC-C-cEEEeecccccccCccccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence            3567888863 3 5999999999866433221 112345799999999998541        012356789999999999


Q ss_pred             HHHHhCCCCCCCC
Q psy10603        378 VEMSSGKTNLSGV  390 (407)
Q Consensus       378 ~e~~~g~~~~~~~  390 (407)
                      +||++|+.||.+.
T Consensus       211 ~ell~g~~pf~~~  223 (343)
T 3dbq_A          211 YYMTYGKTPFQQI  223 (343)
T ss_dssp             HHHHHSSCTTTTC
T ss_pred             HHHHhCCCcchhh
Confidence            9999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.20  E-value=1e-11  Score=119.22  Aligned_cols=79  Identities=25%  Similarity=0.391  Sum_probs=61.1

Q ss_pred             cCCccEEEecC-CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~-~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.+ ...+||+|||+++......    .....+||+.|+|||++.+.   .++.++||||+||+++||++|+
T Consensus       175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~  247 (387)
T 1kob_A          175 IKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDRE---PVGFYTDMWAIGVLGYVLLSGL  247 (387)
T ss_dssp             CCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSC
T ss_pred             cchHHeEEecCCCCceEEEecccceecCCCc----ceeeeccCCCccCchhccCC---CCCCcccEeeHhHHHHHHHhCC
Confidence            35678898743 3469999999998654322    12334799999999998653   3468899999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       248 ~Pf~~~~  254 (387)
T 1kob_A          248 SPFAGED  254 (387)
T ss_dssp             CSSCCSS
T ss_pred             CCCCCCC
Confidence            9998753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.20  E-value=5.5e-12  Score=119.10  Aligned_cols=78  Identities=33%  Similarity=0.488  Sum_probs=59.5

Q ss_pred             cCCccEEEecCCC---ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~---~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|+++.....   .+||+|||+++.......   .....+||+.|+|||++.+..   ++.++||||+||++|||++
T Consensus       142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~  215 (342)
T 2qr7_A          142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTANFVAPEVLERQG---YDAACDIWSLGVLLYTMLT  215 (342)
T ss_dssp             CCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC---CBCCSSCCSSCCCHHHHHHHH---HHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC---ceeccCCCccccCHHHhcCCC---CCCccCeeeHhHHHHHHhc
Confidence            3456888755432   499999999986543221   223457999999999986532   4678999999999999999


Q ss_pred             CCCCCCC
Q psy10603        383 GKTNLSG  389 (407)
Q Consensus       383 g~~~~~~  389 (407)
                      |++||.+
T Consensus       216 g~~Pf~~  222 (342)
T 2qr7_A          216 GYTPFAN  222 (342)
T ss_dssp             SSCSSCS
T ss_pred             CCCCCCC
Confidence            9999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.20  E-value=1.2e-11  Score=118.15  Aligned_cols=78  Identities=27%  Similarity=0.397  Sum_probs=60.4

Q ss_pred             CCccEEEec-CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        307 ARANIFLTA-EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       307 ~~~nill~~-~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      ++.|+++.. ....+||+|||+++.......    ....+||+.|+|||++...   .++.++||||+||+++||++|+.
T Consensus       214 kp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~  286 (373)
T 2x4f_A          214 KPENILCVNRDAKQIKIIDFGLARRYKPREK----LKVNFGTPEFLAPEVVNYD---FVSFPTDMWSVGVIAYMLLSGLS  286 (373)
T ss_dssp             CGGGEEEEETTTTEEEECCCSSCEECCTTCB----CCCCCSSCTTCCHHHHTTC---BCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CHHHEEEecCCCCcEEEEeCCCceecCCccc----cccccCCCcEeChhhccCC---CCCcHHhHHHHHHHHHHHHhCCC
Confidence            467998853 344699999999986643222    2234799999999998543   24678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       287 pf~~~~  292 (373)
T 2x4f_A          287 PFLGDN  292 (373)
T ss_dssp             TTCCSS
T ss_pred             CCCCCC
Confidence            998753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.19  E-value=7.2e-12  Score=117.21  Aligned_cols=78  Identities=24%  Similarity=0.416  Sum_probs=60.8

Q ss_pred             cCCccEEEecC-CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~-~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.. ...+|++|||+++.+....    ......||+.|+|||++.+..   ++.++||||+||+++||++|+
T Consensus       128 lkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~  200 (321)
T 1tki_A          128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDV---VSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             CCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCE---ECHHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChhhcCcHHhcCCC---CCchhhHHHHHHHHHHHHhCC
Confidence            35678888763 3469999999997654322    223457999999999986532   468999999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       201 ~pf~~~  206 (321)
T 1tki_A          201 NPFLAE  206 (321)
T ss_dssp             CTTCCS
T ss_pred             CCCcCC
Confidence            999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.19  E-value=1.3e-11  Score=117.88  Aligned_cols=77  Identities=38%  Similarity=0.623  Sum_probs=58.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....      ....+||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       170 ikp~NIll~~~~~-~kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~el~~g~~  240 (371)
T 4exu_A          170 LKPGNLAVNEDCE-LKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWM--HYNQTVDIWSVGCIMAEMLTGKT  240 (371)
T ss_dssp             CCGGGEEECTTCC-EEECSTTCC--------------CTTCCCTTSCHHHHSCCS--CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHeEECCCCC-EEEEecCcccccccC------cCCcccCccccCHHHhcCCC--CCCcHHhHHHHHHHHHHHHhCCC
Confidence            3567999987765 999999999755332      22357899999999986532  35688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       241 pf~~~~  246 (371)
T 4exu_A          241 LFKGKD  246 (371)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.19  E-value=1.6e-11  Score=115.09  Aligned_cols=77  Identities=27%  Similarity=0.423  Sum_probs=61.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++..+||+|||+++.......    .....||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       156 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~  229 (330)
T 3nsz_A          156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQ--MYDYSLDMWSLGCMLASMIFRKE  229 (330)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSCCSCGGGCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             CCHHHEEEcCCCCEEEEEeCCCceEcCCCCc----cccccccccccChhhhcCCC--cCCchhhHHHHHHHHHHHHhCCC
Confidence            3567999988876799999999976543322    23357999999999986533  35689999999999999999999


Q ss_pred             CCC
Q psy10603        386 NLS  388 (407)
Q Consensus       386 ~~~  388 (407)
                      ||.
T Consensus       230 p~~  232 (330)
T 3nsz_A          230 PFF  232 (330)
T ss_dssp             SSS
T ss_pred             Ccc
Confidence            994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.19  E-value=1.2e-11  Score=117.08  Aligned_cols=83  Identities=31%  Similarity=0.542  Sum_probs=60.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCC-------CcccccccccccccCcccccCCcCCCCccchHHhHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVP-------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  378 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~  378 (407)
                      .++.|++++.++. +||+|||+++.........       ......+||+.|+|||++....  .++.++||||+||+++
T Consensus       138 lkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Di~slG~il~  214 (353)
T 2b9h_A          138 LKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA--KYSRAMDVWSCGCILA  214 (353)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCC--CCCHHHHHHHHHHHHH
T ss_pred             CCHHHeEEcCCCc-EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCC--CccchhhHHHHHHHHH
Confidence            3567899987765 9999999997654221110       0122357899999999886432  3568999999999999


Q ss_pred             HHHhCCCCCCCCc
Q psy10603        379 EMSSGKTNLSGVV  391 (407)
Q Consensus       379 e~~~g~~~~~~~~  391 (407)
                      ||++|++||.+..
T Consensus       215 ~l~~g~~pf~~~~  227 (353)
T 2b9h_A          215 ELFLRRPIFPGRD  227 (353)
T ss_dssp             HHHHSSCSCCCSS
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999999764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.18  E-value=1.6e-11  Score=114.74  Aligned_cols=80  Identities=25%  Similarity=0.342  Sum_probs=61.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||+++........ .......||+.|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       165 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~g~~  239 (321)
T 2qkw_B          165 VKSINILLDENFV-PKITDFGISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGR---LTEKSDVYSFGVVLFEVLCARS  239 (321)
T ss_dssp             CCSTTEEECTTCC-EEECCCTTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCB---CCTHHHHHHHHHHHHHHHHCCT
T ss_pred             CCHHHEEECCCCC-EEEeeccccccccccccc-ccccccCCCccccCHHHhcCCC---CCcccchHhHHHHHHHHHhCCC
Confidence            3567999987765 999999999764322211 1123346999999999986543   4689999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       240 p~~~~  244 (321)
T 2qkw_B          240 AIVQS  244 (321)
T ss_dssp             TCSCS
T ss_pred             ccccc
Confidence            99764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.18  E-value=1.2e-11  Score=115.93  Aligned_cols=87  Identities=29%  Similarity=0.404  Sum_probs=46.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCC---------CcccccccccccccCcccccCCcCCCCccchHHhHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVP---------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV  376 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~  376 (407)
                      .++.|++++.++. +||+|||+++.........         .......||+.|+|||++.......++.++||||+||+
T Consensus       164 ikp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i  242 (337)
T 3ll6_A          164 LKVENLLLSNQGT-IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI  242 (337)
T ss_dssp             CCGGGCEECTTSC-EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred             CCcccEEECCCCC-EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence            3567889987765 9999999997654322110         01123469999999999843233345789999999999


Q ss_pred             HHHHHhCCCCCCCCcee
Q psy10603        377 LVEMSSGKTNLSGVVVS  393 (407)
Q Consensus       377 ~~e~~~g~~~~~~~~~~  393 (407)
                      ++||++|+.||.+....
T Consensus       243 l~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          243 LYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             HHHHHHSSCCC------
T ss_pred             HHHHHhCCCCCcchhHH
Confidence            99999999999865443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.18  E-value=1.3e-11  Score=114.72  Aligned_cols=80  Identities=31%  Similarity=0.549  Sum_probs=57.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++.........   ....+||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       128 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~  201 (311)
T 4agu_A          128 VKPENILITKHSV-IKLCDFGFARLLTGPSDY---YDDEVATRWYRSPELLVGDT--QYGPPVDVWAIGCVFAELLSGVP  201 (311)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECC---------------GGGCCHHHHHTCS--CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChhhEEEcCCCC-EEEeeCCCchhccCcccc---cCCCcCCccccChHHHhcCC--CCCcchhhHHHHHHHHHHHhCCC
Confidence            3457899987765 999999999765432221   23457999999999986532  34689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       202 p~~~~~  207 (311)
T 4agu_A          202 LWPGKS  207 (311)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.18  E-value=1.4e-11  Score=115.63  Aligned_cols=79  Identities=34%  Similarity=0.592  Sum_probs=57.1

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. +||+|||+++.+.....   ......||+.|+|||++.+..  .++.++||||+||+++||++|+.|
T Consensus       151 kp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~p  224 (331)
T 4aaa_A          151 KPENILVSQSGV-VKLCDFGFARTLAAPGE---VYDDEVATRWYRAPELLVGDV--KYGKAVDVWAIGCLVTEMFMGEPL  224 (331)
T ss_dssp             CGGGEEECTTSC-EEECCCTTC---------------CCCCCTTCCHHHHTTCT--TCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ChheEEEcCCCc-EEEEeCCCceeecCCcc---ccCCCcCCccccCcccccCCC--CcchHHHHHHHHHHHHHHHhCCCC
Confidence            457899987775 99999999976543222   123357999999999986532  246889999999999999999999


Q ss_pred             CCCCc
Q psy10603        387 LSGVV  391 (407)
Q Consensus       387 ~~~~~  391 (407)
                      |.+..
T Consensus       225 f~~~~  229 (331)
T 4aaa_A          225 FPGDS  229 (331)
T ss_dssp             CCCSS
T ss_pred             CCCCC
Confidence            98754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.18  E-value=5.9e-12  Score=120.49  Aligned_cols=78  Identities=19%  Similarity=0.273  Sum_probs=57.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCC--------cCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN--------KVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++.++. +||+|||+++....      .....+| +.|+|||++.+..        ...++.++||||+||++
T Consensus       232 ikp~NIll~~~~~-~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          232 LRPVDIVLDQRGG-VFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CCGGGEEECTTCC-EEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCC-EEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            3568999988765 99999999975332      1233467 9999999986540        01247899999999999


Q ss_pred             HHHHhCCCCCCCCc
Q psy10603        378 VEMSSGKTNLSGVV  391 (407)
Q Consensus       378 ~e~~~g~~~~~~~~  391 (407)
                      +||++|+.||.+..
T Consensus       304 ~elltg~~Pf~~~~  317 (377)
T 3byv_A          304 YWIWCADLPITKDA  317 (377)
T ss_dssp             HHHHHSSCCC----
T ss_pred             HHHHHCCCCCcccc
Confidence            99999999998643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.18  E-value=6.5e-12  Score=117.77  Aligned_cols=81  Identities=23%  Similarity=0.358  Sum_probs=60.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......... ......+|..|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       143 ikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~ellt~g~  217 (327)
T 3poz_A          143 LAARNVLVKTPQH-VKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVTVWELMTFGS  217 (327)
T ss_dssp             CCGGGEEEEETTE-EEECCTTHHHHHTTTCC--------CCCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CChheEEECCCCC-EEEccCcceeEccCCcccc-cccCCCccccccChHHhccC---CCCchhhhhhhHHHHHHHHhcCC
Confidence            3567999988775 9999999998654332221 12234578899999998753   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       218 ~p~~~~~  224 (327)
T 3poz_A          218 KPYDGIP  224 (327)
T ss_dssp             CTTTTCC
T ss_pred             CCccCCC
Confidence            9998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.18  E-value=1e-11  Score=116.32  Aligned_cols=82  Identities=22%  Similarity=0.315  Sum_probs=58.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++................+|..|+|||++....   ++.++||||+||+++||++ |+
T Consensus       177 lkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          177 LAARNVLVDSNLV-CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT---FSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             CSGGGEEECTTCC-EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCcceEEECCCCC-EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC---CCcHHHHHHHHHHHHHHHcCCC
Confidence            3567999987765 99999999986644322222222335678899999986432   4678999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       253 ~p~~~~~  259 (325)
T 3kul_A          253 RPYWNMT  259 (325)
T ss_dssp             CTTTTSC
T ss_pred             CCcccCC
Confidence            9997653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.17  E-value=1.8e-11  Score=113.65  Aligned_cols=82  Identities=26%  Similarity=0.374  Sum_probs=60.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCC-----------cccccccccccccCcccccCCcCCCCccchHHhHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPG-----------ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLG  374 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G  374 (407)
                      .++.|++++.++. +||+|||+++..........           .....+||+.|+|||++.+.   .++.++||||+|
T Consensus       134 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG  209 (310)
T 3s95_A          134 LNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR---SYDEKVDVFSFG  209 (310)
T ss_dssp             CSTTSEEECTTSC-EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTC---CCCTHHHHHHHH
T ss_pred             CCcCeEEECCCCC-EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC---CCCcHHHHHHHH
Confidence            3567999988765 99999999976543222110           11145799999999998653   356899999999


Q ss_pred             HHHHHHHhCCCCCCCCc
Q psy10603        375 CVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       375 ~~~~e~~~g~~~~~~~~  391 (407)
                      |+++||++|..+|.+..
T Consensus       210 ~~l~el~~g~~~~~~~~  226 (310)
T 3s95_A          210 IVLCEIIGRVNADPDYL  226 (310)
T ss_dssp             HHHHHHHHTCCSSTTTS
T ss_pred             HHHHHHhcCCCCCcchh
Confidence            99999999999998643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.17  E-value=1.8e-11  Score=113.75  Aligned_cols=76  Identities=33%  Similarity=0.574  Sum_probs=55.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++..+|++|||++.......      ....||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~  201 (307)
T 2eva_A          131 LKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMAPEVFEGS---NYSEKCDVFSWGIILWEVITRRK  201 (307)
T ss_dssp             CSGGGEEEETTTTEEEECCCCC------------------CCTTSSCHHHHTCC---CCCTHHHHHHHHHHHHHHHHTCC
T ss_pred             CChhHEEEeCCCCEEEEccccccccccccc------ccCCCCCceEChhhhCCC---CCCcHHHHHHHHHHHHHHHHCCC
Confidence            356799998877668999999997543221      224699999999998653   34689999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       202 p~~~~  206 (307)
T 2eva_A          202 PFDEI  206 (307)
T ss_dssp             TTTTT
T ss_pred             Cchhh
Confidence            99854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.17  E-value=1.1e-11  Score=116.29  Aligned_cols=80  Identities=28%  Similarity=0.476  Sum_probs=55.6

Q ss_pred             CCccEEEecCC----CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        307 ARANIFLTAEG----NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       307 ~~~nill~~~~----~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      ++.|++++.++    ..+||+|||+++.+.....   .....+||+.|+|||++.+..  .++.++||||+||+++||++
T Consensus       159 kp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~  233 (329)
T 3gbz_A          159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGSR--HYSTSVDIWSIACIWAEMLM  233 (329)
T ss_dssp             CGGGEEEEC-----CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEecCCCCccceEEECcCCCccccCCccc---ccCCCcCCccccCHHHhcCCC--CCCcHHHHHHHHHHHHHHHH
Confidence            46788886332    3499999999976543221   123357899999999986543  24689999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |+.+|.+..
T Consensus       234 g~~pf~~~~  242 (329)
T 3gbz_A          234 KTPLFPGDS  242 (329)
T ss_dssp             SSCSSCCSS
T ss_pred             CCCCcCCCC
Confidence            999998653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.17  E-value=1.4e-11  Score=118.42  Aligned_cols=64  Identities=25%  Similarity=0.496  Sum_probs=52.2

Q ss_pred             ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       319 ~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      .+||+|||+++.....      ....+||+.|+|||++.+..   ++.++||||+||+++||++|+.||.+..
T Consensus       234 ~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          234 KVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGSG---YNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             CEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTSC---CCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             ceEecccccccccccc------CccCCCCCcccCChhhcCCC---CCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            5999999999765432      22347999999999997543   5689999999999999999999998643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.17  E-value=1.1e-11  Score=117.84  Aligned_cols=79  Identities=32%  Similarity=0.510  Sum_probs=51.2

Q ss_pred             cCCccEEEecCCC-ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGN-SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~-~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. .+||+|||+++......    .....+||+.|+|||++.+...  .+.++||||+||+++||++|+
T Consensus       142 lkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~  215 (361)
T 3uc3_A          142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEY--DGKIADVWSCGVTLYVMLVGA  215 (361)
T ss_dssp             CCGGGEEECSSSSCCEEECCCCCC-------------------CTTSCHHHHHCSSC--CHHHHHHHHHHHHHHHHHHSS
T ss_pred             CCHHHEEEcCCCCceEEEeecCccccccccC----CCCCCcCCCCcCChhhhcCCCC--CCCeeeeehhHHHHHHHHhCC
Confidence            3567899976543 49999999997433221    1233579999999999875432  234589999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       216 ~Pf~~~  221 (361)
T 3uc3_A          216 YPFEDP  221 (361)
T ss_dssp             CSCC--
T ss_pred             CCCCCC
Confidence            999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.16  E-value=2.6e-11  Score=114.57  Aligned_cols=66  Identities=35%  Similarity=0.637  Sum_probs=52.7

Q ss_pred             CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        317 GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       317 ~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      ...+||+|||+++.....      ....+||+.|+|||++.+.   .++.++||||+||+++||++|+.||.+..
T Consensus       178 ~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecC---CCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            345999999999754322      1235799999999998653   35689999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.16  E-value=1.8e-11  Score=117.63  Aligned_cols=83  Identities=20%  Similarity=0.364  Sum_probs=61.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC----CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT----VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++.++. +||+|||++........    ........+||+.|+|||++.+.. ..++.++||||+||+++||+
T Consensus       154 lkp~NIll~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~el~  231 (389)
T 3gni_B          154 VKASHILISVDGK-VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-QGYDAKSDIYSVGITACELA  231 (389)
T ss_dssp             CSGGGEEECTTCC-EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS-SCBCTHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCC-EEEcccccceeeccccccccccccccccccccccccCHHHHhccC-CCCCcHhHHHHHHHHHHHHH
Confidence            3567999987775 99999999865432111    111122347999999999987531 23578999999999999999


Q ss_pred             hCCCCCCCC
Q psy10603        382 SGKTNLSGV  390 (407)
Q Consensus       382 ~g~~~~~~~  390 (407)
                      +|+.||.+.
T Consensus       232 ~g~~pf~~~  240 (389)
T 3gni_B          232 NGHVPFKDM  240 (389)
T ss_dssp             HSSCTTTTC
T ss_pred             HCCCCCCCC
Confidence            999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.16  E-value=3.7e-11  Score=110.38  Aligned_cols=77  Identities=30%  Similarity=0.518  Sum_probs=59.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.....+||+|||++......     ......||+.|+|||++.+    .++.++||||+||++++|++|+.
T Consensus       157 ikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~~l~~l~~g~~  227 (290)
T 1t4h_A          157 LKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEY  227 (290)
T ss_dssp             CCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEECCCCCEEEeeCCCccccccc-----ccccccCCcCcCCHHHHhc----cCCCcchHHHHHHHHHHHHhCCC
Confidence            34679999754556999999999643321     1233579999999998853    24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       228 pf~~~~  233 (290)
T 1t4h_A          228 PYSECQ  233 (290)
T ss_dssp             TTTTCS
T ss_pred             CCCCcC
Confidence            998643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.16  E-value=2.4e-11  Score=119.82  Aligned_cols=83  Identities=25%  Similarity=0.324  Sum_probs=62.3

Q ss_pred             cCCccEEEe--cCCCceEEecCCcccccccccCC----CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        306 YARANIFLT--AEGNSLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       306 ~~~~nill~--~~~~~~ki~dfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      .++.|++++  .....+||+|||+++.+......    ........||+.|+|||++.+.   .++.++|||||||++||
T Consensus       129 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDvwSlGvil~e  205 (483)
T 3sv0_A          129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI---EQSRRDDLESLGYVLMY  205 (483)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHH
T ss_pred             cCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC---CCChHHHHHHHHHHHHH
Confidence            356799994  33345999999999866533221    1112246799999999998654   35789999999999999


Q ss_pred             HHhCCCCCCCCc
Q psy10603        380 MSSGKTNLSGVV  391 (407)
Q Consensus       380 ~~~g~~~~~~~~  391 (407)
                      |++|+.||.+..
T Consensus       206 lltG~~Pf~~~~  217 (483)
T 3sv0_A          206 FLRGSLPWQGLK  217 (483)
T ss_dssp             HHHSSCTTSSCC
T ss_pred             HHhCCCCCcccc
Confidence            999999999754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.16  E-value=1.6e-11  Score=116.21  Aligned_cols=82  Identities=20%  Similarity=0.336  Sum_probs=62.7

Q ss_pred             cCCccEEEecCC-CceEEecCCcccccccccCC----CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHH
Q psy10603        306 YARANIFLTAEG-NSLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM  380 (407)
Q Consensus       306 ~~~~nill~~~~-~~~ki~dfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~  380 (407)
                      .++.|++++.++ ..+||+|||+++.+......    ........||+.|+|||++.+.   .++.++||||+||+++||
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el  261 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC---GPSRRSDLQSLGYCMLKW  261 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC---CCCchhhHHHHHHHHHHH
Confidence            356799998765 15999999999765433211    1112345799999999998653   357899999999999999


Q ss_pred             HhCCCCCCCC
Q psy10603        381 SSGKTNLSGV  390 (407)
Q Consensus       381 ~~g~~~~~~~  390 (407)
                      ++|+.||.+.
T Consensus       262 ~~g~~pf~~~  271 (352)
T 2jii_A          262 LYGFLPWTNC  271 (352)
T ss_dssp             HHSCCTTGGG
T ss_pred             HhCCCCcccC
Confidence            9999999865

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.15  E-value=2.9e-11  Score=112.93  Aligned_cols=78  Identities=37%  Similarity=0.601  Sum_probs=61.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++......    ......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       146 lkp~Nili~~~~~-~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  217 (326)
T 1blx_A          146 LKPQNILVTSSGQ-IKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKP  217 (326)
T ss_dssp             CCGGGEEECTTCC-EEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHeEEcCCCC-EEEecCcccccccCCC----CccccccccceeCHHHHhcC---CCCcchhHHHHHHHHHHHHcCCC
Confidence            3467899987765 9999999997654322    12335789999999998654   24688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       218 pf~~~~  223 (326)
T 1blx_A          218 LFRGSS  223 (326)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.15  E-value=3.1e-11  Score=112.76  Aligned_cols=78  Identities=29%  Similarity=0.478  Sum_probs=61.2

Q ss_pred             cCCccEEEecCCC---ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~---~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|++++.++.   .+|++|||+++.......    .....||+.|+|||++.+.   .++.++||||+||+++||++
T Consensus       141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~  213 (321)
T 2a2a_A          141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVITYILLS  213 (321)
T ss_dssp             CSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC----CCCCCSCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHH
T ss_pred             CChHHEEEecCCCCcCCEEEccCccceecCcccc----ccccCCCCCccCcccccCC---CCCCccccHHHHHHHHHHHH
Confidence            3467888877663   599999999976543221    2335799999999998643   34689999999999999999


Q ss_pred             CCCCCCCC
Q psy10603        383 GKTNLSGV  390 (407)
Q Consensus       383 g~~~~~~~  390 (407)
                      |+.||.+.
T Consensus       214 g~~pf~~~  221 (321)
T 2a2a_A          214 GASPFLGD  221 (321)
T ss_dssp             SCCSSCCS
T ss_pred             CCCCCCCC
Confidence            99999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.15  E-value=1.6e-11  Score=114.83  Aligned_cols=77  Identities=27%  Similarity=0.413  Sum_probs=60.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......  .......||+.|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       160 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~  233 (326)
T 3uim_A          160 VKAANILLDEEFE-AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGK---SSEKTDVFGYGVMLLELITGQR  233 (326)
T ss_dssp             CSGGGEEECTTCC-EEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSE---ECHHHHHHHHHHHHHHHHHCCC
T ss_pred             CchhhEEECCCCC-EEeccCccccccCcccc--cccccccCCcCccCHHHhccCC---CCccccchhHHHHHHHHHhCCC
Confidence            3567999987765 99999999976543221  1123346999999999986543   4689999999999999999999


Q ss_pred             CCC
Q psy10603        386 NLS  388 (407)
Q Consensus       386 ~~~  388 (407)
                      ||.
T Consensus       234 pf~  236 (326)
T 3uim_A          234 AFD  236 (326)
T ss_dssp             SBC
T ss_pred             ccc
Confidence            995

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.15  E-value=2.1e-11  Score=115.44  Aligned_cols=78  Identities=24%  Similarity=0.455  Sum_probs=51.8

Q ss_pred             cCCccEEEec--CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~--~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.  ....+||+|||+++......    .....+||+.|+|||++.+.   .++.++||||+||+++||++|
T Consensus       174 ikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g  246 (349)
T 2w4o_A          174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEILRGC---AYGPEVDMWSVGIITYILLCG  246 (349)
T ss_dssp             CCGGGEEESSSSTTCCEEECCCC--------------------CGGGSCHHHHTTC---CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCcccEEEecCCCCCCEEEccCccccccCccc----ccccccCCCCccCHHHhcCC---CCCcccchHHHHHHHHHHHhC
Confidence            3567899974  23459999999997653321    12245799999999998653   357899999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       247 ~~pf~~~  253 (349)
T 2w4o_A          247 FEPFYDE  253 (349)
T ss_dssp             SCTTCCT
T ss_pred             CCCCCCC
Confidence            9999754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.15  E-value=3.1e-11  Score=119.50  Aligned_cols=77  Identities=30%  Similarity=0.514  Sum_probs=58.9

Q ss_pred             cCCccEEEecC--CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~--~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++..  ...+||+|||+++.+.....    ....+||+.|+|||++.+    .++.++||||+||++|+|++|
T Consensus       147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g  218 (486)
T 3mwu_A          147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSG  218 (486)
T ss_dssp             CSGGGEEESSSSTTCCEEECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS----CCCHHHHHHHHHHHHHHHHHS
T ss_pred             CchHHEEEecCCCCCCEEEEECCcCeECCCCCc----cCCCcCCCCCCCHHHhCC----CCCchhhHHHHHHHHHHHHhC
Confidence            35678898643  23599999999976543221    234579999999999864    257899999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      ++||.+.
T Consensus       219 ~~pf~~~  225 (486)
T 3mwu_A          219 TPPFYGK  225 (486)
T ss_dssp             SCSSCCS
T ss_pred             CCCCCCC
Confidence            9999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.15  E-value=3.2e-11  Score=113.04  Aligned_cols=64  Identities=38%  Similarity=0.643  Sum_probs=51.7

Q ss_pred             ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCCCCCCc
Q psy10603        319 SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVV  391 (407)
Q Consensus       319 ~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~~~~~~  391 (407)
                      .+||+|||+++.....      .....||+.|+|||++.+.   .++.++||||+||+++||++|+.||.+..
T Consensus       175 ~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          175 DIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             CEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTS---CCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             CceEeeCcccccCccc------cccccCCccccChHHhhCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            5999999999754321      1235799999999998653   35789999999999999999999998653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.15  E-value=2.5e-11  Score=114.92  Aligned_cols=77  Identities=38%  Similarity=0.623  Sum_probs=58.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.....      .....||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       152 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~--~~~~~~Di~slG~il~el~~g~~  222 (353)
T 3coi_A          152 LKPGNLAVNEDCE-LKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWM--HYNQTVDIWSVGCIMAEMLTGKT  222 (353)
T ss_dssp             CCGGGEEECTTCC-EEECSTTCTTC--------------CCSBCCSCHHHHSCCS--CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEeECCCCc-EEEeecccccCCCCC------ccccccCcCcCCHHHHhCcC--CCCchhhHHHHHHHHHHHHhCCC
Confidence            3467899987765 999999999754322      22357899999999986532  34678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       223 pf~~~~  228 (353)
T 3coi_A          223 LFKGKD  228 (353)
T ss_dssp             SSBSSC
T ss_pred             CCCCCC
Confidence            998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.15  E-value=2e-11  Score=114.03  Aligned_cols=78  Identities=32%  Similarity=0.535  Sum_probs=60.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.+...+||+|||+++......     .....||+.|+|||++.....  .+.++||||+||+++||++|+.
T Consensus       175 lkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~--~~~~~Di~slG~il~el~~g~~  247 (320)
T 3a99_A          175 IKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRY--HGRSAAVWSLGILLYDMVCGDI  247 (320)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCB--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEeCCCCCEEEeeCcccccccccc-----ccCCCCCccCCChHHhccCCC--CCccchHHhHHHHHHHHHHCCC
Confidence            356799998555569999999997654322     223469999999999865432  2578899999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       248 pf~~~  252 (320)
T 3a99_A          248 PFEHD  252 (320)
T ss_dssp             SCCSH
T ss_pred             CCCCh
Confidence            99864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.14  E-value=3.4e-11  Score=115.42  Aligned_cols=81  Identities=28%  Similarity=0.425  Sum_probs=62.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++........ .......+|+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       217 lkp~NIll~~~~~-~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          217 LAARNVLVTEDNV-MKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CCGGGEEECTTCC-EEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCcceEEEcCCCc-EEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCC---CCCchhHHHHHHHHHHHHHhCCC
Confidence            3567999988765 999999999765432221 112234678999999998653   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       292 ~p~~~~~  298 (382)
T 3tt0_A          292 SPYPGVP  298 (382)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.14  E-value=1.8e-11  Score=112.44  Aligned_cols=82  Identities=22%  Similarity=0.292  Sum_probs=61.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. ++|+|||+++................+|+.|+|||++.+..   ++.++||||+||+++||++ |+
T Consensus       136 lkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~  211 (287)
T 1u59_A          136 LAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQ  211 (287)
T ss_dssp             CSGGGEEEEETTE-EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CchheEEEcCCCC-EEECcccceeeeccCcceeeccccccccccccCHHHhccCC---CCchhhHHHHHHHHHHHHcCCC
Confidence            3567899987764 99999999986643322212222345789999999986432   4678999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       212 ~p~~~~~  218 (287)
T 1u59_A          212 KPYKKMK  218 (287)
T ss_dssp             CTTTTCC
T ss_pred             CCcccCC
Confidence            9998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.14  E-value=2.6e-11  Score=115.22  Aligned_cols=78  Identities=32%  Similarity=0.560  Sum_probs=54.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......    .....||+.|+|||++.+..  .++.++||||+||+++||++|+.
T Consensus       160 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~  232 (362)
T 3pg1_A          160 LHPGNILLADNND-ITICDFNLAREDTADAN----KTHYVTHRWYRAPELVMQFK--GFTKLVDMWSAGCVMAEMFNRKA  232 (362)
T ss_dssp             CCGGGEEECTTCC-EEECCTTC-------------------CGGGCCHHHHTTCT--TCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHHEEEcCCCC-EEEEecCcccccccccc----cceecccceecCcHHhcCCC--CCCcHhHHHhHHHHHHHHHhCCC
Confidence            3467899987765 99999999975432221    23357999999999986532  25688999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       233 pf~~~  237 (362)
T 3pg1_A          233 LFRGS  237 (362)
T ss_dssp             SCCCS
T ss_pred             CCCCC
Confidence            99874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.14  E-value=1.6e-11  Score=115.05  Aligned_cols=81  Identities=23%  Similarity=0.358  Sum_probs=55.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......... ......+|+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       143 ikp~NIl~~~~~~-~kL~DfG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~ell~~g~  217 (327)
T 3lzb_A          143 LAARNVLVKTPQH-VKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVTVWELMTFGS  217 (327)
T ss_dssp             CCGGGEEEEETTE-EEECCTTC-----------------CCCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCHHHEEEcCCCC-EEEccCcceeEccCccccc-cccCCCccccccCHHHHcCC---CCChHHHHHHHHHHHHHHHHCCC
Confidence            3567999988765 9999999997654332211 12234578899999998653   35689999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       218 ~p~~~~~  224 (327)
T 3lzb_A          218 KPYDGIP  224 (327)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCC
Confidence            9998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.14  E-value=1.8e-11  Score=112.83  Aligned_cols=80  Identities=25%  Similarity=0.359  Sum_probs=56.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++................+|..|+|||++.+.   .++.++||||+||+++||++|..
T Consensus       140 ikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~  215 (295)
T 3ugc_A          140 LATRNILVENENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES---KFSVASDVWSFGVVLYELFTYIE  215 (295)
T ss_dssp             CSGGGEEEEETTE-EEECCCCSCC-------------CTTCGGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCHhhEEEcCCCe-EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC---CCChHHHHHHHHHHHHHHHhccc
Confidence            3567999988765 9999999998664333222222334578889999998654   35789999999999999999999


Q ss_pred             CCCC
Q psy10603        386 NLSG  389 (407)
Q Consensus       386 ~~~~  389 (407)
                      +|..
T Consensus       216 ~~~~  219 (295)
T 3ugc_A          216 KSKS  219 (295)
T ss_dssp             TTCS
T ss_pred             ccCC
Confidence            8874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.14  E-value=2.4e-11  Score=113.89  Aligned_cols=78  Identities=27%  Similarity=0.475  Sum_probs=57.5

Q ss_pred             cCCccEEEec--CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~--~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.  ....+||+|||+++.......    .....||+.|+|||++...   .++.++||||+||+++||++|
T Consensus       157 ikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g  229 (327)
T 3lm5_A          157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNYD---PITTATDMWNIGIIAYMLLTH  229 (327)
T ss_dssp             CCGGGEEESCBTTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CChHHEEEecCCCCCcEEEeeCccccccCCccc----cccccCCcCccCCeeecCC---CCCchhhHHHHHHHHHHHHhC
Confidence            3467889876  233599999999986543221    2335799999999998643   356899999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       230 ~~pf~~~  236 (327)
T 3lm5_A          230 TSPFVGE  236 (327)
T ss_dssp             SCSSCCS
T ss_pred             CCCCCCC
Confidence            9999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.14  E-value=2e-11  Score=112.07  Aligned_cols=79  Identities=28%  Similarity=0.450  Sum_probs=51.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC-CcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. +||+|||+++.......    .....||+.|+|||++... ....++.++||||+||+++||++|+
T Consensus       136 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  210 (290)
T 3fme_A          136 VKPSNVLINALGQ-VKMCDFGISGYLVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR  210 (290)
T ss_dssp             CSGGGCEECTTCC-EEBCCC-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTS
T ss_pred             CCHHHEEECCCCC-EEEeecCCccccccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCC
Confidence            3467889987765 99999999976543221    2234699999999997321 1223568899999999999999999


Q ss_pred             CCCCC
Q psy10603        385 TNLSG  389 (407)
Q Consensus       385 ~~~~~  389 (407)
                      .||.+
T Consensus       211 ~p~~~  215 (290)
T 3fme_A          211 FPYDS  215 (290)
T ss_dssp             CSSCC
T ss_pred             CCccc
Confidence            99985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.13  E-value=2.8e-11  Score=118.04  Aligned_cols=85  Identities=29%  Similarity=0.504  Sum_probs=56.9

Q ss_pred             cCCccEEEecC------------CCceEEecCCcccccccccCC-CCcccccccccccccCcccccCC----cCCCCccc
Q psy10603        306 YARANIFLTAE------------GNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTN----KVGHGRAV  368 (407)
Q Consensus       306 ~~~~nill~~~------------~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~  368 (407)
                      .++.|++++..            ...+||+|||+++........ .......+||+.|+|||++.+..    ...++.++
T Consensus       141 Lkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~  220 (434)
T 2rio_A          141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI  220 (434)
T ss_dssp             CSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHH
T ss_pred             CChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhh
Confidence            35678888653            236999999999876543221 11223457999999999986521    12357899


Q ss_pred             hHHhHHHHHHHHHh-CCCCCCCC
Q psy10603        369 DIWSLGCVLVEMSS-GKTNLSGV  390 (407)
Q Consensus       369 Dvws~G~~~~e~~~-g~~~~~~~  390 (407)
                      ||||+||+++||++ |+.||.+.
T Consensus       221 DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          221 DIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTCST
T ss_pred             hhHhHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999 99999754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.13  E-value=4.3e-11  Score=109.72  Aligned_cols=78  Identities=23%  Similarity=0.406  Sum_probs=59.2

Q ss_pred             cCCccEEEecCCC----ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGN----SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~----~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++..+.    .+||+|||+++....      ......||+.|+|||++.... ..++.++||||+||+++||+
T Consensus       150 ikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~-~~~~~~~Di~slG~~l~~l~  222 (287)
T 4f0f_A          150 LRSPNIFLQSLDENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEE-ESYTEKADTYSFAMILYTIL  222 (287)
T ss_dssp             CSGGGEEESCCCTTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSS-CEECHHHHHHHHHHHHHHHH
T ss_pred             CCcceEEEeccCCCCceeEEeCCCCccccccc------cccccCCCccccCchhhccCC-CCcCchhhHHHHHHHHHHHH
Confidence            3567888876553    389999999975432      123357999999999984322 22467899999999999999


Q ss_pred             hCCCCCCCC
Q psy10603        382 SGKTNLSGV  390 (407)
Q Consensus       382 ~g~~~~~~~  390 (407)
                      +|+.||.+.
T Consensus       223 ~g~~pf~~~  231 (287)
T 4f0f_A          223 TGEGPFDEY  231 (287)
T ss_dssp             HSSCTTTTC
T ss_pred             cCCCCCccc
Confidence            999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.13  E-value=1.5e-11  Score=116.53  Aligned_cols=81  Identities=31%  Similarity=0.416  Sum_probs=61.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.+...... .......||+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       219 ikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~ellt~g~  293 (359)
T 3vhe_A          219 LAARNILLSEKNV-VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGA  293 (359)
T ss_dssp             CSGGGEEECGGGC-EEECCCGGGSCTTSCTTC-EEC--CEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             CChhhEEEcCCCc-EEEEeccceeeecccccc-hhccccCCCceeEChhhhcCC---CCCchhhhhhHHHHHHHHHhcCC
Confidence            3567999987765 999999999765432221 122345689999999998653   35689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       294 ~p~~~~~  300 (359)
T 3vhe_A          294 SPYPGVK  300 (359)
T ss_dssp             CSSTTCC
T ss_pred             CCCCccc
Confidence            9998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.13  E-value=9.5e-12  Score=116.86  Aligned_cols=81  Identities=26%  Similarity=0.421  Sum_probs=56.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-----CCCcccccccccccccCcccccCCc----CCCCccchHHhHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-----VPGELNGFVGTQAYMAPEVFMDTNK----VGHGRAVDIWSLGCV  376 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~Dvws~G~~  376 (407)
                      .++.|++++.++. +||+|||+++.+.....     ........+||+.|+|||++.+...    ..++.++||||+||+
T Consensus       146 ikp~Nill~~~~~-~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i  224 (336)
T 3g2f_A          146 LNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI  224 (336)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEcCCCc-EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence            3567999988765 99999999976543221     1111224579999999999864211    123467999999999


Q ss_pred             HHHHHhCCCCC
Q psy10603        377 LVEMSSGKTNL  387 (407)
Q Consensus       377 ~~e~~~g~~~~  387 (407)
                      ++||++|..+|
T Consensus       225 l~ell~g~~p~  235 (336)
T 3g2f_A          225 YWEIFMRCTDL  235 (336)
T ss_dssp             HHHHHTTBGGG
T ss_pred             HHHHHhcCCcC
Confidence            99999995554

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.13  E-value=3.4e-11  Score=119.45  Aligned_cols=78  Identities=26%  Similarity=0.505  Sum_probs=60.4

Q ss_pred             cCCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++..+  ..+||+|||+++.+.....    ....+||+.|+|||++..    .++.++||||+||++|+|++|
T Consensus       162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~----~~~~~~DiwslG~il~~ll~g  233 (494)
T 3lij_A          162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKK----MKERLGTAYYIAPEVLRK----KYDEKCDVWSIGVILFILLAG  233 (494)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEECBTTBC----BCCCCSCTTTCCHHHHTT----CBCTHHHHHHHHHHHHHHHHS
T ss_pred             CChhhEEEeCCCCCCcEEEEECCCCeECCCCcc----ccccCCCcCeeCHHHHcc----cCCCchhHHHHHHHHHHHHhC
Confidence            356788986543  3499999999976543222    234579999999999853    256899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      ++||.+..
T Consensus       234 ~~pf~~~~  241 (494)
T 3lij_A          234 YPPFGGQT  241 (494)
T ss_dssp             SCSSCCSS
T ss_pred             CCCCCCCC
Confidence            99998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.13  E-value=4e-11  Score=109.18  Aligned_cols=82  Identities=33%  Similarity=0.514  Sum_probs=61.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++++|||++..+...... .......||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       131 l~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~  206 (276)
T 2yex_A          131 IKPENLLLDERDN-LKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGEL  206 (276)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECEETTEE-CCBCCCCSCGGGCCGGGGTCSSB--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHHEEEccCCC-EEEeeCCCccccCCCcch-hcccCCccccCccChHHHhcCCC--CCCcchHHHHHHHHHHHHhCCC
Confidence            3457889987765 999999999765432211 11234579999999999865332  2568999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       207 p~~~~~  212 (276)
T 2yex_A          207 PWDQPS  212 (276)
T ss_dssp             CCSCSC
T ss_pred             CCCCCc
Confidence            998643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.13  E-value=2.1e-11  Score=113.97  Aligned_cols=82  Identities=32%  Similarity=0.558  Sum_probs=61.1

Q ss_pred             cCCccEEEecCCC--ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~--~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++.  .+||+|||+++......    ......||+.|+|||++.......++.++||||+||+++||++|
T Consensus       140 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g  215 (322)
T 2ycf_A          140 LKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG  215 (322)
T ss_dssp             CSGGGEEESSSSSSCCEEECCCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEecCCCCCeEEEccCccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence            3456888876543  49999999997653321    12235799999999998532223457899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       216 ~~pf~~~~  223 (322)
T 2ycf_A          216 YPPFSEHR  223 (322)
T ss_dssp             SCSSCSTT
T ss_pred             CCCCcccc
Confidence            99998643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.13  E-value=3e-11  Score=113.03  Aligned_cols=81  Identities=31%  Similarity=0.498  Sum_probs=44.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC-CcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-NKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. +||+|||+++.......    .....||+.|+|||++... ....++.++||||+||+++||++|+
T Consensus       152 lkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  226 (327)
T 3aln_A          152 IKPSNILLDRSGN-IKLCDFGISGQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR  226 (327)
T ss_dssp             CCGGGEEEETTTE-EEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSC
T ss_pred             CCHHHEEEcCCCC-EEEccCCCceecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC
Confidence            3567999987765 99999999976543221    1223699999999998421 1123467899999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       227 ~pf~~~~  233 (327)
T 3aln_A          227 FPYPKWN  233 (327)
T ss_dssp             CCSSCC-
T ss_pred             CCCCCcc
Confidence            9998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.13  E-value=1.9e-11  Score=114.06  Aligned_cols=78  Identities=24%  Similarity=0.531  Sum_probs=57.7

Q ss_pred             CCccEEE----ecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC-----CcCCCCccchHHhHHHHH
Q psy10603        307 ARANIFL----TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT-----NKVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       307 ~~~nill----~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Dvws~G~~~  377 (407)
                      ++.|+++    +..+ .+||+|||+++.......    .....||+.|+|||++...     ....++.++||||+||++
T Consensus       139 kp~NIll~~~~~~~~-~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il  213 (319)
T 4euu_A          139 KPGNIMRVIGEDGQS-VYKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF  213 (319)
T ss_dssp             SGGGEEEEECTTSCE-EEEECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred             CHHHEEEeccCCCCc-eEEEccCCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence            4568877    3333 499999999976543322    2335799999999998521     112356889999999999


Q ss_pred             HHHHhCCCCCCC
Q psy10603        378 VEMSSGKTNLSG  389 (407)
Q Consensus       378 ~e~~~g~~~~~~  389 (407)
                      +||++|+.||.+
T Consensus       214 ~el~~g~~pf~~  225 (319)
T 4euu_A          214 YHAATGSLPFRP  225 (319)
T ss_dssp             HHHHHSSCSEEC
T ss_pred             HHHHhCCCCCCC
Confidence            999999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.13  E-value=2e-11  Score=124.19  Aligned_cols=81  Identities=22%  Similarity=0.288  Sum_probs=57.5

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. +||+|||+++.+..............+|..|+|||++...   .++.++|||||||+++||++ |+.
T Consensus       463 kp~NILl~~~~~-vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~---~~~~~sDvwSlGv~l~ellt~G~~  538 (613)
T 2ozo_A          463 AARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQK  538 (613)
T ss_dssp             SGGGEEEEETTE-EEECCCSTTTTCC--------------CCTTSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CHHHEEEcCCCc-EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC---CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            468999988765 9999999998764332221112223467899999998643   35789999999999999998 999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       539 Pf~~~~  544 (613)
T 2ozo_A          539 PYKKMK  544 (613)
T ss_dssp             TTTTCC
T ss_pred             CCCCCC
Confidence            999754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.13  E-value=2.4e-11  Score=115.74  Aligned_cols=77  Identities=25%  Similarity=0.484  Sum_probs=57.1

Q ss_pred             cCCccEEEecCC-----CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHH
Q psy10603        306 YARANIFLTAEG-----NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM  380 (407)
Q Consensus       306 ~~~~nill~~~~-----~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~  380 (407)
                      .++.|++++..+     ..+||+|||+++.....      .....||+.|+|||++.+..   ++.++||||+||+++||
T Consensus       158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~el  228 (373)
T 1q8y_A          158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAP---WGCGADIWSTACLIFEL  228 (373)
T ss_dssp             CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCC---CCTHHHHHHHHHHHHHH
T ss_pred             CChHHeEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCC---CCchHhHHHHHHHHHHH
Confidence            346788885332     25999999999765432      12347999999999987542   46899999999999999


Q ss_pred             HhCCCCCCCCc
Q psy10603        381 SSGKTNLSGVV  391 (407)
Q Consensus       381 ~~g~~~~~~~~  391 (407)
                      ++|+.||.+..
T Consensus       229 ~~g~~pf~~~~  239 (373)
T 1q8y_A          229 ITGDFLFEPDE  239 (373)
T ss_dssp             HHSSCCC----
T ss_pred             HhCCCCCCCCc
Confidence            99999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.12  E-value=4.8e-11  Score=108.82  Aligned_cols=75  Identities=28%  Similarity=0.478  Sum_probs=58.4

Q ss_pred             CCccEEE---ecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        307 ARANIFL---TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       307 ~~~nill---~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      ++.|+++   +.++ .++++|||++..+.....    .....||+.|+|||++.+.    ++.++||||+||+++||++|
T Consensus       133 kp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~----~~~~~Di~slG~~l~~l~~g  203 (277)
T 3f3z_A          133 KPENFLFLTDSPDS-PLKLIDFGLAARFKPGKM----MRTKVGTPYYVSPQVLEGL----YGPECDEWSAGVMMYVLLCG  203 (277)
T ss_dssp             SGGGEEESSSSTTC-CEEECCCTTCEECCTTSC----BCCCCSCTTTCCHHHHTTC----BCTTHHHHHHHHHHHHHHHS
T ss_pred             CHHHEEEecCCCCC-cEEEEecccceeccCccc----hhccCCCCCccChHHhccc----CCchhhehhHHHHHHHHHHC
Confidence            4568888   4444 599999999976543222    2345799999999998542    46789999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       204 ~~p~~~~  210 (277)
T 3f3z_A          204 YPPFSAP  210 (277)
T ss_dssp             SCSSCCS
T ss_pred             CCCCCCC
Confidence            9999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.12  E-value=2.5e-11  Score=113.37  Aligned_cols=81  Identities=22%  Similarity=0.306  Sum_probs=54.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......... ......+|+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       163 ikp~NIli~~~~~-~kl~Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ell~~g~  237 (323)
T 3qup_A          163 LAARNCMLAEDMT-VCVADFGLSRKIYSGDYYR-QGCASKLPVKWLALESLADN---LYTVHSDVWAFGVTMWEIMTRGQ  237 (323)
T ss_dssp             CSGGGEEECTTSC-EEECCCCC------------------CCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCcceEEEcCCCC-EEEeecccccccccccccc-ccccccCcccccCchhhcCC---CCCCccchhhHHHHHHHHHhCCC
Confidence            3567999987765 9999999997654322211 12233578899999998653   35689999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       238 ~p~~~~~  244 (323)
T 3qup_A          238 TPYAGIE  244 (323)
T ss_dssp             CTTTTCC
T ss_pred             CCccccC
Confidence            9998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.12  E-value=4.3e-11  Score=109.21  Aligned_cols=79  Identities=29%  Similarity=0.596  Sum_probs=43.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||++........   ......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       138 l~p~Nili~~~~~-~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  210 (278)
T 3cok_A          138 LTLSNLLLTRNMN-IKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRS---AHGLESDVWSLGCMFYTLLIGRP  210 (278)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECC----------------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEEeecceeeccCCCC---cceeccCCCCcCCcchhcCC---CCCchhhHHHHHHHHHHHHhCCC
Confidence            3467889987765 99999999976543221   12235799999999998643   24678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       211 p~~~~~  216 (278)
T 3cok_A          211 PFDTDT  216 (278)
T ss_dssp             SSCCCS
T ss_pred             CCCChh
Confidence            998644

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=5.6e-11  Score=110.22  Aligned_cols=185  Identities=18%  Similarity=0.222  Sum_probs=118.6

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCC--cceEEEEEEeCc---eEEEEEe
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKN--LVKYYGVEIHRE---EMVLFME   82 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~E   82 (407)
                      .++.|....||++.     ..+++|+....     .....+.+|..+|+.+. +..  +.+.+......+   ..|+|||
T Consensus        27 ~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             EEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             ecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            57889999999863     45888875321     33456788999998773 322  344544433332   3589999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-----------------------------------------  121 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-----------------------------------------  121 (407)
                      +++|.++......   .++.++...++.|++..|..||+                                         
T Consensus        97 ~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           97 KIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             ccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999888653321   26777778888888888888885                                         


Q ss_pred             -----------------CCceecCCCCCCEEEecC-CCeEEEEcccCceecCCCCCCCCcccc-----------cccCCc
Q psy10603        122 -----------------NTIVHRDIKSANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGELNG-----------FVGTQA  172 (407)
Q Consensus       122 -----------------~~iiHrdlKp~Nill~~~-~~~vkl~DFGla~~~~~~~~~~~~~~~-----------~~gt~~  172 (407)
                                       ..++|+|++|.||+++++ +..+.|+||+.+..-............           +....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             137999999999999874 456789999988653221110000000           000001


Q ss_pred             ccc-cccccccccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q psy10603        173 YMA-PEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWA  211 (407)
Q Consensus       173 y~a-PE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~  211 (407)
                      ... |+.....     ....+.|+++.++|.+.+|..+|.
T Consensus       254 ~~~~~~~~~r~-----~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          254 HKDIPTVLEKY-----RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CSCHHHHHHHH-----HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCcHHHHHHH-----HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            111 2222110     123689999999999999988874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.12  E-value=5.3e-11  Score=111.63  Aligned_cols=77  Identities=31%  Similarity=0.433  Sum_probs=53.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCcCCC---CccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGH---GRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~---~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++.++. +||+|||+++.+...... ........||+.|+|||++.+......   +.++||||+||+++||+
T Consensus       168 ikp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~  246 (337)
T 3mdy_A          168 LKSKNILVKKNGT-CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA  246 (337)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred             cchHHEEECCCCC-EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence            4567999987775 999999999765432221 111224579999999999865432110   01389999999999999


Q ss_pred             hC
Q psy10603        382 SG  383 (407)
Q Consensus       382 ~g  383 (407)
                      +|
T Consensus       247 tg  248 (337)
T 3mdy_A          247 RR  248 (337)
T ss_dssp             TT
T ss_pred             hc
Confidence            99

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.11  E-value=2.7e-11  Score=115.00  Aligned_cols=77  Identities=36%  Similarity=0.606  Sum_probs=59.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++.......     .....||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       158 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  228 (360)
T 3eqc_A          158 VKPSNILVNSRGE-IKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAVGRY  228 (360)
T ss_dssp             CSGGGEEECTTCC-EEECCCCCCHHHHHHC---------CCCCTTCCHHHHTTC---CCSHHHHHHHHHHHHHHHHHTSC
T ss_pred             ccHHHEEECCCCC-EEEEECCCCccccccc-----ccCCCCCCCeECHHHHcCC---CCCchhhHHHHHHHHHHHHhCCC
Confidence            3567999988775 9999999997553221     1234799999999998653   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       229 pf~~~~  234 (360)
T 3eqc_A          229 PIPPPD  234 (360)
T ss_dssp             CSSCCC
T ss_pred             CCCCCC
Confidence            998643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.11  E-value=1.8e-11  Score=125.00  Aligned_cols=81  Identities=23%  Similarity=0.327  Sum_probs=58.0

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. +||+|||+++.+..............+|..|+|||++...   .++.++||||+||+++||++ |+.
T Consensus       496 kp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~---~~~~~sDvwSlGv~l~ellt~G~~  571 (635)
T 4fl3_A          496 AARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQK  571 (635)
T ss_dssp             SGGGEEEEETTE-EEECCTTHHHHTTC-------------CGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ChHhEEEeCCCC-EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC---CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            468999988775 9999999998665433222222234578899999999643   35789999999999999998 999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       572 Pf~~~~  577 (635)
T 4fl3_A          572 PYRGMK  577 (635)
T ss_dssp             SSTTCC
T ss_pred             CCCCCC
Confidence            998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.11  E-value=2.5e-11  Score=120.09  Aligned_cols=78  Identities=27%  Similarity=0.521  Sum_probs=60.2

Q ss_pred             cCCccEEEec--CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~--~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.  ....+||+|||+++.+....    .....+||+.|+|||++.+    .++.++||||+||++|+|++|
T Consensus       152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g  223 (484)
T 3nyv_A          152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG----TYDEKCDVWSTGVILYILLSG  223 (484)
T ss_dssp             CCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT----CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEEecCCCCCcEEEEeeeeeEEccccc----ccccCCCCccccCceeecC----CCCCcceeHHHHHHHHHHHHC
Confidence            3467888852  23459999999997654322    2234579999999999864    256899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      ++||.+..
T Consensus       224 ~~pf~~~~  231 (484)
T 3nyv_A          224 CPPFNGAN  231 (484)
T ss_dssp             SCSSCCSS
T ss_pred             CCCCCCCC
Confidence            99998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.11  E-value=5e-11  Score=118.57  Aligned_cols=78  Identities=28%  Similarity=0.480  Sum_probs=61.5

Q ss_pred             cCCccEEEecCCC--ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGN--SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~--~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++..+.  .+||+|||++..+....    .....+||+.|+|||++..    .++.++||||+||++++|++|
T Consensus       172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g  243 (504)
T 3q5i_A          172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCG  243 (504)
T ss_dssp             CSGGGEEESSTTCCSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT----CBCTHHHHHHHHHHHHHHHHS
T ss_pred             CcHHHEEEecCCCCccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc----CCCchHHHHHHHHHHHHHHhC
Confidence            3567999987653  59999999997654322    1234579999999999853    246899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      ++||.+..
T Consensus       244 ~~pf~~~~  251 (504)
T 3q5i_A          244 YPPFGGQN  251 (504)
T ss_dssp             SCSSCCSS
T ss_pred             CCCCCCCC
Confidence            99998753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.11  E-value=3.7e-11  Score=112.92  Aligned_cols=82  Identities=23%  Similarity=0.304  Sum_probs=54.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++................+|..|+|||++...   .++.++||||+||+++||++ |+
T Consensus       173 ikp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ellt~g~  248 (333)
T 1mqb_A          173 LAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGE  248 (333)
T ss_dssp             CCGGGEEECTTCC-EEECCCCC-----------------CCCGGGSCHHHHHSC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CChheEEECCCCc-EEECCCCcchhhccccccccccCCCCccccccCchhcccC---CCCchhhhHHHHHHHHHHHcCCC
Confidence            3467899987765 9999999997654332211112233568889999998643   34688999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       249 ~pf~~~~  255 (333)
T 1mqb_A          249 RPYWELS  255 (333)
T ss_dssp             CTTTTCC
T ss_pred             CCcccCC
Confidence            9998653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.11  E-value=1.8e-11  Score=116.73  Aligned_cols=82  Identities=30%  Similarity=0.392  Sum_probs=61.1

Q ss_pred             cCCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-
Q psy10603        306 YARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-  382 (407)
Q Consensus       306 ~~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-  382 (407)
                      .++.|++++.++  ..+||+|||+++.+...... .......||+.|+|||++.+.   .++.++||||+||+++||++ 
T Consensus       207 lkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---~~~~~~DvwslG~il~ellt~  282 (367)
T 3l9p_A          207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSL  282 (367)
T ss_dssp             CCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CChhhEEEecCCCCceEEECCCcccccccccccc-ccCCCcCCcccEECHHHhcCC---CCCcHHHHHHHHHHHHHHHhC
Confidence            356799998543  35999999999755332221 112335689999999998654   35789999999999999998 


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |+.||.+..
T Consensus       283 g~~pf~~~~  291 (367)
T 3l9p_A          283 GYMPYPSKS  291 (367)
T ss_dssp             SCCSSTTCC
T ss_pred             CCCCCCCCC
Confidence            999998653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.11  E-value=2.4e-11  Score=111.16  Aligned_cols=80  Identities=26%  Similarity=0.378  Sum_probs=51.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++........  ......+|+.|+|||++...   .++.++||||+||+++||++ |+
T Consensus       142 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~ell~~g~  215 (281)
T 1mp8_A          142 IAARNVLVSSNDC-VKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGV  215 (281)
T ss_dssp             CSGGGEEEEETTE-EEECC---------------------CCGGGCCHHHHHHC---CCSHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccHHHEEECCCCC-EEECccccccccCccccc--ccccCCCcccccChhhcccC---CCCCccCchHHHHHHHHHHhcCC
Confidence            3567999987764 999999999765432211  12233578899999998643   35689999999999999996 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       216 ~pf~~~~  222 (281)
T 1mp8_A          216 KPFQGVK  222 (281)
T ss_dssp             CTTTTCC
T ss_pred             CCCCcCC
Confidence            9998754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.11  E-value=6.4e-11  Score=108.45  Aligned_cols=76  Identities=26%  Similarity=0.513  Sum_probs=60.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++++|||++.......     .....||+.|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       140 l~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~  210 (284)
T 2vgo_A          140 IKPENLLMGYKGE-LKIADFGWSVHAPSLR-----RRTMCGTLDYLPPEMIEGKT---HDEKVDLWCAGVLCYEFLVGMP  210 (284)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECSSSC-----BCCCCSCGGGCCHHHHTTCC---BCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHEEEcCCCC-EEEecccccccCcccc-----cccccCCCCcCCHHHhccCC---CCcccchhhHHHHHHHHHHCCC
Confidence            3457899987765 9999999996543211     22357999999999986532   4678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       211 pf~~~  215 (284)
T 2vgo_A          211 PFDSP  215 (284)
T ss_dssp             TTCCS
T ss_pred             CCCCC
Confidence            99864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.11  E-value=4.4e-11  Score=109.71  Aligned_cols=77  Identities=31%  Similarity=0.468  Sum_probs=55.5

Q ss_pred             CCccEEEecC--CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~~~--~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      ++.|++++..  ...+||+|||+++.+.....    .....||+.|+|||++..    .++.++||||+||+++||++|+
T Consensus       151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~----~~~~~~Di~slG~il~~ll~g~  222 (285)
T 3is5_A          151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEH----STNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGC  222 (285)
T ss_dssp             SGGGEEESSSSTTCCEEECCCCCCCC--------------CTTGGGCCHHHHTT----CCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CHHHEEEecCCCCCCEEEEeeecceecCCccc----CcCcccccCcCChHHhcc----CCCcccCeehHHHHHHHHHhCC
Confidence            4568888532  24599999999976543221    223579999999999853    2468999999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       223 ~pf~~~~  229 (285)
T 3is5_A          223 LPFTGTS  229 (285)
T ss_dssp             CSSCCSS
T ss_pred             CCCCCCC
Confidence            9998753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.11  E-value=2.9e-11  Score=115.52  Aligned_cols=81  Identities=25%  Similarity=0.308  Sum_probs=49.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++................+|..|+|||++...   .++.++||||+||+++||++ |+
T Consensus       173 lkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~SlG~il~ellt~g~  248 (373)
T 2qol_A          173 LAARNILINSNLV-CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR---KFTSASDVWSYGIVLWEVMSYGE  248 (373)
T ss_dssp             CCGGGEEECTTCC-EEECCC----------------------CTTSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTC-
T ss_pred             CCcceEEEcCCCC-EEECcCccccccccCCccceeccCCCcCCCccChhhhccC---CcCchhcHHHHHHHHHHHHhCCC
Confidence            3567999987765 9999999997654332211112223467889999998653   35689999999999999998 99


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       249 ~P~~~~  254 (373)
T 2qol_A          249 RPYWEM  254 (373)
T ss_dssp             CTTTTC
T ss_pred             CCCCCC
Confidence            999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.10  E-value=6.5e-11  Score=109.95  Aligned_cols=80  Identities=34%  Similarity=0.469  Sum_probs=53.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++........  .......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       160 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  233 (309)
T 2h34_A          160 VKPENILVSADDF-AYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSES---HATYRADIYALTCVLYECLTGSP  233 (309)
T ss_dssp             CCGGGEEECTTSC-EEECSCCC------------------CCGGGCCGGGTCC-------CCCHHHHHHHHHHHHHHSSC
T ss_pred             CChHHEEEcCCCC-EEEecCccCcccccccc--ccccccCCCcCccCHHHHcCC---CCCchHhHHHHHHHHHHHHHCCC
Confidence            3467899987765 99999999976543221  112345799999999998653   34678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       234 pf~~~~  239 (309)
T 2h34_A          234 PYQGDQ  239 (309)
T ss_dssp             SSCSCH
T ss_pred             CCCCch
Confidence            998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.10  E-value=5.1e-11  Score=111.35  Aligned_cols=82  Identities=32%  Similarity=0.529  Sum_probs=55.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCC--cCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +||+|||++........   ......||+.|+|||++....  ...++.++||||+||+++||++|
T Consensus       155 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  230 (326)
T 2x7f_A          155 IKGQNVLLTENAE-VKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG  230 (326)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred             CcHHHEEEcCCCC-EEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence            3567899987665 99999999976542211   123457999999999986311  22356789999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       231 ~~p~~~~~  238 (326)
T 2x7f_A          231 APPLCDMH  238 (326)
T ss_dssp             SCTTTTSC
T ss_pred             CCCCCCCc
Confidence            99998653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.10  E-value=5.7e-11  Score=108.50  Aligned_cols=76  Identities=32%  Similarity=0.576  Sum_probs=57.4

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. ++|+|||++.......     .....||+.|+|||++.+.   .++.++||||+||+++||++|+.|
T Consensus       136 kp~Nili~~~~~-~~l~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~p  206 (279)
T 3fdn_A          136 KPENLLLGSAGE-LKIADFGWSVHAPSSR-----RTDLCGTLDYLPPEMIEGR---MHDEKVDLWSLGVLCYEFLVGKPP  206 (279)
T ss_dssp             CGGGEEECTTSC-EEECSCCEESCC-------------CCCCTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             ChHhEEEcCCCC-EEEEeccccccCCccc-----ccccCCCCCccCHhHhccC---CCCccchhHhHHHHHHHHHHCCCC
Confidence            467899987775 9999999986543221     2234799999999998643   346789999999999999999999


Q ss_pred             CCCCc
Q psy10603        387 LSGVV  391 (407)
Q Consensus       387 ~~~~~  391 (407)
                      |.+..
T Consensus       207 ~~~~~  211 (279)
T 3fdn_A          207 FEANT  211 (279)
T ss_dssp             TCCSS
T ss_pred             CCCCc
Confidence            98643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.10  E-value=6.7e-11  Score=108.21  Aligned_cols=77  Identities=30%  Similarity=0.600  Sum_probs=59.5

Q ss_pred             CCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      ++.|++++.++  ..+||+|||++........    .....||+.|+|||++.+.   .++.++||||+||++++|++|+
T Consensus       132 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~  204 (284)
T 3kk8_A          132 KPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WHGFAGTPGYLSPEVLKKD---PYSKPVDIWACGVILYILLVGY  204 (284)
T ss_dssp             CGGGEEESSSSTTCCEEECCCTTCEECCSSCB----CCCSCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSS
T ss_pred             CHHHEEEecCCCCCcEEEeeceeeEEcccCcc----ccCCCCCcCCcCchhhcCC---CCCcccchHHHHHHHHHHHHCC
Confidence            45688886543  3499999999976543222    2335799999999998653   2468899999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       205 ~pf~~~  210 (284)
T 3kk8_A          205 PPFWDE  210 (284)
T ss_dssp             CSSCCS
T ss_pred             CCCCCC
Confidence            999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.10  E-value=2.9e-11  Score=114.00  Aligned_cols=82  Identities=28%  Similarity=0.365  Sum_probs=62.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||++......... .......||+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       198 ikp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          198 LAARNVLVTHGKV-VKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             CSGGGEEEETTTE-EEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             CChhhEEEcCCCc-EEeCCCccCcccccCccc-eeccCccCccCccCHHHhccC---CCChhHhHHHHHHHHHHHHcCCC
Confidence            4567999987764 999999999765432221 112234678899999998653   35689999999999999998 99


Q ss_pred             CCCCCCce
Q psy10603        385 TNLSGVVV  392 (407)
Q Consensus       385 ~~~~~~~~  392 (407)
                      .||.+...
T Consensus       273 ~p~~~~~~  280 (344)
T 1rjb_A          273 NPYPGIPV  280 (344)
T ss_dssp             CSSTTCCC
T ss_pred             CCcccCCc
Confidence            99987643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.10  E-value=7.4e-11  Score=109.10  Aligned_cols=79  Identities=37%  Similarity=0.623  Sum_probs=61.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++|+|||++........   ......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       145 l~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  217 (303)
T 3a7i_A          145 IKAANVLLSEHGE-VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQS---AYDSKADIWSLGITAIELARGEP  217 (303)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECBTTBC---CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChheEEECCCCC-EEEeecccceecCcccc---ccCccCCCcCccCHHHHhcC---CCCchhhhHHHHHHHHHHccCCC
Confidence            3457889987765 99999999976543221   12345799999999998653   24678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       218 p~~~~~  223 (303)
T 3a7i_A          218 PHSELH  223 (303)
T ss_dssp             TTTTSC
T ss_pred             CCCCcC
Confidence            998653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.10  E-value=3.9e-11  Score=109.00  Aligned_cols=77  Identities=31%  Similarity=0.532  Sum_probs=53.7

Q ss_pred             CCccEEEecC-------CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        307 ARANIFLTAE-------GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       307 ~~~nill~~~-------~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      ++.|++++..       ...+|++|||+++.......     ....||+.|+|||++.+.   .++.++||||+||+++|
T Consensus       135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~  206 (271)
T 3dtc_A          135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRAS---MFSKGSDVWSYGVLLWE  206 (271)
T ss_dssp             SGGGEEESSCCSSSCCSSCCEEECCCCC------------------CCGGGSCHHHHHHC---CCSHHHHHHHHHHHHHH
T ss_pred             chHHEEEecccccccccCcceEEccCCcccccccccc-----cCCCCccceeCHHHhccC---CCCchhhHHHHHHHHHH
Confidence            4568888752       34599999999976543221     234699999999998653   35789999999999999


Q ss_pred             HHhCCCCCCCCc
Q psy10603        380 MSSGKTNLSGVV  391 (407)
Q Consensus       380 ~~~g~~~~~~~~  391 (407)
                      |++|+.||.+..
T Consensus       207 l~~g~~p~~~~~  218 (271)
T 3dtc_A          207 LLTGEVPFRGID  218 (271)
T ss_dssp             HHHCCCTTTTSC
T ss_pred             HHhCCCCCCCCC
Confidence            999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.10  E-value=8.4e-11  Score=109.25  Aligned_cols=79  Identities=38%  Similarity=0.642  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++|+|||++........   ......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       151 l~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  223 (314)
T 3com_A          151 IKAGNILLNTEGH-AKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEI---GYNCVADIWSLGITAIEMAEGKP  223 (314)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECBTTBS---CBCCCCSCGGGCCHHHHSSS---CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEECCCCC-EEEeecccchhhhhhcc---ccCccCCCCCccChhhcCCC---CCCccccHHHHHHHHHHHHhCCC
Confidence            3457889987765 99999999976543221   12335799999999998653   34678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       224 p~~~~~  229 (314)
T 3com_A          224 PYADIH  229 (314)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.09  E-value=3.8e-11  Score=114.65  Aligned_cols=82  Identities=24%  Similarity=0.312  Sum_probs=52.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-C
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-G  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g  383 (407)
                      .++.|++++.++. +||+|||+++.+...... ........+|+.|+|||++.+.   .++.++||||+||+++||++ |
T Consensus       218 lkp~NIll~~~~~-~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwSlG~il~ellt~~  293 (373)
T 3c1x_A          218 LAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRG  293 (373)
T ss_dssp             CCGGGEEECTTCC-EEECCC---------------------CCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cchheEEECCCCC-EEEeeccccccccccccccccccCCCCCcccccChHHhcCC---CCCcHHHHHHHHHHHHHHHhCc
Confidence            3567999987765 999999999765432211 1112234578899999998653   35689999999999999999 7


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      .++|.+..
T Consensus       294 ~~p~~~~~  301 (373)
T 3c1x_A          294 APPYPDVN  301 (373)
T ss_dssp             CCSCTTSC
T ss_pred             CCCCCCCC
Confidence            88888653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.09  E-value=2.7e-11  Score=111.38  Aligned_cols=82  Identities=23%  Similarity=0.331  Sum_probs=59.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+++................+|..|+|||++....   ++.++||||+||+++||++ |+
T Consensus       143 ikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~  218 (291)
T 1xbb_A          143 LAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQ  218 (291)
T ss_dssp             CSGGGEEEEETTE-EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCcceEEEeCCCc-EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC---CChhhhHHHHHHHHHHHHhcCC
Confidence            3567899987764 99999999976543322111122234678899999986432   4678999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       219 ~p~~~~~  225 (291)
T 1xbb_A          219 KPYRGMK  225 (291)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.09  E-value=8e-11  Score=110.69  Aligned_cols=78  Identities=33%  Similarity=0.651  Sum_probs=61.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++........   ......||+.|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       167 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~  239 (335)
T 2owb_A          167 LKLGNLFLNEDLE-VKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKG---HSFEVDVWSIGCIMYTLLVGKP  239 (335)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHHTSC---BCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCchhEEEcCCCC-EEEeeccCceecccCcc---cccccCCCccccCHHHhccCC---CCchhhHHHHHHHHHHHHHCcC
Confidence            3457899987765 99999999976542221   123357999999999986532   4678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      +|.+.
T Consensus       240 pf~~~  244 (335)
T 2owb_A          240 PFETS  244 (335)
T ss_dssp             TTCCS
T ss_pred             CCCCC
Confidence            99864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.09  E-value=4e-11  Score=111.32  Aligned_cols=81  Identities=23%  Similarity=0.373  Sum_probs=61.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......... ......+|+.|+|||++.+..   ++.++||||+||+++||++ |+
T Consensus       176 ikp~NIli~~~~~-~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          176 LAARNILVAEGRK-MKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHI---YTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             CSGGGEEEETTTE-EEECCCTTCEECTTTSCEE-CSSCCCSCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             cchheEEEcCCCC-EEEccccccccccccccce-eccCCCCcccccChhhhcCCC---cCchhhHHHHHHHHHHHHhCCC
Confidence            4567999987765 9999999997654322211 122345788999999986532   4688999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       251 ~p~~~~~  257 (314)
T 2ivs_A          251 NPYPGIP  257 (314)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.09  E-value=3.5e-11  Score=111.99  Aligned_cols=86  Identities=28%  Similarity=0.384  Sum_probs=56.6

Q ss_pred             cCCccEEEecCCC--ceEEecCCcccccccccC----CCCcccccccccccccCcccccCC--cCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGN--SLKLGDFGSAVKISAHTT----VPGELNGFVGTQAYMAPEVFMDTN--KVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~--~~ki~dfGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++.++.  .+||+|||+++.......    ........+||+.|+|||++....  ...++.++||||+||++
T Consensus       137 lkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il  216 (316)
T 2ac3_A          137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL  216 (316)
T ss_dssp             CCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred             CCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence            3467889976553  399999999976532211    011122346999999999986411  01235789999999999


Q ss_pred             HHHHhCCCCCCCCc
Q psy10603        378 VEMSSGKTNLSGVV  391 (407)
Q Consensus       378 ~e~~~g~~~~~~~~  391 (407)
                      +||++|+.||.+..
T Consensus       217 ~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          217 YILLSGYPPFVGRC  230 (316)
T ss_dssp             HHHHHSSCSCCCCC
T ss_pred             HHHHHCCCCCcccc
Confidence            99999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.09  E-value=3.6e-11  Score=117.97  Aligned_cols=80  Identities=28%  Similarity=0.395  Sum_probs=61.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.........  .....+|..|+|||++...   .++.++|||||||+++||++ |+
T Consensus       310 lkp~Nill~~~~~-~kl~DFG~a~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~t~g~  383 (454)
T 1qcf_A          310 LRAANILVSASLV-CKIADFGLARVIEDNEYTA--REGAKFPIKWTAPEAINFG---SFTIKSDVWSFGILLMEIVTYGR  383 (454)
T ss_dssp             CSGGGEEECTTCC-EEECSTTGGGGBCCHHHHT--TCSSSSCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCHHHEEECCCCc-EEEeeCCCceEcCCCceec--cCCCcccccccCHHHhccC---CCCcHHHHHhHHHHHHHHHhCCC
Confidence            3568999988765 9999999997654322111  1223467889999998643   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       384 ~P~~~~~  390 (454)
T 1qcf_A          384 IPYPGMS  390 (454)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.09  E-value=8.7e-11  Score=108.12  Aligned_cols=78  Identities=35%  Similarity=0.677  Sum_probs=60.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||++........   ......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       141 l~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~  213 (294)
T 2rku_A          141 LKLGNLFLNEDLE-VKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKK---GHSFEVDVWSIGCIMYTLLVGKP  213 (294)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHTTS---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CChHhEEEcCCCC-EEEEeccCceecccCcc---ccccccCCCCcCCcchhccC---CCCchhhHHHHHHHHHHHHhCCC
Confidence            3456889987765 99999999976542221   12335799999999998653   24678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       214 p~~~~  218 (294)
T 2rku_A          214 PFETS  218 (294)
T ss_dssp             TTCCS
T ss_pred             CCCCC
Confidence            99864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.09  E-value=2.8e-11  Score=111.14  Aligned_cols=82  Identities=26%  Similarity=0.354  Sum_probs=59.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+++................+|..|+|||++.+..   ++.++||||+||+++||++ |+
T Consensus       147 ikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~  222 (291)
T 1u46_A          147 LAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQ  222 (291)
T ss_dssp             CCGGGEEEEETTE-EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTSC
T ss_pred             CchheEEEcCCCC-EEEccccccccccccccchhhhccCCCCceeeCchhhcCCC---CCchhhHHHHHHHHHHHHhCCC
Confidence            3567899987764 99999999976543322111122345788899999986532   4678999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       223 ~p~~~~~  229 (291)
T 1u46_A          223 EPWIGLN  229 (291)
T ss_dssp             CTTTTCC
T ss_pred             CCcccCC
Confidence            9998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.09  E-value=4e-11  Score=111.41  Aligned_cols=81  Identities=31%  Similarity=0.416  Sum_probs=61.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+++........ .......||+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       174 ikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          174 LAARNILLSEKNV-VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             CSGGGEEECGGGC-EEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CccceEEECCCCC-EEECCCccccccccCccc-eeccCCCcceeecCchhhccc---cccchhHHHHHHHHHHHHHhCCC
Confidence            3567899987765 999999999765432221 112334688999999998653   34689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       249 ~p~~~~~  255 (316)
T 2xir_A          249 SPYPGVK  255 (316)
T ss_dssp             CSSTTCC
T ss_pred             CCCcccc
Confidence            9998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.09  E-value=5.6e-11  Score=110.08  Aligned_cols=79  Identities=33%  Similarity=0.427  Sum_probs=60.0

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. +|++|||+++........ .......||+.|+|||++.+.    ++.++||||+||+++||++|++|
T Consensus       160 kp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          160 KSANILLDEAFT-AKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRGE----ITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             CGGGEEECTTCC-EEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTTE----ECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             CHHHEEEcCCCc-EEEeeccccccccccccc-ccccccCCCcCcCChHHhcCC----CCccchhHHHHHHHHHHHHCCCC
Confidence            457899987665 999999999765432211 112234799999999988542    36789999999999999999999


Q ss_pred             CCCCc
Q psy10603        387 LSGVV  391 (407)
Q Consensus       387 ~~~~~  391 (407)
                      |.+..
T Consensus       234 ~~~~~  238 (307)
T 2nru_A          234 VDEHR  238 (307)
T ss_dssp             BCTTB
T ss_pred             cccCc
Confidence            98643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.09  E-value=5.6e-11  Score=107.76  Aligned_cols=77  Identities=14%  Similarity=0.319  Sum_probs=58.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++++|||++.....        ....||+.|+|||++.+.....++.++||||+||+++||++|+.
T Consensus       139 ikp~Nil~~~~~~-~~l~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  209 (271)
T 3kmu_A          139 LNSRSVMIDEDMT-ARISMADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV  209 (271)
T ss_dssp             CSGGGEEECTTSC-EEEEGGGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred             CccceEEEcCCcc-eeEEeccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            3567899987765 89998888743211        12468999999999876433333347999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       210 p~~~~~  215 (271)
T 3kmu_A          210 PFADLS  215 (271)
T ss_dssp             TTTTSC
T ss_pred             CccccC
Confidence            998653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.08  E-value=4.9e-11  Score=110.71  Aligned_cols=81  Identities=30%  Similarity=0.354  Sum_probs=61.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+++........ .......+|+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       171 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~ellt~g~  245 (313)
T 1t46_A          171 LAARNILLTHGRI-TKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGS  245 (313)
T ss_dssp             CSGGGEEEETTTE-EEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CccceEEEcCCCC-EEEccccccccccccccc-eeccCCCCcceeeChHHhcCC---CCChHHHHHHHHHHHHHHHhCCC
Confidence            3567999987764 999999999765433221 112234578899999998653   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       246 ~p~~~~~  252 (313)
T 1t46_A          246 SPYPGMP  252 (313)
T ss_dssp             CSSTTCC
T ss_pred             CCCCccc
Confidence            9998764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.08  E-value=7.3e-11  Score=109.15  Aligned_cols=83  Identities=27%  Similarity=0.430  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||++........ ........||+.|+|||++.+... ..+.++||||+||+++||++|+.
T Consensus       135 lkp~NIl~~~~~~-~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Di~slG~il~~l~~g~~  211 (305)
T 2wtk_C          135 IKPGNLLLTTGGT-LKISALGVAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDT-FSGFKVDIWSAGVTLYNITTGLY  211 (305)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSC-EESHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccEEEcCCCc-EEeeccccccccCcccc-ccccccCCCCCCCcChhhccCccc-CCcchhhHHHHHHHHHHHHhCCC
Confidence            3567899987765 99999999976542221 112234569999999999864322 12568999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       212 p~~~~~  217 (305)
T 2wtk_C          212 PFEGDN  217 (305)
T ss_dssp             SCCCSS
T ss_pred             CCCCch
Confidence            998753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.08  E-value=5.8e-11  Score=111.01  Aligned_cols=79  Identities=32%  Similarity=0.494  Sum_probs=58.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC---------CCcccccccccccccCcccccCCcCCCCccchHHhHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV---------PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCV  376 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~  376 (407)
                      .++.|++++.++. +||+|||+++........         .......+||+.|+|||++.+.   .++.++||||+||+
T Consensus       190 lkp~NIll~~~~~-~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~i  265 (332)
T 3qd2_B          190 LKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN---NYSHKVDIFSLGLI  265 (332)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCC---CCCTHHHHHHHHHH
T ss_pred             CCcccEEEeCCCC-EEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCC---CCcchhhHHHHHHH
Confidence            3567999987775 999999999866533211         0112345799999999998653   35789999999999


Q ss_pred             HHHHHhCCCCCC
Q psy10603        377 LVEMSSGKTNLS  388 (407)
Q Consensus       377 ~~e~~~g~~~~~  388 (407)
                      ++||++|..++.
T Consensus       266 l~el~~~~~~~~  277 (332)
T 3qd2_B          266 LFELLYSFSTQM  277 (332)
T ss_dssp             HHHHHSCCCCHH
T ss_pred             HHHHHHcCCChh
Confidence            999999877654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.08  E-value=3.9e-11  Score=114.82  Aligned_cols=81  Identities=23%  Similarity=0.292  Sum_probs=59.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......... ......++..|+|||++....   ++.++||||+||+++||++ |+
T Consensus       239 lkp~Nil~~~~~~-~kl~DfG~s~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~t~g~  313 (377)
T 3cbl_A          239 LAARNCLVTEKNV-LKISDFGMSREEADGVYAA-SGGLRQVPVKWTAPEALNYGR---YSSESDVWSFGILLWETFSLGA  313 (377)
T ss_dssp             CSGGGEEECTTCC-EEECCGGGCEECTTSEEEC-CSSCCEEEGGGSCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCHHHEEEcCCCc-EEECcCCCceecCCCceee-cCCCCCCCcCcCCHhHhccCC---CCchhhHHHHHHHHHHHHhCCC
Confidence            3567999987765 9999999997543221111 111224677899999986432   4689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       314 ~p~~~~~  320 (377)
T 3cbl_A          314 SPYPNLS  320 (377)
T ss_dssp             CSSTTSC
T ss_pred             CCCCCCC
Confidence            9998753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.07  E-value=2.4e-11  Score=113.72  Aligned_cols=81  Identities=26%  Similarity=0.331  Sum_probs=61.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||+++................||..|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       153 ikp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~ll~g~~  228 (327)
T 3lxl_A          153 LAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI---FSRQSDVWSFGVVLYELFTYCD  228 (327)
T ss_dssp             CSGGGEEEEETTE-EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CChhhEEECCCCC-EEEcccccceecccCCccceeeccCCccccccCHHHhccCC---CChHHhHHHHHHHHHHHHhCCC
Confidence            3567999988765 99999999986543322211223346888999999986532   4678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       229 p~~~~  233 (327)
T 3lxl_A          229 KSCSP  233 (327)
T ss_dssp             GGGSH
T ss_pred             CCccc
Confidence            98643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.07  E-value=9.2e-11  Score=107.22  Aligned_cols=79  Identities=32%  Similarity=0.502  Sum_probs=58.2

Q ss_pred             cCCccEEEecCCC---ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~---~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|++++.++.   .+|++|||++........    .....||+.|+|||++...   .++.++||||+||+++||++
T Consensus       134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~  206 (283)
T 3bhy_A          134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVITYILLS  206 (283)
T ss_dssp             CSGGGEEESCSSSSSCCEEECCCTTCEECC------------CCCGGGCCHHHHTTC---CCCTHHHHHHHHHHHHHHHH
T ss_pred             CChHHEEEecCCCCCCceEEEecccceeccCCCc----ccccCCCcCccCcceecCC---CCCcchhhhhHHHHHHHHHH
Confidence            3456888876552   599999999976543221    2234699999999998543   34689999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |+.||.+..
T Consensus       207 g~~p~~~~~  215 (283)
T 3bhy_A          207 GASPFLGET  215 (283)
T ss_dssp             SSCTTCCSS
T ss_pred             CCCCCCCcc
Confidence            999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.07  E-value=5.9e-11  Score=109.14  Aligned_cols=81  Identities=35%  Similarity=0.701  Sum_probs=59.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.....+||+|||++........   ......||+.|+|||++..... .++.++||||+||+++||++|+.
T Consensus       148 l~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Di~slG~il~~l~~g~~  223 (295)
T 2clq_A          148 IKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPR-GYGKAADIWSLGCTIIEMATGKP  223 (295)
T ss_dssp             CSGGGEEEETTTCCEEECCTTTCEESCC--------CCCCCCGGGCCHHHHHHGGG-GCSHHHHHHHHHHHHHHHHHTSC
T ss_pred             CChhhEEEECCCCCEEEeecccccccCCCCC---cccccCCCccccChhhhcCCCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence            3457899987445699999999976543211   1223579999999999864321 24678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       224 pf~~~  228 (295)
T 2clq_A          224 PFYEL  228 (295)
T ss_dssp             TTGGG
T ss_pred             CccCC
Confidence            99753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.07  E-value=6.7e-11  Score=110.32  Aligned_cols=81  Identities=25%  Similarity=0.376  Sum_probs=61.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++........ .......+|+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       164 ikp~NIli~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~~g~  238 (322)
T 1p4o_A          164 LAARNCMVAEDFT-VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAE  238 (322)
T ss_dssp             CSGGGEEECTTCC-EEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             CccceEEEcCCCe-EEECcCcccccccccccc-ccccCCCCCCCccChhhhccC---CCCchhhHHHHHHHHHHHHhcCC
Confidence            3567899987765 999999999765432211 112234678999999998653   24689999999999999999 89


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       239 ~p~~~~~  245 (322)
T 1p4o_A          239 QPYQGLS  245 (322)
T ss_dssp             CTTTTSC
T ss_pred             CccccCC
Confidence            9998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.07  E-value=2.9e-11  Score=112.81  Aligned_cols=79  Identities=24%  Similarity=0.328  Sum_probs=59.2

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTN  386 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~~  386 (407)
                      ++.|++++.++. +||+|||+++................+|..|+|||++.+..   ++.++||||+||+++||++|+.|
T Consensus       161 kp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~ll~g~~p  236 (318)
T 3lxp_A          161 AARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK---FYYASDVWSFGVTLYELLTHCDS  236 (318)
T ss_dssp             SGGGEEECTTCC-EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             chheEEEcCCCC-EEECCccccccccccccccccccCCCCCceeeChHHhcCCC---CCcHHHHHHHHHHHHHHHhCCCc
Confidence            457899987765 99999999986644322111123346888999999986533   35789999999999999999999


Q ss_pred             CCC
Q psy10603        387 LSG  389 (407)
Q Consensus       387 ~~~  389 (407)
                      |..
T Consensus       237 ~~~  239 (318)
T 3lxp_A          237 SQS  239 (318)
T ss_dssp             GGS
T ss_pred             ccc
Confidence            874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.07  E-value=6.5e-11  Score=111.20  Aligned_cols=81  Identities=26%  Similarity=0.430  Sum_probs=61.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......... ......+|+.|+|||++.+..   ++.++||||+||+++||++ |+
T Consensus       183 lkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~  257 (334)
T 2pvf_A          183 LAARNVLVTENNV-MKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRV---YTHQSDVWSFGVLMWEIFTLGG  257 (334)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECTTTSSEE-CCSCCCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CccceEEEcCCCC-EEEcccccccccccccccc-ccCCCCcccceeChHHhcCCC---cChHHHHHHHHHHHHHHHhCCC
Confidence            4567999987765 9999999997654322111 112335788999999986532   4688999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       258 ~p~~~~~  264 (334)
T 2pvf_A          258 SPYPGIP  264 (334)
T ss_dssp             CSSTTCC
T ss_pred             CCcCcCC
Confidence            9998753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.07  E-value=8.9e-11  Score=108.65  Aligned_cols=76  Identities=25%  Similarity=0.414  Sum_probs=57.5

Q ss_pred             CCccEEEe--cCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLT--AEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~--~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      ++.|+++.  .....++++|||+++.....     ......||+.|+|||++.+.   .++.++||||+||+++||++|+
T Consensus       133 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~  204 (304)
T 2jam_A          133 KPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQK---PYSKAVDCWSIGVITYILLCGY  204 (304)
T ss_dssp             CGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSC---SCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CHHHEEEecCCCCCCEEEccCCcceecCCC-----ccccccCCCCccChHHhccC---CCCchhhHHHHHHHHHHHHHCC
Confidence            45677772  22345999999999653321     12335799999999998643   3568999999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       205 ~pf~~~  210 (304)
T 2jam_A          205 PPFYEE  210 (304)
T ss_dssp             CTTTTS
T ss_pred             CCCCCC
Confidence            999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.07  E-value=5.2e-11  Score=112.06  Aligned_cols=81  Identities=23%  Similarity=0.312  Sum_probs=60.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++........ .......+|+.|+|||++....   ++.++||||+||+++||++ |+
T Consensus       200 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          200 LATRNCLVGENMV-VKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CSGGGEEECGGGC-EEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCcceEEECCCCe-EEEeecCCCcccccCccc-cccCCCcccceecChhhhccCC---cCcccccHHHHHHHHHHHhcCC
Confidence            3567999987765 999999999765432211 1122346899999999986532   5689999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       275 ~p~~~~~  281 (343)
T 1luf_A          275 QPYYGMA  281 (343)
T ss_dssp             CTTTTSC
T ss_pred             CcCCCCC
Confidence            9998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.07  E-value=6.4e-11  Score=108.26  Aligned_cols=79  Identities=25%  Similarity=0.315  Sum_probs=57.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||++.........  ......+|+.|+|||++...   .++.++||||+||+++||++ |+
T Consensus       139 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~llt~g~  212 (281)
T 3cc6_A          139 IAVRNILVASPEC-VKLGDFGLSRYIEDEDYY--KASVTRLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGK  212 (281)
T ss_dssp             CSGGGEEEEETTE-EEECCCCGGGCC-----------CCCCCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CccceEEECCCCc-EEeCccCCCccccccccc--ccccCCCCcceeCchhhccC---CCCchhccHHHHHHHHHHHhCCC
Confidence            3567899987764 999999999765432211  12234578899999998543   34688999999999999998 99


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       213 ~p~~~~  218 (281)
T 3cc6_A          213 QPFFWL  218 (281)
T ss_dssp             CTTTTS
T ss_pred             CCcccC
Confidence            999754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.06  E-value=4.7e-11  Score=108.47  Aligned_cols=79  Identities=24%  Similarity=0.343  Sum_probs=59.8

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. +|++|||+++.........  .....+|+.|+|||++...   .++.++||||+||+++||++ |+.
T Consensus       133 kp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~ll~~g~~  206 (269)
T 4hcu_A          133 AARNCLVGENQV-IKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGKI  206 (269)
T ss_dssp             CGGGEEECGGGC-EEECCTTGGGGBCCHHHHS--TTSTTCCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             chheEEEcCCCC-EEecccccccccccccccc--ccCcccccccCCHHHhcCC---CCCchhhhHHHHHHHHHHhcCCCC
Confidence            457889977765 9999999997654322111  1234578889999998643   35689999999999999999 999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       207 p~~~~~  212 (269)
T 4hcu_A          207 PYENRS  212 (269)
T ss_dssp             TTTTCC
T ss_pred             CCCCCC
Confidence            998643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.06  E-value=7.9e-11  Score=109.41  Aligned_cols=81  Identities=23%  Similarity=0.304  Sum_probs=55.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.+....... ......+++.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       173 ikp~NIli~~~~~-~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~~~g~  247 (313)
T 3brb_A          173 LAARNCMLRDDMT-VCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGM  247 (313)
T ss_dssp             CSGGGEEECTTSC-EEECSCSCC-----------------CCGGGSCHHHHHSS---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCcceEEEcCCCc-EEEeecCcceecccccccC-cccccCCCccccCchhhcCC---CccchhhhHHHHHHHHHHHhcCC
Confidence            4567999987765 9999999997654332211 12234578899999998653   35689999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       248 ~p~~~~~  254 (313)
T 3brb_A          248 TPYPGVQ  254 (313)
T ss_dssp             CSSTTCC
T ss_pred             CCCccCC
Confidence            9998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.06  E-value=1.1e-10  Score=106.29  Aligned_cols=78  Identities=32%  Similarity=0.477  Sum_probs=52.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++++|||++........    .....||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       137 l~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~  209 (276)
T 2h6d_A          137 LKPENVLLDAHMN-AKIADFGLSNMMSDGEF----LRTSCGSPNYAAPEVISGRLY--AGPEVDIWSCGVILYALLCGTL  209 (276)
T ss_dssp             CCGGGEEECTTSC-EEECCCCGGGCCCC-----------------CCTGGGTTSCC--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CChhhEEECCCCC-EEEeecccccccCCCcc----eecccCCccccCHHHHcCCCC--CCccchHHHHHHHHHHHHhCCC
Confidence            3457889987765 99999999976543221    223468999999999865321  2478999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       210 p~~~~  214 (276)
T 2h6d_A          210 PFDDE  214 (276)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.06  E-value=8.4e-11  Score=109.34  Aligned_cols=80  Identities=33%  Similarity=0.522  Sum_probs=52.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC--CcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +||+|||++........    .....||+.|+|||++...  ....++.++||||+||+++||++|
T Consensus       151 lkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (318)
T 2dyl_A          151 VKPSNILLDERGQ-IKLCDFGISGRLVDDKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG  225 (318)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEECCCCC-EEEEECCCchhccCCcc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence            3457899987765 99999999976543221    2234699999999998531  112346789999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       226 ~~pf~~~  232 (318)
T 2dyl_A          226 QFPYKNC  232 (318)
T ss_dssp             SCTTTTC
T ss_pred             CCCCCCC
Confidence            9999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.06  E-value=3.3e-11  Score=111.31  Aligned_cols=79  Identities=27%  Similarity=0.375  Sum_probs=59.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++++|||++.................||..|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       152 ikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~~  227 (302)
T 4e5w_A          152 LAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK---FYIASDVWSFGVTLHELLTYCD  227 (302)
T ss_dssp             CSGGGEEEEETTE-EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CchheEEEcCCCC-EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC---CCcchhHHHHHHHHHHHHHccC
Confidence            3567999988764 99999999986654332212223446888999999986543   3578999999999999999998


Q ss_pred             CCC
Q psy10603        386 NLS  388 (407)
Q Consensus       386 ~~~  388 (407)
                      ++.
T Consensus       228 p~~  230 (302)
T 4e5w_A          228 SDS  230 (302)
T ss_dssp             GGG
T ss_pred             CCc
Confidence            764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.06  E-value=8.3e-11  Score=109.22  Aligned_cols=78  Identities=28%  Similarity=0.471  Sum_probs=60.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.+...+||+|||+++......     .....||+.|+|||++.+...  .+.++||||+||+++||++|+.
T Consensus       165 lkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~  237 (312)
T 2iwi_A          165 IKDENILIDLRRGCAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQY--HALPATVWSLGILLYDMVCGDI  237 (312)
T ss_dssp             CSGGGEEEETTTTEEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCB--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CChhhEEEeCCCCeEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCC--CCccchHHHHHHHHHHHHHCCC
Confidence            356799998555569999999997654322     233569999999999865432  2457999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      +|.+.
T Consensus       238 pf~~~  242 (312)
T 2iwi_A          238 PFERD  242 (312)
T ss_dssp             SCCSH
T ss_pred             CCCCh
Confidence            99864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.06  E-value=3.7e-11  Score=109.63  Aligned_cols=79  Identities=38%  Similarity=0.623  Sum_probs=60.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   ......||+.|+|||++.+.   .++.++||||+||+++||++|+.
T Consensus       142 l~p~NIl~~~~~~-~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~~  214 (279)
T 2w5a_A          142 LKPANVFLDGKQN-VKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCLLYELCALMP  214 (279)
T ss_dssp             CSGGGEEECSSSC-EEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC----CCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cchhhEEEcCCCC-EEEecCchheeeccccc---cccccCCCccccChHHhccC---CCCchhhHHHHHHHHHHHHHCCC
Confidence            3567899987765 99999999976543211   12234789999999998653   34688999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       215 p~~~~~  220 (279)
T 2w5a_A          215 PFTAFS  220 (279)
T ss_dssp             SSCCSS
T ss_pred             CCcccC
Confidence            998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.06  E-value=8.8e-11  Score=115.08  Aligned_cols=76  Identities=24%  Similarity=0.410  Sum_probs=58.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++......      ....+|..|+|||++...   .++.++||||+||+++||++ |+
T Consensus       315 lkp~Nill~~~~~-~kl~DfG~a~~~~~~~------~~~~~~~~y~aPE~~~~~---~~~~~sDvwslG~~l~el~t~g~  384 (450)
T 1k9a_A          315 LAARNVLVSEDNV-AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREK---KFSTKSDVWSFGILLWEIYSFGR  384 (450)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEECC------------CCCTTTSCHHHHHSS---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCHhhEEECCCCC-EEEeeCCCcccccccc------cCCCCCcceeCHHHhcCC---CCCcHHHHHHHHHHHHHHHhCCC
Confidence            3568999987765 9999999997542211      123578899999998653   35789999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       385 ~P~~~~~  391 (450)
T 1k9a_A          385 VPYPRIP  391 (450)
T ss_dssp             CSSTTSC
T ss_pred             CCCCCCC
Confidence            9998753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.06  E-value=7.6e-11  Score=106.94  Aligned_cols=80  Identities=25%  Similarity=0.321  Sum_probs=60.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. ++++|||++.........  ......+|+.|+|||++.+..   ++.++||||+||+++||++ |+
T Consensus       130 ikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~~g~  203 (268)
T 3sxs_A          130 LAARNCLVDRDLC-VKVSDFGMTRYVLDDQYV--SSVGTKFPVKWSAPEVFHYFK---YSSKSDVWAFGILMWEVFSLGK  203 (268)
T ss_dssp             CSGGGEEECTTCC-EEECCTTCEEECCTTCEE--ECCSCCCCGGGCCHHHHHHSE---EETTHHHHHHHHHHHHHHTTTC
T ss_pred             cCcceEEECCCCC-EEEccCccceecchhhhh--cccCCCcCcccCCHHHHhccC---CchhhhhHHHHHHHHHHHcCCC
Confidence            3567899988765 999999999765432211  112335677899999986532   4678999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       204 ~p~~~~~  210 (268)
T 3sxs_A          204 MPYDLYT  210 (268)
T ss_dssp             CTTTTSC
T ss_pred             CCccccC
Confidence            9998643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.06  E-value=3.8e-11  Score=112.62  Aligned_cols=81  Identities=31%  Similarity=0.401  Sum_probs=61.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++........ .......+|+.|+|||++.+.   .++.++||||+||+++||++ |.
T Consensus       190 lkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~el~t~g~  264 (333)
T 2i1m_A          190 VAARNVLLTNGHV-AKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGL  264 (333)
T ss_dssp             CSGGGCEEEGGGE-EEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             cccceEEECCCCe-EEECccccccccccccce-eecCCCCCCccccCHHHhccC---CCChHHHHHHHHHHHHHHHcCCC
Confidence            3567889987664 999999999765432221 112234578899999998653   25689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       265 ~p~~~~~  271 (333)
T 2i1m_A          265 NPYPGIL  271 (333)
T ss_dssp             CSSTTCC
T ss_pred             CCCcccc
Confidence            9998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.06  E-value=9.1e-11  Score=109.04  Aligned_cols=81  Identities=38%  Similarity=0.575  Sum_probs=54.5

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCC--------cCCCCccchHHhHHHHHH
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN--------KVGHGRAVDIWSLGCVLV  378 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~~~Dvws~G~~~~  378 (407)
                      ++.|++++.  ..+||+|||+++........ .......||+.|+|||++....        ...++.++||||+||+++
T Consensus       154 kp~NIl~~~--~~~kL~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~  230 (313)
T 3cek_A          154 KPANFLIVD--GMLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  230 (313)
T ss_dssp             CGGGEEEET--TEEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred             CcccEEEEC--CeEEEeeccccccccCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence            456888854  45999999999765433221 1122347999999999986411        123567899999999999


Q ss_pred             HHHhCCCCCCCC
Q psy10603        379 EMSSGKTNLSGV  390 (407)
Q Consensus       379 e~~~g~~~~~~~  390 (407)
                      ||++|+.||.+.
T Consensus       231 el~~g~~pf~~~  242 (313)
T 3cek_A          231 YMTYGKTPFQQI  242 (313)
T ss_dssp             HHHHSSCTTTTC
T ss_pred             HHHhCCCchhhH
Confidence            999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.05  E-value=4.5e-11  Score=110.35  Aligned_cols=82  Identities=29%  Similarity=0.532  Sum_probs=57.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC--CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT--VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +||+|||++........  .........||+.|+|||++....  .++.++||||+||+++||++|
T Consensus       147 l~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g  223 (303)
T 2vwi_A          147 VKAGNILLGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR--GYDFKADIWSFGITAIELATG  223 (303)
T ss_dssp             CSGGGEEECTTCC-EEECCCHHHHHCC---------------CCCTTCCHHHHHHHH--CCCTHHHHHHHHHHHHHHHHS
T ss_pred             CChhhEEEcCCCC-EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc--CCCchhhHHHHHHHHHHHHhC
Confidence            3567899987765 99999999976543211  111123457999999999986422  246789999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       224 ~~pf~~~  230 (303)
T 2vwi_A          224 AAPYHKY  230 (303)
T ss_dssp             SCTTTTS
T ss_pred             CCCCccC
Confidence            9999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.05  E-value=9.3e-11  Score=108.79  Aligned_cols=78  Identities=42%  Similarity=0.683  Sum_probs=50.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.......   ......||+.|+|||++...   .++.++||||+||+++||++|+.
T Consensus       162 l~p~NIl~~~~~~-~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~~l~~g~~  234 (310)
T 2wqm_A          162 IKPANVFITATGV-VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHEN---GYNFKSDIWSLGCLLYEMAALQS  234 (310)
T ss_dssp             CCGGGEEECTTSC-EEECCC---------------------CCSSCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcHHHEEEcCCCC-EEEEeccceeeecCCCc---cccccCCCeeEeChHHhCCC---CCCchhhHHHHHHHHHHHHhCCC
Confidence            3456889987765 99999999976543221   12234799999999998643   35689999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       235 p~~~~  239 (310)
T 2wqm_A          235 PFYGD  239 (310)
T ss_dssp             TTC--
T ss_pred             CCccc
Confidence            99764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.05  E-value=1.2e-10  Score=107.27  Aligned_cols=79  Identities=32%  Similarity=0.587  Sum_probs=60.3

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC---CcCCCCccchHHhHHHHHHHHHhC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT---NKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      ++.|++++.++. +||+|||++..+.....    .....||+.|+|||++...   ....++.++||||+||+++||++|
T Consensus       151 ~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g  225 (298)
T 1phk_A          151 KPENILLDDDMN-IKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG  225 (298)
T ss_dssp             SGGGEEECTTCC-EEECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CcceEEEcCCCc-EEEecccchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence            457889987765 99999999976543221    2335799999999998521   122346789999999999999999


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      +.||.+.
T Consensus       226 ~~p~~~~  232 (298)
T 1phk_A          226 SPPFWHR  232 (298)
T ss_dssp             SCSSCCS
T ss_pred             CCCCcCc
Confidence            9999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.05  E-value=1.8e-10  Score=106.00  Aligned_cols=81  Identities=22%  Similarity=0.266  Sum_probs=59.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-C
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-G  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g  383 (407)
                      .++.|++++.++. +||+|||+++.+..... .........+|+.|+|||.+.+.   .++.++||||+||+++||++ |
T Consensus       150 ikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~g~  225 (298)
T 3pls_A          150 LAARNCMLDESFT-VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY---RFTTKSDVWSFGVLLWELLTRG  225 (298)
T ss_dssp             CSGGGEEECTTCC-EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC---CCCHHHHHHHHHHHHHHHHHTS
T ss_pred             CCcceEEEcCCCc-EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC---CCChhhchhhHHHHHHHHhhCC
Confidence            3467899987765 99999999976543221 11223345689999999998643   35689999999999999999 5


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      .++|.+.
T Consensus       226 ~~~~~~~  232 (298)
T 3pls_A          226 APPYRHI  232 (298)
T ss_dssp             CCTTTTS
T ss_pred             CCCCccC
Confidence            5555543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.05  E-value=1.4e-10  Score=107.89  Aligned_cols=84  Identities=19%  Similarity=0.290  Sum_probs=57.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC--CCCcccccccccccccCcccccCC------cCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT--VPGELNGFVGTQAYMAPEVFMDTN------KVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++ ++ .++++|||++........  .........||+.|+|||++....      ...++.++||||+||++
T Consensus       156 lkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il  233 (319)
T 2y4i_B          156 LKSKNVFYD-NG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW  233 (319)
T ss_dssp             CCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred             CChhhEEEe-CC-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence            356789997 34 599999999865432111  111223346999999999986421      12346789999999999


Q ss_pred             HHHHhCCCCCCCCc
Q psy10603        378 VEMSSGKTNLSGVV  391 (407)
Q Consensus       378 ~e~~~g~~~~~~~~  391 (407)
                      +||++|+.||.+..
T Consensus       234 ~el~~g~~p~~~~~  247 (319)
T 2y4i_B          234 YELHAREWPFKTQP  247 (319)
T ss_dssp             HHHHHSSCSSSSCC
T ss_pred             HHHHhCCCCCCCCC
Confidence            99999999998654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.04  E-value=1.2e-10  Score=107.32  Aligned_cols=81  Identities=25%  Similarity=0.334  Sum_probs=58.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-C
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-G  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g  383 (407)
                      .++.|++++.++. +||+|||+++........ ........+|+.|+|||++.+.   .++.++||||+||+++||++ |
T Consensus       154 ikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~~  229 (298)
T 3f66_A          154 LAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRG  229 (298)
T ss_dssp             CSGGGEEECTTCC-EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CchheEEECCCCC-EEECcccccccccccchhccccccCCCCCccccChHHhcCC---CCChHHHHHHHHHHHHHHHhCC
Confidence            3567899987765 999999999765432211 1122344688899999998653   34689999999999999999 7


Q ss_pred             CCCCCCC
Q psy10603        384 KTNLSGV  390 (407)
Q Consensus       384 ~~~~~~~  390 (407)
                      .++|.+.
T Consensus       230 ~~~~~~~  236 (298)
T 3f66_A          230 APPYPDV  236 (298)
T ss_dssp             CCSSTTS
T ss_pred             CCCCccC
Confidence            7777754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.04  E-value=9.1e-11  Score=107.31  Aligned_cols=80  Identities=25%  Similarity=0.390  Sum_probs=60.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.........  .....+|+.|+|||++...   .++.++||||+||+++||++ |+
T Consensus       146 ikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~~l~t~g~  219 (283)
T 3gen_A          146 LAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGK  219 (283)
T ss_dssp             CSGGGEEECTTSC-EEECSTTGGGGBCCHHHHS--TTSTTSCGGGCCHHHHHHC---CCSHHHHHHHHHHHHHHHHTTTC
T ss_pred             CccceEEEcCCCC-EEEcccccccccccccccc--ccCCccCcccCCHHHhccC---CCCchhhHHHHHHHHHHHHhCCC
Confidence            3467899987765 9999999997654322111  1233578889999998644   25789999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       220 ~p~~~~~  226 (283)
T 3gen_A          220 MPYERFT  226 (283)
T ss_dssp             CTTTTSC
T ss_pred             CCccccC
Confidence            9998643

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.03  E-value=7.2e-11  Score=111.05  Aligned_cols=84  Identities=29%  Similarity=0.402  Sum_probs=59.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCC-CcccccccccccccCcccccCCcC---CCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVP-GELNGFVGTQAYMAPEVFMDTNKV---GHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++.++. +||+|||+++......... .......||+.|+|||++.+....   .++.++||||+||+++||+
T Consensus       173 lkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~  251 (342)
T 1b6c_B          173 LKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  251 (342)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEECCCCC-EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence            3567999988775 9999999997654322110 012345799999999998653211   1125799999999999999


Q ss_pred             hC----------CCCCCCC
Q psy10603        382 SG----------KTNLSGV  390 (407)
Q Consensus       382 ~g----------~~~~~~~  390 (407)
                      +|          +.||.+.
T Consensus       252 tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          252 RRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             TTBCBTTBCCCCCCTTTTT
T ss_pred             hccCcCCcccccccCcccc
Confidence            99          6777654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.03  E-value=5.9e-11  Score=110.44  Aligned_cols=83  Identities=31%  Similarity=0.429  Sum_probs=59.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCC------CcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVP------GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      .++.|++++.++. +|++|||++..........      .......||+.|+|||++.......++.++||||+||+++|
T Consensus       160 lkp~NIl~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  238 (317)
T 2buj_A          160 LKPTNILLGDEGQ-PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA  238 (317)
T ss_dssp             CCGGGEEECTTSC-EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCC-EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence            3567899987765 9999999987543211100      00123457999999999865332224678999999999999


Q ss_pred             HHhCCCCCCC
Q psy10603        380 MSSGKTNLSG  389 (407)
Q Consensus       380 ~~~g~~~~~~  389 (407)
                      |++|+.||.+
T Consensus       239 l~~g~~p~~~  248 (317)
T 2buj_A          239 MMFGEGPYDM  248 (317)
T ss_dssp             HHHSSCTTHH
T ss_pred             HHhCCCChhh
Confidence            9999999964

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.03  E-value=1.2e-10  Score=106.24  Aligned_cols=80  Identities=26%  Similarity=0.398  Sum_probs=60.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||++..........  .....+|..|+|||++....   ++.++||||+||+++||++ |+
T Consensus       135 ikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~~~g~  208 (279)
T 1qpc_A          135 LRAANILVSDTLS-CKIADFGLARLIEDNEYTA--REGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGR  208 (279)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECSSSCEEC--CTTCCCCTTTSCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCHhhEEEcCCCC-EEECCCcccccccCccccc--ccCCCCccCccChhhhccCC---CCchhhhHHHHHHHHHHHhCCC
Confidence            3467889987665 9999999997654322111  12345788999999986432   4678999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       209 ~p~~~~~  215 (279)
T 1qpc_A          209 IPYPGMT  215 (279)
T ss_dssp             CSSTTCC
T ss_pred             CCCcccC
Confidence            9998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.03  E-value=8.3e-11  Score=110.67  Aligned_cols=77  Identities=29%  Similarity=0.440  Sum_probs=41.9

Q ss_pred             CCccEEEecC--CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLTAE--GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~~~--~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      ++.|++++.+  ...+||+|||+++......     .....||+.|+|||++....   ++.++||||+||+++||++|+
T Consensus       155 kp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~---~~~~~Di~slG~il~~l~~g~  226 (336)
T 3fhr_A          155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGPEK---YDKSCDMWSLGVIMYILLCGF  226 (336)
T ss_dssp             SGGGEEESCSSTTCCEEECCCTTCEEC---------------------------CH---HHHHHHHHHHHHHHHHHHHSS
T ss_pred             CHHHEEEEecCCCceEEEeccccceeccccc-----cccCCCCcCccChhhhCCCC---CCchhhHHHHHHHHHHHHHCC
Confidence            4578888753  2349999999997553221     22357899999999985432   467899999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       227 ~pf~~~~  233 (336)
T 3fhr_A          227 PPFYSNT  233 (336)
T ss_dssp             CCC----
T ss_pred             CCCCCcc
Confidence            9997644

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.03  E-value=1.9e-10  Score=108.50  Aligned_cols=79  Identities=32%  Similarity=0.518  Sum_probs=61.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCc-cchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR-AVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. ++|+|||++......     ......||+.|+|||++.+...  ++. ++||||+||+++||++|+
T Consensus       178 l~p~Nil~~~~~~-~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~g~  249 (348)
T 2pml_X          178 VKPSNILMDKNGR-VKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESS--YNGAKVDIWSLGICLYVMFYNV  249 (348)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCC--EEHHHHHHHHHHHHHHHHHHSS
T ss_pred             CChHhEEEcCCCc-EEEeccccccccccc-----cccCCCCCcCccCchhhcCCCC--CCcchhhHHHHHHHHHHHHhCC
Confidence            3467899987765 999999999765432     1234579999999999865421  234 899999999999999999


Q ss_pred             CCCCCCce
Q psy10603        385 TNLSGVVV  392 (407)
Q Consensus       385 ~~~~~~~~  392 (407)
                      .||.+...
T Consensus       250 ~pf~~~~~  257 (348)
T 2pml_X          250 VPFSLKIS  257 (348)
T ss_dssp             CSSCCSSC
T ss_pred             CCCCCCCc
Confidence            99986543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.02  E-value=9.5e-11  Score=114.87  Aligned_cols=80  Identities=28%  Similarity=0.403  Sum_probs=56.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++........  ......+|..|+|||++...   .++.++||||+||+++||++ |+
T Consensus       306 lkp~Nill~~~~~-~kl~DfG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~sDvwslG~~l~el~t~g~  379 (452)
T 1fmk_A          306 LRAANILVGENLV-CKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYG---RFTIKSDVWSFGILLTELTTKGR  379 (452)
T ss_dssp             CSGGGEEECGGGC-EEECCCCTTC----------------CCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CChhhEEECCCCC-EEECCCccceecCCCcee--cccCCcccccccCHhHHhcC---CCCccccHHhHHHHHHHHHhCCC
Confidence            3568999987765 999999999765432211  12233578889999998653   35789999999999999999 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       380 ~P~~~~~  386 (452)
T 1fmk_A          380 VPYPGMV  386 (452)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.02  E-value=1e-10  Score=116.06  Aligned_cols=79  Identities=23%  Similarity=0.386  Sum_probs=60.8

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. +||+|||+++........  ......+|..|+|||++....   ++.++|||||||+++||++ |+.
T Consensus       345 kp~NIll~~~~~-~kl~DFG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwSlG~~l~el~t~g~~  418 (495)
T 1opk_A          345 AARNCLVGENHL-VKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLLWEIATYGMS  418 (495)
T ss_dssp             SGGGEEECGGGC-EEECCTTCEECCTTCCEE--CCTTCCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ChhhEEECCCCc-EEEeecccceeccCCcee--ecCCCcCCcceeCHhHHhcCC---CCcHHhHHhHHHHHHHHHhCCCC
Confidence            568999987765 999999999865432211  122335678899999986532   4689999999999999999 999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       419 p~~~~~  424 (495)
T 1opk_A          419 PYPGID  424 (495)
T ss_dssp             SSTTCC
T ss_pred             CCCCCC
Confidence            999764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.02  E-value=1.4e-10  Score=105.84  Aligned_cols=75  Identities=29%  Similarity=0.478  Sum_probs=58.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||++........    .....||+.|+|||++.+.   .++.++||||+||+++||++|..
T Consensus       148 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~~~  219 (284)
T 2a19_B          148 LKPSNIFLVDTKQ-VKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQ---DYGKEVDLYALGLILAELLHVCD  219 (284)
T ss_dssp             CSGGGEEEEETTE-EEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCS---CCCTHHHHHHHHHHHHHHHSCCS
T ss_pred             CCHHHEEEcCCCC-EEECcchhheecccccc----ccccCCcccccChhhhccC---CCcchhhhHHHHHHHHHHHhcCC
Confidence            3567899987765 99999999976543221    2234699999999998653   34689999999999999999998


Q ss_pred             CCC
Q psy10603        386 NLS  388 (407)
Q Consensus       386 ~~~  388 (407)
                      +|.
T Consensus       220 ~~~  222 (284)
T 2a19_B          220 TAF  222 (284)
T ss_dssp             SHH
T ss_pred             cch
Confidence            875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.02  E-value=1.5e-10  Score=105.70  Aligned_cols=76  Identities=24%  Similarity=0.410  Sum_probs=54.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. ++++|||++.......      ....+|+.|+|||++.+.   .++.++||||+||+++||++ |+
T Consensus       143 lkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~t~g~  212 (278)
T 1byg_A          143 LAARNVLVSEDNV-AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREK---KFSTKSDVWSFGILLWEIYSFGR  212 (278)
T ss_dssp             CSGGGEEECTTSC-EEECCCCC------------------CCTTTSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCcceEEEeCCCc-EEEeeccccccccccc------cCCCccccccCHHHhCCC---CCCchhcHHHHHHHHHHHHhCCC
Confidence            3567899987765 9999999997543221      123578899999998643   34689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       213 ~p~~~~~  219 (278)
T 1byg_A          213 VPYPRIP  219 (278)
T ss_dssp             CSCTTSC
T ss_pred             CCCCCCC
Confidence            9998653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.01  E-value=1.5e-10  Score=106.12  Aligned_cols=79  Identities=23%  Similarity=0.373  Sum_probs=60.6

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. ++++|||++........  .......+|+.|+|||++.+.   .++.++||||+||++++|++ |..
T Consensus       138 kp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~ll~~g~~  211 (288)
T 3kfa_A          138 AARNCLVGENHL-VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVLLWEIATYGMS  211 (288)
T ss_dssp             SGGGEEECGGGC-EEECCCCGGGTSCSSSS--EEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CcceEEEcCCCC-EEEccCccceeccCCcc--ccccCCccccCcCChhhhccC---CCCchhhHHHHHHHHHHHHhCCCC
Confidence            457889977765 99999999976543221  112234578899999998653   34689999999999999999 999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       212 p~~~~~  217 (288)
T 3kfa_A          212 PYPGID  217 (288)
T ss_dssp             SSTTCC
T ss_pred             CCCCCC
Confidence            998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.01  E-value=1.2e-10  Score=108.96  Aligned_cols=78  Identities=26%  Similarity=0.269  Sum_probs=57.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.......    .....+|+.|+|||++....   ++.++||||+||+++||++ |+
T Consensus       168 lkp~NIl~~~~~~-~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~ellt~g~  239 (327)
T 1fvr_A          168 LAARNILVGENYV-AKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGG  239 (327)
T ss_dssp             CSGGGEEECGGGC-EEECCTTCEESSCEECC----C----CCTTTCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CccceEEEcCCCe-EEEcccCcCcccccccc----ccCCCCCccccChhhhcccc---CCchhcchHHHHHHHHHHcCCC
Confidence            3567899987765 99999999974332111    12235788999999986432   4678999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       240 ~pf~~~~  246 (327)
T 1fvr_A          240 TPYCGMT  246 (327)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCc
Confidence            9998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.00  E-value=5e-11  Score=114.84  Aligned_cols=78  Identities=24%  Similarity=0.518  Sum_probs=57.0

Q ss_pred             CCccEEE----ecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCC-----cCCCCccchHHhHHHHH
Q psy10603        307 ARANIFL----TAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN-----KVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       307 ~~~nill----~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Dvws~G~~~  377 (407)
                      ++.|+++    +.. ..+||+|||+++.......    .....||+.|+|||++.+..     ...++.++||||+||++
T Consensus       139 kp~NIll~~~~~~~-~~~kL~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il  213 (396)
T 4eut_A          139 KPGNIMRVIGEDGQ-SVYKLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF  213 (396)
T ss_dssp             CGGGEEEEECTTSC-EEEEECCGGGCEECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEeecCCCc-eeEEEecCCCceEccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence            4568877    333 3499999999976543222    22357999999999985310     01235789999999999


Q ss_pred             HHHHhCCCCCCC
Q psy10603        378 VEMSSGKTNLSG  389 (407)
Q Consensus       378 ~e~~~g~~~~~~  389 (407)
                      +||++|+.||.+
T Consensus       214 ~el~tg~~Pf~~  225 (396)
T 4eut_A          214 YHAATGSLPFRP  225 (396)
T ss_dssp             HHHHHSSCSEEC
T ss_pred             HHHHHCCCCCCC
Confidence            999999999974

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.00  E-value=8.5e-11  Score=110.00  Aligned_cols=80  Identities=25%  Similarity=0.365  Sum_probs=59.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++................+|..|+|||++.+..   ++.++||||+||+++||++|+.
T Consensus       171 ikp~NIli~~~~~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~il~el~tg~~  246 (326)
T 2w1i_A          171 LATRNILVENENR-VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIE  246 (326)
T ss_dssp             CCGGGEEEEETTE-EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCcceEEEcCCCc-EEEecCcchhhccccccccccccCCCCceeEECchhhcCCC---CCchhhHHHHHHHHHHHHhcCC
Confidence            3567999987765 99999999976543322111122345788899999986532   4678999999999999999998


Q ss_pred             CCCC
Q psy10603        386 NLSG  389 (407)
Q Consensus       386 ~~~~  389 (407)
                      +|..
T Consensus       247 ~~~~  250 (326)
T 2w1i_A          247 KSKS  250 (326)
T ss_dssp             GGGS
T ss_pred             CCCC
Confidence            8864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.00  E-value=2.2e-10  Score=105.00  Aligned_cols=76  Identities=32%  Similarity=0.533  Sum_probs=58.7

Q ss_pred             CCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        307 ARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       307 ~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      ++.|++++.++  ..+|++|||++........    .....||+.|+|||++.+.    ++.++||||+||++++|++|+
T Consensus       148 ~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~----~~~~~Di~slG~~l~~l~~g~  219 (287)
T 2wei_A          148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYYIAPEVLRGT----YDEKCDVWSAGVILYILLSGT  219 (287)
T ss_dssp             CGGGEEESCSSTTCCEEECSTTGGGTBCCCSS----CSCHHHHHTTCCHHHHTTC----CCTHHHHHHHHHHHHHHHHSS
T ss_pred             ChhhEEEecCCCcccEEEeccCcceeecCCCc----cccccCcccccChHHhcCC----CCCchhhHhHHHHHHHHHhCC
Confidence            45688886543  2599999999976543221    2234689999999998542    468899999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       220 ~p~~~~  225 (287)
T 2wei_A          220 PPFYGK  225 (287)
T ss_dssp             CSSCCS
T ss_pred             CCCCCC
Confidence            999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.00  E-value=1.2e-10  Score=105.35  Aligned_cols=79  Identities=24%  Similarity=0.347  Sum_probs=59.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+++........  ......+|..|+|||++...   .++.++||||+||+++||++ |+
T Consensus       130 l~p~Nili~~~~~-~kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~il~~l~~~g~  203 (267)
T 3t9t_A          130 LAARNCLVGENQV-IKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGK  203 (267)
T ss_dssp             CCGGGEEECGGGC-EEECCTTGGGGBCCHHHH--STTSTTCCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CchheEEECCCCC-EEEccccccccccccccc--ccccccccccccChhhhcCC---CccchhchhhhHHHHHHHhccCC
Confidence            3457889977665 999999999765332111  11234578899999998643   24689999999999999999 99


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.+.
T Consensus       204 ~p~~~~  209 (267)
T 3t9t_A          204 IPYENR  209 (267)
T ss_dssp             CTTTTC
T ss_pred             CCCCCC
Confidence            999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.99  E-value=8.1e-11  Score=108.66  Aligned_cols=82  Identities=33%  Similarity=0.532  Sum_probs=58.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC--CcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +|++|||++.........   .....||+.|+|||++...  ....++.++||||+||+++||++|
T Consensus       143 lkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g  218 (302)
T 2j7t_A          143 LKAGNVLMTLEGD-IRLADFGVSAKNLKTLQK---RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI  218 (302)
T ss_dssp             CSGGGEEECTTSC-EEECCCHHHHHHHHHHHC--------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred             CCHHHEEECCCCC-EEEEECCCCccccccccc---cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence            3467899987765 999999998543221111   1234799999999998421  112346789999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       219 ~~p~~~~~  226 (302)
T 2j7t_A          219 EPPHHELN  226 (302)
T ss_dssp             SCTTTTSC
T ss_pred             CCCCccCC
Confidence            99998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=98.99  E-value=1.9e-10  Score=117.90  Aligned_cols=79  Identities=27%  Similarity=0.386  Sum_probs=58.3

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. +||+|||+++........  ......+|+.|+|||++...   .++.++||||+||+++||++ |+.
T Consensus       518 kp~NILl~~~~~-vkL~DFG~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~DiwSlG~il~ellt~g~~  591 (656)
T 2j0j_A          518 AARNVLVSSNDC-VKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGVK  591 (656)
T ss_dssp             SGGGEEEEETTE-EEECCCCCCCSCCC------------CCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             chHhEEEeCCCC-EEEEecCCCeecCCCcce--eccCCCCCcceeCHHHhcCC---CCCchhhHHHHHHHHHHHHHcCCC
Confidence            468999988765 999999999865432221  11233578899999998643   35789999999999999997 999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       592 Pf~~~~  597 (656)
T 2j0j_A          592 PFQGVK  597 (656)
T ss_dssp             TTTTCC
T ss_pred             CCCCCC
Confidence            998754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=98.98  E-value=1.8e-10  Score=105.67  Aligned_cols=76  Identities=28%  Similarity=0.456  Sum_probs=56.8

Q ss_pred             cCCccEEEecCCCc-------eEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHH
Q psy10603        306 YARANIFLTAEGNS-------LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLV  378 (407)
Q Consensus       306 ~~~~nill~~~~~~-------~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~  378 (407)
                      .++.|++++.++..       +|++|||++......       ....||+.|+|||++.+..  .++.++||||+||+++
T Consensus       139 lkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~  209 (289)
T 4fvq_A          139 VCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPK--NLNLATDKWSFGTTLW  209 (289)
T ss_dssp             CCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGG--GCCHHHHHHHHHHHHH
T ss_pred             cCcceEEEecCCcccccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCC--CCCchhHHHHHHHHHH
Confidence            35678888776642       999999999654321       2346899999999987522  2468999999999999


Q ss_pred             HHHh-CCCCCCCC
Q psy10603        379 EMSS-GKTNLSGV  390 (407)
Q Consensus       379 e~~~-g~~~~~~~  390 (407)
                      ||++ |.++|.+.
T Consensus       210 el~~g~~~~~~~~  222 (289)
T 4fvq_A          210 EICSGGDKPLSAL  222 (289)
T ss_dssp             HHHTTTCCTTTTS
T ss_pred             HHHcCCCCCcccc
Confidence            9999 55666554

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	407
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-74
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-13
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-72
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-15
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-71
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-13
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-69
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-12
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-14
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-69
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-15
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-16
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-68
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-12
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-67
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-12
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-66
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-10
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-65
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-16
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-15
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-64
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-10
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-63
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-11
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-12
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-61
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-10
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-61
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-12
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-59
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-09
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-07
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-59
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-09
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-11
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-08
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-08
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-57
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-09
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-57
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-09
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-57
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-10
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-09
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-08
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-56
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-08
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-07
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-05
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-55
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-10
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-08
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-08
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-07
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-09
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-54
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-10
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-08
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-07
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-09
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-08
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-06
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-08
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-52
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-07
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-52
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-06
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-07
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-51
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-12
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-51
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-06
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-06
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-11
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-50
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-08
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-49
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-06
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-08
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-12
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-04
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-04
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-44
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-04
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-05
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-42
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-38
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-19

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 3e-74
 Identities = 87/260 (33%), Positives = 138/260 (53%), Gaps = 12/260 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FGKVY A N ET  L A K I    + +   ++D +VE+ IL   +  N+VK    
Sbjct: 21  GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDA 77

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
             +   + + +E C  G +++++   E  L E  ++   KQ +DA++ LH+N I+HRD+K
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM--DTNKVGHG 188
           + NI  T +G+ +KL DFG + K +         + F+GT  +MAPEV M   +    + 
Sbjct: 138 AGNILFTLDGD-IKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELC 246
              D+WSLG  L+EM+  + P  E  +  +++ K+   E PT+  P   S   + F + C
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252

Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  +   R T  +LLQHPF+
Sbjct: 253 LEKNVDARWTTSQLLQHPFV 272

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 37/160 (23%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVL-------PPMSEDSVKVYA 307
             I     HP  IV   +      ++   +L ++   G V         P++E  ++V  
Sbjct: 60  IDILASCDHPN-IVKLLDAFYYENNL--WILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 308 R---------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 346
           +                      NI  T +G+ +KL DFG + K +         + F+G
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQ---RRDSFIG 172

Query: 347 TQAYMAPEVFM--DTNKVGHGRAVDIWSLGCVLVEMSSGK 384
           T  +MAPEV M   +    +    D+WSLG  L+EM+  +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  227 bits (581), Expect = 1e-72
 Identities = 78/258 (30%), Positives = 132/258 (51%), Gaps = 11/258 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A +    E+VA+K++    +      +D++ E+R L+ +   N ++Y G 
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 83

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +      L ME C  G+   L++  +  L EV +   T   +  ++ LH + ++HRD+K
Sbjct: 84  YLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + NI L+  G  +KLGDFGSA  ++         N FVGT  +MAPEV +  ++  +   
Sbjct: 143 AGNILLSEPGL-VKLGDFGSASIMA-------PANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES-LSDEGQAFAELCLRH 249
           VD+WSLG   +E++  K P     +    ++ +   E+P +     S+  + F + CL+ 
Sbjct: 195 VDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 250 DPAQRATIFELLQHPFLI 267
            P  R T   LL+H F++
Sbjct: 254 IPQDRPTSEVLLKHRFVL 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 72.3 bits (177), Expect = 9e-15
 Identities = 37/163 (22%), Positives = 56/163 (34%), Gaps = 40/163 (24%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRS-------VPASVLQDYLKLGIVLPPMSEDSVKVYA 307
               + L+HP   +          +          S             P+ E  +    
Sbjct: 66  VRFLQKLRHPN-TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVT 121

Query: 308 R---------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVG 346
                                  NI L+  G  +KLGDFGSA  ++         N FVG
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMA-------PANSFVG 173

Query: 347 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
           T  +MAPEV +  ++  +   VD+WSLG   +E++  K  L  
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (570), Expect = 1e-71
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 12/256 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G+FG VY A   ++  ++A+K +   +   A     +  E+ I   +   N+++ YG 
Sbjct: 15  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 74

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L +E    GT+   +Q       E     Y  +L +A+S  H   ++HRDIK
Sbjct: 75  FHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIK 133

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   
Sbjct: 134 PENLLLGSAGE-LKIADFGWSVHAPSSRR-----TTLCGTLDYLPPEMIEGR---MHDEK 184

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD+WSLG +  E   GK P+   ++  +   ++   E  T P+ +++  +      L+H+
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHN 242

Query: 251 PAQRATIFELLQHPFL 266
           P+QR  + E+L+HP++
Sbjct: 243 PSQRPMLREVLEHPWI 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 24/81 (29%), Positives = 33/81 (40%), Gaps = 9/81 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ L + G  LK+ DFG +V   +            GT  Y+ PE+        H   V
Sbjct: 135 ENLLLGSAGE-LKIADFGWSVHAPSSRR-----TTLCGTLDYLPPEMIEGR---MHDEKV 185

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WSLG +  E   GK     
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEA 206

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  221 bits (563), Expect = 2e-69
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 17/282 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+      TG   A K +    ++D   V+    E++ +  +    LV  +  
Sbjct: 35  GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDA 91

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                EMV+  E  + G L   V    + + E     Y +Q+   +  +HEN  VH D+K
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 151

Query: 131 SANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI  T + ++ LKL DFG    +    +    +    GT  + APEV         G 
Sbjct: 152 PENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAPEVAEGK---PVGY 204

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFAELC 246
             D+WS+G +   + SG  P+   +++ + +  V   +     +    +S++G+ F    
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263

Query: 247 LRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDY 288
           L  DP  R TI + L+HP+L  +          +P+S     
Sbjct: 264 LLADPNTRMTIHQALEHPWL--TPGNAPGRDSQIPSSRYTKI 303

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 63.9 bits (155), Expect = 7e-12
 Identities = 34/164 (20%), Positives = 59/164 (35%), Gaps = 39/164 (23%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVL-------PPMSEDSVKVYA 307
                +L+HP  +V+  +   +   +   ++ +++  G +          MSED    Y 
Sbjct: 74  IQTMSVLRHPT-LVNLHDAFEDDNEM--VMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130

Query: 308 R---------------------ANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFV 345
           R                      NI  T + ++ LKL DFG    +    +    +    
Sbjct: 131 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTT 186

Query: 346 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
           GT  + APEV         G   D+WS+G +   + SG +   G
Sbjct: 187 GTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGLSPFGG 227

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 4e-69
 Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 19/266 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G+         G+++  KE+      +A   + ++ E+ +L  +   N+V+YY  
Sbjct: 13  GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHPNIVRYYDR 71

Query: 71  EIHREE--MVLFMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHE---- 121
            I R    + + ME C  G L S++         L E  V R   QL  A+   H     
Sbjct: 72  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131

Query: 122 -NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM 180
            +T++HRD+K AN+FL  + N +KLGDFG A  ++  T+       FVGT  YM+PE   
Sbjct: 132 GHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSF---AKAFVGTPYYMSPEQMN 187

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ 240
                 +    DIWSLGC+L E+ +   P+    S  ++  K+  G+   IP   SDE  
Sbjct: 188 RM---SYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRYSDELN 243

Query: 241 AFAELCLRHDPAQRATIFELLQHPFL 266
                 L      R ++ E+L++P +
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 30/81 (37%), Positives = 42/81 (51%), Gaps = 7/81 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           AN+FL  + N +KLGDFG A  ++  T+       FVGT  YM+PE         +    
Sbjct: 143 ANVFLDGKQN-VKLGDFGLARILNHDTSF---AKAFVGTPYYMSPEQMNRM---SYNEKS 195

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           DIWSLGC+L E+ +     + 
Sbjct: 196 DIWSLGCLLYELCALMPPFTA 216

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 7e-69
 Identities = 76/257 (29%), Positives = 120/257 (46%), Gaps = 8/257 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G+V  AVN  T E VA+K +    +      +++  E+ I + +N +N+VK+YG 
Sbjct: 14  GEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                   LF+E C+ G L   ++  + G+PE   +R+  QL+  +  LH   I HRDIK
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 130

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L    N LK+ DFG A     +      LN   GT  Y+APE+     +  H   
Sbjct: 131 PENLLLDERDN-LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLK--RREFHAEP 186

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMGETPTIPESLSDEGQAFAELCLRH 249
           VD+WS G VL  M +G+ PW +   + Q               + +     A     L  
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 246

Query: 250 DPAQRATIFELLQHPFL 266
           +P+ R TI ++ +  + 
Sbjct: 247 NPSARITIPDIKKDRWY 263

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.0 bits (176), Expect = 7e-15
 Identities = 27/81 (33%), Positives = 36/81 (44%), Gaps = 4/81 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ L    N LK+ DFG A     +      LN   GT  Y+APE+     +  H   V
Sbjct: 132 ENLLLDERDN-LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLK--RREFHAEPV 187

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+WS G VL  M +G+     
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQ 208

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 9e-69
 Identities = 74/263 (28%), Positives = 133/263 (50%), Gaps = 18/263 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  VY  ++ ET   VA  E+Q  K   +   +    E  +L+G+   N+V++Y  
Sbjct: 18  GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN--TI 124
                  ++ +VL  EL T GTL++ ++     +   ++R + +Q++  +  LH     I
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K  NIF+T    S+K+GD G A    A           +GT  +MAPE++ +   
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEMYEE--- 187

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSDEGQAFA 243
             +  +VD+++ G  ++EM++ + P++E  +  QI  +V  G  P +  +    E +   
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
           E C+R +  +R +I +LL H F 
Sbjct: 247 EGCIRQNKDERYSIKDLLNHAFF 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 38/176 (21%), Positives = 69/176 (39%), Gaps = 45/176 (25%)

Query: 255 ATIFELLQHPF---LIVSCEEDVCNPRS-------VPASVLQDYLKLGIVLPPMSEDSVK 304
           A + + LQHP       S E  V   +        + +  L+ YLK       M    ++
Sbjct: 59  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLR 115

Query: 305 VYAR-----------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL 341
            + R                        NIF+T    S+K+GD G A    A        
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----- 170

Query: 342 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSGVVVSAEVF 397
              +GT  +MAPE++ +     +  +VD+++ G  ++EM++ +   S    +A+++
Sbjct: 171 KAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 3e-68
 Identities = 86/274 (31%), Positives = 140/274 (51%), Gaps = 15/274 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG  G VYTA++  TG+ VA++++ L +Q     + +   E+ ++      N+V Y   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNPNIVNYLDS 85

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            +  +E+ + ME    G+L  +V   E  + E  +    ++ + A+  LH N ++HRDIK
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NI L  +G+ +KL DFG   +I+   +   + +  VGT  +MAPEV        +G  
Sbjct: 144 SDNILLGMDGS-VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK---AYGPK 196

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI--PESLSDEGQAFAELCLR 248
           VDIWSLG + +EM  G+ P+   ++  + ++ +    TP +  PE LS   + F   CL 
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 249 HDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPA 282
            D  +R +  ELLQH FL ++       P    A
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.2 bits (156), Expect = 3e-12
 Identities = 35/153 (22%), Positives = 57/153 (37%), Gaps = 30/153 (19%)

Query: 255 ATIFELLQHPFLI--VSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYAR---- 308
             +    ++P ++  +           V   +    L   +    M E  +    R    
Sbjct: 68  ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127

Query: 309 -----------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYM 351
                             NI L  +G+ +KL DFG   +I+   +   + +  VGT  +M
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQS---KRSTMVGTPYWM 183

Query: 352 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
           APEV        +G  VDIWSLG + +EM  G+
Sbjct: 184 APEVVTRK---AYGPKVDIWSLGIMAIEMIEGE 213

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 4e-67
 Identities = 67/262 (25%), Positives = 114/262 (43%), Gaps = 14/262 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G F  V  A    T    A+K ++         V  +  E  ++  ++    VK Y  
Sbjct: 17  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 76

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               E++   +     G L   ++       E   R YT ++V A+  LH   I+HRD+K
Sbjct: 77  FQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 135

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L  + + +++ DFG+A K+ +  +     N FVGT  Y++PE+  +       ++
Sbjct: 136 PENILLNEDMH-IQITDFGTA-KVLSPESKQARANSFVGTAQYVSPELLTEK---SACKS 190

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            D+W+LGC++ ++ +G  P+    + Y I  K+   E    PE    + +   E  L  D
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLD 248

Query: 251 PAQRATIFE------LLQHPFL 266
             +R    E      L  HPF 
Sbjct: 249 ATKRLGCEEMEGYGPLKAHPFF 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.5 bits (154), Expect = 6e-12
 Identities = 32/155 (20%), Positives = 58/155 (37%), Gaps = 33/155 (21%)

Query: 257 IFELLQHPFLIVSCEEDVCNPRSVPASVLQ-----DYLKLGIVLPPMSEDSVKVYAR--- 308
           +   L HPF  V                L      + LK    +    E   + Y     
Sbjct: 61  VMSRLDHPF-FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118

Query: 309 ------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY 350
                              NI L  + + +++ DFG+A K+ +  +     N FVGT  Y
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTA-KVLSPESKQARANSFVGTAQY 176

Query: 351 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           ++PE+  +       ++ D+W+LGC++ ++ +G  
Sbjct: 177 VSPELLTEK---SACKSSDLWALGCIIYQLVAGLP 208

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  213 bits (544), Expect = 1e-66
 Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 15/260 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG V+  V   TG +   K I      D   VK+   E+ I+  ++   L+  +  
Sbjct: 38  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDA 94

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              + EMVL +E  + G L   + + +  + E  V  Y +Q  + +  +HE++IVH DIK
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 154

Query: 131 SANIFLTAEGN-SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI    +   S+K+ DFG A K++        +     T  + APE+         G 
Sbjct: 155 PENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEFAAPEIVDRE---PVGF 207

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFAELC 246
             D+W++G +   + SG  P+A  + + + +  V   +         S+S E + F +  
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266

Query: 247 LRHDPAQRATIFELLQHPFL 266
           L+ +P +R T+ + L+HP+L
Sbjct: 267 LQKEPRKRLTVHDALEHPWL 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 58.1 bits (140), Expect = 6e-10
 Identities = 32/164 (19%), Positives = 55/164 (33%), Gaps = 39/164 (23%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRS-------VPASVLQDYLKLGIVLPPMSEDSVKVYA 307
            +I   L HP  +++  +   +          +    L D +        MSE  V  Y 
Sbjct: 77  ISIMNQLHHPK-LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYM 133

Query: 308 R---------------------ANIFLTAEGN-SLKLGDFGSAVKISAHTTVPGELNGFV 345
           R                      NI    +   S+K+ DFG A K++        +    
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTT 189

Query: 346 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
            T  + APE+         G   D+W++G +   + SG +  +G
Sbjct: 190 ATAEFAAPEIVDRE---PVGFYTDMWAIGVLGYVLLSGLSPFAG 230

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 1e-65
 Identities = 59/257 (22%), Positives = 114/257 (44%), Gaps = 11/257 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY    +     VA+K + +      + ++    E+ +L      N++ + G 
Sbjct: 17  GSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ +  + C   +L   +   E     + +    +Q    +  LH  +I+HRD+K
Sbjct: 73  STA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           S NIFL  +   +K+GDFG A  + +  +   +     G+  +MAPEV    +K  +   
Sbjct: 132 SNNIFLHEDLT-VKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMG----ETPTIPESLSDEGQAFAELC 246
            D+++ G VL E+ +G+ P++  ++  QI+F VG G    +   +  +     +     C
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAEC 249

Query: 247 LRHDPAQRATIFELLQH 263
           L+    +R    ++L  
Sbjct: 250 LKKKRDERPLFPQILAS 266

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.4 bits (185), Expect = 6e-16
 Identities = 24/82 (29%), Positives = 42/82 (51%), Gaps = 2/82 (2%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NIFL  +   +K+GDFG A  + +  +   +     G+  +MAPEV    +K  +    
Sbjct: 133 NNIFLHEDLT-VKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190

Query: 369 DIWSLGCVLVEMSSGKTNLSGV 390
           D+++ G VL E+ +G+   S +
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNI 212

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 5e-65
 Identities = 78/307 (25%), Positives = 137/307 (44%), Gaps = 55/307 (17%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V+   +  +G ++A K I  H +        ++ EL++L   N   +V +YG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDI 129
                E+ + ME    G+L+ +++     +PE ++ + +  ++  ++ L E + I+HRD+
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 131

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K +NI + + G  +KL DFG + ++          N FVGT++YM+PE    T    +  
Sbjct: 132 KPSNILVNSRGE-IKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGT---HYSV 182

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSN--------------------------------- 216
             DIWS+G  LVEM+ G+ P    D+                                  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 217 --------YQIMFKVGMGETPTIPES-LSDEGQAFAELCLRHDPAQRATIFELLQHPFLI 267
                   ++++  +     P +P    S E Q F   CL  +PA+RA + +L+ H F+ 
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302

Query: 268 VSCEEDV 274
            S  E+V
Sbjct: 303 RSDAEEV 309

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.8 bits (178), Expect = 7e-15
 Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 9/77 (11%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           +NI + + G  +KL DFG + ++          N FVGT++YM+PE    T    +    
Sbjct: 134 SNILVNSRGE-IKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGT---HYSVQS 184

Query: 369 DIWSLGCVLVEMSSGKT 385
           DIWS+G  LVEM+ G+ 
Sbjct: 185 DIWSMGLSLVEMAVGRY 201

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-64
 Identities = 64/260 (24%), Positives = 110/260 (42%), Gaps = 16/260 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V+  V   + +    K +++   +     K    E+ IL     +N++  +  
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHES 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               EE+V+  E  +   +   + ++   L E  +  Y  Q+ +A+  LH + I H DI+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129

Query: 131 SANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
             NI      +S +K+ +FG A ++                  Y APEV           
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYAPEVHQHD---VVST 182

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFAELC 246
           A D+WSLG ++  + SG  P+   ++N QI+  +   E        + +S E   F +  
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 247 LRHDPAQRATIFELLQHPFL 266
           L  +   R T  E LQHP+L
Sbjct: 242 LVKERKSRMTASEALQHPWL 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 26/160 (16%), Positives = 48/160 (30%), Gaps = 39/160 (24%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRS-------VPASVLQDYLKLGIVLPPMSEDSVKVYA 307
            +I  + +H   I+   E   +          +    + + +        ++E  +  Y 
Sbjct: 52  ISILNIARHRN-ILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYV 108

Query: 308 R---------------------ANIFLTAEGNS-LKLGDFGSAVKISAHTTVPGELNGFV 345
                                  NI      +S +K+ +FG A ++              
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLF 164

Query: 346 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
               Y APEV           A D+WSLG ++  + SG  
Sbjct: 165 TAPEYYAPEVHQHD---VVSTATDMWSLGTLVYVLLSGIN 201

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 8e-63
 Identities = 67/258 (25%), Positives = 110/258 (42%), Gaps = 12/258 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRIL-EGINQKNLVKYYG 69
           G+G FGKV+ A   +T +  A+K ++         V+  +VE R+L        L   + 
Sbjct: 11  GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 70

Query: 70  VEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               +E +   ME    G L   +QS            Y  +++  +  LH   IV+RD+
Sbjct: 71  TFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 129

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           K  NI L  +G+  K+ DFG   +           N F GT  Y+APE+ +      +  
Sbjct: 130 KLDNILLDKDGHI-KIADFGMCKENMLGDAKT---NTFCGTPDYIAPEILLGQ---KYNH 182

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
           +VD WS G +L EM  G+ P+  +  + + +F     + P  P  L  E +         
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 250 DPAQRATIF-ELLQHPFL 266
           +P +R  +  ++ QHP  
Sbjct: 241 EPEKRLGVRGDIRQHPLF 258

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.5 bits (146), Expect = 8e-11
 Identities = 25/77 (32%), Positives = 37/77 (48%), Gaps = 7/77 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI L  +G+  K+ DFG   +           N F GT  Y+APE+ +      +  +V
Sbjct: 132 DNILLDKDGHI-KIADFGMCKENMLGDAKT---NTFCGTPDYIAPEILLGQ---KYNHSV 184

Query: 369 DIWSLGCVLVEMSSGKT 385
           D WS G +L EM  G++
Sbjct: 185 DWWSFGVLLYEMLIGQS 201

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  199 bits (508), Expect = 3e-62
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 20/269 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI------QLHKQNDARFVKDMLVELRILEGIN-QKN 63
           G+G    V   ++  T +  A+K I          +      +  L E+ IL  ++   N
Sbjct: 12  GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 71

Query: 64  LVKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT 123
           +++            L  +L  +G L   +   +  L E   R+  + L++ I ALH+  
Sbjct: 72  IIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLN 130

Query: 124 IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM--- 180
           IVHRD+K  NI L  + N +KL DFG + ++         L    GT +Y+APE+     
Sbjct: 131 IVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSM 185

Query: 181 DTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSD 237
           + N  G+G+ VD+WS G ++  + +G  P+        ++  +  G         +  SD
Sbjct: 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
             +      L   P +R T  E L HPF 
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 64.7 bits (157), Expect = 2e-12
 Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 8/80 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFM---DTNKVGHG 365
            NI L  + N +KL DFG + ++         L    GT +Y+APE+     + N  G+G
Sbjct: 139 ENILLDDDMN-IKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYG 193

Query: 366 RAVDIWSLGCVLVEMSSGKT 385
           + VD+WS G ++  + +G  
Sbjct: 194 KEVDMWSTGVIMYTLLAGSP 213

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 20/285 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G F +V  A +  T +LVA+K I   K+        M  E+ +L  I   N+V    +
Sbjct: 18  GTGAFSEVILAEDKRTQKLVAIKCI--AKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + L M+L + G L   +   +    E    R   Q++DA+  LH+  IVHRD+K
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134

Query: 131 SANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
             N+   +  E + + + DFG +      +     L+   GT  Y+APEV        + 
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGSV----LSTACGTPGYVAPEVLAQK---PYS 187

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFAEL 245
           +AVD WS+G +   +  G  P+ + +++ ++  ++   E        + +SD  + F   
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK 290
            +  DP +R T  + LQHP++      D    +++  SV +   K
Sbjct: 247 LMEKDPEKRFTCEQALQHPWI----AGDTALDKNIHQSVSEQIKK 287

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.5 bits (141), Expect = 3e-10
 Identities = 19/80 (23%), Positives = 32/80 (40%), Gaps = 7/80 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
             +   E + + + DFG +      +     L+   GT  Y+APEV        + +AVD
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSV----LSTACGTPGYVAPEVLAQK---PYSKAVD 191

Query: 370 IWSLGCVLVEMSSGKTNLSG 389
            WS+G +   +  G      
Sbjct: 192 CWSIGVIAYILLCGYPPFYD 211

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 8e-61
 Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 25/276 (9%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKD---MLVELRILEGINQ--KNLV 65
           G G FG VY+ +       VA+K ++  + +D   + +   + +E+ +L+ ++     ++
Sbjct: 13  GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 72

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
           +        +  VL +E            +    L E L R +  Q+++A+   H   ++
Sbjct: 73  RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVL 132

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRDIK  NI +      LKL DFGS   +            F GT+ Y  PE        
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-----TDFDGTRVYSPPEWIR--YHR 185

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
            HGR+  +WSLG +L +M  G  P+   +   +              + +S E Q     
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQRVSSECQHLIRW 237

Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVP 281
           CL   P+ R T  E+  HP++     +DV  P+   
Sbjct: 238 CLALRPSDRPTFEEIQNHPWM-----QDVLLPQETA 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (158), Expect = 2e-12
 Identities = 25/77 (32%), Positives = 32/77 (41%), Gaps = 7/77 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI +      LKL DFGS   +            F GT+ Y  PE         HGR+ 
Sbjct: 139 ENILIDLNRGELKLIDFGSGALLKDTVY-----TDFDGTRVYSPPEWIR--YHRYHGRSA 191

Query: 369 DIWSLGCVLVEMSSGKT 385
            +WSLG +L +M  G  
Sbjct: 192 AVWSLGILLYDMVCGDI 208

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-59
 Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 15/261 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FGKV       TG   AMK ++         V   + E R+L+      L      
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               + +   ME    G L   +   E    E   R Y  ++V A+  LH   +V+RDIK
Sbjct: 74  FQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ L  +G+ +K+ DFG   +  +       +  F GT  Y+APEV  D     +GRA
Sbjct: 133 LENLMLDKDGH-IKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDN---DYGRA 185

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W LG V+ EM  G+ P+  Y+ +++ +F++ + E    P +LS E ++     L+ D
Sbjct: 186 VDWWGLGVVMYEMMCGRLPF--YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243

Query: 251 PAQR-----ATIFELLQHPFL 266
           P QR     +   E+++H F 
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFF 264

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.2 bits (132), Expect = 5e-09
 Identities = 37/159 (23%), Positives = 59/159 (37%), Gaps = 31/159 (19%)

Query: 255 ATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIVL---PPMSEDSVKVYAR--- 308
           + + +  +HPFL         + R        +  +L   L      +E+  + Y     
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115

Query: 309 ------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY 350
                              N+ L  +G+ +K+ DFG   +  +       +  F GT  Y
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGAT---MKTFCGTPEY 171

Query: 351 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
           +APEV  D     +GRAVD W LG V+ EM  G+     
Sbjct: 172 LAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 8e-59
 Identities = 57/269 (21%), Positives = 107/269 (39%), Gaps = 14/269 (5%)

Query: 11  GQGRFGKVYTAVNNETGE--LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V   V     +   VA+K   L +  +    ++M+ E +I+  ++   +V+  
Sbjct: 18  GCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           GV    E ++L ME+   G L   +    + +P   V     Q+   +  L E   VHRD
Sbjct: 76  GV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           + + N+ L       K+ DFG +  + A  +     +       + APE           
Sbjct: 135 LAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---KFS 190

Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G  + E  S G++P+ +     ++M  +  G+    P     E  A    C 
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249

Query: 248 RHDPAQR---ATIFELLQHPFLIVSCEED 273
            +    R    T+ + ++  +  ++ + +
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (113), Expect = 9e-07
 Identities = 15/72 (20%), Positives = 24/72 (33%), Gaps = 4/72 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ L       K+ DFG +  + A  +     +       + APE              
Sbjct: 138 RNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR---KFSSRS 193

Query: 369 DIWSLGCVLVEM 380
           D+WS G  + E 
Sbjct: 194 DVWSYGVTMWEA 205

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  192 bits (488), Expect = 9e-59
 Identities = 58/261 (22%), Positives = 111/261 (42%), Gaps = 18/261 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V+   +   G   AMK ++       + V+    E  +L  +    +++ +G 
Sbjct: 13  GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT 72

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               +++ + M+   EG     +       P  + + Y  ++  A+  LH   I++RD+K
Sbjct: 73  FQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 131

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             NI L   G+ +K+ DFG A  +   T          GT  Y+APEV        + ++
Sbjct: 132 PENILLDKNGH-IKITDFGFAKYVPDVTYT------LCGTPDYIAPEVVSTK---PYNKS 181

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           +D WS G ++ EM +G  P+ +  +  +   K+   E    P   +++ +      +  D
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRD 239

Query: 251 PAQR-----ATIFELLQHPFL 266
            +QR         ++  HP+ 
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWF 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.7 bits (131), Expect = 5e-09
 Identities = 40/205 (19%), Positives = 70/205 (34%), Gaps = 45/205 (21%)

Query: 215 SNYQIMFKVGMGETPTIPESLSDE-GQAFAELCLRHDPAQR----------ATIFELLQH 263
            ++QI+  +G G    +    S   G+ +A   L+ +   R            +  ++ H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 264 PF---LIVSCEEDVCNPRSVPASVLQDYLKLGIVLPPMSEDSVKVYAR------------ 308
           PF   +  + ++       +      +   L            K YA             
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 309 ---------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 359
                     NI L   G+ +K+ DFG A  +   T          GT  Y+APEV    
Sbjct: 124 DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYT------LCGTPDYIAPEVVSTK 176

Query: 360 NKVGHGRAVDIWSLGCVLVEMSSGK 384
               + +++D WS G ++ EM +G 
Sbjct: 177 ---PYNKSIDWWSFGILIYEMLAGY 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-58
 Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 18/265 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR---FVKDMLVELRILEGINQKNLVKY 67
           G G+F  V       TG   A K I+  +   +R     +D+  E+ IL+ I   N++  
Sbjct: 19  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 78

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           + V  ++ +++L +EL   G L   +   ++ L E     + KQ+++ +  LH   I H 
Sbjct: 79  HEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHF 137

Query: 128 DIKSANIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           D+K  NI L         +K+ DFG A KI        E     GT  ++APE+      
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYE-- 191

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQA 241
              G   D+WS+G +   + SG  P+   D+  + +  V             + S   + 
Sbjct: 192 -PLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249

Query: 242 FAELCLRHDPAQRATIFELLQHPFL 266
           F    L  DP +R TI + LQHP++
Sbjct: 250 FIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (148), Expect = 4e-11
 Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 10/83 (12%)

Query: 310 NIFLTAEGNS---LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 366
           NI L         +K+ DFG A KI        E     GT  ++APE+         G 
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYE---PLGL 195

Query: 367 AVDIWSLGCVLVEMSSGKTNLSG 389
             D+WS+G +   + SG +   G
Sbjct: 196 EADMWSIGVITYILLSGASPFLG 218

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 7e-58
 Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 14/261 (5%)

Query: 11  GQGRFGKVYTAV--NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG V        +  + VA+K ++ ++ ND     ++L E  +++ ++   +V+  
Sbjct: 16  GSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G+    E  +L ME+   G L   +Q     + +  +     Q+   +  L E+  VHRD
Sbjct: 75  GI-CEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           + + N+ L  +    K+ DFG +  + A                + APE           
Sbjct: 133 LAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---KFS 188

Query: 189 RAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
              D+WS G ++ E  S G++P+       ++   +  GE    P     E      LC 
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247

Query: 248 RHDPAQRAT---IFELLQHPF 265
            +D   R     +   L++ +
Sbjct: 248 TYDVENRPGFAAVELRLRNYY 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 1e-08
 Identities = 15/72 (20%), Positives = 23/72 (31%), Gaps = 3/72 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           A   L    +  K+ DFG +  + A                + APE              
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY---KFSSKS 191

Query: 369 DIWSLGCVLVEM 380
           D+WS G ++ E 
Sbjct: 192 DVWSFGVLMWEA 203

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-57
 Identities = 52/253 (20%), Positives = 100/253 (39%), Gaps = 11/253 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG V+        + VA+K I+    ++  F++    E  ++  ++   LV+ YGV
Sbjct: 14  GSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 68

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
            + +  + L  E    G L   +++         +      + + ++ L E  ++HRD+ 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + N  +      +K+ DFG    +           G      + +PEVF  +    +   
Sbjct: 129 ARNCLVGENQV-IKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFS---RYSSK 182

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            D+WS G ++ E+ S  +   E  SN +++  +  G     P   S         C +  
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKER 242

Query: 251 PAQRATIFELLQH 263
           P  R     LL+ 
Sbjct: 243 PEDRPAFSRLLRQ 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (123), Expect = 4e-08
 Identities = 16/76 (21%), Positives = 28/76 (36%), Gaps = 6/76 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N  +      +K+ DFG    +           G      + +PEVF  +    +    
Sbjct: 130 RNCLVGENQV-IKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFS---RYSSKS 183

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G ++ E+ S  
Sbjct: 184 DVWSFGVLMWEVFSEG 199

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-57
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 27/269 (10%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  GKV    N  T E  A+K +Q    +  +  +++ +  R        ++V+   V
Sbjct: 21  GLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRAS---QCPHIVRIVDV 73

Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTED-GLPEVLVRRYTKQLVDAISALHENTIV 125
                  R+ +++ ME    G L S +Q   D    E       K + +AI  LH   I 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 133

Query: 126 HRDIKSANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTN 183
           HRD+K  N+  T++  +  LKL DFG A + ++H ++         T  Y+APEV     
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TTPCYTPYYVAPEVLGPE- 188

Query: 184 KVGHGRAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGE---TPTIPESLSD 237
              + ++ D+WSLG ++  +  G  P+        +  +  ++ MG+          +S+
Sbjct: 189 --KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 238 EGQAFAELCLRHDPAQRATIFELLQHPFL 266
           E +      L+ +P QR TI E + HP++
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (135), Expect = 2e-09
 Identities = 29/159 (18%), Positives = 55/159 (34%), Gaps = 41/159 (25%)

Query: 260 LLQHPFLI--VSCEEDVCNPRS--------VPASVLQDYLKLGIVLPPMSEDSVKVYAR- 308
             Q P ++  V   E++   R         +    L   ++        +E       + 
Sbjct: 61  ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKS 119

Query: 309 --------------------ANIFLTAEGNS--LKLGDFGSAVKISAHTTVPGELNGFVG 346
                                N+  T++  +  LKL DFG A + ++H ++         
Sbjct: 120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TTPCY 175

Query: 347 TQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           T  Y+APEV        + ++ D+WSLG ++  +  G  
Sbjct: 176 TPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCGYP 211

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  189 bits (482), Expect = 2e-57
 Identities = 62/265 (23%), Positives = 118/265 (44%), Gaps = 18/265 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG+VY     +TG++ AMK +   ++  +       +  + L ++   +   +V  
Sbjct: 13  GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 72

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
                  +++   ++L   G L   +        E  +R Y  +++  +  +H   +V+R
Sbjct: 73  SYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K ANI L   G+ +++ D G A   S       + +  VGT  YMAPEV      V +
Sbjct: 132 DLKPANILLDEHGH-VRISDLGLACDFS-----KKKPHASVGTHGYMAPEVLQ--KGVAY 183

Query: 188 GRAVDIWSLGCVLVEMSSGKRPW-AEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
             + D +SLGC+L ++  G  P+      +   + ++ +     +P+S S E ++  E  
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243

Query: 247 LRHDPAQRATIF-----ELLQHPFL 266
           L+ D  +R         E+ + PF 
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFF 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.7 bits (131), Expect = 7e-09
 Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 8/81 (9%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI L   G+ +++ D G A   S       + +  VGT  YMAPEV      V +  + 
Sbjct: 136 ANILLDEHGH-VRISDLGLACDFS-----KKKPHASVGTHGYMAPEVLQ--KGVAYDSSA 187

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D +SLGC+L ++  G +    
Sbjct: 188 DWFSLGCMLFKLLRGHSPFRQ 208

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 5e-57
 Identities = 64/284 (22%), Positives = 120/284 (42%), Gaps = 35/284 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDAR--FVKDMLVELRILEGINQKNLVKYY 68
           G+G+F  VY A +  T ++VA+K+I+L  +++A+    +  L E+++L+ ++  N++   
Sbjct: 7   GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
               H+  + L  +   E  LE +++     L    ++ Y    +  +  LH++ I+HRD
Sbjct: 67  DAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           +K  N+ L   G  LKL DFG A    +           V T+ Y APE+        +G
Sbjct: 126 LKPNNLLLDENGV-LKLADFGLAKSFGSPNRAY---THQVVTRWYRAPELLFGAR--MYG 179

Query: 189 RAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPE------------ 233
             VD+W++GC+L E+           + D   +I   +G       P+            
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 234 -----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                      +  D+     +     +P  R T  + L+  + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.1 bits (142), Expect = 2e-10
 Identities = 26/81 (32%), Positives = 36/81 (44%), Gaps = 6/81 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ L   G  LKL DFG A    +           V T+ Y APE+        +G  V
Sbjct: 129 NNLLLDENGV-LKLADFGLAKSFGSPNRAY---THQVVTRWYRAPELLFGAR--MYGVGV 182

Query: 369 DIWSLGCVLVEMSSGKTNLSG 389
           D+W++GC+L E+      L G
Sbjct: 183 DMWAVGCILAELLLRVPFLPG 203

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 5e-57
 Identities = 54/255 (21%), Positives = 99/255 (38%), Gaps = 19/255 (7%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG V        G  VA+K I      +    +  L E  ++  +   NLV+  GV
Sbjct: 16  GKGEFGDVMLGDY--RGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 71  EIH-REEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRD 128
            +  +  + +  E   +G+L   ++S     L    + +++  + +A+  L  N  VHRD
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           + + N+ ++ +    K+ DFG   + S+                + APE   +       
Sbjct: 129 LAARNVLVSEDNV-AKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREK---KFS 178

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
              D+WS G +L E+ S  R          ++ +V  G     P+          + C  
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238

Query: 249 HDPAQRATIFELLQH 263
            D A R +  +L + 
Sbjct: 239 LDAAMRPSFLQLREQ 253

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 30/182 (16%), Positives = 57/182 (31%), Gaps = 46/182 (25%)

Query: 237 DEGQAFAELCLRHDPAQRATIFEL-----LQHPFLIVSCEEDVCNPRS--------VPAS 283
             G   A  C+++D   +A + E      L+H   +V     +   +         +   
Sbjct: 28  YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSN-LVQLLGVIVEEKGGLYIVTEYMAKG 86

Query: 284 VLQDYLKLGIVLPPMSEDSVKVYAR---------------------ANIFLTAEGNSLKL 322
            L DYL+       +  D +  ++                       N+ ++ +    K+
Sbjct: 87  SLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKV 144

Query: 323 GDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS 382
            DFG   + S+                + APE   +          D+WS G +L E+ S
Sbjct: 145 SDFGLTKEASSTQD------TGKLPVKWTAPEALREK---KFSTKSDVWSFGILLWEIYS 195

Query: 383 GK 384
             
Sbjct: 196 FG 197

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 9e-57
 Identities = 52/253 (20%), Positives = 99/253 (39%), Gaps = 11/253 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG V           VA+K I+    ++  F++    E +++  ++ + LV+ YGV
Sbjct: 13  GTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              +  + +  E    G L + ++          +    K + +A+  L     +HRD+ 
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
           + N  +  +G  +K+ DFG +  +           G      +  PEV M +        
Sbjct: 128 ARNCLVNDQGV-VKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYS---KFSSK 181

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
            DIW+ G ++ E+ S  +   E  +N +    +  G     P   S++       C    
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241

Query: 251 PAQRATIFELLQH 263
             +R T   LL +
Sbjct: 242 ADERPTFKILLSN 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.2 bits (122), Expect = 6e-08
 Identities = 17/73 (23%), Positives = 29/73 (39%), Gaps = 6/73 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N  +  +G  +K+ DFG +  +           G      +  PEV M +         D
Sbjct: 130 NCLVNDQGV-VKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYS---KFSSKSD 183

Query: 370 IWSLGCVLVEMSS 382
           IW+ G ++ E+ S
Sbjct: 184 IWAFGVLMWEIYS 196

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 6e-56
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 34/283 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A N  TGE+VA+K+I+L  + +       + E+ +L+ +N  N+VK   V
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                ++ L  E   +   + +  S   G+P  L++ Y  QL+  ++  H + ++HRD+K
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  EG  +KL DFG A                V T  Y APE+ +      +  A
Sbjct: 130 PQNLLINTEGA-IKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKY--YSTA 183

Query: 191 VDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPE-------------- 233
           VDIWSLGC+  EM + +  +    E D  ++I   +G  +    P               
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243

Query: 234 ----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                      L ++G++     L +DP +R +    L HPF 
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.9 bits (126), Expect = 2e-08
 Identities = 27/80 (33%), Positives = 36/80 (45%), Gaps = 6/80 (7%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +  EG  +KL DFG A                V T  Y APE+ +      +  AVD
Sbjct: 132 NLLINTEGA-IKLADFGLARAFGVPVRTY---THEVVTLWYRAPEILLGCKY--YSTAVD 185

Query: 370 IWSLGCVLVEMSSGKTNLSG 389
           IWSLGC+  EM + +    G
Sbjct: 186 IWSLGCIFAEMVTRRALFPG 205

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-55
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 15/259 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G+FG+V+    N     VA+K ++    +   F+     E  +++ +  + LV+ Y V
Sbjct: 22  GAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYAV 76

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDG-LPEVLVRRYTKQLVDAISALHENTIVHRDI 129
               E + +  E    G+L   +++     L    +     Q+ + ++ + E   +HRD+
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           ++ANI ++   +  K+ DFG A  I  +        G      + APE            
Sbjct: 136 RAANILVSDTLSC-KIADFGLARLIEDNEYTA--REGAKFPIKWTAPEAINYGT---FTI 189

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             D+WS G +L E+ +  R      +N +++  +  G     P++  +E      LC + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249

Query: 250 DPAQRATIFELLQ--HPFL 266
            P  R T   L      F 
Sbjct: 250 RPEDRPTFDYLRSVLEDFF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.5 bits (115), Expect = 5e-07
 Identities = 37/216 (17%), Positives = 67/216 (31%), Gaps = 48/216 (22%)

Query: 208 RPWAEYD-----SNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQR------AT 256
           +PW E +        +++ ++G G+   +     +     A   L+            A 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN 60

Query: 257 IFELLQHPFLIVSCEEDVCNPRS-------VPASVLQDYLKLGIVLPPMSEDSVKVYAR- 308
           + + LQH   +V     V            +    L D+LK       ++ + +   A  
Sbjct: 61  LMKQLQHQR-LVRLY-AVVTQEPIYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQ 117

Query: 309 --------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQ 348
                               ANI ++   +  K+ DFG A  I  +        G     
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTA--REGAKFPI 174

Query: 349 AYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
            + APE              D+WS G +L E+ +  
Sbjct: 175 KWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHG 207

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 4e-55
 Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 12/256 (4%)

Query: 11  GQGRFGKVYTAVN---NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G+FG V+  +          VA+K             +  L E   +   +  ++VK 
Sbjct: 16  GEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV I    + + MELCT G L S +Q  +  L    +  Y  QL  A++ L     VHR
Sbjct: 74  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           DI + N+ +++    +KLGDFG +  +   T    + +       +MAPE          
Sbjct: 133 DIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFR---RF 186

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCL 247
             A D+W  G  + E+        +   N  ++ ++  GE   +P +      +    C 
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCW 246

Query: 248 RHDPAQRATIFELLQH 263
            +DP++R    EL   
Sbjct: 247 AYDPSRRPRFTELKAQ 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (102), Expect = 2e-05
 Identities = 17/71 (23%), Positives = 30/71 (42%), Gaps = 6/71 (8%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ +++    +KLGDFG +  +   T    + +       +MAPE            A D
Sbjct: 138 NVLVSSNDC-VKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFR---RFTSASD 191

Query: 370 IWSLGCVLVEM 380
           +W  G  + E+
Sbjct: 192 VWMFGVCMWEI 202

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 6e-55
 Identities = 72/291 (24%), Positives = 115/291 (39%), Gaps = 48/291 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG VY A   ++GELVA+K++   K+   R       EL+I+  ++  N+V+    
Sbjct: 29  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYF 81

Query: 71  EIHREE------MVLFMELCTEGTLESLVQSTEDG--LPEVLVRRYTKQLVDAISALHEN 122
                E      + L ++   E         +     LP + V+ Y  QL  +++ +H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            I HRDIK  N+ L  +   LKL DFGSA ++            ++ ++ Y APE+    
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICSRYYRAPELIF-- 195

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT------------ 230
               +  ++D+WS GCVL E+  G+  +       Q++  + +  TPT            
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 231 ---------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                                 E  A     L + P  R T  E   H F 
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (142), Expect = 3e-10
 Identities = 46/227 (20%), Positives = 76/227 (33%), Gaps = 45/227 (19%)

Query: 201 VEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE-SLSDEGQAFAELCLRHDPAQR---AT 256
           V  + G+ P    + +Y     +G G    + +  L D G+  A   +  D   +     
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ 65

Query: 257 IFELLQHPFLIVSCEEDVCNPRS-------------VPASVLQDYLKLGIVLPPMSEDSV 303
           I   L H   IV       +                VP +V +           +    V
Sbjct: 66  IMRKLDHCN-IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 304 KVYAR---------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN 342
           K+Y                        N+ L  +   LKL DFGSA ++           
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----V 180

Query: 343 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
            ++ ++ Y APE+        +  ++D+WS GCVL E+  G+    G
Sbjct: 181 SYICSRYYRAPELIF--GATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 7e-55
 Identities = 61/258 (23%), Positives = 100/258 (38%), Gaps = 11/258 (4%)

Query: 11  GQGRFGKVYTAVNNET---GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG V     +        VA+K ++    +    + D + E+  +  ++ +NL++ 
Sbjct: 17  GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           YGV +    M +  EL   G+L   ++  +       + RY  Q+ + +  L     +HR
Sbjct: 77  YGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 135

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+ + N+ L      +K+GDFG    +  +              A+ APE          
Sbjct: 136 DLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---TF 191

Query: 188 GRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQAFAEL 245
             A D W  G  L EM + G+ PW    +  QI+ K+   GE    PE    +       
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250

Query: 246 CLRHDPAQRATIFELLQH 263
           C  H P  R T   L   
Sbjct: 251 CWAHKPEDRPTFVALRDF 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.7 bits (123), Expect = 4e-08
 Identities = 18/71 (25%), Positives = 24/71 (33%), Gaps = 4/71 (5%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L      +K+GDFG    +  +              A+ APE            A D
Sbjct: 141 NLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR---TFSHASD 196

Query: 370 IWSLGCVLVEM 380
            W  G  L EM
Sbjct: 197 TWMFGVTLWEM 207

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 60/263 (22%), Positives = 103/263 (39%), Gaps = 13/263 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G   +V+ A +      VA+K ++     D  F      E +    +N   +V  Y  
Sbjct: 16  GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDT 75

Query: 71  EIHREE----MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                       + ME     TL  +V +    +              A++  H+N I+H
Sbjct: 76  GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIH 134

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K ANI ++   N++K+ DFG A  I+       +    +GT  Y++PE         
Sbjct: 135 RDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---S 190

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE---TPTIPESLSDEGQAFA 243
                D++SLGCVL E+ +G+ P+   DS   + ++    +        E LS +  A  
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVV 249

Query: 244 ELCLRHDPAQRATIFELLQHPFL 266
              L  +P  R      ++   +
Sbjct: 250 LKALAKNPENRYQTAAEMRADLV 272

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 51.7 bits (123), Expect = 4e-08
 Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI ++   N++K+ DFG A  I+       +    +GT  Y++PE              
Sbjct: 140 ANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---SVDARS 195

Query: 369 DIWSLGCVLVEMSSGK 384
           D++SLGCVL E+ +G+
Sbjct: 196 DVYSLGCVLYEVLTGE 211

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 53/253 (20%), Positives = 98/253 (38%), Gaps = 11/253 (4%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G++G+VY  V  +    VA+K ++        F+K    E  +++ I   NLV+  GV
Sbjct: 26  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLGV 81

Query: 71  EIHREEMVLFMELCTEGTLES-LVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDI 129
                   +  E  T G L   L +     +  V++     Q+  A+  L +   +HRD+
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
            + N  +      +K+ DFG +  ++  T       G      + APE            
Sbjct: 142 AARNCLVGENHL-VKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYN---KFSI 195

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             D+W+ G +L E+++            Q+   +        PE   ++       C + 
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255

Query: 250 DPAQRATIFELLQ 262
           +P+ R +  E+ Q
Sbjct: 256 NPSDRPSFAEIHQ 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.2 bits (114), Expect = 6e-07
 Identities = 29/183 (15%), Positives = 54/183 (29%), Gaps = 40/183 (21%)

Query: 235 LSDEGQAFAELCLRHDPAQR------ATIFELLQHPF---LIVSCEED---VCNPRSVPA 282
                   A   L+ D  +       A + + ++HP    L+  C  +         +  
Sbjct: 38  WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97

Query: 283 SVLQDYLKLGIVLPPMSEDSVKVYAR---------------------ANIFLTAEGNSLK 321
             L DYL+       +S   +   A                       N  +      +K
Sbjct: 98  GNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VK 155

Query: 322 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMS 381
           + DFG +  ++  T       G      + APE              D+W+ G +L E++
Sbjct: 156 VADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVLLWEIA 210

Query: 382 SGK 384
           +  
Sbjct: 211 TYG 213

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 15/259 (5%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+    N T   VA+K ++    +   F++    E ++++ +  + LV+ Y V
Sbjct: 26  GQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLYAV 80

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLP-EVLVRRYTKQLVDAISALHENTIVHRDI 129
            +  E + +  E  ++G+L   ++           +     Q+   ++ +     VHRD+
Sbjct: 81  -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139

Query: 130 KSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR 189
           ++ANI +       K+ DFG A  I  +        G      + APE  +         
Sbjct: 140 RAANILVGENLV-CKVADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAALYG---RFTI 193

Query: 190 AVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRH 249
             D+WS G +L E+++  R       N +++ +V  G     P    +        C R 
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 253

Query: 250 DPAQRATIFELLQ--HPFL 266
           +P +R T   L      + 
Sbjct: 254 EPEERPTFEYLQAFLEDYF 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (133), Expect = 3e-09
 Identities = 19/76 (25%), Positives = 29/76 (38%), Gaps = 6/76 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
           ANI +       K+ DFG A  I  +        G      + APE  +           
Sbjct: 142 ANILVGENLV-CKVADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAALYG---RFTIKS 195

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G +L E+++  
Sbjct: 196 DVWSFGILLTELTTKG 211

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-54
 Identities = 64/289 (22%), Positives = 122/289 (42%), Gaps = 40/289 (13%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V +A +N     VA+K+I         + +  L E++IL     +N++    +
Sbjct: 17  GEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 71  ----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
                I + + V  +       L  L++     L    +  +  Q++  +  +H   ++H
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLH 132

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+K +N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G
Sbjct: 133 RDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKG 189

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT---------------- 230
           + +++DIWS+GC+L EM S +  +       Q+   +G+  +P+                
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 231 -------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                        +  +   +     +  L  +P +R  + + L HP+L
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.7 bits (141), Expect = 3e-10
 Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 3/75 (4%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           N+ L    + LK+ DFG A          G L  +V T+ Y APE+ +  N  G+ +++D
Sbjct: 139 NLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML--NSKGYTKSID 195

Query: 370 IWSLGCVLVEMSSGK 384
           IWS+GC+L EM S +
Sbjct: 196 IWSVGCILAEMLSNR 210

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-54
 Identities = 51/255 (20%), Positives = 99/255 (38%), Gaps = 8/255 (3%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI--QLHKQNDARFVKDMLVELRILEGINQKNLVKYY 68
           G G FG VY  +    GE V +     +L +    +  K++L E  ++  ++  ++ +  
Sbjct: 18  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 77

Query: 69  GVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRD 128
           G+      + L  +L   G L   V+  +D +    +  +  Q+   ++ L +  +VHRD
Sbjct: 78  GI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRD 136

Query: 129 IKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHG 188
           + + N+ +    + +K+ DFG A  + A         G      +MA E  +      + 
Sbjct: 137 LAARNVLVKTPQH-VKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHR---IYT 191

Query: 189 RAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLR 248
              D+WS G  + E+ +      +     +I   +  GE    P   + +       C  
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251

Query: 249 HDPAQRATIFELLQH 263
            D   R    EL+  
Sbjct: 252 IDADSRPKFRELIIE 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (122), Expect = 8e-08
 Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 5/76 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +    + +K+ DFG A  + A         G      +MA E  +      +    
Sbjct: 140 RNVLVKTPQH-VKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHR---IYTHQS 194

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G  + E+ +  
Sbjct: 195 DVWSYGVTVWELMTFG 210

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 4e-54
 Identities = 55/277 (19%), Positives = 104/277 (37%), Gaps = 17/277 (6%)

Query: 11  GQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G G FG+V +      G+    VA+K   L      +  +D L E  I+   +  N++  
Sbjct: 35  GAGEFGEVCSGHLKLPGKREIFVAIK--TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92

Query: 68  YGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
            GV      +++  E    G+L+S ++  +     + +    + +   +  L +   VHR
Sbjct: 93  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 152

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN--GFVGTQAYMAPEVFMDTNKV 185
           D+ + NI + +     K+ DFG +  +   T+ P   +  G      + APE        
Sbjct: 153 DLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--- 208

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
               A D+WS G V+ E+ S         +N  ++  +        P             
Sbjct: 209 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD 268

Query: 246 CLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPA 282
           C + D   R    +++         ++ + NP S+ A
Sbjct: 269 CWQKDRNHRPKFGQIVNT------LDKMIRNPNSLKA 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.6 bits (115), Expect = 5e-07
 Identities = 19/74 (25%), Positives = 30/74 (40%), Gaps = 6/74 (8%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN--GFVGTQAYMAPEVFMDTNKVGHGR 366
            NI + +     K+ DFG +  +   T+ P   +  G      + APE            
Sbjct: 157 RNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR---KFTS 212

Query: 367 AVDIWSLGCVLVEM 380
           A D+WS G V+ E+
Sbjct: 213 ASDVWSYGIVMWEV 226

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-54
 Identities = 51/256 (19%), Positives = 96/256 (37%), Gaps = 10/256 (3%)

Query: 11  GQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVK 66
           G G FG+VY  +   +       VA+K   L      +   D L E  I+   +  N+++
Sbjct: 16  GAGEFGEVYKGMLKTSSGKKEVPVAIK--TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
             GV    + M++  E    G L+  ++  +     + +    + +   +  L     VH
Sbjct: 74  LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 133

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVG 186
           RD+ + NI + +     K+ DFG +  +          +G      + APE         
Sbjct: 134 RDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK--- 189

Query: 187 HGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELC 246
              A D+WS G V+ E+ +         SN+++M  +  G     P             C
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQC 249

Query: 247 LRHDPAQRATIFELLQ 262
            + + A+R    +++ 
Sbjct: 250 WQQERARRPKFADIVS 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.8 bits (136), Expect = 1e-09
 Identities = 17/76 (22%), Positives = 28/76 (36%), Gaps = 4/76 (5%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI + +     K+ DFG +  +          +G      + APE            A 
Sbjct: 139 RNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK---FTSAS 194

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G V+ E+ +  
Sbjct: 195 DVWSFGIVMWEVMTYG 210

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-53
 Identities = 54/258 (20%), Positives = 93/258 (36%), Gaps = 11/258 (4%)

Query: 11  GQGRFGKVYTAV---NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKY 67
           G+G FG VY      N+      A+K   L++  D   V   L E  I++  +  N++  
Sbjct: 36  GRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 68  YGVEIHRE-EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVH 126
            G+ +  E   ++ +     G L + +++         +  +  Q+   +  L     VH
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 153

Query: 127 RDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           RD+ + N  L  E  ++K+ DFG A  +            G      +MA E        
Sbjct: 154 RDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-- 210

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL 245
                 D+WS G +L E+ +   P     + + I   +  G     PE   D        
Sbjct: 211 -FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269

Query: 246 CLRHDPAQRATIFELLQH 263
           C       R +  EL+  
Sbjct: 270 CWHPKAEMRPSFSELVSR 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (122), Expect = 7e-08
 Identities = 18/78 (23%), Positives = 27/78 (34%), Gaps = 5/78 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
            N  L  E  ++K+ DFG A  +            G      +MA E             
Sbjct: 159 RNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK---FTTK 214

Query: 368 VDIWSLGCVLVEMSSGKT 385
            D+WS G +L E+ +   
Sbjct: 215 SDVWSFGVLLWELMTRGA 232

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-53
 Identities = 53/283 (18%), Positives = 99/283 (34%), Gaps = 24/283 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G+G FG+V  A   + G  +     ++ +       +D   EL +L  +    N++   G
Sbjct: 19  GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 78

Query: 70  VEIHREEMVLFMELCTEGTLESLVQ---------------STEDGLPEVLVRRYTKQLVD 114
              HR  + L +E    G L   ++               ST   L    +  +   +  
Sbjct: 79  ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138

Query: 115 AISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYM 174
            +  L +   +HRD+ + NI +       K+ DFG +     +               +M
Sbjct: 139 GMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVK----KTMGRLPVRWM 193

Query: 175 APEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPES 234
           A E    +    +    D+WS G +L E+ S         +  ++  K+  G     P +
Sbjct: 194 AIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNP 277
             DE       C R  P +R +  ++L     ++   +   N 
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.5 bits (112), Expect = 1e-06
 Identities = 16/76 (21%), Positives = 26/76 (34%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI +       K+ DFG +     +               +MA E    +    +    
Sbjct: 156 RNILVGENYV-AKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYS---VYTTNS 207

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G +L E+ S  
Sbjct: 208 DVWSYGVLLWEIVSLG 223

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (446), Expect = 9e-53
 Identities = 59/280 (21%), Positives = 101/280 (36%), Gaps = 35/280 (12%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           G+G FG+V+ A     +  E   +VA+K   L ++  A    D   E  ++   +  N+V
Sbjct: 22  GEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQST-----------------------EDGLPE 102
           K  GV    + M L  E    G L   ++S                           L  
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 103 VLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG 162
                  +Q+   ++ L E   VHRD+ + N  +      +K+ DFG +  I +      
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYYKA 198

Query: 163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK 222
           +         +M PE         +    D+W+ G VL E+ S         ++ ++++ 
Sbjct: 199 D-GNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254

Query: 223 VGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
           V  G     PE+   E      LC    PA R +   + +
Sbjct: 255 VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.8 bits (123), Expect = 4e-08
 Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 5/76 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N  +      +K+ DFG +  I +      +         +M PE         +    
Sbjct: 169 RNCLVGENMV-VKIADFGLSRNIYSADYYKAD-GNDAIPIRWMPPESIFYNR---YTTES 223

Query: 369 DIWSLGCVLVEMSSGK 384
           D+W+ G VL E+ S  
Sbjct: 224 DVWAYGVVLWEIFSYG 239

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  175 bits (443), Expect = 2e-52
 Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 36/283 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G VY A NN  GE  A+K+I+L K+++       + E+ IL+ +   N+VK Y V
Sbjct: 11  GEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
              ++ +VL  E      L+ L+   E GL  V  + +  QL++ I+  H+  ++HRD+K
Sbjct: 69  IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  EG  LK+ DFG A           +    + T  Y AP+V M + K  +   
Sbjct: 128 PQNLLINREGE-LKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKK--YSTT 181

Query: 191 VDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPE-------------- 233
           +DIWS+GC+  EM +G   +    E D   +I   +G   +   P               
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 234 ----------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                      L + G       L+ DP QR T  + L+H + 
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 49.5 bits (117), Expect = 2e-07
 Identities = 23/76 (30%), Positives = 33/76 (43%), Gaps = 5/76 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
               L      LK+ DFG A           +    + T  Y AP+V M + K  +   +
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKK--YSTTI 182

Query: 369 DIWSLGCVLVEMSSGK 384
           DIWS+GC+  EM +G 
Sbjct: 183 DIWSVGCIFAEMVNGT 198

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 18/261 (6%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG+V    + E+G   AMK +   K    + ++  L E RIL+ +N   LVK    
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                 + + ME    G + S ++       E   R Y  Q+V     LH   +++RD+K
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +  +G  +++ DFG A ++   T          GT   +APE+ +     G+ +A
Sbjct: 169 PENLLIDQQGY-IQVTDFGFAKRVKGRTWT------LCGTPEALAPEIILSK---GYNKA 218

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHD 250
           VD W+LG ++ EM++G  P+  +      +++  +      P   S + +      L+ D
Sbjct: 219 VDWWALGVLIYEMAAGYPPF--FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276

Query: 251 PAQR-----ATIFELLQHPFL 266
             +R       + ++  H + 
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWF 297

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 45.6 bits (107), Expect = 6e-06
 Identities = 34/154 (22%), Positives = 60/154 (38%), Gaps = 34/154 (22%)

Query: 255 ATIFELLQHPFLI--VSCEEDVCNPRSVPASVLQDYLKLGIV-LPPMSEDSVKVYAR--- 308
             I + +  PFL+      +D  N   V   V    +   +  +   SE   + YA    
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 309 ------------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAY 350
                              N+ +  +G  +++ DFG A ++   T          GT   
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWT------LCGTPEA 204

Query: 351 MAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK 384
           +APE+ +     G+ +AVD W+LG ++ EM++G 
Sbjct: 205 LAPEIILSK---GYNKAVDWWALGVLIYEMAAGY 235

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-51
 Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 43/298 (14%)

Query: 11  GQGRFGKVYTAVNNET-GELVAMKEIQLHKQNDARFVKDM--LVELRILEGINQKNLVKY 67
           G+G +GKV+ A + +  G  VA+K +++    +   +  +  +  LR LE     N+V+ 
Sbjct: 16  GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75

Query: 68  YGVEI-----HREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
           + V          ++ L  E   +     L +  E G+P   ++    QL+  +  LH +
Sbjct: 76  FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT 182
            +VHRD+K  NI +T+ G   KL DFG A   S    +       V T  Y APEV + +
Sbjct: 136 RVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMAL----TSVVVTLWYRAPEVLLQS 190

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPE------ 233
               +   VD+WS+GC+  EM   K  +    + D   +I+  +G+      P       
Sbjct: 191 ---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 234 ----------------SLSDEGQAFAELCLRHDPAQRATIFELLQHPFL--IVSCEED 273
                            + + G+     CL  +PA+R + +  L HP+   +  C+E+
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKEN 305

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.9 bits (118), Expect = 2e-07
 Identities = 27/76 (35%), Positives = 36/76 (47%), Gaps = 8/76 (10%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            NI +T+ G   KL DFG A   S    +       V T  Y APEV + +    +   V
Sbjct: 145 QNILVTSSGQI-KLADFGLARIYSFQMAL----TSVVVTLWYRAPEVLLQS---SYATPV 196

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS+GC+  EM   K
Sbjct: 197 DLWSVGCIFAEMFRRK 212

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-51
 Identities = 71/295 (24%), Positives = 125/295 (42%), Gaps = 44/295 (14%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           GQG FG+V+ A + +TG+ VA+K++ +  + +  F    L E++IL+ +  +N+V    +
Sbjct: 19  GQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEI 77

Query: 71  EIHREE--------MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHEN 122
              +          + L  + C E  L  L+ +         ++R  + L++ +  +H N
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136

Query: 123 TIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMD 181
            I+HRD+K+AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ + 
Sbjct: 137 KILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL- 194

Query: 182 TNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTI-------- 231
             +  +G  +D+W  GC++ EM +           +Q+  + ++    TP +        
Sbjct: 195 -GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253

Query: 232 --------------------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                                           +  L  DPAQR    + L H F 
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.5 bits (156), Expect = 3e-12
 Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 4/82 (4%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKIS-AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           AN+ +T +G  LKL DFG A   S A  + P      V T  Y  PE+ +   +  +G  
Sbjct: 146 ANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL--GERDYGPP 202

Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           +D+W  GC++ EM +    + G
Sbjct: 203 IDLWGAGCIMAEMWTRSPIMQG 224

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 36/284 (12%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G +G V+ A N ET E+VA+K ++L   +D       L E+ +L+ +  KN+V+ + V
Sbjct: 11  GEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
               +++ L  E C +   +       D  PE+ V+ +  QL+  +   H   ++HRD+K
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI-VKSFLFQLLKGLGFCHSRNVLHRDLK 128

Query: 131 SANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 190
             N+ +   G   KL +FG A             +  V T  Y  P+V        +  +
Sbjct: 129 PQNLLINRNGEL-KLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKL--YSTS 182

Query: 191 VDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKV--------------------------- 223
           +D+WS GC+  E+++  RP    +     + ++                           
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 224 -GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                   +   L+  G+   +  L+ +P QR +  E LQHP+ 
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.6 bits (112), Expect = 1e-06
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 6/76 (7%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +   G   KL +FG A             +  V T  Y  P+V        +  ++
Sbjct: 130 QNLLINRNGEL-KLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKL--YSTSI 183

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS GC+  E+++  
Sbjct: 184 DMWSAGCIFAELANAG 199

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 8e-51
 Identities = 55/280 (19%), Positives = 102/280 (36%), Gaps = 32/280 (11%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEI---QLHKQNDARFVKDMLVELRILEGINQ-KNLVK 66
           G G FGKV  A      +     ++    L ++ D+   + ++ EL+++  +   +N+V 
Sbjct: 46  GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 105

Query: 67  YYGVEIHREEMVLFMELCTEGTLESLVQS----------------------TEDGLPEVL 104
             G       + L  E C  G L + ++S                        + L    
Sbjct: 106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 165

Query: 105 VRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGEL 164
           +  +  Q+   +  L   + VHRD+ + N+ +T     +K+ DFG A  I + +      
Sbjct: 166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARDIMSDSN-YVVR 223

Query: 165 NGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM-SSGKRPWAEYDSNYQIMFKV 223
                   +MAPE   +     +    D+WS G +L E+ S G  P+     +      +
Sbjct: 224 GNARLPVKWMAPESLFEG---IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
             G     P   ++E     + C   D  +R +   L   
Sbjct: 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (108), Expect = 4e-06
 Identities = 19/77 (24%), Positives = 31/77 (40%), Gaps = 5/77 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +T     +K+ DFG A  I + +              +MAPE   +     +    
Sbjct: 193 RNVLVTHGKV-VKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEG---IYTIKS 247

Query: 369 DIWSLGCVLVEMSSGKT 385
           D+WS G +L E+ S   
Sbjct: 248 DVWSYGILLWEIFSLGV 264

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  171 bits (434), Expect = 1e-50
 Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 55/294 (18%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYG 69
           G+G++ +V+ A+N    E V +K ++  K+      K +  E++ILE +    N++    
Sbjct: 44  GRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLAD 97

Query: 70  VEIHREE--MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHR 127
           +          L  E       + L Q+    L +  +R Y  +++ A+   H   I+HR
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHR 153

Query: 128 DIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGH 187
           D+K  N+ +  E   L+L D+G A             N  V ++ +  PE+ +D     +
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLVDYQ--MY 207

Query: 188 GRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------------- 224
             ++D+WSLGC+L  M   K P+     NY  + ++                        
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 225 -------------MGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPF 265
                                  +S E   F +  LR+D   R T  E ++HP+
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 61.0 bits (147), Expect = 6e-11
 Identities = 28/151 (18%), Positives = 58/151 (38%), Gaps = 31/151 (20%)

Query: 259 ELLQHPFLIVSCEEDVCNPRSVPASVLQDYLK---LGIVLPPMSEDSVKVYAR------- 308
            L   P  I++  + V +P S   +++ +++       +   +++  ++ Y         
Sbjct: 85  NLRGGPN-IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALD 143

Query: 309 --------------ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 354
                          N+ +  E   L+L D+G A             N  V ++ +  PE
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPE 199

Query: 355 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           + +D     +  ++D+WSLGC+L  M   K 
Sbjct: 200 LLVDYQ--MYDYSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-50
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 19/269 (7%)

Query: 11  GQGRFGKVYTA---VNNETGELVAMKEIQLHKQ-NDARFVKDMLVELRILEGINQK-NLV 65
           G G +GKV+       ++TG+L AMK ++       A+  +    E ++LE I Q   LV
Sbjct: 33  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 92

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
             +       ++ L ++    G L + +    +   E  V+ Y  ++V A+  LH+  I+
Sbjct: 93  TLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGII 151

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           +RDIK  NI L + G+ + L DFG + +  A  T       F GT  YMAP++    +  
Sbjct: 152 YRDIKLENILLDSNGH-VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDS- 207

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWA---EYDSNYQIMFKVGMGETPTIPESLSDEGQAF 242
           GH +AVD WSLG ++ E+ +G  P+    E +S  +I  ++   E P  P+ +S   +  
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSALAKDL 266

Query: 243 AELCLRHDPAQR-----ATIFELLQHPFL 266
            +  L  DP +R         E+ +H F 
Sbjct: 267 IQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (124), Expect = 4e-08
 Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 14/151 (9%)

Query: 235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIVSCEEDVCNPRSVPASVLQDYLKLGIV 294
           L    Q   +L L  D      +F  L         E +V          L+   KLGI+
Sbjct: 94  LHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVLALEHLHKLGII 151

Query: 295 LPPMSEDSVKVYARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPE 354
              +  +        NI L + G+ + L DFG + +  A  T       F GT  YMAP+
Sbjct: 152 YRDIKLE--------NILLDSNGH-VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPD 200

Query: 355 VFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT 385
           +    +  GH +AVD WSLG ++ E+ +G +
Sbjct: 201 IVRGGDS-GHDKAVDWWSLGVLMYELLTGAS 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 48/291 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V +AV+  TG  VA+K++    Q++  F K    ELR+L+ +  +N++    V
Sbjct: 27  GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 71  EIHRE------EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
               E      +  L M        + +     + L E  ++    Q++  +  +H   I
Sbjct: 86  FTPDETLDDFTDFYLVMPFMGTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K  N+ +  +    K+ DFG A +  +  T      G+V T+ Y APEV ++  +
Sbjct: 143 IHRDLKPGNLAVNEDCEL-KILDFGLARQADSEMT------GYVVTRWYRAPEVILNWMR 195

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP--------------- 229
             + + VDIWS+GC++ EM +GK  +   D   Q+   + +  TP               
Sbjct: 196 --YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 230 --------------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL 266
                         +I  + S       E  L  D  QR T  E L HP+ 
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (110), Expect = 2e-06
 Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 8/78 (10%)

Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           +       E   LK+ DFG A +  +  T      G+V T+ Y APEV ++  +  + + 
Sbjct: 148 KPGNLAVNEDCELKILDFGLARQADSEMT------GYVVTRWYRAPEVILNWMR--YTQT 199

Query: 368 VDIWSLGCVLVEMSSGKT 385
           VDIWS+GC++ EM +GKT
Sbjct: 200 VDIWSVGCIMAEMITGKT 217

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 3e-48
 Identities = 49/270 (18%), Positives = 89/270 (32%), Gaps = 23/270 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G FG +Y   +   GE VA+K   +  ++       + +E +I + +     +     
Sbjct: 16  GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRW 70

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
                +  + +      +LE L            V     Q++  I  +H    +HRD+K
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 130

Query: 131 SANIFLTAEGNSLKL--GDFGSAVKISAHTT----VPGELNGFVGTQAYMAPEVFMDTNK 184
             N  +        +   DFG A K     T       E     GT  Y +    +    
Sbjct: 131 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-- 188

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE------TPTIPESLSDE 238
               R  D+ SLG VL+  + G  PW    +  +      + E         + +    E
Sbjct: 189 -EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247

Query: 239 GQAFAELCLRHDPAQR---ATIFELLQHPF 265
              +   C       +   + + +L ++ F
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.5 bits (125), Expect = 2e-08
 Identities = 19/83 (22%), Positives = 26/83 (31%), Gaps = 9/83 (10%)

Query: 310 NIFLTAEGNSLKL--GDFGSAVKISAHTT----VPGELNGFVGTQAYMAPEVFMDTNKVG 363
           N  +        +   DFG A K     T       E     GT  Y +    +      
Sbjct: 133 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---E 189

Query: 364 HGRAVDIWSLGCVLVEMSSGKTN 386
             R  D+ SLG VL+  + G   
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLP 212

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  163 bits (414), Expect = 4e-48
 Identities = 60/280 (21%), Positives = 103/280 (36%), Gaps = 25/280 (8%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+G FG ++   N    + VA+K     +++DA  ++D     ++L G      V Y+G 
Sbjct: 14  GEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71

Query: 71  EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIK 130
           E      VL ++L    +LE L+           V    KQ++  + ++HE ++V+RDIK
Sbjct: 72  E--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 128

Query: 131 SANIFLTAE----GNSLKLGDFGSAVKI----SAHTTVPGELNGFVGTQAYMAPEVFMDT 182
             N  +        N + + DFG         +       E     GT  YM+    +  
Sbjct: 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR 188

Query: 183 NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIMFKVGMGETPTIPESL----S 236
                 R  D+ +LG V +    G  PW      +N Q   ++G  +  T    L     
Sbjct: 189 ---EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245

Query: 237 DEGQAFAELCLRHDPAQR---ATIFELLQHPFLIVSCEED 273
           +E   +                 +  L       ++  ED
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 65.2 bits (158), Expect = 2e-12
 Identities = 17/88 (19%), Positives = 26/88 (29%), Gaps = 11/88 (12%)

Query: 310 NIFLTAE----GNSLKLGDFGSAVKI----SAHTTVPGELNGFVGTQAYMAPEVFMDTNK 361
           N  +        N + + DFG         +       E     GT  YM+    +    
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-- 188

Query: 362 VGHGRAVDIWSLGCVLVEMSSGKTNLSG 389
               R  D+ +LG V +    G     G
Sbjct: 189 -EQSRRDDLEALGHVFMYFLRGSLPWQG 215

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 5e-48
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 21/267 (7%)

Query: 11  GQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV 65
           GQG FG VY  V      +E    VA+K   +++    R   + L E  +++  N  ++V
Sbjct: 29  GQGSFGMVYEGVAKGVVKDEPETRVAIK--TVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 66  KYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG---------LPEVLVRRYTKQLVDAI 116
           +  GV    +  ++ MEL T G L+S ++S                  + +   ++ D +
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 117 SALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAP 176
           + L+ N  VHRD+ + N  +  +   +K+GDFG    I           G +    +M+P
Sbjct: 147 AYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG-LLPVRWMSP 204

Query: 177 EVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS 236
           E   D          D+WS G VL E+++      +  SN Q++  V  G     P++  
Sbjct: 205 ESLKDG---VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 261

Query: 237 DEGQAFAELCLRHDPAQRATIFELLQH 263
           D       +C +++P  R +  E++  
Sbjct: 262 DMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (89), Expect = 8e-04
 Identities = 19/76 (25%), Positives = 30/76 (39%), Gaps = 5/76 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N  +  +   +K+GDFG    I           G +    +M+PE   D          
Sbjct: 162 RNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG-LLPVRWMSPESLKDG---VFTTYS 216

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G VL E+++  
Sbjct: 217 DVWSFGVVLWEIATLA 232

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-47
 Identities = 61/276 (22%), Positives = 102/276 (36%), Gaps = 31/276 (11%)

Query: 11  GQGRFGKVYTA-----VNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNL 64
           G G FGKV  A     + ++    VA+K   L         + ++ EL++L  + N  N+
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 65  VKYYGVEIHREEMVLFMELCTEGTLESLVQSTEDG-----------------LPEVLVRR 107
           V   G        ++  E C  G L + ++   D                  L    +  
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
           ++ Q+   ++ L     +HRD+ + NI LT    + K+ DFG A  I   +    +    
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVK-GNA 207

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK-VGMG 226
                +MAPE   +     +    D+WS G  L E+ S               +K +  G
Sbjct: 208 RLPVKWMAPESIFNCV---YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264

Query: 227 ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ 262
                PE    E     + C   DP +R T  +++Q
Sbjct: 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-46
 Identities = 55/276 (19%), Positives = 106/276 (38%), Gaps = 30/276 (10%)

Query: 11  GQGRFGKVYTAVNNETGE-------LVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-K 62
           G+G FG+V  A      +        VA+K   L      + + D++ E+ +++ I + K
Sbjct: 22  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 63  NLVKYYGVEIHREEMVLFMELCTEGTLESLVQ---------------STEDGLPEVLVRR 107
           N++   G       + + +E  ++G L   +Q               + E+ L    +  
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 108 YTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGF 167
              Q+   +  L     +HRD+ + N+ +T +    K+ DFG A +   H     +    
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLA-RDIHHIDYYKKTTNG 197

Query: 168 VGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGE 227
                +MAPE   D     +    D+WS G +L E+ +            ++   +  G 
Sbjct: 198 RLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
               P + ++E       C    P+QR T  +L++ 
Sbjct: 255 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (89), Expect = 7e-04
 Identities = 19/76 (25%), Positives = 31/76 (40%), Gaps = 5/76 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAV 368
            N+ +T +    K+ DFG A +   H     +         +MAPE   D     +    
Sbjct: 164 RNVLVTEDNVM-KIADFGLA-RDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQS 218

Query: 369 DIWSLGCVLVEMSSGK 384
           D+WS G +L E+ +  
Sbjct: 219 DVWSFGVLLWEIFTLG 234

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 49/304 (16%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G +G V  A + +TG  VA+K++    Q+     K    ELR+L+ +  +N++    V
Sbjct: 27  GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 71  -----EIHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIV 125
                 +     V  +       L ++V+     L +  V+    Q++  +  +H   I+
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADII 143

Query: 126 HRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKV 185
           HRD+K +N+ +  +    K+ DFG A       T      G+V T+ Y APE+ ++    
Sbjct: 144 HRDLKPSNLAVNEDCEL-KILDFGLARHTDDEMT------GYVATRWYRAPEIMLNWMH- 195

Query: 186 GHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--------------- 230
            + + VDIWS+GC++ E+ +G+  +   D   Q+   + +  TP                
Sbjct: 196 -YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 231 --------------IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL---IVSCEED 273
                         +    +       E  L  D  +R T  + L H +        +E 
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314

Query: 274 VCNP 277
           V +P
Sbjct: 315 VADP 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (96), Expect = 1e-04
 Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 8/82 (9%)

Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
           + +     E   LK+ DFG A       T      G+V T+ Y APE+ ++     + + 
Sbjct: 148 KPSNLAVNEDCELKILDFGLARHTDDEMT------GYVATRWYRAPEIMLNWMH--YNQT 199

Query: 368 VDIWSLGCVLVEMSSGKTNLSG 389
           VDIWS+GC++ E+ +G+T   G
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPG 221

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 6e-44
 Identities = 62/288 (21%), Positives = 104/288 (36%), Gaps = 45/288 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G+GRFG+V+       GE VA+K     ++           E+     +  +N++ +   
Sbjct: 12  GKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFR----EAEIYQTVMLRHENILGFIAA 65

Query: 71  EIHRE----EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--- 123
           +        ++ L  +    G+L   +      +    + +        ++ LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 124 -----IVHRDIKSANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPE 177
                I HRD+KS NI +   G    + D G AV+  SA  T+    N  VGT+ YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 178 VFMDTNKVGHGR---AVDIWSLGCVLVEMSSGKRP-------------WAEYDSNYQIMF 221
           V  D+  + H       DI+++G V  E++                      D + + M 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 222 KVGMGE--TPTIPESLS-----DEGQAFAELCLRHDPAQRATIFELLQ 262
           KV   +   P IP                  C   + A R T   + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (153), Expect = 9e-12
 Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 5/80 (6%)

Query: 309 ANIFLTAEGNSLKLGDFGSAVKI-SAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGR- 366
            NI +   G    + D G AV+  SA  T+    N  VGT+ YMAPEV  D+  + H   
Sbjct: 137 KNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195

Query: 367 --AVDIWSLGCVLVEMSSGK 384
               DI+++G V  E++   
Sbjct: 196 FKRADIYAMGLVFWEIARRC 215

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-42
 Identities = 70/322 (21%), Positives = 117/322 (36%), Gaps = 63/322 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGV 70
           G G  G V  A +      VA+K++    QN     K    EL +++ +N KN++    V
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 71  EIHR------EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTI 124
              +      +++ L MEL      + +            +     Q++  I  LH   I
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAGI 140

Query: 125 VHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNK 184
           +HRD+K +NI + ++    K+ DFG A            +  +V T+ Y APEV +    
Sbjct: 141 IHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFM----MTPYVVTRYYRAPEVILGM-- 193

Query: 185 VGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPE----------- 233
            G+   VDIWS+GC++ EM   K  +           KV        PE           
Sbjct: 194 -GYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 234 ------------------------------SLSDEGQAFAELCLRHDPAQRATIFELLQH 263
                                           + + +      L  DPA+R ++ + LQH
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 264 PFLIVSCEEDVCNPRSVPASVL 285
           P++  +   D     + P  + 
Sbjct: 312 PYI--NVWYDPAEVEAPPPQIY 331

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (97), Expect = 9e-05
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 8/76 (10%)

Query: 310 NIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVD 369
           NI + ++    K+ DFG A            +  +V T+ Y APEV +     G+   VD
Sbjct: 149 NIVVKSDCTL-KILDFGLARTAGTSFM----MTPYVVTRYYRAPEVILGM---GYKENVD 200

Query: 370 IWSLGCVLVEMSSGKT 385
           IWS+GC++ EM   K 
Sbjct: 201 IWSVGCIMGEMVRHKI 216

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-42
 Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 30/276 (10%)

Query: 11  GQGRFGKVYTAV-----NNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNL 64
           G+G FG+V  A         T   VA+K   L +       + ++ EL+IL  I    N+
Sbjct: 22  GRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 65  VKYYGVEIHREEMVLF-MELCTEGTLESLVQS---------------TEDGLPEVLVRRY 108
           V   G        ++  +E C  G L + ++S                +D L    +  Y
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 109 TKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFV 168
           + Q+   +  L     +HRD+ + NI L+ +   +K+ DFG A  I              
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD-YVRKGDAR 197

Query: 169 GTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR-PWAEYDSNYQIMFKVGMGE 227
               +MAPE   D     +    D+WS G +L E+ S    P+     + +   ++  G 
Sbjct: 198 LPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 254

Query: 228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH 263
               P+  + E       C   +P+QR T  EL++H
Sbjct: 255 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (349), Expect = 4e-38
 Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 62/314 (19%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRI-------LEGINQKN 63
           G G F  V+ A +      VAMK ++  K        ++ +  R+        + +   +
Sbjct: 22  GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81

Query: 64  LVKYYGVEIHREE----MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           ++K      H+      +V+  E+  E  L  + +    G+P + V++ +KQL+  +  +
Sbjct: 82  ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 141

Query: 120 HENT-IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEV 178
           H    I+H DIK  N+ +    +   L     A   +A           + T+ Y +PEV
Sbjct: 142 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEV 200

Query: 179 FMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPW---------AEYDSNYQIMFKVG----- 224
            +       G   DIWS  C++ E+ +G   +          + D   QI+  +G     
Sbjct: 201 LLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 225 --------------------------------MGETPTIPESLSDEGQAFAELCLRHDPA 252
                                           + E     +  + E   F    L+ DP 
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317

Query: 253 QRATIFELLQHPFL 266
           +RA    L+ HP+L
Sbjct: 318 KRADAGGLVNHPWL 331

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 48.5 bits (114), Expect = 8e-07
 Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 4/77 (5%)

Query: 308 RANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRA 367
             N+ +    +   L     A   +A           + T+ Y +PEV +       G  
Sbjct: 154 PENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGA---PWGCG 209

Query: 368 VDIWSLGCVLVEMSSGK 384
            DIWS  C++ E+ +G 
Sbjct: 210 ADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.5 bits (203), Expect = 4e-19
 Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 31/203 (15%)

Query: 11  GQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFV-------KDMLVELRILEGINQKN 63
           G+G+   V+   + E      +K  ++   +  +             V          + 
Sbjct: 9   GEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 64  LVKYYGVEIHR----EEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISAL 119
           L K  G+ + +    E   + MEL                +           +++ ++  
Sbjct: 68  LQKLQGLAVPKVYAWEGNAVLMELIDAKE--------LYRVRVENPDEVLDMILEEVAKF 119

Query: 120 HENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVF 179
           +   IVH D+   N+ ++ EG  + + DF  +V++         L               
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVG-EEGWREILE--------RDVRNI 168

Query: 180 MDTNKVGHGRAVDIWSLGCVLVE 202
           +      +    DI S    +++
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	407
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.61
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.59
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.59
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.59
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.59
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.58
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.58
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.58
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.57
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.57
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.56
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.56
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.55
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.55
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.52
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.52
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.51
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.49
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.49
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.49
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.48
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.48
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.47
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.47
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.46
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.46
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.46
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.46
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.45
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.44
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.43
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.42
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.42
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.42
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.42
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.42
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.41
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.4
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.4
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.39
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.39
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.39
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.38
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.38
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.37
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.37
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.36
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.36
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.34
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.3
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.3
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.29
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.29
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.28
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.27
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.25
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.22
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.2
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.2
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.18
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.15
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.08
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.15
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.57
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.85
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.19
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	88.35

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-64  Score=456.91  Aligned_cols=254  Identities=26%  Similarity=0.476  Sum_probs=219.2

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .++.....||+|+||+||+|++..+++.||+|++.+....+....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            35566679999999999999999999999999997654333344567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....    
T Consensus        86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~----  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS----  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC----
T ss_pred             eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCC----
Confidence            999999999999764 4599999999999999999999999999999999999999865 6999999999765432    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       .....+||+.|||||++.+   ..++.++|||||||++|||++|+.||... +..+....+. ...+.+|+.+|+++++
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~-~~~~~~p~~~s~~~~~  233 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEG---RMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRIS-RVEFTFPDFVTEGARD  233 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHH-TTCCCCCTTSCHHHHH
T ss_pred             -cccccCCCCcccCHHHHcC---CCCCchhhhhhHhHHHHHHhcCCCCCCCC-CHHHHHHHHH-cCCCCCCccCCHHHHH
Confidence             2245689999999999965   34689999999999999999999999753 3334444443 3455678899999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+.+||++||++|||+.|+++||||.
T Consensus       234 li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         234 LISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            99999999999999999999999985

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=454.94  Aligned_cols=258  Identities=29%  Similarity=0.447  Sum_probs=214.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|+++.+|+.||||+++....  .+..+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            45566799999999999999999999999999976432  2234668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||++|+|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+...... .
T Consensus        84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~-~  160 (271)
T d1nvra_          84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE-R  160 (271)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEE-C
T ss_pred             ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcc-c
Confidence            9999999999864 45699999999999999999999999999999999999998765 6999999999876533221 2


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC-CCCCCCCCccCHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM-GETPTIPESLSDEGQA  241 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~  241 (407)
                      ..+..+||+.|||||++.+.  ..++.++|||||||++|||++|+.||............... ...+..+..+|+++++
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~--~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRR--EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCS--SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cccceeeCcCccCHhHhcCC--CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence            23567899999999998653  23467899999999999999999999865444333333322 2233334678999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+.+||++||++|||+.|+++||||.
T Consensus       239 li~~~L~~dP~~R~t~~eil~hpwf~  264 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKDRWYN  264 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            99999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-62  Score=448.43  Aligned_cols=251  Identities=30%  Similarity=0.523  Sum_probs=215.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe----CceEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH----REEMVLF   80 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv   80 (407)
                      .++.+||+|+||+||+|++..+++.||+|++..... .....+.+.+|+++|++++|||||++++++..    +..+|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            345589999999999999999999999999986543 33456778999999999999999999999875    3568999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENT--IVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      ||||++|+|.+++++. ..+++..++.++.||+.||+|||+++  |+||||||+|||++++++.+||+|||+|+..... 
T Consensus        91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            9999999999999764 45999999999999999999999998  9999999999999765557999999999754322 


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC-CCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP-TIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~s~  237 (407)
                          ...+.+||+.|||||++.+    .++.++|||||||++|||++|+.||.+..+..+....+..+..| .++...++
T Consensus       169 ----~~~~~~GT~~Y~aPE~~~~----~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         169 ----FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ----ccCCcccCccccCHHHhCC----CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence                2245689999999999853    37899999999999999999999998766666665565555443 35667899


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      ++++++.+||++||++|||+.|+++||||
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence            99999999999999999999999999997

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-63  Score=458.40  Aligned_cols=253  Identities=30%  Similarity=0.525  Sum_probs=219.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|++..+|+.||||++......+....+.+.+|+++|++++|||||++++++.+++.+|+|||||+
T Consensus        19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   98 (309)
T d1u5ra_          19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL   98 (309)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence            34489999999999999999999999999987665566667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....       ..
T Consensus        99 ~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~-------~~  169 (309)
T d1u5ra_          99 GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP-------AN  169 (309)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS-------BC
T ss_pred             CCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC-------CC
Confidence            9999877654 45699999999999999999999999999999999999999764 799999999976532       23


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC-CCCccCHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT-IPESLSDEGQAFAE  244 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~~i~  244 (407)
                      ..+||+.|||||++.+.....|+.++|||||||++|||++|+.||.+.. ..+.+..+..+..+. .+..+|+++++|+.
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~~~~li~  248 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            4689999999999975444457889999999999999999999998644 344455554444444 35578999999999


Q ss_pred             HhcccCCCCcCCHHHHhcCCeeee
Q psy10603        245 LCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +||++||++|||+.|+++|||+..
T Consensus       249 ~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         249 SCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHCcCChhHCcCHHHHHhCHHhcC
Confidence            999999999999999999999853

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-62  Score=450.56  Aligned_cols=249  Identities=33%  Similarity=0.528  Sum_probs=214.2

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ....||+|+||+||+|++..+|+.||||++......+   .+.+.+|+.+|++++|||||++++++.+++.+|+|||||+
T Consensus        24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            3348999999999999999999999999998654433   3568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|.+++..  ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.....   ...
T Consensus       101 gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~---~~~  174 (293)
T d1yhwa1         101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS---KRS  174 (293)
T ss_dssp             TCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTC---CBC
T ss_pred             CCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeeccccc---ccc
Confidence            9999998865  3599999999999999999999999999999999999998865 699999999988754322   234


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC--CCCCCccCHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET--PTIPESLSDEGQAFA  243 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~i  243 (407)
                      ..+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+.... ..+..+.....  ...|..+|+++++||
T Consensus       175 ~~~gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR---KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTPELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             CCCSCGGGCCHHHHSS---SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred             ccccCCCccChhhhcC---CCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence            5689999999999965   34688999999999999999999999864433 33333333322  345678999999999


Q ss_pred             HHhcccCCCCcCCHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      .+||++||++|||+.|+++||||.
T Consensus       251 ~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHHccCChhHCcCHHHHhcCHhhC
Confidence            999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=448.98  Aligned_cols=256  Identities=29%  Similarity=0.504  Sum_probs=210.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--CceEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--REEMVL   79 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l   79 (407)
                      .++.....||+|+||+||+|++..+|+.||||++..... +....+.+.+|+++|++++|||||++++++.+  .+.+|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            355667799999999999999999999999999986544 34456788999999999999999999999864  456899


Q ss_pred             EEecCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         80 FMELCTEGTLESLVQS---TEDGLPEVLVRRYTKQLVDAISALHENT-----IVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~-----iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      |||||++|+|.+++..   ....+++..++.++.||+.||+|||+++     |+||||||+|||++.++ .+||+|||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccce
Confidence            9999999999999854   2456999999999999999999999976     99999999999999875 6999999999


Q ss_pred             eecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCC
Q psy10603        152 VKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTI  231 (407)
Q Consensus       152 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  231 (407)
                      +.+.....   .....+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+. +..+....+..+..+.+
T Consensus       162 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~---~~~~~~~DIwSlGvilyel~tg~~Pf~~~-~~~~~~~~i~~~~~~~~  234 (269)
T d2java1         162 RILNHDTS---FAKAFVGTPYYMSPEQMNR---MSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFRRI  234 (269)
T ss_dssp             HHC--------------CCCSCCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCCCCC
T ss_pred             eecccCCC---ccccCCCCcccCCHHHHcC---CCCChHHHHHhhCHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCC
Confidence            87654322   2345789999999999854   34789999999999999999999999854 44555666666777788


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCee
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFL  266 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~  266 (407)
                      |..+|+++++|+.+||+.||.+|||+.|+++|||+
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            89999999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-62  Score=451.81  Aligned_cols=253  Identities=34%  Similarity=0.576  Sum_probs=216.7

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      ...||+|+||+||+|++..+|+.||||++......   ..+.+.+|+++|++++|||||++++++.+++.+|+|||||++
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            44899999999999999999999999999764322   246788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.+++.+....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......   ...+
T Consensus        94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~---~~~~  169 (288)
T d2jfla1          94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQ---RRDS  169 (288)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHH---HHTC
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCcc---cccc
Confidence            999999876666799999999999999999999999999999999999999875 699999999976543211   1245


Q ss_pred             cccCCccccccccccc--ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC--CCCccCHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT--IPESLSDEGQAF  242 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~--~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~~  242 (407)
                      .+||+.|||||++...  ....++.++|||||||++|||++|+.||.+.. ..+.+..+..+..+.  .|..+|+++++|
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            6899999999998532  23457899999999999999999999998654 334445555454443  356899999999


Q ss_pred             HHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +.+||++||++|||+.|+++||||.
T Consensus       249 i~~~L~~dp~~R~t~~ell~hp~~~  273 (288)
T d2jfla1         249 LKKCLEKNVDARWTTSQLLQHPFVT  273 (288)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccC
Confidence            9999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-62  Score=451.77  Aligned_cols=257  Identities=26%  Similarity=0.430  Sum_probs=215.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            45666799999999999999999999999999976433333345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||++|+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.+...... .
T Consensus        89 y~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~-~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQ-A  165 (288)
T ss_dssp             CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC-------
T ss_pred             ccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCcc-c
Confidence            99999999998764 4599999999999999999999999999999999999999875 6999999999877543221 2


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAF  242 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~  242 (407)
                      ...+.+||+.|||||++.+   ..++.++|||||||++|||++|+.||... +......++.. ..+.+|..+|+++++|
T Consensus       166 ~~~~~~GT~~Y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~-~~~~~p~~~s~~~~~l  240 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTE---KSACKSSDLWALGCIIYQLVAGLPPFRAG-NEYLIFQKIIK-LEYDFPEKFFPKARDL  240 (288)
T ss_dssp             ----CCCCGGGCCHHHHHT---CCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHT-TCCCCCTTCCHHHHHH
T ss_pred             ccccccCCccccCceeecc---CCCCcccceehhhHHHHHHhhCCCCCCCc-CHHHHHHHHHc-CCCCCCccCCHHHHHH
Confidence            2345689999999999864   35789999999999999999999999853 34444444443 3456788999999999


Q ss_pred             HHHhcccCCCCcCCHHH------HhcCCeee
Q psy10603        243 AELCLRHDPAQRATIFE------LLQHPFLI  267 (407)
Q Consensus       243 i~~~l~~dp~~R~t~~e------~l~hp~~~  267 (407)
                      |.+||++||++|||+.|      +++||||.
T Consensus       241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~  271 (288)
T d1uu3a_         241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFE  271 (288)
T ss_dssp             HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred             HHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence            99999999999999988      47889884

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=455.54  Aligned_cols=256  Identities=29%  Similarity=0.432  Sum_probs=220.6

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.+...||+|+||+||+|++..+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            45667779999999999999999999999999998653323334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||++|+|..++... ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......   
T Consensus        85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~---  159 (337)
T d1o6la_          85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG---  159 (337)
T ss_dssp             ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT---
T ss_pred             eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC---
Confidence            999999999998764 4599999999999999999999999999999999999999875 69999999998754322   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      ......+||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+. +..+....+. ...+.+|..+|+++++
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~---~~y~~~~DiwSlGvilyeml~G~~pf~~~-~~~~~~~~i~-~~~~~~p~~~s~~~~d  234 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELIL-MEEIRFPRTLSPEAKS  234 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS---SCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHH-HCCCCCCTTSCHHHHH
T ss_pred             cccccceeCHHHhhhhhccC---CCCChhhcccchhhHHHHHHHCCCCCCCc-CHHHHHHHHh-cCCCCCCccCCHHHHH
Confidence            22356799999999999865   35689999999999999999999999854 3334433333 3456778999999999


Q ss_pred             HHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      ||.+||++||.+|++     +.|+++||||.
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCcccc
Confidence            999999999999994     89999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-61  Score=445.64  Aligned_cols=253  Identities=27%  Similarity=0.397  Sum_probs=198.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.+...||+|+||+||+|++..+|+.||||++.......  ..+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            345569999999999999999999999999997653322  235678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec--CCCeEEEEcccCceecCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~--~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+..  +++.+||+|||+|+......   
T Consensus        89 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---  164 (307)
T d1a06a_          89 VSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---  164 (307)
T ss_dssp             CCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             cCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---
Confidence            999999999965 456999999999999999999999999999999999999963  34579999999997654332   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDE  238 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~  238 (407)
                       ...+.+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+.. ..+....+..+..   ...+..+|++
T Consensus       165 -~~~~~~GT~~y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         165 -VLSTACGTPGYVAPEVLAQ---KPYSKAVDCWSIGVIAYILLCGYPPFYDEN-DAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             ---------CTTSCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             -eeeeeeeCccccCcHHHcC---CCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCCCCCccccCCCHH
Confidence             2345789999999999864   347899999999999999999999998643 3344444443332   2345679999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++|+.+||++||++|||+.|+++||||.
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            99999999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-61  Score=451.25  Aligned_cols=253  Identities=29%  Similarity=0.498  Sum_probs=209.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||+|+++...  +....+++.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            344458999999999999999999999999997643  334457789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++|+|.+++.+. +.+++..++.++.|++.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.....     
T Consensus        86 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~-----  158 (322)
T d1s9ja_          86 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-----  158 (322)
T ss_dssp             CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH-----
T ss_pred             CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC-----
Confidence            9999999999754 459999999999999999999997 5999999999999998875 6999999999876432     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH-----------------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI-----------------------  219 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~-----------------------  219 (407)
                      ..++.+||+.|||||++.+   ..|+.++||||+||++|||++|+.||...+.....                       
T Consensus       159 ~~~~~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             TC---CCSSCCCCHHHHHC---SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ccccccCCccccCchHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            1245799999999999965   35789999999999999999999999754322111                       


Q ss_pred             ------------------HHHHhCCCCCCCC-CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        220 ------------------MFKVGMGETPTIP-ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       220 ------------------~~~~~~~~~~~~~-~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                                        .........|..+ ..+|.++++|+.+||++||.+|||+.|+|+||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                              0111112222333 247899999999999999999999999999999963

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-60  Score=444.54  Aligned_cols=253  Identities=23%  Similarity=0.388  Sum_probs=218.8

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.....||+|+||+||+|++..+|+.||||++++....+.+..+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            45666779999999999999999999999999997643333334577889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||+||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....    
T Consensus        84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~~----  157 (316)
T d1fota_          84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDV----  157 (316)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSC----
T ss_pred             eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEeccc----
Confidence            99999999999875 45589999999999999999999999999999999999998865 6999999999876432    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                        ..+.+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+. +..+...++..+ .+.+|..+|+++++
T Consensus       158 --~~~~~Gt~~Y~APE~l~~---~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~s~~~~~  230 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNA-ELRFPPFFNEDVKD  230 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTT---CCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHC-CCCCCTTSCHHHHH
T ss_pred             --cccccCcccccCHHHHcC---CCCCchhhccccchhHHHHHhCCCCCCCc-CHHHHHHHHHcC-CCCCCCCCCHHHHH
Confidence              245789999999999854   34688999999999999999999999854 344444444443 34567889999999


Q ss_pred             HHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        242 FAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++.+||++||.+|+     |++|+++||||.
T Consensus       231 li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~  261 (316)
T d1fota_         231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  261 (316)
T ss_dssp             HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             HHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence            99999999999996     899999999984

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.1e-60  Score=447.97  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=216.1

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            344558999999999999999999999999996542   33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-CCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-GNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |++|+|.+++....+.+++..++.++.||+.||+|||++|||||||||+|||++.+ ++.+||+|||+|+.+....    
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc----
Confidence            99999999996656679999999999999999999999999999999999999753 3579999999998765432    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~  239 (407)
                      .....+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+. +..+.+..+..+..   +..+..+|+++
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~---~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  256 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEG---KPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISEDG  256 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHT---CCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred             ccceecCcccccCHHHHcC---CCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            2345789999999999865   34688999999999999999999999854 34444444433322   22335789999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++||.+||++||++|||+.|+|+||||..
T Consensus       257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         257 KDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-59  Score=444.41  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=215.6

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecC
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELC   84 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~   84 (407)
                      .....||+|+||+||+|++..+|+.||||++....   ....+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            34459999999999999999999999999997543   223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec-CCCeEEEEcccCceecCCCCCCCCc
Q psy10603         85 TEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA-EGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        85 ~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~-~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      ++|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|||+|+.+....    .
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~  184 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----I  184 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----C
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC----c
Confidence            999999888665666999999999999999999999999999999999999973 23579999999998875432    2


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---CCCCCccCHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---PTIPESLSDEGQ  240 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~  240 (407)
                      .....||+.|||||++.+   ..++.++|||||||++|||++|+.||.+.. ....+..+..+..   +..+..+|++++
T Consensus       185 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDR---EPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             EEEECSSGGGCCHHHHTT---CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             eeeccCcccccCHHHHcC---CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            345689999999999854   346899999999999999999999998643 3344444443332   234567999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        241 AFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +||.+||++||.+|||+.|+|+||||..
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999999853

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-59  Score=445.97  Aligned_cols=257  Identities=24%  Similarity=0.406  Sum_probs=217.8

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccC---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN---DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      .++.....||+|+||+||+|++..+|+.||||++.+....   ......+..+|+++++.++|||||++++++.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            4667778999999999999999999999999999754321   2222333445688889999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +|||||++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+....
T Consensus        84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~~~  161 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK  161 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSSSC
T ss_pred             EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCCCc
Confidence            999999999999999764 4589999999999999999999999999999999999998865 69999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc-hHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS-NYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                           ....+||+.|||||++...  ..++.++|||||||++|||++|+.||..... ....+.+......+.+|..+|+
T Consensus       162 -----~~~~~GT~~y~APE~~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  234 (364)
T d1omwa3         162 -----PHASVGTHGYMAPEVLQKG--VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  234 (364)
T ss_dssp             -----CCSCCSCGGGCCHHHHSTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred             -----ccccccccccchhHHhhcC--CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence                 2456899999999998542  4578999999999999999999999986433 2233444455566677889999


Q ss_pred             HHHHHHHHhcccCCCCcCC-----HHHHhcCCeee
Q psy10603        238 EGQAFAELCLRHDPAQRAT-----IFELLQHPFLI  267 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t-----~~e~l~hp~~~  267 (407)
                      ++++||.+||++||++|||     ++|+++||||.
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence            9999999999999999999     79999999984

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-59  Score=433.87  Aligned_cols=254  Identities=27%  Similarity=0.395  Sum_probs=215.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND---ARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .....||+|+||+||+|++..+|+.||||++.+.....   ....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus        13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (293)
T d1jksa_          13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL   92 (293)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            34458999999999999999999999999997643221   123467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCC---eEEEEcccCceecCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGN---SLKLGDFGSAVKISAHT  158 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~---~vkl~DFGla~~~~~~~  158 (407)
                      |||++|+|.++++.. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.   .+||+|||+|+......
T Consensus        93 E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~  171 (293)
T d1jksa_          93 ELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN  171 (293)
T ss_dssp             ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred             EcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence            999999999999764 45999999999999999999999999999999999999987653   59999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC---CCCCcc
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP---TIPESL  235 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (407)
                          ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.+. +..+....+..+...   ..+..+
T Consensus       172 ----~~~~~~~t~~y~APE~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         172 ----EFKNIFGTPEFVAPEIVNY---EPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             ----BCSCCCCCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             ----cccccCCCCcccCHHHHcC---CCCCCcccchhhhHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCCCCchhcCCC
Confidence                2345689999999999964   34689999999999999999999999854 344444444443322   234678


Q ss_pred             CHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      |+++++||.+||++||++|||+.|+++||||.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  275 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  275 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            99999999999999999999999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.3e-59  Score=426.24  Aligned_cols=258  Identities=26%  Similarity=0.398  Sum_probs=217.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCc------HHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCc
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQND------ARFVKDMLVELRILEGIN-QKNLVKYYGVEIHRE   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   75 (407)
                      ++.....||+|+||+||+|++..+|+.||||++.+.....      ....+.+.+|+.+|++++ |||||++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            4566779999999999999999999999999998654321      234457889999999997 999999999999999


Q ss_pred             eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      .+|||||||++|+|.++++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~  161 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLD  161 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             ceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchheeEcc
Confidence            99999999999999999976 44699999999999999999999999999999999999998765 69999999998875


Q ss_pred             CCCCCCCcccccccCCccccccccccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCC---C
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDT---NKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGET---P  229 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~---~  229 (407)
                      ....    ....+||+.|+|||.+...   ....++.++||||+||++|||++|+.||.+.. .......+..+..   .
T Consensus       162 ~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         162 PGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-QMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             TTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCT
T ss_pred             CCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-HHHHHHHHHhCCCCCCC
Confidence            4322    2456899999999998642   22346789999999999999999999998643 3334443433322   2


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..+..+|+++++|+.+||++||++|||+.|+++||||.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence            23357999999999999999999999999999999984

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-59  Score=443.96  Aligned_cols=251  Identities=26%  Similarity=0.403  Sum_probs=216.9

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+++|+.++|||||++++++...+.+++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            34445999999999999999999999999999754433334456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +.+|+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.+...      
T Consensus       123 ~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~------  194 (350)
T d1rdqe_         123 VAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR------  194 (350)
T ss_dssp             CTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC------
T ss_pred             ccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeecccc------
Confidence            9999999998664 4599999999999999999999999999999999999998865 6999999999876532      


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHH
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFA  243 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i  243 (407)
                      ....+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+. +.......+..+ .+..|..+|+++.++|
T Consensus       195 ~~~~~Gt~~Y~APE~~~~---~~~~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~s~~~~~li  269 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSG-KVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             BCCCEECGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHC-CCCCCTTCCHHHHHHH
T ss_pred             cccccCccccCCHHHHcC---CCCCccccccchhHHHHHHHhCCCCCCCc-CHHHHHHHHhcC-CCCCCccCCHHHHHHH
Confidence            245689999999999965   34689999999999999999999999854 344444444433 4556788999999999


Q ss_pred             HHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        244 ELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       244 ~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      ++||++||.+|+     |+.|+++||||.
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             HHHhhhCHHhccccccccHHHHHcCcccc
Confidence            999999999995     899999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=438.43  Aligned_cols=256  Identities=26%  Similarity=0.431  Sum_probs=217.6

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHh-cCCCCCcceEEEEEEeCceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILE-GINQKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv   80 (407)
                      .++.+...||+|+||+||+|++..+|+.||||++++.........+.+.+|..++. .++|||||++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46777889999999999999999999999999997543222223456677877765 69999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCC
Q psy10603         81 MELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~  160 (407)
                      ||||++|+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......  
T Consensus        82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~--  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD--  157 (320)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--
T ss_pred             EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhccccc--
Confidence            9999999999999764 4599999999999999999999999999999999999998765 69999999998654332  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                       ...+..+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.+. +..++...+.. ..+.+|..+|++++
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~-~~~~~p~~~s~~~~  231 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLG---QKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRM-DNPFYPRWLEKEAK  231 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTT---CCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHH-CCCCCCTTSCHHHH
T ss_pred             -ccccccCCCCCcCCHHHHcC---CCCCchhhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHc-CCCCCCccCCHHHH
Confidence             22345689999999999965   34689999999999999999999999854 34444444443 45677889999999


Q ss_pred             HHHHHhcccCCCCcCCHH-HHhcCCeee
Q psy10603        241 AFAELCLRHDPAQRATIF-ELLQHPFLI  267 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~-e~l~hp~~~  267 (407)
                      +|+.+||++||++|||+. |+++||||.
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~  259 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFR  259 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred             HHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence            999999999999999995 899999984

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-59  Score=428.75  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=208.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.....||+|+||+||+|+.+   ..||||+++.... +.+..+.+.+|+.+|++++|||||++++++. .+.+++|||
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            4556679999999999999754   3599999976543 3345678999999999999999999999864 567899999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      ||++|+|.+++......+++..+..++.||+.||+|||+++||||||||+|||++.++ .+||+|||+|+....... ..
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~~-~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSG-SH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC---------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeeccccCC-cc
Confidence            9999999999977666799999999999999999999999999999999999998865 699999999977643221 12


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCC----CCCCccCHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETP----TIPESLSDE  238 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~s~~  238 (407)
                      ......||+.|||||++.......++.++|||||||++|||+||+.||.+..+.......+..+..+    .++..++++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            2345689999999999976544557899999999999999999999998766655555544444332    356778999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      +++++.+||+.||++|||+.|++++.
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            99999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-59  Score=426.16  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=208.7

Q ss_pred             eecccccCeEEEEEEEC--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          8 VSPGQGRFGKVYTAVNN--ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ++||+|+||+||+|.+.  .+++.||||+++... .+....+++.+|+++|++++|||||++++++.. +..+||||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            47999999999999864  456789999996543 344556789999999999999999999999854 56789999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      +|+|.++++. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+...........
T Consensus        91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC--
T ss_pred             CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhcccccccccccc
Confidence            9999999975 45599999999999999999999999999999999999999865 799999999987754433222234


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHH
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAE  244 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~  244 (407)
                      ...||+.|||||++...   .++.++|||||||++|||+| |+.||.+. +..++...+..+..+..|..+|+++.+++.
T Consensus       169 ~~~gt~~y~APE~l~~~---~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~-~~~~~~~~i~~~~~~~~p~~~~~~~~~li~  244 (277)
T d1xbba_         169 HGKWPVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKGERMGCPAGCPREMYDLMN  244 (277)
T ss_dssp             --CCCGGGCCHHHHHHC---EEEHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCceecCchhhcCC---CCCchhhhccchhhhhHHhhCCCCCCCCC-CHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence            45789999999998653   36789999999999999998 89999864 345666677778888899999999999999


Q ss_pred             HhcccCCCCcCCHHHHh---cCCee
Q psy10603        245 LCLRHDPAQRATIFELL---QHPFL  266 (407)
Q Consensus       245 ~~l~~dp~~R~t~~e~l---~hp~~  266 (407)
                      +||+.||++|||+.|++   +|+|+
T Consensus       245 ~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         245 LCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            99999999999999984   55553

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-58  Score=422.61  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=213.3

Q ss_pred             ecccccCeEEEEEEECCC--CcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCCC
Q psy10603          9 SPGQGRFGKVYTAVNNET--GELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCTE   86 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~~   86 (407)
                      +||+|+||+||+|.++.+  +..||||+++..  .+....+++.+|+++|++++|||||++++++.. +.+|+|||||++
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~   92 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG   92 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCC
Confidence            599999999999987644  457999998753  344556789999999999999999999998864 568999999999


Q ss_pred             CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCcccc
Q psy10603         87 GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNG  166 (407)
Q Consensus        87 g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~~  166 (407)
                      |+|.+++...+..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+............
T Consensus        93 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~  171 (285)
T d1u59a_          93 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSA  171 (285)
T ss_dssp             EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCS
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhcccccccccccccc
Confidence            999999876666799999999999999999999999999999999999999865 7999999999887654333233345


Q ss_pred             cccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHHHHHH
Q psy10603        167 FVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQAFAEL  245 (407)
Q Consensus       167 ~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~  245 (407)
                      ..||+.|||||++...   .++.++|||||||++|||+| |+.||.+.. ..+....+..+..+.+|+.+|+++.+++.+
T Consensus       172 ~~gt~~y~aPE~~~~~---~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  247 (285)
T d1u59a_         172 GKWPLKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRMECPPECPPELYALMSD  247 (285)
T ss_dssp             SCCCGGGCCHHHHHHC---EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCccccChHHHhCC---CCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            6789999999998643   46889999999999999998 999998654 445666777788888999999999999999


Q ss_pred             hcccCCCCcCCHHHH---hcCCeee
Q psy10603        246 CLRHDPAQRATIFEL---LQHPFLI  267 (407)
Q Consensus       246 ~l~~dp~~R~t~~e~---l~hp~~~  267 (407)
                      ||+.||++|||+.++   |+|+|+.
T Consensus       248 cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         248 CWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            999999999999887   4566653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-58  Score=419.62  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=205.8

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.+...||+|+||+||+|++. +++.||||+++.....    .+++.+|+++|++++|||||++++++..++.+++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            35677789999999999999986 5678999998754332    256889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||++|+|.+++......+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++........ 
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCce-
Confidence            99999999999877667789999999999999999999999999999999999999865 6999999999876543221 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       ......||+.|||||++..   ..++.++|||||||++|||+|+..|+....+..+....+..+..+..|..+++++.+
T Consensus       158 -~~~~~~gt~~y~aPE~l~~---~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  233 (263)
T d1sm2a_         158 -SSTGTKFPVKWASPEVFSF---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ  233 (263)
T ss_dssp             --------CTTSCCHHHHTT---CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             -eecceecCcccCChHHhcC---CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHH
Confidence             2234578999999999864   347899999999999999999654444445666677777777888888999999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhcC
Q psy10603        242 FAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++.+||++||++|||+.|+++|
T Consensus       234 li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-58  Score=425.00  Aligned_cols=250  Identities=21%  Similarity=0.324  Sum_probs=215.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||+||+|++..+|+.||||+++.....    .+++.+|+++|++++|||||++++++.+.+.+++|||
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            455566999999999999999999999999998654322    3568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+........ 
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~-  171 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT-  171 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSE-
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCce-
Confidence            99999999998653 45689999999999999999999999999999999999998865 6999999999876443221 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       ......||+.|||||++..   ..++.++|||||||++|||++|..||....+..+....+..+..+..|..+|+++++
T Consensus       172 -~~~~~~g~~~y~aPE~~~~---~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         172 -AHAGAKFPIKWTAPESLAY---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             -EETTEEECGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -eeccccccccccChHHHcC---CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence             2234568999999999865   347899999999999999999877776555566666666677788889999999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc
Q psy10603        242 FAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      |+.+||+.||++|||+.|+++
T Consensus       248 li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=429.61  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=203.5

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEecCC
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--DARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      ..||+|+||+||+|++..+|+.||||+++.....  +....+.+.+|+.+|++++|||||++++++..++.+|+|||||.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            4799999999999999999999999998754332  22234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCccc
Q psy10603         86 EGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELN  165 (407)
Q Consensus        86 ~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~~~  165 (407)
                      ++++..+.. ....+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......   ...
T Consensus        84 ~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~---~~~  158 (299)
T d1ua2a_          84 TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNR---AYT  158 (299)
T ss_dssp             EEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCC---CCC
T ss_pred             chHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcc---ccc
Confidence            887776654 455699999999999999999999999999999999999999865 699999999977654321   234


Q ss_pred             ccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC----------------
Q psy10603        166 GFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE----------------  227 (407)
Q Consensus       166 ~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~----------------  227 (407)
                      ..+||+.|+|||++...  ..++.++|||||||++|||++|..||....+. +.+..+..  +.                
T Consensus       159 ~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CSCCCCTTCCHHHHTTC--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             ceecChhhccHHHHccC--CCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccchhh
Confidence            56899999999998643  34689999999999999999999999864433 32222110  00                


Q ss_pred             ----CCCC-----CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 ----TPTI-----PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 ----~~~~-----~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                          .+..     ...+|+++++|+.+||++||++|||+.|+|+||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence                0011     135689999999999999999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=429.80  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=213.8

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||+++...    .....+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            455569999999999999999999999999997542    1234577999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC-CCeEEEEcccCceecCCCCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE-GNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~-~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+||+|.++++.....+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++......    
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC----
Confidence            99999999997655569999999999999999999999999999999999999754 3469999999998764332    


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCC---CCCccCHHH
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPT---IPESLSDEG  239 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~  239 (407)
                      ......||+.|+|||.+.+   ..++.++|||||||++|+|++|+.||... +..+....+..+....   .+..+|+++
T Consensus       159 ~~~~~~~t~~y~ape~~~~---~~~~~~~DiWSlGvily~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVHQH---DVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             EEEEEESCGGGSCHHHHTT---CEECHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             cccccccccccccchhccC---CCCCchhhcccHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            2245678999999999854   34688999999999999999999999854 3444444444333221   124689999


Q ss_pred             HHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        240 QAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       240 ~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      ++|+.+||++||++|||+.|+++||||..
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            99999999999999999999999999853

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.6e-58  Score=423.37  Aligned_cols=254  Identities=21%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc---EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE---LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      .+.....||+|+||+||+|++..+++   .||||.+...  ......+++.+|+++|++++|||||++++++..++.+++
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            34556699999999999999987765   5788877543  344556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||++|+|.+++......+++.++..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-----------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccCCCC
Confidence            9999999999999877666799999999999999999999999999999999999998764 699999999987654322


Q ss_pred             CC--CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        160 VP--GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       160 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      ..  .......||+.|||||++..   ..++.++|||||||++|||+| |+.||.+. +..+....+..+..+..|..++
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQY---RKFTSASDVWSYGIVMWEVMSYGERPYWDM-TNQDVINAIEQDYRLPPPMDCP  259 (299)
T ss_dssp             ------------CGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cceeeecccccCCccccCHHHHhc---CCCCcccccccchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCCCCccch
Confidence            21  11223567999999999854   346889999999999999998 89999864 4456666777777788888999


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++.+++.+||+.||++|||+.|++++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-58  Score=430.01  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=211.6

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc-----EEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCce
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE-----LVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREE   76 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~-----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~   76 (407)
                      ++.+...||+|+||+||+|++..+++     .||+|.+....  +....+.+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            34556699999999999999876554     69999886432  333456788999999998 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy10603         77 MVLFMELCTEGTLESLVQSTE----------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANI  134 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~----------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Ni  134 (407)
                      +|+|||||++|+|.++++...                      ..+++..+..++.||+.||.|||+++||||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            999999999999999997543                      2378899999999999999999999999999999999


Q ss_pred             EEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCC
Q psy10603        135 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEY  213 (407)
Q Consensus       135 ll~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~  213 (407)
                      |++.++ .+||+|||+|+........ ....+..||+.|||||++.+   ..++.++|||||||++|||+| |+.||.+.
T Consensus       196 ll~~~~-~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         196 LVTHGK-VVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE---GIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             EEETTT-EEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ccccCC-eEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC---CCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            998764 7999999999876543221 12234678999999999864   346899999999999999998 89999876


Q ss_pred             CchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        214 DSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      .........+..+..+..|..+|+++++||.+||+.||++|||+.|+++|.
T Consensus       271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  321 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  321 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            555555555566677888899999999999999999999999999999763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=411.54  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=218.5

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      +++.+..+||+|+||+||+|+++ +++.||||+++.....+    +.+.+|+.++++++||||+++++++.+++.+++||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            46778889999999999999985 67889999998654332    46889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||+++|+|..++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.+.....  
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~--  155 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEY--  155 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSC--
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCc--
Confidence            99999999999876666799999999999999999999999999999999999999765 699999999977654322  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQ  240 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  240 (407)
                      .......||+.|+|||++.+   ..++.++|||||||++|||+| |+.||... +..+...++..+..+..|..++++++
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~---~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~  231 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMY---SKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRLYRPHLASEKVY  231 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             eeecccCCCCCcCCcHHhcC---CCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCCCCcccccHHHH
Confidence            22345678999999999865   346889999999999999998 89999865 45566777777888888999999999


Q ss_pred             HHHHHhcccCCCCcCCHHHHhcC
Q psy10603        241 AFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       241 ~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +|+.+||++||++|||+.|+++|
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-58  Score=422.83  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=208.5

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHhcCC--CCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDA---RFVKDMLVELRILEGIN--QKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~   77 (407)
                      .+.....||+|+||+||+|++..+|+.||||++.+....+.   ...+++.+|+.+|++++  |||||++++++.+++..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            34556699999999999999999999999999976433221   11234568999999887  89999999999999999


Q ss_pred             EEEEecCCC-CCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         78 VLFMELCTE-GTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        78 ~lv~E~~~~-g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      |+||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||+|+....
T Consensus        85 ~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            999999976 678888765 345999999999999999999999999999999999999987666899999999976543


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccC
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLS  236 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s  236 (407)
                      .     ..++.+||+.|+|||++...  ..++.++|||||||++|||++|+.||...   .....     ....++..+|
T Consensus       164 ~-----~~~~~~GT~~y~aPE~~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~i~~-----~~~~~~~~~s  228 (273)
T d1xwsa_         164 T-----VYTDFDGTRVYSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHD---EEIIR-----GQVFFRQRVS  228 (273)
T ss_dssp             S-----CBCCCCSCGGGSCHHHHHHS--CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHHH-----CCCCCSSCCC
T ss_pred             c-----cccccccCCCcCCHHHHcCC--CCCCcccccccceeeehhHhhCCCCCCCc---hHHhh-----cccCCCCCCC
Confidence            2     23457899999999998653  23467899999999999999999999742   12111     2345677899


Q ss_pred             HHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        237 DEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      +++++|+.+||++||++|||+.|+++||||.
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  259 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  259 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            9999999999999999999999999999984

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=415.67  Aligned_cols=254  Identities=20%  Similarity=0.287  Sum_probs=209.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCC----cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG----ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      .++....||+|+||+||+|.++.++    ..||||++...  ......+++.+|+++|++++|||||++++++.+.+..+
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4567779999999999999987655    47999998643  33444567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +|||||.+|++.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.+....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC--------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhcccCCC
Confidence            99999999999998877767799999999999999999999999999999999999999865 69999999998765433


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      ..........||+.|||||++.+   ..++.++|||||||++|||++|..|+....+..+....+..+..+..|..++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~---~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             ---------CCCGGGSCHHHHHS---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             ccceEeccCCCCccccCHHHHcc---CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            22222344578999999999854   346889999999999999999777766556667777777788888889999999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      +.+++.+||+.||++|||+.|+++
T Consensus       242 l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         242 IYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=416.72  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=211.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||+||+|+++ +++.||||+++.....    .+.+.+|+++|++++|||||++++++. ++.+|+|||
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~E   87 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEE
Confidence            3455668999999999999976 5778999999754322    256889999999999999999999864 566799999


Q ss_pred             cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.+...... 
T Consensus        88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~-  165 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT-  165 (272)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE-
T ss_pred             eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCccc-
Confidence            999999998775432 2489999999999999999999999999999999999998764 6999999999887543221 


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                       ......||+.|||||++...   .++.++|||||||++|||+||..|+....+..+....+..+..+..|..+++++.+
T Consensus       166 -~~~~~~gt~~y~APE~~~~~---~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHC---EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -cccccCCcccccChHHHhCC---CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence             22446789999999998642   36889999999999999999766665556666777777788888889999999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc--CCee
Q psy10603        242 FAELCLRHDPAQRATIFELLQ--HPFL  266 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~--hp~~  266 (407)
                      ++.+||+.||++|||+.|+++  |+||
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            999999999999999999987  5665

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=420.59  Aligned_cols=258  Identities=29%  Similarity=0.498  Sum_probs=207.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFM   81 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   81 (407)
                      .++.....||+|+||+||+|++..+|+.||||+++.... .....+++.+|+++|++++|||||++++++.+++.+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            345556699999999999999999999999999975432 2233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||.++.+..........+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+......   
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~---  156 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPV---  156 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCS---
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCc---
Confidence            99987655555444556799999999999999999999999999999999999998765 69999999997764332   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--CC------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--GE------------  227 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~~------------  227 (407)
                      ......+||+.|+|||++...  ..++.++|||||||++|+|++|+.||.+.+.. ..+..+..  +.            
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~--~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGC--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ccceeecccceeeehhhhccc--cCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhccccccc
Confidence            123456899999999998653  33578999999999999999999999864332 22222110  00            


Q ss_pred             ---CCCC-----------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        228 ---TPTI-----------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       228 ---~~~~-----------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                         .+..           ...+|+++++|+.+||++||++|||+.|+++||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~  287 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence               0001           135689999999999999999999999999999984

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=427.92  Aligned_cols=245  Identities=28%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             ecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCcceEEEEEEe----CceEEEEEec
Q psy10603          9 SPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEG-INQKNLVKYYGVEIH----REEMVLFMEL   83 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~~~lv~E~   83 (407)
                      .||+|+||+||+|++..+++.||||+++..        ..+.+|+.++.+ .+|||||++++++.+    +..+|+||||
T Consensus        19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy   90 (335)
T d2ozaa1          19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   90 (335)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             EeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence            599999999999999999999999998632        345679988755 589999999999876    4679999999


Q ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC--CCeEEEEcccCceecCCCCCC
Q psy10603         84 CTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE--GNSLKLGDFGSAVKISAHTTV  160 (407)
Q Consensus        84 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~--~~~vkl~DFGla~~~~~~~~~  160 (407)
                      |+||+|.++++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+  ...+||+|||+|+......  
T Consensus        91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--  168 (335)
T d2ozaa1          91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--  168 (335)
T ss_dssp             CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--
T ss_pred             CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC--
Confidence            99999999997643 469999999999999999999999999999999999999863  2469999999998765432  


Q ss_pred             CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchH--HHHHHHhCCCCCCCC----Cc
Q psy10603        161 PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNY--QIMFKVGMGETPTIP----ES  234 (407)
Q Consensus       161 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~----~~  234 (407)
                        .....+||+.|||||++.+   ..|+.++|||||||++|+|+||+.||.+.....  ..+..........+|    ..
T Consensus       169 --~~~~~~gt~~y~aPE~~~~---~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (335)
T d2ozaa1         169 --SLTTPCYTPYYVAPEVLGP---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE  243 (335)
T ss_dssp             --CCCCCSCCCSSCCCCCCCG---GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHH
T ss_pred             --ccccccCCcccCCcHHHcC---CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccccc
Confidence              2345689999999999864   346899999999999999999999997543221  112222222222223    35


Q ss_pred             cCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        235 LSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       235 ~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                      +|+++++||.+||++||++|||+.|+++||||..
T Consensus       244 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            8999999999999999999999999999999853

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-56  Score=412.75  Aligned_cols=255  Identities=24%  Similarity=0.324  Sum_probs=203.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc----eEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE----EMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l   79 (407)
                      +.....||+|+||+||+|++..+|+.||||+++.....+....+++.+|+++|+.++|||||++++++...+    .+|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            455669999999999999999999999999998776667777788999999999999999999999988654    4899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||+||+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+........
T Consensus        89 vmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC----
T ss_pred             EEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhccccc
Confidence            99999999999988654 4599999999999999999999999999999999999999865 599999999877654333


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CCCCC--CCCCccC
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MGETP--TIPESLS  236 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~~~~--~~~~~~s  236 (407)
                      ........+||+.|||||++.+   ..+++++|||||||++|||+||+.||.+.. ..+...+.. .+..+  ..+..+|
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARG---DSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ------------TTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             cccccccccCcccccCHHHHcC---CCCCcceecccchHHHHHHHhCCCCCCCcC-HHHHHHHHHhcCCCCCchhccCCC
Confidence            3333456789999999999854   347899999999999999999999998643 334433333 22222  2346799


Q ss_pred             HHHHHHHHHhcccCCCCcC-CHHHHhcCCe
Q psy10603        237 DEGQAFAELCLRHDPAQRA-TIFELLQHPF  265 (407)
Q Consensus       237 ~~~~~~i~~~l~~dp~~R~-t~~e~l~hp~  265 (407)
                      ++++++|.+||++||++|| |++++ .|+|
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l-~~~l  271 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEM-RADL  271 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHH-HHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHH-HHHH
Confidence            9999999999999999999 55554 4544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=407.08  Aligned_cols=254  Identities=24%  Similarity=0.412  Sum_probs=200.5

Q ss_pred             ccceeeecccccCeEEEEEEECC-CC--cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNE-TG--ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~-~~--~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      ++.+...||+|+||+||+|++.. ++  ..||||++......+.+..+++.+|+.+|++++|||||++++++.+ +.+++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            56677799999999999998643 33  3689999876655555667889999999999999999999999965 56789


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||++|++.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CC
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhcccCCC
Confidence            9999999999998876666799999999999999999999999999999999999999865 799999999988754433


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHH-hCCCCCCCCCccCH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKV-GMGETPTIPESLSD  237 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~s~  237 (407)
                      .........||+.|+|||++.+   ..++.++|||||||++|||+| |+.||.+.. ..+....+ ..+..+..+..+|+
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKT---RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHH---CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cceecCccccCcccCCHHHHhC---CCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-HHHHHHHHHhCCCCCCCcccccH
Confidence            2222334567889999999965   346789999999999999998 899998654 33443443 45567777889999


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ++++++.+||..||++|||+.|+++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=404.05  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   79 (407)
                      .+.....||+|+||+||+|++..++   ..||||.++..  .+....+.+.+|+.+|++++|||||++++++. ++.+|+
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3455669999999999999987554   46888887533  34555678999999999999999999999985 567899


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC------------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccCCcc
Confidence            9999999999998877677799999999999999999999999999999999999999865 799999999987653322


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      .  ......||+.|+|||++..   ..++.++|||||||++|||++ |.+||... +..+....+..+..+.+|..+|++
T Consensus       164 ~--~~~~~~gt~~y~apE~l~~---~~~~~~~DiwSlGvil~e~lt~g~~P~~~~-~~~~~~~~i~~~~~~~~~~~~~~~  237 (273)
T d1mp8a_         164 Y--KASKGKLPIKWMAPESINF---RRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERLPMPPNCPPT  237 (273)
T ss_dssp             ---------CCGGGCCHHHHHH---CCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred             e--eccceecCcccchhhHhcc---CCCCCccccccchHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCHH
Confidence            1  2234578999999999864   346889999999999999998 89999854 344566667778888889999999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ++++|.+||+.||++|||+.|+++|
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999876

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=411.27  Aligned_cols=253  Identities=27%  Similarity=0.482  Sum_probs=200.1

Q ss_pred             ceeeecccccCeEEEEEEECCC-CcEEEEEEEeccccCcHHHHHHHHHHHHHHh---cCCCCCcceEEEEEEe-----Cc
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNET-GELVAMKEIQLHKQNDARFVKDMLVELRILE---GINQKNLVKYYGVEIH-----RE   75 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~---~l~hpniv~~~~~~~~-----~~   75 (407)
                      .....||+|+||+||+|++..+ ++.||||+++.....+ .....+.+|+.+|+   .++||||+++++++..     ..
T Consensus        10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_          10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            3345999999999999999766 5679999997543221 11223456666655   4589999999999863     34


Q ss_pred             eEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKIS  155 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~  155 (407)
                      .++++||||.++++..........+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~~~~  167 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYS  167 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCCCCC
T ss_pred             eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhhhhc
Confidence            68999999999888766666667799999999999999999999999999999999999998865 69999999987654


Q ss_pred             CCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh----CC-----
Q psy10603        156 AHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----MG-----  226 (407)
Q Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~----~~-----  226 (407)
                      ...    .....+||+.|||||++.+   ..++.++|||||||++|||++|+.||.+.... ..+..+.    ..     
T Consensus       168 ~~~----~~~~~~gT~~Y~APE~~~~---~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         168 FQM----ALTSVVVTLWYRAPEVLLQ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             GGG----GGCCCCCCCTTCCHHHHTT---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGGS
T ss_pred             ccc----cCCCcccChhhcCcchhcC---CCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchhcc
Confidence            322    2356789999999999865   45789999999999999999999999865432 2222110    00     


Q ss_pred             -----------------CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 -----------------ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 -----------------~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                       ..+.++..+|+++++|+.+||++||++|||+.|+|+||||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~  297 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  297 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence                             00123456899999999999999999999999999999984

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-55  Score=405.97  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=205.4

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      .+....+||+|+||+||+|+++ +|+.||||+++.... +....+++.+|+.+|++++|||||++++++...+..+++||
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            3445569999999999999986 789999999976543 23335678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+.++++..+.+ ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|........   
T Consensus        81 ~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~---  155 (286)
T d1ob3a_          81 HLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR---  155 (286)
T ss_dssp             CCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC------
T ss_pred             eehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCcc---
Confidence            998877776664 456699999999999999999999999999999999999998865 699999999977643321   


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh--CCCC------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG--MGET------------  228 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~--~~~~------------  228 (407)
                      ......||+.|+|||.+...  ..++.++|||||||++|||++|+.||.+..+.. .+.++.  .+..            
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~--~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ------CCCTTCCHHHHTTC--CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccceecccchhhhHHHHhCC--CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhccchhhhh
Confidence            22445789999999998643  346899999999999999999999998644332 222111  0000            


Q ss_pred             --------------CCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        229 --------------PTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       229 --------------~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                    +..+..+|+++++|+++||++||++|||+.|+++||||.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                          112456789999999999999999999999999999984

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=404.27  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=207.9

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEe
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFME   82 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E   82 (407)
                      ++.+...||+|+||+||+|+++.+ +.||||++......    .+.+.+|+.+|++++|||||++++++. .+.+++|||
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E   91 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   91 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence            456677999999999999998765 56999999754432    256889999999999999999999984 556899999


Q ss_pred             cCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         83 LCTEGTLESLVQST-EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        83 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||++|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.......  
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~--  168 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY--  168 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCc--
Confidence            99999999887543 34599999999999999999999999999999999999998865 699999999987643322  


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHHHHH
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDEGQA  241 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  241 (407)
                      .......||+.|+|||++..   ..++.++|||||||++|||++|..|+.......+.+..+..+..+..+..+|+++++
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~---~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALY---GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  245 (285)
T ss_dssp             -------CCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             eeeccccccccccChHHHhC---CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence            12234578999999999965   346889999999999999999877776566666777777777788889999999999


Q ss_pred             HHHHhcccCCCCcCCHHHHhc--CCeee
Q psy10603        242 FAELCLRHDPAQRATIFELLQ--HPFLI  267 (407)
Q Consensus       242 ~i~~~l~~dp~~R~t~~e~l~--hp~~~  267 (407)
                      ++.+||+.||++|||+.++++  ++|+.
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            999999999999999999987  66663

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=413.72  Aligned_cols=250  Identities=28%  Similarity=0.422  Sum_probs=200.9

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC------ceEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR------EEMV   78 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~   78 (407)
                      +...+||+|+||+||+|++..+|+.||||++......       ..+|+++|++++||||+++++++...      ..+|
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            3344899999999999999999999999999754322       23699999999999999999998643      3589


Q ss_pred             EEEecCCCCCHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         79 LFMELCTEGTLESLVQ--STEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      ||||||+++.+..+..  .....+++..++.+++||+.||+|||++||+||||||+|||++.++..+||+|||+++.+..
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9999998775544432  23456999999999999999999999999999999999999998776799999999987654


Q ss_pred             CCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC---------
Q psy10603        157 HTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG---------  226 (407)
Q Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~---------  226 (407)
                      ..    ...+.+||+.|+|||++.+.  ..++.++||||+||++|||++|+.||.......+...... .+         
T Consensus       176 ~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         176 GE----PNVSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             TS----CCCSCCSCTTSCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             Cc----ccccccccccccChHHhhcc--cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            32    23456899999999987543  4578999999999999999999999986543322211110 00         


Q ss_pred             --------CCC---------CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 --------ETP---------TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 --------~~~---------~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                              ..+         .....+++++.+|+.+||++||++|||+.|+|+||||.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  307 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  307 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence                    001         11235789999999999999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-55  Score=409.98  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=207.3

Q ss_pred             ccceeeecccccCeEEEEEEECCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGE----LVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMV   78 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   78 (407)
                      ++.....||+|+||+||+|++..+|+    +||+|.+...  .+.+..+++.+|+++|++++|||||++++++.++ ..+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            45666799999999999999988886    5788877533  2333457789999999999999999999998764 578


Q ss_pred             EEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCC
Q psy10603         79 LFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHT  158 (407)
Q Consensus        79 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~  158 (407)
                      +++||+.+|+|.+.+......+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+......
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTTTTC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceeccccc
Confidence            88999999999998877777799999999999999999999999999999999999999864 79999999998765432


Q ss_pred             CCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCH
Q psy10603        159 TVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSD  237 (407)
Q Consensus       159 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~  237 (407)
                      .. .......||+.|||||++.+   ..++.++|||||||++|||+| |.+||.+.. ..++...+..+..+..|..+++
T Consensus       166 ~~-~~~~~~~gt~~y~APE~l~~---~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-~~~~~~~i~~~~~~~~p~~~~~  240 (317)
T d1xkka_         166 KE-YHAEGGKVPIKWMALESILH---RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTI  240 (317)
T ss_dssp             C---------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-GGGHHHHHHHTCCCCCCTTBCH
T ss_pred             cc-ccccccccCccccChHHHhc---CCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCCCCCcccCH
Confidence            21 12234578999999999865   347899999999999999998 788987543 4445556666778888899999


Q ss_pred             HHHHHHHHhcccCCCCcCCHHHHhcCCe
Q psy10603        238 EGQAFAELCLRHDPAQRATIFELLQHPF  265 (407)
Q Consensus       238 ~~~~~i~~~l~~dp~~R~t~~e~l~hp~  265 (407)
                      ++.+++.+||+.||++|||+.|+++|..
T Consensus       241 ~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         241 DVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999998743

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=407.01  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=209.1

Q ss_pred             ccceeeecccccCeEEEEEEECCCCcE--EEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCceEEE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETGEL--VAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREEMVL   79 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l   79 (407)
                      ++.+...||+|+||+||+|+++.+|..  ||||.++..  ......+.+.+|+++|.++ +|||||++++++.+.+.+++
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            567778999999999999999988875  567776533  2333456789999999998 79999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEE
Q psy10603         80 FMELCTEGTLESLVQST---------------EDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLK  144 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vk  144 (407)
                      ||||+++|+|.++++..               ...+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+|
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~~k  167 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAK  167 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEE
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-ceE
Confidence            99999999999998643               24689999999999999999999999999999999999999865 699


Q ss_pred             EEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCchHHHHHHH
Q psy10603        145 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKR-PWAEYDSNYQIMFKV  223 (407)
Q Consensus       145 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~-Pf~~~~~~~~~~~~~  223 (407)
                      |+|||+|+.......    .....||+.|+|||.+..   ..++.++|||||||++|||++|.. ||. ..+..+....+
T Consensus       168 l~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~---~~~~~~sDvwSfGvil~ell~~~~~p~~-~~~~~~~~~~i  239 (309)
T d1fvra_         168 IADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY---SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL  239 (309)
T ss_dssp             ECCTTCEESSCEECC----C----CCTTTCCHHHHHH---CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHG
T ss_pred             Ecccccccccccccc----ccceecCCcccchHHhcc---CCCCccceeehhHHHHHHHHhcCCCCCC-CCCHHHHHHHH
Confidence            999999976543221    234578999999999965   346889999999999999999765 565 45566666777


Q ss_pred             hCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        224 GMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       224 ~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      ..+..+..|..+++++++||.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7788888899999999999999999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=403.37  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=212.1

Q ss_pred             cceeeecccccCeEEEEEEECCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEEE
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETG---ELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMVL   79 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l   79 (407)
                      ++|..+||+|+||+||+|++..++   ..||||+++.  ..+....+++.+|+++|++++|||||++++++.. ++..++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            356678999999999999986543   3689999864  3455667889999999999999999999999876 468999


Q ss_pred             EEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         80 FMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        80 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||||++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.+ ..+||+|||+++.......
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhcccccc
Confidence            999999999999998777778899999999999999999999999999999999999875 4799999999987654322


Q ss_pred             C-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 V-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                      . ........||+.|+|||++..   ..++.++||||||+++|||+||..||....+..+....+..+..+..|..++++
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~  262 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQT---QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  262 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHH
T ss_pred             ccceecccccccccccChHHHhc---CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHH
Confidence            2 122334678999999999864   346899999999999999999888887655555566667778888889999999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +.+++.+||+.||++|||+.|+++|
T Consensus       263 l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         263 LYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-54  Score=407.71  Aligned_cols=247  Identities=26%  Similarity=0.422  Sum_probs=203.5

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeC--ceEEEEE
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHR--EEMVLFM   81 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~   81 (407)
                      .....||+|+||+||+|++..+|+.||||+++...      .+++.+|+++|++++ ||||+++++++...  ..+++||
T Consensus        38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            34458999999999999999999999999986432      256788999999996 99999999998754  4699999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||++++|..+.    ..+++..++.+++||+.||+|||++||+||||||+|||++.++..+||+|||+|+......   
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---
Confidence            999999997654    3499999999999999999999999999999999999999877789999999998765432   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh----------------C
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG----------------M  225 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~----------------~  225 (407)
                       .....+||+.|+|||.+.+.  ..++.++||||+||++|||++|+.||....+.......+.                .
T Consensus       185 -~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 -EYNVRVASRYFKGPELLVDY--QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTC--CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             -cccccccCccccCcccccCC--CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence             23556899999999998653  3468899999999999999999999986554332211100                0


Q ss_pred             CC--------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 GE--------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 ~~--------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                      ..                    .......+|+++++||++||++||.+|||+.|+|+||||.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            00                    0011235789999999999999999999999999999995

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=409.64  Aligned_cols=253  Identities=24%  Similarity=0.417  Sum_probs=202.3

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc----eEEEEEec
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE----EMVLFMEL   83 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~lv~E~   83 (407)
                      ..||+|+||+||+|+++.+|+.||||++++.  ......+++.+|+.+|++++||||+++++++....    ..++++||
T Consensus        14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~   91 (345)
T d1pmea_          14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH   91 (345)
T ss_dssp             EECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             EEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence            4999999999999999999999999999753  34556678899999999999999999999987653    23444555


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +.+|+|.++++..  .+++..++.++.|++.||+|||++|||||||||+|||++.++ .+||+|||+|+...........
T Consensus        92 ~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~~~~~  168 (345)
T d1pmea_          92 LMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGF  168 (345)
T ss_dssp             CCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCT
T ss_pred             ecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCcccee
Confidence            6789999999653  599999999999999999999999999999999999998765 6999999999876554433334


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-------------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-------------------  224 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-------------------  224 (407)
                      ....+||+.|+|||++...  ..++.++||||+||++|||++|+.||..............                   
T Consensus       169 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T d1pmea_         169 LTEYVATRWYRAPEIMLNS--KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR  246 (345)
T ss_dssp             TCCCCSCGGGCCGGGTTTB--CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             eccccccceechHHHhhcC--CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence            4567899999999998543  3468899999999999999999999976443211111100                   


Q ss_pred             -----CCCC--C---CCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        225 -----MGET--P---TIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       225 -----~~~~--~---~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                           ....  .   .....+|+++++|+.+||++||++|||+.|+|+||||.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~  299 (345)
T d1pmea_         247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  299 (345)
T ss_dssp             HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence                 0000  0   11346789999999999999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=402.76  Aligned_cols=255  Identities=25%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             ccceeeecccccCeEEEEEEECC-----CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC-c
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNE-----TGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR-E   75 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~   75 (407)
                      ++.....||+|+||+||+|++..     +++.||||+++..  ......+.+.+|..++.++ +|+||+.+++++..+ +
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            35556699999999999999754     4578999998643  2334456788888888776 578999999987664 4


Q ss_pred             eEEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCC
Q psy10603         76 EMVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEG  140 (407)
Q Consensus        76 ~~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~  140 (407)
                      .+++|||||++|+|.++++...               ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence            6899999999999999986532               3488999999999999999999999999999999999998865


Q ss_pred             CeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCchHHH
Q psy10603        141 NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-KRPWAEYDSNYQI  219 (407)
Q Consensus       141 ~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g-~~Pf~~~~~~~~~  219 (407)
                       .+||+|||+|+........ ......+||+.|||||++.+   ..++.++|||||||++|||++| ..||.........
T Consensus       172 -~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~---~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         172 -VVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -CEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -cEEEccCcchhhccccccc-cccCceeeCccccchhHhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             6999999999876433221 22345689999999999865   3468999999999999999987 5678766655566


Q ss_pred             HHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCC
Q psy10603        220 MFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHP  264 (407)
Q Consensus       220 ~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp  264 (407)
                      ...+..+..+..|..+++++++++.+||+.||++|||+.|+++|.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L  291 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  291 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            666667778888999999999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-54  Score=401.64  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=213.2

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      ++.+...||+|+||+||+|++.     .+++.||||+++..  ......+++.+|+++|++++||||+++++++...+..
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            4556669999999999999874     45678999998743  3445567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q psy10603         78 VLFMELCTEGTLESLVQSTE-----------------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANI  134 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Ni  134 (407)
                      +++|||+++|+|.++++...                       ..+++..+..++.|++.||+|||+++||||||||+||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI  171 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  171 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence            99999999999999986432                       2378899999999999999999999999999999999


Q ss_pred             EEecCCCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCC-CCCCCC
Q psy10603        135 FLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK-RPWAEY  213 (407)
Q Consensus       135 ll~~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~-~Pf~~~  213 (407)
                      |++.++ .+||+|||+|+.+...... ....+..||+.|+|||++..   ..++.++|||||||++|||++|. +||.+ 
T Consensus       172 Lld~~~-~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-  245 (301)
T d1lufa_         172 LVGENM-VVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPYYG-  245 (301)
T ss_dssp             EECGGG-CEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCTTTT-
T ss_pred             EECCCC-cEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc---CCCChhhhhccchhhHHHHHccCCCCCCC-
Confidence            999865 6999999999876433221 12245678999999999864   34789999999999999999996 56664 


Q ss_pred             CchHHHHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        214 DSNYQIMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      .+..+....+..+..+.+|..+++++.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4566777778888888899999999999999999999999999999865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=409.42  Aligned_cols=247  Identities=30%  Similarity=0.457  Sum_probs=199.3

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc------eEEEEE
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE------EMVLFM   81 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~~lv~   81 (407)
                      ..||+|+||+||+|++..+|+.||||++.... .+....+.+.+|+++|++++|||||++++++...+      .+|+||
T Consensus        24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            38999999999999999999999999997543 35556778999999999999999999999987654      579999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      ||| +.+|..+.+.  ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....    
T Consensus       103 e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~~~----  174 (346)
T d1cm8a_         103 PFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSE----  174 (346)
T ss_dssp             ECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSS----
T ss_pred             ecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceeccCCc----
Confidence            999 5678877754  3599999999999999999999999999999999999998865 6999999999876432    


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHh-CC--------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVG-MG--------------  226 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~-~~--------------  226 (407)
                        .+..+||+.|+|||++.+.  ..++.++||||+||++|||++|+.||.+.+.......... .+              
T Consensus       175 --~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         175 --MTGYVVTRWYRAPEVILNW--MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             --CCSSCSCGGGCCTHHHHTT--TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             --cccccccccccCHHHHcCC--CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence              3456899999999998643  3468899999999999999999999986543222111000 00              


Q ss_pred             ---------C-----CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 ---------E-----TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 ---------~-----~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                               .     ...+...+++++.+||.+||++||++|||+.|+|+||||.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence                     0     1123456799999999999999999999999999999995

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=395.29  Aligned_cols=256  Identities=26%  Similarity=0.450  Sum_probs=213.2

Q ss_pred             cceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceEEEEEec
Q psy10603          4 VTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         4 ~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~E~   83 (407)
                      +.....||+|+||+||+|++..+|+.||||+++.... +....+++.+|+.+|+.++||||+++++++...+..++|+|+
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            4445699999999999999999999999999976543 445567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCCc
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPGE  163 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~~  163 (407)
                      +.+++|..+++. ...+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|+.......   .
T Consensus        83 ~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~---~  157 (292)
T d1unla_          83 CDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVR---C  157 (292)
T ss_dssp             CSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCS---C
T ss_pred             cccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCc---c
Confidence            999998887754 55699999999999999999999999999999999999998765 699999999988654332   1


Q ss_pred             ccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHhC--C---------------
Q psy10603        164 LNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFKVGM--G---------------  226 (407)
Q Consensus       164 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~~~~--~---------------  226 (407)
                      .....+++.|+|||++...  ..++.++|||||||++|||++|+.||....+..+....+..  +               
T Consensus       158 ~~~~~~~~~~~~pe~~~~~--~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTC--SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ceeeccccchhhhhHhccC--CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            2344678899999998653  33688999999999999999999998655554443332210  0               


Q ss_pred             -----------CCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        227 -----------ETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       227 -----------~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                 .....+..+++++.+|+.+||++||.+|||+.|+|+||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence                       01123356789999999999999999999999999999984

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=409.27  Aligned_cols=260  Identities=28%  Similarity=0.436  Sum_probs=213.5

Q ss_pred             ccceeeecccccCeEEEEEEE---CCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVN---NETGELVAMKEIQLHKQ-NDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~---~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~   77 (407)
                      ++.+...||+|+||+||+|++   ..+|+.||||++++... .+....+.+.+|+++|++++| |||+++++++.+.+.+
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            345556999999999999987   45789999999865432 122234567889999999988 8999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCC
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAH  157 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~  157 (407)
                      +++|||+.+|+|.+++.... .+++..+..+++||+.||+|||+++|+||||||+|||++.++ .+||+|||+++.+...
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECCGG
T ss_pred             eeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhccc
Confidence            99999999999999997644 488999999999999999999999999999999999999875 6999999999876543


Q ss_pred             CCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--chHHHHHHHhCCCCCCCCCcc
Q psy10603        158 TTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYD--SNYQIMFKVGMGETPTIPESL  235 (407)
Q Consensus       158 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (407)
                      ..  .......||+.|+|||.+.... ..++.++|||||||++|||++|+.||....  .....+.+......+.+|..+
T Consensus       183 ~~--~~~~~~~g~~~~~~pe~~~~~~-~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         183 ET--ERAYDFCGTIEYMAPDIVRGGD-SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             GG--GGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cc--ccccccccccccchhHHhhcCC-cCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            22  1234568999999999986532 346789999999999999999999997543  222333333334566778889


Q ss_pred             CHHHHHHHHHhcccCCCCcC-----CHHHHhcCCeee
Q psy10603        236 SDEGQAFAELCLRHDPAQRA-----TIFELLQHPFLI  267 (407)
Q Consensus       236 s~~~~~~i~~~l~~dp~~R~-----t~~e~l~hp~~~  267 (407)
                      |+++++|+.+||++||++||     |++|+++||||.
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~  296 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  296 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence            99999999999999999999     589999999984

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=402.60  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=200.8

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe--------Cce
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH--------REE   76 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~~~   76 (407)
                      .....||+|+||+||+|++..+|+.||||++...... ....+++.+|+.+|++++||||+++++++..        .+.
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~   91 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   91 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence            3445999999999999999999999999998765332 2344668899999999999999999998754        346


Q ss_pred             EEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCC
Q psy10603         77 MVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISA  156 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~  156 (407)
                      +|+|||||.++++.... .....+++..++.+++|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus        92 ~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~~~~  169 (318)
T d3blha1          92 IYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSL  169 (318)
T ss_dssp             EEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCC
T ss_pred             EEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeeeccc
Confidence            89999999987776554 3455699999999999999999999999999999999999999865 699999999987654


Q ss_pred             CCCC-CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHHhCCCCCCCC-
Q psy10603        157 HTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKVGMGETPTIP-  232 (407)
Q Consensus       157 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~~~~~~~~~~-  232 (407)
                      .... .....+.+||+.|+|||++...  ..+++++|||||||++|||++|+.||.+..+....  +........+... 
T Consensus       170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~--~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         170 AKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             -----CCCCCSCCSCGGGCCHHHHTTC--SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccceecCHHHhhHHHHcCC--CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            3221 2223456899999999998653  35789999999999999999999999864433221  1121111111100 


Q ss_pred             ---------------------------CccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        233 ---------------------------ESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       233 ---------------------------~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                                                 ...++++.+|+.+||++||++|||+.|+|+||||.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence                                       01367889999999999999999999999999995

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=392.77  Aligned_cols=244  Identities=23%  Similarity=0.389  Sum_probs=201.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe-CceEEEE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH-REEMVLF   80 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv   80 (407)
                      +++.+...||+|+||.||+|++.  |+.||||+++...     ..+.+.+|+++|++++||||+++++++.+ ++.+|+|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            35667779999999999999984  7789999986432     23568899999999999999999998865 4568999


Q ss_pred             EecCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCC
Q psy10603         81 MELCTEGTLESLVQSTE-DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        81 ~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~  159 (407)
                      |||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++...... 
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCCCC-
Confidence            99999999999986532 3489999999999999999999999999999999999999875 69999999997654322 


Q ss_pred             CCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHHHHHHHhCCCCCCCCCccCHH
Q psy10603        160 VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQIMFKVGMGETPTIPESLSDE  238 (407)
Q Consensus       160 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~s~~  238 (407)
                           ....+|+.|+|||++.+   ..++.++|||||||++|||+| |++||... +..+....+..+..+.+|..++++
T Consensus       158 -----~~~~~~~~y~aPE~l~~---~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~  228 (262)
T d1byga_         158 -----DTGKLPVKWTAPEALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA  228 (262)
T ss_dssp             ---------CCTTTSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred             -----ccccccccCCChHHHhC---CCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCCCCCccCCHH
Confidence                 33568899999999865   346899999999999999998 68888754 455667777788889999999999


Q ss_pred             HHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        239 GQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       239 ~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      +++++.+||..||.+|||+.|++++
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=391.98  Aligned_cols=252  Identities=22%  Similarity=0.362  Sum_probs=208.8

Q ss_pred             ccceeeecccccCeEEEEEEECCCC-------cEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeC
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNNETG-------ELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHR   74 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~~~~-------~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~   74 (407)
                      ++.....||+|+||+||+|++..++       ..||||+++..  ...+....+.+|...+.++ +|||||++++++.++
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4556679999999999999976554       37999998653  3445567788999999887 799999999999999


Q ss_pred             ceEEEEEecCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC
Q psy10603         75 EEMVLFMELCTEGTLESLVQSTE---------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE  139 (407)
Q Consensus        75 ~~~~lv~E~~~~g~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~  139 (407)
                      +.+++|||||++|+|.+++....               ..+++.++..++.||+.||+|||+++||||||||+|||++.+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  171 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence            99999999999999999996542               348999999999999999999999999999999999999887


Q ss_pred             CCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHH
Q psy10603        140 GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQ  218 (407)
Q Consensus       140 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~  218 (407)
                      + .+||+|||+++........ .......||+.|+|||++.+   ..++.++|||||||++|||++ |.+||.+. +..+
T Consensus       172 ~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~---~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-~~~~  245 (299)
T d1fgka_         172 N-VMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE  245 (299)
T ss_dssp             C-CEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHH
T ss_pred             C-CeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC---CCCCchhhhHHhHHHHHHhccCCCCCCCCC-CHHH
Confidence            5 6999999999876543322 22345678999999999865   357899999999999999998 68888753 4455


Q ss_pred             HHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       219 ~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ....+..+..+..|..+|+++++++.+||++||++|||+.|+++
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            66666778888899999999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-53  Score=393.87  Aligned_cols=253  Identities=24%  Similarity=0.350  Sum_probs=210.9

Q ss_pred             ccceeeecccccCeEEEEEEE-----CCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCcceEEEEEEeCce
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVN-----NETGELVAMKEIQLHKQNDARFVKDMLVELRILEGI-NQKNLVKYYGVEIHREE   76 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~   76 (407)
                      ++.+...||+|+||+||+|++     ..+++.||||+++..  ........+.+|+.++.++ +|||||++++++.+++.
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            345566999999999999986     356679999999754  3344566789999999998 69999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC
Q psy10603         77 MVLFMELCTEGTLESLVQSTE-----------------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE  139 (407)
Q Consensus        77 ~~lv~E~~~~g~L~~~~~~~~-----------------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~  139 (407)
                      +++|||||++|+|.++++...                 ..+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG  181 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence            999999999999999986532                 248899999999999999999999999999999999999886


Q ss_pred             CCeEEEEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCchHH
Q psy10603        140 GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKRPWAEYDSNYQ  218 (407)
Q Consensus       140 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~-g~~Pf~~~~~~~~  218 (407)
                      + .+|++|||+++........ ......+||+.|+|||++..   ..++.++|||||||++|||+| |.+||........
T Consensus       182 ~-~~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         182 R-ITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             T-EEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             C-cccccccchheeccCCCcc-eEeeecccChHHcCHHHhcC---CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            4 7999999999876543221 22345689999999999864   346899999999999999999 5555655444444


Q ss_pred             HHHHHhCCCCCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhc
Q psy10603        219 IMFKVGMGETPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQ  262 (407)
Q Consensus       219 ~~~~~~~~~~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~  262 (407)
                      ....+..+..+..|..+++++.+||.+||+.||++|||+.|+++
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            44455566778888899999999999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=390.73  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=212.4

Q ss_pred             ccceeeecccccCeEEEEEEEC-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCceE
Q psy10603          3 SVTFSVSPGQGRFGKVYTAVNN-----ETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHREEM   77 (407)
Q Consensus         3 ~~~~~~~iG~G~~g~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   77 (407)
                      +++....||+|+||+||+|.+.     .+++.||||+++..  ...+....+.+|+++|++++|||||++++++..++..
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            3455668999999999999875     34578999998643  3445566789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcc
Q psy10603         78 VLFMELCTEGTLESLVQSTE---------DGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDF  148 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DF  148 (407)
                      ++|||||++|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+||
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl~DF  177 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDF  177 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEECCT
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-eEEEeec
Confidence            99999999999999875321         2368889999999999999999999999999999999998764 6999999


Q ss_pred             cCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCchHHHHHHHhCCC
Q psy10603        149 GSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK-RPWAEYDSNYQIMFKVGMGE  227 (407)
Q Consensus       149 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~-~Pf~~~~~~~~~~~~~~~~~  227 (407)
                      |+|+.+...... .......||+.|+|||.+.+   ..++.++|||||||++|||+||. .||.+ .+..+....+..+.
T Consensus       178 Gla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~---~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         178 GMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD---GVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGG  252 (308)
T ss_dssp             TCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH---CCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTC
T ss_pred             ccceeccCCcce-eeccceecccccCCHHHHcc---CCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCC
Confidence            999876543221 12244578999999999865   34678999999999999999985 66764 45566666777778


Q ss_pred             CCCCCCccCHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        228 TPTIPESLSDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       228 ~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                      .+..|..+++++.+++.+||+.||++|||+.|++++
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            888899999999999999999999999999999873

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=398.23  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=190.2

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEe------CceEEEEE
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIH------REEMVLFM   81 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~~lv~   81 (407)
                      .+||+|+||+||+|++..+|+.||||++.... .+....+++.+|+.+|++++|||||++++++..      ...+|+||
T Consensus        23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence            39999999999999999999999999997654 345556788999999999999999999999864      36799999


Q ss_pred             ecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCC
Q psy10603         82 ELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVP  161 (407)
Q Consensus        82 E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~  161 (407)
                      |||.++.+..+.    ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+|++|||+++......   
T Consensus       102 Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~---  173 (355)
T d2b1pa1         102 ELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF---  173 (355)
T ss_dssp             ECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----------
T ss_pred             eccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhcccccc---
Confidence            999876554432    3489999999999999999999999999999999999999875 59999999987655432   


Q ss_pred             CcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHHHH--HhC--------------
Q psy10603        162 GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIMFK--VGM--------------  225 (407)
Q Consensus       162 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~~~--~~~--------------  225 (407)
                       ..+..+||+.|+|||++.+   ..+++++||||+||++|||++|+.||.+.+........  ...              
T Consensus       174 -~~~~~~~t~~y~aPE~l~~---~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         174 -MMTPYVVTRYYRAPEVILG---MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             --------CCTTCCHHHHTT---CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             -ccccccccccccChhhhcC---CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence             2345689999999999965   35688999999999999999999999854432221110  000              


Q ss_pred             -----CCCCC--------C-----------CCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeeee
Q psy10603        226 -----GETPT--------I-----------PESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLIV  268 (407)
Q Consensus       226 -----~~~~~--------~-----------~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~~  268 (407)
                           +..+.        +           +...|+++++|+++||.+||++|||++|+|+||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                 00000        0           0124678999999999999999999999999999953

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=397.07  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=198.8

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeC-----ceEEEEEe
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHR-----EEMVLFME   82 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~E   82 (407)
                      ..||+|+||+||+|++..+|+.||||++.... .+....+++.+|+++|++++|||||++++++...     ...+++||
T Consensus        24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            48999999999999999999999999997653 3444567789999999999999999999998643     23466677


Q ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCceecCCCCCCCC
Q psy10603         83 LCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSAVKISAHTTVPG  162 (407)
Q Consensus        83 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla~~~~~~~~~~~  162 (407)
                      |+.+|+|.++++.  ..+++..++.+++||+.||+|||++||+||||||+|||++.++ .+|++|||++......     
T Consensus       103 ~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~~~-----  174 (348)
T d2gfsa1         103 HLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDE-----  174 (348)
T ss_dssp             ECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CCTGG-----
T ss_pred             eecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhcccCcc-----
Confidence            7889999999854  4599999999999999999999999999999999999999875 6999999998665322     


Q ss_pred             cccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHHH--HHHhC---------------
Q psy10603        163 ELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQIM--FKVGM---------------  225 (407)
Q Consensus       163 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~~--~~~~~---------------  225 (407)
                       ..+..||+.|+|||++...  ..++.++|||||||++|+|++|+.||.+.+......  .....               
T Consensus       175 -~~~~~g~~~y~apE~~~~~--~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         175 -MTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             -GSSSCHHHHTSCHHHHTTC--SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             -cccccccccccCchhhcCC--ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence             2456899999999987543  346789999999999999999999998644321111  11000               


Q ss_pred             -------CCCCC-----CCCccCHHHHHHHHHhcccCCCCcCCHHHHhcCCeee
Q psy10603        226 -------GETPT-----IPESLSDEGQAFAELCLRHDPAQRATIFELLQHPFLI  267 (407)
Q Consensus       226 -------~~~~~-----~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l~hp~~~  267 (407)
                             ...+.     ....+|+++++||.+||++||.+|||+.|+|+||||.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence                   00011     1245789999999999999999999999999999996

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=376.55  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=192.4

Q ss_pred             CccceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcceEEEEEEeCc----eE
Q psy10603          2 SSVTFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLVKYYGVEIHRE----EM   77 (407)
Q Consensus         2 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~   77 (407)
                      +++.....||+|+||+||+|++  +|+.||||+++...  ..  .....+|+..+.+++|||||++++++..++    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            5677888999999999999986  58899999986432  11  111224555567899999999999988654    68


Q ss_pred             EEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEEecCCCeEEEEccc
Q psy10603         78 VLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHE--------NTIVHRDIKSANIFLTAEGNSLKLGDFG  149 (407)
Q Consensus        78 ~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~--------~~iiHrdlKp~Nill~~~~~~vkl~DFG  149 (407)
                      |+|||||++|+|.+++++.  .+++.....++.|++.||.|||+        +||+||||||+|||++.++ .+||+|||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG  153 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence            9999999999999999763  48999999999999999999996        5999999999999998875 69999999


Q ss_pred             CceecCCCCCC-CCcccccccCCccccccccccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----------
Q psy10603        150 SAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNK---VGHGRAVDIWSLGCVLVEMSSGKRPWAEYD-----------  214 (407)
Q Consensus       150 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~---~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~-----------  214 (407)
                      +++........ .......+||+.|||||++.+...   ..++.++|||||||++|||+||..||....           
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            99876543221 122345789999999999864321   124678999999999999999998874311           


Q ss_pred             --chHHHHHHH--hCCCCCCCCCcc-----CHHHHHHHHHhcccCCCCcCCHHHHhcC
Q psy10603        215 --SNYQIMFKV--GMGETPTIPESL-----SDEGQAFAELCLRHDPAQRATIFELLQH  263 (407)
Q Consensus       215 --~~~~~~~~~--~~~~~~~~~~~~-----s~~~~~~i~~~l~~dp~~R~t~~e~l~h  263 (407)
                        .........  ..+..|.+|...     ..++.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              111222221  223345555433     2458899999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-50  Score=370.18  Aligned_cols=253  Identities=21%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcc-eEEEEEEeCceEEEEEec
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNLV-KYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~E~   83 (407)
                      .....||+|+||+||+|++..+|+.||||++......     +++.+|+++++.++|+|++ .+.++..+.+..++||||
T Consensus        10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_          10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            3455999999999999999999999999998754332     2467899999999887655 556666778889999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEec--CCCeEEEEcccCceecCCCCCC-
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTA--EGNSLKLGDFGSAVKISAHTTV-  160 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~--~~~~vkl~DFGla~~~~~~~~~-  160 (407)
                      ++ +++...+......+++..+..++.|++.||+|||++||+||||||+|||++.  .+..+||+|||+|+.+...... 
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            95 5666666666667999999999999999999999999999999999999864  2346999999999887543221 


Q ss_pred             ---CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCchHHH--HHHH----hCCCCCCC
Q psy10603        161 ---PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSNYQI--MFKV----GMGETPTI  231 (407)
Q Consensus       161 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~~~~--~~~~----~~~~~~~~  231 (407)
                         .......+||+.|||||++.+   ..++.++|||||||++|||++|+.||.........  ..+.    .....+..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLG---IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTT---BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             ceeccccCCcCCCccccCHHHHhC---CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence               122345689999999999864   34789999999999999999999999754332111  1111    11112234


Q ss_pred             CCccCHHHHHHHHHhcccCCCCcCCHHHH---hcCCee
Q psy10603        232 PESLSDEGQAFAELCLRHDPAQRATIFEL---LQHPFL  266 (407)
Q Consensus       232 ~~~~s~~~~~~i~~~l~~dp~~R~t~~e~---l~hp~~  266 (407)
                      +..+|+++.+++..||+.||++||++.++   |+|++.
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            56789999999999999999999998754   566653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.4e-49  Score=365.06  Aligned_cols=248  Identities=21%  Similarity=0.257  Sum_probs=199.4

Q ss_pred             ceeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-CCcceEEEEEEeCceEEEEEec
Q psy10603          5 TFSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-KNLVKYYGVEIHREEMVLFMEL   83 (407)
Q Consensus         5 ~~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~E~   83 (407)
                      .....||+|+||+||+|++..+|+.||||++......     ..+.+|++.++.++| +|++.+++++......++||||
T Consensus         8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            3455899999999999999999999999998654322     235678888888877 8999999999999999999999


Q ss_pred             CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecC----CCeEEEEcccCceecCCCCC
Q psy10603         84 CTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAE----GNSLKLGDFGSAVKISAHTT  159 (407)
Q Consensus        84 ~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~----~~~vkl~DFGla~~~~~~~~  159 (407)
                      + +++|.++++.....+++.++..++.|++.||+|||++||+||||||+|||++..    .+.+||+|||+|+.+.....
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            9 689999987766679999999999999999999999999999999999999742    34699999999988653321


Q ss_pred             C----CCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCc--hHHHHHHHh----CCCCC
Q psy10603        160 V----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDS--NYQIMFKVG----MGETP  229 (407)
Q Consensus       160 ~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~--~~~~~~~~~----~~~~~  229 (407)
                      .    .......+||+.|||||++.+   ..+++++|||||||++|||++|+.||.+...  ......++.    ....+
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~---~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLG---REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTT---CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccceeecccCceEEchhhcCHHHhcC---CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            1    122345789999999999864   3578999999999999999999999975432  222221111    11112


Q ss_pred             CCCCccCHHHHHHHHHhcccCCCCcCCHHHHh
Q psy10603        230 TIPESLSDEGQAFAELCLRHDPAQRATIFELL  261 (407)
Q Consensus       230 ~~~~~~s~~~~~~i~~~l~~dp~~R~t~~e~l  261 (407)
                      .++..+|+++.+++..|+..+|++||+...+.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            23467889999999999999999999977654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-45  Score=351.89  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=188.3

Q ss_pred             eeeecccccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-----------CCCcceEEEEEEe-
Q psy10603          6 FSVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-----------QKNLVKYYGVEIH-   73 (407)
Q Consensus         6 ~~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~~-   73 (407)
                      ....||+|+||+||+|++..+|+.||||+++..    ....+.+.+|+.+|+.++           |+||+++++++.. 
T Consensus        17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            445999999999999999999999999999643    233456778888887765           5789999988764 


Q ss_pred             -CceEEEEEecCCCCCHHH--HHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEecCCC-----eEE
Q psy10603         74 -REEMVLFMELCTEGTLES--LVQSTEDGLPEVLVRRYTKQLVDAISALHE-NTIVHRDIKSANIFLTAEGN-----SLK  144 (407)
Q Consensus        74 -~~~~~lv~E~~~~g~L~~--~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~iiHrdlKp~Nill~~~~~-----~vk  144 (407)
                       ....+++|+++..+....  ........+++..++.++.||+.||+|||+ .||+||||||+|||++.++.     .+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence             346677777765544322  233344568999999999999999999998 89999999999999986543     489


Q ss_pred             EEcccCceecCCCCCCCCcccccccCCcccccccccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCch-----HHH
Q psy10603        145 LGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKRPWAEYDSN-----YQI  219 (407)
Q Consensus       145 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~DiwSlGv~l~em~~g~~Pf~~~~~~-----~~~  219 (407)
                      ++|||.+......      ....+||+.|+|||++..   ..++.++||||+||++++|++|+.||......     ...
T Consensus       173 l~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         173 IADLGNACWYDEH------YTNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             ECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT---CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             Eeecccccccccc------cccccccccccChhhccc---cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence            9999999765432      234689999999999864   34688999999999999999999999743211     000


Q ss_pred             HHH--HhCCC---------------------------------------CCCCCCccCHHHHHHHHHhcccCCCCcCCHH
Q psy10603        220 MFK--VGMGE---------------------------------------TPTIPESLSDEGQAFAELCLRHDPAQRATIF  258 (407)
Q Consensus       220 ~~~--~~~~~---------------------------------------~~~~~~~~s~~~~~~i~~~l~~dp~~R~t~~  258 (407)
                      +..  ...+.                                       ....+...++++++|+.+||++||.+|||+.
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            000  00000                                       0111234567899999999999999999999


Q ss_pred             HHhcCCeee
Q psy10603        259 ELLQHPFLI  267 (407)
Q Consensus       259 e~l~hp~~~  267 (407)
                      |+|+||||.
T Consensus       324 e~L~Hp~f~  332 (362)
T d1q8ya_         324 GLVNHPWLK  332 (362)
T ss_dssp             HHHTCGGGT
T ss_pred             HHhcCcccC
Confidence            999999995

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.3e-27  Score=204.03  Aligned_cols=134  Identities=17%  Similarity=0.243  Sum_probs=105.6

Q ss_pred             eeecccccCeEEEEEEECCCCcEEEEEEEeccccC---------------cHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Q psy10603          7 SVSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN---------------DARFVKDMLVELRILEGINQKNLVKYYGVE   71 (407)
Q Consensus         7 ~~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   71 (407)
                      ..+||+|+||+||+|++. +|+.||||+++.....               .........+|...|.++.|++++..++..
T Consensus         5 g~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             CCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            468999999999999885 6899999987632110               011123456788999999999999988653


Q ss_pred             EeCceEEEEEecCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603         72 IHREEMVLFMELCTEGTLESLVQSTEDGLPEVLVRRYTKQLVDAISALHENTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus        72 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                        .  .+++|||+++..+..        +++..+..++.|++.||.|||++||+||||||+|||++++  .++|+|||+|
T Consensus        84 --~--~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG~a  149 (191)
T d1zara2          84 --G--NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQS  149 (191)
T ss_dssp             --T--TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTC
T ss_pred             --C--CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECCCc
Confidence              2  379999999866532        4455577899999999999999999999999999999864  4999999999


Q ss_pred             eecC
Q psy10603        152 VKIS  155 (407)
Q Consensus       152 ~~~~  155 (407)
                      +...
T Consensus       150 ~~~~  153 (191)
T d1zara2         150 VEVG  153 (191)
T ss_dssp             EETT
T ss_pred             ccCC
Confidence            7754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=1.4e-16  Score=143.66  Aligned_cols=84  Identities=30%  Similarity=0.458  Sum_probs=61.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++.++. +||+|||+|+....... ........||+.|||||++.......++.++||||+||++|||+||+.
T Consensus       130 lKp~NiLl~~~~~-~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~  207 (276)
T d1uwha_         130 LKSNNIFLHEDLT-VKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL  207 (276)
T ss_dssp             CCGGGEEEETTSS-EEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHEEEcCCCC-EEEccccceeeccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence            4567999988775 99999999976543221 122334579999999999975444446789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       208 Pf~~~~  213 (276)
T d1uwha_         208 PYSNIN  213 (276)
T ss_dssp             TTTTCC
T ss_pred             CCCCCC
Confidence            999754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=2.4e-16  Score=141.65  Aligned_cols=81  Identities=33%  Similarity=0.525  Sum_probs=62.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +||+|||+|+.+...... ......+||+.|||||++.+...  ++.++||||+||++|||++|+.
T Consensus       129 iKp~NILl~~~~~-~KL~DFG~a~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~--~~~~~DiwSlGvilyeml~G~~  204 (271)
T d1nvra_         129 IKPENLLLDERDN-LKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRREF--HAEPVDVWSCGIVLTAMLAGEL  204 (271)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECEETTEE-CCBCCCCSCGGGSCTHHHHCSSB--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccHHHEEECCCCC-EEEccchhheeeccCCcc-ccccceeeCcCccCHhHhcCCCC--CCCceeeeHhHHHHHHHHhCCC
Confidence            4567999988775 999999999866432221 12234689999999999875432  3578999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       205 pf~~~  209 (271)
T d1nvra_         205 PWDQP  209 (271)
T ss_dssp             SCSSS
T ss_pred             CCCCC
Confidence            99754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=4e-16  Score=139.65  Aligned_cols=77  Identities=31%  Similarity=0.560  Sum_probs=62.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +||+|||+|+......     ....+||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       132 iKp~Nill~~~~~-~kl~DFG~a~~~~~~~-----~~~~~Gt~~Y~APE~~~~~---~~~~~~DiwSlGvilyell~G~~  202 (263)
T d2j4za1         132 IKPENLLLGSAGE-LKIADFGWSVHAPSSR-----RTTLCGTLDYLPPEMIEGR---MHDEKVDLWSLGVLCYEFLVGKP  202 (263)
T ss_dssp             CCGGGEEECTTSC-EEECCCCSCSCCCCCC-----CEETTEEGGGCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             eccccceecCCCC-EeecccceeeecCCCc-----ccccCCCCcccCHHHHcCC---CCCchhhhhhHhHHHHHHhcCCC
Confidence            4678999988775 9999999997654321     2345799999999999753   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       203 Pf~~~~  208 (263)
T d2j4za1         203 PFEANT  208 (263)
T ss_dssp             TTCCSS
T ss_pred             CCCCCC
Confidence            998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=7e-16  Score=142.93  Aligned_cols=79  Identities=35%  Similarity=0.619  Sum_probs=64.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+|+.......   .....+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       131 lKP~NILl~~~g~-vkl~DFG~a~~~~~~~~---~~~~~~GT~~Y~aPE~~~~~---~y~~~~DiwSlGvilyeml~G~~  203 (337)
T d1o6la_         131 IKLENLMLDKDGH-IKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDN---DYGRAVDWWGLGVVMYEMMCGRL  203 (337)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCSCCTTC---CBCCCEECGGGCCGGGGSSS---CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHeEecCCCC-EEEeecccccccccCCc---ccccceeCHHHhhhhhccCC---CCChhhcccchhhHHHHHHHCCC
Confidence            4577999988876 99999999986543222   23346899999999999754   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|-.
T Consensus       204 pf~~~~  209 (337)
T d1o6la_         204 PFYNQD  209 (337)
T ss_dssp             SSCCSS
T ss_pred             CCCCcC
Confidence            998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=2.3e-16  Score=145.61  Aligned_cols=76  Identities=37%  Similarity=0.626  Sum_probs=61.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+.+....     ....+||+.|||||++.+.   .++.++||||+||+++||++|+.
T Consensus       131 iKP~NILl~~~~~-vkl~DFGla~~~~~~~-----~~~~~GT~~Y~APEvl~~~---~y~~~~DiWSlGvil~ell~G~~  201 (322)
T d1s9ja_         131 VKPSNILVNSRGE-IKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGT---HYSVQSDIWSMGLSLVEMAVGRY  201 (322)
T ss_dssp             CSGGGEEECTTCC-EEECCCCCCHHHHHHT-----C---CCSSCCCCHHHHHCS---CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCHHHeeECCCCC-EEEeeCCCccccCCCc-----cccccCCccccCchHHcCC---CCCcHHHHHHHHHHHHHHHHCCC
Confidence            4578999988776 9999999998654322     2346899999999999764   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       202 Pf~~~  206 (322)
T d1s9ja_         202 PIPPP  206 (322)
T ss_dssp             CSSCC
T ss_pred             CCCCC
Confidence            99864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=6.9e-16  Score=138.64  Aligned_cols=77  Identities=30%  Similarity=0.518  Sum_probs=61.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.+...+||+|||+|+.....     .....+||+.|||||++.+    .++.++||||+||++|||++|+.
T Consensus       140 iKp~NILl~~~~~~~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~----~~~~~~DIwSlGvilyel~~g~~  210 (270)
T d1t4ha_         140 LKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE----KYDESVDVYAFGMCMLEMATSEY  210 (270)
T ss_dssp             CCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT----CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cChhhceeeCCCCCEEEeecCcceeccCC-----ccCCcccCccccCHHHhCC----CCCCcCchhhHHHHHHHHHHCCC
Confidence            45779999765556999999999643221     1234689999999999853    25789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       211 Pf~~~~  216 (270)
T d1t4ha_         211 PYSECQ  216 (270)
T ss_dssp             TTTTCS
T ss_pred             CCCCcc
Confidence            998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=3.9e-16  Score=141.54  Aligned_cols=80  Identities=28%  Similarity=0.634  Sum_probs=60.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +|++|||+|+.+...... ......+||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       134 iKp~NIll~~~~~-vkl~DFG~a~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~---~~~~~~DiwSlGvilyell~g~~  208 (288)
T d1uu3a_         134 LKPENILLNEDMH-IQITDFGTAKVLSPESKQ-ARANSFVGTAQYVSPELLTEK---SACKSSDLWALGCIIYQLVAGLP  208 (288)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECC-----------CCCCGGGCCHHHHHTC---CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccccccCCCce-EEecccccceecccCCcc-cccccccCCccccCceeeccC---CCCcccceehhhHHHHHHhhCCC
Confidence            4567999988776 999999999866432221 123345799999999999654   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       209 Pf~~~  213 (288)
T d1uu3a_         209 PFRAG  213 (288)
T ss_dssp             SSCCS
T ss_pred             CCCCc
Confidence            99864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=2.3e-16  Score=141.78  Aligned_cols=79  Identities=38%  Similarity=0.647  Sum_probs=59.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+|+.+......   ....+||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       140 iKp~NIll~~~~~-vkl~DFG~a~~~~~~~~~---~~~~~gt~~Y~APE~l~~~---~~~~~~DIwSlGvilyel~tg~~  212 (269)
T d2java1         140 LKPANVFLDGKQN-VKLGDFGLARILNHDTSF---AKAFVGTPYYMSPEQMNRM---SYNEKSDIWSLGCLLYELCALMP  212 (269)
T ss_dssp             CCGGGEEECTTSC-EEECCHHHHHHC--------------CCCSCCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CchhhcCcCCCCc-EEEeeccceeecccCCCc---cccCCCCcccCCHHHHcCC---CCChHHHHHhhCHHHHHHhhCCC
Confidence            4578999988775 999999999876432221   2346899999999999653   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       213 Pf~~~~  218 (269)
T d2java1         213 PFTAFS  218 (269)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=6.6e-16  Score=140.32  Aligned_cols=79  Identities=37%  Similarity=0.598  Sum_probs=63.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +||+|||+|+.+.....   .....+||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       142 iKp~NILl~~~~~-vkl~DFG~a~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~---~~~~~~DiwSlGvilyemltG~~  214 (293)
T d1yhwa1         142 IKSDNILLGMDGS-VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK---AYGPKVDIWSLGIMAIEMIEGEP  214 (293)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHSSS---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcHHHeEECCCCc-Eeeccchhheeeccccc---cccccccCCCccChhhhcCC---CCCchhceehHhHHHHHHhhCCC
Confidence            4567999988765 99999999987643222   12345799999999999753   34789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       215 Pf~~~~  220 (293)
T d1yhwa1         215 PYLNEN  220 (293)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=7.1e-16  Score=141.25  Aligned_cols=78  Identities=40%  Similarity=0.637  Sum_probs=63.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +||+|||+|+....       ....+||+.|||||++.+.....++.++||||+||++|||++|+.
T Consensus       141 iKp~NILl~~~~~-~Kl~DFG~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~  212 (309)
T d1u5ra_         141 VKAGNILLSEPGL-VKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  212 (309)
T ss_dssp             CSGGGEEEETTTE-EEECCCTTCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcceEEECCCCC-EEEeecccccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCC
Confidence            4567999988765 99999999975432       123579999999999975443346789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       213 Pf~~~~  218 (309)
T d1u5ra_         213 PLFNMN  218 (309)
T ss_dssp             TTTTSC
T ss_pred             CCCCCC
Confidence            998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.56  E-value=9.2e-16  Score=142.99  Aligned_cols=76  Identities=28%  Similarity=0.555  Sum_probs=62.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+.+...      ....+||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       167 IKP~NILl~~~g~-ikL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~---~~~~~~DiwSlGvilyemltG~~  236 (350)
T d1rdqe_         167 LKPENLLIDQQGY-IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSK---GYNKAVDWWALGVLIYEMAAGYP  236 (350)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCHHHcccCCCCC-EEeeeceeeeecccc------cccccCccccCCHHHHcCC---CCCccccccchhHHHHHHHhCCC
Confidence            4678999988775 999999999876432      2245799999999999753   34689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       237 Pf~~~~  242 (350)
T d1rdqe_         237 PFFADQ  242 (350)
T ss_dssp             SSCCSS
T ss_pred             CCCCcC
Confidence            998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.56  E-value=1.1e-15  Score=140.37  Aligned_cols=75  Identities=33%  Similarity=0.563  Sum_probs=62.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +||+|||+|+......      ...+||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       130 iKp~NILl~~~g~-vkL~DFG~a~~~~~~~------~~~~Gt~~Y~APE~l~~~---~y~~~~DiwSlGvilyemltG~~  199 (316)
T d1fota_         130 LKPENILLDKNGH-IKITDFGFAKYVPDVT------YTLCGTPDYIAPEVVSTK---PYNKSIDWWSFGILIYEMLAGYT  199 (316)
T ss_dssp             CCGGGEEECTTSC-EEECCCSSCEECSSCB------CCCCSCTTTCCHHHHTTC---CBCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCchheeEcCCCC-EEEecCccceEecccc------ccccCcccccCHHHHcCC---CCCchhhccccchhHHHHHhCCC
Confidence            4578999988775 9999999998654322      235799999999998653   34689999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       200 Pf~~~  204 (316)
T d1fota_         200 PFYDS  204 (316)
T ss_dssp             TTCCS
T ss_pred             CCCCc
Confidence            99874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.55  E-value=1.3e-15  Score=142.84  Aligned_cols=77  Identities=32%  Similarity=0.566  Sum_probs=62.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++..+. +||+|||+|+.+....     ....+||+.|||||++....  .++.++||||+||++|||++|+.
T Consensus       133 lKP~NILl~~~g~-iKl~DFGla~~~~~~~-----~~~~~GT~~y~APE~~~~~~--~~~~~~DiwSlGvilyemltG~~  204 (364)
T d1omwa3         133 LKPANILLDEHGH-VRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGV--AYDSSADWFSLGCMLFKLLRGHS  204 (364)
T ss_dssp             CSGGGEEECSSSC-EEECCCTTCEECSSSC-----CCSCCSCGGGCCHHHHSTTC--CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eccceeEEcCCCc-EEEeeeceeeecCCCc-----ccccccccccchhHHhhcCC--CCCcccchhHHHHHHHHHHhCCC
Confidence            4678999988775 9999999998654322     23457999999999986433  35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       205 Pf~~~  209 (364)
T d1omwa3         205 PFRQH  209 (364)
T ss_dssp             SSCSS
T ss_pred             CCCCC
Confidence            99864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=8e-16  Score=139.52  Aligned_cols=82  Identities=33%  Similarity=0.544  Sum_probs=63.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC--CcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT--NKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++.++. +||+|||+|+.......   .....+||+.|||||++...  ....++.++||||+||++|||++|
T Consensus       136 iKp~NIll~~~~~-~Kl~DFG~a~~~~~~~~---~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg  211 (288)
T d2jfla1         136 LKAGNILFTLDGD-IKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI  211 (288)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECHHHHH---HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS
T ss_pred             cChhheeECCCCC-EEEEechhhhccCCCcc---cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC
Confidence            3567999988775 99999999976533211   12345799999999998532  223457899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       212 ~~Pf~~~~  219 (288)
T d2jfla1         212 EPPHHELN  219 (288)
T ss_dssp             SCTTTTSC
T ss_pred             CCCCCCCC
Confidence            99998754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=3.4e-15  Score=136.26  Aligned_cols=79  Identities=33%  Similarity=0.536  Sum_probs=62.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++..+. +||+|||+|+........   ....+||+.|||||++....  .++.++||||+||++|||++|++
T Consensus       126 iKp~NIli~~~~~-~KL~DFG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~el~~g~~  199 (299)
T d1ua2a_         126 LKPNNLLLDENGV-LKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAELLLRVP  199 (299)
T ss_dssp             CCGGGEEECTTCC-EEECCCGGGSTTTSCCCC---CCCSCCCCTTCCHHHHTTCS--CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcceEEecCCCc-cccccCccccccCCCccc---ccceecChhhccHHHHccCC--CCChhhhhhhcchHHHHHHhCcC
Confidence            4567999987775 999999999766443221   23457999999999986543  35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       200 pf~~~  204 (299)
T d1ua2a_         200 FLPGD  204 (299)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=2.5e-15  Score=135.30  Aligned_cols=79  Identities=32%  Similarity=0.521  Sum_probs=62.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.+...+|++|||+|+......     ....+||+.|||||++.+...  ++.++||||+||++|||++|+.
T Consensus       136 iKp~NIll~~~~~~vkl~DFG~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~~~--~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         136 IKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRY--HGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             CSGGGEEEETTTTEEEECCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCB--CHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcccceEEecCCCeEEECccccceeccccc-----ccccccCCCcCCHHHHcCCCC--CCcccccccceeeehhHhhCCC
Confidence            456799998776679999999997543221     234579999999999875432  3567999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       209 Pf~~~~  214 (273)
T d1xwsa_         209 PFEHDE  214 (273)
T ss_dssp             SCCSHH
T ss_pred             CCCCch
Confidence            998743

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=3.4e-15  Score=136.61  Aligned_cols=79  Identities=25%  Similarity=0.419  Sum_probs=50.7

Q ss_pred             cCCccEEEec--CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTA--EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~--~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|+++..  ++..+|++|||+|+......    .....+||+.|||||++.+.   .++.++||||+||++|||++|
T Consensus       133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~GT~~y~APE~~~~~---~~~~~~DiwSlGvilyell~g  205 (307)
T d1a06a_         133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQK---PYSKAVDCWSIGVIAYILLCG  205 (307)
T ss_dssp             CCGGGEEESSSSTTCCEEECCC----------------------CTTSCHHHHTTC---CCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecccceeecccCCCceEEEeccceeEEccCCC----eeeeeeeCccccCcHHHcCC---CCCcHHHhhhhhHHHHHHHhC
Confidence            3567888853  33469999999997654322    12345799999999999654   357899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      +.||.+..
T Consensus       206 ~~Pf~~~~  213 (307)
T d1a06a_         206 YPPFYDEN  213 (307)
T ss_dssp             SCSCCCSS
T ss_pred             CCCCCCCC
Confidence            99998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=9.3e-15  Score=134.43  Aligned_cols=79  Identities=33%  Similarity=0.602  Sum_probs=63.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++..+. +|++|||+++.......   .....+||+.|+|||++.+.   .++.++||||+||++|||++|+.
T Consensus       129 ikp~NiL~~~~~~-~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvilyemltG~~  201 (320)
T d1xjda_         129 LKLDNILLDKDGH-IKIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQ---KYNHSVDWWSFGVLLYEMLIGQS  201 (320)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCBCCCCTTC---CBCCCCSCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcccceeecCCCc-eeccccchhhhcccccc---cccccCCCCCcCCHHHHcCC---CCCchhhhhhhhHHHHHHHhCCC
Confidence            4567999987775 99999999986543222   22345799999999999754   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|-.
T Consensus       202 PF~~~~  207 (320)
T d1xjda_         202 PFHGQD  207 (320)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998743

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=4.3e-15  Score=134.45  Aligned_cols=82  Identities=22%  Similarity=0.292  Sum_probs=63.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+|+.+..............||+.|||||++....   ++.++||||+||++|||+| |+
T Consensus       135 lKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVwS~Gv~l~E~lt~G~  210 (285)
T d1u59a_         135 LAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK---FSSRSDVWSYGVTMWEALSYGQ  210 (285)
T ss_dssp             CSGGGEEEEETTE-EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CchhheeeccCCc-eeeccchhhhcccccccccccccccccCccccChHHHhCCC---CCccchhhcchHHHHHHHhCCC
Confidence            3567999988765 99999999987654333222233456899999999986542   4689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       211 ~Pf~~~~  217 (285)
T d1u59a_         211 KPYKKMK  217 (285)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCC
Confidence            9998753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=4.1e-15  Score=137.29  Aligned_cols=82  Identities=28%  Similarity=0.365  Sum_probs=63.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+|+........ .......||+.|||||++.+.   .++.++||||+||++|||+| |+
T Consensus       190 lKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwS~Gvil~emlt~g~  264 (325)
T d1rjba_         190 LAARNVLVTHGKV-VKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGILLWEIFSLGV  264 (325)
T ss_dssp             CSGGGEEEETTTE-EEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             CchhccccccCCe-EEEeeccccccccCCCce-eeeccccCCCccCChHHHcCC---CCCcceeccchhHHHHHHHhCCC
Confidence            4567999988765 999999999865443221 112345689999999998654   35789999999999999998 89


Q ss_pred             CCCCCCce
Q psy10603        385 TNLSGVVV  392 (407)
Q Consensus       385 ~~~~~~~~  392 (407)
                      +||.|...
T Consensus       265 ~Pf~~~~~  272 (325)
T d1rjba_         265 NPYPGIPV  272 (325)
T ss_dssp             CSSTTCCC
T ss_pred             CCCCCCCH
Confidence            99998643

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.1e-14  Score=133.22  Aligned_cols=77  Identities=38%  Similarity=0.613  Sum_probs=62.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++..+. +|++|||+++......    .....+||+.|||||++.+.   .++.++||||+||++|||++|++
T Consensus       142 iKp~NILi~~~~~-~kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~---~y~~~~DiwSlG~il~ell~g~~  213 (305)
T d1blxa_         142 LKPQNILVTSSGQ-IKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKP  213 (305)
T ss_dssp             CCGGGEEECTTCC-EEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTC---CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccEEEEcCCCC-eeecchhhhhhhcccc----cCCCcccChhhcCcchhcCC---CCChhehhhchHHHHHHHHHCCC
Confidence            3567999988775 9999999997543322    22346899999999998653   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.|.
T Consensus       214 pf~~~  218 (305)
T d1blxa_         214 LFRGS  218 (305)
T ss_dssp             SCCCS
T ss_pred             CCCCC
Confidence            99875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=4.4e-15  Score=133.89  Aligned_cols=82  Identities=23%  Similarity=0.331  Sum_probs=62.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+|+.+..............||+.|||||++....   ++.++||||+||++|||+| |+
T Consensus       133 lKp~Nill~~~~~-~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~sDiwS~Gv~l~ellt~g~  208 (277)
T d1xbba_         133 LAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK---FSSKSDVWSFGVLMWEAFSYGQ  208 (277)
T ss_dssp             CSGGGEEEEETTE-EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CcchhhcccccCc-ccccchhhhhhccccccccccccccCCCceecCchhhcCCC---CCchhhhccchhhhhHHhhCCC
Confidence            4567999988775 99999999986654332222223456899999999986543   4689999999999999998 99


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       209 ~Pf~~~~  215 (277)
T d1xbba_         209 KPYRGMK  215 (277)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.47  E-value=1e-14  Score=135.80  Aligned_cols=78  Identities=31%  Similarity=0.483  Sum_probs=61.7

Q ss_pred             cCCccEEEecC-CCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAE-GNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~-~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.+ ...+||+|||+|+.+....    .....+||+.|||||++.+.   .++.++||||+||++|||++|+
T Consensus       150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~---~~~~~~DiwSlGvilyell~G~  222 (350)
T d1koaa2         150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGK---PVGYYTDMWSVGVLSYILLSGL  222 (350)
T ss_dssp             CCGGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTC---CBCHHHHHHHHHHHHHHHHHSS
T ss_pred             echhHeeeccCCCCeEEEeecchheeccccc----ccceecCcccccCHHHHcCC---CCChhHhhhhhhHHHHHHHhCC
Confidence            45679998643 3469999999998764322    23346799999999999753   3468999999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||.|-
T Consensus       223 ~Pf~~~  228 (350)
T d1koaa2         223 SPFGGE  228 (350)
T ss_dssp             CSSCCS
T ss_pred             CCCCCC
Confidence            999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.47  E-value=1.2e-14  Score=135.43  Aligned_cols=79  Identities=25%  Similarity=0.391  Sum_probs=62.9

Q ss_pred             cCCccEEEec-CCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTA-EGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~-~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .+++|+|++. ....+||+|||+|+.+....    ......||+.|||||++.+.   .++.++||||+||++|||++|+
T Consensus       153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvilyelltG~  225 (352)
T d1koba_         153 IKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDRE---PVGFYTDMWAIGVLGYVLLSGL  225 (352)
T ss_dssp             CCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTC---CBCHHHHHHHHHHHHHHHHHSC
T ss_pred             cccccccccccCCCeEEEeecccceecCCCC----ceeeccCcccccCHHHHcCC---CCCCccchHHHHHHHHHHHhCC
Confidence            3677999974 33469999999998765432    12345799999999998653   3578999999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.|..
T Consensus       226 ~Pf~~~~  232 (352)
T d1koba_         226 SPFAGED  232 (352)
T ss_dssp             CSSCCSS
T ss_pred             CCCCCCC
Confidence            9999754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.4e-14  Score=134.12  Aligned_cols=79  Identities=29%  Similarity=0.435  Sum_probs=61.9

Q ss_pred             cCCccEEEecCC--CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC
Q psy10603        306 YARANIFLTAEG--NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG  383 (407)
Q Consensus       306 ~~~~nill~~~~--~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g  383 (407)
                      .++.|++++..+  ..+|++|||+|+.......    ....+||+.|||||++.+.   .++.++||||+||++|||+||
T Consensus       137 iKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~---~y~~~~DiwSlGvily~lltg  209 (335)
T d2ozaa1         137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPE---KYDKSCDMWSLGVIMYILLCG  209 (335)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEECCCCCC----CCCCSCCCSSCCCCCCCGG---GGSHHHHHHHHHHHHHHHTTS
T ss_pred             ccccccccccccccccccccccceeeeccCCCc----cccccCCcccCCcHHHcCC---CCCHHHHHHhhchhHHHHhhC
Confidence            356799997533  3599999999986544322    2345799999999998653   257899999999999999999


Q ss_pred             CCCCCCCc
Q psy10603        384 KTNLSGVV  391 (407)
Q Consensus       384 ~~~~~~~~  391 (407)
                      ++||.|-.
T Consensus       210 ~~Pf~~~~  217 (335)
T d2ozaa1         210 YPPFYSNH  217 (335)
T ss_dssp             SCSCEETT
T ss_pred             CCCCCCCC
Confidence            99998653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.2e-14  Score=131.44  Aligned_cols=80  Identities=23%  Similarity=0.255  Sum_probs=52.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++.++. +||+|||+|+................||+.|||||++.+.   .++.++||||+||++|||++|..
T Consensus       136 lKp~NILl~~~~~-~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~~sDI~S~Gvil~el~t~~~  211 (283)
T d1mqba_         136 LAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGE  211 (283)
T ss_dssp             CCGGGEEECTTCC-EEECCCCC-----------------CCCGGGSCHHHHHSC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccceEEECCCCe-EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC---CCCCcccccccHHHHHHHHhCCC
Confidence            3567999988775 9999999998654332222222344689999999998654   35789999999999999999544


Q ss_pred             -CCCC
Q psy10603        386 -NLSG  389 (407)
Q Consensus       386 -~~~~  389 (407)
                       ++.+
T Consensus       212 ~~~~~  216 (283)
T d1mqba_         212 RPYWE  216 (283)
T ss_dssp             CTTTT
T ss_pred             Ccccc
Confidence             4543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.2e-14  Score=132.52  Aligned_cols=81  Identities=30%  Similarity=0.370  Sum_probs=57.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC-C
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-K  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g-~  384 (407)
                      .++.|++++.++. +||+|||+|+........ .......||+.|||||++.+.   .++.++||||+||++|||++| .
T Consensus       160 lKp~NILl~~~~~-~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~---~~~~~sDiwS~Gvil~ellt~~~  234 (299)
T d1ywna1         160 LAARNILLSEKNV-VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGA  234 (299)
T ss_dssp             CCGGGEEECGGGC-EEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCccceeECCCCc-EEEccCcchhhccccccc-cccCceeeCccccchhHhhcC---CCCcccceeehHHHHHHHHhCCC
Confidence            4577999988775 999999999865433222 123345799999999999653   357899999999999999986 5


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       235 ~p~~~~~  241 (299)
T d1ywna1         235 SPYPGVK  241 (299)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            6888754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.46  E-value=1.7e-14  Score=130.07  Aligned_cols=82  Identities=30%  Similarity=0.499  Sum_probs=56.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. .+++|||+++...............+||+.|||||++.+.   .++.++||||+||++|||+||+.
T Consensus       137 iKP~NIll~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~~DiwSlGvilyelltG~~  212 (277)
T d1o6ya_         137 VKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD---SVDARSDVYSLGCVLYEVLTGEP  212 (277)
T ss_dssp             CSGGGEEEETTSC-EEECCCTTCEECC----------------TTCCHHHHTTC---CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcccccCcccc-ceeehhhhhhhhccccccccccccccCcccccCHHHHcCC---CCCcceecccchHHHHHHHhCCC
Confidence            4567999988776 9999999987554333322334456899999999998653   35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       213 Pf~~~~  218 (277)
T d1o6ya_         213 PFTGDS  218 (277)
T ss_dssp             SCCCSS
T ss_pred             CCCCcC
Confidence            998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.45  E-value=1.4e-14  Score=132.00  Aligned_cols=81  Identities=27%  Similarity=0.337  Sum_probs=52.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCC--CcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVP--GELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-  382 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-  382 (407)
                      .++.|+|++.++. +||+|||+|+.+.......  .......||+.|||||++.+.   .++.++|||||||++|||+| 
T Consensus       154 lKp~NILl~~~~~-~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~sDvwS~Gvvl~el~t~  229 (299)
T d1jpaa_         154 LAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR---KFTSASDVWSYGIVMWEVMSY  229 (299)
T ss_dssp             CCGGGEEECTTCC-EEECCC-----------------------CGGGSCHHHHHSC---CCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccceEEECCCCc-EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC---CCCcccccccchHHHHHHHhC
Confidence            4567999988775 9999999998665332211  112234689999999998653   35788999999999999998 


Q ss_pred             CCCCCCCC
Q psy10603        383 GKTNLSGV  390 (407)
Q Consensus       383 g~~~~~~~  390 (407)
                      |++||.+.
T Consensus       230 g~~Pf~~~  237 (299)
T d1jpaa_         230 GERPYWDM  237 (299)
T ss_dssp             SCCTTTTC
T ss_pred             CCCCCCCC
Confidence            89999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=5.3e-14  Score=130.86  Aligned_cols=82  Identities=34%  Similarity=0.652  Sum_probs=65.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++. +||+|||+|+...............+||+.|+|||++....  .++.++||||+||+++||++|++
T Consensus       135 IKp~NILl~~~~~-~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DiwSlG~il~eml~g~~  211 (345)
T d1pmea_         135 LKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK--GYTKSIDIWSVGCILAEMLSNRP  211 (345)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC--SCSTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcceEEECCCCC-EEEcccCceeeccCCCccceeeccccccceechHHHhhcCC--CCCchhhhhccCceehHHhhCCC
Confidence            3567999988775 99999999986654433333345568999999999986543  34688999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+-
T Consensus       212 pf~~~  216 (345)
T d1pmea_         212 IFPGK  216 (345)
T ss_dssp             SCCCS
T ss_pred             CCCCC
Confidence            99864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=5e-14  Score=127.97  Aligned_cols=79  Identities=29%  Similarity=0.470  Sum_probs=62.1

Q ss_pred             cCCccEEEecCCC---ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGN---SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~---~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|++++.++.   .+|++|||+|+.......    .....||+.|||||++.+.   .++.++||||+||++|||++
T Consensus       139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~~---~~~~~~DiwSlGvilyell~  211 (293)
T d1jksa_         139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYE---PLGLEADMWSIGVITYILLS  211 (293)
T ss_dssp             CSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB----CSCCCCCGGGCCHHHHTTC---CBCTHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCCcccceEecchhhhhhcCCCcc----ccccCCCCcccCHHHHcCC---CCCCcccchhhhHHHHHHHc
Confidence            3567888876653   499999999976543221    2345799999999999653   35789999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |+.||.|..
T Consensus       212 g~~Pf~~~~  220 (293)
T d1jksa_         212 GASPFLGDT  220 (293)
T ss_dssp             SSCSSCCSS
T ss_pred             CCCCCCCCC
Confidence            999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=2.2e-14  Score=131.84  Aligned_cols=81  Identities=23%  Similarity=0.358  Sum_probs=60.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+|+......... ......||+.|||||++.+.   .++.++||||+||++|||+| |+
T Consensus       137 lKp~NIll~~~~~-~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~---~~~~~sDvwS~Gvil~el~t~g~  211 (317)
T d1xkka_         137 LAARNVLVKTPQH-VKITDFGLAKLLGAEEKEY-HAEGGKVPIKWMALESILHR---IYTHQSDVWSYGVTVWELMTFGS  211 (317)
T ss_dssp             CCGGGEEEEETTE-EEECCCSHHHHTTTTCC---------CCTTTSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             chhhcceeCCCCC-eEeeccccceecccccccc-cccccccCccccChHHHhcC---CCChhhhhhhHHHHHHHHHHCCC
Confidence            3567999988775 9999999998765433221 12334689999999998754   35789999999999999998 89


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       212 ~p~~~~~  218 (317)
T d1xkka_         212 KPYDGIP  218 (317)
T ss_dssp             CTTTTSC
T ss_pred             CCCCCCC
Confidence            9998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=2.4e-14  Score=130.72  Aligned_cols=83  Identities=29%  Similarity=0.380  Sum_probs=60.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-CCCcccccccccccccCcccccCCcC---CCCccchHHhHHHHHHHHH
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTNKV---GHGRAVDIWSLGCVLVEMS  381 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~Dvws~G~~~~e~~  381 (407)
                      .++.|++++.++. +||+|||+++....... ........+||+.|||||++.+....   .++.++|||||||++|||+
T Consensus       134 lKp~NILl~~~~~-~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~  212 (303)
T d1vjya_         134 LKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  212 (303)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCccceEEcCCCC-eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence            4567999988775 99999999986643222 12223356799999999998653211   1356899999999999999


Q ss_pred             hCCCCCCC
Q psy10603        382 SGKTNLSG  389 (407)
Q Consensus       382 ~g~~~~~~  389 (407)
                      ||.++|..
T Consensus       213 tg~~~~~~  220 (303)
T d1vjya_         213 RRCSIGGI  220 (303)
T ss_dssp             HTBCBTTB
T ss_pred             hCCCCCCc
Confidence            99988753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=3.5e-14  Score=126.94  Aligned_cols=79  Identities=24%  Similarity=0.347  Sum_probs=51.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.+......  ......||+.|||||++.+.   .++.++||||+||++|||+| |+
T Consensus       127 lKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~---~~~~k~DVwS~Gvil~el~t~~~  200 (263)
T d1sm2a_         127 LAARNCLVGENQV-IKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGK  200 (263)
T ss_dssp             CSGGGEEECGGGC-EEECSCC--------------------CTTSCCHHHHTTC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cchhheeecCCCC-eEecccchheeccCCCce--eecceecCcccCChHHhcCC---CCCchhhhcchHHHHHHHHHCCC
Confidence            4567999988775 999999999866433221  12235789999999998654   35789999999999999999 56


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      ++|.+.
T Consensus       201 ~~~~~~  206 (263)
T d1sm2a_         201 IPYENR  206 (263)
T ss_dssp             CTTCSC
T ss_pred             CCCCCC
Confidence            666643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=6.1e-14  Score=128.96  Aligned_cols=82  Identities=32%  Similarity=0.572  Sum_probs=63.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCC-CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTV-PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++. +|++|||+++.+...... .......+||+.|+|||++....  .++.++||||+||+++||++|+
T Consensus       143 lKp~NILl~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~--~~~~k~DiwSlGvil~el~~g~  219 (318)
T d3blha1         143 MKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWTRS  219 (318)
T ss_dssp             CCGGGEEECTTSC-EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCchheeecCCCc-EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCC--CCCcHHHcccCCceeeeHhhCC
Confidence            3567999988775 999999999766533221 22233457999999999987543  3578999999999999999999


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      +||.+.
T Consensus       220 ~pf~~~  225 (318)
T d3blha1         220 PIMQGN  225 (318)
T ss_dssp             CSCCCS
T ss_pred             CCCCCC
Confidence            999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=3.7e-14  Score=127.38  Aligned_cols=78  Identities=26%  Similarity=0.366  Sum_probs=59.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC-C
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-K  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g-~  384 (407)
                      .++.|++++.++. +||+|||+|+.+......  ......||+.|||||++....   ++.++||||+||++|||+|| +
T Consensus       135 iKp~NIll~~~~~-~Kl~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~---~~~~sDvwS~Gvvl~ellt~~~  208 (272)
T d1qpca_         135 LRAANILVSDTLS-CKIADFGLARLIEDNEYT--AREGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGR  208 (272)
T ss_dssp             CSGGGEEECTTSC-EEECCCTTCEECSSSCEE--CCTTCCCCTTTSCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTTC
T ss_pred             cchhheeeecccc-eeeccccceEEccCCccc--cccccCCcccccChHHHhCCC---CCchhhhhhhHHHHHHHHhCCC
Confidence            4567999988765 999999999876432211  122346899999999986532   46899999999999999995 5


Q ss_pred             CCCCC
Q psy10603        385 TNLSG  389 (407)
Q Consensus       385 ~~~~~  389 (407)
                      ++|.+
T Consensus       209 ~~~~~  213 (272)
T d1qpca_         209 IPYPG  213 (272)
T ss_dssp             CSSTT
T ss_pred             CCCCC
Confidence            55554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.41  E-value=7.5e-14  Score=126.77  Aligned_cols=84  Identities=21%  Similarity=0.278  Sum_probs=63.4

Q ss_pred             cCCccEEEecC----CCceEEecCCcccccccccC----CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHH
Q psy10603        306 YARANIFLTAE----GNSLKLGDFGSAVKISAHTT----VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVL  377 (407)
Q Consensus       306 ~~~~nill~~~----~~~~ki~dfGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~  377 (407)
                      .++.|++++..    ...+|++|||+|+.......    ........+||+.|||||++.+.   .++.++||||+||++
T Consensus       127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~---~~~~~~DiwSlG~~l  203 (293)
T d1csna_         127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR---EQSRRDDLEALGHVF  203 (293)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC---CCCHHHHHHHHHHHH
T ss_pred             CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC---CCChHHHHHHhhHHH
Confidence            35678898642    34599999999986543221    11223456899999999998653   357899999999999


Q ss_pred             HHHHhCCCCCCCCce
Q psy10603        378 VEMSSGKTNLSGVVV  392 (407)
Q Consensus       378 ~e~~~g~~~~~~~~~  392 (407)
                      +||++|+.||.|...
T Consensus       204 ~elltg~~Pf~~~~~  218 (293)
T d1csna_         204 MYFLRGSLPWQGLKA  218 (293)
T ss_dssp             HHHHHSSCTTSSCCS
T ss_pred             HHHHhCCCcCCCccc
Confidence            999999999987643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.40  E-value=6.3e-14  Score=126.08  Aligned_cols=81  Identities=31%  Similarity=0.565  Sum_probs=63.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccC---CcCCCCccchHHhHHHHHHHHHh
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDT---NKVGHGRAVDIWSLGCVLVEMSS  382 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~Dvws~G~~~~e~~~  382 (407)
                      .++.|++++.++. +||+|||+++.+.....    ....+||+.|+|||.+.+.   ....++.++||||+||+++||++
T Consensus       136 lkp~Nill~~~~~-~kl~DFG~a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~  210 (277)
T d1phka_         136 LKPENILLDDDMN-IKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA  210 (277)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEcCCCC-eEEccchheeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc
Confidence            3457999987765 99999999987654222    2335799999999998642   22235678999999999999999


Q ss_pred             CCCCCCCCc
Q psy10603        383 GKTNLSGVV  391 (407)
Q Consensus       383 g~~~~~~~~  391 (407)
                      |+.||.+..
T Consensus       211 g~~Pf~~~~  219 (277)
T d1phka_         211 GSPPFWHRK  219 (277)
T ss_dssp             SSCSSCCSS
T ss_pred             CCCCCCCCC
Confidence            999999764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=7.9e-14  Score=128.27  Aligned_cols=82  Identities=34%  Similarity=0.587  Sum_probs=63.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +||+|||+++.+......  ......||+.|++||.+..... .++.++||||+||++|||++|+.
T Consensus       155 iKp~Nill~~~~~-vkL~DFG~a~~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~-~~~~ksDIWSlG~iLyelltG~~  230 (322)
T d1vzoa_         155 IKLENILLDSNGH-VVLTDFGLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDS-GHDKAVDWWSLGVLMYELLTGAS  230 (322)
T ss_dssp             CCGGGEEECTTSC-EEESCSSEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccceeecCCCC-EEEeeccchhhhcccccc--cccccccccccchhHHhhcCCc-CCCchhhhHHHHHHHHHHHhCCC
Confidence            4567999988875 999999999876443322  2234579999999999975432 35678999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       231 PF~~~~  236 (322)
T d1vzoa_         231 PFTVDG  236 (322)
T ss_dssp             TTSCTT
T ss_pred             CCCCCC
Confidence            998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=1.4e-13  Score=128.33  Aligned_cols=80  Identities=30%  Similarity=0.552  Sum_probs=64.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|+|++.++..+||+|||+++.+.....    ....+||+.|+|||++.+..  .++.++||||+||++|||++|++
T Consensus       148 iKp~NILl~~~~~~~kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~~DIwSlG~il~el~~g~~  221 (350)
T d1q5ka_         148 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGAT--DYTSSIDVWSAGCVLAELLLGQP  221 (350)
T ss_dssp             CCGGGEEECTTTCCEEECCCTTCEECCTTSC----CCSCCSCTTSCCHHHHTTCS--SCCTHHHHHHHHHHHHHHHHTSC
T ss_pred             CCcceEEEecCCCceeEecccchhhccCCcc----cccccccccccChHHhhccc--CCCcceeecccceEEEehhhCCC
Confidence            4678999988876799999999986643322    23457999999999986543  35789999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       222 pf~~~~  227 (350)
T d1q5ka_         222 IFPGDS  227 (350)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=9.5e-14  Score=126.44  Aligned_cols=79  Identities=34%  Similarity=0.575  Sum_probs=62.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +|++|||+|+.......   .....+||+.|+|||++.....  ++.++||||+||++|||++|+.
T Consensus       128 iKpeNIl~~~~~~-~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~apE~~~~~~~--~~~~~DiwSlGvily~m~~G~~  201 (298)
T d1gz8a_         128 LKPQNLLINTEGA-IKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRRA  201 (298)
T ss_dssp             CCGGGEEECTTSC-EEECSTTHHHHHCCCSB---CTTCCBCCCTTCCHHHHTTCSS--CCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCchheeecccCc-ceeccCCcceeccCCcc---cceeecccceeeehhhhccccC--CCccccccccchhhhHHhhCCC
Confidence            4577999987765 99999999976543222   2234579999999999865433  3678999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       202 Pf~~~  206 (298)
T d1gz8a_         202 LFPGD  206 (298)
T ss_dssp             SCCCS
T ss_pred             CCCCC
Confidence            99875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=1.2e-13  Score=123.01  Aligned_cols=80  Identities=25%  Similarity=0.389  Sum_probs=62.3

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +||+|||+++.+......  ......||+.|+|||++...   .++.++||||+||++|||+| |+
T Consensus       126 lk~~Nill~~~~~-~kl~DfG~a~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~ksDiwS~G~~l~el~t~g~  199 (258)
T d1k2pa_         126 LAARNCLVNDQGV-VKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGK  199 (258)
T ss_dssp             CSGGGEEECTTCC-EEECCCSSCCBCSSSSCC--CCCCSCCCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccceeEEEcCCCc-EEECcchhheeccCCCce--eecccCCCCCcCCcHHhcCC---CCCcceeecccchhhHhHHhcCC
Confidence            3567999987765 999999999765443221  22335799999999998754   35789999999999999998 89


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       200 ~Pf~~~~  206 (258)
T d1k2pa_         200 MPYERFT  206 (258)
T ss_dssp             CTTTTSC
T ss_pred             CCCCCCC
Confidence            9998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=4.8e-14  Score=126.68  Aligned_cols=82  Identities=26%  Similarity=0.354  Sum_probs=60.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+++.+..............||..|+|||++.+..   ++.++|||||||++|||+| |+
T Consensus       137 ikp~NIll~~~~~-vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Di~S~Gvil~emlt~G~  212 (273)
T d1u46a_         137 LAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQ  212 (273)
T ss_dssp             CCGGGEEEEETTE-EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE---EEHHHHHHHHHHHHHHHHTTSC
T ss_pred             ecHHHhccccccc-eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC---CCcchhhhhhHHHHHHHHhCCC
Confidence            3567999988764 99999999987644332222223446788999999997543   4688999999999999998 89


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+..
T Consensus       213 ~Pf~~~~  219 (273)
T d1u46a_         213 EPWIGLN  219 (273)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCcC
Confidence            9998753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=6.1e-14  Score=126.07  Aligned_cols=80  Identities=26%  Similarity=0.378  Sum_probs=52.1

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++.++. +|++|||+|+.+......  ......||+.|+|||++...   .++.++||||+||++|||++ |+
T Consensus       134 lKp~NIll~~~~~-~Kl~DfG~a~~~~~~~~~--~~~~~~gt~~y~apE~l~~~---~~~~~~DiwSlGvil~e~lt~g~  207 (273)
T d1mp8a_         134 IAARNVLVSSNDC-VKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGV  207 (273)
T ss_dssp             CSGGGEEEEETTE-EEECC---------------------CCGGGCCHHHHHHC---CCSHHHHHHHHHHHHHHHHTTSC
T ss_pred             cchhheeecCCCc-EEEccchhheeccCCcce--eccceecCcccchhhHhccC---CCCCccccccchHHHHHHHhcCC
Confidence            4567999988775 999999999865432221  12334689999999999653   35789999999999999998 89


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       208 ~P~~~~~  214 (273)
T d1mp8a_         208 KPFQGVK  214 (273)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCC
Confidence            9998753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.37  E-value=1.4e-13  Score=125.28  Aligned_cols=84  Identities=26%  Similarity=0.328  Sum_probs=62.5

Q ss_pred             cCCccEEEec--CCCceEEecCCcccccccccCC----CCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHH
Q psy10603        306 YARANIFLTA--EGNSLKLGDFGSAVKISAHTTV----PGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVE  379 (407)
Q Consensus       306 ~~~~nill~~--~~~~~ki~dfGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e  379 (407)
                      .+++|+++..  .+..++++|||+|+.+......    .......+||+.|||||++.+.   .++.++||||+||+++|
T Consensus       129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~~l~e  205 (299)
T d1ckia_         129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI---EQSRRDDLESLGYVLMY  205 (299)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB---CCCHHHHHHHHHHHHHH
T ss_pred             CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC---CCCChhhEEecCHHHHH
Confidence            3567888753  2345999999999876432221    1223456899999999998654   35789999999999999


Q ss_pred             HHhCCCCCCCCce
Q psy10603        380 MSSGKTNLSGVVV  392 (407)
Q Consensus       380 ~~~g~~~~~~~~~  392 (407)
                      |++|+.||.+...
T Consensus       206 l~tg~~P~~~~~~  218 (299)
T d1ckia_         206 FNLGSLPWQGLKA  218 (299)
T ss_dssp             HHHSSCTTCCCC-
T ss_pred             HHhCCCcccccch
Confidence            9999999987544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.37  E-value=9.5e-14  Score=125.62  Aligned_cols=79  Identities=22%  Similarity=0.333  Sum_probs=59.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++.++. +||+|||+|+.......  .......||+.|||||++.+.   .++.++||||+||++|||++|+.
T Consensus       141 lKp~NILl~~~~~-~Kl~DFG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~---~~~~k~DiwS~Gv~l~ell~~~~  214 (287)
T d1opja_         141 LAARNCLVGENHL-VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYN---KFSIKSDVWAFGVLLWEIATYGM  214 (287)
T ss_dssp             CSGGGEEECGGGC-EEECCCCCTTTCCSSSS--EEETTEEECGGGCCHHHHHHC---CCSHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCeEEECCCCc-EEEccccceeecCCCCc--eeeccccccccccChHHHcCC---CCCchhhhhhHHHHHHHHHhCCC
Confidence            3567999988775 99999999986543222  112334689999999998654   35789999999999999999655


Q ss_pred             -CCCCC
Q psy10603        386 -NLSGV  390 (407)
Q Consensus       386 -~~~~~  390 (407)
                       +|.+.
T Consensus       215 p~~~~~  220 (287)
T d1opja_         215 SPYPGI  220 (287)
T ss_dssp             CSSTTC
T ss_pred             CCCCcc
Confidence             45554

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.36  E-value=1e-13  Score=126.36  Aligned_cols=81  Identities=22%  Similarity=0.267  Sum_probs=60.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC-
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK-  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~-  384 (407)
                      .++.|++++.++. +||+|||+|+.+...... .......||+.|+|||++.+.   .++.++|||||||++|||++|. 
T Consensus       166 lKp~NILld~~~~-~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         166 LATRNCLVGENMV-VKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CSGGGEEECGGGC-EEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             EcccceEECCCCc-EEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHccC---CCChhhhhccchhhHHHHHccCC
Confidence            4677999988765 999999999765433221 122345789999999999753   3578999999999999999985 


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       241 ~p~~~~~  247 (301)
T d1lufa_         241 QPYYGMA  247 (301)
T ss_dssp             CTTTTSC
T ss_pred             CCCCCCC
Confidence            6788654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=2.6e-13  Score=126.13  Aligned_cols=77  Identities=36%  Similarity=0.614  Sum_probs=62.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||+|+......      ...+||+.|+|||++.+..  .++.++||||+||+++||++|++
T Consensus       147 iKp~NIL~~~~~~-~kl~Dfg~a~~~~~~~------~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlGvil~ell~g~~  217 (346)
T d1cm8a_         147 LKPGNLAVNEDCE-LKILDFGLARQADSEM------TGYVVTRWYRAPEVILNWM--RYTQTVDIWSVGCIMAEMITGKT  217 (346)
T ss_dssp             CCGGGEEECTTCC-EEECCCTTCEECCSSC------CSSCSCGGGCCTHHHHTTT--CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCcchhhcccccc-cccccccceeccCCcc------ccccccccccCHHHHcCCC--CCCccchhhcchHHHHHHHHCcC
Confidence            3567999988776 9999999997654322      3457999999999987543  24689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       218 pf~~~~  223 (346)
T d1cm8a_         218 LFKGSD  223 (346)
T ss_dssp             SSCCSS
T ss_pred             CCCCCC
Confidence            998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.34  E-value=2.3e-13  Score=123.05  Aligned_cols=79  Identities=33%  Similarity=0.617  Sum_probs=59.7

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++.++. +|++|||+|........   ......||+.|+|||.+....  .++.++||||+||+++||++|+.
T Consensus       126 iKp~NIll~~~~~-~kl~DfG~a~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~--~~~~~~DiwslGv~l~el~~G~~  199 (286)
T d1ob3a_         126 LKPQNLLINREGE-LKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSK--KYSTTIDIWSVGCIFAEMVNGTP  199 (286)
T ss_dssp             CCGGGEEECTTSC-EEECCTTHHHHHCC------------CCCTTCCHHHHTTCC--SCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCceeeEcCCCC-EEecccccceecccCcc---ccceecccchhhhHHHHhCCC--CCCcceeehhcCcHHHHHHHCCC
Confidence            4568999988775 99999999976543222   123447999999999987543  34789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.+.
T Consensus       200 pf~~~  204 (286)
T d1ob3a_         200 LFPGV  204 (286)
T ss_dssp             SCCCS
T ss_pred             CCCCC
Confidence            99865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=3.5e-13  Score=121.62  Aligned_cols=78  Identities=26%  Similarity=0.344  Sum_probs=53.5

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC-
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK-  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~-  384 (407)
                      .++.|++++.++. +||+|||+|+.......  .......||+.|+|||++....   ++.++||||+||++|||++|. 
T Consensus       139 lKp~NIll~~~~~-~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~ksDI~S~Giil~el~t~~~  212 (285)
T d1fmka3         139 LRAANILVGENLV-CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELTTKGR  212 (285)
T ss_dssp             CSGGGEEECGGGC-EEECCCCTTC----------------CCGGGSCHHHHHHCC---CCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ccceEEEECCCCc-EEEcccchhhhccCCCc--eeeccccccccccChHHHhCCC---CCcHHhhhcchHHHHHHHhCCC
Confidence            3567999988765 99999999976543221  1123346899999999997543   468999999999999999954 


Q ss_pred             CCCCC
Q psy10603        385 TNLSG  389 (407)
Q Consensus       385 ~~~~~  389 (407)
                      +++.+
T Consensus       213 p~~~~  217 (285)
T d1fmka3         213 VPYPG  217 (285)
T ss_dssp             CSSTT
T ss_pred             CCCCC
Confidence            44554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=7.3e-13  Score=121.09  Aligned_cols=81  Identities=22%  Similarity=0.249  Sum_probs=60.9

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccC-CCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTT-VPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|+|++..+. +||+|||+++....... .........||+.|+|||++...   .++.++|||||||+++||+||+
T Consensus       156 LK~~NILl~~~~~-~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDI~SfGivl~El~t~~  231 (311)
T d1r0pa_         156 LAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRG  231 (311)
T ss_dssp             CSGGGEEECTTCC-EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ccHHhEeECCCCC-EEEecccchhhccccccccceecccccccccccChHHHhcC---CCCChhHhhhhHHHHHHHHHCC
Confidence            4567999987665 99999999987543322 11223345789999999998653   3578999999999999999988


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      .||..-
T Consensus       232 ~p~~~~  237 (311)
T d1r0pa_         232 APPYPD  237 (311)
T ss_dssp             CCSCC-
T ss_pred             CCCCCC
Confidence            877643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=8e-13  Score=120.21  Aligned_cols=81  Identities=28%  Similarity=0.425  Sum_probs=63.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|+|++.++. +|++|||+++........ .......||+.|+|||++.+.   .++.++|||||||++|||++ |+
T Consensus       161 iKp~NiLl~~~~~-~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~---~y~~k~DiwS~Gvvl~ell~~g~  235 (299)
T d1fgka_         161 LAARNVLVTEDNV-MKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGG  235 (299)
T ss_dssp             CSGGGEEECTTCC-EEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ecccceeecCCCC-eEeccchhhccccccccc-cccccCCCChhhhhhhHhcCC---CCCchhhhHHhHHHHHHhccCCC
Confidence            4567999988876 999999999866433222 223445799999999998653   35789999999999999998 79


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       236 ~p~~~~~  242 (299)
T d1fgka_         236 SPYPGVP  242 (299)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=5.9e-13  Score=122.23  Aligned_cols=79  Identities=24%  Similarity=0.401  Sum_probs=61.2

Q ss_pred             cCCccEEEecCC-CceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC
Q psy10603        306 YARANIFLTAEG-NSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK  384 (407)
Q Consensus       306 ~~~~nill~~~~-~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~  384 (407)
                      .++.|++++.++ ..+|++|||+++......    ......+|+.|+|||.+.+.   .++.++||||+||++|||++|+
T Consensus       128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~~~~~~t~~y~ape~~~~~---~~~~~~DiWSlGvily~ll~G~  200 (321)
T d1tkia_         128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHD---VVSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             CCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTC---EECHHHHHHHHHHHHHHHHHSS
T ss_pred             ccccceeecCCCceEEEEcccchhhccccCC----cccccccccccccchhccCC---CCCchhhcccHHHHHHHHHhCC
Confidence            356799997543 469999999997653322    12345799999999998653   2468999999999999999999


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      .||.+-.
T Consensus       201 ~Pf~~~~  207 (321)
T d1tkia_         201 NPFLAET  207 (321)
T ss_dssp             CTTCCSS
T ss_pred             CCCCCCC
Confidence            9998743

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.28  E-value=1.3e-12  Score=120.50  Aligned_cols=78  Identities=27%  Similarity=0.412  Sum_probs=63.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|+|++.++..+|++|||+|+.......    ....+||+.|+|||++.+..  .++.++|+||+||+++||++|+.
T Consensus       155 iKp~NILi~~~~~~vkl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~~l~e~~~g~~  228 (328)
T d3bqca1         155 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQ--MYDYSLDMWSLGCMLASMIFRKE  228 (328)
T ss_dssp             CSGGGEEEETTTTEEEECCGGGCEECCTTCC----CCSCCSCGGGCCHHHHTTCC--CCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             ccccceEEcCCCCeeeecccccceeccCCCc----ccccccCccccCcccccCCC--CCCcccchhhhhhhhHHhccCCC
Confidence            4578999998777799999999976543222    23457999999999987543  24789999999999999999999


Q ss_pred             CCCC
Q psy10603        386 NLSG  389 (407)
Q Consensus       386 ~~~~  389 (407)
                      ||..
T Consensus       229 pf~~  232 (328)
T d3bqca1         229 PFFH  232 (328)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9974

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=1.2e-12  Score=119.55  Aligned_cols=81  Identities=25%  Similarity=0.361  Sum_probs=61.8

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhC-C
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSG-K  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g-~  384 (407)
                      .++.|+|++.++. +||+|||+|+......... ......||+.|+|||.+.+..   ++.++||||+||+++||+|| +
T Consensus       159 lk~~NiLld~~~~-~Kl~DFGla~~~~~~~~~~-~~~~~~~t~~y~aPe~l~~~~---~~~~~Dv~S~G~il~El~t~~~  233 (308)
T d1p4oa_         159 LAARNCMVAEDFT-VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAE  233 (308)
T ss_dssp             CSGGGEEECTTCC-EEECCTTCCCGGGGGGCEE-GGGSSEECGGGCCHHHHHHCC---CCHHHHHHHHHHHHHHHHHTSC
T ss_pred             EcCCceeecCCce-EEEeecccceeccCCccee-eccceecccccCCHHHHccCC---CCcccccccHHHHHHHHHhCCC
Confidence            3567999987765 9999999998654433221 223457999999999987543   46789999999999999998 5


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      +||.+..
T Consensus       234 ~p~~~~~  240 (308)
T d1p4oa_         234 QPYQGLS  240 (308)
T ss_dssp             CTTTTSC
T ss_pred             CCCCCCC
Confidence            7887653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=1.4e-12  Score=116.21  Aligned_cols=75  Identities=24%  Similarity=0.409  Sum_probs=54.1

Q ss_pred             CCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CCC
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GKT  385 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~~  385 (407)
                      ++.|++++.++. +|++|||+++.....      .....+|..|+|||++.+.   .++.++|||||||++|||+| |++
T Consensus       130 kp~Nil~~~~~~-~kl~dfg~s~~~~~~------~~~~~~~~~y~aPE~l~~~---~~t~~sDIwSfG~il~el~t~~~~  199 (262)
T d1byga_         130 AARNVLVSEDNV-AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREK---KFSTKSDVWSFGILLWEIYSFGRV  199 (262)
T ss_dssp             SGGGEEECTTSC-EEECCCCC------------------CCTTTSCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             chHhheecCCCC-EeecccccceecCCC------CccccccccCCChHHHhCC---CCChHHHHHhHHHHHHHHHHCCCC
Confidence            457899988776 999999999754321      1234689999999998754   35789999999999999998 788


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.+..
T Consensus       200 p~~~~~  205 (262)
T d1byga_         200 PYPRIP  205 (262)
T ss_dssp             SCTTSC
T ss_pred             CCCCCC
Confidence            888643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.22  E-value=2.2e-12  Score=117.85  Aligned_cols=80  Identities=30%  Similarity=0.357  Sum_probs=61.4

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHh-CC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSS-GK  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~-g~  384 (407)
                      .++.|++++..+. +|++|||+++.+..... ........||+.|+|||++...   .++.++|||||||+++||+| |.
T Consensus       171 LKp~NIl~~~~~~-~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DIwS~G~~l~ellt~g~  245 (311)
T d1t46a_         171 LAARNILLTHGRI-TKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGS  245 (311)
T ss_dssp             CSGGGEEEETTTE-EEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHC---CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cccccccccccCc-ccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCC---CCCCcccccchHHHHHHHHhCCC
Confidence            3567999988765 99999999986543222 1223346799999999999653   35789999999999999998 67


Q ss_pred             CCCCCC
Q psy10603        385 TNLSGV  390 (407)
Q Consensus       385 ~~~~~~  390 (407)
                      ++|.+.
T Consensus       246 p~~~~~  251 (311)
T d1t46a_         246 SPYPGM  251 (311)
T ss_dssp             CSSTTC
T ss_pred             CCCCCC
Confidence            777654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=2.6e-12  Score=117.35  Aligned_cols=78  Identities=24%  Similarity=0.222  Sum_probs=58.0

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCC-
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGK-  384 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~-  384 (407)
                      .++.|++++..+. +||+|||+|+.......    .....||..|+|||.+....   ++.++|||||||+++||++|. 
T Consensus       153 lkp~NIL~~~~~~-~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~---~~~~sDvwSfGvil~ell~~~~  224 (309)
T d1fvra_         153 LAARNILVGENYV-AKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGG  224 (309)
T ss_dssp             CSGGGEEECGGGC-EEECCTTCEESSCEECC----C----CCTTTCCHHHHHHCE---ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccceEEEcCCCc-eEEcccccccccccccc----ccceecCCcccchHHhccCC---CCccceeehhHHHHHHHHhcCC
Confidence            3567999988775 99999999975443222    22346899999999996542   468999999999999999965 


Q ss_pred             CCCCCCc
Q psy10603        385 TNLSGVV  391 (407)
Q Consensus       385 ~~~~~~~  391 (407)
                      ++|.+..
T Consensus       225 ~p~~~~~  231 (309)
T d1fvra_         225 TPYCGMT  231 (309)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCC
Confidence            6787643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=5e-12  Score=117.74  Aligned_cols=77  Identities=35%  Similarity=0.569  Sum_probs=54.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. ++++|||+++......    .....+||+.|+|||++.+.   .++.++||||+||+++||++|++
T Consensus       145 lKP~Nil~~~~~~-~kl~df~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~---~~~~~~DiwSlG~~l~ell~g~~  216 (355)
T d2b1pa1         145 LKPSNIVVKSDCT-LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGM---GYKENVDIWSVGCIMGEMVRHKI  216 (355)
T ss_dssp             CCGGGEEECTTCC-EEECCCCC-------------------CCTTCCHHHHTTC---CCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCccccccccccc-eeeechhhhhcccccc----ccccccccccccChhhhcCC---CCCCCcccccccchHHHHhhCCC
Confidence            3577999988776 9999999987654322    22345799999999999753   35789999999999999999999


Q ss_pred             CCCCC
Q psy10603        386 NLSGV  390 (407)
Q Consensus       386 ~~~~~  390 (407)
                      ||.|.
T Consensus       217 pF~~~  221 (355)
T d2b1pa1         217 LFPGR  221 (355)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.18  E-value=5.2e-12  Score=117.28  Aligned_cols=77  Identities=32%  Similarity=0.649  Sum_probs=58.2

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .++.|++++.++. +|++|||++......      .....||+.|+|||++.+...  ++.++||||+||++|||++|++
T Consensus       147 iKp~NILi~~~~~-~kl~dfg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~--~~~~~DiwSlGv~l~~ll~g~~  217 (348)
T d2gfsa1         147 LKPSNLAVNEDCE-LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGRT  217 (348)
T ss_dssp             CCGGGEEECTTCC-EEECCC----CCTGG------GSSSCHHHHTSCHHHHTTCSC--CCTTHHHHHHHHHHHHHHHSSC
T ss_pred             cCCcccccccccc-ccccccchhcccCcc------cccccccccccCchhhcCCcc--CCcccchhhhhHHHHHHHhCCC
Confidence            4577999988876 999999999654322      234579999999999865432  4689999999999999999999


Q ss_pred             CCCCCc
Q psy10603        386 NLSGVV  391 (407)
Q Consensus       386 ~~~~~~  391 (407)
                      ||.|..
T Consensus       218 pF~~~~  223 (348)
T d2gfsa1         218 LFPGTD  223 (348)
T ss_dssp             SCCCSS
T ss_pred             CCCCCC
Confidence            998753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=1.2e-11  Score=111.66  Aligned_cols=77  Identities=26%  Similarity=0.506  Sum_probs=59.6

Q ss_pred             cCCccEEEecCCCceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHHHhCCC
Q psy10603        306 YARANIFLTAEGNSLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEMSSGKT  385 (407)
Q Consensus       306 ~~~~nill~~~~~~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~~~g~~  385 (407)
                      .+++|++++..+. +|++|||.|+........   .....+++.|+|||++.....  ++.++||||+||+++||++|+.
T Consensus       127 iKP~NIli~~~~~-~kl~DFG~a~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~--~~~~~DiwSlG~il~ell~g~~  200 (292)
T d1unla_         127 LKPQNLLINRNGE-LKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFGAKL--YSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_dssp             CSGGGEEECTTCC-EEECCCTTCEECCSCCSC---CCSCCSCGGGCCHHHHTTCSC--CCTHHHHHHHHHHHHHHTTTSC
T ss_pred             ccCcccccccCCc-eeeeecchhhcccCCCcc---ceeeccccchhhhhHhccCCC--CCchhhccccchHHHHHhhCCC
Confidence            3567999988765 999999999876543322   223467889999999875432  4689999999999999999998


Q ss_pred             CCC
Q psy10603        386 NLS  388 (407)
Q Consensus       386 ~~~  388 (407)
                      ||-
T Consensus       201 p~~  203 (292)
T d1unla_         201 PLF  203 (292)
T ss_dssp             CSC
T ss_pred             CCC
Confidence            863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.08  E-value=2.3e-11  Score=113.40  Aligned_cols=77  Identities=25%  Similarity=0.489  Sum_probs=57.6

Q ss_pred             cCCccEEEecCCC-----ceEEecCCcccccccccCCCCcccccccccccccCcccccCCcCCCCccchHHhHHHHHHHH
Q psy10603        306 YARANIFLTAEGN-----SLKLGDFGSAVKISAHTTVPGELNGFVGTQAYMAPEVFMDTNKVGHGRAVDIWSLGCVLVEM  380 (407)
Q Consensus       306 ~~~~nill~~~~~-----~~ki~dfGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Dvws~G~~~~e~  380 (407)
                      .+++|++++..+.     .++++|||.+.......      ...+||+.|+|||++...   .++.++|+||+||+++||
T Consensus       152 lKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el  222 (362)
T d1q8ya_         152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFEL  222 (362)
T ss_dssp             CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTC---CCCTHHHHHHHHHHHHHH
T ss_pred             CChhHeeeeccCcccccceeeEeeccccccccccc------ccccccccccChhhcccc---CCCccccccchHHHHHHH
Confidence            3456888876543     48999999997543322      235799999999998754   356899999999999999


Q ss_pred             HhCCCCCCCCc
Q psy10603        381 SSGKTNLSGVV  391 (407)
Q Consensus       381 ~~g~~~~~~~~  391 (407)
                      ++|+.||.+..
T Consensus       223 ~~g~~pF~~~~  233 (362)
T d1q8ya_         223 ITGDFLFEPDE  233 (362)
T ss_dssp             HHSSCCC----
T ss_pred             HHCCCCCCCCc
Confidence            99999998643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.15  E-value=1.3e-05  Score=69.78  Aligned_cols=75  Identities=17%  Similarity=0.055  Sum_probs=49.1

Q ss_pred             ccCeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCC-CCCcceEEEEEEeCceEEEEEecCCCCCHHH
Q psy10603         13 GRFGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGIN-QKNLVKYYGVEIHREEMVLFMELCTEGTLES   91 (407)
Q Consensus        13 G~~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~E~~~~g~L~~   91 (407)
                      ++.+.||+..  ..++.+.+|+.........   ..+.+|...|..+. +--+.+++.....++..++|||+++|.++..
T Consensus        25 ~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          25 MSPAKVYKLV--GENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             CSSSEEEEEE--CSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             CCCCcEEEEE--eCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            3446899875  3456678888754322221   23456777665543 3335667777778889999999999988765


Q ss_pred             H
Q psy10603         92 L   92 (407)
Q Consensus        92 ~   92 (407)
                      .
T Consensus       100 ~  100 (263)
T d1j7la_         100 E  100 (263)
T ss_dssp             H
T ss_pred             c
Confidence            4

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.86  E-value=1.6e-05  Score=73.73  Aligned_cols=79  Identities=14%  Similarity=0.116  Sum_probs=47.4

Q ss_pred             eecccccCeEEEEEEECCCCcEEEEEEEeccccC--c--HHHHHHHHHHHHHHhcCC---CCCcceEEEEEEeCceEEEE
Q psy10603          8 VSPGQGRFGKVYTAVNNETGELVAMKEIQLHKQN--D--ARFVKDMLVELRILEGIN---QKNLVKYYGVEIHREEMVLF   80 (407)
Q Consensus         8 ~~iG~G~~g~V~~~~~~~~~~~vAvK~i~~~~~~--~--~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv   80 (407)
                      ..||.|....||++.+..+++.+++|.-.+....  +  .....+..+|.+.|+.+.   ...+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            3789999999999988877888999975431100  0  001123445776665442   2346666655  34556789


Q ss_pred             EecCCCCC
Q psy10603         81 MELCTEGT   88 (407)
Q Consensus        81 ~E~~~~g~   88 (407)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99998654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.57  E-value=0.00033  Score=60.09  Aligned_cols=74  Identities=12%  Similarity=0.006  Sum_probs=47.5

Q ss_pred             eccccc-CeEEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC--CCcceEEEEEEeCceEEEEEecCC
Q psy10603          9 SPGQGR-FGKVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ--KNLVKYYGVEIHREEMVLFMELCT   85 (407)
Q Consensus         9 ~iG~G~-~g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~E~~~   85 (407)
                      .+..|. -+.||+... ..+..+.+|.-......      .+.+|...|+.+..  -.+.+++....+.+..++|||+++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            334444 467898864 34666888976544322      23456655554432  336677887778888999999998


Q ss_pred             CCCH
Q psy10603         86 EGTL   89 (407)
Q Consensus        86 ~g~L   89 (407)
                      |-++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.85  E-value=0.0014  Score=58.46  Aligned_cols=67  Identities=12%  Similarity=0.083  Sum_probs=40.4

Q ss_pred             EEEEEEECCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCC-----CCcceEE--EEEEeCceEEEEEecCCCCC
Q psy10603         17 KVYTAVNNETGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQ-----KNLVKYY--GVEIHREEMVLFMELCTEGT   88 (407)
Q Consensus        17 ~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-----pniv~~~--~~~~~~~~~~lv~E~~~~g~   88 (407)
                      .||++.. .+|+.|++|+.++.....    +++..|...|..|..     +..+..-  ......+..+.++++++|..
T Consensus        37 ~vy~v~~-~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          37 RVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             EEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             eeEEEEc-CCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            6999865 468889999987543332    334556666654432     2222221  12345677899999998633

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.50  E-value=0.024  Score=51.54  Aligned_cols=72  Identities=15%  Similarity=0.165  Sum_probs=42.8

Q ss_pred             ecccccCeEEEEEEECC-------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCc-ceEEEEEEeCceEEEE
Q psy10603          9 SPGQGRFGKVYTAVNNE-------TGELVAMKEIQLHKQNDARFVKDMLVELRILEGINQKNL-VKYYGVEIHREEMVLF   80 (407)
Q Consensus         9 ~iG~G~~g~V~~~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv   80 (407)
                      .|+.|--=.+|++....       ..+.|.+++.. .. ...   ....+|..+++.+.-.++ .++++++.  +  .+|
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I  119 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETE---SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  119 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chh---hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence            56656666899987643       23556666653 21 111   233467777776643343 46777653  3  578


Q ss_pred             EecCCCCCH
Q psy10603         81 MELCTEGTL   89 (407)
Q Consensus        81 ~E~~~~g~L   89 (407)
                      +||++|..+
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.19  E-value=0.27  Score=42.41  Aligned_cols=29  Identities=28%  Similarity=0.398  Sum_probs=24.1

Q ss_pred             CCceecCCCCCCEEEecCCCeEEEEcccCc
Q psy10603        122 NTIVHRDIKSANIFLTAEGNSLKLGDFGSA  151 (407)
Q Consensus       122 ~~iiHrdlKp~Nill~~~~~~vkl~DFGla  151 (407)
                      .|+||+|+.++||+++.+ ...-|+||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~-~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGD-ELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETT-EEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccc-cceeEeccccc
Confidence            379999999999999864 34579999876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=88.35  E-value=0.021  Score=46.11  Aligned_cols=23  Identities=22%  Similarity=0.484  Sum_probs=18.4

Q ss_pred             CCccEEEecCCCceEEecCCccccc
Q psy10603        307 ARANIFLTAEGNSLKLGDFGSAVKI  331 (407)
Q Consensus       307 ~~~nill~~~~~~~ki~dfGla~~~  331 (407)
                      ++.|++++..  .++++|||+|+..
T Consensus       130 KP~NILv~~~--~~~liDFG~a~~~  152 (191)
T d1zara2         130 SQYNVLVSEE--GIWIIDFPQSVEV  152 (191)
T ss_dssp             STTSEEEETT--EEEECCCTTCEET
T ss_pred             ChhheeeeCC--CEEEEECCCcccC
Confidence            5789999864  3899999999654